Citrus Sinensis ID: 010434

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-
Protein Sequence
MEAYAKVPCLSNNQSNVYVYVAPDFIETTHLPDSCAFITKVPVVLNGSVDKPSYEDLRKLLESGFDLTWSDWSWSLSMTHFFPECNDYYGGIIRKFICYQDDILFHEISRRSYRNIESRLGVWISFLLGFPVDVLIIGRFILAPIVFLVFLIHKYRTTLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKPCFSSSRHISGREIESDSSTEFLVSEWTEECSFNDSYA
Secondary Structure (PSIPRED)
ccccEEEcccccccccEEEEEccccEEccccccccEEEEEEEEccccccccccHHHHHHHHHcccEEEEccccccccccccccccccccccEEcEEEEEEcccccccccccccccccccccHHHHHHcccHHHHHHHHHHHHHHHHHHHHHEEEEcccccHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHcccccccEEEEEEEccccEEEEEEcccccccHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEccccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEEcccccccccccccccccccccccccccccccEEEEEcccccccccccccccccccccccccccHHHHHHHHHHHccccccccccccccccccHHHHHHHHHccccEEcccccHHHHHHHHHHHHHHcccccccccccccHHHHHHHHcccccccccccccccccccccccccccccccccEEEcccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccEccccccccEEEEEEEccccEHccccccccEEEEEEcccccccccccHHHHHHHHHcccccccccccHHHHHcccccccccccccEEEcccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHccccccccEEccEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHHccccccEEEEEEEcccccHHHHEcccccccccccHHHHHHHHHHHHHHHHHHHcccccEEEEcccccccEEEcccccccHcHHcHHHHcccccccccccEEEEEEEcccHHHHHHccccEEEccHHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHccccEEEEccccccHHHHHHHHHHHHHHHHccccccccHHHHHHHHccccccccccccccEEcccccccccccccccccccccccccccEEccccc
Coil and Loop (DISEMBL)
meayakvpclsnnqsnvyvyvapdfietthlpdscafitkvpvvlngsvdkpsYEDLRKLLESGFdltwsdwswslsmthffpecndyyggIIRKFICYQDDILFHEISRRSYRNIESRLGVWISFLLGFPVDVLIIGRFILAPIVFLVFLIHKYRTTLQTVDNIEKFLHNqqswmpkrysypeiiAVTNhfthklgqggfgsvykgqlhTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYefmpngsldrhifpkenkgqtfgWEKLQEIALGTARGVAYlhngcdmcilhfdikphnilldhnfipkvsdfglakfhpkendfvsisatrgtigyiapelisrnfgtvscksdvYGFGMVLLEMaggrrnsnmnairsskayfpswvydqlnkggdlelrnVTEIESVIARKLCMIGLWCiqvkaadrpsMTKVLEMLEGsmddlqmppkpcfsssrhisgreiesdsstEFLVSEWteecsfndsya
Flexible Loop (DISEMBL)
meayakvpclsnnqsNVYVYVAPDFIETTHLPDSCAFITKVPVVLNGSVDKPSYEDLRKLLESGFDLTWSDWSWSLSMTHFFPECNDYYGGIIRKFICYQDDILFHEISRRSYRNIESRLGVWISFLLGFPVDVLIIGRFILAPIVFLVFLIHKYRTTLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIApelisrnfgtvSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKPCFSSSRhisgreiesdssteflvsewteecsfndsya
Low Complexity Region (SEG)
MEAYAKVPCLSNNQSNVYVYVAPDFIETTHLPDSCAFITKVPVVLNGSVDKPSYEDLRKLLESGFdltwsdwswslsMTHFFPECNDYYGGIIRKFICYQDDILFHEISRRSYRNIESRLGVWISFLLGFPVDVLIIGRFILAPIVFLVFLIHKYRTTLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKPCFSSSRHISGREIESDSSTEFLVSEWTEECSFNDSYA
Disordered region (IsUnstruct)
******VPCLSNNQSNVYVYVAPDFIETTHLPDSCAFITKVPVVLNGSVDKPSYEDLRKLLESGFDLTWSDWSWSLSMTHFFPECNDYYGGIIRKFICYQDDILFHEISRRSYRNIESRLGVWISFLLGFPVDVLIIGRFILAPIVFLVFLIHKYRTTLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAA**************************************************************
Disordered Region (DISOPRED)
*EAYAKVPCLSNNQSNVYVYVAPDFIETTHLPDSCAFITKVPVVLNGSVDKPSYEDLRKLLESGFDLTWSDWSWSLSMTHFFPECNDYYGGIIRKFICYQDDILFHE***********RLGVWISFLLGFPVDVLIIGRFILAPIVFLVFLIHKYRTTLQ*********HNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENS*FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS******S**AYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKPCFS**********************************
Disordered Region (DISEMBL)
MEAYAKVPCLSNNQSNVYVYVAPDFIETTHLPDSCAFITKVPVVLNGSVDKPSYEDLRKLLESGFDLTWSDWSWSLSMTHFFPECNDYYGGIIRKFICYQDDILFHEISRRSYRNIESRLGVWISFLLGFPVDVLIIGRFILAPIVFLVFLIHKYRTTLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKPCFSSSRHISGREIESDSSTEFLVSEWTEECSFNDSYA
Disordered Region (DISPRO)
*EAYAKVPCLSNNQSNVYVYVAPDFIETTHLPDSCAFITKVPVVLNGSVDKPSYEDLRKLLESGFDLTWSDWSWSLSMTHFFPECNDYYGGIIRKFICYQDDILFHEISRRSYRNIESRLGVWISFLLGFPVDVLIIGRFILAPIVFLVFLIHKYRTTLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKPCFSSS********************************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEAYAKVPCLSNNQSNVYVYVAPDFIETTHLPDSCAFITKVPVVLNGSVDKPSYEDLRKLLESGFDLTWSDWSWSLSMTHFFPECNDYYGGIIRKFICYQDDILFHEISRRSYRNIESRLGVWISFLLGFPVDVLIIGRFILAPIVFLVFLIHKYRTTLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKPCFSSSRHISGREIESDSSTEFLVSEWTEECSFNDSYA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	511	2.2.26 [Sep-21-2011]
Q9FID5	806	Probable receptor-like pr	no	no	0.592	0.375	0.523	5e-87
Q9FID6	813	Probable receptor-like pr	no	no	0.604	0.380	0.495	3e-86
Q3ECH2	892	Probable receptor-like pr	no	no	0.696	0.399	0.446	2e-85
Q8RWZ5	821	G-type lectin S-receptor-	no	no	0.643	0.400	0.460	4e-74
Q9FLV4	872	G-type lectin S-receptor-	no	no	0.643	0.377	0.422	1e-72
O64477	828	G-type lectin S-receptor-	no	no	0.561	0.346	0.470	4e-69
Q9XID3	829	G-type lectin S-receptor-	no	no	0.641	0.395	0.414	4e-67
Q39203	797	G-type lectin S-receptor-	no	no	0.616	0.395	0.412	3e-61
C0LGH3	1033	Probable LRR receptor-lik	no	no	0.692	0.342	0.376	2e-59
O65238	872	G-type lectin S-receptor-	no	no	0.557	0.326	0.413	1e-58

>sp|Q9FID5|Y5393_ARATH Probable receptor-like protein kinase At5g39030 OS=Arabidopsis thaliana GN=At5g39030 PE=2 SV=1

 Score =  322 bits (824), Expect = 5e-87,   Method: Compositional matrix adjust.
 Identities = 168/321 (52%), Positives = 215/321 (66%), Gaps = 18/321 (5%)

Query: 180 YSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGR 239
           Y+Y E+  +T  F++ +G+GGFG+VY G L  GR +AVK+L++ K SAE+FINEV+++ +
Sbjct: 488 YTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVASMSQ 547

Query: 240 IHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARG 299
             HVN+V LLGFC EGSKRA+VYEF+ NGSLD+  F   NK  T     L  IALG ARG
Sbjct: 548 TSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQ--FMSRNKSLTQDVTTLYGIALGIARG 605

Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
           + YLH GC   I+HFDIKP NILLD N  PKVSDFGLAK   K    +S+  TRGTIGYI
Sbjct: 606 LEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIGYI 665

Query: 360 APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRS--SKAYFPSWVYDQLNKG 417
           APE+ SR +G VS KSDVY FGM++++M G R    +  + S  S  YFP W+Y  L  G
Sbjct: 666 APEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPDWIYKDLEDG 725

Query: 418 ------GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMP 471
                 GD     +T+ E  IA+K+ ++GLWCIQ   +DRPSM +V+EM+EGS+D L++P
Sbjct: 726 EQTWIFGD----EITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEGSLDALEIP 781

Query: 472 PKPCFSSSRHISGREIESDSS 492
           PKP    S HIS   I   SS
Sbjct: 782 PKP----SMHISTEVITESSS 798

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1

 Score =  319 bits (818), Expect = 3e-86,   Method: Compositional matrix adjust.
 Identities = 157/317 (49%), Positives = 212/317 (66%), Gaps = 8/317 (2%)

Query: 178 KRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTI 237
           K+Y Y E+  +T  F+H +G+GGFG+VY+G L  GR +AVK+L++ K + ++FINEV+++
Sbjct: 484 KQYIYAELKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEVTSM 543

Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
            +  HVN+V LLGFC EGSKRA++ EF+ +GSLD+  F   NK  T     L  IALG A
Sbjct: 544 SQTSHVNIVSLLGFCYEGSKRAIISEFLEHGSLDQ--FISRNKSLTPNVTTLYGIALGIA 601

Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
           RG+ YLH GC   I+HFDIKP NILLD NF PKV+DFGLAK   K    +S+  TRGTIG
Sbjct: 602 RGLEYLHYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGTIG 661

Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG 417
           YIAPE++SR +G +S KSDVY +GM++L+M G R          S AYFP W+Y  L  G
Sbjct: 662 YIAPEVVSRMYGGISHKSDVYSYGMLVLDMIGARNKVETTTCNGSTAYFPDWIYKDLENG 721

Query: 418 GDLEL--RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKPC 475
               +    + E ++ I +K+ ++ LWCI+   +DRP M KV+EM+EGS+D L++PPKP 
Sbjct: 722 DQTWIIGDEINEEDNKIVKKMILVSLWCIRPCPSDRPPMNKVVEMIEGSLDALELPPKP- 780

Query: 476 FSSSRHISGREIESDSS 492
              SRHIS   +   SS
Sbjct: 781 ---SRHISTELVLESSS 794

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q3ECH2|Y1670_ARATH Probable receptor-like protein kinase At1g67000 OS=Arabidopsis thaliana GN=At1g67000 PE=2 SV=2

 Score =  317 bits (812), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 174/390 (44%), Positives = 239/390 (61%), Gaps = 34/390 (8%)

Query: 135 LIIGRFILAPIVFLVFLIHKYRTTL----QTVDNIEKFLHNQQSWMP-KRYSYPEIIAVT 189
           + +G      IVFLV L   +R  +    +T D +   L   ++ +P K Y+Y E+  +T
Sbjct: 498 IALGALTGVVIVFLVLLCPCFRVQIFRKRKTSDEVR--LQKLKALIPLKHYTYAEVKKMT 555

Query: 190 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQL 248
             FT  +G+GGFG VY G L    ++AVK+L++SK +  E+FINEV+++ +  HVN+V L
Sbjct: 556 KSFTEVVGRGGFGIVYSGTLSDSSMVAVKVLKDSKGTDGEDFINEVASMSQTSHVNIVSL 615

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LGFC EGS+RA++YEF+ NGSLD+ I  K +       + L  IALG ARG+ YLH GC 
Sbjct: 616 LGFCCEGSRRAIIYEFLGNGSLDKFISDKSS--VNLDLKTLYGIALGVARGLEYLHYGCK 673

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             I+HFDIKP N+LLD N  PKVSDFGLAK   K+   +S+  TRGTIGYIAPE+ISR +
Sbjct: 674 TRIVHFDIKPQNVLLDDNLCPKVSDFGLAKLCEKKESILSLLDTRGTIGYIAPEMISRLY 733

Query: 369 GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA---YFPSWVYDQLNKG-------- 417
           G+VS KSDVY +GM++LEM G R+    +    S     YFP W+Y  L K         
Sbjct: 734 GSVSHKSDVYSYGMLVLEMIGARKKERFDQNSRSDGSSIYFPEWIYKDLEKANIKDIEKT 793

Query: 418 --GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKPC 475
             G L    ++  E  IARK+ ++GLWCIQ   +DRP M KV+EM+EGS+D L++PP+P 
Sbjct: 794 ENGGLIENGISSEEEEIARKMTLVGLWCIQSSPSDRPPMNKVVEMMEGSLDALEVPPRPV 853

Query: 476 FSSSRHISGREI--------ESDSSTEFLV 497
               + IS   +        ES S+++ LV
Sbjct: 854 L---QQISASSVSDSFWNSEESSSASDILV 880

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1

 Score =  279 bits (714), Expect = 4e-74,   Method: Compositional matrix adjust.
 Identities = 159/345 (46%), Positives = 216/345 (62%), Gaps = 16/345 (4%)

Query: 145 IVFLVFLIHKYRTTL----QTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGG 200
           ++F+ F IHK +  +    Q     + FL N  S MP R++Y ++ + TN+F+ KLGQGG
Sbjct: 445 LIFVAFRIHKRKKMILEAPQESSEEDNFLENL-SGMPIRFAYKDLQSATNNFSVKLGQGG 503

Query: 201 FGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL 260
           FGSVY+G L  G  +AVK LE      +EF  EVS IG IHH+++V+L GFC+EG+ R L
Sbjct: 504 FGSVYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLL 563

Query: 261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHN 320
            YEF+  GSL+R IF K++      W+    IALGTA+G+AYLH  CD  I+H DIKP N
Sbjct: 564 AYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPEN 623

Query: 321 ILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 380
           ILLD NF  KVSDFGLAK   +E   V  +  RGT GY+APE I+ N+  +S KSDVY +
Sbjct: 624 ILLDDNFNAKVSDFGLAKLMTREQSHV-FTTMRGTRGYLAPEWIT-NY-AISEKSDVYSY 680

Query: 381 GMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG-----DLELRNVTEIESVIARK 435
           GMVLLE+ GGR+N + +   S K +FPS+ + ++ +G      D +++NV   +  + R 
Sbjct: 681 GMVLLELIGGRKNYDPSET-SEKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRA 739

Query: 436 LCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKPCFSSSR 480
           +    LWCIQ     RPSM+KV++MLEG    +Q PP      SR
Sbjct: 740 M-KTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQ-PPSSSTMGSR 782

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1

 Score =  274 bits (700), Expect = 1e-72,   Method: Compositional matrix adjust.
 Identities = 147/348 (42%), Positives = 213/348 (61%), Gaps = 19/348 (5%)

Query: 135 LIIGRFILAPIV--FLVFLIHKYRTTLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHF 192
           +++G  +L  ++   L + + + RT  +   N      +     P  ++Y ++   TN+F
Sbjct: 478 IVVGMLVLVALLGMLLYYNLDRKRTLKRAAKNSLILCDS-----PVSFTYRDLQNCTNNF 532

Query: 193 THKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAE-EFINEVSTIGRIHHVNVVQLLGF 251
           +  LG GGFG+VYKG +    L+AVK L+ +    E EFI EV+TIG +HH+N+V+L G+
Sbjct: 533 SQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEVNTIGSMHHMNLVRLCGY 592

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
           CSE S R LVYE+M NGSLD+ IF  E       W    EIA+ TA+G+AY H  C   I
Sbjct: 593 CSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGIAYFHEQCRNRI 652

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           +H DIKP NILLD NF PKVSDFGLAK   +E+  V ++  RGT GY+APE +S     +
Sbjct: 653 IHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHV-VTMIRGTRGYLAPEWVSNR--PI 709

Query: 372 SCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE-----LRNVT 426
           + K+DVY +GM+LLE+ GGRRN +M +  +   ++P W Y +L  G  L+     L+ V 
Sbjct: 710 TVKADVYSYGMLLLEIVGGRRNLDM-SYDAEDFFYPGWAYKELTNGTSLKAVDKRLQGVA 768

Query: 427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKP 474
           E E V+  K   +  WCIQ + + RPSM +V+++LEG+ D++ +PP P
Sbjct: 769 EEEEVV--KALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLPPMP 814

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1

 Score =  262 bits (670), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 143/304 (47%), Positives = 194/304 (63%), Gaps = 17/304 (5%)

Query: 180 YSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGR 239
           +SY E+   T +F+ KLG GGFGSV+KG L     IAVK LE      ++F  EV TIG 
Sbjct: 483 FSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEVVTIGT 542

Query: 240 IHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQ-TFGWEKLQEIALGTAR 298
           I HVN+V+L GFCSEGSK+ LVY++MPNGSLD H+F  + + +   GW+   +IALGTAR
Sbjct: 543 IQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTAR 602

Query: 299 GVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIG 357
           G+AYLH+ C  CI+H DIKP NILLD  F PKV+DFGLAK   +  DF  +  T RGT G
Sbjct: 603 GLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGR--DFSRVLTTMRGTRG 660

Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG 417
           Y+APE IS     ++ K+DVY +GM+L E+  GRRN+  +     + +FPSW    L K 
Sbjct: 661 YLAPEWISGV--AITAKADVYSYGMMLFELVSGRRNTEQSENEKVR-FFPSWAATILTKD 717

Query: 418 GDLEL-------RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQM 470
           GD+          +  +IE V   + C +  WCIQ + + RP+M++V+++LEG + ++  
Sbjct: 718 GDIRSLVDPRLEGDAVDIEEVT--RACKVACWCIQDEESHRPAMSQVVQILEGVL-EVNP 774

Query: 471 PPKP 474
           PP P
Sbjct: 775 PPFP 778

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1

 Score =  256 bits (653), Expect = 4e-67,   Method: Compositional matrix adjust.
 Identities = 141/340 (41%), Positives = 206/340 (60%), Gaps = 12/340 (3%)

Query: 174 SWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINE 233
           S  P +++Y E+   T  F  KLG GGFG+VY+G L    ++AVK LE  +   ++F  E
Sbjct: 468 SGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEKQFRME 527

Query: 234 VSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIA 293
           V+TI   HH+N+V+L+GFCS+G  R LVYEFM NGSLD  +F  ++  +   WE    IA
Sbjct: 528 VATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDS-AKFLTWEYRFNIA 586

Query: 294 LGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISAT 352
           LGTA+G+ YLH  C  CI+H DIKP NIL+D NF  KVSDFGLAK  +PK+N + ++S+ 
Sbjct: 587 LGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRY-NMSSV 645

Query: 353 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYD 412
           RGT GY+APE ++     ++ KSDVY +GMVLLE+  G+RN +++  +++   F  W Y+
Sbjct: 646 RGTRGYLAPEWLANL--PITSKSDVYSYGMVLLELVSGKRNFDVSE-KTNHKKFSIWAYE 702

Query: 413 QLNKGG-----DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD 467
           +  KG      D  L     ++     ++     WCIQ +   RP+M KV++MLEG + +
Sbjct: 703 EFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEG-ITE 761

Query: 468 LQMPPKPCFSSSRHISGREIESDSSTEFLVSEWTEECSFN 507
           ++ P  P   S    SG  + +  ++ F+ S  T   SF+
Sbjct: 762 IKNPLCPKTISEVSFSGNSMSTSHASMFVASGPTRSSSFS 801

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1

 Score =  236 bits (602), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 142/344 (41%), Positives = 192/344 (55%), Gaps = 29/344 (8%)

Query: 134 VLIIGRFILAPIVFLVFLIHKYRTTLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFT 193
           + ++G  +L P++ L     + +T  Q  D              K +S+ E+ + TN F+
Sbjct: 412 ISVLGFTLLVPLILLKRSRKRKKTRKQDEDGFAVLNL-------KVFSFKELQSATNGFS 464

Query: 194 HKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
            K+G GGFG+V+KG L  +   +AVK LE       EF  EV TIG I HVN+V+L GFC
Sbjct: 465 DKVGHGGFGAVFKGTLPGSSTFVAVKRLERPGSGESEFRAEVCTIGNIQHVNLVRLRGFC 524

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           SE   R LVY++MP GSL  ++       +   WE    IALGTA+G+AYLH GC  CI+
Sbjct: 525 SENLHRLLVYDYMPQGSLSSYL--SRTSPKLLSWETRFRIALGTAKGIAYLHEGCRDCII 582

Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPELISRNFGTV 371
           H DIKP NILLD ++  KVSDFGLAK   +  DF  + AT RGT GY+APE IS     +
Sbjct: 583 HCDIKPENILLDSDYNAKVSDFGLAKLLGR--DFSRVLATMRGTWGYVAPEWISGL--PI 638

Query: 372 SCKSDVYGFGMVLLEMAGGRRNSNMNA-------IRSSKAYFPSWVYDQLNKGG-----D 419
           + K+DVY FGM LLE+ GGRRN  +N+           K +FP W   ++ +G      D
Sbjct: 639 TTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPEKWFFPPWAAREIIQGNVDSVVD 698

Query: 420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 463
             L      E V   ++  + +WCIQ     RP+M  V++MLEG
Sbjct: 699 SRLNGEYNTEEVT--RMATVAIWCIQDNEEIRPAMGTVVKMLEG 740

Serine/threonine-protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2

 Score =  230 bits (587), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 142/377 (37%), Positives = 211/377 (55%), Gaps = 23/377 (6%)

Query: 135  LIIGRFILAPIVFLVFLIHKYRTTLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHF-- 192
            +I+G  +L+ I  +V  I + R    T D  E+ L       P  ++Y E+ + T  F  
Sbjct: 640  VIVGVGLLSIISGVVIFIIRKRRKRYTDD--EEIL--SMDVKPYTFTYSELKSATQDFDP 695

Query: 193  THKLGQGGFGSVYKGQLHTGRLIAVKMLE-NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
            ++KLG+GGFG VYKG+L+ GR +AVK+L   S+    +F+ E+  I  + H N+V+L G 
Sbjct: 696  SNKLGEGGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAEIVAISAVQHRNLVKLYGC 755

Query: 252  CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
            C EG  R LVYE++PNGSLD+ +F +  K     W    EI LG ARG+ YLH    + I
Sbjct: 756  CYEGEHRLLVYEYLPNGSLDQALFGE--KTLHLDWSTRYEICLGVARGLVYLHEEARLRI 813

Query: 312  LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
            +H D+K  NILLD   +PKVSDFGLAK +  +   +S +   GTIGY+APE   R  G +
Sbjct: 814  VHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHIS-TRVAGTIGYLAPEYAMR--GHL 870

Query: 372  SCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL--RNVTEIE 429
            + K+DVY FG+V LE+  GR NS+ N +   K Y   W ++   KG ++EL    +TE  
Sbjct: 871  TEKTDVYAFGVVALELVSGRPNSDEN-LEDEKRYLLEWAWNLHEKGREVELIDHQLTEFN 929

Query: 430  SVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKPCF--------SSSRH 481
                +++  I L C Q   A RP M++V+ ML G ++   +  KP +        +++  
Sbjct: 930  MEEGKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEVSDVTSKPGYLTDWRFDDTTASS 989

Query: 482  ISGREIESDSSTEFLVS 498
            ISG  + +  ++E   S
Sbjct: 990  ISGFPLRNTQASESFTS 1006

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2

 Score =  227 bits (579), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 129/312 (41%), Positives = 182/312 (58%), Gaps = 27/312 (8%)

Query: 176 MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSA-EEFINEV 234
           +P+++ + E+   T +F  ++G GGFGSVYKG L    LIAVK + N      +EF  E+
Sbjct: 501 LPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLHGRQEFCTEI 560

Query: 235 STIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIAL 294
           + IG I H N+V+L GFC+ G +  LVYE+M +GSL++ +F     G    W++  +IAL
Sbjct: 561 AIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLF--SGNGPVLEWQERFDIAL 618

Query: 295 GTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG 354
           GTARG+AYLH+GCD  I+H D+KP NILL  +F PK+SDFGL+K   +E   +  +  RG
Sbjct: 619 GTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSL-FTTMRG 677

Query: 355 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRN----SNMNAIRSSK------- 403
           T GY+APE I+     +S K+DVY +GMVLLE+  GR+N    S  N++           
Sbjct: 678 TRGYLAPEWITN--AAISEKADVYSYGMVLLELVSGRKNCSFRSRSNSVTEDNNQNHSST 735

Query: 404 -------AYFPSWVYDQLNKGGDLEL---RNVTEIESVIARKLCMIGLWCIQVKAADRPS 453
                   YFP +  D   +G  +EL   R    + S  A KL  I L C+  + A RP+
Sbjct: 736 TTTSTGLVYFPLYALDMHEQGRYMELADPRLEGRVTSQEAEKLVRIALCCVHEEPALRPT 795

Query: 454 MTKVLEMLEGSM 465
           M  V+ M EGS+
Sbjct: 796 MAAVVGMFEGSI 807

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	511
255570697	631	kinase, putative [Ricinus communis] gi|2	0.945	0.765	0.553	1e-154
224108395	348	predicted protein [Populus trichocarpa]	0.675	0.991	0.657	1e-131
224101781	348	predicted protein [Populus trichocarpa]	0.673	0.988	0.658	1e-129
357130561	663	PREDICTED: probable receptor-like protei	0.962	0.742	0.481	1e-127
357135051	680	PREDICTED: probable receptor-like protei	0.925	0.695	0.497	1e-127
326509433	685	predicted protein [Hordeum vulgare subsp	0.906	0.675	0.483	1e-126
13377507	689	TAK14 [Triticum aestivum]	0.931	0.690	0.484	1e-125
8575484	650	receptor-like kinase [Oryza sativa Japon	0.904	0.710	0.5	1e-125
326508416	666	predicted protein [Hordeum vulgare subsp	0.951	0.729	0.474	1e-125
326516936	691	predicted protein [Hordeum vulgare subsp	0.933	0.690	0.487	1e-124

>gi|255570697|ref|XP_002526303.1| kinase, putative [Ricinus communis] gi|223534384|gb|EEF36092.1| kinase, putative [Ricinus communis]

 Score =  551 bits (1419), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 281/508 (55%), Positives = 359/508 (70%), Gaps = 25/508 (4%)

Query: 2   EAYAKVPCLSNNQSNVYVYVAPDFIETTHLPDSCAFITKVPVVLNGSVDKPSYEDLRKLL 61
           +AY  VPC S N S+VYV  +   I  + L  SC+FI++VP +   +V  PSY+ + +L+
Sbjct: 145 QAYRDVPCFSGNGSHVYVSYSTYVI--SDLQGSCSFISRVPTIYQ-NVLYPSYQSILQLM 201

Query: 62  ESGFDLTWSDWSWSLSMTHFFPECNDYYGGIIRKFICYQDDILFHEISRRSYRNIESRLG 121
             GFDL WS             EC D    I    IC    +    +    Y  I   + 
Sbjct: 202 ALGFDLEWS------------VECRD---CIADGGICSLSSVGTPNVYECYYSGI--YIP 244

Query: 122 VWISFLLGFPVDVLI----IGRFILAPIVFLVFLIHKYRTTLQTVDNIEKFLHNQQSWMP 177
             +S +     D+L+    I RF++APIV + FLIHKYRT  +T ++ E  L N+ S MP
Sbjct: 245 AAVSLIFAAIWDILLAINLIARFVVAPIVIVGFLIHKYRTQKKTEESKENLLPNEPSMMP 304

Query: 178 KRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTI 237
           +RYSY +IIA+TN+F  K+G+GGFG+VYKGQL  G L+AVKML +SKFS ++FI+EVSTI
Sbjct: 305 RRYSYSDIIAITNNFKDKIGKGGFGTVYKGQLPDGFLVAVKMLGDSKFSDKDFIDEVSTI 364

Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
           G+IHH NVVQL+GFCSEGS  AL++E++  GSLD+HIF +E + Q F WEK  +IA+GTA
Sbjct: 365 GKIHHANVVQLVGFCSEGSYHALLFEYIARGSLDKHIFSREAEFQPFSWEKRLQIAIGTA 424

Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
           RG+ +LH GCD+CILHFDIKPHN+LL HNFIPKVSDFGLAKF+PKENDFVS+S  RGTIG
Sbjct: 425 RGIEHLHVGCDVCILHFDIKPHNVLLHHNFIPKVSDFGLAKFYPKENDFVSVSTARGTIG 484

Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG 417
           YIAPELIS+N G+VSCKSDVY +G++LLEM GGRRN N N   S K +F SWVYD LN+G
Sbjct: 485 YIAPELISKNLGSVSCKSDVYSYGILLLEMVGGRRNINPNGNSSGKVHFASWVYDHLNEG 544

Query: 418 GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKPCFS 477
           GDLEL +V E E+ IA+KLC++GLWCI   ++DRPSMTKV+EMLEG +DDLQ+PP P  S
Sbjct: 545 GDLELESVNEAEAAIAKKLCIVGLWCINKNSSDRPSMTKVVEMLEGKIDDLQLPPSP-LS 603

Query: 478 SSRHISGREIESDSSTEFLVSEWTEECS 505
              H++    +SDSSTE L+SE  E+ S
Sbjct: 604 FPDHVAAEGPQSDSSTELLISETVEKSS 631

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224108395|ref|XP_002314832.1| predicted protein [Populus trichocarpa] gi|222863872|gb|EEF01003.1| predicted protein [Populus trichocarpa]

 Score =  474 bits (1221), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 228/347 (65%), Positives = 279/347 (80%), Gaps = 2/347 (0%)

Query: 157 TTLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIA 216
           TT + +DN ++FL  QQ  MP+RYSY +IIA+TN+F +KLGQGGFG+VYKGQL  G  +A
Sbjct: 2   TTKKAIDNEQRFLRRQQHSMPRRYSYSDIIAITNNFENKLGQGGFGTVYKGQLRDGFSVA 61

Query: 217 VKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFP 276
           VKML+N K + E+FINEVS IGRIH VN+V L+GFCSEG  RALV+E+M NGSLD+ +F 
Sbjct: 62  VKMLDNPKCNDEDFINEVSIIGRIHQVNIVWLMGFCSEGCHRALVFEYMANGSLDKLLFS 121

Query: 277 KENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGL 336
           +E +    GWEKL +IALGTARG+ +LH GC++CILH DIKP N+LLD+NFIPKVSDFGL
Sbjct: 122 REAERHLVGWEKLLQIALGTARGIEHLHGGCNVCILHSDIKPQNVLLDNNFIPKVSDFGL 181

Query: 337 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM 396
           +KF+P+E DFVSIS TRGTIGYIAPE+ISRN G VSCKSDVY FGM+LLEMAG RRNSN 
Sbjct: 182 SKFYPEEKDFVSISTTRGTIGYIAPEMISRNLGAVSCKSDVYSFGMLLLEMAGRRRNSNS 241

Query: 397 NAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTK 456
               SS+ YFPSWVYD L +  DL+L NVTEIE+ I RKLC++GLWCIQ  A+DRPSMTK
Sbjct: 242 KGNCSSEVYFPSWVYDHLIERADLQLENVTEIEAGIPRKLCLVGLWCIQKAASDRPSMTK 301

Query: 457 VLEMLEGSMDDLQMPPKPCFSSSRHISGREIESDSSTEFLVSEWTEE 503
           V+EMLE ++DDLQ+PP    S  + IS +E +SDSSTE L+S+  E+
Sbjct: 302 VVEMLEANVDDLQLPPN-ALSFPQSIS-KEPQSDSSTELLISDTVEQ 346

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224101781|ref|XP_002312418.1| predicted protein [Populus trichocarpa] gi|222852238|gb|EEE89785.1| predicted protein [Populus trichocarpa]

 Score =  469 bits (1207), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 228/346 (65%), Positives = 272/346 (78%), Gaps = 2/346 (0%)

Query: 157 TTLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIA 216
           TT +   N E FL NQQ  MPKRY++ +IIA+TN+F  KLGQGGFG+VYKGQL    L+A
Sbjct: 2   TTKKASGNEEIFLVNQQHLMPKRYTFSDIIAITNNFKDKLGQGGFGNVYKGQLRDAFLVA 61

Query: 217 VKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFP 276
           VKML N+K + E+FINEVS IGRIHHVN+V+L+GFCSEGS RALV+E+M NGSLD+ +F 
Sbjct: 62  VKMLGNAKCNDEDFINEVSIIGRIHHVNIVRLVGFCSEGSYRALVFEYMANGSLDKLLFS 121

Query: 277 KENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGL 336
           +E +     WEKL +IA+GTARG+ +LH GC +CILH DIKPHN+LLD NFIPKVSDFGL
Sbjct: 122 RETELLLVSWEKLLQIAVGTARGIEHLHGGCSVCILHLDIKPHNVLLDSNFIPKVSDFGL 181

Query: 337 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM 396
           AKF+P E DFVSIS TRGTIGY APE+ISRN G VSCKSDVY FGM+LLEMAG RR SN 
Sbjct: 182 AKFYPSEKDFVSISTTRGTIGYFAPEMISRNLGAVSCKSDVYSFGMLLLEMAGRRRKSNS 241

Query: 397 NAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTK 456
               SS  YFPSWVYD L++GGDLEL NVTEIE+ IARKLC+ GLWCIQ  A+DRP+MTK
Sbjct: 242 KGNCSSDVYFPSWVYDHLSEGGDLELENVTEIEAAIARKLCIAGLWCIQKAASDRPTMTK 301

Query: 457 VLEMLEGSMDDLQMPPKPCFSSSRHISGREIESDSSTEFLVSEWTE 502
           V+EML  ++DDLQ+P     S  + IS +E +SDSSTE L+ E  +
Sbjct: 302 VVEMLGANIDDLQLPSN-ALSFPQSIS-KEPQSDSSTESLIPETAD 345

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357130561|ref|XP_003566916.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Brachypodium distachyon]

 Score =  462 bits (1190), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 256/532 (48%), Positives = 348/532 (65%), Gaps = 40/532 (7%)

Query: 4   YAKVPCLSNNQSNVYVYVAPDFIETTHLPDSCAFITKVPVVLNGSV-DKPSYEDLRKLLE 62
           Y+ V CLS+  S VY+ +   ++E  +L  SC ++    +   G+  D   Y D  K L 
Sbjct: 140 YSPVACLSSKNSFVYLLIDSVYVE--NLEPSCGYLAMFLLGGRGNYYDFSHYADFLKYLR 197

Query: 63  SGFDLTWSDWSWSLSMTHFFPECNDY--------YGGIIRKFICYQDDILFHEIS----- 109
            GF + + +    L+   +   C D+         G  I+      +DILF +       
Sbjct: 198 GGFSVQFPETETPLNYIQYINRCIDWSIQQPVFSTGVSIKN---RTEDILFIDFRFWACI 254

Query: 110 ---RRSYRNIESRLGVWISF----------LLGFPVD--VLIIGRFILAPIVFLVFLIHK 154
              +R Y +I   +   I F          +L   +   + ++ RF+LAP++ L+FL HK
Sbjct: 255 FGVKRPYNDILLYIKDMIRFDPSLYHKLPPILAMWIVKWIAVLCRFVLAPLMVLLFLAHK 314

Query: 155 YRTTLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL 214
           Y  T  T+D +EKFL  QQ   P RY+Y +I+AVT+HF  KLGQGG+GSV+KG LH G +
Sbjct: 315 YWKTRITIDAVEKFLRMQQMIGPTRYTYTDIVAVTSHFRDKLGQGGYGSVFKGVLHPGDV 374

Query: 215 -IAVKMLEN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDR 272
            +AVKML++ S  + E+FI+EVSTIGRIHHVNVV L+GFCSE  +RALVYE+MP+GSLD+
Sbjct: 375 HVAVKMLDSKSNCNGEDFISEVSTIGRIHHVNVVCLIGFCSEEMRRALVYEYMPHGSLDK 434

Query: 273 HIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVS 332
           +IF  E   ++F W+KL EIALG ARG+ YLH GC+M I+HFDIKPHNILLD NF+PKV+
Sbjct: 435 YIFSAE---KSFSWDKLNEIALGIARGINYLHQGCEMQIVHFDIKPHNILLDSNFVPKVA 491

Query: 333 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR 392
           DFGLAK +P++N FV +SA RGTIGYIAPE+ISR+FG +S KSDVY FGM+LLEMAGGRR
Sbjct: 492 DFGLAKLYPRDNSFVPLSALRGTIGYIAPEMISRSFGAISSKSDVYSFGMLLLEMAGGRR 551

Query: 393 NSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE-SVIARKLCMIGLWCIQVKAADR 451
           N + NA+ SS++Y+PSWVYDQL +  +L   +V+  E   + RKLC++GLWCIQ+++ DR
Sbjct: 552 NVDANAVNSSQSYYPSWVYDQLTRQEELGEISVSVAEMHELERKLCIVGLWCIQMRSQDR 611

Query: 452 PSMTKVLEMLEGSMDDLQMPPKPCFSSSRHISGREIESDSSTEFLVSEWTEE 503
           P+M++V+EMLEGS+  LQMP +P F    HI   +    SS    VSE  +E
Sbjct: 612 PTMSEVIEMLEGSVGGLQMPSRPFFCDEGHIHIEDSYHFSSELTAVSEEEDE 663

Source: Brachypodium distachyon

Species: Brachypodium distachyon

Genus: Brachypodium

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357135051|ref|XP_003569125.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Brachypodium distachyon]

 Score =  461 bits (1186), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 253/509 (49%), Positives = 331/509 (65%), Gaps = 36/509 (7%)

Query: 4   YAKVPCLSNNQSNVYVYVAPDFIETTHLPDSCAFITKVPVVL--NGSVD-----KPSYED 56
           Y  V CLS N S+VYV V+        L   C ++   P+    N S D       SYED
Sbjct: 156 YKPVDCLSANNSHVYVLVSELGCSVHELEPYCGYLAMSPLSFGDNHSSDWLQPQNTSYED 215

Query: 57  LRKLLESGF------DLTWSDWSWSLSMT---------HFFPECNDYYGGIIRKFI--CY 99
           + +L+  GF      + T   W   + +T          +F E     GG I  +    +
Sbjct: 216 ITQLIRKGFVVGFPGETTTRPWRRGVCVTINRCLNNSISYFKEQTS--GGSIMNWTHAFF 273

Query: 100 QDDILFHEISRRSYRNIESRLGVWISFLLGFPVDVL----IIGRFILAPIVFLVFLIHKY 155
             +I F E    S  N  +   + +   +   + +L    ++ RF+LAP+V  +FL +KY
Sbjct: 274 WSEIHFLECVITSSNNYYTTRSLLVVTTIVSSIAILKFIFVLCRFVLAPMVVWIFLAYKY 333

Query: 156 RTTLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL- 214
             T  T+D +EKFL  QQ   P RY+Y +I A+T HF  KLGQGG+GSVYKG L  G + 
Sbjct: 334 WKTRITIDVVEKFLRIQQMIGPTRYAYTDITAITGHFRDKLGQGGYGSVYKGVLLPGDVH 393

Query: 215 IAVKMLE-NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRH 273
           +AVKMLE NS  + E+FI+EVSTIGRIHHVNVV+L+GFCSE  KRALVYE+MP+GSLD++
Sbjct: 394 VAVKMLEGNSSCNGEDFISEVSTIGRIHHVNVVRLVGFCSEEMKRALVYEYMPHGSLDKY 453

Query: 274 IFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSD 333
           IF  E   ++F W+KL EIALG ARG+ YLH GCDM ILHFDIKPHNILLD NF+PKV+D
Sbjct: 454 IFSAE---KSFSWDKLNEIALGIARGINYLHQGCDMQILHFDIKPHNILLDSNFVPKVAD 510

Query: 334 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRN 393
           FGLAK +P++N FV +SA RGTIGYIAPE+ISR+FG +S KSDVY FGM+LLEMAGGRRN
Sbjct: 511 FGLAKLYPRDNSFVPLSALRGTIGYIAPEMISRSFGVISSKSDVYSFGMLLLEMAGGRRN 570

Query: 394 SNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPS 453
           ++ NA RSS+AY+PSWVYDQL +    E+    ++   + +KLC++GLWCIQ+K+ DRP+
Sbjct: 571 ADPNAARSSQAYYPSWVYDQLTQQEAGEISPAADMHE-LEKKLCVVGLWCIQMKSHDRPT 629

Query: 454 MTKVLEMLEGSMDDLQMPPKPCFSSSRHI 482
           M++V+E+LE     LQMP +P F    HI
Sbjct: 630 MSEVIEVLEAGAHGLQMPSRPFFCDEEHI 658

Source: Brachypodium distachyon

Species: Brachypodium distachyon

Genus: Brachypodium

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|326509433|dbj|BAJ91633.1| predicted protein [Hordeum vulgare subsp. vulgare]

 Score =  458 bits (1179), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 245/507 (48%), Positives = 331/507 (65%), Gaps = 44/507 (8%)

Query: 4   YAKVPCLSNNQSNVYVYVAPDFIETTHLPDSCAFITKVPVVLNGSVDKPSYEDLRKLLES 63
           Y  V C+S + S VYV    D      L  SC ++   P+  +  V K SY D  +++ +
Sbjct: 177 YMPVTCMSTSYSFVYVLTGTDSGAVGSLEPSCGYLAMTPLD-SRWVAKASYADTIEIMRN 235

Query: 64  GFDL-----------------------TWSDWSWSLSMTHFFPECNDYYGGIIRKFICYQ 100
           GF L                       T  DW  SL+    F      +GG + + +   
Sbjct: 236 GFPLQYRGGGSITECTMEFTLQLDEVKTVKDWVLSLATVDLF------FGGCMIRLLM-- 287

Query: 101 DDILFHEISRRSYRNIESRLGVWISFLLGFPVDVLIIGRFILAPIVFLVFLIHKYRTTLQ 160
             +L  + +   +    S + V   +L+ +   + ++ RF+LAP+  L+FL +KY  T  
Sbjct: 288 -QVLMQKNNVYMFFYYFSMIAVIALWLVKW---IAVLCRFVLAPMAVLIFLGYKYLKTRV 343

Query: 161 TVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL-IAVKM 219
           T+D +EKFL  QQ   P RY+Y +I A+T+HF   LGQGG+GSV+KG L  G + +AVKM
Sbjct: 344 TIDAVEKFLRLQQMLGPTRYAYTDITAITSHFRDMLGQGGYGSVFKGVLLPGNVHVAVKM 403

Query: 220 LE-NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 278
           LE NS  + E+FI+EVSTIGRIHHVNVV+L+GFCSE  +RALVYE+MP GSLD++IF  E
Sbjct: 404 LEGNSSCNGEDFISEVSTIGRIHHVNVVRLMGFCSEEMRRALVYEYMPRGSLDKYIFSTE 463

Query: 279 NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK 338
              + F W+KL EIALG ARG+ YLH GCDM ILHFDIKPHNILLD+NFIP+V+DFGLAK
Sbjct: 464 ---KCFSWDKLNEIALGIARGINYLHQGCDMQILHFDIKPHNILLDNNFIPRVADFGLAK 520

Query: 339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA 398
            +P++N FV +SA RGTIGYIAPE+ISR+FG +S KSDVY FGM+LLEM+GGRRN++ NA
Sbjct: 521 LYPRDNSFVPLSALRGTIGYIAPEMISRSFGAISSKSDVYSFGMLLLEMSGGRRNADSNA 580

Query: 399 IRSSKAYFPSWVYDQLNKG--GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTK 456
             SS+AY+PSWVYD+L +   G++     TE+   + RKLC++GLWCIQ+++ DRP+M++
Sbjct: 581 ATSSQAYYPSWVYDRLTQQDVGEISAPIATEMHE-LERKLCIVGLWCIQMRSHDRPTMSE 639

Query: 457 VLEMLEGSMDDLQMPPKPCFSSSRHIS 483
           V+EMLEG  + LQMP +P F    H +
Sbjct: 640 VIEMLEGGFEGLQMPSRPFFCDEEHTA 666

Source: Hordeum vulgare subsp. vulgare

Species: Hordeum vulgare

Genus: Hordeum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|13377507|gb|AAK20744.1| TAK14 [Triticum aestivum]

 Score =  455 bits (1170), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 245/506 (48%), Positives = 328/506 (64%), Gaps = 30/506 (5%)

Query: 3   AYAKVPCLSNNQSNVYVYVAPDFIETTHLPDSCAFITKVPVVLNGSVD-----KPSYEDL 57
           +Y  V CLS   S+VYV+V+        L   C ++   P ++  SVD       SY DL
Sbjct: 158 SYKPVACLSAKDSHVYVWVSESVCGVEDLKPYCGYVALTPFLVTYSVDLQQLRNASYVDL 217

Query: 58  RKLLESGFDLTW-----SDWSWSLSMTHFFPECNDYYGGIIR--KFICYQDDILFHEIS- 109
            KL+  GF + +        S S ++         Y+   I     + +   I + E+  
Sbjct: 218 TKLISKGFTVYFPVEAGDIRSVSRTINICLNRTTSYFKEQISGTSIVNWTHAIFWSEVHF 277

Query: 110 ---------RRSYRNIESRLGVWISFLLGFPVDVLIIGRFILAPIVFLVFLIHKYRTTLQ 160
                      +Y      L V I   +G    + ++ RF+LAP+   +FL +KY  T+ 
Sbjct: 278 LECVTDTNFGSTYTTESLLLVVTILSAIGISKFLFVLCRFLLAPLAVWIFLGYKYWKTMI 337

Query: 161 TVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL-IAVKM 219
            +D +EKFL  QQ   P RYSY +I+A+T+HF  KLGQGG+G+VYKG L  G + +AVKM
Sbjct: 338 IIDAVEKFLRIQQMIGPTRYSYTDIVAITSHFRDKLGQGGYGTVYKGVLLPGDVHVAVKM 397

Query: 220 LE-NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 278
           LE NS  + E+FI+EVSTIGRIHHVNVV+L+GFCSE  +RALVYE+MP+GSLD++IF  E
Sbjct: 398 LEGNSNCNGEDFISEVSTIGRIHHVNVVRLVGFCSEEMRRALVYEYMPHGSLDKYIFSAE 457

Query: 279 NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK 338
              ++F W+KL EIALG ARG+ YLH GCDM ILHFDIKPHNILLD NF+PKV+DFGLAK
Sbjct: 458 ---KSFSWDKLNEIALGIARGINYLHQGCDMQILHFDIKPHNILLDSNFVPKVADFGLAK 514

Query: 339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA 398
            +P+ + FV +SA RGT+GYIAPE+ISR+FG +S KSDVY FGM+LLEMAGGRRN++ NA
Sbjct: 515 LYPRGDSFVPLSAMRGTVGYIAPEMISRSFGVISSKSDVYSFGMLLLEMAGGRRNADPNA 574

Query: 399 IRSSKAYFPSWVYDQLNK--GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTK 456
             SS+AY+PSWVYDQL +   G+ E+  V      + +KLC++GLWCIQ++++DRP+M +
Sbjct: 575 GSSSQAYYPSWVYDQLTREEAGE-EISPVAADMHELEKKLCVVGLWCIQMRSSDRPTMGE 633

Query: 457 VLEMLEGSMDDLQMPPKPCFSSSRHI 482
           V+E+LE     LQMP +P F    HI
Sbjct: 634 VIEILEAGAGGLQMPSRPFFCDEGHI 659

Source: Triticum aestivum

Species: Triticum aestivum

Genus: Triticum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|8575484|gb|AAF78019.1|AF238475_1 receptor-like kinase [Oryza sativa Japonica Group]

 Score =  454 bits (1169), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 249/498 (50%), Positives = 326/498 (65%), Gaps = 36/498 (7%)

Query: 4   YAKVPCLSNNQSNVYVYVAPDFIETTHLPDSCAFITKVPVVLNGS-------VDKPSYED 56
           Y  V CLS ++S VYV+         +L  SC ++   P  L GS       +   SY+D
Sbjct: 151 YMPVACLSTSRSFVYVFTGQQSAYIQNLEPSCGYLATTP--LGGSKLNSTSALQNVSYQD 208

Query: 57  LRKLLESGFDL----TWSDWSWSLSMTHFFPECNDYYGGIIRKFICYQDDILFHE---IS 109
           + KL+ +GF +    T S W+        F EC      I    I    D  F     + 
Sbjct: 209 VVKLMMTGFAVRFPFTVSGWN--------FKECLALSIRIANIAII---DFYFWSCFLLG 257

Query: 110 RRSYRNIESRLGVWISFLLGFPVDVLIIGRFILAPIVFLVFLIHKYRTTLQTVDNIEKFL 169
            RS+ N+     V  + LL       ++ RF+LAP+   +FL HKY     T+D +EKFL
Sbjct: 258 DRSHNNLIYTYMVVDTALLILKWTA-VLCRFVLAPLAVFIFLAHKYWRNKITIDAVEKFL 316

Query: 170 HNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE 229
             Q +  P RY+Y ++ A+T HF  KLGQGG+GSVYKG L     +AVK+LEN+  + EE
Sbjct: 317 QMQLTLGPTRYAYTDLTAITGHFGEKLGQGGYGSVYKGVLPGYVNVAVKVLENANCNGEE 376

Query: 230 FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKL 289
           FI+EVSTIGRIHHVNVV+L+GFCSE  +RALVYE+MP GSLD++IF  +   ++F W+KL
Sbjct: 377 FISEVSTIGRIHHVNVVRLVGFCSEELRRALVYEYMPRGSLDKYIFSSK---RSFSWDKL 433

Query: 290 QEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 349
            EIALG ARG+ YLH GCDM ILHFDIKPHNILLD NF+PKV+DFGLAK +P++N FV +
Sbjct: 434 NEIALGIARGINYLHQGCDMQILHFDIKPHNILLDDNFVPKVADFGLAKLYPRDNSFVPL 493

Query: 350 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW 409
           +A RGTIGYIAPE+ISR+FG +S KSDVY FGM+LLEMAGGRRNS+M+A  SS+AY+PSW
Sbjct: 494 NALRGTIGYIAPEMISRSFGVISSKSDVYSFGMLLLEMAGGRRNSDMHAGNSSQAYYPSW 553

Query: 410 VYDQLNKG----GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM 465
           VYD+L +     G++    V  +   + RKLC+IGL CIQ+K+ DRP+M++V+EMLEG +
Sbjct: 554 VYDRLIEQQVGVGEISAATVANMHE-LERKLCIIGLHCIQMKSHDRPTMSEVIEMLEGGV 612

Query: 466 DDLQMPPKPCFSSSRHIS 483
             LQMPP+P F     +S
Sbjct: 613 VGLQMPPRPFFCDDESMS 630

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|326508416|dbj|BAJ99475.1| predicted protein [Hordeum vulgare subsp. vulgare]

 Score =  453 bits (1166), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 247/521 (47%), Positives = 329/521 (63%), Gaps = 35/521 (6%)

Query: 4   YAKVPCLSNNQSNVYVYVAPDFIETTHLPDSCAFITKVPVV-------LNGSVDKPSYED 56
           Y  V CLS N + VYV      I   +L  SC ++  +P          N   +  SY D
Sbjct: 148 YIPVACLSTNDTYVYVLTGYGSILMEYLEPSCGYLAMIPWPWDSPGPWCNKPQENASYAD 207

Query: 57  LRKLLESGFDLTWSDWSWSLSMT----------HFFPECNDYYGGIIRKFICYQDDILFH 106
           + K +  GF + +    +  S +              +C+      + K +       + 
Sbjct: 208 VVKSMRIGFAVRFPFRYFRRSTSIKECLIRQFRDLSQDCSYGVKSCVPKILLVDGAFWYC 267

Query: 107 EISRRSYRNIESRLGVWISFLLGFPVDVLIIGRFILAPIVFLVFLIHKYRTTLQTVDNIE 166
            +    + +    +   I F+  F   + ++ RF+LAP+V L+FL HKY  T  T+D +E
Sbjct: 268 LVDATGFGDYALSI---IPFVFWFVKWIAVLCRFVLAPLVVLIFLAHKYWKTRITIDAVE 324

Query: 167 KFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL-IAVKMLE-NSK 224
           KFL  QQ   P RY+Y +I A+T+HF  KLGQGG+GSV+KG L  G + +AVKMLE N  
Sbjct: 325 KFLRMQQMLGPMRYAYTDITAITSHFRDKLGQGGYGSVFKGVLLPGNVHVAVKMLEGNPN 384

Query: 225 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTF 284
            + E+FINEVSTIGRIHHVNVV+L+GFCSE  +RALVYE+MP GSLD++IF   + G++F
Sbjct: 385 CNGEDFINEVSTIGRIHHVNVVRLMGFCSEEMRRALVYEYMPQGSLDKYIF---SSGKSF 441

Query: 285 GWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 344
            W+KL EIALG ARG+ YLH GCDM ILHFDIKPHNILLD+NF+PKV+DFGLAK +P++N
Sbjct: 442 CWDKLAEIALGIARGIDYLHQGCDMQILHFDIKPHNILLDNNFVPKVADFGLAKLYPRDN 501

Query: 345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA 404
            FV   A RGTIGYIAPE+ISR+FG +S KSDVY FGM+LLEMAGGRRN++ NA  +S+A
Sbjct: 502 SFVPSRALRGTIGYIAPEMISRSFGAISSKSDVYSFGMLLLEMAGGRRNADPNAANTSQA 561

Query: 405 YFPSWVYDQLNKG---GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEML 461
           Y+PSWVYD+L +    G++     TE+   + RKLC++GLWCIQ++  DRP+M+ V+EML
Sbjct: 562 YYPSWVYDRLTQQDHVGEIFAHVYTEMHE-LERKLCIVGLWCIQMRCQDRPTMSDVIEML 620

Query: 462 EGSMDDLQMPPKPCFSSSRHISGREIESDSSTEFLVSEWTE 502
           EG +  LQMP +P F    H    +      T  L SE TE
Sbjct: 621 EGGIHSLQMPSRPFFCDEGHNHAED------TYHLSSELTE 655

Source: Hordeum vulgare subsp. vulgare

Species: Hordeum vulgare

Genus: Hordeum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|326516936|dbj|BAJ96460.1| predicted protein [Hordeum vulgare subsp. vulgare] gi|326526275|dbj|BAJ97154.1| predicted protein [Hordeum vulgare subsp. vulgare]

 Score =  453 bits (1165), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 247/507 (48%), Positives = 330/507 (65%), Gaps = 30/507 (5%)

Query: 3   AYAKVPCLSNNQSNVYVYVAPDFIETTHLPDSCAFITKVPVVLNGSVD-----KPSYEDL 57
           AY  V CLS N S+VYV+V+        L   C ++ K+ +    S D       SY D+
Sbjct: 159 AYKPVACLSANNSHVYVWVSDYECMVEDLEPYCGYLAKILLGNEYSTDSLQLHNASYADI 218

Query: 58  RKLLESGF------DLTWSDWSWSL---------SMTHFFPECNDYYGGIIRKFICYQDD 102
            +++  GF      D T    S  L         +   +F E +   G +    + +  +
Sbjct: 219 IQVISRGFTVKFPVDTTRPSPSVKLRKNINLCLNNSISYFKEQSSGAGIMNWAHVFFWSE 278

Query: 103 ILFHE----ISRRSYRNIESRLGV-WISFLLGFPVDVLIIGRFILAPIVFLVFLIHKYRT 157
           + F E    +S   Y   +  L V  I   +  P  + ++ RF+LAP+   +FL +KY  
Sbjct: 279 VHFLECVTQLSSDHYYTTQFVLVVVTIVSAIAIPKFLFVLCRFLLAPLAVWIFLAYKYWK 338

Query: 158 TLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL-IA 216
           T   +D +EKFL  QQ   P RY+Y +IIA+T HF  KLGQGG+G+VYKG L  G + +A
Sbjct: 339 TRIIIDAVEKFLRIQQLIGPTRYAYTDIIAITRHFRDKLGQGGYGTVYKGVLLPGDVHVA 398

Query: 217 VKMLE-NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIF 275
           VKMLE NS  + E+FI+EVSTIGRIHHVNVV+L+GFCSE  +RALVYE+MPNGSLD++IF
Sbjct: 399 VKMLEGNSNCNGEDFISEVSTIGRIHHVNVVRLMGFCSEELRRALVYEYMPNGSLDKYIF 458

Query: 276 PKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFG 335
             E   ++F W+KL EIALG ARG+ YLH GCDM ILHFDIKPHNILLD+NF+PKV+DFG
Sbjct: 459 STE---KSFSWDKLNEIALGIARGINYLHQGCDMQILHFDIKPHNILLDNNFVPKVADFG 515

Query: 336 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN 395
           LAK +P+ + FV +SA RGT+GYIAPE+ISR+FG +S KSDVY FGM+LLEMAGGRRN++
Sbjct: 516 LAKLYPRGDSFVPLSAMRGTVGYIAPEMISRSFGVISSKSDVYSFGMLLLEMAGGRRNAD 575

Query: 396 MNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMT 455
            N   SS+AY+PSWVYDQL +    E+  V      + +KLC++GLWCIQ+++ DRP+M+
Sbjct: 576 PNMGSSSQAYYPSWVYDQLTREEAGEISPVAVDMHELEKKLCVVGLWCIQMRSRDRPTMS 635

Query: 456 KVLEMLEGSMDDLQMPPKPCFSSSRHI 482
           +V+E+LE  +D LQMP +P F    HI
Sbjct: 636 EVIEILEAGVDGLQMPSRPFFCDEGHI 662

Source: Hordeum vulgare subsp. vulgare

Species: Hordeum vulgare

Genus: Hordeum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	511
TAIR|locus:2204480	666	AT1G66910 [Arabidopsis thalian	0.870	0.668	0.404	3e-85
TAIR|locus:2176737	665	PR5K "PR5-like receptor kinase	0.726	0.557	0.458	9.1e-84
TAIR|locus:2019688	674	AT1G66930 [Arabidopsis thalian	0.710	0.538	0.464	9.3e-84
TAIR|locus:2177152	806	AT5G39030 [Arabidopsis thalian	0.600	0.380	0.523	4.1e-81
TAIR|locus:2141862	853	AT4G18250 [Arabidopsis thalian	0.637	0.382	0.479	1.4e-80
TAIR|locus:2177142	813	AT5G39020 [Arabidopsis thalian	0.681	0.428	0.460	2.2e-80
TAIR|locus:2019713	892	AT1G67000 [Arabidopsis thalian	0.739	0.423	0.444	6e-80
TAIR|locus:2176717	638	AT5G38260 [Arabidopsis thalian	0.716	0.573	0.456	7.6e-80
TAIR|locus:2020583	799	AT1G70250 [Arabidopsis thalian	0.655	0.419	0.474	4.8e-78
TAIR|locus:2176697	588	AT5G38240 [Arabidopsis thalian	0.565	0.491	0.508	1.9e-74

TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)]

 Score = 853 (305.3 bits), Expect = 3.0e-85, P = 3.0e-85
 Identities = 192/475 (40%), Positives = 281/475 (59%)

Query:    45 LNGSVDKPSYEDLRKLLESGFXXXXXXXXXXXXMTHFFPECNDYYGGIIRKFICYQDDIL 104
             LN     PS ++L+  LE GF             +     C   +     +F+CY     
Sbjct:   208 LNTLESTPSTDNLKIALEDGFALEVNSDCRTCIDSK--GACG--FSQTSSRFVCY----- 258

Query:   105 FHEISRRSYRN-IESRLGVWISFLLGFPVDVLIIGRFILAPIVFLVFLIHKYRTTL---- 159
             + +  +   RN +  +L   + ++LG       +   IL  +  L  LI + R TL    
Sbjct:   259 YRQEPQNPTRNKVILKLFFIVIYVLGIGAASFAMMGVILV-VTCLNCLIRRQRKTLNDPR 317

Query:   160 -QTVDNIEKFLHNQQSWMP-KRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAV 217
              +T D+  +   N ++ +P K YSY ++ ++T  F   +G+GGFG+VY+G L+ GR +AV
Sbjct:   318 MRTSDDSRQ--QNLKALIPLKHYSYAQVTSITKSFAEVIGKGGFGTVYRGTLYDGRSVAV 375

Query:   218 KMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK 277
             K+L+ S+ + E+FINEV+++ +  HVN+V LLGFCSEG KRA++YEFM NGSLD+ I  K
Sbjct:   376 KVLKESQGNGEDFINEVASMSQTSHVNIVTLLGFCSEGYKRAIIYEFMENGSLDKFISSK 435

Query:   278 ENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLA 337
               K  T  W +L  IALG ARG+ YLH+GC   I+HFDIKP N+LLD N  PKVSDFGLA
Sbjct:   436 --KSSTMDWRELYGIALGVARGLEYLHHGCRTRIVHFDIKPQNVLLDDNLSPKVSDFGLA 493

Query:   338 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMN 397
             K   ++   +S+  TRGTIGYIAPE+ SR +G VS KSDVY +GM++L++ G R  ++  
Sbjct:   494 KLCERKESILSLMDTRGTIGYIAPEVFSRVYGRVSHKSDVYSYGMLVLDIIGARNKTSTE 553

Query:   398 AIRSSKA--YFPSWVYDQLNK---GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRP 452
                SS +  YFP W+Y  L K   G  +E   ++  E  IA+K+ ++GLWCIQ    DRP
Sbjct:   554 DTTSSTSSMYFPEWIYRDLEKAHNGKSIETA-ISNEEDEIAKKMTLVGLWCIQPWPLDRP 612

Query:   453 SMTKVLEMLEGSMDDLQMPPKPCFSSSRHISGREIESDSSTEFLVSEWTEECSFN 507
             +M +V+EM+EG++D L++PP+P     + I    ++  S+    +S +TE CS N
Sbjct:   613 AMNRVVEMMEGNLDALEVPPRPVL---QQIPTATLQESSTFSEDISAYTEICSIN 664

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 839 (300.4 bits), Expect = 9.1e-84, P = 9.1e-84
 Identities = 175/382 (45%), Positives = 243/382 (63%)

Query:   135 LIIGRFILAPIVFLVFLIHKYRTTLQTVDNIEKFLHNQQSW-MPKRYSYPEIIAVTNHFT 193
             LI+G      ++ L+ ++   RT  + + N E    N ++  M KRYSY  +  +TN F 
Sbjct:   277 LIVGVSAALTLMILIVVVIIVRT--KNMRNSEWNDQNVEAVAMLKRYSYTRVKKMTNSFA 334

Query:   194 HKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
             H LG+GGFG+VYKG+L  +GR +AVK+L+ S+ + EEFINEV+++ R  HVN+V LLGFC
Sbjct:   335 HVLGKGGFGTVYKGKLADSGRDVAVKILKVSEGNGEEFINEVASMSRTSHVNIVSLLGFC 394

Query:   253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
              E +KRA++YEFMPNGSLD++I    N      WE+L ++A+G +RG+ YLHN C   I+
Sbjct:   395 YEKNKRAIIYEFMPNGSLDKYI--SANMSTKMEWERLYDVAVGISRGLEYLHNRCVTRIV 452

Query:   313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
             HFDIKP NIL+D N  PK+SDFGLAK    +   +S+   RGT GYIAPE+ S+NFG VS
Sbjct:   453 HFDIKPQNILMDENLCPKISDFGLAKLCKNKESIISMLHMRGTFGYIAPEMFSKNFGAVS 512

Query:   373 CKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA--YFPSWVYDQLNKGGDLEL--RNVTEI 428
              KSDVY +GMV+LEM G +    +    S+    YFP WVY    KG    +   ++T+ 
Sbjct:   513 HKSDVYSYGMVVLEMIGAKNIEKVEYSGSNNGSMYFPEWVYKDFEKGEITRIFGDSITDE 572

Query:   429 ESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKPC-FSSSRHISGREI 487
             E  IA+KL ++ LWCIQ+  +DRP M KV+EMLEG+++ LQ+PP P  FS    +     
Sbjct:   573 EEKIAKKLVLVALWCIQMNPSDRPPMIKVIEMLEGNLEALQVPPNPLLFSPEETVPDTLE 632

Query:   488 ESDSSTEFLVSEWTEECSFNDS 509
             +SD ++ F      E  +  DS
Sbjct:   633 DSDDTSTFFNPSHFERGTLLDS 654

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)]

 Score = 820 (293.7 bits), Expect = 9.3e-84, Sum P(2) = 9.3e-84
 Identities = 177/381 (46%), Positives = 242/381 (63%)

Query:   124 ISFLLGFPVDVLIIGRFILAPIVFLVFLIH--KYRTTLQTVDNIEKFLHNQQSWMP-KRY 180
             ++ ++G  V +  IG FI     FLV L    K R       + ++     ++ +P K Y
Sbjct:   281 MAIIIGIFVALCTIGGFI----AFLVLLCPCCKVRIFRNRKTSDDRRQEKLKALIPLKHY 336

Query:   181 SYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFS-AEEFINEVSTIGR 239
             +Y ++  +T  F   +G+GGFG VY+G L  GR++AVK+L+ SK + +E+FINEVS++ +
Sbjct:   337 TYAQVKRMTKSFAEVVGRGGFGIVYRGTLCDGRMVAVKVLKESKGNNSEDFINEVSSMSQ 396

Query:   240 IHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARG 299
               HVN+V LLGFCSEGS+RA++YEF+ NGSLD+ I   E          L  IALG ARG
Sbjct:   397 TSHVNIVSLLGFCSEGSRRAIIYEFLENGSLDKFI--SEKTSVILDLTALYGIALGVARG 454

Query:   300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
             + YLH GC   I+HFDIKP N+LLD N  PKVSDFGLAK   K+   +S+  TRGTIGYI
Sbjct:   455 LEYLHYGCKTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCEKKESVMSLMDTRGTIGYI 514

Query:   360 APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM--NAIRSSKAYFPSWVYDQLNKG 417
             APE+ISR +G+VS KSDVY +GM++ EM G R+      N+   S  YFP W+Y  L K 
Sbjct:   515 APEMISRVYGSVSHKSDVYSYGMLVFEMIGARKKERFGQNSANGSSMYFPEWIYKDLEKA 574

Query:   418 --GDLE-LR-NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPK 473
               GDLE +   ++  E  IA+K+ ++GLWCIQ   +DRP M KV+EM+EGS+D L++PP+
Sbjct:   575 DNGDLEHIEIGISSEEEEIAKKMTLVGLWCIQSSPSDRPPMNKVVEMMEGSLDALEVPPR 634

Query:   474 PCFSSSRHISGREIESDSSTE 494
             P      H+ G  +ES   TE
Sbjct:   635 PVLQQI-HV-GPLLESSWITE 653

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2177152 AT5G39030 [Arabidopsis thaliana (taxid:3702)]

 Score = 814 (291.6 bits), Expect = 4.1e-81, P = 4.1e-81
 Identities = 166/317 (52%), Positives = 214/317 (67%)

Query:   180 YSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGR 239
             Y+Y E+  +T  F++ +G+GGFG+VY G L  GR +AVK+L++ K SAE+FINEV+++ +
Sbjct:   488 YTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVASMSQ 547

Query:   240 IHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARG 299
               HVN+V LLGFC EGSKRA+VYEF+ NGSLD+  F   NK  T     L  IALG ARG
Sbjct:   548 TSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQ--FMSRNKSLTQDVTTLYGIALGIARG 605

Query:   300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
             + YLH GC   I+HFDIKP NILLD N  PKVSDFGLAK   K    +S+  TRGTIGYI
Sbjct:   606 LEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIGYI 665

Query:   360 APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRS--SKAYFPSWVYDQLNKG 417
             APE+ SR +G VS KSDVY FGM++++M G R    +  + S  S  YFP W+Y  L  G
Sbjct:   666 APEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPDWIYKDLEDG 725

Query:   418 GDLEL--RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKPC 475
                 +    +T+ E  IA+K+ ++GLWCIQ   +DRPSM +V+EM+EGS+D L++PPKP 
Sbjct:   726 EQTWIFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEGSLDALEIPPKP- 784

Query:   476 FSSSRHISGREIESDSS 492
                S HIS   I   SS
Sbjct:   785 ---SMHISTEVITESSS 798

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)]

 Score = 809 (289.8 bits), Expect = 1.4e-80, P = 1.4e-80
 Identities = 166/346 (47%), Positives = 226/346 (65%)

Query:   141 ILAPIVFLVFLI---HKYRTTLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLG 197
             +L  IV +  ++   H  R +    +NIE  +      M KRYS+ ++  +TN F H +G
Sbjct:   473 VLISIVVIALVVRARHAKRKSELNDENIEAVV------MLKRYSFEKVKKMTNSFDHVIG 526

Query:   198 QGGFGSVYKGQLH--TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG 255
             +GGFG+VYKG+L   +GR IA+K+L+ SK + EEFINE+ ++ R  HVN+V L GFC EG
Sbjct:   527 KGGFGTVYKGKLPDASGRDIALKILKESKGNGEEFINELVSMSRASHVNIVSLFGFCYEG 586

Query:   256 SKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFD 315
             S+RA++YEFMPNGSLD+ I   EN      W+ L  IA+G ARG+ YLHN C   I+HFD
Sbjct:   587 SQRAIIYEFMPNGSLDKFI--SENMSTKIEWKTLYNIAVGVARGLEYLHNSCVSKIVHFD 644

Query:   316 IKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKS 375
             IKP NIL+D +  PK+SDFGLAK   K+   +S+   RGT+GYIAPE+ S+N+G VS KS
Sbjct:   645 IKPQNILIDEDLCPKISDFGLAKLCKKKESIISMLDARGTVGYIAPEMFSKNYGGVSHKS 704

Query:   376 DVYGFGMVLLEMAGGRRNSNM--NAIRSSKAYFPSWVYDQLNKGGDLELRN----VTEIE 429
             DVY +GMV+LEM G  +   +  +A   S  YFP WVY+ L +   + L        E E
Sbjct:   705 DVYSYGMVVLEMIGATKREEVETSATDKSSMYFPDWVYEDLERKETMRLLEDHIIEEEEE 764

Query:   430 SVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS-MDDLQMPPKP 474
               I +++ ++GLWCIQ   +DRP M KV+EMLEGS ++ LQ+PPKP
Sbjct:   765 EKIVKRMTLVGLWCIQTNPSDRPPMRKVVEMLEGSRLEALQVPPKP 810

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2177142 AT5G39020 [Arabidopsis thaliana (taxid:3702)]

 Score = 807 (289.1 bits), Expect = 2.2e-80, P = 2.2e-80
 Identities = 168/365 (46%), Positives = 236/365 (64%)

Query:   134 VLIIGRFI-LAP-IVFLVFLIHKYRTTLQTVDN-IEKFLHNQQSWMPKRYSYPEIIAVTN 190
             ++++G  I LA  IV ++ LI + +      +N +  F       + K+Y Y E+  +T 
Sbjct:   442 LIVVGSVIGLATFIVIIMLLIRQMKRKKNKKENSVIMF-----KLLLKQYIYAELKKITK 496

Query:   191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
              F+H +G+GGFG+VY+G L  GR +AVK+L++ K + ++FINEV+++ +  HVN+V LLG
Sbjct:   497 SFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEVTSMSQTSHVNIVSLLG 556

Query:   251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
             FC EGSKRA++ EF+ +GSLD+ I    NK  T     L  IALG ARG+ YLH GC   
Sbjct:   557 FCYEGSKRAIISEFLEHGSLDQFI--SRNKSLTPNVTTLYGIALGIARGLEYLHYGCKTR 614

Query:   311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
             I+HFDIKP NILLD NF PKV+DFGLAK   K    +S+  TRGTIGYIAPE++SR +G 
Sbjct:   615 IVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGTIGYIAPEVVSRMYGG 674

Query:   371 VSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL--RNVTEI 428
             +S KSDVY +GM++L+M G R          S AYFP W+Y  L  G    +    + E 
Sbjct:   675 ISHKSDVYSYGMLVLDMIGARNKVETTTCNGSTAYFPDWIYKDLENGDQTWIIGDEINEE 734

Query:   429 ESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKPCFSSSRHISGREIE 488
             ++ I +K+ ++ LWCI+   +DRP M KV+EM+EGS+D L++PPKP    SRHIS  E+ 
Sbjct:   735 DNKIVKKMILVSLWCIRPCPSDRPPMNKVVEMIEGSLDALELPPKP----SRHIS-TELV 789

Query:   489 SDSST 493
              +SS+
Sbjct:   790 LESSS 794

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

TAIR|locus:2019713 AT1G67000 [Arabidopsis thaliana (taxid:3702)]

 Score = 803 (287.7 bits), Expect = 6.0e-80, P = 6.0e-80
 Identities = 181/407 (44%), Positives = 252/407 (61%)

Query:   111 RSYRNIESRLGVWISFLLGFPVDVLIIGRFILAPIVFLVFLIHKYRTTLQTVDNIEKFLH 170
             R +R   + L  +    LG    V+I+   +L P  F V +  K +T+    D +   L 
Sbjct:   483 RRHRRFIATLVRYTFIALGALTGVVIVFLVLLCPC-FRVQIFRKRKTS----DEVR--LQ 535

Query:   171 NQQSWMP-KRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFS-AE 228
               ++ +P K Y+Y E+  +T  FT  +G+GGFG VY G L    ++AVK+L++SK +  E
Sbjct:   536 KLKALIPLKHYTYAEVKKMTKSFTEVVGRGGFGIVYSGTLSDSSMVAVKVLKDSKGTDGE 595

Query:   229 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEK 288
             +FINEV+++ +  HVN+V LLGFC EGS+RA++YEF+ NGSLD+ I  K +       + 
Sbjct:   596 DFINEVASMSQTSHVNIVSLLGFCCEGSRRAIIYEFLGNGSLDKFISDKSSVNLDL--KT 653

Query:   289 LQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 348
             L  IALG ARG+ YLH GC   I+HFDIKP N+LLD N  PKVSDFGLAK   K+   +S
Sbjct:   654 LYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLCPKVSDFGLAKLCEKKESILS 713

Query:   349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA-IRS--SKAY 405
             +  TRGTIGYIAPE+ISR +G+VS KSDVY +GM++LEM G R+    +   RS  S  Y
Sbjct:   714 LLDTRGTIGYIAPEMISRLYGSVSHKSDVYSYGMLVLEMIGARKKERFDQNSRSDGSSIY 773

Query:   406 FPSWVYDQLNKGG--DLE-------LRN-VTEIESVIARKLCMIGLWCIQVKAADRPSMT 455
             FP W+Y  L K    D+E       + N ++  E  IARK+ ++GLWCIQ   +DRP M 
Sbjct:   774 FPEWIYKDLEKANIKDIEKTENGGLIENGISSEEEEIARKMTLVGLWCIQSSPSDRPPMN 833

Query:   456 KVLEMLEGSMDDLQMPPKPCFS--SSRHISG---REIESDSSTEFLV 497
             KV+EM+EGS+D L++PP+P     S+  +S       ES S+++ LV
Sbjct:   834 KVVEMMEGSLDALEVPPRPVLQQISASSVSDSFWNSEESSSASDILV 880

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176717 AT5G38260 [Arabidopsis thaliana (taxid:3702)]

 Score = 802 (287.4 bits), Expect = 7.6e-80, P = 7.6e-80
 Identities = 178/390 (45%), Positives = 237/390 (60%)

Query:   119 RLGVWISFLLGFPVDVLIIGRFILAPIVFLVFLIHKYRTT--LQTVDNIEKFLHNQQSWM 176
             ++G+ I    GF      +G  ++  +  L F   K RT+  L+  DN  K L       
Sbjct:   260 KMGIGIGLGCGF------LGATLIT-VCLLCFFFQKRRTSHHLRPRDNNLKGLVQL---- 308

Query:   177 PKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVST 236
              K+YSY E+  +T  F+H LG+GGFG+VY G L  GR +AVK+L++ K + E+FINEV++
Sbjct:   309 -KQYSYAEVRKITKLFSHTLGKGGFGTVYGGNLCDGRKVAVKILKDFKSNGEDFINEVAS 367

Query:   237 IGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGT 296
             + +  HVN+V LLGFC EGSKRA+VYEF+ NGSLD+  F  E K        L  IALG 
Sbjct:   368 MSQTSHVNIVSLLGFCYEGSKRAIVYEFLENGSLDQ--FLSEKKSLNLDVSTLYRIALGV 425

Query:   297 ARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 356
             ARG+ YLH+GC   I+HFDIKP NILLD  F PKVSDFGLAK   K    +S+   RGTI
Sbjct:   426 ARGLDYLHHGCKTRIVHFDIKPQNILLDDTFCPKVSDFGLAKLCEKRESILSLLDARGTI 485

Query:   357 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS--NMNAIRSSKAYFPSWVYDQL 414
             GYIAPE+ S  +G VS KSDVY +GM++LEM G +        A  SS AYFP W+Y  L
Sbjct:   486 GYIAPEVFSGMYGRVSHKSDVYSYGMLVLEMIGAKNKEIEETAASNSSSAYFPDWIYKNL 545

Query:   415 NKGGDLEL--RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPP 472
               G D       ++  +  +A+K+ ++GLWCIQ    +RP M +++EM+EGS+D L++PP
Sbjct:   546 ENGEDTWKFGDEISREDKEVAKKMTLVGLWCIQPSPLNRPPMNRIVEMMEGSLDVLEVPP 605

Query:   473 KPCFSSSRHISGREIESDSSTEFLVSEWTE 502
             KP    S H S   +   SS     S +TE
Sbjct:   606 KP----SIHYSAEPLPQLSSFSEENSIYTE 631

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)]

 Score = 785 (281.4 bits), Expect = 4.8e-78, P = 4.8e-78
 Identities = 165/348 (47%), Positives = 227/348 (65%)

Query:   135 LIIG-RFILAPIVFLVFLIHKYRTT-LQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHF 192
             LI+G   +LA ++ +V ++ K R   ++  D  EK +  +   M KR+SY ++  +T  F
Sbjct:   405 LILGVSSVLATMIIIV-IVGKVRANNMRKSDLNEKNM--EAVVMLKRFSYVQVKKMTKSF 461

Query:   193 THKLGQGGFGSVYKGQLHTG-RLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
              + LG+GGFG+VYKG+L  G R +AVK+L+ S    E+FINE++++ R  H N+V LLGF
Sbjct:   462 ENVLGKGGFGTVYKGKLPDGSRDVAVKILKESNEDGEDFINEIASMSRTSHANIVSLLGF 521

Query:   252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
             C EG K+A++YE MPNGSLD+ I   +N      W+ L  IA+G + G+ YLH+ C   I
Sbjct:   522 CYEGRKKAIIYELMPNGSLDKFI--SKNMSAKMEWKTLYNIAVGVSHGLEYLHSHCVSRI 579

Query:   312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
             +HFDIKP NIL+D +  PK+SDFGLAK        +S+   RGTIGYIAPE+ S+NFG V
Sbjct:   580 VHFDIKPQNILIDGDLCPKISDFGLAKLCKNNESIISMLHARGTIGYIAPEVFSQNFGGV 639

Query:   372 SCKSDVYGFGMVLLEMAGGRRNSN-MNAIRSSKA-YFPSWVYDQLNKGGDLELR--NVTE 427
             S KSDVY +GMV+LEM G R      NA  S+ + YFP W+Y  L KG  +      +TE
Sbjct:   640 SHKSDVYSYGMVVLEMIGARNIGRAQNAGSSNTSMYFPDWIYKDLEKGEIMSFLADQITE 699

Query:   428 IESV-IARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKP 474
              E   I +K+ ++GLWCIQ    DRP M+KV+EMLEGS++ LQ+PPKP
Sbjct:   700 EEDEKIVKKMVLVGLWCIQTNPYDRPPMSKVVEMLEGSLEALQIPPKP 747

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176697 AT5G38240 [Arabidopsis thaliana (taxid:3702)]

 Score = 751 (269.4 bits), Expect = 1.9e-74, P = 1.9e-74
 Identities = 155/305 (50%), Positives = 202/305 (66%)

Query:   196 LGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG 255
             +G+GGFG+VYKG L  GR +AVK+L++S  + E+FINEV++I +  HVN+V LLGFC E 
Sbjct:   287 VGRGGFGTVYKGNLRDGRKVAVKILKDSNGNCEDFINEVASISQTSHVNIVSLLGFCFEK 346

Query:   256 SKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFD 315
             SKRA+VYEF+ NGSLD+                L  IALG ARG+ YLH GC   I+HFD
Sbjct:   347 SKRAIVYEFLENGSLDQ--------SSNLDVSTLYGIALGVARGIEYLHFGCKKRIVHFD 398

Query:   316 IKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKS 375
             IKP N+LLD N  PKV+DFGLAK   K+   +S+  TRGTIGYIAPEL SR +G VS KS
Sbjct:   399 IKPQNVLLDENLKPKVADFGLAKLCEKQESILSLLDTRGTIGYIAPELFSRVYGNVSHKS 458

Query:   376 DVYGFGMVLLEMAGGRRNSNM-NA-IRSSKAYFPSWVYDQLNKGGDLELR--NVTEIESV 431
             DVY +GM++LEM G R    + NA   +S AYFP W++  L  G  ++L    +T  E  
Sbjct:   459 DVYSYGMLVLEMTGARNKERVQNADSNNSSAYFPDWIFKDLENGDYVKLLADGLTREEED 518

Query:   432 IARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKPCF----SSSRHISGREI 487
             IA+K+ ++GLWCIQ + +DRPSM KV+ M+EG++D L  PPKP       ++   S +  
Sbjct:   519 IAKKMILVGLWCIQFRPSDRPSMNKVVGMMEGNLDSLDPPPKPLLHMPMQNNNAESSQPS 578

Query:   488 ESDSS 492
             E DSS
Sbjct:   579 EEDSS 583

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	511
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-49
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-49
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-48
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-47
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-45
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-44
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-41
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-38
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-32
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-31
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-31
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-30
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-29
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-28
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-28
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-27
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-27
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-26
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-25
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-25
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-25
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-25
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-25
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-24
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-24
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-24
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-24
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-23
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-23
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-23
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-23
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-23
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-23
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-23
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-23
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-23
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-23
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-22
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-22
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-22
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-22
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-21
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-21
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-21
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	8e-21
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-21
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-20
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-20
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-20
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-20
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-20
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	9e-20
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-19
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-19
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-19
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-18
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-18
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-18
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-18
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	7e-18
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-17
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-17
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-17
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-17
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-17
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-16
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-16
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-16
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	9e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	9e-16
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-15
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-15
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-15
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-15
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-15
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	9e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-14
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-14
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-14
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-14
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-14
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-14
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-14
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-14
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	7e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	9e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	9e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-14
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-13
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-13
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-13
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-12
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-12
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-12
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-12
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	8e-12
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	9e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	9e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-11
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-10
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-10
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-10
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	6e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-08
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-08
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-07
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	6e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	6e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	6e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-07
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	9e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-06
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-06
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-06
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-06
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	9e-06
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	9e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-04
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	6e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	8e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	9e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.001
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.002
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.002
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	0.002
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.002
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	0.002
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	0.003

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  170 bits (434), Expect = 1e-49
 Identities = 83/281 (29%), Positives = 132/281 (46%), Gaps = 36/281 (12%)

Query: 192 FTHKLGQGGFGSVYKGQL-----HTGRLIAVKMLENSKFSA--EEFINEVSTIGRIHHVN 244
              KLG+G FG VYKG L          +AVK L+        EEF+ E   + ++ H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
           +V+LLG C+E     +V E+MP G L  ++  ++N+ +      L   AL  ARG+ YL 
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLE 120

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
                  +H D+   N L+  N + K+SDFGL++    ++D+  +   +  I ++APE  
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKVKGGKLPIRWMAPE-- 174

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL 422
           S   G  + KSDV+ FG++L E+   G      M+            V + L KG  L  
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE---------VLEYLKKGYRLPK 225

Query: 423 RNV--TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEML 461
                 E+  ++        L C      DRP+ ++++E+L
Sbjct: 226 PPNCPPELYKLM--------LQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  169 bits (431), Expect = 4e-49
 Identities = 76/283 (26%), Positives = 132/283 (46%), Gaps = 42/283 (14%)

Query: 191 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFI---NEVSTIGRIHHVNVV 246
               KLG G FG+VYK +   TG+++AVK+L+     +++      E+  + R+ H N+V
Sbjct: 2   ELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIV 61

Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L+    +     LV E+   G L  ++     +G     ++ ++IAL   RG+ YLH+ 
Sbjct: 62  RLIDAFEDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLHS- 116

Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               I+H D+KP NILLD N + K++DFGLAK   K +  ++     GT  Y+APE++  
Sbjct: 117 --NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV--GTPWYMAPEVLLG 172

Query: 367 NFGTVSCKSDVYGFGMVLLEMAGGR----------RNSNMNAIRSSKAYFPSWVYDQLNK 416
             G    K DV+  G++L E+  G+          +   +  I      F    +   ++
Sbjct: 173 GNG-YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSE 231

Query: 417 GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
                     E + +I          C+    + RP+  ++L+
Sbjct: 232 ----------EAKDLIK--------KCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  168 bits (427), Expect = 1e-48
 Identities = 82/281 (29%), Positives = 129/281 (45%), Gaps = 37/281 (13%)

Query: 192 FTHKLGQGGFGSVYKGQL-----HTGRLIAVKMLENSKFSA--EEFINEVSTIGRIHHVN 244
              KLG+G FG VYKG+L          +AVK L+        EEF+ E   + ++ H N
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
           VV+LLG C+E     +V E+M  G L  ++  ++N+        L   AL  ARG+ YL 
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRP-KLSLSDLLSFALQIARGMEYLE 119

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
                  +H D+   N L+  N + K+SDFGL++    + D+      +  I ++APE  
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-DYYRKRGGKLPIRWMAPE-- 173

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL 422
           S   G  + KSDV+ FG++L E+   G +    M+            V + L  G  L  
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE---------VLEYLKNGYRLPQ 224

Query: 423 RNV--TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEML 461
                 E+  ++        L C      DRP+ ++++E+L
Sbjct: 225 PPNCPPELYDLM--------LQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  163 bits (414), Expect = 3e-47
 Identities = 65/196 (33%), Positives = 107/196 (54%), Gaps = 13/196 (6%)

Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           LG+GGFG+VY  +   TG+ +A+K++  E+S    EE + E+  + +++H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
            + +   LV E+   GSL   +   +        +++  I L    G+ YLH+     I+
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLL---KENEGKLSEDEILRILLQILEGLEYLHS---NGII 114

Query: 313 HFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           H D+KP NILLD  N   K++DFGL+K    +   +      GT  Y+APE++    G  
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGK-GYY 171

Query: 372 SCKSDVYGFGMVLLEM 387
           S KSD++  G++L E+
Sbjct: 172 SEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  159 bits (406), Expect = 1e-45
 Identities = 81/283 (28%), Positives = 133/283 (46%), Gaps = 38/283 (13%)

Query: 191 HFTHKLGQGGFGSVYKGQLH-----TGRLIAVKMLENSKFSA--EEFINEVSTIGRIHHV 243
               KLG+G FG VYKG L      T   +AVK L+        EEF+ E S + ++ H 
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61

Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           N+V+LLG C++G    +V E+MP G L   +      G+    + L ++AL  A+G+ YL
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYL 118

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
                   +H D+   N L+  N + K+SDFGL++   +++ +      +  I ++APE 
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPES 175

Query: 364 ISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE 421
           +    G  + KSDV+ FG++L E+   G +    M+            V + L  G  L 
Sbjct: 176 L--KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE---------VLELLEDGYRLP 224

Query: 422 LRNV---TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEML 461
            R      E+  ++ +        C      DRP+ ++++E L
Sbjct: 225 -RPENCPDELYELMLQ--------CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  156 bits (398), Expect = 2e-44
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGF 251
           KLG+G FG VY  +   TG+L+A+K+++  K     E  + E+  + ++ H N+V+L   
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
             +  K  LV E+   G L   +  K+    +   ++ +         + YLH      I
Sbjct: 66  FEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSE--DEARFYLRQILSALEYLH---SKGI 118

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKF---HPKENDFVSISATRGTIGYIAPELISRNF 368
           +H D+KP NILLD +   K++DFGLA+      K   FV      GT  Y+APE++    
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV------GTPEYMAPEVLLGK- 171

Query: 369 GTVSCKSDVYGFGMVLLEMAGGR 391
                  D++  G++L E+  G+
Sbjct: 172 -GYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  149 bits (378), Expect = 1e-41
 Identities = 83/284 (29%), Positives = 134/284 (47%), Gaps = 39/284 (13%)

Query: 195 KLGQGGFGSVYKGQLHTG----RLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQL 248
           KLG+G FG VYKG+L         +AVK L+      E  +F+ E   + ++ H NVV+L
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 249 LGFCSEGSKRALVYEFMPNGSLD------RHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           LG C+E     LV E+M  G L       R +FP   K  T   + L   A+  A+G+ Y
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEK-STLSLKDLLSFAIQIAKGMEY 120

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
           L +      +H D+   N L+  + + K+SDFGL++    ++ +   +  +  I ++APE
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 363 LISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDL 420
            +    G  + KSDV+ FG++L E+   G      ++            V + L KG  L
Sbjct: 178 SL--KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS---------NEEVLEYLRKGYRL 226

Query: 421 EL-RNVT-EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
                   E+  ++        L C Q+   DRP+ ++++E LE
Sbjct: 227 PKPEYCPDELYELM--------LSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  140 bits (355), Expect = 3e-38
 Identities = 68/210 (32%), Positives = 102/210 (48%), Gaps = 25/210 (11%)

Query: 194 HKLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLL 249
             LG+G FGSVY      TG L+AVK +E   +S+   E    E+  +  + H N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 250 GFCSEGSKRAL-VY-EFMPNGSLDRHIFPKENKGQTFGWEKLQE--IALGTA---RGVAY 302
           G   +  K  L ++ E++  GSL   +       + FG  KL E  I   T     G+AY
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLL-------KKFG--KLPEPVIRKYTRQILEGLAY 116

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
           LH      I+H DIK  NIL+D + + K++DFG AK            + RGT  ++APE
Sbjct: 117 LH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173

Query: 363 LISRNFGTVSCKSDVYGFGMVLLEMAGGRR 392
           +I          +D++  G  ++EMA G+ 
Sbjct: 174 VIRG--EEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  123 bits (310), Expect = 6e-32
 Identities = 61/200 (30%), Positives = 103/200 (51%), Gaps = 13/200 (6%)

Query: 194 HKLGQGGFGSVYKG-QLHTGRLIAVKML-ENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
            K+G+GGFG VYK     TG+ +A+K++   SK   E+ INE+  + +  H N+V+  G 
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
             +  +  +V EF   GSL   +   ++  QT    ++  +     +G+ YLH+     I
Sbjct: 66  YLKKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLKGLEYLHS---NGI 119

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           +H DIK  NILL  +   K+ DFGL+          ++    GT  ++APE+I+      
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVING--KPY 174

Query: 372 SCKSDVYGFGMVLLEMAGGR 391
             K+D++  G+  +E+A G+
Sbjct: 175 DYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  120 bits (302), Expect = 5e-31
 Identities = 81/275 (29%), Positives = 133/275 (48%), Gaps = 32/275 (11%)

Query: 192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
              ++G G FG V+ G     R +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
           C+E S   LV+EFM +G L  ++  +  K   F  E L  + L    G+AYL +     +
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYLESS---NV 121

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSPEVFS--FSKY 178

Query: 372 SCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG-----GDLELRNVT 426
           S KSDV+ FG+++ E+    +    N  RS+     S V + +N G       L  ++V 
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPYEN--RSN-----SEVVETINAGFRLYKPRLASQSVY 231

Query: 427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEML 461
           E+              C + +  DRPS + +L  L
Sbjct: 232 ELMQ-----------HCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  120 bits (302), Expect = 7e-31
 Identities = 78/280 (27%), Positives = 134/280 (47%), Gaps = 41/280 (14%)

Query: 196 LGQGGFGSVYKGQLH-TGR---LIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQLL 249
           +G G FG V +G+L   G+    +A+K L+      +  +F+ E S +G+  H N+++L 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G  ++     ++ E+M NGSLD+  F +EN G+ F   +L  +  G A G+ YL    +M
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDK--FLRENDGK-FTVGQLVGMLRGIASGMKYL---SEM 125

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
             +H D+   NIL++ N + KVSDFGL++         +    +  I + APE I+  + 
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA--YR 183

Query: 370 TVSCKSDVYGFGMVLLE-MAGGRRNSNMNAIRSSKAYFPSW------VYDQLNKGGDLEL 422
             +  SDV+ FG+V+ E M+ G R              P W      V   +  G    L
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGER--------------PYWDMSNQDVIKAVEDG--YRL 227

Query: 423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
               +  S + +    + L C Q    +RP+ ++++  L+
Sbjct: 228 PPPMDCPSALYQ----LMLDCWQKDRNERPTFSQIVSTLD 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  119 bits (300), Expect = 1e-30
 Identities = 67/194 (34%), Positives = 101/194 (52%), Gaps = 10/194 (5%)

Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLE-NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS 253
           KLG G FG V++G       +A+K+L+ +     ++F  EV  + R+ H +++ L   CS
Sbjct: 13  KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72

Query: 254 EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILH 313
            G    ++ E M  GSL    F +  +GQ      L ++A   A G+AYL    +   +H
Sbjct: 73  VGEPVYIITELMEKGSL--LAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIH 127

Query: 314 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC 373
            D+   NIL+  + + KV+DFGLA+   KE D    S  +    + APE  S   GT S 
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARL-IKE-DVYLSSDKKIPYKWTAPEAASH--GTFST 183

Query: 374 KSDVYGFGMVLLEM 387
           KSDV+ FG++L EM
Sbjct: 184 KSDVWSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  116 bits (293), Expect = 1e-29
 Identities = 65/193 (33%), Positives = 104/193 (53%), Gaps = 8/193 (4%)

Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLG G FG V+ G  +    +AVK L+    S E F+ E   + ++ H  +VQL   CSE
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V E+M  GSL    F K  +G+     +L ++A   A G+AYL +      +H 
Sbjct: 73  EEPIYIVTEYMSKGSLLD--FLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHR 127

Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D+   NIL+  N + K++DFGLA+   +++++ +    +  I + APE    N+G  + K
Sbjct: 128 DLAARNILVGENLVCKIADFGLARL-IEDDEYTAREGAKFPIKWTAPEAA--NYGRFTIK 184

Query: 375 SDVYGFGMVLLEM 387
           SDV+ FG++L E+
Sbjct: 185 SDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  112 bits (282), Expect = 3e-28
 Identities = 60/196 (30%), Positives = 104/196 (53%), Gaps = 9/196 (4%)

Query: 192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           F  +LG G FG V+ G+      +A+KM+     S ++FI E   + ++ H N+VQL G 
Sbjct: 8   FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
           C++     +V E+M NG L    + +E KG+  G E L ++       + YL +      
Sbjct: 68  CTKQRPIFIVTEYMANGCLLN--YLRERKGK-LGTEWLLDMCSDVCEAMEYLESN---GF 121

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           +H D+   N L+  + + KVSDFGLA++   ++ + S   T+  + +  PE+   ++   
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARY-VLDDQYTSSQGTKFPVKWAPPEVF--DYSRF 178

Query: 372 SCKSDVYGFGMVLLEM 387
           S KSDV+ FG+++ E+
Sbjct: 179 SSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  111 bits (280), Expect = 8e-28
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 8/204 (3%)

Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHV 243
           EI   +     KLG G FG V++G  +    +AVK L+      ++F+ E   + ++ H 
Sbjct: 2   EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61

Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
            ++QL   C+      +V E M  GSL  ++  +   G+     +L ++A   A G+AYL
Sbjct: 62  KLIQLYAVCTLEEPIYIVTELMKYGSLLEYL--QGGAGRALKLPQLIDMAAQVASGMAYL 119

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
                   +H D+   N+L+  N I KV+DFGLA+   KE+ + +    +  I + APE 
Sbjct: 120 EA---QNYIHRDLAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAPEA 175

Query: 364 ISRNFGTVSCKSDVYGFGMVLLEM 387
               +   S KSDV+ FG++L E+
Sbjct: 176 A--LYNRFSIKSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  108 bits (273), Expect = 7e-27
 Identities = 72/280 (25%), Positives = 123/280 (43%), Gaps = 45/280 (16%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 250
           ++G+G FG VY  +    G+L  +K ++ S  S +E    +NEV  + +++H N+++   
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
              E  K  +V E+   G L + I  ++ +G+ F  E++ +  +     + YLH      
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRK 123

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR---N 367
           ILH DIKP NI L  N + K+ DFG++K     +         GT  Y++PEL      N
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYYLSPELCQNKPYN 181

Query: 368 FGTVSCKSDVYGFGMVLLEMAGGRR-------NSNMNAIRSSKAYFPSWVYDQLNKGGDL 420
           +     KSD++  G VL E+   +              I   +       Y  +      
Sbjct: 182 Y-----KSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-------YPPIPSQYSS 229

Query: 421 ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM 460
           ELRN+  + S             +Q    +RPS+ ++L+ 
Sbjct: 230 ELRNL--VSS------------LLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  109 bits (273), Expect = 7e-27
 Identities = 80/274 (29%), Positives = 125/274 (45%), Gaps = 30/274 (10%)

Query: 194 HKLGQGGFGSVYKGQLHT-GRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           HKLG G +G VY+G        +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           +      ++ EFM  G+L  ++  +E   Q      L  +A   +  + YL        +
Sbjct: 72  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFI 126

Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+   N L+  N + KV+DFGL++     + + + +  +  I + APE  S  +   S
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE--SLAYNKFS 183

Query: 373 CKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP----SWVYDQLNKGGDLELRNVTEI 428
            KSDV+ FG++L E+A               + +P    S VY+ L KG  +E R     
Sbjct: 184 IKSDVWAFGVLLWEIA-----------TYGMSPYPGIDLSQVYELLEKGYRME-RPEGCP 231

Query: 429 ESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
             V       +   C Q   +DRPS  ++ +  E
Sbjct: 232 PKVYE-----LMRACWQWNPSDRPSFAEIHQAFE 260

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  109 bits (274), Expect = 9e-27
 Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 18/206 (8%)

Query: 192 FTHKLGQGGFGSVYKGQL-----HTGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVN 244
           F  +LG+G FG V   +      +TG  +AVK L +S  +    +F  E+  +  + H N
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 245 VVQLLGFCSEGSKRA--LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           +V+  G C +   R+  L+ E++P+GSL    + + ++ Q    ++L   +    +G+ Y
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLR--DYLQRHRDQ-INLKRLLLFSSQICKGMDY 124

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAP 361
           L +      +H D+   NIL++   + K+SDFGLAK  P++ D+  +     + I + AP
Sbjct: 125 LGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181

Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEM 387
           E +  +    S  SDV+ FG+ L E+
Sbjct: 182 ECLRTS--KFSSASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  110 bits (275), Expect = 2e-26
 Identities = 68/209 (32%), Positives = 99/209 (47%), Gaps = 17/209 (8%)

Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFS----AEEFINEVSTIGRI-HHVNVVQLL 249
           KLG+G FG VY  +    +L+A+K+L     S     E F+ E+  +  + H  N+V+L 
Sbjct: 7   KLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
            F  +     LV E++  GSL   +  K  +       +   I       + YLH     
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSL-EDLLKKIGRKGPLSESEALFILAQILSALEYLH---SK 120

Query: 310 CILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR----GTIGYIAPELI 364
            I+H DIKP NILLD +  + K+ DFGLAK  P      SI A      GT GY+APE++
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180

Query: 365 SR-NFGTVSCKSDVYGFGMVLLEMAGGRR 392
              +    S  SD++  G+ L E+  G  
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLP 209

Length = 384

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  107 bits (270), Expect = 2e-26
 Identities = 67/217 (30%), Positives = 111/217 (51%), Gaps = 20/217 (9%)

Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEE-----------FINEVSTIGRIHHV 243
           +G+G +G VY    + TG ++AVK +E     A               +E+ T+  + H+
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           N+VQ LGF +     ++  E++P GS+   +      G+ F  + ++        G+AYL
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCL---RTYGR-FEEQLVRFFTEQVLEGLAYL 124

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
           H+     ILH D+K  N+L+D + I K+SDFG++K      D     + +G++ ++APE+
Sbjct: 125 HS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181

Query: 364 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNAI 399
           I       S K D++  G V+LEM  GRR  S+  AI
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  105 bits (264), Expect = 1e-25
 Identities = 78/290 (26%), Positives = 123/290 (42%), Gaps = 62/290 (21%)

Query: 194 HKLGQGGFGSVYKGQLH--TGRLIAVK---MLENSKFSAEEFINEVSTIGRIHHVNVVQL 248
             LGQG  G VYK + H  TG++ A+K   +  + +F  ++ + E+ T+       VV+ 
Sbjct: 7   KVLGQGSSGVVYKVR-HKPTGKIYALKKIHVDGDEEFR-KQLLRELKTLRSCESPYVVKC 64

Query: 249 LG-FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            G F  EG    +V E+M  GSL   +       +      L  IA    +G+ YLH   
Sbjct: 65  YGAFYKEGEIS-IVLEYMDGGSLADLLKKVGKIPEPV----LAYIARQILKGLDYLHT-- 117

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP----KENDFVSISATRGTIGYIAPEL 363
              I+H DIKP N+L++     K++DFG++K       + N FV      GT+ Y++PE 
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV------GTVTYMSPER 171

Query: 364 I-SRNFGTVSCKSDVYGFGMVLLEMAGGR-----RNSN-----MNAIRSSKAYFPSWVYD 412
           I   ++      +D++  G+ LLE A G+              M AI       PS   +
Sbjct: 172 IQGESYSY---AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP--PSLPAE 226

Query: 413 QLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
           + +           E    I+         C+Q     RPS     E+L+
Sbjct: 227 EFSP----------EFRDFISA--------CLQKDPKKRPS---AAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  104 bits (261), Expect = 2e-25
 Identities = 63/193 (32%), Positives = 103/193 (53%), Gaps = 9/193 (4%)

Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLG G FG V+ G  +    +AVK L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V E+M  GSL    F K+ +G+      L ++A   A G+AY+     M  +H 
Sbjct: 73  -EPIYIVTEYMSKGSL--LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHR 126

Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D++  NIL+    + K++DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 183

Query: 375 SDVYGFGMVLLEM 387
           SDV+ FG++L E+
Sbjct: 184 SDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  104 bits (261), Expect = 3e-25
 Identities = 69/208 (33%), Positives = 115/208 (55%), Gaps = 20/208 (9%)

Query: 196 LGQGGFGSVYKGQL-HTGR---LIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +G G FG V +G+L   G+    +A+K L++  ++    +F++E S +G+  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G  ++     ++ EFM NG+LD   F ++N GQ F   +L  +  G A G+ YL    +M
Sbjct: 72  GVVTKSRPVMIITEFMENGALDS--FLRQNDGQ-FTVIQLVGMLRGIAAGMKYL---SEM 125

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKF---HPKENDFVSISATRGTIGYIAPELIS- 365
             +H D+   NIL++ N + KVSDFGL++F      +  + S    +  I + APE I+ 
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185

Query: 366 RNFGTVSCKSDVYGFGMVLLE-MAGGRR 392
           R F   +  SDV+ +G+V+ E M+ G R
Sbjct: 186 RKF---TSASDVWSYGIVMWEVMSYGER 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  103 bits (258), Expect = 6e-25
 Identities = 76/239 (31%), Positives = 120/239 (50%), Gaps = 43/239 (17%)

Query: 196 LGQGGFGSVYKGQLHTGRLIAVKMLE---NSKFSAE----EFINEVSTIGRIHHVNVVQL 248
           LG+G +G+VY G  + G+LIAVK +E   ++  +AE    +   EV  +  + HVN+VQ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIAL-----GTARGVAYL 303
           LG C + +  ++  EF+P GS+   +         FG   L E            GVAYL
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSIL-------NRFG--PLPEPVFCKYTKQILDGVAYL 118

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK------FHPKENDFVSISATRGTIG 357
           HN    C++H DIK +N++L  N I K+ DFG A+       H   ++   + +  GT  
Sbjct: 119 HNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNM--LKSMHGTPY 173

Query: 358 YIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNAIRSSKAYFPS 408
           ++APE+I+ + +G    KSD++  G  + EMA G+       R + M  I + +   P 
Sbjct: 174 WMAPEVINESGYGR---KSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR 229

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  103 bits (259), Expect = 6e-25
 Identities = 68/224 (30%), Positives = 102/224 (45%), Gaps = 50/224 (22%)

Query: 194 HKLGQGGFGSVYKG-QLHTGRLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +K+G G FG VY    L TG L+AVK +   +N   + +E  +E+  +  + H N+V+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 250 G-------------FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGT 296
           G             +CS G+   L+        LD H+              ++   L  
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEH---GRILDEHV--------------IRVYTLQL 108

Query: 297 ARGVAYLH-NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF--HPKENDFVSISATR 353
             G+AYLH +G    I+H DIKP NI LDHN + K+ DFG A    +        + +  
Sbjct: 109 LEGLAYLHSHG----IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA 164

Query: 354 GTIGYIAPELISRN-----FGTVSCKSDVYGFGMVLLEMAGGRR 392
           GT  Y+APE+I+               D++  G V+LEMA G+R
Sbjct: 165 GTPAYMAPEVITGGKGKGHGRAA----DIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 1e-24
 Identities = 61/197 (30%), Positives = 100/197 (50%), Gaps = 13/197 (6%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
                +G+G FG V  G  + G+ +AVK L++   +A+ F+ E S +  + H N+VQLLG
Sbjct: 9   KLGATIGKGEFGDVMLG-DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
              +G+   +V E+M  GSL  ++  +     T    +    AL    G+ YL    +  
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITL--AQQLGFALDVCEGMEYLE---EKN 122

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
            +H D+   N+L+  + + KVSDFGLAK   +  D     + +  + + APE +      
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALRE--KK 175

Query: 371 VSCKSDVYGFGMVLLEM 387
            S KSDV+ FG++L E+
Sbjct: 176 FSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  102 bits (255), Expect = 1e-24
 Identities = 65/194 (33%), Positives = 104/194 (53%), Gaps = 9/194 (4%)

Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLGQG FG V+ G  +    +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V E+M  GSL    F K   G+     +L ++A   A G+AY+     M  +H 
Sbjct: 73  -EPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 126

Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 183

Query: 375 SDVYGFGMVLLEMA 388
           SDV+ FG++L E+ 
Sbjct: 184 SDVWSFGILLTELT 197

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  102 bits (255), Expect = 2e-24
 Identities = 82/279 (29%), Positives = 127/279 (45%), Gaps = 47/279 (16%)

Query: 196 LGQGGFGSVYKG-QLHTGRLIAVK--MLENSKFSAEEFIN----EVSTIGRIHHVNVVQL 248
           LG G FGSVY+G  L  G   AVK   L +   + +E +     E++ + ++ H N+VQ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR---GVAYLHN 305
           LG   E     +  E +P GSL           + +G      I L T +   G+ YLH 
Sbjct: 68  LGTEREEDNLYIFLELVPGGSL-------AKLLKKYGSFPEPVIRLYTRQILLGLEYLH- 119

Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
             D   +H DIK  NIL+D N + K++DFG+AK    E  F    + +G+  ++APE+I+
Sbjct: 120 --DRNTVHRDIKGANILVDTNGVVKLADFGMAK-QVVEFSF--AKSFKGSPYWMAPEVIA 174

Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW-----VYDQLNKGGDL 420
           +  G     +D++  G  +LEMA G+               P W     V      G   
Sbjct: 175 QQ-GGYGLAADIWSLGCTVLEMATGK---------------PPWSQLEGVAAVFKIGRSK 218

Query: 421 ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
           EL  + +  S  A+   +    C+Q   + RP+  ++LE
Sbjct: 219 ELPPIPDHLSDEAKDFILK---CLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  101 bits (254), Expect = 4e-24
 Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 25/207 (12%)

Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
              K+G+G  G VYK     TG+ +A+K +   K + E  INE+  +    H N+V    
Sbjct: 23  NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYD 82

Query: 251 FCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
               G +  +V E+M  GSL       F + N+ Q      +  +     +G+ YLH+  
Sbjct: 83  SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQ------IAYVCREVLQGLEYLHS-- 134

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPEL 363
              ++H DIK  NILL  +   K++DFG A    K   K N  V      GT  ++APE+
Sbjct: 135 -QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV------GTPYWMAPEV 187

Query: 364 ISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           I R       K D++  G++ +EMA G
Sbjct: 188 IKRK--DYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 4e-24
 Identities = 72/275 (26%), Positives = 131/275 (47%), Gaps = 33/275 (12%)

Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSA--EEFINEVSTIGRIHHVNVVQLLGFC 252
           K+G+G FG VYKG L     +AVK   ++       +F+ E   + +  H N+V+L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
            +     +V E +P GSL   +  K+N+      +KL +++L  A G+ YL +    CI 
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTV---KKLLQMSLDAAAGMEYLESKN--CI- 115

Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-SISATRGTI--GYIAPELISRNFG 369
           H D+   N L+  N + K+SDFG+++   +E   + ++S     I   + APE +  N+G
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEAL--NYG 170

Query: 370 TVSCKSDVYGFGMVLLEM--AGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE 427
             + +SDV+ +G++L E    G      M+  ++          +++  G  +    +  
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR---------ERIESGYRMPAPQLCP 221

Query: 428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
            E     +L +    C      +RPS +++   L+
Sbjct: 222 EE---IYRLMLQ---CWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 1e-23
 Identities = 69/267 (25%), Positives = 125/267 (46%), Gaps = 33/267 (12%)

Query: 196 LGQGGFGSVYKG----QLHTGRL-IAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG    +    ++ +A+K+L    S  + +E ++E   +  + H +VV+L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   S+  L+ + MP G L  ++  + +K    G + L    +  A+G++YL    +
Sbjct: 75  LGICL-SSQVQLITQLMPLGCLLDYV--RNHKD-NIGSQYLLNWCVQIAKGMSYLE---E 127

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    +         +  I ++A E I    
Sbjct: 128 KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI--LH 185

Query: 369 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT 426
              + KSDV+ +G+ + E+   G +    + A+          + D L KG  L    + 
Sbjct: 186 RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---------IPDLLEKGERLPQPPIC 236

Query: 427 EIESVIARKLCMIGLWCIQVKAADRPS 453
            I+      + M+ + C  + A  RP+
Sbjct: 237 TID------VYMVLVKCWMIDAESRPT 257

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =   99 bits (249), Expect = 1e-23
 Identities = 62/194 (31%), Positives = 105/194 (54%), Gaps = 11/194 (5%)

Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLG G FG V+ G  +    +A+K L+    S E F+ E + + ++ H  +V+L    ++
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72

Query: 255 GSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILH 313
                ++ E+M NGSL D   F K  +G      KL ++A   A G+A++        +H
Sbjct: 73  -EPIYIITEYMENGSLVD---FLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIH 125

Query: 314 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC 373
            D++  NIL+      K++DFGLA+   ++N++ +    +  I + APE I  N+GT + 
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAI--NYGTFTI 182

Query: 374 KSDVYGFGMVLLEM 387
           KSDV+ FG++L E+
Sbjct: 183 KSDVWSFGILLTEI 196

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 1e-23
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 28/208 (13%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKM--LENSKFSAEEF----INEVSTIGRIHHVNVVQ 247
           KLG+G +G VYK +   TG ++A+K   L+N +   E      + E+S +  + H N+V+
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE---EGIPSTALREISLLKELKHPNIVK 62

Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
           LL       K  LV+E+     L +++   + +        ++ I     RG+AY H   
Sbjct: 63  LLDVIHTERKLYLVFEYCDM-DLKKYL---DKRPGPLSPNLIKSIMYQLLRGLAYCH--- 115

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI-- 364
              ILH D+KP NIL++ + + K++DFGLA+ F      +        T+ Y APE++  
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV---TLWYRAPEILLG 172

Query: 365 SRNFGT-VSCKSDVYGFGMVLLEMAGGR 391
           S+++ T V    D++  G +  EM  G+
Sbjct: 173 SKHYSTAV----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 99.3 bits (248), Expect = 2e-23
 Identities = 66/201 (32%), Positives = 107/201 (53%), Gaps = 17/201 (8%)

Query: 194 HKLGQGGFGSVYKG--QLHTGRLI--AVKMLENSKFSA--EEFINEVSTIGRIHHVNVVQ 247
            +LG G FGSV KG   + +G+ +  AVK L+    +A  +EF+ E S + ++ H  +V+
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
           L+G C +G    LV E  P G L +++     K +      L+E+A   A G+AYL    
Sbjct: 61  LIGVC-KGEPLMLVMELAPLGPLLKYL----KKRREIPVSDLKELAHQVAMGMAYLE-SK 114

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISR 366
               +H D+   N+LL +    K+SDFG+++      + + + +A R  + + APE I  
Sbjct: 115 HF--VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI-- 170

Query: 367 NFGTVSCKSDVYGFGMVLLEM 387
           N+G  S KSDV+ +G+ L E 
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEA 191

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 99.1 bits (247), Expect = 2e-23
 Identities = 77/272 (28%), Positives = 124/272 (45%), Gaps = 35/272 (12%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLG 250
           KLG+G +GSVYK + L   +  A+K ++    S    E+ +NE+  +  ++H N++    
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
              +G+K  +V E+ P G L + I  ++ K +    +++  I +   RG+  LH   +  
Sbjct: 67  AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQK 123

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ILH D+K  NILL  N + K+ D G++K   K      I    GT  Y+APE+       
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI----GTPHYMAPEVWKGR--P 177

Query: 371 VSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR----NVT 426
            S KSD++  G +L EMA         A RS +               DL  +       
Sbjct: 178 YSYKSDIWSLGCLLYEMATFA--PPFEA-RSMQ---------------DLRYKVQRGKYP 219

Query: 427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVL 458
            I  + ++ L       +QVK   RP+  K+L
Sbjct: 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 98.9 bits (246), Expect = 3e-23
 Identities = 72/216 (33%), Positives = 120/216 (55%), Gaps = 24/216 (11%)

Query: 190 NHFTHK--LGQGGFGSVYKGQLHT-GR---LIAVKMLEN--SKFSAEEFINEVSTIGRIH 241
           +H T +  +G G FG V++G L   GR    +A+K L+   ++   ++F++E S +G+  
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 242 HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVA 301
           H N+++L G  ++     ++ E+M NG+LD+  + +++ G+ F   +L  +  G A G+ 
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDK--YLRDHDGE-FSSYQLVGMLRGIAAGMK 121

Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGY 358
           YL    DM  +H D+   NIL++ N   KVSDFGL++    E+D      T G    I +
Sbjct: 122 YL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRV--LEDDPEGTYTTSGGKIPIRW 176

Query: 359 IAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRR 392
            APE I+ R F +    SDV+ FG+V+ E M+ G R
Sbjct: 177 TAPEAIAYRKFTSA---SDVWSFGIVMWEVMSFGER 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 98.6 bits (245), Expect = 4e-23
 Identities = 64/193 (33%), Positives = 103/193 (53%), Gaps = 9/193 (4%)

Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLGQG FG V+ G  +    +A+K L+      E F+ E   + ++ H  +V L    SE
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V EFM  GSL    F KE  G+     +L ++A   A G+AY+     M  +H 
Sbjct: 73  -EPIYIVTEFMGKGSLLD--FLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHR 126

Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D++  NIL+  N + K++DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 183

Query: 375 SDVYGFGMVLLEM 387
           SDV+ FG++L E+
Sbjct: 184 SDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 97.7 bits (243), Expect = 7e-23
 Identities = 76/221 (34%), Positives = 121/221 (54%), Gaps = 26/221 (11%)

Query: 196 LGQGGFGSVYKGQLHT-GR---LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +G G FG V  G+L   G+    +A+K L+   ++    +F++E S +G+  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G  ++     +V E+M NGSLD   F +++ GQ F   +L  +  G A G+ YL    DM
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDA--FLRKHDGQ-FTVIQLVGMLRGIASGMKYL---SDM 125

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELIS- 365
             +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG    I + APE I+ 
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTAPEAIAY 183

Query: 366 RNFGTVSCKSDVYGFGMVLLE-MAGGRRN----SNMNAIRS 401
           R F   +  SDV+ +G+V+ E M+ G R     SN + I++
Sbjct: 184 RKF---TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA 221

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 97.3 bits (243), Expect = 7e-23
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 35/207 (16%)

Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAE---EFINEVSTIGRIHHVNVVQLLG 250
            +G+G FG VYKG  L TG  +A+K +   K   E     + E+  +  + H N+V+ +G
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQE--IALGTA---RGVAYLHN 305
                    ++ E+  NGSL + I       + FG     E  +A+      +G+AYLH 
Sbjct: 67  SIETSDSLYIILEYAENGSLRQII-------KKFG--PFPESLVAVYVYQVLQGLAYLHE 117

Query: 306 -GCDMCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIA 360
            G    ++H DIK  NIL   + + K++DFG+A         +   V      GT  ++A
Sbjct: 118 QG----VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV------GTPYWMA 167

Query: 361 PELISRNFGTVSCKSDVYGFGMVLLEM 387
           PE+I       S  SD++  G  ++E+
Sbjct: 168 PEVI--EMSGASTASDIWSLGCTVIEL 192

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 97.9 bits (244), Expect = 9e-23
 Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 27/217 (12%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGR------LIAVKMLEN--SKFSAEEFINEVSTIGRIHH 242
               +LG+G FG V+ G+ +         L+AVK L+   S  + ++F  E   +    H
Sbjct: 8   VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67

Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSLDRH-----------IFPKENKGQTFGWEKLQE 291
            N+V+  G C+EG    +V+E+M +G L++              P    G+     +L +
Sbjct: 68  ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE-LTLSQLLQ 126

Query: 292 IALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 351
           IA+  A G+ YL        +H D+   N L+ ++ + K+ DFG+++      D+  +  
Sbjct: 127 IAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-DVYTTDYYRVGG 182

Query: 352 TRG-TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
                I ++ PE I   +   + +SDV+ FG+VL E+
Sbjct: 183 HTMLPIRWMPPESIM--YRKFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 97.0 bits (241), Expect = 1e-22
 Identities = 59/193 (30%), Positives = 104/193 (53%), Gaps = 8/193 (4%)

Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLG G FG V+ G  +    +AVK L+    S + F+ E + +  + H  +V+L    ++
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                ++ E+M  GSL    F K ++G      KL + +   A G+AY+        +H 
Sbjct: 73  EEPIYIITEYMAKGSLLD--FLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHR 127

Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D++  N+L+  + + K++DFGLA+   ++N++ +    +  I + APE I  NFG+ + K
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAI--NFGSFTIK 184

Query: 375 SDVYGFGMVLLEM 387
           SDV+ FG++L E+
Sbjct: 185 SDVWSFGILLYEI 197

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 21/212 (9%)

Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS 253
           KLG+G +GSVYK     TG+++A+K++   +   +E I E+S + +     +V+  G   
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPV-EEDLQEIIKEISILKQCDSPYIVKYYGSYF 68

Query: 254 EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILH 313
           + +   +V E+   GS+   I    NK  T   E++  I   T +G+ YLH+      +H
Sbjct: 69  KNTDLWIVMEYCGAGSV-SDIMKITNK--TLTEEEIAAILYQTLKGLEYLHS---NKKIH 122

Query: 314 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IG---YIAPELISRNFG 369
            DIK  NILL+     K++DFG++             A R T IG   ++APE+I     
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSG------QLTDTMAKRNTVIGTPFWMAPEVIQEI-- 174

Query: 370 TVSCKSDVYGFGMVLLEMAGGR-RNSNMNAIR 400
             + K+D++  G+  +EMA G+   S+++ +R
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMR 206

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 95.7 bits (238), Expect = 3e-22
 Identities = 59/196 (30%), Positives = 103/196 (52%), Gaps = 9/196 (4%)

Query: 192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           F  +LG G FG V  G+      +A+KM++    S +EFI E   + ++ H  +VQL G 
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
           C++     +V E+M NG L  ++      G+ F   +L E+      G+AYL +      
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYL---REHGKRFQPSQLLEMCKDVCEGMAYLES---KQF 121

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           +H D+   N L+D     KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVL--LYSKF 178

Query: 372 SCKSDVYGFGMVLLEM 387
           S KSDV+ FG+++ E+
Sbjct: 179 SSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 95.3 bits (237), Expect = 5e-22
 Identities = 75/287 (26%), Positives = 127/287 (44%), Gaps = 43/287 (14%)

Query: 196 LGQGGFGSVYKGQLH----TGRLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQL 248
           LG+G FGSV +GQL     +   +AVK ++    +    EEF++E + +    H NV++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 249 LGFCSEGSKRA------LVYEFMPNGSLDRHIFPKENKGQTFGW--EKLQEIALGTARGV 300
           +G C E S         ++  FM +G L   +      G       + L +  +  A G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 301 AYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 360
            YL N      +H D+   N +L  +    V+DFGL+K     + +      +  + +IA
Sbjct: 127 EYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183

Query: 361 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDL 420
            E ++    T   KSDV+ FG+ + E+A  R  +    + + +      +YD L  G  L
Sbjct: 184 IESLADRVYTS--KSDVWAFGVTMWEIA-TRGQTPYPGVENHE------IYDYLRHGNRL 234

Query: 421 ELRNVTEIESVIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLE 462
           +             + C+  L+     C +    DRP+ TK+ E+LE
Sbjct: 235 K-----------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 94.9 bits (236), Expect = 6e-22
 Identities = 57/196 (29%), Positives = 100/196 (51%), Gaps = 9/196 (4%)

Query: 192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           F  +LG G FG V+ G+      +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 8   FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
           C++     +V EFM NG L  ++  ++ +G+    + L  +      G+ YL        
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYL--RQRQGK-LSKDMLLSMCQDVCEGMEYLERN---SF 121

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           +H D+   N L+    + KVSDFG+ ++   ++++ S S  +  + +  PE+   NF   
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRY-VLDDEYTSSSGAKFPVKWSPPEVF--NFSKY 178

Query: 372 SCKSDVYGFGMVLLEM 387
           S KSDV+ FG+++ E+
Sbjct: 179 SSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 19/207 (9%)

Query: 196 LGQGGFGSVYKGQLHT------GRLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQ 247
           LGQG FG VY+G             +A+K +  +    E  EF+NE S +   +  +VV+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 248 LLGFCSEGSKRALVYEFMPNGSLD---RHIFPKE---NKGQTFGWEKLQEIALGTARGVA 301
           LLG  S G    +V E M  G L    R   P+            +K  ++A   A G+A
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YL        +H D+   N ++  +   K+ DFG+ +   + + +         + ++AP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMA 388
           E  S   G  + KSDV+ FG+VL EMA
Sbjct: 191 E--SLKDGVFTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 94.1 bits (234), Expect = 1e-21
 Identities = 72/281 (25%), Positives = 122/281 (43%), Gaps = 36/281 (12%)

Query: 196 LGQGGFGSVYKGQLHTG--RLIAVK--MLENSKF---------SAEEFINEVSTIG-RIH 241
           LG G FG VYK +       L+A+K   + N  F         S  + ++EV+ I  ++ 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 242 HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVA 301
           H N+V+      E  +  +V + +    L  H    + K Q F  E++  I +     + 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YLH   +  I+H D+ P+NI+L  +    ++DFGLAK    E+   S+    GTI Y  P
Sbjct: 128 YLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV---GTILYSCP 182

Query: 362 ELI-SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDL 420
           E++ +  +G    K+DV+ FG +L +M   +       + S        VY+ L      
Sbjct: 183 EIVKNEPYGE---KADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP----- 234

Query: 421 ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEML 461
                   E + +  +  +   C+   A  RP + +V  M+
Sbjct: 235 --------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 93.8 bits (234), Expect = 2e-21
 Identities = 65/206 (31%), Positives = 111/206 (53%), Gaps = 24/206 (11%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFIN--EVSTIGRI-HHVNVVQLLG 250
           +LG G FGSVY  +   TG L+A+K ++   +S EE +N  EV ++ ++  H N+V+L  
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH-NGCDM 309
              E  +   V+E+M  G+L  +   K+ KG+ F    ++ I     +G+A++H +G   
Sbjct: 66  VFRENDELYFVFEYM-EGNL--YQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--- 119

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN----DFVSISATRGTIGYIAPELIS 365
              H D+KP N+L+    + K++DFGLA+   +      D+VS   TR    Y APE++ 
Sbjct: 120 -FFHRDLKPENLLVSGPEVVKIADFGLAR-EIRSRPPYTDYVS---TR---WYRAPEILL 171

Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGR 391
           R+  + S   D++  G ++ E+   R
Sbjct: 172 RS-TSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 93.0 bits (232), Expect = 4e-21
 Identities = 62/195 (31%), Positives = 99/195 (50%), Gaps = 24/195 (12%)

Query: 194 HKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFS-AEEFIN-----EVSTIGRIHHVNVV 246
            KLG+G +  VYK     TGR++A+K ++  +   A++ IN     E+  +  + H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
            LL      S   LV+EFM    L++ I   ++K        ++   L T RG+ YLH+ 
Sbjct: 66  GLLDVFGHKSNINLVFEFME-TDLEKVI---KDKSIVLTPADIKSYMLMTLRGLEYLHS- 120

Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               ILH D+KP+N+L+  + + K++DFGLA+     N  ++      T  Y APEL+  
Sbjct: 121 --NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYRAPELL-- 174

Query: 367 NFGTVSCKSDVYGFG 381
            FG    +   YG G
Sbjct: 175 -FG---ARH--YGVG 183

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 92.6 bits (231), Expect = 5e-21
 Identities = 64/214 (29%), Positives = 108/214 (50%), Gaps = 35/214 (16%)

Query: 194 HKLGQGGFGSVYKGQ-LHTGRLIAVK--MLENSKFSAEEF----INEVSTIGRIHHVNVV 246
            ++G+G +G VYK +   TG L+A+K   +EN K   E F    I E+  + ++ H N+V
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEK---EGFPITAIREIKLLQKLRHPNIV 61

Query: 247 QLLGFCSEGSKRA--LVYEFMP---NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVA 301
           +L    +   K +  +V+E+M     G LD       +    F   +++        G+ 
Sbjct: 62  RLKEIVTSKGKGSIYMVFEYMDHDLTGLLD-------SPEVKFTESQIKCYMKQLLEGLQ 114

Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--TIGYI 359
           YLH+     ILH DIK  NIL++++ + K++DFGLA+ + K N   S   T    T+ Y 
Sbjct: 115 YLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN---SADYTNRVITLWYR 168

Query: 360 APELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 391
            PEL+  +  +G    + D++  G +L E+  G+
Sbjct: 169 PPELLLGATRYGP---EVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 91.6 bits (227), Expect = 8e-21
 Identities = 64/201 (31%), Positives = 104/201 (51%), Gaps = 27/201 (13%)

Query: 194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG-FC 252
             +G+G FG V  G  + G  +AVK ++N   +A+ F+ E S + ++ H N+VQLLG   
Sbjct: 12  QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIV 69

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQT-FGWEKLQEIALGTARGVAYLHNGCDMCI 311
            E     +V E+M  GSL  ++    ++G++  G + L + +L     + YL        
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---F 123

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT----IGYIAPE-LISR 366
           +H D+   N+L+  + + KVSDFGL K           S+T+ T    + + APE L  +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK---------EASSTQDTGKLPVKWTAPEALREK 174

Query: 367 NFGTVSCKSDVYGFGMVLLEM 387
            F T   KSDV+ FG++L E+
Sbjct: 175 KFST---KSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 92.0 bits (229), Expect = 9e-21
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 21/206 (10%)

Query: 194 HKLGQGGFGSVYKGQ-LHTGRLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLL 249
             +G+G +G V K +   TG ++A+K     E+ +   +  + EV  + ++ H N+V L 
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
                  +  LV+E++    L+     + + G     + ++       + +AY H+    
Sbjct: 67  EAFRRKGRLYLVFEYVERTLLE---LLEASPG-GLPPDAVRSYIWQLLQAIAYCHS---H 119

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKF--HPKENDFVSISATRGTIGYIAPELI--S 365
            I+H DIKP NIL+  + + K+ DFG A+       +      ATR    Y APEL+   
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR---WYRAPELLVGD 176

Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGR 391
            N+G      DV+  G ++ E+  G 
Sbjct: 177 TNYGK---PVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 20/203 (9%)

Query: 195 KLGQGGFGSVYKGQLH--TGRLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQLLG 250
           +LG G  G V K   H  TG+++AVK +      A   + + E+  + + +   +V   G
Sbjct: 8   ELGAGNSGVVSKVL-HRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                   ++  E+M  GSLD+    KE +G+      L +IA+   +G+ YLH      
Sbjct: 67  AFYNNGDISICMEYMDGGSLDK--ILKEVQGR-IPERILGKIAVAVLKGLTYLHE--KHK 121

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNF 368
           I+H D+KP NIL++     K+ DFG++    +     FV      GT  Y+APE I  N 
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV------GTSSYMAPERIQGND 175

Query: 369 GTVSCKSDVYGFGMVLLEMAGGR 391
            +V  KSD++  G+ L+E+A GR
Sbjct: 176 YSV--KSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 73/284 (25%), Positives = 123/284 (43%), Gaps = 46/284 (16%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 250
            +G+G FG+V K +    G+++  K ++    + +E    ++EV+ +  + H N+V+   
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 251 FCSEGSKRAL--VYEFMPNGSLDRHI--FPKENK--GQTFGWEKLQEIALGTARGVAYLH 304
              + S + L  V E+   G L + I    KE K   + F W  L ++ L     +   H
Sbjct: 67  RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA----LYECH 122

Query: 305 NGCD--MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
           N  D    +LH D+KP NI LD N   K+ DFGLAK    ++ F       GT  Y++PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV--GTPYYMSPE 180

Query: 363 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLN---KGG- 418
            ++    +   KSD++  G ++ E+                  F +    QL    K G 
Sbjct: 181 QLNHM--SYDEKSDIWSLGCLIYELCALS------------PPFTARNQLQLASKIKEGK 226

Query: 419 --DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM 460
              +  R  +E+  VI           + V    RPS  ++L++
Sbjct: 227 FRRIPYRYSSELNEVIKS--------MLNVDPDKRPSTEELLQL 262

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 90.0 bits (223), Expect = 3e-20
 Identities = 58/193 (30%), Positives = 102/193 (52%), Gaps = 15/193 (7%)

Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
            +G+G FG+V +G+ +TG+ +AVK ++    +A+ F+ E + + ++HH N+V+LLG    
Sbjct: 13  IIGEGEFGAVLQGE-YTGQKVAVKNIK-CDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V E M  G+L    F +          +L + +L  A G+ YL +     ++H 
Sbjct: 71  NGLY-IVMELMSKGNLVN--FLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHR 124

Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D+   NIL+  + + KVSDFGLA+      D      ++  + + APE +       S K
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVD-----NSKLPVKWTAPEALKHK--KFSSK 177

Query: 375 SDVYGFGMVLLEM 387
           SDV+ +G++L E+
Sbjct: 178 SDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 89.3 bits (221), Expect = 4e-20
 Identities = 63/196 (32%), Positives = 109/196 (55%), Gaps = 17/196 (8%)

Query: 196 LGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAE---EFINEVSTIGRIHHVNVVQLLGFC 252
           LG+G FG V+KG L     +AVK  +      E   +F++E   + +  H N+V+L+G C
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKED-LPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           ++     +V E +P G     +  K+++ +T   ++L + AL  A G+AYL +    CI 
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKT---KQLVKFALDAAAGMAYLES--KNCI- 115

Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA--TRGTIGYIAPELISRNFGT 370
           H D+   N L+  N + K+SDFG+++   +E+D +  S+   +  I + APE +  N+G 
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEAL--NYGR 170

Query: 371 VSCKSDVYGFGMVLLE 386
            S +SDV+ +G++L E
Sbjct: 171 YSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 89.7 bits (222), Expect = 4e-20
 Identities = 64/212 (30%), Positives = 110/212 (51%), Gaps = 14/212 (6%)

Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLG G FG V+    +    +AVK ++    S E F+ E + +  + H  +V+L    ++
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72

Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                ++ EFM  GSL    F K ++G      KL + +   A G+A++        +H 
Sbjct: 73  -EPIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHR 126

Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D++  NIL+  + + K++DFGLA+   ++N++ +    +  I + APE I  NFG+ + K
Sbjct: 127 DLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAI--NFGSFTIK 183

Query: 375 SDVYGFGMVLLEMAGGRRN-----SNMNAIRS 401
           SDV+ FG++L+E+    R      SN   IR+
Sbjct: 184 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA 215

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 89.8 bits (223), Expect = 5e-20
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 33/228 (14%)

Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKML--ENSKFSAEEFINEVS 235
           EI      F  +LG+G FG VYKG+L       +   +A+K L         +EF  E  
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60

Query: 236 TIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIF-----PKENKGQTFGWEKLQ 290
            +  + H N+V LLG C++     +++E++ +G L  H F     P  + G   G E ++
Sbjct: 61  LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDL--HEFLVRNSPHSDVGAESGDETVK 118

Query: 291 E---------IALGTARGVAYL--HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF 339
                     IA+  A G+ YL  H+      +H D+   N L+      K+SDFGL++ 
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRD 173

Query: 340 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
               + +   S +   + ++ PE I   +G  + +SD++ FG+VL E+
Sbjct: 174 IYSADYYRVQSKSLLPVRWMPPEAIL--YGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 88.7 bits (221), Expect = 6e-20
 Identities = 67/233 (28%), Positives = 110/233 (47%), Gaps = 35/233 (15%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG V   +   TG+L A+K+L+  K       E  + E + + RI+H  +V+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58

Query: 251 FCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFGWEKLQ----EIALGTARGVAYLH 304
             +  ++  L  V E+ P G L  H+    +K   F  E+ +    EI L     + YLH
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHL----SKEGRFSEERARFYAAEIVLA----LEYLH 110

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
           +   + I++ D+KP NILLD +   K++DFGLAK     ++    +   GT  Y+APE++
Sbjct: 111 S---LGIIYRDLKPENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAPEVL 165

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGGR-----RNSN--MNAIRSSKAYFPSWV 410
                  +   D +  G++L EM  G+      +       I      FP ++
Sbjct: 166 LGKGYGKAV--DWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFL 216

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 89.4 bits (222), Expect = 6e-20
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 17/205 (8%)

Query: 192 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMLENSKFSA-EEFINEVSTIGRIHHVNV 245
           F  +LG+G FGSV        Q +TG ++AVK L++S      +F  E+  +  + H N+
Sbjct: 8   FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67

Query: 246 VQLLGFCSEGSKRA--LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V+  G C    +R   LV E++P GSL  ++   +   +     KL   A    +G+ YL
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYL 124

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 362
             G    + H D+   NIL++     K+ DFGL K  P++ ++  +       I + APE
Sbjct: 125 --GSKRYV-HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE 181

Query: 363 LISRNFGTVSCKSDVYGFGMVLLEM 387
            ++ +    S  SDV+ FG+VL E+
Sbjct: 182 SLTES--KFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 89.1 bits (221), Expect = 7e-20
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 27/208 (12%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           LG+G +G VY  + L T   IA+K +   +S++  +    E++    + H N+VQ LG  
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV-QPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 253 SEGSKRALVYEFMPNGSLDRHIF----PKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           SE     +  E +P GSL   +     P ++  QT  +   Q +      G+ YLH   D
Sbjct: 75  SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLH---D 126

Query: 309 MCILHFDIKPHNILLD-HNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPEL 363
             I+H DIK  N+L++ ++ + K+SDFG    LA  +P    F       GT+ Y+APE+
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF------TGTLQYMAPEV 180

Query: 364 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           I +        +D++  G  ++EMA G+
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 89.0 bits (221), Expect = 9e-20
 Identities = 68/205 (33%), Positives = 103/205 (50%), Gaps = 20/205 (9%)

Query: 195 KLGQGGFGSVYKGQL-HTGRLIAVK--MLENSKFSAEEFINEVSTIGRIHHVNVVQLLG- 250
           +LG+G  GSV K +L +TG + A+K    + +    ++ + E+          +V+  G 
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67

Query: 251 FCSEGSKR-ALVYEFMPNGSLDRHIFPK-ENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           F  E S    +  E+   GSLD  I+ K + +G   G + L +IA    +G++YLH    
Sbjct: 68  FLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---S 123

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-SISAT-RGTIGYIAPELISR 366
             I+H DIKP NILL      K+ DFG++       + V S++ T  GT  Y+APE I  
Sbjct: 124 RKIIHRDIKPSNILLTRKGQVKLCDFGVS------GELVNSLAGTFTGTSFYMAPERIQG 177

Query: 367 NFGTVSCKSDVYGFGMVLLEMAGGR 391
                S  SDV+  G+ LLE+A  R
Sbjct: 178 --KPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 88.2 bits (219), Expect = 1e-19
 Identities = 65/201 (32%), Positives = 98/201 (48%), Gaps = 17/201 (8%)

Query: 195 KLGQGGFGSVYKGQLHT--GRLI--AVKMLENSKFSA--EEFINEVSTIGRIHHVNVVQL 248
           KLG G FG V +G+  T  G++I  AVK L++ K S   ++F+ E + +  + H N+++L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 249 LGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            G         +V E  P GSL DR    +++    F    L + A+  A G+ YL +  
Sbjct: 62  YGVVLT-HPLMMVTELAPLGSLLDRL---RKDALGHFLISTLCDYAVQIANGMRYLES-- 115

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPELISR 366
               +H D+   NILL  +   K+ DFGL +  P+  D   +         + APE  S 
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE--SL 172

Query: 367 NFGTVSCKSDVYGFGMVLLEM 387
              T S  SDV+ FG+ L EM
Sbjct: 173 RTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 65/213 (30%), Positives = 110/213 (51%), Gaps = 37/213 (17%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE-----FINEVSTIGRIHHVNVVQL 248
           KLG+G + +VYKG+   TG ++A+K +      AEE      I E+S +  + H N+V+L
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEI---HLDAEEGTPSTAIREISLMKELKHENIVRL 63

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKG-------QTFGWEKLQEIALGTARGVA 301
                  +K  LV+E+M +  L +++     +G       ++F ++ L+        G+A
Sbjct: 64  HDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLK--------GIA 114

Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIA 360
           + H   +  +LH D+KP N+L++     K++DFGLA+ F    N F   S    T+ Y A
Sbjct: 115 FCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF---SNEVVTLWYRA 168

Query: 361 PELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           P+++  SR   T S   D++  G ++ EM  GR
Sbjct: 169 PDVLLGSR---TYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 71/233 (30%), Positives = 104/233 (44%), Gaps = 51/233 (21%)

Query: 191 HFTHKLGQGGFGSVYKG-QLHTGRLIAVK--MLENSKFSAEEF----INEVSTIGRIHHV 243
               KLG+G FG VYK  Q+ TGR++A+K  ++ N K   + F    + E+  + ++ H 
Sbjct: 11  EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK---DGFPITALREIKILKKLKHP 67

Query: 244 NVVQLLGFCSEGS-----KRALVYEFMP------NGSLDRHIFPKENKGQTFGWEKLQEI 292
           NVV L+    E       KR  VY   P      +G L       EN        +++  
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL-------ENPSVKLTESQIKCY 120

Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH------------ 340
            L    G+ YLH   +  ILH DIK  NIL+D+  I K++DFGLA+ +            
Sbjct: 121 MLQLLEGINYLH--ENH-ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177

Query: 341 PKENDFVSISATRGTIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 391
                + ++  TR    Y  PEL+   R + T     D++G G V  EM   R
Sbjct: 178 GGTRKYTNLVVTR---WYRPPELLLGERRYTT---AVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 86.9 bits (215), Expect = 4e-19
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 16/204 (7%)

Query: 196 LGQGGFGSVYKG--QLHTGR--LIAVKMLENSKFSAEE--FINEVSTIGRIHHVNVVQLL 249
           LG G FG + +G  +L + R   +A+  L       +   F+ E  T+G+  H N+V+L 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G  + G+   +V E+M NG+LD   F ++++GQ     +L  +  G A G+ YL    +M
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDS--FLRKHEGQLVA-GQLMGMLPGLASGMKYL---SEM 126

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
             +H  +  H +L++ + + K+S F   +    E  + ++S  +  + + APE I   + 
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSG-KSPVLWAAPEAI--QYH 183

Query: 370 TVSCKSDVYGFGMVLLE-MAGGRR 392
             S  SDV+ FG+V+ E M+ G R
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 85.7 bits (212), Expect = 1e-18
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 20/202 (9%)

Query: 196 LGQGGFGSVY-----KGQLHTGRLIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG+G FG V           TG ++AVK L  E  + +   +  E++ +  ++H N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 249 LGFCSEGSKRA--LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
            G CSE   +   L+ E++P GSL R   PK          +L   A     G+AYLH+ 
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSL-RDYLPKHK----LNLAQLLLFAQQICEGMAYLHS- 125

Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPELIS 365
                +H D+   N+LLD++ + K+ DFGLAK  P+ +++  +       + + A E + 
Sbjct: 126 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 366 RNFGTVSCKSDVYGFGMVLLEM 387
            N    S  SDV+ FG+ L E+
Sbjct: 184 EN--KFSYASDVWSFGVTLYEL 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 85.7 bits (213), Expect = 2e-18
 Identities = 67/233 (28%), Positives = 106/233 (45%), Gaps = 38/233 (16%)

Query: 196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 250
           LG G FG V   +   +G+  A+K+L  +K       E  +NE   +  I H  +V L G
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQ----EIALGTARGVAYLHNG 306
              + S   LV E++P G L  H+     K   F     +    ++ L     + YLH+ 
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHL----RKSGRFPEPVARFYAAQVVLA----LEYLHS- 119

Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-S 365
             + I++ D+KP N+LLD +   K++DFG AK               GT  Y+APE+I S
Sbjct: 120 --LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTPEYLAPEIILS 172

Query: 366 RNFGTVSCKS-DVYGFGMVLLEMAGG----RRNSNMN---AIRSSKAYFPSWV 410
           + +G    K+ D +  G+++ EM  G      ++ +     I   K  FPS+ 
Sbjct: 173 KGYG----KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFF 221

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 39/233 (16%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     S+   +  + E+  +  ++H N+++LL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGW--EKLQEIALGTARGVAYLH-NGC 307
                    LV+EFM           K  K +  G     ++       +G+A+ H +G 
Sbjct: 66  VFRHKGDLYLVFEFM------DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG- 118

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI-- 364
              ILH D+KP N+L++   + K++DFGLA+ F      +     TR    Y APEL+  
Sbjct: 119 ---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR---WYRAPELLLG 172

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVY-DQLNK 416
            + + T     D++  G +  E+   R              FP     DQL K
Sbjct: 173 DKGYST---PVDIWSVGCIFAELLSRR------------PLFPGKSEIDQLFK 210

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 35/221 (15%)

Query: 196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVS----TIGRI-HHVNVVQLL 249
           +G+G F +V   +   T +  A+K+L+  +   E+ +  V      + R+  H  +++L 
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68

Query: 250 G-FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
             F  E      V E+ PNG L ++I     K  +   +  +  A      + YLH+   
Sbjct: 69  YTFQDE-ENLYFVLEYAPNGELLQYI----RKYGSLDEKCTRFYAAEILLALEYLHS--- 120

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKF-----HPKENDFVSISATR---------- 353
             I+H D+KP NILLD +   K++DFG AK       P+ N   + +             
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180

Query: 354 ---GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
              GT  Y++PEL++         SD++  G ++ +M  G+
Sbjct: 181 SFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 84.1 bits (208), Expect = 3e-18
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 13/201 (6%)

Query: 195 KLGQGGFGSVYKGQLHT-GRLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G FG V+K       R+ A+K ++ SK +    EE I+E   + ++    +++   
Sbjct: 7   KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
              +  K  +V E+  NG L  H   K  +G+    +++    +    G+A+LH+     
Sbjct: 67  SFLDKGKLNIVMEYAENGDL--HKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--- 121

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ILH DIK  N+ LD     K+ D G+AK      +F   +   GT  Y++PEL       
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA--NTIVGTPYYLSPELCEDK--P 177

Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
            + KSDV+  G+VL E   G+
Sbjct: 178 YNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 83.6 bits (207), Expect = 6e-18
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 24/203 (11%)

Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 252
           K+G+G  G V       TGR +AVK ++  K    E + NEV  +    H N+V++    
Sbjct: 26  KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
             G +  +V EF+  G+L   I       +    E++  + L   + +++LH      ++
Sbjct: 86  LVGDELWVVMEFLEGGALT-DIVTHTRMNE----EQIATVCLAVLKALSFLHA---QGVI 137

Query: 313 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISRN- 367
           H DIK  +ILL  +   K+SDFG    ++K  P+    V      GT  ++APE+ISR  
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPEVISRLP 191

Query: 368 FGTVSCKSDVYGFGMVLLEMAGG 390
           +GT   + D++  G++++EM  G
Sbjct: 192 YGT---EVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 83.5 bits (206), Expect = 7e-18
 Identities = 69/261 (26%), Positives = 126/261 (48%), Gaps = 38/261 (14%)

Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+V+KG  +  G  I    A+K +++   + + +E  + +  +G + H  +V+L
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C  G+   LV +  P GSL  H+  ++++  +   ++L    +  A+G+ YL    +
Sbjct: 75  LGICP-GASLQLVTQLSPLGSLLDHV--RQHRD-SLDPQRLLNWCVQIAKGMYYLE---E 127

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H ++   NILL  + I +++DFG+A     ++     S  +  I ++A E I   F
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI--LF 185

Query: 369 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT 426
           G  + +SDV+ +G+ + EM   G    + M          P  V D L KG         
Sbjct: 186 GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR---------PHEVPDLLEKG--------- 227

Query: 427 EIESVIARKLCMIGLWCIQVK 447
             E +   ++C I ++ + VK
Sbjct: 228 --ERLAQPQICTIDVYMVMVK 246

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 83.7 bits (207), Expect = 7e-18
 Identities = 66/226 (29%), Positives = 105/226 (46%), Gaps = 47/226 (20%)

Query: 196 LGQGGFGSVYKGQ---LHTGR---LIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQ 247
           +GQG FG V++ +   L       ++AVKML  E S     +F  E + +    H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 248 LLGFCSEGSKRALVYEFMPNGSLD---RHIFPK----------------ENKGQTFGWEK 288
           LLG C+ G    L++E+M  G L+   RH  P+                 N       E+
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 289 LQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-------FHP 341
           L  IA   A G+AYL    +   +H D+   N L+  N + K++DFGL++       +  
Sbjct: 133 LC-IAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188

Query: 342 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
            END + I        ++ PE I   +   + +SDV+ +G+VL E+
Sbjct: 189 SENDAIPIR-------WMPPESIF--YNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 66/280 (23%), Positives = 119/280 (42%), Gaps = 43/280 (15%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLL 249
           K+G+G F  VYK   L  GR++A+K ++  +       ++ + E+  + ++ H NV++ L
Sbjct: 9   KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
               E ++  +V E    G L R I   + + +      + +  +     + ++H+    
Sbjct: 69  ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---K 125

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
            I+H DIKP N+ +    + K+ D GL +F   +    +  +  GT  Y++PE I  N  
Sbjct: 126 RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHEN-- 181

Query: 370 TVSCKSDVYGFGMVLLEMAGGR---RNSNMNAIRSSK-------AYFPSWVYDQLNKGGD 419
             + KSD++  G +L EMA  +       MN     K          P+  Y +      
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSE------ 235

Query: 420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
            ELR++                 CI      RP ++ VL+
Sbjct: 236 -ELRDLVSR--------------CINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 29/214 (13%)

Query: 195 KLGQGGFGSVYKGQLHT------GRLIAVKMLENSKFSA-EEFINEVSTIGRIHHVNVVQ 247
           +LG+G FG V+  + H         L+AVK L+ +  SA ++F  E   +  + H ++V+
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 248 LLGFCSEGSKRALVYEFMPNGSLDR---------HIFPKENKGQTFG---WEKLQEIALG 295
             G C+EG    +V+E+M +G L+R          I     +    G     ++  IA  
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKIL-AGGEDVAPGQLTLGQMLAIASQ 130

Query: 296 TARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA-TRG 354
            A G+ YL     +  +H D+   N L+    + K+ DFG+++      D+  +   T  
Sbjct: 131 IASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-DIYSTDYYRVGGRTML 186

Query: 355 TIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
            I ++ PE ++ R F T   +SD++ FG+VL E+
Sbjct: 187 PIRWMPPESILYRKFTT---ESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 34/223 (15%)

Query: 192 FTHKLGQGGFGSVY---------------KGQLHTGRLIAVKML--ENSKFSAEEFINEV 234
              KLG+G FG V+                       L+AVKML  + +K +  +F+ E+
Sbjct: 9   LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 235 STIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI--------FPKENKGQTFGW 286
             + R+ + N+++LLG C       ++ E+M NG L++ +        F   N   +   
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 287 EKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 346
             L  +A+  A G+ YL     +  +H D+   N L+ +++  K++DFG+++ +    D+
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR-NLYSGDY 184

Query: 347 VSISATRGT--IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
             I   R    I ++A E I    G  +  SDV+ FG+ L EM
Sbjct: 185 YRIQG-RAVLPIRWMAWESIL--LGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 38/215 (17%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKM--LENSKFSAEEF----INEVSTIGRIHHVNVVQ 247
           K+GQG FG V+K +   T +++A+K   +EN K   E F    + E+  +  + H NVV 
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVLMENEK---EGFPITALREIKILQLLKHENVVN 75

Query: 248 LLGFCS-----EGSKRA---LVYEFMPN---GSLDRHIFPKENKGQTFGWEKLQEIALGT 296
           L+  C          +    LV+EF  +   G L        NK   F   +++++    
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLL-------SNKNVKFTLSEIKKVMKML 128

Query: 297 ARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATR-G 354
             G+ Y+H      ILH D+K  NIL+  + I K++DFGLA+ F   +N   +    R  
Sbjct: 129 LNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185

Query: 355 TIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEM 387
           T+ Y  PEL+   R++G      D++G G ++ EM
Sbjct: 186 TLWYRPPELLLGERDYGP---PIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 21/203 (10%)

Query: 197 GQGGFGSVYKGQL-HTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQL-LG 250
           G+G FG V   Q   T ++ A+K +   K     S    +NE   +  ++H  +V L   
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           F  E     LV + +  G L  H+    ++   F  E+++         + YLH+     
Sbjct: 69  FQDE-ENMYLVVDLLLGGDLRYHL----SQKVKFSEEQVKFWICEIVLALEYLHS---KG 120

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISATRGTIGYIAPELISRNFG 369
           I+H DIKP NILLD      ++DF +A K  P        ++T GT GY+APE++ R   
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL----TTSTSGTPGYMAPEVLCRQ-- 174

Query: 370 TVSCKSDVYGFGMVLLEMAGGRR 392
             S   D +  G+   E   G+R
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 82.2 bits (203), Expect = 3e-17
 Identities = 69/219 (31%), Positives = 104/219 (47%), Gaps = 32/219 (14%)

Query: 194 HKLGQGGFGSVYKGQ-LHTGRLIAVK-MLENSKFSAEEF---INEVSTIGRIHHVNVVQL 248
            ++G G FG+VY  + + T  ++A+K M  + K S E++   I EV  + ++ H N ++ 
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQE-----IALGTARGVAYL 303
            G         LV E+    + D  I     K        LQE     I  G  +G+AYL
Sbjct: 81  KGCYLREHTAWLVMEYCLGSASD--ILEVHKKP-------LQEVEIAAICHGALQGLAYL 131

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
           H+      +H DIK  NILL      K++DFG A      N FV      GT  ++APE+
Sbjct: 132 HS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEV 182

Query: 364 I-SRNFGTVSCKSDVYGFGMVLLEMAGGRRNS--NMNAI 399
           I + + G    K DV+  G+  +E+A  R+    NMNA+
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNAM 220

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 82.0 bits (202), Expect = 3e-17
 Identities = 79/307 (25%), Positives = 135/307 (43%), Gaps = 51/307 (16%)

Query: 182 YPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL---IAVKMLEN--SKFSAEEFINEVST 236
           YP +      F   +G+G FG V K ++    L    A+K ++   SK    +F  E+  
Sbjct: 1   YPVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60

Query: 237 IGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSL------------DRHIFPKENKGQT 283
           + ++ HH N++ LLG C       L  E+ P+G+L            D       +   T
Sbjct: 61  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120

Query: 284 FGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 343
              ++L   A   ARG+ YL        +H D+   NIL+  N++ K++DFGL++    +
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQ 174

Query: 344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNAIRS 401
             +V  +  R  + ++A E  S N+   +  SDV+ +G++L E+   GG     M     
Sbjct: 175 EVYVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE- 231

Query: 402 SKAYFPSWVYDQLNKGGDLE--LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVL- 458
                   +Y++L +G  LE  L    E+  ++ +        C + K  +RPS  ++L 
Sbjct: 232 --------LYEKLPQGYRLEKPLNCDDEVYDLMRQ--------CWREKPYERPSFAQILV 275

Query: 459 ---EMLE 462
               MLE
Sbjct: 276 SLNRMLE 282

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 81.3 bits (201), Expect = 4e-17
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 22/215 (10%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLE-NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS 253
           LG G FG VYK Q   TG   A K+++  S+   E+F+ E+  +    H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 254 EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILH 313
             +K  ++ EF   G+LD  I  +  +G T    +++ +       + +LH+     ++H
Sbjct: 73  YENKLWILIEFCDGGALD-SIMLELERGLTEP--QIRYVCRQMLEALNFLHSHK---VIH 126

Query: 314 FDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELIS-RNF 368
            D+K  NILL  +   K++DFG          K + F+      GT  ++APE+++   F
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI------GTPYWMAPEVVACETF 180

Query: 369 GT--VSCKSDVYGFGMVLLEMAGGR-RNSNMNAIR 400
                  K+D++  G+ L+E+A     +  +N +R
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR 215

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 81.1 bits (200), Expect = 4e-17
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 18/206 (8%)

Query: 195 KLGQGGFGSVYKGQLHTGRLIA---VKMLENSKFSAEE--FINEVSTIGRIHHVNVVQLL 249
           ++G G FG V  G+ H G   A   VK L  S    E+  F+ EV     ++H NV+Q L
Sbjct: 2   EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEK---LQEIALGTARGVAYLHNG 306
           G C E     LV EF P G L  ++  + N+G      +   LQ +A   A G+ +LH  
Sbjct: 62  GQCIESIPYLLVLEFCPLGDLKNYL--RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ- 118

Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS- 365
                +H D+   N  L  +   K+ D+GLA     E+ +++       + ++APEL+  
Sbjct: 119 --ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176

Query: 366 --RNFGTV--SCKSDVYGFGMVLLEM 387
             ++      + KS+++  G+ + E+
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 81.4 bits (201), Expect = 5e-17
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 16/205 (7%)

Query: 192 FTHKLGQGGFGSVYK----GQLHTGRLI--AVKMLENSKFSAEE--FINEVSTIGRI-HH 242
           F   LG G FG V +    G   +  ++  AVKML+ +  S+E    ++E+  +  + +H
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98

Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
            N+V LLG C+ G    ++ E+   G L   +  K     T   E L   +   A+G+A+
Sbjct: 99  ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL--EDLLSFSYQVAKGMAF 156

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
           L +    CI H D+   N+LL H  I K+ DFGLA+    ++++V     R  + ++APE
Sbjct: 157 LAS--KNCI-HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213

Query: 363 LISRNFGTVSCKSDVYGFGMVLLEM 387
            I     T   +SDV+ +G++L E+
Sbjct: 214 SIFNCVYTF--ESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 81.3 bits (201), Expect = 5e-17
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 32/218 (14%)

Query: 194 HKLGQGGFGSVYKGQL-----HTGRL-IAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
             LG+G FG V K +            +AVKML++     +  + ++E+  +  I  H N
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSL------DRHIFPKENK------GQTFGWEKLQEI 292
           ++ LLG C++     +V E+  +G+L       R      +        +T   + L   
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISA 351
           A   ARG+ +L +    CI H D+   N+L+  + + K++DFGLA+  H    D+     
Sbjct: 138 AYQVARGMEFLAS--KKCI-HRDLAARNVLVTEDHVMKIADFGLARDIH--HIDYYR-KT 191

Query: 352 TRG--TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
           T G   + ++APE +     T   +SDV+ FG++L E+
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTH--QSDVWSFGVLLWEI 227

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 80.3 bits (198), Expect = 8e-17
 Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 38/218 (17%)

Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSA----------EEFINEVSTIGRIHHVN 244
           +G G FGSVY G    +G L+AVK +E    SA          +    E++ +  + H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 245 VVQLLGFCSEGSKRALVYEFMPNGS----LDRHIFPKENKGQTFGWEKLQEIALGTARGV 300
           +VQ LG   +     +  E++P GS    L+ +   +E   + F  + L+        G+
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILK--------GL 119

Query: 301 AYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR------- 353
            YLHN     I+H DIK  NIL+D+    K+SDFG++K   K       + T        
Sbjct: 120 NYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISK---KLEANSLSTKTNGARPSLQ 173

Query: 354 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           G++ ++APE++ +   T   K+D++  G +++EM  G+
Sbjct: 174 GSVFWMAPEVVKQTSYTR--KADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 58/215 (26%), Positives = 107/215 (49%), Gaps = 30/215 (13%)

Query: 195 KLGQGGFGSVYKGQLHT------GRLIAVKMLENSKFSA-EEFINEVSTIGRIHHVNVVQ 247
           +LG+G FG V+  + +         L+AVK L++   +A ++F  E   +  + H ++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIF-------------PKENKGQTFGWEKLQEIAL 294
             G C +G    +V+E+M +G L++ +              P++ KG+  G  ++  IA 
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE-LGLSQMLHIAS 130

Query: 295 GTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA-TR 353
             A G+ YL        +H D+   N L+  N + K+ DFG+++      D+  +   T 
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-DVYSTDYYRVGGHTM 186

Query: 354 GTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
             I ++ PE ++ R F T   +SDV+ FG++L E+
Sbjct: 187 LPIRWMPPESIMYRKFTT---ESDVWSFGVILWEI 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 23/203 (11%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
            +G+G FG VYK     T +++A+K+  LE ++   E+   E+  + +     + +  G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
             +GSK  ++ E+   GS    +     K        +  I      G+ YLH    +  
Sbjct: 68  FLKGSKLWIIMEYCGGGSC-LDLL----KPGKLDETYIAFILREVLLGLEYLHEEGKI-- 120

Query: 312 LHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISRN 367
            H DIK  NILL      K++DFG    L     K N FV      GT  ++APE+I + 
Sbjct: 121 -HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV------GTPFWMAPEVIKQ- 172

Query: 368 FGTVSCKSDVYGFGMVLLEMAGG 390
                 K+D++  G+  +E+A G
Sbjct: 173 -SGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 75/290 (25%), Positives = 129/290 (44%), Gaps = 44/290 (15%)

Query: 196 LGQGGFGSVYKGQLHTGRLI---AVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLL 249
           LG+G FGSV +GQL+    I   AVK ++    ++   E+F++E   +    H NV++L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 250 GFCSEGSKR------ALVYEFMPNGSLDRHIFPKE--NKGQTFGWEKLQEIALGTARGVA 301
           G C +  +        ++  FM +G L   +      +  Q    + L +     A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YL +      +H D+   N +L+ N    V+DFGL+K     + +      +  + +IA 
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 362 E-LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDL 420
           E L  R + T   KSDV+ FG+ + E+A  R  +    + +S+      +YD L +G  L
Sbjct: 184 ESLADRVYTT---KSDVWSFGVTMWEIA-TRGQTPYPGVENSE------IYDYLRQGNRL 233

Query: 421 ELRNVTEIESVIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLEGSM 465
           +               C+ GL+     C  +   DRPS   +   LE ++
Sbjct: 234 K-----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 79.5 bits (196), Expect = 1e-16
 Identities = 75/293 (25%), Positives = 129/293 (44%), Gaps = 65/293 (22%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSA-------EEFINEVSTIGRIHHVNVVQ 247
           LG G F S Y+ + + TG L+AVK +   + ++       E    E+  + R++H ++++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
           +LG   E S   L  E+M  GS+   +    +K   F    +        RG++YLH   
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLL----SKYGAFKEAVIINYTEQLLRGLSYLH--- 120

Query: 308 DMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR---------GTIG 357
           +  I+H D+K  N+L+D      +++DFG A         ++   T          GTI 
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQRLRIADFGAAA-------RLAAKGTGAGEFQGQLLGTIA 173

Query: 358 YIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRS--------SKAYFPS 408
           ++APE++    +G  SC  DV+  G V++EMA  +   N     +        + A    
Sbjct: 174 FMAPEVLRGEQYGR-SC--DVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP 230

Query: 409 WVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEML 461
            + + L+ G    LR+VT              L C++++  DRP      E+L
Sbjct: 231 SIPEHLSPG----LRDVT--------------LRCLELQPEDRP---PSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 26/204 (12%)

Query: 195 KLGQGGFGSV-YKGQLHTGRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 252
           K+G+G  G V    + HTG+ +AVK ++  K    E + NEV  +   HH NVV +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 253 SEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
             G +  +V EF+  G+L D     + N+      E++  + L   R ++YLHN     +
Sbjct: 89  LVGDELWVVMEFLEGGALTDIVTHTRMNE------EQIATVCLSVLRALSYLHN---QGV 139

Query: 312 LHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISR- 366
           +H DIK  +ILL  +   K+SDFG    ++K  PK    V      GT  ++APE+ISR 
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV------GTPYWMAPEVISRL 193

Query: 367 NFGTVSCKSDVYGFGMVLLEMAGG 390
            +GT   + D++  G++++EM  G
Sbjct: 194 PYGT---EVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 80.6 bits (199), Expect = 2e-16
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 19/203 (9%)

Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSA--EEFINEVSTIGRIHHVNVVQLLGF 251
           ++G G  G+VYK     TGRL A+K++  +       +   E+  +  ++H NVV+    
Sbjct: 81  RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                +  ++ EFM  GSL+      E        + L ++A     G+AYLH      I
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIADE--------QFLADVARQILSGIAYLHR---RHI 189

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR--NFG 369
           +H DIKP N+L++     K++DFG+++   +  D  + S   GTI Y++PE I+   N G
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV--GTIAYMSPERINTDLNHG 247

Query: 370 TVS-CKSDVYGFGMVLLEMAGGR 391
                  D++  G+ +LE   GR
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 31/210 (14%)

Query: 195 KLGQGGFGSVYK-GQLHTGRLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLG 250
           ++G+G  G V+K     TG  +A+K +   +       + + E+  +    H  VV+LL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 251 FCSEGSKRALVYEFMPNG------SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
               GS   LV E+MP+         +R +   + K                 +GVAY+H
Sbjct: 67  VFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKS----------YMRMLLKGVAYMH 116

Query: 305 -NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
            NG    I+H D+KP N+L+  + + K++DFGLA+   +E      S    T  Y APEL
Sbjct: 117 ANG----IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPEL 171

Query: 364 I--SRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           +  +R +       D++  G +  E+  G 
Sbjct: 172 LYGARKYDP---GVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 38/216 (17%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
            +G G    VY    L     +A+K   LE  + S +E   EV  + + +H NVV+    
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67

Query: 252 CSEGSKRALVYEFMPNGS-LD--RHIFPK----ENKGQTFGWEKLQEIALGTARGVAYLH 304
              G +  LV  ++  GS LD  +  +P+    E    T   E L+        G+ YLH
Sbjct: 68  FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLK--------GLEYLH 119

Query: 305 -NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF--------HPKENDFVSISATRGT 355
            NG     +H DIK  NILL  +   K++DFG++                FV      GT
Sbjct: 120 SNG----QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV------GT 169

Query: 356 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
             ++APE++ +  G    K+D++ FG+  +E+A G 
Sbjct: 170 PCWMAPEVMEQVHGYDF-KADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 26/206 (12%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
            +G+G +G V K +   TG+++A+K     E+ K   +  + E+  + ++ H N+V L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                 +  LV+EF+ +  LD      E         ++++      RG+ + H+     
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDD----LEKYPNGLDESRVRKYLFQILRGIEFCHSHN--- 120

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKF--HPKE--NDFVSISATRGTIGYIAPELISR 366
           I+H DIKP NIL+  + + K+ DFG A+    P E   D+V   ATR    Y APEL+  
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV---ATR---WYRAPELLVG 174

Query: 367 N--FGTVSCKSDVYGFGMVLLEMAGG 390
           +  +G      D++  G ++ EM  G
Sbjct: 175 DTKYGR---AVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 78.7 bits (194), Expect = 3e-16
 Identities = 70/203 (34%), Positives = 99/203 (48%), Gaps = 19/203 (9%)

Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENS---KFSAEEF-INEVSTIGRIHHVNVVQLLG 250
           LG+GGFG V   Q+  TG++ A K LE     K   E   +NE   + +++   VV L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66

Query: 251 FCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           +  E +K AL  V   M  G L  HI+   N G  F  E+    A     G+  LH    
Sbjct: 67  YAYE-TKDALCLVLTLMNGGDLKFHIYNMGNPG--FDEERAVFYAAEITCGLEDLHR--- 120

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             I++ D+KP NILLD     ++SD GLA     E +  +I    GT+GY+APE++    
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGE--TIRGRVGTVGYMAPEVVKNER 177

Query: 369 GTVSCKSDVYGFGMVLLEMAGGR 391
            T S   D +G G ++ EM  G+
Sbjct: 178 YTFS--PDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 25/216 (11%)

Query: 192 FTHKLGQGGFGSVYKGQLHT-----GRLIAVKMLE--NSKFSAEEFINEVSTIGRIHHVN 244
           F  +LG+  FG +YKG L+       +L+A+K L+  N+     EF  E S +  +HH N
Sbjct: 9   FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68

Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIF---PKENKG----------QTFGWEKLQE 291
           +V LLG  ++     +++E++  G L   +    P  + G           +        
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 292 IALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 351
           IA+  A G+ YL +      +H D+   NIL+      K+SD GL++     + +     
Sbjct: 129 IAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185

Query: 352 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
           +   I ++ PE I   +G  S  SD++ FG+VL E+
Sbjct: 186 SLLPIRWMPPEAIM--YGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 78.7 bits (194), Expect = 4e-16
 Identities = 69/215 (32%), Positives = 109/215 (50%), Gaps = 30/215 (13%)

Query: 192 FTHKLGQGGFGSVYKGQLH--TGRLIAVK----MLENSKFSAEEFINEVSTIGRIHHVNV 245
              +LG+G +GSVYK  LH  TG  +A+K     L+ SKF+  + I E+  + +     +
Sbjct: 5   VLDELGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFN--QIIMELDILHKAVSPYI 61

Query: 246 VQLLG-FCSEGSKRALVY---EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVA 301
           V   G F  EG+    VY   E+M  GSLD+ ++      +    + L+ I     +G+ 
Sbjct: 62  VDFYGAFFIEGA----VYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLK 116

Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIA 360
           +L    +  I+H D+KP N+L++ N   K+ DFG++      N   S++ T  G   Y+A
Sbjct: 117 FLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSG-----NLVASLAKTNIGCQSYMA 169

Query: 361 PELIS----RNFGTVSCKSDVYGFGMVLLEMAGGR 391
           PE I         T + +SDV+  G+ +LEMA GR
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 65/201 (32%), Positives = 95/201 (47%), Gaps = 15/201 (7%)

Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVVQLLG 250
           LG+GGFG V   Q+  TG++ A K LE  +    +     +NE   + +++   VV L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                    LV   M  G L  HI+   N G  F  E+    A     G+  LH      
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FEEERALFYAAEILCGLEDLHR---EN 122

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
            ++ D+KP NILLD     ++SD GLA   P+     SI    GT+GY+APE+++    T
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYT 179

Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
           +S   D +G G ++ EM  G+
Sbjct: 180 LS--PDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 78.1 bits (192), Expect = 5e-16
 Identities = 61/228 (26%), Positives = 110/228 (48%), Gaps = 49/228 (21%)

Query: 196 LGQGGFGSVYKGQLH--TGR----LIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQ 247
           LG+G FG V K       GR     +AVKML+ +  S+E  + ++E + + +++H +V++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 248 LLGFCSEGSKRALVYEFMPNGSL-------------------DRHIFPKENKGQ------ 282
           L G CS+     L+ E+   GSL                   +R+    +N  +      
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 283 ---TFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF 339
              +F W+         +RG+ YL    +M ++H D+   N+L+      K+SDFGL++ 
Sbjct: 128 DLISFAWQ--------ISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176

Query: 340 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
             +E+ +V  S  R  + ++A E +  +  T   +SDV+ FG++L E+
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYTT--QSDVWSFGVLLWEI 222

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 77.8 bits (191), Expect = 5e-16
 Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 26/210 (12%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLG-FC 252
           +G G +G VYKG+ + TG+L A+K+++ +    EE   E++ + +  HH N+    G F 
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 253 SEG-----SKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +       +  LV EF   GS+   I  K  KG T   E +  I     RG+++LH   
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGLSHLHQ-- 129

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPEL 363
              ++H DIK  N+LL  N   K+ DFG    L +   + N F+      GT  ++APE+
Sbjct: 130 -HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMAPEV 182

Query: 364 ISRNF---GTVSCKSDVYGFGMVLLEMAGG 390
           I+ +     T   KSD++  G+  +EMA G
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 77.5 bits (191), Expect = 6e-16
 Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 33/208 (15%)

Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEE---FINEVSTIGRIHHVNVVQL 248
           LGQG FG VY    + TGR +AVK +    +S  + +E      E+  +  + H  +VQ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFP----KENKGQTFGWEKLQEIALGTARGVAYLH 304
            G   +    ++  E+MP GS+   +       E   + +  + L+        GV YLH
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE--------GVEYLH 121

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK----FHPKENDFVSISATRGTIGYIA 360
                 I+H DIK  NIL D     K+ DFG +K             S++   GT  +++
Sbjct: 122 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT---GTPYWMS 175

Query: 361 PELIS-RNFGTVSCKSDVYGFGMVLLEM 387
           PE+IS   +G    K+DV+  G  ++EM
Sbjct: 176 PEVISGEGYGR---KADVWSVGCTVVEM 200

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 76.7 bits (189), Expect = 9e-16
 Identities = 71/275 (25%), Positives = 120/275 (43%), Gaps = 37/275 (13%)

Query: 196 LGQGGFGS--VYKGQLHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 250
           LG+G FG   +Y+ +     L+  K +  ++ S +E    +NE+  +  + H N++    
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
              + +   +  E+   G+L   I     KGQ F  E +          V+Y+H      
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKI--VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--- 121

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPEL---ISR 366
           ILH DIK  NI L    + K+ DFG++K         S++ T  GT  Y++PEL   +  
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISK---ILGSEYSMAETVVGTPYYMSPELCQGVKY 178

Query: 367 NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT 426
           NF     KSD++  G VL E+   +        R+  A  P  +  ++ +G      N T
Sbjct: 179 NF-----KSDIWALGCVLYELLTLK--------RTFDATNPLNLVVKIVQG------NYT 219

Query: 427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEML 461
            + SV + +L  +    +Q     RP+  +VL+  
Sbjct: 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 77.0 bits (189), Expect = 9e-16
 Identities = 56/199 (28%), Positives = 100/199 (50%), Gaps = 19/199 (9%)

Query: 195 KLGQGGFGSVYKGQLHT-GRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           ++G+G FG V+ G+L      +AVK    +       +F+ E   + +  H N+V+L+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
           C++     +V E +  G     +     +G     ++L ++    A G+ YL +    CI
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFL---RTEGPRLKVKELIQMVENAAAGMEYLESKH--CI 116

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT----IGYIAPELISRN 367
            H D+   N L+    + K+SDFG+++   +E D V  ++T G     + + APE +  N
Sbjct: 117 -HRDLAARNCLVTEKNVLKISDFGMSR---EEEDGV-YASTGGMKQIPVKWTAPEAL--N 169

Query: 368 FGTVSCKSDVYGFGMVLLE 386
           +G  S +SDV+ FG++L E
Sbjct: 170 YGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 69/205 (33%), Positives = 101/205 (49%), Gaps = 25/205 (12%)

Query: 196 LGQGGFGSVYKGQLHTG----RLIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +G+G FG VY G L          AVK L         E+F+ E   +    H NV+ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 250 GFC--SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
           G C  SEGS   +V  +M +G L R+    E    T   + L    L  A+G+ YL +  
Sbjct: 63  GICLPSEGSP-LVVLPYMKHGDL-RNFIRSETHNPTV--KDLIGFGLQVAKGMEYLAS-- 116

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGT---IGYIAPE- 362
               +H D+   N +LD +F  KV+DFGLA+  + KE  + S+    G    + ++A E 
Sbjct: 117 -KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE--YYSVHNHTGAKLPVKWMALES 173

Query: 363 LISRNFGTVSCKSDVYGFGMVLLEM 387
           L ++ F T   KSDV+ FG++L E+
Sbjct: 174 LQTQKFTT---KSDVWSFGVLLWEL 195

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 25/208 (12%)

Query: 191 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQL 248
               ++G G +G VYK + + TG L+A+K+++       E I  E+S +    H N+V  
Sbjct: 6   ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAY 65

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIAL---GTARGVAYLHN 305
            G      K  +V E+   GSL   I+       T G     +IA     T +G+AYLH 
Sbjct: 66  FGSYLRRDKLWIVMEYCGGGSLQ-DIY-----QVTRGPLSELQIAYVCRETLKGLAYLHE 119

Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAP 361
                 +H DIK  NILL  +   K++DFG++        K   F+      GT  ++AP
Sbjct: 120 ---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI------GTPYWMAP 170

Query: 362 ELISRNF-GTVSCKSDVYGFGMVLLEMA 388
           E+ +    G    K D++  G+  +E+A
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELA 198

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 30/213 (14%)

Query: 196 LGQGGFGSVYKGQL------HTGRL-IAVKMLENSKFSAE--EFINEVSTIGRIHHVNVV 246
           LG G FG VY+G         +G + +AVK L       E  EF+ E   +   +H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFG-----WEKLQEIALGTARGVA 301
           +LLG C     + ++ E M  G L  ++  ++ + + FG      ++L +I L  A+G  
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 302 YLHNGCDMCILHFDIKPHNILL-----DHNFIPKVSDFGLAKFHPKENDFVSISATRG-T 355
           YL     M  +H D+   N L+     D + + K+ DFGLA+   K +D+          
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK-SDYYRKEGEGLLP 176

Query: 356 IGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           + ++APE L+   F T   +SDV+ FG+++ E+
Sbjct: 177 VRWMAPESLLDGKFTT---QSDVWSFGVLMWEI 206

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 62/203 (30%), Positives = 107/203 (52%), Gaps = 21/203 (10%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLEN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           +LG G FG VYK +   TG L A K++E  S+   E+++ E+  +   +H  +V+LLG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
               K  ++ EF P G++D  I  + ++G T    ++Q I       + YLH+   M I+
Sbjct: 79  YWDGKLWIMIEFCPGGAVDA-IMLELDRGLT--EPQIQVICRQMLEALQYLHS---MKII 132

Query: 313 HFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELI---S 365
           H D+K  N+LL  +   K++DFG++    K   + + F+      GT  ++APE++   +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI------GTPYWMAPEVVMCET 186

Query: 366 RNFGTVSCKSDVYGFGMVLLEMA 388
                   K+D++  G+ L+EMA
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMA 209

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 26/210 (12%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCS 253
           +G G +G VYKG+ + TG+L A+K+++ ++   EE   E++ + +  HH N+    G   
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83

Query: 254 EGSKRA------LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
           + S         LV EF   GS+   +  K  KG     + +  I     RG+A+LH   
Sbjct: 84  KKSPPGHDDQLWLVMEFCGAGSVTDLV--KNTKGNALKEDWIAYICREILRGLAHLHA-- 139

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPEL 363
              ++H DIK  N+LL  N   K+ DFG    L +   + N F+      GT  ++APE+
Sbjct: 140 -HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMAPEV 192

Query: 364 ISRNF---GTVSCKSDVYGFGMVLLEMAGG 390
           I+ +     T   +SD++  G+  +EMA G
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 71/231 (30%), Positives = 116/231 (50%), Gaps = 35/231 (15%)

Query: 196 LGQGGFGSVYKGQLHTGR----LIAVKMLENSKFSAEEFI---NEVSTIGRIHHVNVVQL 248
           LGQG FG V+  +  TG     L A+K+L+ +     + +    E   +  ++H  +V+L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 249 -LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEK----LQEIALGTARGVAYL 303
              F +EG K  L+ +F+  G L    F + +K   F  E     L E+AL     + +L
Sbjct: 64  HYAFQTEG-KLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALA----LDHL 114

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
           H+   + I++ D+KP NILLD     K++DFGL+K    +++  + S   GT+ Y+APE+
Sbjct: 115 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFC-GTVEYMAPEV 169

Query: 364 ISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNAIRSSKAYFP 407
           ++R   T S  +D + FG+++ EM  G        R   M  I  +K   P
Sbjct: 170 VNRRGHTQS--ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP 218

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 26/214 (12%)

Query: 192 FTHKLGQGGFGSVYKGQLHTGRL---IAVKMLEN--SKFSAEEFINEVSTIGRI-HHVNV 245
           F   +G+G FG V +  +    L    A+KML+   S+    +F  E+  + ++ HH N+
Sbjct: 6   FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65

Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHI-----------FPKEN-KGQTFGWEKLQEIA 293
           + LLG C       +  E+ P G+L   +           F KE+    T   ++L + A
Sbjct: 66  INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 294 LGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 353
              A G+ YL    +   +H D+   N+L+  N   K++DFGL++    E  +V  +  R
Sbjct: 126 SDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGR 179

Query: 354 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
             + ++A E  S N+   + KSDV+ FG++L E+
Sbjct: 180 LPVRWMAIE--SLNYSVYTTKSDVWSFGVLLWEI 211

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 21/201 (10%)

Query: 195 KLGQGGFGSVYKG---QLHTGRLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQL 248
           +LG G FG+V KG      + + +AVK+L+N        +E + E + + ++ +  +V++
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL--HNG 306
           +G C E     LV E    G L++  F ++NK  T   + + E+    + G+ YL   N 
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNK--FLQKNKHVTE--KNITELVHQVSMGMKYLEETN- 115

Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELIS 365
                +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE + 
Sbjct: 116 ----FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM- 170

Query: 366 RNFGTVSCKSDVYGFGMVLLE 386
            N+   S KSDV+ FG+++ E
Sbjct: 171 -NYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 75.7 bits (186), Expect = 3e-15
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 24/210 (11%)

Query: 196 LGQGGFGSVYKGQLH----TGRLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQL 248
           LG+G FGSV + QL     + + +AVKML+   FS+   EEF+ E + +    H NV++L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 249 LGFC--SEGSKR----ALVYEFMPNGSLDRHIFPKENK-GQ---TFGWEKLQEIALGTAR 298
           +G    S    R     ++  FM +G L  H F   ++ G+   T   + L    +  A 
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDL--HTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 299 GVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 358
           G+ YL +      +H D+   N +L+ N    V+DFGL+K     + +    A++  + +
Sbjct: 125 GMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181

Query: 359 IAPELISRNFGTVSCKSDVYGFGMVLLEMA 388
           +A E ++ N  T    SDV+ FG+ + E+ 
Sbjct: 182 LALESLADNVYTT--HSDVWAFGVTMWEIM 209

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 75.0 bits (184), Expect = 5e-15
 Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 14/204 (6%)

Query: 195 KLGQGGFGSVYKGQLHTG---RLIAVKMLENSKFSAEE--FINEVSTIGRIHHVNVVQLL 249
           ++G G FG V  G++++G     + VK L  S    E+  F+ E      + H N++Q L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFP-KENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           G C+E +   LV EF P G L  ++   ++ +  T     LQ +A   A G+ +LH    
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-- 119

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
              +H D+   N LL  +   K+ D+GL+    KE+ +V+       + +IAPEL+    
Sbjct: 120 -NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 369 GTV-----SCKSDVYGFGMVLLEM 387
           G +     + +S+V+  G+ + E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 74.8 bits (184), Expect = 5e-15
 Identities = 79/296 (26%), Positives = 119/296 (40%), Gaps = 62/296 (20%)

Query: 196 LGQGGFGSVYKGQLHTGRL-------IAVKMLENSKFSAEE--FINEVSTIGRIHHVNVV 246
           LG G FG VY+G  + GR        +AVK L  S    +E  F+ E   + + +H N+V
Sbjct: 14  LGHGAFGEVYEGL-YRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72

Query: 247 QLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           +L+G   E   R ++ E M  G L    R   P+  +  +   + L   A   A+G  YL
Sbjct: 73  RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132

Query: 304 H-NGCDMCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRG----- 354
             N      +H DI   N LL       + K++DFG+A+      D    S  R      
Sbjct: 133 EENH----FIHRDIAARNCLLTCKGPGRVAKIADFGMAR------DIYRASYYRKGGRAM 182

Query: 355 -TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-------GRRNSNMNAIRSSKAYF 406
             I ++ PE      G  + K+DV+ FG++L E+         GR N             
Sbjct: 183 LPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE----------- 229

Query: 407 PSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
              V + +  GG L+          + R    I   C Q    DRP+   +LE ++
Sbjct: 230 ---VMEFVTGGGRLD--PPKGCPGPVYR----IMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 6e-15
 Identities = 69/254 (27%), Positives = 104/254 (40%), Gaps = 38/254 (14%)

Query: 198 QGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHV-----NVVQLLGF 251
           +G FGSVY  +   TG   A+K+L+ S   A+  +  V     I  +      V +L   
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFG-----WEK--LQEIALGTARGVAYLH 304
                   LV E++  G     I       +T G     W K  + E+ LG    V  LH
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLI-------KTLGGLPEDWAKQYIAEVVLG----VEDLH 114

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
                 I+H DIKP N+L+D     K++DFGL++   +   FV      GT  Y+APE I
Sbjct: 115 ---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV------GTPDYLAPETI 165

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN 424
                      D +  G V+ E   G    +     +  A F + +  ++N   +++   
Sbjct: 166 LGVGDDKMS--DWWSLGCVIFEFLFGYPPFHAE---TPDAVFDNILSRRINWPEEVKEFC 220

Query: 425 VTEIESVIARKLCM 438
             E   +I R LCM
Sbjct: 221 SPEAVDLINRLLCM 234

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 74.7 bits (183), Expect = 6e-15
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 25/211 (11%)

Query: 195 KLGQGGFGSVYKGQLHTGRL-------IAVKMLENSKFSAE--EFINEVSTIGRIHHVNV 245
           +LGQG FG VY+G +  G +       +A+K +  +    E  EF+NE S +   +  +V
Sbjct: 13  ELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71

Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKE--NKGQTF-GWEKLQEIALGTARG 299
           V+LLG  S+G    ++ E M  G L    R + P+   N  Q     +K+ ++A   A G
Sbjct: 72  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--TIG 357
           +AYL+       +H D+   N ++  +F  K+ DFG+ +    E D+      +G   + 
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLPVR 186

Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMA 388
           +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 187 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 215

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 74.7 bits (183), Expect = 7e-15
 Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 26/204 (12%)

Query: 195 KLGQGGFGSVYKGQLHT-GRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 252
           K+G+G  G V    + + G+L+AVK ++  K    E + NEV  +    H NVV++    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 253 SEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
             G +  +V EF+  G+L D     + N+      E++  + L   + ++ LH      +
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNE------EQIAAVCLAVLKALSVLHA---QGV 137

Query: 312 LHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISR- 366
           +H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELISR 
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPELISRL 191

Query: 367 NFGTVSCKSDVYGFGMVLLEMAGG 390
            +G    + D++  G++++EM  G
Sbjct: 192 PYGP---EVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 74.2 bits (183), Expect = 8e-15
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 24/210 (11%)

Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGF-- 251
           +G+G +G VYK     TG+L+A+K+++  +   EE   E + + +  +H N+    G   
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFI 73

Query: 252 ----CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
                    +  LV E    GS+   +     KG+    E +  I   T RG+AYLH   
Sbjct: 74  KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK 133

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPEL 363
              ++H DIK  NILL  N   K+ DFG    L     + N F+      GT  ++APE+
Sbjct: 134 ---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI------GTPYWMAPEV 184

Query: 364 ISRNFG---TVSCKSDVYGFGMVLLEMAGG 390
           I+ +     +   +SDV+  G+  +E+A G
Sbjct: 185 IACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 74.7 bits (183), Expect = 8e-15
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 19/203 (9%)

Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVVQLLG 250
           LG+GGFG V   Q+  TG++ A K LE  +    +     +NE   + +++   VV L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEI--ALGTARGVAYLHNGCD 308
                    LV   M  G L  HI+   + G+  G+E+ + +  A     G+  LH    
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIY---HMGEA-GFEEGRAVFYAAEICCGLEDLHQ--- 120

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             I++ D+KP NILLD +   ++SD GLA   P+     +I    GT+GY+APE++    
Sbjct: 121 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNER 177

Query: 369 GTVSCKSDVYGFGMVLLEMAGGR 391
            T S   D +  G +L EM  G+
Sbjct: 178 YTFS--PDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 74.0 bits (181), Expect = 9e-15
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 26/210 (12%)

Query: 196 LGQGGFGSVYKGQLHTGRL---IAVKMLEN--SKFSAEEFINEVSTIGRI-HHVNVVQLL 249
           +G+G FG V K ++    L    A+K ++   SK    +F  E+  + ++ HH N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHI-----------FPKEN-KGQTFGWEKLQEIALGTA 297
           G C       L  E+ P+G+L   +           F   N    T   ++L   A   A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
           RG+ YL        +H D+   NIL+  N++ K++DFGL++    +  +V  +  R  + 
Sbjct: 123 RGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 176

Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
           ++A E  S N+   +  SDV+ +G++L E+
Sbjct: 177 WMAIE--SLNYSVYTTNSDVWSYGVLLWEI 204

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 68/221 (30%), Positives = 104/221 (47%), Gaps = 32/221 (14%)

Query: 194 HKLGQGGFGSVY-KGQLHTGRLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVVQL 248
           H++G G FG+VY     HT  ++AVK +  S     E     I EV  + ++ H N ++ 
Sbjct: 27  HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIAL-----GTARGVAYL 303
            G   +     LV E+    + D     K+          LQE+ +     G  +G+AYL
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSASDLLEVHKK---------PLQEVEIAAITHGALQGLAYL 137

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
           H+     ++H DIK  NILL      K++DFG A      N FV      GT  ++APE+
Sbjct: 138 HS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEV 188

Query: 364 I-SRNFGTVSCKSDVYGFGMVLLEMAGGRRNS--NMNAIRS 401
           I + + G    K DV+  G+  +E+A  R+    NMNA+ +
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNAMSA 228

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 65/232 (28%), Positives = 107/232 (46%), Gaps = 43/232 (18%)

Query: 192 FTHKLGQGGFGSV---------------YKGQLHTGR--LIAVKML--ENSKFSAEEFIN 232
           F  KLG+G FG V               +   +  GR  L+AVK+L  + +K +  +F+ 
Sbjct: 9   FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68

Query: 233 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLD-----RHIFPKENKGQ----- 282
           EV  + R+   N+++LLG C +     ++ E+M NG L+      H+  KE  G      
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 283 -----TFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLA 337
                   +  L  +AL  A G+ YL +   +  +H D+   N L+  N   K++DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 338 KFHPKENDFVSISATRGT--IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
           + +    D+  I   R    I ++A E I    G  +  SDV+ FG+ L E+
Sbjct: 186 R-NLYAGDYYRIQG-RAVLPIRWMAWECIL--MGKFTTASDVWAFGVTLWEI 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 26/204 (12%)

Query: 195 KLGQGGFGSV-YKGQLHTGRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 252
           K+G+G  G V    + H+GR +AVKM++  K    E + NEV  +    H NVV++    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQT-FGWEKLQEIALGTARGVAYLHNGCDMCI 311
             G +  ++ EF+  G+L   +       QT    E++  +     + + YLH+     +
Sbjct: 88  LVGEELWVLMEFLQGGALTDIV------SQTRLNEEQIATVCESVLQALCYLHS---QGV 138

Query: 312 LHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISRN 367
           +H DIK  +ILL  +   K+SDFG    ++K  PK    V      GT  ++APE+ISR 
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVISRT 192

Query: 368 -FGTVSCKSDVYGFGMVLLEMAGG 390
            +GT   + D++  G++++EM  G
Sbjct: 193 PYGT---EVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 63/211 (29%), Positives = 108/211 (51%), Gaps = 38/211 (18%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKM--LENSKFSAEE-----FINEVSTIGRIHHVNVV 246
           K+G+G +G VYKG+   TG+++A+K   LE    S EE      I E+S +  + H N+V
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLE----SEEEGVPSTAIREISLLKELQHPNIV 62

Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHI--FPKENKGQTFGWEKLQEIALGTARGVAYLH 304
            L     + S+  L++EF+ +  L +++   PK   GQ    E ++       +G+ + H
Sbjct: 63  CLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCH 118

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-----FHPKENDFVSISATRGTIGYI 359
           +     +LH D+KP N+L+D+  + K++DFGLA+          ++ V       T+ Y 
Sbjct: 119 S---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-------TLWYR 168

Query: 360 APELISRNFGTV--SCKSDVYGFGMVLLEMA 388
           APE++    G+   S   D++  G +  EMA
Sbjct: 169 APEVL---LGSPRYSTPVDIWSIGTIFAEMA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 70/242 (28%), Positives = 108/242 (44%), Gaps = 55/242 (22%)

Query: 194 HKLGQGGFGSVYKGQ-LHTGRLIAVKML-----ENSKFSAEEFINEVSTIGRIHHVNVVQ 247
            KLG+G + +VYKG+   TG+L+A+K +     E + F+A   I E S +  + H N+V 
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTA---IREASLLKDLKHANIVT 67

Query: 248 LLGFCSEGSKRALVYEFMPNG---SLDRH-IFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           L           LV+E++       +D        +  + F ++ L        RG+AY 
Sbjct: 68  LHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL--------RGLAYC 119

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-----FHPKENDFVSISATRGTIGY 358
           H      +LH D+KP N+L+      K++DFGLA+          N+ V       T+ Y
Sbjct: 120 H---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-------TLWY 169

Query: 359 IAPE--LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP--SWVYDQL 414
             P+  L S  + T     D++G G +  EMA GR              FP  + V DQL
Sbjct: 170 RPPDVLLGSTEYST---SLDMWGVGCIFYEMATGR------------PLFPGSTDVEDQL 214

Query: 415 NK 416
           +K
Sbjct: 215 HK 216

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 17/202 (8%)

Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVK--MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           KLG+G + +V+KG+   T  L+A+K   LE+ + +    I EVS +  + H N+V L   
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                   LV+E++ +  L +++   +N G       ++       RG++Y H      I
Sbjct: 72  IHTERCLTLVFEYLDS-DLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKI 124

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           LH D+KP N+L++     K++DFGLA+   K     + S    T+ Y  P+++    G+ 
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVL---LGST 179

Query: 372 --SCKSDVYGFGMVLLEMAGGR 391
             S   D++G G +L EMA GR
Sbjct: 180 EYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 55/185 (29%), Positives = 92/185 (49%), Gaps = 33/185 (17%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE------FINEVSTIGRI---HHVNV 245
           +G+G +G+VYK + L+TGR +A+K +   +    E       + E++ + ++    H N+
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKV---RVPLSEEGIPLSTLREIALLKQLESFEHPNI 63

Query: 246 VQLLGFC-----SEGSKRALVYEFMP---NGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
           V+LL  C         K  LV+E +       L +   PK   G     E ++++     
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKC--PK--PG--LPPETIKDLMRQLL 117

Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
           RGV +LH+     I+H D+KP NIL+  +   K++DFGLA+ +  E    S+     T+ 
Sbjct: 118 RGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV---TLW 171

Query: 358 YIAPE 362
           Y APE
Sbjct: 172 YRAPE 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 72.4 bits (178), Expect = 4e-14
 Identities = 71/233 (30%), Positives = 111/233 (47%), Gaps = 38/233 (16%)

Query: 196 LGQGGFGSVYKGQLH--TGRLIAVKM--LENSKFSAEEFINEVSTIGRIHH-VNVVQLLG 250
           +G+G FG+V K  LH  +G ++AVK       +   +  + ++  + R      +V+  G
Sbjct: 12  IGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70

Query: 251 --FCSEGSKRALV-YEFMPNGSLDR-HIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
             F  EG     +  E M + SLD+ + +  E        E L +IA+ T + + YL   
Sbjct: 71  ALF-REGD--CWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE- 125

Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR--GTIGYIAPELI 364
            ++ I+H D+KP NILLD N   K+ DFG++     +    SI+ TR  G   Y+APE I
Sbjct: 126 -ELKIIHRDVKPSNILLDRNGNIKLCDFGISG-QLVD----SIAKTRDAGCRPYMAPERI 179

Query: 365 SRNFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW--VYDQL 414
             +       +SDV+  G+ L E+A G            K  +P W  V+DQL
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATG------------KFPYPKWNSVFDQL 220

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 56/211 (26%), Positives = 103/211 (48%), Gaps = 25/211 (11%)

Query: 195 KLGQGGFGSVYKGQLHT------GRLIAVKMLENSKFSA-EEFINEVSTIGRIHHVNVVQ 247
           +LG+G FG V+  + +         L+AVK L+++  +A ++F  E   +  + H ++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRH---------IFPKENKGQTFGWEKLQEIALGTAR 298
             G C EG    +V+E+M +G L++          +  + N+       ++  IA   A 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 299 GVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA-TRGTIG 357
           G+ YL        +H D+   N L+  N + K+ DFG+++      D+  +   T   I 
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR-DVYSTDYYRVGGHTMLPIR 187

Query: 358 YIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           ++ PE ++ R F T   +SDV+  G+VL E+
Sbjct: 188 WMPPESIMYRKFTT---ESDVWSLGVVLWEI 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 73.0 bits (179), Expect = 5e-14
 Identities = 71/260 (27%), Positives = 108/260 (41%), Gaps = 74/260 (28%)

Query: 196 LGQGGFGSVYK------GQLHTGRLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 246
           LG+G FG V +       +  + R +AVKML+    ++E    + E+  +  I HH+NVV
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74

Query: 247 QLLGFCSE-GSKRALVYEFMPNGSLD------RHIF-PKENKGQTFGWEKLQEI------ 292
            LLG C++ G    ++ E+   G+L       R  F P  NK       K +E       
Sbjct: 75  NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134

Query: 293 --------------------------------------------ALGTARGVAYLHNGCD 308
                                                       +   ARG+ +L     
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL--ASR 192

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
            CI H D+   NILL  N + K+ DFGLA+   K+ D+V     R  + ++APE I   F
Sbjct: 193 KCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI---F 248

Query: 369 GTV-SCKSDVYGFGMVLLEM 387
             V + +SDV+ FG++L E+
Sbjct: 249 DKVYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 74.5 bits (183), Expect = 6e-14
 Identities = 49/201 (24%), Positives = 99/201 (49%), Gaps = 20/201 (9%)

Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           + +G  G+ YKG+     +   VK + +         +E++ +G++ H N+V+L+G C  
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS---SEIADMGKLQHPNIVKLIGLCRS 754

Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                L++E++   +L   +       +   WE+ ++IA+G A+ + +LH  C   ++  
Sbjct: 755 EKGAYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807

Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           ++ P  I++D    P +    L      +      SA      Y+APE  +R    ++ K
Sbjct: 808 NLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA------YVAPE--TRETKDITEK 858

Query: 375 SDVYGFGMVLLEMAGGRRNSN 395
           SD+YGFG++L+E+  G+  ++
Sbjct: 859 SDIYGFGLILIELLTGKSPAD 879

Length = 968

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 71.6 bits (175), Expect = 6e-14
 Identities = 61/214 (28%), Positives = 111/214 (51%), Gaps = 24/214 (11%)

Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           ++G+G FG VYKG    T  ++A+K+  LE ++   E+   E++ + +     + +  G 
Sbjct: 11  RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
             +G+K  ++ E++  GS    + P   + +T+    L+EI     +G+ YLH+      
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLKPGPLE-ETYIATILREIL----KGLDYLHSERK--- 122

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELISRN 367
           +H DIK  N+LL      K++DFG+A        K N FV      GT  ++APE+I ++
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEVIKQS 176

Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNAIR 400
                 K+D++  G+  +E+A G   NS+++ +R
Sbjct: 177 --AYDFKADIWSLGITAIELAKGEPPNSDLHPMR 208

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 71.9 bits (176), Expect = 6e-14
 Identities = 66/203 (32%), Positives = 99/203 (48%), Gaps = 19/203 (9%)

Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVVQLLG 250
           LG+GGFG V   Q+  TG++ A K LE  +    +     +NE   + +++   VV L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66

Query: 251 FCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           +  E +K AL  V   M  G L  HI+   N G  F  ++    A     G+  L     
Sbjct: 67  YAYE-TKDALCLVLTIMNGGDLKFHIYNMGNPG--FDEQRAIFYAAELCCGLEDLQR--- 120

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             I++ D+KP NILLD     ++SD GLA   P+     ++    GT+GY+APE+I+   
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEK 177

Query: 369 GTVSCKSDVYGFGMVLLEMAGGR 391
            T S   D +G G ++ EM  G+
Sbjct: 178 YTFS--PDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 71.9 bits (176), Expect = 7e-14
 Identities = 68/212 (32%), Positives = 102/212 (48%), Gaps = 27/212 (12%)

Query: 195 KLGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRIHHVN 244
           +LGQG FG VY        KG+  T   +AVK +  S    E  EF+NE S +      +
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAET--RVAVKTVNESASLRERIEFLNEASVMKGFTCHH 70

Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQEI---ALGTAR 298
           VV+LLG  S+G    +V E M +G L    R + P+           LQE+   A   A 
Sbjct: 71  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130

Query: 299 GVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--TI 356
           G+AYL+       +H D+   N ++ H+F  K+ DFG+ +    E D+      +G   +
Sbjct: 131 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLPV 185

Query: 357 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 388
            ++APE  S   G  +  SD++ FG+VL E+ 
Sbjct: 186 RWMAPE--SLKDGVFTTSSDMWSFGVVLWEIT 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 71.9 bits (176), Expect = 7e-14
 Identities = 55/207 (26%), Positives = 100/207 (48%), Gaps = 28/207 (13%)

Query: 196 LGQGGFGSVY------KGQLHTGRLIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQ 247
           LG+G FG V       +G  +TG  +AVK L  E+      +   E+  +  ++H N+V+
Sbjct: 12  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 248 LLGFCSEGSKRA--LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
             G C+E       L+ EF+P+GSL  ++   +NK      ++  + A+   +G+ YL +
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYLGS 127

Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPELI 364
                 +H D+   N+L++     K+ DFGL K    + ++ ++     + + + APE +
Sbjct: 128 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184

Query: 365 SRNFGTVSCK----SDVYGFGMVLLEM 387
                 +  K    SDV+ FG+ L E+
Sbjct: 185 ------IQSKFYIASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 71.4 bits (175), Expect = 8e-14
 Identities = 58/201 (28%), Positives = 85/201 (42%), Gaps = 15/201 (7%)

Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVVQLLG 250
           LG+GGFG V   Q+  TG++ A K L+  +    +     +NE   + ++    +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                    LV   M  G L  HI+     G  F   +    A     G+ +LH      
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG--FPEARAIFYAAQIICGLEHLHQ---RR 115

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           I++ D+KP N+LLD +   ++SD GLA           I    GT GY+APE++      
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQG--EV 170

Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
                D +  G  L EM  GR
Sbjct: 171 YDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 71.1 bits (174), Expect = 9e-14
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 15/198 (7%)

Query: 195 KLGQGGFGSVYKG--QLHTGRL-IAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +LG G FG V KG  ++   ++ +A+K+L  EN K   +E + E   + ++ +  +V+++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G C E     LV E    G L++ +  K+++        + E+    + G+ YL      
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITV---SNVVELMHQVSMGMKYLE---GK 114

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRNF 368
             +H D+   N+LL +    K+SDFGL+K     ++ + + SA +  + + APE I  NF
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI--NF 172

Query: 369 GTVSCKSDVYGFGMVLLE 386
              S +SDV+ +G+ + E
Sbjct: 173 RKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 71.3 bits (175), Expect = 9e-14
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 16/199 (8%)

Query: 195 KLGQGGFGSVYKG--QLHTGRLI--AVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQL 248
            +G+G FG VY+G         I  AVK  +N  S    E+F+ E   + +  H ++V+L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           +G  +E +   +V E  P G L R  + + NK        L   +   +  +AYL +   
Sbjct: 73  IGVITE-NPVWIVMELAPLGEL-RS-YLQVNKYSL-DLASLILYSYQLSTALAYLES--- 125

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
              +H DI   N+L+      K+ DFGL+++  ++  +   S  +  I ++APE I  NF
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY-LEDESYYKASKGKLPIKWMAPESI--NF 182

Query: 369 GTVSCKSDVYGFGMVLLEM 387
              +  SDV+ FG+ + E+
Sbjct: 183 RRFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 71.6 bits (175), Expect = 9e-14
 Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 17/202 (8%)

Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVK--MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           KLG+G + +V+KG+   T  L+A+K   LE+ + +    I EVS +  + H N+V L   
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                   LV+E++ +  L +++   ++ G       ++       RG+AY H      +
Sbjct: 73  VHTDKSLTLVFEYL-DKDLKQYM---DDCGNIMSMHNVKIFLYQILRGLAYCHR---RKV 125

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI--SRNFG 369
           LH D+KP N+L++     K++DFGLA+   K     + S    T+ Y  P+++  S  + 
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183

Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
           T   + D++G G +  EMA GR
Sbjct: 184 T---QIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 38/162 (23%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE------FINEVSTIGRIHHVNVVQ 247
           K+G+G +G VYK +   TG ++A+K +   +   E+       I E+S +  ++H N+V+
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKI---RLETEDEGVPSTAIREISLLKELNHPNIVR 62

Query: 248 LLGFCSEGSKRALVYEFM-----------PNGSLDRHIFPKENKGQTFGWEKLQEIALGT 296
           LL      +K  LV+EF+           P   LD  +         + ++ LQ      
Sbjct: 63  LLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKS------YLYQLLQ------ 110

Query: 297 ARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK 338
             G+AY H+     +LH D+KP N+L+D     K++DFGLA+
Sbjct: 111 --GIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 72/289 (24%), Positives = 121/289 (41%), Gaps = 49/289 (16%)

Query: 196 LGQGGFGSVYKGQLH------TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQ 247
           LG+G FG V+  +           L+ VK L+ +K      EF  E+    ++ H NVV+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIF---PKENKGQTFGWEKLQEIALGT--ARGVAY 302
           LLG C E     ++ E+   G L + +     K+ K +       Q++AL T  A G+ +
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK------FHPKENDFVSISATRGTI 356
           L N      +H D+   N L+      KVS   L+K      ++   N  + +       
Sbjct: 133 LSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR------ 183

Query: 357 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQ-LN 415
            ++APE +  +    S KSDV+ FG+++ E+               +  F     ++ LN
Sbjct: 184 -WLAPEAVQED--DFSTKSDVWSFGVLMWEV-----------FTQGELPFYGLSDEEVLN 229

Query: 416 --KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
             + G LEL     +      +L  +   C  V   DRPS ++++  L 
Sbjct: 230 RLQAGKLELP----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 20/206 (9%)

Query: 196 LGQGGFGSVYKGQLH--TGRLIAVKMLENSKFSAEE--FINEVSTIGR-IHHVNVVQLLG 250
           LG+G +G V K + H  TG ++AVK +  +  S E+   + ++    R +     V   G
Sbjct: 9   LGRGAYGVVDKMR-HVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67

Query: 251 -FCSEGSKRALVYEFMP--NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
               EG     V+  M   + SLD+      +KG T   + L +IA+   + + YLH+  
Sbjct: 68  ALFREGD----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-- 121

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-- 365
            + ++H D+KP N+L++ N   K+ DFG++ +     D V+ +   G   Y+APE I+  
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTIDAGCKPYMAPERINPE 178

Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGR 391
            N      KSDV+  G+ ++E+A GR
Sbjct: 179 LNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 51/216 (23%), Positives = 100/216 (46%), Gaps = 25/216 (11%)

Query: 185 IIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKML--ENSKFSAEEFINEVSTIGRIHH 242
            +   +       +    +          L+AVK+L  + S  + E+F+ EV  + R+  
Sbjct: 22  HLCEADGLQDFSEKAFAENDNADA---PVLVAVKVLRPDASDNAREDFLKEVKILSRLSD 78

Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSLD----RHIFPKENK---GQTFGWEKLQEIALG 295
            N+ +LLG C+      ++ E+M NG L+    +H+          ++  +  L  +A  
Sbjct: 79  PNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQ 138

Query: 296 TARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT 355
            A G+ YL +   +  +H D+   N L+  N+  K++DFG+++ +   +D+  +   +G 
Sbjct: 139 IASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSR-NLYSSDYYRV---QGR 191

Query: 356 ----IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
               I ++A E +    G  + KSDV+ FG+ L E+
Sbjct: 192 APLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 17/202 (8%)

Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVK--MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           KLG+G + +VYKG+   T  L+A+K   LE+ + +    I EVS +  + H N+V L   
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                   LV+E++ +  L +++   ++ G +     ++       RG+ Y H      +
Sbjct: 73  IHTEKSLTLVFEYL-DKDLKQYL---DDCGNSINMHNVKLFLFQLLRGLNYCHR---RKV 125

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI--SRNFG 369
           LH D+KP N+L++     K++DFGLA+   K     + S    T+ Y  P+++  S ++ 
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183

Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
           T   + D++G G +  EM+ GR
Sbjct: 184 T---QIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 44/215 (20%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE--------FINEVSTIGRIHHVNV 245
           K+G+G +G V+K +   TG+++A+K     KF   E         + E+  + ++ H N+
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLKQLKHPNL 62

Query: 246 VQLLGFCSEGSKRALVYEFMPN---GSLDRHIFPK---ENKGQTFGWEKLQEIALGTARG 299
           V L+       K  LV+E+  +     L+++  P+   E+  +   W+ LQ         
Sbjct: 63  VNLIEVFRRKRKLHLVFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQ--------A 112

Query: 300 VAYLH-NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF-HPKENDFVSISATRGTIG 357
           V + H + C    +H D+KP NIL+      K+ DFG A+      +D+    ATR    
Sbjct: 113 VNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR---W 165

Query: 358 YIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGG 390
           Y APEL+     +G      DV+  G V  E+  G
Sbjct: 166 YRAPELLVGDTQYGP---PVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.5 bits (170), Expect = 4e-13
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 24/201 (11%)

Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           LG G  G+VYK   L T R++AVK+  L+ +    ++ ++E+  + +     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
              ++ ++  EFM  GSLD +    E          L  IA+   +G+ YL +   + IL
Sbjct: 69  FVENRISICTEFMDGGSLDVYRKIPE--------HVLGRIAVAVVKGLTYLWS---LKIL 117

Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-SISATR-GTIGYIAPELISRNFGT 370
           H D+KP N+L++     K+ DFG++         V SI+ T  GT  Y+APE IS     
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVST------QLVNSIAKTYVGTNAYMAPERISGE--Q 169

Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
               SDV+  G+  +E+A GR
Sbjct: 170 YGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 69.6 bits (171), Expect = 4e-13
 Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 26/204 (12%)

Query: 194 HKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFIN--EVSTIGRI-HHVNVVQLL 249
            K+G+G F  V K Q   TG+  A+K ++    S E+  N  E+  + R+  H N+++L+
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64

Query: 250 G--FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH-NG 306
              F  +  + ALV+E M + +L   I   + + +    ++++       + + ++H NG
Sbjct: 65  EVLFDRKTGRLALVFELM-DMNLYELI---KGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120

Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAK---FHPKENDFVSISATRGTIGYIAPEL 363
               I H DIKP NIL+  + + K++DFG  +     P   +++S   TR    Y APE 
Sbjct: 121 ----IFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPYTEYIS---TR---WYRAPEC 169

Query: 364 ISRNFGTVSCKSDVYGFGMVLLEM 387
           +  + G    K D++  G V  E+
Sbjct: 170 LLTD-GYYGPKMDIWAVGCVFFEI 192

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 69.1 bits (169), Expect = 4e-13
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 43/216 (19%)

Query: 196 LGQGGFGSVY------KGQLHTGRLIAV-KMLENSKFSAEEFINEVSTIGRIHHVNVVQL 248
           +G+G FG V+        +L   + I V +M ++ + +A+   NE   +  + H N+++ 
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHI-------FPKENKGQTFGWEKLQEIALGTARGVA 301
                E     +V E+ P G+L  +I         ++     F      +I L       
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFF-----VQILLA------ 113

Query: 302 YLHNGCDMCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISATRGTIG--- 357
            LH+     ILH D+K  NILLD H  + K+ DFG++K         S S     +G   
Sbjct: 114 -LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI------LSSKSKAYTVVGTPC 166

Query: 358 YIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGGRR 392
           YI+PEL   + +     KSD++  G VL E+A  +R
Sbjct: 167 YISPELCEGKPYNQ---KSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 69.6 bits (170), Expect = 4e-13
 Identities = 54/205 (26%), Positives = 103/205 (50%), Gaps = 23/205 (11%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIH---HVNVVQ 247
           ++G G +G+VYK +  H+G  +A+K +    N        + EV+ + R+    H N+V+
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 248 LLGFCS-----EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           L+  C+       +K  LV+E +     D   +  +        E ++++     RG+ +
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQ---DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
           LH  C   I+H D+KP NIL+      K++DFGLA+ +  +   ++++    T+ Y APE
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVVTLWYRAPE 177

Query: 363 LISRNFGTVSCKSDVYGFGMVLLEM 387
           ++ ++  T +   D++  G +  EM
Sbjct: 178 VLLQS--TYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 69.2 bits (169), Expect = 5e-13
 Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 21/204 (10%)

Query: 196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSKF---SAEEF-INEVSTIGRIHHVNVVQLLG 250
           LG+GGFG V   Q+ +TG++ A K L+  +    S E+  + E   + +++   +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR---GVAYLHNGC 307
                +   LV   M  G L  HI+   N G+  G E ++ +   +A+   G+ +LH   
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIY---NVGER-GLE-MERVIHYSAQITCGILHLH--- 112

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
            M I++ D+KP N+LLD     ++SD GLA       D  +I+   GT GY+APE++   
Sbjct: 113 SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK---DGKTITQRAGTNGYMAPEILKEE 169

Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
               S   D +  G  + EM  GR
Sbjct: 170 --PYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 69.7 bits (170), Expect = 5e-13
 Identities = 69/222 (31%), Positives = 107/222 (48%), Gaps = 36/222 (16%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENS-KFSAEEF---INEVSTIGRIHHVNVVQLL 249
           ++G G FG+VY  + + T  ++A+K +  S K S E++   I EV  + RI H N ++  
Sbjct: 32  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91

Query: 250 GFCSEGSKRALVYEFMPNGS---LDRHIFPKENKGQTFGWEKLQEIAL-----GTARGVA 301
           G         LV E+    +   L+ H  P            LQE+ +     G  +G+A
Sbjct: 92  GCYLREHTAWLVMEYCLGSASDLLEVHKKP------------LQEVEIAAITHGALQGLA 139

Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YLH+     ++H DIK  NILL      K++DFG A      N FV      GT  ++AP
Sbjct: 140 YLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYWMAP 190

Query: 362 ELI-SRNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNAIRS 401
           E+I + + G    K DV+  G+  +E+A  +    NMNA+ +
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 232

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 69.2 bits (169), Expect = 6e-13
 Identities = 59/224 (26%), Positives = 104/224 (46%), Gaps = 35/224 (15%)

Query: 192 FTHKLGQGGFGSVY----KGQLHTGR-------------LIAVKML--ENSKFSAEEFIN 232
           F  KLG+G FG V+    +G                   L+AVKML  + +K +  +F+ 
Sbjct: 9   FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68

Query: 233 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQ-------TFG 285
           E+  + R+   N+++LL  C       ++ E+M NG L++ +   E +         T  
Sbjct: 69  EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128

Query: 286 WEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 345
           +  L  +A   A G+ YL +   +  +H D+   N L+  N+  K++DFG+++ +    D
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSR-NLYSGD 184

Query: 346 FVSISATRGT--IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
           +  I   R    I +++ E I    G  +  SDV+ FG+ L E+
Sbjct: 185 YYRIQG-RAVLPIRWMSWESIL--LGKFTTASDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 25/204 (12%)

Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLE-NSKFSAEEFINEVSTIGRIHHVN---VVQLLG 250
           LG G  GSV K   + TG ++A K++   +K S  + I  +  +  +H      +V   G
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQI--LRELQIMHECRSPYIVSFYG 70

Query: 251 -FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
            F +E +   +  EFM  GSLDR I+    KG     E L +IA+    G+ YL+N    
Sbjct: 71  AFLNENNI-CMCMEFMDCGSLDR-IY---KKGGPIPVEILGKIAVAVVEGLTYLYN--VH 123

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRN 367
            I+H DIKP NIL++     K+ DFG++    +   + FV      GT  Y++PE I   
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV------GTSTYMSPERIQG- 176

Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
            G  + KSDV+  G+ ++E+A G+
Sbjct: 177 -GKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 68.4 bits (168), Expect = 7e-13
 Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 40/212 (18%)

Query: 196 LGQGGFGSVY---KGQLHTGRLIAVKMLENSKFSAEEFINEVST----IGRIHHVNVVQL 248
           + +G +G V+   K    TG + A+K+++ +    +  +++V T    + +     VV+L
Sbjct: 1   ISKGAYGRVFLAKKKS--TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 249 LGFCSEGSKRAL--VYEFMPNG---SLDRHI--FPKENKGQTFGWEKLQEIALGTARGVA 301
             + S   K+ L  V E++P G   SL  ++    ++            EI L     + 
Sbjct: 59  --YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-----EIVLA----LE 107

Query: 302 YLH-NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF------HPKENDFVSISATRG 354
           YLH NG    I+H D+KP NIL+D N   K++DFGL+K           +D        G
Sbjct: 108 YLHSNG----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163

Query: 355 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 386
           T  YIAPE+I    G  S   D +  G +L E
Sbjct: 164 TPDYIAPEVI-LGQGH-SKTVDWWSLGCILYE 193

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 67.8 bits (165), Expect = 1e-12
 Identities = 60/215 (27%), Positives = 109/215 (50%), Gaps = 26/215 (12%)

Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           ++G+G FG V+KG    T +++A+K+  LE ++   E+   E++ + +     V +  G 
Sbjct: 11  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 252 CSEGSKRALVYEFMPNGS-LDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
             +G+K  ++ E++  GS LD        +   F   ++  +     +G+ YLH+     
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLL------RAGPFDEFQIATMLKEILKGLDYLHSEKK-- 122

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELISR 366
            +H DIK  N+LL      K++DFG+A        K N FV      GT  ++APE+I +
Sbjct: 123 -IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEVIQQ 175

Query: 367 NFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNAIR 400
           +      K+D++  G+  +E+A G   NS+M+ +R
Sbjct: 176 S--AYDSKADIWSLGITAIELAKGEPPNSDMHPMR 208

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 69/285 (24%), Positives = 127/285 (44%), Gaps = 50/285 (17%)

Query: 191 HFTHKLGQGGFGSVY--KGQLHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNV 245
               K+G+G FG +Y  K +  +   + +K ++ +K   +E      EV  + ++ H N+
Sbjct: 3   EIIKKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           V       E  +  +V E+   G L + I     +G  F  +++    +  + G+ ++H 
Sbjct: 62  VTFFASFQENGRLFIVMEYCDGGDLMKRI--NRQRGVLFSEDQILSWFVQISLGLKHIH- 118

Query: 306 GCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPEL 363
             D  ILH DIK  NI L  N  + K+ DFG+A+   + ND + ++ T  GT  Y++PE+
Sbjct: 119 --DRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR---QLNDSMELAYTCVGTPYYLSPEI 173

Query: 364 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMN-----AIRSSKAYF----PSWVYDQL 414
                   + K+D++  G VL E+   +     N      ++  + YF    P++  D  
Sbjct: 174 CQNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRD-- 229

Query: 415 NKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
                        + S+I++          +V   DRPS+T +L+
Sbjct: 230 -------------LRSLISQ--------LFKVSPRDRPSITSILK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 13/204 (6%)

Query: 194 HKLGQGGFGSVYKGQLHTGRLIA---VKMLENSKFSAE--EFINEVSTIGRIHHVNVVQL 248
            ++G G FG V   +++T   +A   VK L+ +  S E  EF+ +      + H N++Q 
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C E     LV+E+   G L  ++  ++   +      LQ +A   A GV ++H    
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK--- 117

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRN 367
              LH D+   N  L  +   KV D+G+     KE+   +       + ++APEL+   +
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177

Query: 368 FGTVSCK----SDVYGFGMVLLEM 387
            G ++ +    S+V+  G+ L E+
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 30/216 (13%)

Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V         K +      +AVKML++     +  + ++E+  +  I  H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWE------------KLQEI 292
           ++ LLG C++     ++ E+   G+L  ++  +   G  + ++             L   
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
               ARG+ YL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 143 TYQVARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 200 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 30/216 (13%)

Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLEN--SKFSAEEFINEVSTIGRI-HHVN 244
           LG+G FG V         K + +    +AVKML++  ++    + I+E+  +  I  H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIF------------PKENKGQTFGWEKLQEI 292
           ++ LLG C++     ++ E+   G+L  ++             P +   +   ++ L   
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
           A   ARG+ YL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 146 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 203 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 54/214 (25%), Positives = 101/214 (47%), Gaps = 36/214 (16%)

Query: 194 HKLGQGGFGSVYKGQ-LHTGRLIAVKM--LENSK----FSAEEFINEVSTIGRIHHVNVV 246
           +++G+G +G VY+ +   +G ++A+K   ++N +     S+   + E++ +  + H N+V
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS---LREITLLLNLRHPNIV 69

Query: 247 QLLGFCSEGSKRA----LVYEFMPN--GSLDRHIFPKENKGQTFGWEKLQEIALGTARGV 300
           +L        K      LV E+      SL       +N    F   +++ + L   RG+
Sbjct: 70  ELKEVVV--GKHLDSIFLVMEYCEQDLASL------LDNMPTPFSESQVKCLMLQLLRGL 121

Query: 301 AYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYI 359
            YLH   +  I+H D+K  N+LL      K++DFGLA+ +         ++    T+ Y 
Sbjct: 122 QYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK---PMTPKVVTLWYR 175

Query: 360 APELISRNFG-TVSCKS-DVYGFGMVLLEMAGGR 391
           APEL+    G T    + D++  G +L E+   +
Sbjct: 176 APELL---LGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 67.9 bits (167), Expect = 2e-12
 Identities = 60/244 (24%), Positives = 94/244 (38%), Gaps = 48/244 (19%)

Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLEN---SKFSAEEFINEVSTIGRIHHVNVVQ 247
               +G G +G V       TGR +A+K + N       A+  + E+  +  + H N++ 
Sbjct: 4   LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIG 63

Query: 248 LLG-FCSEGSKR----ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           LL        +      +V E M    L + I       Q    + +Q       RG+ Y
Sbjct: 64  LLDILRPPSPEDFNDVYIVTELMET-DLHKVI----KSPQPLTDDHIQYFLYQILRGLKY 118

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF----HPKENDFVSISATRGTIGY 358
           LH+     ++H D+KP NIL++ N   K+ DFGLA+       ++        TR    Y
Sbjct: 119 LHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR---WY 172

Query: 359 IAPELISRNFGTVSCKS-----DVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP-SWVYD 412
            APEL+      +S        D++  G +  E+               K  FP     D
Sbjct: 173 RAPELL------LSSSRYTKAIDIWSVGCIFAELLTR------------KPLFPGRDYID 214

Query: 413 QLNK 416
           QLN 
Sbjct: 215 QLNL 218

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 41/213 (19%)

Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKML-----ENSKFSAEEFINEVSTIGRIHHVNVVQL 248
           KLG+G + +VYKG+    G+L+A+K++     E + F+A   I E S +  + H N+V L
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA---IREASLLKGLKHANIVLL 68

Query: 249 LGFCSEGSKRALVYEFMPNG---SLDRH---IFPKENKGQTFGWEKLQEIALGTARGVAY 302
                      LV+E++       +D+H   + P+  K   F ++ L        RG++Y
Sbjct: 69  HDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVK--LFLFQLL--------RGLSY 118

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF-----HPKENDFVSISATRGTIG 357
           +H      ILH D+KP N+L+      K++DFGLA+      H   N+ V       T+ 
Sbjct: 119 IHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-------TLW 168

Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           Y  P+++  +    +C  D++G G + +EM  G
Sbjct: 169 YRPPDVLLGSTEYSTC-LDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 55/205 (26%), Positives = 106/205 (51%), Gaps = 18/205 (8%)

Query: 196 LGQGGFGSVYKG----QLHTGRL-IAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG    +  T ++ +A+K+L  +       EF++E   +  + H ++V+L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + LV + MP+G L  ++   ++     G + L    +  A+G+ YL    +
Sbjct: 75  LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLE---E 127

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLA+    +    +    +  I ++A E I  ++
Sbjct: 128 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI--HY 185

Query: 369 GTVSCKSDVYGFGMVLLEMA--GGR 391
              + +SDV+ +G+ + E+   GG+
Sbjct: 186 RKFTHQSDVWSYGVTIWELMTFGGK 210

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 67.2 bits (164), Expect = 3e-12
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 32/213 (15%)

Query: 193 THKLGQGGFGSVYKGQ-LHTGRLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQL 248
             K+G+G +G VYK +   T   IA+K +   +  +      I E+S +  + H N+V+L
Sbjct: 7   VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHI--FPKENKGQ----TFGWEKLQEIALGTARGVAY 302
                   +  LV+E++ +  L +H+   P   K      T+ ++ L        RG+AY
Sbjct: 67  QDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQIL--------RGIAY 117

Query: 303 LHNGCDMCILHFDIKPHNILLDH-NFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIA 360
            H+     +LH D+KP N+L+D      K++DFGLA+ F      F        T+ Y A
Sbjct: 118 CHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV---TLWYRA 171

Query: 361 PELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           PE++  SR++ T     D++  G +  EM   +
Sbjct: 172 PEILLGSRHYST---PVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 28/218 (12%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVVQLL 249
           ++G G FG+VY  + +    ++A+K +  S   + E     I EV  + ++ H N +Q  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 250 GFCSEGSKRALVYEFMPNGS---LDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           G         LV E+    +   L+ H  P +         ++  +  G  +G+AYLH+ 
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV-------EIAAVTHGALQGLAYLHS- 133

Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-S 365
               ++H D+K  NILL    + K+ DFG A      N FV      GT  ++APE+I +
Sbjct: 134 --HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILA 185

Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGRRNS--NMNAIRS 401
            + G    K DV+  G+  +E+   R+    NMNA+ +
Sbjct: 186 MDEGQYDGKVDVWSLGITCIEL-AERKPPLFNMNAMSA 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 42/216 (19%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVK--MLENSKFSAEEF-INEVSTIGRIHHVNVVQLLG 250
           K+G+G +G+V+K +   T  ++A+K   L++         + E+  +  + H N+V+L  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 251 FCSEGSKRALVYEFMP----------NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGV 300
                 K  LV+E+            NG +D  I       ++F ++ L        +G+
Sbjct: 67  VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIV------KSFMFQLL--------KGL 112

Query: 301 AYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGY 358
           A+ H+     +LH D+KP N+L++ N   K++DFGLA+    P        SA   T+ Y
Sbjct: 113 AFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR----CYSAEVVTLWY 165

Query: 359 IAPELISRNFGT--VSCKSDVYGFGMVLLEMAGGRR 392
             P+++   FG    S   D++  G +  E+A   R
Sbjct: 166 RPPDVL---FGAKLYSTSIDMWSAGCIFAELANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 23/204 (11%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLEN-SKFSAEEFINEVSTIGRIHHVNVVQLL-GF 251
           +LG G FG VYK Q   TG L A K+++  S+   E+++ E+  +    H N+V+LL  F
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
             E +   L+ EF   G++D  +   E   +     +++ +   T   + YLH   +  I
Sbjct: 72  YYENNLWILI-EFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLH---ENKI 124

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHP----KENDFVSISATRGTIGYIAPELI--- 364
           +H D+K  NIL   +   K++DFG++  +     + + F+      GT  ++APE++   
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI------GTPYWMAPEVVMCE 178

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMA 388
           +        K+DV+  G+ L+EMA
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMA 202

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 24/203 (11%)

Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 252
           K+GQG  G+VY    + TG+ +A+K +   +   +E I NE+  +    H N+V  L   
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 253 SEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFG--WEKLQEIALGTARGVAYLHNGCDM 309
             G +  +V E++  GSL D       ++GQ      E LQ +    +  V         
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV--------- 136

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRN- 367
             +H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R  
Sbjct: 137 --IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKA 191

Query: 368 FGTVSCKSDVYGFGMVLLEMAGG 390
           +G    K D++  G++ +EM  G
Sbjct: 192 YGP---KVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 56/216 (25%), Positives = 104/216 (48%), Gaps = 30/216 (13%)

Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V         K + +    +AVKML++     +  + ++E+  +  I  H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKG------------QTFGWEKLQEI 292
           ++ LLG C++     ++ E+   G+L  ++  +   G            +   ++ L   
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
           A   ARG+ YL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 140 AYQVARGMEYL--ASQKCI-HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 197 RLPVKWMAPEALFDRVY---THQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 59/200 (29%), Positives = 104/200 (52%), Gaps = 18/200 (9%)

Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKML-ENSKFSA-EEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K+L EN+   A +E ++E   +  +    V +L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   S   LV + MP G L  ++  +ENK +  G + L    +  A+G++YL    +
Sbjct: 75  LGICLT-STVQLVTQLMPYGCLLDYV--RENKDR-IGSQDLLNWCVQIAKGMSYLE---E 127

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE-LISRN 367
           + ++H D+   N+L+      K++DFGLA+    +         +  I ++A E ++ R 
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR 187

Query: 368 FGTVSCKSDVYGFGMVLLEM 387
           F   + +SDV+ +G+ + E+
Sbjct: 188 F---THQSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 66.8 bits (163), Expect = 4e-12
 Identities = 67/229 (29%), Positives = 103/229 (44%), Gaps = 26/229 (11%)

Query: 196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 249
           LG+G FG V   +L  +GRL AVK+L+      ++ +    T  RI     +H  + QL 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 250 GFCSEGSKRAL-VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
             C +   R   V EF+  G L  HI     K + F   + +  A      + +LH   D
Sbjct: 63  -CCFQTPDRLFFVMEFVNGGDLMFHI----QKSRRFDEARARFYAAEITSALMFLH---D 114

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             I++ D+K  N+LLDH    K++DFG+ K         + S   GT  YIAPE++    
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQEML 172

Query: 369 GTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNAIRSSKAYFPSWV 410
              S   D +  G++L EM  G         +    AI + +  +P+W+
Sbjct: 173 YGPSV--DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL 219

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 23/204 (11%)

Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLG- 250
           +LG G  G V K Q     LI  + L   E       + I E+  +   +   +V   G 
Sbjct: 12  ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           F S+G + ++  E M  GSLD+ +     + +    E L ++++   RG+AYL       
Sbjct: 72  FYSDG-EISICMEHMDGGSLDQVL----KEAKRIPEEILGKVSIAVLRGLAYLREKHQ-- 124

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNF 368
           I+H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE +    
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQ--- 175

Query: 369 GT-VSCKSDVYGFGMVLLEMAGGR 391
           GT  S +SD++  G+ L+E+A GR
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 65.6 bits (160), Expect = 6e-12
 Identities = 73/252 (28%), Positives = 114/252 (45%), Gaps = 26/252 (10%)

Query: 195 KLGQGGFG-SVYKGQLHTGRLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G FG ++       G+   +K +  SK S    EE   EV+ +  + H N+VQ   
Sbjct: 7   KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
              E     +V ++   G L + I     +G  F  +++ +  +     + ++H   D  
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKI--NAQRGVLFPEDQILDWFVQICLALKHVH---DRK 121

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPELI-SRNF 368
           ILH DIK  NI L  +   K+ DFG+A+     N  V ++ T  GT  Y++PE+  +R +
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVL---NSTVELARTCIGTPYYLSPEICENRPY 178

Query: 369 GTVSCKSDVYGFGMVLLEM--------AGGRRNSNMNAIRSSKAYFPS-WVYDQLNKGGD 419
                KSD++  G VL EM        AG  +N  +  IR S     S + YD  N    
Sbjct: 179 NN---KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQ 235

Query: 420 LELRNVTEIESV 431
           L  RN  +  SV
Sbjct: 236 LFKRNPRDRPSV 247

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 66.0 bits (161), Expect = 7e-12
 Identities = 55/210 (26%), Positives = 103/210 (49%), Gaps = 39/210 (18%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKG------QTFGWEKLQEIALGTARGVAYLH 304
                +K  LV+EF+ +  L + +      G      +++ ++ LQ        G+A+ H
Sbjct: 67  VIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQ--------GLAFCH 117

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-----FHPKENDFVSISATRGTIGYI 359
           +     +LH D+KP N+L++     K++DFGLA+          ++ V       T+ Y 
Sbjct: 118 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------TLWYR 167

Query: 360 APELI--SRNFGTVSCKSDVYGFGMVLLEM 387
           APE++   + + T     D++  G +  EM
Sbjct: 168 APEILLGCKYYSTA---VDIWSLGCIFAEM 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 50/199 (25%), Positives = 94/199 (47%), Gaps = 12/199 (6%)

Query: 195 KLGQGGFGSVYKGQLHTGR----LIAVKMLENSKFSA-EEFINEVSTIGRIHHVNVVQLL 249
           K+G+G F  VY+      R    L  V++ E     A ++ + E+  + +++H NV++ L
Sbjct: 9   KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
               E ++  +V E    G L + I   + + +      + +  +     V ++H+    
Sbjct: 69  DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---R 125

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
            ++H DIKP N+ +    + K+ D GL +F   +    +  +  GT  Y++PE I  N  
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHEN-- 181

Query: 370 TVSCKSDVYGFGMVLLEMA 388
             + KSD++  G +L EMA
Sbjct: 182 GYNFKSDIWSLGCLLYEMA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 65.4 bits (159), Expect = 9e-12
 Identities = 63/261 (24%), Positives = 113/261 (43%), Gaps = 38/261 (14%)

Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMLENSKFSA--EEFINEVS 235
           EI   T  F  +LG+  FG VYKG L         + +A+K L++       EEF +E  
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60

Query: 236 TIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIF---PKENKGQTFGWEKLQ-- 290
              R+ H N+V LLG  ++    ++++ +  +  L   +    P  + G T   + ++  
Sbjct: 61  MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120

Query: 291 -------EIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 343
                   I    A G+ +L +     ++H D+   N+L+      K+SD GL +     
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177

Query: 344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM--------AGGRRNSN 395
           + +  +  +   I +++PE I   +G  S  SD++ +G+VL E+         G      
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIM--YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235

Query: 396 MNAIRSSKAYF-----PSWVY 411
           +  IR+ +        P+WVY
Sbjct: 236 IEMIRNRQVLPCPDDCPAWVY 256

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 66.0 bits (161), Expect = 9e-12
 Identities = 59/191 (30%), Positives = 92/191 (48%), Gaps = 40/191 (20%)

Query: 196 LGQGGFGSVYKGQLHTG----RLIAVKMLENSKF----------SAEEFINEVSTIGRIH 241
           LG+GG+G V++ +  TG    ++ A+K+L+ +             AE  I E      + 
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEA-----VK 58

Query: 242 HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRH-----IFPKENKGQTFGWEKLQEIALGT 296
           H  +V L+     G K  L+ E++  G L  H     IF  E+    +    L EI+L  
Sbjct: 59  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIF-MEDTACFY----LSEISLA- 112

Query: 297 ARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GT 355
              + +LH      I++ D+KP NILLD     K++DFGL K    E    +++ T  GT
Sbjct: 113 ---LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG---TVTHTFCGT 163

Query: 356 IGYIAPELISR 366
           I Y+APE++ R
Sbjct: 164 IEYMAPEILMR 174

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 59/206 (28%), Positives = 104/206 (50%), Gaps = 29/206 (14%)

Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           K+G+G FG V+KG    T +++A+K+  LE ++   E+   E++ + +     V +  G 
Sbjct: 11  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFP---KENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
             + +K  ++ E++  GS    + P    E +  T     L+EI     +G+ YLH+   
Sbjct: 71  YLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATI----LREIL----KGLDYLHSEKK 122

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELI 364
              +H DIK  N+LL  +   K++DFG+A        K N FV      GT  ++APE+I
Sbjct: 123 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEVI 173

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGG 390
            ++      K+D++  G+  +E+A G
Sbjct: 174 KQS--AYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 55/199 (27%), Positives = 97/199 (48%), Gaps = 16/199 (8%)

Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   S   L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    +
Sbjct: 75  LGICLT-STVQLITQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---E 127

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    +         +  I ++A E I    
Sbjct: 128 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR- 186

Query: 369 GTVSCKSDVYGFGMVLLEM 387
              + +SDV+ +G+ + E+
Sbjct: 187 -IYTHQSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 29/207 (14%)

Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAE--EFIN----EVSTIGRIHHVNVVQL 248
           LGQG FG VY      TGR +AVK ++    S E  + +N    E+  +  + H  +VQ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 249 LGFCSEGSKRAL--VYEFMPNGSLDRHIFP----KENKGQTFGWEKLQEIALGTARGVAY 302
            G   +  +R L    E MP GS+   +       EN  + +  + L+        GV+Y
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILE--------GVSY 121

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAP 361
           LH+     I+H DIK  NIL D     K+ DFG +K           + +  GT  +++P
Sbjct: 122 LHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178

Query: 362 ELIS-RNFGTVSCKSDVYGFGMVLLEM 387
           E+IS   +G    K+D++  G  ++EM
Sbjct: 179 EVISGEGYGR---KADIWSVGCTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 63.6 bits (154), Expect = 4e-11
 Identities = 55/200 (27%), Positives = 100/200 (50%), Gaps = 18/200 (9%)

Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 252
           K+GQG  G+VY    + TG+ +A+K +   +   +E I NE+  +    + N+V  L   
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPK-ENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
             G +  +V E++  GSL   +     ++GQ      +  +     + + +LH+     +
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQ------IAAVCRECLQALDFLHSNQ---V 136

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           +H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R    
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRK--A 191

Query: 371 VSCKSDVYGFGMVLLEMAGG 390
              K D++  G++ +EM  G
Sbjct: 192 YGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 63.8 bits (155), Expect = 4e-11
 Identities = 59/216 (27%), Positives = 106/216 (49%), Gaps = 30/216 (13%)

Query: 196 LGQGGFGSVYKGQLH--------TGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V + + +            +AVKML+++    +  + I+E+  +  I  H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQ--TFGWEKLQE----------I 292
           ++ LLG C++     ++ E+   G+L   +  +   G   TF   K+ E           
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
           A   ARG+ YL +    CI H D+   N+L+  + + K++DFGLA+     + +   S  
Sbjct: 140 AYQVARGMEYLES--RRCI-HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 197 RLPVKWMAPEALFDRVY---THQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 63.8 bits (155), Expect = 5e-11
 Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 31/229 (13%)

Query: 171 NQQSW-MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKF 225
           N+  W +P+RY+             ++G G +GSV       TG  +A+K L     S+ 
Sbjct: 7   NKTVWELPERYTSL----------KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI 56

Query: 226 SAEEFINEVSTIGRIHHVNVVQLLG-FCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQ 282
            A+    E++ +  + H NV+ LL  F S  S       Y  MP    D     ++  G 
Sbjct: 57  FAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDL----QKIMGH 112

Query: 283 TFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 342
               +K+Q +      G+ Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    
Sbjct: 113 PLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADA 169

Query: 343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           E        TR    Y APE+I  N+   +   D++  G ++ EM  G+
Sbjct: 170 E--MTGYVVTR---WYRAPEVI-LNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 62.8 bits (152), Expect = 5e-11
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 25/205 (12%)

Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKML-------ENSK-FSAEEFINEVSTIGRIHHVNVV 246
           LGQG FG VY    + TGR +A K +       E SK  SA E   E+  +  + H  +V
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALEC--EIQLLKNLQHERIV 67

Query: 247 QLLGFCSEGSKRALV--YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
           Q  G   + +++ L    E+MP GS+   +       ++   +  ++I      G++YLH
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMSYLH 123

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPEL 363
           +     I+H DIK  NIL D     K+ DFG +K           I +  GT  +++PE+
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180

Query: 364 IS-RNFGTVSCKSDVYGFGMVLLEM 387
           IS   +G    K+DV+  G  ++EM
Sbjct: 181 ISGEGYGR---KADVWSLGCTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 62.7 bits (152), Expect = 9e-11
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 23/205 (11%)

Query: 195 KLGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 248
           KLG+G + +VYKG      QL   ++I++K  E   F+A   I E S +  + H N+V L
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTA---IREASLLKGLKHANIVLL 68

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
                       V+E+M     D   +  ++ G    +  ++       RG+AY+H    
Sbjct: 69  HDIIHTKETLTFVFEYM---HTDLAQYMIQHPGGLHPY-NVRLFMFQLLRGLAYIHG--- 121

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ILH D+KP N+L+ +    K++DFGLA+   K     + S+   T+ Y  P+++    
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVL---L 176

Query: 369 GTV--SCKSDVYGFGMVLLEMAGGR 391
           G    S   D++G G + +EM  G+
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 60/238 (25%), Positives = 94/238 (39%), Gaps = 69/238 (28%)

Query: 196 LGQGGFGSVYKGQL----HTGRLIAVKMLE-----NSKFSAEEFINEVSTIGRIHHVNVV 246
           +G+G FG V    L     TG++ A+K+L           A     E   +       +V
Sbjct: 9   IGRGAFGEV---WLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADADSPWIV 64

Query: 247 QLLGFCSEGSKRAL--VYEFMPNGSL-----DRHIFPKENKGQTFGWEK--LQEIALGTA 297
           +L  + S   +  L  V E+MP G L      + +FP+E         +  + E+ L   
Sbjct: 65  KL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE-------TARFYIAELVLA-- 113

Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK------------------- 338
             +  +H    +  +H DIKP NIL+D +   K++DFGL K                   
Sbjct: 114 --LDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168

Query: 339 --------FHPKENDFVSISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
                       +   V  ++T GT  YIAPE L    +G    + D +  G++L EM
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG---LECDWWSLGVILYEM 223

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 27/205 (13%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLG-- 250
           LG G  G V K     +G ++A K+  LE       + I E+  +   H  N   ++G  
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVL---HECNSPYIVGFY 65

Query: 251 --FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
             F S+G + ++  E M  GSLD+ +     K        L +I++   RG+ YL     
Sbjct: 66  GAFYSDG-EISICMEHMDGGSLDQVL----KKAGRIPENILGKISIAVLRGLTYLREKHK 120

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISR 366
             I+H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE +  
Sbjct: 121 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQG 172

Query: 367 NFGTVSCKSDVYGFGMVLLEMAGGR 391
              TV   SD++  G+ L+EMA GR
Sbjct: 173 THYTVQ--SDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 64.1 bits (156), Expect = 1e-10
 Identities = 59/201 (29%), Positives = 87/201 (43%), Gaps = 34/201 (16%)

Query: 211 TGRLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVVQLL--GFCSEGSKRALVYEF 264
           TG  +A+K+L       E     F  E +   R++H N+V LL  G    G   A V+E+
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFEY 60

Query: 265 MPNGSLDRHI-----FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPH 319
           +P  +L   +      P    G+         + L     +A  HN     I+H D+KP 
Sbjct: 61  VPGRTLREVLAADGALPAGETGR---------LMLQVLDALACAHNQ---GIVHRDLKPQ 108

Query: 320 NILL---DHNFIPKVSDFGLAKFHPKENDFVSISATR-----GTIGYIAPELISRNFGTV 371
           NI++         KV DFG+    P   D    + TR     GT  Y APE + R    V
Sbjct: 109 NIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL-RG-EPV 166

Query: 372 SCKSDVYGFGMVLLEMAGGRR 392
           +  SD+Y +G++ LE   G+R
Sbjct: 167 TPNSDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 74/277 (26%), Positives = 112/277 (40%), Gaps = 38/277 (13%)

Query: 192 FTHKLGQGGFGSVYKGQLHT-GRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQ 247
           F   +G+G +G V   +  T G+   +K L     S  E      E   + ++ H N+V 
Sbjct: 4   FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63

Query: 248 LL-GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
               +  E     +V  F   G L   +  KE KG+     ++ E  +  A  + YLH  
Sbjct: 64  YRESWEGEDGLLYIVMGFCEGGDLYHKL--KEQKGKLLPENQVVEWFVQIAMALQYLH-- 119

Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
            +  ILH D+K  N+ L    I KV D G+A+    + D    S   GT  Y++PEL S 
Sbjct: 120 -EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA--STLIGTPYYMSPELFSN 176

Query: 367 NFGTVSCKSDVYGFGMVLLEMAGGRRNSN---MNAI--RSSKAYFPSWVYDQLNKGGDLE 421
                + KSDV+  G  + EMA  +   N   MN++  R  +   P    D   + G+L 
Sbjct: 177 K--PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGEL- 233

Query: 422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVL 458
                     IA  L          +   RPS+  +L
Sbjct: 234 ----------IATMLSK--------RPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 54/200 (27%), Positives = 100/200 (50%), Gaps = 18/200 (9%)

Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 252
           K+GQG  G+VY    + TG+ +A++ +   +   +E I NE+  +    + N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPK-ENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
             G +  +V E++  GSL   +     ++GQ      +  +     + + +LH+     +
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQ------IAAVCRECLQALEFLHSNQ---V 137

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           +H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R    
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRK--A 192

Query: 371 VSCKSDVYGFGMVLLEMAGG 390
              K D++  G++ +EM  G
Sbjct: 193 YGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 31/208 (14%)

Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFIN----EVSTIGRIHHVNVVQ 247
           LG+G FG VY      TGR +AVK +    +S+ +++E +N    E+  +  + H  +VQ
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VNALECEIQLLKNLRHDRIVQ 68

Query: 248 LLGFCSEGSKRAL--VYEFMPNGSLDRHIFP----KENKGQTFGWEKLQEIALGTARGVA 301
             G   +  ++ L    E+MP GS+   +       EN  + +  + LQ        GV+
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQ--------GVS 120

Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIA 360
           YLH+     I+H DIK  NIL D     K+ DFG +K           I +  GT  +++
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177

Query: 361 PELIS-RNFGTVSCKSDVYGFGMVLLEM 387
           PE+IS   +G    K+DV+     ++EM
Sbjct: 178 PEVISGEGYGR---KADVWSVACTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 35/214 (16%)

Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLL 249
            +G+G +G V       TG  +A+K +  S F  + F    + E+  + R  H N++ +L
Sbjct: 12  YIGEGAYGMVCSATHKPTGVKVAIKKI--SPFEHQTFCQRTLREIKILRRFKHENIIGIL 69

Query: 250 GFCSEGSKRA-----LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
                 S  +     +V E M     D +   K  K Q    + +Q       RG+ Y+H
Sbjct: 70  DIIRPPSFESFNDVYIVQELMET---DLY---KLIKTQHLSNDHIQYFLYQILRGLKYIH 123

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-------FVSISATRGTIG 357
              +  +LH D+KP N+LL+ N   K+ DFGLA+    E+D       +V   ATR    
Sbjct: 124 -SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV---ATR---W 174

Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           Y APE I  N    +   D++  G +L EM   R
Sbjct: 175 YRAPE-IMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 18/204 (8%)

Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+GGFG V   Q+  TG+L A K L   +       E  + E   + ++H   +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   LV   M  G L  HI+  + +   F   +          G+ +LH      
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RR 117

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR---GTIGYIAPELISRN 367
           I++ D+KP N+LLD++   ++SD GLA    K+      S T+   GT G++APEL+   
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQ----SKTKGYAGTPGFMAPELLQGE 172

Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
               S   D +  G+ L EM   R
Sbjct: 173 EYDFSV--DYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 53/205 (25%), Positives = 100/205 (48%), Gaps = 22/205 (10%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLE-----NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           K+G+G F  VY+   L  G  +A+K ++     ++K +  + I E+  + +++H NV++ 
Sbjct: 9   KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAK-ARADCIKEIDLLKQLNHPNVIKY 67

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHI--FPKENK--GQTFGWEKLQEIALGTARGVAYLH 304
                E ++  +V E    G L R I  F K+ +   +   W+   ++       + ++H
Sbjct: 68  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SALEHMH 123

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
           +     ++H DIKP N+ +    + K+ D GL +F   +    +  +  GT  Y++PE I
Sbjct: 124 S---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERI 178

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAG 389
             N    + KSD++  G +L EMA 
Sbjct: 179 HEN--GYNFKSDIWSLGCLLYEMAA 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 23/206 (11%)

Query: 198 QGGFGSVYKGQLHTG-----RLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           +G FG ++ G L          + VK +++  S+      + E   +  + H N++ +L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 251 FCSEGSKRALV-YEFMPNGSLD------RHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
            C E  +   V Y +M  G+L       R    + N  Q    ++L  +A+  A G++YL
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLG--EANNPQALSTQQLVHMAIQIACGMSYL 133

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPE 362
           H      ++H DI   N ++D     K++D  L++   P +   +  +  R  + ++A E
Sbjct: 134 HK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR-PVKWMALE 189

Query: 363 LISRNFGTVSCKSDVYGFGMVLLEMA 388
            +       S  SDV+ FG++L E+ 
Sbjct: 190 SLVNKE--YSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 51/169 (30%), Positives = 79/169 (46%), Gaps = 33/169 (19%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKM--LENSKFSAEEF----INEVSTIGRIHHVNVVQL 248
           +G+G +G VYK +   TG L+A+K   L+N K   E F    I E+  + +++H N+V L
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKILRQLNHRNIVNL 71

Query: 249 ----------LGFCSEGSKRALVYEFMPN---GSLDRHIFPKENKGQTFGWEKLQEIALG 295
                     L F  +     LV+E+M +   G L       E+    F  + ++     
Sbjct: 72  KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL-------ESGLVHFSEDHIKSFMKQ 124

Query: 296 TARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 344
              G+ Y H       LH DIK  NILL++    K++DFGLA+ +  E 
Sbjct: 125 LLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 27/206 (13%)

Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHV---NVVQLL 249
           +G+G +G+VY+G  + TGR++A+K+  L+       +   EV+ + ++      N+ +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH-NGCD 308
           G   +G +  ++ E+   GS+ R +       + +    ++E+ +     + Y+H  G  
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVA----LKYIHKVG-- 121

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR----GTIGYIAPELI 364
             ++H DIK  NIL+ +    K+ DFG+A            S+ R    GT  ++APE+I
Sbjct: 122 --VIHRDIKAANILVTNTGNVKLCDFGVAA------LLNQNSSKRSTFVGTPYWMAPEVI 173

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGG 390
                    K+D++  G+ + EMA G
Sbjct: 174 -TEGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 60.3 bits (146), Expect = 3e-10
 Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 15/201 (7%)

Query: 194 HKLGQGGFGSVY----KGQLHTGRLIAVKMLENSKFSAEEFIN---EVSTIGRIHHVNVV 246
            +LG+G FG+VY    K  +   RL  +K +   + +  E +    E   + ++ H  +V
Sbjct: 6   QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +      E     ++ E+     LD  +   ++ G+T    ++ E  +    GV Y+H  
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH-- 123

Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               ILH D+K  NI L +N + K+ DFG+++      D    +   GT  Y++PE +  
Sbjct: 124 -QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLA--TTFTGTPYYMSPEALKH 179

Query: 367 NFGTVSCKSDVYGFGMVLLEM 387
                  KSD++  G +L EM
Sbjct: 180 Q--GYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 60.9 bits (147), Expect = 3e-10
 Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 16/199 (8%)

Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 252
           K+GQG  G+V+    + TG+ +A+K +   K   +E I NE+  +  + + N+V  L   
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
             G +  +V E++  GSL   +             ++  +     + + +LH      ++
Sbjct: 86  LVGDELFVVMEYLAGGSLTDVV-----TETCMDEAQIAAVCRECLQALEFLHANQ---VI 137

Query: 313 HFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           H DIK  N+LL  +   K++DFG  A+  P+++     S   GT  ++APE+++R     
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRK--AY 192

Query: 372 SCKSDVYGFGMVLLEMAGG 390
             K D++  G++ +EM  G
Sbjct: 193 GPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 36/210 (17%)

Query: 194 HKLGQGGFGSVYKGQ-LHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLL 249
            ++G G +G VYK + LHTG L AVK+++      FS  +   E+  +    H N+V   
Sbjct: 15  QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ--QEIFMVKECKHCNIVAYF 72

Query: 250 GFCSEGSKRALVYEFMPNGSLDR--HIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
           G      K  +  E+   GSL    H+    ++ Q      +  +   T +G+AYLH+  
Sbjct: 73  GSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQ------IAYVCRETLQGLAYLHSKG 126

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-------GTIGYIA 360
            M   H DIK  NILL  N   K++DFG+A           I+AT        GT  ++A
Sbjct: 127 KM---HRDIKGANILLTDNGDVKLADFGVA---------AKITATIAKRKSFIGTPYWMA 174

Query: 361 PEL--ISRNFGTVSCKSDVYGFGMVLLEMA 388
           PE+  + +N G  +   D++  G+  +E+A
Sbjct: 175 PEVAAVEKN-GGYNQLCDIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 25/205 (12%)

Query: 195 KLGQGGFGSVYKGQLH--TGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           +LG G  G V+K   H  +G ++A K+  LE       + I E+  +   +   +V   G
Sbjct: 12  ELGAGNGGVVFK-VSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70

Query: 251 -FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
            F S+G + ++  E M  GSLD+ +     K      + L ++++   +G+ YL      
Sbjct: 71  AFYSDG-EISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKHK- 124

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRN 367
            I+H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE +   
Sbjct: 125 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQ-- 175

Query: 368 FGT-VSCKSDVYGFGMVLLEMAGGR 391
            GT  S +SD++  G+ L+EMA GR
Sbjct: 176 -GTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 67/266 (25%), Positives = 102/266 (38%), Gaps = 75/266 (28%)

Query: 191 HFTHKLGQGGFGSVYKGQL------HTGRLIAVKMLENSKFSAEE--FINEVSTIGRI-H 241
                LG G FG V +          +   +AVKML+    ++E    ++E+  +  I +
Sbjct: 10  RLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGN 69

Query: 242 HVNVVQLLG--------------FCSEGSK----RALVYEFMP----------------- 266
           H+NVV LLG              FC  G+     RA    F P                 
Sbjct: 70  HLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVE 129

Query: 267 --------NGSLDRHIFPKENKGQTFGWEKLQEI----------------ALGTARGVAY 302
                          +F +     +      QE                 +   ARG+ +
Sbjct: 130 QSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEF 189

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
           L      CI H D+   NILL  N + K+ DFGLA+   K+ D+V   + R  + ++APE
Sbjct: 190 L--ASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246

Query: 363 LISRNFGTV-SCKSDVYGFGMVLLEM 387
            I   F  V + +SDV+ FG++L E+
Sbjct: 247 SI---FDKVYTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 38/212 (17%)

Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           +G+GGFG VY   +  TG++ A+K L+  +   ++        G    +N   +L   S 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--------GETLALNERIMLSLVST 53

Query: 255 GS---------------KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARG 299
           G                K   + + M  G L  H+    ++   F  ++++  A     G
Sbjct: 54  GDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL----SQHGVFSEKEMRFYATEIILG 109

Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
           + ++HN     +++ D+KP NILLD +   ++SD GLA    K+    S+    GT GY+
Sbjct: 110 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYM 162

Query: 360 APELISRNFGTV-SCKSDVYGFGMVLLEMAGG 390
           APE++ +  GT     +D +  G +L ++  G
Sbjct: 163 APEVLQK--GTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 60.4 bits (147), Expect = 6e-10
 Identities = 47/190 (24%), Positives = 81/190 (42%), Gaps = 21/190 (11%)

Query: 191 HFTHKLGQGGFGSVYKGQL---HTGRLIAVKMLENSKFSAEEF----INEVSTIGRIHHV 243
                +G+G +G VYK +      G+  A+K  +  K            E++ +  + H 
Sbjct: 3   EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHE 62

Query: 244 NVVQLLGFCSEGSKRA--LVYEFMPNGSLDRHI--FPKENKGQTFGWEKLQEIALGTARG 299
           NVV L+    E + ++  L++++  +      I  F ++ K  +     ++ +      G
Sbjct: 63  NVVSLVEVFLEHADKSVYLLFDYAEHDLW--QIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 300 VAYLHNGCDMCILHFDIKPHNILL----DHNFIPKVSDFGLA-KFHPKENDFVSISATRG 354
           V YLH      +LH D+KP NIL+        + K+ D GLA  F+        +     
Sbjct: 121 VHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177

Query: 355 TIGYIAPELI 364
           TI Y APEL+
Sbjct: 178 TIWYRAPELL 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 60.2 bits (146), Expect = 7e-10
 Identities = 60/229 (26%), Positives = 95/229 (41%), Gaps = 40/229 (17%)

Query: 179 RYSYPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLEN---SKFSAEEFINEV 234
           RY   E+I          G+G +G V      HTG  +A+K + +       A   + E+
Sbjct: 1   RYKIQEVI----------GKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREI 50

Query: 235 STIGRIHHVNVVQLLGFCSEGSKRA-----LVYEFMPNGSLDRHIFPKENKGQTFGWEKL 289
             +  + H ++V++       S+R      +V+E M +   D H   K N   T   E  
Sbjct: 51  KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTP--EHH 105

Query: 290 QEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE------ 343
           Q       R + Y+H      + H D+KP NIL + +   K+ DFGLA+    +      
Sbjct: 106 QFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 162

Query: 344 -NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
             D+V   ATR    Y APEL    F   +   D++  G +  E+  G+
Sbjct: 163 WTDYV---ATR---WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 60.1 bits (146), Expect = 7e-10
 Identities = 67/239 (28%), Positives = 103/239 (43%), Gaps = 48/239 (20%)

Query: 196 LGQGGFGSV----YKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVV 246
           LG+G FG V     KG   T  L AVK+L+      ++ +    T  R+      H  + 
Sbjct: 3   LGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 247 QLLGFCSEGSKRAL--VYEFMPNGSLDRHI-----FPKENKGQTFGWEKLQEIALGTARG 299
           QL       +K  L  V E++  G L  HI     F  E + + +      EI LG    
Sbjct: 60  QL--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFD-EPRARFYA----AEIVLG---- 108

Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN--DFVSISATRGTIG 357
           + +LH   +  I++ D+K  N+LLD     K++DFG+     KE     V+ S   GT  
Sbjct: 109 LQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMC----KEGILGGVTTSTFCGTPD 161

Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNAIRSSKAYFPSW 409
           YIAPE++S      +   D +  G++L EM  G+        +    +I   +  +P W
Sbjct: 162 YIAPEILSYQPYGPAV--DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRW 218

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 53/211 (25%), Positives = 106/211 (50%), Gaps = 34/211 (16%)

Query: 195 KLGQGGFGSVYKGQ--LHTGRLIAVKMLENSKFSAEEFINEVSTIGRI---------HHV 243
           ++G+G +G V+K +   + GR +A+K +   +    E    +STI  +          H 
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAVLRHLETFEHP 64

Query: 244 NVVQLLGFCS-----EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGW--EKLQEIALGT 296
           NVV+L   C+       +K  LV+E      +D+ +    +K    G   E ++++    
Sbjct: 65  NVVRLFDVCTVSRTDRETKLTLVFE-----HVDQDLTTYLDKVPEPGVPTETIKDMMFQL 119

Query: 297 ARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 356
            RG+ +LH+     ++H D+KP NIL+  +   K++DFGLA+ +  +   +++++   T+
Sbjct: 120 LRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTL 173

Query: 357 GYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
            Y APE++ ++  + +   D++  G +  EM
Sbjct: 174 WYRAPEVLLQS--SYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 36/211 (17%)

Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           +G+GGFG VY   +  TG++ A+K L+  +   ++        G    +N   +L   S 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--------GETLALNERIMLSLVST 53

Query: 255 GS---------------KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARG 299
           G                K + + + M  G L  H+    ++   F   +++  A     G
Sbjct: 54  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEAEMRFYAAEIILG 109

Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
           + ++HN     +++ D+KP NILLD +   ++SD GLA    K+    S+    GT GY+
Sbjct: 110 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYM 162

Query: 360 APELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           APE++ +     S  +D +  G +L ++  G
Sbjct: 163 APEVLQKGVAYDS-SADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 58.4 bits (142), Expect = 2e-09
 Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 38/210 (18%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQL- 248
           ++ +G +G VY+ +   TG ++A+K L+  K   E F    + E++ + ++ H N+V + 
Sbjct: 12  RIEEGTYGVVYRARDKKTGEIVALKKLKMEK-EKEGFPITSLREINILLKLQHPNIVTVK 70

Query: 249 ---LGFCSEGSKRALVYEFMPNG--SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
              +G  S   K  +V E++ +   SL       E   Q F   +++ + L    GVA+L
Sbjct: 71  EVVVG--SNLDKIYMVMEYVEHDLKSL------METMKQPFLQSEVKCLMLQLLSGVAHL 122

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLA-KF-HPKENDFVSISATRG--TIGYI 359
           H   D  ILH D+K  N+LL++  I K+ DFGLA ++  P +        T+   T+ Y 
Sbjct: 123 H---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP------YTQLVVTLWYR 173

Query: 360 APELISRNFGT--VSCKSDVYGFGMVLLEM 387
           APEL+    G    S   D++  G +  E+
Sbjct: 174 APELL---LGAKEYSTAIDMWSVGCIFAEL 200

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 64/229 (27%), Positives = 107/229 (46%), Gaps = 39/229 (17%)

Query: 196 LGQGGFGSVYKG---------QLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVV 246
           LGQG F  ++KG         +LH   ++   + ++ +  +E F    S + ++ H ++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQ-TFGWEKLQEIALGTARGVAY-LH 304
              G C  G +  +V E++  GSLD ++  K+NK      W KL+      A+ +A+ LH
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISW-KLE-----VAKQLAWALH 114

Query: 305 NGCDMCILHFDIKPHNILLDHN---------FIPKVSDFGLA-KFHPKENDFVSISATRG 354
              D  + H ++   N+LL            FI K+SD G++    PKE     I   R 
Sbjct: 115 FLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFI-KLSDPGISITVLPKE-----ILLER- 167

Query: 355 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK 403
            I ++ PE I  N   +S  +D + FG  L E+  G  +  ++A+ S K
Sbjct: 168 -IPWVPPECI-ENPQNLSLAADKWSFGTTLWEIFSG-GDKPLSALDSQK 213

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 20/206 (9%)

Query: 196 LGQGGFGSVY----KGQLHTGRLIAVKMLENSKF-----SAEEFINEVSTIGRIHHVNVV 246
           LG G +G V+     G    G+L A+K+L+ +       +AE    E   +  +     +
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 247 QLL--GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
             L   F ++ +K  L+ +++  G L  H++ +E+    F      E+ +  A  V  L 
Sbjct: 68  VTLHYAFQTD-TKLHLILDYVNGGELFTHLYQREH----F---TESEVRVYIAEIVLALD 119

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
           +   + I++ DIK  NILLD      ++DFGL+K    E +  + S   GTI Y+APE+I
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC-GTIEYMAPEVI 178

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGG 390
               G      D +  G++  E+  G
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 59.4 bits (143), Expect = 3e-09
 Identities = 76/317 (23%), Positives = 138/317 (43%), Gaps = 58/317 (18%)

Query: 176 MPKRYSYPEIIAVTNHFTHKLGQGGFGSVY------KGQLHTGRLIAVKMLENSKFSAEE 229
           MP +Y   E          K+G G FG V+        +    + I+ + L+  + S  +
Sbjct: 1   MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS--Q 58

Query: 230 FINEVSTIGRIHHVNVVQLLG-FCSEGSKRA-LVYEFMPNGSLDRHIFPKENKGQTFGWE 287
            + EV+ +  + H N+V+ +  F ++ +++  ++ EF   G L R+I   +   + FG  
Sbjct: 59  LVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI---QKCYKMFG-- 113

Query: 288 KLQEIAL-----GTARGVAYLHNGCD----MCILHFDIKPHNILLDHNF----------- 327
           K++E A+          +AY HN  D      +LH D+KP NI L               
Sbjct: 114 KIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173

Query: 328 ------IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 381
                 I K+ DFGL+K    E+      +  GT  Y +PEL+     +   KSD++  G
Sbjct: 174 NLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG 230

Query: 382 MVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGL 441
            ++ E+  G+   +       KA   S +  +L +G DL ++  ++  +++ + L     
Sbjct: 231 CIIYELCSGKTPFH-------KANNFSQLISELKRGPDLPIKGKSKELNILIKNL----- 278

Query: 442 WCIQVKAADRPSMTKVL 458
             + + A +RPS  + L
Sbjct: 279 --LNLSAKERPSALQCL 293

Length = 1021

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 58.6 bits (142), Expect = 5e-09
 Identities = 58/226 (25%), Positives = 87/226 (38%), Gaps = 43/226 (19%)

Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKM----LENSKFSAEEFINEVSTIGRIHHVNVVQLL 249
            +G+GG G VY        R +A+K     L  +    + F+ E      + H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 250 GFCSEGSKRALVYEFMP--NGSLDRHIF---------PKENKGQTFGWEKLQEIALGTAR 298
             CS+G     VY  MP   G   + +           KE   +T        I      
Sbjct: 69  SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKT-SVGAFLSIFHKICA 124

Query: 299 GVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF-HPKENDFVSISATR---- 353
            + Y+H+     +LH D+KP NILL       + D+G A F   +E D + I        
Sbjct: 125 TIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181

Query: 354 -----------GTIGYIAPELISRNFGT-VSCKSDVYGFGMVLLEM 387
                      GT  Y+APE   R  G   S  +D+Y  G++L +M
Sbjct: 182 YSSMTIPGKIVGTPDYMAPE---RLLGVPASESTDIYALGVILYQM 224

Length = 932

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 5e-09
 Identities = 65/260 (25%), Positives = 103/260 (39%), Gaps = 60/260 (23%)

Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVST----IGRIHHVNVVQLL 249
            LG+G  G V+  +L  TG+L A+K+L+  +      +  V T    +  + H  +  L 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 250 GFCSEGSKRALVYEFMPNGSLDR-------HIFPKENKGQTFGWEKLQEIALGTARGVAY 302
                 +   LV ++ P G L R            E   + +  E L  +AL       Y
Sbjct: 68  ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLS-EEVARFYAAEVL--LAL------EY 118

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK---------------------FHP 341
           LH    + I++ D+KP NILL  +    +SDF L+K                      + 
Sbjct: 119 LHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175

Query: 342 KENDFVS-ISATR-----GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR---R 392
             ++  S   + R     GT  YIAPE+IS +    +   D +  G++L EM  G    +
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEMLYGTTPFK 233

Query: 393 NSNMNA----IRSSKAYFPS 408
            SN +     I   +  FP 
Sbjct: 234 GSNRDETFSNILKKEVTFPG 253

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 57.0 bits (137), Expect = 5e-09
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 34/209 (16%)

Query: 194 HKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFI---NEVSTIGRIHHVNVVQLL 249
            ++G G +G VYK + ++TG L A+K+++      E+F     E+  +    H N+V   
Sbjct: 15  QRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYF 72

Query: 250 GFCSEGSKRALVYEFMPNGSLDR--HIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
           G      K  +  EF   GSL    H+    ++ Q      +  ++  T +G+ YLH+  
Sbjct: 73  GSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQ------IAYVSRETLQGLYYLHSKG 126

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-------GTIGYIA 360
            M   H DIK  NILL  N   K++DFG++           I+AT        GT  ++A
Sbjct: 127 KM---HRDIKGANILLTDNGHVKLADFGVS---------AQITATIAKRKSFIGTPYWMA 174

Query: 361 PELIS-RNFGTVSCKSDVYGFGMVLLEMA 388
           PE+ +    G  +   D++  G+  +E+A
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 57.6 bits (139), Expect = 5e-09
 Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 22/154 (14%)

Query: 239 RIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKG-----QTFGWEKLQEIA 293
            ++H +V+++      G+   +V   +P+ S D + +  +        Q    EK     
Sbjct: 113 NVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEK----- 164

Query: 294 LGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 353
                G+ YLH      I+H D+K  NI ++      + D G A+F      F+ ++   
Sbjct: 165 -QILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA--- 217

Query: 354 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
           GT+   APE+++R+    + K+D++  G+VL EM
Sbjct: 218 GTVETNAPEVLARD--KYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 29/212 (13%)

Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCS 253
           +G+G +G VYK      G L AVK+L+      EE   E + +  + +H NVV+  G   
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89

Query: 254 E-----GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           +     G +  LV E    GS+   +      GQ      +  I  G   G+ +LHN   
Sbjct: 90  KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR- 148

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-------GTIGYIAP 361
             I+H D+K +NILL      K+ DFG++           +++TR       GT  ++AP
Sbjct: 149 --IIHRDVKGNNILLTTEGGVKLVDFGVS---------AQLTSTRLRRNTSVGTPFWMAP 197

Query: 362 ELIS---RNFGTVSCKSDVYGFGMVLLEMAGG 390
           E+I+   +   +   + DV+  G+  +E+  G
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 56.9 bits (138), Expect = 6e-09
 Identities = 62/217 (28%), Positives = 92/217 (42%), Gaps = 49/217 (22%)

Query: 196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSA---EEFI-NEVSTIGRIHHVNVVQLLG 250
           LG GGFG V   ++    R  A+K ++         +E I +E   +   +H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58

Query: 251 FCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIAL---GTAR------- 298
           + +   K+ +  + E+   G L               W  L++  L    TAR       
Sbjct: 59  YRTFKDKKYIYMLMEYCLGGEL---------------WTILRDRGLFDEYTARFYIACVV 103

Query: 299 -GVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK---FHPKENDFVSISATRG 354
               YLHN     I++ D+KP N+LLD N   K+ DFG AK      K   F       G
Sbjct: 104 LAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC------G 154

Query: 355 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           T  Y+APE+I  N G      D +  G++L E+  GR
Sbjct: 155 TPEYVAPEIIL-NKGY-DFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 57.4 bits (139), Expect = 6e-09
 Identities = 33/96 (34%), Positives = 55/96 (57%), Gaps = 9/96 (9%)

Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
           RG+ YLH+     ILH DIKP N+L++ N + K+ DFGLA+   + ++   ++    T  
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE-EPDESKHMTQEVVTQY 169

Query: 358 YIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           Y APE++  SR++ +     D++  G +  E+ G R
Sbjct: 170 YRAPEILMGSRHYTS---AVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 42/211 (19%)

Query: 196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFI---NEVS----------TIGRIH 241
           LG+G FG V   +   TG L A+K L+      +  I   +EV           T     
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALK------KGDIIARDEVESLMCEKRIFETANSER 60

Query: 242 HVNVVQLLGFCSEGSKRA-LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGV 300
           H  +V L   C +       V E+   G L  HI         F   +    A     G+
Sbjct: 61  HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHI-----HTDVFSEPRAVFYAACVVLGL 114

Query: 301 AYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK----FHPKENDFVSISATRGTI 356
            YLH   +  I++ D+K  N+LLD     K++DFGL K    F  + + F       GT 
Sbjct: 115 QYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC------GTP 165

Query: 357 GYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
            ++APE+++    T +   D +G G+++ EM
Sbjct: 166 EFLAPEVLTETSYTRAV--DWWGLGVLIYEM 194

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 57.0 bits (138), Expect = 7e-09
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 26/208 (12%)

Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G+G +G V       T   +A+K + N+   +  A+  + E+  +  + H NV+ +   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 252 CSEGSKRA-----LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
                + A     +VYE M     D H   + +  QT   +  Q       RG+ Y+H+ 
Sbjct: 73  MPPPHREAFNDVYIVYELM---DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSA 127

Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELI- 364
               +LH D+KP N+LL+ N   K+ DFGLA+   ++ DF++    TR    Y APEL+ 
Sbjct: 128 N---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR---WYRAPELLL 181

Query: 365 -SRNFGTVSCKSDVYGFGMVLLEMAGGR 391
               + T     DV+  G +  E+ G +
Sbjct: 182 NCSEYTTA---IDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 57.1 bits (138), Expect = 7e-09
 Identities = 65/233 (27%), Positives = 101/233 (43%), Gaps = 38/233 (16%)

Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 250
           LG G FG V   +   TG   A+K L+  +       +    E S +  + H  +V ++ 
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 251 FCSEGSKRALVYEFMPNGSLDRHI-----FPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
              + ++   + EF+  G L  H+     FP  N    F      E+ L       YLH+
Sbjct: 86  SFQDENRVYFLLEFVVGGELFTHLRKAGRFP--NDVAKF---YHAELVLA----FEYLHS 136

Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI- 364
             D  I++ D+KP N+LLD+    KV+DFG AK  P +  F       GT  Y+APE+I 
Sbjct: 137 -KD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-DRTFTLC----GTPEYLAPEVIQ 188

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGGR----RNSNMNA---IRSSKAYFPSWV 410
           S+  G      D +  G++L E   G      ++       I + +  FP+W 
Sbjct: 189 SKGHGKA---VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWF 238

Length = 329

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 56.4 bits (136), Expect = 8e-09
 Identities = 53/222 (23%), Positives = 100/222 (45%), Gaps = 51/222 (22%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE------FINEVSTIGRIHHVN-VV 246
           K+G+G +G VYK +  +TG+L+A+K    ++   +E       + E+S +  +     +V
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQMLSESIYIV 64

Query: 247 QLLGFCSEGSKRA-----LVYEFMP---------NGSLDRHIFPKENKGQTFGWEKLQEI 292
           +LL       K       LV+E++          NG       P     ++F ++ L+  
Sbjct: 65  RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLP-AKTIKSFMYQLLK-- 121

Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 351
                 GVA+ H      ++H D+KP N+L+D    + K++D GL +        + + +
Sbjct: 122 ------GVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-----AFSIPVKS 167

Query: 352 TRG---TIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMA 388
                 T+ Y APE++  S ++ T     D++  G +  EM+
Sbjct: 168 YTHEIVTLWYRAPEVLLGSTHYST---PVDIWSVGCIFAEMS 206

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 18/202 (8%)

Query: 196 LGQGGFGSV-YKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 250
           LG+G FG V    +  +G+  A+K+L+     A++ +    T  R+     H  +  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                 +   V E++  G L  H+    ++ + F  ++ +         + YLH+G    
Sbjct: 63  SFQTKDRLCFVMEYVNGGELFFHL----SRERVFSEDRTRFYGAEIVSALDYLHSGK--- 115

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 369
           I++ D+K  N++LD +   K++DFGL K      D  ++    GT  Y+APE++  N +G
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D +G G+V+ EM  GR
Sbjct: 174 RA---VDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 66/230 (28%), Positives = 106/230 (46%), Gaps = 28/230 (12%)

Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHV---NVVQLLGF 251
           LG+G FG V   +L   G   AVK L+      ++ +       R+  +   N      +
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 252 CSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           C+  +K  L  V EF+  G L  HI   ++KG+ F   +    A     G+ +LH+    
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHI---QDKGR-FDLYRATFYAAEIVCGLQFLHSKG-- 116

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR--GTIGYIAPELISRN 367
            I++ D+K  N++LD +   K++DFG+     KEN F    A+   GT  YIAPE++   
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMC----KENVFGDNRASTFCGTPDYIAPEILQGL 171

Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNAIRSSKAYFPSWV 410
             T S   D + FG++L EM  G+        +    +IR    ++P W+
Sbjct: 172 KYTFSV--DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWI 219

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 17/202 (8%)

Query: 196 LGQGGFGSV-YKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 250
           LG+G FG V    +  TGR  A+K+L+     A++ +    T  R+     H  +  L  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                 +   V E+   G L  H+    ++ + F  ++ +         + YLH+  +  
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHS--EKN 116

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 369
           +++ D+K  N++LD +   K++DFGL K   K  D  ++    GT  Y+APE++  N +G
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDYG 174

Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D +G G+V+ EM  GR
Sbjct: 175 RA---VDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 32/226 (14%)

Query: 196 LGQGGFGSVYKGQL-------HTGRLIAV----KMLENSKFSAEEFINEVSTIGRIHHVN 244
           LGQG F ++YKG L         G    V    K+L +    +  F    S + ++ H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
           +V+L G C    +  +V E++  G LD  +F    K       KL  +A   A  + YL 
Sbjct: 63  LVKLYGVCVR-DENIMVEEYVKFGPLD--VFLHREKNNVSLHWKLD-VAKQLASALHYLE 118

Query: 305 NGCDMCILHFDIKPHNILL-----DHNFIP--KVSDFGLAKFHPKENDFVSISATRGTIG 357
              D  ++H ++   NIL+     +  ++P  K+SD G+        + V        I 
Sbjct: 119 ---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE------RIP 169

Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK 403
           +IAPE I     +++  +D + FG  LLE+        ++ + SS+
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEIC-SNGEEPLSTLSSSE 214

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 57/252 (22%), Positives = 100/252 (39%), Gaps = 62/252 (24%)

Query: 176 MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEF---- 230
           + +RY     I    H    LG+G +G V K     TG+++A+K ++  + S +      
Sbjct: 6   ISERY-----IQKGAH----LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQ 56

Query: 231 -----------INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL----DRHIF 275
                      + E+  +  I H N++ L+    EG    LV + M    L    DR I 
Sbjct: 57  LVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIR 115

Query: 276 PKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFG 335
             E++ +    + L         G+  LH       +H D+ P NI ++   I K++DFG
Sbjct: 116 LTESQVKCILLQIL--------NGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFG 164

Query: 336 LAK------FHPKENDFVSISATRG------TIGYIAPELISRNFG----TVSCKSDVYG 379
           LA+      +    +   ++           T+ Y APEL+    G      +   D++ 
Sbjct: 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELL---MGAEKYHFAV--DMWS 219

Query: 380 FGMVLLEMAGGR 391
            G +  E+  G+
Sbjct: 220 VGCIFAELLTGK 231

Length = 335

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 28/214 (13%)

Query: 188 VTNHFT--HKLGQGGFGSV--YKGQLHTGRLIAVKMLENSKFS----AEEFINEVSTIGR 239
           +TN +     +G G FG V   + QL TG+ +A+K +    FS    A+    E+  +  
Sbjct: 8   ITNRYVDLQPVGMGAFGLVCSARDQL-TGQNVAIKKIMKP-FSTPVLAKRTYRELKLLKH 65

Query: 240 IHHVNVVQLLG-FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR 298
           + H N++ L   F S       V E +     D H        +    + +Q       R
Sbjct: 66  LRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEK---QFIQYFLYQILR 119

Query: 299 GVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH-PKENDFVSISATRGTIG 357
           G+ Y+H+     ++H D+KP NIL++ N   K+ DFGLA+   P+   +VS      T  
Sbjct: 120 GLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS------TRY 170

Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           Y APE I   +     + D++  G +  EM  G+
Sbjct: 171 YRAPE-IMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 63/235 (26%), Positives = 101/235 (42%), Gaps = 38/235 (16%)

Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 249
           LG+G FG V+  +L  T +  A+K L+      ++ +       R+      H  +  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL- 61

Query: 250 GFCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +C+  +K  L  V E++  G L  HI         F   +    A     G+ +LH+  
Sbjct: 62  -YCTFQTKENLFFVMEYLNGGDLMFHI----QSCHKFDLPRATFYAAEIICGLQFLHS-- 114

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH----PKENDFVSISATRGTIGYIAPE- 362
              I++ D+K  NILLD +   K++DFG+ K +     K   F       GT  YIAPE 
Sbjct: 115 -KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC------GTPDYIAPEI 167

Query: 363 LISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNAIRSSKAYFPSWV 410
           L+ + + T     D + FG++L EM  G+             +IR     +P W+
Sbjct: 168 LLGQKYNT---SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWL 219

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 48/238 (20%)

Query: 171 NQQSW-MPKRYSYPEIIAVTNHFTHKLGQGGFGSV-YKGQLHTGRLIAVKMLE---NSKF 225
           N+  W +P RY   ++  V        G G +G+V       TG  +A+K L     S+ 
Sbjct: 7   NKTIWEVPDRYR--DLKQV--------GSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL 56

Query: 226 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRH-----IFP---- 276
            A+    E+  +  + H NV+ LL              F P+ SLDR      + P    
Sbjct: 57  FAKRAYRELRLLKHMKHENVIGLLDV------------FTPDLSLDRFHDFYLVMPFMGT 104

Query: 277 ---KENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSD 333
              K  K +    +++Q +     +G+ Y+H      I+H D+KP N+ ++ +   K+ D
Sbjct: 105 DLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD 161

Query: 334 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           FGLA+    +++      TR    Y APE+I  N+   +   D++  G ++ EM  G+
Sbjct: 162 FGLAR--QTDSEMTGYVVTR---WYRAPEVI-LNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 55.3 bits (134), Expect = 3e-08
 Identities = 70/262 (26%), Positives = 114/262 (43%), Gaps = 84/262 (32%)

Query: 178 KRYSYPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFIN---- 232
           ++Y   EI+        KLG+G +G V+K     T  ++A+K +    F A  F N    
Sbjct: 7   RKY---EIL-------QKLGKGAYGIVWKAIDRRTKEVVALKKI----FDA--FRNATDA 50

Query: 233 -----EVSTIGRI-HHVNVVQLLGFCSEGSKRA-------LVYEFMPNGSLDRHIFPKEN 279
                E+  +  +  H N+V+LL        +A       LV+E+M     D H   + N
Sbjct: 51  QRTFREIMFLQELGDHPNIVKLLNVI-----KAENDKDIYLVFEYMET---DLHAVIRAN 102

Query: 280 KGQTFGWEKLQE-----IALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                    L++     I     + + Y+H+G    ++H D+KP NILL+ +   K++DF
Sbjct: 103 I--------LEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADF 151

Query: 335 GLAK---------FHPKENDFVSISATRGTIGYIAPELI--SRNFGT-VSCKSDVYGFGM 382
           GLA+          +P   D+V   ATR    Y APE++  S  +   V    D++  G 
Sbjct: 152 GLARSLSELEENPENPVLTDYV---ATR---WYRAPEILLGSTRYTKGV----DMWSVGC 201

Query: 383 VLLEMAGGRR----NSNMNAIR 400
           +L EM  G+      S +N + 
Sbjct: 202 ILGEMLLGKPLFPGTSTLNQLE 223

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 28/207 (13%)

Query: 196 LGQGGFGSV-YKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 250
           LG+G FG V    +  TG+  A+K+L+     A++ +    T  R+     H  +  L  
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62

Query: 251 FCSEGSKRALVYEFMPNGSLDRH-----IFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
                 +   V E+   G L  H     +F  E++ + +G E +   ALG      YLH+
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHLSRERVF-SEDRARFYGAEIVS--ALG------YLHS 113

Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
            CD  +++ D+K  N++LD +   K++DFGL K    +    ++    GT  Y+APE++ 
Sbjct: 114 -CD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLE 168

Query: 366 RN-FGTVSCKSDVYGFGMVLLEMAGGR 391
            N +G      D +G G+V+ EM  GR
Sbjct: 169 DNDYGRA---VDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 55.0 bits (133), Expect = 4e-08
 Identities = 62/234 (26%), Positives = 99/234 (42%), Gaps = 40/234 (17%)

Query: 171 NQQSW-MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAE 228
           N+  W +P RY     +          G G +G V       TGR +A+K L +  F + 
Sbjct: 7   NKTVWEVPDRYQNLSPV----------GSGAYGQVCSAFDTKTGRKVAIKKL-SRPFQSA 55

Query: 229 EF----INEVSTIGRIHHVNVVQLLG-FCSEGSKRA-----LVYEFMPNGSLDRHIFPKE 278
                   E+  +  + H NV+ LL  F    S        LV   M    L+  +    
Sbjct: 56  IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIV---- 110

Query: 279 NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK 338
            K Q    + +Q +     RG+ Y+H      I+H D+KP NI ++ +   K+ DFGLA+
Sbjct: 111 -KCQKLSDDHIQFLVYQILRGLKYIH-SAG--IIHRDLKPSNIAVNEDCELKILDFGLAR 166

Query: 339 FHPKE-NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
               E   +V   ATR    Y APE++  N+   +   D++  G ++ E+  G+
Sbjct: 167 HTDDEMTGYV---ATR---WYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 42/214 (19%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGF 251
           +G+G +G V K +   T  ++A+K  ++S+ +    E  + E+  +  +   N+V+L   
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 252 CSEGSKRALVYEF-----------MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGV 300
                K  LV+E+           MPNG                  EK++       + +
Sbjct: 69  FRRRGKLYLVFEYVEKNMLELLEEMPNGVPP---------------EKVRSYIYQLIKAI 113

Query: 301 AYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND--FVSISATRGTIGY 358
            + H      I+H DIKP N+L+ HN + K+ DFG A+   + ++  +    ATR    Y
Sbjct: 114 HWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATR---WY 167

Query: 359 IAPELISRNFGTVSCKS-DVYGFGMVLLEMAGGR 391
            +PEL+    G    K+ D++  G +L E++ G+
Sbjct: 168 RSPELL---LGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 58/221 (26%), Positives = 106/221 (47%), Gaps = 22/221 (9%)

Query: 196 LGQGGFGSVY---KGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGR--IHHVNVVQLL 249
           LG G +G V+   K   H +G+L A+K+L+ +    +    E +   R  + H+     L
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 250 -----GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
                 F ++ +K  L+ +++  G L  H+  +E   +       QE+ + +   V  L 
Sbjct: 68  VTLHYAFQTD-TKLHLILDYINGGELFTHLSQRERFKE-------QEVQIYSGEIVLALE 119

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPEL 363
           +   + I++ DIK  NILLD N    ++DFGL+K FH  E +     +  GTI Y+AP++
Sbjct: 120 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE--RAYSFCGTIEYMAPDI 177

Query: 364 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA 404
           +    G      D +  G+++ E+  G     ++  ++S+A
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA 218

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 54.2 bits (130), Expect = 7e-08
 Identities = 46/167 (27%), Positives = 72/167 (43%), Gaps = 23/167 (13%)

Query: 231 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQ 290
             E   +  I+H +++QL G  +      L+   +P    D + +    +        + 
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAIC--DIL 185

Query: 291 EIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 350
            I     R + YLH      I+H DIK  NI ++H     + DFG A F       V I+
Sbjct: 186 AIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFP------VDIN 236

Query: 351 ATR-----GTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGR 391
           A +     GTI   APEL++R+ +G      D++  G+VL EMA   
Sbjct: 237 ANKYYGWAGTIATNAPELLARDPYGPA---VDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 53.9 bits (129), Expect = 9e-08
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 5/91 (5%)

Query: 297 ARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 356
           A+G+ +L      CI H D+   NILL  N + K+ DFGLA+   K+ D+V     R  +
Sbjct: 189 AKGMEFL--ASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245

Query: 357 GYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
            ++APE I     T+  +SDV+ FG++L E+
Sbjct: 246 KWMAPETIFDRVYTI--QSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 18/201 (8%)

Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLEN----SKFSAEEFINEVSTIGRIHHVNVVQL-L 249
           +G+G FG V +  +  T R+ A+K +      S+      + E + + +++   +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
            F S   K  LV  F+  G L  H+       Q  G   L      TA  +  L N    
Sbjct: 61  SFQSPE-KLYLVLAFINGGELFHHL-------QREGRFDLSRARFYTAELLCALENLHKF 112

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
            +++ D+KP NILLD+     + DFGL K + K++D    +   GT  Y+APEL+    G
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCGTPEYLAPELLL-GHG 169

Query: 370 TVSCKSDVYGFGMVLLEMAGG 390
                 D +  G++L EM  G
Sbjct: 170 YTKA-VDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 32/213 (15%)

Query: 196 LGQGGFGSVYKGQL----HTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVN----VVQ 247
           +G+G FG V   Q+     TG + A+K+++ S   A+E ++       I  ++    + Q
Sbjct: 9   VGRGHFGEV---QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQ 65

Query: 248 LLGFCSEGSKRALVYEFMPNGSL----DRHIFP-KENKGQTFGWEKLQEIALGTARGVAY 302
           L     +     LV E+ P G L    +R+     E+  Q +    L E+ L        
Sbjct: 66  LQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY----LAELVLA------- 114

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
           +H+   M  +H DIKP N+L+D     K++DFG A          S     GT  YIAPE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPE 173

Query: 363 LISRNFGTVSCKSDV----YGFGMVLLEMAGGR 391
           +++   G       V    +  G++  EM  GR
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 18/202 (8%)

Query: 196 LGQGGFGSV-YKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 250
           LG+G FG V    +  TGR  A+K+L      A++ +    T  R+     H  +  L  
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                 +   V E+   G L  H+    ++ + F  E+ +         + YLH+     
Sbjct: 63  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHS---RD 115

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 369
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  Y+APE++  N +G
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D +G G+V+ EM  GR
Sbjct: 174 RA---VDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 59/238 (24%), Positives = 95/238 (39%), Gaps = 54/238 (22%)

Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVST----IGRIHHVNVVQLLG 250
           +G+G FG V   Q   TG + A+K L  S+   +E +  V      +    +  VV+L  
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL-- 66

Query: 251 FCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           + S   +  L  + E++P G +   +  K+    TF  E+ +     T   +  +H    
Sbjct: 67  YYSFQDENYLYLIMEYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHK--- 119

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAK--------------FHPKENDFVSISA--- 351
           +  +H DIKP N+LLD     K+SDFGL                 H   ++F+   +   
Sbjct: 120 LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPM 179

Query: 352 -------------------TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
                              T GT  YIAPE+  +      C  D +  G+++ EM  G
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC--DWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 65/236 (27%), Positives = 109/236 (46%), Gaps = 40/236 (16%)

Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGR------IHHVNVVQL 248
           LG+G FG V   +L  T    A+K L+      ++ + E + + R        H  +  L
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDV-ECTMVERRVLALAWEHPFLTHL 61

Query: 249 LGFCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH-N 305
             FC+  +K  L  V E++  G L  HI   ++ G+ F   + +  A     G+ +LH  
Sbjct: 62  --FCTFQTKEHLFFVMEYLNGGDLMFHI---QSSGR-FDEARARFYAAEIICGLQFLHKK 115

Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH----PKENDFVSISATRGTIGYIAP 361
           G    I++ D+K  N+LLD +   K++DFG+ K +     K + F       GT  YIAP
Sbjct: 116 G----IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC------GTPDYIAP 165

Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNAIRSSKAYFPSWV 410
           E++       S   D + FG++L EM  G+        +   ++I + + +FP W+
Sbjct: 166 EILKGQKYNESV--DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWI 219

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 5/91 (5%)

Query: 297 ARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 356
           ARG+ +L      C+ H D+   N+LL    I K+ DFGLA+    ++++VS  +T   +
Sbjct: 247 ARGMEFL--ASKNCV-HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303

Query: 357 GYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
            ++APE I  N  T    SDV+ +G++L E+
Sbjct: 304 KWMAPESIFDNLYTT--LSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 51.7 bits (124), Expect = 4e-07
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 41/214 (19%)

Query: 196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 249
           +G+G +  V   +L  T R+ A+K+++    + +E I+ V T   +     +H  +V L 
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHI-----FPKENKGQTFGWEKLQEIALGTARGVAYLH 304
                 S+   V EF+  G L  H+      P+E+           EI+L     + +LH
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-----EISLA----LNFLH 113

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
                 I++ D+K  N+LLD     K++D+G+ K   +  D  S     GT  YIAPE++
Sbjct: 114 ERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC--GTPNYIAPEIL 168

Query: 365 SRNFGTVSCKSDVYGF-------GMVLLEMAGGR 391
                    + + YGF       G+++ EM  GR
Sbjct: 169 ---------RGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 27/204 (13%)

Query: 196 LGQGGFGSVYKGQLHTGR----LIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLG 250
           +G G FG V+  +         L  + + E  +   E+ + NE   +  + H  +++L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66

Query: 251 FCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           F +E  +R L  + E++P G L  ++        + G     EI       + YLH+   
Sbjct: 67  FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCA----LEYLHS--- 119

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIAPELI-SR 366
             I++ D+KP NILLD     K++DFG AK           + T  GT  Y+APE+I S+
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTLCGTPEYLAPEVIQSK 173

Query: 367 NFGTVSCKSDVYGFGMVLLEMAGG 390
                    D +  G+++ EM  G
Sbjct: 174 GHNKA---VDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 27/83 (32%), Positives = 45/83 (54%), Gaps = 5/83 (6%)

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN--F 368
           ++H D+KP NILLD +   K+ DFG++       D  + + + G   Y+APE I      
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTRSAGCAAYMAPERIDPPDPN 192

Query: 369 GTVSCKSDVYGFGMVLLEMAGGR 391
                ++DV+  G+ L+E+A G+
Sbjct: 193 PKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 51.2 bits (122), Expect = 6e-07
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 21/204 (10%)

Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +     A   E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 85  FTP----ARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 140

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 141 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 191

Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 51.1 bits (122), Expect = 6e-07
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 35/200 (17%)

Query: 211 TGRLIAVKM--LENSKFSAEEFI----NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF 264
           TG L+ V++  LEN     EE +    NEV       H N++      + GS   ++  F
Sbjct: 24  TGTLVTVRITDLENC---TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF 80

Query: 265 MPNGS---LDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH-NGCDMCILHFDIKPHN 320
           M  GS   L +  FP E   +      +  I  G  RG+ YLH NG     +H +IK  +
Sbjct: 81  MAYGSANSLLKTYFP-EGMSEAL----IGNILFGALRGLNYLHQNGY----IHRNIKASH 131

Query: 321 ILLDHNFIPKVSDFGLAKFHPKEN---------DFVSISATRGTIGYIAPELISRNFGTV 371
           IL+  + +  +S  GL+  +             DF   S +   + +++PEL+ ++    
Sbjct: 132 ILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTS--VLPWLSPELLRQDLYGY 187

Query: 372 SCKSDVYGFGMVLLEMAGGR 391
           + KSD+Y  G+   E+A GR
Sbjct: 188 NVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 50.7 bits (121), Expect = 6e-07
 Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 54/229 (23%)

Query: 196 LGQGGFGSVYKGQLHTGR-------------------------LIAVKMLENSKFS-AEE 229
           LGQG   ++Y G+L                              + +K+L+ S    A  
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 230 FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQT-FGWEK 288
           F    S + ++ H+++  + G C  GS+  +V EF+ +G LD  +  ++ KG+    W+ 
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD--VCLRKEKGRVPVAWKI 120

Query: 289 LQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN--------FIPKVSDFGLAKFH 340
              +A   A  ++YL    D  ++H ++   NILL           FI K+SD G++   
Sbjct: 121 T--VAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFI-KLSDPGVS--- 171

Query: 341 PKENDFVSISATRGT--IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
                F ++S       I +IAPE +     ++S  +D + FG  LLE+
Sbjct: 172 -----FTALSREERVERIPWIAPECV-PGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 51.1 bits (122), Expect = 6e-07
 Identities = 61/213 (28%), Positives = 91/213 (42%), Gaps = 34/213 (15%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGRL--IAVKMLENSKFSAEEFINEV----STIGRIHHVN 244
           +F   LG G FG V            +A+K  E SK   ++ ++ V      +  I+H  
Sbjct: 33  NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92

Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENK--GQTFGWEKLQEIALGTARGVAY 302
            V L G   + S   LV EF+  G      F + NK      G     +I L       Y
Sbjct: 93  CVNLYGSFKDESYLYLVLEFVIGGEF--FTFLRRNKRFPNDVGCFYAAQIVLI----FEY 146

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-----GTIG 357
           L +   + I++ D+KP N+LLD +   K++DFG AK          +  TR     GT  
Sbjct: 147 LQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAK----------VVDTRTYTLCGTPE 193

Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           YIAPE++  N G     +D +  G+ + E+  G
Sbjct: 194 YIAPEIL-LNVGHGKA-ADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 50.0 bits (119), Expect = 9e-07
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 20/199 (10%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVK--MLENSKFSAEEFINEVSTIGRIHHVNVVQLL-GF 251
           +G+G FG     Q +++ +  A+K   L  S  + E+   E   + ++ H N+V     F
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
            ++G    +V E+   G L + I  K  +G+ F  + + +  +    GV ++H   +  +
Sbjct: 68  EADG-HLYIVMEYCDGGDLMQKI--KLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRV 121

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKF--HPKENDFVSISATR-GTIGYIAPELISRNF 368
           LH DIK  NI L  N   K+ DFG A+    P      + + T  GT  Y+ PE I  N 
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-----GAYACTYVGTPYYVPPE-IWENM 175

Query: 369 GTVSCKSDVYGFGMVLLEM 387
              + KSD++  G +L E+
Sbjct: 176 -PYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 50.8 bits (121), Expect = 9e-07
 Identities = 70/246 (28%), Positives = 105/246 (42%), Gaps = 31/246 (12%)

Query: 159 LQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQL----HTGRL 214
           L+   NI+ FL N+   + ++    ++ A        +G+G FG V   QL     + ++
Sbjct: 15  LRKNKNIDNFL-NRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEV---QLVRHKSSQKV 70

Query: 215 IAVKMLENSKFS------AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL--VYEFMP 266
            A+K+L  SKF       +  F  E   +   +   VVQL  FC+    + L  V E+MP
Sbjct: 71  YAMKLL--SKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMP 126

Query: 267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN 326
            G L   +    N      W K       TA  V  L     M ++H D+KP N+LLD +
Sbjct: 127 GGDL---VNLMSNYDVPEKWAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKH 178

Query: 327 FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT--VSCKSDVYGFGMVL 384
              K++DFG       E   V      GT  YI+PE++    G      + D +  G+ L
Sbjct: 179 GHLKLADFGTC-MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237

Query: 385 LEMAGG 390
            EM  G
Sbjct: 238 FEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 37/216 (17%)

Query: 192 FTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVN-----V 245
           F   LG+G FG V   +   T  L A+K+L+      ++ +       R+  +      +
Sbjct: 4   FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFL 63

Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQE-----IALGTARGV 300
            QL        +   V E++  G L  HI       Q  G  K +E      A   A G+
Sbjct: 64  TQLHSCFQTMDRLYFVMEYVNGGDLMYHI-------QQVG--KFKEPHAVFYAAEIAIGL 114

Query: 301 AYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR---GTIG 357
            +LH+     I++ D+K  N++LD     K++DFG+ K +           TR   GT  
Sbjct: 115 FFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK-----TTRTFCGTPD 166

Query: 358 YIAPELIS-RNFGTVSCKS-DVYGFGMVLLEMAGGR 391
           YIAPE+I+ + +G    KS D + FG++L EM  G+
Sbjct: 167 YIAPEIIAYQPYG----KSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 50.1 bits (119), Expect = 1e-06
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 19/203 (9%)

Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 249
           +G+G +  V   +L  T R+ A+K+++    + +E I+ V T   +     +H  +V L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
                 S+   V E++  G L  H+  +    +        EI+L     + YLH   + 
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH---ER 115

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 368
            I++ D+K  N+LLD     K++D+G+ K   +  D  + S   GT  YIAPE++   ++
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDY 173

Query: 369 GTVSCKSDVYGFGMVLLEMAGGR 391
           G      D +  G+++ EM  GR
Sbjct: 174 GF---SVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 62/222 (27%), Positives = 94/222 (42%), Gaps = 46/222 (20%)

Query: 191 HFTHKLGQGGFGSVYKGQL----HTGRLIAVKMLENSKF-----SAEEFINEVSTIGRIH 241
                +G+G FG V   QL     + ++ A+K+L  SKF     S   F  E   I  + 
Sbjct: 46  DVIKVIGRGAFGEV---QLVRHKSSKQVYAMKLL--SKFEMIKRSDSAFFWEERDI--MA 98

Query: 242 HVN---VVQLLGFCSEGSKRAL--VYEFMPNGSL----DRHIFPKENKGQTFGWEKL--Q 290
           H N   +VQL    +    + L  V E+MP G L      +  P++       W +    
Sbjct: 99  HANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK-------WARFYTA 149

Query: 291 EIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 350
           E+ L     +  +H+   M  +H D+KP N+LLD +   K++DFG        N  V   
Sbjct: 150 EVVLA----LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRCD 201

Query: 351 ATRGTIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGG 390
              GT  YI+PE++      G    + D +  G+ L EM  G
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 12/99 (12%)

Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF---HPKENDFVSIS--AT 352
           RG+ Y+H+     ++H D+KP N+L++ +   ++ DFG+A+     P E+ +      AT
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174

Query: 353 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           R    Y APEL+  +    +   D++  G +  EM G R
Sbjct: 175 R---WYRAPELL-LSLPEYTTAIDMWSVGCIFAEMLGRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 31/225 (13%)

Query: 196 LGQGGFGSVY---KGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGR--IHHVNVVQLL 249
           LG G +G V+   K   H TG+L A+K+L+ +    +    E +   R  + HV     L
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67

Query: 250 -----GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
                 F +E +K  L+ +++  G +  H++ ++N  +        EI L     + +LH
Sbjct: 68  VTLHYAFQTE-AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA----LEHLH 122

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-----GTIGYI 359
               + I++ DIK  NILLD      ++DFGL+K      +F+S    R     GTI Y+
Sbjct: 123 K---LGIVYRDIKLENILLDSEGHVVLTDFGLSK------EFLSEEKERTYSFCGTIEYM 173

Query: 360 APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA 404
           APE+I R  G      D +  G+++ E+  G     +   R++++
Sbjct: 174 APEII-RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 59/233 (25%), Positives = 95/233 (40%), Gaps = 47/233 (20%)

Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 250
           +G+G FG V   Q   TG + A+K+L  +    +E +  +     I      + VV++  
Sbjct: 9   IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
              +     L+ EF+P G +   +  K+    T   E+ Q     T   +  +H    + 
Sbjct: 69  SFQDKLNLYLIMEFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQ---LG 121

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLA----KFH------------PKENDFVSISATR- 353
            +H DIKP N+LLD     K+SDFGL     K H            P +  F ++++ R 
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181

Query: 354 ----------------GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
                           GT  YIAPE+  +      C  D +  G+++ EM  G
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLC--DWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 36/212 (16%)

Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVS-TIGRIHHVNVVQLLGFC- 252
           +G+G FG VY+ +   T R+ A+K+L   +  A++   EV+ TIG   ++ V  LL    
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK---EVAHTIGE-RNILVRTLLDESP 56

Query: 253 ---------SEGSKRALVYEFMPNGSLDRHI-----FPKENKGQTFGWEKLQEIALGTAR 298
                       S   LV ++M  G L  H+     F  E++ + +    + E+ L    
Sbjct: 57  FIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS-EDRAKFY----IAELVLA--- 108

Query: 299 GVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 358
            + +LH      I++ D+KP NILLD      + DFGL+K +  +N   +     GT  Y
Sbjct: 109 -LEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC--GTTEY 162

Query: 359 IAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           +APE++    G      D +  G+++ EM  G
Sbjct: 163 LAPEVLLDEKGYTK-HVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 35/102 (34%), Positives = 57/102 (55%), Gaps = 7/102 (6%)

Query: 287 EKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 346
           E L   +   A+G+++L      CI H D+   NILL H  I K+ DFGLA+    ++++
Sbjct: 214 EDLLSFSYQVAKGMSFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270

Query: 347 VSISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEM 387
           V     R  + ++APE I   F  V + +SDV+ +G++L E+
Sbjct: 271 VVKGNARLPVKWMAPESI---FNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 45/220 (20%)

Query: 190 NHFT--HKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK-FSAEEFINEVSTIGRI----H 241
             F    ++GQGG+G V+  +   TG ++A+K ++ S  F   E +  V T   I     
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE-VRHVLTERDILTTTK 59

Query: 242 HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR--- 298
              +V+LL    +     L  E++P G   R +    N G       L E     AR   
Sbjct: 60  SEWLVKLLYAFQDDEYLYLAMEYVPGGDF-RTLL--NNLGV------LSE---DHARFYM 107

Query: 299 -----GVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS-AT 352
                 V  LH   ++  +H D+KP N L+D +   K++DFGL+K        V+ + + 
Sbjct: 108 AEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK------GIVTYANSV 158

Query: 353 RGTIGYIAPELI-SRNFG-TVSCKSDVYGFGMVLLEMAGG 390
            G+  Y+APE++  + +  TV    D +  G +L E   G
Sbjct: 159 VGSPDYMAPEVLRGKGYDFTV----DYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 25/205 (12%)

Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLE-----NSKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +G+G FG V   +    G+  AVK+L+     N K            +  + H  +V L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
                  K   V +F+  G L  H+     + ++F   + +  A   A  + YLH+   +
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHL----QRERSFPEPRARFYAAEIASALGYLHS---I 115

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR----GTIGYIAPELIS 365
            I++ D+KP NILLD      ++DFGL K      + ++ S T     GT  Y+APE+I 
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK------EGIAQSDTTTTFCGTPEYLAPEVIR 169

Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGG 390
           +         D +  G VL EM  G
Sbjct: 170 KQ--PYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 17/201 (8%)

Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVST-IGRIHHVNVVQLL 249
           +G+G FG V   +    G+  AVK+L+      K   +  + E +  +  + H  +V L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
                  K   V +++  G L  H+     + ++F   + +  A   A  + YLH+   +
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHL----QRERSFPEPRARFYAAEIASALGYLHS---L 115

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
            I++ D+KP NILLD      ++DFGL K   + +   + S   GT  Y+APE++ +   
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQPY 173

Query: 370 TVSCKSDVYGFGMVLLEMAGG 390
             +   D +  G VL EM  G
Sbjct: 174 DRTV--DWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 60/207 (28%), Positives = 88/207 (42%), Gaps = 26/207 (12%)

Query: 196 LGQGGFGSVYKGQL----HTGRLIAVKMLENSKFS------AEEFINEVSTIGRIHHVNV 245
           +G+G FG V   QL     T ++ A+K+L  SKF       +  F  E   +   +   V
Sbjct: 51  IGRGAFGEV---QLVRHKSTRKVYAMKLL--SKFEMIKRSDSAFFWEERDIMAFANSPWV 105

Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           VQL     +     +V E+MP G L   +   +   +   W +       TA  V  L  
Sbjct: 106 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFY-----TAEVVLALDA 157

Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
              M  +H D+KP N+LLD +   K++DFG      KE   V      GT  YI+PE++ 
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLK 216

Query: 366 RNFGT--VSCKSDVYGFGMVLLEMAGG 390
              G      + D +  G+ L EM  G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 31/210 (14%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVK-MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS 253
           +G G FG VY+   + T   +A+K +L++ ++   E +     +  ++H+N++ L  +  
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDYYY 129

Query: 254 EGSKRA--------LVYEFMPNGSLDRHI--FPKENKGQTFGWEKLQEIALGTARGVAYL 303
               +         +V EF+P  ++ +++  + + N        KL    L   R +AY+
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQL--CRALAYI 186

Query: 304 HNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
           H+     I H D+KP N+L+D N    K+ DFG AK        VS   +R    Y APE
Sbjct: 187 HS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR---FYRAPE 240

Query: 363 LI--SRNFGTVSCKSDVYGFGMVLLEMAGG 390
           L+  + N+ T     D++  G ++ EM  G
Sbjct: 241 LMLGATNYTT---HIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 27/211 (12%)

Query: 192 FTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFIN----EVSTIGRIHHVNVV 246
           F   LG+G FG V   +   T  L A+K+L+      ++ +     E   +        +
Sbjct: 4   FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFL 63

Query: 247 QLLGFCSEGSKRA-LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQE-----IALGTARGV 300
             L  C +   R   V E++  G L  HI       Q  G  K +E      A   + G+
Sbjct: 64  TQLHSCFQTVDRLYFVMEYVNGGDLMYHI-------QQVG--KFKEPQAVFYAAEISVGL 114

Query: 301 AYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 360
            +LH      I++ D+K  N++LD     K++DFG+ K H  +   V+     GT  YIA
Sbjct: 115 FFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIA 169

Query: 361 PELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           PE+I+  +       D + +G++L EM  G+
Sbjct: 170 PEIIA--YQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 48.9 bits (116), Expect = 4e-06
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 11/185 (5%)

Query: 206 KGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM 265
           +G     +++A  ++ N +  A    +E+  +    H  +V+         K  L+ E+ 
Sbjct: 88  RGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147

Query: 266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH 325
             G L++ I  +  +   F   +  E+ L   + V  L       ++H D+K  NI L  
Sbjct: 148 SGGDLNKQIKQRLKEHLPF---QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMP 204

Query: 326 NFIPKVSDFGLAKFHPKENDFVSI---SATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 382
             I K+ DFG +K   + +D VS+   S+  GT  Y+APEL  R     S K+D++  G+
Sbjct: 205 TGIIKLGDFGFSK---QYSDSVSLDVASSFCGTPYYLAPELWERK--RYSKKADMWSLGV 259

Query: 383 VLLEM 387
           +L E+
Sbjct: 260 ILYEL 264

Length = 478

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 63/237 (26%), Positives = 96/237 (40%), Gaps = 55/237 (23%)

Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG---- 250
           +G+G FG V   Q   TG + A+K+L  +    +E +  +    R     +V+  G    
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHI----RAERDILVEADGAWVV 64

Query: 251 --FCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
             F S   KR L  + EF+P G +   +  K+    T   E  Q     T   +  +H  
Sbjct: 65  KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQ- 119

Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLA----KFH------------PKENDFVSIS 350
             +  +H DIKP N+LLD     K+SDFGL     K H            P +  F +++
Sbjct: 120 --LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177

Query: 351 ATR-----------------GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           + R                 GT  YIAPE+  +      C  D +  G+++ EM  G
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLC--DWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 48.3 bits (115), Expect = 6e-06
 Identities = 30/91 (32%), Positives = 51/91 (56%), Gaps = 5/91 (5%)

Query: 297 ARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 356
           A+G+ +L      CI H D+   N+LL    + K+ DFGLA+    ++++V     R  +
Sbjct: 222 AQGMDFL--ASKNCI-HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278

Query: 357 GYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
            ++APE I     TV  +SDV+ +G++L E+
Sbjct: 279 KWMAPESIFDCVYTV--QSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 61/232 (26%), Positives = 99/232 (42%), Gaps = 38/232 (16%)

Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV         + +AVK L     S   A     E+  +  + H NV+ LL  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 252 CS------EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
            +        ++  LV   M    L+  +     K Q    E +Q +     RG+ Y+H+
Sbjct: 83  FTPATSIENFNEVYLVTNLM-GADLNNIV-----KCQKLSDEHVQFLIYQLLRGLKYIHS 136

Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
                I+H D+KP N+ ++ +   ++ DFGLA+    +++     ATR    Y APE I 
Sbjct: 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMTGYVATR---WYRAPE-IM 187

Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVY-DQLNK 416
            N+   +   D++  G ++ E+  G            KA FP   Y DQL +
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKG------------KALFPGNDYIDQLKR 227

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 31/214 (14%)

Query: 191 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVN----- 244
           +F   LG+G FG V   +   T  L A+K+L+      ++ +       R+  ++     
Sbjct: 3   NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62

Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQE-----IALGTARG 299
           + QL        +   V E++  G L   I       Q  G  + +E      A   A G
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYVNGGDLMYQI-------QQVG--RFKEPHAVFYAAEIAIG 113

Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN--DFVSISATRGTIG 357
           + +LH+     I++ D+K  N++LD     K++DFG+     KEN  D V+     GT  
Sbjct: 114 LFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMC----KENMWDGVTTKTFCGTPD 166

Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           YIAPE+I+  +       D + FG++L EM  G+
Sbjct: 167 YIAPEIIA--YQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 47.3 bits (112), Expect = 9e-06
 Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 17/201 (8%)

Query: 196 LGQGGFGSVYKGQLHTG-RLIAVKMLENS----KFSAEEFINEVSTIGR-IHHVNVVQLL 249
           +G+G FG V   +     +  AVK+L+      K   +  ++E + + + + H  +V L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
                  K   V +++  G L  H+     + + F   + +  A   A  + YLH+   +
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARFYAAEIASALGYLHS---L 115

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
            I++ D+KP NILLD      ++DFGL K + + N   + S   GT  Y+APE++ +   
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQ-- 171

Query: 370 TVSCKSDVYGFGMVLLEMAGG 390
                 D +  G VL EM  G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 47.3 bits (112), Expect = 9e-06
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 17/201 (8%)

Query: 196 LGQGGFGSVYKGQLHT-GRLIAVKMLENSKFSAEEFINEVST-----IGRIHHVNVVQLL 249
           +G+G FG V   +  + G   AVK+L+      ++  N +       +  + H  +V L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
                  K   V +++  G L  H+     + + F   + +  A   A  + YLH+   +
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHL----QRERCFLEPRARFYAAEVASAIGYLHS---L 115

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
            I++ D+KP NILLD      ++DFGL K   +  +  + S   GT  Y+APE++ +   
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKE-- 171

Query: 370 TVSCKSDVYGFGMVLLEMAGG 390
                 D +  G VL EM  G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 41/137 (29%), Positives = 67/137 (48%), Gaps = 11/137 (8%)

Query: 259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKP 318
           ALV ++   G L + I  +    +TF   +   + +     V ++H+     ++H DIK 
Sbjct: 115 ALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKS 171

Query: 319 HNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR---GTIGYIAPELISRNFGTVSCKS 375
            NILL  N + K+ DFG +K +      VS    R   GT  Y+APE+  R     S K+
Sbjct: 172 ANILLCSNGLVKLGDFGFSKMYAAT---VSDDVGRTFCGTPYYVAPEIWRRK--PYSKKA 226

Query: 376 DVYGFGMVLLEMAGGRR 392
           D++  G++L E+   +R
Sbjct: 227 DMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 26/216 (12%)

Query: 191 HFTHKLGQGGFG---SVYKGQLHTGRLIAVKMLEN---SKFSAEEFINEVSTIGRIH--- 241
               +LGQG +G   S    +      +A+K + N    K  A+  + E+  +   H   
Sbjct: 3   ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLL--RHFRG 60

Query: 242 HVNVVQL--LGFCSEGSKRAL-VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR 298
           H N+  L  +     G+   L +YE +    L + I      GQ       Q        
Sbjct: 61  HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQII----RSGQPLTDAHFQSFIYQILC 116

Query: 299 GVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FH--PKENDFVSISATRGT 355
           G+ Y+H+     +LH D+KP N+L++ +   K+ DFGLA+ F   P EN    ++    T
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENA-GFMTEYVAT 172

Query: 356 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
             Y APE I  +F + +   DV+  G +L E+ G +
Sbjct: 173 RWYRAPE-IMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 50/198 (25%), Positives = 93/198 (46%), Gaps = 27/198 (13%)

Query: 200 GFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC-SEGSKR 258
           G  S  +G+    RLIA K ++    +A +  NE+  +GR++H N++++     SE +  
Sbjct: 181 GVNSTNQGKPKCERLIA-KRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTY 239

Query: 259 AL-------VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
            +       +Y FM + + D        K +    +  + I       V Y+H   D  +
Sbjct: 240 MITQKYDFDLYSFMYDEAFDW-------KDRPLLKQT-RAIMKQLLCAVEYIH---DKKL 288

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS-ATRGTIGYIAPELISRNFGT 370
           +H DIK  NI L+ +    + DFG A   P E +  +      GT+   +PE+++ +   
Sbjct: 289 IHRDIKLENIFLNCDGKIVLGDFGTAM--PFEKEREAFDYGWVGTVATNSPEILAGD--- 343

Query: 371 VSCK-SDVYGFGMVLLEM 387
             C+ +D++  G++LL+M
Sbjct: 344 GYCEITDIWSCGLILLDM 361

Length = 501

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 54/280 (19%), Positives = 109/280 (38%), Gaps = 57/280 (20%)

Query: 203 SVYKGQLHTGRLIAVKMLE----NSKFSAEEFINEVSTIGRIHHVNVVQLLGF----CSE 254
           S+YKG  +  + + ++  +      K   +   NE+  + RI   N++++ GF      +
Sbjct: 35  SIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
             + +L+ E+   G L R +  KE   +   ++   ++A+   +G+  L+         +
Sbjct: 94  LPRLSLILEYCTRGYL-REVLDKE---KDLSFKTKLDMAIDCCKGLYNLYK--------Y 141

Query: 315 DIKPH------NILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             KP+      + L+  N+  K+   GL K                 + Y + ++++  F
Sbjct: 142 TNKPYKNLTSVSFLVTENYKLKIICHGLEKILS-----SPPFKNVNFMVYFSYKMLNDIF 196

Query: 369 GTVSCKSDVYGFGMVLLEMAGGR---RNSNMNAIRSSKAYFPSWVYDQL---NKGGDLEL 422
              + K D+Y  G+VL E+  G+    N     I           YD +   N    L L
Sbjct: 197 SEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI-----------YDLIINKNNSLKLPL 245

Query: 423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
               EI+ ++          C    +  RP++ ++L  L 
Sbjct: 246 DCPLEIKCIVEA--------CTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 36/133 (27%), Positives = 54/133 (40%), Gaps = 46/133 (34%)

Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGL---------AKF-----HPKEND 345
           +  +H    M  +H DIKP NIL+D +   K++DFGL         +K+     H +++ 
Sbjct: 114 IESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170

Query: 346 F------VSISATR---------------------GTIGYIAPELISRNFGTVSCKSDVY 378
                    I   R                     GT  YIAPE++ R   T  C  D +
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC--DWW 228

Query: 379 GFGMVLLEMAGGR 391
             G++L EM  G+
Sbjct: 229 SVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 45.4 bits (108), Expect = 4e-05
 Identities = 47/218 (21%), Positives = 83/218 (38%), Gaps = 44/218 (20%)

Query: 196 LGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFI---NEVSTIGRIHHVNVVQLLGFC 252
                   + K +  T  L+AVK +     S E+      E+ T  ++ H N++  +   
Sbjct: 10  FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68

Query: 253 SEGSKRALVYEFMPNGS----LDRHIFPKENKGQTFGWEKLQEIAL-----GTARGVAYL 303
              S+  +V   M  GS    L  H FP          E L E+A+          + Y+
Sbjct: 69  IVDSELYVVSPLMAYGSCEDLLKTH-FP----------EGLPELAIAFILKDVLNALDYI 117

Query: 304 HNGCDMCILHFDIKPHNILLD----------HNFIPKVS-DFGLAKFHPKENDFVSISAT 352
           H+      +H  +K  +ILL              +  +         H    DF   S+ 
Sbjct: 118 HS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH----DF-PKSSV 169

Query: 353 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           +  + +++PE++ +N    + KSD+Y  G+   E+A G
Sbjct: 170 K-NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 29/219 (13%)

Query: 189 TNHFTHKLGQGGFGSVYK-GQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIH-HVNVV 246
           T      +G+G +G V+K      G   AVK+L+      EE   E + +  +  H NVV
Sbjct: 19  TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVV 78

Query: 247 QLLGF-----CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVA 301
           +  G         G +  LV E    GS+   +     +G+      +  I      G+ 
Sbjct: 79  KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ 138

Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-------G 354
           +LH       +H D+K +NILL      K+ DFG++           +++TR       G
Sbjct: 139 HLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVS---------AQLTSTRLRRNTSVG 186

Query: 355 TIGYIAPELIS---RNFGTVSCKSDVYGFGMVLLEMAGG 390
           T  ++APE+I+   +   T   + DV+  G+  +E+  G
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 45.0 bits (106), Expect = 6e-05
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 10/95 (10%)

Query: 196 LGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 246
           LG+G FG V +       +  T R +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 15  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74

Query: 247 QLLGFCSE-GSKRALVYEFMPNGSLDRHIFPKENK 280
            LLG C++ G    ++ EF   G+L  ++  K  +
Sbjct: 75  NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGE 109

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 44.1 bits (104), Expect = 9e-05
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 27/207 (13%)

Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 249
           LG+G FG V   +L  T  + A+K+L+      ++ ++   T  RI      H  +  L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL- 61

Query: 250 GFCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH-NG 306
             C   +K  L  V E++  G L   I     + + F   + +  A      + +LH +G
Sbjct: 62  -HCCFQTKDRLFFVMEYVNGGDLMFQI----QRSRKFDEPRSRFYAAEVTLALMFLHRHG 116

Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR--GTIGYIAPELI 364
               +++ D+K  NILLD     K++DFG+     KE     ++ T   GT  YIAPE++
Sbjct: 117 ----VIYRDLKLDNILLDAEGHCKLADFGMC----KEGILNGVTTTTFCGTPDYIAPEIL 168

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGGR 391
                  S   D +  G+++ EM  G+
Sbjct: 169 QELEYGPSV--DWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 25/76 (32%), Positives = 46/76 (60%), Gaps = 2/76 (2%)

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           +H D+   N+L+    + K+ DFGLA+   ++++++S  +T   + ++APE I  N  T 
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320

Query: 372 SCKSDVYGFGMVLLEM 387
              SDV+ FG++L E+
Sbjct: 321 L--SDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 58/244 (23%), Positives = 107/244 (43%), Gaps = 37/244 (15%)

Query: 195 KLGQGGFGSVYKGQLHTG---RLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG- 250
           K+G+G +G VYK +   G   R  A+K +E +  S      E++ +  + H NV+ L   
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA-CREIALLRELKHPNVISLQKV 66

Query: 251 FCSEGSKRA-LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR--------GVA 301
           F S   ++  L++++  +       F + +K      +K  ++  G  +        G+ 
Sbjct: 67  FLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN----KKPVQLPRGMVKSLLYQILDGIH 122

Query: 302 YLHNGCDMCILHFDIKPHNILL----DHNFIPKVSDFGLAK-FHPKENDFVSISATRGTI 356
           YLH      +LH D+KP NIL+          K++D G A+ F+        +     T 
Sbjct: 123 YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 357 GYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGRR--NSNMNAIRSSKAYFPSWVYD 412
            Y APEL+  +R++   +   D++  G +  E+       +     I++S  Y     +D
Sbjct: 180 WYRAPELLLGARHY---TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH----HD 232

Query: 413 QLNK 416
           QL++
Sbjct: 233 QLDR 236

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 51/209 (24%), Positives = 93/209 (44%), Gaps = 23/209 (11%)

Query: 195 KLGQGGFGSVYKGQLHTG---RLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG- 250
           K+G+G +G VYK +   G   +  A+K +E +  S      E++ +  + H NV+ L   
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA-CREIALLRELKHPNVIALQKV 66

Query: 251 FCSEGSKRA-LVYEFMPNG---SLDRHIFPKENKG-QTFGWEKLQEIALGTARGVAYLHN 305
           F S   ++  L++++  +     +  H   K NK         ++ +      G+ YLH 
Sbjct: 67  FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126

Query: 306 GCDMCILHFDIKPHNILL----DHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIA 360
                +LH D+KP NIL+          K++D G A+ F+        +     T  Y A
Sbjct: 127 N---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 361 PELI--SRNFGTVSCKSDVYGFGMVLLEM 387
           PEL+  +R++   +   D++  G +  E+
Sbjct: 184 PELLLGARHY---TKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 20/150 (13%)

Query: 256 SKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFD 315
           S+  LV E++  G L  H+     + +    E  +  A      + +LH   +  I++ D
Sbjct: 69  SRLFLVIEYVNGGDLMFHM----QRQRKLPEEHARFYAAEICIALNFLH---ERGIIYRD 121

Query: 316 IKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCK 374
           +K  N+LLD +   K++D+G+ K      D  + S   GT  YIAPE++    +G     
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGF---S 176

Query: 375 SDVYGFGMVLLEMAGGRR-------NSNMN 397
            D +  G+++ EM  GR        N +MN
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIITDNPDMN 206

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 27/82 (32%), Positives = 42/82 (51%), Gaps = 4/82 (4%)

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR---NF 368
           +H DIKP N+LLD N   +++DFG +     ++  V  S   GT  YI+PE++       
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182

Query: 369 GTVSCKSDVYGFGMVLLEMAGG 390
           G    + D +  G+ + EM  G
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 39/221 (17%)

Query: 196 LGQGGFGSVYKGQLHTGR------LIAVKMLENSKFSAEEF-------INEVSTIGRIH- 241
           +G GGFG VY+ Q  +        +  ++ LEN     E         I++++    IH 
Sbjct: 20  IGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHN 79

Query: 242 --HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEK------LQEIA 293
             H+ + +  G C    +  + Y F+    L++ +   EN  + F   K      ++ I 
Sbjct: 80  IDHLGIPKYYG-CGSFKRCRMYYRFI---LLEKLV---ENTKEIFKRIKCKNKKLIKNIM 132

Query: 294 LGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF---HPKENDFVSIS 350
                 + Y+H   +  I H DIKP NI++D N    + D+G+A     H K  ++    
Sbjct: 133 KDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQ 189

Query: 351 AT--RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG 389
               RGT+ Y    L + N   V+ + D+   G  +L+ AG
Sbjct: 190 KDLHRGTLYYAG--LDAHNGACVTRRGDLESLGYCMLKWAG 228

Length = 294

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 41.2 bits (96), Expect = 8e-04
 Identities = 28/82 (34%), Positives = 42/82 (51%), Gaps = 4/82 (4%)

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR---NF 368
           +H DIKP NIL+D N   +++DFG +     E+  V  S   GT  YI+PE++       
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182

Query: 369 GTVSCKSDVYGFGMVLLEMAGG 390
           G    + D +  G+ + EM  G
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 41.8 bits (98), Expect = 9e-04
 Identities = 39/148 (26%), Positives = 69/148 (46%), Gaps = 16/148 (10%)

Query: 198 QGGFGSVYKGQL-HTGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           +G FG VY G+  +  +L AVK+++ +    K    +   E   +       +V L    
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73

Query: 253 SEGSKRALVYEFMPNGSLDR--HIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
              +   LV E++  G +    HI+   ++     +  + E+AL     + YLH      
Sbjct: 74  QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY--ISEVALA----LDYLHR---HG 124

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAK 338
           I+H D+KP N+L+ +    K++DFGL+K
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 48/160 (30%), Positives = 73/160 (45%), Gaps = 22/160 (13%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSK-FSAEEFIN---EVSTIGRIHHVNVVQLLG 250
           +G+G FG V   Q   TG++ A+K L  S+ F  ++  +   E   +       VV L  
Sbjct: 9   IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYY 68

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWE----KLQEIALGTARGVAYLHNG 306
              +     L+ EF+P G L   +     K  TF  +     + E  L     +  +H  
Sbjct: 69  SFQDAQYLYLIMEFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLA----IEAVHK- 119

Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKEND 345
             +  +H DIKP NIL+D     K+SDFGL+  FH K++D
Sbjct: 120 --LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH-KQHD 156

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 26/88 (29%), Positives = 42/88 (47%), Gaps = 9/88 (10%)

Query: 192 FTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSKFSAEE--FINEVSTIGRI-HH 242
           F   LG G FG V +   +          +AVKML+ S    E    ++E+  +  + +H
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98

Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSL 270
           +N+V LLG C+ G    ++ E+   G L
Sbjct: 99  INIVNLLGACTVGGPTLVITEYCCYGDL 126

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 28/95 (29%), Positives = 50/95 (52%), Gaps = 15/95 (15%)

Query: 196 LGQGGFGSVYKGQLH------TGRLIAVKMLENSKFSAEE--FINEVSTIGRIH-HVNVV 246
           LG G FG V +   H      +   +AVKML+++  S+E+   ++E+  +  +  H+N+V
Sbjct: 45  LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104

Query: 247 QLLGFCSEGSKRALVYEFMPNGSL------DRHIF 275
            LLG C++G    ++ E+   G L      ++H F
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTF 139

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 40.5 bits (95), Expect = 0.002
 Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 10/94 (10%)

Query: 299 GVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 358
           G+ +LH+     I+H D+KP NI++  +   K+ DFGLA+          ++    T  Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 183

Query: 359 IAPELISRNFGT-VSCKSDVYGFGMVLLEMAGGR 391
            APE+I    G       D++  G ++ EM  G 
Sbjct: 184 RAPEVI---LGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 38.5 bits (90), Expect = 0.002
 Identities = 31/157 (19%), Positives = 58/157 (36%), Gaps = 15/157 (9%)

Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVV--QLLGFC 252
            L  G    VY         + +K+  + +  A+    EV+ +  +    +   ++L   
Sbjct: 5   LLKGGLTNRVYLLGTKDEDYV-LKINPSREKGAD-REREVAILQLLARKGLPVPKVLASG 62

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
                  L+ E++   +LD        +      E + E  L     +A LH    + + 
Sbjct: 63  ESDGWSYLLMEWIEGETLD--------EVSEEEKEDIAEQ-LAEL--LAKLHQLPLLVLC 111

Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 349
           H D+ P NIL+D   I  + D+  A + P   D  + 
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYGPPAFDLAAA 148

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 40.1 bits (94), Expect = 0.002
 Identities = 51/220 (23%), Positives = 93/220 (42%), Gaps = 40/220 (18%)

Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE-NSKFSAEEFINEVSTIGRIHHVNVVQL----- 248
           LG G  G V+        + +AVK +      S +  + E+  I R+ H N+V++     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 249 ---------LGFCSEGSKRALVYEFMPN--GSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
                    +G  +E +   +V E+M     ++       E   + F ++ L        
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLL-------- 124

Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLD-HNFIPKVSDFGLAKF---HPKENDFVSISATR 353
           RG+ Y+H+     +LH D+KP N+ ++  + + K+ DFGLA+    H     ++S     
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV- 180

Query: 354 GTIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 391
            T  Y +P L+    N+       D++  G +  EM  G+
Sbjct: 181 -TKWYRSPRLLLSPNNYTKA---IDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 34/105 (32%), Positives = 48/105 (45%), Gaps = 20/105 (19%)

Query: 296 TARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF-----------HPKEN 344
           T   + YLHN     I+H D+KP N+L+      K++DFGL+K               E 
Sbjct: 110 TVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166

Query: 345 DFVSISATR--GTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLE 386
           D       +  GT  YIAPE+I R  +G      D +  G++L E
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGK---PVDWWAMGIILYE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	511
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.98
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.98
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.98
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.79
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.78
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.77
PRK10345	210	hypothetical protein; Provisional	99.76
smart00090	237	RIO RIO-like kinase.	99.76
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.7
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.69
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.68
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.66
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.66
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.6
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.58
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.55
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.44
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.44
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.35
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.34
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.25
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.23
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.17
KOG1243	690	consensus Protein kinase [General function predict	99.08
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.04
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.99
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.96
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.88
KOG3087	229	consensus Serine/threonine protein kinase [General	98.88
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.78
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.74
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.71
COG4248	637	Uncharacterized protein with protein kinase and he	98.61
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.52
PF14380	94	WAK_assoc: Wall-associated receptor kinase C-termi	98.52
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.49
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.43
PRK09902	216	hypothetical protein; Provisional	98.36
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.33
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.28
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.19
PF01636	239	APH: Phosphotransferase enzyme family This family	98.14
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.05
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.05
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.02
PRK10593	297	hypothetical protein; Provisional	97.93
PLN02876	822	acyl-CoA dehydrogenase	97.92
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.87
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.83
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.68
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.68
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.65
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.59
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.46
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.38
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.36
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.31
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.29
PRK05231	319	homoserine kinase; Provisional	97.21
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.02
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.75
COG2334	331	Putative homoserine kinase type II (protein kinase	96.56
PLN02236	344	choline kinase	96.43
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.4
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.33
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.29
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.25
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.21
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.03
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.01
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.99
PRK11768	325	serine/threonine protein kinase; Provisional	95.83
KOG2270	520	consensus Serine/threonine protein kinase involved	95.78
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.66
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.31
PLN02756	418	S-methyl-5-thioribose kinase	95.29
PRK06148	1013	hypothetical protein; Provisional	95.29
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	94.13
KOG1093	725	consensus Predicted protein kinase (contains TBC a	94.04
PTZ00384	383	choline kinase; Provisional	93.75
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	93.54
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	93.47

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-56  Score=458.87  Aligned_cols=283  Identities=43%  Similarity=0.776  Sum_probs=240.6

Q ss_pred             CCCCCChHHHHHHHhhhc--cccCcCCcEEEEEEEecCCcEEEEEEeccCccc-HHHHHHHHHHhccccccceEEeecee
Q 010434          176 MPKRYSYPEIIAVTNHFT--HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFC  252 (511)
Q Consensus       176 ~~~~~~~~ei~~~t~~~~--~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~-~~~f~~Ev~~l~~l~H~niv~l~g~~  252 (511)
                      ..+.|++.||..+|++|.  +.||+||||.||+|.+++|+.||||.+...... ..+|.+|+.++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            457799999999999998  589999999999999999999999988775544 66799999999999999999999999


Q ss_pred             ccCC-ceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeee
Q 010434          253 SEGS-KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKV  331 (511)
Q Consensus       253 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl  331 (511)
                      .+++ .++||||||++|+|.++++.....  +++|.++++||.++|+||+|||..+..+|+||||||+|||||+++++||
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            9998 499999999999999999765433  8999999999999999999999998889999999999999999999999


Q ss_pred             ecccccccCCC-CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhh
Q 010434          332 SDFGLAKFHPK-ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWV  410 (511)
Q Consensus       332 ~DFGla~~~~~-~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~  410 (511)
                      +|||+|+..+. ..... ... .||.+|+|||++..  |..|.|+|||||||+|+||+||+++.+... ......+..|.
T Consensus       219 sDFGLa~~~~~~~~~~~-~~~-~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w~  293 (361)
T KOG1187|consen  219 SDFGLAKLGPEGDTSVS-TTV-MGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEWA  293 (361)
T ss_pred             cCccCcccCCcccccee-eec-CCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCC-CcccccHHHHH
Confidence            99999987665 32211 111 79999999999975  589999999999999999999999887654 22234478888


Q ss_pred             HHhhhcCCcccccccc----hhHH-HHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          411 YDQLNKGGDLELRNVT----EIES-VIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       411 ~~~~~~~~~~~~~~~~----~~~~-~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                      ...+.++...++.++.    +... ....++..++.+|++.+|.+||+|.+|+++|+...
T Consensus       294 ~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  294 KPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            7777776444443322    2222 45677999999999999999999999999996644

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-49  Score=403.74  Aligned_cols=260  Identities=29%  Similarity=0.497  Sum_probs=226.4

Q ss_pred             HHHHHHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       184 ei~~~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      ++......+.++||+|-||.||.|.+++...||+|.++......++|.+|+.+|++|+|+|||+++|+|+.+...+||||
T Consensus       202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE  281 (468)
T KOG0197|consen  202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE  281 (468)
T ss_pred             eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence            44555566788999999999999999988899999999888888999999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      ||++|+|.++|..  ..+..+...+++.++.|||+||+||++   +++|||||.++|||++++..+||+|||||+.. .+
T Consensus       282 ~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-~d  355 (468)
T KOG0197|consen  282 YMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLI-GD  355 (468)
T ss_pred             ecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEccccccccc-CC
Confidence            9999999999932  456789999999999999999999999   79999999999999999999999999999944 44


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                      +.+.......-++.|.|||.+..  +.+|.|||||||||+||||+| |+.|+......+        +.+.+.++.++.-
T Consensus       356 ~~Y~~~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e--------v~~~le~GyRlp~  425 (468)
T KOG0197|consen  356 DEYTASEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE--------VLELLERGYRLPR  425 (468)
T ss_pred             CceeecCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCHHH--------HHHHHhccCcCCC
Confidence            44555566778999999999975  489999999999999999998 777766544332        5667777776653


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                            +..++..+.+|+..||+.+|++|||+..+...|+...
T Consensus       426 ------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  426 ------PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             ------CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence                  3346778999999999999999999999998888643

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-48  Score=393.66  Aligned_cols=259  Identities=31%  Similarity=0.494  Sum_probs=213.8

Q ss_pred             hhccccCcCCcEEEEEEEecCCcEEEEEEeccCccc---HHHHHHHHHHhccccccceEEeeceeccCC-ceeEEEeecC
Q 010434          191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGS-KRALVYEFMP  266 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~---~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~~~  266 (511)
                      .+.+.||+|+||+||+|.+++...||||++.....+   .++|.+|+.++.+++|||||+++|+|.+.. ..++|||||+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            345669999999999999985555999999774433   458999999999999999999999999987 7999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCc-eecccCCcCceEEcCCC-CeeeecccccccCCCCC
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC-ILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-ivH~DIkp~NILl~~~~-~~kl~DFGla~~~~~~~  344 (511)
                      +|+|.++++..  ....+++..+++++.+||+||+|||+   .+ ||||||||+|||++.++ ++||+|||+++......
T Consensus       124 ~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  124 GGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            99999999643  45789999999999999999999999   46 99999999999999997 99999999998655432


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                        ...+...||+.|||||++.+....++.|+|||||||++|||+||+.||......       .-.+.....+.+..+. 
T Consensus       199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-------~~~~~v~~~~~Rp~~p-  268 (362)
T KOG0192|consen  199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-------QVASAVVVGGLRPPIP-  268 (362)
T ss_pred             --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcCCCCCCC-
Confidence              234557799999999999842237999999999999999999999999764321       1123333344443332 


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCC
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQ  469 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~  469 (511)
                           ..+.+.+..++.+||+.||+.||++.+++.+|+.......
T Consensus       269 -----~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  269 -----KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             -----ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence                 2256788899999999999999999999999997655433

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.6e-47  Score=371.20  Aligned_cols=257  Identities=25%  Similarity=0.359  Sum_probs=211.5

Q ss_pred             HHHHHHhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCcc--------cHHHHHHHHHHhccccccceEEeeceecc
Q 010434          184 EIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKF--------SAEEFINEVSTIGRIHHVNVVQLLGFCSE  254 (511)
Q Consensus       184 ei~~~t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~~--------~~~~f~~Ev~~l~~l~H~niv~l~g~~~~  254 (511)
                      +.....|-+.+.||+|+||.|-+|. -++|+.||||++++...        ......+|+++|++|+|||||++++++..
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~  247 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV  247 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence            3455566778999999999999997 56899999999976322        22335799999999999999999999999


Q ss_pred             CCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC---CCeee
Q 010434          255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN---FIPKV  331 (511)
Q Consensus       255 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~---~~~kl  331 (511)
                      ....||||||+.||+|.+.+.    .++.+.+..-..++.|++.|+.|||+   +||+||||||+|||+..+   ..+||
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKI  320 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKI  320 (475)
T ss_pred             CCceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEe
Confidence            999999999999999999884    34567777778899999999999999   799999999999999766   88999


Q ss_pred             ecccccccCCCCCCceeeccccCCccccchhcccccCCC-cCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhh
Q 010434          332 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWV  410 (511)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~-~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~  410 (511)
                      +|||+|+.....   .-+...+||+.|.|||++...... +..|.|+||+||+||-+++|.+||.....       +.-+
T Consensus       321 tDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~-------~~sl  390 (475)
T KOG0615|consen  321 TDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT-------DPSL  390 (475)
T ss_pred             cccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC-------CccH
Confidence            999999987633   245778899999999999764223 33489999999999999999999975432       2224


Q ss_pred             HHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          411 YDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       411 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      .+++.++....   .+..+..++.+..+++.|||..||++|||+.|+++.
T Consensus       391 ~eQI~~G~y~f---~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  391 KEQILKGRYAF---GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             HHHHhcCcccc---cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            55555554332   223677788999999999999999999999999864

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-46  Score=361.66  Aligned_cols=252  Identities=25%  Similarity=0.385  Sum_probs=208.3

Q ss_pred             CChHHHHHHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEecc--CcccHHHHHHHHHHhccccccceEEeeceeccCC
Q 010434          180 YSYPEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS  256 (511)
Q Consensus       180 ~~~~ei~~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~  256 (511)
                      .+..|++.     .+.||+|..|+|||+.++ +++.+|+|++..  +....++..+|++++.+.+|||||+++|.|....
T Consensus        76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~  150 (364)
T KOG0581|consen   76 ISLSDLER-----LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG  150 (364)
T ss_pred             cCHHHhhh-----hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence            45555543     568999999999999864 789999999944  4445678999999999999999999999998888


Q ss_pred             c-eeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccc
Q 010434          257 K-RALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFG  335 (511)
Q Consensus       257 ~-~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFG  335 (511)
                      . ..|+||||.+|||++++    ...+++++..+-+|+.+|++||.|||..  ++|+||||||+|||++++|++||+|||
T Consensus       151 ~~isI~mEYMDgGSLd~~~----k~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFG  224 (364)
T KOG0581|consen  151 EEISICMEYMDGGSLDDIL----KRVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFG  224 (364)
T ss_pred             ceEEeehhhcCCCCHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecccc
Confidence            4 99999999999999988    2336799999999999999999999963  899999999999999999999999999


Q ss_pred             ccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchh--hHHh
Q 010434          336 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW--VYDQ  413 (511)
Q Consensus       336 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~--~~~~  413 (511)
                      .++.....    ......||..|||||.+.++  .|+.++||||||+.++|+++|+-|+....     .....|  +...
T Consensus       225 VS~~lvnS----~a~tfvGT~~YMsPERi~g~--~Ys~~sDIWSLGLsllE~a~GrfP~~~~~-----~~~~~~~~Ll~~  293 (364)
T KOG0581|consen  225 VSGILVNS----IANTFVGTSAYMSPERISGE--SYSVKSDIWSLGLSLLELAIGRFPYPPPN-----PPYLDIFELLCA  293 (364)
T ss_pred             ccHHhhhh----hcccccccccccChhhhcCC--cCCcccceecccHHHHHHhhCCCCCCCcC-----CCCCCHHHHHHH
Confidence            99865443    23556799999999999986  89999999999999999999999987641     111222  2223


Q ss_pred             hhcCCcccccccchhHH-HHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          414 LNKGGDLELRNVTEIES-VIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       414 ~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      +..+....      .+. .++++++.++..||+.||.+|||++|+++
T Consensus       294 Iv~~ppP~------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  294 IVDEPPPR------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             HhcCCCCC------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            32222222      222 47889999999999999999999999986

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-45  Score=379.12  Aligned_cols=246  Identities=25%  Similarity=0.418  Sum_probs=213.9

Q ss_pred             HHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEecc----CcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLEN----SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~----~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      .+|...+.||+|||+.||.++. .+|..||+|++.+    .....+...+||++.+.|+|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            3555668899999999999995 8999999999976    4446678999999999999999999999999999999999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      |+|++++|..++    +..+++++..++.+..||+.||.|||+   .+|+|||||..|+||+++.++||+|||||.....
T Consensus        98 ELC~~~sL~el~----Krrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELL----KRRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHH----HhcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecC
Confidence            999999999987    356789999999999999999999999   6999999999999999999999999999998775


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                      +...  ....+|||.|+|||++.+.  ..+..+||||+||++|-|+.|++||+.....+        .+..+......  
T Consensus       171 ~~Er--k~TlCGTPNYIAPEVl~k~--gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke--------ty~~Ik~~~Y~--  236 (592)
T KOG0575|consen  171 DGER--KKTLCGTPNYIAPEVLNKS--GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE--------TYNKIKLNEYS--  236 (592)
T ss_pred             cccc--cceecCCCcccChhHhccC--CCCCchhhhhhhhHHHhhhhCCCCcccchHHH--------HHHHHHhcCcc--
Confidence            5432  2556899999999999876  77899999999999999999999998765443        45555443221  


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                           .+..++....+|+..+|+.||.+|||+++|+.
T Consensus       237 -----~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  237 -----MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             -----cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                 33356677889999999999999999999986

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-46  Score=349.18  Aligned_cols=262  Identities=26%  Similarity=0.405  Sum_probs=216.5

Q ss_pred             HHhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeec-eeccCCc-eeEE
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLG-FCSEGSK-RALV  261 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g-~~~~~~~-~~lV  261 (511)
                      +.+.+.++||.|.||+|||+. +.+|..+|.|.++-.   ....++...|+.+|++|+|||||++++ -+.++.. ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            446677899999999999997 779999999998753   335578999999999999999999998 4555555 8999


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCC-CceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD-MCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~-~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      ||++..|+|...|...+..++.+++..+++++.|+++||..+|...+ .-|+||||||.||+|+.+|.+||+||||++++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            99999999999986666677889999999999999999999998332 24999999999999999999999999999988


Q ss_pred             CCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcc
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDL  420 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (511)
                      .....+  ....+|||.||+||.+..+  .++.||||||+||++|||+.-+.||......+        +...+.++...
T Consensus       179 ~s~~tf--A~S~VGTPyYMSPE~i~~~--~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~--------L~~KI~qgd~~  246 (375)
T KOG0591|consen  179 SSKTTF--AHSLVGTPYYMSPERIHES--GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS--------LCKKIEQGDYP  246 (375)
T ss_pred             cchhHH--HHhhcCCCcccCHHHHhcC--CCCcchhHHHHHHHHHHHHhcCCCcccccHHH--------HHHHHHcCCCC
Confidence            766543  2556799999999999887  89999999999999999999999997653211        33445555322


Q ss_pred             cccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          421 ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       421 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      .+     ..+-++..+..++..|+..||+.||+...+++.+...++
T Consensus       247 ~~-----p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~l~  287 (375)
T KOG0591|consen  247 PL-----PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSELD  287 (375)
T ss_pred             CC-----cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHHhc
Confidence            22     235678899999999999999999996666666655443

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.7e-45  Score=388.48  Aligned_cols=260  Identities=27%  Similarity=0.458  Sum_probs=218.8

Q ss_pred             HHhhhccccCcCCcEEEEEEEec------CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCcee
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  259 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~  259 (511)
                      .--.+.++||+|.||.||+|+..      +.+.||||.|+...  ...++|.+|+++++.++|||||+|+|.|.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            33346789999999999999743      34689999998743  35689999999999999999999999999999999


Q ss_pred             EEEeecCCCCcccccccCCC------c----CCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCe
Q 010434          260 LVYEFMPNGSLDRHIFPKEN------K----GQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIP  329 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~  329 (511)
                      +|+|||..|+|.++|.....      .    ..+|+..+.+.||.|||.||+||-+   +.+|||||..+|+|+.++..+
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEE
Confidence            99999999999998853321      1    2348999999999999999999998   699999999999999999999


Q ss_pred             eeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccch
Q 010434          330 KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPS  408 (511)
Q Consensus       330 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~  408 (511)
                      ||+||||+|.....+.+.......-+++|||||.+.  ++.+|++||||||||+|||+++ |+.|+......+       
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl--y~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------  713 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL--YGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------  713 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhh--cCcccchhhhhhhhhhhhhhhccccCcccccchHH-------
Confidence            999999999777666655444556789999999986  4699999999999999999998 888876544332       


Q ss_pred             hhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          409 WVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       409 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                       +.+.+.++..+.      .++.++.++..|+..||+.+|++||+++||-..|+....
T Consensus       714 -VIe~i~~g~lL~------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  714 -VIECIRAGQLLS------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             -HHHHHHcCCccc------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence             556666665533      445567889999999999999999999999999987544

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-45  Score=383.89  Aligned_cols=260  Identities=27%  Similarity=0.449  Sum_probs=216.0

Q ss_pred             HHHHHHhhhccccCcCCcEEEEEEEecC----CcEEEEEEecc--CcccHHHHHHHHHHhccccccceEEeeceeccCCc
Q 010434          184 EIIAVTNHFTHKLGQGGFGSVYKGQLHT----GRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  257 (511)
Q Consensus       184 ei~~~t~~~~~~LG~G~fg~Vykg~~~~----g~~vAvK~l~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~  257 (511)
                      ||....-.+.+.||.|.||.|++|.++.    ...||||.|+.  .+....+|+.|+.||++.+||||++|.|+.+....
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P  704 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP  704 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence            3344444455789999999999998652    35799999987  34456789999999999999999999999999999


Q ss_pred             eeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccc
Q 010434          258 RALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLA  337 (511)
Q Consensus       258 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla  337 (511)
                      ..||.|||+||+|+.+|..   +.+.+++.++..++.+||.||.||-.   +++|||||.++|||++.|..+||+||||+
T Consensus       705 vMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccce
Confidence            9999999999999999833   33569999999999999999999997   89999999999999999999999999999


Q ss_pred             ccCCCCCC-ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhh
Q 010434          338 KFHPKEND-FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLN  415 (511)
Q Consensus       338 ~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  415 (511)
                      +....+.. ..++..-..+++|.|||.+.-  ..+|.+|||||||+++||.++ |.+|+.....++        +.+.++
T Consensus       779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd--------VIkaIe  848 (996)
T KOG0196|consen  779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------VIKAIE  848 (996)
T ss_pred             eecccCCCccccccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccchHH--------HHHHHH
Confidence            98765542 223333446789999999863  589999999999999999776 888887654332        455566


Q ss_pred             cCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                      ++.++.      .+.+++..|.+|+++|||+|-.+||.+.+|+.+|+...
T Consensus       849 ~gyRLP------pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI  892 (996)
T KOG0196|consen  849 QGYRLP------PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI  892 (996)
T ss_pred             hccCCC------CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence            665544      23346778999999999999999999999999998754

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=347.68  Aligned_cols=244  Identities=25%  Similarity=0.423  Sum_probs=197.2

Q ss_pred             hhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          191 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .+.++||.|+||+||+|+++ ++..||||.+....   ...+-...|+.+|+.++|||||++++++..++..+||||||.
T Consensus        13 ~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~   92 (429)
T KOG0595|consen   13 ELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCN   92 (429)
T ss_pred             eehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCC
Confidence            34567999999999999854 68999999986643   345668899999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC------CCeeeecccccccC
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN------FIPKVSDFGLAKFH  340 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~------~~~kl~DFGla~~~  340 (511)
                      +|+|.++|.    ..+.+++...+.++.|||.||++||+   .+||||||||.||||+.+      -.+||+|||+|+.+
T Consensus        93 gGDLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   93 GGDLSDYIR----RRGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            999999993    34589999999999999999999999   699999999999999765      56899999999987


Q ss_pred             CCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcc
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDL  420 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (511)
                      ....   -....+|++-|||||++..+  .|+.|+|+||.|+++|+|++|+.||+.....+        +...++++...
T Consensus       166 ~~~~---~a~tlcGSplYMAPEV~~~~--~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e--------L~~~~~k~~~~  232 (429)
T KOG0595|consen  166 QPGS---MAETLCGSPLYMAPEVIMSQ--QYDAKADLWSIGTILYQCLTGKPPFDAETPKE--------LLLYIKKGNEI  232 (429)
T ss_pred             Cchh---HHHHhhCCccccCHHHHHhc--cccchhhHHHHHHHHHHHHhCCCCccccCHHH--------HHHHHhccccc
Confidence            6433   23567899999999999754  89999999999999999999999998654332        22223333222


Q ss_pred             cccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHH
Q 010434          421 ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVL  458 (511)
Q Consensus       421 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl  458 (511)
                      .    ...+...+..+.++....++.+|.+|-+..+-.
T Consensus       233 ~----~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  233 V----PVLPAELSNPLRELLISLLQRNPKDRISFEDFF  266 (429)
T ss_pred             c----CchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence            1    123333444555677777788888887766554

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.5e-43  Score=355.73  Aligned_cols=262  Identities=27%  Similarity=0.434  Sum_probs=204.4

Q ss_pred             HHHhhhccccCcCCcEEEEEEEe------cCCcEEEEEEeccCc--ccHHHHHHHHHHhccc-cccceEEeeceeccC-C
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMLENSK--FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEG-S  256 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~------~~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~-~  256 (511)
                      ...+.+.++||+|+||.||+|..      .+++.||||+++...  ...+.+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            34567788999999999999963      235689999997532  2345789999999999 899999999988654 4


Q ss_pred             ceeEEEeecCCCCcccccccCCC---------------------------------------------------------
Q 010434          257 KRALVYEFMPNGSLDRHIFPKEN---------------------------------------------------------  279 (511)
Q Consensus       257 ~~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------  279 (511)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            67899999999999988743211                                                         


Q ss_pred             -cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeeccccCCccc
Q 010434          280 -KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY  358 (511)
Q Consensus       280 -~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  358 (511)
                       ...++++..+..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++...............++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence             02358899999999999999999998   69999999999999999999999999999865443333233344567899


Q ss_pred             cchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHHHHH
Q 010434          359 IAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLC  437 (511)
Q Consensus       359 ~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  437 (511)
                      +|||++.+.  .++.++||||||+++|||++ |+.||......       ......+..+.....      +...+..+.
T Consensus       243 ~aPE~~~~~--~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~------~~~~~~~l~  307 (338)
T cd05102         243 MAPESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-------EEFCQRLKDGTRMRA------PENATPEIY  307 (338)
T ss_pred             cCcHHhhcC--CCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-------HHHHHHHhcCCCCCC------CCCCCHHHH
Confidence            999998764  78999999999999999997 99998653221       112222333222211      123356788


Q ss_pred             HHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          438 MIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       438 ~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      +++.+||+.||++|||+.+++++|+....
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999997543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-43  Score=358.54  Aligned_cols=264  Identities=27%  Similarity=0.474  Sum_probs=214.6

Q ss_pred             HHHHHHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccCCceeE
Q 010434          184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  260 (511)
Q Consensus       184 ei~~~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  260 (511)
                      ||......+.+.||+|.||+||+|++.  ..||||+|+....   ..+.|.+||..+++-+|.||+-+.|+|.+... +|
T Consensus       388 eIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI  464 (678)
T KOG0193|consen  388 EIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI  464 (678)
T ss_pred             ccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence            444444456789999999999999987  4799999987433   45789999999999999999999999998877 99


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      |.-+|+|.+|..+++..+   ..|...+.+.||.|||+||.|||.   ++|||||||..||+|.+++.+||+||||+..-
T Consensus       465 iTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  465 ITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             eehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeee
Confidence            999999999999996554   678899999999999999999999   79999999999999999999999999999765


Q ss_pred             CCCCCceeeccccCCccccchhccccc-CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      .............|...|||||+++.+ ...+++.|||||||+++|||++|..|+.....+.        +.-++..+  
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq--------IifmVGrG--  608 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ--------IIFMVGRG--  608 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh--------eEEEeccc--
Confidence            544333344555688999999998643 3478999999999999999999999987332211        11111111  


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      .-..+........++.|.+|+..||..++++||.+.+|+.+|+....
T Consensus       609 ~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  609 YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            11222333555667889999999999999999999999999887554

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1e-42  Score=339.30  Aligned_cols=238  Identities=25%  Similarity=0.373  Sum_probs=201.4

Q ss_pred             hhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      ..+.+.||+|+||.||.++ .++++.+|+|++++..    ...+...+|..++.+++||.||++.-.|.+.+++|||+||
T Consensus        27 F~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~  106 (357)
T KOG0598|consen   27 FEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDY  106 (357)
T ss_pred             eeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEec
Confidence            3456899999999999997 5679999999998743    3456788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +.||.|..+|    ++.+.+++..+.-.+..|+.||.|||+   ++|+||||||+|||||++|.++|+||||++......
T Consensus       107 ~~GGeLf~hL----~~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  107 LNGGELFYHL----QREGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             cCCccHHHHH----HhcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence            9999999988    455789999999999999999999999   799999999999999999999999999998654443


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      .  .+...+||+.|||||++.+.  .++..+|+||+|+++|||++|.+||.......        +++.+.++....   
T Consensus       180 ~--~t~tfcGT~eYmAPEil~~~--gy~~~vDWWsLGillYeML~G~pPF~~~~~~~--------~~~~I~~~k~~~---  244 (357)
T KOG0598|consen  180 D--ATRTFCGTPEYMAPEILLGK--GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK--------MYDKILKGKLPL---  244 (357)
T ss_pred             C--ccccccCCccccChHHHhcC--CCCcccchHhHHHHHHHHhhCCCCCcCccHHH--------HHHHHhcCcCCC---
Confidence            2  23456899999999999886  89999999999999999999999998755332        334444433222   


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCC
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRP  452 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP  452 (511)
                         .+..++...++++...|+.||++|-
T Consensus       245 ---~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  245 ---PPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ---CCccCCHHHHHHHHHHhccCHHHhc
Confidence               2222456788899999999999995

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=381.17  Aligned_cols=267  Identities=27%  Similarity=0.467  Sum_probs=217.6

Q ss_pred             hHHHHHHHhhhccccCcCCcEEEEEEEec--CCc----EEEEEEecc--CcccHHHHHHHHHHhccccccceEEeeceec
Q 010434          182 YPEIIAVTNHFTHKLGQGGFGSVYKGQLH--TGR----LIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLLGFCS  253 (511)
Q Consensus       182 ~~ei~~~t~~~~~~LG~G~fg~Vykg~~~--~g~----~vAvK~l~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~  253 (511)
                      ++++....-.+.+.||+|.||.||.|...  +|.    .||||.+++  +.....+|.+|..+|+.++|||||+++|+|.
T Consensus       686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l  765 (1025)
T KOG1095|consen  686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL  765 (1025)
T ss_pred             cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence            33444555566788999999999999854  343    599999987  3556789999999999999999999999999


Q ss_pred             cCCceeEEEeecCCCCcccccccCCC---cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCee
Q 010434          254 EGSKRALVYEFMPNGSLDRHIFPKEN---KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPK  330 (511)
Q Consensus       254 ~~~~~~lV~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~k  330 (511)
                      +....++++|||++|+|..+|...+.   ....|+...++.++.|||+|+.||++   +++|||||.++|+||++...+|
T Consensus       766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VK  842 (1025)
T KOG1095|consen  766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVK  842 (1025)
T ss_pred             CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEE
Confidence            99999999999999999999943311   14578999999999999999999999   7999999999999999999999


Q ss_pred             eecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchh
Q 010434          331 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSW  409 (511)
Q Consensus       331 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~  409 (511)
                      |+|||||+...+.+.+.....+.-+.+|||||.+..  +.+|.|+|||||||++||++| |..|+.......        
T Consensus       843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--------  912 (1025)
T KOG1095|consen  843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--------  912 (1025)
T ss_pred             EcccchhHhhhhchheeccCccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHH--------
Confidence            999999996655555444444567889999999986  599999999999999999999 677775433221        


Q ss_pred             hHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          410 VYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       410 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                      +...+.++.+++      .+..++.++.+|+..||+.+|++||++..+++.++.....
T Consensus       913 v~~~~~~ggRL~------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  913 VLLDVLEGGRLD------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             HHHHHHhCCccC------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence            333334444433      3334567889999999999999999999999988765543

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-42  Score=337.72  Aligned_cols=255  Identities=30%  Similarity=0.373  Sum_probs=201.5

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC-cccHHHHHHHHHHhccccccceEEeeceeccCC--ceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS--KRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~--~~~lV~e~~  265 (511)
                      ....+.||+|+||+||++... +|...|||.+... ....+.+.+|+.+|.+++|||||+.+|......  ..++.|||+
T Consensus        19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~   98 (313)
T KOG0198|consen   19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA   98 (313)
T ss_pred             hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence            344678999999999999854 5999999998663 222567899999999999999999999854444  688999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC-CCCeeeecccccccCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~-~~~~kl~DFGla~~~~~~~  344 (511)
                      ++|+|.+++.   ..+..|++..+.....||++||+|||+   ++|+|+||||+|||++. ++.+||+|||+++......
T Consensus        99 ~~GsL~~~~~---~~g~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   99 PGGSLSDLIK---RYGGKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             CCCcHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999983   222379999999999999999999998   79999999999999999 7999999999998665311


Q ss_pred             C-ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          345 D-FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       345 ~-~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      . .......+||+.|||||++... .....++|||||||++.||+||++||...      .....++.........    
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~~~~----  241 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGREDSL----  241 (313)
T ss_pred             ccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhccCCC----
Confidence            1 1122346799999999999851 13335999999999999999999998653      1112223332222211    


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                        +..+..++....+++..|++.+|+.|||++++++..--
T Consensus       242 --P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  242 --PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             --CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence              13455577889999999999999999999999986543

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-42  Score=352.48  Aligned_cols=253  Identities=29%  Similarity=0.455  Sum_probs=205.6

Q ss_pred             hccccCcCCcEEEEEEEec--CC---cEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          192 FTHKLGQGGFGSVYKGQLH--TG---RLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       192 ~~~~LG~G~fg~Vykg~~~--~g---~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      +.++||+|+||.||+|++.  ++   ..||||..+.+    .....+|++|+++++.++|||||+++|++......++||
T Consensus       161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm  240 (474)
T KOG0194|consen  161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM  240 (474)
T ss_pred             ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence            4589999999999999854  23   23899998752    335678999999999999999999999999999999999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      |+|+||+|.++|.   ..+..++..++..++.+.|.||+|||+   ++++||||.++|+|++.++.+||+||||++... 
T Consensus       241 El~~gGsL~~~L~---k~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~-  313 (474)
T KOG0194|consen  241 ELCNGGSLDDYLK---KNKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS-  313 (474)
T ss_pred             EecCCCcHHHHHH---hCCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCc-
Confidence            9999999999993   233479999999999999999999999   799999999999999999999999999987554 


Q ss_pred             CCCceeec-cccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhh-hcCCc
Q 010434          343 ENDFVSIS-ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQL-NKGGD  419 (511)
Q Consensus       343 ~~~~~~~~-~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~  419 (511)
                        .+.... ...-+..|+|||.+..  +.+|.++|||||||++||+.+ |..|+......        .+...+ .++.+
T Consensus       314 --~~~~~~~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------~v~~kI~~~~~r  381 (474)
T KOG0194|consen  314 --QYVMKKFLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------EVKAKIVKNGYR  381 (474)
T ss_pred             --ceeeccccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCCHH--------HHHHHHHhcCcc
Confidence              111112 3357889999999976  489999999999999999998 77787654322        123333 33333


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCC
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQ  469 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~  469 (511)
                      .....      ..+..+..++.+||+.+|++||||.++.+.|+.......
T Consensus       382 ~~~~~------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  382 MPIPS------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             CCCCC------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            33322      335667788889999999999999999999988665544

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=6.5e-41  Score=333.79  Aligned_cols=244  Identities=19%  Similarity=0.314  Sum_probs=198.4

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEEeccCccc----HHHHHHHHHHhccccccceEEeeceecc----CCceeEEEeec
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRALVYEFM  265 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~----~~~f~~Ev~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~  265 (511)
                      ..||+|++|.||+|.. +|+.||||+++.....    .+.|.+|+.++.+++|||||+++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            4699999999999998 5899999999764332    3678899999999999999999999866    35678999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++|+|.+++.    ....+++....+++.+++.||.|||+.  .+++||||||+|||+++++.+||+|||+++...... 
T Consensus       105 ~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        105 TRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            9999999983    235789999999999999999999973  478899999999999999999999999998654322 


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhh-hcCCcccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQL-NKGGDLELRN  424 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  424 (511)
                          ....++..|+|||.+.+....++.++|||||||++|||++|+.||......       . +...+ ........  
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-------~-~~~~i~~~~~~~~~--  243 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-------E-IYDLIINKNNSLKL--  243 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-------H-HHHHHHhcCCCCCC--
Confidence                234588999999999764457899999999999999999999999753221       1 22222 12222211  


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                          +...+..+.+++.+||+.||++|||++++++.|+.
T Consensus       244 ----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~  278 (283)
T PHA02988        244 ----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL  278 (283)
T ss_pred             ----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence                11245678899999999999999999999999975

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.1e-41  Score=338.12  Aligned_cols=263  Identities=24%  Similarity=0.372  Sum_probs=199.1

Q ss_pred             HHhhhccccCcCCcEEEEEEEecC-----------------CcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEe
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLHT-----------------GRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQL  248 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~~-----------------g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l  248 (511)
                      ..+.+.++||+|+||.||++..++                 +..||+|.+....  ....+|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            455677899999999999997532                 3479999987632  234579999999999999999999


Q ss_pred             eceeccCCceeEEEeecCCCCcccccccCC---------------CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceec
Q 010434          249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKE---------------NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILH  313 (511)
Q Consensus       249 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH  313 (511)
                      ++++.+....++||||+++|+|.+++....               .....+++..+.+++.||+.||+|||+   .+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence            999999999999999999999998874321               112357899999999999999999998   69999


Q ss_pred             ccCCcCceEEcCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhC--C
Q 010434          314 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG--R  391 (511)
Q Consensus       314 ~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg--~  391 (511)
                      |||||+|||+++++.+||+|||+++...............++..|+|||++...  .++.++||||||+++|||+++  .
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC--CCCchhhhHHHHHHHHHHHHccCC
Confidence            999999999999999999999999865443332223344568899999998654  789999999999999999975  4


Q ss_pred             CCCCcccccccccccchhhHHhhhcCC-cccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          392 RNSNMNAIRSSKAYFPSWVYDQLNKGG-DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       392 ~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      .|+.......    ....+........ .....    ....++..+.+++.+||+.+|++|||+.+|.+.|++
T Consensus       240 ~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         240 QPYGELTDEQ----VIENAGEFFRDQGRQVYLF----RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCCcCCHHH----HHHHHHHHhhhcccccccc----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            4554321111    0111111111110 00000    111234678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=7.7e-41  Score=346.58  Aligned_cols=258  Identities=26%  Similarity=0.452  Sum_probs=202.8

Q ss_pred             HhhhccccCcCCcEEEEEEEe------cCCcEEEEEEeccCc--ccHHHHHHHHHHhccc-cccceEEeeceeccCCcee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMLENSK--FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRA  259 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~------~~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~  259 (511)
                      .+.+.++||+|+||.||+++.      .++..||||+++...  ...+.+.+|+.++..+ +||||++++++|..+...+
T Consensus        36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~  115 (375)
T cd05104          36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL  115 (375)
T ss_pred             HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence            456678999999999999963      246689999997533  2345789999999999 8999999999999999999


Q ss_pred             EEEeecCCCCcccccccCCC------------------------------------------------------------
Q 010434          260 LVYEFMPNGSLDRHIFPKEN------------------------------------------------------------  279 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~------------------------------------------------------------  279 (511)
                      +||||+++|+|.+++.....                                                            
T Consensus       116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (375)
T cd05104         116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI  195 (375)
T ss_pred             eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence            99999999999888743210                                                            


Q ss_pred             -----------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          280 -----------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       280 -----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                                 ....+++..+.+++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..........
T Consensus       196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  272 (375)
T cd05104         196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV  272 (375)
T ss_pred             ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence                       12358899999999999999999998   6999999999999999999999999999986654433222


Q ss_pred             eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      .....++..|+|||.+.+.  .++.++||||||+++|||++ |..|+......       ....+.+..+......    
T Consensus       273 ~~~~~~~~~y~aPE~~~~~--~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~----  339 (375)
T cd05104         273 KGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-------SKFYKMIKEGYRMLSP----  339 (375)
T ss_pred             cCCCCCCcceeChhHhcCC--CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-------HHHHHHHHhCccCCCC----
Confidence            2334467789999998764  78999999999999999998 78787543211       1122222222211111    


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                        ...+.++.+++.+||+.||++|||+.+|+++|+..
T Consensus       340 --~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         340 --ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             --CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence              12245788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-41  Score=339.55  Aligned_cols=262  Identities=23%  Similarity=0.331  Sum_probs=204.7

Q ss_pred             HhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccC--CceeEEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVY  262 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~lV~  262 (511)
                      .+.-.++||+|.||.|||++ ..+|+.||+|++..+.   ....-..+||.+|++|+||||++|.+...+.  ...|||+
T Consensus       118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF  197 (560)
T KOG0600|consen  118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF  197 (560)
T ss_pred             HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence            34445799999999999998 6789999999987643   2344568999999999999999999998776  6899999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      |||++ +|.-++   ...+-.++..++..++.|++.||+|+|.   ++|+|||||.+|||||.+|.+||+|||||+++..
T Consensus       198 eYMdh-DL~GLl---~~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  198 EYMDH-DLSGLL---SSPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             ecccc-hhhhhh---cCCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            99966 777776   2345689999999999999999999998   7999999999999999999999999999998765


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc---------cccchhhHHh
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK---------AYFPSWVYDQ  413 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~---------~~~~~~~~~~  413 (511)
                      .... ..+..+.|.+|+|||.+.+. ..|+.+.|+||.||+|.||+.|++.+.....-+.-         ..-..|-...
T Consensus       271 ~~~~-~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  271 SGSA-PYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             CCCc-ccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            5432 35677789999999999887 48999999999999999999999888764322100         0001111101


Q ss_pred             hhcCCc-----ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          414 LNKGGD-----LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       414 ~~~~~~-----~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      +-....     .-.+...+....++....+|+..+|..||.+|.|+.++++
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            110000     0011122334455677889999999999999999999875

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-42  Score=349.04  Aligned_cols=251  Identities=31%  Similarity=0.463  Sum_probs=218.6

Q ss_pred             hhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCC
Q 010434          191 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGS  269 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  269 (511)
                      ...++||-|.||.||.|.|+ -...||||.|+.+....++|+.|+.+|+.|+|||+|+|+|+|+.+...|||.|||..|+
T Consensus       270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGN  349 (1157)
T KOG4278|consen  270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGN  349 (1157)
T ss_pred             eeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCcc
Confidence            34689999999999999976 35789999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceee
Q 010434          270 LDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI  349 (511)
Q Consensus       270 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  349 (511)
                      |.+||.  +-....++...++.++.||+.||+||..   +++|||||.++|+|+.++..+||+||||++++..+ .+...
T Consensus       350 LLdYLR--ecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD-TYTAH  423 (1157)
T KOG4278|consen  350 LLDYLR--ECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD-TYTAH  423 (1157)
T ss_pred             HHHHHH--HhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCC-ceecc
Confidence            999983  3334567888899999999999999998   79999999999999999999999999999988654 34444


Q ss_pred             ccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccchh
Q 010434          350 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEI  428 (511)
Q Consensus       350 ~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  428 (511)
                      ..+.-++.|.|||-+.-+  .++.|+|||+|||+|||+.| |..|+...+        ...+|..++++.+++      .
T Consensus       424 AGAKFPIKWTAPEsLAyN--tFSiKSDVWAFGVLLWEIATYGMsPYPGid--------lSqVY~LLEkgyRM~------~  487 (1157)
T KOG4278|consen  424 AGAKFPIKWTAPESLAYN--TFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVYGLLEKGYRMD------G  487 (1157)
T ss_pred             cCccCcccccCccccccc--ccccchhhHHHHHHHHHHHhcCCCCCCCcc--------HHHHHHHHhcccccc------C
Confidence            556678999999988644  89999999999999999998 777775443        234788888877655      3


Q ss_pred             HHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          429 ESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       429 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      +..+++++.+|++.||+.+|.+||++.|+-+.+|.
T Consensus       488 PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt  522 (1157)
T KOG4278|consen  488 PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET  522 (1157)
T ss_pred             CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence            44567899999999999999999999999887765

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-42  Score=340.22  Aligned_cols=264  Identities=24%  Similarity=0.374  Sum_probs=208.8

Q ss_pred             HHHHhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCcccHHHH--HHHHHHhcccc-ccceEEeeceeccCC-ceeE
Q 010434          186 IAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEF--INEVSTIGRIH-HVNVVQLLGFCSEGS-KRAL  260 (511)
Q Consensus       186 ~~~t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~~~~~~f--~~Ev~~l~~l~-H~niv~l~g~~~~~~-~~~l  260 (511)
                      .-.+|...++||.|.||+||+|+ ..+|..||||.+++.-...++.  ++|+..|++|+ |||||+|..++.+.. .+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            34577888999999999999998 5579999999998865556655  67999999999 999999999998877 9999


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      ||||| ..+|..++.   .++..+++..+..|+.||++||+|+|+   +|+.|||+||+|||+..+..+||+||||||..
T Consensus        88 VfE~M-d~NLYqLmK---~R~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   88 VFEFM-DCNLYQLMK---DRNRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eHHhh-hhhHHHHHh---hcCCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccc
Confidence            99999 568998883   346899999999999999999999999   69999999999999999999999999999976


Q ss_pred             CCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccc---------ccccchhhH
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSS---------KAYFPSWVY  411 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~---------~~~~~~~~~  411 (511)
                      ....   ..+..+.|.+|+|||++.+. +.|+.+.|+||+||+++|+.+-++-|.+...-+.         ......|..
T Consensus       161 ~Skp---PYTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  161 RSKP---PYTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             ccCC---CcchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence            5444   34566789999999999876 7899999999999999999999987765432210         001111111


Q ss_pred             -HhhhcCCccccc-----ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          412 -DQLNKGGDLELR-----NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       412 -~~~~~~~~~~~~-----~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                       ..+.......++     .........+.+..+++..|++.||.+|||+++.+++
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence             111111111111     1112223366788899999999999999999999974

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.7e-41  Score=330.26  Aligned_cols=249  Identities=32%  Similarity=0.548  Sum_probs=195.5

Q ss_pred             hccccCcCCcEEEEEEEec-----CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          192 FTHKLGQGGFGSVYKGQLH-----TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       192 ~~~~LG~G~fg~Vykg~~~-----~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+.||.|.||.||+|.++     .+..|+||+++...  ...++|.+|++.+.+++||||++++|++......++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4678999999999999876     35789999996532  2367899999999999999999999999988889999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++...  ....+++..+..|+.|||+||.|||+   .+++|+||+++|||+++++.+||+|||+++......
T Consensus        83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            9999999998433  24679999999999999999999999   689999999999999999999999999998774333


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      .............|+|||.+...  .++.++||||||+++|||++ |+.|+.....        ..+...+.++..... 
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~--~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--------~~~~~~~~~~~~~~~-  226 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDG--EYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--------EEIIEKLKQGQRLPI-  226 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHS--EESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--------HHHHHHHHTTEETTS-
T ss_pred             ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccc--------cccccccccccccee-
Confidence            33333445578899999999775  68999999999999999999 6777644321        112233333322221 


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEML  461 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L  461 (511)
                           ...++..+..++..||+.+|++|||+.++++.|
T Consensus       227 -----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  227 -----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                 122356788999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.1e-40  Score=324.14  Aligned_cols=251  Identities=25%  Similarity=0.432  Sum_probs=203.9

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      .+.+.++||+|+||.||++.++++..+|+|.+.......++|.+|+.++++++||||+++++++.++...++||||+++|
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~   84 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENG   84 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCC
Confidence            35567889999999999999888889999998776667789999999999999999999999999999999999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      +|.+++...   ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++....... ..
T Consensus        85 ~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~  157 (256)
T cd05114          85 CLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TS  157 (256)
T ss_pred             cHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ec
Confidence            999987422   2468999999999999999999998   6999999999999999999999999999876543221 12


Q ss_pred             eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      .....++..|+|||.+...  .++.++||||||+++|||++ |+.|+.......        ....+.++.....     
T Consensus       158 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~--------~~~~i~~~~~~~~-----  222 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFS--KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE--------VVEMISRGFRLYR-----  222 (256)
T ss_pred             cCCCCCchhhCChhhcccC--ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHCCCCCCC-----
Confidence            2233466789999998754  68899999999999999999 888886432111        1222222221111     


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                       +...+..+.+++.+||+.+|.+|||+.++++.|.
T Consensus       223 -~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         223 -PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             -CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             1112456889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=329.12  Aligned_cols=259  Identities=23%  Similarity=0.314  Sum_probs=209.1

Q ss_pred             HHhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCcc--cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      .-|.+.+.||.|.-++||+|. .+.+..||||++...+.  +.+...+|+..+..++||||++++..|..++.+++||.|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf  105 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF  105 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence            345667899999999999998 67889999999976444  356889999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      |.+||+.+++...-  ...+.+..+..|..++++||.|||+   .|.||||||+.||||+++|.+||+|||.+-..-...
T Consensus       106 Ma~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            99999999984332  3459999999999999999999999   699999999999999999999999999865443332


Q ss_pred             Cceee--ccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchh-hHHhhhcCC-cc
Q 010434          345 DFVSI--SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW-VYDQLNKGG-DL  420 (511)
Q Consensus       345 ~~~~~--~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~-~~  420 (511)
                      .....  ....||+.|||||++..+...|+.|+||||||++..||++|..||....        |.- +...+.... .+
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p--------PmkvLl~tLqn~pp~~  252 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP--------PMKVLLLTLQNDPPTL  252 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC--------hHHHHHHHhcCCCCCc
Confidence            22211  4457999999999987777789999999999999999999999985422        111 111222211 11


Q ss_pred             cc-cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          421 EL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       421 ~~-~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .. ....+....+.+.+.+++..||+.||.+|||++++++
T Consensus       253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            11 1123355567788999999999999999999999985

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1e-40  Score=328.72  Aligned_cols=255  Identities=25%  Similarity=0.381  Sum_probs=202.4

Q ss_pred             HHHHhhhccccCcCCcEEEEEEEec----CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCcee
Q 010434          186 IAVTNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  259 (511)
Q Consensus       186 ~~~t~~~~~~LG~G~fg~Vykg~~~----~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~  259 (511)
                      ....+.+.+.||+|+||.||+|.++    .+..||+|+++...  ...+.|.+|+.++++++||||++++|++..+...+
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            3445677889999999999999753    46789999987642  23457999999999999999999999999999999


Q ss_pred             EEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      +||||+++|+|.+++..   ....+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+|++|||.+..
T Consensus        83 lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          83 IVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            99999999999998832   23578999999999999999999998   6999999999999999999999999998764


Q ss_pred             CCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCC
Q 010434          340 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGG  418 (511)
Q Consensus       340 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  418 (511)
                      ...... .......++..|+|||.+.+.  .++.++||||||+++||+++ |+.||......        ...+.+.++.
T Consensus       157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--------~~~~~~~~~~  225 (266)
T cd05064         157 DKSEAI-YTTMSGKSPVLWAAPEAIQYH--HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--------DVIKAVEDGF  225 (266)
T ss_pred             ccccch-hcccCCCCceeecCHHHHhhC--CccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCCC
Confidence            322211 111223356789999998764  78899999999999999775 99998653221        1222222222


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          419 DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       419 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      ...      .+..++..+.+++..||+.+|++||++.++++.|+.
T Consensus       226 ~~~------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         226 RLP------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             CCC------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence            111      122345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-40  Score=325.70  Aligned_cols=256  Identities=29%  Similarity=0.416  Sum_probs=208.0

Q ss_pred             HHHHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          186 IAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       186 ~~~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      ....+++.++||+|+||.||+|..++++.||+|.++......++|.+|+.++++++|+||+++++++...+..+++|||+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            34556778999999999999999888889999999876667788999999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++++|.+++...  .+..+++..+..++.|++.|+.|||+   .+++|+||||+||++++++.+||+|||+++.......
T Consensus        84 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          84 KYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             cCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            999999988432  24578999999999999999999998   6999999999999999999999999999987653221


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                       ........+..|+|||.+.+.  .++.++||||||+++|||++ |+.|+......        .+...+.......   
T Consensus       159 -~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~---  224 (261)
T cd05068         159 -EAREGAKFPIKWTAPEAALYN--RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--------EVLQQVDQGYRMP---  224 (261)
T ss_pred             -cccCCCcCceeccCccccccC--CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCC---
Confidence             111222345689999998764  78899999999999999999 88887543211        1222222221111   


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                         .....+..+.+++.+|++.+|.+||++.++++.|+.
T Consensus       225 ---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         225 ---CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ---CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence               112234678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-41  Score=341.46  Aligned_cols=243  Identities=27%  Similarity=0.399  Sum_probs=206.3

Q ss_pred             ccccCcCCcEEEEEEE-ecCCcEEEEEEeccCcccH-HHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCc
Q 010434          193 THKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSA-EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL  270 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~~~~-~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  270 (511)
                      .++||+|+-|.||.+. ..+++.||||++....+.. +-.++|+.+|+..+|+|||++++.+..++.++.|||||++|+|
T Consensus       278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL  357 (550)
T KOG0578|consen  278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL  357 (550)
T ss_pred             hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence            3689999999999997 6688999999998866654 4578999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeec
Q 010434          271 DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  350 (511)
Q Consensus       271 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  350 (511)
                      .+.+     ....+++.++..|+.+++.||+|||.   .+|+|||||.+||||+.++.+||+|||++..+......  -.
T Consensus       358 TDvV-----t~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K--R~  427 (550)
T KOG0578|consen  358 TDVV-----TKTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK--RS  427 (550)
T ss_pred             hhhh-----hcccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccCc--cc
Confidence            9988     33569999999999999999999998   69999999999999999999999999998876655432  25


Q ss_pred             cccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHH
Q 010434          351 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  430 (511)
Q Consensus       351 ~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  430 (511)
                      ...||+.|||||++.+.  .|.+|.||||||++++||+-|.+||-.....        .....+......++.    ..+
T Consensus       428 TmVGTPYWMAPEVvtrk--~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl--------rAlyLIa~ng~P~lk----~~~  493 (550)
T KOG0578|consen  428 TMVGTPYWMAPEVVTRK--PYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYLIATNGTPKLK----NPE  493 (550)
T ss_pred             cccCCCCccchhhhhhc--ccCccccchhhhhHHHHHhcCCCCccCCChH--------HHHHHHhhcCCCCcC----Ccc
Confidence            56799999999999886  8999999999999999999999998542211        112222233333333    344


Q ss_pred             HHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          431 VIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       431 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .++..+.+++.+||+.|+++||+++|+|+
T Consensus       494 klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  494 KLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             ccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            56788999999999999999999999986

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3e-40  Score=323.82  Aligned_cols=254  Identities=26%  Similarity=0.426  Sum_probs=206.5

Q ss_pred             HHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      ..+.+.++||+|+||.||+|..+++..||+|.+.......+.+.+|+.++++++|+||+++++.+..+...+++|||+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   85 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK   85 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence            34556789999999999999988888999999877666678999999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      ++|.+++..  .....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++....... .
T Consensus        86 ~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05072          86 GSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-T  159 (261)
T ss_pred             CcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCce-e
Confidence            999998843  234578999999999999999999998   6999999999999999999999999999986543321 1


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                      ......++..|+|||++...  .++.++||||||+++|||++ |+.|+.......        ....+.......     
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~~~-----  224 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--------VMSALQRGYRMP-----  224 (261)
T ss_pred             ccCCCccceecCCHHHhccC--CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--------HHHHHHcCCCCC-----
Confidence            12233467789999998654  78889999999999999998 888885432111        122222221111     


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                       ....++..+.+++.+|++.+|++||++++++++|+.
T Consensus       225 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         225 -RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             -CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             111234668899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.7e-40  Score=330.87  Aligned_cols=249  Identities=26%  Similarity=0.350  Sum_probs=198.4

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +...+.||+|+||.||++.. .+|+.||+|.+....    .....+.+|+.++.+++|+||+++.+.+.+++..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            44567899999999999985 579999999986532    2234678999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++...  ....+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++......
T Consensus        82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            9999998877322  23468999999999999999999998   699999999999999999999999999998654332


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                         ......||..|+|||++.+.  .++.++|||||||++|||++|+.||........    ...+...+...       
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~----~~~~~~~~~~~-------  220 (285)
T cd05631         157 ---TVRGRVGTVGYMAPEVINNE--KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK----REEVDRRVKED-------  220 (285)
T ss_pred             ---eecCCCCCCCccCHhhhcCC--CCCcccCchhHHHHHHHHHhCCCCCCCCCcchh----HHHHHHHhhcc-------
Confidence               12344689999999999764  789999999999999999999999875432110    01111111111       


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCC-----HHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPS-----MTKVLE  459 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~evl~  459 (511)
                      .......++..+.+++.+||+.||++||+     ++++++
T Consensus       221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            01122334567889999999999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-40  Score=336.79  Aligned_cols=248  Identities=27%  Similarity=0.375  Sum_probs=203.8

Q ss_pred             HHhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccC----cc--cHHHHHHHHHHhcccc-ccceEEeeceeccCCcee
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENS----KF--SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRA  259 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~----~~--~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~  259 (511)
                      ..|.+.+.||+|+||.|+.|. ..+|..||+|++.+.    ..  ..+...+|+.++++++ ||||++++.++....+.+
T Consensus        17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~   96 (370)
T KOG0583|consen   17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY   96 (370)
T ss_pred             CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence            355667899999999999997 457899999987653    21  2345667999999998 999999999999999999


Q ss_pred             EEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC-CCeeeecccccc
Q 010434          260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAK  338 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~-~~~kl~DFGla~  338 (511)
                      +||||+.+|+|.+++.    ..+++.+.....++.|++.|++|+|+   ++|+||||||+|||+|.+ +++||+|||++.
T Consensus        97 ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   97 IVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             EEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            9999999999999993    35789999999999999999999999   699999999999999999 999999999999


Q ss_pred             cCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCC
Q 010434          339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG  418 (511)
Q Consensus       339 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  418 (511)
                      ....  ........+||+.|+|||++.+....-..++||||+||+||.|++|+.||+.....        .++..+..+.
T Consensus       170 ~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~--------~l~~ki~~~~  239 (370)
T KOG0583|consen  170 ISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP--------NLYRKIRKGE  239 (370)
T ss_pred             ccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH--------HHHHHHhcCC
Confidence            7741  22244677899999999999876213358999999999999999999999873321        1233333321


Q ss_pred             cccccccchhHHHH-HHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          419 DLELRNVTEIESVI-ARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       419 ~~~~~~~~~~~~~~-~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      . .      .+..+ +..+..++.+|++.||.+|+|+.++++
T Consensus       240 ~-~------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  240 F-K------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             c-c------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            1 1      22222 678899999999999999999999984

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.3e-40  Score=340.17  Aligned_cols=259  Identities=24%  Similarity=0.442  Sum_probs=202.0

Q ss_pred             HHhhhccccCcCCcEEEEEEEec------CCcEEEEEEeccCcc--cHHHHHHHHHHhccc-cccceEEeeceeccCCce
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKR  258 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~  258 (511)
                      ..+.+.++||+|+||.||++...      ++..||||+++....  ..+.+.+|+.+++.+ +|+|||+++++|......
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            34566789999999999998732      345899999975322  345688999999999 899999999999999999


Q ss_pred             eEEEeecCCCCcccccccCC------------------------------------------------------------
Q 010434          259 ALVYEFMPNGSLDRHIFPKE------------------------------------------------------------  278 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~------------------------------------------------------------  278 (511)
                      ++||||+++|+|.+++....                                                            
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            99999999999998774321                                                            


Q ss_pred             ------CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeeccc
Q 010434          279 ------NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT  352 (511)
Q Consensus       279 ------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  352 (511)
                            ....++++..+.+++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++..............
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                  012358899999999999999999998   69999999999999999999999999999865443322222334


Q ss_pred             cCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHH
Q 010434          353 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESV  431 (511)
Q Consensus       353 ~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  431 (511)
                      .++..|+|||++.+.  .++.++||||||+++|||++ |+.||.......       ........+.....      ...
T Consensus       275 ~~~~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-------~~~~~~~~~~~~~~------~~~  339 (374)
T cd05106         275 RLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-------KFYKMVKRGYQMSR------PDF  339 (374)
T ss_pred             CCccceeCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccccccH-------HHHHHHHcccCccC------CCC
Confidence            467789999998654  78999999999999999997 999986532211       11122222111111      111


Q ss_pred             HHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          432 IARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       432 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                      .+..+.+++.+||+.||++|||+.+|+++|+..
T Consensus       340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            346788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5e-40  Score=325.46  Aligned_cols=257  Identities=25%  Similarity=0.428  Sum_probs=205.4

Q ss_pred             HHHhhhccccCcCCcEEEEEEEec------CCcEEEEEEeccCcc--cHHHHHHHHHHhccccccceEEeeceeccCCce
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  258 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~  258 (511)
                      ..++.+.+.||+|+||.||+|...      +++.||||.++....  ..+.|.+|++++++++|+||+++++++..+...
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            456778899999999999999753      347899999876433  346899999999999999999999999999999


Q ss_pred             eEEEeecCCCCcccccccCC----------CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCC
Q 010434          259 ALVYEFMPNGSLDRHIFPKE----------NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFI  328 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~  328 (511)
                      ++||||+++++|.+++....          .....+++..+..++.|++.|++|||+   .+++|+||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence            99999999999999885331          223468899999999999999999998   69999999999999999999


Q ss_pred             eeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccc
Q 010434          329 PKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFP  407 (511)
Q Consensus       329 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~  407 (511)
                      +||+|||+++...............+++.|+|||++.+.  .++.++||||||+++|||++ |+.|+.......      
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------  232 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------  232 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccC--CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------
Confidence            999999999765433222222334467899999998764  78999999999999999998 999875432211      


Q ss_pred             hhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          408 SWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       408 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                        ..+....+....      .....+..+.+++..||+.||++|||+.||++.|+
T Consensus       233 --~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         233 --VIECITQGRLLQ------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             --HHHHHHcCCcCC------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence              112222221111      11234567889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.9e-40  Score=326.24  Aligned_cols=256  Identities=24%  Similarity=0.426  Sum_probs=204.4

Q ss_pred             HhhhccccCcCCcEEEEEEEecC------CcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHT------GRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  260 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~------g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  260 (511)
                      .+.+.+.||+|+||.||+|...+      ...||+|.+....  ...++|.+|+.++.+++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   85 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM   85 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence            34567899999999999998542      2579999986532  234578999999999999999999999999999999


Q ss_pred             EEeecCCCCcccccccCCC------------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCC
Q 010434          261 VYEFMPNGSLDRHIFPKEN------------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFI  328 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~  328 (511)
                      +|||+++|+|.+++.....            ....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.
T Consensus        86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~  162 (283)
T cd05048          86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT  162 (283)
T ss_pred             EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence            9999999999988743211            11568899999999999999999998   69999999999999999999


Q ss_pred             eeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccc
Q 010434          329 PKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFP  407 (511)
Q Consensus       329 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~  407 (511)
                      +||+|||+++...............+++.|+|||.+.+.  .++.++||||||+++|||++ |..|+......       
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-------  233 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------  233 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhccC--cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-------
Confidence            999999999865443322223344578899999988654  78999999999999999998 99888643221       


Q ss_pred             hhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          408 SWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       408 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                       .+...+.......      .+..++..+.+++.+||+.||.+||++++|++.|++
T Consensus       234 -~~~~~i~~~~~~~------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         234 -EVIEMIRSRQLLP------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -HHHHHHHcCCcCC------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence             1222333322111      223456789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.8e-40  Score=322.57  Aligned_cols=254  Identities=30%  Similarity=0.463  Sum_probs=205.4

Q ss_pred             HHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      ..+.+.++||+|+||.||+|..+ +++.||+|.+..+....+++.+|+.++++++|+||+++++++..+...+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            34556789999999999999854 68899999998766667789999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +++|.+++..  .....+++..++.++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++....... 
T Consensus        86 ~~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-  159 (263)
T cd05052          86 YGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-  159 (263)
T ss_pred             CCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccccee-
Confidence            9999998732  223568999999999999999999998   6999999999999999999999999999986543321 


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                      .......++..|+|||.+.+.  .++.++||||||+++|||++ |..|+.......        ..+.+.......    
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~----  225 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYELLEKGYRME----  225 (263)
T ss_pred             eccCCCCCccccCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHCCCCCC----
Confidence            111223356789999988654  78899999999999999998 888875432211        122222221111    


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                        .....+..+.+++.+||+.+|++|||+.+++++|+.
T Consensus       226 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         226 --RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             --CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence              122245678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.3e-39  Score=319.09  Aligned_cols=251  Identities=28%  Similarity=0.461  Sum_probs=203.5

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      .+.+.+.||+|+||.||+|+..++..+|+|.++......++|.+|+.++.+++||||+++++++.+....+++|||+++|
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG   84 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence            34567899999999999999877778999998876666788999999999999999999999999999999999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      +|.+++..   ....+++..++.++.||+.||+|||+   .+++|+||||+||++++++.+||+|||+++....... ..
T Consensus        85 ~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~  157 (256)
T cd05113          85 CLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TS  157 (256)
T ss_pred             cHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCce-ee
Confidence            99998832   22368999999999999999999998   6999999999999999999999999999876543321 12


Q ss_pred             eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      .....++..|+|||.+...  .++.++||||||+++|||++ |+.|+......        .......+.......    
T Consensus       158 ~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~----  223 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYS--KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--------ETVEKVSQGLRLYRP----  223 (256)
T ss_pred             cCCCccChhhCCHHHHhcC--cccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHhcCCCCCCC----
Confidence            2233467789999998754  68899999999999999998 88887543211        122222222211111    


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                        ...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       224 --~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         224 --HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             --CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence              113467889999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-40  Score=322.24  Aligned_cols=254  Identities=28%  Similarity=0.443  Sum_probs=203.2

Q ss_pred             HhhhccccCcCCcEEEEEEEec----CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~----~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      .+.+.+.||+|+||.||+|.++    +...||||.++...  ....+|.+|+.++.+++||||+++++++..+...+++|
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   84 (266)
T cd05033           5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT   84 (266)
T ss_pred             HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence            4566789999999999999864    24589999986533  23467999999999999999999999999999999999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+++++|.+++..   ....+++..+..++.|++.|++|||+   .+|+|+||||+|||+++++.+||+|||+++....
T Consensus        85 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          85 EYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            99999999998832   23478999999999999999999998   6999999999999999999999999999987753


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCccc
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (511)
                      ...........++..|+|||.+...  .++.++||||||+++|||++ |..|+......        ...+.+.......
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~  228 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--------DVIKAVEDGYRLP  228 (266)
T ss_pred             cccceeccCCCCCccccChhhhccC--CCccccchHHHHHHHHHHHccCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence            3322222333467889999998764  78899999999999999998 88887543211        1122222221111


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                      .      ....+..+.+++.+||+.+|++||++.+|+++|+..
T Consensus       229 ~------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         229 P------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             C------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1      112356788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-40  Score=320.20  Aligned_cols=250  Identities=28%  Similarity=0.457  Sum_probs=203.1

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      .+.+.+.||+|+||.||++..+++..+|+|.+.......++|.+|+.++++++|+||+++++++......++||||++++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG   84 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence            35567899999999999999887889999998776667778999999999999999999999999999999999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      +|.+++...   ...+++..+..++.|++.|++|||+   .+++|+||||+||++++++.+||+|||+++....... ..
T Consensus        85 ~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~  157 (256)
T cd05059          85 CLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TS  157 (256)
T ss_pred             CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccc-cc
Confidence            999988422   2478999999999999999999998   6999999999999999999999999999986543221 11


Q ss_pred             eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      .....++..|+|||.+.+.  .++.++||||||+++|||++ |+.|+.......        ............      
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~------  221 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYS--RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--------VVESVSAGYRLY------  221 (256)
T ss_pred             cCCCCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--------HHHHHHcCCcCC------
Confidence            1223355689999998764  78899999999999999998 788876432211        122222221111      


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHH
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLEML  461 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L  461 (511)
                      .+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            1122456789999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=9.5e-40  Score=330.25  Aligned_cols=256  Identities=24%  Similarity=0.401  Sum_probs=201.1

Q ss_pred             HHhhhccccCcCCcEEEEEEEec-CCc----EEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeE
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH-TGR----LIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  260 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~-~g~----~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  260 (511)
                      ..++..+.||+|+||.||+|++. ++.    .||||+++..  ....++|.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            34556688999999999999853 343    4899998653  23456899999999999999999999999764 5789


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      ++||+++|+|.+++..   ....+++..+++++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++..
T Consensus        86 v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          86 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccc
Confidence            9999999999998842   23468999999999999999999998   69999999999999999999999999999876


Q ss_pred             CCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      .............++..|+|||.+.+.  .++.++||||||+++|||++ |+.|++......        ..........
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~  229 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGER  229 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHhCCCC
Confidence            544333222333457789999998764  78899999999999999998 999886432111        1222222221


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      ....      ..++..+..++.+||+.+|.+||++.+++..|.....
T Consensus       230 ~~~~------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         230 LPQP------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             CCCC------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence            1111      1123567889999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-41  Score=337.65  Aligned_cols=246  Identities=24%  Similarity=0.344  Sum_probs=202.1

Q ss_pred             hhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCcc----cHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEee
Q 010434          191 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKF----SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      .|.+.||.|+|++|++++ ..+++.+|||++.+...    ..+-...|-.+|.+| +||.|++|+-.|.++..+|+|+||
T Consensus        76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~  155 (604)
T KOG0592|consen   76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY  155 (604)
T ss_pred             chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence            467889999999999998 56899999999976322    233456788889999 899999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.++|    .+-+.|++.-.+..+.+|+.||+|||+   .|||||||||+|||||+|+++||+|||-|+.+....
T Consensus       156 A~nGdll~~i----~K~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  156 APNGDLLDLI----KKYGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             cCCCcHHHHH----HHhCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence            9999999999    345789999999999999999999999   699999999999999999999999999999775432


Q ss_pred             Cc---------eee--ccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHh
Q 010434          345 DF---------VSI--SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQ  413 (511)
Q Consensus       345 ~~---------~~~--~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~  413 (511)
                      ..         ...  ...+||..|.+||++...  ..++.+|+|+|||+||.|+.|.+||.....-        .+.+.
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~--~~~~~sDiWAlGCilyQmlaG~PPFra~Ney--------liFqk  298 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS--PAGPSSDLWALGCILYQMLAGQPPFRAANEY--------LIFQK  298 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcCC--CCCcccchHHHHHHHHHHhcCCCCCccccHH--------HHHHH
Confidence            21         111  235699999999999875  8889999999999999999999999764321        12333


Q ss_pred             hhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          414 LNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       414 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      +..-.       .+++..+++...+|+.+.|..||.+|+|..+|-+.
T Consensus       299 I~~l~-------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  299 IQALD-------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHHhc-------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            32211       11333344677889999999999999999999764

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.7e-39  Score=317.09  Aligned_cols=257  Identities=27%  Similarity=0.432  Sum_probs=208.9

Q ss_pred             HHHHHHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       184 ei~~~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      +|...++++.++||+|+||.||++..++++.||+|.+.......++|.+|+.++++++|+||+++++++. ....+++||
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence            3456678888999999999999999888999999999887777889999999999999999999999874 456899999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++++|.+++..  ..+..+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          81 YMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             cCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            9999999998733  234578999999999999999999998   69999999999999999999999999999766532


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                      .. .......++..|+|||++...  .++.++||||||+++|||++ |+.|+......        .....+........
T Consensus       156 ~~-~~~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~  224 (260)
T cd05067         156 EY-TAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--------EVIQNLERGYRMPR  224 (260)
T ss_pred             Cc-ccccCCcccccccCHHHhccC--CcCcccchHHHHHHHHHHHhCCCCCCCCCChH--------HHHHHHHcCCCCCC
Confidence            21 112233467889999998754  78899999999999999998 99998643211        12222222221111


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                            ....+..+.+++.+||+.+|++|||++++++.|+.
T Consensus       225 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         225 ------PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                  12234578999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1e-39  Score=323.35  Aligned_cols=258  Identities=24%  Similarity=0.379  Sum_probs=200.7

Q ss_pred             HHHhhhccccCcCCcEEEEEEEec------CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCce
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  258 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~  258 (511)
                      ...+.+.++||+|+||.||+|...      ++..||||++....  ....+|.+|+.++++++||||+++++++.++...
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~   84 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   84 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence            445667789999999999998743      35689999986532  2345789999999999999999999999999999


Q ss_pred             eEEEeecCCCCcccccccCCCc------CCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeee
Q 010434          259 ALVYEFMPNGSLDRHIFPKENK------GQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVS  332 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~  332 (511)
                      ++||||+++|+|.+++......      ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEEC
Confidence            9999999999999887432211      2357889999999999999999998   699999999999999999999999


Q ss_pred             cccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhH
Q 010434          333 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVY  411 (511)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~  411 (511)
                      |||+++...............++..|+|||.+.+.  .++.++||||||+++|||++ |..|+......        ...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--------~~~  231 (277)
T cd05062         162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--------QVL  231 (277)
T ss_pred             CCCCccccCCcceeecCCCCccCHhhcChhHhhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHH
Confidence            99998765443322222233467889999998754  78999999999999999998 67777543211        111


Q ss_pred             HhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          412 DQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       412 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      +...+......      ....+..+.+++.+||+.+|++|||+.+++++|+.
T Consensus       232 ~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         232 RFVMEGGLLDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHHcCCcCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            22222211111      12234578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-41  Score=338.81  Aligned_cols=267  Identities=25%  Similarity=0.370  Sum_probs=213.8

Q ss_pred             HHHHHHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCc-c-cHHHHHHHHHHhccccccceEEeeceeccCCceeEE
Q 010434          184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSK-F-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       184 ei~~~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~-~-~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  261 (511)
                      |.-...-.|.++||+|-||.|..+...++..||||+++... . ...+|.+|+++|.+++|||||+|+|+|..++..++|
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence            44444556789999999999999999888999999998733 2 347999999999999999999999999999999999


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      +|||++|+|..++..++.  ..+......+|+.|||.||+||.+   .++|||||.++|+|+|.++++||+|||+++-..
T Consensus       614 ~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccc
Confidence            999999999999854432  224566777899999999999999   799999999999999999999999999999766


Q ss_pred             CCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh--CCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          342 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG--GRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      ....+........+++|||||.+..  |.+|++||||+||+++||+++  ..+|+.....+....    ..-..+..+..
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vve----n~~~~~~~~~~  762 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVE----NAGEFFRDQGR  762 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHH----hhhhhcCCCCc
Confidence            6666666666778999999998875  499999999999999999876  556765433222110    11111111111


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                      ..   ....+..++..+.++++.||..+.++|||++++...|...
T Consensus       763 ~~---~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  763 QV---VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ce---eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            11   1113445667888999999999999999999999988764

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.3e-40  Score=313.59  Aligned_cols=256  Identities=23%  Similarity=0.324  Sum_probs=198.2

Q ss_pred             ccccCcCCcEEEEEEEec-CCcEEEEEEeccCccc---HHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          193 THKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~---~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      .-++|+|+||.|||++.+ +|+.||||++..++.+   .+-.++|++.|++++|+|+|.|+.+|....+++||+||++..
T Consensus         7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhT   86 (396)
T KOG0593|consen    7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHT   86 (396)
T ss_pred             hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchH
Confidence            457999999999999965 7999999999776543   345789999999999999999999999999999999999775


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      -|.++    +.....++.+.+.+++.|++.|+.|+|+   .+++||||||+||||+.++.+||+|||.|+.......  .
T Consensus        87 vL~eL----e~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd--~  157 (396)
T KOG0593|consen   87 VLHEL----ERYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD--N  157 (396)
T ss_pred             HHHHH----HhccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCcc--h
Confidence            55543    2344678999999999999999999999   5999999999999999999999999999998764332  2


Q ss_pred             eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc--------cchhhHHhhhcCC--
Q 010434          349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY--------FPSWVYDQLNKGG--  418 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~--  418 (511)
                      .+..+.|.+|+|||.+.+. .+|....||||+||++.||++|.+-|.....-+ +.+        +.....+......  
T Consensus       158 YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD-QLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID-QLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             hhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHH-HHHHHHHHHcccCHHHHHHhccCCce
Confidence            3556689999999999874 378899999999999999999998775533211 111        1111111111111  


Q ss_pred             ---c-ccccccchh---HHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          419 ---D-LELRNVTEI---ESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       419 ---~-~~~~~~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                         . ++...+...   ...++.-+.+++..|+++||.+|++-++++.
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence               1 111111112   2234456789999999999999999998874

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.3e-39  Score=339.52  Aligned_cols=259  Identities=25%  Similarity=0.401  Sum_probs=203.2

Q ss_pred             HhhhccccCcCCcEEEEEEEec------CCcEEEEEEeccCc--ccHHHHHHHHHHhcccc-ccceEEeeceeccCCcee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSK--FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRA  259 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~  259 (511)
                      .+.+.++||+|+||.||+|+..      .+..||||+++...  ...+.|.+|+.++++++ ||||+++++++.+....+
T Consensus        38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~  117 (400)
T cd05105          38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY  117 (400)
T ss_pred             ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence            4456689999999999999742      23479999996532  23567999999999996 999999999999999999


Q ss_pred             EEEeecCCCCcccccccCCC------------------------------------------------------------
Q 010434          260 LVYEFMPNGSLDRHIFPKEN------------------------------------------------------------  279 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~------------------------------------------------------------  279 (511)
                      |||||+++|+|.+++.....                                                            
T Consensus       118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (400)
T cd05105         118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA  197 (400)
T ss_pred             EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence            99999999999887743210                                                            


Q ss_pred             --------------------------------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC
Q 010434          280 --------------------------------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF  327 (511)
Q Consensus       280 --------------------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~  327 (511)
                                                      ....+++..+..++.|++.||+|||+   .+|+|+||||+|||+++++
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~~  274 (400)
T cd05105         198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGK  274 (400)
T ss_pred             hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCCC
Confidence                                            12358899999999999999999998   6999999999999999999


Q ss_pred             CeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCccccccccccc
Q 010434          328 IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYF  406 (511)
Q Consensus       328 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~  406 (511)
                      .+||+|||+++...............++..|+|||.+.+.  .++.++||||||+++|||++ |+.|+......      
T Consensus       275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~------  346 (400)
T cd05105         275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN--LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD------  346 (400)
T ss_pred             EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCcccchh------
Confidence            9999999999866443332222334577889999998764  78899999999999999997 88887543211      


Q ss_pred             chhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          407 PSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       407 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                       ......+..+....      ....++..+.+++.+||+.+|++|||+.+|.++|+...
T Consensus       347 -~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         347 -STFYNKIKSGYRMA------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             -HHHHHHHhcCCCCC------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence             11222222221111      12234567889999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.1e-39  Score=317.64  Aligned_cols=253  Identities=30%  Similarity=0.477  Sum_probs=207.2

Q ss_pred             HHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcc-cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .-+.+.++||.|+||.||+|...+++.+|+|.+..... ..+++.+|+.++++++|+||+++++++......++||||++
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   85 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME   85 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence            34567789999999999999988899999999977544 56789999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +++|.+++...  .+..+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++........ 
T Consensus        86 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-  159 (261)
T cd05148          86 KGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-  159 (261)
T ss_pred             cCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence            99999998432  34678999999999999999999998   6999999999999999999999999999976543321 


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                       ......++..|+|||.+...  .++.++||||||+++++|++ |+.|+......        .............    
T Consensus       160 -~~~~~~~~~~~~~PE~~~~~--~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~----  224 (261)
T cd05148         160 -LSSDKKIPYKWTAPEAASHG--TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--------EVYDQITAGYRMP----  224 (261)
T ss_pred             -cccCCCCceEecCHHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHHhCCcCC----
Confidence             12234467889999998754  78899999999999999998 78888543311        1222222221111    


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                        .+..++..+.+++.+||+.+|.+|||+.++++.|+.
T Consensus       225 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         225 --CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             --CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence              122345678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-41  Score=338.19  Aligned_cols=239  Identities=28%  Similarity=0.470  Sum_probs=199.1

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCcccc
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRH  273 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~  273 (511)
                      +=||+|+.|-||+|++. ++.||||+++.-+      ..+++-|++|+|+||+.+.|+|+...-.|||||||+.|-|...
T Consensus       130 eWlGSGaQGAVF~Grl~-netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V  202 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRLH-NETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV  202 (904)
T ss_pred             hhhccCcccceeeeecc-CceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence            45999999999999987 7899999875422      2468889999999999999999999999999999999999999


Q ss_pred             cccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeecccc
Q 010434          274 IFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR  353 (511)
Q Consensus       274 l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  353 (511)
                      |    ..+.+++...+..+..+||.||.|||.   +.|||||||.-||||..+..+||+|||-++......   ..-...
T Consensus       203 L----ka~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkMSFa  272 (904)
T KOG4721|consen  203 L----KAGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKMSFA  272 (904)
T ss_pred             H----hccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhhh---hhhhhh
Confidence            8    456789999999999999999999999   699999999999999999999999999988654432   223456


Q ss_pred             CCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHH
Q 010434          354 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIA  433 (511)
Q Consensus       354 gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  433 (511)
                      ||..|||||+++++  ..+.|.|||||||+||||+||..|+..-+...       .++..-.+  .+.+    ..+..++
T Consensus       273 GTVaWMAPEvIrne--PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-------IIwGVGsN--sL~L----pvPstcP  337 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNE--PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-------IIWGVGSN--SLHL----PVPSTCP  337 (904)
T ss_pred             hhHhhhCHHHhhcC--CcccccceehhHHHHHHHHhcCCCccccchhe-------eEEeccCC--cccc----cCcccCc
Confidence            99999999999987  89999999999999999999999975432111       01111111  1111    1455667


Q ss_pred             HHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          434 RKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       434 ~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                      +-+..|+.+||+.+|.+||++.+++..|+-.
T Consensus       338 ~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  338 DGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             hHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            7889999999999999999999999999753

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.2e-39  Score=303.91  Aligned_cols=261  Identities=23%  Similarity=0.352  Sum_probs=204.1

Q ss_pred             HhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCccc---HHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~~~---~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +|.-.++||+|.||.||+|+ ..+|+.||||+++..+..   ....++|++.|+.++|+||+.|++.|...+..-||+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            44456789999999999998 568999999999775432   45688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      |+. +|...|   +.+...++...+..++.++++|++|||+   +.|+||||||.|+|++++|.+||+|||+|+.+...+
T Consensus        83 m~t-dLe~vI---kd~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   83 MPT-DLEVVI---KDKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ccc-cHHHHh---cccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            954 888887   3455789999999999999999999999   699999999999999999999999999999987665


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccc------------cccccchhh--
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRS------------SKAYFPSWV--  410 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~------------~~~~~~~~~--  410 (511)
                      ...  +..+.|..|+|||.+-+. ..|+...|+||.||++.||+-|.+-+.....-+            ....+|++.  
T Consensus       156 ~~~--~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  156 RIQ--THQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             ccc--ccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence            433  333688999999998776 578999999999999999998886654432111            011112111  


Q ss_pred             --HHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          411 --YDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       411 --~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                        +..+...   ............+....+++..++..||.+|+|++|++++=-
T Consensus       233 pdY~~~~~~---P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y  283 (318)
T KOG0659|consen  233 PDYVKIQQF---PKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY  283 (318)
T ss_pred             ccHHHHhcC---CCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence              0111100   000011122233456789999999999999999999987543

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-40  Score=328.46  Aligned_cols=242  Identities=22%  Similarity=0.247  Sum_probs=197.8

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+.++||+|+||.||++... +|+.||+|++....    ...+.+.+|+.++++++||||+++++++.++...++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   82 (291)
T cd05612           3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY   82 (291)
T ss_pred             ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence            456789999999999999854 78999999986532    2345688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++.    ....+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++......
T Consensus        83 ~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  155 (291)
T cd05612          83 VPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT  155 (291)
T ss_pred             CCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence            99999999883    33578999999999999999999998   699999999999999999999999999998653321


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                           ....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||.....        ...++.+..+. ..   
T Consensus       156 -----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~-~~---  216 (291)
T cd05612         156 -----WTLCGTPEYLAPEVIQSK--GHNKAVDWWALGILIYEMLVGYPPFFDDNP--------FGIYEKILAGK-LE---  216 (291)
T ss_pred             -----ccccCChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC-cC---
Confidence                 234589999999998765  678999999999999999999999865321        11222222221 11   


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCC-----HHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPS-----MTKVLEM  460 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~evl~~  460 (511)
                         .+...+..+.+++.+||+.||.+||+     +.++++.
T Consensus       217 ---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         217 ---FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ---CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence               12223567889999999999999995     8888764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-40  Score=331.24  Aligned_cols=238  Identities=22%  Similarity=0.315  Sum_probs=192.4

Q ss_pred             cCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCc
Q 010434          196 LGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL  270 (511)
Q Consensus       196 LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  270 (511)
                      ||+|+||.||+++.. +++.||+|++...    ......+.+|+.++++++||||+++++++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999854 6889999998652    23445788999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeec
Q 010434          271 DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  350 (511)
Q Consensus       271 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  350 (511)
                      .+++.    ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 ~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~  151 (312)
T cd05585          81 FHHLQ----REGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTN  151 (312)
T ss_pred             HHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccc
Confidence            99883    23568999999999999999999998   6999999999999999999999999999985433221  123


Q ss_pred             cccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHH
Q 010434          351 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  430 (511)
Q Consensus       351 ~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  430 (511)
                      ...||+.|+|||++.+.  .++.++|||||||++|||++|+.||......        ..........       ...+.
T Consensus       152 ~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~~~--------~~~~~~~~~~-------~~~~~  214 (312)
T cd05585         152 TFCGTPEYLAPELLLGH--GYTKAVDWWTLGVLLYEMLTGLPPFYDENVN--------EMYRKILQEP-------LRFPD  214 (312)
T ss_pred             cccCCcccCCHHHHcCC--CCCCccceechhHHHHHHHhCCCCcCCCCHH--------HHHHHHHcCC-------CCCCC
Confidence            45699999999999765  7889999999999999999999998643221        1112211111       11223


Q ss_pred             HHHHHHHHHHHHhcCcCCCCCCC---HHHHHH
Q 010434          431 VIARKLCMIGLWCIQVKAADRPS---MTKVLE  459 (511)
Q Consensus       431 ~~~~~l~~l~~~Cl~~~P~~RPs---~~evl~  459 (511)
                      .++..+.+++.+||+.||++||+   +.++++
T Consensus       215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            34567889999999999999986   555554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.6e-39  Score=322.74  Aligned_cols=258  Identities=23%  Similarity=0.350  Sum_probs=203.8

Q ss_pred             HHHhhhccccCcCCcEEEEEEEec------CCcEEEEEEeccCcc--cHHHHHHHHHHhccccccceEEeeceeccCCce
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  258 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~  258 (511)
                      ...+.+.++||+|+||.||+|...      +++.||||++.....  ..+.|.+|+.++..++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            345677889999999999999853      257899999975432  245788999999999999999999999999999


Q ss_pred             eEEEeecCCCCcccccccCC------------CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC
Q 010434          259 ALVYEFMPNGSLDRHIFPKE------------NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN  326 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~  326 (511)
                      ++++||+++++|.+++....            .....+++..+..++.|++.||+|||+   .+++||||||+||+++++
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCC
Confidence            99999999999998874211            123468899999999999999999998   699999999999999999


Q ss_pred             CCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccc
Q 010434          327 FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAY  405 (511)
Q Consensus       327 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~  405 (511)
                      +.+||+|||+++...............+++.|+|||.+...  .++.++||||||+++|||++ |..|+.....      
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------  232 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------  232 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------
Confidence            99999999998865444332223344567899999998653  78899999999999999998 7777654221      


Q ss_pred             cchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          406 FPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                        ..+.+.+.+.....      ....++..+..++..||+.+|++||++++|+..|+.
T Consensus       233 --~~~~~~i~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         233 --QDVIEMIRNRQVLP------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             --HHHHHHHHcCCcCC------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence              11222333322211      122345668899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3e-39  Score=317.58  Aligned_cols=255  Identities=29%  Similarity=0.432  Sum_probs=205.2

Q ss_pred             HHHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      ...+.+.++||+|+||.||+|+.++...||+|+++......++|.+|+.++++++|+||+++++++.+ ...++||||++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   83 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence            34577889999999999999988777789999998766667889999999999999999999998754 56799999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +|+|.+++..  ..+..+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++........
T Consensus        84 ~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          84 KGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCcHHHHHhh--ccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            9999998842  233568999999999999999999998   69999999999999999999999999999866443321


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                       ......++..|+|||+..+.  .++.++||||||+++|||++ |+.|+.....        ..............    
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--------~~~~~~~~~~~~~~----  223 (262)
T cd05071         159 -ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYRMP----  223 (262)
T ss_pred             -cccCCcccceecCHhHhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--------HHHHHHHhcCCCCC----
Confidence             12234467789999988654  78999999999999999999 7777754321        11222222221111    


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                        ....++..+.+++.+|++.+|++||++.+++++|+..
T Consensus       224 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         224 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             --CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence              1233556788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1e-39  Score=331.23  Aligned_cols=240  Identities=22%  Similarity=0.328  Sum_probs=195.1

Q ss_pred             cccCcCCcEEEEEEEe-cCCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          194 HKLGQGGFGSVYKGQL-HTGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      +.||+|+||.||+++. .+|+.||||+++..    ......+.+|+.++++++||||+++.+.+..+...++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4689999999999985 57899999999753    223456889999999999999999999999999999999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      +|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~  151 (323)
T cd05571          81 ELFFHLS----RERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--T  151 (323)
T ss_pred             cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--c
Confidence            9988873    34578999999999999999999998   6999999999999999999999999999875332221  1


Q ss_pred             eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchh
Q 010434          349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEI  428 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  428 (511)
                      .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......        ....+... ...      .
T Consensus       152 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--------~~~~~~~~-~~~------~  214 (323)
T cd05571         152 MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELILME-EIR------F  214 (323)
T ss_pred             ccceecCccccChhhhcCC--CCCccccCcccchhhhhhhcCCCCCCCCCHHH--------HHHHHHcC-CCC------C
Confidence            2344699999999999764  78899999999999999999999986432111        11111111 111      2


Q ss_pred             HHHHHHHHHHHHHHhcCcCCCCCC-----CHHHHHH
Q 010434          429 ESVIARKLCMIGLWCIQVKAADRP-----SMTKVLE  459 (511)
Q Consensus       429 ~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~  459 (511)
                      +..++..+.+++.+||+.||++||     ++.++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            223456788999999999999999     7999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4e-39  Score=315.89  Aligned_cols=253  Identities=28%  Similarity=0.452  Sum_probs=204.1

Q ss_pred             HHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      ..+.+.++||+|+||.||++..+++..+|+|.+.......+.|.+|+.++++++|+|++++++++.+ ...+++|||+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~   84 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSK   84 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCC
Confidence            4567788999999999999998888899999998766677889999999999999999999998854 568999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      ++|.+++..  .....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++......... 
T Consensus        85 ~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05070          85 GSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence            999998843  223568999999999999999999998   69999999999999999999999999999865443221 


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                      ......++..|+|||.+.+.  .++.++||||||+++|||++ |+.|+......        ...+.+.......     
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~-----  223 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--------EVLEQVERGYRMP-----  223 (260)
T ss_pred             cccCCCCCccccChHHHhcC--CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCC-----
Confidence            11223356789999988654  78899999999999999999 88888543211        1122222221111     


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                       .+...+..+.+++.+|++.+|.+|||+.++++.|+.
T Consensus       224 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         224 -CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             122345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-39  Score=306.13  Aligned_cols=238  Identities=28%  Similarity=0.390  Sum_probs=202.8

Q ss_pred             CChHHHHHHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcc----cHHHHHHHHHHhccccccceEEeeceecc
Q 010434          180 YSYPEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSE  254 (511)
Q Consensus       180 ~~~~ei~~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~  254 (511)
                      +++.+.     .+.+.||.|+||.|.+++.+ +|..+|+|+|++...    ..+...+|-.+|+.+.||.++++.+.+.+
T Consensus        41 ~~l~df-----e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d  115 (355)
T KOG0616|consen   41 YSLQDF-----ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD  115 (355)
T ss_pred             cchhhh-----hheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence            555543     45678999999999999854 689999999977432    34567899999999999999999999999


Q ss_pred             CCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecc
Q 010434          255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF  334 (511)
Q Consensus       255 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DF  334 (511)
                      .+..+|||||++||.|..++    ++.+++++...+-+|.||+.||+|||+   .+|++||+||+|||||.+|.+||.||
T Consensus       116 ~~~lymvmeyv~GGElFS~L----rk~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDF  188 (355)
T KOG0616|consen  116 NSNLYMVMEYVPGGELFSYL----RKSGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDF  188 (355)
T ss_pred             CCeEEEEEeccCCccHHHHH----HhcCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEec
Confidence            99999999999999999998    456789999999999999999999999   79999999999999999999999999


Q ss_pred             cccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhh
Q 010434          335 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQL  414 (511)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  414 (511)
                      |.|+.....     +-..+||+.|+|||.+...  .+..++|.|||||++|||+.|.+||....        +..+++.+
T Consensus       189 GFAK~v~~r-----T~TlCGTPeYLAPEii~sk--~ynkavDWWalGVLIYEMlaG~pPF~~~~--------~~~iY~KI  253 (355)
T KOG0616|consen  189 GFAKRVSGR-----TWTLCGTPEYLAPEIIQSK--GYNKAVDWWALGVLIYEMLAGYPPFYDDN--------PIQIYEKI  253 (355)
T ss_pred             cceEEecCc-----EEEecCCccccChHHhhcC--CCCcchhHHHHHHHHHHHHcCCCCCcCCC--------hHHHHHHH
Confidence            999976543     3456799999999999875  78889999999999999999999996543        23456666


Q ss_pred             hcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCC
Q 010434          415 NKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADR  451 (511)
Q Consensus       415 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R  451 (511)
                      -++...       ++..++..+.+|+...||.|-.+|
T Consensus       254 ~~~~v~-------fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  254 LEGKVK-------FPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HhCccc-------CCcccCHHHHHHHHHHHhhhhHhh
Confidence            554322       444456778889999999999998

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.2e-39  Score=321.87  Aligned_cols=256  Identities=25%  Similarity=0.414  Sum_probs=201.8

Q ss_pred             HhhhccccCcCCcEEEEEEEe-----cCCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-----HTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-----~~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  261 (511)
                      ..++.++||+|+||.||+|..     .+++.+|+|.+....  ....+|.+|+.++++++||||+++++++..+...+++
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   85 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML   85 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence            456678999999999999974     246799999987532  2335789999999999999999999999999999999


Q ss_pred             EeecCCCCcccccccCCC-------------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCC
Q 010434          262 YEFMPNGSLDRHIFPKEN-------------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFI  328 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~  328 (511)
                      |||+++++|.+++.....             ....+++..++.++.|++.||+|||+   .+++|+||||+|||+++++.
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~  162 (283)
T cd05090          86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLH  162 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCc
Confidence            999999999998743211             12458899999999999999999998   69999999999999999999


Q ss_pred             eeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccc
Q 010434          329 PKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFP  407 (511)
Q Consensus       329 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~  407 (511)
                      +||+|||+++...............++..|+|||++.+.  .++.++||||||+++|||++ |..|+.....        
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--------  232 (283)
T cd05090         163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--------  232 (283)
T ss_pred             EEeccccccccccCCcceecccCCCccceecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------
Confidence            999999999865443322222334467789999998754  68899999999999999998 8888754221        


Q ss_pred             hhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          408 SWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       408 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      ..+.+.........      ....++..+.+++.+||+.+|++||++.+|+++|..
T Consensus       233 ~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 QEVIEMVRKRQLLP------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHHHcCCcCC------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11222222222111      112245678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.4e-40  Score=333.83  Aligned_cols=262  Identities=26%  Similarity=0.405  Sum_probs=213.8

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccH---HHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~---~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      .|++.+.||+|+||.||||+- .+.+.||+|.+.+.....   +...+|++++++++|||||.++++|+...+.++|.||
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~   82 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY   82 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence            356678899999999999984 478999999997754443   4578999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +.+ +|..++    ...+.++++.+..|+.++..||.|||+   .+|+|||+||.||||+.++.+|++|||+|+......
T Consensus        83 a~g-~L~~il----~~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   83 AVG-DLFTIL----EQDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhh-hHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            966 999988    455789999999999999999999999   599999999999999999999999999999776543


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                        ...+..+||+-|||||+..+.  .++..+|.||+||++|||.+|++||-.....       ..+...+.+        
T Consensus       155 --~vltsikGtPlYmAPElv~e~--pyd~~sDlWslGcilYE~~~G~PPF~a~si~-------~Lv~~I~~d--------  215 (808)
T KOG0597|consen  155 --SVLTSIKGTPLYMAPELVEEQ--PYDHTSDLWSLGCILYELYVGQPPFYARSIT-------QLVKSILKD--------  215 (808)
T ss_pred             --eeeeeccCcccccCHHHHcCC--CccchhhHHHHHHHHHHHhcCCCCchHHHHH-------HHHHHHhcC--------
Confidence              234566799999999999865  8999999999999999999999998654321       111111111        


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH--HHhcCcCCCCCCCCCCCC
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGSMDDLQMPPKPCFS  477 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~--~Le~~~~~l~~p~~p~~~  477 (511)
                      +...+...+..+..++...|+.||.+|.|..+++.  ..++.....+.|..+.+.
T Consensus       216 ~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~  270 (808)
T KOG0597|consen  216 PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFD  270 (808)
T ss_pred             CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhccccccccc
Confidence            11133356778899999999999999999999986  445544445555555443

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.1e-39  Score=332.13  Aligned_cols=256  Identities=24%  Similarity=0.335  Sum_probs=199.1

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      .+.+.++||+|+||.||+++.. +|..+|+|.+....  ...+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   85 (331)
T cd06649           6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM   85 (331)
T ss_pred             cceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecC
Confidence            3455688999999999999854 78899999986532  23467999999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++|+|.+++.    ....+++..+..++.|++.||.|||+.  .+|+||||||+|||+++++.+||+|||+++...... 
T Consensus        86 ~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  158 (331)
T cd06649          86 DGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (331)
T ss_pred             CCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence            9999999883    234689999999999999999999973  469999999999999999999999999987553321 


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc-----------chh-----
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF-----------PSW-----  409 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~-----------~~~-----  409 (511)
                         .....||..|+|||++.+.  .++.++||||||+++|||++|+.||...........+           +..     
T Consensus       159 ---~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         159 ---ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             ---cccCCCCcCcCCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence               2334689999999999764  7889999999999999999999998643221100000           000     


Q ss_pred             ----------------------hHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHH
Q 010434          410 ----------------------VYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEML  461 (511)
Q Consensus       410 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L  461 (511)
                                            ..+.+.....     .......++..+.+++.+||+.||++|||+.++++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPP-----PKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCC-----cCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                  0000000000     0001112456789999999999999999999998754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.3e-39  Score=320.92  Aligned_cols=259  Identities=24%  Similarity=0.418  Sum_probs=203.9

Q ss_pred             HhhhccccCcCCcEEEEEEEe------cCCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceeccCCceeEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~------~~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  261 (511)
                      .+.+.+.||+|+||.||++..      .++..+|+|.+.... ...+.+.+|+.++++++||||+++++++..+...++|
T Consensus         6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (288)
T cd05093           6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV   85 (288)
T ss_pred             HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            445678899999999999974      234579999987633 3456799999999999999999999999999999999


Q ss_pred             EeecCCCCcccccccCC---------CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeee
Q 010434          262 YEFMPNGSLDRHIFPKE---------NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVS  332 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~  332 (511)
                      |||+++++|.+++....         .....+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl~  162 (288)
T cd05093          86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIG  162 (288)
T ss_pred             EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEec
Confidence            99999999998874322         122358999999999999999999998   699999999999999999999999


Q ss_pred             cccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhH
Q 010434          333 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVY  411 (511)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~  411 (511)
                      |||+++...............++..|+|||++...  .++.++||||||++++||++ |..|+.......        ..
T Consensus       163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--------~~  232 (288)
T cd05093         163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--------VI  232 (288)
T ss_pred             cCCccccccCCceeecCCCCCccccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HH
Confidence            99999865443322222334467899999998764  78899999999999999998 888875432211        12


Q ss_pred             HhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          412 DQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       412 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      ..+..+.....      ....+..+.+++.+||+.||.+|||+.+|++.|+....
T Consensus       233 ~~i~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         233 ECITQGRVLQR------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHHHcCCcCCC------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            22222221111      11234568999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.4e-39  Score=329.44  Aligned_cols=243  Identities=24%  Similarity=0.329  Sum_probs=198.4

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .+.+.+.||+|+||.||+++.. +|+.||||++....    ...+.+.+|+.++++++||||+++++.+.+++..++|||
T Consensus        19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   98 (329)
T PTZ00263         19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE   98 (329)
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence            3566789999999999999864 68999999987532    234678999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++.....
T Consensus        99 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         99 FVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             CCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            999999999883    33578999999999999999999998   69999999999999999999999999999865432


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      .     ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ...+..+..+. ... 
T Consensus       172 ~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~-~~~-  234 (329)
T PTZ00263        172 T-----FTLCGTPEYLAPEVIQSK--GHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRIYEKILAGR-LKF-  234 (329)
T ss_pred             c-----ceecCChhhcCHHHHcCC--CCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHHHHHHhcCC-cCC-
Confidence            2     234589999999999765  678999999999999999999999864321        11222222221 111 


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCC-----HHHHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPS-----MTKVLEM  460 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~evl~~  460 (511)
                           +..++..+.+++.+||+.||.+||+     +.++++.
T Consensus       235 -----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        235 -----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             -----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                 1123456889999999999999987     6887753

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.7e-39  Score=314.42  Aligned_cols=247  Identities=23%  Similarity=0.403  Sum_probs=195.1

Q ss_pred             cccCcCCcEEEEEEEec-CCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCc
Q 010434          194 HKLGQGGFGSVYKGQLH-TGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL  270 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  270 (511)
                      ++||+|+||.||+|... +++.+|+|.+...  ......|.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            47999999999999864 7899999987643  22346799999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeec
Q 010434          271 DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  350 (511)
Q Consensus       271 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  350 (511)
                      .+++.   ..+..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++.............
T Consensus        81 ~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLR---TEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            99883   223568999999999999999999998   699999999999999999999999999987543221111111


Q ss_pred             cccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccchhH
Q 010434          351 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE  429 (511)
Q Consensus       351 ~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  429 (511)
                      ....+..|+|||.+.+.  .++.++||||||+++|||++ |..|+.......        ....+.......      ..
T Consensus       155 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--------~~~~~~~~~~~~------~~  218 (252)
T cd05084         155 MKQIPVKWTAPEALNYG--RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--------TREAIEQGVRLP------CP  218 (252)
T ss_pred             CCCCceeecCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--------HHHHHHcCCCCC------Cc
Confidence            12245679999998654  68899999999999999997 888775432111        112222211111      12


Q ss_pred             HHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          430 SVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       430 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                      ...+..+.+++.+||+.+|++|||+.+|+++|+
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            233567889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.8e-39  Score=314.93  Aligned_cols=245  Identities=24%  Similarity=0.435  Sum_probs=196.2

Q ss_pred             ccCcCCcEEEEEEEe---cCCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          195 KLGQGGFGSVYKGQL---HTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       195 ~LG~G~fg~Vykg~~---~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      +||+|+||.||+|.+   +++..+|+|+++....   ..+++.+|+.++++++||||+++++++.. ...++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            689999999999964   3678999999865332   34679999999999999999999999854 5678999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce-
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-  347 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-  347 (511)
                      +|.+++.    ....+++..+..++.|++.||+|||+   ++++|+||||+||++++++.+||+|||+++......... 
T Consensus        81 ~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            9999883    23468999999999999999999998   699999999999999999999999999998765443221 


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                      ......++..|+|||.+...  .++.++|+||||+++|||++ |+.||.......        +.+.+.++.....    
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~i~~~~~~~~----  219 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYY--KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--------VTQMIESGERMEC----  219 (257)
T ss_pred             ecCCCCCCccccCHhHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHCCCCCCC----
Confidence            11223356799999988653  78889999999999999998 898986532211        2233333322221    


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                        +..++..+.+++.+||+.||++||++.+|++.|++
T Consensus       220 --~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         220 --PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             --CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence              12245678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.7e-39  Score=346.86  Aligned_cols=251  Identities=20%  Similarity=0.223  Sum_probs=200.8

Q ss_pred             hhhccccCcCCcEEEEEEEec-C-CcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-T-GRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~-g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      |.+.+.||+|+||.||++... + ++.||+|.+.... .....+.+|+.++++++|||||++++++..++..+|||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            567789999999999999743 3 6788999765433 334567889999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +|+|.+++........++++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence            999998875433345678999999999999999999998   69999999999999999999999999999876543322


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                      .......||+.|+|||++.+.  .++.++|||||||++|||++|+.|+......        .+...+..+....     
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--------~~~~~~~~~~~~~-----  290 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERK--RYSKKADMWSLGVILYELLTLHRPFKGPSQR--------EIMQQVLYGKYDP-----  290 (478)
T ss_pred             ccccccCCCccccCHhHhCCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCC-----
Confidence            223445699999999998764  7899999999999999999999998643221        1122221111111     


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                       .+..++..+.+++.+||+.+|++||++.+++.
T Consensus       291 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence             11224567889999999999999999999864

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-39  Score=317.73  Aligned_cols=258  Identities=26%  Similarity=0.398  Sum_probs=204.4

Q ss_pred             HHHhhhccccCcCCcEEEEEEEec------CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCce
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  258 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~  258 (511)
                      ...+.+.+.||+|+||.||+|..+      ++..||+|.+....  .....+.+|+.++++++|+||+++++++..+...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            345566789999999999999754      24689999986543  2345789999999999999999999999999999


Q ss_pred             eEEEeecCCCCcccccccCCC------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeee
Q 010434          259 ALVYEFMPNGSLDRHIFPKEN------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVS  332 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~  332 (511)
                      ++||||+++|+|.+++.....      ....+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence            999999999999998853321      12357899999999999999999998   699999999999999999999999


Q ss_pred             cccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhH
Q 010434          333 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVY  411 (511)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~  411 (511)
                      |||+++...............++..|+|||.+...  .++.++||||||+++|||++ |..|+.......        ..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--------~~  231 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--------VL  231 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcC--CCCcccchHHHHHHHHHhhccCCCCCccCCHHH--------HH
Confidence            99999865544332223344578899999998654  78899999999999999998 888875432211        22


Q ss_pred             HhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          412 DQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       412 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      +..........+      ...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       232 ~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         232 KFVIDGGHLDLP------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             HHHhcCCCCCCC------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            222222222211      1235678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.3e-39  Score=322.25  Aligned_cols=259  Identities=24%  Similarity=0.439  Sum_probs=205.1

Q ss_pred             HhhhccccCcCCcEEEEEEEec------CCcEEEEEEeccCcc-cHHHHHHHHHHhccccccceEEeeceeccCCceeEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  261 (511)
                      .+.+.+.||+|+||.||+++..      ++..+++|.+..... ..+.+.+|+.++++++|+||+++++++..+...++|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV   85 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence            3455688999999999999742      356799999876433 346799999999999999999999999999999999


Q ss_pred             EeecCCCCcccccccCC------------CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCe
Q 010434          262 YEFMPNGSLDRHIFPKE------------NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIP  329 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~  329 (511)
                      |||+++++|.+++....            .....+++..+..++.||+.|++|||+   .+++||||||+||++++++.+
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~  162 (291)
T cd05094          86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLV  162 (291)
T ss_pred             EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcE
Confidence            99999999999884322            123458999999999999999999998   699999999999999999999


Q ss_pred             eeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccch
Q 010434          330 KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPS  408 (511)
Q Consensus       330 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~  408 (511)
                      ||+|||+++...............++..|+|||.+...  .++.++||||||+++|||++ |+.|+.......       
T Consensus       163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------  233 (291)
T cd05094         163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------  233 (291)
T ss_pred             EECCCCcccccCCCceeecCCCCCcceeecChHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------
Confidence            99999999765443322222334567899999998764  78899999999999999998 998875432211       


Q ss_pred             hhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          409 WVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       409 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                       ..+....+.....      ....+..+.+++.+||+.+|++|||+.+|+++|+....
T Consensus       234 -~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         234 -VIECITQGRVLER------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             -HHHHHhCCCCCCC------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence             1222222221111      12235678899999999999999999999999998644

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.6e-39  Score=330.44  Aligned_cols=260  Identities=28%  Similarity=0.461  Sum_probs=202.2

Q ss_pred             HHhhhccccCcCCcEEEEEEEec------CCcEEEEEEeccCcc--cHHHHHHHHHHhccc-cccceEEeeceec-cCCc
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCS-EGSK  257 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l-~H~niv~l~g~~~-~~~~  257 (511)
                      ..+++.+.||+|+||.||+|...      +++.||+|+++....  ..+.+.+|+.++.++ +|+||++++++|. .+..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            45677899999999999999632      357899999875322  235678899999999 8999999999875 4567


Q ss_pred             eeEEEeecCCCCcccccccCCCc---------------------------------------------------------
Q 010434          258 RALVYEFMPNGSLDRHIFPKENK---------------------------------------------------------  280 (511)
Q Consensus       258 ~~lV~e~~~~gsL~~~l~~~~~~---------------------------------------------------------  280 (511)
                      .++++||+++++|.+++......                                                         
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            88999999999999887432110                                                         


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeeccccCCccccc
Q 010434          281 GQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA  360 (511)
Q Consensus       281 ~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~A  360 (511)
                      ..+++|..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++...............++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            2368999999999999999999998   6999999999999999999999999999987644333233334456788999


Q ss_pred             hhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHH
Q 010434          361 PELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMI  439 (511)
Q Consensus       361 PE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  439 (511)
                      ||++.+.  .++.++|||||||++|||++ |..|+......       ......+..+....      .+...+..+.++
T Consensus       244 PE~~~~~--~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~~------~~~~~~~~~~~l  308 (337)
T cd05054         244 PESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-------EEFCRRLKEGTRMR------APEYATPEIYSI  308 (337)
T ss_pred             cHHhcCC--CCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-------HHHHHHHhccCCCC------CCccCCHHHHHH
Confidence            9998764  78999999999999999998 98888542211       11112222221111      112234678899


Q ss_pred             HHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          440 GLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       440 ~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                      +.+||+.+|++||++.+++++|+..+
T Consensus       309 ~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         309 MLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHH
Confidence            99999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=331.77  Aligned_cols=249  Identities=20%  Similarity=0.262  Sum_probs=200.5

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+.++||+|+||.||+|+.. +++.||||+++...    ...+.+.+|+.++.+++||||+++++++.++...++||||
T Consensus         3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   82 (333)
T cd05600           3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY   82 (333)
T ss_pred             cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence            456789999999999999865 68999999997532    2345788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++.    ....+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++....  
T Consensus        83 ~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          83 VPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             CCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            99999999883    34578999999999999999999998   6999999999999999999999999999975543  


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCC-ccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG-DLELR  423 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  423 (511)
                         ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......        ....+.... .....
T Consensus       154 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~~~~~~~  220 (333)
T cd05600         154 ---YANSVVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--------TWENLKYWKETLQRP  220 (333)
T ss_pred             ---ccCCcccCccccChhHhcCC--CCCCccceecchHHHhhhhhCCCCCCCCCHHH--------HHHHHHhccccccCC
Confidence               12345699999999999765  78899999999999999999999986543221        111111110 01111


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      ........++..+.+++.+||+.+|.+||++.++++.
T Consensus       221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            1110112346678899999999999999999999875

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.1e-39  Score=320.12  Aligned_cols=262  Identities=21%  Similarity=0.319  Sum_probs=206.1

Q ss_pred             HHHHhhhccccCcCCcEEEEEEEecC-----CcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceecc-CCc
Q 010434          186 IAVTNHFTHKLGQGGFGSVYKGQLHT-----GRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSK  257 (511)
Q Consensus       186 ~~~t~~~~~~LG~G~fg~Vykg~~~~-----g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~-~~~  257 (511)
                      ...++.+.+.||+|+||.||+|...+     +..||+|++...  ....+.+.+|+.++++++|+||+++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            34566677899999999999998665     789999998753  2235678999999999999999999998765 577


Q ss_pred             eeEEEeecCCCCcccccccCCCc----CCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeec
Q 010434          258 RALVYEFMPNGSLDRHIFPKENK----GQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSD  333 (511)
Q Consensus       258 ~~lV~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~D  333 (511)
                      .++++||+++++|.+++......    +..+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence            89999999999999987443221    2569999999999999999999998   6999999999999999999999999


Q ss_pred             ccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHH
Q 010434          334 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYD  412 (511)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~  412 (511)
                      ||+++...............++..|+|||++.+.  .++.++||||||+++||+++ |+.|+.......        ...
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~  230 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNK--EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE--------MAA  230 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcC--CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH--------HHH
Confidence            9999865433322222334467789999998764  68899999999999999999 999986532211        122


Q ss_pred             hhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          413 QLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       413 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      .+........      ...++..+.+++.+||+.+|++|||+.++++.|+....
T Consensus       231 ~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         231 YLKDGYRLAQ------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HHHcCCCCCC------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            2222211111      11234568899999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.3e-39  Score=321.85  Aligned_cols=247  Identities=23%  Similarity=0.313  Sum_probs=196.2

Q ss_pred             cCcCCcEEEEEEEe-cCCcEEEEEEeccCcc----cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCc
Q 010434          196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL  270 (511)
Q Consensus       196 LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  270 (511)
                      ||+|+||+||++.. .+|+.+|+|.+.....    ..+.+..|+.++++++|+||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999985 4789999999865322    235678899999999999999999999999999999999999999


Q ss_pred             ccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeec
Q 010434          271 DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  350 (511)
Q Consensus       271 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  350 (511)
                      ..++.........+++..+..++.||+.||+|||+   .+|+||||||+||++++++.+||+|||+++.......  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            88775443445679999999999999999999998   6999999999999999999999999999976543322  123


Q ss_pred             cccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHH
Q 010434          351 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  430 (511)
Q Consensus       351 ~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  430 (511)
                      ...||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.........    ..........       ....+.
T Consensus       156 ~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~----~~~~~~~~~~-------~~~~~~  222 (280)
T cd05608         156 GYAGTPGFMAPELLQGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQRILND-------SVTYPD  222 (280)
T ss_pred             ccCCCcCccCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH----HHHHHhhccc-------CCCCcc
Confidence            34689999999999764  7889999999999999999999998653321100    0011111110       111223


Q ss_pred             HHHHHHHHHHHHhcCcCCCCCC-----CHHHHHHH
Q 010434          431 VIARKLCMIGLWCIQVKAADRP-----SMTKVLEM  460 (511)
Q Consensus       431 ~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~~  460 (511)
                      .++..+.+++.+||+.||++||     ++.++++.
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            3567788999999999999999     77888763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2e-39  Score=330.25  Aligned_cols=263  Identities=19%  Similarity=0.262  Sum_probs=193.9

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccC-----CceeE
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRAL  260 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~-----~~~~l  260 (511)
                      |.+.++||+|+||.||+|+. .+|+.||||++...   ......+.+|+.++++++||||+++++++...     ...++
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            45678999999999999985 47899999998652   22345788999999999999999999987543     24799


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      ||||++ ++|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        82 v~e~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          82 VFELME-SDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEecCC-CCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            999995 68888772    33569999999999999999999998   69999999999999999999999999999865


Q ss_pred             CCCCCc-eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc-------ccchhhHH
Q 010434          341 PKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA-------YFPSWVYD  412 (511)
Q Consensus       341 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~-------~~~~~~~~  412 (511)
                      ...... .......||+.|+|||++.+....++.++|||||||++|||++|+.||..........       .-+.....
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            332211 1123346899999999987533478899999999999999999999986532111000       00000000


Q ss_pred             hhhcC---------CcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          413 QLNKG---------GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       413 ~~~~~---------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      .+...         ...............+..+.+++.+||+.||++|||+.++++.
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            00000         0000000000111234567899999999999999999999863

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.8e-39  Score=321.47  Aligned_cols=256  Identities=26%  Similarity=0.430  Sum_probs=202.4

Q ss_pred             hhccccCcCCcEEEEEEEec------CCcEEEEEEeccCcc--cHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          191 HFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      .+.++||+|+||.||+|+..      +...+|+|.+.....  ..+++.+|+.++++++||||+++++.+..++..++++
T Consensus         3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (290)
T cd05045           3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV   82 (290)
T ss_pred             cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence            45678999999999999742      235799998865332  3467999999999999999999999999999999999


Q ss_pred             eecCCCCcccccccCC--------------------CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceE
Q 010434          263 EFMPNGSLDRHIFPKE--------------------NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNIL  322 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NIL  322 (511)
                      ||+++|+|.+++....                    .....+++..++.++.|++.||+|||+   .+++||||||+|||
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nil  159 (290)
T cd05045          83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVL  159 (290)
T ss_pred             EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEE
Confidence            9999999998864221                    122468899999999999999999998   69999999999999


Q ss_pred             EcCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccc
Q 010434          323 LDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRS  401 (511)
Q Consensus       323 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~  401 (511)
                      +++++.+||+|||+++...............++..|+|||.+.+.  .++.++||||||+++|||++ |+.|+....   
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~---  234 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIA---  234 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC--CcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence            999999999999999865443332222334567889999988654  78899999999999999998 888885432   


Q ss_pred             cccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          402 SKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                           +..+.+..........      ...++..+.+++.+||+.+|++||++.++++.|+...
T Consensus       235 -----~~~~~~~~~~~~~~~~------~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         235 -----PERLFNLLKTGYRMER------PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             -----HHHHHHHHhCCCCCCC------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence                 1122233332221111      1223467889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.1e-38  Score=368.44  Aligned_cols=266  Identities=22%  Similarity=0.448  Sum_probs=202.8

Q ss_pred             CCChHHHHHHHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCc
Q 010434          179 RYSYPEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  257 (511)
Q Consensus       179 ~~~~~ei~~~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~  257 (511)
                      .+++.++... ....+.||+|+||.||+|+. .+|..||||.++.....   ..+|++.+++++|||||+++|+|.++..
T Consensus       682 ~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~  757 (968)
T PLN00113        682 SITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKG  757 (968)
T ss_pred             hhhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence            3455555443 23356899999999999985 57899999998653322   2346888999999999999999999999


Q ss_pred             eeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccc
Q 010434          258 RALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLA  337 (511)
Q Consensus       258 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla  337 (511)
                      .++||||+++|+|.+++       ..++|..+.+++.|+|+||+|||..+.++|+||||||+||+++.++.+++. ||.+
T Consensus       758 ~~lv~Ey~~~g~L~~~l-------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~  829 (968)
T PLN00113        758 AYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP  829 (968)
T ss_pred             CEEEEeCCCCCcHHHHH-------hcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence            99999999999999998       248999999999999999999997666899999999999999999998886 6655


Q ss_pred             ccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcC
Q 010434          338 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG  417 (511)
Q Consensus       338 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  417 (511)
                      ......      ....+|+.|+|||++...  .++.|+|||||||++|||++|+.|++.....  ......|........
T Consensus       830 ~~~~~~------~~~~~t~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~  899 (968)
T PLN00113        830 GLLCTD------TKCFISSAYVAPETRETK--DITEKSDIYGFGLILIELLTGKSPADAEFGV--HGSIVEWARYCYSDC  899 (968)
T ss_pred             cccccC------CCccccccccCcccccCC--CCCcccchhhHHHHHHHHHhCCCCCCcccCC--CCcHHHHHHHhcCcc
Confidence            433221      223588999999998764  7899999999999999999999998643221  122233332221111


Q ss_pred             C-----cccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          418 G-----DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       418 ~-----~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      .     +..+............++.+++.+||+.+|++||||.+|+++|+....
T Consensus       900 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            0     111111111223345578899999999999999999999999997543

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.4e-39  Score=316.68  Aligned_cols=254  Identities=27%  Similarity=0.426  Sum_probs=197.4

Q ss_pred             hccccCcCCcEEEEEEEecC-Cc--EEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccC------Ccee
Q 010434          192 FTHKLGQGGFGSVYKGQLHT-GR--LIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKRA  259 (511)
Q Consensus       192 ~~~~LG~G~fg~Vykg~~~~-g~--~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~------~~~~  259 (511)
                      +.++||+|+||.||+|+..+ +.  .+|+|.++..   ....+.|.+|+.++++++|+||+++++++...      ...+
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            46789999999999998653 33  6999988653   23456789999999999999999999987432      2468


Q ss_pred             EEEeecCCCCcccccccCC--CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccc
Q 010434          260 LVYEFMPNGSLDRHIFPKE--NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLA  337 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla  337 (511)
                      +++||+++|+|.+++....  .....+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||++
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcc
Confidence            9999999999988763221  223468999999999999999999998   69999999999999999999999999999


Q ss_pred             ccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhc
Q 010434          338 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNK  416 (511)
Q Consensus       338 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  416 (511)
                      +...............+++.|+|||.+.+.  .++.++||||||+++|||++ |+.|+.....        ....+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~~  229 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADR--VYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--------SEIYDYLRQ  229 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCC--CcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHc
Confidence            876543322222233467789999998764  78899999999999999999 7888754221        112333333


Q ss_pred             CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          417 GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                      +.....      ...++..+.+++.+||+.+|++|||+.++++.|+..
T Consensus       230 ~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         230 GNRLKQ------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            322211      112345688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=9.5e-39  Score=313.40  Aligned_cols=253  Identities=28%  Similarity=0.446  Sum_probs=203.1

Q ss_pred             HHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      ..+.+.++||+|+||.||++..+++..+|+|.+.......+.|.+|+.++++++|+|++++++++.. ...+++|||+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~   84 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGK   84 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCC
Confidence            4566778999999999999998777789999987766667789999999999999999999998854 568899999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      ++|.+++...  ....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++....... .
T Consensus        85 ~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~  158 (260)
T cd05069          85 GSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-T  158 (260)
T ss_pred             CCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-c
Confidence            9999988432  23468999999999999999999998   6999999999999999999999999999976543321 1


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                      ......++..|+|||.+.+.  .++.++||||||+++|||++ |+.|+.......        ............     
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~-----  223 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--------VLEQVERGYRMP-----  223 (260)
T ss_pred             ccCCCccchhhCCHHHhccC--CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCC-----
Confidence            11233467889999988654  78899999999999999999 888875432111        112222221111     


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                       .....+..+.+++.+||+.+|++||++++|++.|+.
T Consensus       224 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 -CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             122345678999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.6e-39  Score=346.20  Aligned_cols=253  Identities=24%  Similarity=0.297  Sum_probs=201.5

Q ss_pred             HhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCC--------
Q 010434          189 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS--------  256 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~--------  256 (511)
                      .|.+.++||+|+||.||+++ ..+|+.||||++....   .....+.+|+..+..++|+|++++...+....        
T Consensus        33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~  112 (496)
T PTZ00283         33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL  112 (496)
T ss_pred             CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence            56677899999999999998 4579999999986543   23456889999999999999999988764322        


Q ss_pred             ceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccc
Q 010434          257 KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGL  336 (511)
Q Consensus       257 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGl  336 (511)
                      ..++||||+++|+|.+++.........+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFGl  189 (496)
T PTZ00283        113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGF  189 (496)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence            3679999999999999886544455679999999999999999999998   6999999999999999999999999999


Q ss_pred             cccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhc
Q 010434          337 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK  416 (511)
Q Consensus       337 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  416 (511)
                      ++...............||+.|+|||++.+.  .++.++||||||+++|||++|+.||......       . +......
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-------~-~~~~~~~  259 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFDGENME-------E-VMHKTLA  259 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-------H-HHHHHhc
Confidence            9876543222222445699999999999764  7899999999999999999999998653221       1 1222222


Q ss_pred             CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          417 GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      +....      .+..++..+.+++.+||+.+|.+||++.+++++
T Consensus       260 ~~~~~------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        260 GRYDP------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCCCC------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            11111      122345678899999999999999999999864

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.6e-39  Score=328.02  Aligned_cols=257  Identities=23%  Similarity=0.335  Sum_probs=198.7

Q ss_pred             HHHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          186 IAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       186 ~~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      ....|.+.++||+|+||.||++... ++..+|+|.+....  ...+.+.+|++++++++|+||+++++++.+++..++||
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            3445667889999999999999855 68899999886532  23467999999999999999999999999999999999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+++|+|.+++.    ....+++..+..++.|++.||.|||+.  .+++|+||||+|||+++++.+||+|||++.....
T Consensus        83 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          83 EHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             ecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            9999999999883    235689999999999999999999972  4799999999999999999999999999875533


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc-------ch-------
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF-------PS-------  408 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~-------~~-------  408 (511)
                      ..    .....||..|+|||++.+.  .++.++|||||||++|||++|+.|+...........+       +.       
T Consensus       157 ~~----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (333)
T cd06650         157 SM----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR  230 (333)
T ss_pred             hc----cccCCCCccccCHHHhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence            21    1334689999999998764  6889999999999999999999998653221100000       00       


Q ss_pred             ----------------------hhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          409 ----------------------WVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       409 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                                            .....+........     .....+..+.+++.+||+.||++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL-----PSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             cCCccchhhhhcccccccccHHHHHHHHhcCCCccC-----CCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                                  00000000000000     00113456889999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=9e-39  Score=317.29  Aligned_cols=254  Identities=25%  Similarity=0.393  Sum_probs=197.9

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCc----EEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGR----LIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~----~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      +++.+.||+|+||.||+|.+. +++    .+++|.+....  ....++.+|+..+++++||||+++++++.. ...++++
T Consensus         9 ~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~   87 (279)
T cd05111           9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVT   87 (279)
T ss_pred             ceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEE
Confidence            345678999999999999853 454    47888875432  234578889999999999999999999864 5578999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+++|+|.+++..   ....+++..+..++.||+.||+|||+   .+++|+||||+|||+++++.+||+|||+++....
T Consensus        88 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          88 QLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            99999999999842   23578999999999999999999998   6999999999999999999999999999986543


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCccc
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (511)
                      ...........++..|+|||.+...  .++.++||||||+++|||++ |+.|+......        ...+.+..+....
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~  231 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFG--RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--------EVPDLLEKGERLA  231 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCcCC
Confidence            3322223345577899999998754  78999999999999999998 99888653221        1222223322222


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      ...      ..+..+..++.+||+.+|++|||+.++++.|.....
T Consensus       232 ~~~------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         232 QPQ------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             CCC------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            111      123456789999999999999999999999987553

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.6e-39  Score=321.84  Aligned_cols=260  Identities=20%  Similarity=0.269  Sum_probs=198.2

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      +.+.+.||+|+||.||+++.+ +++.||||+++...   ...+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07848           3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV   82 (287)
T ss_pred             ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence            456789999999999999865 68899999987532   33567889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      +++.+..+.    .....+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++.......
T Consensus        83 ~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          83 EKNMLELLE----EMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             CCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            988776543    223568999999999999999999998   6999999999999999999999999999986543221


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc-------cccchhhHHhhhcCC
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK-------AYFPSWVYDQLNKGG  418 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~~~~  418 (511)
                       .......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.........       ...+...........
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07848         156 -ANYTEYVATRWYRSPELLLGA--PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP  232 (287)
T ss_pred             -ccccccccccccCCcHHHcCC--CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence             112334589999999998764  6889999999999999999999998653221100       001110001000000


Q ss_pred             ------ccccccc----chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          419 ------DLELRNV----TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       419 ------~~~~~~~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                            .......    ......++..+.+++.+||+.||++|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                  0000000    0112235677999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8e-39  Score=315.16  Aligned_cols=255  Identities=28%  Similarity=0.444  Sum_probs=200.1

Q ss_pred             hhccccCcCCcEEEEEEEec-C---CcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccCCc------
Q 010434          191 HFTHKLGQGGFGSVYKGQLH-T---GRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK------  257 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~-~---g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~------  257 (511)
                      .+.+.||+|+||.||+|+.. +   +..||||.++....   ..+.+.+|+..++.++||||+++++++.....      
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   81 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK   81 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence            45678999999999999854 2   36899999875432   34578999999999999999999998866554      


Q ss_pred             eeEEEeecCCCCcccccccCC--CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccc
Q 010434          258 RALVYEFMPNGSLDRHIFPKE--NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFG  335 (511)
Q Consensus       258 ~~lV~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFG  335 (511)
                      .++++||+++|+|..++....  .....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCcc
Confidence            789999999999998874432  123468999999999999999999998   699999999999999999999999999


Q ss_pred             ccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhh
Q 010434          336 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQL  414 (511)
Q Consensus       336 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  414 (511)
                      +++...............++..|+|||.+.+.  .++.++||||||+++|||++ |..|+......        ...+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--------~~~~~~  228 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--------EIYDYL  228 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHH
Confidence            99866544332222233457789999998654  78899999999999999999 88887543211        122222


Q ss_pred             hcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          415 NKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       415 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                      ..+....      .+...+..+.+++.+||+.||.+|||+.++++.|+..
T Consensus       229 ~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         229 RHGNRLK------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HcCCCCC------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            2222221      1223456789999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.7e-39  Score=320.93  Aligned_cols=260  Identities=23%  Similarity=0.328  Sum_probs=195.3

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      |.+.++||.|+||.||+|... +++.||+|.++..  ......+.+|+.++++++||||+++++++..+...++||||++
T Consensus         7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   86 (288)
T cd07871           7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD   86 (288)
T ss_pred             ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence            556789999999999999854 7899999998653  2234578899999999999999999999999999999999997


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                       |+|.+++.   ..+..+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++....... 
T Consensus        87 -~~l~~~l~---~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-  158 (288)
T cd07871          87 -SDLKQYLD---NCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-  158 (288)
T ss_pred             -cCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence             48888763   233568899999999999999999998   6999999999999999999999999999976433221 


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc-------chhhHHhhhcCC-
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF-------PSWVYDQLNKGG-  418 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~~~~~-  418 (511)
                       ......+++.|+|||.+.+. ..++.++||||+|+++|||++|+.||............       +...+....... 
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         159 -TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             -cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence             22344589999999988653 36789999999999999999999998653321100000       000000000000 


Q ss_pred             --ccccc-----ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          419 --DLELR-----NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       419 --~~~~~-----~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                        .....     ........++..+.+++.+||+.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence              00000     000011123456789999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.9e-39  Score=321.59  Aligned_cols=258  Identities=24%  Similarity=0.420  Sum_probs=203.8

Q ss_pred             HhhhccccCcCCcEEEEEEEec------CCcEEEEEEeccCc--ccHHHHHHHHHHhccc-cccceEEeeceeccCCcee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSK--FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRA  259 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~  259 (511)
                      .+.+.+.||+|+||.||++...      +...+|+|.+....  ....++.+|+.++.++ +|+||+++++++..+...+
T Consensus        13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   92 (293)
T cd05053          13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLY   92 (293)
T ss_pred             HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeE
Confidence            4456689999999999999753      23689999987532  2345688999999999 8999999999999999999


Q ss_pred             EEEeecCCCCcccccccCC------------CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC
Q 010434          260 LVYEFMPNGSLDRHIFPKE------------NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF  327 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~  327 (511)
                      ++|||+++|+|.+++....            .....+++..++.++.|++.||+|||+   .+|+|+||||+|||+++++
T Consensus        93 li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~~~  169 (293)
T cd05053          93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDH  169 (293)
T ss_pred             EEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcCCC
Confidence            9999999999998874321            234578999999999999999999998   6999999999999999999


Q ss_pred             CeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCccccccccccc
Q 010434          328 IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYF  406 (511)
Q Consensus       328 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~  406 (511)
                      .+||+|||+++...............++..|+|||.+...  .++.++||||||+++|||++ |..|+......      
T Consensus       170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------  241 (293)
T cd05053         170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE------  241 (293)
T ss_pred             eEEeCccccccccccccceeccCCCCCCccccCHHHhccC--CcCcccceeehhhHHHHHhcCCCCCCCCCCHH------
Confidence            9999999999876544332333334467889999988654  78899999999999999997 88887532211      


Q ss_pred             chhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          407 PSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       407 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                        .+.+.+..+....      .+...+..+.+++.+||+.+|++|||+.++++.|+..+
T Consensus       242 --~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         242 --ELFKLLKEGYRME------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             --HHHHHHHcCCcCC------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence              1222222222211      11123457889999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.8e-39  Score=330.42  Aligned_cols=246  Identities=26%  Similarity=0.417  Sum_probs=192.0

Q ss_pred             hhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          191 HFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      .+.++||+|+||.||+++. .+|+.||||++....  ...+.+.+|++++++++|+||+++++++..++..++||||+++
T Consensus        77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  156 (353)
T PLN00034         77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG  156 (353)
T ss_pred             hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence            3467899999999999985 478999999986532  2346789999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|.+..        ...+..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++.......  
T Consensus       157 ~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--  223 (353)
T PLN00034        157 GSLEGTH--------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--  223 (353)
T ss_pred             Ccccccc--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence            9986543        34577888999999999999998   6999999999999999999999999999986543221  


Q ss_pred             eeccccCCccccchhcccccC---CCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          348 SISATRGTIGYIAPELISRNF---GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~---~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      ......||..|+|||++....   ...+.++|||||||++|||++|+.||.......    +.. ..........     
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~----~~~-~~~~~~~~~~-----  293 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD----WAS-LMCAICMSQP-----  293 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc----HHH-HHHHHhccCC-----
Confidence            123456999999999875321   134568999999999999999999987322111    000 0011111111     


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                       ......++..+.+++.+||+.||++|||+.|+++.
T Consensus       294 -~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        294 -PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             -CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             11222345678999999999999999999999874

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-38  Score=311.41  Aligned_cols=256  Identities=29%  Similarity=0.475  Sum_probs=207.5

Q ss_pred             HHHHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          186 IAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       186 ~~~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      ....+.+.++||+|+||.||++..++++.+|||.+.......+++.+|+.++++++|+||+++++++..+...++||||+
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            34456677899999999999999888899999999877777889999999999999999999999999989999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++++|.+++..  ..+..+++..+..++.+++.|++|||+   .+++|+||||+||++++++.+||+|||+++...... 
T Consensus        84 ~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-  157 (261)
T cd05034          84 SKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-  157 (261)
T ss_pred             CCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchh-
Confidence            99999998843  233578999999999999999999998   599999999999999999999999999988664321 


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      ........++..|+|||.+.+.  .++.++|+||||++++||++ |+.|+......        ...+.........   
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~---  224 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--------EVLEQVERGYRMP---  224 (261)
T ss_pred             hhhhhccCCCccccCHHHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCC---
Confidence            1111223356789999998764  68899999999999999998 89888543211        1222222221111   


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                         .+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus       225 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         225 ---RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence               111124678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.9e-39  Score=324.61  Aligned_cols=258  Identities=23%  Similarity=0.321  Sum_probs=194.0

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      .|.+.++||+|+||.||+|+.. +++.||||++....  .....+.+|+.++++++||||+++++++.++...++||||+
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   85 (303)
T cd07869           6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV   85 (303)
T ss_pred             cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence            4566789999999999999865 78999999987532  23456789999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      + ++|.+++.   .....+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++.......
T Consensus        86 ~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  158 (303)
T cd07869          86 H-TDLCQYMD---KHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH  158 (303)
T ss_pred             C-cCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence            5 67766663   233568999999999999999999998   6999999999999999999999999999875432221


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhh----------
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLN----------  415 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------  415 (511)
                        ......+|+.|+|||++.+. ..++.++|||||||++|||++|+.||..........   ..+...+.          
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  232 (303)
T cd07869         159 --TYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQL---ERIFLVLGTPNEDTWPGV  232 (303)
T ss_pred             --cCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH---HHHHHHhCCCChhhccch
Confidence              22345589999999998653 357889999999999999999999996532110000   00000000          


Q ss_pred             -cC-----CcccccccchhHH-----HHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          416 -KG-----GDLELRNVTEIES-----VIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       416 -~~-----~~~~~~~~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                       ..     .............     ..+..+.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence             00     0000000000111     12356789999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.3e-39  Score=326.12  Aligned_cols=240  Identities=23%  Similarity=0.325  Sum_probs=194.0

Q ss_pred             cccCcCCcEEEEEEEe-cCCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          194 HKLGQGGFGSVYKGQL-HTGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      +.||+|+||.||+++. .+|+.||+|++...    ......+.+|+.++++++||||+++++.+......++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4689999999999985 47899999998753    223456788999999999999999999999999999999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      +|..++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~  151 (323)
T cd05595          81 ELFFHLS----RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--T  151 (323)
T ss_pred             cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--c
Confidence            9988772    33578999999999999999999998   6999999999999999999999999999875322221  2


Q ss_pred             eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchh
Q 010434          349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEI  428 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  428 (511)
                      .....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||.......        ....+.... ..      .
T Consensus       152 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--------~~~~~~~~~-~~------~  214 (323)
T cd05595         152 MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELILMEE-IR------F  214 (323)
T ss_pred             cccccCCcCcCCcccccCC--CCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcCC-CC------C
Confidence            2345689999999998764  78899999999999999999999986432211        111111110 11      1


Q ss_pred             HHHHHHHHHHHHHHhcCcCCCCCC-----CHHHHHH
Q 010434          429 ESVIARKLCMIGLWCIQVKAADRP-----SMTKVLE  459 (511)
Q Consensus       429 ~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~  459 (511)
                      +..++..+.+++.+||+.||++||     ++.++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            223456788999999999999998     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=5.6e-39  Score=319.98  Aligned_cols=259  Identities=23%  Similarity=0.362  Sum_probs=190.4

Q ss_pred             hhhccccCcCCcEEEEEEEe--cCCcEEEEEEeccCc---ccHHHHHHHHHHhccc---cccceEEeeceec-----cCC
Q 010434          190 NHFTHKLGQGGFGSVYKGQL--HTGRLIAVKMLENSK---FSAEEFINEVSTIGRI---HHVNVVQLLGFCS-----EGS  256 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~--~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l---~H~niv~l~g~~~-----~~~  256 (511)
                      |.+.++||+|+||.||+++.  .+|+.||||.+....   .....+.+|+.+++++   +||||+++++++.     ...
T Consensus         3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~   82 (290)
T cd07862           3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   82 (290)
T ss_pred             cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence            55678999999999999985  357889999986532   2334667788777665   6999999999884     345


Q ss_pred             ceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccc
Q 010434          257 KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGL  336 (511)
Q Consensus       257 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGl  336 (511)
                      ..++||||++ ++|.+++...  ....+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+
T Consensus        83 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          83 KLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             cEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            6899999996 6888877322  23468999999999999999999998   6999999999999999999999999999


Q ss_pred             cccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc--------c-
Q 010434          337 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF--------P-  407 (511)
Q Consensus       337 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~--------~-  407 (511)
                      ++......   ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||........-..+        + 
T Consensus       157 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~  231 (290)
T cd07862         157 ARIYSFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  231 (290)
T ss_pred             eEeccCCc---ccccccccccccChHHHhCC--CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence            98654331   22345689999999998754  7889999999999999999999998754321100000        0 


Q ss_pred             hhhHHh-hhcCC--cccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          408 SWVYDQ-LNKGG--DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       408 ~~~~~~-~~~~~--~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .|-... +....  .............++..+.+++.+||+.||++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            000000 00000  00000001111234567789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=9.2e-39  Score=314.91  Aligned_cols=256  Identities=25%  Similarity=0.378  Sum_probs=192.4

Q ss_pred             cccCcCCcEEEEEEEecC---CcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          194 HKLGQGGFGSVYKGQLHT---GRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~---g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      ++||+|+||.||+|...+   ...+|+|.+....  .....|.+|+.+++.++|+||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            469999999999997543   3578888876532  23457899999999999999999999999999999999999999


Q ss_pred             CcccccccCCC-cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          269 SLDRHIFPKEN-KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       269 sL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      +|.+++..... .....++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99998854332 12345788899999999999999998   699999999999999999999999999987544333222


Q ss_pred             eeccccCCccccchhccccc-----CCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCccc
Q 010434          348 SISATRGTIGYIAPELISRN-----FGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~-----~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (511)
                      ......++..|+|||++...     ...++.++||||||+++|||++ |..|+.......       ........ ....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~~~-~~~~  229 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-------VLKQVVRE-QDIK  229 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHHhhc-cCcc
Confidence            22334467789999987531     1256889999999999999999 677765432111       11111111 1111


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                      ...+ .....++..+.+++..|| .||++|||+++|+++|.
T Consensus       230 ~~~~-~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         230 LPKP-QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCC-cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1111 123345566778888898 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.9e-39  Score=326.49  Aligned_cols=241  Identities=22%  Similarity=0.316  Sum_probs=195.1

Q ss_pred             cccCcCCcEEEEEEEe-cCCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          194 HKLGQGGFGSVYKGQL-HTGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      +.||+|+||.||++.. .+|+.||+|++...    ......+.+|+.++++++||||+++.+++..+...++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4689999999999985 47899999999753    234457889999999999999999999999999999999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      +|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~  151 (328)
T cd05593          81 ELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--T  151 (328)
T ss_pred             CHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--c
Confidence            9988773    33578999999999999999999998   6999999999999999999999999999875332211  2


Q ss_pred             eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchh
Q 010434          349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEI  428 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  428 (511)
                      .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......        ....+... ..      ..
T Consensus       152 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~Pf~~~~~~~--------~~~~~~~~-~~------~~  214 (328)
T cd05593         152 MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELILME-DI------KF  214 (328)
T ss_pred             cccccCCcCccChhhhcCC--CCCccCCccccchHHHHHhhCCCCCCCCCHHH--------HHHHhccC-Cc------cC
Confidence            2345699999999998764  77899999999999999999999986432211        11111111 11      12


Q ss_pred             HHHHHHHHHHHHHHhcCcCCCCCC-----CHHHHHHH
Q 010434          429 ESVIARKLCMIGLWCIQVKAADRP-----SMTKVLEM  460 (511)
Q Consensus       429 ~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~~  460 (511)
                      +..++..+.+++.+||+.||++||     ++.++++.
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            223456788999999999999997     89998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-39  Score=319.29  Aligned_cols=267  Identities=28%  Similarity=0.381  Sum_probs=203.5

Q ss_pred             hccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhcc--ccccceEEeeceeccCC----ceeEEEeec
Q 010434          192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGR--IHHVNVVQLLGFCSEGS----KRALVYEFM  265 (511)
Q Consensus       192 ~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~--l~H~niv~l~g~~~~~~----~~~lV~e~~  265 (511)
                      +.+.+|+|+||.||||+++ ++.||||++..  .+.+.|.+|-++.+.  ++|+||+++++.-..+.    ...||++|.
T Consensus       214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~--~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh  290 (534)
T KOG3653|consen  214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPE--QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH  290 (534)
T ss_pred             hHHHhhcCccceeehhhcc-CceeEEEecCH--HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence            4678999999999999987 59999999854  356678888777664  58999999999865544    788999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhC------CCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG------CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~------~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      ++|+|.++|     ....++|....+|+..+++||+|||..      ..+.|+|||||++||||.+|+++.|+|||||..
T Consensus       291 ~kGsL~dyL-----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~  365 (534)
T KOG3653|consen  291 PKGSLCDYL-----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR  365 (534)
T ss_pred             cCCcHHHHH-----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence            999999999     457899999999999999999999973      346799999999999999999999999999987


Q ss_pred             CCCCCCceeeccccCCccccchhcccccCCC----cCccchHHHHHHHHHHHHhCCCCCCcccccccccccc--------
Q 010434          340 HPKENDFVSISATRGTIGYIAPELISRNFGT----VSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP--------  407 (511)
Q Consensus       340 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~----~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~--------  407 (511)
                      +............+||.+|||||++.+....    .-.+.||||+|.+||||++...-.+.......+..|.        
T Consensus       366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt  445 (534)
T KOG3653|consen  366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT  445 (534)
T ss_pred             ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence            7654443344456799999999999764321    1246899999999999999765443222222222221        


Q ss_pred             --hhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          408 --SWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       408 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                        +.-.-.+.+..+..+++.- .......-+++.+..||..||+-|.|+.=|-+.+......
T Consensus       446 ~e~mq~~VV~kK~RP~~p~~W-~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~  506 (534)
T KOG3653|consen  446 LEEMQELVVRKKQRPKIPDAW-RKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML  506 (534)
T ss_pred             HHHHHHHHHhhccCCCChhhh-hcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence              1111122333344443322 2224456789999999999999999999998888764433

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.3e-38  Score=313.07  Aligned_cols=257  Identities=21%  Similarity=0.326  Sum_probs=204.8

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+.++||+|+||.||+|+. .+++.||||.+...    ......|.+|+.++++++||||+++++++...+..++++||
T Consensus         4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   83 (267)
T cd08228           4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL   83 (267)
T ss_pred             eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence            45678999999999999985 47899999987542    22345789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++.........+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            99999998874333344568999999999999999999998   699999999999999999999999999988654332


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      .  ......+++.|+|||.+.+.  .++.++|+||||+++|||++|+.|+.......     .. ..+.+......    
T Consensus       161 ~--~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-----~~-~~~~~~~~~~~----  226 (267)
T cd08228         161 T--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----FS-LCQKIEQCDYP----  226 (267)
T ss_pred             H--HHhcCCCCccccChhhhccC--CCCchhhHHHHHHHHHHHhcCCCCCccccccH-----HH-HHHHHhcCCCC----
Confidence            1  12234588899999998764  67889999999999999999999975432110     11 11222221111    


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                       .......+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus       227 -~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         227 -PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             -CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence             112233556789999999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=9.6e-39  Score=318.41  Aligned_cols=261  Identities=25%  Similarity=0.400  Sum_probs=202.8

Q ss_pred             HHHHhhhccccCcCCcEEEEEEEec------CCcEEEEEEeccCcc--cHHHHHHHHHHhccccccceEEeeceeccCCc
Q 010434          186 IAVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  257 (511)
Q Consensus       186 ~~~t~~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~  257 (511)
                      ....+.+.++||+|+||.||+|..+      .+..||+|.+.....  ....+.+|+.++++++||||+++++++.++..
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3456677889999999999999643      245899999865432  33468899999999999999999999999999


Q ss_pred             eeEEEeecCCCCcccccccCCC------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeee
Q 010434          258 RALVYEFMPNGSLDRHIFPKEN------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKV  331 (511)
Q Consensus       258 ~~lV~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl  331 (511)
                      .++||||+++|+|.+++.....      ....+++..+..++.|++.||+|||+   ++|+||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999843211      12346788899999999999999998   69999999999999999999999


Q ss_pred             ecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhh
Q 010434          332 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWV  410 (511)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~  410 (511)
                      +|||+++...............++..|+|||.+.+.  .++.++||||||+++|||++ |..|+.......        .
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--------~  230 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--------V  230 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccC--CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--------H
Confidence            999999865433322222223457789999998754  78899999999999999998 677775432111        1


Q ss_pred             HHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          411 YDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       411 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                      .+.+..+.....      ....+..+.+++.+||+.+|++|||+.++++.|+...
T Consensus       231 ~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         231 LKFVMDGGYLDQ------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHHHHcCCCCCC------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            122222211111      1123467899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-39  Score=335.01  Aligned_cols=244  Identities=25%  Similarity=0.375  Sum_probs=208.7

Q ss_pred             hhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          191 HFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      .+.+.||.|+-|.|-.|+. .+|+.+|||++.+.    ........+|+.+|+-|.||||++|++++++..++|+|.||+
T Consensus        15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv   94 (786)
T KOG0588|consen   15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV   94 (786)
T ss_pred             eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence            3467899999999999984 58999999999663    223456789999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++|-|.+++    -..+++++....+++.||+.|+.|+|+   .+|+|||+||+|+|||.++++||+|||+|.+-.... 
T Consensus        95 ~gGELFdyl----v~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk-  166 (786)
T KOG0588|consen   95 PGGELFDYL----VRKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK-  166 (786)
T ss_pred             CCchhHHHH----HhhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc-
Confidence            999999998    345789999999999999999999999   799999999999999999999999999998655443 


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                        -....+|++.|.|||++.+. ..-..++||||.||+||.|++|+.||+....+.        ++..+..+.       
T Consensus       167 --lLeTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~--------LLlKV~~G~-------  228 (786)
T KOG0588|consen  167 --LLETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV--------LLLKVQRGV-------  228 (786)
T ss_pred             --cccccCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCccHHH--------HHHHHHcCc-------
Confidence              34566899999999999886 345789999999999999999999999654332        233333331       


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      -+++..++.+.++|+..|+..||++|.|+.+|++.
T Consensus       229 f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  229 FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence            23556678899999999999999999999999984

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.4e-38  Score=313.84  Aligned_cols=256  Identities=26%  Similarity=0.390  Sum_probs=192.3

Q ss_pred             cccCcCCcEEEEEEEec---CCcEEEEEEeccCcc--cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          194 HKLGQGGFGSVYKGQLH---TGRLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~---~g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      +.||+|+||.||+|...   ++..+|+|.++....  ....|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            36899999999999854   346799999876432  3357899999999999999999999999999999999999999


Q ss_pred             CcccccccCCC-cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          269 SLDRHIFPKEN-KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       269 sL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      +|.+++..... .....++..+..++.|++.|++|||+   .+++|+||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99998854322 22356788889999999999999998   699999999999999999999999999997544333222


Q ss_pred             eeccccCCccccchhcccccCC-----CcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCccc
Q 010434          348 SISATRGTIGYIAPELISRNFG-----TVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~-----~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (511)
                      ......++..|+|||++.+..+     .++.++|+||||+++|||++ |+.||.......        ............
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~  229 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--------VLTYTVREQQLK  229 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--------HHHHHhhcccCC
Confidence            2233457889999999864321     35789999999999999996 998986432211        000000111111


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                      ...+. .....+..+.+++..|+ .+|++|||+.+|+..|+
T Consensus       230 ~~~~~-~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         230 LPKPR-LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCc-cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11110 11123345777889998 58999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.7e-39  Score=327.70  Aligned_cols=245  Identities=24%  Similarity=0.278  Sum_probs=199.7

Q ss_pred             HHHhhhccccCcCCcEEEEEEEecC--CcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeE
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQLHT--GRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  260 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~~~--g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  260 (511)
                      ...+.+.++||+|+||.||+|..++  +..||+|.+...    ....+.+.+|+.+++.++||||+++++++.++...++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3456778899999999999998543  368999998653    2244678899999999999999999999999999999


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      ||||+++|+|.+++.    ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       109 v~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        109 VLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             EEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            999999999999883    33578999999999999999999998   69999999999999999999999999999865


Q ss_pred             CCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcc
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDL  420 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (511)
                      ....     ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ...++.+..+.. 
T Consensus       182 ~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--------~~~~~~i~~~~~-  245 (340)
T PTZ00426        182 DTRT-----YTLCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPFYANEP--------LLIYQKILEGII-  245 (340)
T ss_pred             CCCc-----ceecCChhhcCHHHHhCC--CCCccccccchhhHHHHHhcCCCCCCCCCH--------HHHHHHHhcCCC-
Confidence            4321     234689999999999764  678999999999999999999999865321        122333333211 


Q ss_pred             cccccchhHHHHHHHHHHHHHHhcCcCCCCCC-----CHHHHHHH
Q 010434          421 ELRNVTEIESVIARKLCMIGLWCIQVKAADRP-----SMTKVLEM  460 (511)
Q Consensus       421 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~~  460 (511)
                      .      .+..++..+.+++.+|++.+|++|+     +++++++.
T Consensus       246 ~------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 Y------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             C------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            1      1122345678899999999999995     89998774

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.8e-38  Score=322.04  Aligned_cols=236  Identities=25%  Similarity=0.342  Sum_probs=187.3

Q ss_pred             cccCcCCcEEEEEEEec-CCcEEEEEEeccCc----ccHHHHHHHHH-HhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK----FSAEEFINEVS-TIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~----~~~~~f~~Ev~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      +.||+|+||.||+++.. +|+.||||++....    ....++..|.. +++.++||||+++++.+.+....++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999864 78999999986532    22345556655 46789999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--  151 (323)
T cd05575          81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--  151 (323)
T ss_pred             CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--
Confidence            99988873    34578999999999999999999998   6999999999999999999999999999875322221  


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......        ..+.+.... ..      
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~-~~------  214 (323)
T cd05575         152 TTSTFCGTPEYLAPEVLRKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE--------MYDNILNKP-LR------  214 (323)
T ss_pred             ccccccCChhhcChhhhcCC--CCCccccccccchhhhhhhcCCCCCCCCCHHH--------HHHHHHcCC-CC------
Confidence            22344689999999998764  78899999999999999999999986532211        122222111 11      


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHH
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMT  455 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~  455 (511)
                      ....++..+.+++.+||+.||++||++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         215 LKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            1122356788999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-38  Score=307.72  Aligned_cols=250  Identities=31%  Similarity=0.498  Sum_probs=205.1

Q ss_pred             cccCcCCcEEEEEEEecC----CcEEEEEEeccCccc--HHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQLHT----GRLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~----g~~vAvK~l~~~~~~--~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      ++||+|+||.||++....    +..+|+|.+......  .+.+.+|+..+.+++|+|++++++++..+...+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999998653    889999999774433  57899999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCc-----CCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          268 GSLDRHIFPKENK-----GQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       268 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ++|.+++......     ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||.++....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999998443211     4779999999999999999999998   6999999999999999999999999999987765


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCccc
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (511)
                      ...........++..|+|||.+...  .++.++||||+|++++||++ |+.|+.....        ....+.+..+....
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~  227 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEVLEYLRKGYRLP  227 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCC
Confidence            5433333455688999999998765  78899999999999999998 5888865421        11223333222211


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                            ....++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       228 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         228 ------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  22233677889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3e-38  Score=308.57  Aligned_cols=251  Identities=29%  Similarity=0.506  Sum_probs=203.2

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      .+.+.++||+|+||.||++...+++.+|+|.+........+|.+|++++++++|||++++++++......++|+||++++
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG   84 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence            44567899999999999998877889999999876667788999999999999999999999999999999999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      +|.+++..   ....++++.+..++.+++.|++|||+   .+++|+||||+||+++.++.+||+|||+++....... ..
T Consensus        85 ~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~  157 (256)
T cd05112          85 CLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TS  157 (256)
T ss_pred             cHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcc-cc
Confidence            99988732   23468999999999999999999998   6999999999999999999999999999876543321 11


Q ss_pred             eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      .....++.+|+|||.+.+.  .++.++||||||+++|||++ |+.|+.......        ..+.+.++......    
T Consensus       158 ~~~~~~~~~~~aPe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~----  223 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFS--KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--------VVETINAGFRLYKP----  223 (256)
T ss_pred             cCCCccchhhcCHhHhccC--CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--------HHHHHhCCCCCCCC----
Confidence            1233356789999998754  78899999999999999998 888886432211        22222222111111    


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                        ...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       224 --~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         224 --RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             --CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence              112467889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=331.76  Aligned_cols=249  Identities=25%  Similarity=0.441  Sum_probs=209.2

Q ss_pred             hhccccCcCCcEEEEEEEec---CC--cEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          191 HFTHKLGQGGFGSVYKGQLH---TG--RLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~---~g--~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      ...++||.|-||.||+|...   .|  -.||||.-+.+  ..+.+.|++|+.+|+.++|||||+|+|+|.+ ...+||||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE  470 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME  470 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence            45678999999999999843   23  36899998773  3467889999999999999999999999977 57899999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      .++-|.|..++   +.....|+...+...+.||..||+|||+   ++.|||||..+|||+.+...+||+||||++....+
T Consensus       471 L~~~GELr~yL---q~nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  471 LAPLGELREYL---QQNKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             cccchhHHHHH---HhccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            99999999999   3445789999999999999999999999   79999999999999999999999999999998877


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                      ..+... ..+-++.|||||.+.  +..+|.+||||.|||.+||++. |.+||..-...+        +.-+++++.++. 
T Consensus       545 ~yYkaS-~~kLPIKWmaPESIN--fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD--------VI~~iEnGeRlP-  612 (974)
T KOG4257|consen  545 AYYKAS-RGKLPIKWMAPESIN--FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD--------VIGHIENGERLP-  612 (974)
T ss_pred             chhhcc-ccccceeecCccccc--hhcccchhhHHHHHHHHHHHHHhcCCccccccccc--------eEEEecCCCCCC-
Confidence            666543 555789999999985  4599999999999999999986 889986543222        233455555544 


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                           .++.+++.|..++.+||..+|.+||++.++...|+.
T Consensus       613 -----~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd  648 (974)
T KOG4257|consen  613 -----CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD  648 (974)
T ss_pred             -----CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence                 344567889999999999999999999999877654

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-38  Score=309.99  Aligned_cols=247  Identities=30%  Similarity=0.484  Sum_probs=196.9

Q ss_pred             cccCcCCcEEEEEEEec--C--CcEEEEEEeccCcc--cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQLH--T--GRLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~--~--g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      ++||+|+||.||+|+..  +  +..+|+|.+.....  ..+++.+|+.++++++|+||+++++++. ....++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999742  2  36899999876544  4568999999999999999999999876 4567999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|.+++.    ....+++..+..++.|++.||+|||.   .+++|+||||+|||++.++.+||+|||+++.........
T Consensus        80 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLK----KRREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            99999983    22378999999999999999999998   699999999999999999999999999998664433221


Q ss_pred             -eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          348 -SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       348 -~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                       ......++..|+|||.+...  .++.++||||||+++|||++ |+.|++......        +...+.......    
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~--------~~~~~~~~~~~~----  218 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYG--KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--------VIAMLESGERLP----  218 (257)
T ss_pred             ccccCccccccccCHHHhcCC--CCCccchHHHHHHHHHHHHcCCCCCcccCCHHH--------HHHHHHcCCcCC----
Confidence             11223346789999998654  78899999999999999998 999986543211        122222222111    


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                        ....++..+.+++.+||+.+|++||++.++++.|++.
T Consensus       219 --~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         219 --RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence              1122456788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1e-38  Score=316.87  Aligned_cols=255  Identities=24%  Similarity=0.426  Sum_probs=200.2

Q ss_pred             hhhccccCcCCcEEEEEEEec------CCcEEEEEEeccC-cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      ..+.++||+|+||.||++..+      ++..+|+|.+... ....++|.+|++++++++|+||+++++++..+...++++
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   86 (280)
T cd05092           7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVF   86 (280)
T ss_pred             ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEE
Confidence            345689999999999999632      3568999988653 334568999999999999999999999999999999999


Q ss_pred             eecCCCCcccccccCCC-----------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeee
Q 010434          263 EFMPNGSLDRHIFPKEN-----------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKV  331 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl  331 (511)
                      ||+++|+|.+++.....           ....+++..+..++.|++.|++|||+   .+++|+||||+|||+++++.+||
T Consensus        87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~kL  163 (280)
T cd05092          87 EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKI  163 (280)
T ss_pred             ecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEEE
Confidence            99999999988743221           12358999999999999999999998   69999999999999999999999


Q ss_pred             ecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhh
Q 010434          332 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWV  410 (511)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~  410 (511)
                      +|||+++...............+++.|+|||.+.+.  .++.++||||||+++|||++ |+.|+.......        .
T Consensus       164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~  233 (280)
T cd05092         164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--------A  233 (280)
T ss_pred             CCCCceeEcCCCceeecCCCccccccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--------H
Confidence            999999765433222222233457889999998764  78999999999999999998 888875432111        1


Q ss_pred             HHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          411 YDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       411 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      ......+....      ....++..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       234 ~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         234 IECITQGRELE------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHHHcCccCC------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            11222221111      112245678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.5e-38  Score=317.58  Aligned_cols=261  Identities=24%  Similarity=0.380  Sum_probs=200.2

Q ss_pred             HhhhccccCcCCcEEEEEEEecC-----------------CcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHT-----------------GRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLL  249 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~-----------------g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~  249 (511)
                      .+.+.++||+|+||.||++...+                 +..||+|.+....  ...++|.+|+.++++++||||++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~   85 (296)
T cd05051           6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL   85 (296)
T ss_pred             hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            45667899999999999987542                 2468999987643  3456899999999999999999999


Q ss_pred             ceeccCCceeEEEeecCCCCcccccccCCC-------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceE
Q 010434          250 GFCSEGSKRALVYEFMPNGSLDRHIFPKEN-------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNIL  322 (511)
Q Consensus       250 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NIL  322 (511)
                      +++..+...++++||+++++|.+++.....       ....+++..++.++.|++.||+|||+   .+++|+||||+||+
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Nil  162 (296)
T cd05051          86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCL  162 (296)
T ss_pred             EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhcee
Confidence            999999999999999999999998843321       12368999999999999999999998   69999999999999


Q ss_pred             EcCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh--CCCCCCccccc
Q 010434          323 LDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG--GRRNSNMNAIR  400 (511)
Q Consensus       323 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt--g~~p~~~~~~~  400 (511)
                      +++++.++|+|||+++...............++..|+|||.+.+.  .++.++||||||+++|||++  +..|+..... 
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-  239 (296)
T cd05051         163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG--KFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-  239 (296)
T ss_pred             ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC--CCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence            999999999999998765443332223344577899999998764  78899999999999999998  5566543221 


Q ss_pred             ccccccchhhHHhhhcCC-cccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          401 SSKAYFPSWVYDQLNKGG-DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                             ..+........ .............++..+.+++.+||+.+|.+|||+.+|++.|+
T Consensus       240 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 -------QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             -------HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence                   11111111110 00000000111223467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.1e-38  Score=321.01  Aligned_cols=262  Identities=24%  Similarity=0.407  Sum_probs=205.0

Q ss_pred             HHHHHhhhccccCcCCcEEEEEEEec--------CCcEEEEEEeccC--cccHHHHHHHHHHhccc-cccceEEeeceec
Q 010434          185 IIAVTNHFTHKLGQGGFGSVYKGQLH--------TGRLIAVKMLENS--KFSAEEFINEVSTIGRI-HHVNVVQLLGFCS  253 (511)
Q Consensus       185 i~~~t~~~~~~LG~G~fg~Vykg~~~--------~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~  253 (511)
                      +....+.+.++||+|+||.||++...        ++..+|+|.+...  ....+++.+|+.++.++ +||||+++++++.
T Consensus        15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            33456778899999999999999742        2357999998753  23345788999999999 7999999999999


Q ss_pred             cCCceeEEEeecCCCCcccccccCCC------------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCce
Q 010434          254 EGSKRALVYEFMPNGSLDRHIFPKEN------------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNI  321 (511)
Q Consensus       254 ~~~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NI  321 (511)
                      .+...++||||+++|+|.+++.....            ....+++..+++++.|++.||+|||+   .+++|+||||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Ni  171 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNV  171 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHhe
Confidence            99999999999999999999854321            12458999999999999999999998   6999999999999


Q ss_pred             EEcCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCccccc
Q 010434          322 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIR  400 (511)
Q Consensus       322 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~  400 (511)
                      +++.++.+||+|||+++...............+++.|+|||.+.+.  .++.++||||||+++|||++ |..|+......
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~  249 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  249 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC--CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            9999999999999998765433222222223356789999998764  68899999999999999998 77887543211


Q ss_pred             ccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          401 SSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                              .+...+......+      .....+..+.+++.+||+.+|++|||+.+|++.|+...
T Consensus       250 --------~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         250 --------ELFKLLKEGHRMD------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             --------HHHHHHHcCCCCC------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence                    1222222222111      12234567888999999999999999999999998744

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.2e-38  Score=324.46  Aligned_cols=248  Identities=21%  Similarity=0.311  Sum_probs=193.9

Q ss_pred             cccCcCCcEEEEEEEec-CCcEEEEEEeccCc----ccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      +.||+|+||.||++..+ +++.+|+|+++...    ...+.+.+|+.++.++ +||||+++++++..+...++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999854 68899999997532    2334577888888776 899999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|..++.    ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 ~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--  151 (329)
T cd05618          81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--  151 (329)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--
Confidence            99988772    33579999999999999999999998   6999999999999999999999999999875432221  


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccc-ccccchhhHHhhhcCCcccccccc
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSS-KAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                      ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||........ ......++.+.+.... ..     
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-~~-----  223 (329)
T cd05618         152 TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-IR-----  223 (329)
T ss_pred             ccccccCCccccCHHHHcCC--CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-CC-----
Confidence            12344689999999999765  778999999999999999999999964321111 1111223333332221 11     


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCC------HHHHHH
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPS------MTKVLE  459 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs------~~evl~  459 (511)
                       .+..++..+.+++.+||+.||++||+      +.++++
T Consensus       224 -~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         224 -IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             -CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence             22234567889999999999999998      466654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.6e-38  Score=315.06  Aligned_cols=254  Identities=25%  Similarity=0.426  Sum_probs=199.6

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCc----EEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGR----LIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~----~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  261 (511)
                      .+++.++||+|+||.||+|.+ .+|+    .||+|+++..  ....+++.+|+.++.+++|+||+++++++.. ...+++
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~   86 (279)
T cd05109           8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLV   86 (279)
T ss_pred             heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEE
Confidence            445568999999999999984 3454    4899998653  2235678999999999999999999999975 457899


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      +||+++|+|.+++..   ....+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++...
T Consensus        87 ~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          87 TQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            999999999998842   23568999999999999999999998   699999999999999999999999999998765


Q ss_pred             CCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcc
Q 010434          342 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDL  420 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (511)
                      ............++..|+|||.+.+.  .++.++||||||+++|||++ |..|++......        +...+..+...
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~  230 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHR--RFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--------IPDLLEKGERL  230 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHCCCcC
Confidence            44332222333457789999998754  78899999999999999998 888876432111        12222222221


Q ss_pred             cccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          421 ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       421 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                      ..      +...+..+.+++..||+.||++||++.++++.|+...
T Consensus       231 ~~------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         231 PQ------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             CC------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            11      1223567889999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.3e-38  Score=313.12  Aligned_cols=258  Identities=21%  Similarity=0.331  Sum_probs=205.7

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .+++.+.||+|+||.||++.. .+++.+|||.+....    ...++|.+|+.++++++|+||+++++++.+++..+++||
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE   82 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence            355678899999999999984 589999999886522    234578999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++++|.+++.........+++..+..++.||+.||+|||+   .+++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            999999999874333345678999999999999999999998   69999999999999999999999999998765443


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      ..  ......++..|+|||.+...  .++.++|+||||+++|||++|..|+.......     . ...+.+......   
T Consensus       160 ~~--~~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~-~~~~~~~~~~~~---  226 (267)
T cd08229         160 TT--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----Y-SLCKKIEQCDYP---  226 (267)
T ss_pred             Cc--ccccccCCcCccCHHHhcCC--CccchhhHHHHHHHHHHHHhCCCCcccccchH-----H-HHhhhhhcCCCC---
Confidence            22  12334588999999998764  68899999999999999999999985432110     0 011111111111   


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                        .......+..+.+++.+||+.+|.+||||.+|+++++..
T Consensus       227 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         227 --PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             --CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence              111223566789999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.5e-38  Score=311.89  Aligned_cols=256  Identities=25%  Similarity=0.430  Sum_probs=206.0

Q ss_pred             HHHHHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          185 IIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       185 i~~~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +...++.+.++||+|+||.||++..+++..+|+|.+.......+.|.+|+.++++++|+||+++++++.+ ...+++|||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            3445667789999999999999998788899999987766567789999999999999999999999887 778999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++++|.+++..  ..+..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++......
T Consensus        82 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          82 MAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             CCCCcHHHHHHh--CCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999998843  234568999999999999999999998   699999999999999999999999999997654322


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      . .......++..|+|||++...  .++.++|+||||+++++|++ |+.|+.......        ....+..+....  
T Consensus       157 ~-~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~~~--  223 (260)
T cd05073         157 Y-TAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--------VIRALERGYRMP--  223 (260)
T ss_pred             c-ccccCCcccccccCHhHhccC--CcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHhCCCCCC--
Confidence            1 112233467789999998754  78889999999999999998 888875432111        111222221111  


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                          .....+..+.+++.+|++.+|++||++.+++++|+.
T Consensus       224 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 ----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                112345678899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.2e-38  Score=308.46  Aligned_cols=246  Identities=26%  Similarity=0.417  Sum_probs=197.0

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCcc
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLD  271 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  271 (511)
                      ++||+|+||.||+|..++++.+|+|.+....  .....|.+|+.++++++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            4799999999999998889999999986532  23457899999999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeecc
Q 010434          272 RHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA  351 (511)
Q Consensus       272 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  351 (511)
                      +++..   ....+++..+..++.|++.||.|||+   .+++|+||||+||++++++.+||+|||++........ .....
T Consensus        81 ~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~  153 (250)
T cd05085          81 SFLRK---KKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGL  153 (250)
T ss_pred             HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCC
Confidence            98732   23468999999999999999999998   6999999999999999999999999999875432211 11122


Q ss_pred             ccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccchhHH
Q 010434          352 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  430 (511)
Q Consensus       352 ~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  430 (511)
                      ..++..|+|||++...  .++.++||||||+++|||++ |..|+.......        ............      ...
T Consensus       154 ~~~~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--------~~~~~~~~~~~~------~~~  217 (250)
T cd05085         154 KQIPIKWTAPEALNYG--RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--------AREQVEKGYRMS------CPQ  217 (250)
T ss_pred             CCCcccccCHHHhccC--CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--------HHHHHHcCCCCC------CCC
Confidence            3356789999998654  78899999999999999998 888885432211        112222221111      112


Q ss_pred             HHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          431 VIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       431 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                      .++..+.+++.+|++.+|++||++.++++.|.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            24567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.8e-38  Score=312.43  Aligned_cols=254  Identities=28%  Similarity=0.455  Sum_probs=200.4

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CC---cEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TG---RLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g---~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      .++..+.||+|+||.||+|+.. ++   ..+|+|.+...  ....+++.+|++++++++|+|++++.+++......++||
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT   85 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence            4455688999999999999864 33   37999998653  234567999999999999999999999999999999999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+++++|.+++..   ....+++..+..++.|++.|++|||+   .+++|+||||+||++++++.+||+|||++.....
T Consensus        86 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          86 EYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            99999999998832   23578999999999999999999998   6999999999999999999999999999876543


Q ss_pred             CCCcee-eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcc
Q 010434          343 ENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDL  420 (511)
Q Consensus       343 ~~~~~~-~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (511)
                      ...... ......+..|+|||++...  .++.++||||||+++|||++ |+.|+......        .....+......
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--------~~~~~i~~~~~~  229 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--------EVMKAINDGFRL  229 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcC--CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHHHHhcCCCC
Confidence            322111 1122245689999998754  67899999999999999997 99998543211        122222222111


Q ss_pred             cccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          421 ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       421 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                      .      .....+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       230 ~------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         230 P------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             C------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1      1112346788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.4e-39  Score=325.87  Aligned_cols=248  Identities=21%  Similarity=0.313  Sum_probs=195.9

Q ss_pred             cccCcCCcEEEEEEEec-CCcEEEEEEeccCc----ccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      +.||+|+||.||+++.+ +++.||||+++...    ...+.+..|..++.++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999854 68999999997532    2334578899999888 799999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|.+++.    ....+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--  151 (329)
T cd05588          81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--  151 (329)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--
Confidence            99988772    33579999999999999999999998   6999999999999999999999999999874322221  


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccc-cccccchhhHHhhhcCCcccccccc
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRS-SKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                      ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||+...... .......+..+.+.... ..     
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~-----  223 (329)
T cd05588         152 TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-IR-----  223 (329)
T ss_pred             ccccccCCccccCHHHHcCC--CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC-CC-----
Confidence            12345689999999999764  78899999999999999999999997533221 11112233333333221 11     


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCC------HHHHHH
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPS------MTKVLE  459 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs------~~evl~  459 (511)
                       .+..++..+.+++.+||+.||.+|||      +.++++
T Consensus       224 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         224 -IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence             11224567889999999999999997      677764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.5e-38  Score=315.00  Aligned_cols=255  Identities=26%  Similarity=0.405  Sum_probs=199.0

Q ss_pred             HhhhccccCcCCcEEEEEEEec------CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  260 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  260 (511)
                      .+.+.+.||+|+||.||+|...      .+..||+|.+....  .....|.+|+.++++++|+||+++++++.+....++
T Consensus         7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   86 (277)
T cd05036           7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFI   86 (277)
T ss_pred             HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEE
Confidence            3455689999999999999864      35789999886532  234579999999999999999999999999899999


Q ss_pred             EEeecCCCCcccccccCCC---cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC---Ceeeecc
Q 010434          261 VYEFMPNGSLDRHIFPKEN---KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF---IPKVSDF  334 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~---~~kl~DF  334 (511)
                      ||||+++++|.+++.....   ....+++..+.+++.||+.||+|||+   .+++|+||||+||+++.++   .+||+||
T Consensus        87 v~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~df  163 (277)
T cd05036          87 LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADF  163 (277)
T ss_pred             EEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccC
Confidence            9999999999998843321   12368999999999999999999998   6999999999999998764   6999999


Q ss_pred             cccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHh
Q 010434          335 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQ  413 (511)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  413 (511)
                      |+++................+..|+|||++.+.  .++.++|||||||++|||++ |+.||.......        ..+.
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--------~~~~  233 (277)
T cd05036         164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG--IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--------VMEF  233 (277)
T ss_pred             ccccccCCccceecCCCCCccHhhCCHHHHhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHH
Confidence            999876433222222223346789999998654  78999999999999999997 888886432211        1222


Q ss_pred             hhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          414 LNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       414 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                      +.......      ....++..+.+++.+||+.+|++|||+.+|++.|.
T Consensus       234 ~~~~~~~~------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 VTGGGRLD------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHcCCcCC------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            22221111      11223567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-40  Score=324.62  Aligned_cols=242  Identities=23%  Similarity=0.349  Sum_probs=203.6

Q ss_pred             ccccCcCCcEEEEEEE-ecCCcEEEEEEecc--CcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCC
Q 010434          193 THKLGQGGFGSVYKGQ-LHTGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGS  269 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  269 (511)
                      .+.||+|.||.||||. ..+++.||+|++..  .+...++..+|+.++..++++||.+++|.+..+..+.++|||+.+|+
T Consensus        18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs   97 (467)
T KOG0201|consen   18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS   97 (467)
T ss_pred             chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence            4789999999999998 45789999999876  44566789999999999999999999999999999999999999999


Q ss_pred             cccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceee
Q 010434          270 LDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI  349 (511)
Q Consensus       270 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  349 (511)
                      +.+.+    ..+..+.+..+.-|..++..|+.|||.   .+.+|||||+.|||+..+|.+||+|||.+-.........  
T Consensus        98 v~~lL----~~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr--  168 (467)
T KOG0201|consen   98 VLDLL----KSGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR--  168 (467)
T ss_pred             hhhhh----ccCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhcc--
Confidence            99988    344566888888899999999999999   699999999999999999999999999997765544322  


Q ss_pred             ccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhH
Q 010434          350 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE  429 (511)
Q Consensus       350 ~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  429 (511)
                      ...+||+.|||||++...  .|+.|+||||||++.+||++|.+|+.....-..-..              +....++...
T Consensus       169 ~tfvGTPfwMAPEVI~~~--~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl--------------Ipk~~PP~L~  232 (467)
T KOG0201|consen  169 KTFVGTPFWMAPEVIKQS--GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL--------------IPKSAPPRLD  232 (467)
T ss_pred             ccccccccccchhhhccc--cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe--------------ccCCCCCccc
Confidence            566799999999999865  899999999999999999999999865433111111              1111122233


Q ss_pred             HHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          430 SVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       430 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ...++.+++++..||+.||+.||++.++++
T Consensus       233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  233 GDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             cccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            467788999999999999999999999985

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=317.18  Aligned_cols=249  Identities=27%  Similarity=0.349  Sum_probs=198.4

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc----cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      ++..++||+|+||.||++.. .+++.||||++.....    ....+.+|+.++++++||||+++++.+..+...++||||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            45668899999999999985 4789999999865322    234578899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++...  ....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||+++......
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          82 MNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             cCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            9999999877422  23568999999999999999999998   699999999999999999999999999998654332


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      .   .....|+..|+|||++.+.  .++.++||||||+++|||++|+.||........    ...+...+...       
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~--~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~----~~~~~~~~~~~-------  220 (285)
T cd05605         157 T---IRGRVGTVGYMAPEVVKNE--RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK----REEVERRVKED-------  220 (285)
T ss_pred             c---cccccCCCCccCcHHhcCC--CCCccccchhHHHHHHHHHHCCCCCCCCchhhH----HHHHHHHhhhc-------
Confidence            1   1234689999999998754  788999999999999999999999875322110    01111111111       


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCC-----CHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRP-----SMTKVLE  459 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~  459 (511)
                      .......++..+.+++..||+.||++||     ++.++++
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            0112233567788999999999999999     8888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.8e-38  Score=330.90  Aligned_cols=262  Identities=23%  Similarity=0.411  Sum_probs=203.9

Q ss_pred             HHHHHhhhccccCcCCcEEEEEEEec------CCcEEEEEEeccCcc--cHHHHHHHHHHhcccc-ccceEEeeceeccC
Q 010434          185 IIAVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSKF--SAEEFINEVSTIGRIH-HVNVVQLLGFCSEG  255 (511)
Q Consensus       185 i~~~t~~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~  255 (511)
                      +......+.++||+|+||.||+|++.      .+..||||+++....  ..+.+.+|+.++.++. |||||++++++...
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            33444556789999999999999853      346899999976422  2457899999999997 99999999999999


Q ss_pred             CceeEEEeecCCCCcccccccCCC--------------------------------------------------------
Q 010434          256 SKRALVYEFMPNGSLDRHIFPKEN--------------------------------------------------------  279 (511)
Q Consensus       256 ~~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------  279 (511)
                      ...++|+||+++|+|.++++....                                                        
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            999999999999999988853211                                                        


Q ss_pred             --------------------------------------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCce
Q 010434          280 --------------------------------------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNI  321 (511)
Q Consensus       280 --------------------------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NI  321 (511)
                                                            ....+++..+..++.|++.||+|||+   .+++||||||+||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~Ni  270 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNV  270 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceE
Confidence                                                  11347888999999999999999998   6999999999999


Q ss_pred             EEcCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCccccc
Q 010434          322 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIR  400 (511)
Q Consensus       322 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~  400 (511)
                      |+++++.+||+|||+++...............++..|+|||.+.+.  .++.++||||||+++|||++ |+.|+......
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN--LYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC--CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            9999999999999999865433322222334577899999998764  68899999999999999998 88887543211


Q ss_pred             ccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          401 SSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                             ......+..+....      .+..++..+.+++..||+.+|.+||++++|++.|+..
T Consensus       349 -------~~~~~~~~~~~~~~------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         349 -------EQFYNAIKRGYRMA------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             -------HHHHHHHHcCCCCC------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                   11122222222111      1112356788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-38  Score=318.22  Aligned_cols=264  Identities=23%  Similarity=0.382  Sum_probs=197.7

Q ss_pred             HHHhhhccccCcCCcEEEEEEEecC---------------CcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEee
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQLHT---------------GRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLL  249 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~~~---------------g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~  249 (511)
                      ...+.+.++||+|+||.||++...+               ...||+|.+...  ....+.|.+|++++++++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3456678899999999999986432               235899998653  22345799999999999999999999


Q ss_pred             ceeccCCceeEEEeecCCCCcccccccCC--------CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCce
Q 010434          250 GFCSEGSKRALVYEFMPNGSLDRHIFPKE--------NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNI  321 (511)
Q Consensus       250 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NI  321 (511)
                      +++......++||||+++++|.+++....        .....+++..++.++.|++.||+|||+   .+++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhE
Confidence            99999999999999999999998874321        111247899999999999999999998   6999999999999


Q ss_pred             EEcCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhC--CCCCCcccc
Q 010434          322 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG--RRNSNMNAI  399 (511)
Q Consensus       322 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg--~~p~~~~~~  399 (511)
                      ++++++.+||+|||+++...............++..|+|||.+...  .++.++||||||++++||+++  ..|+.....
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC--CcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            9999999999999999765433322222334467899999988754  789999999999999999984  455543221


Q ss_pred             cccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          400 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                      ..    ..................   ......+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus       239 ~~----~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         239 EQ----VIENTGEFFRNQGRQIYL---SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HH----HHHHHHHhhhhccccccC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            11    000011111110000000   011123467999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-38  Score=316.49  Aligned_cols=258  Identities=26%  Similarity=0.402  Sum_probs=197.2

Q ss_pred             hhccccCcCCcEEEEEEEe-----cCCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccC--CceeEE
Q 010434          191 HFTHKLGQGGFGSVYKGQL-----HTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALV  261 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~-----~~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~lV  261 (511)
                      .+.+.||+|+||.||++..     .+++.||+|++....  ...+.|.+|+.++++++||||+++++++...  ...+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            5678899999999988642     367899999987643  2456789999999999999999999988653  457899


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      |||+++++|.+++.     ...+++..+..++.|++.||+|||+   .+|+|+||||+|||+++++.+||+|||+++...
T Consensus        87 ~e~~~~~~l~~~~~-----~~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          87 MEYVPLGSLRDYLP-----KHKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             ecCCCCCCHHHHHH-----HcCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccC
Confidence            99999999999882     2459999999999999999999998   699999999999999999999999999998765


Q ss_pred             CCCCcee-eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc-------ccchhhHHh
Q 010434          342 KENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA-------YFPSWVYDQ  413 (511)
Q Consensus       342 ~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~-------~~~~~~~~~  413 (511)
                      ....... .....++..|+|||.+...  .++.++||||||+++|||++|+.|+..........       .......+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhccc--CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence            4332111 1222356779999998754  78899999999999999999998875432110000       000000111


Q ss_pred             hhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          414 LNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       414 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                      .......      ..+..++..+.+++..||+.+|++|||+++++++|+..
T Consensus       237 ~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         237 LERGMRL------PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhcCCCC------CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            1111110      11223456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.7e-38  Score=308.06  Aligned_cols=258  Identities=24%  Similarity=0.371  Sum_probs=206.5

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .+.+.++||+|+||.||+|... +|+.||+|.++..    ....+.+.+|+.++++++|+|++++++++..++..++|||
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   82 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence            3567789999999999999865 8999999988642    2235679999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++|+|.+++......+..+++..+..++.+++.||+|||+   .+++|+||+|+||+++.++.++|+|||+++.....
T Consensus        83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            999999998875433445678999999999999999999998   69999999999999999999999999998765433


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      ..  ......++..|+|||.+.+.  .++.++||||||+++|+|++|+.|+......     ... ..+.+..+..... 
T Consensus       160 ~~--~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~-~~~~~~~~~~~~~-  228 (267)
T cd08224         160 TT--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYS-LCKKIEKCDYPPL-  228 (267)
T ss_pred             Cc--ccceecCCccccCHHHhccC--CCCchhcHHHHHHHHHHHHHCCCCcccCCcc-----HHH-HHhhhhcCCCCCC-
Confidence            21  11334588899999998754  6889999999999999999999998543211     001 1122222111111 


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                          .....+..+.+++.+||+.+|++|||+.+|+++|+..
T Consensus       229 ----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         229 ----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             ----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence                1124556788999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-38  Score=322.23  Aligned_cols=240  Identities=25%  Similarity=0.356  Sum_probs=193.6

Q ss_pred             cccCcCCcEEEEEEEe----cCCcEEEEEEeccCc-----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          194 HKLGQGGFGSVYKGQL----HTGRLIAVKMLENSK-----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~----~~g~~vAvK~l~~~~-----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      ++||+|+||.||+++.    .+++.||||+++...     .....+.+|+.++++++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999974    357899999987532     2335678999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          82 LSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            99999998872    34568899999999999999999998   699999999999999999999999999987543222


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      .  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||.......        ....+..+. ..   
T Consensus       155 ~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~pf~~~~~~~--------~~~~~~~~~-~~---  218 (323)
T cd05584         155 T--VTHTFCGTIEYMAPEILMRS--GHGKAVDWWSLGALMYDMLTGAPPFTAENRKK--------TIDKILKGK-LN---  218 (323)
T ss_pred             C--cccccCCCccccChhhccCC--CCCCcceecccHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCC-CC---
Confidence            1  12334689999999998765  67889999999999999999999986543211        112222211 11   


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCC-----CHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRP-----SMTKVLE  459 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~  459 (511)
                         .+..++..+.+++.+||+.+|++||     ++.++++
T Consensus       219 ---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         219 ---LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ---CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence               1222456788999999999999999     7888876

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.4e-38  Score=307.42  Aligned_cols=246  Identities=26%  Similarity=0.427  Sum_probs=194.5

Q ss_pred             ccCcCCcEEEEEEEec---CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCC
Q 010434          195 KLGQGGFGSVYKGQLH---TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGS  269 (511)
Q Consensus       195 ~LG~G~fg~Vykg~~~---~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  269 (511)
                      .||+|+||.||+|.+.   ++..||+|++....  ...++|.+|+.++++++||||+++++++.. ...++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999753   45679999987643  234679999999999999999999999854 57899999999999


Q ss_pred             cccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce-e
Q 010434          270 LDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-S  348 (511)
Q Consensus       270 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~  348 (511)
                      |.+++..   ....+++..+.+++.|++.||+|||+   .+++|+||||+|||++.++.+||+|||+++......... .
T Consensus        81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            9998732   23578999999999999999999998   699999999999999999999999999998654433221 1


Q ss_pred             eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      .....++..|+|||.+...  .++.++||||||+++|||++ |..|+.......        +...+..+.....     
T Consensus       155 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~-----  219 (257)
T cd05115         155 RSAGKWPLKWYAPECINFR--KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--------VMSFIEQGKRLDC-----  219 (257)
T ss_pred             cCCCCCCcccCCHHHHccC--CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--------HHHHHHCCCCCCC-----
Confidence            1223346789999998754  68899999999999999996 999986432211        2222233222221     


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                       +...+..+.+++..||+.+|++||++.+|.+.|+.
T Consensus       220 -~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         220 -PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             -CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence             12235678889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.5e-38  Score=320.60  Aligned_cols=264  Identities=23%  Similarity=0.421  Sum_probs=205.8

Q ss_pred             HHHHHHhhhccccCcCCcEEEEEEEec--------CCcEEEEEEeccCc--ccHHHHHHHHHHhccc-cccceEEeecee
Q 010434          184 EIIAVTNHFTHKLGQGGFGSVYKGQLH--------TGRLIAVKMLENSK--FSAEEFINEVSTIGRI-HHVNVVQLLGFC  252 (511)
Q Consensus       184 ei~~~t~~~~~~LG~G~fg~Vykg~~~--------~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l-~H~niv~l~g~~  252 (511)
                      ++...++.+.++||+|+||.||++...        .+..||+|.++...  ...+++.+|+.+++++ +||||+++++++
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            344556778899999999999999632        12479999887532  2346899999999999 799999999999


Q ss_pred             ccCCceeEEEeecCCCCcccccccCCC------------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCc
Q 010434          253 SEGSKRALVYEFMPNGSLDRHIFPKEN------------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHN  320 (511)
Q Consensus       253 ~~~~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~N  320 (511)
                      ..+...++++||+++|+|.+++.....            ....+++..+..++.|++.||+|||+   .+++||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N  164 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARN  164 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccce
Confidence            999999999999999999998853221            23458899999999999999999998   699999999999


Q ss_pred             eEEcCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccc
Q 010434          321 ILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAI  399 (511)
Q Consensus       321 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~  399 (511)
                      ||++.++.+||+|||+++...............++..|+|||++.+.  .++.++||||||+++|||++ |..|+.....
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC--CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            99999999999999999865443322222333456789999998764  78899999999999999998 7777754321


Q ss_pred             cccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          400 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      ..        ..+.+........      ....+..+.+++.+||+.+|++|||+.++++.|+....
T Consensus       243 ~~--------~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         243 EE--------LFKLLKEGHRMDK------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             HH--------HHHHHHcCCCCCC------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            11        2222222222111      11234578899999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.3e-38  Score=307.82  Aligned_cols=248  Identities=25%  Similarity=0.388  Sum_probs=202.0

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      +.+.+.||+|++|.||++..+ +++.|++|.+...   ....+++.+|+.++++++||||+++++++.++...++||||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA   81 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence            345688999999999999854 6899999998653   335678999999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++++|.+++...  .+..+++..+..++.|++.||.|||+   .+++|+||||+||++++++.+||+|||+++.......
T Consensus        82 ~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          82 ENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            999999988432  24678999999999999999999998   6999999999999999999999999999886654332


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                      .  .....+++.|+|||++.+.  .++.++|+||||+++|||++|+.|+......        ........+....    
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~----  220 (256)
T cd08529         157 F--ANTIVGTPYYLSPELCEDK--PYNEKSDVWALGVVLYECCTGKHPFDANNQG--------ALILKIIRGVFPP----  220 (256)
T ss_pred             h--hhccccCccccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCCCC----
Confidence            1  1334588999999998764  6889999999999999999999998654311        1122222221111    


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                        ....++..+.+++.+||+.+|++||++.++++.
T Consensus       221 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         221 --VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             --CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence              222456778999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.8e-38  Score=318.86  Aligned_cols=262  Identities=23%  Similarity=0.411  Sum_probs=206.0

Q ss_pred             HHHHHhhhccccCcCCcEEEEEEEe--------cCCcEEEEEEeccC--cccHHHHHHHHHHhccc-cccceEEeeceec
Q 010434          185 IIAVTNHFTHKLGQGGFGSVYKGQL--------HTGRLIAVKMLENS--KFSAEEFINEVSTIGRI-HHVNVVQLLGFCS  253 (511)
Q Consensus       185 i~~~t~~~~~~LG~G~fg~Vykg~~--------~~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~  253 (511)
                      +....+.+.+.||+|+||.||+++.        .++..||+|.+...  ....+++.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            4455667788999999999999963        13457999998653  23446799999999999 8999999999999


Q ss_pred             cCCceeEEEeecCCCCcccccccCCC------------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCce
Q 010434          254 EGSKRALVYEFMPNGSLDRHIFPKEN------------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNI  321 (511)
Q Consensus       254 ~~~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NI  321 (511)
                      .....+++|||+++|+|.+++.....            ....+++..+..++.||+.||+|||+   .+++||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceE
Confidence            99999999999999999998854321            12468899999999999999999998   6999999999999


Q ss_pred             EEcCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCccccc
Q 010434          322 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIR  400 (511)
Q Consensus       322 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~  400 (511)
                      ++++++.+||+|||+++...............++..|+|||++.+.  .++.++||||||+++|||++ |..|+..... 
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-  245 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-  245 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCCH-
Confidence            9999999999999999876544333223334467889999998764  68899999999999999998 6777643321 


Q ss_pred             ccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          401 SSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                             ..+.+.+........      ...++..+..++..||+.+|.+|||+.++++.|+...
T Consensus       246 -------~~~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         246 -------EELFKLLKEGHRMDK------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             -------HHHHHHHHcCCcCCC------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence                   112223332222111      1234567888999999999999999999999998744

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-38  Score=315.29  Aligned_cols=254  Identities=23%  Similarity=0.335  Sum_probs=200.7

Q ss_pred             HhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCcc---------------cHHHHHHHHHHhccccccceEEeecee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKF---------------SAEEFINEVSTIGRIHHVNVVQLLGFC  252 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~~---------------~~~~f~~Ev~~l~~l~H~niv~l~g~~  252 (511)
                      .|.+.+.||+|.||.|-++. ..+++.||||++.+.+.               ..+...+|+.+|++++|||||+|+.+.
T Consensus        98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL  177 (576)
T KOG0585|consen   98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL  177 (576)
T ss_pred             heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence            45566789999999999998 45799999999965321               135788999999999999999999998


Q ss_pred             cc--CCceeEEEeecCCCCcccccccCCCcCCc-cCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCe
Q 010434          253 SE--GSKRALVYEFMPNGSLDRHIFPKENKGQT-FGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIP  329 (511)
Q Consensus       253 ~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~-l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~  329 (511)
                      .+  .++.|||+|||..|.+...=     ...+ ++..+.++++.++..||+|||.   ++|+||||||+|+||++++++
T Consensus       178 DDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~V  249 (576)
T KOG0585|consen  178 DDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTV  249 (576)
T ss_pred             cCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcE
Confidence            65  57899999999999886532     2234 9999999999999999999999   699999999999999999999


Q ss_pred             eeecccccccCCCCC---CceeeccccCCccccchhcccccC--CCcCccchHHHHHHHHHHHHhCCCCCCccccccccc
Q 010434          330 KVSDFGLAKFHPKEN---DFVSISATRGTIGYIAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA  404 (511)
Q Consensus       330 kl~DFGla~~~~~~~---~~~~~~~~~gt~~y~APE~~~~~~--~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~  404 (511)
                      ||+|||.+.......   .........||+.|+|||......  ...+.+.||||+||+||.|+.|+.||.......   
T Consensus       250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~---  326 (576)
T KOG0585|consen  250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE---  326 (576)
T ss_pred             EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH---
Confidence            999999987663321   112234467999999999886521  234678899999999999999999997654322   


Q ss_pred             ccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          405 YFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                           +++.+.+... .++    ...++...+.+|++++|+.||+.|.+..+|.....-
T Consensus       327 -----l~~KIvn~pL-~fP----~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv  375 (576)
T KOG0585|consen  327 -----LFDKIVNDPL-EFP----ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV  375 (576)
T ss_pred             -----HHHHHhcCcc-cCC----CcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence                 3344333221 111    112456788999999999999999999999876654

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6e-39  Score=326.68  Aligned_cols=251  Identities=23%  Similarity=0.314  Sum_probs=196.8

Q ss_pred             hhhccccCcCCcEEEEEEEe----cCCcEEEEEEeccC-----cccHHHHHHHHHHhccc-cccceEEeeceeccCCcee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL----HTGRLIAVKMLENS-----KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRA  259 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~----~~g~~vAvK~l~~~-----~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~  259 (511)
                      +.+.++||+|+||.||+++.    .+++.||+|++...     ....+.+.+|+.++.++ +|+||+++++++..+...+
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            35678999999999999874    36889999998652     22345688899999999 5999999999999999999


Q ss_pred             EEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      +||||+++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        82 lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          82 LILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            9999999999999883    33568999999999999999999998   6999999999999999999999999999986


Q ss_pred             CCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          340 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       340 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      ....... ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||........    ...+...+.... 
T Consensus       155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~~~~~~~~~~-  227 (332)
T cd05614         155 FLSEEKE-RTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNT----QSEVSRRILKCD-  227 (332)
T ss_pred             ccccCCC-ccccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCC----HHHHHHHHhcCC-
Confidence            5333221 12234699999999998753 3478899999999999999999999865332211    111222221111 


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCC-----CHHHHHHH
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRP-----SMTKVLEM  460 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~~  460 (511)
                      ..      .+..++..+.+++.+||+.||++||     +++++++.
T Consensus       228 ~~------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         228 PP------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CC------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            11      1223456788899999999999999     77788753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2e-38  Score=321.40  Aligned_cols=235  Identities=26%  Similarity=0.328  Sum_probs=189.8

Q ss_pred             cccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      +.||+|+||.||+++.+ +++.||||++...    ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999864 6899999998753    23445678898888876 699999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|.+++.    ....+++..+..++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||+++.......  
T Consensus        81 g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--  151 (320)
T cd05590          81 GDLMFHIQ----KSRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--  151 (320)
T ss_pred             chHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--
Confidence            99998873    33578999999999999999999998   6999999999999999999999999999875432221  


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||.......        +...+..... .      
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--------~~~~i~~~~~-~------  214 (320)
T cd05590         152 TTSTFCGTPDYIAPEILQEM--LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--------LFEAILNDEV-V------  214 (320)
T ss_pred             cccccccCccccCHHHHcCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--------HHHHHhcCCC-C------
Confidence            12344689999999998764  78899999999999999999999997543211        2222222111 1      


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCH
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSM  454 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~  454 (511)
                      .+..++..+.+++.+||+.||++||++
T Consensus       215 ~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         215 YPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            112245678899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-38  Score=307.97  Aligned_cols=248  Identities=29%  Similarity=0.464  Sum_probs=203.0

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      .+++.+.||+|+||.||++... |+.||+|.+.......+.+.+|+.++++++|+||+++++++......++||||++++
T Consensus         7 ~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   85 (256)
T cd05039           7 ELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKG   85 (256)
T ss_pred             hccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCC
Confidence            4566789999999999999865 899999999775555678999999999999999999999999899999999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      +|.+++...  ....+++..+..++.|++.||.|||+   .+++|+||||+||++++++.+||+|||.++......    
T Consensus        86 ~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~----  156 (256)
T cd05039          86 SLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----  156 (256)
T ss_pred             cHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc----
Confidence            999988322  22468999999999999999999998   699999999999999999999999999998653322    


Q ss_pred             eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                       .....+..|+|||.+...  .++.++||||||+++|||++ |+.|+......        .+...+.......      
T Consensus       157 -~~~~~~~~~~ape~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~------  219 (256)
T cd05039         157 -DSGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPHVEKGYRME------  219 (256)
T ss_pred             -ccCCCcccccCchhhcCC--cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHhcCCCCC------
Confidence             233456789999998653  78889999999999999997 88887543211        1222222221111      


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      .....+..+.+++.+||+.+|++|||+.+++++|+.
T Consensus       220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            112345678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.2e-38  Score=321.23  Aligned_cols=241  Identities=21%  Similarity=0.288  Sum_probs=193.4

Q ss_pred             cccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      ++||+|+||.||+|+.. +++.||||++...    ....+.+..|..++..+ +||||+++++++..+...++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999854 6889999998753    22345678899988866 799999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|..++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--  151 (321)
T cd05591          81 GDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--  151 (321)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--
Confidence            99988873    33568999999999999999999998   6999999999999999999999999999875432221  


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||.......        ....+......       
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--------~~~~i~~~~~~-------  214 (321)
T cd05591         152 TTTTFCGTPDYIAPEILQEL--EYGPSVDWWALGVLMYEMMAGQPPFEADNEDD--------LFESILHDDVL-------  214 (321)
T ss_pred             cccccccCccccCHHHHcCC--CCCCccceechhHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCCC-------
Confidence            12345689999999998764  78899999999999999999999997543211        12222221110       


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCC-------CHHHHHHH
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRP-------SMTKVLEM  460 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RP-------s~~evl~~  460 (511)
                      .+..++..+.+++..||+.||++||       ++.++++.
T Consensus       215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            1112346788899999999999999       88888753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.1e-38  Score=312.28  Aligned_cols=255  Identities=27%  Similarity=0.473  Sum_probs=199.8

Q ss_pred             HHhhhccccCcCCcEEEEEEEec-CC---cEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEE
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH-TG---RLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~-~g---~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  261 (511)
                      ..+++.+.||+|+||.||+|... ++   ..||||.+...  ....++|.+|+.++++++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            34567889999999999999854 33   36999998753  23456899999999999999999999999999999999


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      |||+++|+|.+++..   ....+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++...
T Consensus        84 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          84 TEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccc
Confidence            999999999998732   23568999999999999999999998   699999999999999999999999999987654


Q ss_pred             CCCCceeeccc---cCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcC
Q 010434          342 KENDFVSISAT---RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKG  417 (511)
Q Consensus       342 ~~~~~~~~~~~---~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  417 (511)
                      ...........   ..+..|+|||.+...  .++.++||||||+++|||++ |..|+.......        ....+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--------~~~~i~~~  227 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------VINAIEQD  227 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccC--cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--------HHHHHHcC
Confidence            43221111111   124579999998754  78899999999999999886 998886432211        11111111


Q ss_pred             CcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          418 GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                      ....      ....++..+.+++.+||+.+|.+||++.+|+.+|+..
T Consensus       228 ~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 YRLP------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CcCC------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1111      1122346688999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.8e-38  Score=314.66  Aligned_cols=261  Identities=24%  Similarity=0.373  Sum_probs=197.4

Q ss_pred             HhhhccccCcCCcEEEEEEEec-----------------CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-----------------TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLL  249 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-----------------~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~  249 (511)
                      .+.+.++||+|+||.||++...                 ++..+|+|++....  ...++|.+|+.++++++|+||++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~   85 (296)
T cd05095           6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL   85 (296)
T ss_pred             hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence            3566789999999999998532                 24579999987532  2346899999999999999999999


Q ss_pred             ceeccCCceeEEEeecCCCCcccccccCCC-------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceE
Q 010434          250 GFCSEGSKRALVYEFMPNGSLDRHIFPKEN-------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNIL  322 (511)
Q Consensus       250 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NIL  322 (511)
                      +++..+...+++|||+++|+|.+++.....       ....+++..+..++.|++.||+|||+   .+++|+||||+|||
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Nil  162 (296)
T cd05095          86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCL  162 (296)
T ss_pred             EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheEE
Confidence            999999999999999999999988754321       12358899999999999999999998   69999999999999


Q ss_pred             EcCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh--CCCCCCccccc
Q 010434          323 LDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG--GRRNSNMNAIR  400 (511)
Q Consensus       323 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt--g~~p~~~~~~~  400 (511)
                      +++++.++|+|||+++...............++..|+|||...+.  .++.++||||||+++|||++  |..|+......
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC--CccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            999999999999999865443322222333456789999987653  78999999999999999998  55666432211


Q ss_pred             ccccccchhhHHhhhcC-CcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          401 SSKAYFPSWVYDQLNKG-GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       401 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                      ..    ........... ......    ....++..+.+++.+||+.||++||++.+|++.|+
T Consensus       241 ~~----~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 QV----IENTGEFFRDQGRQVYLP----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HH----HHHHHHHHhhccccccCC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            10    00000111110 001111    11123467889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=299.35  Aligned_cols=266  Identities=26%  Similarity=0.323  Sum_probs=211.7

Q ss_pred             HHHhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceeccCCc-----ee
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK-----RA  259 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~-----~~  259 (511)
                      ..+|++.++||+|||+-||.++ +.+++.+|+|++.-.. .+.+..++|++..++++||||++++++...+..     .|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            3466778999999999999998 7789999999987644 566788999999999999999999999865444     89


Q ss_pred             EEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      |+++|...|+|.+.+...+.++..+++.+++.|+.+|++||++||.. ..++.||||||.|||+.+.+.+++.|||.++.
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence            99999999999999977777788999999999999999999999984 23599999999999999999999999999876


Q ss_pred             CCCCCCce-------eeccccCCccccchhcccccC-CCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhH
Q 010434          340 HPKENDFV-------SISATRGTIGYIAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVY  411 (511)
Q Consensus       340 ~~~~~~~~-------~~~~~~gt~~y~APE~~~~~~-~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~  411 (511)
                      .+-.....       .-.....|..|+|||.+.-.. ..+++++|||||||+||+|+.|..||+..........+.    
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA----  254 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA----  254 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe----
Confidence            54321110       012234789999999986432 368899999999999999999999998654322111110    


Q ss_pred             HhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          412 DQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       412 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                        +..+. ...+    ....++..+.+++.+|+|.||.+||+..+++..++..
T Consensus       255 --v~n~q-~s~P----~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  255 --VQNAQ-ISIP----NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             --eeccc-cccC----CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence              01111 1111    1111678899999999999999999999999988753

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.1e-38  Score=331.27  Aligned_cols=251  Identities=21%  Similarity=0.248  Sum_probs=192.3

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+.++||+|+||.||+|+. ++++.||||++....    ...+.+.+|+.++.+++||||+++++++.++...++||||
T Consensus         3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~   82 (381)
T cd05626           3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (381)
T ss_pred             ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence            34567899999999999984 578999999996532    2345688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          83 IPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            99999999883    33568999999999999999999998   699999999999999999999999999976432110


Q ss_pred             Cc---------------------------------------------eeeccccCCccccchhcccccCCCcCccchHHH
Q 010434          345 DF---------------------------------------------VSISATRGTIGYIAPELISRNFGTVSCKSDVYG  379 (511)
Q Consensus       345 ~~---------------------------------------------~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS  379 (511)
                      ..                                             .......||+.|+|||.+.+.  .++.++||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwS  233 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDWWS  233 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC--CCCCccceee
Confidence            00                                             001123599999999998764  6889999999


Q ss_pred             HHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHH--hcCcCCCCCCCHHHH
Q 010434          380 FGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLW--CIQVKAADRPSMTKV  457 (511)
Q Consensus       380 ~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--Cl~~~P~~RPs~~ev  457 (511)
                      |||++|||++|+.||........       .................    .++..+.+++.+  |+..+|..||++.++
T Consensus       234 lG~il~elltG~~Pf~~~~~~~~-------~~~i~~~~~~~~~~~~~----~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         234 VGVILFEMLVGQPPFLAPTPTET-------QLKVINWENTLHIPPQV----KLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             hhhHHHHHHhCCCCCcCCCHHHH-------HHHHHccccccCCCCCC----CCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            99999999999999965432111       11111111111111111    134556667766  556677779999999


Q ss_pred             HHH
Q 010434          458 LEM  460 (511)
Q Consensus       458 l~~  460 (511)
                      ++.
T Consensus       303 l~h  305 (381)
T cd05626         303 KAH  305 (381)
T ss_pred             hcC
Confidence            874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1e-38  Score=324.16  Aligned_cols=242  Identities=22%  Similarity=0.322  Sum_probs=194.2

Q ss_pred             cccCcCCcEEEEEEEe-cCCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          194 HKLGQGGFGSVYKGQL-HTGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      +.||+|+||.||++.. .+|+.||+|++...    ......+.+|+.++..++||||+++.+++......++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4689999999999984 57899999999753    223456788999999999999999999999999999999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      +|.+++.    ....+++..+..++.||+.||+|||+.  .+|+||||||+|||+++++.+||+|||+++.......  .
T Consensus        81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~  152 (325)
T cd05594          81 ELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T  152 (325)
T ss_pred             cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence            9988772    335789999999999999999999962  5899999999999999999999999999875432221  1


Q ss_pred             eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchh
Q 010434          349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEI  428 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  428 (511)
                      .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||.......        ........ ...      .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--------~~~~i~~~-~~~------~  215 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELILME-EIR------F  215 (325)
T ss_pred             cccccCCcccCCHHHHccC--CCCCccccccccceeeeeccCCCCCCCCCHHH--------HHHHHhcC-CCC------C
Confidence            2344699999999998764  78899999999999999999999986432211        11111111 111      1


Q ss_pred             HHHHHHHHHHHHHHhcCcCCCCCC-----CHHHHHHH
Q 010434          429 ESVIARKLCMIGLWCIQVKAADRP-----SMTKVLEM  460 (511)
Q Consensus       429 ~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~~  460 (511)
                      +..++..+.+++.+||+.||++|+     ++.++++.
T Consensus       216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            122456788999999999999996     89999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.4e-38  Score=315.31  Aligned_cols=255  Identities=26%  Similarity=0.419  Sum_probs=199.5

Q ss_pred             hhhccccCcCCcEEEEEEEec------CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEE
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  261 (511)
                      +++.++||+|+||.||++..+      ++..||+|++....  ...++|.+|+.++++++||||+++++++..+...+++
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv   86 (288)
T cd05050           7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL   86 (288)
T ss_pred             ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence            445678999999999999853      46799999986532  2346799999999999999999999999999999999


Q ss_pred             EeecCCCCcccccccCC------------------CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEE
Q 010434          262 YEFMPNGSLDRHIFPKE------------------NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL  323 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl  323 (511)
                      +||+++|+|.+++....                  .....+++..++.++.|++.||+|||+   .+++||||||+||++
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil~  163 (288)
T cd05050          87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLV  163 (288)
T ss_pred             EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheEe
Confidence            99999999998884321                  112357899999999999999999998   699999999999999


Q ss_pred             cCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCccccccc
Q 010434          324 DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSS  402 (511)
Q Consensus       324 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~  402 (511)
                      ++++.+||+|||+++................+..|+|||.+.+.  .++.++||||||+++|||++ |..|+......  
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~--  239 (288)
T cd05050         164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE--  239 (288)
T ss_pred             cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence            99999999999998755433222222233456789999988764  78899999999999999997 77777432211  


Q ss_pred             ccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          403 KAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                            .....+..+....      .....+..+.+++.+||+.+|.+|||+.|+++.|+.
T Consensus       240 ------~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 ------EVIYYVRDGNVLS------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ------HHHHHHhcCCCCC------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                  1122222222111      111235678899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.2e-38  Score=310.64  Aligned_cols=250  Identities=26%  Similarity=0.451  Sum_probs=197.6

Q ss_pred             cccCcCCcEEEEEEEecC-------CcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          194 HKLGQGGFGSVYKGQLHT-------GRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~-------g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.||+|+||.||+|+.++       ++.+|||.+....  ....+|.+|+.++++++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998542       2589999886533  3456899999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCC---cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC-----Ceeeecccc
Q 010434          265 MPNGSLDRHIFPKEN---KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF-----IPKVSDFGL  336 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~-----~~kl~DFGl  336 (511)
                      +++++|.+++.....   ....+++..+..++.|++.||+|||+   .+++|+||||+||+++.+.     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999998853221   23458899999999999999999998   6999999999999999887     899999999


Q ss_pred             cccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhh
Q 010434          337 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLN  415 (511)
Q Consensus       337 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  415 (511)
                      ++...............++..|+|||.+.+.  .++.++||||||+++|||++ |+.|+.......        ....+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~  227 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDG--KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--------VLQHVT  227 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccC--CcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--------HHHHHh
Confidence            9765433322222333467899999998754  78999999999999999998 888875432111        111222


Q ss_pred             cCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                      ......      ....++..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       228 ~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         228 AGGRLQ------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             cCCccC------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            211111      22234567889999999999999999999999986

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-39  Score=327.49  Aligned_cols=249  Identities=24%  Similarity=0.330  Sum_probs=200.7

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      |.+.++||+|+||.||++... +|+.||||++....    .....+.+|+.++..++|+||+++++++.++...++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (350)
T cd05573           3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY   82 (350)
T ss_pred             ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence            456789999999999999855 78999999997532    3446788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++++|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          83 MPGGDLMNLLI----RKDVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             CCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            99999999883    22678999999999999999999998   799999999999999999999999999998654432


Q ss_pred             ---------------------------CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcc
Q 010434          345 ---------------------------DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMN  397 (511)
Q Consensus       345 ---------------------------~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~  397 (511)
                                                 .........||+.|+|||++.+.  .++.++|||||||++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccCCCCCCCC
Confidence                                       00112344699999999999875  7899999999999999999999998754


Q ss_pred             cccccccccchhhHHhhhc-CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCC-HHHHHHH
Q 010434          398 AIRSSKAYFPSWVYDQLNK-GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPS-MTKVLEM  460 (511)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-~~evl~~  460 (511)
                      ....        ....+.. ..........    .+++.+.+++..|++ +|.+||+ +.++++.
T Consensus       234 ~~~~--------~~~~i~~~~~~~~~p~~~----~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         234 TLQE--------TYNKIINWKESLRFPPDP----PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CHHH--------HHHHHhccCCcccCCCCC----CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            3211        1111211 1111111111    146778899999998 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.8e-38  Score=318.88  Aligned_cols=240  Identities=23%  Similarity=0.305  Sum_probs=189.8

Q ss_pred             cccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      ++||+|+||.||+|+.. +++.||||+++..    ....+.+..|..++..+ +||||+++++++..+...++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999854 6889999999753    22344566777777654 899999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|..++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--  151 (316)
T cd05592          81 GDLMFHIQ----SSGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--  151 (316)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--
Confidence            99988873    33568999999999999999999998   6999999999999999999999999999975433221  


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......        .+...+.... ..      
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~~-~~------  214 (316)
T cd05592         152 KASTFCGTPDYIAPEILKGQ--KYNESVDWWSFGVLLYEMLIGQSPFHGEDED--------ELFDSILNDR-PH------  214 (316)
T ss_pred             ccccccCCccccCHHHHcCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCC-CC------
Confidence            22344689999999999765  6889999999999999999999998654321        1122221111 11      


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHH-HHHH
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMT-KVLE  459 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~-evl~  459 (511)
                      .+..++..+.+++.+||+.+|++||++. ++++
T Consensus       215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            1222456678899999999999999975 4543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-38  Score=310.45  Aligned_cols=250  Identities=26%  Similarity=0.450  Sum_probs=194.5

Q ss_pred             cccCcCCcEEEEEEEec-CCc--EEEEEEeccC--cccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQLH-TGR--LIAVKMLENS--KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~-~g~--~vAvK~l~~~--~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      +.||+|+||.||+|.++ ++.  .+|+|.++..  ....+.+.+|+.++.++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36899999999999865 343  5788988752  33456799999999999 899999999999999999999999999


Q ss_pred             CCcccccccCC------------CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccc
Q 010434          268 GSLDRHIFPKE------------NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFG  335 (511)
Q Consensus       268 gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFG  335 (511)
                      |+|.+++....            .....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence            99999874322            122358999999999999999999998   699999999999999999999999999


Q ss_pred             ccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhh
Q 010434          336 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQL  414 (511)
Q Consensus       336 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  414 (511)
                      +++.....   ........+..|+|||++...  .++.++||||||+++|||++ |+.||......        -....+
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--------~~~~~~  224 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------ELYEKL  224 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCccccCHH--------HHHHHH
Confidence            98632211   111222346789999998654  78899999999999999997 89888543211        112222


Q ss_pred             hcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          415 NKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       415 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                      ......+.      ....+..+.+++.+||+.+|.+|||+.++++.|+..+
T Consensus       225 ~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         225 PQGYRLEK------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             hCCCCCCC------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            22211111      1123456889999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.8e-38  Score=319.26  Aligned_cols=260  Identities=24%  Similarity=0.426  Sum_probs=202.9

Q ss_pred             HHhhhccccCcCCcEEEEEEEec--------CCcEEEEEEeccCc--ccHHHHHHHHHHhccc-cccceEEeeceeccCC
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH--------TGRLIAVKMLENSK--FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGS  256 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~--------~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~  256 (511)
                      ..+.+.++||+|+||.||+++..        ....+|+|.++...  ....++.+|+.+++++ +||||+++++++..+.
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            45567789999999999999632        24579999987532  2345789999999999 6999999999999999


Q ss_pred             ceeEEEeecCCCCcccccccCCC------------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEc
Q 010434          257 KRALVYEFMPNGSLDRHIFPKEN------------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD  324 (511)
Q Consensus       257 ~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~  324 (511)
                      ..+++|||+++|+|.+++.....            ....+++..+..++.|++.||+|||+   .+++|+||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence            99999999999999998854221            23468999999999999999999998   6999999999999999


Q ss_pred             CCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccc
Q 010434          325 HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSK  403 (511)
Q Consensus       325 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~  403 (511)
                      +++.+||+|||+++...............++..|+|||.+.+.  .++.++||||||+++|||++ |..|+.....    
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----  242 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR--VYTHQSDVWSFGILMWEIFTLGGSPYPGIPV----  242 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccC--CcCccchhhHHHHHHHHHHhCCCCCCCCCCH----
Confidence            9999999999999866443222222223355689999998754  78899999999999999998 7888754321    


Q ss_pred             cccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          404 AYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                          ..+...+........      ...++..+.+++.+||+.+|++|||+.++++.|+....
T Consensus       243 ----~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         243 ----EELFKLLREGHRMDK------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             ----HHHHHHHHcCCCCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence                112222322222111      12234578889999999999999999999999987553

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=7.8e-38  Score=314.45  Aligned_cols=257  Identities=25%  Similarity=0.423  Sum_probs=202.6

Q ss_pred             HHHhhhccccCcCCcEEEEEEEec------CCcEEEEEEeccCc--ccHHHHHHHHHHhccc-cccceEEeeceeccCCc
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSK--FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSK  257 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~  257 (511)
                      ...+.+.++||+|+||.||++...      ++..||||+++...  ...+.+.+|+.+++++ +|+||+++++++.....
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            345666789999999999999732      34589999987632  2345789999999999 79999999999999999


Q ss_pred             eeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccc
Q 010434          258 RALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLA  337 (511)
Q Consensus       258 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla  337 (511)
                      .+++|||+++|+|.+++...  ....+++..+..++.|++.||+|||+   .+++|+||||+|||++.++.+|++|||++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccc
Confidence            99999999999999988422  22348999999999999999999998   69999999999999999999999999999


Q ss_pred             ccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhc
Q 010434          338 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNK  416 (511)
Q Consensus       338 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  416 (511)
                      +...............++..|+|||.+...  .++.++||||||+++|||++ |+.|+.......       ........
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-------~~~~~~~~  259 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-------KFYKLIKE  259 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccC--CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-------HHHHHHHc
Confidence            866544332222334567889999998754  68899999999999999998 888875432211       11122222


Q ss_pred             CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          417 GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      +....      .....+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       260 ~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         260 GYRMA------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             CCcCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence            21111      111234578899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-38  Score=329.07  Aligned_cols=255  Identities=23%  Similarity=0.237  Sum_probs=192.4

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      .|.+.++||+|+||.||++.. .+++.||+|...     .+.+.+|+.++++++||||+++++++..+...++|+|++. 
T Consensus        93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-  166 (391)
T PHA03212         93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-  166 (391)
T ss_pred             CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-
Confidence            456678999999999999984 578999999753     2457899999999999999999999999999999999994 


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      ++|..++.    ....+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus       167 ~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~  238 (391)
T PHA03212        167 TDLYCYLA----AKRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-N  238 (391)
T ss_pred             CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-c
Confidence            68877762    23568999999999999999999998   6999999999999999999999999999975432211 1


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc------------------ccc--
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA------------------YFP--  407 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~------------------~~~--  407 (511)
                      ......||+.|+|||++.+.  .++.++|||||||++|||++|+.|+-.........                  .++  
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARD--PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccCccCCCChhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            12345699999999998764  78999999999999999999998764321110000                  000  


Q ss_pred             -----hhhHHhhhcCCc--ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          408 -----SWVYDQLNKGGD--LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       408 -----~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                           ...+........  ............++..+.+++.+||+.||++|||++|+++
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                 000000000000  0000001112235667889999999999999999999986

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.1e-38  Score=309.91  Aligned_cols=256  Identities=22%  Similarity=0.339  Sum_probs=189.2

Q ss_pred             cccCcCCcEEEEEEEecCC---cEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          194 HKLGQGGFGSVYKGQLHTG---RLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g---~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      ++||+|+||.||+|...++   ..+++|.+....  ...+.|.+|+.+++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999975433   356677765432  34568999999999999999999999999999999999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      +|.+++.........+++..+..++.||++||+|||+   .+++|+||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999885433333457788889999999999999998   6999999999999999999999999999864322221112


Q ss_pred             eccccCCccccchhccccc-----CCCcCccchHHHHHHHHHHHHhC-CCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          349 ISATRGTIGYIAPELISRN-----FGTVSCKSDVYGFGMVLLEMAGG-RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~-----~~~~s~ksDVwS~Gvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                      .....++..|+|||++...     ...++.++||||||+++|||+++ ..|+......       ......+... ....
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~~~-~~~~  229 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-------EVLNHVIKDQ-QVKL  229 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHhhc-cccc
Confidence            2344578899999987532     12457899999999999999974 5566432211       1111111111 1111


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                      ..+ .....++..+.+++..|| .+|++||++++|++.|.
T Consensus       230 ~~~-~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         230 FKP-QLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCC-ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            111 111224566788899999 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.5e-38  Score=319.34  Aligned_cols=242  Identities=25%  Similarity=0.339  Sum_probs=191.4

Q ss_pred             hhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc----ccHHHHHHHHHHh---ccccccceEEeeceeccCCceeEEE
Q 010434          191 HFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK----FSAEEFINEVSTI---GRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~----~~~~~f~~Ev~~l---~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      .+.++||+|+||.||++.. .+|+.||||+++...    ...+.+.+|+.++   ++++||||+++++++..+...++||
T Consensus         2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~   81 (324)
T cd05589           2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM   81 (324)
T ss_pred             eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence            4568899999999999985 478999999997532    2334566676654   5678999999999999999999999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+++|+|..++.     ...+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++....
T Consensus        82 E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          82 EYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             cCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            9999999988762     2469999999999999999999998   6999999999999999999999999999875332


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                      ...  ......||+.|+|||.+.+.  .++.++|||||||++|||++|+.||.......        ....+......  
T Consensus       154 ~~~--~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~G~~pf~~~~~~~--------~~~~i~~~~~~--  219 (324)
T cd05589         154 FGD--RTSTFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE--------VFDSIVNDEVR--  219 (324)
T ss_pred             CCC--cccccccCccccCHhHhcCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCC--
Confidence            221  12345689999999998764  78899999999999999999999986543211        11222211111  


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCC-----CHHHHHH
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRP-----SMTKVLE  459 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~  459 (511)
                           .+..++..+.+++.+||+.||.+||     ++.++++
T Consensus       220 -----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         220 -----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                 1122456788899999999999999     5667665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=9.7e-38  Score=317.41  Aligned_cols=247  Identities=20%  Similarity=0.287  Sum_probs=194.2

Q ss_pred             cccCcCCcEEEEEEEe-cCCcEEEEEEeccCc----ccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      +.||+|+||.||+++. .+++.+|+|+++...    ...+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999985 468899999997632    2345688899999888 699999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--  151 (327)
T cd05617          81 GDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--  151 (327)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--
Confidence            99988772    33579999999999999999999998   6999999999999999999999999999875322221  


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||....... ......++........ ..      
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~-~~------  221 (327)
T cd05617         152 TTSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIITDNP-DMNTEDYLFQVILEKP-IR------  221 (327)
T ss_pred             ceecccCCcccCCHHHHCCC--CCCchheeehhHHHHHHHHhCCCCCCccCCCc-ccccHHHHHHHHHhCC-CC------
Confidence            12345699999999998764  78899999999999999999999996432211 1111223333332221 11      


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCH------HHHHH
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSM------TKVLE  459 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~------~evl~  459 (511)
                      .+..++..+.+++.+||+.||++||++      .++++
T Consensus       222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  259 (327)
T cd05617         222 IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKS  259 (327)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence            222345667889999999999999984      56654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.5e-38  Score=321.95  Aligned_cols=262  Identities=28%  Similarity=0.443  Sum_probs=201.3

Q ss_pred             HHHhhhccccCcCCcEEEEEEEe------cCCcEEEEEEeccCcc--cHHHHHHHHHHhccc-cccceEEeeceecc-CC
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMLENSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSE-GS  256 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~------~~g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~-~~  256 (511)
                      ...+.+.++||+|+||.||+|..      .+++.||||+++....  ....+.+|+.++.++ +||||+++++++.. +.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            34567789999999999999963      3578999999976332  345688999999999 78999999998854 45


Q ss_pred             ceeEEEeecCCCCcccccccCCC---------------------------------------------------------
Q 010434          257 KRALVYEFMPNGSLDRHIFPKEN---------------------------------------------------------  279 (511)
Q Consensus       257 ~~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------  279 (511)
                      ..+++|||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999988743210                                                         


Q ss_pred             ------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeecccc
Q 010434          280 ------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR  353 (511)
Q Consensus       280 ------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  353 (511)
                            ....+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++...............
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                  01347899999999999999999998   699999999999999999999999999998654333222223344


Q ss_pred             CCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHH
Q 010434          354 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVI  432 (511)
Q Consensus       354 gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  432 (511)
                      ++..|+|||.+...  .++.++||||||+++|||++ |..|+......       ......+..+......      ...
T Consensus       243 ~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~------~~~  307 (343)
T cd05103         243 LPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFCRRLKEGTRMRAP------DYT  307 (343)
T ss_pred             CCcceECcHHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-------HHHHHHHhccCCCCCC------CCC
Confidence            67789999998654  78899999999999999997 88887542211       1122222222222211      112


Q ss_pred             HHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          433 ARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       433 ~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      +..+.+++..||+.+|++|||+.+|++.|+....
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            4568889999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4e-38  Score=310.18  Aligned_cols=254  Identities=28%  Similarity=0.457  Sum_probs=200.7

Q ss_pred             HHhhhccccCcCCcEEEEEEEec-C---CcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEE
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH-T---GRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~-~---g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  261 (511)
                      ..+.+.+.||+|+||.||+|... +   +..+|+|.++...  ...+.|.+|+.++.+++||||+++++++..+...++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            34566789999999999999853 2   3479999986533  2346799999999999999999999999999999999


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      |||+++++|.+++..   ....+++..+..++.|++.||+|||+   .+++|+||||+|||++.++.+||+|||+++...
T Consensus        84 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          84 TEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            999999999998832   23468999999999999999999998   699999999999999999999999999998765


Q ss_pred             CCCCcee-eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          342 KENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       342 ~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      ....... .....++..|+|||.+.+.  .++.++|+||||+++||+++ |+.|+.......        ....+.+...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~~~~~~  227 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--------VIKAIEEGYR  227 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccC--ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--------HHHHHhCCCc
Confidence            4332211 1122245689999998764  78899999999999999886 998875432211        1222222211


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      ..      .....+..+.+++.+|++.+|.+||+|.++++.|+.
T Consensus       228 ~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         228 LP------APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             CC------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence            11      111234678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.6e-38  Score=318.14  Aligned_cols=236  Identities=25%  Similarity=0.347  Sum_probs=185.7

Q ss_pred             cccCcCCcEEEEEEEe-cCCcEEEEEEeccCc----ccHHHHHHHHH-HhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK----FSAEEFINEVS-TIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~----~~~~~f~~Ev~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      ++||+|+||.||+++. .+|+.||+|++....    .....+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999985 468999999986532    22344556654 57889999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|..++.    ....+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--  151 (321)
T cd05603          81 GELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--  151 (321)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--
Confidence            99988772    33568899999999999999999998   6999999999999999999999999999875322221  


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      ......||+.|+|||.+.+.  .++.++|||||||++|||++|+.||.......        ..+.+.... ..      
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~i~~~~-~~------  214 (321)
T cd05603         152 TTSTFCGTPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ--------MYDNILHKP-LQ------  214 (321)
T ss_pred             ccccccCCcccCCHHHhcCC--CCCCcCcccccchhhhhhhcCCCCCCCCCHHH--------HHHHHhcCC-CC------
Confidence            12344689999999998764  68899999999999999999999986543211        122221111 11      


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHH
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMT  455 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~  455 (511)
                      .+...+..+.+++.+||+.+|.+||+..
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         215 LPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            1112345688999999999999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.4e-38  Score=310.92  Aligned_cols=260  Identities=27%  Similarity=0.430  Sum_probs=196.1

Q ss_pred             hhhccccCcCCcEEEEEEEe-----cCCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceecc--CCceeEE
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-----HTGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALV  261 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-----~~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~--~~~~~lV  261 (511)
                      +.+.+.||+|+||.||++..     .+++.||+|.+.... ...+.|.+|+.++++++||||+++++++..  ....++|
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   85 (284)
T cd05081           6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV   85 (284)
T ss_pred             ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEE
Confidence            34567899999999999974     357899999987643 335678999999999999999999998743  3567899


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      +||+++|+|.+++..   ....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++...
T Consensus        86 ~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          86 MEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             EEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            999999999998832   23468999999999999999999998   699999999999999999999999999998765


Q ss_pred             CCCCceee-ccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccc-----cc---ccchhhHH
Q 010434          342 KENDFVSI-SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSS-----KA---YFPSWVYD  412 (511)
Q Consensus       342 ~~~~~~~~-~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~-----~~---~~~~~~~~  412 (511)
                      ........ ....++..|+|||.+.+.  .++.++||||||+++|||++|..++........     ..   .......+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccC--CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            44332111 122244569999998654  688999999999999999998766432211000     00   00000111


Q ss_pred             hhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          413 QLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       413 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      .+.......      ....++..+.+++.+||+.+|++|||+.+|++.|+.
T Consensus       238 ~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         238 LLKNNGRLP------APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             HHhcCCcCC------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence            111111111      112234678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.5e-38  Score=318.34  Aligned_cols=240  Identities=23%  Similarity=0.308  Sum_probs=191.2

Q ss_pred             cccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      +.||+|+||.||+|... +++.||||+++..    ....+.+..|..++..+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999854 6789999999763    23345677788888764 899999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|.+++.    ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  151 (316)
T cd05619          81 GDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--  151 (316)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--
Confidence            99998872    33568999999999999999999998   6999999999999999999999999999875322221  


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......        .+.+.+.... ..      
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~~-~~------  214 (316)
T cd05619         152 KTCTFCGTPDYIAPEILLGQ--KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--------ELFQSIRMDN-PC------  214 (316)
T ss_pred             ceeeecCCccccCHHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC-CC------
Confidence            12334589999999998764  7889999999999999999999998653321        1122222111 11      


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHH-HHHH
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMT-KVLE  459 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~-evl~  459 (511)
                      .+..++..+.+++.+||+.||++||++. ++.+
T Consensus       215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         215 YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            1122456788999999999999999997 5643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.9e-39  Score=325.52  Aligned_cols=250  Identities=22%  Similarity=0.260  Sum_probs=198.4

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc----cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+.++||+|+||.||+++. .+|+.||+|+++....    ..+.+.+|+.+++.++|+||+++++++.++...++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (330)
T cd05601           3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY   82 (330)
T ss_pred             ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence            45678999999999999985 4789999999976322    345688899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++..   ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          83 QPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            999999998832   23579999999999999999999998   699999999999999999999999999998665433


Q ss_pred             CceeeccccCCccccchhccccc----CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcC-Cc
Q 010434          345 DFVSISATRGTIGYIAPELISRN----FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG-GD  419 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~----~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~  419 (511)
                      .. ......||+.|+|||++...    ...++.++|||||||++|||++|+.||.......        .+..+... ..
T Consensus       157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--------~~~~i~~~~~~  227 (330)
T cd05601         157 MV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK--------TYNNIMNFQRF  227 (330)
T ss_pred             ce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH--------HHHHHHcCCCc
Confidence            22 22344689999999998632    2367889999999999999999999986532211        11111111 11


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .....    ...++..+.+++..|++ +|++|||+.++++
T Consensus       228 ~~~~~----~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         228 LKFPE----DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             cCCCC----CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            11111    11245667889999998 9999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.3e-38  Score=312.96  Aligned_cols=262  Identities=26%  Similarity=0.321  Sum_probs=202.8

Q ss_pred             HHHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      ...+++.++||+|+||+||++.. .+|+.+|+|++...  ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            44566778999999999999985 46899999988653  2335689999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++++|.+++.    ..+.+++..+..++.+++.||.|||+.  ++++|+||||+||++++++.++|+|||++......
T Consensus        84 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          84 FMDCGSLDRIYK----KGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             cCCCCCHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            999999998872    235789999999999999999999973  58999999999999999999999999998654222


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      .    .....|+..|+|||++.+.  .++.++||||||+++|+|++|+.||............+..+...+.........
T Consensus       158 ~----~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd06620         158 I----ADTFVGTSTYMSPERIQGG--KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP  231 (284)
T ss_pred             c----cCccccCcccCCHHHHccC--CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC
Confidence            1    1234689999999998654  788999999999999999999999875433211111111111111111000000


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                      ..  ....++..+.+++.+||+.||++|||+.+++++..
T Consensus       232 ~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~  268 (284)
T cd06620         232 RL--PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP  268 (284)
T ss_pred             CC--CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence            00  11225567889999999999999999999998643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.2e-38  Score=316.17  Aligned_cols=258  Identities=24%  Similarity=0.423  Sum_probs=200.2

Q ss_pred             hhhccccCcCCcEEEEEEEec-CC--cEEEEEEeccC--cccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEe
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TG--RLIAVKMLENS--KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g--~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      +.+.+.||+|+||.||+|... ++  ..+++|.++..  ....+.|.+|+.++.++ +||||+++++++......++++|
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e   83 (297)
T cd05089           4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE   83 (297)
T ss_pred             ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence            456788999999999999864 33  35788888642  23446799999999999 79999999999999999999999


Q ss_pred             ecCCCCcccccccCCC------------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeee
Q 010434          264 FMPNGSLDRHIFPKEN------------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKV  331 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl  331 (511)
                      |+++|+|.+++.....            ....+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEEE
Confidence            9999999998843221            12358999999999999999999998   69999999999999999999999


Q ss_pred             ecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhh
Q 010434          332 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWV  410 (511)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~  410 (511)
                      +|||++......   ........+..|+|||.+...  .++.++||||||+++|||++ |+.||.......        .
T Consensus       161 ~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--------~  227 (297)
T cd05089         161 ADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYS--VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--------L  227 (297)
T ss_pred             CCcCCCccccce---eccCCCCcCccccCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------H
Confidence            999998642211   111122345679999998754  68899999999999999997 988885432111        1


Q ss_pred             HHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCC
Q 010434          411 YDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQ  469 (511)
Q Consensus       411 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~  469 (511)
                      ...+..+....      ....++..+.+++..||+.+|.+|||+.++++.|+.......
T Consensus       228 ~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~  280 (297)
T cd05089         228 YEKLPQGYRME------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK  280 (297)
T ss_pred             HHHHhcCCCCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            22222221111      112245678899999999999999999999999988776543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=7.6e-38  Score=306.11  Aligned_cols=247  Identities=29%  Similarity=0.470  Sum_probs=197.7

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeecee-ccCCceeEEEeecCC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC-SEGSKRALVYEFMPN  267 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~-~~~~~~~lV~e~~~~  267 (511)
                      .+.+.+.||+|+||.||++..+ |..+|+|.++... ..+.|.+|+.++++++|+|++++++++ .+++..++++||+++
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~   84 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK   84 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence            4566789999999999999765 7889999986543 456899999999999999999999975 456778999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      ++|.+++..  .....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++......   
T Consensus        85 ~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          85 GSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            999998732  223458999999999999999999998   699999999999999999999999999987543322   


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                        ....++..|+|||++...  .++.++||||||+++|||++ |+.|+.......        +...+..+....     
T Consensus       157 --~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~-----  219 (256)
T cd05082         157 --DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKMD-----  219 (256)
T ss_pred             --CCCccceeecCHHHHccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhcCCCCC-----
Confidence              223456789999998764  78899999999999999997 888875432111        112222221111     


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                       ....++..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       220 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         220 -APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence             112345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=333.91  Aligned_cols=252  Identities=27%  Similarity=0.447  Sum_probs=211.1

Q ss_pred             ccccCcCCcEEEEEEE-ecCC----cEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          193 THKLGQGGFGSVYKGQ-LHTG----RLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~-~~~g----~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      .++||+|+||+||||. .+.|    -+||||++...  .....++++|+.+|.++.|||+++|+|+|.... ..||++||
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m  779 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM  779 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence            3589999999999997 4444    37999998763  345689999999999999999999999997755 88999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      |.|+|.+++.   ..+..+..+.++.|..|||+||.|||.   ++++||||.++|||+.+-..+|+.|||+|+....+..
T Consensus       780 P~G~LlDyvr---~hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  780 PLGCLLDYVR---EHRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             ccchHHHHHH---HhhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            9999999984   345789999999999999999999998   7999999999999999999999999999998877665


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      ........-.+.|||-|.+...  .++.+||||||||++||++| |.+|++....++        +-+.++.+.++.   
T Consensus       854 ey~~~~gK~pikwmale~i~~~--~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e--------I~dlle~geRLs---  920 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIR--KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE--------IPDLLEKGERLS---  920 (1177)
T ss_pred             cccccccccCcHHHHHHHhhcc--CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH--------hhHHHhccccCC---
Confidence            5555555678899999998764  89999999999999999988 888887654433        444555555433   


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                         .+..++.++..++.+||..|+..||+++++...+.....+
T Consensus       921 ---qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  921 ---QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             ---CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence               3344567888999999999999999999998877664443

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.1e-38  Score=323.02  Aligned_cols=244  Identities=23%  Similarity=0.322  Sum_probs=196.3

Q ss_pred             ccccCcCCcEEEEEEE-ecCCcEEEEEEeccCcc----cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          193 THKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      .++||+|+||.||.++ ..+|..+|+|+|+++..    ..+....|-.+|....+|+||+|+-.|.+...+||||||+||
T Consensus       146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG  225 (550)
T KOG0605|consen  146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG  225 (550)
T ss_pred             heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence            4689999999999998 55899999999988543    345678899999999999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC----
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE----  343 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~----  343 (511)
                      |++..+|    .....|+++.....+.+++.||+.||+   .|+|||||||+|+|||..|++||+||||+.-....    
T Consensus       226 GD~mTLL----~~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~  298 (550)
T KOG0605|consen  226 GDMMTLL----MRKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE  298 (550)
T ss_pred             ccHHHHH----HhcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence            9999988    345789999999999999999999999   79999999999999999999999999998532110    


Q ss_pred             -----------------CCcee------e------------------ccccCCccccchhcccccCCCcCccchHHHHHH
Q 010434          344 -----------------NDFVS------I------------------SATRGTIGYIAPELISRNFGTVSCKSDVYGFGM  382 (511)
Q Consensus       344 -----------------~~~~~------~------------------~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gv  382 (511)
                                       .....      .                  -..+|||.|||||++.+.  .++..+|+||+||
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k--gY~~~cDwWSLG~  376 (550)
T KOG0605|consen  299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK--GYGKECDWWSLGC  376 (550)
T ss_pred             hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC--CCCccccHHHHHH
Confidence                             00000      0                  012499999999999986  6899999999999


Q ss_pred             HHHHHHhCCCCCCcccccccccccchhhHHhhhcCC-cccccccchhHHHHHHHHHHHHHHhcCcCCCCCCC---HHHHH
Q 010434          383 VLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG-DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPS---MTKVL  458 (511)
Q Consensus       383 ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---~~evl  458 (511)
                      ++|||+.|.+||......+        ++..+.... .+..+    ....++.+..+++.+|+. ||++|--   +.||-
T Consensus       377 ImyEmLvGyPPF~s~tp~~--------T~rkI~nwr~~l~fP----~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK  443 (550)
T KOG0605|consen  377 IMYEMLVGYPPFCSETPQE--------TYRKIVNWRETLKFP----EEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK  443 (550)
T ss_pred             HHHHHHhCCCCCCCCCHHH--------HHHHHHHHhhhccCC----CcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence            9999999999998766444        344333322 11111    112234678889999998 9999965   55554

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1e-38  Score=323.04  Aligned_cols=237  Identities=25%  Similarity=0.328  Sum_probs=191.4

Q ss_pred             cccCcCCcEEEEEEEe----cCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          194 HKLGQGGFGSVYKGQL----HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~----~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      ++||+|+||.||+++.    .+|+.+|+|++....   .....+.+|+.++++++||||+++++++..+...++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    368899999997632   234567889999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++....... 
T Consensus        82 ~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-  153 (318)
T cd05582          82 GGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-  153 (318)
T ss_pred             CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence            999998872    33568999999999999999999998   6999999999999999999999999999876533321 


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                       ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||......        .....+.... ..     
T Consensus       154 -~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~--------~~~~~i~~~~-~~-----  216 (318)
T cd05582         154 -KAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--------ETMTMILKAK-LG-----  216 (318)
T ss_pred             -ceecccCChhhcCHHHHcCC--CCCCccceeccceEeeeeccCCCCCCCCCHH--------HHHHHHHcCC-CC-----
Confidence             12344689999999998764  6789999999999999999999998653221        1112221111 11     


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCHHH
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSMTK  456 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~e  456 (511)
                       .+..++..+.+++.+||+.||++||++.+
T Consensus       217 -~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         217 -MPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence             12234567889999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.8e-38  Score=312.63  Aligned_cols=244  Identities=25%  Similarity=0.364  Sum_probs=191.6

Q ss_pred             cCcCCcEEEEEEEe-cCCcEEEEEEeccCcc----cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCc
Q 010434          196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL  270 (511)
Q Consensus       196 LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  270 (511)
                      ||+|+||.||+++. .+|+.+|+|.+.....    ....+..|++++++++||||+++.+++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999985 4689999999864221    234566799999999999999999999999999999999999999


Q ss_pred             ccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeec
Q 010434          271 DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  350 (511)
Q Consensus       271 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  350 (511)
                      .+++...  ....+++..+..++.|++.||+|||+   .+++||||||+||++++++.++|+|||++.......   ...
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~  152 (277)
T cd05607          81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TIT  152 (277)
T ss_pred             HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eee
Confidence            8877422  23468999999999999999999998   699999999999999999999999999987654332   123


Q ss_pred             cccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHH
Q 010434          351 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  430 (511)
Q Consensus       351 ~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  430 (511)
                      ...|+..|+|||++.+.  .++.++|||||||++|||++|+.|+.........    ..+....... ....     ...
T Consensus       153 ~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~----~~~~~~~~~~-~~~~-----~~~  220 (277)
T cd05607         153 QRAGTNGYMAPEILKEE--PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK----EELKRRTLED-EVKF-----EHQ  220 (277)
T ss_pred             ccCCCCCccCHHHHccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH----HHHHHHhhcc-cccc-----ccc
Confidence            44689999999998765  6889999999999999999999998643211100    0011111110 0000     112


Q ss_pred             HHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          431 VIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       431 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .++..+.+++..||+.||++||++.|+++
T Consensus       221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         221 NFTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             cCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence            34567889999999999999999977654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.4e-38  Score=318.23  Aligned_cols=257  Identities=26%  Similarity=0.457  Sum_probs=198.3

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCc--EEEEEEeccC--cccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGR--LIAVKMLENS--KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~--~vAvK~l~~~--~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      -+.+.+.||+|+||.||+|... ++.  .+|+|.++..  ....+.|.+|+.++.++ +|+||+++++++..++..++||
T Consensus         8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~   87 (303)
T cd05088           8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI   87 (303)
T ss_pred             hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence            4456789999999999999854 454  4678877542  23446789999999999 8999999999999999999999


Q ss_pred             eecCCCCcccccccCC------------CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCee
Q 010434          263 EFMPNGSLDRHIFPKE------------NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPK  330 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~k  330 (511)
                      ||+++|+|.+++....            .....+++..++.++.|++.||+|||+   .+++||||||+|||+++++.+|
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~k  164 (303)
T cd05088          88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAK  164 (303)
T ss_pred             EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcEE
Confidence            9999999999884332            123468999999999999999999998   6999999999999999999999


Q ss_pred             eecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchh
Q 010434          331 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSW  409 (511)
Q Consensus       331 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~  409 (511)
                      |+|||+++.....   .......++..|+|||.+.+.  .++.++||||||+++|||++ |..||.......        
T Consensus       165 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------  231 (303)
T cd05088         165 IADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------  231 (303)
T ss_pred             eCccccCcccchh---hhcccCCCcccccCHHHHhcc--CCcccccchhhhhHHHHHHhcCCCCcccCChHH--------
Confidence            9999998632211   111222346789999988654  68899999999999999998 998885432211        


Q ss_pred             hHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          410 VYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       410 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                      ..+.........      .....+..+.+++.+||+.+|++||++.+++++|+..+..
T Consensus       232 ~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         232 LYEKLPQGYRLE------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             HHHHHhcCCcCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            112222211111      1112345678999999999999999999999998865433

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-38  Score=310.13  Aligned_cols=255  Identities=20%  Similarity=0.320  Sum_probs=214.8

Q ss_pred             hHHHHHHHhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCcc----cHHHHHHHHHHhccccccceEEeeceeccCC
Q 010434          182 YPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGS  256 (511)
Q Consensus       182 ~~ei~~~t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~  256 (511)
                      -..-.+-+|.|.+.||+|.||.|-++. ...|+.||||.+++++.    +.-...+|+++|..|+||||+.++.+|++.+
T Consensus        47 hkhnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd  126 (668)
T KOG0611|consen   47 HKHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD  126 (668)
T ss_pred             cccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc
Confidence            334456678888999999999999997 57899999999987543    2334678999999999999999999999999


Q ss_pred             ceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccc
Q 010434          257 KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGL  336 (511)
Q Consensus       257 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGl  336 (511)
                      +..|||||..+|.|.+|+    ...+.|++.....++.||..|+.|+|+   .+++|||||.+|||||.|+++||+||||
T Consensus       127 KIvivMEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGL  199 (668)
T KOG0611|consen  127 KIVIVMEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGL  199 (668)
T ss_pred             eEEEEEEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccch
Confidence            999999999999999999    455789999999999999999999999   5999999999999999999999999999


Q ss_pred             cccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhc
Q 010434          337 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK  416 (511)
Q Consensus       337 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  416 (511)
                      +.++....   -....+|++-|.+||.+.+. ..-.+..|-||+||+||-|+.|.-||+..+...        +..++..
T Consensus       200 SNly~~~k---fLqTFCGSPLYASPEIvNG~-PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~--------lvrQIs~  267 (668)
T KOG0611|consen  200 SNLYADKK---FLQTFCGSPLYASPEIVNGT-PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR--------LVRQISR  267 (668)
T ss_pred             hhhhcccc---HHHHhcCCcccCCccccCCC-CCCCCccchhhHHHHHHHHhhcccccCCchHHH--------HHHHhhc
Confidence            98876543   24667899999999999875 234688999999999999999999998765332        3445555


Q ss_pred             CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          417 GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      +...+...+        ....-|++|||-.||++|.|+.+|.....-
T Consensus       268 GaYrEP~~P--------SdA~gLIRwmLmVNP~RRATieDiAsHWWv  306 (668)
T KOG0611|consen  268 GAYREPETP--------SDASGLIRWMLMVNPERRATIEDIASHWWV  306 (668)
T ss_pred             ccccCCCCC--------chHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence            544333322        345679999999999999999999877653

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=8.1e-38  Score=305.69  Aligned_cols=247  Identities=29%  Similarity=0.447  Sum_probs=197.0

Q ss_pred             cccCcCCcEEEEEEEecC--C--cEEEEEEeccCcc--cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQLHT--G--RLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~--g--~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      ++||+|++|.||+|.+.+  +  ..||||.+.....  ..+.|.+|+.++++++||||+++++++.. ...++++||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            478999999999998543  3  3699999977443  45689999999999999999999999988 889999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      ++|.+++.....  ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++.........
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999998843221  578999999999999999999998   699999999999999999999999999998765433221


Q ss_pred             -eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhh-cCCcccccc
Q 010434          348 -SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLN-KGGDLELRN  424 (511)
Q Consensus       348 -~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  424 (511)
                       ......++..|+|||.+...  .++.++||||||+++|||++ |+.|+.......        ...... ......   
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~---  221 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTR--TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--------ILKKIDKEGERLE---  221 (257)
T ss_pred             ecccCCCCCceecCHHHhccc--CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHhcCCcCC---
Confidence             11234578899999998764  78899999999999999998 999985432111        111111 111111   


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                         .....+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       222 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 ---RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ---CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence               11234567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-37  Score=306.13  Aligned_cols=239  Identities=23%  Similarity=0.354  Sum_probs=186.5

Q ss_pred             cccCcCCcEEEEEEEecC-------------CcEEEEEEeccCcc-cHHHHHHHHHHhccccccceEEeeceeccCCcee
Q 010434          194 HKLGQGGFGSVYKGQLHT-------------GRLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  259 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~-------------g~~vAvK~l~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~  259 (511)
                      +.||+|+||.||+|+..+             ...||+|.+..... ....|.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999997532             23689998866432 3457889999999999999999999999999999


Q ss_pred             EEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCC-------eeee
Q 010434          260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFI-------PKVS  332 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~-------~kl~  332 (511)
                      +||||+++|+|..++.   .....+++..+.+++.||+.||+|||+   .+|+||||||+|||++.++.       +|++
T Consensus        81 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          81 MVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEecccCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            9999999999988773   223568999999999999999999998   69999999999999987664       8999


Q ss_pred             cccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHH-hCCCCCCcccccccccccchhhH
Q 010434          333 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA-GGRRNSNMNAIRSSKAYFPSWVY  411 (511)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ell-tg~~p~~~~~~~~~~~~~~~~~~  411 (511)
                      |||++......      ....++..|+|||.+... ..++.++||||||+++|||+ +|+.|+.......        ..
T Consensus       155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--------~~  219 (262)
T cd05077         155 DPGIPITVLSR------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--------KE  219 (262)
T ss_pred             CCCCCccccCc------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--------HH
Confidence            99998754322      234578899999988632 46889999999999999998 5777765432111        00


Q ss_pred             HhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHH
Q 010434          412 DQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEML  461 (511)
Q Consensus       412 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L  461 (511)
                       ...... ....      ......+.+++.+||+.||.+||++.++++.|
T Consensus       220 -~~~~~~-~~~~------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         220 -RFYEGQ-CMLV------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             -HHHhcC-ccCC------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence             111110 0110      01135678899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.8e-38  Score=317.77  Aligned_cols=240  Identities=24%  Similarity=0.310  Sum_probs=193.3

Q ss_pred             cccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      +.||+|+||.||++..+ +++.||||+++..    ....+.+.+|..++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 6889999999753    22345678899998887 799999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|..++.    ....+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++.......  
T Consensus        81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  151 (318)
T cd05570          81 GDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--  151 (318)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--
Confidence            99988872    33579999999999999999999998   6999999999999999999999999999875322221  


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......        ....+..... .      
T Consensus       152 ~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~--------~~~~i~~~~~-~------  214 (318)
T cd05570         152 TTSTFCGTPDYIAPEILSYQ--PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE--------LFQSILEDEV-R------  214 (318)
T ss_pred             cccceecCccccCHHHhcCC--CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH--------HHHHHHcCCC-C------
Confidence            12334589999999999764  78899999999999999999999986533211        1122211111 1      


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCH-----HHHHH
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSM-----TKVLE  459 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~-----~evl~  459 (511)
                      .+..++..+.+++.+||+.||++|||+     .++++
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            112345678899999999999999999     88875

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.6e-38  Score=317.12  Aligned_cols=239  Identities=23%  Similarity=0.297  Sum_probs=190.5

Q ss_pred             cccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      ++||+|+||.||+++.+ +|+.||+|.++..    ....+.+..|..++... +||||+++++++.+++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999864 6899999999763    23445677788888754 899999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|.+++.    ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  151 (316)
T cd05620          81 GDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--  151 (316)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--
Confidence            99998873    23568999999999999999999998   6999999999999999999999999999874322211  


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||......        .+.+.+.... ..      
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--------~~~~~~~~~~-~~------  214 (316)
T cd05620         152 RASTFCGTPDYIAPEILQGL--KYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--------ELFESIRVDT-PH------  214 (316)
T ss_pred             ceeccCCCcCccCHHHHcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC-CC------
Confidence            12345689999999999765  7889999999999999999999998654321        1122222111 11      


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHH-HHH
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMT-KVL  458 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~-evl  458 (511)
                      .+..++..+.+++.+||+.||++||++. +++
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         215 YPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            1112456788899999999999999984 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.6e-37  Score=306.22  Aligned_cols=251  Identities=27%  Similarity=0.370  Sum_probs=196.8

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccc-cccceEEeeceeccC------CceeE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEG------SKRAL  260 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~------~~~~l  260 (511)
                      .+.+.++||+|+||.||+|.. .+++.||+|.+........++.+|+.++.++ +|+||+++++++...      ...++
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i   86 (272)
T cd06637           7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL   86 (272)
T ss_pred             hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence            345567899999999999985 4688999999977666677899999999998 799999999998643      45789


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      +|||+++++|.+++..  .....+++..+..++.|++.||+|||+   .+|+|+||||+||++++++.+||+|||+++..
T Consensus        87 v~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          87 VMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             EEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            9999999999998732  234578999999999999999999998   69999999999999999999999999998765


Q ss_pred             CCCCCceeeccccCCccccchhccccc---CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcC
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG  417 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~---~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  417 (511)
                      .....  ......|+..|+|||++...   ...++.++|||||||++|||++|+.|+.......        ........
T Consensus       162 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~--------~~~~~~~~  231 (272)
T cd06637         162 DRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--------ALFLIPRN  231 (272)
T ss_pred             ccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH--------HHHHHhcC
Confidence            33221  22345589999999998532   2357889999999999999999999986432111        00111111


Q ss_pred             CcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          418 GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .....     ....++..+.+++.+||+.+|.+|||+.++++
T Consensus       232 ~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         232 PAPRL-----KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CCCCC-----CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            10000     11123457889999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-37  Score=302.64  Aligned_cols=247  Identities=26%  Similarity=0.443  Sum_probs=197.3

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEEeccCcc--cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCcc
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLD  271 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  271 (511)
                      ++||+|+||.||++..++++.||+|.+.....  ..+.|.+|+.++++++|+||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            47999999999999977799999999876433  3567999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeecc
Q 010434          272 RHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA  351 (511)
Q Consensus       272 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  351 (511)
                      +++..   ....+++..+..++.+++.||+|||+   .+++|+||||+||+++.++.+||+|||+++.............
T Consensus        81 ~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRK---KKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            98832   23468899999999999999999998   5999999999999999999999999999986543221111122


Q ss_pred             ccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccchhHH
Q 010434          352 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  430 (511)
Q Consensus       352 ~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  430 (511)
                      ..++..|+|||.+.+.  .++.++|+||||+++|||++ |..|+.......        ....+.......      .+.
T Consensus       155 ~~~~~~y~~PE~~~~~--~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--------~~~~~~~~~~~~------~~~  218 (251)
T cd05041         155 KQIPIKWTAPEALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--------TRERIESGYRMP------APQ  218 (251)
T ss_pred             CcceeccCChHhhccC--CCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--------HHHHHhcCCCCC------CCc
Confidence            3346789999998654  78899999999999999998 777775432111        111222111111      112


Q ss_pred             HHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          431 VIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       431 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                      ..+..+.+++.+||+.+|.+|||+.+|++.|.
T Consensus       219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            33567889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.8e-38  Score=326.80  Aligned_cols=253  Identities=21%  Similarity=0.270  Sum_probs=200.4

Q ss_pred             HHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEE
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  261 (511)
                      ...+.+.++||+|+||.||+++.. +++.||+|++...    ....+.+.+|+.+++.++||||+++++++.++...++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            345667789999999999999854 6899999999652    22345578999999999999999999999999999999


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      |||+++|+|.+++.     ...++...+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++...
T Consensus       122 ~Ey~~gg~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         122 MEYMPGGDLVNLMS-----NYDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            99999999999872     2358888999999999999999998   699999999999999999999999999997654


Q ss_pred             CCCCceeeccccCCccccchhccccc--CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcC-C
Q 010434          342 KENDFVSISATRGTIGYIAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG-G  418 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~  418 (511)
                      .... .......||+.|+|||++.+.  .+.++.++|||||||++|||++|+.||......        ..+..+... .
T Consensus       194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~~~~  264 (370)
T cd05596         194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIMDHKN  264 (370)
T ss_pred             CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--------HHHHHHHcCCC
Confidence            3221 112345699999999998653  134789999999999999999999998754321        122222221 1


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhcCcCCCC--CCCHHHHHHH
Q 010434          419 DLELRNVTEIESVIARKLCMIGLWCIQVKAAD--RPSMTKVLEM  460 (511)
Q Consensus       419 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~evl~~  460 (511)
                      ......    ...++..+.+++.+||+.+|.+  |||+.++++.
T Consensus       265 ~~~~~~----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         265 SLTFPD----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             cCCCCC----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            111111    1124567888999999999988  9999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.7e-38  Score=309.34  Aligned_cols=254  Identities=23%  Similarity=0.290  Sum_probs=198.4

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .+.+.++||+|+||.||+|+. .+++.||+|++.... .....+.+|+.++.+++||||+++++.+..+...++|+||++
T Consensus        10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~   89 (267)
T cd06646          10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG   89 (267)
T ss_pred             hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence            456678999999999999985 578999999987533 344568899999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +++|.+++.    ....+++..+..++.|++.||.|||+   .+|+|+||||+||++++++.+||+|||+++....... 
T Consensus        90 ~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06646          90 GGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-  161 (267)
T ss_pred             CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence            999998873    23578999999999999999999998   6999999999999999999999999999986532211 


Q ss_pred             eeeccccCCccccchhccccc-CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          347 VSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~-~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                       ......++..|+|||.+... .+.++.++||||||+++|||++|+.|+..........        .+... .......
T Consensus       162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--------~~~~~-~~~~~~~  231 (267)
T cd06646         162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--------LMSKS-NFQPPKL  231 (267)
T ss_pred             -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--------eeecC-CCCCCCC
Confidence             12334588999999987432 2357889999999999999999999875332111000        00000 0000000


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEML  461 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L  461 (511)
                      . ....++..+.+++.+||+.+|++|||++++++.|
T Consensus       232 ~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 K-DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             c-cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0 1123456788999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.3e-37  Score=308.81  Aligned_cols=247  Identities=25%  Similarity=0.370  Sum_probs=194.6

Q ss_pred             hhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          191 HFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      .+.++||+|+||.||+|.. .+++.||+|++...  ....++|.+|+.++++++||||+++++++......++||||+++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   83 (279)
T cd06619           4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG   83 (279)
T ss_pred             hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence            4567899999999999984 57899999998653  22346799999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      ++|..+        ..+++..+..++.|++.||+|||+   .+|+|+||||+|||++.++.+||+|||++.......   
T Consensus        84 ~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---  149 (279)
T cd06619          84 GSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---  149 (279)
T ss_pred             CChHHh--------hcCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence            998654        246788999999999999999998   699999999999999999999999999997654321   


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                       .....+|..|+|||.+.+.  .++.++||||||+++|+|++|+.|+........... +...............     
T Consensus       150 -~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~-----  220 (279)
T cd06619         150 -AKTYVGTNAYMAPERISGE--QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM-PLQLLQCIVDEDPPVL-----  220 (279)
T ss_pred             -ccCCCCChhhcCceeecCC--CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc-hHHHHHHHhccCCCCC-----
Confidence             2345689999999998765  688999999999999999999999865332211111 1111111111111111     


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      .....+..+.+++.+||+.+|++||++.++++.
T Consensus       221 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         221 PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            111234568899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.7e-38  Score=308.93  Aligned_cols=252  Identities=30%  Similarity=0.467  Sum_probs=197.8

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHH---HHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAE---EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~---~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      |.+.+.||+|+||+||+++.. +++.+|+|.+........   ...+|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            356789999999999999955 567999999987554333   3456999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++++|.+++.    ....+++..+..++.|+++||++||+   .+++|+||||+||++++++.++|+|||.+......  
T Consensus        81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--  151 (260)
T PF00069_consen   81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--  151 (260)
T ss_dssp             TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTST--
T ss_pred             cccccccccc----cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--
Confidence            9999999883    45678999999999999999999999   69999999999999999999999999998764222  


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                      ........++..|+|||.+... ...+.++||||+|+++|+|++|+.|+...........    ..+.....    ....
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~----~~~~~~~~----~~~~  222 (260)
T PF00069_consen  152 NENFNPFVGTPEYMAPEVLQQG-KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI----IEKILKRP----LPSS  222 (260)
T ss_dssp             TSEBSSSSSSGGGSCHHHHTTT-SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH----HHHHHHTH----HHHH
T ss_pred             cccccccccccccccccccccc-ccccccccccccccccccccccccccccccchhhhhh----hhhccccc----cccc
Confidence            2234556689999999998721 3789999999999999999999999875411111100    11110000    0000


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ..........+.+++.+||+.||++|||+.++++
T Consensus       223 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  223 SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0001111267899999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-37  Score=309.99  Aligned_cols=263  Identities=22%  Similarity=0.349  Sum_probs=200.5

Q ss_pred             HHhhhccccCcCCcEEEEEEEe-----cCCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccC--Cce
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQL-----HTGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKR  258 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~-----~~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~  258 (511)
                      .++...++||+|+||.||+++.     .++..||+|.++..  ....+.+.+|+.++++++|||++++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3556678899999999999973     35789999998653  22346799999999999999999999998765  568


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      ++||||+++++|.+++..   ....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++
T Consensus        84 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccc
Confidence            899999999999998732   23468999999999999999999998   699999999999999999999999999998


Q ss_pred             cCCCCCCce-eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccc-------cccccchhh
Q 010434          339 FHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRS-------SKAYFPSWV  410 (511)
Q Consensus       339 ~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~-------~~~~~~~~~  410 (511)
                      ......... ......++..|+|||.+.+.  .++.++||||||+++|||++++.|........       .........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQS--KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL  235 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccC--CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence            665433221 11234467789999998754  68899999999999999999876543211100       000001111


Q ss_pred             HHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          411 YDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       411 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                      ...+..+....      ....++..+.+++.+||+.+|.+|||+.++++.|+..
T Consensus       236 ~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         236 VRVLEEGKRLP------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHcCccCC------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11122221111      1123456799999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.4e-38  Score=318.31  Aligned_cols=237  Identities=25%  Similarity=0.334  Sum_probs=187.1

Q ss_pred             cccCcCCcEEEEEEEe-cCCcEEEEEEeccC----cccHHHHHHHHH-HhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQL-HTGRLIAVKMLENS----KFSAEEFINEVS-TIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~----~~~~~~f~~Ev~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      +.||+|+||.||+++. .+|+.+|+|++...    ......+..|.. +++.++||||+++++.+..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999985 47899999998653    223345666665 46778999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|..++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++.......  
T Consensus        81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--  151 (325)
T cd05604          81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--  151 (325)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--
Confidence            99988772    34578999999999999999999998   6999999999999999999999999999875322221  


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......        +.+.+.... ..      
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--------~~~~~~~~~-~~------  214 (325)
T cd05604         152 TTTTFCGTPEYLAPEVIRKQ--PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--------MYDNILHKP-LV------  214 (325)
T ss_pred             CcccccCChhhCCHHHHcCC--CCCCcCccccccceehhhhcCCCCCCCCCHHH--------HHHHHHcCC-cc------
Confidence            12345699999999998764  78899999999999999999999986532211        122222211 11      


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHH
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTK  456 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~e  456 (511)
                      .....+..+.+++.+|++.+|.+||++.+
T Consensus       215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         215 LRPGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence            11123456778999999999999998863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=9.6e-38  Score=316.77  Aligned_cols=244  Identities=23%  Similarity=0.281  Sum_probs=193.5

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc----ccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEe
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      +++.+.||+|+||.||+|+.. +++.||||++....    ...+.+..|..++..+ +|++|+++++++...+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME   81 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence            345789999999999999854 67899999987532    2334567788888777 68999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++.....
T Consensus        82 ~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          82 YVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             CCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            999999988873    33568999999999999999999998   69999999999999999999999999998754322


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      ..  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......        +...+..... .  
T Consensus       155 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~--------~~~~i~~~~~-~--  219 (323)
T cd05616         155 GV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--------LFQSIMEHNV-A--  219 (323)
T ss_pred             CC--ccccCCCChhhcCHHHhcCC--CCCCccchhchhHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCC-C--
Confidence            21  12345689999999999764  78999999999999999999999986543211        2222222111 1  


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCH-----HHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSM-----TKVLE  459 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~-----~evl~  459 (511)
                          .+..++..+.+++.+|++.+|.+|++.     .++.+
T Consensus       220 ----~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~  256 (323)
T cd05616         220 ----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  256 (323)
T ss_pred             ----CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence                122345678899999999999999984     56643

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=8.9e-38  Score=317.16  Aligned_cols=244  Identities=24%  Similarity=0.298  Sum_probs=193.5

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccccc-cceEEeeceeccCCceeEEEe
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRIHH-VNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H-~niv~l~g~~~~~~~~~lV~e  263 (511)
                      +.+.+.||+|+||.||+|+.. +++.||||++...    ....+.+..|+.++..++| ++|+++++++...+..++|||
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME   81 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence            356789999999999999854 6789999998753    2345678889999999966 568889999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++|+|.+++.    ....+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          82 YVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            999999998873    33568999999999999999999998   69999999999999999999999999998743222


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      ..  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||.......        ....+.... ..  
T Consensus       155 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~~--------~~~~i~~~~-~~--  219 (324)
T cd05587         155 GK--TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--------LFQSIMEHN-VS--  219 (324)
T ss_pred             CC--ceeeecCCccccChhhhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCC-CC--
Confidence            11  12344689999999999764  68899999999999999999999986543211        122222211 11  


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCH-----HHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSM-----TKVLE  459 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~-----~evl~  459 (511)
                          .+..++..+.+++.+||+.||.+||+.     .++++
T Consensus       220 ----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  256 (324)
T cd05587         220 ----YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE  256 (324)
T ss_pred             ----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                112345678899999999999999986     56554

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.8e-38  Score=329.85  Aligned_cols=258  Identities=19%  Similarity=0.216  Sum_probs=192.9

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      .+.+.++||+|+||.||++... +++.||||...     ...+.+|+.++++++|+|||++++++..++..++|||++ .
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~  243 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-R  243 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-C
Confidence            3556688999999999999854 68899999642     234678999999999999999999999999999999999 5


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      ++|.+++..   ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.........
T Consensus       244 ~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        244 SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            788877632   23479999999999999999999998   699999999999999999999999999998654332221


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcc--ccc--
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDL--ELR--  423 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~--  423 (511)
                      ......||..|+|||++.+.  .++.++|||||||++|||++|..++-..........+...+.+.+......  +..  
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~--~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGD--PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             cccccCCCcCCcCHHHHcCC--CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence            22334699999999999765  789999999999999999998765432211111111112222222111100  000  


Q ss_pred             ---------------------ccc--hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          424 ---------------------NVT--EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       424 ---------------------~~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                                           ...  ......+..+.+|+.+||+.||++|||+.|+++.
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                                 000  0001233468889999999999999999999864

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-37  Score=308.76  Aligned_cols=262  Identities=26%  Similarity=0.443  Sum_probs=202.6

Q ss_pred             HhhhccccCcCCcEEEEEEEec-----CCcEEEEEEeccCccc--HHHHHHHHHHhccccccceEEeeceecc--CCcee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-----TGRLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRA  259 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-----~g~~vAvK~l~~~~~~--~~~f~~Ev~~l~~l~H~niv~l~g~~~~--~~~~~  259 (511)
                      .+.+.++||+|+||.||++++.     ++..+|||.+......  .++|.+|+.++++++|+||+++++++..  +...+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            3456689999999999999853     4689999999775543  6789999999999999999999999877  56789


Q ss_pred             EEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      ++|||+++++|.+++...   ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++..
T Consensus        85 lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            999999999999998422   2369999999999999999999998   6999999999999999999999999999987


Q ss_pred             CCCCCCce-eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc-------ccchhhH
Q 010434          340 HPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA-------YFPSWVY  411 (511)
Q Consensus       340 ~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~-------~~~~~~~  411 (511)
                      ........ ......++..|+|||.+...  .++.++||||||++++||++|+.|+..........       .......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTS--KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccC--CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            66333221 11223456679999998754  78899999999999999999998875432111000       0001111


Q ss_pred             HhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          412 DQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       412 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                      ..+.......      ....++..+.+++.+||+.+|.+|||+.+|+++|+..
T Consensus       237 ~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         237 ELLKEGERLP------RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHcCCcCC------CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1112111111      1122346788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=9.6e-38  Score=304.54  Aligned_cols=248  Identities=25%  Similarity=0.354  Sum_probs=200.9

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      .+.+.++||+|+||.||+|... +++.+|+|.+..... .+++.+|+.++++++|+||+++++++..+...++++||+++
T Consensus         4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   82 (256)
T cd06612           4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA   82 (256)
T ss_pred             cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence            3456788999999999999965 489999999876433 67899999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      ++|.+++.   ..+..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++........  
T Consensus        83 ~~L~~~l~---~~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--  154 (256)
T cd06612          83 GSVSDIMK---ITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--  154 (256)
T ss_pred             CcHHHHHH---hCccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence            99999873   234678999999999999999999998   6999999999999999999999999999986654321  


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      ......++..|+|||.+.+.  .++.++||||||+++|+|++|+.|+.........       . ........    ...
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~-~~~~~~~~----~~~  220 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------F-MIPNKPPP----TLS  220 (256)
T ss_pred             ccccccCCccccCHHHHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------h-hhccCCCC----CCC
Confidence            12334478899999998765  7889999999999999999999998653221100       0 00000000    111


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ....++..+.+++.+||+.+|++|||+.+|++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            23345567889999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8.1e-38  Score=322.54  Aligned_cols=249  Identities=24%  Similarity=0.279  Sum_probs=190.3

Q ss_pred             hhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          191 HFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      .+.++||+|+||+||++.. .+++.||||++....    ...+.+.+|+.++.+++|+||+++++.+.++...++||||+
T Consensus         4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~   83 (363)
T cd05628           4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFL   83 (363)
T ss_pred             eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCC
Confidence            4567899999999999985 468999999996532    23356788999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++|+|.+++.    ....+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus        84 ~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          84 PGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             CCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            9999999883    34579999999999999999999998   6999999999999999999999999999875432110


Q ss_pred             c---------------------------------eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCC
Q 010434          346 F---------------------------------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR  392 (511)
Q Consensus       346 ~---------------------------------~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~  392 (511)
                      .                                 .......||+.|+|||++.+.  .++.++|||||||++|||++|+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC--CCCCchhhhhhHHHHHHHHhCCC
Confidence            0                                 001234699999999999765  78899999999999999999999


Q ss_pred             CCCcccccccccccchhhHHhhhcC-CcccccccchhHHHHHHHHHHHHHHhc--CcCCCCCCCHHHHHHH
Q 010434          393 NSNMNAIRSSKAYFPSWVYDQLNKG-GDLELRNVTEIESVIARKLCMIGLWCI--QVKAADRPSMTKVLEM  460 (511)
Q Consensus       393 p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~Cl--~~~P~~RPs~~evl~~  460 (511)
                      ||......        ..+..+... .........    .++..+.+++.+++  ..++..||++.++++.
T Consensus       235 Pf~~~~~~--------~~~~~i~~~~~~~~~p~~~----~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         235 PFCSETPQ--------ETYKKVMNWKETLIFPPEV----PISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCHH--------HHHHHHHcCcCcccCCCcC----CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            99653321        122222221 111111111    12344555555533  3344567999999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.3e-37  Score=305.20  Aligned_cols=250  Identities=26%  Similarity=0.389  Sum_probs=191.2

Q ss_pred             cccCcCCcEEEEEEEec----CCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceec-cCCceeEEEeecC
Q 010434          194 HKLGQGGFGSVYKGQLH----TGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCS-EGSKRALVYEFMP  266 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~----~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~-~~~~~~lV~e~~~  266 (511)
                      +.||+|+||.||+|...    ++..+|+|.+...  ....+.+.+|+.+++.++||||+++++++. .+...++++||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    2457999998542  234568899999999999999999999775 4566889999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +|+|.+++..   ....+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++........
T Consensus        81 ~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            9999998832   23456788889999999999999998   69999999999999999999999999999754332211


Q ss_pred             e--eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCC-CCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          347 V--SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       347 ~--~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      .  ......++..|+|||.+.+.  .++.++||||||+++|||++|. .|+......       . ....+..+..... 
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-------~-~~~~~~~~~~~~~-  223 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF-------D-ITVYLLQGRRLLQ-  223 (262)
T ss_pred             eecccccCcCCccccChhHhccC--ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------H-HHHHHhcCCCCCC-
Confidence            1  11233467789999998754  7889999999999999999964 454332111       1 1112222211111 


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                           ....+..+.+++..||+.+|++||++.+|++.|+...
T Consensus       224 -----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         224 -----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             -----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence                 1123457889999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-38  Score=325.52  Aligned_cols=249  Identities=24%  Similarity=0.287  Sum_probs=194.9

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+.++||+|+||.||+++. .+|+.||||++....    .....+.+|+.++..++||||+++++++.++...++||||
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~   82 (364)
T cd05599           3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY   82 (364)
T ss_pred             ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence            34568999999999999985 478999999997532    2335678899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++.    ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          83 LPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            99999999883    23569999999999999999999998   699999999999999999999999999987543211


Q ss_pred             Cce------------------------------------eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHH
Q 010434          345 DFV------------------------------------SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA  388 (511)
Q Consensus       345 ~~~------------------------------------~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ell  388 (511)
                      ...                                    ......||+.|+|||++.+.  .++.++|||||||++|||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC--CCCCeeeeecchhHHHHhh
Confidence            000                                    00123589999999998764  7889999999999999999


Q ss_pred             hCCCCCCcccccccccccchhhHHhhhc-CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCC---HHHHHHH
Q 010434          389 GGRRNSNMNAIRSSKAYFPSWVYDQLNK-GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPS---MTKVLEM  460 (511)
Q Consensus       389 tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---~~evl~~  460 (511)
                      +|+.||.......        ....+.. .........    ..+++.+.+++..|+. +|.+|++   +.++++.
T Consensus       234 ~G~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~~----~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         234 VGYPPFCSDNPQE--------TYRKIINWKETLQFPDE----VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             cCCCCCCCCCHHH--------HHHHHHcCCCccCCCCC----CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            9999996543211        1111111 111111111    1234567788888996 9999998   8888763

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=7.8e-38  Score=315.18  Aligned_cols=261  Identities=23%  Similarity=0.353  Sum_probs=195.7

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      +|.+.++||+|+||.||+|+.+ +++.||+|.++..  ......+.+|+.++++++||||+++++++..+...++||||+
T Consensus         7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   86 (309)
T cd07872           7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL   86 (309)
T ss_pred             ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence            3556789999999999999854 6889999998753  223456889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++ +|.+++.   ..+..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++.......
T Consensus        87 ~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          87 DK-DLKQYMD---DCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CC-CHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            75 7777662   223568999999999999999999998   6999999999999999999999999999975433221


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc-------chhhHHhhhcC-
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF-------PSWVYDQLNKG-  417 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~~~~-  417 (511)
                        ......+|+.|+|||.+.+. ..++.++||||||+++|||++|+.||............       +...+..+... 
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         160 --TYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             --ccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence              12334578999999988653 36788999999999999999999998654321100000       00000000000 


Q ss_pred             --Cccccc-----ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          418 --GDLELR-----NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       418 --~~~~~~-----~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                        ......     ........++..+.+++.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence              000000     000111234567889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.7e-38  Score=311.56  Aligned_cols=239  Identities=25%  Similarity=0.362  Sum_probs=186.2

Q ss_pred             ccCcCCcEEEEEEEecC-------------------------CcEEEEEEeccCcc-cHHHHHHHHHHhccccccceEEe
Q 010434          195 KLGQGGFGSVYKGQLHT-------------------------GRLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQL  248 (511)
Q Consensus       195 ~LG~G~fg~Vykg~~~~-------------------------g~~vAvK~l~~~~~-~~~~f~~Ev~~l~~l~H~niv~l  248 (511)
                      +||+|+||.||+|.+..                         ...||+|++..... ...+|.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997421                         13589999865432 34578999999999999999999


Q ss_pred             eceeccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC-
Q 010434          249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF-  327 (511)
Q Consensus       249 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~-  327 (511)
                      ++++.++...++||||+++|+|..++..   ....+++..+..++.||++||+|||+   .+|+||||||+|||++.++ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCc
Confidence            9999999999999999999999988732   23578999999999999999999998   6999999999999997643 


Q ss_pred             ------CeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHH-hCCCCCCccccc
Q 010434          328 ------IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA-GGRRNSNMNAIR  400 (511)
Q Consensus       328 ------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ell-tg~~p~~~~~~~  400 (511)
                            .+|++|||++......      ....++..|+|||.+.+. ..++.++||||||+++|||+ +|+.|+......
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~  228 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERTPS  228 (274)
T ss_pred             ccCccceeeecCCccccccccc------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence                  3799999987643222      223477889999988653 46789999999999999984 688887643221


Q ss_pred             ccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          401 SSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                      .        ..........  ..      ......+.+++.+||+.+|++|||+.+|++.|+
T Consensus       229 ~--------~~~~~~~~~~--~~------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         229 E--------KERFYEKKHR--LP------EPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             H--------HHHHHHhccC--CC------CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            1        0111111110  11      112346888999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-37  Score=307.34  Aligned_cols=256  Identities=26%  Similarity=0.430  Sum_probs=202.4

Q ss_pred             HHhhhccccCcCCcEEEEEEEec-CCc----EEEEEEeccCcc--cHHHHHHHHHHhccccccceEEeeceeccCCceeE
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH-TGR----LIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  260 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~-~g~----~vAvK~l~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  260 (511)
                      ..+++.++||+|+||.||+|..+ +|.    .+|+|.+.....  ...++.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            34566789999999999999854 333    699998876432  34678999999999999999999999987 78899


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      |+||+++|+|.+++..   ....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++..
T Consensus        86 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          86 ITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence            9999999999998842   23458999999999999999999998   69999999999999999999999999999876


Q ss_pred             CCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      .............++..|+|||.+...  .++.++|+||||+++|||++ |+.|++......        +.+.+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~  229 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHR--IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--------IPDLLEKGER  229 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcC--CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--------HHHHHhCCCC
Confidence            544332222233356789999988653  78899999999999999998 999986543211        2222222222


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      ....      ...+..+.+++..||..+|.+||++.++++.|+....
T Consensus       230 ~~~~------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         230 LPQP------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             CCCC------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1111      1123467889999999999999999999999987544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.1e-37  Score=305.05  Aligned_cols=253  Identities=26%  Similarity=0.408  Sum_probs=199.9

Q ss_pred             hhhccccCcCCcEEEEEEEecC--CcEEEEEEeccC-----------cccHHHHHHHHHHhcc-ccccceEEeeceeccC
Q 010434          190 NHFTHKLGQGGFGSVYKGQLHT--GRLIAVKMLENS-----------KFSAEEFINEVSTIGR-IHHVNVVQLLGFCSEG  255 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~~--g~~vAvK~l~~~-----------~~~~~~f~~Ev~~l~~-l~H~niv~l~g~~~~~  255 (511)
                      +.+.+.||+|+||.||+|....  ++.+|+|.+...           .....++.+|+.++.+ ++||||+++++++.++
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            3456789999999999998654  789999987532           1123467889988865 7999999999999999


Q ss_pred             CceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccc
Q 010434          256 SKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFG  335 (511)
Q Consensus       256 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFG  335 (511)
                      +..+++|||+++++|.+++.........+++..++.++.|++.||.|||+.  .+++|+||+|+||++++++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg  159 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFG  159 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEeccc
Confidence            999999999999999988743333456799999999999999999999962  579999999999999999999999999


Q ss_pred             ccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhh
Q 010434          336 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLN  415 (511)
Q Consensus       336 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  415 (511)
                      ++.......   ......++..|+|||.+.+.  .++.++||||||+++|||++|+.|+.......        ......
T Consensus       160 ~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~--------~~~~~~  226 (269)
T cd08528         160 LAKQKQPES---KLTSVVGTILYSCPEIVKNE--PYGEKADVWAFGCILYQMCTLQPPFYSTNMLS--------LATKIV  226 (269)
T ss_pred             ceeeccccc---ccccccCcccCcChhhhcCC--CCchHHHHHHHHHHHHHHHhCCCcccccCHHH--------HHHHHh
Confidence            998654432   23445689999999998754  68999999999999999999999985432211        111111


Q ss_pred             cCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                      .......     .....+..+.+++.+||+.||++||++.++.++++
T Consensus       227 ~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         227 EAVYEPL-----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             hccCCcC-----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            1111111     11123567889999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=9.7e-38  Score=304.96  Aligned_cols=248  Identities=23%  Similarity=0.318  Sum_probs=199.7

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      +.+.++||+|+||.||+++.. +++.+|+|.++..  ....+.+.+|+.++++++|+||+++++.+..+...+++|||++
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD   81 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence            345789999999999999854 7899999998642  3345678899999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +|+|.+++..  ..+..+++..+..++.|++.||.|||+   .+++|+||||+||++++++.++++|||+++........
T Consensus        82 ~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          82 GGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             CCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            9999887732  234568999999999999999999998   69999999999999999999999999998765443221


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                        .....+++.|+|||++.+.  .++.++|+||||+++|+|++|+.||.......        ....+..+....     
T Consensus       157 --~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~-----  219 (255)
T cd08219         157 --ACTYVGTPYYVPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPFQANSWKN--------LILKVCQGSYKP-----  219 (255)
T ss_pred             --cccccCCccccCHHHHccC--CcCchhhhhhhchhheehhhccCCCCCCCHHH--------HHHHHhcCCCCC-----
Confidence              1234588899999998764  68899999999999999999999986432111        111222221111     


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                       .+..++..+.+++.+||+.+|++|||+.+++..
T Consensus       220 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 -LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence             112345668899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.6e-38  Score=329.25  Aligned_cols=250  Identities=23%  Similarity=0.280  Sum_probs=192.3

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      |.+.++||+|+||.||+++. .+++.||||++....    ...+.+.+|+.++++++|+||+++++.+.+++..++||||
T Consensus         3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~   82 (376)
T cd05598           3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (376)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence            45678999999999999984 468999999986522    2345688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++..+....
T Consensus        83 ~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          83 IPGGDMMSLLI----RLGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            99999999883    33568899999999999999999998   699999999999999999999999999975321100


Q ss_pred             C-----------------------------------------ceeeccccCCccccchhcccccCCCcCccchHHHHHHH
Q 010434          345 D-----------------------------------------FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV  383 (511)
Q Consensus       345 ~-----------------------------------------~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvl  383 (511)
                      .                                         ........||+.|+|||++.+.  .++.++|||||||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvi  233 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC--CCCcceeeeeccce
Confidence            0                                         0001123599999999999765  68899999999999


Q ss_pred             HHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCC---CHHHHHHH
Q 010434          384 LLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRP---SMTKVLEM  460 (511)
Q Consensus       384 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP---s~~evl~~  460 (511)
                      +|||++|+.||........       ...............    ...++..+.+++.+|+ .+|.+|+   |+.++++.
T Consensus       234 lyell~G~~Pf~~~~~~~~-------~~~i~~~~~~~~~~~----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         234 LYEMLVGQPPFLADTPAET-------QLKVINWETTLHIPS----QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             eeehhhCCCCCCCCCHHHH-------HHHHhccCccccCCC----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            9999999999975432211       111111111111111    1123455667777766 4999999   88998864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1e-37  Score=307.56  Aligned_cols=256  Identities=24%  Similarity=0.371  Sum_probs=201.4

Q ss_pred             HHHhhhccccCcCCcEEEEEEEecC----CcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeE
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQLHT----GRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  260 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~~~----g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  260 (511)
                      ...+.+.++||+|+||.||+|...+    ...||||......  ...+.|.+|+.++++++||||+++++++.+ ...++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3456677899999999999998543    3479999886532  345689999999999999999999999875 55789


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      ||||+++|+|.+++..   ....+++..+..++.+++.||+|||+   .+++|+||||+||+++.++.+||+|||+++..
T Consensus        84 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          84 VMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeec
Confidence            9999999999999832   23468999999999999999999998   69999999999999999999999999999866


Q ss_pred             CCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      ....... .....++..|+|||.+...  .++.++||||||++++||++ |..||.......        ....+..+..
T Consensus       158 ~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~~~  226 (270)
T cd05056         158 EDESYYK-ASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--------VIGRIENGER  226 (270)
T ss_pred             cccccee-cCCCCccccccChhhhccC--CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHcCCc
Confidence            5442211 2233356789999988654  68899999999999999986 999986543211        1122222222


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      ...      ...++..+.+++.+|+..+|.+|||+.++++.|+...+
T Consensus       227 ~~~------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         227 LPM------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             CCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            211      12345678899999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.5e-37  Score=302.98  Aligned_cols=265  Identities=25%  Similarity=0.316  Sum_probs=198.4

Q ss_pred             HhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCcc---cHHHHHHHHHHhccccccc-eEEeeceeccCC------c
Q 010434          189 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVN-VVQLLGFCSEGS------K  257 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~n-iv~l~g~~~~~~------~  257 (511)
                      .+...++||+|.||+||+|+ ..+|+.||+|++.....   .....++|+.++++++|+| ||+|++++...+      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            34445789999999999998 55789999999976433   4556789999999999999 999999997766      8


Q ss_pred             eeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccc
Q 010434          258 RALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLA  337 (511)
Q Consensus       258 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla  337 (511)
                      .++|+||+ .-+|.+++.........++...+..++.||++||+|||+   ++|+||||||.||||+++|.+||+|||+|
T Consensus        92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchH
Confidence            89999999 568888884433222457778999999999999999999   69999999999999999999999999999


Q ss_pred             ccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccc------------cccc
Q 010434          338 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRS------------SKAY  405 (511)
Q Consensus       338 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~------------~~~~  405 (511)
                      +-..-...  ..+...+|..|.|||++.+. ..|+...||||+||++.||++++.-|.......            ....
T Consensus       168 ra~~ip~~--~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  168 RAFSIPMR--TYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             HHhcCCcc--cccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            86543322  23556789999999999887 368999999999999999999988776533211            0011


Q ss_pred             cchhhHHhhhcCCcccccccchhHH---HHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          406 FPSWVYDQLNKGGDLELRNVTEIES---VIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       406 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      +|....-.-.+..............   .......+++.+||+.+|.+|.|++.++++
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            1100000000000000000111111   122467889999999999999999999875

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.3e-37  Score=302.42  Aligned_cols=240  Identities=23%  Similarity=0.349  Sum_probs=189.1

Q ss_pred             cccCcCCcEEEEEEEecCC-----------cEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          194 HKLGQGGFGSVYKGQLHTG-----------RLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g-----------~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      +.||+|+||.||+|...+.           ..+++|.+.........|.+|+.++++++||||+++++++.. ...++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            4699999999999986533           258888876654447889999999999999999999999988 7789999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC-------Ceeeeccc
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF-------IPKVSDFG  335 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~-------~~kl~DFG  335 (511)
                      ||+++|+|.+++...   ...+++..+..++.||+.||+|||+   .+|+|+||||+|||++.++       .+||+|||
T Consensus        80 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          80 EYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            999999999988322   2378999999999999999999998   6999999999999999888       79999999


Q ss_pred             ccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhC-CCCCCcccccccccccchhhHHhh
Q 010434          336 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG-RRNSNMNAIRSSKAYFPSWVYDQL  414 (511)
Q Consensus       336 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~  414 (511)
                      +++.....      ....++..|+|||++......++.++||||||+++|||++| ..|+.......       + ....
T Consensus       154 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-------~-~~~~  219 (259)
T cd05037         154 IPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-------K-ERFY  219 (259)
T ss_pred             cccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-------H-HHHH
Confidence            99865431      22346778999999875434688999999999999999994 66654432111       0 0011


Q ss_pred             hcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          415 NKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       415 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                      .........  .      ...+.+++.+||+.+|.+|||+.++++.|+
T Consensus       220 ~~~~~~~~~--~------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         220 QDQHRLPMP--D------CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             hcCCCCCCC--C------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            111111111  0      157889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.3e-37  Score=313.69  Aligned_cols=254  Identities=22%  Similarity=0.299  Sum_probs=196.4

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      +.+.++||+|+||.||++.. .++..+|+|.+...  ....+++.+|++++.+++||||+++++++..++..++||||++
T Consensus         3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~   82 (308)
T cd06615           3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD   82 (308)
T ss_pred             ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence            35568899999999999985 46889999998653  2234568899999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +++|.+++.    ....+++..+..++.|+++||.|||+.  .+++|+||||+|||++.++.+||+|||++.......  
T Consensus        83 ~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  154 (308)
T cd06615          83 GGSLDQVLK----KAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  154 (308)
T ss_pred             CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence            999999983    235689999999999999999999972  489999999999999999999999999987543221  


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchh---h-------------
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW---V-------------  410 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~---~-------------  410 (511)
                        .....++..|+|||.+.+.  .++.++|+||||+++|||++|+.|+...........+...   .             
T Consensus       155 --~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         155 --ANSFVGTRSYMSPERLQGT--HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             --cccCCCCcCccChhHhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence              1334688999999998764  6889999999999999999999998643221111000000   0             


Q ss_pred             ------------HHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          411 ------------YDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       411 ------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                                  .+.+......     ......++..+.+++.+||+.+|++|||+.+|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPP-----KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCc-----cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                        0000000000     00001245678899999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.9e-38  Score=328.07  Aligned_cols=249  Identities=22%  Similarity=0.260  Sum_probs=189.8

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+.++||+|+||.||+++. .+++.||+|++....    ...+.+.+|+.++++++|+||+++++.+.++...++||||
T Consensus         3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~   82 (382)
T cd05625           3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY   82 (382)
T ss_pred             cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence            34567899999999999985 578899999987532    2345688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          83 IPGGDMMSLLI----RMGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            99999999873    23568899999999999999999998   699999999999999999999999999975321100


Q ss_pred             C---------------------------------------------ceeeccccCCccccchhcccccCCCcCccchHHH
Q 010434          345 D---------------------------------------------FVSISATRGTIGYIAPELISRNFGTVSCKSDVYG  379 (511)
Q Consensus       345 ~---------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS  379 (511)
                      .                                             ........||+.|+|||++.+.  .++.++||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwS  233 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWS  233 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC--CCCCeeeEEe
Confidence            0                                             0001123589999999999765  7889999999


Q ss_pred             HHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCC---HHH
Q 010434          380 FGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPS---MTK  456 (511)
Q Consensus       380 ~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---~~e  456 (511)
                      |||++|||++|+.||........       ...............    ...+++.+.+++.+++ .+|++|++   +.+
T Consensus       234 lGvil~elltG~~Pf~~~~~~~~-------~~~i~~~~~~~~~p~----~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e  301 (382)
T cd05625         234 VGVILYEMLVGQPPFLAQTPLET-------QMKVINWQTSLHIPP----QAKLSPEASDLIIKLC-RGPEDRLGKNGADE  301 (382)
T ss_pred             chHHHHHHHhCCCCCCCCCHHHH-------HHHHHccCCCcCCCC----cccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence            99999999999999965432110       111111111111111    1123445666666665 49999987   777


Q ss_pred             HHH
Q 010434          457 VLE  459 (511)
Q Consensus       457 vl~  459 (511)
                      +++
T Consensus       302 i~~  304 (382)
T cd05625         302 IKA  304 (382)
T ss_pred             Hhc
Confidence            765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.1e-38  Score=324.27  Aligned_cols=252  Identities=21%  Similarity=0.288  Sum_probs=198.1

Q ss_pred             HHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      ..+.+.++||+|+||.||+++.. +++.+|+|++...    ....+.+.+|+.+++.++||||+++++++.++...++||
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM  122 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            45667789999999999999854 6889999998652    223456889999999999999999999999999999999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+++|+|.+++.     ...+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++....
T Consensus       123 Ey~~gg~L~~~l~-----~~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         123 EYMPGGDLVNLMS-----NYDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             cCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            9999999999882     2358899999999999999999998   6999999999999999999999999999986543


Q ss_pred             CCCceeeccccCCccccchhcccccC--CCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcC-Cc
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG-GD  419 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~--~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~  419 (511)
                      ... .......||+.|+|||++.+..  +.++.++|||||||++|||++|+.||.......        .+..+... ..
T Consensus       195 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~--------~~~~i~~~~~~  265 (370)
T cd05621         195 TGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG--------TYSKIMDHKNS  265 (370)
T ss_pred             CCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCcc
Confidence            221 1223456999999999986542  247889999999999999999999996543211        12222211 11


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCC--CCCHHHHHHH
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAAD--RPSMTKVLEM  460 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~evl~~  460 (511)
                      .....    ...++..+.+++..|++.++.+  |||+.++++.
T Consensus       266 ~~~p~----~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         266 LNFPE----DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             cCCCC----cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            11111    1234566778889999865544  8999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.4e-37  Score=306.32  Aligned_cols=252  Identities=25%  Similarity=0.323  Sum_probs=196.0

Q ss_pred             HHhhh--ccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          188 VTNHF--THKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       188 ~t~~~--~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      +++++  ...||+|+||.||+|.. +++..||+|.+.... ...+.+.+|+.++++++|+||+++++++..++..++|+|
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   85 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME   85 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence            34444  35799999999999984 467899999887643 345689999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCcc--CHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC-CCCeeeecccccccC
Q 010434          264 FMPNGSLDRHIFPKENKGQTF--GWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH-NFIPKVSDFGLAKFH  340 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~-~~~~kl~DFGla~~~  340 (511)
                      |+++++|.+++...   ...+  ++..+..++.||+.||+|||+   .+|+|+||||+||+++. ++.+||+|||++...
T Consensus        86 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          86 QVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             cCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            99999999988422   2344  788899999999999999998   69999999999999976 679999999998765


Q ss_pred             CCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcc
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDL  420 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (511)
                      .....  ......++..|+|||.+.+....++.++||||||+++|+|++|+.|+.........      ........   
T Consensus       160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~------~~~~~~~~---  228 (268)
T cd06624         160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA------MFKVGMFK---  228 (268)
T ss_pred             ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh------Hhhhhhhc---
Confidence            43221  12233588999999998654335788999999999999999999998542211100      00000000   


Q ss_pred             cccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          421 ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       421 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                         .....+..+...+..++.+||+.+|.+|||+.++++
T Consensus       229 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         229 ---IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             ---cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence               011123345567889999999999999999999985

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.7e-37  Score=309.54  Aligned_cols=247  Identities=24%  Similarity=0.343  Sum_probs=198.7

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      ++.+.++||+|+||.||+|.. .+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++.+..+...++||||++
T Consensus        21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~  100 (296)
T cd06654          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (296)
T ss_pred             ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence            445567899999999999984 578999999987633 345678999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +++|.+++.     ...+++..+..++.|++.||+|||+   .+|+|+||||+||+++.++.+||+|||++........ 
T Consensus       101 ~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-  171 (296)
T cd06654         101 GGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (296)
T ss_pred             CCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence            999999872     2458999999999999999999998   6999999999999999999999999999876443221 


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                       ......+++.|+|||.+.+.  .++.++||||||+++|||++|+.||.......       ......... .....   
T Consensus       172 -~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-------~~~~~~~~~-~~~~~---  237 (296)
T cd06654         172 -KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-------ALYLIATNG-TPELQ---  237 (296)
T ss_pred             -ccCcccCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-------hHHHHhcCC-CCCCC---
Confidence             11334588999999998764  67899999999999999999999986543211       111111111 11111   


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                       ....++..+.+++.+||+.+|++|||+.++++
T Consensus       238 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         238 -NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             -CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence             12335567889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-38  Score=291.56  Aligned_cols=252  Identities=23%  Similarity=0.371  Sum_probs=210.4

Q ss_pred             CCCChHHHHHHHhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeecee
Q 010434          178 KRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFC  252 (511)
Q Consensus       178 ~~~~~~ei~~~t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~  252 (511)
                      +.+++.+     .++.+.||+|.||.||.|+ .+++-.||+|++.++.    ...+++.+|+++-..|+||||+++++++
T Consensus        17 ~~~~l~d-----feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f   91 (281)
T KOG0580|consen   17 KTWTLDD-----FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF   91 (281)
T ss_pred             cccchhh-----ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence            4455554     3457899999999999998 4578899999997643    3457899999999999999999999999


Q ss_pred             ccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeee
Q 010434          253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVS  332 (511)
Q Consensus       253 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~  332 (511)
                      .+..+.||++||.++|+|.+.+.  ......+++.....+..|+|.|+.|+|.   ++|+||||||+|+|++.++..|++
T Consensus        92 hd~~riyLilEya~~gel~k~L~--~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiA  166 (281)
T KOG0580|consen   92 HDSKRIYLILEYAPRGELYKDLQ--EGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIA  166 (281)
T ss_pred             eccceeEEEEEecCCchHHHHHH--hcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeecc
Confidence            99999999999999999999883  2345678888889999999999999998   799999999999999999999999


Q ss_pred             cccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHH
Q 010434          333 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYD  412 (511)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~  412 (511)
                      |||-+-..+...    -...+||..|.+||+..+.  ..+.+.|+|++|++.||++.|.+||.....        ...++
T Consensus       167 dfGwsV~~p~~k----R~tlcgt~dyl~pEmv~~~--~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--------~etYk  232 (281)
T KOG0580|consen  167 DFGWSVHAPSNK----RKTLCGTLDYLPPEMVEGR--GHDKFVDLWSLGVLCYEFLVGLPPFESQSH--------SETYK  232 (281)
T ss_pred             CCCceeecCCCC----ceeeecccccCCHhhcCCC--CccchhhHHHHHHHHHHHHhcCCchhhhhh--------HHHHH
Confidence            999886554222    2456799999999999876  778899999999999999999999976542        22455


Q ss_pred             hhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          413 QLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       413 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      .+.+....       .+..++....+++..|+..+|.+|.+..|+++.
T Consensus       233 rI~k~~~~-------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  233 RIRKVDLK-------FPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             HHHHcccc-------CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            55543221       224456778899999999999999999999874

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-38  Score=326.09  Aligned_cols=249  Identities=24%  Similarity=0.289  Sum_probs=192.9

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      |.+.++||+|+||.||++.. .+|+.||||++....    ...+.+.+|+.++++++||||+++++++.++...++||||
T Consensus         3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~   82 (377)
T cd05629           3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF   82 (377)
T ss_pred             ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence            34568999999999999984 578999999986532    2345688899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++.    ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          83 LPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            99999999883    33578999999999999999999998   699999999999999999999999999996332110


Q ss_pred             Cc------------e---------------------------------eeccccCCccccchhcccccCCCcCccchHHH
Q 010434          345 DF------------V---------------------------------SISATRGTIGYIAPELISRNFGTVSCKSDVYG  379 (511)
Q Consensus       345 ~~------------~---------------------------------~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS  379 (511)
                      ..            .                                 ......||+.|+|||++.+.  .++.++||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwS  233 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC--CCCCceeeEe
Confidence            00            0                                 00123599999999998765  7889999999


Q ss_pred             HHHHHHHHHhCCCCCCcccccccccccchhhHHhhhc-CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCC---CCHH
Q 010434          380 FGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK-GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADR---PSMT  455 (511)
Q Consensus       380 ~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R---Ps~~  455 (511)
                      |||++|||++|+.||.......        .+..+.. .........    ..++..+.+++.+|++ +|.+|   |++.
T Consensus       234 lGvil~elltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~p~~----~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENSHE--------TYRKIINWRETLYFPDD----IHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCHHH--------HHHHHHccCCccCCCCC----CCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            9999999999999986533211        1111111 111111111    1234567889999997 66665   6999


Q ss_pred             HHHHH
Q 010434          456 KVLEM  460 (511)
Q Consensus       456 evl~~  460 (511)
                      ++++.
T Consensus       301 ~~l~h  305 (377)
T cd05629         301 EIKSH  305 (377)
T ss_pred             HHhcC
Confidence            98874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.1e-37  Score=342.36  Aligned_cols=265  Identities=25%  Similarity=0.342  Sum_probs=204.3

Q ss_pred             CCCChHHHHHHHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceec
Q 010434          178 KRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCS  253 (511)
Q Consensus       178 ~~~~~~ei~~~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~  253 (511)
                      ..|...++....|.+.++||+|+||.||+++. .++..+|+|.+....   .....|..|+.++++|+|||||++++++.
T Consensus         3 ~~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~   82 (1021)
T PTZ00266          3 GKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFL   82 (1021)
T ss_pred             ccccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence            34444555666777889999999999999985 467899999986532   23467899999999999999999999874


Q ss_pred             c--CCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCC----CCceecccCCcCceEEcCC-
Q 010434          254 E--GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC----DMCILHFDIKPHNILLDHN-  326 (511)
Q Consensus       254 ~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~----~~~ivH~DIkp~NILl~~~-  326 (511)
                      .  ....+|||||+++|+|.++|.........+++..++.|+.||+.||+|||+..    ..+|+|+||||+||||+.+ 
T Consensus        83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~  162 (1021)
T PTZ00266         83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI  162 (1021)
T ss_pred             ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence            4  45689999999999999988543333467999999999999999999999732    1459999999999999642 


Q ss_pred             ----------------CCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhC
Q 010434          327 ----------------FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG  390 (511)
Q Consensus       327 ----------------~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg  390 (511)
                                      ..+||+|||+++.......   .....||+.|+|||++.+....++.++|||||||+||||++|
T Consensus       163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG  239 (1021)
T PTZ00266        163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG  239 (1021)
T ss_pred             cccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence                            3589999999986543221   234469999999999865544688999999999999999999


Q ss_pred             CCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          391 RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       391 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      +.||.....       ...+...+........       ...+..+.+|+..||+.+|.+||++.+++.
T Consensus       240 k~PF~~~~~-------~~qli~~lk~~p~lpi-------~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        240 KTPFHKANN-------FSQLISELKRGPDLPI-------KGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCCCCcCCc-------HHHHHHHHhcCCCCCc-------CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            999864221       1112222222221111       113467889999999999999999999984

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-37  Score=324.63  Aligned_cols=263  Identities=20%  Similarity=0.234  Sum_probs=198.2

Q ss_pred             HHHHHHhhhccccCcCCcEEEEEEEec---CCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeE
Q 010434          184 EIIAVTNHFTHKLGQGGFGSVYKGQLH---TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  260 (511)
Q Consensus       184 ei~~~t~~~~~~LG~G~fg~Vykg~~~---~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  260 (511)
                      .+....+.+.++||+|+||.||++...   .+..||+|.+...    ..+.+|+.++++++||||+++++++......++
T Consensus        88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l  163 (392)
T PHA03207         88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM  163 (392)
T ss_pred             hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence            344456777899999999999999743   4678999988653    245689999999999999999999999999999


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      +||++. ++|.+++    .....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       164 v~e~~~-~~l~~~l----~~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        164 VMPKYK-CDLFTYV----DRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EehhcC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            999995 6787777    234679999999999999999999998   69999999999999999999999999999866


Q ss_pred             CCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc--------------c
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY--------------F  406 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~--------------~  406 (511)
                      .............||+.|+|||++...  .++.++|||||||++|||++|+.||...........              +
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~  313 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALD--PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF  313 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence            544332223345699999999999764  788999999999999999999999865432211000              0


Q ss_pred             chh----hHHhh---hcCCcccccccch-hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          407 PSW----VYDQL---NKGGDLELRNVTE-IESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       407 ~~~----~~~~~---~~~~~~~~~~~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      +..    ....+   ............. ....++..+.+++.+||+.||++|||+.+++..
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000    00000   0000000000000 011234567889999999999999999999864

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=321.38  Aligned_cols=265  Identities=23%  Similarity=0.346  Sum_probs=212.3

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEe
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      ..|.++||+|.||.|+++..+ +++.+|||++++.    ..+.+..+.|.+++... +||.++.|+..+...++.++|||
T Consensus       370 F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvme  449 (694)
T KOG0694|consen  370 FRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVME  449 (694)
T ss_pred             eEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEE
Confidence            345689999999999999865 6889999999884    44667788888888777 59999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+.||++..+.     +...+++..+.-++..|+.||.|||+   .+||+||||.+|||||.+|.+||+||||++.....
T Consensus       450 y~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  450 YVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             ecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCCC
Confidence            99999965544     44689999999999999999999999   69999999999999999999999999999865433


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      ..  .+++.+||+.|||||++.+.  .|+...|.|||||+||||+.|..||...+.++        +.+.+...      
T Consensus       522 g~--~TsTfCGTpey~aPEil~e~--~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee--------~FdsI~~d------  583 (694)
T KOG0694|consen  522 GD--RTSTFCGTPEFLAPEVLTEQ--SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE--------VFDSIVND------  583 (694)
T ss_pred             CC--ccccccCChhhcChhhhccC--cccchhhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHhcC------
Confidence            32  45677899999999999886  89999999999999999999999998665433        22222211      


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCH----HHHH-----------HHHhcCcCCCCCCCCCCCCCCCCCC
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSM----TKVL-----------EMLEGSMDDLQMPPKPCFSSSRHIS  483 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~----~evl-----------~~Le~~~~~l~~p~~p~~~~~~~~~  483 (511)
                       ....+..++++...++.+++..+|++|--+    .+.+           +.|+.  ..++.|=+|...+.+..+
T Consensus       584 -~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~--r~i~PPf~P~i~~~~D~s  655 (694)
T KOG0694|consen  584 -EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLN--RRIKPPFVPTIKGPEDVS  655 (694)
T ss_pred             -CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhh--ccCCCCCCcccCChhhhc
Confidence             122444567788899999999999999766    3332           23433  334455566666655443

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.6e-37  Score=306.03  Aligned_cols=247  Identities=22%  Similarity=0.328  Sum_probs=198.7

Q ss_pred             HHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      ..+...+.||+|+||.||+|... +++.||+|.+...  ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            34555678999999999999854 6889999998643  23446789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++++|.+++.     ...+++..+..++.|++.|+.|||+   .+++|+||+|+||++++++.++|+|||+++......
T Consensus        84 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          84 LGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             cCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            99999998872     2568999999999999999999998   699999999999999999999999999987654332


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      .  ......++..|+|||.+.+.  .++.++||||||+++|||++|+.|+.......        ....+......    
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~~~~~~----  219 (277)
T cd06642         156 I--KRNTFVGTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNSDLHPMR--------VLFLIPKNSPP----  219 (277)
T ss_pred             h--hhhcccCcccccCHHHhCcC--CCchhhhHHHHHHHHHHHHhCCCCCcccchhh--------HHhhhhcCCCC----
Confidence            1  11234578899999998765  68899999999999999999999975432111        11111111111    


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                        .....++..+.+++.+||+.+|++||++.++++.
T Consensus       220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         220 --TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             --CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence              1222345678899999999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-38  Score=319.91  Aligned_cols=249  Identities=26%  Similarity=0.379  Sum_probs=208.5

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCc-eeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK-RALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~-~~lV~e  263 (511)
                      .|...+++|+|+||.++..+.+ +++.+++|.+....   ...+...+|+.++++++|||||.+.+.+.+++. .+|||+
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~   84 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME   84 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence            3556789999999999999754 67899999987633   344578999999999999999999999998888 999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |++||+|.+.|..  .++..++++++..++.|++.|+.|||+   .+|+|||||+.||+++.+..+||+|||+|+.....
T Consensus        85 Y~eGg~l~~~i~~--~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   85 YCEGGDLAQLIKE--QKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             ecCCCCHHHHHHH--HhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999843  336789999999999999999999997   69999999999999999999999999999987665


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      ...  .....||+.|+.||.+.+.  .|..|+|||||||.+|||++-+++|.......       .+.+ +.+..     
T Consensus       160 ~~~--a~tvvGTp~YmcPEil~d~--pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~-------Li~k-i~~~~-----  222 (426)
T KOG0589|consen  160 DSL--ASTVVGTPYYMCPEILSDI--PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE-------LILK-INRGL-----  222 (426)
T ss_pred             hhh--hheecCCCcccCHHHhCCC--CCCccCcchhhcchHHHHHhcccccCccchHH-------HHHH-Hhhcc-----
Confidence            432  2456799999999999886  89999999999999999999999987654322       2222 22221     


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                       ....+..++..+..++..|++.+|+.||++.+++.+
T Consensus       223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence             112445567889999999999999999999999874

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.4e-37  Score=321.78  Aligned_cols=255  Identities=22%  Similarity=0.292  Sum_probs=199.0

Q ss_pred             HHHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeE
Q 010434          186 IAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  260 (511)
Q Consensus       186 ~~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  260 (511)
                      ....+.+.++||+|+||.||++..+ +++.+|+|++...    ....+.+.+|+.+++.++||||+++++.+.++...++
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  120 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            3456667789999999999999854 6889999998642    2234567899999999999999999999999999999


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      ||||+++|+|.+++.     ...++...+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       121 v~Ey~~gg~L~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~  192 (371)
T cd05622         121 VMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (371)
T ss_pred             EEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence            999999999999872     2358889999999999999999998   69999999999999999999999999999865


Q ss_pred             CCCCCceeeccccCCccccchhcccccC--CCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcC-
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG-  417 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  417 (511)
                      ..... .......||+.|+|||++....  +.++.++|||||||++|||++|+.||.......        .+..+... 
T Consensus       193 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--------~~~~i~~~~  263 (371)
T cd05622         193 NKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--------TYSKIMNHK  263 (371)
T ss_pred             CcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCC
Confidence            43322 1223456999999999986542  247889999999999999999999997543211        12222221 


Q ss_pred             CcccccccchhHHHHHHHHHHHHHHhcCcCCCC--CCCHHHHHHHH
Q 010434          418 GDLELRNVTEIESVIARKLCMIGLWCIQVKAAD--RPSMTKVLEML  461 (511)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~evl~~L  461 (511)
                      .......    ...++..+.+++.+|++.++.+  ||++.++++..
T Consensus       264 ~~~~~~~----~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         264 NSLTFPD----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             CcccCCC----cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            1111111    1234567788999999844443  78999998754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.2e-37  Score=314.27  Aligned_cols=239  Identities=23%  Similarity=0.288  Sum_probs=190.7

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC----cccHHHHHHHHHHhcccc-ccceEEeeceeccCCceeEEEe
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS----KFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      +++.+.||+|+||.||++.. .+|+.||+|++...    ....+.+..|..++..+. |++|+++.+++......++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            45678999999999999985 47899999998753    223456788999988885 5778889999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++|+|.+++.    ....+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++.....
T Consensus        82 y~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          82 YVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            999999998872    33569999999999999999999998   69999999999999999999999999998754322


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      ..  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||......        .+.+.+..... .  
T Consensus       155 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~~~~~-~--  219 (323)
T cd05615         155 GV--TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--------ELFQSIMEHNV-S--  219 (323)
T ss_pred             Cc--cccCccCCccccCHHHHcCC--CCCCccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCC-C--
Confidence            21  12334589999999998764  6889999999999999999999998654321        12222222111 1  


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSM  454 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~  454 (511)
                          .+..++..+.+++.+||+.+|.+|++.
T Consensus       220 ----~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         220 ----YPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ----CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                112345677889999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=304.03  Aligned_cols=249  Identities=24%  Similarity=0.299  Sum_probs=197.3

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc------cHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~------~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      +...+.||+|++|.||++.. .+++.+|+|.+.....      ..+.+.+|+.++++++||||+++++++.++...++|+
T Consensus         4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   83 (263)
T cd06625           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM   83 (263)
T ss_pred             ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence            34567899999999999985 4689999999865321      2346889999999999999999999999999999999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+++++|.+++.    ....+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||+++....
T Consensus        84 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          84 EYMPGGSVKDQLK----AYGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EECCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            9999999998873    23568899999999999999999998   6999999999999999999999999999875543


Q ss_pred             CCCcee-eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccc
Q 010434          343 ENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       343 ~~~~~~-~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (511)
                      ...... .....++..|+|||.+.+.  .++.++||||||+++|||++|+.|+.......       ............ 
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~-  226 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGE--GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-------AIFKIATQPTNP-  226 (263)
T ss_pred             cccccccccCCCcCccccCcceeccC--CCCchhhhHHHHHHHHHHHhCCCCccccchHH-------HHHHHhccCCCC-
Confidence            221111 1234578899999999875  68899999999999999999999985432110       011111111111 


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                           ..+..++..+.+++.+||+.+|.+|||+.++++.
T Consensus       227 -----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         227 -----QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -----CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                 1223345678899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.7e-38  Score=331.03  Aligned_cols=261  Identities=20%  Similarity=0.259  Sum_probs=188.8

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccC--------Ccee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--------SKRA  259 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--------~~~~  259 (511)
                      .|.+.++||+|+||.||+|.. .+++.||||++....   ....+|+.++++++|||||++.+++...        ...+
T Consensus        67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~  143 (440)
T PTZ00036         67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN  143 (440)
T ss_pred             eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence            355678999999999999985 478999999885532   2345799999999999999998876321        2366


Q ss_pred             EEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC-Ceeeecccccc
Q 010434          260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF-IPKVSDFGLAK  338 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~-~~kl~DFGla~  338 (511)
                      +||||+++ +|.+++......+..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++ .+||+|||+++
T Consensus       144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla~  219 (440)
T PTZ00036        144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAK  219 (440)
T ss_pred             EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence            89999975 6666553333345679999999999999999999998   6999999999999998664 79999999998


Q ss_pred             cCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccch----hhHHhh
Q 010434          339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPS----WVYDQL  414 (511)
Q Consensus       339 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~----~~~~~~  414 (511)
                      .......   .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||........-.....    ...+.+
T Consensus       220 ~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~  295 (440)
T PTZ00036        220 NLLAGQR---SVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL  295 (440)
T ss_pred             hccCCCC---cccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            6543322   1234589999999998653 3688999999999999999999999865432110000000    000000


Q ss_pred             hc--C--Ccccccc--cch----hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          415 NK--G--GDLELRN--VTE----IESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       415 ~~--~--~~~~~~~--~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      ..  .  .......  ...    .+...+..+.+++.+||+.||.+|||+.++++.
T Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            00  0  0000000  000    111234678899999999999999999999853

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1e-37  Score=322.84  Aligned_cols=259  Identities=22%  Similarity=0.321  Sum_probs=193.9

Q ss_pred             hccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCC-----ceeEEE
Q 010434          192 FTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS-----KRALVY  262 (511)
Q Consensus       192 ~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~-----~~~lV~  262 (511)
                      +.++||+|+||.||++.. .+|+.||||.+....   ...+.+.+|+.+++.++|+||+++++++....     ..++|+
T Consensus         4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~   83 (372)
T cd07853           4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT   83 (372)
T ss_pred             ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence            467899999999999985 578999999986532   23467889999999999999999999997766     789999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+. ++|.+.+.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        84 e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          84 ELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             eccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9996 57777662    34579999999999999999999998   6999999999999999999999999999986543


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc---------cch-----
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY---------FPS-----  408 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~---------~~~-----  408 (511)
                      ... .......+|..|+|||.+.+. ..++.++|||||||++|||++|+.||...........         ...     
T Consensus       156 ~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~  233 (372)
T cd07853         156 DES-KHMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC  233 (372)
T ss_pred             Ccc-ccCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            321 122344578999999998764 3578899999999999999999999865432110000         000     


Q ss_pred             -hhHHhhhcCC-ccc-ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          409 -WVYDQLNKGG-DLE-LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       409 -~~~~~~~~~~-~~~-~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                       .....+.... ... ...........+..+.+++.+||+.||++|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence             0000000000 000 000000112235678899999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.6e-37  Score=307.11  Aligned_cols=256  Identities=23%  Similarity=0.304  Sum_probs=197.5

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccc-cccceEEeeceec-----cCCceeEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCS-----EGSKRALV  261 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~-----~~~~~~lV  261 (511)
                      ++.+.+.||+|+||.||++.. .+++.+|+|.+.......+++.+|+.+++++ +||||+++++++.     .+...++|
T Consensus        19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv   98 (286)
T cd06638          19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV   98 (286)
T ss_pred             ceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence            344567899999999999985 4688999999876544556788999999999 6999999999873     34568999


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      |||+++++|.+++......+..+++..+..++.|++.||.|||+   .+++||||||+||++++++.+||+|||+++...
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  175 (286)
T cd06638          99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  175 (286)
T ss_pred             EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence            99999999998774333345678999999999999999999998   699999999999999999999999999987654


Q ss_pred             CCCCceeeccccCCccccchhccccc---CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCC
Q 010434          342 KENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG  418 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~---~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  418 (511)
                      ....  ......|+..|+|||.+...   ...++.++|||||||++|||++|+.|+.......       ... ......
T Consensus       176 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-------~~~-~~~~~~  245 (286)
T cd06638         176 STRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-------ALF-KIPRNP  245 (286)
T ss_pred             cCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-------HHh-hccccC
Confidence            3221  12334589999999987532   1357889999999999999999999986432111       000 111111


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHH
Q 010434          419 DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEML  461 (511)
Q Consensus       419 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L  461 (511)
                      .....    .....+..+..++.+||+.+|++|||+.++++.+
T Consensus       246 ~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         246 PPTLH----QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             CCccc----CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            11111    1112345688999999999999999999998753

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.9e-37  Score=308.47  Aligned_cols=259  Identities=24%  Similarity=0.367  Sum_probs=189.4

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc---ccHHHHHHHHHHhccc---cccceEEeeceecc-----CCc
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK---FSAEEFINEVSTIGRI---HHVNVVQLLGFCSE-----GSK  257 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l---~H~niv~l~g~~~~-----~~~  257 (511)
                      |.+.+.||+|+||.||++... +|+.||+|.++...   .....+.+|+.+++++   +||||+++++++..     ...
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~   81 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK   81 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence            456788999999999999854 78999999986522   2234566787777665   69999999998754     345


Q ss_pred             eeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccc
Q 010434          258 RALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLA  337 (511)
Q Consensus       258 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla  337 (511)
                      .+++|||++ ++|.+++..  .....+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||++
T Consensus        82 ~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          82 VTLVFEHVD-QDLRTYLDK--VPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             EEEEEcccc-cCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCcc
Confidence            789999997 478777632  223458999999999999999999998   69999999999999999999999999999


Q ss_pred             ccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc---------ch
Q 010434          338 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF---------PS  408 (511)
Q Consensus       338 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~---------~~  408 (511)
                      +......   ......+|..|+|||++.+.  .++.++|||||||++|||++|++||............         ..
T Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07863         156 RIYSCQM---ALTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD  230 (288)
T ss_pred             ccccCcc---cCCCccccccccCchHhhCC--CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            8654322   12334588999999998764  7899999999999999999999998643221100000         00


Q ss_pred             hhHHhhhcCCccc---ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          409 WVYDQLNKGGDLE---LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       409 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      |-...-.......   ..........++..+.+++.+||+.||++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000000000000   00011122235567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2e-37  Score=319.02  Aligned_cols=258  Identities=21%  Similarity=0.226  Sum_probs=191.4

Q ss_pred             HHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccCC------c
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS------K  257 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~------~  257 (511)
                      ..|.+.++||+|+||.||++.. .+|+.||||++...   ......+.+|+.+++.++||||+++++++....      .
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  100 (359)
T cd07876          21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD  100 (359)
T ss_pred             hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence            3556678999999999999985 46899999998653   233467889999999999999999999886443      4


Q ss_pred             eeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccc
Q 010434          258 RALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLA  337 (511)
Q Consensus       258 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla  337 (511)
                      .++||||+++ +|.+.+.      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       101 ~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876         101 VYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             eEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence            7899999965 5555441      347889999999999999999998   69999999999999999999999999999


Q ss_pred             ccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc--------cccch-
Q 010434          338 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK--------AYFPS-  408 (511)
Q Consensus       338 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~--------~~~~~-  408 (511)
                      +......   ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||........-        ..... 
T Consensus       171 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  245 (359)
T cd07876         171 RTACTNF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF  245 (359)
T ss_pred             cccccCc---cCCCCcccCCCCCchhccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence            7543321   12344689999999999764  7889999999999999999999998653211100        00000 


Q ss_pred             ------hhHHhhhcCCccc------------ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          409 ------WVYDQLNKGGDLE------------LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       409 ------~~~~~~~~~~~~~------------~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                            .+...........            ...........+..+.+++.+||+.||++|||+.|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                  0000000000000            000001112234668899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.5e-37  Score=315.66  Aligned_cols=239  Identities=25%  Similarity=0.332  Sum_probs=187.6

Q ss_pred             cccCcCCcEEEEEEEec-CCcEEEEEEeccCc----ccHHHHHHHHH-HhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK----FSAEEFINEVS-TIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~----~~~~~f~~Ev~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      +.||+|+||.||+++.. +++.||+|++....    .....+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999854 67899999986532    22334555544 46778999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 ~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--  151 (325)
T cd05602          81 GELFYHLQ----RERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--  151 (325)
T ss_pred             CcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--
Confidence            99998873    33568889999999999999999998   6999999999999999999999999999975432221  


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||.......        .++.+.... ..      
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~i~~~~-~~------  214 (325)
T cd05602         152 TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--------MYDNILNKP-LQ------  214 (325)
T ss_pred             CcccccCCccccCHHHHcCC--CCCCccccccccHHHHHHhcCCCCCCCCCHHH--------HHHHHHhCC-cC------
Confidence            12345699999999998764  78899999999999999999999986433211        112221111 01      


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHH
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTKVL  458 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl  458 (511)
                      ....++..+.+++.+||+.+|.+||++.+.+
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            1123456788999999999999999977433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.4e-37  Score=305.19  Aligned_cols=251  Identities=24%  Similarity=0.333  Sum_probs=197.1

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC-cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      +++.++||+|+||.||+|... ++..+|+|.+... ....+.+.+|+.+++.++|||++++++++..+...++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            455678999999999999865 5788999998653 33456789999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      ++|..++..   ...++++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++........  
T Consensus        87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--  158 (282)
T cd06643          87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--  158 (282)
T ss_pred             CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc--
Confidence            999887632   23579999999999999999999998   6999999999999999999999999999875433221  


Q ss_pred             eeccccCCccccchhccccc---CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          348 SISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~---~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      ......++..|+|||++...   ...++.++|||||||++|||++|+.|+.......        .............. 
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~-  229 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--------VLLKIAKSEPPTLA-  229 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--------HHHHHhhcCCCCCC-
Confidence            12334588999999997421   2357789999999999999999999986432110        11111111111111 


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                         .+..++..+.+++.+||+.+|.+||++.++++.
T Consensus       230 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         230 ---QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             ---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               122245678899999999999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.7e-37  Score=306.62  Aligned_cols=262  Identities=23%  Similarity=0.296  Sum_probs=194.9

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      +.+.++||+|++|.||+|+.. +++.||||.+...   ....+.+.+|+.++++++||||+++++++.++...++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL   81 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence            345678999999999999864 7899999998653   223467889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      + ++|.+++... ..+..+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++.......
T Consensus        82 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          82 S-MDLKKYLDSL-PKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             C-CCHHHHHhcC-CCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            7 6887776322 224678999999999999999999998   6999999999999999999999999999875433221


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc-------cchhhHHhhhc--
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY-------FPSWVYDQLNK--  416 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~-------~~~~~~~~~~~--  416 (511)
                        ......+++.|+|||.+.+. ..++.++||||||++++||++|+.|+...........       .....+.....  
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         157 --VYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             --cccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence              12334578899999988653 3568899999999999999999999864321110000       00000000000  


Q ss_pred             -----CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          417 -----GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       417 -----~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                           ...............++.++.+++.+||+.||++|||+.+|++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                 0000000000111224567889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.4e-37  Score=309.72  Aligned_cols=249  Identities=26%  Similarity=0.335  Sum_probs=195.5

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc----cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +...+.||+|+||+||++.. .+++.+|+|.+.....    ....+.+|+.++++++|+|++.+.+.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            34457899999999999985 4789999999865332    234578899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++++|.+++...  ....+++..+..++.|++.||.|||+   ++|+||||||+||++++++.+||+|||++.......
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            9999999877422  23469999999999999999999998   699999999999999999999999999987654322


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      .   .....|+..|+|||.+.+.  .++.++|+||||+++|||++|+.||........    ...+.........     
T Consensus       157 ~---~~~~~g~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~----~~~~~~~~~~~~~-----  222 (285)
T cd05632         157 S---IRGRVGTVGYMAPEVLNNQ--RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK----REEVDRRVLETEE-----  222 (285)
T ss_pred             c---ccCCCCCcCccChHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhhhcccc-----
Confidence            1   1234589999999998764  788999999999999999999999865322110    0011111111100     


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCC-----HHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPS-----MTKVLE  459 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~evl~  459 (511)
                        .....++..+.+++..||+.||++||+     +.++++
T Consensus       223 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         223 --VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             --ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence              112234456788999999999999999     667765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5.3e-37  Score=299.72  Aligned_cols=249  Identities=24%  Similarity=0.340  Sum_probs=201.3

Q ss_pred             hhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      |.+.+.||.|+||.||.++ ..+++.+++|.+...   .....++.+|+.++++++|+||+++++++.+....+++|||+
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~   81 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA   81 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence            4567899999999999998 456899999998653   334567899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++++|.+++...  ....+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||+++.......
T Consensus        82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          82 NGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             CCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            999999988432  24578999999999999999999998   6999999999999999999999999999986644432


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                        ......+++.|+|||.+.+.  .++.++||||||+++|||++|+.|+......       . ....+..+....    
T Consensus       157 --~~~~~~~~~~y~ape~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------~-~~~~~~~~~~~~----  220 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGV--KYNFKSDIWALGCVLYELLTLKRTFDATNPL-------N-LVVKIVQGNYTP----  220 (256)
T ss_pred             --cccccCCCccccCHhhcCCC--CCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-------H-HHHHHHcCCCCC----
Confidence              12344589999999998764  5788999999999999999999998643211       1 111222211111    


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEML  461 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L  461 (511)
                        ....++..+.+++.+||+.+|.+||++.++++.+
T Consensus       221 --~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         221 --VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             --CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence              1133456788999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.9e-37  Score=309.34  Aligned_cols=252  Identities=26%  Similarity=0.448  Sum_probs=196.0

Q ss_pred             hhccccCcCCcEEEEEEEe-cCCc----EEEEEEeccCcc--cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          191 HFTHKLGQGGFGSVYKGQL-HTGR----LIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~-~~g~----~vAvK~l~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      ...+.||+|+||.||+|.. .+|.    .+|+|.+.....  ...++.+|+.++++++||||++++|++... ..++++|
T Consensus        10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e   88 (303)
T cd05110          10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQ   88 (303)
T ss_pred             eeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeeh
Confidence            3457899999999999985 3444    579998865332  234789999999999999999999998754 4679999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++|+|.+++..   ....+++..+..++.|++.||+|||+   .+|+|+||||+||++++++.+||+|||+++.....
T Consensus        89 ~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          89 LMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             hcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCc
Confidence            9999999998732   23468999999999999999999998   69999999999999999999999999999876543


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                      ..........++..|+|||.+.+.  .++.++||||||+++|||++ |+.|+.......        ..+.+..+.....
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~  232 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIHYR--KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--------IPDLLEKGERLPQ  232 (303)
T ss_pred             ccccccCCCccccccCCHHHhccC--CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHCCCCCCC
Confidence            322222334467799999998754  78899999999999999997 888875432111        1122222222111


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                      .      ...+..+..++..||..+|++||++.++++.|+...
T Consensus       233 ~------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         233 P------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             C------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1      112356788999999999999999999999998744

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.5e-37  Score=309.79  Aligned_cols=249  Identities=26%  Similarity=0.347  Sum_probs=196.1

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc----cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +...+.||+|+||.||++.. .+++.+|||.+.....    ..+.+.+|+.++++++|+|++.+.+.+..++..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            34567899999999999985 4789999999865322    234578899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++++|.+++...  ....+++..+..++.|++.||.|||+   .+|+|+||||+||++++++.++|+|||++.......
T Consensus        82 ~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          82 MNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             cCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            9999999887322  23468999999999999999999998   799999999999999999999999999987654332


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      .   .....|+..|+|||++.+.  .++.++||||||+++|||++|+.||.........    ...........      
T Consensus       157 ~---~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~----~~~~~~~~~~~------  221 (285)
T cd05630         157 T---IKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR----EEVERLVKEVQ------  221 (285)
T ss_pred             c---ccCCCCCccccChHHHcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCccchH----HHHHhhhhhhh------
Confidence            1   1234689999999998764  7889999999999999999999999653211100    00011111000      


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCC-----HHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPS-----MTKVLE  459 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~evl~  459 (511)
                       ......++..+.+++..||+.||++|||     +.++++
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         222 -EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence             0112234567889999999999999999     888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.3e-37  Score=314.39  Aligned_cols=263  Identities=17%  Similarity=0.227  Sum_probs=193.4

Q ss_pred             hccccCcC--CcEEEEEEEe-cCCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          192 FTHKLGQG--GFGSVYKGQL-HTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       192 ~~~~LG~G--~fg~Vykg~~-~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      +.++||+|  +||+||++.. ++|+.||+|.+.....   ..+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  7899999985 5789999999875322   2345678999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++|+|.+++...  ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.++++||+.+........
T Consensus        82 ~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            999999988322  23458999999999999999999998   6999999999999999999999999986543321111


Q ss_pred             ce-----eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccc-----ccccchhh-----
Q 010434          346 FV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSS-----KAYFPSWV-----  410 (511)
Q Consensus       346 ~~-----~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~-----~~~~~~~~-----  410 (511)
                      ..     ......++..|+|||++.+....++.++|||||||++|||++|+.||........     ....+...     
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence            00     0112346778999999876434688999999999999999999999864221100     00000000     


Q ss_pred             -HHh-------------hhcCCc-------ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          411 -YDQ-------------LNKGGD-------LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       411 -~~~-------------~~~~~~-------~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                       ...             ...+..       ............++..+.+++.+||+.||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence             000             000000       0000001122345678899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.1e-37  Score=304.80  Aligned_cols=257  Identities=27%  Similarity=0.334  Sum_probs=198.6

Q ss_pred             hhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc--cHHHHHHHHHHhccccccceEEeeceecc--CCceeEEEeec
Q 010434          191 HFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALVYEFM  265 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~  265 (511)
                      .+.++||.|++|.||++.. .+++.+|+|.+.....  ...++.+|++++++++||||+++++++..  ....++||||+
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~   83 (287)
T cd06621           4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC   83 (287)
T ss_pred             EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEec
Confidence            4567899999999999986 4689999999875332  45679999999999999999999998854  34689999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++++|.+++.........+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++........
T Consensus        84 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (287)
T cd06621          84 EGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA  160 (287)
T ss_pred             CCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence            9999988764333345678999999999999999999998   6999999999999999999999999999875432221


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                          ....++..|+|||.+.+.  .++.++||||||+++|||++|+.|++......   ..+......+.......+...
T Consensus       161 ----~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd06621         161 ----GTFTGTSFYMAPERIQGK--PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP---LGPIELLSYIVNMPNPELKDE  231 (287)
T ss_pred             ----ccccCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcccCCC---CChHHHHHHHhcCCchhhccC
Confidence                233478899999998764  78899999999999999999999987543210   001111222222111111111


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .......++.+.+++.+||+.+|.+|||+.++++
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            1111224567899999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.6e-38  Score=308.35  Aligned_cols=240  Identities=23%  Similarity=0.314  Sum_probs=186.7

Q ss_pred             cccCcCCcEEEEEEEec-C-------CcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          194 HKLGQGGFGSVYKGQLH-T-------GRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~-~-------g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      ++||+|+||.||+|... .       ...+|+|.+.... ...+.|.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            47999999999999753 2       2358889886533 3346789999999999999999999999998999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCC--------eeeecccc
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFI--------PKVSDFGL  336 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~--------~kl~DFGl  336 (511)
                      +++|+|.+++..   .+..+++..+..++.||+.||+|||+   ++|+||||||+||+++.++.        ++++|||+
T Consensus        81 ~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          81 VKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             CCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            999999998842   23468999999999999999999998   79999999999999987765        58999998


Q ss_pred             cccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCC-CCCCcccccccccccchhhHHhhh
Q 010434          337 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNAIRSSKAYFPSWVYDQLN  415 (511)
Q Consensus       337 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~  415 (511)
                      +......      ....++..|+|||++.+. ..++.++||||||+++|||++|. .|+.......        ......
T Consensus       155 ~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--------~~~~~~  219 (258)
T cd05078         155 SITVLPK------EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--------KLQFYE  219 (258)
T ss_pred             ccccCCc------hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--------HHHHHH
Confidence            8644321      234578899999998753 35788999999999999999995 4443221110        011111


Q ss_pred             cCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                      ..  ...      +.....++.+++.+||+.+|++|||++++++.|+
T Consensus       220 ~~--~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         220 DR--HQL------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             cc--ccC------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            11  111      1112356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=7.5e-37  Score=308.87  Aligned_cols=199  Identities=23%  Similarity=0.343  Sum_probs=160.2

Q ss_pred             ccccCcCCcEEEEEEEec---CCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceecc--CCceeEEEeecCC
Q 010434          193 THKLGQGGFGSVYKGQLH---TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALVYEFMPN  267 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~~---~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~~  267 (511)
                      ..+||+|+||.||+|+..   +++.+|+|.+.... ....+.+|+.++++++||||+++++++..  +...+++|||++ 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence            368999999999999854   56899999986543 33567899999999999999999998854  456789999985 


Q ss_pred             CCcccccccCC-----CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEE----cCCCCeeeecccccc
Q 010434          268 GSLDRHIFPKE-----NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL----DHNFIPKVSDFGLAK  338 (511)
Q Consensus       268 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl----~~~~~~kl~DFGla~  338 (511)
                      ++|.+++....     .....+++..+..++.||+.||+|||+   .+|+||||||+|||+    +.++.+||+|||+++
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            57766553211     122468999999999999999999998   699999999999999    456789999999998


Q ss_pred             cCCCCCC-ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcc
Q 010434          339 FHPKEND-FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMN  397 (511)
Q Consensus       339 ~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~  397 (511)
                      ....... ........||+.|+|||++.+. ..++.++||||+||++|||++|+.||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            6543321 1122345689999999998753 35788999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.3e-37  Score=300.72  Aligned_cols=253  Identities=23%  Similarity=0.336  Sum_probs=201.4

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceecc--CCceeEEEe
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALVYE  263 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~--~~~~~lV~e  263 (511)
                      |++.+.||.|+||.||++.. .+++.+|+|.+..+.   ...+.+.+|+.++++++|+||+++++++..  +...+++||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e   81 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME   81 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence            34567899999999999984 578999999986533   234568899999999999999999997753  456789999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCC--CCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC--DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      |+++++|.+++.........+++..+..++.|++.||+|||..+  ..+++|+||||+||++++++.+||+|||+++...
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~  161 (265)
T cd08217          82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG  161 (265)
T ss_pred             hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence            99999999988544344578999999999999999999999321  2699999999999999999999999999998765


Q ss_pred             CCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccc
Q 010434          342 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (511)
                      .....  .....++..|+|||.+...  .++.++|+||||+++++|++|+.|+......        ...+....+... 
T Consensus       162 ~~~~~--~~~~~~~~~~~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~-  228 (265)
T cd08217         162 HDSSF--AKTYVGTPYYMSPEQLNHM--SYDEKSDIWSLGCLIYELCALSPPFTARNQL--------QLASKIKEGKFR-  228 (265)
T ss_pred             CCccc--ccccccCCCccChhhhcCC--CCCchhHHHHHHHHHHHHHHCCCcccCcCHH--------HHHHHHhcCCCC-
Confidence            44321  2334689999999998764  6889999999999999999999998754311        122222222111 


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                           ......+..+.+++.+|++.+|++|||+.+|+++
T Consensus       229 -----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         229 -----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                 1223456788999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=6e-37  Score=299.38  Aligned_cols=246  Identities=28%  Similarity=0.476  Sum_probs=196.9

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      .+.+.+.||+|+||.||++.. +++.+|+|.+.... ..+.+.+|+.++++++|||++++++++..+ ..+++|||++++
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~   83 (254)
T cd05083           7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG   83 (254)
T ss_pred             HceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence            456778999999999999975 57889999986532 456899999999999999999999998664 479999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      +|.+++...  ....+++..+..++.|++.|+.|||+   .+++||||||+||+++.++.+||+|||+++......    
T Consensus        84 ~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----  154 (254)
T cd05083          84 NLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----  154 (254)
T ss_pred             CHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence            999988432  23468999999999999999999998   699999999999999999999999999987543221    


Q ss_pred             eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                       .....+..|+|||.+.+.  .++.++|+||||+++|||++ |+.|+.......        .......+.....     
T Consensus       155 -~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~-----  218 (254)
T cd05083         155 -DNSKLPVKWTAPEALKHK--KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--------VKECVEKGYRMEP-----  218 (254)
T ss_pred             -CCCCCCceecCHHHhccC--CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--------HHHHHhCCCCCCC-----
Confidence             223356789999998653  78899999999999999997 888875432211        1222222222111     


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                       ...++..+.+++.+||+.+|++||++.++++.|+.
T Consensus       219 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         219 -PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence             12345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-37  Score=301.51  Aligned_cols=245  Identities=23%  Similarity=0.329  Sum_probs=198.9

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      +.+.+.||.|+||.||+|+.. +++.+|+|++....  .....+.+|+.+++.++|+||+++++++.++...++|+||++
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   82 (274)
T cd06609           3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG   82 (274)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence            456788999999999999854 68999999986532  344678999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +++|.+++..     ..+++..+..++.|++.|+.|||+   .+++|+||+|+||++++++.++|+|||+++....... 
T Consensus        83 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  153 (274)
T cd06609          83 GGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-  153 (274)
T ss_pred             CCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence            9999998831     278999999999999999999998   6999999999999999999999999999987654321 


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                       ......++..|+|||.+.+.  .++.++||||||+++|||++|+.|++.....        .....+..........  
T Consensus       154 -~~~~~~~~~~y~~PE~~~~~--~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--------~~~~~~~~~~~~~~~~--  220 (274)
T cd06609         154 -KRNTFVGTPFWMAPEVIKQS--GYDEKADIWSLGITAIELAKGEPPLSDLHPM--------RVLFLIPKNNPPSLEG--  220 (274)
T ss_pred             -ccccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCcccCchH--------HHHHHhhhcCCCCCcc--
Confidence             12334588899999998765  5899999999999999999999998643211        1111111111111111  


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                         ..++..+.+++.+||+.+|++|||++++++
T Consensus       221 ---~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         221 ---NKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ---cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence               114567889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.9e-37  Score=295.19  Aligned_cols=256  Identities=22%  Similarity=0.289  Sum_probs=196.0

Q ss_pred             ccccCcCCcEEEEEEEe-cCCcEEEEEEeccCccc---HHHHHHHHHHhccccccceEEeeceec--cCCceeEEEeecC
Q 010434          193 THKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCS--EGSKRALVYEFMP  266 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~---~~~f~~Ev~~l~~l~H~niv~l~g~~~--~~~~~~lV~e~~~  266 (511)
                      .++|++|.||.||+|+. ++++.||+|+++.....   .-.-++|+.+|.+++|||||.+..+..  +-+..|||||||+
T Consensus        81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E  160 (419)
T KOG0663|consen   81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE  160 (419)
T ss_pred             HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence            46899999999999985 57899999999764421   123589999999999999999988764  4467999999996


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      . +|...+.   ...++++...+.-+..|+++|++|||.   ..|+||||||+|+|++..|.+||+|||||+.++...  
T Consensus       161 h-DLksl~d---~m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~--  231 (419)
T KOG0663|consen  161 H-DLKSLME---TMKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL--  231 (419)
T ss_pred             h-hHHHHHH---hccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc--
Confidence            5 8887773   334789999999999999999999999   599999999999999999999999999999887653  


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccc------------cccccchhhHHhh
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRS------------SKAYFPSWVYDQL  414 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~------------~~~~~~~~~~~~~  414 (511)
                      ...+..+-|.+|+|||.+.+. ..+++..|+||+||++.||+++++-|.....-.            ++..+|....-..
T Consensus       232 k~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~  310 (419)
T KOG0663|consen  232 KPYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA  310 (419)
T ss_pred             ccCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence            355777889999999999876 589999999999999999999998776543211            0111111100000


Q ss_pred             hcCCcccccc------cchhHHH-HHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          415 NKGGDLELRN------VTEIESV-IARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       415 ~~~~~~~~~~------~~~~~~~-~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      .+  ......      ...+... ++..-.+++...+..||.+|.|+++.++.
T Consensus       311 ~k--~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  311 VK--KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             hh--ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            00  000000      0001111 44566789999999999999999999864

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.8e-37  Score=298.14  Aligned_cols=248  Identities=25%  Similarity=0.357  Sum_probs=197.3

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceecc-CCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~  264 (511)
                      |.+.+.||.|++|.||+++.+ +++.+|+|.+....   ...+.+.+|+.++++++|+|++++++.+.. +...+++|||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            456789999999999999854 67899999986532   234578999999999999999999998764 4567899999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++++|.+++..  .....+++..+..++.+++.|+++||+   .+++|+||||+||+++.++.++|+|||+++......
T Consensus        82 ~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          82 CEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             cCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            999999988842  234568999999999999999999998   699999999999999999999999999998664332


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      .  ......+++.|+|||++.+.  .++.++||||||++++||++|+.|++.....       .... .+..+....   
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-------~~~~-~~~~~~~~~---  221 (257)
T cd08223         157 D--MASTLIGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFNAKDMN-------SLVY-RIIEGKLPP---  221 (257)
T ss_pred             C--ccccccCCcCccChhHhcCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-------HHHH-HHHhcCCCC---
Confidence            2  12334588999999998764  7888999999999999999999998643211       1111 111111111   


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                         .....+..+.+++.+|++.+|++|||+.++++.
T Consensus       222 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         222 ---MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ---CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence               223355678899999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.1e-37  Score=307.63  Aligned_cols=260  Identities=22%  Similarity=0.333  Sum_probs=196.9

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      +.+.++||+|+||.||+|..+ +++.+|+|.+.....   ..+.+.+|++++++++||||+++++++..+...++|+||+
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   82 (286)
T cd07846           3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV   82 (286)
T ss_pred             eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence            456789999999999999865 689999999865322   3467889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++++|.++..    ....+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++........
T Consensus        83 ~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          83 DHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  155 (286)
T ss_pred             CccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence            9999887652    23458999999999999999999998   6999999999999999999999999999886544321


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc-------cccchhhHHhhhcC-
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK-------AYFPSWVYDQLNKG-  417 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~~~-  417 (511)
                        ......++..|+|||++.+. ..++.++||||||+++|||++|++|+.........       ..+........... 
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         156 --VYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             --ccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence              12334578899999998653 35778999999999999999999888543211100       00000000000000 


Q ss_pred             -----Ccccccc---cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          418 -----GDLELRN---VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       418 -----~~~~~~~---~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                           .......   .......++..+.+++.+||+.+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                 0000000   00111234677899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=8.7e-37  Score=297.65  Aligned_cols=248  Identities=31%  Similarity=0.516  Sum_probs=198.6

Q ss_pred             hccccCcCCcEEEEEEEecC-----CcEEEEEEeccCcc--cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          192 FTHKLGQGGFGSVYKGQLHT-----GRLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       192 ~~~~LG~G~fg~Vykg~~~~-----g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+.||.|+||.||+++..+     +..||+|++.....  ..+.+.+|+..+.+++|+||+++++++.+.+..+++|||
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            56789999999999998653     48899999976443  467899999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++++|.+++....  ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||+++......
T Consensus        83 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       83 MEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             cCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            99999999883222  1228999999999999999999998   699999999999999999999999999998765543


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      .... ....++..|+|||.+..  ..++.++||||+|++++||++ |+.|+.....        ....+.......... 
T Consensus       158 ~~~~-~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~-  225 (258)
T smart00219      158 YYKK-KGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EEVLEYLKKGYRLPK-  225 (258)
T ss_pred             cccc-ccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCCCCCC-
Confidence            2221 13347889999999854  378899999999999999998 7777754211        112222222222211 


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEML  461 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L  461 (511)
                           ....+..+.+++.+|++.+|++|||+.++++.|
T Consensus       226 -----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      226 -----PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -----CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                 112466788999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.7e-37  Score=308.97  Aligned_cols=261  Identities=22%  Similarity=0.335  Sum_probs=196.2

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      .|.+.++||+|+||.||+|+.. +++.||+|.++..  ......+.+|+.++++++||||+++++++..+...++||||+
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~   86 (301)
T cd07873           7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL   86 (301)
T ss_pred             ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence            4556788999999999999854 6889999998653  233457889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      + ++|.+++..   .+..+++..+..++.|++.||+|||+   .+|+|+||||+||++++++.+||+|||+++.......
T Consensus        87 ~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          87 D-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             c-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            6 588877632   23568899999999999999999998   6999999999999999999999999999975433221


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc-------cchhhHHhhhcCC
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY-------FPSWVYDQLNKGG  418 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~-------~~~~~~~~~~~~~  418 (511)
                        ......+++.|+|||.+.+. ..++.++||||||+++|||++|+.||...........       .....+..+....
T Consensus       160 --~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         160 --TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             --cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence              12334578899999988653 3578899999999999999999999865432110000       0000000000000


Q ss_pred             ---cccccc-----cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          419 ---DLELRN-----VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       419 ---~~~~~~-----~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                         ......     .......++..+.+++.+||+.||.+|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence               000000     00111234567889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=7.9e-37  Score=300.58  Aligned_cols=252  Identities=21%  Similarity=0.265  Sum_probs=196.4

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .+.+.++||+|+||.||+++. .+++.||+|.++... .....+.+|+.+++.++||||+++++.+..+...++++||++
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~   89 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG   89 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence            456678999999999999985 468999999987643 334568899999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +++|.+++.    ..+.+++..+..++.|++.|+.|||+   .+++|+||||+||+++.++.+||+|||++.......  
T Consensus        90 ~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--  160 (267)
T cd06645          90 GGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--  160 (267)
T ss_pred             CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence            999999872    33578999999999999999999998   699999999999999999999999999987553321  


Q ss_pred             eeeccccCCccccchhcccc-cCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          347 VSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~-~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                      .......|+..|+|||++.. ..+.++.++|||||||++|||++|+.|+.......       .+..........  ...
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-------~~~~~~~~~~~~--~~~  231 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-------ALFLMTKSNFQP--PKL  231 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-------hHHhhhccCCCC--Ccc
Confidence            12234468999999998742 12367889999999999999999999874322110       001000000000  000


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      . ....++..+.+++.+||+.+|++|||+.++++
T Consensus       232 ~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         232 K-DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             c-ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            0 01123456788999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.5e-37  Score=302.02  Aligned_cols=254  Identities=26%  Similarity=0.404  Sum_probs=195.3

Q ss_pred             hhccccCcCCcEEEEEEEec----CCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCC------c
Q 010434          191 HFTHKLGQGGFGSVYKGQLH----TGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS------K  257 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~----~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~------~  257 (511)
                      .+.+.||+|+||.||+|...    +++.||||++....   ...+++.+|+.++++++||||+++++++....      .
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   81 (273)
T cd05074           2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI   81 (273)
T ss_pred             cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence            45678999999999999743    46899999986532   23457899999999999999999999885432      2


Q ss_pred             eeEEEeecCCCCcccccccCC--CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccc
Q 010434          258 RALVYEFMPNGSLDRHIFPKE--NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFG  335 (511)
Q Consensus       258 ~~lV~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFG  335 (511)
                      .++++||+++|+|.+++....  .....+++..+..++.|++.||+|||+   .+|+|+||||+||++++++.+||+|||
T Consensus        82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg  158 (273)
T cd05074          82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFG  158 (273)
T ss_pred             eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECccc
Confidence            368899999999988764322  122358899999999999999999998   699999999999999999999999999


Q ss_pred             ccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhh
Q 010434          336 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQL  414 (511)
Q Consensus       336 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  414 (511)
                      +++...............++..|++||.+...  .++.++||||||+++|||++ |+.|+.......        .....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--------~~~~~  228 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADN--VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--------IYNYL  228 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcC--ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH--------HHHHH
Confidence            99866443322222333456789999988654  67889999999999999999 788775432111        12222


Q ss_pred             hcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          415 NKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       415 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      ........      ....+..+.+++.+||+.+|++|||+.++++.|++
T Consensus       229 ~~~~~~~~------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         229 IKGNRLKQ------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             HcCCcCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            22211111      11234678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.1e-36  Score=304.18  Aligned_cols=251  Identities=26%  Similarity=0.354  Sum_probs=197.2

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .+.+.++||+|+||.||+|+.. +++.+|+|++.... ...+.+.+|+.+++.++|+||+++++.+..+...++||||++
T Consensus        13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   92 (292)
T cd06644          13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP   92 (292)
T ss_pred             hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence            4567789999999999999864 58999999987643 345678999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +++|..++..   ....+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++........ 
T Consensus        93 ~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-  165 (292)
T cd06644          93 GGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ-  165 (292)
T ss_pred             CCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence            9999887632   23568999999999999999999998   6999999999999999999999999999865332211 


Q ss_pred             eeeccccCCccccchhccccc---CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          347 VSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~---~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                       ......++..|+|||++...   ...++.++|||||||++|||++|+.|+......        ...............
T Consensus       166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~  236 (292)
T cd06644         166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSEPPTLS  236 (292)
T ss_pred             -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--------HHHHHHhcCCCccCC
Confidence             11334578899999998531   135678999999999999999999998543211        111111111111111


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                          ....++..+.+++.+||+.+|++||++.++++
T Consensus       237 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         237 ----QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ----CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                12234556888999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-37  Score=314.56  Aligned_cols=257  Identities=21%  Similarity=0.277  Sum_probs=190.8

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccC------Cce
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKR  258 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~------~~~  258 (511)
                      .|.+.+.||+|+||.||++.. .+++.||||++....   ...+.+.+|+.++++++||||+++++++...      ...
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07878          16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV   95 (343)
T ss_pred             hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence            455568899999999999984 578899999986532   2345688999999999999999999987543      346


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      +++++++ +++|.+++     ....+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++
T Consensus        96 ~~~~~~~-~~~l~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~  166 (343)
T cd07878          96 YLVTNLM-GADLNNIV-----KCQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR  166 (343)
T ss_pred             EEEeecC-CCCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccce
Confidence            8999988 78888776     23569999999999999999999998   699999999999999999999999999998


Q ss_pred             cCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc-------ccchhhH
Q 010434          339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA-------YFPSWVY  411 (511)
Q Consensus       339 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~-------~~~~~~~  411 (511)
                      .....     .....||..|+|||++.+. ..++.++||||||+++|||++|+.||..........       ..+....
T Consensus       167 ~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07878         167 QADDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL  240 (343)
T ss_pred             ecCCC-----cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            65432     2334589999999998653 367889999999999999999999986432110000       0000000


Q ss_pred             HhhhcC---------CcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          412 DQLNKG---------GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       412 ~~~~~~---------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      ..+...         ................+.+.+++.+|++.||.+|||+.++++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000         0000000000111123457889999999999999999999863

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.9e-37  Score=298.92  Aligned_cols=247  Identities=25%  Similarity=0.360  Sum_probs=199.1

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      |.+.++||+|+||.||++.. .+|+.+|+|.+...   ....+++.+|+.++++++||||+++++++.+.+..++|+||+
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC   81 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence            45678999999999999984 47899999998653   234467999999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++++|.+++..  .....+++..+.+++.|++.|++|||+   .+++|+||+|+||+++.++.++|+|||++........
T Consensus        82 ~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          82 EGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            99999988732  223468999999999999999999998   6999999999999999999999999999976544321


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                      .  .....|++.|+|||.+.+.  ..+.++|+||||+++++|++|+.|+......       ..+ .....+....    
T Consensus       157 ~--~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------~~~-~~~~~~~~~~----  220 (256)
T cd08218         157 L--ARTCIGTPYYLSPEICENR--PYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-------NLV-LKIIRGSYPP----  220 (256)
T ss_pred             h--hhhccCCccccCHHHhCCC--CCCCccchhHHHHHHHHHHcCCCCccCCCHH-------HHH-HHHhcCCCCC----
Confidence            1  1233478899999998764  6888999999999999999999998643211       111 1111221111    


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                        .....+..+.+++.+||+.+|.+||++.+|++
T Consensus       221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         221 --VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             --CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence              22234567889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8e-37  Score=300.38  Aligned_cols=247  Identities=26%  Similarity=0.398  Sum_probs=195.7

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCccc----------HHHHHHHHHHhccccccceEEeeceeccCCce
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFS----------AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  258 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~----------~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~  258 (511)
                      +.+...||+|+||.||+|.. .+++.+|+|.+......          .+.+.+|+.++++++||||+++++++.+....
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            34567899999999999985 46889999988653211          24688999999999999999999999999999


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      ++++||+++++|.+++.    ....+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||+++
T Consensus        82 ~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          82 NIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             EEEEEecCCCCHHHHHH----hccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            99999999999999882    23568999999999999999999998   699999999999999999999999999988


Q ss_pred             cCCCCCCce----eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhh
Q 010434          339 FHPKENDFV----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQL  414 (511)
Q Consensus       339 ~~~~~~~~~----~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  414 (511)
                      .........    ......|+..|+|||.+.+.  .++.++|+||||+++|+|++|+.||.......        .....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~  224 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT--SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--------AIFKI  224 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccC--CCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--------HHHHH
Confidence            665321111    11223478899999998764  67889999999999999999999986532111        01111


Q ss_pred             hcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          415 NKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       415 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .......      .+...+..+.+++.+||+.+|.+||++.++++
T Consensus       225 ~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         225 GENASPE------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             hccCCCc------CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            1111111      22234567889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=8.3e-37  Score=300.13  Aligned_cols=248  Identities=29%  Similarity=0.431  Sum_probs=196.1

Q ss_pred             hhccccCcCCcEEEEEEEecCCcEEEEEEeccCcc-------cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKF-------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~-------~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      ...+.||+|+||.||+|...+|+.+|||.++....       ..+.+.+|+.++++++|+||+++++++.+....++++|
T Consensus         3 ~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (265)
T cd06631           3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME   82 (265)
T ss_pred             cccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence            44678999999999999988899999999864321       12468899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++++|.+++.    ....+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||+++.....
T Consensus        83 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          83 FVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             cCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            999999999883    23468899999999999999999998   68999999999999999999999999998765321


Q ss_pred             CCc----eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          344 NDF----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       344 ~~~----~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      ...    .......++..|+|||++.+.  .++.++||||||+++|+|++|+.|+.......      . .. .......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~-~~-~~~~~~~  225 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINES--GYGRKSDIWSIGCTVFEMATGKPPLASMDRLA------A-MF-YIGAHRG  225 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCC--CCcchhhHHHHHHHHHHHHhCCCccccCChHH------H-HH-HhhhccC
Confidence            111    111234588999999998764  67899999999999999999999986432111      0 00 1111100


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ..    ......++..+.+++.+||+.+|.+||++.++++
T Consensus       226 ~~----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         226 LM----PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CC----CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00    1122234567889999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.2e-36  Score=299.61  Aligned_cols=246  Identities=22%  Similarity=0.338  Sum_probs=199.6

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      .+...++||.|+||.||+|... +++.||+|.+....  ...+.+.+|+.++++++|+||+++++++.++...++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            3445678999999999999864 68899999987532  34567899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++|+|.+++.     ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++........
T Consensus        85 ~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          85 GGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            9999999872     2468899999999999999999998   6999999999999999999999999999976543321


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                        ......++..|+|||.+.+.  .++.++|+||||+++|||++|..|+.......        .........      .
T Consensus       157 --~~~~~~~~~~y~apE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~~~~------~  218 (277)
T cd06640         157 --KRNTFVGTPFWMAPEVIQQS--AYDSKADIWSLGITAIELAKGEPPNSDMHPMR--------VLFLIPKNN------P  218 (277)
T ss_pred             --ccccccCcccccCHhHhccC--CCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--------HhhhhhcCC------C
Confidence              12334578899999998764  68899999999999999999999986432211        111111111      1


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      ......++..+.+++.+||+.+|++||++.++++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            12334566788899999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-37  Score=302.57  Aligned_cols=251  Identities=24%  Similarity=0.332  Sum_probs=199.2

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .+.+.++||.|+||.||++... ++..+|+|.+.... ...+.|.+|+.++++++|+||+++++.+..+...++||||++
T Consensus         6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (280)
T cd06611           6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD   85 (280)
T ss_pred             HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence            4667789999999999999864 68999999986533 345679999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +++|.+++.   ..+..+++..+..++.|++.||.|||+   .+|+|+||||+||+++.++.++|+|||++........ 
T Consensus        86 ~~~L~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-  158 (280)
T cd06611          86 GGALDSIML---ELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-  158 (280)
T ss_pred             CCcHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence            999999873   223579999999999999999999998   6999999999999999999999999999875433221 


Q ss_pred             eeeccccCCccccchhccccc---CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          347 VSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~---~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                       ......+++.|+|||.+...   ...++.++|+||||+++|||++|+.|+.......        ....+.........
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~  229 (280)
T cd06611         159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--------VLLKILKSEPPTLD  229 (280)
T ss_pred             -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--------HHHHHhcCCCCCcC
Confidence             12334588999999987532   1356789999999999999999999986532111        11111111111111


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                          .+..++..+.+++..||+.+|.+||++.++++
T Consensus       230 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         230 ----QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             ----CcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence                12234567888999999999999999999976

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=9.3e-37  Score=305.79  Aligned_cols=248  Identities=24%  Similarity=0.346  Sum_probs=199.0

Q ss_pred             HHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      ..+.+.++||+|+||.||++.. .+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            3455678999999999999985 579999999987633 34567889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++++|.+++.     ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++........
T Consensus        99 ~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          99 AGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             CCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            9999999872     2468899999999999999999998   6999999999999999999999999999876543321


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                        ......+++.|+|||.+.+.  .++.++|+||||+++|+|++|+.||........       .... ........   
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~-------~~~~-~~~~~~~~---  235 (297)
T cd06656         171 --KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-------LYLI-ATNGTPEL---  235 (297)
T ss_pred             --CcCcccCCccccCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh-------eeee-ccCCCCCC---
Confidence              11334588899999998764  678999999999999999999999865332110       0000 00011111   


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                       .....++..+.+++.+||+.+|++||++.++++
T Consensus       236 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         236 -QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             -CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             122334566788999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.9e-37  Score=301.05  Aligned_cols=253  Identities=27%  Similarity=0.407  Sum_probs=197.2

Q ss_pred             hccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc-----------cHHHHHHHHHHhccccccceEEeeceeccCCcee
Q 010434          192 FTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF-----------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  259 (511)
Q Consensus       192 ~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~-----------~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~  259 (511)
                      ..+.||+|+||.||+|.. .+|+.+|+|.++....           ..+.+.+|+.++++++|+|++++++++......+
T Consensus         5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (272)
T cd06629           5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS   84 (272)
T ss_pred             ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence            457899999999999984 4689999998753111           1245788999999999999999999999999999


Q ss_pred             EEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      +||||+++++|.+++.    ....+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||+++.
T Consensus        85 lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          85 IFLEYVPGGSIGSCLR----TYGRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             EEEecCCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            9999999999999883    22578999999999999999999998   6999999999999999999999999999976


Q ss_pred             CCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          340 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       340 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      ..............++..|+|||.+......++.++|+||||+++|||++|+.|+.......       ...+.......
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~  230 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-------AMFKLGNKRSA  230 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-------HHHHhhccccC
Confidence            54332222223445889999999987642347899999999999999999999985422110       01111111111


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      ...  .......++..+.+++.+||+.+|.+|||+.+|++.
T Consensus       231 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         231 PPI--PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CcC--CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            111  111223456788999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=302.87  Aligned_cols=258  Identities=22%  Similarity=0.290  Sum_probs=201.0

Q ss_pred             ccccCcCCcEEEEEEEe-cCCcEEEEEEecc---CcccHHHHHHHHHHhccccccceEEeeceecc-----CCceeEEEe
Q 010434          193 THKLGQGGFGSVYKGQL-HTGRLIAVKMLEN---SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-----GSKRALVYE  263 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~-----~~~~~lV~e  263 (511)
                      .+.||+|+||.|..+.. .+|..||||++.+   +....+.-.+|+.+++.++|+||+.+.+.+..     -+..|+|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            46799999999999984 5789999999874   44567788999999999999999999998854     456899999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      +| ..+|...|    ..++.|+.+....+..|+++||.|+|+   .+|+|||+||+|+|++.+...||+|||||+.....
T Consensus       107 lM-etDL~~ii----k~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~  178 (359)
T KOG0660|consen  107 LM-ETDLHQII----KSQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF  178 (359)
T ss_pred             HH-hhHHHHHH----HcCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeecccc
Confidence            99 67898888    344569999999999999999999999   59999999999999999999999999999987654


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc-------ccchhhHHhh--
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA-------YFPSWVYDQL--  414 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~-------~~~~~~~~~~--  414 (511)
                      .....++....|.+|.|||.+... ..+|...||||.||++.||++|++-|.+......-.       .-+......+  
T Consensus       179 ~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s  257 (359)
T KOG0660|consen  179 FEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS  257 (359)
T ss_pred             CcccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence            222334667789999999988643 689999999999999999999998876543211000       0011111111  


Q ss_pred             -------hcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          415 -------NKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       415 -------~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                             ..-................+...+++.+||..||.+|+|++|.++
T Consensus       258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence                   111111111112222345567889999999999999999999986

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.7e-37  Score=340.42  Aligned_cols=259  Identities=22%  Similarity=0.297  Sum_probs=198.7

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+.++||+|+||.||+|... +|+.||||++....    ...+.|.+|++++++++||||+++++++.+++..+++|||
T Consensus         4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY   83 (932)
T PRK13184          4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY   83 (932)
T ss_pred             eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence            456789999999999999854 68999999986532    2345799999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCC-------CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccc
Q 010434          265 MPNGSLDRHIFPKE-------NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLA  337 (511)
Q Consensus       265 ~~~gsL~~~l~~~~-------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla  337 (511)
                      +++|+|.+++....       .....+++..+.+++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCcc
Confidence            99999998874311       112456788899999999999999998   69999999999999999999999999999


Q ss_pred             ccCCCCCCc----------------eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccc
Q 010434          338 KFHPKENDF----------------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRS  401 (511)
Q Consensus       338 ~~~~~~~~~----------------~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~  401 (511)
                      +........                .......||+.|+|||.+.+.  .++.++|||||||++|||++|+.|+.......
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~--~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV--PASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC--CCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            865221100                001123599999999998765  78999999999999999999999986532211


Q ss_pred             cccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCC-CHHHHHHHHhcCc
Q 010434          402 SKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRP-SMTKVLEMLEGSM  465 (511)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-s~~evl~~Le~~~  465 (511)
                      .  .    ........  ...    .....++..+.+++.+|++.||++|| ++.++++.|+...
T Consensus       239 i--~----~~~~i~~P--~~~----~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l  291 (932)
T PRK13184        239 I--S----YRDVILSP--IEV----APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL  291 (932)
T ss_pred             h--h----hhhhccCh--hhc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            0  0    00000000  000    01123456788899999999999995 5677777776543

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.4e-37  Score=303.45  Aligned_cols=260  Identities=22%  Similarity=0.299  Sum_probs=196.9

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      +.+.++||+|+||.||+|+.+ +|+.||+|++....   ...+.+.+|+.++++++|+|++++++++..+...++||||+
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~   82 (286)
T cd07847           3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC   82 (286)
T ss_pred             eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence            456678999999999999865 68999999986532   23456889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++++|..++.    ....+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++........
T Consensus        83 ~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          83 DHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             CccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            9988887652    23468999999999999999999998   6999999999999999999999999999987654332


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc----cchhhHH---hhhcC-
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY----FPSWVYD---QLNKG-  417 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~----~~~~~~~---~~~~~-  417 (511)
                        ......++..|+|||.+.+. ..++.++||||||+++|||++|+.||...........    +..++..   ..... 
T Consensus       156 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         156 --DYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             --cccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence              11233478899999998653 3578899999999999999999999864322110000    0000000   00000 


Q ss_pred             -----Cccccc---ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          418 -----GDLELR---NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       418 -----~~~~~~---~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                           ......   ........++..+.+++.+||+.+|++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence                 000000   000111234577889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=9e-37  Score=305.85  Aligned_cols=246  Identities=24%  Similarity=0.363  Sum_probs=197.9

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      +.+.++||.|+||.||+|.. .+|+.||+|.+.... ...+.+.+|+.+++.++|||++++++++..+...++|+||+++
T Consensus        21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  100 (296)
T cd06655          21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG  100 (296)
T ss_pred             EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence            44567899999999999984 578999999986533 3456789999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      ++|.+++.     ...+++..+..++.|++.|++|||+   .+++|+||||+||+++.++.+||+|||++......... 
T Consensus       101 ~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-  171 (296)
T cd06655         101 GSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-  171 (296)
T ss_pred             CcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence            99999872     2468999999999999999999998   69999999999999999999999999998765433221 


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                       .....++..|+|||.+.+.  .++.++|||||||++|+|++|+.||........       ... ..........    
T Consensus       172 -~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-------~~~-~~~~~~~~~~----  236 (296)
T cd06655         172 -RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-------LYL-IATNGTPELQ----  236 (296)
T ss_pred             -CCCcCCCccccCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHH-HHhcCCcccC----
Confidence             1334588999999998764  688999999999999999999999865432110       011 1111111111    


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ....++..+.+++.+||+.+|.+|||+.++++
T Consensus       237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            12234567888999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.1e-36  Score=307.44  Aligned_cols=198  Identities=23%  Similarity=0.341  Sum_probs=159.4

Q ss_pred             cccCcCCcEEEEEEEec---CCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceec--cCCceeEEEeecCCC
Q 010434          194 HKLGQGGFGSVYKGQLH---TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS--EGSKRALVYEFMPNG  268 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~---~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~--~~~~~~lV~e~~~~g  268 (511)
                      .+||+|+||.||+|+..   ++..||+|.+.... ....+.+|+.++++++||||+++++++.  .+...++|+||+++ 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence            58999999999999854   45789999986543 3346889999999999999999999884  35677899999864 


Q ss_pred             CcccccccC-----CCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEE----cCCCCeeeeccccccc
Q 010434          269 SLDRHIFPK-----ENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL----DHNFIPKVSDFGLAKF  339 (511)
Q Consensus       269 sL~~~l~~~-----~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl----~~~~~~kl~DFGla~~  339 (511)
                      +|.+++...     ......+++..+..++.||+.||.|||+   .+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            666554211     1123468999999999999999999998   699999999999999    5668999999999986


Q ss_pred             CCCCCCc-eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcc
Q 010434          340 HPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMN  397 (511)
Q Consensus       340 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~  397 (511)
                      ....... .......+|+.|+|||.+.+. ..++.++||||||+++|||++|+.||...
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            5433211 122344689999999998653 35789999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=316.39  Aligned_cols=240  Identities=24%  Similarity=0.328  Sum_probs=187.6

Q ss_pred             cCcCCcEEEEEEEec-CCcEEEEEEeccCc----ccHHHHHHHHHHhccc---cccceEEeeceeccCCceeEEEeecCC
Q 010434          196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSK----FSAEEFINEVSTIGRI---HHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       196 LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l---~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      ||+|+||.||+++.. +|+.||||++....    .....+..|..++.+.   +||||+++++.+.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999854 68999999986532    1233456677777665   699999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--  151 (330)
T cd05586          81 GELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--  151 (330)
T ss_pred             ChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--
Confidence            99988872    34578999999999999999999998   6999999999999999999999999999875432221  


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      ......||..|+|||++.+. ..++.++|||||||++|||++|+.||......        .....+..+. ..+.    
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~-~~~~----  217 (330)
T cd05586         152 TTNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--------QMYRNIAFGK-VRFP----  217 (330)
T ss_pred             CccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHH--------HHHHHHHcCC-CCCC----
Confidence            12345699999999998653 24788999999999999999999998653221        1222222211 1111    


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCC----CHHHHHH
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRP----SMTKVLE  459 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RP----s~~evl~  459 (511)
                       ...++..+.+++.+||+.||.+||    ++.++++
T Consensus       218 -~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 -KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             -CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence             112456778899999999999998    5666665

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-36  Score=302.74  Aligned_cols=252  Identities=25%  Similarity=0.348  Sum_probs=198.4

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      +++.+.||+|+||.||++..+ +|+.+|+|.+...  ....+.+.+|+.++.+++|+||+++++.+..+...++||||++
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (286)
T cd06622           3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD   82 (286)
T ss_pred             hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence            566789999999999999865 7899999988653  2234679999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +++|..++... .....+++..+..++.|++.||.|||+.  .+++|+||||+||+++.++.+||+|||++.......  
T Consensus        83 ~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  157 (286)
T cd06622          83 AGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--  157 (286)
T ss_pred             CCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence            99998887332 1234789999999999999999999963  589999999999999999999999999987553322  


Q ss_pred             eeeccccCCccccchhcccccC----CCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          347 VSISATRGTIGYIAPELISRNF----GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~----~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                        .....++..|+|||.+.+..    ..++.++|+|||||++|||++|+.||.......        ....+....... 
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~~~-  226 (286)
T cd06622         158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--------IFAQLSAIVDGD-  226 (286)
T ss_pred             --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--------HHHHHHHHhhcC-
Confidence              13345788999999885431    235789999999999999999999986432111        111111110000 


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                        .......++..+.+++.+||+.+|++||++.++++
T Consensus       227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         227 --PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             --CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence              11123336677889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-37  Score=311.43  Aligned_cols=253  Identities=18%  Similarity=0.235  Sum_probs=193.9

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+.+.||+|+||.||+++. .+++.||+|++...    ....+.|.+|+.++..++|+||+++++++.++...++||||
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (331)
T cd05597           3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY   82 (331)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence            45678999999999999985 46899999998652    22345688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++.   .....+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus        83 ~~g~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          83 YVGGDLLTLLS---KFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             CCCCcHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            99999999883   224568999999999999999999998   699999999999999999999999999987654332


Q ss_pred             CceeeccccCCccccchhccccc---CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhc-CCcc
Q 010434          345 DFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK-GGDL  420 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~---~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~  420 (511)
                      .. ......||+.|+|||++...   .+.++.++|||||||++|||++|+.||.......        .+..+.. ....
T Consensus       157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~--------~~~~i~~~~~~~  227 (331)
T cd05597         157 TV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TYGKIMNHKEHF  227 (331)
T ss_pred             Cc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH--------HHHHHHcCCCcc
Confidence            21 11234589999999998631   2357889999999999999999999986532211        1111111 1111


Q ss_pred             cccccchhHHHHHHHHHHHHHHhcCc--CCCCCCCHHHHHHH
Q 010434          421 ELRNVTEIESVIARKLCMIGLWCIQV--KAADRPSMTKVLEM  460 (511)
Q Consensus       421 ~~~~~~~~~~~~~~~l~~l~~~Cl~~--~P~~RPs~~evl~~  460 (511)
                      ....   ....++..+.+++.+|+..  ++..||++.++++.
T Consensus       228 ~~~~---~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         228 QFPP---DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             cCCC---ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            1111   1112455677788887754  33448899999875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=299.28  Aligned_cols=254  Identities=26%  Similarity=0.365  Sum_probs=200.5

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhccc-cccceEEeeceeccCC------ceeE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGS------KRAL  260 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~------~~~l  260 (511)
                      .+.+.+.||+|+||.||+|..+ +++.+++|++.......++|.+|+.+++++ +|+||+++++++....      ..++
T Consensus         7 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~l   86 (275)
T cd06608           7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWL   86 (275)
T ss_pred             heeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEE
Confidence            4556789999999999999864 678999999987666677899999999999 7999999999996544      4899


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      ||||+++++|.+++......+..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++...
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~  163 (275)
T cd06608          87 VMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL  163 (275)
T ss_pred             EEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence            999999999998874433335689999999999999999999998   69999999999999999999999999998765


Q ss_pred             CCCCCceeeccccCCccccchhccccc---CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcC
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG  417 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~---~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  417 (511)
                      .....  ......++..|+|||.+...   ...++.++||||||+++++|++|+.|+.......        ....+...
T Consensus       164 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~  233 (275)
T cd06608         164 DSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--------ALFKIPRN  233 (275)
T ss_pred             ccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--------HHHHhhcc
Confidence            43221  12334588999999987532   2356789999999999999999999986422110        11111111


Q ss_pred             CcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          418 GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .....    ......+..+.+++.+||+.||++|||+.++++
T Consensus       234 ~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         234 PPPTL----KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             CCCCC----CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11111    122335677889999999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=319.61  Aligned_cols=246  Identities=25%  Similarity=0.420  Sum_probs=206.9

Q ss_pred             hccccCcCCcEEEEEEEec--CCc--EEEEEEeccCcc--cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          192 FTHKLGQGGFGSVYKGQLH--TGR--LIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       192 ~~~~LG~G~fg~Vykg~~~--~g~--~vAvK~l~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      +.++||+|.||.|++|.|.  +|+  .||||.++....  ...+|++|+.+|.+|+|+|+++|+|+..+ ....+|+|.+
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            4578999999999999864  444  699999987544  56899999999999999999999999988 7889999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      +.|||.+.|..  .....|-...+..++.|||.||.||..   +++|||||..+|+||...-.+||+||||.+-++....
T Consensus       193 plGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  193 PLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             ccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            99999999854  455778899999999999999999998   7999999999999999999999999999998887766


Q ss_pred             ceeecc-ccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          346 FVSISA-TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       346 ~~~~~~-~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      ...+.. ..-+..|.|||.++.  +.++.+||||+|||++|||+| |..||-...        ...+.+.++++.++.  
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--------g~qIL~~iD~~erLp--  335 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--------GIQILKNIDAGERLP--  335 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCC--------HHHHHHhccccccCC--
Confidence            555543 346789999999975  599999999999999999998 566765432        122445555444433  


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                          .++.+++++.++++.||..+|.+|||+..+.+
T Consensus       336 ----RPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  336 ----RPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             ----CCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence                34456789999999999999999999999974

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.1e-36  Score=301.72  Aligned_cols=253  Identities=26%  Similarity=0.321  Sum_probs=196.8

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccc-cccceEEeeceeccC-----CceeEEE
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEG-----SKRALVY  262 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~-----~~~~lV~  262 (511)
                      +.+.+.||+|+||.||++.. .+++.+|+|.+.......+.+.+|+.+++++ +|||++++++++...     ...++|+
T Consensus        24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~  103 (291)
T cd06639          24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVL  103 (291)
T ss_pred             eEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEE
Confidence            34467899999999999985 5789999999876555567788999999999 899999999998643     3589999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+++++|.+++......+..+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++....
T Consensus       104 ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~  180 (291)
T cd06639         104 ELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS  180 (291)
T ss_pred             EECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence            9999999998874433345678999999999999999999998   6999999999999999999999999999876543


Q ss_pred             CCCceeeccccCCccccchhcccccC---CCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNF---GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~---~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      ....  .....++..|+|||.+....   ..++.++|||||||++|||++|+.|+.......       .+. .+.....
T Consensus       181 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-------~~~-~~~~~~~  250 (291)
T cd06639         181 TRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-------TLF-KIPRNPP  250 (291)
T ss_pred             cccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-------HHH-HHhcCCC
Confidence            2211  12345889999999875431   136889999999999999999999986432111       011 1111111


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ....    ........+.+++.+||+.+|++||++.++++
T Consensus       251 ~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         251 PTLL----HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             CCCC----cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1111    11223456889999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5.8e-37  Score=315.07  Aligned_cols=257  Identities=21%  Similarity=0.230  Sum_probs=191.0

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccC------Cce
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKR  258 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~------~~~  258 (511)
                      .+.+.+.||+|+||.||++.. .+++.||||.+....   ...+.+.+|+.+++.++||||+++++++...      ...
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   97 (355)
T cd07874          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV   97 (355)
T ss_pred             ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence            455678999999999999984 468999999987532   2345788999999999999999999987543      356


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      ++||||+++ +|.+.+.      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        98 ~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          98 YLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             EEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence            899999965 5655541      358899999999999999999998   699999999999999999999999999998


Q ss_pred             cCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc--------cccch--
Q 010434          339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK--------AYFPS--  408 (511)
Q Consensus       339 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~--------~~~~~--  408 (511)
                      ......   ......||..|+|||++.+.  .++.++|||||||++|||++|+.||.........        ...+.  
T Consensus       168 ~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         168 TAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             cCCCcc---ccCCccccCCccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            643322   12344689999999998765  6889999999999999999999998653211100        00000  


Q ss_pred             -----hhHHhhhcCCcc---c---------ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          409 -----WVYDQLNKGGDL---E---------LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       409 -----~~~~~~~~~~~~---~---------~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                           .+..........   .         ...........+..+.+++.+||+.||++|||+.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                 000000000000   0         000011122234678899999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=293.10  Aligned_cols=249  Identities=22%  Similarity=0.302  Sum_probs=204.7

Q ss_pred             HHhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      ..+.+.+.||+|.|+.||++. .++|+.+|+|+++..   ..+-++..+|+++.+.|+|||||+|.+...+.+..+||+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            345667899999999999996 568999999998653   3356788899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC---CCCeeeecccccccC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH---NFIPKVSDFGLAKFH  340 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~---~~~~kl~DFGla~~~  340 (511)
                      +|.|++|-.-|-    .....++...-....||++||.|+|.   .+|+|||+||+|+||.+   .--+||+|||+|...
T Consensus        91 ~m~G~dl~~eIV----~R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   91 LVTGGELFEDIV----AREFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             cccchHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            999999976552    22457788888999999999999999   59999999999999954   346899999999877


Q ss_pred             CCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcc
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDL  420 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (511)
                      ...   ..-....|||+|||||++++.  +++..+|||+.||+||-|+.|+.||......        -+++++.++...
T Consensus       164 ~~g---~~~~G~~GtP~fmaPEvvrkd--py~kpvDiW~cGViLfiLL~G~~PF~~~~~~--------rlye~I~~g~yd  230 (355)
T KOG0033|consen  164 NDG---EAWHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYEQIKAGAYD  230 (355)
T ss_pred             CCc---cccccccCCCcccCHHHhhcC--CCCCcchhhhhhHHHHHHHhCCCCCCCccHH--------HHHHHHhccccC
Confidence            622   122455699999999999886  8999999999999999999999999774432        256666655322


Q ss_pred             cccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          421 ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       421 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      . +  ...+..+++...+|+.+||..||.+|.|+.|.++
T Consensus       231 ~-~--~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  231 Y-P--SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             C-C--CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            1 1  1134456678889999999999999999998874

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=9.3e-37  Score=302.84  Aligned_cols=260  Identities=20%  Similarity=0.265  Sum_probs=193.7

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      +.+.++||+|+||.||+++.. +|+.+|+|.+....   .....+.+|+.++++++||||+++++++.+....++|+||+
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC   81 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence            456688999999999999854 78999999986532   22356888999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      + ++|.+++..   ....+++..+..++.||++||.|||+   ++++|+||||+||+++.++.+||+|||+++.......
T Consensus        82 ~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          82 D-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             C-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            6 577776532   23569999999999999999999998   6999999999999999999999999999986543221


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc--------cccchhhHHhhhcC
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK--------AYFPSWVYDQLNKG  417 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~  417 (511)
                        ......++..|+|||.+.+. ..++.++||||||+++|||++|+.|+.........        .......+..+...
T Consensus       155 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         155 --CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             --CcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence              12334578899999998653 35688999999999999999999885432111000        00000001111100


Q ss_pred             Ccc-ccccc------chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          418 GDL-ELRNV------TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       418 ~~~-~~~~~------~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ... .....      .+....++..+.+++.+||+.||.+|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            000 00000      0111234577889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=9.5e-37  Score=305.08  Aligned_cols=261  Identities=23%  Similarity=0.315  Sum_probs=196.5

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCccc------HHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFS------AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~------~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      +.+.++||+|+||.||+|... +|+.||||.+......      ...+.+|+.++++++|+||+++++++.++...++||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            455678999999999999854 6899999999764322      345778999999999999999999999999999999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+ +|+|.+++...   ...+++..+..++.||++||+|||+   .+++|+||||+||+++.++.+||+|||+++....
T Consensus        82 e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          82 EFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             ccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            999 99999988321   2379999999999999999999998   6999999999999999999999999999987654


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc----c---chhhHHhhh
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY----F---PSWVYDQLN  415 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~----~---~~~~~~~~~  415 (511)
                      ...  ......++..|+|||.+.+. ..++.++||||||++++||++|.+++...........    +   ....+....
T Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         155 PNR--KMTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             CCc--cccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence            322  12334567889999988543 3678899999999999999999777654321100000    0   000000000


Q ss_pred             ---cCCc---ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          416 ---KGGD---LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       416 ---~~~~---~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                         ....   .............+..+.+++.+||+.+|++|||+.++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence               0000   00000111223346788999999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.3e-36  Score=301.55  Aligned_cols=251  Identities=26%  Similarity=0.353  Sum_probs=196.1

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccc-cccceEEeeceecc------CCceeE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSE------GSKRAL  260 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~------~~~~~l  260 (511)
                      .+.+.++||.|+||.||+|.. .+++.+|+|.+........++..|+.++.++ +|+||+++++++..      ....++
T Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i   96 (282)
T cd06636          17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWL   96 (282)
T ss_pred             hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEE
Confidence            445568999999999999985 5789999999877655667889999999998 79999999999853      457899


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      +|||+++|+|.+++..  .....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||+++..
T Consensus        97 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~  171 (282)
T cd06636          97 VMEFCGAGSVTDLVKN--TKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  171 (282)
T ss_pred             EEEeCCCCcHHHHHHH--ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence            9999999999998732  234568899999999999999999998   69999999999999999999999999998754


Q ss_pred             CCCCCceeeccccCCccccchhccccc---CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcC
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG  417 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~---~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  417 (511)
                      .....  ......|+..|+|||.+...   ...++.++||||||+++|||++|+.|+.......        ........
T Consensus       172 ~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~--------~~~~~~~~  241 (282)
T cd06636         172 DRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR--------ALFLIPRN  241 (282)
T ss_pred             hcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh--------hhhhHhhC
Confidence            32211  11334588999999987531   2367889999999999999999999986432111        01111111


Q ss_pred             CcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          418 GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ...     ......++..+.+++.+||+.||.+|||+.++++
T Consensus       242 ~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         242 PPP-----KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             CCC-----CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            111     1112234567899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=298.16  Aligned_cols=253  Identities=24%  Similarity=0.317  Sum_probs=199.7

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .+.+.++||+|+||.||++.. .+++.+|+|.+.... ...+.+.+|+.++++++||||+++++++..+...+++|||++
T Consensus         4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~   83 (262)
T cd06613           4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG   83 (262)
T ss_pred             ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence            345678999999999999985 467899999987633 345789999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +++|.+++..   ....+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++........ 
T Consensus        84 ~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  156 (262)
T cd06613          84 GGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-  156 (262)
T ss_pred             CCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence            9999998732   23578999999999999999999998   6999999999999999999999999999876543221 


Q ss_pred             eeeccccCCccccchhccccc-CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          347 VSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~-~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                       ......++..|+|||.+... .+.++.++|+||||+++|||++|+.|+........       .. ...... .... .
T Consensus       157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-------~~-~~~~~~-~~~~-~  225 (262)
T cd06613         157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-------LF-LISKSN-FPPP-K  225 (262)
T ss_pred             -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-------HH-HHHhcc-CCCc-c
Confidence             12334588899999998642 12678899999999999999999999865331110       11 111110 0000 0


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .......+..+.+++.+||+.+|.+|||+.+|+.
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1123345677899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.3e-36  Score=313.46  Aligned_cols=258  Identities=21%  Similarity=0.238  Sum_probs=191.7

Q ss_pred             HHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccC------Cc
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SK  257 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~------~~  257 (511)
                      ..|.+.++||+|+||.||++.. ..++.||||++...   ....+.+.+|+.+++.++||||+++++++...      ..
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~  103 (364)
T cd07875          24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  103 (364)
T ss_pred             cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence            3456678999999999999984 46889999998753   23446788999999999999999999987543      35


Q ss_pred             eeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccc
Q 010434          258 RALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLA  337 (511)
Q Consensus       258 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla  337 (511)
                      .++||||+++ +|.+.+.      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       104 ~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         104 VYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             EEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            7999999965 6666551      347899999999999999999998   69999999999999999999999999999


Q ss_pred             ccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccc--------ccccchh
Q 010434          338 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSS--------KAYFPSW  409 (511)
Q Consensus       338 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~--------~~~~~~~  409 (511)
                      +......   ......+|..|+|||++.+.  .++.++|||||||++|||++|+.||........        ....+.+
T Consensus       174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (364)
T cd07875         174 RTAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  248 (364)
T ss_pred             cccCCCC---cccCCcccCCcCCHHHHhCC--CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            8653322   12344689999999999764  788999999999999999999999865322110        0000000


Q ss_pred             -------hHHhhhcCCcc------------cccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          410 -------VYDQLNKGGDL------------ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       410 -------~~~~~~~~~~~------------~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                             +..........            ...............+.+++.+|++.||++|||+.++++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                   00000000000            0000001111234568899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.9e-37  Score=297.84  Aligned_cols=246  Identities=28%  Similarity=0.391  Sum_probs=197.6

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc------ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK------FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~------~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      +...+.||+|+||.||+|..+ +++.|++|.+....      ...+.+.+|+.++++++|+||+++++++..+...++++
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            345678999999999999865 78999999986532      13457899999999999999999999999999999999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+++++|.+++.    ....+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++.....
T Consensus        82 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          82 ELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            9999999999883    23468999999999999999999998   6999999999999999999999999999876543


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                      ..   ......++..|+|||.+... ..++.++|+||||+++|+|++|+.|+......       ............   
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~---  220 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-------AAVFKIGRSKEL---  220 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-------HHHHHHHhcccC---
Confidence            32   12344588999999998654 13789999999999999999999998653311       111111110111   


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                         ......++..+.+++.+||+.+|.+||++.++++
T Consensus       221 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         221 ---PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ---CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence               1122234567888999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.8e-37  Score=288.60  Aligned_cols=246  Identities=26%  Similarity=0.337  Sum_probs=204.0

Q ss_pred             ccccCcCCcEEEEEEE-ecCCcEEEEEEeccC-----cccH----HHHHHHHHHhccc-cccceEEeeceeccCCceeEE
Q 010434          193 THKLGQGGFGSVYKGQ-LHTGRLIAVKMLENS-----KFSA----EEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~-----~~~~----~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV  261 (511)
                      ++.||.|.-++|-++. -.+|+.+|+|++...     ..+.    +.-.+|+.+|+++ .||||+++.++++.+...++|
T Consensus        22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV  101 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV  101 (411)
T ss_pred             HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence            5679999999999887 457899999998541     1122    3457899999998 599999999999999999999


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      +|.|+.|.|.|++    ...-.+++....+|+.|+.+|++|||.   .+|+||||||+|||+|+|.++||+|||.|+..+
T Consensus       102 Fdl~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen  102 FDLMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             hhhcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeeccC
Confidence            9999999999999    455789999999999999999999999   699999999999999999999999999999776


Q ss_pred             CCCCceeeccccCCccccchhccccc----CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcC
Q 010434          342 KENDFVSISATRGTIGYIAPELISRN----FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG  417 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  417 (511)
                      ...   ..+..+||++|+|||.+..+    ...|+...|+|++||++|.|+.|.+||.-..        ...+...+.++
T Consensus       175 ~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--------QmlMLR~ImeG  243 (411)
T KOG0599|consen  175 PGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--------QMLMLRMIMEG  243 (411)
T ss_pred             Cch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--------HHHHHHHHHhc
Confidence            654   35677899999999988543    2468889999999999999999999985321        12233444444


Q ss_pred             CcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          418 GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .. ...  .....+++....+++.+|||.||.+|.|++|++.
T Consensus       244 ky-qF~--speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  244 KY-QFR--SPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             cc-ccC--CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            32 222  2355677888999999999999999999999986

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.8e-36  Score=297.03  Aligned_cols=253  Identities=26%  Similarity=0.403  Sum_probs=196.5

Q ss_pred             hhccccCcCCcEEEEEEEec------CCcEEEEEEeccCcc--cHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          191 HFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      ...++||+|+||.||+|+.+      +.+.+|+|.+.....  ..++|.+|+.++++++|+||+++++++.+....++||
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   87 (275)
T cd05046           8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMIL   87 (275)
T ss_pred             eeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEE
Confidence            34568999999999999853      346899999866433  3468999999999999999999999999999999999


Q ss_pred             eecCCCCcccccccCCCc-----CCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccc
Q 010434          263 EFMPNGSLDRHIFPKENK-----GQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLA  337 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla  337 (511)
                      ||+++|+|.+++......     ...+++..+..++.|++.||+|||+   .+|+|+||||+||+++.++.++++|||++
T Consensus        88 e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~~  164 (275)
T cd05046          88 EYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLS  164 (275)
T ss_pred             EecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcccccc
Confidence            999999999988433211     1268999999999999999999998   59999999999999999999999999998


Q ss_pred             ccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhc
Q 010434          338 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNK  416 (511)
Q Consensus       338 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  416 (511)
                      +...... ........++..|+|||.+.+.  ..+.++||||||+++++|++ |..|+......       . .......
T Consensus       165 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-------~-~~~~~~~  233 (275)
T cd05046         165 KDVYNSE-YYKLRNALIPLRWLAPEAVQED--DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-------E-VLNRLQA  233 (275)
T ss_pred             cccCccc-ccccCCceeEEeecChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccchH-------H-HHHHHHc
Confidence            7543222 1122333467789999988754  67889999999999999998 67777432211       1 1111111


Q ss_pred             CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          417 GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                      +. ....    ....++..+.+++.+||+.+|.+|||+.+++++|.
T Consensus       234 ~~-~~~~----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 GK-LELP----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CC-cCCC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            11 1110    11123467889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.6e-37  Score=316.52  Aligned_cols=248  Identities=25%  Similarity=0.290  Sum_probs=191.6

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +++.+.||+|+||.||++.. .+++.||||++...    ....+.+.+|+.++.+++|+||+++++.+.++...++||||
T Consensus         3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~   82 (360)
T cd05627           3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF   82 (360)
T ss_pred             ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence            34567899999999999985 46899999999652    22345688899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++.    ....+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          83 LPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             CCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            99999999883    33578999999999999999999998   799999999999999999999999999987543211


Q ss_pred             Cc---------------------------------eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCC
Q 010434          345 DF---------------------------------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR  391 (511)
Q Consensus       345 ~~---------------------------------~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~  391 (511)
                      ..                                 .......||+.|+|||++.+.  .++.++|||||||++|||++|+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC--CCCCcceeccccceeeecccCC
Confidence            00                                 001124599999999999765  7889999999999999999999


Q ss_pred             CCCCcccccccccccchhhHHhhhcC-CcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCC---HHHHHH
Q 010434          392 RNSNMNAIRSSKAYFPSWVYDQLNKG-GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPS---MTKVLE  459 (511)
Q Consensus       392 ~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---~~evl~  459 (511)
                      .||......        .....+... .........    .++..+.+++.+++. +|.+|++   +.++++
T Consensus       234 ~Pf~~~~~~--------~~~~~i~~~~~~~~~p~~~----~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~  292 (360)
T cd05627         234 PPFCSETPQ--------ETYRKVMNWKETLVFPPEV----PISEKAKDLILRFCT-DSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCCCHH--------HHHHHHHcCCCceecCCCC----CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence            998654321        122222211 111111111    134566777777664 9999985   566654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=9.7e-37  Score=302.70  Aligned_cols=260  Identities=22%  Similarity=0.289  Sum_probs=194.0

Q ss_pred             hhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          191 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      +..+.||.|++|.||+|+.. +|+.||||.+....   ...+.+.+|++++++++||||+++++++.++...++||||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   82 (284)
T cd07860           3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH   82 (284)
T ss_pred             eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence            44678999999999999854 78999999986532   233578999999999999999999999999999999999995


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                       ++|.+++..  ..+..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||+++....... 
T Consensus        83 -~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          83 -QDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             -cCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence             688877632  234578999999999999999999998   6999999999999999999999999999876543221 


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc-------cchhhHHhhhc---
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY-------FPSWVYDQLNK---  416 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~-------~~~~~~~~~~~---  416 (511)
                       ......++..|+|||.+.+. ..++.++||||||+++|||++|+.|+...........       -+...+.....   
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         156 -TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             -ccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence             12333478899999988653 3468899999999999999999998854321110000       00000000000   


Q ss_pred             ----CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          417 ----GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       417 ----~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                          ...............++..+.+++.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                0000000001111234567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-36  Score=313.21  Aligned_cols=189  Identities=21%  Similarity=0.318  Sum_probs=159.5

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      .+.+.++||+|+||.||+|+.. +++.||+|+....     ....|+.++++++|+||+++++++..+...++|+|++ .
T Consensus        67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~  140 (357)
T PHA03209         67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-S  140 (357)
T ss_pred             CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-C
Confidence            4566789999999999999854 5789999975432     2356999999999999999999999999999999999 4


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      ++|.+++.   .....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++......   
T Consensus       141 ~~l~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---  211 (357)
T PHA03209        141 SDLYTYLT---KRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---  211 (357)
T ss_pred             CcHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc---
Confidence            68877763   234679999999999999999999998   699999999999999999999999999997533221   


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCC
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS  394 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~  394 (511)
                      ......||..|+|||++.+.  .++.++|||||||++|||+++..++
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        212 AFLGLAGTVETNAPEVLARD--KYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccccccccccccCCeecCCC--CCCchhhHHHHHHHHHHHHHcCCcc
Confidence            12334589999999998764  7889999999999999999865543

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.4e-36  Score=303.75  Aligned_cols=243  Identities=26%  Similarity=0.365  Sum_probs=194.4

Q ss_pred             cccCcCCcEEEEEEEe-cCCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCcc
Q 010434          194 HKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLD  271 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  271 (511)
                      .+||+|+||.||++.. .++..||||.+.... ...+.+.+|+.+++.++|+||+++++.+..++..++||||+++++|.
T Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~  107 (292)
T cd06658          28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT  107 (292)
T ss_pred             hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence            5799999999999985 468899999986533 34567899999999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeecc
Q 010434          272 RHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA  351 (511)
Q Consensus       272 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  351 (511)
                      +++.     ...+++..+..++.||+.||+|||+   .+|+||||||+||++++++.+||+|||++........  ....
T Consensus       108 ~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~  177 (292)
T cd06658         108 DIVT-----HTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKS  177 (292)
T ss_pred             HHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCce
Confidence            8872     2458999999999999999999998   6999999999999999999999999999875543221  1133


Q ss_pred             ccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHH
Q 010434          352 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESV  431 (511)
Q Consensus       352 ~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  431 (511)
                      ..++..|+|||.+.+.  .++.++||||||+++|||++|+.|+.......        ....+.........    ....
T Consensus       178 ~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~----~~~~  243 (292)
T cd06658         178 LVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--------AMRRIRDNLPPRVK----DSHK  243 (292)
T ss_pred             eecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcCCCccc----cccc
Confidence            4588999999998764  68889999999999999999999986432111        11111111111111    1112


Q ss_pred             HHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          432 IARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       432 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      .+..+..++.+||+.+|.+|||+.++++.
T Consensus       244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         244 VSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            34567889999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.3e-36  Score=309.61  Aligned_cols=253  Identities=18%  Similarity=0.233  Sum_probs=194.4

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+.++||+|+||.||+++.+ +++.+|+|++.+.    ....+.|.+|+.++..++|+||+++++.+.+....++||||
T Consensus         3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey   82 (332)
T cd05623           3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY   82 (332)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence            456789999999999999865 5789999998642    22334588899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++..   ....+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          83 YVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             cCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            999999999832   23568999999999999999999998   799999999999999999999999999987543332


Q ss_pred             CceeeccccCCccccchhccccc---CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcC-Ccc
Q 010434          345 DFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG-GDL  420 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~---~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~  420 (511)
                      . .......||+.|+|||++...   .+.++.++|||||||++|||++|+.||.......        .+..+... ...
T Consensus       157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~--------~~~~i~~~~~~~  227 (332)
T cd05623         157 T-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TYGKIMNHKERF  227 (332)
T ss_pred             c-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH--------HHHHHhCCCccc
Confidence            2 112334699999999998631   2367889999999999999999999986532211        11222111 111


Q ss_pred             cccccchhHHHHHHHHHHHHHHhcCcCCCC--CCCHHHHHHH
Q 010434          421 ELRNVTEIESVIARKLCMIGLWCIQVKAAD--RPSMTKVLEM  460 (511)
Q Consensus       421 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~evl~~  460 (511)
                      ....   ....++..+.+++.+|+..++.+  ||++.++++.
T Consensus       228 ~~p~---~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         228 QFPA---QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             cCCC---ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            1111   11234566778888888654444  6899999865

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.3e-36  Score=296.84  Aligned_cols=246  Identities=23%  Similarity=0.331  Sum_probs=198.3

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      .+.+.++||+|+||.||+|.. .+++.+|+|.+....  ...+.+.+|+.++.+++||||+++++++..+...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            455677899999999999985 468999999986533  23457889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++++|.+++.     ...+++..+..++.|++.|+.|||+   .+++|+||+|+||+++.++.++|+|||++........
T Consensus        85 ~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          85 GGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            9999998872     2468999999999999999999998   6999999999999999999999999999876543221


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                        ......++..|+|||.+...  .++.++|+||||+++|+|++|..|+......        .....+......     
T Consensus       157 --~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~-----  219 (277)
T cd06641         157 --KRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELAKGEPPHSELHPM--------KVLFLIPKNNPP-----  219 (277)
T ss_pred             --hhccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCccchH--------HHHHHHhcCCCC-----
Confidence              11234578899999998754  6788999999999999999999998642211        111112111111     


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                       .....++..+.+++.+||+.+|.+||++.++++.
T Consensus       220 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         220 -TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             -CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence             1222345678899999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.3e-36  Score=303.02  Aligned_cols=243  Identities=25%  Similarity=0.375  Sum_probs=194.9

Q ss_pred             cccCcCCcEEEEEEEe-cCCcEEEEEEeccC-cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCcc
Q 010434          194 HKLGQGGFGSVYKGQL-HTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLD  271 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  271 (511)
                      .+||+|+||.||++.. .+++.||+|.+... ....+.+.+|+.++..++||||+++++++..+...++++||+++++|.
T Consensus        27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~  106 (297)
T cd06659          27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT  106 (297)
T ss_pred             hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence            4799999999999985 47899999998653 334567889999999999999999999999999999999999999998


Q ss_pred             cccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeecc
Q 010434          272 RHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA  351 (511)
Q Consensus       272 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  351 (511)
                      .++     ....+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++.......  ....
T Consensus       107 ~~~-----~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~  176 (297)
T cd06659         107 DIV-----SQTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKS  176 (297)
T ss_pred             HHH-----hhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccc
Confidence            876     22468999999999999999999998   6999999999999999999999999999875543321  1233


Q ss_pred             ccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHH
Q 010434          352 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESV  431 (511)
Q Consensus       352 ~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  431 (511)
                      ..++..|+|||++.+.  .++.++||||||+++|||++|+.|+.......        ....+.........    ....
T Consensus       177 ~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~----~~~~  242 (297)
T cd06659         177 LVGTPYWMAPEVISRT--PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--------AMKRLRDSPPPKLK----NAHK  242 (297)
T ss_pred             eecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhccCCCCcc----ccCC
Confidence            4588999999998764  67899999999999999999999986432111        11111111111111    1122


Q ss_pred             HHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          432 IARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       432 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      .+..+.+++.+||+.+|.+||++.++++.
T Consensus       243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         243 ISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            34567889999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.3e-36  Score=301.75  Aligned_cols=262  Identities=23%  Similarity=0.295  Sum_probs=198.6

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      |.+.+.||+|+||.||+|.. .+|+.||+|++....   ...+.+.+|+.++++++||||+++++++..+...++|+||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   81 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM   81 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence            45678899999999999985 478999999987633   23468999999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                       +++|.+++..   ....+++..+..++.||+.||+|||+   .+++|+||||+||++++++.++|+|||++........
T Consensus        82 -~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          82 -PSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             -CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence             9999988732   23679999999999999999999998   6999999999999999999999999999986654332


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc-------chhhHHhhhc--
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF-------PSWVYDQLNK--  416 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~~~--  416 (511)
                       .......++..|+|||.+.+. ..++.++||||+|++++||++|++++............       ....+.....  
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             -CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence             112344689999999998653 35688999999999999999998777543211100000       0000000000  


Q ss_pred             -CCcccccc-----cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          417 -GGDLELRN-----VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       417 -~~~~~~~~-----~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                       ........     ..+.....+..+.+++.+||+.+|++|||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence             00000000     011112345788999999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.8e-36  Score=294.20  Aligned_cols=246  Identities=23%  Similarity=0.357  Sum_probs=196.7

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      |.+.+.||+|+||.||++.. .+++.+|||.+....   ...+.+.+|+.++++++|||++++++.+..+...++||||+
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA   81 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence            45678999999999999985 478899999986532   23567899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC-CCeeeecccccccCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~-~~~kl~DFGla~~~~~~~  344 (511)
                      ++++|.+++..  ..+..+++..+.+++.+++.||+|||+   .+++|+||+|+||+++++ ..+||+|||++.......
T Consensus        82 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          82 PGGTLAEYIQK--RCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999998842  224568999999999999999999998   699999999999999855 468999999998664432


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      .   .....++..|+|||.+.+.  .++.++||||||+++|+|++|+.|++.....       .... .........   
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-------~~~~-~~~~~~~~~---  220 (256)
T cd08220         157 K---AYTVVGTPCYISPELCEGK--PYNQKSDIWALGCVLYELASLKRAFEAANLP-------ALVL-KIMSGTFAP---  220 (256)
T ss_pred             c---ccccccCCcccCchhccCC--CCCcccchHHHHHHHHHHHhCCCCcccCchH-------HHHH-HHHhcCCCC---
Confidence            1   1234588899999998764  6788999999999999999999998653221       1111 111111111   


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                         .....+..+.+++.+||+.+|++|||+.++++
T Consensus       221 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         221 ---ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ---CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence               11224567889999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2e-36  Score=322.51  Aligned_cols=258  Identities=19%  Similarity=0.282  Sum_probs=187.2

Q ss_pred             HHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccccc------cceEEeeceeccC-Ccee
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIHH------VNVVQLLGFCSEG-SKRA  259 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H------~niv~l~g~~~~~-~~~~  259 (511)
                      ..|.+.++||+|+||.||++.. .+++.||||+++.......++..|+.++.+++|      .+++++++++..+ ...+
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~  208 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC  208 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence            3456678999999999999985 468899999997644444566777777777654      4589999988654 5788


Q ss_pred             EEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC------------
Q 010434          260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF------------  327 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~------------  327 (511)
                      +|||++ +++|.+++.    ....+++..+..|+.||+.||+|||+.  .+|+||||||+|||++.++            
T Consensus       209 iv~~~~-g~~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~  281 (467)
T PTZ00284        209 IVMPKY-GPCLLDWIM----KHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALP  281 (467)
T ss_pred             EEEecc-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccC
Confidence            999988 778888773    235799999999999999999999972  4899999999999998765            


Q ss_pred             ----CeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccc-
Q 010434          328 ----IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSS-  402 (511)
Q Consensus       328 ----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~-  402 (511)
                          .+||+|||++......     .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||+....... 
T Consensus       282 ~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~  354 (467)
T PTZ00284        282 PDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGL--GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL  354 (467)
T ss_pred             CCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                4999999987643221     2345699999999999765  788999999999999999999999975432110 


Q ss_pred             ------ccccch-hhHH--------hhhcCCcccc-ccc----------chhHHHHHHHHHHHHHHhcCcCCCCCCCHHH
Q 010434          403 ------KAYFPS-WVYD--------QLNKGGDLEL-RNV----------TEIESVIARKLCMIGLWCIQVKAADRPSMTK  456 (511)
Q Consensus       403 ------~~~~~~-~~~~--------~~~~~~~~~~-~~~----------~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~e  456 (511)
                            ...+|. |...        .......... ...          ..........+++|+.+||+.||++|||+.|
T Consensus       355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e  434 (467)
T PTZ00284        355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ  434 (467)
T ss_pred             HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence                  000111 1100        0000000000 000          0000111356789999999999999999999


Q ss_pred             HHH
Q 010434          457 VLE  459 (511)
Q Consensus       457 vl~  459 (511)
                      +++
T Consensus       435 ~L~  437 (467)
T PTZ00284        435 MTT  437 (467)
T ss_pred             Hhc
Confidence            987

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.8e-36  Score=308.65  Aligned_cols=253  Identities=18%  Similarity=0.238  Sum_probs=194.8

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+.++||+|+||.||+++.. +++.||+|++...    ....+.+.+|+.++..++|+||+++++++.+++..++||||
T Consensus         3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey   82 (331)
T cd05624           3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY   82 (331)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence            456789999999999999854 6889999998652    22344588899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++..   ....+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          83 YVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             CCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            999999999832   23578999999999999999999998   799999999999999999999999999997654433


Q ss_pred             CceeeccccCCccccchhccccc---CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhc-CCcc
Q 010434          345 DFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK-GGDL  420 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~---~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~  420 (511)
                      .. ......||+.|+|||++.+.   .+.++.++||||||+++|||++|+.||.......        ....+.. ....
T Consensus       157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--------~~~~i~~~~~~~  227 (331)
T cd05624         157 TV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TYGKIMNHEERF  227 (331)
T ss_pred             ce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH--------HHHHHHcCCCcc
Confidence            21 12335699999999998642   1357889999999999999999999986432211        1111111 1111


Q ss_pred             cccccchhHHHHHHHHHHHHHHhcCcCCCC--CCCHHHHHHH
Q 010434          421 ELRNVTEIESVIARKLCMIGLWCIQVKAAD--RPSMTKVLEM  460 (511)
Q Consensus       421 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~evl~~  460 (511)
                      ....   ....++..+.+++.+|++.++++  |+++.++++.
T Consensus       228 ~~p~---~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         228 QFPS---HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             cCCC---ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            1111   11224567788888888865544  4688888754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-36  Score=301.12  Aligned_cols=260  Identities=23%  Similarity=0.331  Sum_probs=191.6

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      +.+.++||+|++|.||+|..+ +++.||||.+....  .....+.+|+.++++++|+||+++++++.++...++||||++
T Consensus         7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (291)
T cd07844           7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD   86 (291)
T ss_pred             eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence            456689999999999999865 78999999986532  233567899999999999999999999999999999999997


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                       ++|.+++..   ....+++..+..++.|++.||.|||+   .+++|+||||+||++++++.+||+|||+++....... 
T Consensus        87 -~~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-  158 (291)
T cd07844          87 -TDLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-  158 (291)
T ss_pred             -CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence             488887732   23478999999999999999999998   6999999999999999999999999999875432211 


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc--------cchhhHHhhhcC-
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY--------FPSWVYDQLNKG-  417 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~--------~~~~~~~~~~~~-  417 (511)
                       ......++..|+|||.+.+. ..++.++||||||+++|||++|+.||...........        .....+...... 
T Consensus       159 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         159 -TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             -cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence             11223468899999988653 3578899999999999999999999864321100000        000000000000 


Q ss_pred             --C--cccccccchhH---HHHH--HHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          418 --G--DLELRNVTEIE---SVIA--RKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       418 --~--~~~~~~~~~~~---~~~~--~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                        .  ...........   ..+.  ..+.+++.+||+.+|++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence              0  00000000000   0112  56788999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-36  Score=295.80  Aligned_cols=246  Identities=22%  Similarity=0.365  Sum_probs=196.3

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC--cccHHHHHHHHHHhcccc---ccceEEeeceeccCCceeEEEe
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS--KFSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~---H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      |.+.++||+|+||.||+|.. .+++.+|+|.+...  ....+++.+|+.++++++   |||++++++++..+...++|||
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e   82 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME   82 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence            34567899999999999985 57899999998653  334567889999999996   9999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++++|.+++.     ...+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          83 YAEGGSVRTLMK-----AGPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             cCCCCcHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            999999998872     2378999999999999999999998   69999999999999999999999999999876543


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      ..  ......|+..|+|||.+.+. ..++.++|+||||+++|+|++|+.|+.......       .. ..+.......+.
T Consensus       155 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-------~~-~~~~~~~~~~~~  223 (277)
T cd06917         155 SS--KRSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-------AM-MLIPKSKPPRLE  223 (277)
T ss_pred             cc--ccccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhh-------hh-hccccCCCCCCC
Confidence            31  12334588999999988643 256889999999999999999999986432211       01 011111011111


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                           ....+..+.+++.+||+.||++||++.++++
T Consensus       224 -----~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         224 -----DNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             -----cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence                 1114567889999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.2e-36  Score=296.41  Aligned_cols=246  Identities=26%  Similarity=0.341  Sum_probs=189.8

Q ss_pred             hhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc------ccHHHHHHHHHHhccccccceEEeeceecc--CCceeEE
Q 010434          191 HFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK------FSAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALV  261 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~------~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~--~~~~~lV  261 (511)
                      ...+.||+|+||.||++.. .+++.||+|.+....      ...+.+.+|+.++++++||||+++++++.+  +...+++
T Consensus         5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~   84 (266)
T cd06651           5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF   84 (266)
T ss_pred             cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence            4467899999999999985 468999999986421      123468899999999999999999998865  3567899


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      +||+++++|.+++.    ....+++.....++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++...
T Consensus        85 ~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          85 MEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            99999999999883    23468999999999999999999998   699999999999999999999999999987543


Q ss_pred             CCCCc-eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcc
Q 010434          342 KENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDL  420 (511)
Q Consensus       342 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (511)
                      ..... .......++..|+|||.+.+.  .++.++||||||+++|||++|+.|+......       ..+......... 
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-------~~~~~~~~~~~~-  227 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGE--GYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-------AAIFKIATQPTN-  227 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCC--CCCchhhhHHHHHHHHHHHHCCCCccccchH-------HHHHHHhcCCCC-
Confidence            22111 111234588999999998764  7889999999999999999999998643211       111111111111 


Q ss_pred             cccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          421 ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       421 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                           ...+..+.+.+..++ +||..+|++||++.+|++
T Consensus       228 -----~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         228 -----PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             -----CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                 112333445566666 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=324.65  Aligned_cols=255  Identities=21%  Similarity=0.235  Sum_probs=197.8

Q ss_pred             hhccccCcCCcEEEEEEEecCC-cEEEEEEecc-CcccHHHHHHHHHHhcccc-ccceEEeec-eecc----C--CceeE
Q 010434          191 HFTHKLGQGGFGSVYKGQLHTG-RLIAVKMLEN-SKFSAEEFINEVSTIGRIH-HVNVVQLLG-FCSE----G--SKRAL  260 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~~g-~~vAvK~l~~-~~~~~~~f~~Ev~~l~~l~-H~niv~l~g-~~~~----~--~~~~l  260 (511)
                      .+.+.|.+|||+.||.+....+ ..+|+|++-. ++...+...+|+.+|+.|+ |+|||.+++ ....    .  -..+|
T Consensus        40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll  119 (738)
T KOG1989|consen   40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL  119 (738)
T ss_pred             EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence            4567899999999999996655 9999998754 5556678899999999997 999999999 3321    1  24679


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      +||||++|.|-+++..+.  ...|++..+++|+.++++|+++||. +..+|||||||-+||||+.+++.||||||.|.-.
T Consensus       120 LmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~  196 (738)
T KOG1989|consen  120 LMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK  196 (738)
T ss_pred             ehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence            999999999999985433  3459999999999999999999998 4667999999999999999999999999998643


Q ss_pred             CCCC-Cceee------ccccCCccccchhcccccC-CCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHH
Q 010434          341 PKEN-DFVSI------SATRGTIGYIAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYD  412 (511)
Q Consensus       341 ~~~~-~~~~~------~~~~gt~~y~APE~~~~~~-~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~  412 (511)
                      .... .....      -...-|+.|+|||++.-.- -.+++|+|||+|||+||-|+....||+......           
T Consensus       197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-----------  265 (738)
T KOG1989|consen  197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-----------  265 (738)
T ss_pred             cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-----------
Confidence            2222 11000      1123689999999974321 278999999999999999999999998652211           


Q ss_pred             hhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          413 QLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       413 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                       +..+ ...++    ....++..|..||..||+.||.+||++-+|++.+-...
T Consensus       266 -Ilng-~Y~~P----~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~  312 (738)
T KOG1989|consen  266 -ILNG-NYSFP----PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA  312 (738)
T ss_pred             -EEec-cccCC----CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence             0000 01111    11346788999999999999999999999998775533

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.3e-36  Score=292.87  Aligned_cols=256  Identities=22%  Similarity=0.308  Sum_probs=200.8

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      +++.+.||.|+||.||+|.. .++..+|+|++....  ...+.+.+|+..++.++|+|++++++.+..+...++++|+++
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   82 (267)
T cd06610           3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS   82 (267)
T ss_pred             ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence            45678899999999999984 468899999986533  245789999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +++|.+++.... ....+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++.........
T Consensus        83 ~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          83 GGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             CCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            999999884321 12468999999999999999999998   69999999999999999999999999998766544322


Q ss_pred             e--eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          347 V--SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       347 ~--~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      .  ......++..|+|||.+... ...+.++|+||||+++|||++|+.|+.......       ...+... ........
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-------~~~~~~~-~~~~~~~~  229 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMK-------VLMLTLQ-NDPPSLET  229 (267)
T ss_pred             cccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhh-------hHHHHhc-CCCCCcCC
Confidence            1  11233588999999998654 367899999999999999999999986432110       0111111 11111110


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                       ......++..+.+++..||+.||++|||+.++++
T Consensus       230 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         230 -GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             -ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence             0012345677889999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-36  Score=307.17  Aligned_cols=253  Identities=26%  Similarity=0.338  Sum_probs=210.0

Q ss_pred             HHHHHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcc----cHHHHHHHHHHhcccc-ccceEEeeceeccCCc
Q 010434          184 EIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKF----SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSK  257 (511)
Q Consensus       184 ei~~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~  257 (511)
                      +-....|.+.+.||+|.||.||+++.+ +|+.+|+|.+.+...    +.+...+|+++|+++. |||||.+.+.++....
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            334445667789999999999999865 599999999976433    4468999999999998 9999999999999999


Q ss_pred             eeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC----CCeeeec
Q 010434          258 RALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN----FIPKVSD  333 (511)
Q Consensus       258 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~----~~~kl~D  333 (511)
                      .++|||++.||.|.+.|...     .+++.....++.|++.|+.|||+   .+|+||||||+|+|+...    +.+|++|
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~D  182 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLID  182 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEee
Confidence            99999999999999998433     39999999999999999999999   799999999999999543    5799999


Q ss_pred             ccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHh
Q 010434          334 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQ  413 (511)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~  413 (511)
                      ||++......   ......+||+.|+|||++...  .++..+||||+|+++|.|++|..||........        ...
T Consensus       183 FGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~--~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~--------~~~  249 (382)
T KOG0032|consen  183 FGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGR--PYGDEVDVWSIGVILYILLSGVPPFWGETEFEI--------FLA  249 (382)
T ss_pred             CCCceEccCC---ceEeeecCCccccCchhhcCC--CCCcccchhHHHHHHHHHhhCCCCCcCCChhHH--------HHH
Confidence            9999987662   244667899999999999854  889999999999999999999999977543221        112


Q ss_pred             hhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          414 LNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       414 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      +..+..   .-..+....++..+.+++..++..||..|+|+.++++.
T Consensus       250 i~~~~~---~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  250 ILRGDF---DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             HHcCCC---CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            222211   11223455567889999999999999999999999984

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5.3e-36  Score=301.27  Aligned_cols=253  Identities=19%  Similarity=0.198  Sum_probs=197.5

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+.+.||+|+||.||++... +++.||+|.+....    ...+.+.+|+.++++++||||+++++.+..+...++||||
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (305)
T cd05609           3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY   82 (305)
T ss_pred             ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence            345688999999999999854 67899999987643    2345788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++++|.+++.    ....+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++......
T Consensus        83 ~~g~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          83 VEGGDCATLLK----NIGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             CCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            99999999882    23568999999999999999999998   699999999999999999999999999987421110


Q ss_pred             C-------------ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhH
Q 010434          345 D-------------FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVY  411 (511)
Q Consensus       345 ~-------------~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~  411 (511)
                      .             ........++..|+|||.+...  .++.++|+||||+++|||++|+.|+......        .+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~vl~el~~g~~pf~~~~~~--------~~~  225 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--------ELF  225 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHH
Confidence            0             0011123478899999998754  6889999999999999999999998643211        112


Q ss_pred             HhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          412 DQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       412 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      ............    ....++..+.+++.+||+.+|++||+..++.++|+.
T Consensus       226 ~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         226 GQVISDDIEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHHhcccCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            222111110000    111345678899999999999999998777777765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-37  Score=315.04  Aligned_cols=245  Identities=28%  Similarity=0.396  Sum_probs=202.6

Q ss_pred             ccCcCCcEEEEEEEe-cCCcEEEEEEecc-CcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCccc
Q 010434          195 KLGQGGFGSVYKGQL-HTGRLIAVKMLEN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDR  272 (511)
Q Consensus       195 ~LG~G~fg~Vykg~~-~~g~~vAvK~l~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~  272 (511)
                      +||+|.||+||-|+. ++...+|||-+.. +....+-+..|+.+-++|+|.|||+.+|.+.+++..-+.||-+|||||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            699999999999984 4667899999865 55566778999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcCCcc--CHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEc-CCCCeeeecccccccCCCCCCceee
Q 010434          273 HIFPKENKGQTF--GWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSI  349 (511)
Q Consensus       273 ~l~~~~~~~~~l--~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~  349 (511)
                      ++.   .+=+++  .+..+--...||++||.|||.   ..|||||||-+|||++ -.|.+||+|||-++....-+.  .+
T Consensus       662 LLr---skWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~T  733 (1226)
T KOG4279|consen  662 LLR---SKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CT  733 (1226)
T ss_pred             HHH---hccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCCc--cc
Confidence            983   333566  788888999999999999998   5999999999999996 468999999999886544332  22


Q ss_pred             ccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhH
Q 010434          350 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE  429 (511)
Q Consensus       350 ~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  429 (511)
                      ....||..|||||++......|..++|||||||++.||.||++||-...... ...|        +-+   .....+.++
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-AAMF--------kVG---myKvHP~iP  801 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-AAMF--------KVG---MYKVHPPIP  801 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-Hhhh--------hhc---ceecCCCCc
Confidence            4456999999999998766789999999999999999999999986432211 0111        111   111234477


Q ss_pred             HHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          430 SVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       430 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .+++.+...++++|+.++|.+||+++++++
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            888999999999999999999999999986

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-36  Score=303.07  Aligned_cols=264  Identities=21%  Similarity=0.272  Sum_probs=194.7

Q ss_pred             hhhccccCcCCcEEEEEEEec---CCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccC--CceeE
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH---TGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRAL  260 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~---~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~l  260 (511)
                      +.+.++||+|+||.||+|+..   +++.||+|.+....    ...+.+.+|+.++.+++||||+++++++.+.  ...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            456788999999999999854   47999999987632    2346788999999999999999999999887  78999


Q ss_pred             EEeecCCCCcccccccCCC-cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC----CCCeeeeccc
Q 010434          261 VYEFMPNGSLDRHIFPKEN-KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH----NFIPKVSDFG  335 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~----~~~~kl~DFG  335 (511)
                      ||||+++ +|.+++..... ....+++..+..++.|++.||+|||+   .+|+||||||+||+++.    ++.+||+|||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999975 56555432222 23478999999999999999999998   69999999999999999    9999999999


Q ss_pred             ccccCCCCCC-ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchh-----
Q 010434          336 LAKFHPKEND-FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW-----  409 (511)
Q Consensus       336 la~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~-----  409 (511)
                      +++....... ........++..|+|||.+.+. ..++.++||||||++++||++|+.|+........ ...+..     
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~  235 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIK-KSNPFQRDQLE  235 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCccccc-ccchhHHHHHH
Confidence            9986644332 1122334578899999987653 3578899999999999999999999875433220 000000     


Q ss_pred             -hHHhhh---------------------cCCccccc--ccc-hhHH--HHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          410 -VYDQLN---------------------KGGDLELR--NVT-EIES--VIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       410 -~~~~~~---------------------~~~~~~~~--~~~-~~~~--~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                       +...+.                     ........  ... ....  ..+..+.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence             000000                     00000000  000 0111  34457889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.1e-36  Score=295.31  Aligned_cols=250  Identities=26%  Similarity=0.414  Sum_probs=197.2

Q ss_pred             hhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc-------cHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          191 HFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF-------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~-------~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      ...+.||+|+||.||++.. .+++.+|+|.+.....       ..+.+.+|+.++++++|+||+++++++.++...++|+
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~   82 (268)
T cd06630           3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV   82 (268)
T ss_pred             cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence            3457899999999999984 5789999999865321       2457899999999999999999999999999999999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC-CeeeecccccccCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHP  341 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~-~~kl~DFGla~~~~  341 (511)
                      ||+++++|.+++.    ...++++..+..++.|++.||+|||+   .+++|+||+|+||+++.++ .+||+|||++....
T Consensus        83 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          83 EWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             eccCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            9999999999873    23578999999999999999999998   6999999999999998776 59999999987665


Q ss_pred             CCCCce--eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          342 KENDFV--SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       342 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      ......  ......++..|+|||.+.+.  .++.++||||+|+++++|++|+.|+........    .....+...... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~-  228 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGE--QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH----LALIFKIASATT-  228 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCcch----HHHHHHHhccCC-
Confidence            432111  11233578899999998764  678999999999999999999999864322110    111111111111 


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                           ....+..++..+.+++.+|++.+|.+|||+.++++
T Consensus       229 -----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         229 -----APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             -----CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                 11233456678899999999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-36  Score=306.32  Aligned_cols=273  Identities=22%  Similarity=0.268  Sum_probs=197.3

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccC-----CceeE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRAL  260 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~-----~~~~l  260 (511)
                      .+.+.++||+|+||.||+|.. .+|+.||||.+...  ......+.+|+.++++++|+||+++++++...     ...++
T Consensus         6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   85 (336)
T cd07849           6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI   85 (336)
T ss_pred             ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence            355678999999999999984 57899999998642  22446788999999999999999999987543     35799


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      ++||++ ++|.+++     ....+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++..
T Consensus        86 v~e~~~-~~l~~~~-----~~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          86 VQELME-TDLYKLI-----KTQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             Eehhcc-cCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            999996 4777665     23569999999999999999999998   69999999999999999999999999999765


Q ss_pred             CCCCCce-eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc--------cchhh-
Q 010434          341 PKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY--------FPSWV-  410 (511)
Q Consensus       341 ~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~--------~~~~~-  410 (511)
                      ....... ......||..|+|||.+.+. ..++.++||||||+++|||++|+.||...........        .+... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN  235 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            4332211 11234588999999987543 3678899999999999999999999864321110000        00000 


Q ss_pred             -------HHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH--HhcCcCCCCCC
Q 010434          411 -------YDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM--LEGSMDDLQMP  471 (511)
Q Consensus       411 -------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~--Le~~~~~l~~p  471 (511)
                             ...+..................+..+.+++.+||+.+|++|||+.++++.  ++...+....|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~  305 (336)
T cd07849         236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEP  305 (336)
T ss_pred             HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcc
Confidence                   00000000000000001112235678899999999999999999999985  55544433333

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.6e-36  Score=295.15  Aligned_cols=251  Identities=25%  Similarity=0.349  Sum_probs=199.0

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      +.+.++||+|+||.||++..+ +++.+|+|.+....  ...+++.+|+.++++++||||+++++.+..+...++++||++
T Consensus         3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (265)
T cd06605           3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD   82 (265)
T ss_pred             chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence            345678999999999999865 68999999987642  345678999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +++|.+++...   ...+++..+.+++.|++.||+|||+.  .+++|+||||+||++++++.+||+|||.+........ 
T Consensus        83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  156 (265)
T cd06605          83 GGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-  156 (265)
T ss_pred             CCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence            99999988322   26789999999999999999999982  5999999999999999999999999999875532221 


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                         ....++..|+|||.+.+.  .++.++||||||+++|+|++|+.|+........  . .....+..........    
T Consensus       157 ---~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~-~~~~~~~~~~~~~~~~----  224 (265)
T cd06605         157 ---KTFVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPPENDPPD--G-IFELLQYIVNEPPPRL----  224 (265)
T ss_pred             ---hcccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCccccccc--c-HHHHHHHHhcCCCCCC----
Confidence               125588899999998765  788999999999999999999999865421110  0 0111111111111111    


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                       ....++..+.+++..||+.+|++|||+.+++.
T Consensus       225 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         225 -PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             -ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence             11125677899999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6.2e-36  Score=293.11  Aligned_cols=252  Identities=27%  Similarity=0.423  Sum_probs=199.2

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      |...++||+|+||.||+|.. .+++.||+|.+.....   ..+.+.+|+.++++++|+||+++++++......++|+||+
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC   81 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence            44568999999999999985 4789999999876544   4568899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++++|.+++.    .+..+++..+..++.+++.||+|||+   .+++|+||+|+||++++++.+||+|||++........
T Consensus        82 ~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          82 SGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            9999999883    23468899999999999999999998   6999999999999999999999999999987654432


Q ss_pred             cee--eccccCCccccchhcccccC-CCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          346 FVS--ISATRGTIGYIAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       346 ~~~--~~~~~gt~~y~APE~~~~~~-~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                      ...  .....++..|+|||++.+.. ...+.++||||||+++|||++|+.||.......      ...+. .........
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~------~~~~~-~~~~~~~~~  227 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF------QIMFH-VGAGHKPPI  227 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH------HHHHH-HhcCCCCCC
Confidence            211  12345789999999987642 237889999999999999999999986432110      01111 111111111


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ..    ....+..+.+++.+||+.+|.+|||+.+++.
T Consensus       228 ~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         228 PD----SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             Cc----ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11    1123566788999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1e-35  Score=297.74  Aligned_cols=249  Identities=24%  Similarity=0.352  Sum_probs=199.2

Q ss_pred             HHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC-cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      .++.+.+.||+|+||.||++.. .+++.||+|.+... ....+.+.+|+.++++++||||+++++.+..+...++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            3556678999999999999984 47889999998653 334567899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++++|.+++.     ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++........
T Consensus        99 ~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          99 AGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            9999999872     2457899999999999999999998   6999999999999999999999999998875543322


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                        ......+++.|+|||.+.+.  .++.++||||||+++|+|++|+.||.........       .. .........   
T Consensus       171 --~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-------~~-~~~~~~~~~---  235 (293)
T cd06647         171 --KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------YL-IATNGTPEL---  235 (293)
T ss_pred             --ccccccCChhhcCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-------ee-hhcCCCCCC---
Confidence              11334588899999998764  6789999999999999999999998654321100       00 000101111   


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                       .....++..+.+++.+||+.+|.+||++.+++.+
T Consensus       236 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         236 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             1122345678899999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.3e-35  Score=298.66  Aligned_cols=247  Identities=26%  Similarity=0.334  Sum_probs=194.0

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .+.+.++||+|+||.||+|+.. +|+.||+|.+....    ...+++.+|+.++++++||||+++++++..+...++|+|
T Consensus        16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   95 (307)
T cd06607          16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME   95 (307)
T ss_pred             hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence            3556688999999999999854 68999999986422    123568899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |++ |+|.+++.   .....+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++......
T Consensus        96 ~~~-g~l~~~~~---~~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          96 YCL-GSASDILE---VHKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             hhC-CCHHHHHH---HcccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            996 56666552   223568999999999999999999998   69999999999999999999999999998765332


Q ss_pred             CCceeeccccCCccccchhcccc-cCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          344 NDFVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                            ....++..|+|||++.. ..+.++.++||||||+++|||++|+.|+.......       .... +........
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-------~~~~-~~~~~~~~~  234 (307)
T cd06607         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYH-IAQNDSPTL  234 (307)
T ss_pred             ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-------HHHH-HhcCCCCCC
Confidence                  22347889999998742 22468899999999999999999999986432111       0111 111111111


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHH
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEML  461 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L  461 (511)
                           .....+..+.+++.+||+.+|++||++.+++...
T Consensus       235 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         235 -----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             -----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence                 1223456789999999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-36  Score=297.93  Aligned_cols=260  Identities=23%  Similarity=0.292  Sum_probs=194.7

Q ss_pred             hhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          191 HFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .+.++||.|++|.||+|.. .+|+.||+|++....   ...+.+.+|+.++++++|||++++++++.++...+++|||++
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~   81 (283)
T cd07835           2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD   81 (283)
T ss_pred             chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence            4567899999999999985 479999999986532   234678999999999999999999999999999999999994


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                       ++|.+++...  ....+++..+..++.|+++||+|||+   .+++|+||+|+||+++.++.++|+|||+++....... 
T Consensus        82 -~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-  154 (283)
T cd07835          82 -LDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-  154 (283)
T ss_pred             -cCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence             6888887322  22468999999999999999999998   6999999999999999999999999999875533221 


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc-------cchhhHHhhhc---
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY-------FPSWVYDQLNK---  416 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~-------~~~~~~~~~~~---  416 (511)
                       ......++..|+|||++.+. ..++.++||||||+++|||++|+.||...........       ...+.+.....   
T Consensus       155 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07835         155 -TYTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD  232 (283)
T ss_pred             -ccCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence             11233468899999987653 3568899999999999999999999864322110000       00000000000   


Q ss_pred             ----CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          417 ----GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       417 ----~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                          ...............++..+.+++.+|++.+|++|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                0000001111122234567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1e-35  Score=295.01  Aligned_cols=252  Identities=23%  Similarity=0.350  Sum_probs=192.2

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcc--cHHHHHHHHHH-hccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKF--SAEEFINEVST-IGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~--~~~~f~~Ev~~-l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      +.+.+.||+|+||.||+++.+ +|+.||+|.++....  ...++..|+.. ++.++||||+++++++..+...+++|||+
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~   82 (283)
T cd06617           3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM   82 (283)
T ss_pred             ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence            345678999999999999864 699999999876432  33456667765 55668999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      + |+|.+++......+..+++..+..++.|++.||+|||++  .+++||||||+||+++.++.+||+|||+++...... 
T Consensus        83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (283)
T cd06617          83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-  158 (283)
T ss_pred             c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence            6 688776643333446799999999999999999999982  389999999999999999999999999987654321 


Q ss_pred             ceeeccccCCccccchhccccc--CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          346 FVSISATRGTIGYIAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~--~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                        ......++..|+|||.+.+.  ...++.++|+||||+++|||++|+.|+.......      ...... ........ 
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~~~~-  228 (283)
T cd06617         159 --AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF------QQLKQV-VEEPSPQL-  228 (283)
T ss_pred             --ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH------HHHHHH-HhcCCCCC-
Confidence              11234578899999988642  1356889999999999999999999985421110      001111 11111111 


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                          ....++..+.+++.+||+.+|.+||++.++++
T Consensus       229 ----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         229 ----PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             ----CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                11124567889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=6.1e-36  Score=291.99  Aligned_cols=247  Identities=25%  Similarity=0.390  Sum_probs=197.2

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      +.+.+.||+|+||.||+|..+ +|..+|+|.+...   ....+.+.+|+.++++++|+||+++++.+..+...++|+||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   81 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC   81 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence            456788999999999999865 6889999998653   234567889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC-CeeeecccccccCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~-~~kl~DFGla~~~~~~~  344 (511)
                      ++++|.+++..  ..+..+++..+..++.|++.||+|||+   .+++|+||||+||++++++ .+||+|||.+.......
T Consensus        82 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          82 DGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            99999998742  233468999999999999999999998   6999999999999998885 56999999987664332


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      .  ......|++.|+|||.+...  .++.++|+||||++++||++|+.|+......       .++..... .....   
T Consensus       157 ~--~~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~-~~~~~---  221 (257)
T cd08225         157 E--LAYTCVGTPYYLSPEICQNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-------QLVLKICQ-GYFAP---  221 (257)
T ss_pred             c--cccccCCCccccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHhc-ccCCC---
Confidence            2  12234588999999988654  6889999999999999999999998643211       11222111 11111   


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                         .....+..+.+++.+||+.+|++|||+.++++
T Consensus       222 ---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         222 ---ISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             ---CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence               11223467889999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-36  Score=296.22  Aligned_cols=260  Identities=23%  Similarity=0.287  Sum_probs=195.1

Q ss_pred             hhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccC--CceeEEEee
Q 010434          191 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVYEF  264 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~  264 (511)
                      ++.++||+|+||.||+|+.. +|+.+|+|.+..+.   ...+.+.+|+.++++++|+|++++++++...  ...++|+||
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~   81 (287)
T cd07840           2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY   81 (287)
T ss_pred             eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence            45678999999999999865 58999999997642   3346789999999999999999999999887  889999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++ +|.+++..   ....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++.......
T Consensus        82 ~~~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          82 MDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             ccc-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            974 88877732   22578999999999999999999998   699999999999999999999999999998665443


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc-------chhhHHhhhc-
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF-------PSWVYDQLNK-  416 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~~~-  416 (511)
                      . .......++..|+|||.+.+. ..++.++||||||+++|||++|+.|+...........+       ....+..... 
T Consensus       155 ~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         155 S-ADYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             c-ccccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence            2 112334578899999987653 35789999999999999999999998653321100000       0000000000 


Q ss_pred             ----CCcccccc---cchhHHH-HHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          417 ----GGDLELRN---VTEIESV-IARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       417 ----~~~~~~~~---~~~~~~~-~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                          ........   ..+.... ++..+.+++.+||+.+|.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                00000000   0011111 2677899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-36  Score=327.91  Aligned_cols=257  Identities=26%  Similarity=0.435  Sum_probs=210.5

Q ss_pred             hhccccCcCCcEEEEEEEec----C----CcEEEEEEeccC--cccHHHHHHHHHHhccc-cccceEEeeceeccCCcee
Q 010434          191 HFTHKLGQGGFGSVYKGQLH----T----GRLIAVKMLENS--KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRA  259 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~----~----g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~  259 (511)
                      .+.+.||+|.||.|++|..+    .    ...||||+++..  ....+.+..|+++++.+ +|+||+.++|.|.+.+..+
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~  378 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY  378 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence            45679999999999999743    1    457999999873  33567899999999999 6999999999999999999


Q ss_pred             EEEeecCCCCcccccccCC---C-------cC--CccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC
Q 010434          260 LVYEFMPNGSLDRHIFPKE---N-------KG--QTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF  327 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~  327 (511)
                      +|+||+..|+|.+++...+   .       ..  ..++...++.++.|||.||+||++   .+++||||.++|||+.++.
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~~~  455 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITKNK  455 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecCCC
Confidence            9999999999999985443   0       01  249999999999999999999998   6999999999999999999


Q ss_pred             CeeeecccccccCCCCCCceee-ccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccc
Q 010434          328 IPKVSDFGLAKFHPKENDFVSI-SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAY  405 (511)
Q Consensus       328 ~~kl~DFGla~~~~~~~~~~~~-~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~  405 (511)
                      .+||+|||+|+.......+... +..+-+..|||||.+...  .++.||||||||++||||+| |..|+...       .
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~--~ft~kSDVWSfGI~L~EifsLG~~PYp~~-------~  526 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR--VFTSKSDVWSFGILLWEIFTLGGTPYPGI-------P  526 (609)
T ss_pred             EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccC--cccccchhhHHHHHHHHHhhCCCCCCCCC-------C
Confidence            9999999999977766655422 222256789999999874  89999999999999999998 56666431       1


Q ss_pred             cchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          406 FPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                      ...-+++.+.++.+.+.+.      .+..++..+++.||+.+|++||+++++++.++..+
T Consensus       527 ~~~~l~~~l~~G~r~~~P~------~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  527 PTEELLEFLKEGNRMEQPE------HCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             cHHHHHHHHhcCCCCCCCC------CCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            1222455777777666443      33567889999999999999999999999999843

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.8e-35  Score=294.55  Aligned_cols=243  Identities=25%  Similarity=0.347  Sum_probs=195.3

Q ss_pred             ccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCc
Q 010434          193 THKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL  270 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  270 (511)
                      .++||+|++|.||++.. .+++.+|+|.+.... ...+.+.+|+.++++++||||+++++++..++..++++||+++++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L  103 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL  103 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence            46899999999999985 578999999986533 3345688999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeec
Q 010434          271 DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  350 (511)
Q Consensus       271 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  350 (511)
                      .+++..     ..+++..+..++.|++.||+|||+   .+++||||+|+||+++.++.++|+|||++........  ...
T Consensus       104 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~  173 (285)
T cd06648         104 TDIVTH-----TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRK  173 (285)
T ss_pred             HHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccc
Confidence            998722     468999999999999999999998   6999999999999999999999999998875543221  112


Q ss_pred             cccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHH
Q 010434          351 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  430 (511)
Q Consensus       351 ~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  430 (511)
                      ...|+..|+|||.+.+.  .++.++||||||+++|||++|+.|+......        .....+.........    ...
T Consensus       174 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--------~~~~~~~~~~~~~~~----~~~  239 (285)
T cd06648         174 SLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--------QAMKRIRDNLPPKLK----NLH  239 (285)
T ss_pred             cccCCccccCHHHhcCC--CCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--------HHHHHHHhcCCCCCc----ccc
Confidence            34588999999998764  6889999999999999999999998543211        111122221111111    111


Q ss_pred             HHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          431 VIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       431 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .++..+.+++.+||+.+|++|||+.++++
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         240 KVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            24567899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-36  Score=299.26  Aligned_cols=261  Identities=20%  Similarity=0.284  Sum_probs=197.6

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      +++.++||+|+||.||+|..+ +++.||||.++..   ....+.+.+|++++++++|+||+++++++..++..+++|||+
T Consensus         3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   82 (288)
T cd07833           3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV   82 (288)
T ss_pred             eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence            556789999999999999865 6889999998653   223467899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      +++.+..+.    .....+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++........
T Consensus        83 ~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          83 ERTLLELLE----ASPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             CCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            987776654    223558999999999999999999998   6999999999999999999999999999987655432


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc-------cccchhhHHhhhcCC
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK-------AYFPSWVYDQLNKGG  418 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~~~~  418 (511)
                      . ......++..|+|||++... ..++.++||||||+++|+|++|+.|+.........       ..++...........
T Consensus       156 ~-~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         156 S-PLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             c-cccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            1 12334578899999998753 26788999999999999999999988643211100       000000000000000


Q ss_pred             ------cccccccc----hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          419 ------DLELRNVT----EIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       419 ------~~~~~~~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                            ........    ..+..++..+.+++.+||+.+|++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                  00000000    011224678999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.9e-35  Score=294.97  Aligned_cols=241  Identities=27%  Similarity=0.384  Sum_probs=196.8

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+.+.||+|+||.||++... +++.+|+|++....    ...+.+.+|++++++++||||+++++++.++...++||||
T Consensus         3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (290)
T cd05580           3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY   82 (290)
T ss_pred             eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence            456789999999999999854 68999999986532    2346788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++++|.+++.    ....+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||+++..... 
T Consensus        83 ~~~~~L~~~~~----~~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          83 VPGGELFSHLR----KSGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             CCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            99999999883    33678999999999999999999998   69999999999999999999999999999865443 


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                          .....+++.|+|||.+...  ..+.++||||||+++|+|++|+.|+.....        .........+. ..   
T Consensus       155 ----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~-~~---  216 (290)
T cd05580         155 ----TYTLCGTPEYLAPEIILSK--GYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKILEGK-VR---  216 (290)
T ss_pred             ----CCCCCCCccccChhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCC-cc---
Confidence                1334588999999998754  678899999999999999999999865331        11222222111 11   


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCC-----CHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRP-----SMTKVLE  459 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~  459 (511)
                         .+...+..+.+++.+||+.+|.+||     ++.++++
T Consensus       217 ---~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         217 ---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ---CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence               1122356788999999999999998     7777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=292.64  Aligned_cols=246  Identities=25%  Similarity=0.364  Sum_probs=202.3

Q ss_pred             hhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCC
Q 010434          191 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGS  269 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  269 (511)
                      .+..+||+|+||+|||+..+ .|+.+|||.+.. ..+.++.+.|+.++++++.|++|+++|.+-....+++|||||..|+
T Consensus        36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS  114 (502)
T KOG0574|consen   36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS  114 (502)
T ss_pred             HHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence            45679999999999999754 799999999855 3467899999999999999999999999999999999999999999


Q ss_pred             cccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceee
Q 010434          270 LDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI  349 (511)
Q Consensus       270 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  349 (511)
                      ..+.+   +.++++|+++.+..++...+.||+|||.   +.-+|||||+.||||+.+|.+||+|||.|-.+...-  ...
T Consensus       115 iSDI~---R~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AKR  186 (502)
T KOG0574|consen  115 ISDIM---RARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AKR  186 (502)
T ss_pred             HHHHH---HHhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH--Hhh
Confidence            99998   3456899999999999999999999998   788999999999999999999999999986543321  122


Q ss_pred             ccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhH
Q 010434          350 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE  429 (511)
Q Consensus       350 ~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  429 (511)
                      ....||+.|||||++..-  .|..++||||+|+...||..|++|+.....-..--.+|        .......    .-+
T Consensus       187 NTVIGTPFWMAPEVI~EI--GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP--------T~PPPTF----~KP  252 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEI--GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP--------TKPPPTF----KKP  252 (502)
T ss_pred             CccccCcccccHHHHHHh--ccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc--------CCCCCCC----CCh
Confidence            445699999999999865  78899999999999999999999986532111000000        0000111    134


Q ss_pred             HHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          430 SVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       430 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ++-+..+.+++..||-.+|++|-|+.++++
T Consensus       253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  253 EEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             HhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            455677889999999999999999998876

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.8e-37  Score=299.11  Aligned_cols=252  Identities=26%  Similarity=0.313  Sum_probs=189.7

Q ss_pred             ccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCC-----ceeEEEeecC
Q 010434          193 THKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS-----KRALVYEFMP  266 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~-----~~~lV~e~~~  266 (511)
                      .+.+|.|+||.||+|++. +++.||||+.-.+..   ---+|+.+|+++.|||||+|.-+|....     ...+||||||
T Consensus        29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP  105 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP  105 (364)
T ss_pred             eEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence            468999999999999954 579999998754332   1236999999999999999998884322     2348999997


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC-CCeeeecccccccCCCCCC
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~-~~~kl~DFGla~~~~~~~~  345 (511)
                      . +|.+.+......+..++...+.-+..||.+||+|||+   ++|+||||||.|+|+|.+ +.+||+|||.|+.......
T Consensus       106 ~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep  181 (364)
T KOG0658|consen  106 E-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP  181 (364)
T ss_pred             H-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence            6 8877774333446778888899999999999999999   799999999999999977 9999999999998766544


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcC--------
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG--------  417 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------  417 (511)
                      ..   ....|..|+|||.+-+. ..|+.+.||||.||++.||+-|++-|........-    ..+.+.+.-.        
T Consensus       182 ni---SYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL----~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  182 NI---SYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQL----VEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             ce---eEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHH----HHHHHHhCCCCHHHHhhc
Confidence            32   23467789999999876 58999999999999999999999877653322100    0011111000        


Q ss_pred             -------Ccccccccc---hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          418 -------GDLELRNVT---EIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       418 -------~~~~~~~~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                             ....+....   -.....+++..+++.++++.+|.+|.++.|++.
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                   000110000   133345678899999999999999999999875

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.1e-35  Score=292.30  Aligned_cols=246  Identities=24%  Similarity=0.297  Sum_probs=190.3

Q ss_pred             hhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc------ccHHHHHHHHHHhccccccceEEeeceeccC--CceeEE
Q 010434          191 HFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK------FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALV  261 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~------~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~lV  261 (511)
                      .+.++||+|+||.||+|.. .+|+.||||.+....      ...+.+.+|+.++++++||||+++++++.+.  ...+++
T Consensus         5 ~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v   84 (265)
T cd06652           5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF   84 (265)
T ss_pred             eEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEE
Confidence            4467899999999999985 468999999875321      1235788899999999999999999988653  467899


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      |||+++++|.+++.    ....+++....+++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++...
T Consensus        85 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          85 MEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            99999999999873    22458899999999999999999998   699999999999999999999999999987543


Q ss_pred             CCCCc-eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcc
Q 010434          342 KENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDL  420 (511)
Q Consensus       342 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (511)
                      ..... .......++..|+|||.+.+.  .++.++||||||+++|||++|+.|+.......       ........... 
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~-  227 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGE--GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-------AIFKIATQPTN-  227 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCC--CCCcchhHHHHHHHHHHHhhCCCCCCccchHH-------HHHHHhcCCCC-
Confidence            22111 112334588999999998764  68899999999999999999999986431110       01111111101 


Q ss_pred             cccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          421 ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       421 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                           ...+..++..+.+++..|+. +|++||+++++++
T Consensus       228 -----~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         228 -----PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             -----CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                 11233455677888899985 9999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=9.6e-36  Score=297.19  Aligned_cols=259  Identities=21%  Similarity=0.299  Sum_probs=192.2

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc---ccHHHHHHHHHHhcccc-ccceEEeeceeccCCc-----ee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSK-----RA  259 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~-----~~  259 (511)
                      +.+.+.||+|+||.||+|.. .+|+.||||.+....   .....+.+|+.++++++ |+||+++++++.....     .+
T Consensus         3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~   82 (295)
T cd07837           3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY   82 (295)
T ss_pred             ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence            45567899999999999985 478999999986532   23457889999999994 6999999999876655     89


Q ss_pred             EEEeecCCCCcccccccCCCc-CCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC-CCCeeeeccccc
Q 010434          260 LVYEFMPNGSLDRHIFPKENK-GQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH-NFIPKVSDFGLA  337 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~-~~~~kl~DFGla  337 (511)
                      +||||+++ +|.+++...... ...+++..+..++.||+.||+|||+   .+|+||||||+||+++. ++.+||+|||++
T Consensus        83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccc
Confidence            99999975 788777433222 4578999999999999999999998   69999999999999998 899999999998


Q ss_pred             ccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcC
Q 010434          338 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG  417 (511)
Q Consensus       338 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  417 (511)
                      +.......  ......+++.|+|||.+.+. ..++.++||||||+++|||++|..|+...........    +...+...
T Consensus       159 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~----~~~~~~~~  231 (295)
T cd07837         159 RAFSIPVK--SYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH----IFKLLGTP  231 (295)
T ss_pred             eecCCCcc--ccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHHHhCCC
Confidence            75533211  11223467889999988643 3578999999999999999999998864321110000    00000000


Q ss_pred             -----------------CcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          418 -----------------GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       418 -----------------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                                       ..............++..+.+++.+||+.+|.+||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                             000000011112235677889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.6e-36  Score=293.62  Aligned_cols=245  Identities=23%  Similarity=0.299  Sum_probs=198.9

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+.++||.|+||.||++... +++.+|+|.+....    ...+.+.+|++++++++||||+++++++.++...++|+||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL   81 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence            456789999999999999865 68999999986532    3456899999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++++|.+++.    ...++++..+..++.|+++||.|||+   .+++|+||+|+||++++++.++|+|||++.......
T Consensus        82 ~~~~~L~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          82 LLGGDLRYHLS----QKVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999883    22578999999999999999999998   699999999999999999999999999987654432


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                         ......|+..|+|||.+.+.  ..+.++|+||||+++|+|++|+.|+.......     ..+....... .      
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~-~------  217 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQ--GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-----RDQIRAKQET-A------  217 (258)
T ss_pred             ---cccccCCChhhcCHHHHccc--CCCCcccchhhHHHHHHHHhCCCCCCCCCccH-----HHHHHHHhcc-c------
Confidence               12345588899999998765  58899999999999999999999987543211     1122221111 0      


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCH--HHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSM--TKVL  458 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~--~evl  458 (511)
                      ....+...+..+.+++.+||+.+|.+||+.  ++++
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            011222345788899999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.1e-35  Score=285.88  Aligned_cols=248  Identities=27%  Similarity=0.372  Sum_probs=201.0

Q ss_pred             hhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccC--CceeEEEee
Q 010434          191 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVYEF  264 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~  264 (511)
                      ...+.||+|++|.||+|... +++.|++|++....   ...+.+.+|+.++++++|+||+++++.+...  ...++++||
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~   82 (260)
T cd06606           3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY   82 (260)
T ss_pred             eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence            34578999999999999865 78999999987644   3467899999999999999999999999888  889999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++++|.+++.    ....+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        83 ~~~~~L~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          83 VSGGSLSSLLK----KFGKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             cCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            99999999883    22389999999999999999999998   699999999999999999999999999998766544


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      .........++..|+|||.+...  ..+.++||||||+++++|++|+.|+......      ............      
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~------  221 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGE--EYGRAADIWSLGCTVIEMATGKPPWSELGNP------MAALYKIGSSGE------  221 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCch------HHHHHhccccCC------
Confidence            32112345688999999998765  5889999999999999999999998654310      011111111011      


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ....+...+..+.+++.+|++.+|.+||++.++++
T Consensus       222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            11122334678999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3e-35  Score=287.99  Aligned_cols=249  Identities=27%  Similarity=0.378  Sum_probs=201.2

Q ss_pred             hhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          191 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      ++.+.||+|++|.||+++.. +++.||||++....  ...+.+.+|+..+.+++|+|++++++++..+...++|+||+++
T Consensus         4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (264)
T cd06623           4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG   83 (264)
T ss_pred             eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence            45689999999999999865 59999999987643  3457899999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      ++|.+++.    ....+++..+..++.|+++|++|||+.  .+++|+||+|+||+++.++.++|+|||++......... 
T Consensus        84 ~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-  156 (264)
T cd06623          84 GSLADLLK----KVGKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-  156 (264)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence            99999983    226789999999999999999999972  49999999999999999999999999998866443321 


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                       .....++..|+|||.+...  .++.++|+||||+++|+|++|+.|+.......    ... ....+.......      
T Consensus       157 -~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~----~~~-~~~~~~~~~~~~------  222 (264)
T cd06623         157 -CNTFVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLPPGQPS----FFE-LMQAICDGPPPS------  222 (264)
T ss_pred             -ccceeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCccccccC----HHH-HHHHHhcCCCCC------
Confidence             1234578899999998764  78899999999999999999999986543211    011 111111111111      


Q ss_pred             hHHH-HHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          428 IESV-IARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       428 ~~~~-~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      .... ++..+.+++.+||+.+|++|||+.++++.
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            1122 56789999999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=8.5e-36  Score=295.24  Aligned_cols=256  Identities=20%  Similarity=0.276  Sum_probs=191.8

Q ss_pred             hhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC--cccHHHHHHHHHHhcccc-ccceEEeeceeccC--CceeEEEee
Q 010434          191 HFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS--KFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEG--SKRALVYEF  264 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~--~~~~lV~e~  264 (511)
                      ++.++||+|+||.||+|+. .+++.+|+|.++..  ........+|+.++.++. |+|++++++++.++  +..++|+||
T Consensus         2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~   81 (282)
T cd07831           2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL   81 (282)
T ss_pred             ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence            4578899999999999985 47899999998763  223345568999999885 99999999999877  889999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      ++ |+|.+.+..   ....+++..+..++.|++.||+|||+   .+++|+||||+||+++. +.+||+|||+++......
T Consensus        82 ~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          82 MD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             CC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            96 577776622   23578999999999999999999998   69999999999999999 999999999998654332


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccc--------ccccchhhHHhhhc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSS--------KAYFPSWVYDQLNK  416 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~  416 (511)
                      ..   ....++..|+|||.+... +.++.++|||||||++|||++|..|+........        ....+.+ ......
T Consensus       154 ~~---~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  228 (282)
T cd07831         154 PY---TEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKFRK  228 (282)
T ss_pred             Cc---CCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhhcc
Confidence            21   223478899999976543 3578899999999999999999999865332110        0000111 111111


Q ss_pred             CCccc--ccc-----cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          417 GGDLE--LRN-----VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       417 ~~~~~--~~~-----~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .....  ...     .......++..+.+++.+||+.+|++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            10000  000     00112245678999999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.2e-35  Score=295.12  Aligned_cols=242  Identities=24%  Similarity=0.341  Sum_probs=186.9

Q ss_pred             ccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc----cHHHHHHHHHHhc---cccccceEEeeceeccCCceeEEEeecC
Q 010434          195 KLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF----SAEEFINEVSTIG---RIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       195 ~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~---~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .||+|+||.||++.. .+++.+|+|.+.....    ....+.+|..++.   ..+||||+.+.+++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999985 4689999999865322    1233455554433   3479999999999999899999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +|+|.+++.    ....+++..+..++.|++.||+|||+   .+|+|+||||+|||+++++.+||+|||++.......  
T Consensus        81 ~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--  151 (279)
T cd05633          81 GGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (279)
T ss_pred             CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence            999998873    33569999999999999999999998   699999999999999999999999999987543322  


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                        .....||..|+|||.+.+. ..++.++||||||++++||++|+.||.......     ...+. ......      ..
T Consensus       152 --~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~-~~~~~~------~~  216 (279)
T cd05633         152 --PHASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEID-RMTLTV------NV  216 (279)
T ss_pred             --ccCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-----HHHHH-HHhhcC------Cc
Confidence              1234589999999987532 257889999999999999999999986532211     00111 111000      11


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCC-----CHHHHHHH
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRP-----SMTKVLEM  460 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~~  460 (511)
                      ..+..++..+.+++..||+.||++||     |++++++.
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            12334567888999999999999999     69999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1e-35  Score=289.98  Aligned_cols=247  Identities=28%  Similarity=0.413  Sum_probs=201.4

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      +.+.++||+|+||.||+++. .+++.+|+|.+....   ....++.+|+.++++++|+||+++++++.++...++|+||+
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA   81 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence            45678999999999999974 478899999987532   34557889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++++|.+++......+..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||+++...... 
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~-  157 (256)
T cd08530          82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM-  157 (256)
T ss_pred             CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence            9999999875433345678999999999999999999998   699999999999999999999999999998765441 


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                         .....++..|+|||.+.+.  .++.++|+||||+++|||++|+.|+.......        ...........     
T Consensus       158 ---~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~-----  219 (256)
T cd08530         158 ---AKTQIGTPHYMAPEVWKGR--PYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--------LRYKVQRGKYP-----  219 (256)
T ss_pred             ---cccccCCccccCHHHHCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcCCCC-----
Confidence               1234578899999998764  67889999999999999999999986543211        11111111111     


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                       .....++..+.+++.+|++.+|++|||+.++++
T Consensus       220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         220 -PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             -CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             122345677899999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-35  Score=297.77  Aligned_cols=250  Identities=24%  Similarity=0.298  Sum_probs=196.9

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcc----cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +++.+.||+|+||.||++... +++.+|+|.+.....    ..+.+.+|+.++.+++|+||+++++.+..+...++||||
T Consensus         3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   82 (316)
T cd05574           3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY   82 (316)
T ss_pred             eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence            445678999999999999865 589999999876432    345788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++++|.+++.  ...+..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~L~~~~~--~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          83 CPGGELFRLLQ--RQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             cCCCCHHHHHH--hCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            99999999873  2234679999999999999999999998   699999999999999999999999999987543221


Q ss_pred             Cce---------------------------eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcc
Q 010434          345 DFV---------------------------SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMN  397 (511)
Q Consensus       345 ~~~---------------------------~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~  397 (511)
                      ...                           ......||..|+|||++.+.  .++.++||||||+++|+|++|+.|+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD--GHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC--CCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            110                           01123578899999998764  6789999999999999999999998654


Q ss_pred             cccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCC----HHHHHH
Q 010434          398 AIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPS----MTKVLE  459 (511)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs----~~evl~  459 (511)
                      ....       .........  ....    ....++..+.+++.+||+.+|++|||    +.++++
T Consensus       236 ~~~~-------~~~~~~~~~--~~~~----~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         236 NRDE-------TFSNILKKE--VTFP----GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             chHH-------HHHHHhcCC--ccCC----CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            3211       011111111  1111    11115678999999999999999999    666665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.9e-35  Score=284.08  Aligned_cols=246  Identities=27%  Similarity=0.428  Sum_probs=199.0

Q ss_pred             hhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcc-cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          191 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      ...+.||+|++|.||++..+ +++.+++|++..... ..+.+.+|+..+++++|+|++++++++..+...++++||++++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~   82 (253)
T cd05122           3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG   82 (253)
T ss_pred             eeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence            34678999999999999865 789999999977443 5678999999999999999999999999999999999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      +|.+++...   ...+++..+..++.|++.||++||.   .+++|+||+|+||++++++.++|+|||.+........   
T Consensus        83 ~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---  153 (253)
T cd05122          83 SLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---  153 (253)
T ss_pred             cHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence            999987322   2578999999999999999999998   6999999999999999999999999999876654432   


Q ss_pred             eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchh
Q 010434          349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEI  428 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  428 (511)
                      .....++..|+|||.+...  ..+.++||||||+++++|++|+.|+.......       ..... .........    .
T Consensus       154 ~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~-~~~~~~~~~----~  219 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGK--PYDYKADIWSLGITAIELAEGKPPYSELPPMK-------ALFKI-ATNGPPGLR----N  219 (253)
T ss_pred             ccceecCCcccCHHHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCchHH-------HHHHH-HhcCCCCcC----c
Confidence            2334588999999998765  57899999999999999999999986532111       01111 111111111    1


Q ss_pred             HHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          429 ESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       429 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ...++..+.+++..||+.||++|||+.++++
T Consensus       220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1113567889999999999999999999985

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.2e-35  Score=290.62  Aligned_cols=246  Identities=22%  Similarity=0.309  Sum_probs=195.8

Q ss_pred             cCcCCcEEEEEEEec-CCcEEEEEEeccCcc----cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCc
Q 010434          196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL  270 (511)
Q Consensus       196 LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  270 (511)
                      ||+|+||.||+++.. +|+.+|+|.+.....    ..+.+.+|+.++++++||||+++++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999965 599999999866432    346788999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC-----
Q 010434          271 DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-----  345 (511)
Q Consensus       271 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~-----  345 (511)
                      .+++.    ....+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++........     
T Consensus        81 ~~~l~----~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLE----NVGSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            99883    22378999999999999999999998   6999999999999999999999999999875443321     


Q ss_pred             -ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          346 -FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       346 -~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                       ........++..|+|||.....  ..+.++||||||++++||++|+.|+......        ........+. .....
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~-~~~~~  222 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQ--GHSKTVDWWSLGCILYEFLVGIPPFHGETPE--------EIFQNILNGK-IEWPE  222 (265)
T ss_pred             ccccccCcccCccccCHHHhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhcCC-cCCCc
Confidence             0122334578899999998765  5788999999999999999999998654321        1122222211 11110


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      .    ...+..+..++.+||+.+|++|||+.++.+.|+-
T Consensus       223 ~----~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         223 D----VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             c----ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence            0    0135678899999999999999999777776653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.8e-35  Score=292.83  Aligned_cols=248  Identities=27%  Similarity=0.360  Sum_probs=199.4

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      +.+.+.||+|++|.||+|..+ +++.+|+|.+.......+.+.+|++.+++++|+|++++++.+..+...++++||++++
T Consensus        21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~  100 (286)
T cd06614          21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG  100 (286)
T ss_pred             chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence            344578999999999999866 6899999999775545678999999999999999999999999999999999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      +|.+++...   ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++........  .
T Consensus       101 ~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~  172 (286)
T cd06614         101 SLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--K  172 (286)
T ss_pred             cHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--h
Confidence            999998322   2479999999999999999999998   6999999999999999999999999998875543321  1


Q ss_pred             eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchh
Q 010434          349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEI  428 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  428 (511)
                      .....++..|+|||.+.+.  .++.++|+||||+++|+|++|+.|+.......        .............    ..
T Consensus       173 ~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~----~~  238 (286)
T cd06614         173 RNSVVGTPYWMAPEVIKRK--DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--------ALFLITTKGIPPL----KN  238 (286)
T ss_pred             hccccCCcccCCHhHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcCCCCC----cc
Confidence            1233478899999998764  67899999999999999999999976432111        0111111111111    11


Q ss_pred             HHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          429 ESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       429 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ...++..+.+++.+||+.+|.+|||+.++++
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            2224567889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.2e-35  Score=296.42  Aligned_cols=261  Identities=21%  Similarity=0.268  Sum_probs=194.3

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccC--CceeEEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVY  262 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~lV~  262 (511)
                      .+.+.+.||+|+||.||+|..+ +++.+|+|.++....   ....+.+|+.++++++||||+++.+++...  ...++||
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~   85 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM   85 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence            4566789999999999999865 688999999975322   234578899999999999999999998776  8899999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||++ ++|.+++..   ....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++....
T Consensus        86 e~~~-~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          86 EYVE-HDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             hhcC-cCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            9996 588887732   22468999999999999999999998   6999999999999999999999999999986654


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc-------chhhHHhhh
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF-------PSWVYDQLN  415 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~~  415 (511)
                      ...  ......++..|+|||.+.+. ..++.++|+||||+++|||++|+.|+...........+       ....+....
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
T cd07843         159 PLK--PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS  235 (293)
T ss_pred             Ccc--ccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence            321  12334578899999988653 34688999999999999999999998643221100000       000000000


Q ss_pred             c---CC-----cccccc-cchhHHH-HHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          416 K---GG-----DLELRN-VTEIESV-IARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       416 ~---~~-----~~~~~~-~~~~~~~-~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .   ..     ...... ....... ++..+.+++.+||+.+|++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            0   00     000000 0001111 3567889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.6e-35  Score=293.87  Aligned_cols=262  Identities=22%  Similarity=0.314  Sum_probs=196.4

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      +.+.++||.|++|.||+|+.+ +|+.||||.++...  ...+.+.+|+.++++++|+||+++++++...+..++||||++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD   81 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence            345689999999999999964 68999999987632  245678899999999999999999999999999999999997


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      + +|.+++.... ....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++....... 
T Consensus        82 ~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          82 K-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             c-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            5 7877763322 23568999999999999999999998   6999999999999999999999999999975433211 


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc-------chhhHHhhhcCCc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF-------PSWVYDQLNKGGD  419 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~~~~~~  419 (511)
                       ......++..|+|||.+.+. ..++.++||||||+++|||++|+.|+............       ....+..+.....
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             -ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence             11234578899999988653 35688999999999999999999998653321100000       0000011110000


Q ss_pred             c--ccc-----ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          420 L--ELR-----NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       420 ~--~~~-----~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .  ...     .........+..+.+++.+|++.||.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0  000     001122234667889999999999999999999975

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=6.2e-35  Score=295.32  Aligned_cols=248  Identities=26%  Similarity=0.336  Sum_probs=194.6

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc----cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +...+.||+|+||.||+++. .++..+|+|.+.....    ....+.+|+.++++++|+|++++++++.++...++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            44467899999999999985 4689999999865321    235688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      ++ |+|.+.+.   ....++++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++...... 
T Consensus       107 ~~-g~l~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-  178 (317)
T cd06635         107 CL-GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-  178 (317)
T ss_pred             CC-CCHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence            96 57766653   234568999999999999999999998   69999999999999999999999999998754322 


Q ss_pred             CceeeccccCCccccchhcccc-cCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          345 DFVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~-~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                           ....++..|+|||.+.. ..+.++.++||||||+++|||++|+.|+.......        ....+........ 
T Consensus       179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~-  244 (317)
T cd06635         179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNESPTL-  244 (317)
T ss_pred             -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--------HHHHHHhccCCCC-
Confidence                 23458889999998743 22468899999999999999999999875432111        1111111111111 


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                          .....+..+.+++.+||+.+|.+||++.++++.+.-
T Consensus       245 ----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         245 ----QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             ----CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence                112344668899999999999999999999986654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.9e-35  Score=294.78  Aligned_cols=260  Identities=23%  Similarity=0.296  Sum_probs=189.8

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      |.+.++||+|+||.||+|.. .+|+.||+|.+....  .....+.+|+.++++++|+||+++.+++..+...++|+||++
T Consensus         7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~   86 (291)
T cd07870           7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH   86 (291)
T ss_pred             eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence            44567899999999999985 468999999986532  233467899999999999999999999999999999999995


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                       ++|.+++..   ....+++..+..++.|++.||+|||+   .+|+|+||||+||+++.++.+||+|||+++....... 
T Consensus        87 -~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  158 (291)
T cd07870          87 -TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-  158 (291)
T ss_pred             -CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-
Confidence             677666532   22467888999999999999999998   6999999999999999999999999999875433221 


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc-------ccc-hhhHHhhhcCC
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA-------YFP-SWVYDQLNKGG  418 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~-------~~~-~~~~~~~~~~~  418 (511)
                       ......++..|+|||.+.+. ..++.++||||||+++|||++|+.||..........       ..+ ......+....
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         159 -TYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             -CCCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence             11333478899999998653 257789999999999999999999986432110000       000 00000000000


Q ss_pred             c--cc------ccccchhHH--HHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          419 D--LE------LRNVTEIES--VIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       419 ~--~~------~~~~~~~~~--~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .  ..      .........  ..+..+.+++.+|++.||++|||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            0  00      000000000  01356778999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.3e-35  Score=294.04  Aligned_cols=243  Identities=27%  Similarity=0.342  Sum_probs=191.7

Q ss_pred             cCcCCcEEEEEEEe-cCCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCc
Q 010434          196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL  270 (511)
Q Consensus       196 LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  270 (511)
                      ||+|+||+||++.. .+|+.+|+|.+....    ...+.+.+|+.++++++||||+++.+.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999974 468999999986532    2345678899999999999999999999999999999999999999


Q ss_pred             ccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeec
Q 010434          271 DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  350 (511)
Q Consensus       271 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  350 (511)
                      .+++...  ....+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++.......   ...
T Consensus        81 ~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~  152 (277)
T cd05577          81 KYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIK  152 (277)
T ss_pred             HHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccc
Confidence            9888432  22468999999999999999999998   699999999999999999999999999987654322   123


Q ss_pred             cccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHH
Q 010434          351 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  430 (511)
Q Consensus       351 ~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  430 (511)
                      ...++..|+|||.+.+.  .++.++||||||+++++|++|+.||.........        ..+......   .......
T Consensus       153 ~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--------~~~~~~~~~---~~~~~~~  219 (277)
T cd05577         153 GRAGTPGYMAPEVLQGE--VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK--------EELKRRTLE---MAVEYPD  219 (277)
T ss_pred             cccCCCCcCCHHHhcCC--CCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH--------HHHHhcccc---ccccCCc
Confidence            34578899999998764  6889999999999999999999998654321110        011111000   0111223


Q ss_pred             HHHHHHHHHHHHhcCcCCCCCC-----CHHHHHH
Q 010434          431 VIARKLCMIGLWCIQVKAADRP-----SMTKVLE  459 (511)
Q Consensus       431 ~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~  459 (511)
                      .++..+.+++.+||+.+|.+||     ++.++++
T Consensus       220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            3467788999999999999999     6666764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.6e-35  Score=296.56  Aligned_cols=265  Identities=23%  Similarity=0.273  Sum_probs=194.1

Q ss_pred             HHHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccCC-----
Q 010434          186 IAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS-----  256 (511)
Q Consensus       186 ~~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~-----  256 (511)
                      ....+.+.++||+|+||.||+|..+ +|+.||+|.++..   ......+.+|+.++++++||||+++++++.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            3445667789999999999999965 6899999998653   223457789999999999999999999987654     


Q ss_pred             -----ceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeee
Q 010434          257 -----KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKV  331 (511)
Q Consensus       257 -----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl  331 (511)
                           ..++|+||+++ ++.+.+..   ....+++..+..++.|++.||+|||+   .+|+|+||||+||++++++.+||
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEe
Confidence                 78999999976 66665522   23578999999999999999999998   69999999999999999999999


Q ss_pred             ecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccch---
Q 010434          332 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPS---  408 (511)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~---  408 (511)
                      +|||++........ .......++..|+|||.+.+. ...+.++||||||+++|||++|+.|+...........+..   
T Consensus       158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~  235 (302)
T cd07864         158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG  235 (302)
T ss_pred             CcccccccccCCcc-cccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            99999986654332 111223467889999988643 3568899999999999999999999864321110000000   


Q ss_pred             ----hhHHhhhcCCcc--------cccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          409 ----WVYDQLNKGGDL--------ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       409 ----~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                          ..+..+.+....        ...........++..+.+++.+||+.+|.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                000000000000        000000011124577899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.8e-35  Score=294.31  Aligned_cols=253  Identities=26%  Similarity=0.323  Sum_probs=190.9

Q ss_pred             hccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc--ccHHHHHHHHHHhcccc-ccceEEeeceeccCCceeEEEeecCC
Q 010434          192 FTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK--FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       192 ~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      +.++||+|+||.||++.. .+++.+|+|.+....  .....+.+|+.++.++. |+||+++++++..+...+++|||++ 
T Consensus         8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-   86 (288)
T cd06616           8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-   86 (288)
T ss_pred             HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-
Confidence            356899999999999985 468999999986532  33457899999999996 9999999999998899999999985 


Q ss_pred             CCccccccc-CCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          268 GSLDRHIFP-KENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       268 gsL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +++.++... .......+++..+..++.+++.||+|||+.  .+++||||||+||+++.++.+||+|||+++....... 
T Consensus        87 ~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-  163 (288)
T cd06616          87 ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA-  163 (288)
T ss_pred             CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc-
Confidence            455443210 112236799999999999999999999973  5899999999999999999999999999976543221 


Q ss_pred             eeeccccCCccccchhcccccC-CCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          347 VSISATRGTIGYIAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~-~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                        .....|+..|+|||.+.+.. ..++.++||||||+++|||++|+.||......      ...+. .........+.  
T Consensus       164 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~-~~~~~~~~~~~--  232 (288)
T cd06616         164 --KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV------FDQLT-QVVKGDPPILS--  232 (288)
T ss_pred             --cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH------HHHHh-hhcCCCCCcCC--
Confidence              12335888999999986531 25788999999999999999999998643200      00011 11111111111  


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ......++..+.+++.+||+.+|++|||+.+|++
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111235667899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.3e-35  Score=287.41  Aligned_cols=240  Identities=24%  Similarity=0.319  Sum_probs=192.8

Q ss_pred             cCcCCcEEEEEEEec-CCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCc
Q 010434          196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL  270 (511)
Q Consensus       196 LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  270 (511)
                      ||.|+||.||+++.. +++.+|+|.+....    ...+.+.+|+.++++++||||+++++++.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999864 58999999986532    2346799999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeec
Q 010434          271 DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  350 (511)
Q Consensus       271 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  350 (511)
                      .+++.    ....+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||+++......   ...
T Consensus        81 ~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~  150 (262)
T cd05572          81 WTILR----DRGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW  150 (262)
T ss_pred             HHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence            99883    23458999999999999999999998   699999999999999999999999999998665432   112


Q ss_pred             cccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhc-CCcccccccchhH
Q 010434          351 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK-GGDLELRNVTEIE  429 (511)
Q Consensus       351 ~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  429 (511)
                      ...++..|+|||.+...  .++.++|+||||+++|+|++|..|+.......      ......... .....      .+
T Consensus       151 ~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~------~~  216 (262)
T cd05572         151 TFCGTPEYVAPEIILNK--GYDFSVDYWSLGILLYELLTGRPPFGEDDEDP------MEIYNDILKGNGKLE------FP  216 (262)
T ss_pred             cccCCcCccChhHhcCC--CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH------HHHHHHHhccCCCCC------CC
Confidence            33578899999998754  67899999999999999999999986543211      111121111 11111      11


Q ss_pred             HHHHHHHHHHHHHhcCcCCCCCCC-----HHHHHH
Q 010434          430 SVIARKLCMIGLWCIQVKAADRPS-----MTKVLE  459 (511)
Q Consensus       430 ~~~~~~l~~l~~~Cl~~~P~~RPs-----~~evl~  459 (511)
                      ...+..+..++.+||+.+|++||+     +.|+++
T Consensus       217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            222567899999999999999999     666664

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-35  Score=291.53  Aligned_cols=259  Identities=21%  Similarity=0.266  Sum_probs=197.9

Q ss_pred             hhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          191 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .+.+.||+|++|.||++..+ +|+.+|+|.+.....   ....+.+|+.++++++|+||+++++++..+...++|+||++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (283)
T cd05118           2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD   81 (283)
T ss_pred             ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence            34678999999999999854 789999999866432   35678899999999999999999999999999999999997


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      + +|.+++..   ....+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||.+.......  
T Consensus        82 ~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--  152 (283)
T cd05118          82 T-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--  152 (283)
T ss_pred             C-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence            5 77777632   23579999999999999999999998   699999999999999999999999999997665443  


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc-------cchhhHHhhhc---
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY-------FPSWVYDQLNK---  416 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~-------~~~~~~~~~~~---  416 (511)
                      .......++..|+|||.+.+. ...+.++|+||||+++|+|++|+.||...........       .....+....+   
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR  231 (283)
T ss_pred             ccccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence            112334578899999998653 3678999999999999999999988854332110000       00000000000   


Q ss_pred             -----CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          417 -----GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       417 -----~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                           ...............++.++.+++..||+.||.+||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                 0000011112234456788999999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.5e-35  Score=285.77  Aligned_cols=249  Identities=28%  Similarity=0.430  Sum_probs=202.5

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      +.+.+.||.|+||.||++... +++.+|+|.+....   ...+.+.+|++++++++|+|++++.+.+..+...++|+||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~   81 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA   81 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence            345678999999999999854 68999999987643   34567899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++++|.+++......+..+++..+..++.+++.||.|||+   .+++|+||+|+||++++++.++|+|||++........
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  158 (258)
T cd08215          82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD  158 (258)
T ss_pred             CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence            9999999885443335789999999999999999999998   6999999999999999999999999999986654431


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                        ......|++.|+|||.+.+.  .++.++|+||+|+++++|++|+.|++.....        .+...........    
T Consensus       159 --~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~----  222 (258)
T cd08215         159 --LAKTVVGTPYYLSPELCQNK--PYNYKSDIWSLGCVLYELCTLKHPFEGENLL--------ELALKILKGQYPP----  222 (258)
T ss_pred             --eecceeeeecccChhHhccC--CCCccccHHHHHHHHHHHHcCCCCCCCCcHH--------HHHHHHhcCCCCC----
Confidence              22334588999999988764  6889999999999999999999998654311        1222222221111    


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                        .+...+..+.+++.+||+.+|++|||+.++++
T Consensus       223 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         223 --IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             --CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              11134567889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.9e-35  Score=301.30  Aligned_cols=263  Identities=18%  Similarity=0.244  Sum_probs=195.1

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceecc----CCceeE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRAL  260 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~----~~~~~l  260 (511)
                      .+.+.+.||+|+||.||+|.. .+|+.||+|.+....   ...+.+.+|+.++++++||||+++++++..    ....++
T Consensus         6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l   85 (334)
T cd07855           6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV   85 (334)
T ss_pred             ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence            345567899999999999984 479999999986532   244678889999999999999999998753    356899


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      |+||+. ++|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+||++++++.+||+|||+++..
T Consensus        86 v~e~~~-~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          86 VMDLME-SDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEehhh-hhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            999995 68888772    33569999999999999999999998   69999999999999999999999999999765


Q ss_pred             CCCCCce--eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc--------cccc---
Q 010434          341 PKENDFV--SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK--------AYFP---  407 (511)
Q Consensus       341 ~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~--------~~~~---  407 (511)
                      .......  ......++..|+|||.+.+. ..++.++||||||+++|||++|+.||........-        ...+   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            4332211  11234688999999998653 35789999999999999999999998653211000        0000   


Q ss_pred             -----hhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          408 -----SWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       408 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                           ..+......................+..+.+++.+||+.+|.+|||+.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                 00000000000000000111223346789999999999999999999999874

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.2e-35  Score=301.11  Aligned_cols=263  Identities=21%  Similarity=0.258  Sum_probs=194.9

Q ss_pred             HHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC---cccHHHHHHHHHHhccc-cccceEEeeceeccC--CceeE
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS---KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEG--SKRAL  260 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~--~~~~l  260 (511)
                      ..+.+.++||+|+||.||+|... +|+.+|||.+...   ......+.+|+.+++++ +||||+++++++...  ...++
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            45667789999999999999864 6889999988542   22345678899999999 999999999988543  46799


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      ||||++ ++|..++.    . ..+++..+..++.||+.||+|||+   .+|+|+||||+||+++.++.+||+|||+++..
T Consensus        87 v~e~~~-~~L~~~~~----~-~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          87 VFEYME-TDLHAVIR----A-NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             Eecccc-cCHHHHHh----c-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            999996 58888772    1 278899999999999999999998   69999999999999999999999999999866


Q ss_pred             CCCCCc---eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc-------ccchhh
Q 010434          341 PKENDF---VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA-------YFPSWV  410 (511)
Q Consensus       341 ~~~~~~---~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~-------~~~~~~  410 (511)
                      ......   .......|+..|+|||.+.+. ..++.++||||||+++|||++|+.|+..........       ..+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            443321   122334588999999987653 467889999999999999999999986432111000       000000


Q ss_pred             HH---------hhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          411 YD---------QLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       411 ~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      ..         .+.................++..+.+++.+||+.+|++|||+.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            00         000000000011111222246778999999999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.9e-35  Score=300.30  Aligned_cols=263  Identities=21%  Similarity=0.282  Sum_probs=195.3

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccC-----CceeE
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRAL  260 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~-----~~~~l  260 (511)
                      |.+.+.||+|+||.||+++. .+++.||||.+...   ......+.+|+.++++++|+||+++++++...     ...++
T Consensus         7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l   86 (337)
T cd07858           7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI   86 (337)
T ss_pred             eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence            45567899999999999984 57899999998652   23445778999999999999999999988654     34799


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      |+||+. ++|.+++.    ....+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++..
T Consensus        87 v~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          87 VYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            999995 68887772    34579999999999999999999998   69999999999999999999999999999865


Q ss_pred             CCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc--------cch-h--
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY--------FPS-W--  409 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~--------~~~-~--  409 (511)
                      .....  ......++..|+|||.+.+. ..++.++||||||+++|+|++|+.||...........        .+. +  
T Consensus       159 ~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         159 SEKGD--FMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             CCCcc--cccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            44321  12334578899999987643 2578999999999999999999999864321100000        000 0  


Q ss_pred             -----hHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH--Hhc
Q 010434          410 -----VYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM--LEG  463 (511)
Q Consensus       410 -----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~--Le~  463 (511)
                           ......................++..+.+++.+||+.+|++|||+.++++.  ++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~  296 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS  296 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence                 000000000000000111223456788999999999999999999999875  544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.6e-35  Score=295.24  Aligned_cols=262  Identities=17%  Similarity=0.180  Sum_probs=193.0

Q ss_pred             ccccCcCCcEEEEEEEecCCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCC
Q 010434          193 THKLGQGGFGSVYKGQLHTGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGS  269 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  269 (511)
                      .+.+|.|+++.||+++. +++.||||++...   ....+.+.+|+.++++++|+||+++++++.+....+++|||+++|+
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34456666666666655 6899999998653   3345679999999999999999999999999999999999999999


Q ss_pred             cccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc---
Q 010434          270 LDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF---  346 (511)
Q Consensus       270 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~---  346 (511)
                      |.+++...  ....+++..+..++.|++.||+|||+   .+|+|+||||+||+++.++.+||+|||.+.........   
T Consensus        86 l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          86 CEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             HHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            99988422  23468899999999999999999998   69999999999999999999999999988654322110   


Q ss_pred             --eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccc-----ccccchhhHH----h--
Q 010434          347 --VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSS-----KAYFPSWVYD----Q--  413 (511)
Q Consensus       347 --~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~-----~~~~~~~~~~----~--  413 (511)
                        .......++..|+|||.+......++.++||||||+++|||++|+.||........     ....+.+...    .  
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE  240 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence              11123347789999999876544678899999999999999999999875321110     0000000000    0  


Q ss_pred             --hhc------CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          414 --LNK------GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       414 --~~~------~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                        ...      ...............++..+.+++.+||+.||++|||++++++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence              000      00000001112334456788899999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5.9e-35  Score=293.23  Aligned_cols=263  Identities=24%  Similarity=0.306  Sum_probs=189.5

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCC--------
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS--------  256 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~--------  256 (511)
                      .+.+.++||+|+||.||++... +++.||||.+....   .....+.+|+.++++++||||+++++++....        
T Consensus        13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   92 (310)
T cd07865          13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG   92 (310)
T ss_pred             heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence            4566789999999999999854 68999999986422   22345678999999999999999999986543        


Q ss_pred             ceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccc
Q 010434          257 KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGL  336 (511)
Q Consensus       257 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGl  336 (511)
                      ..++||||++ ++|.+.+.   .....+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+
T Consensus        93 ~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          93 SFYLVFEFCE-HDLAGLLS---NKNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             eEEEEEcCCC-cCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCC
Confidence            3599999996 47777662   223468999999999999999999998   6999999999999999999999999999


Q ss_pred             cccCCCCCCc--eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc-------ccc
Q 010434          337 AKFHPKENDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA-------YFP  407 (511)
Q Consensus       337 a~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~-------~~~  407 (511)
                      +.........  .......++..|+|||.+.+. ..++.++||||||+++|||++|+.|+..........       .++
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9865433211  111234578899999988653 346789999999999999999999886543211000       000


Q ss_pred             hhhHHhhhc---CCccccccc--chhHH-----HHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          408 SWVYDQLNK---GGDLELRNV--TEIES-----VIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       408 ~~~~~~~~~---~~~~~~~~~--~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ..+......   .........  .....     .....+.+++.+||+.||.+|||++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            000000000   000000000  00000     11345678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-36  Score=306.12  Aligned_cols=239  Identities=27%  Similarity=0.421  Sum_probs=195.7

Q ss_pred             cccCcCCcEEEEEEE-ecCCcEEEEEEeccC-cc---cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          194 HKLGQGGFGSVYKGQ-LHTGRLIAVKMLENS-KF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~-~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      +.||.|+||-||.+. ..+.+.||||++..+ +.   .-++.+.||..|.+++|||++.+.|++..+...+|||||| -|
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG  110 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG  110 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence            469999999999998 457899999998653 22   3467899999999999999999999999999999999999 56


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      |-.|++.   -..+++.+..+..|..+.+.||+|||+   ++.||||||+.||||++.|.+||+|||.|......++   
T Consensus       111 SAsDlle---VhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAns---  181 (948)
T KOG0577|consen  111 SASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANS---  181 (948)
T ss_pred             cHHHHHH---HHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCchhc---
Confidence            8888773   345789999999999999999999999   7999999999999999999999999999987655544   


Q ss_pred             eccccCCccccchhcccc-cCCCcCccchHHHHHHHHHHHHhCCCCCC-cccccccccccchhhHHhhhcCCcccccccc
Q 010434          349 ISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSN-MNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~-~~~~~s~ksDVwS~Gvll~elltg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                         .+|||.|||||++.. ..|.|+-|+||||+|++..||...++|.- +++...        +|. +.+...+.+.   
T Consensus       182 ---FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA--------LYH-IAQNesPtLq---  246 (948)
T KOG0577|consen  182 ---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYH-IAQNESPTLQ---  246 (948)
T ss_pred             ---ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH--------HHH-HHhcCCCCCC---
Confidence               459999999998743 23789999999999999999999998853 333221        222 2222222222   


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                        ..+-+..++.++..||+.-|.+|||..+++.
T Consensus       247 --s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  247 --SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             --CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence              2334567889999999999999999888774

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2e-35  Score=294.29  Aligned_cols=255  Identities=22%  Similarity=0.283  Sum_probs=198.3

Q ss_pred             hhhccccCcCCcEEEEEEEe----cCCcEEEEEEeccCc-----ccHHHHHHHHHHhccc-cccceEEeeceeccCCcee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL----HTGRLIAVKMLENSK-----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRA  259 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~----~~g~~vAvK~l~~~~-----~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~  259 (511)
                      +.+.+.||+|+||.||+++.    .++..+|||+++...     ...+.+.+|+.++.++ +||||+++.+.+..+...+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            34568899999999999974    357899999986532     2345688999999999 6999999999999999999


Q ss_pred             EEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      +||||+++|+|.+++.    ....+++..+..++.|+++||+|||+   .+++|+||||+||+++.++.++|+|||+++.
T Consensus        82 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          82 LILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            9999999999998873    23568999999999999999999998   6999999999999999999999999999876


Q ss_pred             CCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          340 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       340 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      ........ .....|+..|+|||.+.+.....+.++||||||+++|||++|+.|+........    .....+...... 
T Consensus       155 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----~~~~~~~~~~~~-  228 (288)
T cd05583         155 FLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS----QSEISRRILKSK-  228 (288)
T ss_pred             cccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch----HHHHHHHHHccC-
Confidence            54432211 123458899999999866433478899999999999999999999864321110    011111111110 


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                            ......++..+.+++.+||+.+|++|||+.++.+.|+-
T Consensus       229 ------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         229 ------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                  01122245668889999999999999999988887764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.6e-35  Score=293.98  Aligned_cols=260  Identities=18%  Similarity=0.220  Sum_probs=181.9

Q ss_pred             HHHHHhhhccccCcCCcEEEEEEEecC----CcEEEEEEeccCccc--H----------HHHHHHHHHhccccccceEEe
Q 010434          185 IIAVTNHFTHKLGQGGFGSVYKGQLHT----GRLIAVKMLENSKFS--A----------EEFINEVSTIGRIHHVNVVQL  248 (511)
Q Consensus       185 i~~~t~~~~~~LG~G~fg~Vykg~~~~----g~~vAvK~l~~~~~~--~----------~~f~~Ev~~l~~l~H~niv~l  248 (511)
                      +....+.+.++||+|+||.||+|...+    +..+|+|+.......  .          .....+...+..++|+|++++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            334456678899999999999998653    456777764332211  1          122344455667789999999


Q ss_pred             eceeccCC----ceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEc
Q 010434          249 LGFCSEGS----KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD  324 (511)
Q Consensus       249 ~g~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~  324 (511)
                      ++++....    ..++++|++. .++.+.+.    .....++..+..++.|++.||+|||+   .+|+||||||+|||++
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~  160 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFK----RIKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVD  160 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhc-cCHHHHHH----hhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEc
Confidence            98765433    3457777763 34544441    12345788899999999999999998   6999999999999999


Q ss_pred             CCCCeeeecccccccCCCCCCc-----eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccc
Q 010434          325 HNFIPKVSDFGLAKFHPKENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAI  399 (511)
Q Consensus       325 ~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~  399 (511)
                      .++.+||+|||+++........     .......||+.|+|||++.+.  .++.++||||||+++|||++|+.||.....
T Consensus       161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~--~~~~~~DiwSlG~~l~el~~g~~P~~~~~~  238 (294)
T PHA02882        161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA--CVTRRGDLESLGYCMLKWAGIKLPWKGFGH  238 (294)
T ss_pred             CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence            9999999999999865432211     111234699999999998765  789999999999999999999999975422


Q ss_pred             ccccccc-chhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          400 RSSKAYF-PSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       400 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                      ....... .......+.++. ..       ....++.+.+++..|++.+|++||++.++++.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~-~~-------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        239 NGNLIHAAKCDFIKRLHEGK-IK-------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             chHHHHHhHHHHHHHhhhhh-hc-------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            1110000 000111111111 01       1123467889999999999999999999998763

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.5e-35  Score=293.33  Aligned_cols=261  Identities=21%  Similarity=0.290  Sum_probs=191.8

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      +++.++||+|++|.||+|..+ +|+.||+|.+....   ...+.+.+|+.++++++|+||+++++++..+...++||||+
T Consensus         4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (294)
T PLN00009          4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL   83 (294)
T ss_pred             eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence            456789999999999999864 78999999986532   23457889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC-CCCeeeecccccccCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~-~~~~kl~DFGla~~~~~~~  344 (511)
                      + ++|.+++..  .....+++..+..++.||+.||+|||+   .+++|+||+|+||+++. ++.+||+|||+++......
T Consensus        84 ~-~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         84 D-LDLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             c-ccHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            5 577776622  223346888999999999999999998   69999999999999985 5679999999997654322


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc-------chhhHHh----
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF-------PSWVYDQ----  413 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~-------~~~~~~~----  413 (511)
                      .  ......+++.|+|||.+.+. ..++.++||||||+++|+|++|+.|+............       ....+..    
T Consensus       158 ~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        158 R--TFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             c--ccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence            1  11234578899999988653 35788999999999999999999998643221100000       0000000    


Q ss_pred             --hhc-CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          414 --LNK-GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       414 --~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                        ... ...............++..+.+++.+|++.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence              000 0000000001112234567889999999999999999999986

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.7e-35  Score=296.54  Aligned_cols=263  Identities=21%  Similarity=0.281  Sum_probs=193.2

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccC--CceeEEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVY  262 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~lV~  262 (511)
                      .+.+.++||+|+||.||+|.. .+|+.||+|.+.....   ....+.+|+.++++++|+||+++++++.+.  +..++||
T Consensus         8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   87 (309)
T cd07845           8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM   87 (309)
T ss_pred             ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence            345678899999999999985 4689999999865322   233567899999999999999999998654  5689999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+. ++|.+++..   ....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++....
T Consensus        88 e~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          88 EYCE-QDLASLLDN---MPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             ecCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            9996 478777632   23578999999999999999999999   6999999999999999999999999999986644


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc-------chhhHHhhh
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF-------PSWVYDQLN  415 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~~  415 (511)
                      ...  ......++..|+|||.+.+. ..++.++||||||+++|||++|+.|+............       ....+....
T Consensus       161 ~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         161 PAK--PMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             ccC--CCCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            321  12333467889999998653 35788999999999999999999998643221100000       000000000


Q ss_pred             cC---Ccccc-----cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHH
Q 010434          416 KG---GDLEL-----RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEML  461 (511)
Q Consensus       416 ~~---~~~~~-----~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L  461 (511)
                      ..   .....     ..........++.+.+++.+||+.||++|||+.++++.-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~  291 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS  291 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            00   00000     000011122467788999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-35  Score=290.64  Aligned_cols=264  Identities=23%  Similarity=0.327  Sum_probs=193.7

Q ss_pred             hhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhcc--ccccceEEeeceeccC----CceeEEEe
Q 010434          190 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGR--IHHVNVVQLLGFCSEG----SKRALVYE  263 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~--l~H~niv~l~g~~~~~----~~~~lV~e  263 (511)
                      -.+.+.||+|.||.||+|.+. |..||||++..  .+.+.+.+|.++.+.  |+|+||+.+++.=..+    ..++||.+
T Consensus       213 I~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s--rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd  289 (513)
T KOG2052|consen  213 IVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS--RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD  289 (513)
T ss_pred             eEEEEEecCccccceeecccc-CCceEEEEecc--cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence            345678999999999999998 89999999854  345678888888776  4999998888754332    35789999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHh-----CCCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN-----GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-----~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      |.++|||.|+|     ...+++.+..++++..+|.||++||.     +..+.|.|||||+.|||+..|+.+.|+|+|||-
T Consensus       290 YHe~GSL~DyL-----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv  364 (513)
T KOG2052|consen  290 YHEHGSLYDYL-----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  364 (513)
T ss_pred             cccCCcHHHHH-----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence            99999999999     33789999999999999999999995     235679999999999999999999999999998


Q ss_pred             cCCCCCCce--eeccccCCccccchhcccccCCC----cCccchHHHHHHHHHHHHhCC----------CCCCccccccc
Q 010434          339 FHPKENDFV--SISATRGTIGYIAPELISRNFGT----VSCKSDVYGFGMVLLEMAGGR----------RNSNMNAIRSS  402 (511)
Q Consensus       339 ~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~----~s~ksDVwS~Gvll~elltg~----------~p~~~~~~~~~  402 (511)
                      ......+..  .....+||.+|||||++......    .-..+||||||.++||++-.-          .||......+ 
T Consensus       365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D-  443 (513)
T KOG2052|consen  365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD-  443 (513)
T ss_pred             EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC-
Confidence            766553322  23456799999999998653211    113589999999999998421          2332211111 


Q ss_pred             ccccchhhHHhh-hcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          403 KAYFPSWVYDQL-NKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       403 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                       ..+.+ +.+.+ .+..++.+++. ....+....+.+++..||..||.-|-|+-.+-+.|....
T Consensus       444 -Ps~ee-MrkVVCv~~~RP~ipnr-W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  444 -PSFEE-MRKVVCVQKLRPNIPNR-WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             -CCHHH-HhcceeecccCCCCCcc-cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence             11000 01110 11112222221 133445677889999999999999999988888877644

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=7.7e-35  Score=296.02  Aligned_cols=261  Identities=20%  Similarity=0.286  Sum_probs=191.6

Q ss_pred             cccCcC--CcEEEEEEEe-cCCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          194 HKLGQG--GFGSVYKGQL-HTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G--~fg~Vykg~~-~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      ..||+|  +||+||+++. .+|+.||+|++.....   ..+.+.+|+.+++.++||||+++++++..+...++|+||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  9999999985 4799999999875332   235788999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      ++|.+++...  ....+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+|++||+.+..........
T Consensus        84 ~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          84 GSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            9999887432  23458999999999999999999998   699999999999999999999999998654322211110


Q ss_pred             e-----eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc------cccchhh------
Q 010434          348 S-----ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK------AYFPSWV------  410 (511)
Q Consensus       348 ~-----~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~------~~~~~~~------  410 (511)
                      .     .....++..|+|||++.+....++.++||||||+++|||++|+.|+.........      ..+..+.      
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence            0     0112356679999999765456789999999999999999999998653211100      0000000      


Q ss_pred             -HHhhh-----------cC-----Ccccc---cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          411 -YDQLN-----------KG-----GDLEL---RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       411 -~~~~~-----------~~-----~~~~~---~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                       .....           +.     .....   ..........+..+.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence             00000           00     00000   0011123446678999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-35  Score=288.27  Aligned_cols=243  Identities=23%  Similarity=0.253  Sum_probs=189.0

Q ss_pred             cccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc----cHHHHHHHHHH-hccccccceEEeeceeccCCceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF----SAEEFINEVST-IGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~----~~~~f~~Ev~~-l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      +.||+|+||.||++.. .+|+.||||++.....    ....+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4689999999999985 4689999999865332    12234555544 4455899999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      ++|.+++.    ....+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||+++.....    
T Consensus        82 ~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----  150 (260)
T cd05611          82 GDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----  150 (260)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceecccc----
Confidence            99999882    33568999999999999999999998   69999999999999999999999999998754331    


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                        ....++..|+|||.+.+.  .++.++||||||+++|||++|..|+......        ............   ....
T Consensus       151 --~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~---~~~~  215 (260)
T cd05611         151 --KKFVGTPDYLAPETILGV--GDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--------AVFDNILSRRIN---WPEE  215 (260)
T ss_pred             --ccCCCCcCccChhhhcCC--CCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhcccC---CCCc
Confidence              233578899999998765  5789999999999999999999998643221        111222111110   0111


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                      ....++..+.+++.+||+.+|++||++.++.+.|.
T Consensus       216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            22235677899999999999999998876666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.5e-35  Score=292.49  Aligned_cols=251  Identities=22%  Similarity=0.353  Sum_probs=191.7

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc--ccHHHHHHHHHHhcccc-ccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK--FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      +.+.++||+|+||.||+|+.+ +++.||||.++...  ....++..|+.++.+.+ |+||+++++++.++...+++|||+
T Consensus        17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   96 (296)
T cd06618          17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM   96 (296)
T ss_pred             heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence            456789999999999999976 48999999997643  23456777887777775 999999999999999999999998


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      + ++|.+++..   ....+++..+..++.|++.||+|||+.  .+|+|+||+|+||++++++.+||+|||++........
T Consensus        97 ~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          97 S-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             C-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence            5 466665522   234799999999999999999999973  4899999999999999999999999999876543221


Q ss_pred             ceeeccccCCccccchhcccccC--CCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~--~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                         .....++..|+|||.+.+..  +.++.++||||||+++|||++|+.|+.......      . ..............
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~-~~~~~~~~~~~~~~  240 (296)
T cd06618         171 ---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF------E-VLTKILQEEPPSLP  240 (296)
T ss_pred             ---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH------H-HHHHHhcCCCCCCC
Confidence               12334788999999987542  457889999999999999999999985421110      0 11111111111111


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      .    ...++..+.+++.+||+.+|.+||++.++++.
T Consensus       241 ~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         241 P----NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             C----CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1    11234678899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4e-35  Score=287.29  Aligned_cols=248  Identities=23%  Similarity=0.342  Sum_probs=194.3

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEecc------CcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLEN------SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~------~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      |.+.++||+|+||.||+++.. .+..+++|+++.      ......++..|+.++++++||||+++++++.+....++||
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            566789999999999999854 355566666643      1223346778999999999999999999999999999999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+++++|.+++......+..+++..+..++.|++.||.|||+   .+++|+||||+||++++ +.+||+|||+++....
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCC
Confidence            9999999998875433445689999999999999999999998   69999999999999976 4699999999876544


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                      ...  ......++..|+|||.+.+.  .++.++|+||||+++|+|++|+.|+......       . .......+...  
T Consensus       158 ~~~--~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-------~-~~~~~~~~~~~--  223 (260)
T cd08222         158 SCD--LATTFTGTPYYMSPEALKHQ--GYDSKSDIWSLGCILYEMCCLAHAFEGQNFL-------S-VVLRIVEGPTP--  223 (260)
T ss_pred             Ccc--cccCCCCCcCccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHH-------H-HHHHHHcCCCC--
Confidence            322  12334588899999988653  6788999999999999999999998542211       1 11111111111  


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                          ..+..++..+.+++.+||+.+|++||++.++++
T Consensus       224 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         224 ----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                123345677889999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.5e-36  Score=307.86  Aligned_cols=243  Identities=25%  Similarity=0.383  Sum_probs=200.4

Q ss_pred             hccccCcCCcEEEEEEEec-CCcEEEEEEecc-----CcccHHHHHHHHHHhccccccceEEeeceeccCCc--eeEEEe
Q 010434          192 FTHKLGQGGFGSVYKGQLH-TGRLIAVKMLEN-----SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK--RALVYE  263 (511)
Q Consensus       192 ~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~-----~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~--~~lV~e  263 (511)
                      |.++||+|+|-+||||... +|..||--.++.     +....+.|..|+.+|+.|+||||++++.++.+...  .-+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            4578999999999999753 677777544432     34445889999999999999999999999877655  668999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC-CCeeeecccccccCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPK  342 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~-~~~kl~DFGla~~~~~  342 (511)
                      .+..|+|..|+    .+-+.++...+..|+.||++||.|||+. +++|+|||||.+||+|+.+ |.+||+|+|||.....
T Consensus       124 L~TSGtLr~Y~----kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  124 LFTSGTLREYR----KKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             cccCCcHHHHH----HHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            99999999998    3446788899999999999999999985 6799999999999999765 8999999999997655


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                      ...    ....|||.|||||+...   .|....|||||||.++||+|+..|+.....       +..+|+.+..+..+..
T Consensus       199 s~a----ksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-------~AQIYKKV~SGiKP~s  264 (632)
T KOG0584|consen  199 SHA----KSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECTN-------PAQIYKKVTSGIKPAA  264 (632)
T ss_pred             ccc----ceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhCC-------HHHHHHHHHcCCCHHH
Confidence            432    22569999999999874   688999999999999999999999865432       4567888777754432


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                           +...-.+.+..++.+||.. .++|||+.|+|+
T Consensus       265 -----l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  265 -----LSKVKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             -----hhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence                 2222246788999999999 899999999987

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=8.3e-35  Score=291.09  Aligned_cols=242  Identities=26%  Similarity=0.355  Sum_probs=193.1

Q ss_pred             cccCcCCcEEEEEEEe-cCCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCcc
Q 010434          194 HKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLD  271 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  271 (511)
                      .+||+|+||.||++.. .+|+.||||.+.... .....+.+|+.++++++|+|++++++++..++..+++|||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            5799999999999986 478999999986533 34557899999999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeecc
Q 010434          272 RHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA  351 (511)
Q Consensus       272 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  351 (511)
                      +++.     ...+++..+..++.|++.|++|||+   .+++|+||+|+||++++++.++|+|||++........  ....
T Consensus       106 ~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~  175 (292)
T cd06657         106 DIVT-----HTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS  175 (292)
T ss_pred             HHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence            8762     2458999999999999999999998   6999999999999999999999999999875543221  1133


Q ss_pred             ccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHH
Q 010434          352 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESV  431 (511)
Q Consensus       352 ~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  431 (511)
                      ..++..|+|||.+.+.  .++.++|+||||+++|||++|..|+.......        ....+.........    ....
T Consensus       176 ~~~~~~y~~pE~~~~~--~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~--------~~~~~~~~~~~~~~----~~~~  241 (292)
T cd06657         176 LVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--------AMKMIRDNLPPKLK----NLHK  241 (292)
T ss_pred             cccCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhhCCcccC----Cccc
Confidence            4588999999988654  67889999999999999999999986432111        11111111111111    1112


Q ss_pred             HHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          432 IARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       432 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ++..+.+++.+||+.+|.+||++.++++
T Consensus       242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         242 VSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            3456788999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4e-35  Score=292.32  Aligned_cols=250  Identities=22%  Similarity=0.295  Sum_probs=194.5

Q ss_pred             hhccccCcCCcEEEEEEEe----cCCcEEEEEEeccCc-----ccHHHHHHHHHHhccc-cccceEEeeceeccCCceeE
Q 010434          191 HFTHKLGQGGFGSVYKGQL----HTGRLIAVKMLENSK-----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAL  260 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~----~~g~~vAvK~l~~~~-----~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~l  260 (511)
                      .+.++||+|+||.||+++.    .+|+.||+|++....     ...+.+.+|+.++.++ +|+||+++.+.+..+...++
T Consensus         3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (290)
T cd05613           3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL   82 (290)
T ss_pred             eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence            4567899999999999975    368999999986522     2346788999999999 69999999999999999999


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      |+||+++++|.+++.    ....+++..+..++.|++.||.|||+   .+++|+||+|+|||+++++.+||+|||+++..
T Consensus        83 v~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          83 ILDYINGGELFTHLS----QRERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            999999999999883    23568899999999999999999998   69999999999999999999999999999765


Q ss_pred             CCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcc
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDL  420 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (511)
                      ..... .......|+..|+|||.+.......+.++||||||+++|+|++|+.|+.........   .. +.+...... .
T Consensus       156 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~---~~-~~~~~~~~~-~  229 (290)
T cd05613         156 HEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ---AE-ISRRILKSE-P  229 (290)
T ss_pred             ccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH---HH-HHHHhhccC-C
Confidence            43221 111234588999999998754345788999999999999999999998643221110   11 111111111 0


Q ss_pred             cccccchhHHHHHHHHHHHHHHhcCcCCCCCC-----CHHHHHH
Q 010434          421 ELRNVTEIESVIARKLCMIGLWCIQVKAADRP-----SMTKVLE  459 (511)
Q Consensus       421 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~  459 (511)
                            .....++..+.+++.+||+.+|++||     ++.++++
T Consensus       230 ------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         230 ------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                  11223456788999999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=287.04  Aligned_cols=254  Identities=23%  Similarity=0.339  Sum_probs=191.2

Q ss_pred             hhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcc---cHHHHHHHHHHhccc---cccceEEeeceeccCCc-----e
Q 010434          191 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKF---SAEEFINEVSTIGRI---HHVNVVQLLGFCSEGSK-----R  258 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l---~H~niv~l~g~~~~~~~-----~  258 (511)
                      .+.++||+|+||.||+|+.+ +++.+|+|.+.....   ....+.+|+.++.++   +|+|++++++++.....     .
T Consensus         2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~   81 (287)
T cd07838           2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL   81 (287)
T ss_pred             eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence            45678999999999999976 589999999964322   234577788777666   69999999999987766     8


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      +++|||++ ++|.+++...  ....+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++.
T Consensus        82 ~l~~e~~~-~~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          82 TLVFEHVD-QDLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             EEEehhcc-cCHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcce
Confidence            99999996 4788776322  22468999999999999999999998   699999999999999999999999999998


Q ss_pred             cCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhc--
Q 010434          339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK--  416 (511)
Q Consensus       339 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--  416 (511)
                      .......   .....++..|+|||.+.+.  .++.++|+||||+++|||++|+.|+.........   .. +.+....  
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~--~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~---~~-~~~~~~~~~  226 (287)
T cd07838         156 IYSFEMA---LTSVVVTLWYRAPEVLLQS--SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL---DK-IFDVIGLPS  226 (287)
T ss_pred             eccCCcc---cccccccccccChHHhccC--CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH---HH-HHHHcCCCC
Confidence            7644322   1233478899999998764  6889999999999999999999888653321100   00 0000000  


Q ss_pred             -----------C---CcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          417 -----------G---GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       417 -----------~---~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                                 .   ...............+..+.+++.+||+.||.+||++.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                       0   000001111223345677889999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-35  Score=290.91  Aligned_cols=259  Identities=23%  Similarity=0.362  Sum_probs=194.1

Q ss_pred             hhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcc--cHHHHHHHHHHhcccc-ccceEEeeceeccCCceeEEEeecC
Q 010434          191 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKF--SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      ++.++||+|+||+||+|+.. +++.||||.+.....  ......+|+..+++++ |+|++++++++..+...++||||+ 
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-   80 (283)
T cd07830           2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-   80 (283)
T ss_pred             eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence            45788999999999999965 588999999866432  3335567999999999 999999999999999999999999 


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +|+|.+++...  .+..+++..+..++.|++.+|.|||+   .+++|+||+|+||++++++.++|+|||+++....... 
T Consensus        81 ~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          81 EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence            88998877322  23578999999999999999999998   6999999999999999999999999999986543322 


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc---------ccchhhHHh-hhc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA---------YFPSWVYDQ-LNK  416 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~---------~~~~~~~~~-~~~  416 (511)
                        .....++..|+|||.+.+. ..++.++|+||||++++||++|+.|+..........         .-..|.... +..
T Consensus       155 --~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             --cCCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence              1234578899999988643 357899999999999999999998885432211000         000010000 000


Q ss_pred             CCcccccc-----cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          417 GGDLELRN-----VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       417 ~~~~~~~~-----~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ........     ........+..+.+++.+||+.+|++|||+.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            00000000     00011112467889999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=282.40  Aligned_cols=245  Identities=25%  Similarity=0.383  Sum_probs=198.7

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      +.+.+.||+|++|.||+++.+ +++.+|+|.+....   ...+.+.+|++++.+++|+|++++++++.++...++++||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA   81 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence            456789999999999999854 68899999997754   34567999999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++++|.+++.    ....+++..+..++.|++.|+.|||+   .+++|+||+|+||+++.++.++|+|||++........
T Consensus        82 ~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          82 ENGSLRQIIK----KFGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCcHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            9999999873    22679999999999999999999998   6999999999999999999999999999987654432


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                      .  .....++..|+|||...+.  ..+.++||||+|+++++|++|+.|+.......      . .... .......    
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~------~-~~~~-~~~~~~~----  218 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMS--GASTASDIWSLGCTVIELLTGNPPYYDLNPMA------A-LFRI-VQDDHPP----  218 (254)
T ss_pred             c--ccccccchhhcCHhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCccHHH------H-HHHH-hccCCCC----
Confidence            1  2334588999999998764  57889999999999999999999986432110      0 1111 1111111    


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                        .+...+..+..++.+||+.+|++|||+.+++.
T Consensus       219 --~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         219 --LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             --CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence              22234567889999999999999999999974

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-34  Score=285.50  Aligned_cols=257  Identities=22%  Similarity=0.294  Sum_probs=203.0

Q ss_pred             hhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcc----cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          191 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      ++.++||+|.-|+||++.+. ++..+|+|++.+...    .......|-+||+.++||.++.|+..++.+...||+||||
T Consensus        80 ~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyC  159 (459)
T KOG0610|consen   80 RLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYC  159 (459)
T ss_pred             HHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecC
Confidence            44678999999999999976 468999999977433    2345667899999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC-
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN-  344 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~-  344 (511)
                      +||+|..+.  +++.++.+++..++-.+..++-||+|||-   +|||.|||||+||||.++|.+-|+||.|+....... 
T Consensus       160 pGGdL~~Lr--qkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  160 PGGDLHSLR--QKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             CCccHHHHH--hhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence            999998876  45567889999999999999999999998   899999999999999999999999999875432100 


Q ss_pred             --------------------------------Cc---------------------eeeccccCCccccchhcccccCCCc
Q 010434          345 --------------------------------DF---------------------VSISATRGTIGYIAPELISRNFGTV  371 (511)
Q Consensus       345 --------------------------------~~---------------------~~~~~~~gt~~y~APE~~~~~~~~~  371 (511)
                                                      ..                     ......+||-.|+|||+++++  .-
T Consensus       235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~--GH  312 (459)
T KOG0610|consen  235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE--GH  312 (459)
T ss_pred             eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC--CC
Confidence                                            00                     000122489999999999987  66


Q ss_pred             CccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCC
Q 010434          372 SCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADR  451 (511)
Q Consensus       372 s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R  451 (511)
                      +.+.|+|+|||++|||+.|+.||.....+.+       ..+.+.+.  ......    .+.+..+.+|+...|..||.+|
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T-------l~NIv~~~--l~Fp~~----~~vs~~akDLIr~LLvKdP~kR  379 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET-------LRNIVGQP--LKFPEE----PEVSSAAKDLIRKLLVKDPSKR  379 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhh-------HHHHhcCC--CcCCCC----CcchhHHHHHHHHHhccChhhh
Confidence            7899999999999999999999987654432       12222221  111111    1456778999999999999999


Q ss_pred             CC----HHHHHH--HHhcCcCC
Q 010434          452 PS----MTKVLE--MLEGSMDD  467 (511)
Q Consensus       452 Ps----~~evl~--~Le~~~~~  467 (511)
                      ..    ++||-+  ..+|....
T Consensus       380 lg~~rGA~eIK~HpFF~gVnWa  401 (459)
T KOG0610|consen  380 LGSKRGAAEIKRHPFFEGVNWA  401 (459)
T ss_pred             hccccchHHhhcCccccCCChh
Confidence            88    888755  44554333

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.2e-34  Score=297.69  Aligned_cols=258  Identities=21%  Similarity=0.228  Sum_probs=191.5

Q ss_pred             HHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccC------Cc
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SK  257 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~------~~  257 (511)
                      ..+...+.||+|+||.||++.. .+|+.||||.+...   ......+.+|+.++++++|+||+++++++...      ..
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            3455668899999999999984 47899999998642   22345788999999999999999999987543      35


Q ss_pred             eeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccc
Q 010434          258 RALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLA  337 (511)
Q Consensus       258 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla  337 (511)
                      .++||||++ ++|.+.+.      ..++...+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||++
T Consensus        96 ~~lv~e~~~-~~l~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          96 VYLVMELMD-ANLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             EEEEEeccC-CCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence            799999995 57777662      128899999999999999999998   69999999999999999999999999999


Q ss_pred             ccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccc--------ccccchh
Q 010434          338 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSS--------KAYFPSW  409 (511)
Q Consensus       338 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~--------~~~~~~~  409 (511)
                      +.......   .....++..|+|||.+.+.  .++.++||||||+++|+|++|+.||........        ....+.+
T Consensus       166 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
T cd07850         166 RTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF  240 (353)
T ss_pred             eeCCCCCC---CCCCcccccccCHHHHhCC--CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            86543221   2334578899999998765  788999999999999999999999864321100        0000000


Q ss_pred             -------hHHhhhcCCccc-------------ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          410 -------VYDQLNKGGDLE-------------LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       410 -------~~~~~~~~~~~~-------------~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                             ......+.....             ...........+..+.+++.+||+.||++|||+.++++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                   000000000000             000000122345678899999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-35  Score=297.46  Aligned_cols=251  Identities=22%  Similarity=0.322  Sum_probs=198.1

Q ss_pred             HHHHhhhccccCcCCcEEEEEEEecCCcEEEEEEecc---CcccHHHHHHHHHHhcccc-ccceEEeeceeccCCceeEE
Q 010434          186 IAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLEN---SKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       186 ~~~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~---~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV  261 (511)
                      ....|.+.++||+||-+.||++...+.+.+|+|.+..   +.....-|.+|+..|.+|+ |.+||+|++|-..++.+|||
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            3345566789999999999999988889999998755   4455678999999999995 99999999999999999999


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      |||= ..+|.++|..  .......| .++.+..|++.|+.++|+   .+|||.||||.|+|+ -.|.+||+|||.|....
T Consensus       439 mE~G-d~DL~kiL~k--~~~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  439 MECG-DIDLNKILKK--KKSIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQ  510 (677)
T ss_pred             eecc-cccHHHHHHh--ccCCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEE-EeeeEEeeeechhcccC
Confidence            9986 5688888832  22233335 788999999999999999   699999999999999 45699999999999887


Q ss_pred             CCCCceeeccccCCccccchhcccccCC---------CcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHH
Q 010434          342 KENDFVSISATRGTIGYIAPELISRNFG---------TVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYD  412 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~~~---------~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~  412 (511)
                      .+..........||+.||+||.+.....         .++.+|||||+||+||+|+.|+.||..-..          .+.
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n----------~~a  580 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN----------QIA  580 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH----------HHH
Confidence            7766555567789999999999854321         378899999999999999999999854211          111


Q ss_pred             hhhc----CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          413 QLNK----GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       413 ~~~~----~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .+..    +..++.+...+.     ..+.+++..||+.||++|||..++|+
T Consensus       581 Kl~aI~~P~~~Iefp~~~~~-----~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  581 KLHAITDPNHEIEFPDIPEN-----DELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HHHhhcCCCccccccCCCCc-----hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            1211    122233322221     12889999999999999999999986

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.5e-34  Score=286.87  Aligned_cols=241  Identities=24%  Similarity=0.336  Sum_probs=186.2

Q ss_pred             ccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc----cHHHHHHHHHH---hccccccceEEeeceeccCCceeEEEeecC
Q 010434          195 KLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF----SAEEFINEVST---IGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       195 ~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~----~~~~f~~Ev~~---l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .||+|+||.||++.. .+++.||+|.+.....    ....+.+|..+   +...+||||+++.+.+......++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999985 4689999999865322    12234555443   444579999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +|+|.+++.    ....+++..+..++.|++.|++|||+   .+++|+||||+||++++++.+||+|||+++....... 
T Consensus        81 g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-  152 (278)
T cd05606          81 GGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-  152 (278)
T ss_pred             CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence            999998873    33579999999999999999999998   6999999999999999999999999999875533221 


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                         ....|+..|+|||.+.+. ..++.++||||+|+++|||++|+.||........     ....... ......     
T Consensus       153 ---~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~-~~~~~~-----  217 (278)
T cd05606         153 ---HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMT-LTMAVE-----  217 (278)
T ss_pred             ---cCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-----HHHHHHh-hccCCC-----
Confidence               234589999999998643 2578899999999999999999999865422110     0011111 111111     


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCC-----CHHHHHH
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRP-----SMTKVLE  459 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~  459 (511)
                       .+...+..+.+++.+|++.+|.+||     ++.++++
T Consensus       218 -~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         218 -LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             -CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence             2222457788999999999999999     9999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-35  Score=315.91  Aligned_cols=269  Identities=18%  Similarity=0.232  Sum_probs=185.2

Q ss_pred             HHHHHhhhccccCcCCcEEEEEEEec--CCcEEEEE------------------EeccCcccHHHHHHHHHHhccccccc
Q 010434          185 IIAVTNHFTHKLGQGGFGSVYKGQLH--TGRLIAVK------------------MLENSKFSAEEFINEVSTIGRIHHVN  244 (511)
Q Consensus       185 i~~~t~~~~~~LG~G~fg~Vykg~~~--~g~~vAvK------------------~l~~~~~~~~~f~~Ev~~l~~l~H~n  244 (511)
                      .....|.+.++||+|+||.||++..+  ++...++|                  .+.........+.+|+.++++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            34456777889999999999998643  22222222                  22222223456889999999999999


Q ss_pred             eEEeeceeccCCceeEEEeecCCCCcccccccCC-CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEE
Q 010434          245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE-NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL  323 (511)
Q Consensus       245 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl  323 (511)
                      ||++++++......++|++++. ++|.+++.... ..........+..++.||+.||+|||+   ++|+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEE
Confidence            9999999999999999999984 56666553221 112234466778899999999999998   699999999999999


Q ss_pred             cCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCC-CCccccccc
Q 010434          324 DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNAIRSS  402 (511)
Q Consensus       324 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p-~~~~~~~~~  402 (511)
                      +.++.+||+|||+++......... .....||..|+|||++.+.  .++.++|||||||++|||++|..+ +........
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~  377 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGD--GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG  377 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence            999999999999998765432211 1234699999999999764  788999999999999999998753 322111100


Q ss_pred             -------------ccccch---hhHHhhhcCCccccc-ccch--hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          403 -------------KAYFPS---WVYDQLNKGGDLELR-NVTE--IESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       403 -------------~~~~~~---~~~~~~~~~~~~~~~-~~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                                   ...++.   ..++.+......... ....  ....++..+.+++.+||+.||++|||+.|+++.
T Consensus       378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                         000111   111111110000000 0000  001123456778999999999999999999863

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.9e-34  Score=290.60  Aligned_cols=248  Identities=25%  Similarity=0.334  Sum_probs=193.2

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      ++...+.||+|+||.||+|+.. +++.+|+|.+...    ....+++.+|+.++++++|+|++++.+++......++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            4445678999999999999854 6889999998642    2234578899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+. |+|.+++..   ....+++..+..++.|++.|+.|||+   .+++|+||+|+||+++.++.+||+|||++......
T Consensus        96 ~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          96 YCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             ccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            996 577766532   23568999999999999999999998   69999999999999999999999999998754322


Q ss_pred             CCceeeccccCCccccchhcccc-cCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          344 NDFVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                            ....++..|+|||.+.+ ..+..+.++||||||+++|||++|+.|+......       ..... .........
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~-~~~~~~~~~  234 (308)
T cd06634         169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYH-IAQNESPAL  234 (308)
T ss_pred             ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-------HHHHH-HhhcCCCCc
Confidence                  23357889999998753 1236788999999999999999999987542111       01111 111111111


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                           .....+..+.+++.+||+.+|++||++.++++...
T Consensus       235 -----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         235 -----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             -----CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence                 12234567889999999999999999999987543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=8.5e-35  Score=296.39  Aligned_cols=256  Identities=21%  Similarity=0.297  Sum_probs=192.1

Q ss_pred             ccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccH---------------HHHHHHHHHhccccccceEEeeceeccCC
Q 010434          193 THKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSA---------------EEFINEVSTIGRIHHVNVVQLLGFCSEGS  256 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~---------------~~f~~Ev~~l~~l~H~niv~l~g~~~~~~  256 (511)
                      .+.||+|+||.||++... +++.||||.+.......               ..+.+|+.++++++|+||+++++++..+.
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   93 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD   93 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence            467999999999999854 78999999986532211               24789999999999999999999999999


Q ss_pred             ceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccc
Q 010434          257 KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGL  336 (511)
Q Consensus       257 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGl  336 (511)
                      ..++||||++ |+|.+++.    ....+++.....++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||+
T Consensus        94 ~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~  165 (335)
T PTZ00024         94 FINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGL  165 (335)
T ss_pred             cEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccc
Confidence            9999999996 68888772    33568999999999999999999998   6999999999999999999999999999


Q ss_pred             cccCCCCCC------------ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc
Q 010434          337 AKFHPKEND------------FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA  404 (511)
Q Consensus       337 a~~~~~~~~------------~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~  404 (511)
                      ++.......            ........++..|+|||.+.+. ..++.++||||||+++|||++|+.|+........  
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--  242 (335)
T PTZ00024        166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ--  242 (335)
T ss_pred             eeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence            976541110            0111233468899999998653 3568899999999999999999999865432110  


Q ss_pred             ccchhhHHhhhcCCc-----------------ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHH
Q 010434          405 YFPSWVYDQLNKGGD-----------------LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEML  461 (511)
Q Consensus       405 ~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L  461 (511)
                        ...+...+.....                 .............+..+.+++..||+.+|++|||+.+++..-
T Consensus       243 --~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~  314 (335)
T PTZ00024        243 --LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE  314 (335)
T ss_pred             --HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence              0001010000000                 000000011122356788999999999999999999998643

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-35  Score=293.02  Aligned_cols=248  Identities=20%  Similarity=0.336  Sum_probs=206.4

Q ss_pred             HHHhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      +..|.+.+.||+|.|..|-+++ .-+|..||||++.+.+   .....+++|++-|+.++|||||+|+.+.....++|||+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            3456667889999999999987 4589999999997744   34567899999999999999999999999999999999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC-CCCeeeecccccccCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHP  341 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~-~~~~kl~DFGla~~~~  341 (511)
                      |.=.+|+|.+||..++   ..+.++...+.+.||..||.|+|+   ..+|||||||+||.+-+ -|-+||.|||++..+.
T Consensus        97 ELGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             EecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence            9999999999995443   679999999999999999999999   89999999999998855 5789999999987654


Q ss_pred             CCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccc
Q 010434          342 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (511)
                      ...   ..+..+|+..|-|||.+.+. ....++.||||+||+||.|++|+.||......+.        ...+...    
T Consensus       171 PG~---kL~TsCGSLAYSAPEILLGD-sYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET--------LTmImDC----  234 (864)
T KOG4717|consen  171 PGK---KLTTSCGSLAYSAPEILLGD-SYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET--------LTMIMDC----  234 (864)
T ss_pred             Ccc---hhhcccchhhccCchhhhcC-ccCCcchhhhHHHHHHHHHHhCCCccccccchhh--------hhhhhcc----
Confidence            433   34667899999999999875 2345789999999999999999999976543332        1111111    


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                         ....+..++.++.+|+..||+.||.+|.+..+|+.
T Consensus       235 ---KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  235 ---KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             ---cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence               12256677889999999999999999999999875

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-34  Score=294.48  Aligned_cols=256  Identities=22%  Similarity=0.330  Sum_probs=188.3

Q ss_pred             hhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccC------CceeE
Q 010434          191 HFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKRAL  260 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~------~~~~l  260 (511)
                      ...+.||+|+||.||+|.. .+|+.||||++...   ......+.+|+.++++++||||+++++++...      ...++
T Consensus        18 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l   97 (342)
T cd07879          18 TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYL   97 (342)
T ss_pred             EEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEE
Confidence            3457899999999999985 47899999998652   22345688999999999999999999988654      34589


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      |+||+.. +|..++      +..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++..
T Consensus        98 v~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~  167 (342)
T cd07879          98 VMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHA  167 (342)
T ss_pred             Eeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence            9999953 665543      2468999999999999999999998   69999999999999999999999999998754


Q ss_pred             CCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc--------cccchhhHH
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK--------AYFPSWVYD  412 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~--------~~~~~~~~~  412 (511)
                      ....     ....++..|+|||.+.+. ..++.++||||||+++|||++|+.||........-        ...+.+ .+
T Consensus       168 ~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~  240 (342)
T cd07879         168 DAEM-----TGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF-VQ  240 (342)
T ss_pred             CCCC-----CCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH-HH
Confidence            3321     234578899999998652 35788999999999999999999998753211100        000000 00


Q ss_pred             hhhcC---------CcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH--Hhc
Q 010434          413 QLNKG---------GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM--LEG  463 (511)
Q Consensus       413 ~~~~~---------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~--Le~  463 (511)
                      .+...         ...............+..+.+++.+||+.||++||++.++++.  +++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~  302 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS  302 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhh
Confidence            00000         0000000000111234678899999999999999999999853  554

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.1e-34  Score=284.55  Aligned_cols=246  Identities=22%  Similarity=0.328  Sum_probs=197.2

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc----ccHHHHHHHHHHhcccc-ccceEEeeceeccCCceeEEEe
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK----FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      |.+.+.||+|+||.||++... +|+.||+|++..+.    ...+.+.+|+.++.+++ |+||+++++++..+...++|||
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd05581           3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE   82 (280)
T ss_pred             ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence            456688999999999999864 79999999987532    23467889999999998 9999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++++|.+++.    ....+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~l~----~~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          83 YAPNGELLQYIR----KYGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            999999999883    33479999999999999999999998   69999999999999999999999999998865443


Q ss_pred             CCc------------------eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc
Q 010434          344 NDF------------------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY  405 (511)
Q Consensus       344 ~~~------------------~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~  405 (511)
                      ...                  .......++..|+|||.+...  .++.++|+||||++++++++|+.|+......     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----  228 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-----  228 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCC--CCChhhhHHHHHHHHHHHHhCCCCCCCccHH-----
Confidence            221                  111233478899999988764  6888999999999999999999998754311     


Q ss_pred             cchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCH----HHHHH
Q 010434          406 FPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSM----TKVLE  459 (511)
Q Consensus       406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~----~evl~  459 (511)
                         ......... ..      ..+..+++.+.+++..||+.+|.+|||+    .++++
T Consensus       229 ---~~~~~~~~~-~~------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         229 ---LTFQKILKL-EY------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ---HHHHHHHhc-CC------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence               111111111 00      1222335678899999999999999999    77664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=9.3e-35  Score=301.83  Aligned_cols=199  Identities=27%  Similarity=0.389  Sum_probs=171.3

Q ss_pred             HHHHHHhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCcccHHHHHHHHHHhcccc-c-----cceEEeeceeccCC
Q 010434          184 EIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRIH-H-----VNVVQLLGFCSEGS  256 (511)
Q Consensus       184 ei~~~t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~-H-----~niv~l~g~~~~~~  256 (511)
                      |....+|.+.+.||+|.||.|-|+. .++++.||||++++...-..+-..|+.+|..|+ |     -|+|+++++|...+
T Consensus       182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~  261 (586)
T KOG0667|consen  182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN  261 (586)
T ss_pred             ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence            4444477888999999999999997 568999999999987766677788999999996 4     38999999999999


Q ss_pred             ceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC--CCeeeecc
Q 010434          257 KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN--FIPKVSDF  334 (511)
Q Consensus       257 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~--~~~kl~DF  334 (511)
                      +.|||+|.+ .-+|.++|.  .++-..++...++.|+.||+.||.+||+   .+|||+||||+||||.+-  ..+||+||
T Consensus       262 HlciVfELL-~~NLYellK--~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDF  335 (586)
T KOG0667|consen  262 HLCIVFELL-STNLYELLK--NNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDF  335 (586)
T ss_pred             ceeeeehhh-hhhHHHHHH--hcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEec
Confidence            999999999 669999984  4445679999999999999999999998   799999999999999543  47999999


Q ss_pred             cccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCC
Q 010434          335 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN  395 (511)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~  395 (511)
                      |.++.......     ...-+..|+|||++.+.  .|+.+.|||||||++.||++|.+-|.
T Consensus       336 GSSc~~~q~vy-----tYiQSRfYRAPEVILGl--pY~~~IDmWSLGCIlAEL~tG~PLfp  389 (586)
T KOG0667|consen  336 GSSCFESQRVY-----TYIQSRFYRAPEVILGL--PYDTAIDMWSLGCILAELFTGEPLFP  389 (586)
T ss_pred             ccccccCCcce-----eeeeccccccchhhccC--CCCCccceeehhhhHHhHhcCccccC
Confidence            99987544321     33467789999999985  89999999999999999999976554

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.2e-34  Score=288.02  Aligned_cols=263  Identities=25%  Similarity=0.278  Sum_probs=189.5

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCC--------
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS--------  256 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~--------  256 (511)
                      .+.+.++||+|+||.||+|..+ +++.+|||.+....   .....+.+|++++++++||||+++++++.+..        
T Consensus         9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   88 (311)
T cd07866           9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG   88 (311)
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence            4556789999999999999854 68999999986522   22346789999999999999999999875433        


Q ss_pred             ceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccc
Q 010434          257 KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGL  336 (511)
Q Consensus       257 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGl  336 (511)
                      ..++|+||+.+ +|...+.   .....+++..+..++.|+++||+|||+   .+++|+||||+||++++++.+||+|||+
T Consensus        89 ~~~lv~~~~~~-~l~~~~~---~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          89 SVYMVTPYMDH-DLSGLLE---NPSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             eEEEEEecCCc-CHHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence            46899999964 5665552   223579999999999999999999998   6999999999999999999999999999


Q ss_pred             cccCCCCCCce---------eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc--
Q 010434          337 AKFHPKENDFV---------SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY--  405 (511)
Q Consensus       337 a~~~~~~~~~~---------~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~--  405 (511)
                      ++.........         ..+...+++.|+|||.+.+. ..++.++||||||+++|||++|+.|+...........  
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            97654332111         11233468889999987643 3578899999999999999999999865332110000  


Q ss_pred             -----cchhhHHh---hhcCC--cccc---cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          406 -----FPSWVYDQ---LNKGG--DLEL---RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       406 -----~~~~~~~~---~~~~~--~~~~---~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                           .+.+.+..   +....  ....   .............+.+++.+||+.+|++|||+.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence                 00000000   00000  0000   0000111223367889999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-34  Score=293.15  Aligned_cols=262  Identities=21%  Similarity=0.265  Sum_probs=197.2

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccCC-----ceeE
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS-----KRAL  260 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~-----~~~l  260 (511)
                      +.+.++||+|+||.||+++.. +++.+|||.+...   ....+.+.+|+.+++.++|+||+++.+++....     ..++
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l   81 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI   81 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence            456789999999999999864 5899999998763   334568999999999999999999999987765     7899


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      +|||++ ++|.+++.    .+..+++..+..++.|++.||+|||+   .+|+|+||||+|||++.++.++|+|||++...
T Consensus        82 v~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          82 VTELME-TDLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             Eecchh-hhHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            999997 57887772    23489999999999999999999998   69999999999999999999999999999876


Q ss_pred             CCCCCc-eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc--------ccc----
Q 010434          341 PKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA--------YFP----  407 (511)
Q Consensus       341 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~--------~~~----  407 (511)
                      ...... .......++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||..........        ..+    
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  232 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK  232 (330)
T ss_pred             cccccccccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence            543210 112334578899999998764 267889999999999999999999986543211000        000    


Q ss_pred             ----hhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          408 ----SWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       408 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                          ......+.................++..+.+++.+||+.+|.+|||+.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                00000000000000000111122346778999999999999999999999873

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-35  Score=291.89  Aligned_cols=239  Identities=26%  Similarity=0.376  Sum_probs=199.2

Q ss_pred             ccccCcCCcEEEEEEE-ecCCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          193 THKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      -+.||+||||.||-++ -.+|+.+|.|.+.+..    ......++|-.++.+++.+.||.+--.+...+.++||+..|.|
T Consensus       190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG  269 (591)
T KOG0986|consen  190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG  269 (591)
T ss_pred             eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence            4689999999999997 4589999999986532    2334578999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|.-+|....+  ..+++..+.-.+.+|+.||++||+   .+||.||+||+|||||+.|+++|+|.|||..++....  
T Consensus       270 GDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~--  342 (591)
T KOG0986|consen  270 GDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP--  342 (591)
T ss_pred             CceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCCc--
Confidence            999999865433  579999999999999999999998   6999999999999999999999999999998776653  


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                       .+...||.||||||++.+.  .|+...|.||+||++|||+.|+.||.........        +.++   +..+.+..+
T Consensus       343 -~~~rvGT~GYMAPEvl~ne--~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~--------eEvd---rr~~~~~~e  408 (591)
T KOG0986|consen  343 -IRGRVGTVGYMAPEVLQNE--VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR--------EEVD---RRTLEDPEE  408 (591)
T ss_pred             -cccccCcccccCHHHHcCC--cccCCccHHHHHhHHHHHHcccCchhhhhhhhhH--------HHHH---HHHhcchhh
Confidence             3455799999999999876  6999999999999999999999999754322111        1111   111223344


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCC
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRP  452 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RP  452 (511)
                      .++.++++..++....|+.||++|-
T Consensus       409 y~~kFS~eakslc~~LL~Kdp~~RL  433 (591)
T KOG0986|consen  409 YSDKFSEEAKSLCEGLLTKDPEKRL  433 (591)
T ss_pred             cccccCHHHHHHHHHHHccCHHHhc
Confidence            6667788889999999999999994

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=302.56  Aligned_cols=249  Identities=24%  Similarity=0.360  Sum_probs=198.5

Q ss_pred             hhccccCcCCcEEEEEEEecC-CcEEEEEEecc-CcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          191 HFTHKLGQGGFGSVYKGQLHT-GRLIAVKMLEN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~~-g~~vAvK~l~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      ++.-.||.|+||.|||++.++ +-..|-|++.. +....++|+-|+.+|..+.||+||+|++.|..+++++++.|||+||
T Consensus        35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG  114 (1187)
T KOG0579|consen   35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG  114 (1187)
T ss_pred             HHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence            445679999999999998664 44567788765 5557789999999999999999999999999999999999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      -.+..+.   .-+..|++.++.-++.|++.||.|||+   .+|||||||+.|||++-+|.++|+|||.+-.....  ...
T Consensus       115 AVDaiml---EL~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qk  186 (1187)
T KOG0579|consen  115 AVDAIML---ELGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQK  186 (1187)
T ss_pred             hHhHHHH---HhccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhH--Hhh
Confidence            9998874   345789999999999999999999999   69999999999999999999999999987533221  122


Q ss_pred             eccccCCccccchhccccc---CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          349 ISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~---~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                      -....||+.|||||+....   ..+|..++||||||++|.||..+.+|...-.        |.-+.-.+.+...+.+.  
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln--------pMRVllKiaKSePPTLl--  256 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSEPPTLL--  256 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc--------hHHHHHHHhhcCCCccc--
Confidence            2455699999999987532   2378899999999999999999998854321        22222222222222222  


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                        .+..-+..+.+++..||..||..||+++++++
T Consensus       257 --qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  257 --QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             --CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence              22234566788999999999999999999985

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-34  Score=285.08  Aligned_cols=259  Identities=24%  Similarity=0.318  Sum_probs=195.7

Q ss_pred             hhccccCcCCcEEEEEEEec-CCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          191 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .+.++||+|+||.||+|+.. +++.+|+|++...   ....+.+.+|+.++++++|+|++++++++.+....++|+||++
T Consensus         2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (282)
T cd07829           2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD   81 (282)
T ss_pred             eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence            34578999999999999855 6999999998764   3334678899999999999999999999999999999999997


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                       ++|.+++...   ...+++..+..++.|++.||+|||+   .+|+|+||+|+||++++++.+||+|||+++....... 
T Consensus        82 -~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          82 -MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             -cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence             5899888322   2479999999999999999999998   6999999999999999999999999999986544322 


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc-------cchhhHHhhhcCC-
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY-------FPSWVYDQLNKGG-  418 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~-------~~~~~~~~~~~~~-  418 (511)
                       ......++..|+|||.+.+. ..++.++||||||+++|||++|+.|+...........       .....+..+.... 
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD  231 (282)
T ss_pred             -ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence             12233467789999998653 3678899999999999999999988865432110000       0000000000000 


Q ss_pred             ---ccc---ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          419 ---DLE---LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       419 ---~~~---~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                         ...   ...........+..+.+++..||+.+|++||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence               000   00000111123567999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-34  Score=279.95  Aligned_cols=247  Identities=23%  Similarity=0.285  Sum_probs=192.0

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC------cccHHHHHHHHHHhccccccceEEeeceeccC--CceeE
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS------KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRAL  260 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~------~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~l  260 (511)
                      +.+.+.||+|+||.||++.. .+++.+|+|.+...      ......+.+|+.++++++|+||+++++++.+.  ...++
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (264)
T cd06653           4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI   83 (264)
T ss_pred             eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence            45578999999999999985 46899999987532      12335788999999999999999999998653  45789


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      ++||+++++|.+++.    ....+++..+.+++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+++..
T Consensus        84 v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          84 FVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            999999999998873    23458899999999999999999998   69999999999999999999999999999754


Q ss_pred             CCCCC-ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          341 PKEND-FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       341 ~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      ..... ........++..|+|||.+.+.  .++.++|+||||++++||++|+.||......       ..+.+.......
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~  227 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGE--GYGRKADVWSVACTVVEMLTEKPPWAEYEAM-------AAIFKIATQPTK  227 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccCHH-------HHHHHHHcCCCC
Confidence            32111 1111234588999999998764  6789999999999999999999998643111       111111111111


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                            ...+..++..+.+++.+|++ +|..||+..+++.
T Consensus       228 ------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         228 ------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                  11334456778899999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=6.7e-34  Score=280.69  Aligned_cols=234  Identities=19%  Similarity=0.255  Sum_probs=181.5

Q ss_pred             cCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEeecCCCCcccc
Q 010434          196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRH  273 (511)
Q Consensus       196 LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~  273 (511)
                      ||+|+||.||++.. .+++.+|+|.+........    |+.....+ +||||+++++.+..++..++||||+++++|.++
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~   99 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL   99 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence            59999999999985 4788999999865432221    22222212 799999999999999999999999999999998


Q ss_pred             cccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC-CeeeecccccccCCCCCCceeeccc
Q 010434          274 IFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISAT  352 (511)
Q Consensus       274 l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~~~~~  352 (511)
                      +.    ....+++..+..++.|+++||.|||+   .+++|+||||+||+++.++ .++|+|||+++......      ..
T Consensus       100 l~----~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~------~~  166 (267)
T PHA03390        100 LK----KEGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS------CY  166 (267)
T ss_pred             HH----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc------cC
Confidence            83    22489999999999999999999998   6899999999999999998 99999999987654322      23


Q ss_pred             cCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHH
Q 010434          353 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVI  432 (511)
Q Consensus       353 ~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  432 (511)
                      .++..|+|||++.+.  .++.++||||||++++||++|+.|+.......  .....+....     ...    .......
T Consensus       167 ~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~-----~~~----~~~~~~~  233 (267)
T PHA03390        167 DGTLDYFSPEKIKGH--NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLKRQ-----QKK----LPFIKNV  233 (267)
T ss_pred             CCCCcccChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHHhh-----ccc----CCccccc
Confidence            588999999999764  67899999999999999999999987432211  1111111111     000    1122245


Q ss_pred             HHHHHHHHHHhcCcCCCCCCC-HHHHHH
Q 010434          433 ARKLCMIGLWCIQVKAADRPS-MTKVLE  459 (511)
Q Consensus       433 ~~~l~~l~~~Cl~~~P~~RPs-~~evl~  459 (511)
                      +..+.+++.+||+.+|.+||+ ++++++
T Consensus       234 ~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        234 SKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             CHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            678899999999999999996 688874

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.2e-34  Score=292.65  Aligned_cols=256  Identities=21%  Similarity=0.266  Sum_probs=191.3

Q ss_pred             HhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCC------ce
Q 010434          189 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS------KR  258 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~------~~  258 (511)
                      +|.+.+.||+|+||.||++. ..+|+.||||.+....   ...+.+.+|+.++++++||||+++++++..+.      ..
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07880          16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF   95 (343)
T ss_pred             ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence            44556789999999999998 4578999999986532   23456889999999999999999999886543      35


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      ++||||+ +++|.+++.     ...+++..+..++.|+++||+|||+   .+|+||||||+||++++++.+||+|||++.
T Consensus        96 ~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~  166 (343)
T cd07880          96 YLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR  166 (343)
T ss_pred             EEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence            8999999 778888762     2468999999999999999999998   699999999999999999999999999997


Q ss_pred             cCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc-------cccchhhH
Q 010434          339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK-------AYFPSWVY  411 (511)
Q Consensus       339 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~-------~~~~~~~~  411 (511)
                      ......     ....++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||.........       ...+....
T Consensus       167 ~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07880         167 QTDSEM-----TGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV  240 (343)
T ss_pred             ccccCc-----cccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            653321     234578899999998653 35788999999999999999999998653211000       00000000


Q ss_pred             HhhhcC---------CcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          412 DQLNKG---------GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       412 ~~~~~~---------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ..+...         ..............++..+.+++.+|++.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            111000         000000001112234567889999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.1e-34  Score=294.69  Aligned_cols=261  Identities=20%  Similarity=0.256  Sum_probs=189.5

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceeccC-----------
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----------  255 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~-----------  255 (511)
                      ++.+.+.||.|+||.||+|.. .+|+.||+|.+.... ...+.+.+|+.++++++||||+++++++...           
T Consensus         6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (342)
T cd07854           6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL   85 (342)
T ss_pred             ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence            455678999999999999985 578999999986633 3456788999999999999999999876543           


Q ss_pred             ---CceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEc-CCCCeee
Q 010434          256 ---SKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD-HNFIPKV  331 (511)
Q Consensus       256 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~-~~~~~kl  331 (511)
                         ...++|+||++ ++|.+++.     ...+++..+..++.||+.||.|||+   .+++||||||+||+++ +++.+||
T Consensus        86 ~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          86 TELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             cccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEE
Confidence               35789999996 58877662     2468999999999999999999998   6999999999999997 4567899


Q ss_pred             ecccccccCCCCCCce-eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc-----
Q 010434          332 SDFGLAKFHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY-----  405 (511)
Q Consensus       332 ~DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~-----  405 (511)
                      +|||+++......... ......++..|+|||.+.+. ..++.++||||||+++|||++|+.||...........     
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~  235 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV  235 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999997653221111 11223478899999987542 3578899999999999999999999864321110000     


Q ss_pred             ----------cchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          406 ----------FPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       406 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                                +.........................++..+.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                      000000000000000000011111234567889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1e-33  Score=285.98  Aligned_cols=241  Identities=27%  Similarity=0.375  Sum_probs=189.0

Q ss_pred             ccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          193 THKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      .++||+|+||.||+|+. .+|+.||+|.+....    ...+.+.+|+.++++++|||++++++++.++...++||||++ 
T Consensus        26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-  104 (313)
T cd06633          26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-  104 (313)
T ss_pred             ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence            46799999999999985 468999999986522    223568899999999999999999999999999999999995 


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|.+++.   .....+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++......    
T Consensus       105 ~~l~~~l~---~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~----  174 (313)
T cd06633         105 GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----  174 (313)
T ss_pred             CCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC----
Confidence            56766652   234568999999999999999999998   69999999999999999999999999988643221    


Q ss_pred             eeccccCCccccchhccccc-CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          348 SISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~-~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                        ....|+..|+|||.+... .+.++.++||||||+++|||++|+.|+.......       ........ .....    
T Consensus       175 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~-------~~~~~~~~-~~~~~----  240 (313)
T cd06633         175 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQN-DSPTL----  240 (313)
T ss_pred             --CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHHhc-CCCCC----
Confidence              234588899999998531 2467889999999999999999999975432111       11111111 11110    


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                       ....++..+.+++.+||+.+|.+||++.+++.
T Consensus       241 -~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         241 -QSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             -CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             11223456888999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=7.4e-34  Score=289.28  Aligned_cols=261  Identities=21%  Similarity=0.248  Sum_probs=188.8

Q ss_pred             hhhccccCcCCcEEEEEEEec-C--CcEEEEEEeccC---cccHHHHHHHHHHhccc-cccceEEeeceecc----CCce
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-T--GRLIAVKMLENS---KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSE----GSKR  258 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~--g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~----~~~~  258 (511)
                      +.+.+.||+|+||.||+++.. +  +..||+|.+...   ....+.+.+|+.+++++ +||||+++++.+..    ....
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~   81 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL   81 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence            456788999999999999854 4  789999998652   22346788999999999 59999999987532    2456


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      ++++||+. ++|.+++.    ....+++..+..++.||+.||+|||+   .+++||||||+||++++++.+||+|||+++
T Consensus        82 ~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          82 YLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            78889885 68888772    34578999999999999999999998   699999999999999999999999999998


Q ss_pred             cCCCCCCc--eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc-------ccchh
Q 010434          339 FHPKENDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA-------YFPSW  409 (511)
Q Consensus       339 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~-------~~~~~  409 (511)
                      ........  .......||..|+|||.+.+. ..++.++|+||||+++|+|++|+.|+........-.       ..+..
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            65432211  111234589999999987543 367889999999999999999999886532110000       00000


Q ss_pred             hHHhhhc---------CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          410 VYDQLNK---------GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       410 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ....+..         ................+..+.+++.+|++.+|++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000         0000000000011123467889999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6e-34  Score=289.72  Aligned_cols=256  Identities=21%  Similarity=0.275  Sum_probs=190.3

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceecc-CCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~  264 (511)
                      |.+.+.||.|+||.||++.. .+++.||||.+...   ....+.+.+|+.++.+++||||+++.+++.. +...++++||
T Consensus        12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~   91 (328)
T cd07856          12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL   91 (328)
T ss_pred             eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence            44568999999999999984 47999999987542   2345678899999999999999999998865 5678999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      + +++|.+++     ...++++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||+++..... 
T Consensus        92 ~-~~~L~~~~-----~~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-  161 (328)
T cd07856          92 L-GTDLHRLL-----TSRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-  161 (328)
T ss_pred             h-ccCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence            8 56888776     23468889999999999999999998   69999999999999999999999999998754321 


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc-------cchhhHHhhhcC
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY-------FPSWVYDQLNKG  417 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~-------~~~~~~~~~~~~  417 (511)
                          .....++..|+|||.+.+. ..++.++||||||+++|||++|+.|+...........       .+.-..+.....
T Consensus       162 ----~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd07856         162 ----MTGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE  236 (328)
T ss_pred             ----cCCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch
Confidence                1233578899999987542 3678999999999999999999999865322110000       000000000000


Q ss_pred             Cc------ccccc---cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          418 GD------LELRN---VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       418 ~~------~~~~~---~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      ..      .....   ..+....++..+.+++.+||+.+|++|||+.+++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00      00000   001112245778999999999999999999998753

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=300.66  Aligned_cols=200  Identities=30%  Similarity=0.458  Sum_probs=172.6

Q ss_pred             hccccCcCCcEEEEEEE-ecCCcEEEEEEecc--CcccHHHHHHHHHHhccccccceEEeeceeccCC------ceeEEE
Q 010434          192 FTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS------KRALVY  262 (511)
Q Consensus       192 ~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~------~~~lV~  262 (511)
                      ..+.||+|+||.||+|+ -.+|+.||||..+.  +....+...+|++++++++|+|||++++.-.+..      ...+||
T Consensus        17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm   96 (732)
T KOG4250|consen   17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM   96 (732)
T ss_pred             ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence            35789999999999999 45899999999977  4556788999999999999999999999865543      567999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEc----CCCCeeeecccccc
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD----HNFIPKVSDFGLAK  338 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~----~~~~~kl~DFGla~  338 (511)
                      |||++|||...+...++ ...|++..++.+..+++.||.|||+   .+|+||||||.||++-    ..-.-||+|||.|+
T Consensus        97 EyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   97 EYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             eecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            99999999999866554 4579999999999999999999998   5999999999999993    23357999999999


Q ss_pred             cCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccc
Q 010434          339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAI  399 (511)
Q Consensus       339 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~  399 (511)
                      -.+.+.   ..+...||..|++||++.++ +.++...|.|||||++||.+||..||.....
T Consensus       173 el~d~s---~~~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  173 ELDDNS---LFTSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             cCCCCC---eeeeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            877665   34566799999999999863 5888999999999999999999999976543

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=273.97  Aligned_cols=235  Identities=29%  Similarity=0.399  Sum_probs=191.2

Q ss_pred             cCcCCcEEEEEEEec-CCcEEEEEEeccCcc----cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCc
Q 010434          196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL  270 (511)
Q Consensus       196 LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  270 (511)
                      ||+|+||.||++... +++.+|+|.+.....    ..+.+.+|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999864 589999999876432    345789999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeec
Q 010434          271 DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  350 (511)
Q Consensus       271 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  350 (511)
                      .+++.    ....+++..+..++.|++.|+.|||+   .+++|+||+|+||+++.++.++|+|||++........  ...
T Consensus        81 ~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~  151 (250)
T cd05123          81 FSHLS----KEGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTN  151 (250)
T ss_pred             HHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--ccc
Confidence            99883    23468999999999999999999998   6999999999999999999999999999876544321  224


Q ss_pred             cccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHH
Q 010434          351 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  430 (511)
Q Consensus       351 ~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  430 (511)
                      ...++..|+|||.+.+.  ..+.++|+||||+++|+|++|+.|+......        ......... ...      .+.
T Consensus       152 ~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~-~~~------~~~  214 (250)
T cd05123         152 TFCGTPEYLAPEVLLGK--GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK--------EIYEKILKD-PLR------FPE  214 (250)
T ss_pred             CCcCCccccChHHhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHhcC-CCC------CCC
Confidence            45588899999998764  6788999999999999999999998644321        111121111 111      222


Q ss_pred             HHHHHHHHHHHHhcCcCCCCCCCHHH
Q 010434          431 VIARKLCMIGLWCIQVKAADRPSMTK  456 (511)
Q Consensus       431 ~~~~~l~~l~~~Cl~~~P~~RPs~~e  456 (511)
                      ..+..+.+++.+||+.||++||++.+
T Consensus       215 ~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         215 FLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            23567889999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.9e-34  Score=290.09  Aligned_cols=254  Identities=21%  Similarity=0.267  Sum_probs=187.4

Q ss_pred             hccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccC------CceeEE
Q 010434          192 FTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKRALV  261 (511)
Q Consensus       192 ~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~------~~~~lV  261 (511)
                      +.+.||+|+||.||++.. .+|+.||+|++....   ...+.+.+|+.++.+++||||+++++++...      ...+++
T Consensus        21 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv  100 (345)
T cd07877          21 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV  100 (345)
T ss_pred             EEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEE
Confidence            457899999999999984 578999999987532   2346788999999999999999999987543      346788


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      ++++ +++|.+++.     ...+++..+..++.|+++||+|||+   .+|+|+||||+||++++++.+||+|||+++...
T Consensus       101 ~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~  171 (345)
T cd07877         101 THLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD  171 (345)
T ss_pred             ehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence            8877 788887762     2468999999999999999999998   699999999999999999999999999987543


Q ss_pred             CCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc-------cccchhhHHhh
Q 010434          342 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK-------AYFPSWVYDQL  414 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~  414 (511)
                      ..     .....++..|+|||.+.+. ..++.++||||||+++|||++|+.|+.........       ...+......+
T Consensus       172 ~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (345)
T cd07877         172 DE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  245 (345)
T ss_pred             cc-----ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            22     1334578899999987652 35788999999999999999999998543211100       00001111101


Q ss_pred             hcC---------CcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          415 NKG---------GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       415 ~~~---------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      ...         ...............+..+.+++.+|++.+|.+||++.++++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            000         0000000000001134568899999999999999999999864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-34  Score=295.98  Aligned_cols=245  Identities=21%  Similarity=0.323  Sum_probs=203.5

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      +.+.++||+|.|+.|..++. .++..||||.+.++..   ..+.+.+|+.+|..++|||||+++.+......+|+||||+
T Consensus        58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya  137 (596)
T KOG0586|consen   58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA  137 (596)
T ss_pred             eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence            34568999999999999984 4799999999987443   3456899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      .+|.+.+++.    +.+.+.......++.|+.+|++|||+   +.|+|||||++||||+.+.++||+|||++..+.... 
T Consensus       138 ~~ge~~~yl~----~~gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~-  209 (596)
T KOG0586|consen  138 SGGELFDYLV----KHGRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL-  209 (596)
T ss_pred             cCchhHHHHH----hcccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeecccc-
Confidence            9999999993    33556668889999999999999999   799999999999999999999999999998876433 


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                        .....+|++.|.|||++.+. ...++++|+||+|+++|-|+.|..||+.....+.+...       +...        
T Consensus       210 --~lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv-------l~gk--------  271 (596)
T KOG0586|consen  210 --MLQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV-------LRGK--------  271 (596)
T ss_pred             --cccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCcccccccchh-------eeee--------
Confidence              24567799999999999886 36789999999999999999999999976654422211       1100        


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      ..++--++-++.++++++|-.+|.+|++++++.+.
T Consensus       272 ~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  272 YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             ecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            11222234567788999999999999999999763

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=323.09  Aligned_cols=250  Identities=28%  Similarity=0.371  Sum_probs=200.0

Q ss_pred             cccCcCCcEEEEEEE-ecCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCC
Q 010434          194 HKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGS  269 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  269 (511)
                      .+||.|.||.||-+. ..+|...|+|-++-..   .......+|..++..|+|||+|+.+|+-...+..+|.||||.+|+
T Consensus      1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred             cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence            479999999999998 5689999999876522   233467889999999999999999999999999999999999999


Q ss_pred             cccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc--e
Q 010434          270 LDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF--V  347 (511)
Q Consensus       270 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~--~  347 (511)
                      |.+.+    ..+....+.....+..|++.|++|||+   .+||||||||.||+|+.+|.+|++|||.|.........  .
T Consensus      1321 La~ll----~~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1321 LASLL----EHGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred             HHHHH----HhcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence            99987    455667777778899999999999999   69999999999999999999999999999876554211  1


Q ss_pred             eeccccCCccccchhcccccC-CCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          348 SISATRGTIGYIAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~-~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                      ......||+-|||||++.+.. ..-.-+.||||+||+++||+||++||...+..- .     .+| ++..+..+.     
T Consensus      1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-a-----IMy-~V~~gh~Pq----- 1461 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-A-----IMY-HVAAGHKPQ----- 1461 (1509)
T ss_pred             HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-H-----HHh-HHhccCCCC-----
Confidence            223456999999999998753 233458999999999999999999986543211 0     011 222222222     


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                       .+..++..-.+++..||+.||++|.++.|+++.=-+
T Consensus      1462 -~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1462 -IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred             -CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcc
Confidence             333477788899999999999999999988775443

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.5e-34  Score=290.69  Aligned_cols=255  Identities=22%  Similarity=0.276  Sum_probs=191.1

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccCCc------ee
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK------RA  259 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~------~~  259 (511)
                      |.+.+.||+|+||.||+|+.. +++.||||++...   ....+.+.+|+.++++++|+|++++++++.....      .+
T Consensus        17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   96 (343)
T cd07851          17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY   96 (343)
T ss_pred             eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence            455688999999999999864 6889999998653   2234567889999999999999999998866554      89


Q ss_pred             EEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      +|+||+ +++|.+++.     ...+++..+..++.|+++||+|||+   .+|+|+||||+||++++++.+||+|||++..
T Consensus        97 lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~  167 (343)
T cd07851          97 LVTHLM-GADLNNIVK-----CQKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH  167 (343)
T ss_pred             EEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence            999998 678988772     2569999999999999999999998   6999999999999999999999999999976


Q ss_pred             CCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc--------cccchhhH
Q 010434          340 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK--------AYFPSWVY  411 (511)
Q Consensus       340 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~--------~~~~~~~~  411 (511)
                      ....     .....++..|+|||.+.+. ..++.++||||||+++|||++|+.||.........        ..-+.+..
T Consensus       168 ~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  241 (343)
T cd07851         168 TDDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ  241 (343)
T ss_pred             cccc-----ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence            5432     2334578899999988643 26788999999999999999999998643211100        00000000


Q ss_pred             Hhh--------hcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          412 DQL--------NKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       412 ~~~--------~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ...        .................++..+.+++.+||+.+|++|||+.+|++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            000        000000000000111223678999999999999999999999975

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=269.26  Aligned_cols=247  Identities=23%  Similarity=0.336  Sum_probs=192.3

Q ss_pred             ccccCcCCcEEEEEEEe-cCCcEEEEEEeccC--cccHHHHHHHHHHhcccc-ccceEEeeceeccCCceeEEEeecCCC
Q 010434          193 THKLGQGGFGSVYKGQL-HTGRLIAVKMLENS--KFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      ...||.|..|.|++... .+|..+|||.+.++  +.+.+..+..+.++..-+ .|.||+.+|+|..+....+.||.| ..
T Consensus        97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~  175 (391)
T KOG0983|consen   97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-ST  175 (391)
T ss_pred             HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HH
Confidence            45799999999999984 57899999999763  334455666777766554 799999999999999999999998 34


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      -+++++   ....+++++..+-++...+..||.||...  ++|+|||+||+|||+|+.|++|++|||.+-..-...   .
T Consensus       176 C~ekLl---krik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---A  247 (391)
T KOG0983|consen  176 CAEKLL---KRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---A  247 (391)
T ss_pred             HHHHHH---HHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccc---c
Confidence            555555   23346799999999999999999999984  899999999999999999999999999986544332   2


Q ss_pred             eccccCCccccchhccccc-CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          349 ISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~-~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      .+...|-+.|||||.+..+ ...|..++||||||+.++||+||+.|+.....+-       .+...+.+.....++    
T Consensus       248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-------e~ltkvln~ePP~L~----  316 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-------EVLTKVLNEEPPLLP----  316 (391)
T ss_pred             cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-------HHHHHHHhcCCCCCC----
Confidence            2344588899999999754 4578889999999999999999999997653221       122222221111111    


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ....++..+++++..||+.|+.+||...++++
T Consensus       317 ~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  317 GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             cccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            12227788999999999999999999999986

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=7.9e-34  Score=309.41  Aligned_cols=250  Identities=28%  Similarity=0.394  Sum_probs=178.2

Q ss_pred             hhhc--cccCcCCcEEEEEEEec-CCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCC--------
Q 010434          190 NHFT--HKLGQGGFGSVYKGQLH-TGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS--------  256 (511)
Q Consensus       190 ~~~~--~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~--------  256 (511)
                      ..|.  +.||+||||.|||++.+ ||+.+|||++...  ........+|+.++++|+|||||+++..+.+..        
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            3444  47999999999999966 8999999998764  333456788999999999999999875332110        


Q ss_pred             --------------------------------------------------------------------------------
Q 010434          257 --------------------------------------------------------------------------------  256 (511)
Q Consensus       257 --------------------------------------------------------------------------------  256 (511)
                                                                                                      
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             -------------------------------ceeEEEeecCCCCcccccccCCCcCCcc-CHHHHHHHHHHHHHHHHHHH
Q 010434          257 -------------------------------KRALVYEFMPNGSLDRHIFPKENKGQTF-GWEKLQEIALGTARGVAYLH  304 (511)
Q Consensus       257 -------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~~l-~~~~~~~i~~~ia~~l~yLH  304 (511)
                                                     .+||=||||+...|.+++..    +... .....++++.+|++||.|+|
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~----N~~~~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR----NHFNSQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh----cccchhhHHHHHHHHHHHHHHHHHH
Confidence                                           12344455555444444411    1111 35677899999999999999


Q ss_pred             hCCCCceecccCCcCceEEcCCCCeeeecccccccCC---C-------------CCCceeeccccCCccccchhcccccC
Q 010434          305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP---K-------------ENDFVSISATRGTIGYIAPELISRNF  368 (511)
Q Consensus       305 ~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~---~-------------~~~~~~~~~~~gt~~y~APE~~~~~~  368 (511)
                      +   ++||||||||.||+||++..+||+|||+|+...   .             .......+...||.-|+|||++.+..
T Consensus       715 ~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 D---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             h---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            8   699999999999999999999999999998621   0             01111235567999999999998753


Q ss_pred             C-CcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcC
Q 010434          369 G-TVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVK  447 (511)
Q Consensus       369 ~-~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~  447 (511)
                      . .++.|+|+||+||+++||+.   ||.....+       ..+...++.+....   ...+...-.+.=..++.|+++.|
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER-------a~iL~~LR~g~iP~---~~~f~~~~~~~e~slI~~Ll~hd  858 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMER-------ASILTNLRKGSIPE---PADFFDPEHPEEASLIRWLLSHD  858 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCchHHH-------HHHHHhcccCCCCC---CcccccccchHHHHHHHHHhcCC
Confidence            2 69999999999999999985   34432222       12334444332222   22222233344567999999999


Q ss_pred             CCCCCCHHHHHH
Q 010434          448 AADRPSMTKVLE  459 (511)
Q Consensus       448 P~~RPs~~evl~  459 (511)
                      |.+|||+.|++.
T Consensus       859 P~kRPtA~eLL~  870 (1351)
T KOG1035|consen  859 PSKRPTATELLN  870 (1351)
T ss_pred             CccCCCHHHHhh
Confidence            999999999974

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-34  Score=277.26  Aligned_cols=254  Identities=21%  Similarity=0.287  Sum_probs=208.0

Q ss_pred             hhccccCcCCcEEEEEEEe------cCCcEEEEEEecc--CcccHHHHHHHHHHhccccccceEEeeceecc-CCceeEE
Q 010434          191 HFTHKLGQGGFGSVYKGQL------HTGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRALV  261 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~------~~g~~vAvK~l~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~-~~~~~lV  261 (511)
                      +.+..+-+|.||.||.|.+      ++.+.|-||.++.  +......|..|...+..++|||+..+.+++.+ ....+.+
T Consensus       287 ~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~  366 (563)
T KOG1024|consen  287 RLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVL  366 (563)
T ss_pred             echhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEE
Confidence            3446789999999999943      4566788998876  34455679999999999999999999999865 5678899


Q ss_pred             EeecCCCCccccccc----CCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccc
Q 010434          262 YEFMPNGSLDRHIFP----KENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLA  337 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~----~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla  337 (511)
                      |.++.-|+|..++..    .....+.++..++..++.|++.|++|||+   ++++|.||.++|.+||+..++||+|=.++
T Consensus       367 y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkltDsaLS  443 (563)
T KOG1024|consen  367 YPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLTDSALS  443 (563)
T ss_pred             EeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEeccchhc
Confidence            999999999998841    22334678899999999999999999998   79999999999999999999999999999


Q ss_pred             ccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhc
Q 010434          338 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNK  416 (511)
Q Consensus       338 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  416 (511)
                      +..-..+...--.....+..||+||.+..+  .++..+|||||||++|||+| |+.|+...+        |..++..+.+
T Consensus       444 RDLFP~DYhcLGDnEnRPvkWMslEal~n~--~yssasDvWsfGVllWELmtlg~~PyaeID--------PfEm~~ylkd  513 (563)
T KOG1024|consen  444 RDLFPGDYHCLGDNENRPVKWMSLEALQNS--HYSSASDVWSFGVLLWELMTLGKLPYAEID--------PFEMEHYLKD  513 (563)
T ss_pred             cccCcccccccCCCCCCcccccCHHHHhhh--hhcchhhhHHHHHHHHHHHhcCCCCccccC--------HHHHHHHHhc
Confidence            865444433333344467899999999876  89999999999999999988 777764433        4556777777


Q ss_pred             CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          417 GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      +.++..      +-.++.+|..++..||...|++||++++++.-|..
T Consensus       514 GyRlaQ------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  514 GYRLAQ------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             cceecC------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            776553      33456789999999999999999999999988865

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=4.9e-33  Score=269.55  Aligned_cols=220  Identities=21%  Similarity=0.162  Sum_probs=174.8

Q ss_pred             CCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCcccccccC
Q 010434          199 GGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK  277 (511)
Q Consensus       199 G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~  277 (511)
                      |.+|.||+++. .+++.+|+|.+....    .+.+|...+....||||+++++++.+....++||||+++|+|.+++.  
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS--   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH--
Confidence            89999999985 478999999987643    33455555666679999999999999999999999999999998873  


Q ss_pred             CCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeeccccCCcc
Q 010434          278 ENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG  357 (511)
Q Consensus       278 ~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  357 (511)
                        ....+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++++|||.+.......     ....++..
T Consensus        78 --~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~  147 (237)
T cd05576          78 --KFLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM  147 (237)
T ss_pred             --HhcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence              22458999999999999999999998   699999999999999999999999999876543321     22346778


Q ss_pred             ccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHHHHH
Q 010434          358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLC  437 (511)
Q Consensus       358 y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  437 (511)
                      |+|||.+...  .++.++||||+|+++|||++|+.|+.......             .......      .+..++..+.
T Consensus       148 y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------~~~~~~~------~~~~~~~~~~  206 (237)
T cd05576         148 YCAPEVGGIS--EETEACDWWSLGAILFELLTGKTLVECHPSGI-------------NTHTTLN------IPEWVSEEAR  206 (237)
T ss_pred             ccCCcccCCC--CCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------ccccccC------CcccCCHHHH
Confidence            9999988654  67889999999999999999997764321100             0000011      1223456788


Q ss_pred             HHHHHhcCcCCCCCCCHH
Q 010434          438 MIGLWCIQVKAADRPSMT  455 (511)
Q Consensus       438 ~l~~~Cl~~~P~~RPs~~  455 (511)
                      +++.+|++.||++||++.
T Consensus       207 ~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         207 SLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHccCCHHHhcCCC
Confidence            999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-33  Score=264.64  Aligned_cols=261  Identities=22%  Similarity=0.225  Sum_probs=206.0

Q ss_pred             cccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccc-cccceEEeeceecc----CCceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSE----GSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~----~~~~~lV~e~~~~  267 (511)
                      ++||-|-.|.|-.+.. .+|+.+|+|+|..+.    ...+|+++--+. .|||||.+++++.+    ...+.+|||.|+|
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meG  143 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEG  143 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcCH----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccc
Confidence            6899999999999975 479999999997643    455788775554 59999999999854    3446689999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC---CCCeeeecccccccCCCCC
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~---~~~~kl~DFGla~~~~~~~  344 (511)
                      |.|...|.  +.....+++.+.-+|..||+.|+.|||+   ++|.||||||+|+|...   |-.+||+|||+|+..... 
T Consensus       144 GeLfsriq--~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~-  217 (400)
T KOG0604|consen  144 GELFSRIQ--DRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP-  217 (400)
T ss_pred             hHHHHHHH--HcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCCC-
Confidence            99998883  3344679999999999999999999998   89999999999999954   567999999999865443 


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                        ......+.|+.|.|||++..+  .++...|+||+||++|-|++|.+||-.+...    .++..+...+..+....   
T Consensus       218 --~~L~TPc~TPyYvaPevlg~e--KydkscdmwSlgVimYIlLCGyPPFYS~hg~----aispgMk~rI~~gqy~F---  286 (400)
T KOG0604|consen  218 --GDLMTPCFTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMKRRIRTGQYEF---  286 (400)
T ss_pred             --ccccCCcccccccCHHHhCch--hcCCCCCccchhHHHHHhhcCCCcccccCCc----cCChhHHhHhhccCccC---
Confidence              345677899999999999876  7888899999999999999999999765432    23333444444443221   


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCCCCCCCCC
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKPCF  476 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~~p~~p~~  476 (511)
                      +.+.+..+++...++++.+|..+|++|-|+.++++.-.- ...-.+|..|..
T Consensus       287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi-~~~~~vp~tpl~  337 (400)
T KOG0604|consen  287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWI-NQYEAVPQTPLS  337 (400)
T ss_pred             CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchh-cccccCCCCCch
Confidence            234667788999999999999999999999999874331 222335555543

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-33  Score=265.29  Aligned_cols=265  Identities=24%  Similarity=0.336  Sum_probs=207.1

Q ss_pred             hHHHHHHHhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCcc-cHHHHHHHHHHhcccc-ccceEEeeceeccCCce
Q 010434          182 YPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKF-SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKR  258 (511)
Q Consensus       182 ~~ei~~~t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~~-~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~  258 (511)
                      +.|+.+.|.   +.||+|+|++|--++ +.+|..+|||++.+... ......+|++++...+ |+||++|+.||+++.+.
T Consensus        75 F~d~YkLt~---e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F  151 (463)
T KOG0607|consen   75 FEDMYKLTS---ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF  151 (463)
T ss_pred             HHHHHHhHH---HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence            456555553   589999999999997 78999999999988544 4567899999999985 99999999999999999


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC---Ceeeeccc
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF---IPKVSDFG  335 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~---~~kl~DFG  335 (511)
                      |||||-|.||+|..+|.    +...+++....++..+||.||.+||.   ++|.|||+||+|||-.+..   -+||+||.
T Consensus       152 YLVfEKm~GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  152 YLVFEKMRGGPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             EEEEecccCchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccc
Confidence            99999999999999983    44679999999999999999999998   7999999999999996543   47999999


Q ss_pred             ccccCCCCCCc-----eeeccccCCccccchhccc---ccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccc------
Q 010434          336 LAKFHPKENDF-----VSISATRGTIGYIAPELIS---RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRS------  401 (511)
Q Consensus       336 la~~~~~~~~~-----~~~~~~~gt~~y~APE~~~---~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~------  401 (511)
                      |+.-.....+.     .....++|+..|||||+..   ++-..|..+.|.||+||++|-|++|.+||...-...      
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG  304 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG  304 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence            87643322221     2234567999999999763   333467889999999999999999999997632211      


Q ss_pred             -cccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          402 -SKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       402 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                       .-..-...+.+.+.++.. +.  +...+..++....+++...+-.++.+|-++.+++.
T Consensus       305 e~Cr~CQ~~LFesIQEGkY-eF--PdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  305 EVCRVCQNKLFESIQEGKY-EF--PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CccHHHHHHHHHHHhccCC-cC--ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence             001112223334444322 22  23356677888888999999999999999988876

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-33  Score=303.06  Aligned_cols=250  Identities=22%  Similarity=0.262  Sum_probs=201.2

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEecc----CcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLEN----SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~----~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      -+.+.+.||+|+||.|..++. .+++.+|+|++++    ...+..-|..|-.+|..-+.+-||.|+-.|.++..+|+|||
T Consensus        76 DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMd  155 (1317)
T KOG0612|consen   76 DFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMD  155 (1317)
T ss_pred             hhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEe
Confidence            345568999999999999985 5789999999987    23355678899999998899999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |||||+|..++.    +-.+++++..+-.+..|..||.-||+   +|+|||||||+|||||..|++||+|||-+-....+
T Consensus       156 Y~pGGDlltLlS----k~~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d  228 (1317)
T KOG0612|consen  156 YMPGGDLLTLLS----KFDRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD  228 (1317)
T ss_pred             cccCchHHHHHh----hcCCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence            999999999882    22379999999999999999999999   89999999999999999999999999987666544


Q ss_pred             CCceeeccccCCccccchhccccc---CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcC-Cc
Q 010434          344 NDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG-GD  419 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~---~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~  419 (511)
                      .. +....++|||.|++||++...   .|.|+..+|.||+||++|||+.|..||-......        .|..+... ..
T Consensus       229 G~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve--------TY~KIm~hk~~  299 (1317)
T KOG0612|consen  229 GT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE--------TYGKIMNHKES  299 (1317)
T ss_pred             Cc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH--------HHHHHhchhhh
Confidence            43 455778899999999998532   2578999999999999999999999996544322        34444433 12


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCC---HHHHHH
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPS---MTKVLE  459 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---~~evl~  459 (511)
                      +.++..    ..++....+|+...+. +|+.|-.   +.++-.
T Consensus       300 l~FP~~----~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  300 LSFPDE----TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             cCCCcc----cccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            222221    2256677778877664 7788877   777754

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.2e-33  Score=265.73  Aligned_cols=274  Identities=22%  Similarity=0.266  Sum_probs=197.5

Q ss_pred             HhhhccccCcCCcEEEEEEEec---C--CcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceecc-CCcee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH---T--GRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRA  259 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~---~--g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~-~~~~~  259 (511)
                      .|+...+||+|.||.|||++-.   +  ...+|+|+++..+   .-.....+|+.+++.++||||+.|..++.+ +...+
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~  104 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW  104 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence            3455678999999999999622   3  2379999997642   223567899999999999999999999877 78899


Q ss_pred             EEEeecCCCCcccccccC-CCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC----CCeeeecc
Q 010434          260 LVYEFMPNGSLDRHIFPK-ENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN----FIPKVSDF  334 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~----~~~kl~DF  334 (511)
                      |++||.+. +|...|+-+ ......++...+..|+.||+.|+.|||++   -|+||||||.|||+..+    |.+||+||
T Consensus       105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecc
Confidence            99999976 666665432 33446789999999999999999999995   79999999999999877    99999999


Q ss_pred             cccccCCCCCCc-eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc-cc-chhh-
Q 010434          335 GLAKFHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA-YF-PSWV-  410 (511)
Q Consensus       335 Gla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~-~~-~~~~-  410 (511)
                      |+++.+...-.. .+....+-|+.|+|||.+.+. ..+|.+.|||+.||++.||+|-.+-|.......... .+ .+.+ 
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            999987654322 234556689999999999876 589999999999999999999877665432211111 11 1111 


Q ss_pred             --HHhhhcCCc---ccccccchh-----------------------HHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          411 --YDQLNKGGD---LELRNVTEI-----------------------ESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       411 --~~~~~~~~~---~~~~~~~~~-----------------------~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                        .+.+.-...   ..+...++.                       ...-++...+|+..+|+.||.+|.|+.+.++..-
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y  339 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY  339 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence              111000000   000000000                       0001123568999999999999999999988654


Q ss_pred             cCcCC
Q 010434          463 GSMDD  467 (511)
Q Consensus       463 ~~~~~  467 (511)
                      -..++
T Consensus       340 F~~d~  344 (438)
T KOG0666|consen  340 FTEDP  344 (438)
T ss_pred             cccCC
Confidence            43333

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3e-32  Score=301.49  Aligned_cols=142  Identities=25%  Similarity=0.378  Sum_probs=126.6

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcc----cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      |.+.++||+|+||.||+|... +++.||||+++....    ..+.+.+|+.++..++|+||+++++++......++||||
T Consensus         6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy   85 (669)
T cd05610           6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY   85 (669)
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence            456789999999999999865 789999999975322    236788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      +++++|.+++.    ....+++..++.++.||+.||+|||.   .+|+||||||+||||+.++.+||+|||+++
T Consensus        86 ~~g~~L~~li~----~~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          86 LIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999883    23468899999999999999999998   699999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-33  Score=267.26  Aligned_cols=236  Identities=23%  Similarity=0.316  Sum_probs=194.0

Q ss_pred             hhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          191 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      .|.+.||+|.||.|.+++ ..+|+.+|+|++++.-    .....-+.|-++|+..+||.+..|.-.|...+++|+||||.
T Consensus       171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya  250 (516)
T KOG0690|consen  171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA  250 (516)
T ss_pred             hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence            466899999999999998 4479999999998732    23344567889999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      .||.|.-++    +....++++..+-....|..||.|||+   .+||.||+|.+|.|||.+|.+||+||||.+---... 
T Consensus       251 nGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g-  322 (516)
T KOG0690|consen  251 NGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG-  322 (516)
T ss_pred             cCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccccc-
Confidence            999998887    345789999999999999999999999   699999999999999999999999999987433222 


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                       ..+...+||+.|+|||++..+  .+....|.|.+||++|||++||.||...+...        +...+.       ...
T Consensus       323 -~t~kTFCGTPEYLAPEVleDn--DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--------LFeLIl-------~ed  384 (516)
T KOG0690|consen  323 -DTTKTFCGTPEYLAPEVLEDN--DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--------LFELIL-------MED  384 (516)
T ss_pred             -ceeccccCChhhcCchhhccc--cccceeehhhhhHHHHHHHhccCcccccchhH--------HHHHHH-------hhh
Confidence             245677899999999999886  88999999999999999999999986543321        111110       011


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCC
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRP  452 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP  452 (511)
                      ..++..++++...|+...|..||.+|.
T Consensus       385 ~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  385 LKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence            124445567778889999999999993

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.98  E-value=6.5e-33  Score=286.86  Aligned_cols=237  Identities=23%  Similarity=0.304  Sum_probs=192.0

Q ss_pred             HhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCcccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEeecC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .+.+...+|.|+|+.|-++. ..+++..+||++.+...   +-.+|+.++.+. +||||+++.+.+.++...++|||.+.
T Consensus       323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~  399 (612)
T KOG0603|consen  323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD  399 (612)
T ss_pred             hhccccccCCCCccceeeeeccccccchhheecccccc---ccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence            44566779999999999987 55789999999977522   233567665555 79999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEE-cCCCCeeeecccccccCCCCCC
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL-DHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl-~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++-|.+.+...    .... ..+..|+.+|+.|+.|||.   ++++|||+||+|||+ ++.++++|+|||.++.....  
T Consensus       400 g~ell~ri~~~----~~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  400 GGELLRRIRSK----PEFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             ccHHHHHHHhc----chhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            99888776322    2233 6778899999999999998   799999999999999 68999999999999876554  


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                         ....+.|..|.|||++...  .+++++|+||||++||+|++|+.|+......       ..+...+..+        
T Consensus       470 ---~~tp~~t~~y~APEvl~~~--~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~--------  529 (612)
T KOG0603|consen  470 ---CDTPALTLQYVAPEVLAIQ--EYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMP--------  529 (612)
T ss_pred             ---hcccchhhcccChhhhccC--CCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCC--------
Confidence               3455689999999999865  8999999999999999999999998764332       1122322222        


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                       .....++....+|+.+|||.||.+||+|.++..
T Consensus       530 -~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  530 -KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             -ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence             122566788899999999999999999999975

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.98  E-value=8.2e-32  Score=258.70  Aligned_cols=237  Identities=25%  Similarity=0.354  Sum_probs=190.5

Q ss_pred             CcEEEEEEEec-CCcEEEEEEeccCcc-c-HHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCccccccc
Q 010434          200 GFGSVYKGQLH-TGRLIAVKMLENSKF-S-AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFP  276 (511)
Q Consensus       200 ~fg~Vykg~~~-~g~~vAvK~l~~~~~-~-~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~  276 (511)
                      +||.||+|+.. +|+.+|+|++..... . .+.+.+|+..+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 589999999976433 2 57899999999999999999999999999999999999999999998732


Q ss_pred             CCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeeccccCCc
Q 010434          277 KENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI  356 (511)
Q Consensus       277 ~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~  356 (511)
                          ...+++..+..++.+++.++.+||+   .+++|+||+|+||++++++.++|+|||.+.......   ......++.
T Consensus        81 ----~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~  150 (244)
T smart00220       81 ----RGRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP  150 (244)
T ss_pred             ----ccCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence                2238999999999999999999999   599999999999999999999999999998765542   223445888


Q ss_pred             cccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHHHH
Q 010434          357 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKL  436 (511)
Q Consensus       357 ~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  436 (511)
                      .|++||.+...  .++.++||||||+++++|++|..|+......       ....+.+.........    ....++..+
T Consensus       151 ~~~~pE~~~~~--~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-------~~~~~~~~~~~~~~~~----~~~~~~~~~  217 (244)
T smart00220      151 EYMAPEVLLGK--GYGKAVDVWSLGVILYELLTGKPPFPGDDQL-------LELFKKIGKPKPPFPP----PEWKISPEA  217 (244)
T ss_pred             CCCCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHhccCCCCcc----ccccCCHHH
Confidence            99999998754  6788999999999999999999988652111       1122222221111100    111145678


Q ss_pred             HHHHHHhcCcCCCCCCCHHHHHH
Q 010434          437 CMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       437 ~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .+++.+|+..+|++||++.++++
T Consensus       218 ~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      218 KDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHccCCchhccCHHHHhh
Confidence            89999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.98  E-value=4.3e-33  Score=279.97  Aligned_cols=242  Identities=26%  Similarity=0.352  Sum_probs=200.3

Q ss_pred             cccCcCCcEEEEEEE-ecCCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCC
Q 010434          194 HKLGQGGFGSVYKGQ-LHTGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGS  269 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  269 (511)
                      +.||+|.||+||-|+ -++|+.||||++.+-   ......+.+|+++|+.++||.||.+--.|+..++.+.|||-+ +|+
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GD  648 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGD  648 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cch
Confidence            689999999999998 468999999999763   334567899999999999999999999999999999999999 566


Q ss_pred             cccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC---CCeeeecccccccCCCCCCc
Q 010434          270 LDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN---FIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       270 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~---~~~kl~DFGla~~~~~~~~~  346 (511)
                      ..+.|...  ..++|++..-.-+..||+.||.|||.   ++|+|.||||+||||.+.   -++||+|||.|+..+...- 
T Consensus       649 MLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-  722 (888)
T KOG4236|consen  649 MLEMILSS--EKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-  722 (888)
T ss_pred             HHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence            66666433  34789999999999999999999998   799999999999999654   4799999999998876532 


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                        .....||+.|+|||++++.  .|...-|+||.||++|--++|.-||+....          +.+++.+..   ..-+.
T Consensus       723 --RrsVVGTPAYLaPEVLrnk--GyNrSLDMWSVGVIiYVsLSGTFPFNEdEd----------IndQIQNAa---FMyPp  785 (888)
T KOG4236|consen  723 --RRSVVGTPAYLAPEVLRNK--GYNRSLDMWSVGVIIYVSLSGTFPFNEDED----------INDQIQNAA---FMYPP  785 (888)
T ss_pred             --hhhhcCCccccCHHHHhhc--cccccccceeeeEEEEEEecccccCCCccc----------hhHHhhccc---cccCC
Confidence              1345699999999999876  788889999999999999999999875321          233333332   22234


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ..+.+++....+++...||.+-++|-|..+-+.
T Consensus       786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             CchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            467788888999999999999999988777653

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=6.6e-34  Score=265.37  Aligned_cols=249  Identities=25%  Similarity=0.340  Sum_probs=194.4

Q ss_pred             cccCcCCcEEEEEEEe-cCCcEEEEEEeccC--cccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEeecCCCC
Q 010434          194 HKLGQGGFGSVYKGQL-HTGRLIAVKMLENS--KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGS  269 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gs  269 (511)
                      ..||.|+||+|+|-.. +.|+..|||.+...  +.+.++++.|..+..+- +.||||+++|.+-.++..++-||.| ..|
T Consensus        70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~S  148 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DIS  148 (361)
T ss_pred             HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhh
Confidence            4699999999999874 57999999999763  34567788898876554 6899999999998889999999999 557


Q ss_pred             ccccccc-CCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          270 LDRHIFP-KENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       270 L~~~l~~-~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      |+.+-.. ...+...+++..+-.|..-...||.||...  ..|+||||||+|||||..|.+||+|||..-.....   ..
T Consensus       149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---iA  223 (361)
T KOG1006|consen  149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---IA  223 (361)
T ss_pred             HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHH---HH
Confidence            7654210 122346788999999999999999999985  89999999999999999999999999987644322   12


Q ss_pred             eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhc---CCccccccc
Q 010434          349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK---GGDLELRNV  425 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  425 (511)
                      .+...|-..|||||.+..+...+..+|||||+|++|+|++||+-|+.....          +.+++..   +....+ ..
T Consensus       224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----------vfeql~~Vv~gdpp~l-~~  292 (361)
T KOG1006|consen  224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----------VFEQLCQVVIGDPPIL-LF  292 (361)
T ss_pred             hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----------HHHHHHHHHcCCCCee-cC
Confidence            244457789999999987655689999999999999999999999865432          2333322   222221 11


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .......+..++.++..|+-.|-++||...++.+
T Consensus       293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            2233446788999999999999999999999875

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.7e-32  Score=265.54  Aligned_cols=261  Identities=23%  Similarity=0.340  Sum_probs=198.0

Q ss_pred             HHHHHHhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCcccH--------HHHHHHHHHhccccccceEEeeceec-
Q 010434          184 EIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSA--------EEFINEVSTIGRIHHVNVVQLLGFCS-  253 (511)
Q Consensus       184 ei~~~t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~~~~--------~~f~~Ev~~l~~l~H~niv~l~g~~~-  253 (511)
                      -....+|-+.+.||+|||+.|||+. +...+.||||+-..++...        +...+|..+-+.|.||.||++++++. 
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL  538 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence            3455566677889999999999997 6678999999864332211        23568999999999999999999995 


Q ss_pred             cCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC---CCCee
Q 010434          254 EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH---NFIPK  330 (511)
Q Consensus       254 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~---~~~~k  330 (511)
                      +.+..|-|+||++|.+|+-++    .....+++...+.|+.||..||.||..- ..+|||-||||.||||-+   -|.+|
T Consensus       539 DtdsFCTVLEYceGNDLDFYL----KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIK  613 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYL----KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIK  613 (775)
T ss_pred             ccccceeeeeecCCCchhHHH----HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeE
Confidence            456788999999999999888    3446799999999999999999999874 578999999999999944   47899


Q ss_pred             eecccccccCCCCCCc-----eeeccccCCccccchhcccc--cCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc
Q 010434          331 VSDFGLAKFHPKENDF-----VSISATRGTIGYIAPELISR--NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK  403 (511)
Q Consensus       331 l~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~--~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~  403 (511)
                      |.||||++.+..+...     ..++...||.+|++||.+--  ....++.|.||||.||++|..+.|++||.-+....  
T Consensus       614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--  691 (775)
T KOG1151|consen  614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--  691 (775)
T ss_pred             eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--
Confidence            9999999987655432     22345569999999997742  24578999999999999999999999997543221  


Q ss_pred             cccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHH
Q 010434          404 AYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVL  458 (511)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl  458 (511)
                       .+  .-+..+-+.....++.    .+..+.....++++||+..-++|....++.
T Consensus       692 -dI--LqeNTIlkAtEVqFP~----KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  692 -DI--LQENTILKATEVQFPP----KPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             -HH--HhhhchhcceeccCCC----CCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence             00  0011111111111211    123445677899999999999998766653

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=237.22  Aligned_cols=256  Identities=23%  Similarity=0.299  Sum_probs=193.1

Q ss_pred             ccccCcCCcEEEEEEE-ecCCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          193 THKLGQGGFGSVYKGQ-LHTGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      .++||+|.||+|||++ ..+++.||+|.+..+   +.-.....+|+-+++.++|.|||++++....+.++.+|+||| ..
T Consensus         7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dq   85 (292)
T KOG0662|consen    7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQ   85 (292)
T ss_pred             HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hH
Confidence            4689999999999998 457889999998653   334567899999999999999999999999999999999999 55


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      +|.++.   ..-++.+..+....++.|+++|+.+.|+   ++++|||+||.|.||+.||+.|++|||+++-++-...  .
T Consensus        86 dlkkyf---dslng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvr--c  157 (292)
T KOG0662|consen   86 DLKKYF---DSLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--C  157 (292)
T ss_pred             HHHHHH---HhcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceE--e
Confidence            888876   2345778999999999999999999999   7999999999999999999999999999997765432  2


Q ss_pred             eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCC-CCcccccccccccchhhHHhhhcCCc--------
Q 010434          349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNAIRSSKAYFPSWVYDQLNKGGD--------  419 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~--------  419 (511)
                      .++..-|..|.+|.++-+. .-+++..|+||-||++.|+....+| |...+... +..--.|+.....+...        
T Consensus       158 ysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvdd-qlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             eeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH-HHHHHHHHhCCCccccCCccccCCC
Confidence            3555689999999998775 4688899999999999999975444 44333221 11101111111111100        


Q ss_pred             ---ccccccchhHHHH----HHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          420 ---LELRNVTEIESVI----ARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       420 ---~~~~~~~~~~~~~----~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                         ..+-........+    ...=++++...+.-+|.+|.++.+.++
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence               0011111122223    334467788888889999999988875

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-32  Score=266.98  Aligned_cols=242  Identities=25%  Similarity=0.314  Sum_probs=196.6

Q ss_pred             HHHHHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc----ccHHHHHHHHHHhccc-cccceEEeeceeccCCc
Q 010434          184 EIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSK  257 (511)
Q Consensus       184 ei~~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~  257 (511)
                      -|.+.-.+|..+||+|+||.|.++.-+ +.+.+|||+|+++-    .+.+--+.|-++|... +-|.+++++.++..-++
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            355556788999999999999999754 56789999998743    2334445677777655 57889999999999999


Q ss_pred             eeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccc
Q 010434          258 RALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLA  337 (511)
Q Consensus       258 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla  337 (511)
                      +|+||||+.+|+|--+|    ++-+.+.+....-.|..||-||-+||+   ++|+.||||.+||+||.+|.+||+|||+.
T Consensus       425 LyFVMEyvnGGDLMyhi----QQ~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmc  497 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHI----QQVGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMC  497 (683)
T ss_pred             eeeEEEEecCchhhhHH----HHhcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccc
Confidence            99999999999998887    344667788888999999999999998   79999999999999999999999999999


Q ss_pred             ccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcC
Q 010434          338 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG  417 (511)
Q Consensus       338 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  417 (511)
                      +..-...  ..+...+||+.|+|||.+.-+  +|+...|.|||||+||||+.|.+||+..+..+        +.+.+.+.
T Consensus       498 KEni~~~--~TTkTFCGTPdYiAPEIi~Yq--PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--------lF~aI~eh  565 (683)
T KOG0696|consen  498 KENIFDG--VTTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--------LFQAIMEH  565 (683)
T ss_pred             cccccCC--cceeeecCCCcccccceEEec--ccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHHc
Confidence            7433222  344567899999999998754  88899999999999999999999999876433        33333332


Q ss_pred             CcccccccchhHHHHHHHHHHHHHHhcCcCCCCC
Q 010434          418 GDLELRNVTEIESVIARKLCMIGLWCIQVKAADR  451 (511)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R  451 (511)
                      .       ...+..++++...+....+...|.+|
T Consensus       566 n-------vsyPKslSkEAv~ickg~ltK~P~kR  592 (683)
T KOG0696|consen  566 N-------VSYPKSLSKEAVAICKGLLTKHPGKR  592 (683)
T ss_pred             c-------CcCcccccHHHHHHHHHHhhcCCccc
Confidence            1       12455667788889999999999999

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=6.1e-31  Score=284.68  Aligned_cols=263  Identities=22%  Similarity=0.232  Sum_probs=165.7

Q ss_pred             hhhccccCcCCcEEEEEEEec-C----CcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeece------eccCCce
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-T----GRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF------CSEGSKR  258 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~----g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~------~~~~~~~  258 (511)
                      +.+.++||+|+||.||+|++. +    +..||||++.... ..+.+.+|  .+.+..+.+++.+...      ...+...
T Consensus       134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (566)
T PLN03225        134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEY  210 (566)
T ss_pred             eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-hhHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCce
Confidence            455689999999999999864 5    7899999876432 22222222  1122222222222211      2456778


Q ss_pred             eEEEeecCCCCcccccccCCC----------------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceE
Q 010434          259 ALVYEFMPNGSLDRHIFPKEN----------------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNIL  322 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~----------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NIL  322 (511)
                      ++||||+++++|.+++.....                .+.......+..++.||+.||+|||+   .+|+||||||+|||
T Consensus       211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~NIL  287 (566)
T PLN03225        211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNII  287 (566)
T ss_pred             EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHHEE
Confidence            999999999999888743210                01112234566899999999999998   69999999999999


Q ss_pred             EcC-CCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCC--------------------CcCccchHHHHH
Q 010434          323 LDH-NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG--------------------TVSCKSDVYGFG  381 (511)
Q Consensus       323 l~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~--------------------~~s~ksDVwS~G  381 (511)
                      +++ ++.+||+|||+|+......... .....+|+.|+|||.+.....                    .++.++||||||
T Consensus       288 l~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG  366 (566)
T PLN03225        288 FSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG  366 (566)
T ss_pred             EeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence            986 5899999999998654332221 234468999999996532211                    234567999999


Q ss_pred             HHHHHHHhCCCCCCccccc------ccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHH
Q 010434          382 MVLLEMAGGRRNSNMNAIR------SSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMT  455 (511)
Q Consensus       382 vll~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~  455 (511)
                      |++|||+++..+.+.....      .....+..|... .......+.....+..........+|+.+||+.||++|||++
T Consensus       367 viL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~  445 (566)
T PLN03225        367 LIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL-VEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAK  445 (566)
T ss_pred             HHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh-hccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHH
Confidence            9999999977665432110      000111111110 000000000000001111123456899999999999999999


Q ss_pred             HHHHH
Q 010434          456 KVLEM  460 (511)
Q Consensus       456 evl~~  460 (511)
                      ++++.
T Consensus       446 e~L~H  450 (566)
T PLN03225        446 AALAH  450 (566)
T ss_pred             HHhCC
Confidence            99873

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=9.6e-31  Score=277.07  Aligned_cols=259  Identities=20%  Similarity=0.255  Sum_probs=176.5

Q ss_pred             hhhccccCcCCcEEEEEEEe-----------------cCCcEEEEEEeccCcc-cHHHH--------------HHHHHHh
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-----------------HTGRLIAVKMLENSKF-SAEEF--------------INEVSTI  237 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-----------------~~g~~vAvK~l~~~~~-~~~~f--------------~~Ev~~l  237 (511)
                      +.+.++||+|+||.||+|.+                 ..++.||||.+..... ..++|              ..|+..+
T Consensus       147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l  226 (507)
T PLN03224        147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC  226 (507)
T ss_pred             ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence            45568999999999999963                 2356899999865322 22333              4466777


Q ss_pred             ccccccce-----EEeeceecc--------CCceeEEEeecCCCCcccccccCCC--------------------cCCcc
Q 010434          238 GRIHHVNV-----VQLLGFCSE--------GSKRALVYEFMPNGSLDRHIFPKEN--------------------KGQTF  284 (511)
Q Consensus       238 ~~l~H~ni-----v~l~g~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~--------------------~~~~l  284 (511)
                      .+++|.|+     ++++++|..        ....+|||||+++++|.++++....                    ....+
T Consensus       227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~  306 (507)
T PLN03224        227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR  306 (507)
T ss_pred             HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence            77766554     677787753        3567999999999999998853211                    11235


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeeccccCCccccchhcc
Q 010434          285 GWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI  364 (511)
Q Consensus       285 ~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~  364 (511)
                      +|..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++........ ......+|+.|+|||.+
T Consensus       307 ~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~l  382 (507)
T PLN03224        307 DINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEEL  382 (507)
T ss_pred             CHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChhhh
Confidence            788899999999999999998   69999999999999999999999999999754432211 11223357899999987


Q ss_pred             cccCC--------------------CcCccchHHHHHHHHHHHHhCCC-CCCcccccccc-----cccchhhHHhhhcCC
Q 010434          365 SRNFG--------------------TVSCKSDVYGFGMVLLEMAGGRR-NSNMNAIRSSK-----AYFPSWVYDQLNKGG  418 (511)
Q Consensus       365 ~~~~~--------------------~~s~ksDVwS~Gvll~elltg~~-p~~~~~~~~~~-----~~~~~~~~~~~~~~~  418 (511)
                      .....                    ....+.||||+||++++|++|.. |+........+     .....|.  .. ...
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~~-~~~  459 (507)
T PLN03224        383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR--MY-KGQ  459 (507)
T ss_pred             cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--hh-ccc
Confidence            53210                    11235799999999999999874 55321111000     0011111  11 111


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhcCcCC---CCCCCHHHHHH
Q 010434          419 DLELRNVTEIESVIARKLCMIGLWCIQVKA---ADRPSMTKVLE  459 (511)
Q Consensus       419 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P---~~RPs~~evl~  459 (511)
                      .....    .....+....+++.++|..+|   .+|+|++|+++
T Consensus       460 ~~~~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        460 KYDFS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             CCCcc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            11111    122345677889999998765   78999999985

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=7.6e-31  Score=278.37  Aligned_cols=252  Identities=28%  Similarity=0.388  Sum_probs=202.9

Q ss_pred             HhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCcccHHHHHHHHHHhccc-cccceEEeeceec-----cCCceeEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCS-----EGSKRALV  261 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~-----~~~~~~lV  261 (511)
                      +..|.+.+|.|.+|.||+++ .++|+.+|+|++.......++...|.++++.. +|||++.++|++.     .++.++||
T Consensus        20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV   99 (953)
T KOG0587|consen   20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV   99 (953)
T ss_pred             ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence            44667899999999999998 67899999999988877788888999999888 6999999999884     46789999


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      ||||.+||..|++..-.  +..+.|..+..|+..++.|+.+||.+   .++|||||-.||||+.++.+||.|||++....
T Consensus       100 MEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQld  174 (953)
T KOG0587|consen  100 MEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  174 (953)
T ss_pred             eeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence            99999999999985443  78999999999999999999999994   89999999999999999999999999987553


Q ss_pred             CCCCceeeccccCCccccchhccccc---CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCC
Q 010434          342 KENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG  418 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~---~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  418 (511)
                      ...  .......||+.|||||++...   ...++..+|+||+|++..||.-|.+|+-....-.  ..|      .+-...
T Consensus       175 sT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr--aLF------~IpRNP  244 (953)
T KOG0587|consen  175 STV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR--ALF------LIPRNP  244 (953)
T ss_pred             ccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh--hhc------cCCCCC
Confidence            322  122445699999999998543   2357789999999999999999999975432111  000      111111


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          419 DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       419 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .+.+    .-+..-++++-+++..||..|-++||++.++++
T Consensus       245 PPkL----krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  245 PPKL----KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             Cccc----cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            1111    123445678889999999999999999999875

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=5.6e-32  Score=250.62  Aligned_cols=264  Identities=23%  Similarity=0.332  Sum_probs=191.9

Q ss_pred             HhhhccccCcCCcEEEEEEE-ecCCcEEEEEEecc---CcccHHHHHHHHHHhccccccceEEeeceecc--------CC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLEN---SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE--------GS  256 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~--------~~  256 (511)
                      ++.-..++|+|.||.||+++ -++|+.||+|+.-.   .+.-....++|+.++..++|+|++.++..|..        ..
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            34435689999999999998 45788899987532   23334677899999999999999999998843        23


Q ss_pred             ceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccc
Q 010434          257 KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGL  336 (511)
Q Consensus       257 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGl  336 (511)
                      ..++|+++|+. +|.-++   .+....++...+.+++.++..||.|+|+   ..|+|||+||.|+||+.++.+||+|||+
T Consensus        98 t~ylVf~~ceh-DLaGlL---sn~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLL---SNRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             eeeeeHHHhhh-hHHHHh---cCccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccc
Confidence            47899999965 676666   2344689999999999999999999999   5999999999999999999999999999


Q ss_pred             cccCCCCCCce--eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc-----------
Q 010434          337 AKFHPKENDFV--SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK-----------  403 (511)
Q Consensus       337 a~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~-----------  403 (511)
                      ++.+.......  ..+...-|..|++||.+.+. ..++++.|||.-||++.||.++.+-+..+.....-           
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            98765544322  22444579999999999875 68899999999999999999998876654322110           


Q ss_pred             -cccchhhHHhhhcCCccc-cccc-chhHHHH------HHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          404 -AYFPSWVYDQLNKGGDLE-LRNV-TEIESVI------ARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       404 -~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~------~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                       ..+|....-.+.+....+ +... ...-++.      ....++++..++..||.+||++++++..
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence             011110000000000001 0000 0000111      1256789999999999999999998764

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=261.30  Aligned_cols=267  Identities=24%  Similarity=0.322  Sum_probs=203.9

Q ss_pred             CCChHHHHHHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhccccc--c----ceEEeece
Q 010434          179 RYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHH--V----NVVQLLGF  251 (511)
Q Consensus       179 ~~~~~ei~~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H--~----niv~l~g~  251 (511)
                      .|...|....+|.+.+++|+|.||.|-.+..+ .+..||||+++.-..-.+.-+-|++++++|.+  |    -+|.+.+|
T Consensus        80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w  159 (415)
T KOG0671|consen   80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDW  159 (415)
T ss_pred             EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence            45566777778888899999999999999743 57899999998755555667789999999942  2    37888999


Q ss_pred             eccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC------
Q 010434          252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH------  325 (511)
Q Consensus       252 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~------  325 (511)
                      +.-.++.|+|+|.+ |-|+.+++  ..+.-.+++...+..|+.|+++++++||+   .+++|-||||+|||+-+      
T Consensus       160 FdyrghiCivfell-G~S~~dFl--k~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~  233 (415)
T KOG0671|consen  160 FDYRGHICIVFELL-GLSTFDFL--KENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKT  233 (415)
T ss_pred             hhccCceEEEEecc-ChhHHHHh--ccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEE
Confidence            99999999999998 77899988  44455789999999999999999999998   69999999999999931      


Q ss_pred             --------------CCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCC
Q 010434          326 --------------NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR  391 (511)
Q Consensus       326 --------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~  391 (511)
                                    +..+||+|||-|+......     +..+.|..|.|||++.+-  .++.++||||+||+|.|+.+|.
T Consensus       234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgL--GwS~pCDvWSiGCIL~ElytG~  306 (415)
T KOG0671|consen  234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGL--GWSQPCDVWSIGCILVELYTGE  306 (415)
T ss_pred             eccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheecc--CcCCccCceeeeeEEEEeeccc
Confidence                          3468999999998765544     334578899999999986  8999999999999999999998


Q ss_pred             CCCCcccccc-------cccccchhhHHhh------hcCCccc---------------cccc----chhHHHHHHHHHHH
Q 010434          392 RNSNMNAIRS-------SKAYFPSWVYDQL------NKGGDLE---------------LRNV----TEIESVIARKLCMI  439 (511)
Q Consensus       392 ~p~~~~~~~~-------~~~~~~~~~~~~~------~~~~~~~---------------~~~~----~~~~~~~~~~l~~l  439 (511)
                      .-|......+       .-..+|..+....      ..+ .++               ...+    ..........|.+|
T Consensus       307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL  385 (415)
T KOG0671|consen  307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL  385 (415)
T ss_pred             eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence            7665433111       1112333222221      000 010               0000    01122345679999


Q ss_pred             HHHhcCcCCCCCCCHHHHHH
Q 010434          440 GLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       440 ~~~Cl~~~P~~RPs~~evl~  459 (511)
                      +..||..||.+|+|+.|++.
T Consensus       386 l~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  386 LRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHHccCccccccHHHHhc
Confidence            99999999999999999975

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-30  Score=235.22  Aligned_cols=199  Identities=27%  Similarity=0.418  Sum_probs=166.3

Q ss_pred             ccccCcCCcEEEEEEE-ecCCcEEEEEEecc--CcccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEeecCCC
Q 010434          193 THKLGQGGFGSVYKGQ-LHTGRLIAVKMLEN--SKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~--~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      ...||+|++|.|-+-+ .++|+..|+|.+..  +.+..+..+.|+.+..+. ..|.+|.++|..-......+.||.| .-
T Consensus        51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~t  129 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DT  129 (282)
T ss_pred             hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hh
Confidence            4579999999998887 56899999999976  445566788899887665 6899999999988889999999999 55


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      ||+++-..--..+..+++..+-+|+..+.+||.|||+.  .+++|||+||+|||++.+|++|++|||.+-.....-   .
T Consensus       130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi---A  204 (282)
T KOG0984|consen  130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI---A  204 (282)
T ss_pred             hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhh---H
Confidence            88776433335678899999999999999999999995  899999999999999999999999999987654322   2


Q ss_pred             eccccCCccccchhcccccC--CCcCccchHHHHHHHHHHHHhCCCCCCcc
Q 010434          349 ISATRGTIGYIAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMN  397 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~--~~~s~ksDVwS~Gvll~elltg~~p~~~~  397 (511)
                      .+...|-..|||||.+..+.  ..|+.||||||+|+.+.||++++.|++..
T Consensus       205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            23345778999999986532  26889999999999999999999998654

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.7e-30  Score=246.07  Aligned_cols=241  Identities=20%  Similarity=0.297  Sum_probs=193.9

Q ss_pred             ccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc----cHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEeecC
Q 010434          193 THKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF----SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      ..+||+|+|..|-.+++ ++.+.+|+|++++.-.    +.+-...|-.+..+. +||.+|-|+.+|..++++++|.||++
T Consensus       255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~  334 (593)
T KOG0695|consen  255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN  334 (593)
T ss_pred             eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence            46799999999999985 4788999999976322    233344555555554 79999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +|+|--++    +....|+++..+-....|..||.|||+   .+|+.||+|.+|+|||.+|.+||.|+|+.+.-..+.+ 
T Consensus       335 ggdlmfhm----qrqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd-  406 (593)
T KOG0695|consen  335 GGDLMFHM----QRQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD-  406 (593)
T ss_pred             Ccceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCCCc-
Confidence            99997666    345679999999999999999999999   7999999999999999999999999999986554443 


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                       .++..+||+.|+|||.+++.  .|....|.|++||+++||+.|+.||+.-........-.+++.+.+.+...-      
T Consensus       407 -~tstfcgtpnyiapeilrge--eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir------  477 (593)
T KOG0695|consen  407 -TTSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR------  477 (593)
T ss_pred             -ccccccCCCcccchhhhccc--ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc------
Confidence             34667899999999999987  788899999999999999999999997655444444455555554443221      


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCC
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADR  451 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~R  451 (511)
                       .+..++-+...++..-|..||++|
T Consensus       478 -iprslsvkas~vlkgflnkdp~er  501 (593)
T KOG0695|consen  478 -IPRSLSVKASHVLKGFLNKDPKER  501 (593)
T ss_pred             -ccceeehhhHHHHHHhhcCCcHHh
Confidence             222334455668888899999999

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=8.3e-29  Score=231.58  Aligned_cols=210  Identities=33%  Similarity=0.564  Sum_probs=181.3

Q ss_pred             cCcCCcEEEEEEEec-CCcEEEEEEeccCcc--cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCccc
Q 010434          196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDR  272 (511)
Q Consensus       196 LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~  272 (511)
                      ||+|++|.||++... +++.+++|++.....  ..+.+.+|+..+++++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999965 489999999876544  35789999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC-CCCeeeecccccccCCCCCCceeecc
Q 010434          273 HIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVSISA  351 (511)
Q Consensus       273 ~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~  351 (511)
                      ++...   ...+++..+..++.++++++++||+   .+++|+||+|+||+++. ++.++|+|||.+........  ....
T Consensus        81 ~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~  152 (215)
T cd00180          81 LLKEN---EGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT  152 (215)
T ss_pred             HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence            87321   1468999999999999999999998   69999999999999999 89999999999986654421  1233


Q ss_pred             ccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHH
Q 010434          352 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESV  431 (511)
Q Consensus       352 ~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  431 (511)
                      ..+...|++||.+... ...+.++|+|++|+++++|                                            
T Consensus       153 ~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l--------------------------------------------  187 (215)
T cd00180         153 IVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL--------------------------------------------  187 (215)
T ss_pred             ccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence            4578899999988653 3677899999999999998                                            


Q ss_pred             HHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          432 IARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       432 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                        ..+.+++..|++.+|.+||++.++++.
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence              457789999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.7e-31  Score=263.58  Aligned_cols=242  Identities=22%  Similarity=0.274  Sum_probs=201.6

Q ss_pred             ccccCcCCcEEEEEEEecCCc-EEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          193 THKLGQGGFGSVYKGQLHTGR-LIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~~~g~-~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      ...||-||||.|=+.+.+... .+|+|++++..    ...+...+|-++|...+.|.||+++-.|.+....|++||-|-|
T Consensus       425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG  504 (732)
T KOG0614|consen  425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG  504 (732)
T ss_pred             hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence            346999999999999876444 48999997732    2445678999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |.|...+    ...+.+......-++..+.+|++|||+   ++||.|||||+|.+||.+|-+||.|||.|+......   
T Consensus       505 GElWTiL----rdRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~---  574 (732)
T KOG0614|consen  505 GELWTIL----RDRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR---  574 (732)
T ss_pred             chhhhhh----hhcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCC---
Confidence            9999888    455788888899999999999999999   799999999999999999999999999999876654   


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      .+-..+||+.|.|||.+.+.  .-...+|.||+|++++||++|++||...+        |...|+.+.++.+     ..+
T Consensus       575 KTwTFcGTpEYVAPEIILnK--GHD~avDyWaLGIli~ELL~G~pPFs~~d--------pmktYn~ILkGid-----~i~  639 (732)
T KOG0614|consen  575 KTWTFCGTPEYVAPEIILNK--GHDRAVDYWALGILIYELLTGSPPFSGVD--------PMKTYNLILKGID-----KIE  639 (732)
T ss_pred             ceeeecCCcccccchhhhcc--CcchhhHHHHHHHHHHHHHcCCCCCCCCc--------hHHHHHHHHhhhh-----hhh
Confidence            24556799999999998765  56778999999999999999999997643        3445666655532     123


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCC-----HHHHHH
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPS-----MTKVLE  459 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~evl~  459 (511)
                      ++..+.+...++++.....+|.+|-.     +.++-+
T Consensus       640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk  676 (732)
T KOG0614|consen  640 FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK  676 (732)
T ss_pred             cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence            55566777888999999999999965     566654

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=8.3e-30  Score=261.07  Aligned_cols=207  Identities=25%  Similarity=0.362  Sum_probs=171.8

Q ss_pred             cccCcCCcEEEEEEE-ecCCcEEEEEEeccCcc----cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          194 HKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      +.||-|+||.|.++. .++...+|+|.|++...    .......|-.||..-..+.||+|+-.|.+.+.+|+||||+|||
T Consensus       635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG  714 (1034)
T KOG0608|consen  635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG  714 (1034)
T ss_pred             eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence            469999999999996 56678899999976332    3345678999999999999999999999999999999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC------
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK------  342 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~------  342 (511)
                      ++-.+|.    +.+.+.++..+-.+..++.|+++.|.   +|+|||||||+|||||.+|.+||.||||..-+..      
T Consensus       715 DmMSLLI----rmgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  715 DMMSLLI----RMGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             cHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence            9998873    34678888899999999999999998   8999999999999999999999999999742110      


Q ss_pred             --CCCc--------------------------------eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHH
Q 010434          343 --ENDF--------------------------------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA  388 (511)
Q Consensus       343 --~~~~--------------------------------~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ell  388 (511)
                        ..+.                                ......+||+.|+|||++.+.  .++..+|.||.||+||||+
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~--g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART--GYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc--CccccchhhHhhHHHHHHh
Confidence              0000                                000123599999999999876  7889999999999999999


Q ss_pred             hCCCCCCcccccccccccchh
Q 010434          389 GGRRNSNMNAIRSSKAYFPSW  409 (511)
Q Consensus       389 tg~~p~~~~~~~~~~~~~~~~  409 (511)
                      .|+.||-.......+..+-.|
T Consensus       866 ~g~~pf~~~tp~~tq~kv~nw  886 (1034)
T KOG0608|consen  866 VGQPPFLADTPGETQYKVINW  886 (1034)
T ss_pred             hCCCCccCCCCCcceeeeeeh
Confidence            999999877766666555544

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=8.6e-30  Score=269.23  Aligned_cols=243  Identities=25%  Similarity=0.286  Sum_probs=181.9

Q ss_pred             cccCcCCcEE-EEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEeecCCCCcc
Q 010434          194 HKLGQGGFGS-VYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLD  271 (511)
Q Consensus       194 ~~LG~G~fg~-Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  271 (511)
                      +.+|.|..|+ ||+|... |+.||||++-...  ..-..+|+..++.- .|||||++++.-.+.+..||..|.| ..+|.
T Consensus       515 eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~  590 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVYE-GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQ  590 (903)
T ss_pred             HHcccCCCCcEEEEEeeC-CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHH
Confidence            5689999885 6999876 8999999875422  12346799988877 6999999999989999999999999 66999


Q ss_pred             cccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC-----CCCeeeecccccccCCCCCCc
Q 010434          272 RHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH-----NFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       272 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~-----~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +++...........-...+.+..|++.|+++||+   .+||||||||.||||+.     ...++|+|||+++........
T Consensus       591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS  667 (903)
T KOG1027|consen  591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS  667 (903)
T ss_pred             HHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence            9985431111112224567788999999999999   79999999999999965     357999999999987765443


Q ss_pred             -eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhC-CCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          347 -VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG-RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       347 -~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                       .......||.||+|||++...  .-+...||||+||++|..++| ..||.....+....         +........  
T Consensus       668 ~~r~s~~sGt~GW~APE~L~~~--~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI---------l~~~~~L~~--  734 (903)
T KOG1027|consen  668 FSRLSGGSGTSGWQAPEQLRED--RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI---------LTGNYTLVH--  734 (903)
T ss_pred             hhcccCCCCcccccCHHHHhcc--ccCcccchhhcCceEEEEecCCccCCCchHHhhhhh---------hcCccceee--
Confidence             334556799999999999875  556789999999999998876 88987654332111         111111110  


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .....+   ....+|+.+|+.++|..||++.+|+.
T Consensus       735 L~~~~d---~eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  735 LEPLPD---CEAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             eccCch---HHHHHHHHHhcCCCcccCCCHHHHhC
Confidence            011111   15678999999999999999999973

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-30  Score=242.87  Aligned_cols=260  Identities=22%  Similarity=0.320  Sum_probs=191.8

Q ss_pred             cccCcCCcEEEEEEEe-cCCcEEEEEEecc---CcccHHHHHHHHHHhccccccceEEeeceeccC-----CceeEEEee
Q 010434          194 HKLGQGGFGSVYKGQL-HTGRLIAVKMLEN---SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRALVYEF  264 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~-----~~~~lV~e~  264 (511)
                      +-||-|+||.||-... .+|+.||.|++.+   +-.+.+.+.+|++.+.-.+|.|++..++.....     ...|.+.|.
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL  138 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL  138 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence            5699999999999985 4899999999865   233557899999999999999999998876443     356788999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      | ..+|.++|.    ..+.++.+.+.-+..||++||.|||+   .+|+||||||.|.|+++|...||+|||+|+....+.
T Consensus       139 m-QSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  139 M-QSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             H-Hhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchhh
Confidence            9 679999884    34679999999999999999999999   599999999999999999999999999999765443


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc------c---hh------
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF------P---SW------  409 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~------~---~~------  409 (511)
                       ...++...-|..|.|||.+.+. ..++.+.||||.||++.||+..+.-|.....-..-..+      |   ..      
T Consensus       211 -~~hMTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG  288 (449)
T KOG0664|consen  211 -RLNMTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG  288 (449)
T ss_pred             -hhhhHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence             2345566688999999999886 68999999999999999999887665432211100000      0   00      


Q ss_pred             hHHh-hhcCCcc-cccccc--hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          410 VYDQ-LNKGGDL-ELRNVT--EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       410 ~~~~-~~~~~~~-~~~~~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      ...+ ++.+... ......  .....-......+...++..+|+.|.+..+.+..+..
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence            0001 1111100 000000  0111112344567778899999999999998876644

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-28  Score=244.65  Aligned_cols=145  Identities=25%  Similarity=0.381  Sum_probs=122.8

Q ss_pred             CCCCCCChHHHHH-HHhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCcccHHHHHHHHHHhcccc-----c---cc
Q 010434          175 WMPKRYSYPEIIA-VTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRIH-----H---VN  244 (511)
Q Consensus       175 ~~~~~~~~~ei~~-~t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~-----H---~n  244 (511)
                      .+.+...+.|... .+|.+.+|||-|.|++||++. ..+.+.||+|+.+....-.+..+.|+++|++++     |   ..
T Consensus        64 GGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~  143 (590)
T KOG1290|consen   64 GGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKC  143 (590)
T ss_pred             CCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCce
Confidence            3445566777777 889999999999999999997 567889999999876666677899999999983     3   36


Q ss_pred             eEEeeceec----cCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCc
Q 010434          245 VVQLLGFCS----EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHN  320 (511)
Q Consensus       245 iv~l~g~~~----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~N  320 (511)
                      ||+|+++|.    .+.+.|||+|++ |.+|.++|...  .-+.++...+.+|+.||+.||.|||..  .+|||-||||+|
T Consensus       144 VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPEN  218 (590)
T KOG1290|consen  144 VVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPEN  218 (590)
T ss_pred             eeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcce
Confidence            999999984    577899999999 77888888433  345688999999999999999999996  699999999999


Q ss_pred             eEEc
Q 010434          321 ILLD  324 (511)
Q Consensus       321 ILl~  324 (511)
                      |||.
T Consensus       219 vLl~  222 (590)
T KOG1290|consen  219 VLLC  222 (590)
T ss_pred             eeee
Confidence            9993

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=2.2e-27  Score=226.00  Aligned_cols=197  Identities=31%  Similarity=0.493  Sum_probs=168.2

Q ss_pred             hhccccCcCCcEEEEEEEecC-CcEEEEEEeccCcc--cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          191 HFTHKLGQGGFGSVYKGQLHT-GRLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~~-g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      .+.+.||+|++|.||++...+ ++.+|+|.+.....  ..+.+.+|+..+.+++|+|++++++++......++++|++++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   81 (225)
T smart00221        2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG   81 (225)
T ss_pred             ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence            456789999999999999764 89999999976543  467899999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCc-cCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          268 GSLDRHIFPKENKGQT-FGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~-l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      ++|.+++...    .. +++..+..++.+++.++.+||+   .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus        82 ~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       82 GDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            9999988322    23 8999999999999999999998   59999999999999999999999999999876554210


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM  396 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~  396 (511)
                       ......++..|++||.+. ....++.++|+|+||++++||++|+.||..
T Consensus       155 -~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 -LLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             -cccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence             112334778899999984 224777899999999999999999999854

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=5.4e-28  Score=221.42  Aligned_cols=255  Identities=17%  Similarity=0.306  Sum_probs=190.8

Q ss_pred             HhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCcccHHHHHHHHHHhcccc-ccceEEeeceeccC--CceeEEEee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEG--SKRALVYEF  264 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~--~~~~lV~e~  264 (511)
                      .|.+.+++|+|.|+.||.|. ..+++.++||+|+.-  ..+...+|+.+|..|. ||||++|++...+.  ....||+||
T Consensus        39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~  116 (338)
T KOG0668|consen   39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY  116 (338)
T ss_pred             hHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence            45667899999999999997 667899999999753  3457889999999997 99999999998654  567899999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC-CCeeeecccccccCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~-~~~kl~DFGla~~~~~~  343 (511)
                      +.+.+...+.       ..|+...+...+.+++.||.|+|+   +||.|||+||+|++||.. -.++|+|+|||.++...
T Consensus       117 v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  117 VNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             hccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            9988876654       678888999999999999999999   899999999999999865 57999999999887655


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc--------------------
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK--------------------  403 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~--------------------  403 (511)
                      ...   .....+..|--||.+-.- ..+...-|+|||||++.+|+..+.||--......+                    
T Consensus       187 ~eY---nVRVASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  187 KEY---NVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             cee---eeeeehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence            432   223355677889988653 57788899999999999999999998543222111                    


Q ss_pred             -cccchhhHHhhhcCCcccccc--cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          404 -AYFPSWVYDQLNKGGDLELRN--VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       404 -~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                       ..++....+.+....+.....  ..+...-.+++..+++...|..|-.+|||++|.+.
T Consensus       263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence             001111111111111110000  01111223467888999999999999999999864

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=3.9e-28  Score=247.15  Aligned_cols=190  Identities=23%  Similarity=0.357  Sum_probs=162.0

Q ss_pred             ccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHH---------HHHHHHHhcccc---ccceEEeeceeccCCcee
Q 010434          193 THKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEE---------FINEVSTIGRIH---HVNVVQLLGFCSEGSKRA  259 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~---------f~~Ev~~l~~l~---H~niv~l~g~~~~~~~~~  259 (511)
                      .+.+|.|+||.|+.+..+ +...|+||++.+.+.-.+.         .-.|+++|.+++   |+||+++++||++++..|
T Consensus       566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy  645 (772)
T KOG1152|consen  566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY  645 (772)
T ss_pred             eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence            467999999999999865 4668999999775543332         346999999997   999999999999999999


Q ss_pred             EEEeec-CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          260 LVYEFM-PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       260 lV~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      |++|-. ++.+|.++|    .....+++.....|+.||+.|+++||.   .+|+|||||-+|+.++.+|.+||+|||.|.
T Consensus       646 l~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgsaa  718 (772)
T KOG1152|consen  646 LETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGSAA  718 (772)
T ss_pred             EEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccchh
Confidence            999975 456888888    345679999999999999999999998   799999999999999999999999999987


Q ss_pred             cCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCC
Q 010434          339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS  394 (511)
Q Consensus       339 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~  394 (511)
                      +....    .....+||.+|.|||++.++ ......-|||++|++||.++....|+
T Consensus       719 ~~ksg----pfd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  719 YTKSG----PFDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             hhcCC----CcceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCC
Confidence            65433    23556799999999999887 34566789999999999998887775

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.7e-26  Score=215.05  Aligned_cols=249  Identities=20%  Similarity=0.314  Sum_probs=188.6

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhccc-cccceEEeece-eccCCceeEEEeec
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGF-CSEGSKRALVYEFM  265 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~-~~~~~~~~lV~e~~  265 (511)
                      .+++.+.||+|.||.+-++..+ +++.+++|.+........+|.+|..---.| .|.||+..++. |...+...+++||+
T Consensus        25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a  104 (378)
T KOG1345|consen   25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA  104 (378)
T ss_pred             hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence            5677889999999999999854 678999999988878889999999876666 58999988765 45566777999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEE-c-CCCCeeeecccccccCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL-D-HNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl-~-~~~~~kl~DFGla~~~~~~  343 (511)
                      |.|+|..-+     ....+.+..-.+++.|++.||.|+|+   +++||||||.+|||| + +...+||+|||+.+..+..
T Consensus       105 P~gdL~snv-----~~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t  176 (378)
T KOG1345|consen  105 PRGDLRSNV-----EAAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT  176 (378)
T ss_pred             ccchhhhhc-----CcccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence            999999877     22457788889999999999999998   799999999999999 3 3358999999998754432


Q ss_pred             CCceeeccccCCccccchhcccc---cCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcc
Q 010434          344 NDFVSISATRGTIGYIAPELISR---NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDL  420 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~---~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (511)
                           ......+..|.|||....   ......+.+|+|.||++++..+||+.||......    ..+-|-+.++.++...
T Consensus       177 -----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~----d~~Y~~~~~w~~rk~~  247 (378)
T KOG1345|consen  177 -----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM----DKPYWEWEQWLKRKNP  247 (378)
T ss_pred             -----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc----CchHHHHHHHhcccCc
Confidence                 123335678999997632   1124567899999999999999999999743322    2244555555554443


Q ss_pred             cccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHH
Q 010434          421 ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKV  457 (511)
Q Consensus       421 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev  457 (511)
                      .++.   ....+++++..+-.+-+..+|++|=-..++
T Consensus       248 ~~P~---~F~~fs~~a~r~Fkk~lt~~~~drcki~~~  281 (378)
T KOG1345|consen  248 ALPK---KFNPFSEKALRLFKKSLTPRFKDRCKIWTA  281 (378)
T ss_pred             cCch---hhcccCHHHHHHHHHhcCCcccccchhHHH
Confidence            3222   233345667777788889999999433333

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=1.9e-26  Score=220.94  Aligned_cols=249  Identities=23%  Similarity=0.262  Sum_probs=181.0

Q ss_pred             ccCcCCcEEEEEEEe-cCCcEEEEEEecc---CcccHHHHHHHHHHhccccccceEEeeceeccC------CceeEEEee
Q 010434          195 KLGQGGFGSVYKGQL-HTGRLIAVKMLEN---SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKRALVYEF  264 (511)
Q Consensus       195 ~LG~G~fg~Vykg~~-~~g~~vAvK~l~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~------~~~~lV~e~  264 (511)
                      .+|.|.- .|--+.. -.+++||+|.+..   .....+...+|...+..++|+||++++.+++-.      ...|+|||+
T Consensus        24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~  102 (369)
T KOG0665|consen   24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL  102 (369)
T ss_pred             ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence            4677776 4545542 2589999998755   233456778899999999999999999998543      457899999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      | .++|...+.      -.++-+.+..|..|++.|++|||+   .+|+||||||+||++..+..+||.|||+|+..... 
T Consensus       103 m-~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-  171 (369)
T KOG0665|consen  103 M-DANLCQVIL------MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-  171 (369)
T ss_pred             h-hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCcc-
Confidence            9 678887763      346677899999999999999999   69999999999999999999999999999854332 


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccc--------cccccchhhHHhhhc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRS--------SKAYFPSWVYDQLNK  416 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~--------~~~~~~~~~~~~~~~  416 (511)
                        ..++....|..|.|||++.+.  .+..++||||.||++.||++|+--|......+        ....-+.. ++++..
T Consensus       172 --~~mtpyVvtRyyrapevil~~--~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F-~~qL~~  246 (369)
T KOG0665|consen  172 --FMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSF-MKQLQP  246 (369)
T ss_pred             --cccCchhheeeccCchheecc--CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHH-HHHhhH
Confidence              345666789999999999876  58999999999999999999986655322110        00000000 000000


Q ss_pred             C--------------------CcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          417 G--------------------GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       417 ~--------------------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      .                    .+...+...+.++--...+.+++.+||-.||++|.++.++++.
T Consensus       247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            0                    0000111111121223456789999999999999999999874

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=7.2e-27  Score=235.27  Aligned_cols=271  Identities=20%  Similarity=0.282  Sum_probs=205.6

Q ss_pred             CCCChHHHHHHHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhcccc------ccceEEeec
Q 010434          178 KRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIH------HVNVVQLLG  250 (511)
Q Consensus       178 ~~~~~~ei~~~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~------H~niv~l~g  250 (511)
                      -++.+.|+...+|.+.-..|+|-|++|-+|.. .-|+.||||++.+++...+.=+.|+++|++|+      --|.++|+-
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r  501 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFR  501 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence            45778899999999999999999999999984 45789999999988777777789999999995      347889999


Q ss_pred             eeccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC-CCe
Q 010434          251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIP  329 (511)
Q Consensus       251 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~-~~~  329 (511)
                      .|...+++|||+|-+ ..+|.+.+... ..+..|....+..++.|+.-||..|..   .+|+|.||||.|||+++. ..+
T Consensus       502 ~F~hknHLClVFE~L-slNLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  502 HFKHKNHLCLVFEPL-SLNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HhhhcceeEEEehhh-hchHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCccee
Confidence            999999999999987 66888877332 234568888999999999999999998   599999999999999875 568


Q ss_pred             eeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccc-------c
Q 010434          330 KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRS-------S  402 (511)
Q Consensus       330 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~-------~  402 (511)
                      ||||||.|.......    .+...-+..|.|||.+.+-  .|+...|+||.||.||||.||+.-|.......       .
T Consensus       577 KLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~--~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~  650 (752)
T KOG0670|consen  577 KLCDFGSASFASENE----ITPYLVSRFYRAPEIILGL--PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL  650 (752)
T ss_pred             eeccCcccccccccc----ccHHHHHHhccCcceeecC--cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence            999999997665443    2333455689999999886  88899999999999999999986654422111       1


Q ss_pred             ccccchhh-------HHhhhcCCcc----------------------------ccc---ccchhHHHHHHHHHHHHHHhc
Q 010434          403 KAYFPSWV-------YDQLNKGGDL----------------------------ELR---NVTEIESVIARKLCMIGLWCI  444 (511)
Q Consensus       403 ~~~~~~~~-------~~~~~~~~~~----------------------------~~~---~~~~~~~~~~~~l~~l~~~Cl  444 (511)
                      ...+|.-+       .+++.....+                            ++.   ..+.........+.+|+..|+
T Consensus       651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml  730 (752)
T KOG0670|consen  651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML  730 (752)
T ss_pred             cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence            11122111       1111110000                            000   011223344567889999999


Q ss_pred             CcCCCCCCCHHHHHH
Q 010434          445 QVKAADRPSMTKVLE  459 (511)
Q Consensus       445 ~~~P~~RPs~~evl~  459 (511)
                      ..||++|.|..+.|+
T Consensus       731 ~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  731 ILDPEKRITVNQALK  745 (752)
T ss_pred             ccChhhcCCHHHHhc
Confidence            999999999999875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-26  Score=239.86  Aligned_cols=248  Identities=22%  Similarity=0.285  Sum_probs=192.1

Q ss_pred             hhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          191 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      ....++|.|.||.|||++ ...+...|||+++... .+..-..+|+-+++..+|||||.++|-+....+..+.|||+.+|
T Consensus        18 ellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycggg   97 (829)
T KOG0576|consen   18 ELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGG   97 (829)
T ss_pred             hheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCC
Confidence            446789999999999998 4579999999998733 34455678999999999999999999999999999999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      +|.+.-+    ..+++++.++........+|++|||+   ++=+|||||-.|||+++.+.+|++|||.+-.+...-  ..
T Consensus        98 slQdiy~----~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati--~K  168 (829)
T KOG0576|consen   98 SLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--AK  168 (829)
T ss_pred             cccceee----ecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh--hh
Confidence            9998763    34789999999999999999999998   688999999999999999999999999876543221  11


Q ss_pred             eccccCCccccchhccc-ccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhc-CCc-cccccc
Q 010434          349 ISATRGTIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK-GGD-LELRNV  425 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~-~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~  425 (511)
                      .....||+.|||||+.. ...|.+..++|||+.|+...|+..-.+|......        ..+.....+ +.. ..+.+ 
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--------mr~l~LmTkS~~qpp~lkD-  239 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--------MRALFLMTKSGFQPPTLKD-  239 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch--------HHHHHHhhccCCCCCcccC-
Confidence            23456999999999862 2236888999999999999999887776432211        111111111 111 11111 


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                         ...-...+-.+++.|+-.+|++|||+..+++
T Consensus       240 ---k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  240 ---KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ---CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence               1122345677999999999999999988764

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=1.7e-25  Score=206.23  Aligned_cols=166  Identities=21%  Similarity=0.210  Sum_probs=123.4

Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|.+++.   ..+..+++..+..++.|++.||+|||+.   +      ||+|||++.++.+|+  ||+++......   
T Consensus         1 GsL~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILE---VRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence            67888873   2245799999999999999999999983   3      999999999999999  99988654322   


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                          ..||+.|+|||++.+.  .++.++|||||||++|||++|+.|+......      ................. ...
T Consensus        64 ----~~g~~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~~~-~~~  130 (176)
T smart00750       64 ----SRVDPYFMAPEVIQGQ--SYTEKADIYSLGITLYEALDYELPYNEEREL------SAILEILLNGMPADDPR-DRS  130 (176)
T ss_pred             ----CCCcccccChHHhcCC--CCcchhhHHHHHHHHHHHHhCCCCccccchh------cHHHHHHHHHhccCCcc-ccc
Confidence                2589999999999765  7889999999999999999999998643211      11111111111111000 011


Q ss_pred             hHHHHHH--HHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          428 IESVIAR--KLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       428 ~~~~~~~--~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      .......  .+.+++.+||+.+|++||++.++++.+..
T Consensus       131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            2223333  68999999999999999999999998764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=3.8e-26  Score=258.33  Aligned_cols=196  Identities=18%  Similarity=0.208  Sum_probs=138.3

Q ss_pred             cccc-cceEEeecee-------ccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 010434          239 RIHH-VNVVQLLGFC-------SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC  310 (511)
Q Consensus       239 ~l~H-~niv~l~g~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~  310 (511)
                      +++| .||++++++|       .+....++++|++ +++|.+++..   ....+++..++.++.||++||+|||+   .+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~---~g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHS---QG  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHh---CC
Confidence            4556 6888888887       3334567888988 6699999842   23569999999999999999999998   69


Q ss_pred             eecccCCcCceEEcC-------------------CCCeeeecccccccCCCCCC--------------ceeeccccCCcc
Q 010434          311 ILHFDIKPHNILLDH-------------------NFIPKVSDFGLAKFHPKEND--------------FVSISATRGTIG  357 (511)
Q Consensus       311 ivH~DIkp~NILl~~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~  357 (511)
                      |+||||||+||||+.                   ++.+|++|||+++.......              ........||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            999999999999954                   45667777777754221000              000112357889


Q ss_pred             ccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHHHHH
Q 010434          358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLC  437 (511)
Q Consensus       358 y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  437 (511)
                      |+|||++.+.  .++.++|||||||+||||++|..|+.....          ....+.....   .  .... .......
T Consensus       181 Y~APE~~~~~--~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----------~~~~~~~~~~---~--~~~~-~~~~~~~  242 (793)
T PLN00181        181 YTSPEEDNGS--SSNCASDVYRLGVLLFELFCPVSSREEKSR----------TMSSLRHRVL---P--PQIL-LNWPKEA  242 (793)
T ss_pred             eEChhhhccC--CCCchhhhhhHHHHHHHHhhCCCchhhHHH----------HHHHHHHhhc---C--hhhh-hcCHHHH
Confidence            9999998764  789999999999999999998877542210          0111111000   0  0000 1123355


Q ss_pred             HHHHHhcCcCCCCCCCHHHHHH
Q 010434          438 MIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       438 ~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .++.+||+.+|.+||+|.++++
T Consensus       243 ~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        243 SFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHHhCCCChhhCcChHHHhh
Confidence            7888999999999999999986

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=4.6e-25  Score=218.62  Aligned_cols=257  Identities=22%  Similarity=0.312  Sum_probs=188.8

Q ss_pred             hhccccCcCCcEEEEEEEec----CCcEEEEEEeccCcccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEeec
Q 010434          191 HFTHKLGQGGFGSVYKGQLH----TGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~----~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      ...++||.|.|++||++.+.    ..+.||+|.+.... ......+|++.|.++ -+.||+++.+++..++..++|+||+
T Consensus        39 ~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~  117 (418)
T KOG1167|consen   39 KVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF  117 (418)
T ss_pred             hhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence            34679999999999999743    46789999986532 455788999999999 5999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC-CCeeeecccccccCCCC-
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKE-  343 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~-~~~kl~DFGla~~~~~~-  343 (511)
                      +.....++.       ..++...+...+..+..||+++|+   .||+||||||+|+|.+.. +.-.|.|||||...... 
T Consensus       118 ~H~~f~~l~-------~~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~  187 (418)
T KOG1167|consen  118 EHDRFRDLY-------RSLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ  187 (418)
T ss_pred             CccCHHHHH-------hcCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence            998888877       467788999999999999999999   699999999999999764 56789999999721100 


Q ss_pred             --------------------------------CCcee---------eccccCCccccchhcccccCCCcCccchHHHHHH
Q 010434          344 --------------------------------NDFVS---------ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM  382 (511)
Q Consensus       344 --------------------------------~~~~~---------~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gv  382 (511)
                                                      ..+..         .....||+||.|||++.+. +.-++++||||-||
T Consensus       188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiDiws~GV  266 (418)
T KOG1167|consen  188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAIDIWSAGV  266 (418)
T ss_pred             hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccceeeccc
Confidence                                            00000         0122399999999999864 67789999999999


Q ss_pred             HHHHHHhCCCCCCcccccccc----------------cccchh--hHH---------hhhcCCcc--------cc--ccc
Q 010434          383 VLLEMAGGRRNSNMNAIRSSK----------------AYFPSW--VYD---------QLNKGGDL--------EL--RNV  425 (511)
Q Consensus       383 ll~elltg~~p~~~~~~~~~~----------------~~~~~~--~~~---------~~~~~~~~--------~~--~~~  425 (511)
                      +++.+++++.||-........                ..++..  +++         ........        +-  ...
T Consensus       267 I~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~  346 (418)
T KOG1167|consen  267 ILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTER  346 (418)
T ss_pred             eeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceee
Confidence            999999999987532211100                000000  000         00000000        00  011


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ....+..+..+.+++.+|+..||.+|.|+++.|+
T Consensus       347 ~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  347 EIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             ccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            1122334557889999999999999999999985

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=3.3e-23  Score=211.12  Aligned_cols=163  Identities=21%  Similarity=0.221  Sum_probs=126.2

Q ss_pred             HHHHhhhccccCcCCcEEEEEEEec--CCcEEEEEEeccC------cccHHHHHHHHHHhccccccceEE-eeceeccCC
Q 010434          186 IAVTNHFTHKLGQGGFGSVYKGQLH--TGRLIAVKMLENS------KFSAEEFINEVSTIGRIHHVNVVQ-LLGFCSEGS  256 (511)
Q Consensus       186 ~~~t~~~~~~LG~G~fg~Vykg~~~--~g~~vAvK~l~~~------~~~~~~f~~Ev~~l~~l~H~niv~-l~g~~~~~~  256 (511)
                      ....|.+.++||+|+||.||+|..+  +++.+|||++...      ....+.|.+|++++++++|+|++. ++++    .
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~   91 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G   91 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence            3345667789999999999999754  5788899987532      112456899999999999999985 5432    4


Q ss_pred             ceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccC-CcCceEEcCCCCeeeeccc
Q 010434          257 KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDI-KPHNILLDHNFIPKVSDFG  335 (511)
Q Consensus       257 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DI-kp~NILl~~~~~~kl~DFG  335 (511)
                      ..++||||+++++|....    .. .      ...++.++++||+|||+   .+|+|||| ||+|||++.++.+||+|||
T Consensus        92 ~~~LVmE~~~G~~L~~~~----~~-~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLAR----PH-G------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             CcEEEEEccCCCCHHHhC----cc-c------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence            579999999999996321    11 1      14678899999999998   69999999 9999999999999999999


Q ss_pred             ccccCCCCCCcee------eccccCCccccchhcccc
Q 010434          336 LAKFHPKENDFVS------ISATRGTIGYIAPELISR  366 (511)
Q Consensus       336 la~~~~~~~~~~~------~~~~~gt~~y~APE~~~~  366 (511)
                      +|+..........      .+...+++.|+|||.+..
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9997755432211      134558889999999854

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.7e-23  Score=196.30  Aligned_cols=253  Identities=20%  Similarity=0.358  Sum_probs=192.1

Q ss_pred             HHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      ...++..||....-|..|+|+++ |..+++|+++...   ...++|..|.-.++-..||||+.++|.|.....+.++..|
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~  268 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY  268 (448)
T ss_pred             hhhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence            34456678999999999999998 5667778886533   3446899999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      ||.|||...++.  ..+-..+..+..+++.++|+|++|||+- +.-|.-.-+.++.+++|++.+++|+- +-+++.    
T Consensus       269 mp~gslynvlhe--~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfs----  340 (448)
T KOG0195|consen  269 MPFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFS----  340 (448)
T ss_pred             ccchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceee----
Confidence            999999998853  3445677889999999999999999984 34455667899999999999988852 111110    


Q ss_pred             CceeeccccCCccccchhcccccCCCc-CccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~-s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                       + ........+.||+||.+.+..... -..+|+|||.+++|||.|..-||.....-+..       .+...++.+.   
T Consensus       341 -f-qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-------mkialeglrv---  408 (448)
T KOG0195|consen  341 -F-QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-------MKIALEGLRV---  408 (448)
T ss_pred             -e-eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-------hhhhhccccc---
Confidence             1 112233678999999997652222 24689999999999999999998653322111       1111122222   


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                         ..+..++..+..++.-|+..||.+||.+..|+-+||..
T Consensus       409 ---~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  409 ---HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             ---cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence               24555678899999999999999999999999999863

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=5.2e-22  Score=201.46  Aligned_cols=261  Identities=20%  Similarity=0.254  Sum_probs=189.6

Q ss_pred             HhhhccccCcCCcEEEEEEEecC--CcEEEEEEeccCc-ccHHHHHHHHHHhccccc----cceEEeecee-ccCCceeE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHT--GRLIAVKMLENSK-FSAEEFINEVSTIGRIHH----VNVVQLLGFC-SEGSKRAL  260 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~--g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H----~niv~l~g~~-~~~~~~~l  260 (511)
                      .+.+.++||+|+||.||++....  ...+|+|...... .....+..|+.++..+.+    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            56677899999999999998554  3578888876532 222278889998888863    5888888888 57788899


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC-----CCeeeeccc
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-----FIPKVSDFG  335 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~-----~~~kl~DFG  335 (511)
                      ||+.+ |.+|.++.....  .+.++....++|+.|++.+|++||+   .+++||||||.|+++...     ..+.|.|||
T Consensus        99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            99988 889998763222  5789999999999999999999998   799999999999999765     468999999


Q ss_pred             ccc--cCCCCCCc--e---e-eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccc
Q 010434          336 LAK--FHPKENDF--V---S-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP  407 (511)
Q Consensus       336 la~--~~~~~~~~--~---~-~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~  407 (511)
                      +++  .+......  .   . ....+||..|.++....+.  ..+.+.|+||++.++.|+..|..||...........+ 
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~--e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~-  249 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI--EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF-  249 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC--ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH-
Confidence            998  32222210  0   1 1345699999999998876  7889999999999999999999998543322111110 


Q ss_pred             hhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          408 SWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       408 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                          ..........  .   .....+..+.++...+-..+..++|....+...|......
T Consensus       250 ----~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  250 ----EKDPRKLLTD--R---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             ----HHHhhhhccc--c---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence                0000000000  0   1111223455555556668999999999999988765544

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=2.9e-21  Score=191.58  Aligned_cols=260  Identities=27%  Similarity=0.360  Sum_probs=194.0

Q ss_pred             hhccccCcCCcEEEEEEEecCCcEEEEEEeccCcc----cHHHHHHHHHHhcccccc-ceEEeeceeccCCceeEEEeec
Q 010434          191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHV-NVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~H~-niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      .+.+.||.|+||.||++...  ..+++|.+.....    ....|.+|+.+++.+.|+ +++++.+++......+++++++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515           3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence            45678999999999999876  8899999876322    367899999999999988 7999999997777789999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC-CeeeecccccccCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~-~~kl~DFGla~~~~~~~  344 (511)
                      .++++.+++...... ..++......+..|++.++.|+|+   .+++|||+||+||+++.+. .+++.|||.++......
T Consensus        81 ~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          81 DGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999665211111 378899999999999999999998   5899999999999999998 79999999998655443


Q ss_pred             Cce----eeccccCCccccchhcccccC-CCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          345 DFV----SISATRGTIGYIAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       345 ~~~----~~~~~~gt~~y~APE~~~~~~-~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      ...    ......||..|+|||.+.... ...+...|+||+|++++++++|..|+......    .........+.....
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~~  232 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILELPT  232 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhcCC
Confidence            221    235566999999999987631 36788999999999999999999995543321    001112222222111


Q ss_pred             c--cccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          420 L--ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       420 ~--~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      .  ...............+.+++..|+..+|..|.++.+....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            1  0000000002223467788889999999999999887753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=1.1e-22  Score=220.04  Aligned_cols=251  Identities=21%  Similarity=0.257  Sum_probs=189.0

Q ss_pred             ccccCcCCcEEEEEEE-ecCCcEEEEEEecc---CcccHH----HHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          193 THKLGQGGFGSVYKGQ-LHTGRLIAVKMLEN---SKFSAE----EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~---~~~~~~----~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      ...+|.|.+|.|+... .......+.|....   ......    .+..|+-+-..++|+|++..+..+.+.....-.|||
T Consensus       323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~  402 (601)
T KOG0590|consen  323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY  402 (601)
T ss_pred             cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence            4579999999777775 33344444443221   111111    255677788889999999988888777766666999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++ +|...+.    ....++...+..++.|+..|++|+|.   ++|.|||+|++|+++..++.+||+|||.+..+....
T Consensus       403 ~~~-Dlf~~~~----~~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  403 CPY-DLFSLVM----SNGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             ccH-HHHHHHh----cccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            999 9988872    23478899999999999999999998   799999999999999999999999999997665443


Q ss_pred             Cc--eeeccccCCccccchhcccccCCCc-CccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccc
Q 010434          345 DF--VSISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       345 ~~--~~~~~~~gt~~y~APE~~~~~~~~~-s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (511)
                      ..  .......|+..|+|||.+.+.  .+ ....||||.|+++..|++|+.||........+.      .+.......-.
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~--~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~~~~~~~  546 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGK--EYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNYSDQRNI  546 (601)
T ss_pred             chhhhhhcCcccCCcCcCccccccc--ccCcchhhhhhccceEEEEecCCCccccccccccch------hhhcccccccc
Confidence            33  445667799999999999876  44 346899999999999999999987654332111      11111112222


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ..........++...+.++.++|+.+|.+|.|+.+|++
T Consensus       547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            33344577778889999999999999999999999986

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=2.3e-21  Score=181.46  Aligned_cols=138  Identities=18%  Similarity=0.214  Sum_probs=107.2

Q ss_pred             ccccCcCCcEEEEEEEecCCcEEEEEEeccCcc---c-------HHHH-----------------HHHHHHhccccccce
Q 010434          193 THKLGQGGFGSVYKGQLHTGRLIAVKMLENSKF---S-------AEEF-----------------INEVSTIGRIHHVNV  245 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~---~-------~~~f-----------------~~Ev~~l~~l~H~ni  245 (511)
                      ...||+|+||.||+|...+|+.||||+++.+..   .       ...|                 .+|+..+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            357999999999999987899999999975321   1       1122                 349999999987766


Q ss_pred             EEeeceeccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHH-HhCCCCceecccCCcCceEEc
Q 010434          246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL-HNGCDMCILHFDIKPHNILLD  324 (511)
Q Consensus       246 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~ivH~DIkp~NILl~  324 (511)
                      .....+..  ...+|||||++++++.....    ....++...+..++.|++.+|.+| |+   .+|+||||||+|||++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE
Confidence            33222221  23389999999887765431    235789999999999999999999 56   6999999999999998


Q ss_pred             CCCCeeeecccccccC
Q 010434          325 HNFIPKVSDFGLAKFH  340 (511)
Q Consensus       325 ~~~~~kl~DFGla~~~  340 (511)
                       ++.++|+|||+|...
T Consensus       153 -~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 -DGKLYIIDVSQSVEH  167 (190)
T ss_pred             -CCcEEEEEccccccC
Confidence             478999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=1.1e-21  Score=181.55  Aligned_cols=260  Identities=19%  Similarity=0.265  Sum_probs=194.8

Q ss_pred             HHHHhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCcccHHHHHHHHHHhccccc-cceEEeeceeccCCceeEEEe
Q 010434          186 IAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHH-VNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       186 ~~~t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H-~niv~l~g~~~~~~~~~lV~e  263 (511)
                      ....+.+.++||+|+||.+|.|. ..+|..||||+-.. ...-.++.-|..+.+.|+| ..|..+..|..+...-.+|||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~-~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS-KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecc-cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            34456677999999999999997 77899999997433 3334467789999888864 678888889999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC---CCeeeecccccccC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN---FIPKVSDFGLAKFH  340 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~---~~~kl~DFGla~~~  340 (511)
                      .. |-||.+++..   ....++...++-++-|++.-++|+|.   ++++||||||+|+|..-+   ..+.++|||||+.+
T Consensus        92 LL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   92 LL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             cc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhh
Confidence            99 8899988632   23578999999999999999999998   799999999999999543   46889999999976


Q ss_pred             CCCCCc-----eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhh
Q 010434          341 PKENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLN  415 (511)
Q Consensus       341 ~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  415 (511)
                      ....+.     .......||.+|.+-....+.  ..+.+-|+-|+|.+|+...-|..||.......-.+     .++.+.
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~--eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q-----KyEkI~  237 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGI--EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ-----KYEKIS  237 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhh--hhhhhhhhhhhcceeeeeecCCCcccccchhhHHH-----HHHHHH
Confidence            544322     122345699999987776554  55778899999999999999999998654333211     222222


Q ss_pred             cCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                      +.....  ........++.++...+..|-+.--++-|...-+.++..
T Consensus       238 EkK~s~--~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  238 EKKMST--PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             HhhcCC--CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence            221111  112244455667777888888888888898766655443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=1.3e-20  Score=181.63  Aligned_cols=261  Identities=19%  Similarity=0.281  Sum_probs=195.6

Q ss_pred             HhhhccccCcCCcEEEEEEE-ecCCcEEEEEEeccCcccHHHHHHHHHHhcccc-ccceEEeeceeccCCceeEEEeecC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      -+.+.++||+|.||..+.|+ +-++++||||.- ..+....++..|.+..+.|. .++|...+-|..++.+-.||+|.+ 
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfE-PrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFE-PRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEec-cccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence            34567899999999999998 567999999964 33445567888998888884 689999998989999999999999 


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC-----CCeeeecccccccCC
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-----FIPKVSDFGLAKFHP  341 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~-----~~~kl~DFGla~~~~  341 (511)
                      |-||.|++   .-.+..++...+..+|.|++.-++|+|+   +.+|.|||||+|+||..-     ..+.+.|||+|+.+.
T Consensus       107 GPSLEDLF---D~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  107 GPSLEDLF---DLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             CcCHHHHH---HHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            88999886   3456789999999999999999999998   799999999999999533     458899999999876


Q ss_pred             CCCCce-----eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhc
Q 010434          342 KENDFV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK  416 (511)
Q Consensus       342 ~~~~~~-----~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  416 (511)
                      ...+..     ......||.+||+-....+.  .-+.+-|+=|+|=+++..+-|..||..-.....+     .-++.+.+
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGr--EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK-----~kYeKIGe  253 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK-----EKYEKIGE  253 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccc--hhhhhhhHHHhhhhhhhhccCCCccccccCcchH-----HHHHHhcc
Confidence            554332     22344599999998877654  6688899999999999999999999764333222     12344433


Q ss_pred             CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          417 GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      ..+.  ....+....++.++..-+.-.-..+-.+-|...-+...+...++
T Consensus       254 ~Kr~--T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld  301 (449)
T KOG1165|consen  254 TKRS--TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD  301 (449)
T ss_pred             cccc--CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence            3222  12223344455555555555555677778887666655544333

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.84  E-value=2.4e-20  Score=174.73  Aligned_cols=141  Identities=21%  Similarity=0.187  Sum_probs=110.3

Q ss_pred             ccccCcCCcEEEEEEEecCCcEEEEEEeccCccc---------------------------HHHHHHHHHHhccccccce
Q 010434          193 THKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFS---------------------------AEEFINEVSTIGRIHHVNV  245 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~---------------------------~~~f~~Ev~~l~~l~H~ni  245 (511)
                      ...||+|+||.||+|...+|+.||||+++.....                           ...+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            3579999999999999778999999998753210                           1123578899999999887


Q ss_pred             EEeeceeccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC
Q 010434          246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH  325 (511)
Q Consensus       246 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~  325 (511)
                      .....+...  ..+|||||++++++.....    ....++.....+++.|++.++.+||+.  .+|+||||||+||+++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE-
Confidence            443333322  2489999998886544321    224678889999999999999999982  4999999999999999 


Q ss_pred             CCCeeeecccccccCCC
Q 010434          326 NFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       326 ~~~~kl~DFGla~~~~~  342 (511)
                      ++.++|+|||+++....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            88999999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=2e-20  Score=194.33  Aligned_cols=221  Identities=21%  Similarity=0.363  Sum_probs=167.8

Q ss_pred             hccccccceEEeeceeccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccC
Q 010434          237 IGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDI  316 (511)
Q Consensus       237 l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DI  316 (511)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+..   ....++|.....+..+|+.||+|||..  .--.|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeee
Confidence            4568899999999999999999999999999999999843   456799999999999999999999984  23399999


Q ss_pred             CcCceEEcCCCCeeeecccccccCCCCCCceeeccccCCccccchhccccc--CCC---cCccchHHHHHHHHHHHHhCC
Q 010434          317 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN--FGT---VSCKSDVYGFGMVLLEMAGGR  391 (511)
Q Consensus       317 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~---~s~ksDVwS~Gvll~elltg~  391 (511)
                      ++.|.++|..+.+||+|||+.................-..-|.|||.++..  ...   .+.+.||||||++++|+++.+
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            999999999999999999998876532111222223345679999998763  112   577899999999999999999


Q ss_pred             CCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          392 RNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       392 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      .||+........    ..+...+.++.....+.......+....+..++..||..+|.+||++.+|-..++....
T Consensus       156 ~~~~~~~~~~~~----~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  156 GPFDLRNLVEDP----DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             CccccccccCCh----HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            999875433321    22233333322222222111122455578899999999999999999999988876443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=1.5e-20  Score=179.02  Aligned_cols=172  Identities=11%  Similarity=0.093  Sum_probs=129.3

Q ss_pred             HHHHHHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHH----------HHHHHHHhccccccceEEeeceec
Q 010434          184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE----------FINEVSTIGRIHHVNVVQLLGFCS  253 (511)
Q Consensus       184 ei~~~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~----------f~~Ev~~l~~l~H~niv~l~g~~~  253 (511)
                      ++...+++..+.||.|+||.||.... ++..+|||.+.......+.          |.+|+..+.+++|++|..+.+++.
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            45555667778999999999999765 5778999999653322222          578999999999999999988754


Q ss_pred             cC--------CceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC
Q 010434          254 EG--------SKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH  325 (511)
Q Consensus       254 ~~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~  325 (511)
                      ..        ...+|+|||++|.+|.++.        .++.    ....+++.++..+|+   .+++|||+||+||+++.
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~  170 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSK  170 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeC
Confidence            32        4578999999999997763        1222    245689999999998   69999999999999999


Q ss_pred             CCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHH
Q 010434          326 NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA  388 (511)
Q Consensus       326 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ell  388 (511)
                      ++ ++|+|||..+.........              .++..  ..+..++|+|+||+.+.-..
T Consensus       171 ~g-i~liDfg~~~~~~e~~a~d--------------~~vle--r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        171 NG-LRIIDLSGKRCTAQRKAKD--------------RIDLE--RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CC-EEEEECCCcccccchhhHH--------------HHHHH--hHhcccccccceeEeehHHH
Confidence            88 9999999876543221100              01111  13446899999999987654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=2.2e-19  Score=167.71  Aligned_cols=183  Identities=15%  Similarity=0.104  Sum_probs=138.5

Q ss_pred             ccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHH-----HHHHHHHHhcccc-ccceEEeeceeccCCceeEEEeecC
Q 010434          193 THKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAE-----EFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~-----~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      ...|++|+||+||.+.- ++.+++.+.+..+....+     .|.+|++++++|+ |+++++++++    ...+++|||++
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            45799999999997755 688899888876544222     5889999999995 5889999886    45699999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccC-CcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDI-KPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DI-kp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      |.+|...+.    .       ....++.|++.+|+++|+   .+|+|||| ||.|||++.++.++|+|||+|........
T Consensus        82 G~~L~~~~~----~-------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         82 GAAMYQRPP----R-------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             CccHHhhhh----h-------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            988865430    0       113577899999999999   69999999 79999999999999999999986544331


Q ss_pred             c----e--e-----eccccCCccccchhcccccCCCcC-ccchHHHHHHHHHHHHhCCCCCC
Q 010434          346 F----V--S-----ISATRGTIGYIAPELISRNFGTVS-CKSDVYGFGMVLLEMAGGRRNSN  395 (511)
Q Consensus       346 ~----~--~-----~~~~~gt~~y~APE~~~~~~~~~s-~ksDVwS~Gvll~elltg~~p~~  395 (511)
                      .    .  .     ......++.|++|+...-. ...+ ...+.++-|.-+|.++|++.+..
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l-~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVL-KRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh-ccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            1    0  0     0122378889999864322 1222 46799999999999999987653

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.79  E-value=8.4e-20  Score=198.42  Aligned_cols=248  Identities=21%  Similarity=0.259  Sum_probs=182.0

Q ss_pred             hhhccccCcCCcEEEEEEEecCCcEEEEEEecc--CcccHHHHHHHHHHhc--cccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLEN--SKFSAEEFINEVSTIG--RIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~--~~~~~~~f~~Ev~~l~--~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      .++.+.||++.|=.|.+++.+.|. |+||++-+  .....+.|.+++.-++  .++|||.+.+.-+-..+...|||-+|.
T Consensus        25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv  103 (1431)
T KOG1240|consen   25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV  103 (1431)
T ss_pred             eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence            455678999999999999988787 89999865  3445667766555444  458999999988877778888999998


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC--CCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKE  343 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~--~~~  343 (511)
                       ..+|.|.+    ....-+..-...=|+.|++.|+.-+|.   .+|+|||||.+||||++=.=+.|+||.--+..  +.+
T Consensus       104 -khnLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  104 -KHNLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             -hhhhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence             45888877    233446666777899999999999998   79999999999999999888899999876643  222


Q ss_pred             CCc--e-eeccccCCccccchhcccccC---------CCcCccchHHHHHHHHHHHHh-CCCCCCcccccccc---cccc
Q 010434          344 NDF--V-SISATRGTIGYIAPELISRNF---------GTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSK---AYFP  407 (511)
Q Consensus       344 ~~~--~-~~~~~~gt~~y~APE~~~~~~---------~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~---~~~~  407 (511)
                      +..  . -....+.-..|+|||.+....         +..+++-||||.||++.||++ |+++|+....-..+   ...+
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~  255 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDP  255 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCH
Confidence            211  0 112333446899999875421         126788999999999999987 68888754322111   1112


Q ss_pred             hhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          408 SWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       408 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      ..+.+.+                 ....++.+++.|+|.||++|-++.+.++.-.|
T Consensus       256 e~~Le~I-----------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  256 EQLLEKI-----------------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             HHHHHhC-----------------cCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            2221111                 12367889999999999999999999986444

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.78  E-value=7.8e-19  Score=172.10  Aligned_cols=231  Identities=22%  Similarity=0.309  Sum_probs=148.0

Q ss_pred             ccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhcccc----------ccceEEeece------
Q 010434          193 THKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRIH----------HVNVVQLLGF------  251 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~----------H~niv~l~g~------  251 (511)
                      .+.||.|+++.||.++.. +|+.+|||+....    ....+++.+|.-.+..+.          |-.++.-++.      
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            467999999999999965 6899999997542    224567777776665532          2222222221      


Q ss_pred             ---eccCC--------ceeEEEeecCCCCccccc---ccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCC
Q 010434          252 ---CSEGS--------KRALVYEFMPNGSLDRHI---FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIK  317 (511)
Q Consensus       252 ---~~~~~--------~~~lV~e~~~~gsL~~~l---~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIk  317 (511)
                         .....        ..+++|+-+ .++|.+.+   +........+....++.+..|+.+.+++||+   .+++|+||+
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi~  172 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGDIK  172 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST-S
T ss_pred             CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEecccc
Confidence               11111        235777777 66887664   2222222345566677888999999999999   799999999


Q ss_pred             cCceEEcCCCCeeeecccccccCCCCCCceeeccccCCccccchhccccc------CCCcCccchHHHHHHHHHHHHhCC
Q 010434          318 PHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN------FGTVSCKSDVYGFGMVLLEMAGGR  391 (511)
Q Consensus       318 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~------~~~~s~ksDVwS~Gvll~elltg~  391 (511)
                      |+|++++.+|.++|+||+.....+..   .  .....+..|.+||.....      .-.+|.+.|.|++|+++|.|.+|+
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~~---~--~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGTR---Y--RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTEE---E--EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCce---e--eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            99999999999999999877643321   1  113456789999976432      125788999999999999999999


Q ss_pred             CCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCC
Q 010434          392 RNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADR  451 (511)
Q Consensus       392 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R  451 (511)
                      .|++........    .|              +..... .++..+..++..+|+.||.+|
T Consensus       248 lPf~~~~~~~~~----~~--------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  248 LPFGLSSPEADP----EW--------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -STCCCGGGSTS----GG--------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCCccccc----cc--------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999876433211    11              011122 567788999999999999988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.77  E-value=4.7e-20  Score=191.70  Aligned_cols=224  Identities=24%  Similarity=0.290  Sum_probs=176.1

Q ss_pred             ccCcCCcEEEEEEE----ecCCcEEEEEEeccCcc---cHHHHHHHHHHhcccc-ccceEEeeceeccCCceeEEEeecC
Q 010434          195 KLGQGGFGSVYKGQ----LHTGRLIAVKMLENSKF---SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       195 ~LG~G~fg~Vykg~----~~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .+|+|.||.|+...    .+.|..+|+|.+++...   .......|..++..++ ||.+|++.-.+..+.+.+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999874    34578899999876221   1225567888888887 9999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +|.|...+    .....+...........+|-+++++|+   .+|+|||+|++||+++.+|.+|+.|||+.+..-...  
T Consensus        81 gg~lft~l----~~~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--  151 (612)
T KOG0603|consen   81 GGDLFTRL----SKEVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--  151 (612)
T ss_pred             cchhhhcc----ccCCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhh--
Confidence            99998776    344567778888888999999999998   799999999999999999999999999988554332  


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                          ..+||..|||||.+.+    ....+|.||||++.+||++|..||...            +...+...       ..
T Consensus       152 ----~~cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~~------------~~~~Il~~-------~~  204 (612)
T KOG0603|consen  152 ----IACGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGGD------------TMKRILKA-------EL  204 (612)
T ss_pred             ----hcccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCchH------------HHHHHhhh-------cc
Confidence                2279999999999873    356899999999999999999998651            11111110       11


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCH
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSM  454 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~  454 (511)
                      ..+.+++.....+...++..+|.+|--.
T Consensus       205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  205 EMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            2455566667777778888888888554

>PRK10345 hypothetical protein; Provisional

Probab=99.76  E-value=2.8e-18  Score=162.48  Aligned_cols=133  Identities=17%  Similarity=0.243  Sum_probs=102.6

Q ss_pred             ccccCcCCcEEEEEEEecCCcEEEEEEeccC-cccHHHHHHHHHHhccc-----cccceEEeeceeccCC---cee-EEE
Q 010434          193 THKLGQGGFGSVYKGQLHTGRLIAVKMLENS-KFSAEEFINEVSTIGRI-----HHVNVVQLLGFCSEGS---KRA-LVY  262 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~-~~~~~~f~~Ev~~l~~l-----~H~niv~l~g~~~~~~---~~~-lV~  262 (511)
                      .+.||+|+||.||. ...++.. +||++... ....+++.+|+.+++.+     .||||++++|++.++.   ..+ +|+
T Consensus         7 ~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~   84 (210)
T PRK10345          7 QSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA   84 (210)
T ss_pred             cceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence            35899999999996 3234444 79987653 33556899999999999     5799999999997763   333 789


Q ss_pred             ee--cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHH-HHHHhCCCCceecccCCcCceEEcC----CCCeeeeccc
Q 010434          263 EF--MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGV-AYLHNGCDMCILHFDIKPHNILLDH----NFIPKVSDFG  335 (511)
Q Consensus       263 e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l-~yLH~~~~~~ivH~DIkp~NILl~~----~~~~kl~DFG  335 (511)
                      ||  +++|+|.+++..     ..+++.  ..++.+++.++ +|||+   .+|+||||||+|||++.    +..++|+||+
T Consensus        85 e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         85 DFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             cCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            99  668999999821     235555  35677888777 99999   69999999999999974    3489999954


Q ss_pred             cc
Q 010434          336 LA  337 (511)
Q Consensus       336 la  337 (511)
                      .+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            33

>smart00090 RIO RIO-like kinase

Probab=99.76  E-value=5.6e-18  Score=164.01  Aligned_cols=140  Identities=18%  Similarity=0.148  Sum_probs=109.0

Q ss_pred             hhhccccCcCCcEEEEEEE--ecCCcEEEEEEeccCcc--------------------c-----HHHHHHHHHHhccccc
Q 010434          190 NHFTHKLGQGGFGSVYKGQ--LHTGRLIAVKMLENSKF--------------------S-----AEEFINEVSTIGRIHH  242 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~--~~~g~~vAvK~l~~~~~--------------------~-----~~~f~~Ev~~l~~l~H  242 (511)
                      +.+.+.||+|+||.||+|.  ..+|+.||||++.....                    +     ...+..|+..+.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            3456789999999999998  56899999999865321                    0     1235689999999975


Q ss_pred             cc--eEEeeceeccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCc-eecccCCcC
Q 010434          243 VN--VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC-ILHFDIKPH  319 (511)
Q Consensus       243 ~n--iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-ivH~DIkp~  319 (511)
                      .+  +.+.+++    ...++||||+++++|.....    ....+.......++.|++.++.+||+   .+ ++|+||||+
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~  178 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEY  178 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChh
Confidence            33  3444443    23589999999988876542    12345666778999999999999998   58 999999999


Q ss_pred             ceEEcCCCCeeeecccccccCC
Q 010434          320 NILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       320 NILl~~~~~~kl~DFGla~~~~  341 (511)
                      ||+++ ++.++|+|||.+....
T Consensus       179 NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhccC
Confidence            99999 8899999999987543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=2.5e-18  Score=190.36  Aligned_cols=198  Identities=24%  Similarity=0.262  Sum_probs=154.4

Q ss_pred             HHHHHHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhcccc---ccceEEeeceeccCCceeE
Q 010434          184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRAL  260 (511)
Q Consensus       184 ei~~~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~---H~niv~l~g~~~~~~~~~l  260 (511)
                      ++-...+.+.+.||+|+||+||+|...+|+.||+|+-+...  .-+|.=-..++.||+   -+-|..+...+.-.+.-+|
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~--~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPN--PWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCC--ceeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence            44445556678899999999999997779999999865432  223433344455555   1223333444455677789


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEc-------CCCCeeeec
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD-------HNFIPKVSD  333 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~-------~~~~~kl~D  333 (511)
                      |+||.+.|+|.+++    +..+.++|.....++.|+++.++.||.   .+|||+||||+|.||.       ++..++|+|
T Consensus       772 v~ey~~~Gtlld~~----N~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLI----NTNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             eeeccccccHHHhh----ccCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEe
Confidence            99999999999998    356789999999999999999999999   7999999999999993       345789999


Q ss_pred             ccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCC
Q 010434          334 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR  392 (511)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~  392 (511)
                      ||.+-.+..-.+........+|-++--+|+..+.  .++.+.|.|.+..+++-|+.|+.
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr--pWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR--PWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCC--CCchhhhhHHHHHHHHHHHHHHH
Confidence            9998544332333345666788899999999875  89999999999999999999973

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.74  E-value=1.8e-17  Score=156.32  Aligned_cols=134  Identities=19%  Similarity=0.207  Sum_probs=106.9

Q ss_pred             hhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcc-----------------------cHHHHHHHHHHhccccccc--
Q 010434          190 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKF-----------------------SAEEFINEVSTIGRIHHVN--  244 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~-----------------------~~~~f~~Ev~~l~~l~H~n--  244 (511)
                      +.+.+.||+|+||.||++...+|+.||||++..+..                       ....+..|...+..+.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            556788999999999999988899999998754321                       1123667888898888874  


Q ss_pred             eEEeeceeccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEc
Q 010434          245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD  324 (511)
Q Consensus       245 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~  324 (511)
                      ++..++.    ...++||||+++++|.+...          ......++.+++.++.++|+   .+++|+||||+||+++
T Consensus        97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~  159 (198)
T cd05144          97 VPKPIDW----NRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVD  159 (198)
T ss_pred             CCceeec----CCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEc
Confidence            4444432    45589999999999977541          02356788999999999998   7999999999999999


Q ss_pred             CCCCeeeecccccccC
Q 010434          325 HNFIPKVSDFGLAKFH  340 (511)
Q Consensus       325 ~~~~~kl~DFGla~~~  340 (511)
                      +++.++|+|||++...
T Consensus       160 ~~~~~~liDfg~~~~~  175 (198)
T cd05144         160 DDEKIYIIDWPQMVST  175 (198)
T ss_pred             CCCcEEEEECCccccC
Confidence            9999999999998644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=1.2e-17  Score=158.80  Aligned_cols=133  Identities=23%  Similarity=0.303  Sum_probs=111.6

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEEeccCcc---------cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKF---------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~---------~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.||+|++|.||+|.. +|..+++|+......         ....+.+|+.++..++|+|++....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5789999999999987 578899998654221         124578899999999999987777777677788999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      +++++|.+++..       ..+ .+..++.+++.+|.+||+   .+++|+|++|.|||++ ++.++|+|||.++.
T Consensus        81 ~~G~~L~~~~~~-------~~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINS-------NGM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHh-------ccH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999988721       122 788999999999999998   6999999999999999 78999999998864

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=4e-17  Score=153.76  Aligned_cols=129  Identities=22%  Similarity=0.300  Sum_probs=104.3

Q ss_pred             ccCcCCcEEEEEEEecCCcEEEEEEeccCc-c--------cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSK-F--------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       195 ~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~-~--------~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      .||+|+||.||+|.. +|..+++|...... .        ..+.+.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999985 47889999864321 1        1256778999999999887655444555666779999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      ++++|.+.+...    ..       .++.+++.+|.+||+   .+++|+|++|+||+++ ++.+++.|||+++.
T Consensus        80 ~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEG----ND-------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhc----HH-------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999998876211    11       789999999999998   6999999999999999 88999999998864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.70  E-value=6.1e-17  Score=159.64  Aligned_cols=199  Identities=19%  Similarity=0.212  Sum_probs=137.2

Q ss_pred             cccceEEeeceecc---------------------------CCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHH
Q 010434          241 HHVNVVQLLGFCSE---------------------------GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIA  293 (511)
Q Consensus       241 ~H~niv~l~g~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~  293 (511)
                      +|||||++.++|.+                           +..+|+||.-++ .+|..++.     ....+.....-|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~-----~~~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLW-----TRHRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHh-----cCCCchHHHHHHH
Confidence            59999999987643                           234678888774 48888873     2456677778899


Q ss_pred             HHHHHHHHHHHhCCCCceecccCCcCceEE--cCCC--CeeeecccccccCCC---CCCceeec-cccCCccccchhccc
Q 010434          294 LGTARGVAYLHNGCDMCILHFDIKPHNILL--DHNF--IPKVSDFGLAKFHPK---ENDFVSIS-ATRGTIGYIAPELIS  365 (511)
Q Consensus       294 ~~ia~~l~yLH~~~~~~ivH~DIkp~NILl--~~~~--~~kl~DFGla~~~~~---~~~~~~~~-~~~gt~~y~APE~~~  365 (511)
                      .|+++|+.|||+   ++|.|||+|++||||  |+|.  ...|+|||.+--...   .-.+.+.. ..-|...-||||+..
T Consensus       348 aQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            999999999999   799999999999999  4554  457899997532111   11122211 233777899999986


Q ss_pred             ccCCCc----CccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHH
Q 010434          366 RNFGTV----SCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGL  441 (511)
Q Consensus       366 ~~~~~~----s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  441 (511)
                      ...|..    -.|+|.|+.|.+.||+++...||-....    ..+..-.|++   .+      .+..++.+++.+++++.
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe----m~L~~r~Yqe---~q------LPalp~~vpp~~rqlV~  491 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE----MLLDTRTYQE---SQ------LPALPSRVPPVARQLVF  491 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch----heechhhhhh---hh------CCCCcccCChHHHHHHH
Confidence            543322    2589999999999999999999865211    1111111111   11      11244445677889999


Q ss_pred             HhcCcCCCCCCCHHHHHHHH
Q 010434          442 WCIQVKAADRPSMTKVLEML  461 (511)
Q Consensus       442 ~Cl~~~P~~RPs~~evl~~L  461 (511)
                      ..|+.||++||+..-....|
T Consensus       492 ~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHhcCCccccCCccHHHhHH
Confidence            99999999999965554444

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.69  E-value=6.8e-17  Score=174.99  Aligned_cols=131  Identities=20%  Similarity=0.290  Sum_probs=107.4

Q ss_pred             hccccCcCCcEEEEEEEecCCcEEEEEE-eccC-c-------ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          192 FTHKLGQGGFGSVYKGQLHTGRLIAVKM-LENS-K-------FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       192 ~~~~LG~G~fg~Vykg~~~~g~~vAvK~-l~~~-~-------~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      ..++||+|+||.||+|.+.+.. +++|+ +.+. .       ...+.+.+|++++.+++|++++....++......++||
T Consensus       337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~  415 (535)
T PRK09605        337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM  415 (535)
T ss_pred             ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence            3578999999999999876443 44443 2221 1       12356889999999999999988877777777889999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      ||+++++|.+++.            ....++.+++++|.+||+   .+++||||||+|||+ +++.++|+|||+++.
T Consensus       416 E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        416 EYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            9999999988772            457899999999999998   699999999999999 678999999999875

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.68  E-value=1.5e-17  Score=170.11  Aligned_cols=174  Identities=21%  Similarity=0.283  Sum_probs=127.8

Q ss_pred             ceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccc
Q 010434          257 KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGL  336 (511)
Q Consensus       257 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGl  336 (511)
                      .+++.|+++...+|.++|..+ ......++...+.++.|++.|++|  +    +.+|+|+||.||+...+..+||+|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y--k----~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY--K----GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh--c----cchhhhccccccccccchhhhhhhhhh
Confidence            478999999999999998433 345667899999999999999999  3    899999999999999999999999999


Q ss_pred             cccCCCCC----CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhC-CCCCCcccccccccccchhhH
Q 010434          337 AKFHPKEN----DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG-RRNSNMNAIRSSKAYFPSWVY  411 (511)
Q Consensus       337 a~~~~~~~----~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg-~~p~~~~~~~~~~~~~~~~~~  411 (511)
                      ........    .....+...||..||+||.+.++  .++.|+||||+|++|+|++.- ...+.-.           -..
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~--~y~~kvdIyaLGlil~EL~~~f~T~~er~-----------~t~  469 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ--QYSEKVDIYALGLILAELLIQFSTQFERI-----------ATL  469 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhh--hhhhhcchhhHHHHHHHHHHHhccHHHHH-----------Hhh
Confidence            87655444    23344666799999999999987  899999999999999999872 1111100           011


Q ss_pred             HhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHH
Q 010434          412 DQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTK  456 (511)
Q Consensus       412 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~e  456 (511)
                      ..++.+...+     ....+. +.=..++.|++.+.|.+||++.+
T Consensus       470 ~d~r~g~ip~-----~~~~d~-p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  470 TDIRDGIIPP-----EFLQDY-PEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             hhhhcCCCCh-----HHhhcC-cHHHHHHHHhcCCCcccCchHHH
Confidence            1122221110     011111 12346889999999999994443

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.66  E-value=3.3e-16  Score=145.88  Aligned_cols=136  Identities=20%  Similarity=0.213  Sum_probs=96.8

Q ss_pred             ccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHH---HH----------------------HHHHHHhccccccc--e
Q 010434          193 THKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAE---EF----------------------INEVSTIGRIHHVN--V  245 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~---~f----------------------~~Ev~~l~~l~H~n--i  245 (511)
                      .+.||+|+||.||++...+|+.||||++........   .+                      ..|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            467999999999999987899999999865322211   11                      24455555554332  3


Q ss_pred             EEeeceeccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC
Q 010434          246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH  325 (511)
Q Consensus       246 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~  325 (511)
                      .+.+++    ...++||||++++.+.......    .... .....++.+++.++.++|..  .+|+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~----~~~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKD----VRLL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhh----hhhc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-
Confidence            333332    2458999999996553221110    0011 56788999999999999982  5999999999999999 


Q ss_pred             CCCeeeecccccccC
Q 010434          326 NFIPKVSDFGLAKFH  340 (511)
Q Consensus       326 ~~~~kl~DFGla~~~  340 (511)
                      ++.++|+|||.+...
T Consensus       150 ~~~~~liDfg~a~~~  164 (187)
T cd05119         150 DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CCcEEEEECcccccc
Confidence            899999999998644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.66  E-value=1.1e-15  Score=135.73  Aligned_cols=134  Identities=22%  Similarity=0.219  Sum_probs=115.0

Q ss_pred             ccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccc--cceEEeeceeccCCceeEEEeecCCCCc
Q 010434          193 THKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHH--VNVVQLLGFCSEGSKRALVYEFMPNGSL  270 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL  270 (511)
                      .+.||+|.++.||++..++ ..+++|....... ...+.+|+.++..++|  .++++++++...++..++++||++++.+
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~   80 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL   80 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence            3579999999999999764 7899999866443 5689999999999977  5899999988888889999999988777


Q ss_pred             ccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          271 DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       271 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      ..+           +......++.++++++++||.....+++|+|++|+||++++++.+++.|||.++.
T Consensus        81 ~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          81 DEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            543           5567788999999999999985445799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.60  E-value=6.3e-16  Score=168.51  Aligned_cols=203  Identities=23%  Similarity=0.268  Sum_probs=136.2

Q ss_pred             ccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCcc
Q 010434          193 THKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLD  271 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  271 (511)
                      .+.+..|+||.||..+.+ +.+.+|+|+ ++...-.+   +   ++.....|.+|                     |+-.
T Consensus        88 IklisngAygavylvrh~~trqrfa~ki-Nkq~lilR---n---ilt~a~npfvv---------------------gDc~  139 (1205)
T KOG0606|consen   88 IKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLILR---N---ILTFAGNPFVV---------------------GDCA  139 (1205)
T ss_pred             eEeeccCCCCceeeeeccccccchhhcc-cccchhhh---c---cccccCCccee---------------------chhh
Confidence            467899999999999866 467888854 33221110   0   22222333333                     3333


Q ss_pred             cccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc-----
Q 010434          272 RHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF-----  346 (511)
Q Consensus       272 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~-----  346 (511)
                      ..+    ..-++++.+.        +.+++|||+   .+|+|||+||+|.+|+.-|.+|+.|||+.+........     
T Consensus       140 tll----k~~g~lPvdm--------vla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg  204 (1205)
T KOG0606|consen  140 TLL----KNIGPLPVDM--------VLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEG  204 (1205)
T ss_pred             hhc----ccCCCCcchh--------hHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhc
Confidence            333    1113444333        778999998   79999999999999999999999999998753321110     


Q ss_pred             --------eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCC
Q 010434          347 --------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG  418 (511)
Q Consensus       347 --------~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  418 (511)
                              ......+||+.|+|||++.++  .|....|+|++|+++||.+-|..||.....++   .|-..+.+.+.   
T Consensus       205 ~I~k~t~Ef~dKqvcgTPeyiaPeVilrq--gygkpvdwwamGiIlyeFLVgcvpffGdtpee---lfg~visd~i~---  276 (1205)
T KOG0606|consen  205 HIEKDTHEFQDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFGQVISDDIE---  276 (1205)
T ss_pred             chHHHHHHhhhccccCCccccChhhhhhh--ccCCCccHHHHHHHHHHHheeeeeccCCCHHH---HHhhhhhhhcc---
Confidence                    111344699999999999886  78889999999999999999999997754322   11111111111   


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhcCcCCCCCC
Q 010434          419 DLELRNVTEIESVIARKLCMIGLWCIQVKAADRP  452 (511)
Q Consensus       419 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP  452 (511)
                            ..+....+.++.++++.+.|+.+|..|-
T Consensus       277 ------wpE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  277 ------WPEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             ------ccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence                  1112333456788899999999999993

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.58  E-value=7.9e-15  Score=142.29  Aligned_cols=133  Identities=16%  Similarity=0.182  Sum_probs=103.3

Q ss_pred             cccC-cCCcEEEEEEEecCCcEEEEEEeccCc--------------ccHHHHHHHHHHhccccccce--EEeeceeccCC
Q 010434          194 HKLG-QGGFGSVYKGQLHTGRLIAVKMLENSK--------------FSAEEFINEVSTIGRIHHVNV--VQLLGFCSEGS  256 (511)
Q Consensus       194 ~~LG-~G~fg~Vykg~~~~g~~vAvK~l~~~~--------------~~~~~f~~Ev~~l~~l~H~ni--v~l~g~~~~~~  256 (511)
                      ..|| .||.|+||+.... +..++||......              .....+.+|++++.+++|+++  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4688 8999999999875 7788998774311              223467889999999998874  67777643322


Q ss_pred             ----ceeEEEeecCC-CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeee
Q 010434          257 ----KRALVYEFMPN-GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKV  331 (511)
Q Consensus       257 ----~~~lV~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl  331 (511)
                          ..++|+|++++ .+|.+++.     ...++..    .+.+|+.+|.+||+   .+|+|+||||+|||++.++.++|
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~-----~~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQ-----EAPLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHh-----cCCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEE
Confidence                23599999997 68888762     1345544    35688999999998   69999999999999999999999


Q ss_pred             eccccccc
Q 010434          332 SDFGLAKF  339 (511)
Q Consensus       332 ~DFGla~~  339 (511)
                      +|||.++.
T Consensus       184 IDfg~~~~  191 (239)
T PRK01723        184 IDFDRGEL  191 (239)
T ss_pred             EECCCccc
Confidence            99998864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.55  E-value=7.6e-16  Score=167.11  Aligned_cols=253  Identities=22%  Similarity=0.257  Sum_probs=188.3

Q ss_pred             hhhccccCcCCcEEEEEEEec--CCcEEEEEEeccCcc---cHHHHHHHHHHhcccc-ccceEEeeceeccCCceeEEEe
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH--TGRLIAVKMLENSKF---SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~--~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      +++.+.||+|.|+.|-.....  ....+|+|.+.....   ..+....|..+-..+. |+|++.+++...+.+..+++.+
T Consensus        22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~  101 (601)
T KOG0590|consen   22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS  101 (601)
T ss_pred             ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence            445667999999999887653  345677776654322   2233344777777776 9999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHH-hCCCCceecccCCcCceEEcCCC-CeeeecccccccCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH-NGCDMCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHP  341 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH-~~~~~~ivH~DIkp~NILl~~~~-~~kl~DFGla~~~~  341 (511)
                      |..++++.+.+.  .......+....-....|+..++.|+| .   .++.|+||||+|.+++..+ ..+++|||+|..+.
T Consensus       102 ~s~g~~~f~~i~--~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  102 YSDGGSLFSKIS--HPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             cccccccccccc--cCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            999999988773  122224566677789999999999999 5   6999999999999999999 99999999999887


Q ss_pred             C-CCCceeeccccC-CccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          342 K-ENDFVSISATRG-TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       342 ~-~~~~~~~~~~~g-t~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      . ...........| ++.|+|||...+. ....+..|+||.|+++.-+++|..|++......  ..+..|.....    .
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~~----~  249 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNKG----R  249 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCcccccccc--ccceeeccccc----c
Confidence            7 454445556668 9999999998763 245678899999999999999999987755433  22223332210    0


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHH
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVL  458 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl  458 (511)
                      ..    ......+......+...++..+|..|.+.+++-
T Consensus       250 ~~----~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  250 FT----QLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             cc----cCccccCChhhhhcccccccCCchhcccccccc
Confidence            00    112233445566778888889999999987774

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.44  E-value=3.9e-13  Score=141.53  Aligned_cols=139  Identities=19%  Similarity=0.201  Sum_probs=98.6

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEEeccCcc---------------------------cH--------------HHHHH
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKF---------------------------SA--------------EEFIN  232 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~---------------------------~~--------------~~f~~  232 (511)
                      +.||.|++|.||+|++++|+.||||+.+..-.                           +.              -+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            46999999999999999999999999854210                           00              03555


Q ss_pred             HHHHhcccc----ccceEEeecee-ccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHH-HHHHHHhC
Q 010434          233 EVSTIGRIH----HVNVVQLLGFC-SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR-GVAYLHNG  306 (511)
Q Consensus       233 Ev~~l~~l~----H~niv~l~g~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-~l~yLH~~  306 (511)
                      |+..+.++.    |.+-+.+-..+ ...+..+|||||++|++|.+......   ...   ...+++..++. .+..+|. 
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~-  275 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLR-  275 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHh-
Confidence            666666652    22223333333 22456799999999999988752211   112   23456666666 4677887 


Q ss_pred             CCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       307 ~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                        .+++|+|+||.||++++++.+++.|||++....
T Consensus       276 --~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 --DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             --CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence              699999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.44  E-value=9.4e-14  Score=134.46  Aligned_cols=204  Identities=22%  Similarity=0.295  Sum_probs=138.5

Q ss_pred             HhccccccceEEeeceecc-----CCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 010434          236 TIGRIHHVNVVQLLGFCSE-----GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC  310 (511)
Q Consensus       236 ~l~~l~H~niv~l~g~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~  310 (511)
                      -|-.+-|.|||+++.|+.+     ..+..++.|||..|+|..+|...+..+..+......++..||..||.|||+ |++.
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence            3445679999999998854     345789999999999999986666667788899999999999999999998 6889


Q ss_pred             eecccCCcCceEEcCCCCeeeecccccccCCCCCCc--eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHH
Q 010434          311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA  388 (511)
Q Consensus       311 ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ell  388 (511)
                      |+|+++..+-|++..++-+|++----....+.....  ......++-++|.|||.=..  ...+..+|||+||+..+||.
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT--TNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc--cccccchhhhhhhHHHHHHH
Confidence            999999999999999999888532211111111100  01123347789999997433  25677899999999999998


Q ss_pred             hCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          389 GGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       389 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      -+.--..    .+.....+.......    ..-+.+         ..=..++..|++..|.+||+|.+++.
T Consensus       277 ilEiq~t----nseS~~~~ee~ia~~----i~~len---------~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  277 ILEIQST----NSESKVEVEENIANV----IIGLEN---------GLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HheeccC----CCcceeehhhhhhhh----eeeccC---------ccccCcCcccccCCCCCCcchhhhhc
Confidence            7753210    111111111000000    000000         00123556799999999999998864

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.35  E-value=3.2e-12  Score=116.81  Aligned_cols=129  Identities=22%  Similarity=0.179  Sum_probs=96.6

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccce-EEeeceeccCCceeEEEeecCCCCccc
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEFMPNGSLDR  272 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL~~  272 (511)
                      +.|+.|.++.||++... ++.+++|+..........+.+|+.++..+.+.++ .+++++..  ...++||||+++.++..
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLT   80 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccc
Confidence            46889999999999865 7889999876543233457889999998876554 34554433  34589999999988764


Q ss_pred             ccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCC--CCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          273 HIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC--DMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       273 ~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      .-         .   ....++.+++++|+.||+..  ...++|+|++|.||+++ ++.+++.|||.+.
T Consensus        81 ~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          81 ED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            31         0   11345678999999999842  22369999999999999 6689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.34  E-value=1.2e-12  Score=136.59  Aligned_cols=252  Identities=21%  Similarity=0.213  Sum_probs=181.0

Q ss_pred             HHHHHHhhhccccCc--CCcEEEEEEEe---cCCcEEEEEEecc---CcccHHHHHHHHHHhccc-cccceEEeeceecc
Q 010434          184 EIIAVTNHFTHKLGQ--GGFGSVYKGQL---HTGRLIAVKMLEN---SKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSE  254 (511)
Q Consensus       184 ei~~~t~~~~~~LG~--G~fg~Vykg~~---~~g~~vAvK~l~~---~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~  254 (511)
                      +....+..+.+.+|.  |.+|.||.+..   .++..+|+|.-+.   .......=.+|+..-.++ .|+|.++....+..
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence            445556677788999  99999999985   3678899997433   122333345666666666 49999998888899


Q ss_pred             CCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHH----HHHHHHhCCCCceecccCCcCceEEcCC-CCe
Q 010434          255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR----GVAYLHNGCDMCILHFDIKPHNILLDHN-FIP  329 (511)
Q Consensus       255 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----~l~yLH~~~~~~ivH~DIkp~NILl~~~-~~~  329 (511)
                      ++..++-.|.+ +.+|..+.+.   ....++...+..+..+...    |+.++|.   ..++|-|+||.||++.++ ...
T Consensus       190 ~~~lfiqtE~~-~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~  262 (524)
T KOG0601|consen  190 SGILFIQTELC-GESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSC  262 (524)
T ss_pred             CCcceeeeccc-cchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheeccccccee
Confidence            99999999988 5788777632   2344566666667777777    9999999   599999999999999999 899


Q ss_pred             eeecccccccCCCCCC---ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc
Q 010434          330 KVSDFGLAKFHPKEND---FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF  406 (511)
Q Consensus       330 kl~DFGla~~~~~~~~---~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~  406 (511)
                      +++|||+........-   ........|...|++||...+   .++.++|+|++|.++++-..+.......       +.
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g-------~~  332 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVG-------KN  332 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCC-------CC
Confidence            9999999987765441   111223358889999999875   6788999999999999998876543221       11


Q ss_pred             chhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          407 PSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       407 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ..|.  ++.+..   +  ..+.....+.++..++.++++.+|..|++.+.+..
T Consensus       333 ~~W~--~~r~~~---i--p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  333 SSWS--QLRQGY---I--PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             CCcc--cccccc---C--chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            2222  111111   1  11122223445666889999999999999877754

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.25  E-value=1.3e-11  Score=131.79  Aligned_cols=139  Identities=16%  Similarity=0.185  Sum_probs=90.7

Q ss_pred             cccCcCCcEEEEEEEecC-CcEEEEEEeccCcc---------------------------cH--------------HHHH
Q 010434          194 HKLGQGGFGSVYKGQLHT-GRLIAVKMLENSKF---------------------------SA--------------EEFI  231 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~-g~~vAvK~l~~~~~---------------------------~~--------------~~f~  231 (511)
                      +.||+|++|.||++++++ |+.||||++...-.                           +.              -+|.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            469999999999999887 99999999864210                           00              1244


Q ss_pred             HHHHHhcccc----ccceEEeeceecc-CCceeEEEeecCCCCcccccccCCC--cCCccCHHHHHHHHHHHHHHHHHHH
Q 010434          232 NEVSTIGRIH----HVNVVQLLGFCSE-GSKRALVYEFMPNGSLDRHIFPKEN--KGQTFGWEKLQEIALGTARGVAYLH  304 (511)
Q Consensus       232 ~Ev~~l~~l~----H~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~l~yLH  304 (511)
                      +|+..+.+++    +.+.+.+-..+.+ .+..+|||||++|+.+.+.-.....  ....+....+..++.|+.       
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence            5555555542    3333333333322 4567899999999999774211110  011233333333344432       


Q ss_pred             hCCCCceecccCCcCceEEcCCC----CeeeecccccccCCC
Q 010434          305 NGCDMCILHFDIKPHNILLDHNF----IPKVSDFGLAKFHPK  342 (511)
Q Consensus       305 ~~~~~~ivH~DIkp~NILl~~~~----~~kl~DFGla~~~~~  342 (511)
                      .   .+++|+|+||.||+++.++    .+++.|||++.....
T Consensus       278 ~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            2   5999999999999999888    999999999876543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.23  E-value=9e-11  Score=111.79  Aligned_cols=141  Identities=21%  Similarity=0.248  Sum_probs=111.8

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEEeccCcc--cHHHHHHHHHHhccccc--cceEEeeceeccC---CceeEEEeecC
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKF--SAEEFINEVSTIGRIHH--VNVVQLLGFCSEG---SKRALVYEFMP  266 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l~H--~niv~l~g~~~~~---~~~~lV~e~~~  266 (511)
                      +.||.|..+.||++...+|+.+++|.......  ....+.+|+++++.+++  .++.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            46899999999999887778999999765432  45678999999999975  4467777777654   26689999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC---------------------------------------  307 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~---------------------------------------  307 (511)
                      +.++.+.+.     ...++...+..++.+++++|..||+..                                       
T Consensus        84 G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            998887652     135778888889999999999998521                                       


Q ss_pred             --------------CCceecccCCcCceEEcC--CCCeeeeccccccc
Q 010434          308 --------------DMCILHFDIKPHNILLDH--NFIPKVSDFGLAKF  339 (511)
Q Consensus       308 --------------~~~ivH~DIkp~NILl~~--~~~~kl~DFGla~~  339 (511)
                                    ...++|+|++|+||+++.  +..+.|.||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          245799999999999998  56689999997753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.17  E-value=3.7e-10  Score=105.46  Aligned_cols=136  Identities=13%  Similarity=0.158  Sum_probs=98.1

Q ss_pred             cccCcCCcEEEEEEEecC-------CcEEEEEEeccCc----------------------cc-HHHHH----HHHHHhcc
Q 010434          194 HKLGQGGFGSVYKGQLHT-------GRLIAVKMLENSK----------------------FS-AEEFI----NEVSTIGR  239 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~-------g~~vAvK~l~~~~----------------------~~-~~~f~----~Ev~~l~~  239 (511)
                      -.||.|--+.||.|...+       +..+|||+.+.+.                      .+ .+.+.    +|++.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997543       5799999874211                      01 11233    79999999


Q ss_pred             ccc--cceEEeeceeccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHH-HhCCCCceecccC
Q 010434          240 IHH--VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL-HNGCDMCILHFDI  316 (511)
Q Consensus       240 l~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~ivH~DI  316 (511)
                      +..  .++.+.+++    ...+|||||+.++.+..-..    ....++......+..+++.+|..| |+   .+++|+|+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L----kd~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL----KDAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh----hccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence            853  466666664    56689999997654422110    112345566778889999999999 77   59999999


Q ss_pred             CcCceEEcCCCCeeeecccccccCC
Q 010434          317 KPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       317 kp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      ++.|||++ ++.+.|+|||.+-...
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999997 4689999999886443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.08  E-value=5.3e-10  Score=118.26  Aligned_cols=165  Identities=18%  Similarity=0.214  Sum_probs=125.2

Q ss_pred             ecCCcEEEEEEeccCcc-cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCcccccccCCCcCCccCHH
Q 010434          209 LHTGRLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWE  287 (511)
Q Consensus       209 ~~~g~~vAvK~l~~~~~-~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~  287 (511)
                      ..++.+|.|...+.+.. ..+...+-++.++.++||||++++.........|||+|-+.  .|..++       ..++..
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~l-------k~l~~~  104 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVL-------KELGKE  104 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHH-------HHhHHH
Confidence            44788999998877543 23446778889999999999999999999999999999873  455555       234456


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeeccccCCccccchhccccc
Q 010434          288 KLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN  367 (511)
Q Consensus       288 ~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~  367 (511)
                      .+.-.+.||+.||.+||.  +.+++|++|....|+++..|..||++|.++........  ......--..|..|+.+..+
T Consensus       105 ~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence            677789999999999996  37899999999999999999999999988754332221  01111223356777765432


Q ss_pred             CCCcCccchHHHHHHHHHHHHhC
Q 010434          368 FGTVSCKSDVYGFGMVLLEMAGG  390 (511)
Q Consensus       368 ~~~~s~ksDVwS~Gvll~elltg  390 (511)
                        .  -..|.|.||++++|++.|
T Consensus       181 --~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 --E--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --c--cchhhhhHHHHHHHHhCc
Confidence              1  346999999999999999

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.04  E-value=7.4e-11  Score=123.43  Aligned_cols=241  Identities=20%  Similarity=0.235  Sum_probs=165.8

Q ss_pred             hhccccCcCCcEEEEEEEe--cCCcEEEEEEeccCccc--HHH-HHHHHHHhccc-cccceEEeeceeccCCceeEEEee
Q 010434          191 HFTHKLGQGGFGSVYKGQL--HTGRLIAVKMLENSKFS--AEE-FINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~--~~g~~vAvK~l~~~~~~--~~~-f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      ++..+||.|.|+.|++...  .++..+++|.+.+.-..  .+. -..|+.+...+ .|.+++.....+......++=-||
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~  347 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF  347 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence            3456899999999999863  47889999998663221  122 24566555555 488888887777777888899999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC-CCeeeecccccccCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~-~~~kl~DFGla~~~~~~  343 (511)
                      +.++++...+    .....+....++++..|++.++.++|+   +.++|+|+||+||++..+ +.-+++|||.+....-.
T Consensus       348 ~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~  420 (524)
T KOG0601|consen  348 CEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS  420 (524)
T ss_pred             hcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccccccee
Confidence            9999887665    233467788899999999999999998   899999999999999876 88899999988632111


Q ss_pred             CCceeeccccCCcccc-chhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          344 NDFVSISATRGTIGYI-APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~-APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                      .     ......-++. .+|.+... ..+-.+.|++|||.-+.|.+++..-....         ..|.  .+..+.....
T Consensus       421 ~-----~~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---------~~~~--~i~~~~~p~~  483 (524)
T KOG0601|consen  421 S-----GVFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESG---------VQSL--TIRSGDTPNL  483 (524)
T ss_pred             c-----ccccccccccccchhhccc-cccccccccccccccccccccCcccCccc---------ccce--eeecccccCC
Confidence            1     1111233444 24544433 36778999999999999999886422110         0010  1111111111


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                            .. ....+..++.-++..++..||.+.++..+.+
T Consensus       484 ------~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  484 ------PG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             ------Cc-hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence                  11 1145666777888999999999888765544

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.99  E-value=1.1e-08  Score=105.43  Aligned_cols=170  Identities=19%  Similarity=0.249  Sum_probs=128.6

Q ss_pred             cEEEEEEEe-cCCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceec----cCCceeEEEeecCC-CCcccc
Q 010434          201 FGSVYKGQL-HTGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCS----EGSKRALVYEFMPN-GSLDRH  273 (511)
Q Consensus       201 fg~Vykg~~-~~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~----~~~~~~lV~e~~~~-gsL~~~  273 (511)
                      -.+.||+.. -+|..+.+|++...+ +....-..-++.++++.|.|+|++..++.    .+..+++||+|+|+ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            357899974 489999999994321 22223345678899999999999999876    35668899999986 577665


Q ss_pred             cccCCC-----------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          274 IFPKEN-----------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       274 l~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      -+....           .+...++..++.++.|++.||.++|+   .|+.-+-+.|++||++.+.+++|+..|.......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            543322           23457789999999999999999999   5888899999999999999999999887765443


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCC
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS  394 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~  394 (511)
                      +.              .  |.+..     -.+-|.=.||.+++-|.+|..+.
T Consensus       446 d~--------------~--~~le~-----~Qq~D~~~lG~ll~aLAt~~~ns  476 (655)
T KOG3741|consen  446 DP--------------T--EPLES-----QQQNDLRDLGLLLLALATGTENS  476 (655)
T ss_pred             CC--------------C--cchhH-----HhhhhHHHHHHHHHHHhhccccc
Confidence            32              0  11211     13569999999999999997653

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.96  E-value=3.9e-09  Score=95.84  Aligned_cols=130  Identities=21%  Similarity=0.254  Sum_probs=95.6

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEE-eccCcc--------cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKM-LENSKF--------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~-l~~~~~--------~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+++|+-+.+|.+.+. |.++.+|. +.+.-.        ..+.-.+|+.++.+++-..|..-.-+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999765 44566664 222211        234567899999988654443333345566777899999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      +++-.|.+.+...           ...++..+-.-+.-||.   .+|+|+|+.++||++..+. +.++||||+..
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9998888887321           24566777777888999   5999999999999997764 99999999974

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.88  E-value=1e-08  Score=95.31  Aligned_cols=124  Identities=23%  Similarity=0.268  Sum_probs=82.3

Q ss_pred             EEEEEEecCCcEEEEEEeccCcc---------------------------cHHHHHHHHHHhcccccc--ceEEeeceec
Q 010434          203 SVYKGQLHTGRLIAVKMLENSKF---------------------------SAEEFINEVSTIGRIHHV--NVVQLLGFCS  253 (511)
Q Consensus       203 ~Vykg~~~~g~~vAvK~l~~~~~---------------------------~~~~f~~Ev~~l~~l~H~--niv~l~g~~~  253 (511)
                      .||.|...+|..+|||+.+....                           ......+|.+.|.++...  ++.+.+++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            48999988999999998742110                           012357799999999754  56777655  


Q ss_pred             cCCceeEEEeecC--CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHH-HHhCCCCceecccCCcCceEEcCCCCee
Q 010434          254 EGSKRALVYEFMP--NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY-LHNGCDMCILHFDIKPHNILLDHNFIPK  330 (511)
Q Consensus       254 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~y-LH~~~~~~ivH~DIkp~NILl~~~~~~k  330 (511)
                        ...+|||||++  +..+..+..      ..++......++.+++..+.. +|.   .+|+|+|+.+.|||++++ .+.
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~------~~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKD------VDLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHH------CGGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEE
T ss_pred             --eCCEEEEEecCCCccchhhHHh------ccccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEE
Confidence              24589999998  555544321      112234456677777776555 466   699999999999999988 999


Q ss_pred             eecccccccC
Q 010434          331 VSDFGLAKFH  340 (511)
Q Consensus       331 l~DFGla~~~  340 (511)
                      ++|||.+...
T Consensus       147 iIDf~qav~~  156 (188)
T PF01163_consen  147 IIDFGQAVDS  156 (188)
T ss_dssp             E--GTTEEET
T ss_pred             EEecCcceec
Confidence            9999988644

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.88  E-value=6.8e-09  Score=93.89  Aligned_cols=140  Identities=21%  Similarity=0.284  Sum_probs=102.0

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEE-eccC--------cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKM-LENS--------KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~-l~~~--------~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      ..+-||+-+.|+++..+ |+...||. ..+.        ....+...+|++.+.+++--.|.--.-++.+...-.|+|||
T Consensus        13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~   91 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF   91 (229)
T ss_pred             eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence            56889999999999887 67767764 2221        12345678899999998755554444456667777899999


Q ss_pred             cCC-CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC---Ceeeeccccccc
Q 010434          265 MPN-GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF---IPKVSDFGLAKF  339 (511)
Q Consensus       265 ~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~---~~kl~DFGla~~  339 (511)
                      +++ .++.+++....  ............+..|-+.+.-||.+   +|+|+||..+||+|..++   .+.++|||++..
T Consensus        92 ~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   92 IDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             ccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            976 36777763322  12233344478899999999999995   999999999999996554   457999999864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.78  E-value=2.1e-09  Score=118.42  Aligned_cols=241  Identities=16%  Similarity=0.139  Sum_probs=156.5

Q ss_pred             cccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc----cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          194 HKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      +-+-+|.++.++..+- ..|...++|.......    ..+....+-.+.-.-+||-+++..--+.-....+|+++|..++
T Consensus       810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~  889 (1205)
T KOG0606|consen  810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG  889 (1205)
T ss_pred             ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence            3577788888887752 2344445554432111    1111122222222223466665555555677889999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC-----
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE-----  343 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~-----  343 (511)
                      +|...++..    ...+.+-.......+..+.+|||.   ..+.|+|++|.|+|...++..+++|||........     
T Consensus       890 ~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~  962 (1205)
T KOG0606|consen  890 DLPSKLHNS----GCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD  962 (1205)
T ss_pred             CchhhhhcC----CCcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence            998877432    345555566667778889999998   35899999999999999999999999844321100     


Q ss_pred             ----------------CC--------ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccc
Q 010434          344 ----------------ND--------FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAI  399 (511)
Q Consensus       344 ----------------~~--------~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~  399 (511)
                                      ..        ........+|+.|.|||...+.  .-...+|+|+.|+.++|.++|..|++....
T Consensus       963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~--~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen  963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR--RHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred             cccccccCccccccccccccccccchhhccccccCCCcccCCcccccc--cCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence                            00        0011234589999999988764  556789999999999999999999876543


Q ss_pred             cccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHH
Q 010434          400 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMT  455 (511)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~  455 (511)
                      ..        +.+.+-.+..    .......+.+....+++...+..+|.+|-.|.
T Consensus      1041 q~--------~f~ni~~~~~----~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1041 QQ--------IFENILNRDI----PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hh--------hhhccccCCC----CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            32        2211111111    11223344456677788888889999997766

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.74  E-value=6.3e-08  Score=95.32  Aligned_cols=132  Identities=17%  Similarity=0.104  Sum_probs=94.3

Q ss_pred             EEEEEEEecCCcEEEEEEeccCcc------------cHHHHHHHHHHhccccccc--eEEeeceecc-----CCceeEEE
Q 010434          202 GSVYKGQLHTGRLIAVKMLENSKF------------SAEEFINEVSTIGRIHHVN--VVQLLGFCSE-----GSKRALVY  262 (511)
Q Consensus       202 g~Vykg~~~~g~~vAvK~l~~~~~------------~~~~f~~Ev~~l~~l~H~n--iv~l~g~~~~-----~~~~~lV~  262 (511)
                      ..|.+..+ +|+.+.||.......            ....+.+|...+.++...+  .+..+++...     ...-+||+
T Consensus        36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            34667665 478899997643221            1124788999988885433  3444555532     23467999


Q ss_pred             eecCCC-CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC-------CCCeeeecc
Q 010434          263 EFMPNG-SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH-------NFIPKVSDF  334 (511)
Q Consensus       263 e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~-------~~~~kl~DF  334 (511)
                      |++++. +|.+++...  .....+......++.+++..+.-||.   .+|+|+|++++|||++.       +..+.++||
T Consensus       115 e~l~~~~sL~~~~~~~--~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl  189 (268)
T PRK15123        115 EDLAPTISLEDYCADW--ATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKLSVIDL  189 (268)
T ss_pred             eeCCCCccHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence            999875 788876211  12345566778999999999999999   69999999999999975       478899999


Q ss_pred             ccccc
Q 010434          335 GLAKF  339 (511)
Q Consensus       335 Gla~~  339 (511)
                      +.++.
T Consensus       190 ~r~~~  194 (268)
T PRK15123        190 HRAQI  194 (268)
T ss_pred             Ccccc
Confidence            98764

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.71  E-value=1.1e-07  Score=91.34  Aligned_cols=134  Identities=24%  Similarity=0.208  Sum_probs=92.6

Q ss_pred             hhccccCcCCcEEEEEEEecCCcEEEEEEeccCc-----------------------ccHHHHHHHHHHhcccccc--ce
Q 010434          191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSK-----------------------FSAEEFINEVSTIGRIHHV--NV  245 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~-----------------------~~~~~f~~Ev~~l~~l~H~--ni  245 (511)
                      .+.++||-|--+.||.|..+.|.++|||.=+...                       .+.....+|.++|.+|...  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            4567899999999999999999999999642110                       0122356788889888644  56


Q ss_pred             EEeeceeccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC
Q 010434          246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH  325 (511)
Q Consensus       246 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~  325 (511)
                      .+-+++    ++.++|||++++-.|...-         ++......++..|++-+.-+-.   .+|+|+|+.+-||++++
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~  237 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEec
Confidence            655544    6679999999887665532         1122222233333333222223   49999999999999999


Q ss_pred             CCCeeeecccccccC
Q 010434          326 NFIPKVSDFGLAKFH  340 (511)
Q Consensus       326 ~~~~kl~DFGla~~~  340 (511)
                      ||.+.++||-.+...
T Consensus       238 dg~~~vIDwPQ~v~~  252 (304)
T COG0478         238 DGDIVVIDWPQAVPI  252 (304)
T ss_pred             CCCEEEEeCcccccC
Confidence            999999999766543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.61  E-value=3.6e-07  Score=92.21  Aligned_cols=266  Identities=14%  Similarity=0.126  Sum_probs=156.9

Q ss_pred             ccccCcCCcEEEEEEEecCCcEEEEEEeccC-cccHHHHHHHHHHhccc-cccceEEeece------eccCCc-eeEEEe
Q 010434          193 THKLGQGGFGSVYKGQLHTGRLIAVKMLENS-KFSAEEFINEVSTIGRI-HHVNVVQLLGF------CSEGSK-RALVYE  263 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~g~------~~~~~~-~~lV~e  263 (511)
                      ...||+|+-+.+|-.--  -..-+-|+.... .....+...   .|... .||-+-.-+.|      .-+.+. .-++|.
T Consensus        16 gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk~a---~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          16 GRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQKVA---ELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             CccccCCccceeeecch--hhchhheeecCCCchHHHHHHH---HhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            46799999999997521  112234554432 222222222   22222 45432221111      112222 456777


Q ss_pred             ecCCCCcccccccC---CCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          264 FMPNGSLDRHIFPK---ENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       264 ~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      .+++.-=-..+++.   ........|+.+++.+..+|.+.+-||.   .|.+-+|+.++|+|+.+++.+.|.|=..-...
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~  167 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN  167 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec
Confidence            66553211112222   2233457899999999999999999998   69999999999999999999999886544333


Q ss_pred             CCCCCceeeccccCCccccchhccc-ccC--CCcCccchHHHHHHHHHHHHhC-CCCCCcccccccc-----cccchhhH
Q 010434          341 PKENDFVSISATRGTIGYIAPELIS-RNF--GTVSCKSDVYGFGMVLLEMAGG-RRNSNMNAIRSSK-----AYFPSWVY  411 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~-~~~--~~~s~ksDVwS~Gvll~elltg-~~p~~~~~~~~~~-----~~~~~~~~  411 (511)
                      ...   .......|...|.+||... +.+  ..-+..+|.|.+|+++++++.| +.|+.........     ..+....+
T Consensus       168 ~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f  244 (637)
T COG4248         168 ANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF  244 (637)
T ss_pred             cCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence            222   2234566889999999764 211  1345679999999999998775 8888753322111     11111111


Q ss_pred             HhhhcCCcccccccc-hhHHHHHHHHHHHHHHhcCc--CCCCCCCHHHHHHHHhcCcCCCC
Q 010434          412 DQLNKGGDLELRNVT-EIESVIARKLCMIGLWCIQV--KAADRPSMTKVLEMLEGSMDDLQ  469 (511)
Q Consensus       412 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~Cl~~--~P~~RPs~~evl~~Le~~~~~l~  469 (511)
                      ....+........+. .-...+++.+..+-.+|+..  ++.-|||++..+..|....+++.
T Consensus       245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~  305 (637)
T COG4248         245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK  305 (637)
T ss_pred             eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence            111111111111111 12334566777777888875  46689999999888876555543

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.52  E-value=2.1e-08  Score=106.68  Aligned_cols=152  Identities=20%  Similarity=0.245  Sum_probs=100.2

Q ss_pred             HHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceee-------ccccCCccccchhccc
Q 010434          293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI-------SATRGTIGYIAPELIS  365 (511)
Q Consensus       293 ~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~-------~~~~gt~~y~APE~~~  365 (511)
                      +.+++.|+.|+|..  .++||++|.|++|.++.++..||+.|+.+.-......+.-.       .-......|.|||++.
T Consensus       105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            34555999999985  89999999999999999999999999976543331111100       1112456899999998


Q ss_pred             ccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhc
Q 010434          366 RNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCI  444 (511)
Q Consensus       366 ~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl  444 (511)
                      ..  ..+.++|+||+|+++|.+.. |+.-+........    ........      .... ......++.++.+=+...+
T Consensus       183 ~~--~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~----~~~~~~~~------~~~~-~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  183 GT--TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS----YSFSRNLL------NAGA-FGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             cc--cccccccceeeeeEEEEEecCCcchhhccCCcch----hhhhhccc------cccc-ccccccCcHHHHHHHHHHh
Confidence            75  67889999999999999994 4443333211110    00000000      0000 0122445566777777889


Q ss_pred             CcCCCCCCCHHHHHH
Q 010434          445 QVKAADRPSMTKVLE  459 (511)
Q Consensus       445 ~~~P~~RPs~~evl~  459 (511)
                      ..++.-||++.++..
T Consensus       250 ~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLS  264 (700)
T ss_pred             cCCcccCcchhhhhc
Confidence            999999998877654

>PF14380 WAK_assoc: Wall-associated receptor kinase C-terminal

Probab=98.52  E-value=6e-07  Score=73.85  Aligned_cols=89  Identities=22%  Similarity=0.378  Sum_probs=58.4

Q ss_pred             ccCCC-CCCceEEEEEcCCcccccCcCCCCceEEEEeeecCC-CCCCCCHHHHHHHHhcCcEEEecC--CccCccccccc
Q 010434            7 VPCLS-NNQSNVYVYVAPDFIETTHLPDSCAFITKVPVVLNG-SVDKPSYEDLRKLLESGFDLTWSD--WSWSLSMTHFF   82 (511)
Q Consensus         7 v~C~~-~~~~~~y~~~~~~~~~~~~l~~sC~~~~~~p~~~~~-~~~~~s~~d~~~~~~~gf~~~~~~--~~~~~~~~~~~   82 (511)
                      |+|.. ++.+.+|.++..     .++...|...+.|||.... .....+..++.++|++||+|+|..  ..| ..|..+.
T Consensus         1 ~~C~~~~~~~~~~~v~~~-----~~~~~~C~~~v~vPV~~~~~~~~~~~~~~~~~~L~~GF~L~w~~~~~~C-~~C~~Sg   74 (94)
T PF14380_consen    1 INCSINSGNSVSYFVFRS-----SDLAGSCQKSVVVPVLGSAVDSIDGSSGNYEEVLKKGFELEWNADSGDC-RECEASG   74 (94)
T ss_pred             CccccCCCCceeEEEeCC-----cccCCcCCEEEEEEECchhhhccccchhHHHHHHhcCcEEEEeCCCCcC-cChhcCC
Confidence            68976 444556666654     4578999999999996521 112337888999999999999994  233 2333333


Q ss_pred             cccccccCCccceeeeccCCc
Q 010434           83 PECNDYYGGIIRKFICYQDDI  103 (511)
Q Consensus        83 ~~C~~~~~~~~~~~~c~~~~~  103 (511)
                      ..|  .|+.....|.|++.+.
T Consensus        75 G~C--gy~~~~~~f~C~C~dg   93 (94)
T PF14380_consen   75 GRC--GYDSNSEQFTCFCSDG   93 (94)
T ss_pred             CEe--CCCCCCceEEEECCCC
Confidence            443  1444456788887653

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.49  E-value=5.8e-07  Score=95.81  Aligned_cols=138  Identities=19%  Similarity=0.236  Sum_probs=90.8

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEEeccCc---------------------------ccH----H----------HHHH
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSK---------------------------FSA----E----------EFIN  232 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~---------------------------~~~----~----------~f~~  232 (511)
                      +-|+.++-|.||+|++++|+.||||+...+-                           ...    +          ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            4589999999999999999999999874311                           011    1          2345


Q ss_pred             HHHHhcccc-----ccceEEeecee-ccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHH-HHHHHh
Q 010434          233 EVSTIGRIH-----HVNVVQLLGFC-SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARG-VAYLHN  305 (511)
Q Consensus       233 Ev~~l~~l~-----H~niv~l~g~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~-l~yLH~  305 (511)
                      |+.-+.++.     .+++ ++=..+ .-.++..|+|||++|-.+.+....+.   ..++..   .++..++++ +..+-.
T Consensus       211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k---~ia~~~~~~f~~q~~~  283 (517)
T COG0661         211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRK---ELAELLVRAFLRQLLR  283 (517)
T ss_pred             HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHH---HHHHHHHHHHHHHHHh
Confidence            555555542     2332 222233 33567799999999999988742222   233322   233333332 111111


Q ss_pred             CCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       306 ~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                         .+++|.|.+|.||+++.++.+.+.|||+.....
T Consensus       284 ---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         284 ---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             ---cCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence               489999999999999999999999999986554

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.43  E-value=9.8e-07  Score=83.68  Aligned_cols=123  Identities=22%  Similarity=0.263  Sum_probs=89.0

Q ss_pred             CCcEEEEEEecc----C----cccHHHHHHHHHHhccccc--cceEEeeceeccC----CceeEEEeecCCC-Ccccccc
Q 010434          211 TGRLIAVKMLEN----S----KFSAEEFINEVSTIGRIHH--VNVVQLLGFCSEG----SKRALVYEFMPNG-SLDRHIF  275 (511)
Q Consensus       211 ~g~~vAvK~l~~----~----~~~~~~f~~Ev~~l~~l~H--~niv~l~g~~~~~----~~~~lV~e~~~~g-sL~~~l~  275 (511)
                      .++.+-+|.+..    +    ........+|...+.++..  -.+++.+++....    ...+||+|++++. +|.+++.
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~  110 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ  110 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence            355666665422    1    1234567888888888753  3345556655442    2347999999874 7888772


Q ss_pred             cCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC---CeeeecccccccC
Q 010434          276 PKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF---IPKVSDFGLAKFH  340 (511)
Q Consensus       276 ~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~---~~kl~DFGla~~~  340 (511)
                      .    ....+......++.+++..++-||.   .+|+|+|++++|||++.+.   .+.++||+.++..
T Consensus       111 ~----~~~~~~~~~~~ll~~l~~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  111 Q----WEQLDPSQRRELLRALARLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             h----hcccchhhHHHHHHHHHHHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            2    1225667788999999999999999   6999999999999998887   8999999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.36  E-value=4.2e-06  Score=78.66  Aligned_cols=136  Identities=18%  Similarity=0.163  Sum_probs=100.6

Q ss_pred             cCcCCcEEEEEEEecCCcEEEEEEecc----C---cccHHHHHHHHHHhcccccc--ceEEeeceecc-----CCceeEE
Q 010434          196 LGQGGFGSVYKGQLHTGRLIAVKMLEN----S---KFSAEEFINEVSTIGRIHHV--NVVQLLGFCSE-----GSKRALV  261 (511)
Q Consensus       196 LG~G~fg~Vykg~~~~g~~vAvK~l~~----~---~~~~~~f~~Ev~~l~~l~H~--niv~l~g~~~~-----~~~~~lV  261 (511)
                      -|+||-+.|++-.+. |+.+-+|.-.+    +   ......|.+|...|.++...  .+.+.+ ++..     .-.-+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            477999999998776 44788998652    1   23456899999999999643  344444 3321     1235699


Q ss_pred             EeecCC-CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCC--eeeecccccc
Q 010434          262 YEFMPN-GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFI--PKVSDFGLAK  338 (511)
Q Consensus       262 ~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~--~kl~DFGla~  338 (511)
                      +|-+++ -+|.+++..  ..-.+.+......+..+++..++-||+   .++.|+|+-++|||++.++.  ++++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~--~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQ--HAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhc--CCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997753 577777621  112355777788999999999999999   69999999999999986666  9999997655

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.33  E-value=5.3e-06  Score=79.85  Aligned_cols=140  Identities=19%  Similarity=0.284  Sum_probs=85.1

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccc--eEEeeceeccCCceeEEEeecCCCC-c
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVN--VVQLLGFCSEGSKRALVYEFMPNGS-L  270 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~n--iv~l~g~~~~~~~~~lV~e~~~~gs-L  270 (511)
                      .+||+|..+.||+.   .|..+++|..... .......+|.+++..+..-.  +.+.+++....+...+|||+++|.+ +
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~-~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~   82 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPG-FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF   82 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCC-CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence            47899999999984   2556778887542 34456788999999886443  4667777777777889999998863 2


Q ss_pred             cccc---------------------ccCCCcCCccC--HHHHHHHHH-------HHH-HHHHHHHhC-CCCceecccCCc
Q 010434          271 DRHI---------------------FPKENKGQTFG--WEKLQEIAL-------GTA-RGVAYLHNG-CDMCILHFDIKP  318 (511)
Q Consensus       271 ~~~l---------------------~~~~~~~~~l~--~~~~~~i~~-------~ia-~~l~yLH~~-~~~~ivH~DIkp  318 (511)
                      ...+                     +.-......+.  +......+.       .+. ....+|... ....++|+|+.|
T Consensus        83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~  162 (226)
T TIGR02172        83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI  162 (226)
T ss_pred             hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence            2111                     11000000111  000000000       000 112222211 124578999999


Q ss_pred             CceEEcCCCCeeeecccccc
Q 010434          319 HNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       319 ~NILl~~~~~~kl~DFGla~  338 (511)
                      .||++++++ +.|.||+.+.
T Consensus       163 ~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       163 GNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CcEEEcCCC-cEEEechhcC
Confidence            999999888 9999999775

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.28  E-value=6.4e-06  Score=87.70  Aligned_cols=139  Identities=17%  Similarity=0.185  Sum_probs=91.4

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEEeccCccc--------------------------------------HHHHHHHHH
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFS--------------------------------------AEEFINEVS  235 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~--------------------------------------~~~f~~Ev~  235 (511)
                      +-||..+.|.||++++++|+.||||+-+..-..                                      .=+|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            469999999999999999999999987532100                                      013555655


Q ss_pred             Hhccc----cccc------eEEeeceeccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHh
Q 010434          236 TIGRI----HHVN------VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN  305 (511)
Q Consensus       236 ~l~~l----~H~n------iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~  305 (511)
                      -..+.    .|-+      |.+++-  .-..++.|+||||+|..+.|.-.-.   ...++...+..-+.+...-+ -++ 
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~---~~gi~~~~i~~~l~~~~~~q-If~-  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAID---KRGISPHDILNKLVEAYLEQ-IFK-  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHH---HcCCCHHHHHHHHHHHHHHH-HHh-
Confidence            44443    3444      333322  2235789999999999988764222   23455554443333322111 223 


Q ss_pred             CCCCceecccCCcCceEEcC----CCCeeeecccccccCCC
Q 010434          306 GCDMCILHFDIKPHNILLDH----NFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       306 ~~~~~ivH~DIkp~NILl~~----~~~~kl~DFGla~~~~~  342 (511)
                         .|++|+|-+|.||+++.    ++.+.+-|||+......
T Consensus       320 ---~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  320 ---TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             ---cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence               48999999999999984    67899999999875543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.19  E-value=1.8e-05  Score=75.57  Aligned_cols=136  Identities=22%  Similarity=0.248  Sum_probs=89.7

Q ss_pred             ccCcCCcEEEEEEEecCCcEEEEEEeccCccc--------------------HHH-----HHHHHHHhcccc--ccceEE
Q 010434          195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFS--------------------AEE-----FINEVSTIGRIH--HVNVVQ  247 (511)
Q Consensus       195 ~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~--------------------~~~-----f~~Ev~~l~~l~--H~niv~  247 (511)
                      .|+.|.-+.||+|...++..+|||+.+.+...                    ..+     ..+|..-|.++.  +..+.+
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            47778888999999888999999998643211                    111     234666666663  334444


Q ss_pred             eeceeccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC
Q 010434          248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF  327 (511)
Q Consensus       248 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~  327 (511)
                      -+++.    +-.|||||+.......    +.-+.-++.......+..++++.+.-|-..  .++||+||+.-|||+. ++
T Consensus       135 Pi~~~----~nVLvMEfIg~~g~pA----P~LkDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~  203 (268)
T COG1718         135 PIAFR----NNVLVMEFIGDDGLPA----PRLKDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DG  203 (268)
T ss_pred             ceeec----CCeEEEEeccCCCCCC----CCcccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CC
Confidence            44443    3379999996541110    111112233335666677777777777652  5899999999999999 88


Q ss_pred             CeeeecccccccCC
Q 010434          328 IPKVSDFGLAKFHP  341 (511)
Q Consensus       328 ~~kl~DFGla~~~~  341 (511)
                      .+.++|||.|-...
T Consensus       204 ~p~iID~~QaV~~~  217 (268)
T COG1718         204 EPYIIDVSQAVTID  217 (268)
T ss_pred             eEEEEECccccccC
Confidence            99999999886543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.14  E-value=1.4e-05  Score=76.32  Aligned_cols=143  Identities=20%  Similarity=0.213  Sum_probs=84.2

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhcccccc--ceEEeeceecc---CCceeEEEeecCCC
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHV--NVVQLLGFCSE---GSKRALVYEFMPNG  268 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~--niv~l~g~~~~---~~~~~lV~e~~~~g  268 (511)
                      +.|+.|..+.||+....+ ..+++|..... .......+|+.++..+...  .+.+++.+...   ....+++|+++++.
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~   80 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR   80 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence            468889999999999876 69999986554 4556788899998888543  34566664422   33468999999998


Q ss_pred             Ccccc----------------c---ccCCCcCCccCHH---------HHHHH------------HHHHHH-HHHHHHh--
Q 010434          269 SLDRH----------------I---FPKENKGQTFGWE---------KLQEI------------ALGTAR-GVAYLHN--  305 (511)
Q Consensus       269 sL~~~----------------l---~~~~~~~~~l~~~---------~~~~i------------~~~ia~-~l~yLH~--  305 (511)
                      .+...                +   +........+.+.         .....            ...+.+ .++.+++  
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (239)
T PF01636_consen   81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL  160 (239)
T ss_dssp             EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence            77761                0   0110001111110         00000            112222 3333332  


Q ss_pred             --CCCCceecccCCcCceEEc-CCCCeeeecccccc
Q 010434          306 --GCDMCILHFDIKPHNILLD-HNFIPKVSDFGLAK  338 (511)
Q Consensus       306 --~~~~~ivH~DIkp~NILl~-~~~~~kl~DFGla~  338 (511)
                        .....++|+|+.|+||+++ +++.+.|.||+.+.
T Consensus       161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence              2346799999999999999 66666899998664

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.05  E-value=5.8e-05  Score=71.37  Aligned_cols=130  Identities=15%  Similarity=0.143  Sum_probs=80.6

Q ss_pred             hccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHH----------HHHHHHHhccccccc--------eEEeeceec
Q 010434          192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE----------FINEVSTIGRIHHVN--------VVQLLGFCS  253 (511)
Q Consensus       192 ~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~----------f~~Ev~~l~~l~H~n--------iv~l~g~~~  253 (511)
                      ..+.+-......|.+-..+ |+.+.+|.........+.          ..+++..+.++....        ++...-.+.
T Consensus        35 ~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~  113 (229)
T PF06176_consen   35 IIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFR  113 (229)
T ss_pred             EEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeecc
Confidence            3445555555556665554 788999987552222222          223344344442221        111111222


Q ss_pred             cCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeec
Q 010434          254 EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSD  333 (511)
Q Consensus       254 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~D  333 (511)
                      -.....|+|||++|..|.+..        .++.    .++..+++++.-||+   .|++|+|..|+|++++++ .+++.|
T Consensus       114 ~~~~~~ll~EYIeG~~l~d~~--------~i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~i~iID  177 (229)
T PF06176_consen  114 YTSSYVLLMEYIEGVELNDIE--------DIDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-GIRIID  177 (229)
T ss_pred             ceeEEEEEEEEecCeecccch--------hcCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-cEEEEE
Confidence            234456899999999887753        1222    355667788999999   699999999999999865 489999


Q ss_pred             ccccc
Q 010434          334 FGLAK  338 (511)
Q Consensus       334 FGla~  338 (511)
                      |+..+
T Consensus       178 ~~~k~  182 (229)
T PF06176_consen  178 TQGKR  182 (229)
T ss_pred             Ccccc
Confidence            98654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.05  E-value=2.7e-05  Score=75.59  Aligned_cols=140  Identities=16%  Similarity=0.162  Sum_probs=85.3

Q ss_pred             cCcCCc-EEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhcccc-ccceEEeeceeccCCceeEEEeecCCCCcccc
Q 010434          196 LGQGGF-GSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRH  273 (511)
Q Consensus       196 LG~G~f-g~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~  273 (511)
                      |-.|.. ..||+.... +..+.||+.....  ..+..+|++++..+. +.-+.+++++...++..++|||+++|.+|...
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            334444 789999765 4788899875533  345778998888874 34566778877766778999999999877643


Q ss_pred             c-------------------ccCCCcCCccCH--HHHH-HHHH-------------------HHHHHHHHHHh----CCC
Q 010434          274 I-------------------FPKENKGQTFGW--EKLQ-EIAL-------------------GTARGVAYLHN----GCD  308 (511)
Q Consensus       274 l-------------------~~~~~~~~~l~~--~~~~-~i~~-------------------~ia~~l~yLH~----~~~  308 (511)
                      .                   +.......++..  .... ....                   .+......|-.    ...
T Consensus        83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  162 (244)
T cd05150          83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED  162 (244)
T ss_pred             hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence            2                   110000001110  0000 0000                   01111222211    112


Q ss_pred             CceecccCCcCceEEcCCCCeeeecccccc
Q 010434          309 MCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       309 ~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      ..++|+|+.|.|||++++....|+||+.+.
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            458999999999999998778899998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.02  E-value=2.1e-05  Score=73.40  Aligned_cols=105  Identities=22%  Similarity=0.191  Sum_probs=83.1

Q ss_pred             HHHHHHhccccc-cceEEeeceeccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCC
Q 010434          231 INEVSTIGRIHH-VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM  309 (511)
Q Consensus       231 ~~Ev~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~  309 (511)
                      .+|.-+++.+++ +++++++|+|-.    +++.||.+.+++...- ..-..-..-+|..+.+||.++++.+.+|+.+...
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            357788888866 699999999944    7899999877664320 0001123468999999999999999999987666


Q ss_pred             ceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       310 ~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      .+.-.|++|+|+-+++++++|+.|...+...
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            7888999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK10593 hypothetical protein; Provisional

Probab=97.93  E-value=0.00014  Score=72.89  Aligned_cols=75  Identities=12%  Similarity=0.083  Sum_probs=56.8

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccc---cceEEeeceecc---CCceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHH---VNVVQLLGFCSE---GSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H---~niv~l~g~~~~---~~~~~lV~e~~~~  267 (511)
                      +.||.|..+.||+....++ .+.+|.. +.......|..|+..++.+.-   ..+.++++++..   .+..+||||++++
T Consensus        20 ~~i~~G~~~~vy~~~~~~~-~~~~k~~-~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G   97 (297)
T PRK10593         20 ECISEQPYAALWALYDSQG-NPMPLMA-RSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG   97 (297)
T ss_pred             eecCCccceeEEEEEcCCC-CEEEEEe-cccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence            4699999999999976655 4666764 332245689999999988853   467888887754   4668999999998


Q ss_pred             CCc
Q 010434          268 GSL  270 (511)
Q Consensus       268 gsL  270 (511)
                      +++
T Consensus        98 ~~~  100 (297)
T PRK10593         98 VSV  100 (297)
T ss_pred             Eec
Confidence            765

>PLN02876 acyl-CoA dehydrogenase

Probab=97.92  E-value=0.00012  Score=83.73  Aligned_cols=147  Identities=13%  Similarity=0.251  Sum_probs=92.6

Q ss_pred             ccccCcCCcEEEEEEEecCC---cEEEEEEeccCc--ccHHHHHHHHHHhcccc-ccce--EEeeceeccC---CceeEE
Q 010434          193 THKLGQGGFGSVYKGQLHTG---RLIAVKMLENSK--FSAEEFINEVSTIGRIH-HVNV--VQLLGFCSEG---SKRALV  261 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~~~g---~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV  261 (511)
                      .++++.|.+..+|+....++   ..+++|+.....  .....+.+|+.+++.+. |.++  .+++++|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            45789999999999876554   467777754422  23467889999999995 6654  7888888664   467899


Q ss_pred             EeecCCCCcccc-----------------------cccCCCc-------CCccCH--HHHHHH---------------HH
Q 010434          262 YEFMPNGSLDRH-----------------------IFPKENK-------GQTFGW--EKLQEI---------------AL  294 (511)
Q Consensus       262 ~e~~~~gsL~~~-----------------------l~~~~~~-------~~~l~~--~~~~~i---------------~~  294 (511)
                      |||+++..+.+.                       |+.-...       +.+..+  .++..+               .-
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            999987654321                       1110000       011111  111111               11


Q ss_pred             HHHHHHHHHHhCCC--------CceecccCCcCceEEcC-CCC-eeeeccccccc
Q 010434          295 GTARGVAYLHNGCD--------MCILHFDIKPHNILLDH-NFI-PKVSDFGLAKF  339 (511)
Q Consensus       295 ~ia~~l~yLH~~~~--------~~ivH~DIkp~NILl~~-~~~-~kl~DFGla~~  339 (511)
                      .+.+.+++|..+..        ..++|+|+++.||+++. +.. .-|.||+++..
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~  257 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL  257 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence            23344667755322        35999999999999975 333 57899998764

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.87  E-value=4.4e-06  Score=88.54  Aligned_cols=182  Identities=19%  Similarity=0.174  Sum_probs=128.9

Q ss_pred             ccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccc-eEEeeceeccCCceeEEEeecCCC-Cc
Q 010434          193 THKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVN-VVQLLGFCSEGSKRALVYEFMPNG-SL  270 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~~~~g-sL  270 (511)
                      -+-+++|+++.++|.+-.-.+...++.+...    ....-++++|.+++||| .+..++-+..+....+.++++..+ +.
T Consensus       247 fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~  322 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS  322 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence            3567899999999976322222334443222    34456888999999999 777777777778888999999776 33


Q ss_pred             ccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeec
Q 010434          271 DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  350 (511)
Q Consensus       271 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  350 (511)
                      ....   ......+...+...+...-++++++||+.   .=+|+|    ||+..+ ...|..||+.+..+.+..   ..+
T Consensus       323 ~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~  388 (829)
T KOG0576|consen  323 ALEM---TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPR  388 (829)
T ss_pred             cccC---ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc---ccc
Confidence            2222   11223344555666777778899999982   348888    777765 678999999887665443   234


Q ss_pred             cccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCC
Q 010434          351 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS  394 (511)
Q Consensus       351 ~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~  394 (511)
                      ...+|+.++|||+...+  .+..+.|+|+.|+-..+|.-|-+|-
T Consensus       389 t~~~~~~~~~pev~~~~--~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  389 TAIGTPEPLAPEVIQEN--TIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             cCCCCCCCCCchhhccc--ccccCCCccCCCcchhhcCCCCCCC
Confidence            55699999999988765  7888999999999878888776654

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.83  E-value=0.00013  Score=70.56  Aligned_cols=75  Identities=17%  Similarity=0.203  Sum_probs=47.8

Q ss_pred             cccCcCCcEE-EEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhcccccc---ceEEeeceeccC---CceeEEEeecC
Q 010434          194 HKLGQGGFGS-VYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHV---NVVQLLGFCSEG---SKRALVYEFMP  266 (511)
Q Consensus       194 ~~LG~G~fg~-Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~---niv~l~g~~~~~---~~~~lV~e~~~  266 (511)
                      +.++.||... ||+.    +..+++|.... .....++.+|++.+..+...   -+.+.++.....   ...+++|++++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~   77 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE   77 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence            3567777764 8875    34577786544 33455788999998877531   344444444332   23578999999


Q ss_pred             CCCcccc
Q 010434          267 NGSLDRH  273 (511)
Q Consensus       267 ~gsL~~~  273 (511)
                      |.++.+.
T Consensus        78 G~~l~~~   84 (235)
T cd05155          78 GETATAA   84 (235)
T ss_pred             CCCCCcc
Confidence            9887543

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.68  E-value=0.00033  Score=65.46  Aligned_cols=124  Identities=27%  Similarity=0.435  Sum_probs=87.8

Q ss_pred             HHhhhccccCcCCc-EEEEEEEecCCcEEEEEEecc---C-------c------------ccHHHHHHHHHHhcccc---
Q 010434          188 VTNHFTHKLGQGGF-GSVYKGQLHTGRLIAVKMLEN---S-------K------------FSAEEFINEVSTIGRIH---  241 (511)
Q Consensus       188 ~t~~~~~~LG~G~f-g~Vykg~~~~g~~vAvK~l~~---~-------~------------~~~~~f~~Ev~~l~~l~---  241 (511)
                      ...+|.+.||.|.- |.|||.++. |+.+|+|+...   .       .            ...+.|..|.+..++|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            45567789999999 999999987 78999999321   0       0            11235889999999885   


Q ss_pred             ccce--EEeeceeccC------------------CceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHH
Q 010434          242 HVNV--VQLLGFCSEG------------------SKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVA  301 (511)
Q Consensus       242 H~ni--v~l~g~~~~~------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~  301 (511)
                      +.++  |+.+||..-.                  ..+.||.||++...             .++..    -+.+|.+-|.
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~----~~~~~~~dl~  178 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIR----DIPQMLRDLK  178 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchh----HHHHHHHHHH
Confidence            3355  9999987211                  12457888775433             22333    3455666678


Q ss_pred             HHHhCCCCceecccCCcCceEEcCCCCeeeeccccc
Q 010434          302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLA  337 (511)
Q Consensus       302 yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla  337 (511)
                      .+|+   .+|+-+|+++.|..     .-||+|||.+
T Consensus       179 ~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence            8998   69999999999975     4589999854

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.68  E-value=0.0003  Score=63.94  Aligned_cols=127  Identities=18%  Similarity=0.247  Sum_probs=85.6

Q ss_pred             ccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEE-eeceeccCCceeEEEeecCCCCcc
Q 010434          193 THKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQ-LLGFCSEGSKRALVYEFMPNGSLD  271 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~-l~g~~~~~~~~~lV~e~~~~gsL~  271 (511)
                      .+.||+|.+|.||+|.+. |..+|+|+-.. ......+..|++++..++-.++.. ++.|-    .-++.|||+.|-+|.
T Consensus        27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~  100 (201)
T COG2112          27 EKELAKGTTSVVYLGEWR-GGEVALKVRRR-DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLG  100 (201)
T ss_pred             hhhhhcccccEEEEeecc-CceEEEEEecC-CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchh
Confidence            567999999999999987 56899997544 335567889999998887655533 33332    234559999887887


Q ss_pred             cccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCC-c-CceEEcCCCCeeeecccccccC
Q 010434          272 RHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIK-P-HNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       272 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIk-p-~NILl~~~~~~kl~DFGla~~~  340 (511)
                      +.-..       .+-+.    ...++++---|..   ++|-|+.|. | +||++.+ ..+.|+||.-|+.-
T Consensus       101 ~~~~~-------~~rk~----l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~k  156 (201)
T COG2112         101 KLEIG-------GDRKH----LLRVLEKAYKLDR---LGIEHGELSRPWKNVLVND-RDVYIIDFDSATFK  156 (201)
T ss_pred             hhhhc-------ccHHH----HHHHHHHHHHHHH---hccchhhhcCCceeEEecC-CcEEEEEccchhhc
Confidence            75411       12223    3334444333443   689999887 4 4555544 49999999988743

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.65  E-value=0.00034  Score=67.40  Aligned_cols=141  Identities=15%  Similarity=0.207  Sum_probs=80.9

Q ss_pred             cccCcCCcEEEEEEEecC--CcEEEEEEeccCcccHHHHHHHHHHhccccccc-eEEeeceeccCCceeEEEeecCCCCc
Q 010434          194 HKLGQGGFGSVYKGQLHT--GRLIAVKMLENSKFSAEEFINEVSTIGRIHHVN-VVQLLGFCSEGSKRALVYEFMPNGSL  270 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~--g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~~~~gsL  270 (511)
                      +.|..|-...+|+....+  +..+++|+........-+-.+|+.++..+...+ .+++++...    ..++|||++|.++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l   79 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL   79 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence            457778888999998664  678999977543222123346888888775333 344444432    2489999998776


Q ss_pred             ccc-----------------cccCCCcC-------Ccc-CHHHHHHHHH----------------------HHHHHHHHH
Q 010434          271 DRH-----------------IFPKENKG-------QTF-GWEKLQEIAL----------------------GTARGVAYL  303 (511)
Q Consensus       271 ~~~-----------------l~~~~~~~-------~~l-~~~~~~~i~~----------------------~ia~~l~yL  303 (511)
                      ...                 ++......       ... -+..+..+..                      .+...+..|
T Consensus        80 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l  159 (235)
T cd05157          80 EPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWL  159 (235)
T ss_pred             CHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHH
Confidence            421                 01111100       011 1222212111                      111111122


Q ss_pred             ----Hh-CCCCceecccCCcCceEEcC-CCCeeeecccccc
Q 010434          304 ----HN-GCDMCILHFDIKPHNILLDH-NFIPKVSDFGLAK  338 (511)
Q Consensus       304 ----H~-~~~~~ivH~DIkp~NILl~~-~~~~kl~DFGla~  338 (511)
                          .. ..+..++|+|+.+.|||+++ +..+.|.||..|.
T Consensus       160 ~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         160 KELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence                11 12357999999999999998 5789999998764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.59  E-value=0.00059  Score=64.11  Aligned_cols=126  Identities=19%  Similarity=0.280  Sum_probs=86.9

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEEeccCc-----------------ccHHHHHHHHHHhcccc------ccceEEeec
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSK-----------------FSAEEFINEVSTIGRIH------HVNVVQLLG  250 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~-----------------~~~~~f~~Ev~~l~~l~------H~niv~l~g  250 (511)
                      ..||+|+.-.||.-  ++.....||+.....                 ....++.+|+.-..++.      +.+|.+++|
T Consensus         7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            57999999999974  556677888876543                 22456677776655554      789999999


Q ss_pred             eeccCCceeEEEeecCC--C----CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEc
Q 010434          251 FCSEGSKRALVYEFMPN--G----SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD  324 (511)
Q Consensus       251 ~~~~~~~~~lV~e~~~~--g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~  324 (511)
                      +...+...-+|+|.+.+  |    +|.+++     ....++. .+.+.+.   +-.+||-.   ..|+.+|++|+||++.
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l-----~~~~~~~-~~~~~L~---~f~~~l~~---~~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYL-----KEGGLTE-ELRQALD---EFKRYLLD---HHIVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHH-----HcCCccH-HHHHHHH---HHHHHHHH---cCCeecCCCcccEEEE
Confidence            99999999999998743  3    344544     1233444 3333333   33455655   5899999999999995


Q ss_pred             CCC----Ceeeec
Q 010434          325 HNF----IPKVSD  333 (511)
Q Consensus       325 ~~~----~~kl~D  333 (511)
                      .+.    .+.|.|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            432    466666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.46  E-value=0.00087  Score=66.98  Aligned_cols=142  Identities=19%  Similarity=0.193  Sum_probs=86.5

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccc--eEEeece------eccCCceeEEEeec
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVN--VVQLLGF------CSEGSKRALVYEFM  265 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~e~~  265 (511)
                      +.+..|....+|+....+ ..+++|+...  ...++...|++++..+++.+  +.+.+..      ...++..++|++|+
T Consensus        20 ~~i~~G~~n~~y~v~~~~-~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i   96 (296)
T cd05153          20 EGISAGIENTNYFVTTDS-GRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL   96 (296)
T ss_pred             ecccCccccceEEEEeCC-CcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence            457777778999987654 4788898764  34556777888888875432  4444432      12345668999999


Q ss_pred             CCCCcccc--------------cccCC----C---cCCccCHHHHH----------HHHHHHHHHHHHHHh----CCCCc
Q 010434          266 PNGSLDRH--------------IFPKE----N---KGQTFGWEKLQ----------EIALGTARGVAYLHN----GCDMC  310 (511)
Q Consensus       266 ~~gsL~~~--------------l~~~~----~---~~~~l~~~~~~----------~i~~~ia~~l~yLH~----~~~~~  310 (511)
                      +|..+...              ++...    .   ......|....          .....+..++.++.+    ....+
T Consensus        97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~  176 (296)
T cd05153          97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG  176 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence            98776431              01000    0   00111222211          111223344555543    22457


Q ss_pred             eecccCCcCceEEcCCCCeeeecccccc
Q 010434          311 ILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       311 ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      ++|+|+.|.||+++++..+.|.||+.+.
T Consensus       177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         177 VIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCccCcCcccEEEeCCceEEEeehhhhc
Confidence            9999999999999998778899998765

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.38  E-value=0.00026  Score=80.14  Aligned_cols=197  Identities=19%  Similarity=0.208  Sum_probs=131.5

Q ss_pred             HHHHHhccccccceEEeeceeccCCce----eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCC
Q 010434          232 NEVSTIGRIHHVNVVQLLGFCSEGSKR----ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC  307 (511)
Q Consensus       232 ~Ev~~l~~l~H~niv~l~g~~~~~~~~----~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~  307 (511)
                      -|...+..+.|+|++.++.|..+....    .+..+++..-++...+    ..-..++....+.+..++.+|++|+|+. 
T Consensus       231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~----q~v~~i~~~~~r~~~~~~~~GL~~~h~~-  305 (1351)
T KOG1035|consen  231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL----QSVGSIPLETLRILHQKLLEGLAYLHSL-  305 (1351)
T ss_pred             HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH----hhccccCHHHHHHHHHHHhhhHHHHHHh-
Confidence            356667788999999999987654332    2445677776776665    3446788999999999999999999983 


Q ss_pred             CCceecccCCcC---ceEEcCCCCeeee--cccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHH
Q 010434          308 DMCILHFDIKPH---NILLDHNFIPKVS--DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM  382 (511)
Q Consensus       308 ~~~ivH~DIkp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gv  382 (511)
                        ...|.-+..+   +--.+.++....+  ||+..+..+.....   ....-+..+.|||....+....+...|+|.+|.
T Consensus       306 --~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  306 --SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             --ccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHH
Confidence              4444444433   4444556666666  88887765543321   222345678888887765455556679999999


Q ss_pred             HHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          383 VLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       383 ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                      ++..+..|..+........       -.                 ........+.+....|+..++++|++..+++...-
T Consensus       381 l~~~~~~~~~i~~~~~~~~-------~~-----------------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f  436 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSAVPV-------SL-----------------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPF  436 (1351)
T ss_pred             HHhhhhhcCcccccccchh-------hh-----------------hccccchhhhhhhhhhcchhhhhccchhhhhhchh
Confidence            9999998875432211100       00                 00000114556777899999999999999987654

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.36  E-value=0.0017  Score=63.62  Aligned_cols=138  Identities=12%  Similarity=0.131  Sum_probs=78.6

Q ss_pred             ccCcCCcEEEEEEEecCCcEEEEEEeccCcccH-HHHHHHHHHhccccccce-EEeeceeccCCceeEEEeecCCCCccc
Q 010434          195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSA-EEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEFMPNGSLDR  272 (511)
Q Consensus       195 ~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~-~~f~~Ev~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL~~  272 (511)
                      .+..|-...+|+.. .+++.+++|+........ -+..+|..+++.+....+ .++++...    ..+||||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            34567778899887 446788899765432111 245778888888854333 33344332    368999999877653


Q ss_pred             c-----------------cccCCCcCCccCHHH-HHHHHHH---------HHHHHHHHHhC-----CCCceecccCCcCc
Q 010434          273 H-----------------IFPKENKGQTFGWEK-LQEIALG---------TARGVAYLHNG-----CDMCILHFDIKPHN  320 (511)
Q Consensus       273 ~-----------------l~~~~~~~~~l~~~~-~~~i~~~---------ia~~l~yLH~~-----~~~~ivH~DIkp~N  320 (511)
                      .                 ++.....+.+++... +.....+         +...+..+-..     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            2                 111111112222211 1111111         11112222111     12468999999999


Q ss_pred             eEEcCCCCeeeecccccc
Q 010434          321 ILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       321 ILl~~~~~~kl~DFGla~  338 (511)
                      |++++++ +.|.||..+.
T Consensus       158 il~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EEEeCCC-CEEEeccccC
Confidence            9999876 7899998775

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.31  E-value=0.0034  Score=63.25  Aligned_cols=143  Identities=21%  Similarity=0.259  Sum_probs=83.2

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhcccccc--ceEEeecee------ccCCceeEEEeec
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHV--NVVQLLGFC------SEGSKRALVYEFM  265 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~--niv~l~g~~------~~~~~~~lV~e~~  265 (511)
                      +.++.|-...+|+....+| .+++|+.... ...++...|++++..|...  .+.+.+...      ..++..++++||+
T Consensus        28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~-~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i  105 (307)
T TIGR00938        28 KGIAEGVENSNYLLTTDVG-RYILTLYEKR-VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL  105 (307)
T ss_pred             cccCCccccceEEEEeCCC-cEEEEEecCC-CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence            3466676689999876545 5778876442 2344556677777776432  234444321      2245678999999


Q ss_pred             CCCCcccc--------------cccCCCc------C--CccCHHHHHH------------HHHHHHHHHHHHHh----CC
Q 010434          266 PNGSLDRH--------------IFPKENK------G--QTFGWEKLQE------------IALGTARGVAYLHN----GC  307 (511)
Q Consensus       266 ~~gsL~~~--------------l~~~~~~------~--~~l~~~~~~~------------i~~~ia~~l~yLH~----~~  307 (511)
                      +|..+...              ++.....      .  ..-.|.....            ....+...++++..    ..
T Consensus       106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~  185 (307)
T TIGR00938       106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL  185 (307)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            88665311              1110000      0  0112222111            11223345555543    23


Q ss_pred             CCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       308 ~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      ..+++|+|++++||++++++...|.||+.+.
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            5789999999999999998777899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.29  E-value=0.0022  Score=66.74  Aligned_cols=74  Identities=14%  Similarity=0.174  Sum_probs=54.2

Q ss_pred             cccCcCCcEEEEEEEecCC-cEEEEEEecc------C--cccHHHHHHHHHHhcccc---ccceEEeeceeccCCceeEE
Q 010434          194 HKLGQGGFGSVYKGQLHTG-RLIAVKMLEN------S--KFSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g-~~vAvK~l~~------~--~~~~~~f~~Ev~~l~~l~---H~niv~l~g~~~~~~~~~lV  261 (511)
                      +.||.|.+..||++...+| +.+.||.-..      .  ....+.+..|.+.|..+.   ..++++++.+  +....++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5689999999999998777 5899998431      1  235567788888888763   2457777776  33557899


Q ss_pred             EeecCCCC
Q 010434          262 YEFMPNGS  269 (511)
Q Consensus       262 ~e~~~~gs  269 (511)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>PRK05231 homoserine kinase; Provisional

Probab=97.21  E-value=0.0045  Score=62.61  Aligned_cols=142  Identities=15%  Similarity=0.199  Sum_probs=78.1

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccc--eEEeec------eeccCCceeEEEeec
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVN--VVQLLG------FCSEGSKRALVYEFM  265 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~n--iv~l~g------~~~~~~~~~lV~e~~  265 (511)
                      +.|+.|....+|+....+| .+++|+.+  ....+....|+..+..|...+  +.+.+.      +....+..++++||+
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l  104 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL  104 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence            3466777789999886655 68889875  223444445556665553222  223222      112245678999999


Q ss_pred             CCCCcccc--------------cccCCC-------cCCccCH-HHHHHH------------H-HHHHHHHHHHHh----C
Q 010434          266 PNGSLDRH--------------IFPKEN-------KGQTFGW-EKLQEI------------A-LGTARGVAYLHN----G  306 (511)
Q Consensus       266 ~~gsL~~~--------------l~~~~~-------~~~~l~~-~~~~~i------------~-~~ia~~l~yLH~----~  306 (511)
                      +|..+...              ++....       ....+.| .....-            . ..+...++.+.+    .
T Consensus       105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  184 (319)
T PRK05231        105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA  184 (319)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence            88765311              011000       0011112 111111            1 111122233321    1


Q ss_pred             CCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       307 ~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      ...+++|+|+.|+||+++++...-|.||+.+.
T Consensus       185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            34689999999999999977666899999775

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.02  E-value=0.0042  Score=62.28  Aligned_cols=140  Identities=22%  Similarity=0.277  Sum_probs=83.1

Q ss_pred             ccCcCCcEEEEEEEecC-------CcEEEEEEeccCcccHHHHHHHHHHhccccccc-eEEeeceeccCCceeEEEeecC
Q 010434          195 KLGQGGFGSVYKGQLHT-------GRLIAVKMLENSKFSAEEFINEVSTIGRIHHVN-VVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       195 ~LG~G~fg~Vykg~~~~-------g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .|..|--..+|+....+       ++.+++|+.........+..+|..++..+.... ..++++++..    .+|+||++
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~   80 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIP   80 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeC
Confidence            45556666899988654       578999997664333345677888877775332 2345555532    35899998


Q ss_pred             CCCcccc-----------------cccCCCc--C-----CccCHHHHHH--------------------------HHHHH
Q 010434          267 NGSLDRH-----------------IFPKENK--G-----QTFGWEKLQE--------------------------IALGT  296 (511)
Q Consensus       267 ~gsL~~~-----------------l~~~~~~--~-----~~l~~~~~~~--------------------------i~~~i  296 (511)
                      |..+...                 ++.....  .     .+.-|..+..                          +...+
T Consensus        81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (302)
T cd05156          81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE  160 (302)
T ss_pred             CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence            8776431                 1111111  0     0111111111                          11222


Q ss_pred             HHHHHHHHh------CCCCceecccCCcCceEEcCC----CCeeeecccccc
Q 010434          297 ARGVAYLHN------GCDMCILHFDIKPHNILLDHN----FIPKVSDFGLAK  338 (511)
Q Consensus       297 a~~l~yLH~------~~~~~ivH~DIkp~NILl~~~----~~~kl~DFGla~  338 (511)
                      ...+..|-.      .....++|+|+.|.||+++++    +.++++||..+.
T Consensus       161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            233344432      245689999999999999885    889999998775

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.75  E-value=0.0072  Score=60.23  Aligned_cols=72  Identities=17%  Similarity=0.290  Sum_probs=47.6

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhcccc---ccceEEeeceeccCCceeEEEeecCCC
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      +.++.|....+|+.. .+++.+.||+-.  ......|..|++-|+.|.   -..+++.+++....+..+||+||++.+
T Consensus        23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             EecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            468889999999987 568899999865  333457888888888883   446788888887777789999999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.56  E-value=0.025  Score=57.48  Aligned_cols=137  Identities=23%  Similarity=0.379  Sum_probs=83.7

Q ss_pred             CcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccc------eEEeec----eeccCCceeEEEeecCCCC
Q 010434          200 GFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVN------VVQLLG----FCSEGSKRALVYEFMPNGS  269 (511)
Q Consensus       200 ~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~n------iv~l~g----~~~~~~~~~lV~e~~~~gs  269 (511)
                      .-..||+....+|+. ++|+.+.. .+..+...|...+..|.-.+      +..+=|    ....+.+.+-+++|++|..
T Consensus        37 ~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~  114 (331)
T COG2334          37 EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRP  114 (331)
T ss_pred             ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcC
Confidence            445789988777777 88988776 67777777888887773222      222222    1122247788999999988


Q ss_pred             ccc-cc--------------------cc--CCCcCCccCHHH-------------HHHHHHHHHHHHHHHHh----CCCC
Q 010434          270 LDR-HI--------------------FP--KENKGQTFGWEK-------------LQEIALGTARGVAYLHN----GCDM  309 (511)
Q Consensus       270 L~~-~l--------------------~~--~~~~~~~l~~~~-------------~~~i~~~ia~~l~yLH~----~~~~  309 (511)
                      +.. .-                    +.  +........|..             -.....++...++.+.+    ....
T Consensus       115 ~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~  194 (331)
T COG2334         115 LERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPA  194 (331)
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCc
Confidence            873 11                    00  111112334441             01133334444444443    2122


Q ss_pred             c---eecccCCcCceEEcCCCC-eeeecccccc
Q 010434          310 C---ILHFDIKPHNILLDHNFI-PKVSDFGLAK  338 (511)
Q Consensus       310 ~---ivH~DIkp~NILl~~~~~-~kl~DFGla~  338 (511)
                      .   +||+|+.|.||+++.+.. ..+.||+-+.
T Consensus       195 ~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         195 LGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             ccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            3   999999999999999875 8899999764

>PLN02236 choline kinase

Probab=96.43  E-value=0.024  Score=58.11  Aligned_cols=140  Identities=19%  Similarity=0.261  Sum_probs=80.3

Q ss_pred             ccCcCCcEEEEEEEecC-----CcEEEEEEeccCcccHHHHHHHHHHhccccccce-EEeeceeccCCceeEEEeecCCC
Q 010434          195 KLGQGGFGSVYKGQLHT-----GRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       195 ~LG~G~fg~Vykg~~~~-----g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      .|-.|-.-.+|+....+     ++.+.+|+........-+-.+|..++..+...++ .++++++..+    .|.+|+++.
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~  118 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR  118 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence            34446667888886532     3689999876532211123568888887754433 3455665443    589999877


Q ss_pred             Ccccc-----------------cccCCCcCC--ccCHHHHHHHHHH-----------------HHHHHHHHH----h-CC
Q 010434          269 SLDRH-----------------IFPKENKGQ--TFGWEKLQEIALG-----------------TARGVAYLH----N-GC  307 (511)
Q Consensus       269 sL~~~-----------------l~~~~~~~~--~l~~~~~~~i~~~-----------------ia~~l~yLH----~-~~  307 (511)
                      +|...                 +|.......  ...|..+.++..+                 +...+..|.    . ..
T Consensus       119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~  198 (344)
T PLN02236        119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ  198 (344)
T ss_pred             CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence            76421                 111111111  1223333333222                 111222222    1 22


Q ss_pred             CCceecccCCcCceEEcC-CCCeeeecccccc
Q 010434          308 DMCILHFDIKPHNILLDH-NFIPKVSDFGLAK  338 (511)
Q Consensus       308 ~~~ivH~DIkp~NILl~~-~~~~kl~DFGla~  338 (511)
                      +..++|+|+++.||++++ +..+.++||..+.
T Consensus       199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             CceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            457899999999999986 4689999998775

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.40  E-value=0.028  Score=55.75  Aligned_cols=69  Identities=12%  Similarity=0.033  Sum_probs=40.3

Q ss_pred             CcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccc--c-ceEEeeceeccCCceeEEEeecCCCCc
Q 010434          197 GQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHH--V-NVVQLLGFCSEGSKRALVYEFMPNGSL  270 (511)
Q Consensus       197 G~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H--~-niv~l~g~~~~~~~~~lV~e~~~~gsL  270 (511)
                      ++|-...|+.....+|+.+++|.-.. ........+|++++..++.  + -+.+....    ...+++|++++|..+
T Consensus        20 ~~g~~~~v~~i~~~~g~~~VlR~p~~-~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~~----~~~~~~y~~i~G~p~   91 (276)
T cd05152          20 ESGLDFQVVFAKDTDGVPWVLRIPRR-PDVSERAAAEKRVLALVRKHLPVQVPDWRVH----TPELIAYPKLPGVPA   91 (276)
T ss_pred             CCcceeEEEEEEcCCCCeEEEEecCC-HHHHHHHHHHHHHHHHHHhcCCCCCCceeee----cCceEEEeccCCCcc
Confidence            44444556655445688999998643 2234567889999988852  1 11222211    123567877777654

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.33  E-value=0.041  Score=55.41  Aligned_cols=142  Identities=21%  Similarity=0.298  Sum_probs=81.8

Q ss_pred             cCCcEE-EEEEEecCCcEEEEEEecc---CcccHHHHHHHHHHhccccc--cceEEeeceeccCC--ceeEEEeecCCCC
Q 010434          198 QGGFGS-VYKGQLHTGRLIAVKMLEN---SKFSAEEFINEVSTIGRIHH--VNVVQLLGFCSEGS--KRALVYEFMPNGS  269 (511)
Q Consensus       198 ~G~fg~-Vykg~~~~g~~vAvK~l~~---~~~~~~~f~~Ev~~l~~l~H--~niv~l~g~~~~~~--~~~lV~e~~~~gs  269 (511)
                      +||++. +|..... ++.++++ ...   .........+|..+|+.+.-  .-+.+.++.|.++.  ..+.||+|.+|..
T Consensus        34 ~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~  111 (321)
T COG3173          34 SGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEV  111 (321)
T ss_pred             cCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEeccee
Confidence            445443 3333332 7788888 321   22234556678888877743  34456677887766  7799999998855


Q ss_pred             cccccccCCCc--------------------------C--------CccCHHHHHHH--------HHHHHHHHHHHHhCC
Q 010434          270 LDRHIFPKENK--------------------------G--------QTFGWEKLQEI--------ALGTARGVAYLHNGC  307 (511)
Q Consensus       270 L~~~l~~~~~~--------------------------~--------~~l~~~~~~~i--------~~~ia~~l~yLH~~~  307 (511)
                      +...+......                          +        +.-.|...++.        .-....-..+|+++.
T Consensus       112 ~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~  191 (321)
T COG3173         112 VWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANR  191 (321)
T ss_pred             ccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcC
Confidence            44333111100                          0        00011111110        011122344554421


Q ss_pred             -----CCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          308 -----DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       308 -----~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                           ...++|+|+++.|++++.+.-+-|.||+++.+-.
T Consensus       192 p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         192 PPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             CCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence                 2458999999999999998889999999987543

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.29  E-value=0.00062  Score=78.91  Aligned_cols=164  Identities=12%  Similarity=0.014  Sum_probs=113.9

Q ss_pred             HHHHHHHHHhccccccceEEeecee--ccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHh
Q 010434          228 EEFINEVSTIGRIHHVNVVQLLGFC--SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN  305 (511)
Q Consensus       228 ~~f~~Ev~~l~~l~H~niv~l~g~~--~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~  305 (511)
                      +..+.|....+...|++++....=.  .+....+..++|+.+|.+...|.....+...+...-....-.+...+..-.|+
T Consensus      1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence            4455666666677899887655433  33456788999999999998886555444444444333333333444444443


Q ss_pred             --CCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHH
Q 010434          306 --GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV  383 (511)
Q Consensus       306 --~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvl  383 (511)
                        +...-.+|+++|+-|.+|..+.++|++++|+.+.......  ......+++-|++|+....-  .++.++|+|..|+.
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~i--k~t~rsdilr~s~~ 1429 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEI--KFTKRSDILRRSLS 1429 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHH--hhhhHHHHHHHHHH
Confidence              2234579999999999999999999999999983222221  22445578899999987664  67778999999999


Q ss_pred             HHHHHhCCCCCC
Q 010434          384 LLEMAGGRRNSN  395 (511)
Q Consensus       384 l~elltg~~p~~  395 (511)
                      +|+..-|..++.
T Consensus      1430 ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1430 LYLRSDGNAYFI 1441 (2724)
T ss_pred             HHHHhcccHHHH
Confidence            999988876653

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.25  E-value=0.0065  Score=60.47  Aligned_cols=130  Identities=17%  Similarity=0.189  Sum_probs=87.6

Q ss_pred             hhccccCcCCcEEEEEEEecCCcEEEEEEeccCcc-----------------------cHHHHHHHHHHhcccccc--ce
Q 010434          191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKF-----------------------SAEEFINEVSTIGRIHHV--NV  245 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~-----------------------~~~~f~~Ev~~l~~l~H~--ni  245 (511)
                      .+.++||-|.-+.||.+...+|++.++|.-.....                       +.-...+|.+.|+.|...  -+
T Consensus        95 svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV  174 (465)
T KOG2268|consen   95 SVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV  174 (465)
T ss_pred             hhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence            45689999999999999999999999995321100                       011234677777777431  23


Q ss_pred             EEeeceeccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC
Q 010434          246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH  325 (511)
Q Consensus       246 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~  325 (511)
                      .+.+    +.++.++|||++.+-.|...-       .......+..-+.++   |--|-.   .|+||+|..-=||++++
T Consensus       175 Pkpi----D~~RH~Vvmelv~g~Pl~~v~-------~v~d~~~ly~~lm~~---Iv~la~---~GlIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  175 PKPI----DHNRHCVVMELVDGYPLRQVR-------HVEDPPTLYDDLMGL---IVRLAN---HGLIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCcc----cccceeeHHHhhcccceeeee-------ecCChHHHHHHHHHH---HHHHHH---cCceecccchheeEEec
Confidence            3333    335678999999888876543       122333444333332   223333   69999999999999999


Q ss_pred             CCCeeeeccccc
Q 010434          326 NFIPKVSDFGLA  337 (511)
Q Consensus       326 ~~~~kl~DFGla  337 (511)
                      +..++++||-..
T Consensus       238 d~~i~vIDFPQm  249 (465)
T KOG2268|consen  238 DDKIVVIDFPQM  249 (465)
T ss_pred             CCCEEEeechHh
Confidence            999999999754

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.21  E-value=0.012  Score=55.75  Aligned_cols=123  Identities=17%  Similarity=0.238  Sum_probs=63.1

Q ss_pred             CcEEEEEEeccCcccHHHHHHHHHHhccccccce-EEeeceeccCCceeEEEeecCCCCcccc-c---------------
Q 010434          212 GRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEFMPNGSLDRH-I---------------  274 (511)
Q Consensus       212 g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL~~~-l---------------  274 (511)
                      ++.|.||+........-+-.+|..+++.+...++ .++++++.++    +|++|+++..|..- +               
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~   77 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLAK   77 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHHH
Confidence            4678899887765555667788888888865444 4556655443    57799977665421 1               


Q ss_pred             -ccCCC---cCCccCHHHHHHH----------------------HHHHHHHHHHHHh-----CCCCceecccCCcCceEE
Q 010434          275 -FPKEN---KGQTFGWEKLQEI----------------------ALGTARGVAYLHN-----GCDMCILHFDIKPHNILL  323 (511)
Q Consensus       275 -~~~~~---~~~~l~~~~~~~i----------------------~~~ia~~l~yLH~-----~~~~~ivH~DIkp~NILl  323 (511)
                       |....   ....--|..+.++                      ...+..-+..+.+     ..+.-+.|+|+.|.|||+
T Consensus        78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~  157 (211)
T PF01633_consen   78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI  157 (211)
T ss_dssp             HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred             HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence             00000   0111112222222                      1111111222211     113568999999999999


Q ss_pred             -cCCCCeeeecccccc
Q 010434          324 -DHNFIPKVSDFGLAK  338 (511)
Q Consensus       324 -~~~~~~kl~DFGla~  338 (511)
                       +.++.++++||..|.
T Consensus       158 ~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  158 NNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             TSSSSCEEE--GTT-E
T ss_pred             ccCCCeEEEecHHHHh
Confidence             888999999998764

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.03  E-value=0.036  Score=55.63  Aligned_cols=30  Identities=33%  Similarity=0.256  Sum_probs=25.9

Q ss_pred             CCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       308 ~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      ..+++|+|+.++||+++. +.+.|.||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            368999999999999987 578999998664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.01  E-value=0.029  Score=56.58  Aligned_cols=32  Identities=19%  Similarity=0.209  Sum_probs=28.5

Q ss_pred             CCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       308 ~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      ..+++|+|+.++|+|+++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45799999999999999999999999987753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.99  E-value=0.033  Score=56.73  Aligned_cols=141  Identities=15%  Similarity=0.239  Sum_probs=78.7

Q ss_pred             ccCcCCcEEEEEEEecC----CcEEEEEEeccCcccHHHHHHHHHHhccccccce-EEeeceeccCCceeEEEeecCCCC
Q 010434          195 KLGQGGFGSVYKGQLHT----GRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEFMPNGS  269 (511)
Q Consensus       195 ~LG~G~fg~Vykg~~~~----g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gs  269 (511)
                      .|..|-.-.+|+....+    +..|.+|+........-+-.+|..+++.+...++ .++++++..+    +|.+|+++..
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~~   96 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINART   96 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCCC
Confidence            45446667788886543    2488999876532222233578888888865444 3556655332    5899997766


Q ss_pred             cccc-----------------cccCCCcC--CccCHHHHHHHHHHH----------------------HHHHHHHHh---
Q 010434          270 LDRH-----------------IFPKENKG--QTFGWEKLQEIALGT----------------------ARGVAYLHN---  305 (511)
Q Consensus       270 L~~~-----------------l~~~~~~~--~~l~~~~~~~i~~~i----------------------a~~l~yLH~---  305 (511)
                      |...                 +|......  .+--|..+.++..++                      ..-+..+..   
T Consensus        97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~  176 (330)
T PLN02421         97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD  176 (330)
T ss_pred             CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence            5321                 11111011  111233332222221                      111222211   


Q ss_pred             --CCCCceecccCCcCceEEcC-CCCeeeeccccccc
Q 010434          306 --GCDMCILHFDIKPHNILLDH-NFIPKVSDFGLAKF  339 (511)
Q Consensus       306 --~~~~~ivH~DIkp~NILl~~-~~~~kl~DFGla~~  339 (511)
                        +.+.-.+|.|+.+.|||+++ ++.++++||..|..
T Consensus       177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence              12335899999999999975 57899999987753

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.83  E-value=0.12  Score=52.44  Aligned_cols=71  Identities=17%  Similarity=0.169  Sum_probs=46.3

Q ss_pred             CcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhcccccc--ceEEee---c--eeccCCceeEEEeecCCCCc
Q 010434          200 GFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHV--NVVQLL---G--FCSEGSKRALVYEFMPNGSL  270 (511)
Q Consensus       200 ~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~--niv~l~---g--~~~~~~~~~lV~e~~~~gsL  270 (511)
                      .-..||+....+|..+++|+......+..+...|+..+..|...  .++...   |  +...++..+.++++++|...
T Consensus        37 ~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         37 YENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             ccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            34578999888888999998765555667777788877766321  122211   2  12224567789999987654

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=95.78  E-value=0.045  Score=55.55  Aligned_cols=137  Identities=18%  Similarity=0.197  Sum_probs=93.1

Q ss_pred             ccCcCCcEEEEEEEecCCcEEEEEEeccCcc----------------------cHH-----HHHHHHHHhccccccceEE
Q 010434          195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKF----------------------SAE-----EFINEVSTIGRIHHVNVVQ  247 (511)
Q Consensus       195 ~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~----------------------~~~-----~f~~Ev~~l~~l~H~niv~  247 (511)
                      .|..|--+.||.+.-.+|..+|||+.+.+-.                      +.+     ....|++-|.||+...|.-
T Consensus       151 CiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~  230 (520)
T KOG2270|consen  151 CISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPC  230 (520)
T ss_pred             ccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            5777888999999988899999999753210                      111     1245777777776544321


Q ss_pred             eeceeccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC
Q 010434          248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF  327 (511)
Q Consensus       248 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~  327 (511)
                      ---+..  ....|||+|+....   +- .+.-+...++...+..+-.+++.-|.-|-+.  -++||.||.--|+|+. +|
T Consensus       231 PePIlL--k~hVLVM~FlGrdg---w~-aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyh-dG  301 (520)
T KOG2270|consen  231 PEPILL--KNHVLVMEFLGRDG---WA-APKLKDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYH-DG  301 (520)
T ss_pred             CCceee--ecceEeeeeccCCC---Cc-CcccccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEE-CC
Confidence            111111  12369999984321   21 1222345678888888888888888888774  5789999999999985 56


Q ss_pred             CeeeecccccccC
Q 010434          328 IPKVSDFGLAKFH  340 (511)
Q Consensus       328 ~~kl~DFGla~~~  340 (511)
                      .+.++|.+.+--.
T Consensus       302 ~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  302 KLYIIDVSQSVEH  314 (520)
T ss_pred             EEEEEEccccccC
Confidence            8899999876543

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.66  E-value=0.1  Score=49.50  Aligned_cols=153  Identities=17%  Similarity=0.207  Sum_probs=98.2

Q ss_pred             CCcEEEEEEEecCCcEEEEEEeccCcc--cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCccccccc
Q 010434          199 GGFGSVYKGQLHTGRLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFP  276 (511)
Q Consensus       199 G~fg~Vykg~~~~g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~  276 (511)
                      +|.++.-+|+.+- .+..+|++.....  +..-|.++.+++++++  .|++|..=  ++.+.-++.|+|-...       
T Consensus        73 ~gNsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-------  140 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-------  140 (308)
T ss_pred             CCceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-------
Confidence            4556666665443 3455666655332  5567889999999987  67777722  3445558888873211       


Q ss_pred             CCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeeccccCCc
Q 010434          277 KENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI  356 (511)
Q Consensus       277 ~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~  356 (511)
                               ....-.|..+ ..+|.-.|+. ..+.+|+|-.|+||+=|..|.+||.|=+..  ..            .+.
T Consensus       141 ---------i~~~N~i~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L--l~------------~~V  195 (308)
T PF07387_consen  141 ---------INFSNFITAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL--LE------------NQV  195 (308)
T ss_pred             ---------cchhHHHHHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh--hh------------hee
Confidence                     0111122222 3567788964 468999999999999999999999986532  11            112


Q ss_pred             cccchhcccccCCCcCccchHHHHHHHHHHHHhCCCC
Q 010434          357 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRN  393 (511)
Q Consensus       357 ~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p  393 (511)
                      .|.--|     +...|.++.+-+|=.-+++++...+.
T Consensus       196 ~~vN~~-----Y~~lT~~aE~~~fv~s~l~~v~~~~~  227 (308)
T PF07387_consen  196 NMVNIE-----YESLTQEAEVKVFVKSCLKLVEKQRS  227 (308)
T ss_pred             eEEeee-----ccccChHHHHHHHHHHHHHHHHHHhc
Confidence            233211     23568899999999999998876543

The function of this family is unknown.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.31  E-value=0.14  Score=52.56  Aligned_cols=71  Identities=20%  Similarity=0.186  Sum_probs=46.2

Q ss_pred             ccCcCCcEEEEEEEecCC-cEEEEEEecc--------CcccHHHHHHHHHHhcccc--cc-ceEEeeceeccCCceeEEE
Q 010434          195 KLGQGGFGSVYKGQLHTG-RLIAVKMLEN--------SKFSAEEFINEVSTIGRIH--HV-NVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       195 ~LG~G~fg~Vykg~~~~g-~~vAvK~l~~--------~~~~~~~f~~Ev~~l~~l~--H~-niv~l~g~~~~~~~~~lV~  262 (511)
                      .||.|.-.-||++..++| +.|+||.-..        -....+.-.-|.+.|....  -| .+++++.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            479999999999997754 6899997421        1234445556777776553  23 34455433  445567999


Q ss_pred             eecCC
Q 010434          263 EFMPN  267 (511)
Q Consensus       263 e~~~~  267 (511)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99865

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.29  E-value=0.26  Score=51.46  Aligned_cols=72  Identities=13%  Similarity=0.150  Sum_probs=48.7

Q ss_pred             ccccCcCCcEEEEEEEecCCcEEEEEEecc-----Cc---ccHHHHHHHHHHhcccc---ccceEEeeceeccCCceeEE
Q 010434          193 THKLGQGGFGSVYKGQLHTGRLIAVKMLEN-----SK---FSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~-----~~---~~~~~f~~Ev~~l~~l~---H~niv~l~g~~~~~~~~~lV  261 (511)
                      .+.||.|.-..||+...+ ++.++||.-..     +.   ...+.-..|++.|+.+.   ..++.+++.++.+  ..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence            357899999999998764 56788997541     11   13333344566665553   3578888888874  45889


Q ss_pred             EeecCC
Q 010434          262 YEFMPN  267 (511)
Q Consensus       262 ~e~~~~  267 (511)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>PRK06148 hypothetical protein; Provisional

Probab=95.29  E-value=0.13  Score=60.37  Aligned_cols=143  Identities=16%  Similarity=0.203  Sum_probs=79.4

Q ss_pred             ccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhcccc-------ccceEEee-ce----ec--cCC-cee
Q 010434          195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIH-------HVNVVQLL-GF----CS--EGS-KRA  259 (511)
Q Consensus       195 ~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~-------H~niv~l~-g~----~~--~~~-~~~  259 (511)
                      .|+ |..-.+|+....+|+.+++|+.+... .......|...+..|.       -|.+++.. |-    ..  ++. +.+
T Consensus        32 ~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~v  109 (1013)
T PRK06148         32 PLD-GERDLNFRLTTDDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRLL  109 (1013)
T ss_pred             ecC-CcCCceEEEEeCCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEEE
Confidence            464 44577899888888899999987642 3334444555554442       23333322 11    11  111 456


Q ss_pred             EEEeecCCCCccccc-----------------------ccCCCcCCccCHHH-----------------HHHHHHHHHHH
Q 010434          260 LVYEFMPNGSLDRHI-----------------------FPKENKGQTFGWEK-----------------LQEIALGTARG  299 (511)
Q Consensus       260 lV~e~~~~gsL~~~l-----------------------~~~~~~~~~l~~~~-----------------~~~i~~~ia~~  299 (511)
                      -+++|++|..+.+..                       +........+.|..                 ...++.++.+.
T Consensus       110 rLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~~  189 (1013)
T PRK06148        110 RLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLAR  189 (1013)
T ss_pred             EEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHHH
Confidence            789999997775411                       11111112233322                 11222223222


Q ss_pred             HHH----HHhCCCCceecccCCcCceEEcCCC--Cee-eeccccccc
Q 010434          300 VAY----LHNGCDMCILHFDIKPHNILLDHNF--IPK-VSDFGLAKF  339 (511)
Q Consensus       300 l~y----LH~~~~~~ivH~DIkp~NILl~~~~--~~k-l~DFGla~~  339 (511)
                      .+-    .-.....++||+|+.++|||++.+.  .+. |+|||-+..
T Consensus       190 ~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        190 FERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            211    1122356899999999999998875  454 999998754

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=94.13  E-value=0.23  Score=48.57  Aligned_cols=77  Identities=19%  Similarity=0.144  Sum_probs=54.1

Q ss_pred             ccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec-CCCCcccc
Q 010434          195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM-PNGSLDRH  273 (511)
Q Consensus       195 ~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~-~~gsL~~~  273 (511)
                      .+..|..+.|+++...+|.+.++|+.........+...+ ..|+.-+-...|++++.-  .....|++|.+ ++.+|.+.
T Consensus         9 ~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~g~-~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~L~~~   85 (253)
T PF04655_consen    9 PPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEARGE-AALRWWNGRGAVRLLAAD--PERGALLLERLDPGRSLASL   85 (253)
T ss_pred             CCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhhHH-hHhheeCCCCceeeeccc--cccchhhhhhccCCCchhhc
Confidence            456788899999999999999999976544322222222 447767777788998764  34568899998 55577654


Q ss_pred             c
Q 010434          274 I  274 (511)
Q Consensus       274 l  274 (511)
                      .
T Consensus        86 ~   86 (253)
T PF04655_consen   86 P   86 (253)
T ss_pred             c
Confidence            3

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=94.04  E-value=0.037  Score=58.38  Aligned_cols=47  Identities=19%  Similarity=0.311  Sum_probs=35.2

Q ss_pred             HHHHHHHHHHhccccccceEEeeceeccC-CceeEEEeecCCCCccccc
Q 010434          227 AEEFINEVSTIGRIHHVNVVQLLGFCSEG-SKRALVYEFMPNGSLDRHI  274 (511)
Q Consensus       227 ~~~f~~Ev~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~~~~gsL~~~l  274 (511)
                      ..........++.+.|+|+...+++-... .+..+|+|++ +.||.+.+
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~   73 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDIL   73 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHH
Confidence            34555667778888999999998887543 3466889998 67888876

>PTZ00384 choline kinase; Provisional

Probab=93.75  E-value=0.44  Score=49.58  Aligned_cols=73  Identities=14%  Similarity=0.189  Sum_probs=43.9

Q ss_pred             ccCcCCcEEEEEEEecCC--c-----EEEEEEeccCcccHHHHHHHHHHhccccccce-EEeeceeccCCceeEEEeecC
Q 010434          195 KLGQGGFGSVYKGQLHTG--R-----LIAVKMLENSKFSAEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       195 ~LG~G~fg~Vykg~~~~g--~-----~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .|..|-...+|++...++  .     .|.++.......-.-+-.+|+.+++.+...++ .++++.+..    .+++||++
T Consensus        57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efIe  132 (383)
T PTZ00384         57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWVE  132 (383)
T ss_pred             EeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEec
Confidence            455577788999875433  2     24444432211111123568888888865444 455666643    59999999


Q ss_pred             CCCcc
Q 010434          267 NGSLD  271 (511)
Q Consensus       267 ~gsL~  271 (511)
                      |..|.
T Consensus       133 Gr~l~  137 (383)
T PTZ00384        133 GNTMG  137 (383)
T ss_pred             cccCC
Confidence            87775

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=93.54  E-value=0.25  Score=47.21  Aligned_cols=59  Identities=20%  Similarity=0.324  Sum_probs=44.5

Q ss_pred             CCcEEEEEEeccCcccHHHHHHHHHHhccc---cccceEEeeceeccCCceeEEEeecCCCCcc
Q 010434          211 TGRLIAVKMLENSKFSAEEFINEVSTIGRI---HHVNVVQLLGFCSEGSKRALVYEFMPNGSLD  271 (511)
Q Consensus       211 ~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l---~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  271 (511)
                      +..++.||.=  .......|..|+.-|..|   +..++.+.+.+.....+.++|+||++-|.++
T Consensus        38 g~~~~FvK~n--~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          38 GTDPFFVKCN--QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             CCcceEEEec--chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            4578888863  222345688887766666   4466788888888999999999999998886

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=93.47  E-value=0.27  Score=50.10  Aligned_cols=105  Identities=14%  Similarity=0.108  Sum_probs=71.0

Q ss_pred             cCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeec
Q 010434          254 EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSD  333 (511)
Q Consensus       254 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~D  333 (511)
                      +....|++|++- ++++...        ....|.+...++.+-+.-+.-+...  .+.-|||+.-.||||+ +|++-|+|
T Consensus       297 e~~y~yl~~kdh-gt~is~i--------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLID  364 (488)
T COG5072         297 ETLYLYLHFKDH-GTPISII--------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLID  364 (488)
T ss_pred             CceEEEEEEecC-Cceeeee--------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEE
Confidence            334456677765 5555332        3346888999999988888888774  7889999999999999 99999999


Q ss_pred             ccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHH
Q 010434          334 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF  380 (511)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~  380 (511)
                      |-++++-...+. .      .....--|-.+.+   .-+.+=|||-+
T Consensus       365 fklsRl~~~q~~-i------sy~rldhp~lF~G---~dd~QFeIYrl  401 (488)
T COG5072         365 FKLSRLSYSQGI-I------SYNRLDHPDLFNG---VDDYQFEIYRL  401 (488)
T ss_pred             eeeeecccCCce-e------eccccCchhhhcC---ccceeeeHHHH
Confidence            999985332221 1      1112234555553   33566677754

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	511
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-50
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-49
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		9e-39
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-38
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-33
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-32
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-32
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-31
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-25
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-25
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-25
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-25
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-24
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-24
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-24
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-24
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		6e-24
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-24
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-23
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-23
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-23
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-23
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-23
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-23
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-23
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-23
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		7e-23
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		8e-23
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-22
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-22
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-22
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-22
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-22
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-22
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-22
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-22
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-22
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-22
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		6e-22
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-22
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-22
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-21
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-21
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-21
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-21
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-21
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-21
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-21
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-21
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		9e-21
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		9e-21
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-20
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-20
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-20
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-20
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-20
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-20
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-20
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-20
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-20
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-20
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-20
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-20
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-20
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-20
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-20
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-20
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-20
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-20
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-20
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-20
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-20
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-20
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-20
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-20
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-20
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-20
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-20
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-20
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-20
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-20
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-20
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-20
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-20
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-20
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		8e-20
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		8e-20
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		8e-20
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		9e-20
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-19
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-19
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-19
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-19
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-19
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-19
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-19
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-19
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-19
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-19
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-19
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		9e-19
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-18
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-18
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-18
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-18
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-18
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-16
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-16
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-16
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-16
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-16
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		9e-16
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-15
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-15
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-15
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-15
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-15
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-15
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-15
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-15
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-15
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-15
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-15
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-15
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-15
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		8e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		9e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		9e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-15
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		9e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-14
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-14
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-14
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-14
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		8e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		9e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		9e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-14
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-13
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-13
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-13
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-13
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-13
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-13
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-13
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-13
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-13
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-13
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-13
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-13
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-13
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-13
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-13
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		7e-13
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-13
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		7e-13
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		7e-13
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-13
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		7e-13
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-13
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-13
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-13
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-13
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		8e-13
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		9e-13
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		9e-13
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		9e-13
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-13
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		9e-13
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-12
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-12
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-12
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-12
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-12
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-12
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-12
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-12
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		7e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		7e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-12
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		8e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-11
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-11
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-11
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-11
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-11
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-11
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-11
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-11
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		7e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		8e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		8e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		8e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		8e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		9e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		9e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		9e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		9e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		7e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		7e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		8e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		8e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		8e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		9e-10
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		9e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-09
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-09
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-09
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-09
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-09
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-09
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-09
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		6e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		7e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		7e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		7e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-08
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		8e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		8e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		9e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-07
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-07
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-07
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-07
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-07
3soa_A	444	Full-Length Human Camkii Length = 444		6e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		6e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		7e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		7e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-07
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		8e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		8e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		9e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		9e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		9e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		9e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		9e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		9e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-06
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-06
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-06
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-06
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		2e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		6e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		6e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		6e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-06
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		7e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		7e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		4e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		8e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		9e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-04
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-04
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-04
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-04
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-04
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-04
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-04
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		3e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-04
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		4e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		4e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-04
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		4e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		5e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-04
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		5e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  196 bits (497), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 118/297 (39%), Positives = 169/297 (56%), Gaps = 15/297 (5%)
Query: 178 KRYSYPEIIAVTNHFTHK--LGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE--FINE 233
           KR+S  E+   +++F++K  LG+GGFG VYKG+L  G L+AVK L+  +    E  F  E
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 234 VSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIA 293
           V  I    H N+++L GFC   ++R LVY +M NGS+   +  +        W K Q IA
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 294 LGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 353
           LG+ARG+AYLH+ CD  I+H D+K  NILLD  F   V DFGLAK    ++  V   A R
Sbjct: 146 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVX-XAVR 204
Query: 354 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAI-RSSKAYFPSWVYD 412
           GTIG+IAPE +S   G  S K+DV+G+G++LLE+  G+R  ++  +          WV  
Sbjct: 205 GTIGHIAPEYLS--TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 262
Query: 413 QLNKGG-----DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 464
            L +       D++L+   + E V   +L  + L C Q    +RP M++V+ MLEG 
Sbjct: 263 LLKEKKLEALVDVDLQGNYKDEEV--EQLIQVALLCTQSSPMERPKMSEVVRMLEGD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  192 bits (488), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 117/297 (39%), Positives = 167/297 (56%), Gaps = 15/297 (5%)
Query: 178 KRYSYPEIIAVTNHFTHK--LGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE--FINE 233
           KR+S  E+   +++F +K  LG+GGFG VYKG+L  G L+AVK L+  +    E  F  E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 234 VSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIA 293
           V  I    H N+++L GFC   ++R LVY +M NGS+   +  +        W K Q IA
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 294 LGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 353
           LG+ARG+AYLH+ CD  I+H D+K  NILLD  F   V DFGLAK    ++  V   A R
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVX-XAVR 196
Query: 354 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAI-RSSKAYFPSWVYD 412
           G IG+IAPE +S   G  S K+DV+G+G++LLE+  G+R  ++  +          WV  
Sbjct: 197 GXIGHIAPEYLS--TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 413 QLNKGG-----DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 464
            L +       D++L+   + E V   +L  + L C Q    +RP M++V+ MLEG 
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEV--EQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  158 bits (399), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/286 (36%), Positives = 156/286 (54%), Gaps = 16/286 (5%)
Query: 188 VTNHFTHK--LGQGGFGSVYKGQLHTGRLIAVKM-LENSKFSAEEFINEVSTIGRIHHVN 244
            TN+F HK  +G G FG VYKG L  G  +A+K     S    EEF  E+ T+    H +
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
           +V L+GFC E ++  L+Y++M NG+L RH++  +    +  WE+  EI +G ARG+ YLH
Sbjct: 97  LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
                 I+H D+K  NILLD NF+PK++DFG++K   + +        +GT+GYI PE  
Sbjct: 157 T---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYF 213
Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG-----D 419
            +  G ++ KSDVY FG+VL E+    R++ + ++         W  +  N G      D
Sbjct: 214 IK--GRLTEKSDVYSFGVVLFEVLCA-RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270
Query: 420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM 465
             L +    ES+  RK     + C+ + + DRPSM  VL  LE ++
Sbjct: 271 PNLADKIRPESL--RKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/286 (36%), Positives = 155/286 (54%), Gaps = 16/286 (5%)
Query: 188 VTNHFTHK--LGQGGFGSVYKGQLHTGRLIAVKM-LENSKFSAEEFINEVSTIGRIHHVN 244
            TN+F HK  +G G FG VYKG L  G  +A+K     S    EEF  E+ T+    H +
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
           +V L+GFC E ++  L+Y++M NG+L RH++  +    +  WE+  EI +G ARG+ YLH
Sbjct: 97  LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
                 I+H D+K  NILLD NF+PK++DFG++K   +          +GT+GYI PE  
Sbjct: 157 T---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYF 213
Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG-----D 419
            +  G ++ KSDVY FG+VL E+    R++ + ++         W  +  N G      D
Sbjct: 214 IK--GRLTEKSDVYSFGVVLFEVLCA-RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270
Query: 420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM 465
             L +    ES+  RK     + C+ + + DRPSM  VL  LE ++
Sbjct: 271 PNLADKIRPESL--RKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  138 bits (347), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 97/296 (32%), Positives = 145/296 (48%), Gaps = 21/296 (7%)
Query: 180 YSYPEIIAVTNHFT--------HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE-- 229
           +S+ E+  VTN+F         +K+G+GGFG VYKG ++   +   K+      + EE  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 230 --FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGW 286
             F  E+  + +  H N+V+LLGF S+G    LVY +MPNGSL DR      +      W
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR--LSCLDGTPPLSW 132
Query: 287 EKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 346
               +IA G A G+ +LH       +H DIK  NILLD  F  K+SDFGLA+   K    
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF 406
           V  S   GT  Y+APE +    G ++ KSD+Y FG+VLLE+  G    + +         
Sbjct: 190 VMXSRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246
Query: 407 PSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
              + D+     D   + + + +S     +  +   C+  K   RP + KV ++L+
Sbjct: 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 96/296 (32%), Positives = 144/296 (48%), Gaps = 21/296 (7%)
Query: 180 YSYPEIIAVTNHFT--------HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE-- 229
           +S+ E+  VTN+F         +K+G+GGFG VYKG ++   +   K+      + EE  
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 68
Query: 230 --FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGS-LDRHIFPKENKGQTFGW 286
             F  E+  + +  H N+V+LLGF S+G    LVY +MPNGS LDR      +      W
Sbjct: 69  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR--LSCLDGTPPLSW 126
Query: 287 EKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 346
               +IA G A G+ +LH       +H DIK  NILLD  F  K+SDFGLA+   K    
Sbjct: 127 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF 406
           V      GT  Y+APE +    G ++ KSD+Y FG+VLLE+  G    + +         
Sbjct: 184 VMXXRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 240
Query: 407 PSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
              + D+     D   + + + +S     +  +   C+  K   RP + KV ++L+
Sbjct: 241 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 296

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  136 bits (343), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 96/296 (32%), Positives = 144/296 (48%), Gaps = 21/296 (7%)
Query: 180 YSYPEIIAVTNHFT--------HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE-- 229
           +S+ E+  VTN+F         +K+G+GGFG VYKG ++   +   K+      + EE  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 230 --FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGS-LDRHIFPKENKGQTFGW 286
             F  E+  + +  H N+V+LLGF S+G    LVY +MPNGS LDR      +      W
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR--LSCLDGTPPLSW 132
Query: 287 EKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 346
               +IA G A G+ +LH       +H DIK  NILLD  F  K+SDFGLA+   K    
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF 406
           V      GT  Y+APE +    G ++ KSD+Y FG+VLLE+  G    + +         
Sbjct: 190 VMXXRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246
Query: 407 PSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
              + D+     D   + + + +S     +  +   C+  K   RP + KV ++L+
Sbjct: 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  131 bits (329), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 96/296 (32%), Positives = 139/296 (46%), Gaps = 21/296 (7%)
Query: 180 YSYPEIIAVTNHFT--------HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE-- 229
           +S+ E+  VTN+F         +K G+GGFG VYKG ++   +   K+      + EE  
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 65
Query: 230 --FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGW 286
             F  E+    +  H N+V+LLGF S+G    LVY + PNGSL DR      +      W
Sbjct: 66  QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDR--LSCLDGTPPLSW 123
Query: 287 EKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 346
               +IA G A G+ +LH       +H DIK  NILLD  F  K+SDFGLA+   K    
Sbjct: 124 HXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF 406
           V  S   GT  Y APE +    G ++ KSD+Y FG+VLLE+  G    + +         
Sbjct: 181 VXXSRIVGTTAYXAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 237
Query: 407 PSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
              + D+     D   +   + +S        +   C+  K   RP + KV ++L+
Sbjct: 238 KEEIEDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 144/274 (52%), Gaps = 24/274 (8%)
Query: 194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 250
            ++G G FG+VYKG+ H    +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 18  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 75
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           + ++  + A+V ++    SL  H+   E K   F  +KL +IA  TARG+ YLH      
Sbjct: 76  YSTK-PQLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHA---KS 128
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 369
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 129 IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 188
Query: 370 TVSCKSDVYGFGMVLLE-MAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEI 428
             S +SDVY FG+VL E M G    SN+N            + + + +G      +++++
Sbjct: 189 PYSFQSDVYAFGIVLYELMTGQLPYSNINN--------RDQIIEMVGRGSLSP--DLSKV 238
Query: 429 ESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
            S   +++  +   C++ K  +RPS  ++L  +E
Sbjct: 239 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 272

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 143/274 (52%), Gaps = 24/274 (8%)
Query: 194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 250
            ++G G FG+VYKG+ H    +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 30  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           + S   + A+V ++    SL  H+   E K   F  +KL +IA  TARG+ YLH      
Sbjct: 88  Y-STAPQLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHA---KS 140
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 369
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 370 TVSCKSDVYGFGMVLLE-MAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEI 428
             S +SDVY FG+VL E M G    SN+N            + + + +G      +++++
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINN--------RDQIIEMVGRGSLSP--DLSKV 250
Query: 429 ESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
            S   +++  +   C++ K  +RPS  ++L  +E
Sbjct: 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 144/274 (52%), Gaps = 24/274 (8%)
Query: 194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 250
            ++G G FG+VYKG+ H    +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 30  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           + ++  + A+V ++    SL  H+   E K   F  +KL +IA  TARG+ YLH      
Sbjct: 88  YSTK-PQLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHA---KS 140
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 369
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 370 TVSCKSDVYGFGMVLLE-MAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEI 428
             S +SDVY FG+VL E M G    SN+N            + + + +G      +++++
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINN--------RDQIIEMVGRGSLSP--DLSKV 250
Query: 429 ESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
            S   +++  +   C++ K  +RPS  ++L  +E
Sbjct: 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 114/201 (56%), Gaps = 10/201 (4%)
Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAE---EFINEVSTIGRIHHVNVVQ 247
           +   K+G G FG+V++ + H G  +AVK+L    F AE   EF+ EV+ + R+ H N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +G  ++    ++V E++  GSL R +  K    +     +   +A   A+G+ YLHN  
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYR-LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR- 156
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
           +  I+H ++K  N+L+D  +  KV DFGL++   K + F+S  +  GT  ++APE++   
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 368 FGTVSCKSDVYGFGMVLLEMA 388
               + KSDVY FG++L E+A
Sbjct: 215 --PSNEKSDVYSFGVILWELA 233

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 112/201 (55%), Gaps = 10/201 (4%)
Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAE---EFINEVSTIGRIHHVNVVQ 247
           +   K+G G FG+V++ + H G  +AVK+L    F AE   EF+ EV+ + R+ H N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +G  ++    ++V E++  GSL R +  K    +     +   +A   A+G+ YLHN  
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYR-LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR- 156
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
           +  I+H D+K  N+L+D  +  KV DFGL++   K + F+      GT  ++APE++   
Sbjct: 157 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 368 FGTVSCKSDVYGFGMVLLEMA 388
               + KSDVY FG++L E+A
Sbjct: 215 --PSNEKSDVYSFGVILWELA 233

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 106/196 (54%), Gaps = 9/196 (4%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           F  ++G G FG V+ G       +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 11  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
           C E +   LV+EFM +G L  ++  +  +G  F  E L  + L    G+AYL    + C+
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYL--RTQRG-LFAAETLLGMCLDVCEGMAYLE---EACV 124
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS--FSRY 181
Query: 372 SCKSDVYGFGMVLLEM 387
           S KSDV+ FG+++ E+
Sbjct: 182 SSKSDVWSFGVLMWEV 197

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 105/196 (53%), Gaps = 9/196 (4%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           F  ++G G FG V+ G       +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 9   FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
           C E +   LV+EFM +G L  ++  +  +G  F  E L  + L    G+AYL      C+
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYL--RTQRG-LFAAETLLGMCLDVCEGMAYLEEA---CV 122
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS--FSRY 179
Query: 372 SCKSDVYGFGMVLLEM 387
           S KSDV+ FG+++ E+
Sbjct: 180 SSKSDVWSFGVLMWEV 195

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 106/196 (54%), Gaps = 9/196 (4%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           F  ++G G FG V+ G       +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 14  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
           C E +   LV+EFM +G L  ++  +  +G  F  E L  + L    G+AYL    + C+
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYL--RTQRG-LFAAETLLGMCLDVCEGMAYLE---EACV 127
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 128 IHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS--FSRY 184
Query: 372 SCKSDVYGFGMVLLEM 387
           S KSDV+ FG+++ E+
Sbjct: 185 SSKSDVWSFGVLMWEV 200

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 72/213 (33%), Positives = 120/213 (56%), Gaps = 13/213 (6%)
Query: 182 YPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFI---NEVSTIG 238
           Y EI A     + ++G G FG+VYKG+ H    +AVK+L+    + E+F    NEV+ + 
Sbjct: 30  YWEIEASEVMLSTRIGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQFQAFRNEVAVLR 87
Query: 239 RIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR 298
           +  HVN++  +G+ ++ +  A+V ++    SL +H+  +E K Q F   +L +IA  TA+
Sbjct: 88  KTRHVNILLFMGYMTKDN-LAIVTQWCEGSSLYKHLHVQETKFQMF---QLIDIARQTAQ 143
Query: 299 GVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 358
           G+ YLH      I+H D+K +NI L      K+ DFGLA    + +    +    G++ +
Sbjct: 144 GMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLW 200
Query: 359 IAPELIS-RNFGTVSCKSDVYGFGMVLLEMAGG 390
           +APE+I  ++    S +SDVY +G+VL E+  G
Sbjct: 201 MAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 105/196 (53%), Gaps = 9/196 (4%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           F  ++G G FG V+ G       +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 12  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
           C E +   LV EFM +G L  ++  +  +G  F  E L  + L    G+AYL    + C+
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYL--RTQRG-LFAAETLLGMCLDVCEGMAYLE---EACV 125
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS--FSRY 182
Query: 372 SCKSDVYGFGMVLLEM 387
           S KSDV+ FG+++ E+
Sbjct: 183 SSKSDVWSFGVLMWEV 198

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 107/196 (54%), Gaps = 9/196 (4%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           F  ++G G FG V+ G       +A+K ++    S ++FI E   + ++ H  +VQL G 
Sbjct: 31  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
           C E +   LV+EFM +G L  ++  +  +G  F  E L  + L    G+AYL    + C+
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYL--RTQRG-LFAAETLLGMCLDVCEGMAYLE---EACV 144
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 145 IHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS--FSRY 201
Query: 372 SCKSDVYGFGMVLLEM 387
           S KSDV+ FG+++ E+
Sbjct: 202 SSKSDVWSFGVLMWEV 217

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/209 (35%), Positives = 114/209 (54%), Gaps = 14/209 (6%)
Query: 194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 250
            ++G G FG+VYKG+ H    +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 14  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           + S   + A+V ++    SL  H+   E K   F   KL +IA  TA+G+ YLH      
Sbjct: 72  Y-STAPQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 124
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 369
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 370 TVSCKSDVYGFGMVLLE-MAGGRRNSNMN 397
             S +SDVY FG+VL E M G    SN+N
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 74/209 (35%), Positives = 115/209 (55%), Gaps = 14/209 (6%)
Query: 194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 250
            ++G G FG+VYKG+ H    +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 14  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           + ++  + A+V ++    SL  H+   E K   F   KL +IA  TA+G+ YLH      
Sbjct: 72  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 124
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 369
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 370 TVSCKSDVYGFGMVLLE-MAGGRRNSNMN 397
             S +SDVY FG+VL E M G    SN+N
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 74/209 (35%), Positives = 115/209 (55%), Gaps = 14/209 (6%)
Query: 194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 250
            ++G G FG+VYKG+ H    +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 16  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 73
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           + ++  + A+V ++    SL  H+   E K   F   KL +IA  TA+G+ YLH      
Sbjct: 74  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 126
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 369
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 127 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 186
Query: 370 TVSCKSDVYGFGMVLLE-MAGGRRNSNMN 397
             S +SDVY FG+VL E M G    SN+N
Sbjct: 187 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 215

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 105/196 (53%), Gaps = 9/196 (4%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           F  ++G G FG V+ G       +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 11  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
           C E +   LV+EFM +G L  ++  +  +G  F  E L  + L    G+AYL    +  +
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYL--RTQRG-LFAAETLLGMCLDVCEGMAYLE---EASV 124
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS--FSRY 181
Query: 372 SCKSDVYGFGMVLLEM 387
           S KSDV+ FG+++ E+
Sbjct: 182 SSKSDVWSFGVLMWEV 197

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 74/209 (35%), Positives = 115/209 (55%), Gaps = 14/209 (6%)
Query: 194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 250
            ++G G FG+VYKG+ H    +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 41  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 98
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           + ++  + A+V ++    SL  H+   E K   F   KL +IA  TA+G+ YLH      
Sbjct: 99  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 151
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 369
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 152 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 211
Query: 370 TVSCKSDVYGFGMVLLE-MAGGRRNSNMN 397
             S +SDVY FG+VL E M G    SN+N
Sbjct: 212 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 240

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 74/209 (35%), Positives = 115/209 (55%), Gaps = 14/209 (6%)
Query: 194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 250
            ++G G FG+VYKG+ H    +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 19  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           + ++  + A+V ++    SL  H+   E K   F   KL +IA  TA+G+ YLH      
Sbjct: 77  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 129
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 369
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 370 TVSCKSDVYGFGMVLLE-MAGGRRNSNMN 397
             S +SDVY FG+VL E M G    SN+N
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 74/209 (35%), Positives = 115/209 (55%), Gaps = 14/209 (6%)
Query: 194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 250
            ++G G FG+VYKG+ H    +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 19  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           + ++  + A+V ++    SL  H+   E K   F   KL +IA  TA+G+ YLH      
Sbjct: 77  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 129
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 369
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 370 TVSCKSDVYGFGMVLLE-MAGGRRNSNMN 397
             S +SDVY FG+VL E M G    SN+N
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 74/209 (35%), Positives = 115/209 (55%), Gaps = 14/209 (6%)
Query: 194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 250
            ++G G FG+VYKG+ H    +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 42  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           + ++  + A+V ++    SL  H+   E K   F   KL +IA  TA+G+ YLH      
Sbjct: 100 YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 152
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 369
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 370 TVSCKSDVYGFGMVLLE-MAGGRRNSNMN 397
             S +SDVY FG+VL E M G    SN+N
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 241

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 74/209 (35%), Positives = 115/209 (55%), Gaps = 14/209 (6%)
Query: 194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 250
            ++G G FG+VYKG+ H    +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 14  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           + ++  + A+V ++    SL  H+   E K   F   KL +IA  TA+G+ YLH      
Sbjct: 72  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 124
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 369
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 370 TVSCKSDVYGFGMVLLE-MAGGRRNSNMN 397
             S +SDVY FG+VL E M G    SN+N
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 74/209 (35%), Positives = 115/209 (55%), Gaps = 14/209 (6%)
Query: 194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 250
            ++G G FG+VYKG+ H    +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 34  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 91
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           + ++  + A+V ++    SL  H+   E K   F   KL +IA  TA+G+ YLH      
Sbjct: 92  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 144
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 369
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 145 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 204
Query: 370 TVSCKSDVYGFGMVLLE-MAGGRRNSNMN 397
             S +SDVY FG+VL E M G    SN+N
Sbjct: 205 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 233

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 74/209 (35%), Positives = 115/209 (55%), Gaps = 14/209 (6%)
Query: 194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 250
            ++G G FG+VYKG+ H    +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 42  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           + ++  + A+V ++    SL  H+   E K   F   KL +IA  TA+G+ YLH      
Sbjct: 100 YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHA---KS 152
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 369
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 370 TVSCKSDVYGFGMVLLE-MAGGRRNSNMN 397
             S +SDVY FG+VL E M G    SN+N
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 241

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 105/198 (53%), Gaps = 9/198 (4%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLGQG FG V+ G  +    +A+K L+    S E F+ E   + +I H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V E+M  GSL    F K   G+     +L ++A   A G+AY+     M  +H 
Sbjct: 85  -EPIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 375 SDVYGFGMVLLEMAGGRR 392
           SDV+ FG++L E+    R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 105/198 (53%), Gaps = 9/198 (4%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLGQG FG V+ G  +    +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V E+M  GSL    F K   G+     +L ++A   A G+AY+     M  +H 
Sbjct: 78  -EPIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 131
Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 188
Query: 375 SDVYGFGMVLLEMAGGRR 392
           SDV+ FG++L E+    R
Sbjct: 189 SDVWSFGILLTELTTKGR 206

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 105/198 (53%), Gaps = 9/198 (4%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLGQG FG V+ G  +    +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V E+M  GSL    F K   G+     +L ++A   A G+AY+     M  +H 
Sbjct: 74  -EPIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 127
Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 184
Query: 375 SDVYGFGMVLLEMAGGRR 392
           SDV+ FG++L E+    R
Sbjct: 185 SDVWSFGILLTELTTKGR 202

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 105/198 (53%), Gaps = 9/198 (4%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLGQG FG V+ G  +    +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V E+M  GSL    F K   G+     +L ++A   A G+AY+     M  +H 
Sbjct: 76  -EPIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 129
Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 186
Query: 375 SDVYGFGMVLLEMAGGRR 392
           SDV+ FG++L E+    R
Sbjct: 187 SDVWSFGILLTELTTKGR 204

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 105/198 (53%), Gaps = 9/198 (4%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLGQG FG V+ G  +    +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V E+M  GSL    F K   G+     +L ++A   A G+AY+     M  +H 
Sbjct: 251 -EPIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 361
Query: 375 SDVYGFGMVLLEMAGGRR 392
           SDV+ FG++L E+    R
Sbjct: 362 SDVWSFGILLTELTTKGR 379

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 105/198 (53%), Gaps = 9/198 (4%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLGQG FG V+ G  +    +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V E+M  GSL    F K   G+     +L ++A   A G+AY+     M  +H 
Sbjct: 85  -EPIYIVIEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 375 SDVYGFGMVLLEMAGGRR 392
           SDV+ FG++L E+    R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 105/198 (53%), Gaps = 9/198 (4%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLGQG FG V+ G  +    +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V E+M  GSL    F K   G+     +L ++A   A G+AY+     M  +H 
Sbjct: 251 -EPIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 361
Query: 375 SDVYGFGMVLLEMAGGRR 392
           SDV+ FG++L E+    R
Sbjct: 362 SDVWSFGILLTELTTKGR 379

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 105/198 (53%), Gaps = 9/198 (4%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLGQG FG V+ G  +    +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V E+M  GSL    F K   G+     +L ++A   A G+AY+     M  +H 
Sbjct: 85  -EPIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 375 SDVYGFGMVLLEMAGGRR 392
           SDV+ FG++L E+    R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 105/198 (53%), Gaps = 9/198 (4%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLGQG FG V+ G  +    +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V E+M  GSL    F K   G+     +L ++A   A G+AY+     M  +H 
Sbjct: 85  -EPIYIVCEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 375 SDVYGFGMVLLEMAGGRR 392
           SDV+ FG++L E+    R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 9/198 (4%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLGQG FG V+ G  +    +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V E+M  GSL    F K   G+     +L ++A   A G+AY+     M  +H 
Sbjct: 75  -EPIXIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 128
Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D++  NIL+  N + KV+DFGLA+   ++N+  +    +  I + APE  +  +G  + K
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLI-EDNEXTARQGAKFPIKWTAPE--AALYGRFTIK 185
Query: 375 SDVYGFGMVLLEMAGGRR 392
           SDV+ FG++L E+    R
Sbjct: 186 SDVWSFGILLTELTTKGR 203

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 105/198 (53%), Gaps = 9/198 (4%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLGQG FG V+ G  +    +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V E+M  GSL    F K   G+     +L ++A   A G+AY+     M  +H 
Sbjct: 251 -EPIYIVGEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 361
Query: 375 SDVYGFGMVLLEMAGGRR 392
           SDV+ FG++L E+    R
Sbjct: 362 SDVWSFGILLTELTTKGR 379

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 125/270 (46%), Gaps = 22/270 (8%)
Query: 194 HKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           HKLG G +G VY+G      L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           +      ++ EFM  G+L  ++  +E   Q      L  +A   +  + YL        +
Sbjct: 77  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 131
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+   N L+  N + KV+DFGL++    +  F + +  +  I + APE ++ N    S
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-FTAHAGAKFPIKWTAPESLAYN--KFS 188
Query: 373 CKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVI 432
            KSDV+ FG++L E+A          +       PS VY+ L K   +E           
Sbjct: 189 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDPSQVYELLEKDYRMER------PEGC 235
Query: 433 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 9/198 (4%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLGQG FG V+ G  +    +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V E+M  GSL    F K   G+     +L ++A   A G+AY+     M  +H 
Sbjct: 85  -EPIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D+   NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 375 SDVYGFGMVLLEMAGGRR 392
           SDV+ FG++L E+    R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 105/198 (53%), Gaps = 9/198 (4%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLGQG FG V+ G  +    +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V E+M  GSL    F K   G+     +L +++   A G+AY+     M  +H 
Sbjct: 82  -EPIYIVTEYMNKGSL--LDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHR 135
Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 192
Query: 375 SDVYGFGMVLLEMAGGRR 392
           SDV+ FG++L E+    R
Sbjct: 193 SDVWSFGILLTELTTKGR 210

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 104/193 (53%), Gaps = 9/193 (4%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLGQG FG V+ G  +    +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V E+M  GSL    F K   G+     +L ++A   A G+AY+     M  +H 
Sbjct: 334 -EPIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 387
Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 444
Query: 375 SDVYGFGMVLLEM 387
           SDV+ FG++L E+
Sbjct: 445 SDVWSFGILLTEL 457

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 105/198 (53%), Gaps = 9/198 (4%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLGQG FG V+ G  +    +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V E+M  GSL    F K   G+     +L +++   A G+AY+     M  +H 
Sbjct: 82  -EPIYIVTEYMNKGSL--LDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHR 135
Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLI-EDNEWTARQGAKFPIKWTAPE--AALYGRFTIK 192
Query: 375 SDVYGFGMVLLEMAGGRR 392
           SDV+ FG++L E+    R
Sbjct: 193 SDVWSFGILLTELTTKGR 210

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 130/275 (47%), Gaps = 22/275 (8%)
Query: 194 HKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           HKLG G +G VY G      L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 97
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           +      +V E+MP G+L  ++  +E   +      L  +A   +  + YL        +
Sbjct: 98  TLEPPFYIVTEYMPYGNLLDYL--RECNREEVTAVVLLYMATQISSAMEYLEKK---NFI 152
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N  T S
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--TFS 209
Query: 373 CKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVI 432
            KSDV+ FG++L E+A     S    I  S+      VYD L KG  +E     + E   
Sbjct: 210 IKSDVWAFGVLLWEIA-TYGMSPYPGIDLSQ------VYDLLEKGYRME-----QPEGCP 257
Query: 433 ARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD 467
            +   ++   C +   ADRPS  +  +  E    D
Sbjct: 258 PKVYELMRA-CWKWSPADRPSFAETHQAFETMFHD 291

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 9/198 (4%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLGQG FG V+ G  +    +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V E+M  GSL    F K   G+     +L ++A   A G+AY+     M  +H 
Sbjct: 85  -EPIYIVIEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D++  NIL+  N + KV+DFGLA+   ++N+  +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEXTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 375 SDVYGFGMVLLEMAGGRR 392
           SDV+ FG++L E+    R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 104/198 (52%), Gaps = 9/198 (4%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLGQG FG V+ G  +    +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V E+M  G L    F K   G+     +L ++A   A G+AY+     M  +H 
Sbjct: 85  -EPIYIVMEYMSKGCL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 375 SDVYGFGMVLLEMAGGRR 392
           SDV+ FG++L E+    R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 104/198 (52%), Gaps = 9/198 (4%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLGQG FG V+ G  +    +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V E+M  G L    F K   G+     +L ++A   A G+AY+     M  +H 
Sbjct: 85  -EPIYIVTEYMSKGCL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 375 SDVYGFGMVLLEMAGGRR 392
           SDV+ FG++L E+    R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 104/198 (52%), Gaps = 9/198 (4%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           KLGQG FG V+ G  +    +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V E+M  GSL    F K   G+     +L ++A   A G+AY+     M  +H 
Sbjct: 252 -EPIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 305
Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D++  NIL+  N + KV+DFGL +   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 362
Query: 375 SDVYGFGMVLLEMAGGRR 392
           SDV+ FG++L E+    R
Sbjct: 363 SDVWSFGILLTELTTKGR 380

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 123/270 (45%), Gaps = 22/270 (8%)
Query: 194 HKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           HKLG G FG VY+G      L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           +      ++ EFM  G+L  ++  +E   Q      L  +A   +  + YL        +
Sbjct: 77  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 131
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+   N L+  N + KV+DFGL++    +       A +  I + APE ++ N    S
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGA-KFPIKWTAPESLAYN--KFS 188
Query: 373 CKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVI 432
            KSDV+ FG++L E+A          +       PS VY+ L K   +E           
Sbjct: 189 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDPSQVYELLEKDYRMER------PEGC 235
Query: 433 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 123/270 (45%), Gaps = 22/270 (8%)
Query: 194 HKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           HKLG G +G VY+G      L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           +      ++ EFM  G+L  ++  +E   Q      L  +A   +  + YL        +
Sbjct: 77  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 131
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+   N L+  N + KV+DFGL++    +       A +  I + APE ++ N    S
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGA-KFPIKWTAPESLAYN--KFS 188
Query: 373 CKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVI 432
            KSDV+ FG++L E+A          +       PS VY+ L K   +E           
Sbjct: 189 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDPSQVYELLEKDYRMER------PEGC 235
Query: 433 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 107/209 (51%), Gaps = 9/209 (4%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHV 243
           EI   +     +LG G FG V+ G  +    +A+K L+    S E F+ E   + ++ H 
Sbjct: 5   EIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHD 64
Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
            +VQL    SE     +V E+M  GSL    F K+ +G+      L ++A   A G+AY+
Sbjct: 65  KLVQLYAVVSE-EPIYIVTEYMNKGSL--LDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 121
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
                M  +H D++  NIL+ +  I K++DFGLA+   ++N+  +    +  I + APE 
Sbjct: 122 ER---MNYIHRDLRSANILVGNGLICKIADFGLARLI-EDNEXTARQGAKFPIKWTAPE- 176
Query: 364 ISRNFGTVSCKSDVYGFGMVLLEMAGGRR 392
            +  +G  + KSDV+ FG++L E+    R
Sbjct: 177 -AALYGRFTIKSDVWSFGILLTELVTKGR 204

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 12/216 (5%)
Query: 172 QQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFI 231
           Q+ W    +  P     T     +LG G FG V+ G  +    +AVK L+    S + F+
Sbjct: 5   QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 61
Query: 232 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQE 291
            E + + ++ H  +V+L    ++     ++ E+M NGSL    F K   G      KL +
Sbjct: 62  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 118
Query: 292 IALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 351
           +A   A G+A++    +   +H D++  NIL+      K++DFGLA+   ++N++ +   
Sbjct: 119 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREG 174
Query: 352 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
            +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 175 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 208

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 12/216 (5%)
Query: 172 QQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFI 231
           Q+ W    +  P     T     +LG G FG V+ G  +    +AVK L+    S + F+
Sbjct: 6   QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 62
Query: 232 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQE 291
            E + + ++ H  +V+L    ++     ++ E+M NGSL    F K   G      KL +
Sbjct: 63  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 119
Query: 292 IALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 351
           +A   A G+A++    +   +H D++  NIL+      K++DFGLA+   ++N++ +   
Sbjct: 120 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREG 175
Query: 352 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
            +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 176 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 209

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHV 243
           EI   +     KLG G FG V+ G  +    +AVK L+    S + F+ E + +  + H 
Sbjct: 8   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD 67
Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
            +V+L    ++     ++ EFM  GSL    F K ++G      KL + +   A G+AY+
Sbjct: 68  KLVRLYAVVTKEEPIYIITEFMAKGSL--LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 125
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
                   +H D++  N+L+  + + K++DFGLA+   ++N++ +    +  I + APE 
Sbjct: 126 ERK---NYIHRDLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEA 181
Query: 364 ISRNFGTVSCKSDVYGFGMVLLEMAG-------GRRNSNMNAIRSSKAYFP 407
           I  NFG  + KS+V+ FG++L E+         GR N+++ +  S     P
Sbjct: 182 I--NFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMP 230

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 15/231 (6%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHV 243
           EI   +     +LG G FG V+ G  +    +AVK L+    S + F+ E + +  + H 
Sbjct: 9   EIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD 68
Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
            +V+L    +      ++ E+M  GSL    F K ++G      KL + +   A G+AY+
Sbjct: 69  KLVRLYAVVTREEPIYIITEYMAKGSL--LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 126
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
                   +H D++  N+L+  + + K++DFGLA+   ++N++ +    +  I + APE 
Sbjct: 127 ERK---NYIHRDLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEA 182
Query: 364 ISRNFGTVSCKSDVYGFGMVLLEMAG-------GRRNSNMNAIRSSKAYFP 407
           I  NFG  + KSDV+ FG++L E+         GR N+++    S     P
Sbjct: 183 I--NFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMP 231

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/207 (35%), Positives = 113/207 (54%), Gaps = 18/207 (8%)
Query: 196 LGQGGFGSVYKGQLH-TGR---LIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +G G FG V  G L   G+    +A+K L++  ++    +F++E S +G+  H NV+ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G  ++ +   ++ EFM NGSLD   F ++N GQ F   +L  +  G A G+ YL    DM
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDS--FLRQNDGQ-FTVIQLVGMLRGIAAGMKYL---ADM 154
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKF-HPKENDFVSISATRGTIG--YIAPELISR 366
             +H D+   NIL++ N + KVSDFGL++F     +D    SA  G I   + APE I  
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI-- 212
Query: 367 NFGTVSCKSDVYGFGMVLLE-MAGGRR 392
            +   +  SDV+ +G+V+ E M+ G R
Sbjct: 213 QYRKFTSASDVWSYGIVMWEVMSYGER 239

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 194 HKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           HKLG G +G VY+G      L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           +      ++ EFM  G+L  ++  +E   Q      L  +A   +  + YL        +
Sbjct: 84  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 195
Query: 373 CKSDVYGFGMVLLEMA 388
            KSDV+ FG++L E+A
Sbjct: 196 IKSDVWAFGVLLWEIA 211

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 194 HKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           HKLG G +G VY+G      L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           +      ++ EFM  G+L  ++  +E   Q      L  +A   +  + YL        +
Sbjct: 80  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 134
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAPAGAKFPIKWTAPESLAYN--KFS 191
Query: 373 CKSDVYGFGMVLLEMA 388
            KSDV+ FG++L E+A
Sbjct: 192 IKSDVWAFGVLLWEIA 207

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 194 HKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           HKLG G +G VY+G      L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           +      ++ EFM  G+L  ++  +E   Q      L  +A   +  + YL        +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 195
Query: 373 CKSDVYGFGMVLLEMA 388
            KSDV+ FG++L E+A
Sbjct: 196 IKSDVWAFGVLLWEIA 211

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 194 HKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           HKLG G +G VY+G      L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           +      ++ EFM  G+L  ++  +E   Q      L  +A   +  + YL        +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 190
Query: 373 CKSDVYGFGMVLLEMA 388
            KSDV+ FG++L E+A
Sbjct: 191 IKSDVWAFGVLLWEIA 206

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 12/216 (5%)
Query: 172 QQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFI 231
           Q+ W    +  P     T     +LG G FG V+ G  +    +AVK L+    S + F+
Sbjct: 10  QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 66
Query: 232 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQE 291
            E + + ++ H  +V+L    ++     ++ E+M NGSL    F K   G      KL +
Sbjct: 67  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 123
Query: 292 IALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 351
           +A   A G+A++    +   +H D++  NIL+      K++DFGLA+   ++N++ +   
Sbjct: 124 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREG 179
Query: 352 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
            +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 180 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 213

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 135/285 (47%), Gaps = 49/285 (17%)
Query: 196 LGQGGFGSVYKGQLHTGR-----LIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQL 248
           +G G FG VYKG L T        +A+K L+      +  +F+ E   +G+  H N+++L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
            G  S+     ++ E+M NG+LD+  F +E  G+ F   +L  +  G A G+ YL N   
Sbjct: 112 EGVISKYKPMMIITEYMENGALDK--FLREKDGE-FSVLQLVGMLRGIAAGMKYLAN--- 165
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELIS 365
           M  +H D+   NIL++ N + KVSDFGL++    E+D  +   T G    I + APE IS
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 366 -RNFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMNAIRSSKAYFPSW------VYDQLNKG 417
            R F   +  SDV+ FG+V+ E M  G R              P W      V   +N G
Sbjct: 224 YRKF---TSASDVWSFGIVMWEVMTYGER--------------PYWELSNHEVMKAINDG 266
Query: 418 GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
               L    +  S I + +    + C Q + A RP    ++ +L+
Sbjct: 267 --FRLPTPMDCPSAIYQLM----MQCWQQERARRPKFADIVSILD 305

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 194 HKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           HKLG G +G VY+G      L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           +      ++ EFM  G+L  ++  +E   Q      L  +A   +  + YL        +
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 190
Query: 373 CKSDVYGFGMVLLEMA 388
            KSDV+ FG++L E+A
Sbjct: 191 IKSDVWAFGVLLWEIA 206

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 194 HKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           HKLG G +G VY+G      L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           +      ++ EFM  G+L  ++  +E   Q      L  +A   +  + YL        +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 190
Query: 373 CKSDVYGFGMVLLEMA 388
            KSDV+ FG++L E+A
Sbjct: 191 IKSDVWAFGVLLWEIA 206

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 194 HKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           HKLG G +G VY+G      L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           +      ++ EFM  G+L  ++  +E   Q      L  +A   +  + YL        +
Sbjct: 81  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 135
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAPAGAKFPIKWTAPESLAYN--KFS 192
Query: 373 CKSDVYGFGMVLLEMA 388
            KSDV+ FG++L E+A
Sbjct: 193 IKSDVWAFGVLLWEIA 208

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 194 HKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           HKLG G +G VY+G      L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           +      ++ EFM  G+L  ++  +E   Q      L  +A   +  + YL        +
Sbjct: 83  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 137
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 194
Query: 373 CKSDVYGFGMVLLEMA 388
            KSDV+ FG++L E+A
Sbjct: 195 IKSDVWAFGVLLWEIA 210

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 194 HKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           HKLG G +G VY+G      L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           +      ++ EFM  G+L  ++  +E   Q      L  +A   +  + YL        +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 190
Query: 373 CKSDVYGFGMVLLEMA 388
            KSDV+ FG++L E+A
Sbjct: 191 IKSDVWAFGVLLWEIA 206

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 194 HKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           HKLG G +G VY+G      L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           +      ++ EFM  G+L  ++  +E   Q      L  +A   +  + YL        +
Sbjct: 81  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 135
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 192
Query: 373 CKSDVYGFGMVLLEMA 388
            KSDV+ FG++L E+A
Sbjct: 193 IKSDVWAFGVLLWEIA 208

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 194 HKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           HKLG G +G VY+G      L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           +      ++ EFM  G+L  ++  +E   Q      L  +A   +  + YL        +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 195
Query: 373 CKSDVYGFGMVLLEMA 388
            KSDV+ FG++L E+A
Sbjct: 196 IKSDVWAFGVLLWEIA 211

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 194 HKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           HKLG G +G VY+G      L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 32  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 91
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           +      ++ EFM  G+L  ++  +E   Q      L  +A   +  + YL        +
Sbjct: 92  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 146
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 203
Query: 373 CKSDVYGFGMVLLEMA 388
            KSDV+ FG++L E+A
Sbjct: 204 IKSDVWAFGVLLWEIA 219

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 194 HKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           HKLG G +G VY+G      L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           +      ++ EFM  G+L  ++  +E   Q      L  +A   +  + YL        +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 195
Query: 373 CKSDVYGFGMVLLEMA 388
            KSDV+ FG++L E+A
Sbjct: 196 IKSDVWAFGVLLWEIA 211

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/217 (33%), Positives = 115/217 (52%), Gaps = 16/217 (7%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHT-GRL---IAVKMLEN--SKFSAEEFINEVSTI 237
           EI A   H    +G G  G V  G+L   G+    +A+K L+   ++    +F++E S +
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104
Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
           G+  H N+++L G  + G    +V E+M NGSLD   F + + GQ F   +L  +  G  
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD--TFLRTHDGQ-FTIMQLVGMLRGVG 161
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-SISATRGTI 356
            G+ YL    D+  +H D+   N+L+D N + KVSDFGL++    + D   + +  +  I
Sbjct: 162 AGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPI 218
Query: 357 GYIAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRR 392
            + APE I+  F T S  SDV+ FG+V+ E +A G R
Sbjct: 219 RWTAPEAIA--FRTFSSASDVWSFGVVMWEVLAYGER 253

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/217 (33%), Positives = 115/217 (52%), Gaps = 16/217 (7%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHT-GRL---IAVKMLEN--SKFSAEEFINEVSTI 237
           EI A   H    +G G  G V  G+L   G+    +A+K L+   ++    +F++E S +
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104
Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
           G+  H N+++L G  + G    +V E+M NGSLD   F + + GQ F   +L  +  G  
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD--TFLRTHDGQ-FTIMQLVGMLRGVG 161
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-SISATRGTI 356
            G+ YL    D+  +H D+   N+L+D N + KVSDFGL++    + D   + +  +  I
Sbjct: 162 AGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI 218
Query: 357 GYIAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRR 392
            + APE I+  F T S  SDV+ FG+V+ E +A G R
Sbjct: 219 RWTAPEAIA--FRTFSSASDVWSFGVVMWEVLAYGER 253

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 194 HKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           HKLG G +G VY+G      L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           +      ++ EFM  G+L  ++  +E   Q      L  +A   +  + YL        +
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 190
Query: 373 CKSDVYGFGMVLLEMA 388
            KSDV+ FG++L E+A
Sbjct: 191 IKSDVWAFGVLLWEIA 206

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 9/204 (4%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHV 243
           E+   T     +LG G FG V+ G  +    +AVK L+    S + F+ E + + ++ H 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
            +V+L    ++     ++ E+M NGSL    F K   G      KL ++A   A G+A++
Sbjct: 69  RLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
               +   +H D++  NIL+      K++DFGLA+   ++N++ +    +  I + APE 
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEA 181
Query: 364 ISRNFGTVSCKSDVYGFGMVLLEM 387
           I  N+GT + KSDV+ FG++L E+
Sbjct: 182 I--NYGTFTIKSDVWSFGILLTEI 203

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 194 HKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           HKLG G +G VY+G      L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           +      ++ EFM  G+L  ++  +E   Q      L  +A   +  + YL        +
Sbjct: 81  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 135
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 192
Query: 373 CKSDVYGFGMVLLEMA 388
            KSDV+ FG++L E+A
Sbjct: 193 IKSDVWAFGVLLWEIA 208

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 12/216 (5%)
Query: 172 QQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFI 231
           Q+ W    +  P     T     +LG G FG V+ G  +    +AVK L+    S + F+
Sbjct: 2   QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 58
Query: 232 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQE 291
            E + + ++ H  +V+L    ++     ++ E+M NGSL    F K   G      KL +
Sbjct: 59  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 115
Query: 292 IALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 351
           +A   A G+A++    +   +H D++  NIL+      K++DFGLA+   ++N+  +   
Sbjct: 116 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREG 171
Query: 352 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
            +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 172 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 205

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 194 HKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           HKLG G +G VY+G      L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           +      ++ EFM  G+L  ++  +E   Q      L  +A   +  + YL        +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 190
Query: 373 CKSDVYGFGMVLLEMA 388
            KSDV+ FG++L E+A
Sbjct: 191 IKSDVWAFGVLLWEIA 206

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 12/216 (5%)
Query: 172 QQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFI 231
           Q+ W    +  P     T     +LG G FG V+ G  +    +AVK L+    S + F+
Sbjct: 1   QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 57
Query: 232 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQE 291
            E + + ++ H  +V+L    ++     ++ E+M NGSL    F K   G      KL +
Sbjct: 58  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 114
Query: 292 IALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 351
           +A   A G+A++    +   +H D++  NIL+      K++DFGLA+   ++N+  +   
Sbjct: 115 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREG 170
Query: 352 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
            +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 171 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 204

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 12/216 (5%)
Query: 172 QQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFI 231
           Q+ W    +  P     T     +LG G FG V+ G  +    +AVK L+    S + F+
Sbjct: 9   QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 65
Query: 232 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQE 291
            E + + ++ H  +V+L    ++     ++ E+M NGSL    F K   G      KL +
Sbjct: 66  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 122
Query: 292 IALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 351
           +A   A G+A++    +   +H D++  NIL+      K++DFGLA+   ++N+  +   
Sbjct: 123 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREG 178
Query: 352 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
            +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 179 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 212

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 9/204 (4%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHV 243
           E+   T     +LG G FG V+ G  +    +AVK L+    S + F+ E + + ++ H 
Sbjct: 4   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 63
Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
            +V+L    ++     ++ E+M NGSL    F K   G      KL ++A   A G+A++
Sbjct: 64  RLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFI 120
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
               +   +H D++  NIL+      K++DFGLA+   ++N++ +    +  I + APE 
Sbjct: 121 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEA 176
Query: 364 ISRNFGTVSCKSDVYGFGMVLLEM 387
           I  N+GT + KSDV+ FG++L E+
Sbjct: 177 I--NYGTFTIKSDVWSFGILLTEI 198

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 12/216 (5%)
Query: 172 QQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFI 231
           Q+ W    +  P     T     +LG G FG V+ G  +    +AVK L+    S + F+
Sbjct: 8   QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 64
Query: 232 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQE 291
            E + + ++ H  +V+L    ++     ++ E+M NGSL    F K   G      KL +
Sbjct: 65  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 121
Query: 292 IALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 351
           +A   A G+A++    +   +H D++  NIL+      K++DFGLA+   ++N+  +   
Sbjct: 122 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREG 177
Query: 352 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
            +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 178 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 211

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 12/216 (5%)
Query: 172 QQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFI 231
           Q+ W    +  P     T     +LG G FG V+ G  +    +AVK L+    S + F+
Sbjct: 6   QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 62
Query: 232 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQE 291
            E + + ++ H  +V+L    ++     ++ E+M NGSL    F K   G      KL +
Sbjct: 63  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 119
Query: 292 IALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 351
           +A   A G+A++    +   +H D++  NIL+      K++DFGLA+   ++N+  +   
Sbjct: 120 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREG 175
Query: 352 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
            +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 176 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 209

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 117/230 (50%), Gaps = 28/230 (12%)
Query: 176 MPKRYSYP---------EIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRL---IAVKMLE- 221
           MP  Y  P         EI A        +G G FG V  G+L   G+    +A+K L+ 
Sbjct: 1   MPHTYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKV 60
Query: 222 -NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENK 280
             ++    +F+ E S +G+  H N++ L G  ++     +V E+M NGSLD   F K+N 
Sbjct: 61  GYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD--TFLKKND 118
Query: 281 GQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 340
           GQ F   +L  +  G + G+ YL    DM  +H D+   NIL++ N + KVSDFGL++  
Sbjct: 119 GQ-FTVIQLVGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 174
Query: 341 PKENDFVSISATRG---TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
             E+D  +   TRG    I + APE I+  F   +  SDV+ +G+V+ E+
Sbjct: 175 --EDDPEAAYTTRGGKIPIRWTAPEAIA--FRKFTSASDVWSYGIVMWEV 220

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 194 HKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           HKLG G +G VY+G      L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           +      ++ EFM  G+L  ++  +E   Q      L  +A   +  + YL        +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+   N L+  N + KV+DFGL++    +       A +  I + APE ++ N    S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGA-KFPIKWTAPESLAYN--KFS 195
Query: 373 CKSDVYGFGMVLLEMA 388
            KSDV+ FG++L E+A
Sbjct: 196 IKSDVWAFGVLLWEIA 211

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 143/293 (48%), Gaps = 42/293 (14%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHT-GR---LIAVKMLENSKFSAE--EFINEVSTI 237
           EI A        +G G FG V  G+L   G+    +A+K L+      +  +F++E S +
Sbjct: 25  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 84
Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
           G+  H N++ L G  ++     ++ E+M NGSLD   F ++N G+ F   +L  +  G  
Sbjct: 85  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLD--AFLRKNDGR-FTVIQLVGMLRGIG 141
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 354
            G+ YL    DM  +H D+   NIL++ N + KVSDFG+++    E+D  +   TRG   
Sbjct: 142 SGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVL--EDDPEAAYTTRGGKI 196
Query: 355 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRRN----SNMNAIRSSKAYFPSW 409
            I + APE I+  +   +  SDV+ +G+V+ E M+ G R     SN + I++ +  +   
Sbjct: 197 PIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGY--- 251
Query: 410 VYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
                        R    ++  IA    M+  W  Q + +DRP   +++ ML+
Sbjct: 252 -------------RLPPPMDCPIALHQLMLDCW--QKERSDRPKFGQIVNMLD 289

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 194 HKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           HKLG G +G VY+G      L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           +      ++ EFM  G+L  ++  +E   Q      L  +A   +  + YL        +
Sbjct: 80  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 134
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+   N L+  N + KV+DFGL++    +       A +  I + APE ++ N    S
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGA-KFPIKWTAPESLAYN--KFS 191
Query: 373 CKSDVYGFGMVLLEMA 388
            KSDV+ FG++L E+A
Sbjct: 192 IKSDVWAFGVLLWEIA 207

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 144/294 (48%), Gaps = 44/294 (14%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHT-GR---LIAVKMLENSKFSAE--EFINEVSTI 237
           EI A        +G G FG V  G+L   G+    +A+K L+      +  +F++E S +
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 63
Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
           G+  H N++ L G  ++     ++ E+M NGSLD   F ++N G+ F   +L  +  G  
Sbjct: 64  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLD--AFLRKNDGR-FTVIQLVGMLRGIG 120
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 354
            G+ YL    DM  +H D+   NIL++ N + KVSDFG+++    E+D  +   TRG   
Sbjct: 121 SGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVL--EDDPEAAYTTRGGKI 175
Query: 355 TIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRRN----SNMNAIRSSKAYFPS 408
            I + APE I+ R F +    SDV+ +G+V+ E M+ G R     SN + I++ +  +  
Sbjct: 176 PIRWTAPEAIAYRKFTSA---SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGY-- 230
Query: 409 WVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
                         R    ++  IA    M+  W  Q + +DRP   +++ ML+
Sbjct: 231 --------------RLPPPMDCPIALHQLMLDCW--QKERSDRPKFGQIVNMLD 268

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 106/204 (51%), Gaps = 9/204 (4%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHV 243
           E+   T     +LG G FG V+ G  +    +AVK L+    S + F+ E + + ++ H 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
            +V+L    ++     ++ E+M NGSL    F K   G      KL ++A   A G+A++
Sbjct: 69  RLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
               +   +H D++  NIL+      K++DFGLA+   ++N+  +    +  I + APE 
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEA 181
Query: 364 ISRNFGTVSCKSDVYGFGMVLLEM 387
           I  N+GT + KSDV+ FG++L E+
Sbjct: 182 I--NYGTFTIKSDVWSFGILLTEI 203

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 112/207 (54%), Gaps = 18/207 (8%)
Query: 196 LGQGGFGSVYKGQLH-TGR---LIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +G G FG V  G L   G+    +A+K L++  ++    +F++E S +G+  H NV+ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G  ++ +   ++ EFM NGSLD   F ++N GQ F   +L  +  G A G+ YL    DM
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDS--FLRQNDGQ-FTVIQLVGMLRGIAAGMKYL---ADM 128
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKF-HPKENDFVSISATRGTIG--YIAPELISR 366
             +H  +   NIL++ N + KVSDFGL++F     +D    SA  G I   + APE I  
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI-- 186
Query: 367 NFGTVSCKSDVYGFGMVLLE-MAGGRR 392
            +   +  SDV+ +G+V+ E M+ G R
Sbjct: 187 QYRKFTSASDVWSYGIVMWEVMSYGER 213

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 144/294 (48%), Gaps = 44/294 (14%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHT-GR---LIAVKMLEN--SKFSAEEFINEVSTI 237
           EI A        +G G FG V  G+L   G+    +A+K L+   +     +F++E S +
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 69
Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
           G+  H N++ L G  ++     ++ E+M NGSLD   F ++N G+ F   +L  +  G  
Sbjct: 70  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLD--AFLRKNDGR-FTVIQLVGMLRGIG 126
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 354
            G+ YL    DM  +H D+   NIL++ N + KVSDFG+++    E+D  +   TRG   
Sbjct: 127 SGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVL--EDDPEAAYTTRGGKI 181
Query: 355 TIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRRN----SNMNAIRSSKAYFPS 408
            I + APE I+ R F +    SDV+ +G+V+ E M+ G R     SN + I++ +  +  
Sbjct: 182 PIRWTAPEAIAYRKFTSA---SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGY-- 236
Query: 409 WVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
                         R    ++  IA    M+  W  Q + +DRP   +++ ML+
Sbjct: 237 --------------RLPPPMDCPIALHQLMLDCW--QKERSDRPKFGQIVNMLD 274

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 106/204 (51%), Gaps = 9/204 (4%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHV 243
           E+   T     +LG G FG V+ G  +    +AVK L+    S + F+ E + + ++ H 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
            +V+L    ++     ++ E+M NGSL    F K   G      KL ++A   A G+A++
Sbjct: 69  RLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
               +   +H D++  NIL+      K++DFGLA+   ++N+  +    +  I + APE 
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEA 181
Query: 364 ISRNFGTVSCKSDVYGFGMVLLEM 387
           I  N+GT + KSDV+ FG++L E+
Sbjct: 182 I--NYGTFTIKSDVWSFGILLTEI 203

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 114/207 (55%), Gaps = 18/207 (8%)
Query: 196 LGQGGFGSVYKGQLHT-GR---LIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +G G FG V +G+L   G+    +A+K L+   ++    EF++E S +G+  H N+++L 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G  +      ++ EFM NG+LD   F + N GQ F   +L  +  G A G+ YL    +M
Sbjct: 82  GVVTNSMPVMILTEFMENGALDS--FLRLNDGQ-FTVIQLVGMLRGIASGMRYL---AEM 135
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELISR 366
             +H D+   NIL++ N + KVSDFGL++F  + +   + +++ G    I + APE I+ 
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIA- 194
Query: 367 NFGTVSCKSDVYGFGMVLLE-MAGGRR 392
            F   +  SD + +G+V+ E M+ G R
Sbjct: 195 -FRKFTSASDAWSYGIVMWEVMSFGER 220

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 12/216 (5%)
Query: 172 QQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFI 231
           Q+ W    +  P     +     KLG G FG V+    +    +AVK ++    S E F+
Sbjct: 2   QKPWEKDAWEIPR---ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFL 58
Query: 232 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQE 291
            E + +  + H  +V+L    ++     ++ EFM  GSL    F K ++G      KL +
Sbjct: 59  AEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSL--LDFLKSDEGSKQPLPKLID 115
Query: 292 IALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 351
            +   A G+A++        +H D++  NIL+  + + K++DFGLA+   ++N++ +   
Sbjct: 116 FSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREG 171
Query: 352 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
            +  I + APE I  NFG+ + KSDV+ FG++L+E+
Sbjct: 172 AKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLMEI 205

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 107/204 (52%), Gaps = 9/204 (4%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHV 243
           E+   T     +LG G FG V+ G  +    +AVK L+    S + F+ E + + ++ H 
Sbjct: 5   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 64
Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
            +V+L    ++     ++ E+M NGSL    F K   G      KL ++A   A G+A++
Sbjct: 65  RLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFI 121
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
               +   +H +++  NIL+      K++DFGLA+   ++N++ +    +  I + APE 
Sbjct: 122 E---ERNYIHRNLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEA 177
Query: 364 ISRNFGTVSCKSDVYGFGMVLLEM 387
           I  N+GT + KSDV+ FG++L E+
Sbjct: 178 I--NYGTFTIKSDVWSFGILLTEI 199

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 112/207 (54%), Gaps = 18/207 (8%)
Query: 196 LGQGGFGSVYKGQLHT-GR---LIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +G G FG V +G+L   G+    +A+K L+   ++    EF++E S +G+  H N+++L 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G  +      ++ EFM NG+LD   F + N GQ F   +L  +  G A G+ YL    +M
Sbjct: 84  GVVTNSMPVMILTEFMENGALDS--FLRLNDGQ-FTVIQLVGMLRGIASGMRYL---AEM 137
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKF-HPKENDFVSISATRGTIG--YIAPELISR 366
             +H D+   NIL++ N + KVSDFGL++F     +D    S+  G I   + APE I+ 
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIA- 196
Query: 367 NFGTVSCKSDVYGFGMVLLE-MAGGRR 392
            F   +  SD + +G+V+ E M+ G R
Sbjct: 197 -FRKFTSASDAWSYGIVMWEVMSFGER 222

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 107/204 (52%), Gaps = 9/204 (4%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHV 243
           EI   +     KLG G FG V+    +    +AVK ++    S E F+ E + +  + H 
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 243
Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
            +V+L    ++     ++ EFM  GSL    F K ++G      KL + +   A G+A++
Sbjct: 244 KLVKLHAVVTK-EPIYIITEFMAKGSL--LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
                   +H D++  NIL+  + + K++DFGLA+   ++N++ +    +  I + APE 
Sbjct: 301 EQ---RNYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEA 356
Query: 364 ISRNFGTVSCKSDVYGFGMVLLEM 387
           I  NFG+ + KSDV+ FG++L+E+
Sbjct: 357 I--NFGSFTIKSDVWSFGILLMEI 378

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 90/328 (27%), Positives = 144/328 (43%), Gaps = 41/328 (12%)
Query: 148 LVFLIHKYRTTLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHF------------THK 195
           L  L+H + T     D +   LH      PKR + P I  V+ ++             HK
Sbjct: 175 LAELVHHHSTV---ADGLITTLHYP---APKR-NKPTIYGVSPNYDKWEMERTDITMKHK 227
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           LG G +G VY+G      L +AVK L+      EEF+ E + +  I H N+VQLLG C+ 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                ++ EFM  G+L  ++  +E   Q      L  +A   +  + YL        +H 
Sbjct: 288 EPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHR 342
Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           ++   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S K
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFSIK 399
Query: 375 SDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIAR 434
           SDV+ FG++L E+A          +        S VY+ L K   +E             
Sbjct: 400 SDVWAFGVLLWEIA-------TYGMSPYPGIDLSQVYELLEKDYRMER------PEGCPE 446
Query: 435 KLCMIGLWCIQVKAADRPSMTKVLEMLE 462
           K+  +   C Q   +DRPS  ++ +  E
Sbjct: 447 KVYELMRACWQWNPSDRPSFAEIHQAFE 474

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 124/270 (45%), Gaps = 22/270 (8%)
Query: 194 HKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           HKLG G +G VY+G      L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 265 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 324
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           +      ++ EFM  G+L  ++  +E   Q      L  +A   +  + YL        +
Sbjct: 325 TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFI 379
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H ++   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 436
Query: 373 CKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVI 432
            KSDV+ FG++L E+A          +        S VY+ L K   +E           
Sbjct: 437 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDLSQVYELLEKDYRMER------PEGC 483
Query: 433 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 484 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 513

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 88/282 (31%), Positives = 141/282 (50%), Gaps = 44/282 (15%)
Query: 196 LGQGGFGSVYKGQLH-TGR---LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +G G FG V  G+L   G+    +A+K L+   ++    +F+ E S +G+  H NVV L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G  + G    +V EFM NG+LD   F +++ GQ F   +L  +  G A G+ YL    DM
Sbjct: 111 GVVTRGKPVMIVIEFMENGALD--AFLRKHDGQ-FTVIQLVGMLRGIAAGMRYL---ADM 164
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELISR 366
             +H D+   NIL++ N + KVSDFGL++    E+D  ++  T G    + + APE I  
Sbjct: 165 GYVHRDLAARNILVNSNLVCKVSDFGLSRV--IEDDPEAVYTTTGGKIPVRWTAPEAI-- 220
Query: 367 NFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV 425
            +   +  SDV+ +G+V+ E M+ G R              P W  D  N+  D+ ++ +
Sbjct: 221 QYRKFTSASDVWSYGIVMWEVMSYGER--------------PYW--DMSNQ--DV-IKAI 261
Query: 426 TEIESVIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLE 462
            E   + A   C  GL      C Q + A+RP   +++ +L+
Sbjct: 262 EEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILD 303

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           F  +LG G FG V  G+      +A+KM++    S +EFI E   +  + H  +VQL G 
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
           C++     ++ E+M NG L  ++    ++ QT   ++L E+       + YL +      
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 126
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSRGSKFPVRWSPPEVLM--YSKF 183
Query: 372 SCKSDVYGFGMVLLEM 387
           S KSD++ FG+++ E+
Sbjct: 184 SSKSDIWAFGVLMWEI 199

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           F  +LG G FG V  G+      +A+KM++    S +EFI E   +  + H  +VQL G 
Sbjct: 12  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 71
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
           C++     ++ E+M NG L  ++    ++ QT   ++L E+       + YL +      
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 125
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 126 LHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLM--YSKF 182
Query: 372 SCKSDVYGFGMVLLEM 387
           S KSD++ FG+++ E+
Sbjct: 183 SSKSDIWAFGVLMWEI 198

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           F  +LG G FG V  G+      +A+KM++    S +EFI E   +  + H  +VQL G 
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
           C++     ++ E+M NG L  ++    ++ QT   ++L E+       + YL +      
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 121
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLM--YSKF 178
Query: 372 SCKSDVYGFGMVLLEM 387
           S KSD++ FG+++ E+
Sbjct: 179 SSKSDIWAFGVLMWEI 194

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           F  +LG G FG V  G+      +A+KM++    S +EFI E   +  + H  +VQL G 
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
           C++     ++ E+M NG L  ++    ++ QT   ++L E+       + YL +      
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 126
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLM--YSKF 183
Query: 372 SCKSDVYGFGMVLLEM 387
           S KSD++ FG+++ E+
Sbjct: 184 SSKSDIWAFGVLMWEI 199

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/233 (33%), Positives = 121/233 (51%), Gaps = 26/233 (11%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMLE--NSKFSAEEFINEVSTI 237
           E+ A        +G G FG V  G+L         +A+K L+   ++    +F+ E S +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
           G+  H N+++L G  ++     +V E+M NGSLD   F +++  Q F   +L  +  G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQ-FTVIQLVGMLRGIA 157
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 354
            G+ YL    DM  +H D+   NIL++ N + KVSDFGLA+    E+D  +   TRG   
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVL--EDDPEAAYTTRGGKI 212
Query: 355 TIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRRN----SNMNAIRS 401
            I + +PE I+ R F   +  SDV+ +G+VL E M+ G R     SN + I++
Sbjct: 213 PIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA 262

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           F  +LG G FG V  G+      +A+KM++    S +EFI E   +  + H  +VQL G 
Sbjct: 19  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 78
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
           C++     ++ E+M NG L  ++    ++ QT   ++L E+       + YL +      
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 132
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLM--YSKF 189
Query: 372 SCKSDVYGFGMVLLEM 387
           S KSD++ FG+++ E+
Sbjct: 190 SSKSDIWAFGVLMWEI 205

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 102/193 (52%), Gaps = 9/193 (4%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           +LG G FG V  G+      +AVKM++    S +EF  E  T+ ++ H  +V+  G CS+
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
                +V E++ NG L  ++    + G+     +L E+      G+A+L +      +H 
Sbjct: 75  EYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHR 128
Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 374
           D+   N L+D +   KVSDFG+ ++   ++ +VS   T+  + + APE+   ++   S K
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVF--HYFKYSSK 185
Query: 375 SDVYGFGMVLLEM 387
           SDV+ FG+++ E+
Sbjct: 186 SDVWAFGILMWEV 198

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           F  +LG G FG V  G+      +A+KM++    S +EFI E   +  + H  +VQL G 
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
           C++     ++ E+M NG L  ++    ++ QT   ++L E+       + YL +      
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 141
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLM--YSKF 198
Query: 372 SCKSDVYGFGMVLLEM 387
           S KSD++ FG+++ E+
Sbjct: 199 SSKSDIWAFGVLMWEI 214

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 121/233 (51%), Gaps = 26/233 (11%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMLE--NSKFSAEEFINEVSTI 237
           E+ A        +G G FG V  G+L         +A+K L+   ++    +F+ E S +
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
           G+  H N+++L G  ++     +V E+M NGSLD   F +++  Q F   +L  +  G A
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQ-FTVIQLVGMLRGIA 128
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 354
            G+ YL    DM  +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG   
Sbjct: 129 SGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKI 183
Query: 355 TIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRRN----SNMNAIRS 401
            I + +PE I+ R F   +  SDV+ +G+VL E M+ G R     SN + I++
Sbjct: 184 PIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA 233

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 121/233 (51%), Gaps = 26/233 (11%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMLE--NSKFSAEEFINEVSTI 237
           E+ A        +G G FG V  G+L         +A+K L+   ++    +F+ E S +
Sbjct: 39  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 98
Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
           G+  H N+++L G  ++     +V E+M NGSLD   F +++  Q F   +L  +  G A
Sbjct: 99  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQ-FTVIQLVGMLRGIA 155
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 354
            G+ YL    DM  +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG   
Sbjct: 156 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKI 210
Query: 355 TIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRRN----SNMNAIRS 401
            I + +PE I+ R F   +  SDV+ +G+VL E M+ G R     SN + I++
Sbjct: 211 PIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA 260

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 121/233 (51%), Gaps = 26/233 (11%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMLE--NSKFSAEEFINEVSTI 237
           E+ A        +G G FG V  G+L         +A+K L+   ++    +F+ E S +
Sbjct: 29  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 88
Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
           G+  H N+++L G  ++     +V E+M NGSLD   F +++  Q F   +L  +  G A
Sbjct: 89  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQ-FTVIQLVGMLRGIA 145
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 354
            G+ YL    DM  +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG   
Sbjct: 146 SGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKI 200
Query: 355 TIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRRN----SNMNAIRS 401
            I + +PE I+ R F   +  SDV+ +G+VL E M+ G R     SN + I++
Sbjct: 201 PIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA 250

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 121/233 (51%), Gaps = 26/233 (11%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMLE--NSKFSAEEFINEVSTI 237
           E+ A        +G G FG V  G+L         +A+K L+   ++    +F+ E S +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
           G+  H N+++L G  ++     +V E+M NGSLD   F +++  Q F   +L  +  G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQ-FTVIQLVGMLRGIA 157
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 354
            G+ YL    DM  +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG   
Sbjct: 158 SGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKI 212
Query: 355 TIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRRN----SNMNAIRS 401
            I + +PE I+ R F   +  SDV+ +G+VL E M+ G R     SN + I++
Sbjct: 213 PIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA 262

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 121/233 (51%), Gaps = 26/233 (11%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMLE--NSKFSAEEFINEVSTI 237
           E+ A        +G G FG V  G+L         +A+K L+   ++    +F+ E S +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
           G+  H N+++L G  ++     +V E+M NGSLD   F +++  Q F   +L  +  G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQ-FTVIQLVGMLRGIA 157
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 354
            G+ YL    DM  +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG   
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKI 212
Query: 355 TIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRRN----SNMNAIRS 401
            I + +PE I+ R F   +  SDV+ +G+VL E M+ G R     SN + I++
Sbjct: 213 PIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA 262

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 121/233 (51%), Gaps = 26/233 (11%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMLE--NSKFSAEEFINEVSTI 237
           E+ A        +G G FG V  G+L         +A+K L+   ++    +F+ E S +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
           G+  H N+++L G  ++     +V E+M NGSLD   F +++  Q F   +L  +  G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQ-FTVIQLVGMLRGIA 157
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 354
            G+ YL    DM  +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG   
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKI 212
Query: 355 TIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRRN----SNMNAIRS 401
            I + +PE I+ R F   +  SDV+ +G+VL E M+ G R     SN + I++
Sbjct: 213 PIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA 262

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 121/233 (51%), Gaps = 26/233 (11%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMLE--NSKFSAEEFINEVSTI 237
           E+ A        +G G FG V  G+L         +A+K L+   ++    +F+ E S +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
           G+  H N+++L G  ++     +V E+M NGSLD   F +++  Q F   +L  +  G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQ-FTVIQLVGMLRGIA 157
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 354
            G+ YL    DM  +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG   
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKI 212
Query: 355 TIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRRN----SNMNAIRS 401
            I + +PE I+ R F   +  SDV+ +G+VL E M+ G R     SN + I++
Sbjct: 213 PIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA 262

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 121/233 (51%), Gaps = 26/233 (11%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMLE--NSKFSAEEFINEVSTI 237
           E+ A        +G G FG V  G+L         +A+K L+   ++    +F+ E S +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
           G+  H N+++L G  ++     +V E+M NGSLD   F +++  Q F   +L  +  G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQ-FTVIQLVGMLRGIA 157
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 354
            G+ YL    DM  +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG   
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKI 212
Query: 355 TIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRRN----SNMNAIRS 401
            I + +PE I+ R F   +  SDV+ +G+VL E M+ G R     SN + I++
Sbjct: 213 PIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA 262

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 120/233 (51%), Gaps = 26/233 (11%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMLE--NSKFSAEEFINEVSTI 237
           E+ A        +G G FG V  G+L         +A+K L+   ++    +F+ E S +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
           G+  H N+++L G  ++     +V E+M NGSLD   F +++  Q F   +L  +  G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQ-FTVIQLVGMLRGIA 157
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 354
            G+ YL    DM  +H D+   NIL++ N + KVSDFGL +    E+D  +   TRG   
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL--EDDPEAAYTTRGGKI 212
Query: 355 TIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRRN----SNMNAIRS 401
            I + +PE I+ R F   +  SDV+ +G+VL E M+ G R     SN + I++
Sbjct: 213 PIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA 262

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 102/196 (52%), Gaps = 9/196 (4%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           F  +LG G FG V  G+      +A+KM++    S +EFI E   +  + H  +VQL G 
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
           C++     ++ E+M NG L  ++    ++ QT   ++L E+       + YL +      
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 141
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           LH D+   N L++   + KVSDFGL+++   + +  S+  ++  + +  PE++   +   
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSV-GSKFPVRWSPPEVLM--YSKF 198
Query: 372 SCKSDVYGFGMVLLEM 387
           S KSD++ FG+++ E+
Sbjct: 199 SSKSDIWAFGVLMWEI 214

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 120/233 (51%), Gaps = 26/233 (11%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMLE--NSKFSAEEFINEVSTI 237
           E+ A        +G G FG V  G+L         +A+K L+   ++    +F+ E S +
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
           G+  H N+++L G  ++     +V E M NGSLD   F +++  Q F   +L  +  G A
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS--FLRKHDAQ-FTVIQLVGMLRGIA 128
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 354
            G+ YL    DM  +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG   
Sbjct: 129 SGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKI 183
Query: 355 TIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRRN----SNMNAIRS 401
            I + +PE I+ R F   +  SDV+ +G+VL E M+ G R     SN + I++
Sbjct: 184 PIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA 233

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 120/233 (51%), Gaps = 26/233 (11%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMLE--NSKFSAEEFINEVSTI 237
           E+ A        +G G FG V  G+L         +A+K L+   ++    +F+ E S +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
           G+  H N+++L G  ++     +V E M NGSLD   F +++  Q F   +L  +  G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS--FLRKHDAQ-FTVIQLVGMLRGIA 157
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 354
            G+ YL    DM  +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG   
Sbjct: 158 SGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKI 212
Query: 355 TIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRRN----SNMNAIRS 401
            I + +PE I+ R F   +  SDV+ +G+VL E M+ G R     SN + I++
Sbjct: 213 PIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA 262

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 120/233 (51%), Gaps = 26/233 (11%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMLE--NSKFSAEEFINEVSTI 237
           E+ A        +G G FG V  G+L         +A+K L+   ++    +F+ E S +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
           G+  H N+++L G  ++     +V E M NGSLD   F +++  Q F   +L  +  G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS--FLRKHDAQ-FTVIQLVGMLRGIA 157
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 354
            G+ YL    DM  +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG   
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKI 212
Query: 355 TIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRRN----SNMNAIRS 401
            I + +PE I+ R F   +  SDV+ +G+VL E M+ G R     SN + I++
Sbjct: 213 PIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA 262

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 9/204 (4%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHV 243
           E+   T     +LG G  G V+ G  +    +AVK L+    S + F+ E + + ++ H 
Sbjct: 9   EVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
            +V+L    ++     ++ E+M NGSL    F K   G      KL ++A   A G+A++
Sbjct: 69  RLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
               +   +H D++  NIL+      K++DFGLA+   ++ +  +    +  I + APE 
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDAEXTAREGAKFPIKWTAPEA 181
Query: 364 ISRNFGTVSCKSDVYGFGMVLLEM 387
           I  N+GT + KSDV+ FG++L E+
Sbjct: 182 I--NYGTFTIKSDVWSFGILLTEI 203

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 19/204 (9%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHV 243
           EI   +     KLG G FG V+    +    +AVK ++    S E F+ E + +  + H 
Sbjct: 178 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 237
Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
            +V+L    ++     ++ EFM  GSL    F K ++G      KL + +   A G+A++
Sbjct: 238 KLVKLHAVVTK-EPIYIITEFMAKGSL--LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 294
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
                   +H D++  NIL+  + + K++DFGLA+              +  I + APE 
Sbjct: 295 EQ---RNYIHRDLRAANILVSASLVCKIADFGLARV-----------GAKFPIKWTAPEA 340
Query: 364 ISRNFGTVSCKSDVYGFGMVLLEM 387
           I  NFG+ + KSDV+ FG++L+E+
Sbjct: 341 I--NFGSFTIKSDVWSFGILLMEI 362

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 192 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 245
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 246 VQLLGFCSEGSKR--ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V+  G C    +R   L+ E++P GSL  ++   +   +     KL +      +G+ YL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 362
             G    I H D+   NIL+++    K+ DFGL K  P++ +F  +       I + APE
Sbjct: 131 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEM 387
            ++ +    S  SDV+ FG+VL E+
Sbjct: 188 SLTES--KFSVASDVWSFGVVLYEL 210

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 23/210 (10%)
Query: 196 LGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 246
           LG+G FG V +       +  T R +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 247 QLLGFCSE-GSKRALVYEFMPNGSLDRHIFPKENK--------GQTFGWEKLQEIALGTA 297
            LLG C++ G    ++ EF   G+L  ++  K N+              E L   +   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
           +G+ +L        +H D+   NILL    + K+ DFGLA+   K+ D+V     R  + 
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
           ++APE I     T+  +SDV+ FG++L E+
Sbjct: 212 WMAPETIFDRVYTI--QSDVWSFGVLLWEI 239

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/230 (31%), Positives = 114/230 (49%), Gaps = 30/230 (13%)
Query: 195 KLGQGGFGSV-YKGQLHTGRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 252
           K+G+G  G V    + HTG+ +AVK ++  K    E + NEV  +   HH NVV +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 253 SEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
             G +  +V EF+  G+L D     + N+      E++  + L   R ++YLHN     +
Sbjct: 112 LVGDELWVVMEFLEGGALTDIVTHTRMNE------EQIATVCLSVLRALSYLHN---QGV 162
Query: 312 LHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISR- 366
           +H DIK  +ILL  +   K+SDFG    ++K  PK    V      GT  ++APE+ISR 
Sbjct: 163 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLV------GTPYWMAPEVISRL 216
Query: 367 NFGTVSCKSDVYGFGMVLLEMAGGR----RNSNMNAIRSSKAYFPSWVYD 412
            +GT   + D++  G++++EM  G         + A+R  +   P  V D
Sbjct: 217 PYGT---EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKD 263

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 192 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 245
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 17  FLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 246 VQLLGFCSEGSKR--ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V+  G C    +R   L+ EF+P GSL  ++   +   +     KL +      +G+ YL
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEFLPYGSLREYL---QKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 362
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 134 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEM 387
            ++ +    S  SDV+ FG+VL E+
Sbjct: 191 SLTES--KFSVASDVWSFGVVLYEL 213

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 78/313 (24%), Positives = 137/313 (43%), Gaps = 47/313 (15%)
Query: 177 PKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL---IAVKMLEN--SKFSAEEFI 231
           P    YP +      F   +G+G FG V K ++    L    A+K ++   SK    +F 
Sbjct: 4   PDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 63
Query: 232 NEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSL------------DRHIFPKE 278
            E+  + ++ HH N++ LLG C       L  E+ P+G+L            D       
Sbjct: 64  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 123
Query: 279 NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK 338
           +   T   ++L   A   ARG+ YL        +H D+   NIL+  N++ K++DFGL++
Sbjct: 124 STASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR 180
Query: 339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNM 396
               +  +V  +  R  + ++A E  S N+   +  SDV+ +G++L E+   GG     M
Sbjct: 181 ---GQEVYVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 235
Query: 397 NAIRSSKAYFPSWVYDQLNKGGDLE--LRNVTEIESVIARKLCMIGLWCIQVKAADRPSM 454
                        +Y++L +G  LE  L    E+  ++ +        C + K  +RPS 
Sbjct: 236 TCAE---------LYEKLPQGYRLEKPLNCDDEVYDLMRQ--------CWREKPYERPSF 278
Query: 455 TKVLEMLEGSMDD 467
            ++L  L   +++
Sbjct: 279 AQILVSLNRMLEE 291

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 23/210 (10%)
Query: 196 LGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 246
           LG+G FG V +       +  T R +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 247 QLLGFCSE-GSKRALVYEFMPNGSLDRHIFPKENK--------GQTFGWEKLQEIALGTA 297
            LLG C++ G    ++ EF   G+L  ++  K N+              E L   +   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
           +G+ +L        +H D+   NILL    + K+ DFGLA+   K+ D+V     R  + 
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
           ++APE I     T+  +SDV+ FG++L E+
Sbjct: 212 WMAPETIFDRVYTI--QSDVWSFGVLLWEI 239

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 78/313 (24%), Positives = 137/313 (43%), Gaps = 47/313 (15%)
Query: 177 PKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL---IAVKMLEN--SKFSAEEFI 231
           P    YP +      F   +G+G FG V K ++    L    A+K ++   SK    +F 
Sbjct: 14  PDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 73
Query: 232 NEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSL------------DRHIFPKE 278
            E+  + ++ HH N++ LLG C       L  E+ P+G+L            D       
Sbjct: 74  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133
Query: 279 NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK 338
           +   T   ++L   A   ARG+ YL        +H D+   NIL+  N++ K++DFGL++
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR 190
Query: 339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNM 396
               +  +V  +  R  + ++A E  S N+   +  SDV+ +G++L E+   GG     M
Sbjct: 191 ---GQEVYVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 245
Query: 397 NAIRSSKAYFPSWVYDQLNKGGDLE--LRNVTEIESVIARKLCMIGLWCIQVKAADRPSM 454
                        +Y++L +G  LE  L    E+  ++ +        C + K  +RPS 
Sbjct: 246 TCAE---------LYEKLPQGYRLEKPLNCDDEVYDLMRQ--------CWREKPYERPSF 288
Query: 455 TKVLEMLEGSMDD 467
            ++L  L   +++
Sbjct: 289 AQILVSLNRMLEE 301

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 27/214 (12%)
Query: 196 LGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 246
           LG+G FG V +       +  T R +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 247 QLLGFCSE-GSKRALVYEFMPNGSLDRHIFPKENK------------GQTFGWEKLQEIA 293
            LLG C++ G    ++ EF   G+L  ++  K N+                  E L   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 294 LGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 353
              A+G+ +L      CI H D+   NILL    + K+ DFGLA+   K+ D+V     R
Sbjct: 155 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 354 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 212 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 243

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 25/212 (11%)
Query: 196 LGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 246
           LG+G FG V +       +  T R +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 247 QLLGFCSE-GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQE----------IALG 295
            LLG C++ G    ++ EF   G+L  ++  K N+   +  E L +           +  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 296 TARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT 355
            A+G+ +L        +H D+   NILL    + K+ DFGLA+   K+ D V     R  
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 356 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
           + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 214 LKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 243

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 27/214 (12%)
Query: 196 LGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 246
           LG+G FG V +       +  T R +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 247 QLLGFCSE-GSKRALVYEFMPNGSLDRHIFPKENK------------GQTFGWEKLQEIA 293
            LLG C++ G    ++ EF   G+L  ++  K N+                  E L   +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 294 LGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 353
              A+G+ +L      CI H D+   NILL    + K+ DFGLA+   K+ D+V     R
Sbjct: 157 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 354 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 214 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 245

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 27/214 (12%)
Query: 196 LGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 246
           LG+G FG V +       +  T R +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 247 QLLGFCSE-GSKRALVYEFMPNGSLDRHIFPKENK------------GQTFGWEKLQEIA 293
            LLG C++ G    ++ EF   G+L  ++  K N+                  E L   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 294 LGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 353
              A+G+ +L      CI H D+   NILL    + K+ DFGLA+   K+ D+V     R
Sbjct: 146 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 354 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 203 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 234

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 191 HFTHKLGQGGFGSVYKGQLHTGR-LIAVK--MLENSKFSAE------EFINEVSTIGRIH 241
            +  ++G+GGFG V+KG+L   + ++A+K  +L +S+   E      EF  EV  +  ++
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 242 HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVA 301
           H N+V+L G      +  +V EF+P G L   +    +K     W     + L  A G+ 
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIE 136
Query: 302 YLHNGCDMCILHFDIKPHNILL---DHN--FIPKVSDFGLAKFHPKENDFVSISATRGTI 356
           Y+ N  +  I+H D++  NI L   D N     KV+DFGL+     +    S+S   G  
Sbjct: 137 YMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----QQSVHSVSGLLGNF 190
Query: 357 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
            ++APE I     + + K+D Y F M+L  +  G
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 27/214 (12%)
Query: 196 LGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 246
           LG+G FG V +       +  T R +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 247 QLLGFCSE-GSKRALVYEFMPNGSLDRHIFPKENK------------GQTFGWEKLQEIA 293
            LLG C++ G    ++ EF   G+L  ++  K N+                  E L   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 294 LGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 353
              A+G+ +L      CI H D+   NILL    + K+ DFGLA+   K+ D+V     R
Sbjct: 146 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 354 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 203 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 234

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 192 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 245
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 13  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 72
Query: 246 VQLLGFCSEGSKR--ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V+  G C    +R   L+ E++P GSL  ++   +   +     KL +      +G+ YL
Sbjct: 73  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 129
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 362
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 130 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 186
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEM 387
            ++ +    S  SDV+ FG+VL E+
Sbjct: 187 SLTES--KFSVASDVWSFGVVLYEL 209

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 192 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 245
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 18  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 77
Query: 246 VQLLGFCSEGSKR--ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V+  G C    +R   L+ E++P GSL  ++   +   +     KL +      +G+ YL
Sbjct: 78  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 134
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 362
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 135 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 191
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEM 387
            ++ +    S  SDV+ FG+VL E+
Sbjct: 192 SLTES--KFSVASDVWSFGVVLYEL 214

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 27/214 (12%)
Query: 196 LGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 246
           LG+G FG V +       +  T R +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 247 QLLGFCSE-GSKRALVYEFMPNGSLDRHIFPKENK------------GQTFGWEKLQEIA 293
            LLG C++ G    ++ EF   G+L  ++  K N+                  E L   +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 294 LGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 353
              A+G+ +L      CI H D+   NILL    + K+ DFGLA+   K+ D+V     R
Sbjct: 192 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 354 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 249 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 280

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 192 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 245
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 246 VQLLGFCSEGSKR--ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V+  G C    +R   L+ E++P GSL  ++   +   +     KL +      +G+ YL
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QAHAERIDHIKLLQYTSQICKGMEYL 133
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 362
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 134 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEM 387
            ++ +    S  SDV+ FG+VL E+
Sbjct: 191 SLTES--KFSVASDVWSFGVVLYEL 213

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 192 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 245
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 246 VQLLGFCSEGSKR--ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V+  G C    +R   L+ E++P GSL  ++   +   +     KL +      +G+ YL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 362
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 131 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEM 387
            ++ +    S  SDV+ FG+VL E+
Sbjct: 188 SLTES--KFSVASDVWSFGVVLYEL 210

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 192 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 245
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 12  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 71
Query: 246 VQLLGFCSEGSKR--ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V+  G C    +R   L+ E++P GSL  ++   +   +     KL +      +G+ YL
Sbjct: 72  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 128
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 362
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 129 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 185
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEM 387
            ++ +    S  SDV+ FG+VL E+
Sbjct: 186 SLTES--KFSVASDVWSFGVVLYEL 208

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 192 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 245
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 19  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 78
Query: 246 VQLLGFCSEGSKR--ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V+  G C    +R   L+ E++P GSL  ++   +   +     KL +      +G+ YL
Sbjct: 79  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 135
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 362
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 136 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 192
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEM 387
            ++ +    S  SDV+ FG+VL E+
Sbjct: 193 SLTES--KFSVASDVWSFGVVLYEL 215

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 192 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 245
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 20  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 79
Query: 246 VQLLGFCSEGSKR--ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V+  G C    +R   L+ E++P GSL  ++   +   +     KL +      +G+ YL
Sbjct: 80  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 136
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 362
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 137 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 193
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEM 387
            ++ +    S  SDV+ FG+VL E+
Sbjct: 194 SLTES--KFSVASDVWSFGVVLYEL 216

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 192 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 245
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 246 VQLLGFCSEGSKR--ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V+  G C    +R   L+ E++P GSL  ++   +   +     KL +      +G+ YL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 362
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 131 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEM 387
            ++ +    S  SDV+ FG+VL E+
Sbjct: 188 SLTES--KFSVASDVWSFGVVLYEL 210

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 192 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 245
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 246 VQLLGFCSEGSKR--ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V+  G C    +R   L+ E++P GSL  ++   +   +     KL +      +G+ YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 362
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 162 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 218
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEM 387
            ++ +    S  SDV+ FG+VL E+
Sbjct: 219 SLTES--KFSVASDVWSFGVVLYEL 241

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 196 LGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 246
           LG+G FG V +       +  T R +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 247 QLLGFCSE-GSKRALVYEFMPNGSLDRHIFPKENK-----------GQTFGWEKLQEIAL 294
            LLG C++ G    ++ EF   G+L  ++  K N+                 E L   + 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 295 GTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG 354
             A+G+ +L      CI H D+   NILL    + K+ DFGLA+   K+ D V     R 
Sbjct: 156 QVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 355 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
            + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 213 PLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 243

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 192 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 245
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 246 VQLLGFCSEGSKR--ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V+  G C    +R   L+ E++P GSL  ++   +   +     KL +      +G+ YL
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 362
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 134 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEM 387
            ++ +    S  SDV+ FG+VL E+
Sbjct: 191 SLTES--KFSVASDVWSFGVVLYEL 213

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 196 LGQGGFGSVYKGQLHTGRLIAVKML-----ENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           +G GGFG VY+     G  +AVK       E+   + E    E      + H N++ L G
Sbjct: 15  IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
            C +     LV EF   G L+R +      G+    + L   A+  ARG+ YLH+   + 
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 311 ILHFDIKPHNILLDH--------NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
           I+H D+K  NIL+          N I K++DFGLA    +E    +  +  G   ++APE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAPE 184
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           +I  +    S  SDV+ +G++L E+  G
Sbjct: 185 VIRASM--FSKGSDVWSYGVLLWELLTG 210

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 192 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 245
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 21  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 80
Query: 246 VQLLGFCSEGSKR--ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V+  G C    +R   L+ E++P GSL  ++   +   +     KL +      +G+ YL
Sbjct: 81  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 137
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 362
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 138 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 194
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEM 387
            ++ +    S  SDV+ FG+VL E+
Sbjct: 195 SLTES--KFSVASDVWSFGVVLYEL 217

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 192 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 245
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 246 VQLLGFCSEGSKR--ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V+  G C    +R   L+ E++P GSL  ++   +   +     KL +      +G+ YL
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 148
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 362
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 149 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 205
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEM 387
            ++ +    S  SDV+ FG+VL E+
Sbjct: 206 SLTES--KFSVASDVWSFGVVLYEL 228

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 17/196 (8%)
Query: 194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG-FC 252
             +G+G FG V  G  + G  +AVK ++N   +A+ F+ E S + ++ H N+VQLLG   
Sbjct: 18  QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIV 75
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQT-FGWEKLQEIALGTARGVAYLHNGCDMCI 311
            E     +V E+M  GSL  ++    ++G++  G + L + +L     + YL        
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 129
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           +H D+   N+L+  + + KVSDFGL K      D   +      + + APE +       
Sbjct: 130 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-----VKWTAPEALRE--AAF 182
Query: 372 SCKSDVYGFGMVLLEM 387
           S KSDV+ FG++L E+
Sbjct: 183 STKSDVWSFGILLWEI 198

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 17/194 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG-FCSE 254
           +G+G FG V  G  + G  +AVK ++N   +A+ F+ E S + ++ H N+VQLLG    E
Sbjct: 201 IGKGEFGDVMLGD-YRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQT-FGWEKLQEIALGTARGVAYLHNGCDMCILH 313
                +V E+M  GSL  ++    ++G++  G + L + +L     + YL        +H
Sbjct: 259 KGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 312
Query: 314 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC 373
            D+   N+L+  + + KVSDFGL K      D   +      + + APE +       S 
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-----VKWTAPEALREK--KFST 365
Query: 374 KSDVYGFGMVLLEM 387
           KSDV+ FG++L E+
Sbjct: 366 KSDVWSFGILLWEI 379

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 17/194 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG-FCSE 254
           +G+G FG V  G  + G  +AVK ++N   +A+ F+ E S + ++ H N+VQLLG    E
Sbjct: 14  IGKGEFGDVMLGD-YRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQT-FGWEKLQEIALGTARGVAYLHNGCDMCILH 313
                +V E+M  GSL  ++    ++G++  G + L + +L     + YL        +H
Sbjct: 72  KGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 125
Query: 314 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC 373
            D+   N+L+  + + KVSDFGL K      D   +      + + APE +       S 
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-----VKWTAPEALREK--KFST 178
Query: 374 KSDVYGFGMVLLEM 387
           KSDV+ FG++L E+
Sbjct: 179 KSDVWSFGILLWEI 192

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 192 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 245
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 15  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 74
Query: 246 VQLLGFCSEGSKR--ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V+  G C    +R   L+ E++P GSL  ++   +   +     KL +      +G+ YL
Sbjct: 75  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 131
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 362
             G    I H ++   NIL+++    K+ DFGL K  P++ ++  +       I + APE
Sbjct: 132 --GTKRYI-HRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE 188
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEM 387
            ++ +    S  SDV+ FG+VL E+
Sbjct: 189 SLTES--KFSVASDVWSFGVVLYEL 211

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 27/214 (12%)
Query: 196 LGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 246
           LG+G FG V +       +  T R +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 247 QLLGFCSE-GSKRALVYEFMPNGSLDRHIFPKENK------------GQTFGWEKLQEIA 293
            LLG C++ G    ++ EF   G+L  ++  K N+                  E L   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 294 LGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 353
              A+G+ +L      CI H D+   NILL    + K+ DFGLA+   K+ D V     R
Sbjct: 155 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 354 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 212 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 243

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 27/214 (12%)
Query: 196 LGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 246
           LG+G FG V +       +  T R +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 247 QLLGFCSE-GSKRALVYEFMPNGSLDRHIFPKENK------------GQTFGWEKLQEIA 293
            LLG C++ G    ++ EF   G+L  ++  K N+                  E L   +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 294 LGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 353
              A+G+ +L      CI H D+   NILL    + K+ DFGLA+   K+ D V     R
Sbjct: 146 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 354 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 203 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 234

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 17/196 (8%)
Query: 194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG-FC 252
             +G+G FG V  G  + G  +AVK ++N   +A+ F+ E S + ++ H N+VQLLG   
Sbjct: 27  QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQT-FGWEKLQEIALGTARGVAYLHNGCDMCI 311
            E     +V E+M  GSL  ++    ++G++  G + L + +L     + YL        
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 138
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           +H D+   N+L+  + + KVSDFGL K      D   +      + + APE +       
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-----VKWTAPEALREK--KF 191
Query: 372 SCKSDVYGFGMVLLEM 387
           S KSDV+ FG++L E+
Sbjct: 192 STKSDVWSFGILLWEI 207

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 192 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 245
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 246 VQLLGFCSEGSKR--ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V+  G C    +R   L+ E++P GSL  ++   +   +     KL +      +G+ YL
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 148
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 362
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 149 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 205
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEM 387
            ++ +    S  SDV+ FG+VL E+
Sbjct: 206 SLTES--KFSVASDVWSFGVVLYEL 228

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 27/214 (12%)
Query: 196 LGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 246
           LG+G FG V +       +  T R +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 247 QLLGFCSE-GSKRALVYEFMPNGSLDRHIFPKENK------------GQTFGWEKLQEIA 293
            LLG C++ G    ++ EF   G+L  ++  K N+                  E L   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 294 LGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 353
              A+G+ +L      CI H D+   NILL    + K+ DFGLA+   K+ D V     R
Sbjct: 146 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 354 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 203 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 234

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 27/214 (12%)
Query: 196 LGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 246
           LG+G FG V +       +  T R +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 247 QLLGFCSE-GSKRALVYEFMPNGSLDRHIFPKENK------------GQTFGWEKLQEIA 293
            LLG C++ G    ++ EF   G+L  ++  K N+                  E L   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 294 LGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 353
              A+G+ +L      CI H D+   NILL    + K+ DFGLA+   K+ D V     R
Sbjct: 155 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 354 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 212 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 243

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 137/313 (43%), Gaps = 47/313 (15%)
Query: 177 PKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL---IAVKMLEN--SKFSAEEFI 231
           P    YP +      F   +G+G FG V K ++    L    A+K ++   SK    +F 
Sbjct: 11  PDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 70
Query: 232 NEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSL------------DRHIFPKE 278
            E+  + ++ HH N++ LLG C       L  E+ P+G+L            D       
Sbjct: 71  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 130
Query: 279 NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK 338
           +   T   ++L   A   ARG+ YL        +H ++   NIL+  N++ K++DFGL++
Sbjct: 131 STASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLSR 187
Query: 339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNM 396
               +  +V  +  R  + ++A E  S N+   +  SDV+ +G++L E+   GG     M
Sbjct: 188 ---GQEVYVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 242
Query: 397 NAIRSSKAYFPSWVYDQLNKGGDLE--LRNVTEIESVIARKLCMIGLWCIQVKAADRPSM 454
                        +Y++L +G  LE  L    E+  ++ +        C + K  +RPS 
Sbjct: 243 TCAE---------LYEKLPQGYRLEKPLNCDDEVYDLMRQ--------CWREKPYERPSF 285
Query: 455 TKVLEMLEGSMDD 467
            ++L  L   +++
Sbjct: 286 AQILVSLNRMLEE 298

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 195 KLGQGGFGSVYKGQLHT------GRLIAVKMLENSKFSA-EEFINEVSTIGRIHHVNVVQ 247
           +LG+G FG V+  + H         L+AVK L+ +  SA ++F  E   +  + H ++V+
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQ-----------TFGWEKLQEIALGT 296
             G C+EG    +V+E+M +G L+R +       +             G  +L  +A   
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 297 ARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 356
           A G+ YL     +  +H D+   N L+    + K+ DFG+++     + +     T   I
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 357 GYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
            ++ PE ++ R F T   +SDV+ FG+VL E+
Sbjct: 202 RWMPPESILYRKFTT---ESDVWSFGVVLWEI 230

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 191 HFTHKLGQGGFGSVYKGQLHTGR-LIAVK--MLENSKFSAE------EFINEVSTIGRIH 241
            +  ++G+GGFG V+KG+L   + ++A+K  +L +S+   E      EF  EV  +  ++
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 242 HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVA 301
           H N+V+L G      +  +V EF+P G L   +    +K     W     + L  A G+ 
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIE 136
Query: 302 YLHNGCDMCILHFDIKPHNILL---DHN--FIPKVSDFGLAKFHPKENDFVSISATRGTI 356
           Y+ N  +  I+H D++  NI L   D N     KV+DF L+     +    S+S   G  
Sbjct: 137 YMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS-----QQSVHSVSGLLGNF 190
Query: 357 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
            ++APE I     + + K+D Y F M+L  +  G
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 191 HFTHKLGQGGFGSVYKGQLHTGR-LIAVK--MLENSKFSAE------EFINEVSTIGRIH 241
            +  ++G+GGFG V+KG+L   + ++A+K  +L +S+   E      EF  EV  +  ++
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 242 HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVA 301
           H N+V+L G      +  +V EF+P G L   +    +K     W     + L  A G+ 
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIE 136
Query: 302 YLHNGCDMCILHFDIKPHNILL---DHN--FIPKVSDFGLAKFHPKENDFVSISATRGTI 356
           Y+ N  +  I+H D++  NI L   D N     KV+DFG +     +    S+S   G  
Sbjct: 137 YMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS-----QQSVHSVSGLLGNF 190
Query: 357 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
            ++APE I     + + K+D Y F M+L  +  G
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 134/290 (46%), Gaps = 44/290 (15%)
Query: 196 LGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG 255
           +G+G FG V K +    + +A+K +E S+   + FI E+  + R++H N+V+L G C   
Sbjct: 17  VGRGAFGVVCKAKWR-AKDVAIKQIE-SESERKAFIVELRQLSRVNHPNIVKLYGACL-- 72
Query: 256 SKRALVYEFMPNGSL-----DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +   LV E+   GSL          P         W       L  ++GVAYLH+     
Sbjct: 73  NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQPKA 126
Query: 311 ILHFDIKPHNILL-DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
           ++H D+KP N+LL     + K+ DFG A      +    ++  +G+  ++APE+   +  
Sbjct: 127 LIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGS-- 179
Query: 370 TVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE-I 428
             S K DV+ +G++L E+   R+  +        A+   W     N      ++N+ + I
Sbjct: 180 NYSEKCDVFSWGIILWEVITRRKPFDEIG---GPAFRIMWAVH--NGTRPPLIKNLPKPI 234
Query: 429 ESVIARKLCMIGLWCIQVKAADRPSMTKVLEML-------EGSMDDLQMP 471
           ES++ R        C     + RPSM ++++++        G+ + LQ P
Sbjct: 235 ESLMTR--------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 276

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 134/290 (46%), Gaps = 44/290 (15%)
Query: 196 LGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG 255
           +G+G FG V K +    + +A+K +E S+   + FI E+  + R++H N+V+L G C   
Sbjct: 16  VGRGAFGVVCKAKWR-AKDVAIKQIE-SESERKAFIVELRQLSRVNHPNIVKLYGACL-- 71
Query: 256 SKRALVYEFMPNGSL-----DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +   LV E+   GSL          P         W       L  ++GVAYLH+     
Sbjct: 72  NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQPKA 125
Query: 311 ILHFDIKPHNILL-DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
           ++H D+KP N+LL     + K+ DFG A      +    ++  +G+  ++APE+   +  
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGS-- 178
Query: 370 TVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE-I 428
             S K DV+ +G++L E+   R+  +        A+   W     N      ++N+ + I
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIG---GPAFRIMWAVH--NGTRPPLIKNLPKPI 233
Query: 429 ESVIARKLCMIGLWCIQVKAADRPSMTKVLEML-------EGSMDDLQMP 471
           ES++ R        C     + RPSM ++++++        G+ + LQ P
Sbjct: 234 ESLMTR--------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 275

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 107/234 (45%), Gaps = 20/234 (8%)
Query: 165 IEKFLHNQQSWMPK-----RYSYPEIIAVTNH----FTHKLGQGGFGSVYKGQLHT-GRL 214
           I+  L  QQ    K       + P+   V NH       ++G+G FG V+ G+L     L
Sbjct: 82  IDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTL 141
Query: 215 IAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDR 272
           +AVK    +       +F+ E   + +  H N+V+L+G C++     +V E +  G    
Sbjct: 142 VAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT 201
Query: 273 HIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVS 332
            +     +G     + L ++    A G+ YL + C  CI H D+   N L+    + K+S
Sbjct: 202 FL---RTEGARLRVKTLLQMVGDAAAGMEYLESKC--CI-HRDLAARNCLVTEKNVLKIS 255
Query: 333 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 386
           DFG+++         S    +  + + APE +  N+G  S +SDV+ FG++L E
Sbjct: 256 DFGMSREEADGVXAASGGLRQVPVKWTAPEAL--NYGRYSSESDVWSFGILLWE 307

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 101/210 (48%), Gaps = 28/210 (13%)
Query: 197 GQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS 256
            +G FG V+K QL     +AVK+       + +   EV ++  + H N++Q +G    G+
Sbjct: 33  ARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91
Query: 257 KRA----LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH-------N 305
                  L+  F   GSL   +     K     W +L  IA   ARG+AYLH       +
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHIAETMARGLAYLHEDIPGLKD 146
Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISATRGTIG---YIAP 361
           G    I H DIK  N+LL +N    ++DFGLA KF   +    S   T G +G   Y+AP
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK----SAGDTHGQVGTRRYMAP 202
Query: 362 ELI--SRNFGTVS-CKSDVYGFGMVLLEMA 388
           E++  + NF   +  + D+Y  G+VL E+A
Sbjct: 203 EVLEGAINFQRDAFLRIDMYAMGLVLWELA 232

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 109/199 (54%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAV----KMLENS--KFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+V+KG  +  G  I +    K++E+   + S +   + +  IG + H ++V+L
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C  GS   LV +++P GSL  H+  ++++G   G + L    +  A+G+ YL    +
Sbjct: 99  LGLCP-GSSLQLVTQYLPLGSLLDHV--RQHRG-ALGPQLLLNWGVQIAKGMYYLE---E 151
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H ++   N+LL      +V+DFG+A   P ++  +  S  +  I ++A E I  +F
Sbjct: 152 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI--HF 209
Query: 369 GTVSCKSDVYGFGMVLLEM 387
           G  + +SDV+ +G+ + E+
Sbjct: 210 GKYTHQSDVWSYGVTVWEL 228

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 106/217 (48%), Gaps = 28/217 (12%)
Query: 192 FTHKLGQGGFGSVYKGQLHT------GRLIAVKMLENSKFSA-EEFINEVSTIGRIHHVN 244
              +LG+G FG V+  + +         L+AVK L++   +A ++F  E   +  + H +
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIF-------------PKENKGQTFGWEKLQE 291
           +V+  G C +G    +V+E+M +G L++ +              P++ KG+  G  ++  
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE-LGLSQMLH 137
Query: 292 IALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 351
           IA   A G+ YL        +H D+   N L+  N + K+ DFG+++     + +     
Sbjct: 138 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 352 TRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           T   I ++ PE ++ R F T   +SDV+ FG++L E+
Sbjct: 195 TMLPIRWMPPESIMYRKFTT---ESDVWSFGVILWEI 228

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 245
               LG+G +G V   QL   R+    +AVK+++  +     E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGVA 301
           V+  G   EG+ + L  E+   G L   I P     E   Q F  + +         GV 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--------GVV 118
Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 26/210 (12%)
Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLG-FC 252
           +G G +G VYKG+ + TG+L A+K+++ +    EE   E++ + +  HH N+    G F 
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 253 SEG-----SKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +       +  LV EF   GS+   I  K  KG T   E +  I     RG+++LH   
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGLSHLHQ-- 147
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPEL 363
              ++H DIK  N+LL  N   K+ DFG    L +   + N F+      GT  ++APE+
Sbjct: 148 -HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMAPEV 200
Query: 364 ISRNF---GTVSCKSDVYGFGMVLLEMAGG 390
           I+ +     T   KSD++  G+  +EMA G
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 195 KLGQGGFGSVYKGQLHT------GRLIAVKMLENSKFSA-EEFINEVSTIGRIHHVNVVQ 247
           +LG+G FG V+  + H         L+AVK L+ +  SA ++F  E   +  + H ++V+
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQ-----------TFGWEKLQEIALGT 296
             G C+EG    +V+E+M +G L+R +       +             G  +L  +A   
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 297 ARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 356
           A G+ YL     +  +H D+   N L+    + K+ DFG+++     + +     T   I
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 357 GYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
            ++ PE ++ R F T   +SDV+ FG+VL E+
Sbjct: 196 RWMPPESILYRKFTT---ESDVWSFGVVLWEI 224

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 245
               LG+G +G V   QL   R+    +AVK+++  +     E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGVA 301
           V+  G   EG+ + L  E+   G L   I P     E   Q F  + +         GV 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--------GVV 118
Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 245
               LG+G +G V   QL   R+    +AVK+++  +     E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGVA 301
           V+  G   EG+ + L  E+   G L   I P     E   Q F  + +         GV 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--------GVV 118
Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 128/273 (46%), Gaps = 38/273 (13%)
Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRIH----HVNVVQLLG 250
           LG+G F  VY+ + +HTG  +A+KM++         +  V    +IH    H ++++L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + +   LV E   NG ++R++   +N+ + F   + +        G+ YLH+     
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQIITGMLYLHSHG--- 132
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNF 368
           ILH D+   N+LL  N   K++DFGLA     P E  +       GT  YI+PE+ +R+ 
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC----GTPNYISPEIATRS- 187
Query: 369 GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG--GDLELRNVT 426
                +SDV+  G +   +  GR   + + ++++           LNK    D E+ +  
Sbjct: 188 -AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----------LNKVVLADYEMPSFL 235
Query: 427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
            IE   A+ L       ++   ADR S++ VL+
Sbjct: 236 SIE---AKDLIH---QLLRRNPADRLSLSSVLD 262

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 245
               LG+G +G V   QL   R+    +AVK+++  +     E    E+     ++H NV
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 67
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGVA 301
           V+  G   EG+ + L  E+   G L   I P     E   Q F  + +         GV 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--------GVV 119
Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           EL+ R         DV+  G+VL  M  G
Sbjct: 177 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 109/199 (54%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAV----KMLENS--KFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+V+KG  +  G  I +    K++E+   + S +   + +  IG + H ++V+L
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C  GS   LV +++P GSL  H+  ++++G   G + L    +  A+G+ YL    +
Sbjct: 81  LGLCP-GSSLQLVTQYLPLGSLLDHV--RQHRG-ALGPQLLLNWGVQIAKGMYYLE---E 133
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H ++   N+LL      +V+DFG+A   P ++  +  S  +  I ++A E I  +F
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI--HF 191
Query: 369 GTVSCKSDVYGFGMVLLEM 387
           G  + +SDV+ +G+ + E+
Sbjct: 192 GKYTHQSDVWSYGVTVWEL 210

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 245
               LG+G +G V   QL   R+    +AVK+++  +     E    E+     ++H NV
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENV 67
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGVA 301
           V+  G   EG+ + L  E+   G L   I P     E   Q F  + +         GV 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--------GVV 119
Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           EL+ R         DV+  G+VL  M  G
Sbjct: 177 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 245
               LG+G +G V   QL   R+    +AVK+++  +     E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGVA 301
           V+  G   EG+ + L  E+   G L   I P     E   Q F  + +         GV 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--------GVV 118
Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 195 KLGQGGFGSVYKGQLHT------GRLIAVKMLENSKFSA-EEFINEVSTIGRIHHVNVVQ 247
           +LG+G FG V+  + H         L+AVK L+ +  SA ++F  E   +  + H ++V+
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQ-----------TFGWEKLQEIALGT 296
             G C+EG    +V+E+M +G L+R +       +             G  +L  +A   
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 297 ARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 356
           A G+ YL     +  +H D+   N L+    + K+ DFG+++     + +     T   I
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 357 GYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
            ++ PE ++ R F T   +SDV+ FG+VL E+
Sbjct: 225 RWMPPESILYRKFTT---ESDVWSFGVVLWEI 253

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 245
               LG+G +G V   QL   R+    +AVK+++  +     E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGVA 301
           V+  G   EG+ + L  E+   G L   I P     E   Q F  + +         GV 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--------GVV 118
Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 107/234 (45%), Gaps = 20/234 (8%)
Query: 165 IEKFLHNQQSWMPK-----RYSYPEIIAVTNH----FTHKLGQGGFGSVYKGQLHT-GRL 214
           I+  L  QQ    K       + P+   V NH       ++G+G FG V+ G+L     L
Sbjct: 82  IDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTL 141
Query: 215 IAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDR 272
           +AVK    +       +F+ E   + +  H N+V+L+G C++     +V E +  G    
Sbjct: 142 VAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT 201
Query: 273 HIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVS 332
            +     +G     + L ++    A G+ YL + C  CI H D+   N L+    + K+S
Sbjct: 202 FL---RTEGARLRVKTLLQMVGDAAAGMEYLESKC--CI-HRDLAARNCLVTEKNVLKIS 255
Query: 333 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 386
           DFG+++         S    +  + + APE +  N+G  S +SDV+ FG++L E
Sbjct: 256 DFGMSREEADGVYAASGGLRQVPVKWTAPEAL--NYGRYSSESDVWSFGILLWE 307

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 245
               LG+G +G V   QL   R+    +AVK+++  +     E    E+     ++H NV
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGVA 301
           V+  G   EG+ + L  E+   G L   I P     E   Q F  + +         GV 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--------GVV 119
Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           EL+ R         DV+  G+VL  M  G
Sbjct: 177 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 245
               LG+G +G V   QL   R+    +AVK+++  +     E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGVA 301
           V+  G   EG+ + L  E+   G L   I P     E   Q F  + +         GV 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--------GVV 118
Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 245
               LG+G +G V   QL   R+    +AVK+++  +     E    E+     ++H NV
Sbjct: 9   LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGVA 301
           V+  G   EG+ + L  E+   G L   I P     E   Q F  + +         GV 
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--------GVV 117
Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 118 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           EL+ R         DV+  G+VL  M  G
Sbjct: 175 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 202

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 245
               LG+G +G V   QL   R+    +AVK+++  +     E    E+     ++H NV
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGVA 301
           V+  G   EG+ + L  E+   G L   I P     E   Q F  + +         GV 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--------GVV 119
Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           EL+ R         DV+  G+VL  M  G
Sbjct: 177 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 245
               LG+G +G V   QL   R+    +AVK+++  +     E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGVA 301
           V+  G   EG+ + L  E+   G L   I P     E   Q F  + +         GV 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--------GVV 118
Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 245
               LG+G +G V   QL   R+    +AVK+++  +     E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGVA 301
           V+  G   EG+ + L  E+   G L   I P     E   Q F  + +         GV 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--------GVV 118
Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 245
               LG+G +G V   QL   R+    +AVK+++  +     E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGVA 301
           V+  G   EG+ + L  E+   G L   I P     E   Q F  + +         GV 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--------GVV 118
Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 245
               LG+G +G V   QL   R+    +AVK+++  +     E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGVA 301
           V+  G   EG+ + L  E+   G L   I P     E   Q F  + +         GV 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--------GVV 118
Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 106/208 (50%), Gaps = 27/208 (12%)
Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           LG+G +G VY G+ L     IA+K +   +S++S +    E++    + H N+VQ LG  
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS-QPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 253 SEGSKRALVYEFMPNGSLDRHIF----PKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           SE     +  E +P GSL   +     P ++  QT G+   Q +      G+ YLH   D
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-----EGLKYLH---D 140
Query: 309 MCILHFDIKPHNILLD-HNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPEL 363
             I+H DIK  N+L++ ++ + K+SDFG    LA  +P    F       GT+ Y+APE+
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT------GTLQYMAPEI 194
Query: 364 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           I +        +D++  G  ++EMA G+
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 245
               LG+G +G V   QL   R+    +AVK+++  +     E    E+     ++H NV
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGVA 301
           V+  G   EG+ + L  E+   G L   I P     E   Q F  + +         GV 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--------GVV 119
Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           EL+ R         DV+  G+VL  M  G
Sbjct: 177 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 245
               LG+G +G V   QL   R+    +AVK+++  +     E    E+     ++H NV
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGVA 301
           V+  G   EG+ + L  E+   G L   I P     E   Q F  + +         GV 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--------GVV 119
Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           EL+ R         DV+  G+VL  M  G
Sbjct: 177 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 245
               LG+G +G V   QL   R+    +AVK+++  +     E    E+     ++H NV
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGVA 301
           V+  G   EG+ + L  E+   G L   I P     E   Q F  + +         GV 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--------GVV 119
Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           EL+ R         DV+  G+VL  M  G
Sbjct: 177 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 105/202 (51%), Gaps = 23/202 (11%)
Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLE-NSKFSAEEFIN-----EVSTIGRIHHVNVVQL 248
           LG+G F +VYK +  +T +++A+K ++   +  A++ IN     E+  +  + H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           L      S  +LV++FM     D  +  K+N         ++   L T +G+ YLH    
Sbjct: 78  LDAFGHKSNISLVFDFM---ETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQ--- 130
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI--S 365
             ILH D+KP+N+LLD N + K++DFGLAK F      +     TR    Y APEL+  +
Sbjct: 131 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTR---WYRAPELLFGA 187
Query: 366 RNFGTVSCKSDVYGFGMVLLEM 387
           R +G      D++  G +L E+
Sbjct: 188 RMYGV---GVDMWAVGCILAEL 206

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 20/203 (9%)
Query: 194 HKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
            KLG+G +GSVYK     TG+++A+K +   +   +E I E+S + +    +VV+  G  
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVP-VESDLQEIIKEISIMQQCDSPHVVKYYGSY 93
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
            + +   +V E+   GS+   I     + +T   +++  I   T +G+ YLH    M  +
Sbjct: 94  FKNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLHF---MRKI 147
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR----GTIGYIAPELISRNF 368
           H DIK  NILL+     K++DFG+A             A R    GT  ++APE+I +  
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVA------GQLTDXMAKRNXVIGTPFWMAPEVI-QEI 200
Query: 369 GTVSCKSDVYGFGMVLLEMAGGR 391
           G  +C +D++  G+  +EMA G+
Sbjct: 201 G-YNCVADIWSLGITAIEMAEGK 222

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 106/208 (50%), Gaps = 27/208 (12%)
Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           LG+G +G VY G+ L     IA+K +   +S++S +    E++    + H N+VQ LG  
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS-QPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 253 SEGSKRALVYEFMPNGSLDRHIF----PKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           SE     +  E +P GSL   +     P ++  QT G+   Q +      G+ YLH   D
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-----EGLKYLH---D 126
Query: 309 MCILHFDIKPHNILLD-HNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPEL 363
             I+H DIK  N+L++ ++ + K+SDFG    LA  +P    F       GT+ Y+APE+
Sbjct: 127 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT------GTLQYMAPEI 180
Query: 364 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           I +        +D++  G  ++EMA G+
Sbjct: 181 IDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 245
               LG+G +G V   QL   R+    +AVK+++  +     E    E+     ++H NV
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGVA 301
           V+  G   EG+ + L  E+   G L   I P     E   Q F  + +         GV 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--------GVV 119
Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           EL+ R         DV+  G+VL  M  G
Sbjct: 177 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 245
               LG+G +G V   QL   R+    +AVK+++  +     E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGVA 301
           V+  G   EG+ + L  E+   G L   I P     E   Q F  + +         GV 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--------GVV 118
Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 195 KLGQGGFGSV-YKGQLHTGRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 252
           K+G+G  G V    + H+GR +AVKM++  K    E + NEV  +    H NVV++    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
             G +  ++ EF+  G+L   +            E++  +     + +AYLH      ++
Sbjct: 112 LVGEELWVLMEFLQGGALTDIV-----SQVRLNEEQIATVCEAVLQALAYLHA---QGVI 163
Query: 313 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
           H DIK  +ILL  +   K+SDFG    ++K  PK    V      GT  ++APE+ISR+ 
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV------GTPYWMAPEVISRSL 217
Query: 369 GTVSCKSDVYGFGMVLLEMAGG 390
              + + D++  G++++EM  G
Sbjct: 218 --YATEVDIWSLGIMVIEMVDG 237

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 104/212 (49%), Gaps = 32/212 (15%)
Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVK--MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           KLG G + +VYKG    TG  +A+K   L++ + +    I E+S +  + H N+V+L   
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 252 CSEGSKRALVYEFMPNG---SLDRHIFPKENKG------QTFGWEKLQEIALGTARGVAY 302
               +K  LV+EFM N     +D        +G      + F W+ LQ        G+A+
Sbjct: 72  IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ--------GLAF 123
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAP 361
            H      ILH D+KP N+L++     K+ DFGLA+ F    N F   S+   T+ Y AP
Sbjct: 124 CHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF---SSEVVTLWYRAP 177
Query: 362 ELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           +++  SR   T S   D++  G +L EM  G+
Sbjct: 178 DVLMGSR---TYSTSIDIWSCGCILAEMITGK 206

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 34/217 (15%)
Query: 196 LGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINE--VSTIGRIHHVNVVQLL---- 249
           +G+G +G+VYKG L   R +AVK+   S  + + FINE  +  +  + H N+ + +    
Sbjct: 21  IGRGRYGAVYKGSLDE-RPVAVKVF--SFANRQNFINEKNIYRVPLMEHDNIARFIVGDE 77
Query: 250 GFCSEGS-KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
              ++G  +  LV E+ PNGSL +++        T  W     +A    RG+AYLH    
Sbjct: 78  RVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCRLAHSVTRGLAYLHTELP 132
Query: 309 M------CILHFDIKPHNILLDHNFIPKVSDFGLAK-------FHPKENDFVSISATRGT 355
                   I H D+   N+L+ ++    +SDFGL+          P E D  +IS   GT
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV-GT 191
Query: 356 IGYIAPELIS-----RNFGTVSCKSDVYGFGMVLLEM 387
           I Y+APE++      R+  +   + D+Y  G++  E+
Sbjct: 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 93/209 (44%), Gaps = 25/209 (11%)
Query: 192 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 245
               LG+G  G V   QL   R+    +AVK+++  +     E    E+     ++H NV
Sbjct: 10  LVQTLGEGAAGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGVA 301
           V+  G   EG+ + L  E+   G L   I P     E   Q F  + +         GV 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--------GVV 118
Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 25/207 (12%)
Query: 193 THKLGQGGFGSVYK-GQLHTGRLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLG 250
           T  LG G FG V+K  +  TG  +A K+++       EE  NE+S + ++ H N++QL  
Sbjct: 94  TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153
Query: 251 FCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEIAL--GTARGVAYLHNGC 307
                +   LV E++  G L DR I       +++   +L  I        G+ ++H   
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRII------DESYNLTELDTILFMKQICEGIRHMHQ-- 205
Query: 308 DMCILHFDIKPHNILL---DHNFIPKVSDFGLA-KFHPKENDFVSISATRGTIGYIAPEL 363
            M ILH D+KP NIL    D   I K+ DFGLA ++ P+E     +    GT  ++APE+
Sbjct: 206 -MYILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPRE----KLKVNFGTPEFLAPEV 259
Query: 364 ISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           ++ +F  VS  +D++  G++   +  G
Sbjct: 260 VNYDF--VSFPTDMWSVGVIAYMLLSG 284

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 194 HKLGQGGFGSVYKGQL------HTGRLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNV 245
            +LGQG FG VY+G             +AVK +  S    E  EF+NE S +      +V
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 79
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQE---IALGTARG 299
           V+LLG  S+G    +V E M +G L    R + P+           LQE   +A   A G
Sbjct: 80  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
           +AYL+       +H D+   N ++ H+F  K+ DFG+ +   + +           + ++
Sbjct: 140 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 196
Query: 360 APELISRNFGTVSCKSDVYGFGMVLLEMA 388
           APE  S   G  +  SD++ FG+VL E+ 
Sbjct: 197 APE--SLKDGVFTTSSDMWSFGVVLWEIT 223

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 194 HKLGQGGFGSVYKGQL------HTGRLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNV 245
            +LGQG FG VY+G             +AVK +  S    E  EF+NE S +      +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQE---IALGTARG 299
           V+LLG  S+G    +V E M +G L    R + P+           LQE   +A   A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
           +AYL+       +H D+   N ++ H+F  K+ DFG+ +   + + +         + ++
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 360 APELISRNFGTVSCKSDVYGFGMVLLEMA 388
           APE  S   G  +  SD++ FG+VL E+ 
Sbjct: 200 APE--SLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 194 HKLGQGGFGSVYKGQL------HTGRLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNV 245
            +LGQG FG VY+G             +AVK +  S    E  EF+NE S +      +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQE---IALGTARG 299
           V+LLG  S+G    +V E M +G L    R + P+           LQE   +A   A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
           +AYL+       +H D+   N ++ H+F  K+ DFG+ +   + +           + ++
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 360 APELISRNFGTVSCKSDVYGFGMVLLEMA 388
           APE  S   G  +  SD++ FG+VL E+ 
Sbjct: 200 APE--SLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 194 HKLGQGGFGSVYKGQL------HTGRLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNV 245
            +LGQG FG VY+G             +AVK +  S    E  EF+NE S +      +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQE---IALGTARG 299
           V+LLG  S+G    +V E M +G L    R + P+           LQE   +A   A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
           +AYL+       +H D+   N ++ H+F  K+ DFG+ +   + +           + ++
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 360 APELISRNFGTVSCKSDVYGFGMVLLEMA 388
           APE  S   G  +  SD++ FG+VL E+ 
Sbjct: 200 APE--SLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 120/281 (42%), Gaps = 34/281 (12%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVK-MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS 253
           LG+G FG   K     TG ++ +K ++   + +   F+ EV  +  + H NV++ +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 254 EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILH 313
           +  +   + E++  G+L   I   ++    + W +    A   A G+AYLH+   M I+H
Sbjct: 78  KDKRLNFITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 314 FDIKPHNILLDHNFIPKVSDFGLAKF------HP------KENDFVSISATRGTIGYIAP 361
            D+  HN L+  N    V+DFGLA+        P      K+ D        G   ++AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE 421
           E+I  N  +   K DV+ FG+VL E+ G         + +   Y P  +   LN  G L+
Sbjct: 192 EMI--NGRSYDEKVDVFSFGIVLCEIIG--------RVNADPDYLPRTMDFGLNVRGFLD 241
Query: 422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
                            I + C  +    RPS  K+   LE
Sbjct: 242 ----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 107/206 (51%), Gaps = 19/206 (9%)
Query: 192 FTHKLGQGGFGSVYKGQL-----HTGRLIAVKMLENSKFSAE-EFINEVSTIGRIHHVNV 245
           +  +LG+G FGSV   +      +TG L+AVK L++S    + +F  E+  +  +H   +
Sbjct: 14  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 73
Query: 246 VQLLGFCSEGSKRA---LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           V+  G  S G  R    LV E++P+G L    F + ++ +     +L   +    +G+ Y
Sbjct: 74  VKYRGV-SYGPGRQSLRLVMEYLPSGCL--RDFLQRHRAR-LDASRLLLYSSQICKGMEY 129
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI-SATRGTIGYIAP 361
           L  G   C+ H D+   NIL++     K++DFGLAK  P + D+  +    +  I + AP
Sbjct: 130 L--GSRRCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 186
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEM 387
           E +S N    S +SDV+ FG+VL E+
Sbjct: 187 ESLSDNI--FSRQSDVWSFGVVLYEL 210

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 107/206 (51%), Gaps = 19/206 (9%)
Query: 192 FTHKLGQGGFGSVYKGQL-----HTGRLIAVKMLENSKFSAE-EFINEVSTIGRIHHVNV 245
           +  +LG+G FGSV   +      +TG L+AVK L++S    + +F  E+  +  +H   +
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 246 VQLLGFCSEGSKRA---LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           V+  G  S G  R    LV E++P+G L    F + ++ +     +L   +    +G+ Y
Sbjct: 87  VKYRGV-SYGPGRQSLRLVMEYLPSGCL--RDFLQRHRAR-LDASRLLLYSSQICKGMEY 142
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI-SATRGTIGYIAP 361
           L  G   C+ H D+   NIL++     K++DFGLAK  P + D+  +    +  I + AP
Sbjct: 143 L--GSRRCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEM 387
           E +S N    S +SDV+ FG+VL E+
Sbjct: 200 ESLSDNI--FSRQSDVWSFGVVLYEL 223

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 107/206 (51%), Gaps = 19/206 (9%)
Query: 192 FTHKLGQGGFGSVYKGQL-----HTGRLIAVKMLENSKFSAE-EFINEVSTIGRIHHVNV 245
           +  +LG+G FGSV   +      +TG L+AVK L++S    + +F  E+  +  +H   +
Sbjct: 15  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 74
Query: 246 VQLLGFCSEGSKRA---LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           V+  G  S G  R    LV E++P+G L    F + ++ +     +L   +    +G+ Y
Sbjct: 75  VKYRGV-SYGPGRQSLRLVMEYLPSGCL--RDFLQRHRAR-LDASRLLLYSSQICKGMEY 130
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI-SATRGTIGYIAP 361
           L  G   C+ H D+   NIL++     K++DFGLAK  P + D+  +    +  I + AP
Sbjct: 131 L--GSRRCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 187
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEM 387
           E +S N    S +SDV+ FG+VL E+
Sbjct: 188 ESLSDNI--FSRQSDVWSFGVVLYEL 211

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 104/203 (51%), Gaps = 21/203 (10%)
Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLEN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           +LG G FG VYK +   TG L A K++E  S+   E++I E+  +    H  +V+LLG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
               K  ++ EF P G++D  I  + ++G T    ++Q +       + +LH+     I+
Sbjct: 86  YHDGKLWIMIEFCPGGAVD-AIMLELDRGLTEP--QIQVVCRQMLEALNFLHSK---RII 139
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELI---S 365
           H D+K  N+L+      +++DFG++    K   K + F+      GT  ++APE++   +
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVMCET 193
Query: 366 RNFGTVSCKSDVYGFGMVLLEMA 388
                   K+D++  G+ L+EMA
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMA 216

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 106/208 (50%), Gaps = 21/208 (10%)
Query: 191 HFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMLENSKFSAE--EFINEVSTIGRIHHVN 244
           HF   +G+G FG VY G L  + G+ I  AVK L       E  +F+ E   +    H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 245 VVQLLGFC--SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           V+ LLG C  SEGS   +V  +M +G L R+    E    T   + L    L  A+G+ +
Sbjct: 91  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 146
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SISATRGTIGYIA 360
           L        +H D+   N +LD  F  KV+DFGLA+  + KE D V + +  +  + ++A
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 203
Query: 361 PE-LISRNFGTVSCKSDVYGFGMVLLEM 387
            E L ++ F T   KSDV+ FG++L E+
Sbjct: 204 LESLQTQKFTT---KSDVWSFGVLLWEL 228

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 20/212 (9%)
Query: 191 HFTHKLGQGGFGSVYK------GQLHTGRLIAVKMLENSKFSAEE--FINEVSTIGRI-H 241
            F   LG G FG V +      G+      +AVKML+++  + E+   ++E+  +  +  
Sbjct: 41  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 100
Query: 242 HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK------ENKGQTFGWEKLQEIALG 295
           H N+V LLG C+ G    ++ E+   G L   +  K      +  G+      L   +  
Sbjct: 101 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 160
Query: 296 TARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT 355
            A+G+A+L      CI H D+   N+LL +  + K+ DFGLA+    +++++     R  
Sbjct: 161 VAQGMAFL--ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 217
Query: 356 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
           + ++APE I     TV  +SDV+ +G++L E+
Sbjct: 218 VKWMAPESIFDCVYTV--QSDVWSYGILLWEI 247

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 20/212 (9%)
Query: 191 HFTHKLGQGGFGSVYK------GQLHTGRLIAVKMLENSKFSAEE--FINEVSTIGRI-H 241
            F   LG G FG V +      G+      +AVKML+++  + E+   ++E+  +  +  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 242 HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK------ENKGQTFGWEKLQEIALG 295
           H N+V LLG C+ G    ++ E+   G L   +  K      +  G+      L   +  
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 168
Query: 296 TARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT 355
            A+G+A+L      CI H D+   N+LL +  + K+ DFGLA+    +++++     R  
Sbjct: 169 VAQGMAFL--ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 225
Query: 356 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
           + ++APE I     TV  +SDV+ +G++L E+
Sbjct: 226 VKWMAPESIFDCVYTV--QSDVWSYGILLWEI 255

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 105/208 (50%), Gaps = 21/208 (10%)
Query: 191 HFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMLENSKFSAE--EFINEVSTIGRIHHVN 244
           HF   +G+G FG VY G L  + G+ I  AVK L       E  +F+ E   +    H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 245 VVQLLGFC--SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           V+ LLG C  SEGS   +V  +M +G L R+    E    T   + L    L  A+G+ Y
Sbjct: 92  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 147
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SISATRGTIGYIA 360
           L        +H D+   N +LD  F  KV+DFGLA+  + KE   V + +  +  + ++A
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204
Query: 361 PE-LISRNFGTVSCKSDVYGFGMVLLEM 387
            E L ++ F T   KSDV+ FG++L E+
Sbjct: 205 LESLQTQKFTT---KSDVWSFGVLLWEL 229

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 106/208 (50%), Gaps = 21/208 (10%)
Query: 191 HFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMLENSKFSAE--EFINEVSTIGRIHHVN 244
           HF   +G+G FG VY G L  + G+ I  AVK L       E  +F+ E   +    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 245 VVQLLGFC--SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           V+ LLG C  SEGS   +V  +M +G L R+    E    T   + L    L  A+G+ +
Sbjct: 93  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 148
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SISATRGTIGYIA 360
           L        +H D+   N +LD  F  KV+DFGLA+  + KE D V + +  +  + ++A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 361 PE-LISRNFGTVSCKSDVYGFGMVLLEM 387
            E L ++ F T   KSDV+ FG++L E+
Sbjct: 206 LESLQTQKFTT---KSDVWSFGVLLWEL 230

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 104/203 (51%), Gaps = 21/203 (10%)
Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLEN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           +LG G FG VYK +   TG L A K++E  S+   E++I E+  +    H  +V+LLG  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
               K  ++ EF P G++D  I  + ++G T    ++Q +       + +LH+     I+
Sbjct: 78  YHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEP--QIQVVCRQMLEALNFLHSK---RII 131
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELI---S 365
           H D+K  N+L+      +++DFG++    K   K + F+      GT  ++APE++   +
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVMCET 185
Query: 366 RNFGTVSCKSDVYGFGMVLLEMA 388
                   K+D++  G+ L+EMA
Sbjct: 186 MKDTPYDYKADIWSLGITLIEMA 208

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 194 HKLGQGGFGSVYKGQL------HTGRLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNV 245
            +LGQG FG VY+G             +AVK +  S    E  EF+NE S +      +V
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 81
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQE---IALGTARG 299
           V+LLG  S+G    +V E M +G L    R + P+           LQE   +A   A G
Sbjct: 82  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
           +AYL+       +H D+   N ++ H+F  K+ DFG+ +   + + +         + ++
Sbjct: 142 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 198
Query: 360 APELISRNFGTVSCKSDVYGFGMVLLEMA 388
           APE  S   G  +  SD++ FG+VL E+ 
Sbjct: 199 APE--SLKDGVFTTSSDMWSFGVVLWEIT 225

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 106/208 (50%), Gaps = 21/208 (10%)
Query: 191 HFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMLENSKFSAE--EFINEVSTIGRIHHVN 244
           HF   +G+G FG VY G L  + G+ I  AVK L       E  +F+ E   +    H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 245 VVQLLGFC--SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           V+ LLG C  SEGS   +V  +M +G L R+    E    T   + L    L  A+G+ +
Sbjct: 152 VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 207
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SISATRGTIGYIA 360
           L        +H D+   N +LD  F  KV+DFGLA+  + KE D V + +  +  + ++A
Sbjct: 208 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 361 PE-LISRNFGTVSCKSDVYGFGMVLLEM 387
            E L ++ F T   KSDV+ FG++L E+
Sbjct: 265 LESLQTQKFTT---KSDVWSFGVLLWEL 289

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 106/208 (50%), Gaps = 21/208 (10%)
Query: 191 HFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMLENSKFSAE--EFINEVSTIGRIHHVN 244
           HF   +G+G FG VY G L  + G+ I  AVK L       E  +F+ E   +    H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 245 VVQLLGFC--SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           V+ LLG C  SEGS   +V  +M +G L R+    E    T   + L    L  A+G+ +
Sbjct: 94  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 149
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SISATRGTIGYIA 360
           L        +H D+   N +LD  F  KV+DFGLA+  + KE D V + +  +  + ++A
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 206
Query: 361 PE-LISRNFGTVSCKSDVYGFGMVLLEM 387
            E L ++ F T   KSDV+ FG++L E+
Sbjct: 207 LESLQTQKFTT---KSDVWSFGVLLWEL 231

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 106/208 (50%), Gaps = 21/208 (10%)
Query: 191 HFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMLENSKFSAE--EFINEVSTIGRIHHVN 244
           HF   +G+G FG VY G L  + G+ I  AVK L       E  +F+ E   +    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 245 VVQLLGFC--SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           V+ LLG C  SEGS   +V  +M +G L R+    E    T   + L    L  A+G+ +
Sbjct: 93  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 148
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SISATRGTIGYIA 360
           L        +H D+   N +LD  F  KV+DFGLA+  + KE D V + +  +  + ++A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 361 PE-LISRNFGTVSCKSDVYGFGMVLLEM 387
            E L ++ F T   KSDV+ FG++L E+
Sbjct: 206 LESLQTQKFTT---KSDVWSFGVLLWEL 230

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 194 HKLGQGGFGSVYKGQL------HTGRLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNV 245
            +LGQG FG VY+G             +AVK +  S    E  EF+NE S +      +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQE---IALGTARG 299
           V+LLG  S+G    +V E M +G L    R + P+           LQE   +A   A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
           +AYL+       +H D+   N ++ H+F  K+ DFG+ +   +   +         + ++
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWM 199
Query: 360 APELISRNFGTVSCKSDVYGFGMVLLEMA 388
           APE  S   G  +  SD++ FG+VL E+ 
Sbjct: 200 APE--SLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 19/206 (9%)
Query: 192 FTHKLGQGGFGSVYKGQL-----HTGRLIAVKMLENSKFSAE-EFINEVSTIGRIHHVNV 245
           +  +LG+G FGSV   +      +TG L+AVK L++S    + +F  E+  +  +H   +
Sbjct: 11  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 70
Query: 246 VQLLGFCSEGSKRA---LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           V+  G  S G  R    LV E++P+G L    F + ++ +     +L   +    +G+ Y
Sbjct: 71  VKYRGV-SYGPGRPELRLVMEYLPSGCL--RDFLQRHRAR-LDASRLLLYSSQICKGMEY 126
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI-SATRGTIGYIAP 361
           L  G   C+ H D+   NIL++     K++DFGLAK  P + D   +    +  I + AP
Sbjct: 127 L--GSRRCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAP 183
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEM 387
           E +S N    S +SDV+ FG+VL E+
Sbjct: 184 ESLSDNI--FSRQSDVWSFGVVLYEL 207

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 106/208 (50%), Gaps = 21/208 (10%)
Query: 191 HFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMLENSKFSAE--EFINEVSTIGRIHHVN 244
           HF   +G+G FG VY G L  + G+ I  AVK L       E  +F+ E   +    H N
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 245 VVQLLGFC--SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           V+ LLG C  SEGS   +V  +M +G L R+    E    T   + L    L  A+G+ +
Sbjct: 98  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 153
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SISATRGTIGYIA 360
           L        +H D+   N +LD  F  KV+DFGLA+  + KE D V + +  +  + ++A
Sbjct: 154 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 210
Query: 361 PE-LISRNFGTVSCKSDVYGFGMVLLEM 387
            E L ++ F T   KSDV+ FG++L E+
Sbjct: 211 LESLQTQKFTT---KSDVWSFGVLLWEL 235

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 192 FTHKLGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRIHHV 243
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 22  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFG---WEKLQEIALGTA 297
           +VV+LLG  S+G    ++ E M  G L    R + P+             K+ ++A   A
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
            G+AYL+       +H D+   N ++  +F  K+ DFG+ +   + + +         + 
Sbjct: 142 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMA 388
           +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 199 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 227

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 191 HFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMLENSKFSAE--EFINEVSTIGRIHHVN 244
           HF   +G+G FG VY G L  + G+ I  AVK L       E  +F+ E   +    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 245 VVQLLGFC--SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           V+ LLG C  SEGS   +V  +M +G L R+    E    T   + L    L  A+G+ Y
Sbjct: 93  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 148
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYI 359
           L        +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    + ++
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWM 204
Query: 360 APE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           A E L ++ F T   KSDV+ FG++L E+
Sbjct: 205 ALESLQTQKFTT---KSDVWSFGVLLWEL 230

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 191 HFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMLENSKFSAE--EFINEVSTIGRIHHVN 244
           HF   +G+G FG VY G L  + G+ I  AVK L       E  +F+ E   +    H N
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 245 VVQLLGFC--SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           V+ LLG C  SEGS   +V  +M +G L R+    E    T   + L    L  A+G+ Y
Sbjct: 112 VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 167
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYI 359
           L        +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    + ++
Sbjct: 168 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWM 223
Query: 360 APE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           A E L ++ F T   KSDV+ FG++L E+
Sbjct: 224 ALESLQTQKFTT---KSDVWSFGVLLWEL 249

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/264 (23%), Positives = 120/264 (45%), Gaps = 28/264 (10%)
Query: 145 IVFLVFLIHKYRTTLQTVDNI------EKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQ 198
           +V ++++ H+ R   +  + +       ++      ++P  +   E+       + +LGQ
Sbjct: 1   LVIMLYVFHRKRNNSRLGNGVLYASVNPEYFSAADVYVPDEW---EVAREKITMSRELGQ 57
Query: 199 GGFGSVYKG------QLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQLLG 250
           G FG VY+G      +      +A+K +  +    E  EF+NE S +   +  +VV+LLG
Sbjct: 58  GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 117
Query: 251 FCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFG---WEKLQEIALGTARGVAYLH 304
             S+G    ++ E M  G L    R + P+             K+ ++A   A G+AYL+
Sbjct: 118 VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN 177
Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
                  +H D+   N ++  +F  K+ DFG+ +   + + +         + +++PE  
Sbjct: 178 AN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE-- 232
Query: 365 SRNFGTVSCKSDVYGFGMVLLEMA 388
           S   G  +  SDV+ FG+VL E+A
Sbjct: 233 SLKDGVFTTYSDVWSFGVVLWEIA 256

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 192 FTHKLGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRIHHV 243
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFG---WEKLQEIALGTA 297
           +VV+LLG  S+G    ++ E M  G L    R + P+             K+ ++A   A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 148
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
            G+AYL+       +H D+   N ++  +F  K+ DFG+ +   + + +         + 
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMA 388
           +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 206 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 234

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 191 HFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMLENSKFSAE--EFINEVSTIGRIHHVN 244
           HF   +G+G FG VY G L  + G+ I  AVK L       E  +F+ E   +    H N
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 245 VVQLLGFC--SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           V+ LLG C  SEGS   +V  +M +G L R+    E    T   + L    L  A+G+ Y
Sbjct: 85  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 140
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYI 359
           L        +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    + ++
Sbjct: 141 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWM 196
Query: 360 APE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           A E L ++ F T   KSDV+ FG++L E+
Sbjct: 197 ALESLQTQKFTT---KSDVWSFGVLLWEL 222

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 192 FTHKLGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRIHHV 243
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 22  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFG---WEKLQEIALGTA 297
           +VV+LLG  S+G    ++ E M  G L    R + P+             K+ ++A   A
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
            G+AYL+       +H D+   N ++  +F  K+ DFG+ +   + + +         + 
Sbjct: 142 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMA 388
           +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 199 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 227

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 191 HFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMLENSKFSAE--EFINEVSTIGRIHHVN 244
           HF   +G+G FG VY G L  + G+ I  AVK L       E  +F+ E   +    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 245 VVQLLGFC--SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           V+ LLG C  SEGS   +V  +M +G L R+    E    T   + L    L  A+G+ Y
Sbjct: 93  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 148
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYI 359
           L        +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    + ++
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWM 204
Query: 360 APE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           A E L ++ F T   KSDV+ FG++L E+
Sbjct: 205 ALESLQTQKFTT---KSDVWSFGVLLWEL 230

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 191 HFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMLENSKFSAE--EFINEVSTIGRIHHVN 244
           HF   +G+G FG VY G L  + G+ I  AVK L       E  +F+ E   +    H N
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 245 VVQLLGFC--SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           V+ LLG C  SEGS   +V  +M +G L R+    E    T   + L    L  A+G+ Y
Sbjct: 111 VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 166
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYI 359
           L        +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    + ++
Sbjct: 167 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWM 222
Query: 360 APE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           A E L ++ F T   KSDV+ FG++L E+
Sbjct: 223 ALESLQTQKFTT---KSDVWSFGVLLWEL 248

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 191 HFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMLENSKFSAE--EFINEVSTIGRIHHVN 244
           HF   +G+G FG VY G L  + G+ I  AVK L       E  +F+ E   +    H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 245 VVQLLGFC--SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           V+ LLG C  SEGS   +V  +M +G L R+    E    T   + L    L  A+G+ Y
Sbjct: 90  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 145
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYI 359
           L        +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    + ++
Sbjct: 146 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWM 201
Query: 360 APE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           A E L ++ F T   KSDV+ FG++L E+
Sbjct: 202 ALESLQTQKFTT---KSDVWSFGVLLWEL 227

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 191 HFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMLENSKFSAE--EFINEVSTIGRIHHVN 244
           HF   +G+G FG VY G L  + G+ I  AVK L       E  +F+ E   +    H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 245 VVQLLGFC--SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           V+ LLG C  SEGS   +V  +M +G L R+    E    T   + L    L  A+G+ Y
Sbjct: 92  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 147
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYI 359
           L        +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    + ++
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWM 203
Query: 360 APE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           A E L ++ F T   KSDV+ FG++L E+
Sbjct: 204 ALESLQTQKFTT---KSDVWSFGVLLWEL 229

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVK--MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           KLG+G + +VYKG+   T  L+A+K   LE+ + +    I EVS +  + H N+V L   
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                   LV+E++ +  L +++   ++ G       ++       RG+AY H      +
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCHR---QKV 121
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           LH D+KP N+L++     K++DFGLA+   K     +      T+ Y  P+++    G+ 
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYDNEVVTLWYRPPDIL---LGST 176
Query: 372 --SCKSDVYGFGMVLLEMAGGR 391
             S + D++G G +  EMA GR
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGR 198

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 192 FTHKLGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRIHHV 243
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 20  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 79
Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFG---WEKLQEIALGTA 297
           +VV+LLG  S+G    ++ E M  G L    R + P+             K+ ++A   A
Sbjct: 80  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 139
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
            G+AYL+       +H D+   N ++  +F  K+ DFG+ +   + + +         + 
Sbjct: 140 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMA 388
           +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 197 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 225

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 191 HFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMLENSKFSAE--EFINEVSTIGRIHHVN 244
           HF   +G+G FG VY G L  + G+ I  AVK L       E  +F+ E   +    H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 245 VVQLLGFC--SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           V+ LLG C  SEGS   +V  +M +G L R+    E    T   + L    L  A+G+ Y
Sbjct: 91  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 146
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYI 359
           L        +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    + ++
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWM 202
Query: 360 APE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           A E L ++ F T   KSDV+ FG++L E+
Sbjct: 203 ALESLQTQKFTT---KSDVWSFGVLLWEL 228

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 191 HFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMLENSKFSAE--EFINEVSTIGRIHHVN 244
           HF   +G+G FG VY G L  + G+ I  AVK L       E  +F+ E   +    H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 245 VVQLLGFC--SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           V+ LLG C  SEGS   +V  +M +G L R+    E    T   + L    L  A+G+ Y
Sbjct: 88  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 143
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYI 359
           L        +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    + ++
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWM 199
Query: 360 APE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           A E L ++ F T   KSDV+ FG++L E+
Sbjct: 200 ALESLQTQKFTT---KSDVWSFGVLLWEL 225

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 192 FTHKLGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRIHHV 243
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 14  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 73
Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFG---WEKLQEIALGTA 297
           +VV+LLG  S+G    ++ E M  G L    R + P+             K+ ++A   A
Sbjct: 74  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 133
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
            G+AYL+       +H D+   N ++  +F  K+ DFG+ +   + +           + 
Sbjct: 134 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 190
Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMA 388
           +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 191 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 219

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 26/218 (11%)
Query: 191 HFTHKLGQGGFGSVYK------GQLHTGRLIAVKMLENSKFSAEE--FINEVSTIGRI-H 241
            F   LG G FG V +      G+      +AVKML+++  + E+   ++E+  +  +  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 242 HVNVVQLLGFCSEGSKRALVYEFMPNGSL------------DRHIFPKENKGQTFGWEKL 289
           H N+V LLG C+ G    ++ E+   G L            +    P  N  +      L
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDL 168
Query: 290 QEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 349
              +   A+G+A+L      CI H D+   N+LL +  + K+ DFGLA+    +++++  
Sbjct: 169 LHFSSQVAQGMAFL--ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 225
Query: 350 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
              R  + ++APE I     TV  +SDV+ +G++L E+
Sbjct: 226 GNARLPVKWMAPESIFDCVYTV--QSDVWSYGILLWEI 261

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE------FINEVSTIGRIHHVNVVQL 248
           K+G+G +G VYK +   GR++A+K +   +  AE+       I E+S +  +HH N+V L
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRI---RLDAEDEGIPSTAIREISLLKELHHPNIVSL 84
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           +          LV+EFM     D      ENK       +++       RGVA+ H    
Sbjct: 85  IDVIHSERCLTLVFEFMEK---DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQ--- 137
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI--SR 366
             ILH D+KP N+L++ +   K++DFGLA+         S +    T+ Y AP+++  S+
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIP--VRSYTHEVVTLWYRAPDVLMGSK 195
Query: 367 NFGTVSCKSDVYGFGMVLLEMAGGR 391
            + T     D++  G +  EM  G+
Sbjct: 196 KYST---SVDIWSIGCIFAEMITGK 217

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 113/234 (48%), Gaps = 35/234 (14%)
Query: 196 LGQGGFGSVY----KGQLHTGRLIAVKMLENSKFSAEEFIN---EVSTIGRIHHVNVVQL 248
           LGQG FG V+      +  +G L A+K+L+ +     + +    E   +  ++H  VV+L
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKL 95
Query: 249 -LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
              F +EG K  L+ +F+  G L    F + +K   F  E ++      A G+ +LH+  
Sbjct: 96  HYAFQTEG-KLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALGLDHLHS-- 148
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAK----FHPKENDFVSISATRGTIGYIAPEL 363
            + I++ D+KP NILLD     K++DFGL+K       K   F       GT+ Y+APE+
Sbjct: 149 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFC------GTVEYMAPEV 201
Query: 364 ISRNFGTVSCKSDVYGFGMVLLEM-------AGGRRNSNMNAIRSSKAYFPSWV 410
           ++R     S  +D + +G+++ EM        G  R   M  I  +K   P ++
Sbjct: 202 VNRQ--GHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFL 253

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 192 FTHKLGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRIHHV 243
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 16  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFG---WEKLQEIALGTA 297
           +VV+LLG  S+G    ++ E M  G L    R + P+             K+ ++A   A
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
            G+AYL+       +H D+   N ++  +F  K+ DFG+ +   + + +         + 
Sbjct: 136 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMA 388
           +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 193 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 221

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 196 LGQGGFGSVYKGQLH----TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG+G FGSV +G L     T   +AVK ++   +S+   EEF++E + +    H NV++L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 249 LGFCSEGS-----KRALVYEFMPNGSLDRHIFPK--ENKGQTFGWEKLQEIALGTARGVA 301
           LG C E S     K  ++  FM  G L  ++     E   +    + L +  +  A G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           YL N      LH D+   N +L  +    V+DFGL+K     + +      +  + +IA 
Sbjct: 162 YLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMA 388
           E ++    T   KSDV+ FG+ + E+A
Sbjct: 219 ESLADRVYT--SKSDVWAFGVTMWEIA 243

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 192 FTHKLGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRIHHV 243
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 23  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFG---WEKLQEIALGTA 297
           +VV+LLG  S+G    ++ E M  G L    R + P+             K+ ++A   A
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
            G+AYL+       +H D+   N ++  +F  K+ DFG+ +   + + +         + 
Sbjct: 143 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 199
Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMA 388
           +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 200 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 228

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE------FINEVSTIGRIHHVNVVQL 248
           K+G+G +G VYK +   GR++A+K +   +  AE+       I E+S +  +HH N+V L
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRI---RLDAEDEGIPSTAIREISLLKELHHPNIVSL 84
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           +          LV+EFM     D      ENK       +++       RGVA+ H    
Sbjct: 85  IDVIHSERCLTLVFEFMEK---DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQ--- 137
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI--SR 366
             ILH D+KP N+L++ +   K++DFGLA+         S +    T+ Y AP+++  S+
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIP--VRSYTHEVVTLWYRAPDVLMGSK 195
Query: 367 NFGTVSCKSDVYGFGMVLLEMAGGR 391
            + T     D++  G +  EM  G+
Sbjct: 196 KYST---SVDIWSIGCIFAEMITGK 217

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 192 FTHKLGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRIHHV 243
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 23  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFG---WEKLQEIALGTA 297
           +VV+LLG  S+G    ++ E M  G L    R + P+             K+ ++A   A
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
            G+AYL+       +H D+   N ++  +F  K+ DFG+ +   + +           + 
Sbjct: 143 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 199
Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMA 388
           +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 200 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 228

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGR----LIAVKML-ENSKFSA-EEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G      +A+K+L EN+   A +E ++E   +  +    V +L
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   S   LV + MP G L  H+  +EN+G+  G + L    +  A+G++YL    D
Sbjct: 85  LGICLT-STVQLVTQLMPYGCLLDHV--RENRGR-LGSQDLLNWCMQIAKGMSYLE---D 137
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
           + ++H D+   N+L+      K++DFGLA+    +         +  I ++A E I R  
Sbjct: 138 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRR 197
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 198 FT--HQSDVWSYGVTVWEL 214

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 195 KLGQGGFGSVYKGQLHTGRL-IAVKML----ENSKFSAEEFINEVSTIGRIHHVNVVQLL 249
           KLG GG  +VY  +     + +A+K +       + + + F  EV    ++ H N+V ++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
               E     LV E++   +L  +I   E+ G     +           G+ + H   DM
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYI---ESHG-PLSVDTAINFTNQILDGIKHAH---DM 130
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
            I+H DIKP NIL+D N   K+ DFG+AK    E      +   GT+ Y +PE  ++   
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKA-LSETSLTQTNHVLGTVQYFSPEQ-AKGEA 188
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
           T  C +D+Y  G+VL EM  G 
Sbjct: 189 TDEC-TDIYSIGIVLYEMLVGE 209

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 194 HKLGQGGFGSVYKGQL------HTGRLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNV 245
            +LGQG FG VY+G             +AVK +  S    E  EF+NE S +      +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQE---IALGTARG 299
           V+LLG  S+G    +V E M +G L    R + P+           LQE   +A   A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
           +AYL+       +H ++   N ++ H+F  K+ DFG+ +   + + +         + ++
Sbjct: 143 MAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 360 APELISRNFGTVSCKSDVYGFGMVLLEMA 388
           APE  S   G  +  SD++ FG+VL E+ 
Sbjct: 200 APE--SLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 194 HKLGQGGFGSVYK------GQLHTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNV 245
            +LG G F  V K      G  +  + I  +  ++S+   S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           + L       +   L+ E +  G L   +  KE+  +    E L++I      GV YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 306 GCDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPAFVAP 186
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 194 HKLGQGGFGSVYKGQL------HTGRLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNV 245
            +LGQG FG VY+G             +AVK +  S    E  EF+NE S +      +V
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 83
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQE---IALGTARG 299
           V+LLG  S+G    +V E M +G L    R + P+           LQE   +A   A G
Sbjct: 84  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
           +AYL+       +H ++   N ++ H+F  K+ DFG+ +   + + +         + ++
Sbjct: 144 MAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 360 APELISRNFGTVSCKSDVYGFGMVLLEMA 388
           APE  S   G  +  SD++ FG+VL E+ 
Sbjct: 201 APE--SLKDGVFTTSSDMWSFGVVLWEIT 227

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 192 FTHKLGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRIHHV 243
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFG---WEKLQEIALGTA 297
           +VV+LLG  S+G    ++ E M  G L    R + P              K+ ++A   A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
            G+AYL+       +H D+   N ++  +F  K+ DFG+ +   + + +         + 
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMA 388
           +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 206 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 234

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 105/208 (50%), Gaps = 21/208 (10%)
Query: 191 HFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMLENSKFSAE--EFINEVSTIGRIHHVN 244
           HF   +G+G FG VY G L  + G+ I  AVK L       E  +F+ E   +    H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 245 VVQLLGFC--SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           V+ LLG C  SEGS   +V  +M +G L R+    E    T   + L    L  A+G+ +
Sbjct: 94  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 149
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SISATRGTIGYIA 360
           L        +H D+   N +LD  F  KV+DFGLA+    KE D V + +  +  + ++A
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMA 206
Query: 361 PE-LISRNFGTVSCKSDVYGFGMVLLEM 387
            E L ++ F T   KSDV+ FG++L E+
Sbjct: 207 LESLQTQKFTT---KSDVWSFGVLLWEL 231

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 192 FTHKLGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRIHHV 243
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 19  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 78
Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFG---WEKLQEIALGTA 297
           +VV+LLG  S+G    ++ E M  G L    R + P              K+ ++A   A
Sbjct: 79  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 138
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
            G+AYL+       +H D+   N ++  +F  K+ DFG+ +   + + +         + 
Sbjct: 139 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 195
Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMA 388
           +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 196 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 224

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 195 KLGQGGFGSVYKGQLHT------GRLIAVKMLENSKFSA-EEFINEVSTIGRIHHVNVVQ 247
           +LG+G FG V+  + +         L+AVK L+++  +A ++F  E   +  + H ++V+
Sbjct: 20  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 79
Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRH---------IFPKENKGQTFGWEKLQEIALGTAR 298
             G C EG    +V+E+M +G L++          +  + N        ++  IA   A 
Sbjct: 80  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAA 139
Query: 299 GVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 358
           G+ YL        +H D+   N L+  N + K+ DFG+++     + +     T   I +
Sbjct: 140 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 196
Query: 359 IAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           + PE ++ R F T   +SDV+  G+VL E+
Sbjct: 197 MPPESIMYRKFTT---ESDVWSLGVVLWEI 223

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 192 FTHKLGQGGFGSVYKG------QLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRIHHV 243
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 16  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFG---WEKLQEIALGTA 297
           +VV+LLG  S+G    ++ E M  G L    R + P+             K+ ++A   A
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
            G+AYL+       +H D+   N  +  +F  K+ DFG+ +   + + +         + 
Sbjct: 136 DGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMA 388
           +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 193 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 221

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 24/216 (11%)
Query: 191 HFTHKLGQGGFGSVYK------GQLHTGRLIAVKMLENSKFSAEE--FINEVSTIGRI-H 241
            F   LG G FG V +      G+      +AVKML+++  + E+   ++E+  +  +  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 242 HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKEN----------KGQTFGWEKLQE 291
           H N+V LLG C+ G    ++ E+   G L   +  K               T     L  
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLH 168
Query: 292 IALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 351
            +   A+G+A+L      CI H D+   N+LL +  + K+ DFGLA+    +++++    
Sbjct: 169 FSSQVAQGMAFL--ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 352 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
            R  + ++APE I     TV  +SDV+ +G++L E+
Sbjct: 226 ARLPVKWMAPESIFDCVYTV--QSDVWSYGILLWEI 259

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 194 HKLGQGGFGSVYK------GQLHTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNV 245
            +LG G F  V K      G  +  + I  +  ++S+   S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           + L       +   L+ E +  G L   +  KE+  +    E L++I      GV YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 306 GCDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 113/234 (48%), Gaps = 35/234 (14%)
Query: 196 LGQGGFGSVYKGQLHTG----RLIAVKMLENSKFSAEEFIN---EVSTIGRIHHVNVVQL 248
           LGQG FG V+  +  +G    +L A+K+L+ +     + +    E   +  ++H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 249 -LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
              F +EG K  L+ +F+  G L    F + +K   F  E ++      A  + +LH+  
Sbjct: 92  HYAFQTEG-KLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS-- 144
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAK----FHPKENDFVSISATRGTIGYIAPEL 363
            + I++ D+KP NILLD     K++DFGL+K       K   F       GT+ Y+APE+
Sbjct: 145 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTVEYMAPEV 197
Query: 364 ISRNFGTVSCKSDVYGFGMVLLEM-------AGGRRNSNMNAIRSSKAYFPSWV 410
           ++R   T S   D + FG+++ EM        G  R   M  I  +K   P ++
Sbjct: 198 VNRRGHTQSA--DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL 249

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 114/234 (48%), Gaps = 35/234 (14%)
Query: 196 LGQGGFGSVYKGQLHTG----RLIAVKMLENSKFSAEEFIN---EVSTIGRIHHVNVVQL 248
           LGQG FG V+  +  +G    +L A+K+L+ +     + +    E   +  ++H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 249 -LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
              F +EG K  L+ +F+  G L    F + +K   F  E ++      A  + +LH+  
Sbjct: 92  HYAFQTEG-KLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS-- 144
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAK----FHPKENDFVSISATRGTIGYIAPEL 363
            + I++ D+KP NILLD     K++DFGL+K       K   F       GT+ Y+APE+
Sbjct: 145 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTVEYMAPEV 197
Query: 364 ISRNFGTVSCKSDVYGFGMVLLEM-------AGGRRNSNMNAIRSSKAYFPSWV 410
           ++R   T S  +D + FG+++ EM        G  R   M  I  +K   P ++
Sbjct: 198 VNRRGHTQS--ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL 249

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 114/234 (48%), Gaps = 35/234 (14%)
Query: 196 LGQGGFGSVYKGQLHTG----RLIAVKMLENSKFSAEEFIN---EVSTIGRIHHVNVVQL 248
           LGQG FG V+  +  +G    +L A+K+L+ +     + +    E   +  ++H  +V+L
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 249 -LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
              F +EG K  L+ +F+  G L    F + +K   F  E ++      A  + +LH+  
Sbjct: 93  HYAFQTEG-KLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS-- 145
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAK----FHPKENDFVSISATRGTIGYIAPEL 363
            + I++ D+KP NILLD     K++DFGL+K       K   F       GT+ Y+APE+
Sbjct: 146 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTVEYMAPEV 198
Query: 364 ISRNFGTVSCKSDVYGFGMVLLEM-------AGGRRNSNMNAIRSSKAYFPSWV 410
           ++R   T S  +D + FG+++ EM        G  R   M  I  +K   P ++
Sbjct: 199 VNRRGHTQS--ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL 250

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 29/210 (13%)
Query: 197 GQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS 256
            +G FG V+K QL     +AVK+       + +   E+ +   + H N++Q +     GS
Sbjct: 24  ARGRFGCVWKAQL-MNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGS 82
Query: 257 KRA----LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC-- 310
                  L+  F   GSL  ++     KG    W +L  +A   +RG++YLH     C  
Sbjct: 83  NLEVELWLITAFHDKGSLTDYL-----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 311 ------ILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISATRGTIG---YIA 360
                 I H D K  N+LL  +    ++DFGLA +F P +        T G +G   Y+A
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPP----GDTHGQVGTRRYMA 193
Query: 361 PELI--SRNFGTVS-CKSDVYGFGMVLLEM 387
           PE++  + NF   +  + D+Y  G+VL E+
Sbjct: 194 PEVLEGAINFQRDAFLRIDMYAMGLVLWEL 223

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 194 HKLGQGGFGSVYK------GQLHTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNV 245
            +LG G F  V K      G  +  + I  +  ++S+   S E+   EVS +  I H NV
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           + L       +   L+ E +  G L   +  KE+  +    E L++I      GV YLH+
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 131
Query: 306 GCDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 132 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 185
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           E++  N+  +  ++D++  G++   +  G
Sbjct: 186 EIV--NYEPLGLEADMWSIGVITYILLSG 212

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 194 HKLGQGGFGSVYK------GQLHTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNV 245
            +LG G F  V K      G  +  + I  +  ++S+   S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           + L       +   L+ E +  G L   +  KE+  +    E L++I      GV YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 306 GCDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 194 HKLGQGGFGSVYK------GQLHTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNV 245
            +LG G F  V K      G  +  + I  +  ++S+   S E+   EVS +  I H NV
Sbjct: 17  EELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           + L       +   L+ E +  G L   +  KE+  +    E L++I      GV YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 306 GCDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 194 HKLGQGGFGSVYK------GQLHTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNV 245
            +LG G F  V K      G  +  + I  +  ++S+   S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           + L       +   L+ E +  G L   +  KE+  +    E L++I      GV YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 306 GCDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 194 HKLGQGGFGSVYK------GQLHTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNV 245
            +LG G F  V K      G  +  + I  +  ++S+   S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           + L       +   L+ E +  G L   +  KE+  +    E L++I      GV YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 306 GCDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 194 HKLGQGGFGSVYK------GQLHTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNV 245
            +LG G F  V K      G  +  + I  +  ++S+   S E+   EVS +  I H NV
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           + L       +   L+ E +  G L   +  KE+  +    E L++I      GV YLH+
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 131
Query: 306 GCDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 132 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 185
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           E++  N+  +  ++D++  G++   +  G
Sbjct: 186 EIV--NYEPLGLEADMWSIGVITYILLSG 212

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 194 HKLGQGGFGSVYK------GQLHTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNV 245
            +LG G F  V K      G  +  + I  +  ++S+   S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           + L       +   L+ E +  G L   +  KE+  +    E L++I      GV YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 306 GCDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 24/203 (11%)
Query: 195 KLGQGGFGSVYKGQLHT-GRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 252
           K+G+G  G V    + + G+L+AVK ++  K    E + NEV  +    H NVV++    
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
             G +  +V EF+  G+L   +            E++  + L   + ++ LH      ++
Sbjct: 96  LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHA---QGVI 147
Query: 313 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISR-N 367
           H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELISR  
Sbjct: 148 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISRLP 201
Query: 368 FGTVSCKSDVYGFGMVLLEMAGG 390
           +G    + D++  G++++EM  G
Sbjct: 202 YGP---EVDIWSLGIMVIEMVDG 221

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 194 HKLGQGGFGSVYK------GQLHTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNV 245
            +LG G F  V K      G  +  + I  +  ++S+   S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           + L       +   L+ E +  G L   +  KE+  +    E L++I      GV YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 306 GCDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 194 HKLGQGGFGSVYK------GQLHTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNV 245
            +LG G F  V K      G  +  + I  +  ++S+   S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           + L       +   L+ E +  G L   +  KE+  +    E L++I      GV YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 306 GCDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 24/203 (11%)
Query: 195 KLGQGGFGSVYKGQLHT-GRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 252
           K+G+G  G V    + + G+L+AVK ++  K    E + NEV  +    H NVV++    
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
             G +  +V EF+  G+L   +            E++  + L   + ++ LH      ++
Sbjct: 87  LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHA---QGVI 138
Query: 313 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISR-N 367
           H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELISR  
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISRLP 192
Query: 368 FGTVSCKSDVYGFGMVLLEMAGG 390
           +G    + D++  G++++EM  G
Sbjct: 193 YGP---EVDIWSLGIMVIEMVDG 212

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 37/222 (16%)
Query: 196 LGQGGFGSVYKGQLH--TGR----LIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQ 247
           LG+G FG V K       GR     +AVKML+ +   +E  + ++E + + +++H +V++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 248 LLGFCSEGSKRALVYEFMPNGSL------DRHIFP----------------KENKGQTFG 285
           L G CS+     L+ E+   GSL       R + P                 + +  T G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 286 WEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 345
              L   A   ++G+ YL    +M ++H D+   NIL+      K+SDFGL++   +E+ 
Sbjct: 151 --DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
           +V  S  R  + ++A E +  +  T   +SDV+ FG++L E+
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIYT--TQSDVWSFGVLLWEI 245

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 196 LGQGGFGSVYKGQL--HTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLL 249
           LG+G FG VY+G    H G  I V +    K     + E+F++E   +  + H ++V+L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G   E     ++ E  P G L  ++   +N  +      L   +L   + +AYL +   +
Sbjct: 76  GIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVL---TLVLYSLQICKAMAYLES---I 128
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
             +H DI   NIL+      K+ DFGL+++   E D+   S TR  I +++PE I  NF 
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSPESI--NFR 185
Query: 370 TVSCKSDVYGFGMVLLEM 387
             +  SDV+ F + + E+
Sbjct: 186 RFTTASDVWMFAVCMWEI 203

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 24/203 (11%)
Query: 195 KLGQGGFGSVYKGQLHT-GRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 252
           K+G+G  G V    + + G+L+AVK ++  K    E + NEV  +    H NVV++    
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
             G +  +V EF+  G+L   +            E++  + L   + ++ LH      ++
Sbjct: 98  LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHA---QGVI 149
Query: 313 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISR-N 367
           H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELISR  
Sbjct: 150 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISRLP 203
Query: 368 FGTVSCKSDVYGFGMVLLEMAGG 390
           +G    + D++  G++++EM  G
Sbjct: 204 YGP---EVDIWSLGIMVIEMVDG 223

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 106/226 (46%), Gaps = 37/226 (16%)
Query: 186 IAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKML----ENSKFSAEEFINEVSTIGRIH 241
           IA T      +G+G FG V++G+   G  +AVK+     E S F   E    V     + 
Sbjct: 2   IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM----LR 56
Query: 242 HVNVVQLLGFCSEGSKRA-------LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIAL 294
           H N+   LGF +  +K         LV ++  +GSL    F   N+  T   E + ++AL
Sbjct: 57  HENI---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR-YTVTVEGMIKLAL 108
Query: 295 GTARGVAYLH-----NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 349
            TA G+A+LH           I H D+K  NIL+  N    ++D GLA  H    D + I
Sbjct: 109 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 168
Query: 350 SATR--GTIGYIAPELIS-----RNFGTVSCKSDVYGFGMVLLEMA 388
           +     GT  Y+APE++      ++F +   ++D+Y  G+V  E+A
Sbjct: 169 APNHRVGTKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 213

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 106/226 (46%), Gaps = 37/226 (16%)
Query: 186 IAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKML----ENSKFSAEEFINEVSTIGRIH 241
           IA T      +G+G FG V++G+   G  +AVK+     E S F   E    V     + 
Sbjct: 1   IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM----LR 55
Query: 242 HVNVVQLLGFCSEGSKRA-------LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIAL 294
           H N+   LGF +  +K         LV ++  +GSL    F   N+  T   E + ++AL
Sbjct: 56  HENI---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR-YTVTVEGMIKLAL 107
Query: 295 GTARGVAYLH-----NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 349
            TA G+A+LH           I H D+K  NIL+  N    ++D GLA  H    D + I
Sbjct: 108 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 167
Query: 350 SATR--GTIGYIAPELIS-----RNFGTVSCKSDVYGFGMVLLEMA 388
           +     GT  Y+APE++      ++F +   ++D+Y  G+V  E+A
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 212

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 106/226 (46%), Gaps = 37/226 (16%)
Query: 186 IAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKML----ENSKFSAEEFINEVSTIGRIH 241
           IA T      +G+G FG V++G+   G  +AVK+     E S F   E    V     + 
Sbjct: 40  IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM----LR 94
Query: 242 HVNVVQLLGFCSEGSKRA-------LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIAL 294
           H N+   LGF +  +K         LV ++  +GSL    F   N+  T   E + ++AL
Sbjct: 95  HENI---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR-YTVTVEGMIKLAL 146
Query: 295 GTARGVAYLH-----NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 349
            TA G+A+LH           I H D+K  NIL+  N    ++D GLA  H    D + I
Sbjct: 147 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 206
Query: 350 SATR--GTIGYIAPELIS-----RNFGTVSCKSDVYGFGMVLLEMA 388
           +     GT  Y+APE++      ++F +   ++D+Y  G+V  E+A
Sbjct: 207 APNHRVGTKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 251

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 188 VTNHFT--HKLGQGGFGSVYK-GQLHTGRLIAVKMLENSKFSA-------EEFINEVSTI 237
           V +H+    +LG G F  V K  Q  TG+  A K ++  + S+       EE   EV+ +
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
             I H N++ L       +   L+ E +  G L   +  KE+  +    + L++I     
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI----L 118
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATR 353
            GV YLH+     I HFD+KP NI+L    +P    K+ DFG+A      N+F +I    
Sbjct: 119 DGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--- 172
Query: 354 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           GT  ++APE++  N+  +  ++D++  G++   +  G
Sbjct: 173 GTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 207

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 24/216 (11%)
Query: 191 HFTHKLGQGGFGSVYK------GQLHTGRLIAVKMLENSKFSAEE--FINEVSTIGRI-H 241
            F   LG G FG V +      G+      +AVKML+++  + E+   ++E+  +  +  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 242 HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKEN----------KGQTFGWEKLQE 291
           H N+V LLG C+ G    ++ E+   G L   +  K               T     L  
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 292 IALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 351
            +   A+G+A+L      CI H D+   N+LL +  + K+ DFGLA+    +++++    
Sbjct: 169 FSSQVAQGMAFL--ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 352 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
            R  + ++APE I     TV  +SDV+ +G++L E+
Sbjct: 226 ARLPVKWMAPESIFDCVYTV--QSDVWSYGILLWEI 259

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 30/220 (13%)
Query: 192 FTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSKF--SAEEFINEVSTIGRI-HH 242
           F   LG G FG V +   +          +AVKML+ S      E  ++E+  +  + +H
Sbjct: 50  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 109
Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSL--------DRHIFPKENKG------QTFGWEK 288
           +N+V LLG C+ G    ++ E+   G L        D  I  K +             E 
Sbjct: 110 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 169
Query: 289 LQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 348
           L   +   A+G+A+L      CI H D+   NILL H  I K+ DFGLA+    ++++V 
Sbjct: 170 LLSFSYQVAKGMAFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARHIKNDSNYVV 226
Query: 349 ISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEM 387
               R  + ++APE I   F  V + +SDV+ +G+ L E+
Sbjct: 227 KGNARLPVKWMAPESI---FNCVYTFESDVWSYGIFLWEL 263

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 188 VTNHFT--HKLGQGGFGSVYK-GQLHTGRLIAVKMLENSKFSA-------EEFINEVSTI 237
           V +H+    +LG G F  V K  Q  TG+  A K ++  + S+       EE   EV+ +
Sbjct: 10  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 69
Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
             I H N++ L       +   L+ E +  G L   +  KE+  +    + L++I     
Sbjct: 70  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI----L 125
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATR 353
            GV YLH+     I HFD+KP NI+L    +P    K+ DFG+A      N+F +I    
Sbjct: 126 DGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--- 179
Query: 354 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           GT  ++APE++  N+  +  ++D++  G++   +  G
Sbjct: 180 GTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 196 LGQGGFGSVYKGQL--HTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLL 249
           LG+G FG VY+G    H G  I V +    K     + E+F++E   +  + H ++V+L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G   E     ++ E  P G L  ++   +N  +      L   +L   + +AYL +   +
Sbjct: 80  GIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVL---TLVLYSLQICKAMAYLES---I 132
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
             +H DI   NIL+      K+ DFGL+++   E D+   S TR  I +++PE I  NF 
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSPESI--NFR 189
Query: 370 TVSCKSDVYGFGMVLLEM 387
             +  SDV+ F + + E+
Sbjct: 190 RFTTASDVWMFAVCMWEI 207

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 106/226 (46%), Gaps = 37/226 (16%)
Query: 186 IAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKML----ENSKFSAEEFINEVSTIGRIH 241
           IA T      +G+G FG V++G+   G  +AVK+     E S F   E    V     + 
Sbjct: 27  IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM----LR 81
Query: 242 HVNVVQLLGFCSEGSKRA-------LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIAL 294
           H N+   LGF +  +K         LV ++  +GSL    F   N+  T   E + ++AL
Sbjct: 82  HENI---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR-YTVTVEGMIKLAL 133
Query: 295 GTARGVAYLH-----NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 349
            TA G+A+LH           I H D+K  NIL+  N    ++D GLA  H    D + I
Sbjct: 134 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 193
Query: 350 SATR--GTIGYIAPELIS-----RNFGTVSCKSDVYGFGMVLLEMA 388
           +     GT  Y+APE++      ++F +   ++D+Y  G+V  E+A
Sbjct: 194 APNHRVGTKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 238

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V         K +      +AVKML++     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWE------------KLQEI 292
           ++ LLG C++     ++ E+   G+L  ++  +   G  + ++             L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
               ARG+ YL      CI H D+   N+L+  N + K++DFGLA+     + + + +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 114/222 (51%), Gaps = 31/222 (13%)
Query: 183 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MLENSKFSAEEFINEVSTIGRI 240
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 70
Query: 241 HHVNVVQL-LGFCSEGSKRALVY-----EFMPNG--SLDRHIFPKENKGQTFGWEKLQEI 292
            H N+V+L   F S G K+ +VY     +++P     + RH + +  +     + KL   
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 351
            L   R +AY+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 184
Query: 352 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 391
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 185 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 118/293 (40%), Gaps = 80/293 (27%)
Query: 169 LHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKG------QLHTGRLIAVKMLEN 222
           L  Q   +P   S  E           LG+G FG V +       +  T R +AVKML+ 
Sbjct: 8   LDEQCERLPYDASKWEFARERLKLGKSLGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKE 67
Query: 223 SKFSAE--EFINEVSTIGRI-HHVNVVQLLGFCS-EGSKRALVYEFMPNGSLDR------ 272
              ++E    + E+  +  I HH+NVV LLG C+ +G    ++ E+   G+L        
Sbjct: 68  GATASEYKALMTELKILTHIGHHLNVVNLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKR 127
Query: 273 -----------HIFPKENK------------------GQTFGWEKLQE------------ 291
                      H+ PK+ K                   ++F     QE            
Sbjct: 128 DLFFLNKDAALHMEPKKEKMEPGLEQGKKPRLDSVTSSESFASSGFQEDKSLSDVEEEED 187
Query: 292 ----------------IALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFG 335
                            +   ARG+ +L +    CI H D+   NILL  N + K+ DFG
Sbjct: 188 SDGFYKEPITMEDLISYSFQVARGMEFLSS--RKCI-HRDLAARNILLSENNVVKICDFG 244
Query: 336 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEM 387
           LA+   K  D+V    TR  + ++APE I   F  + S KSDV+ +G++L E+
Sbjct: 245 LARDIYKNPDYVRKGDTRLPLKWMAPESI---FDKIYSTKSDVWSYGVLLWEI 294

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 194 HKLGQGGFGSVYK------GQLHTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNV 245
            +LG G F  V K      G  +  + I  +  ++S+   S E+   EVS +  I H NV
Sbjct: 17  EELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           + L       +   L+ E +  G L   +  KE+  +    E L++I      GV YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 306 GCDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 105/216 (48%), Gaps = 30/216 (13%)
Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V         K + +    +AVKML++     +  + I+E+  +  I  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGW------------EKLQEI 292
           ++ LLG C++     ++ E+   G+L  ++  +E  G  + +            + L   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
           A   ARG+ YL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 156 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 213 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 196 LGQGGFGSVYKGQL--HTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLL 249
           LG+G FG VY+G    H G  I V +    K     + E+F++E   +  + H ++V+L+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G   E     ++ E  P G L  ++   +N  +      L   +L   + +AYL +   +
Sbjct: 92  GIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVL---TLVLYSLQICKAMAYLES---I 144
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
             +H DI   NIL+      K+ DFGL+++   E D+   S TR  I +++PE I  NF 
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSPESI--NFR 201
Query: 370 TVSCKSDVYGFGMVLLEM 387
             +  SDV+ F + + E+
Sbjct: 202 RFTTASDVWMFAVCMWEI 219

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 106/226 (46%), Gaps = 37/226 (16%)
Query: 186 IAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKML----ENSKFSAEEFINEVSTIGRIH 241
           IA T      +G+G FG V++G+   G  +AVK+     E S F   E    V     + 
Sbjct: 7   IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM----LR 61
Query: 242 HVNVVQLLGFCSEGSKRA-------LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIAL 294
           H N+   LGF +  +K         LV ++  +GSL    F   N+  T   E + ++AL
Sbjct: 62  HENI---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR-YTVTVEGMIKLAL 113
Query: 295 GTARGVAYLH-----NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 349
            TA G+A+LH           I H D+K  NIL+  N    ++D GLA  H    D + I
Sbjct: 114 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 173
Query: 350 SATR--GTIGYIAPELIS-----RNFGTVSCKSDVYGFGMVLLEMA 388
           +     GT  Y+APE++      ++F +   ++D+Y  G+V  E+A
Sbjct: 174 APNHRVGTKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 218

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 179 RYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE--FINEVS 235
           R+   E I     F   LG G F  V   +   T +L+A+K +       +E    NE++
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 236 TIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALG 295
            + +I H N+V L      G    L+ + +  G L   I  K      +       +   
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQ 124
Query: 296 TARGVAYLHNGCDMCILHFDIKPHNIL---LDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
               V YLH   D+ I+H D+KP N+L   LD +    +SDFGL+K    E+    +S  
Sbjct: 125 VLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTA 178
Query: 353 RGTIGYIAPELISRNFGTVSCKSDVYGFGMV 383
            GT GY+APE++++     S   D +  G++
Sbjct: 179 CGTPGYVAPEVLAQK--PYSKAVDCWSIGVI 207

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 35/226 (15%)
Query: 191 HFTHKLGQGGFGSVYKGQLH----TGRLI--AVKMLENSKFSAEE--FINEVSTIGRI-H 241
            F   LG G FG V     +    TG  I  AVKML+    S+E    ++E+  + ++  
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 242 HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK-----------ENKGQ-------- 282
           H N+V LLG C+      L++E+   G L  ++  K           EN+ +        
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 283 TFGWEKLQEIALGTARGVAYLH-NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 341
              +E L   A   A+G+ +L    C    +H D+   N+L+ H  + K+ DFGLA+   
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 342 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
            ++++V     R  + ++APE +    G  + KSDV+ +G++L E+
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEI 267

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 195 KLGQGGFGSVYKGQLH--TGRLI--AVKMLENSKFSAEE----FINEVSTIGRIHHVNVV 246
           KLG G FG V +G+    +G+ +  AVK L+    S  E    FI EV+ +  + H N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L G       + +V E  P GSL   +  ++++G  F    L   A+  A G+ YL + 
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRL--RKHQGH-FLLGTLSRYAVQVAEGMGYLESK 130
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPE-LI 364
                +H D+   N+LL    + K+ DFGL +  P+ +D   +   R     + APE L 
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 187
Query: 365 SRNFGTVSCKSDVYGFGMVLLEM 387
           +R F   S  SD + FG+ L EM
Sbjct: 188 TRTF---SHASDTWMFGVTLWEM 207

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 24/203 (11%)
Query: 195 KLGQGGFGSVYKGQLHT-GRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 252
           K+G+G  G V    + + G+L+AVK ++  K    E + NEV  +    H NVV++    
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
             G +  +V EF+  G+L   +            E++  + L   + ++ LH      ++
Sbjct: 91  LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHA---QGVI 142
Query: 313 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISR-N 367
           H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELISR  
Sbjct: 143 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISRLP 196
Query: 368 FGTVSCKSDVYGFGMVLLEMAGG 390
           +G    + D++  G++++EM  G
Sbjct: 197 YGP---EVDIWSLGIMVIEMVDG 216

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V         K +      +AVKML++     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWE------------KLQEI 292
           ++ LLG C++     ++ E+   G+L  ++  +   G  + ++             L   
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
               ARG+ YL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 30/220 (13%)
Query: 192 FTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSKF--SAEEFINEVSTIGRI-HH 242
           F   LG G FG V +   +          +AVKML+ S      E  ++E+  +  + +H
Sbjct: 43  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 102
Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSL--------DRHIFPKENKG------QTFGWEK 288
           +N+V LLG C+ G    ++ E+   G L        D  I  K +             E 
Sbjct: 103 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 162
Query: 289 LQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 348
           L   +   A+G+A+L      CI H D+   NILL H  I K+ DFGLA+    ++++V 
Sbjct: 163 LLSFSYQVAKGMAFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 219
Query: 349 ISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEM 387
               R  + ++APE I   F  V + +SDV+ +G+ L E+
Sbjct: 220 KGNARLPVKWMAPESI---FNCVYTFESDVWSYGIFLWEL 256

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 195 KLGQGGFGSVYKGQLH--TGRLI--AVKMLENSKFSAEE----FINEVSTIGRIHHVNVV 246
           KLG G FG V +G+    +G+ +  AVK L+    S  E    FI EV+ +  + H N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L G       + +V E  P GSL   +  ++++G  F    L   A+  A G+ YL + 
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRL--RKHQGH-FLLGTLSRYAVQVAEGMGYLESK 130
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPE-LI 364
                +H D+   N+LL    + K+ DFGL +  P+ +D   +   R     + APE L 
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 365 SRNFGTVSCKSDVYGFGMVLLEM 387
           +R F   S  SD + FG+ L EM
Sbjct: 188 TRTF---SHASDTWMFGVTLWEM 207

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 106/226 (46%), Gaps = 37/226 (16%)
Query: 186 IAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKML----ENSKFSAEEFINEVSTIGRIH 241
           IA T      +G+G FG V++G+   G  +AVK+     E S F   E    V     + 
Sbjct: 4   IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM----LR 58
Query: 242 HVNVVQLLGFCSEGSKRA-------LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIAL 294
           H N+   LGF +  +K         LV ++  +GSL    F   N+  T   E + ++AL
Sbjct: 59  HENI---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR-YTVTVEGMIKLAL 110
Query: 295 GTARGVAYLH-----NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 349
            TA G+A+LH           I H D+K  NIL+  N    ++D GLA  H    D + I
Sbjct: 111 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 170
Query: 350 SATR--GTIGYIAPELIS-----RNFGTVSCKSDVYGFGMVLLEMA 388
           +     GT  Y+APE++      ++F +   ++D+Y  G+V  E+A
Sbjct: 171 APNHRVGTKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 215

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V         K +      +AVKML++     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWE------------KLQEI 292
           ++ LLG C++     ++ E+   G+L  ++  +   G  + ++             L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
               ARG+ YL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 179 RYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE--FINEVS 235
           R+   E I     F   LG G F  V   +   T +L+A+K +       +E    NE++
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 236 TIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALG 295
            + +I H N+V L      G    L+ + +  G L   I  K      +       +   
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQ 124
Query: 296 TARGVAYLHNGCDMCILHFDIKPHNIL---LDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
               V YLH   D+ I+H D+KP N+L   LD +    +SDFGL+K    E+    +S  
Sbjct: 125 VLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTA 178
Query: 353 RGTIGYIAPELISRNFGTVSCKSDVYGFGMV 383
            GT GY+APE++++     S   D +  G++
Sbjct: 179 CGTPGYVAPEVLAQK--PYSKAVDCWSIGVI 207

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 30/220 (13%)
Query: 192 FTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSKF--SAEEFINEVSTIGRI-HH 242
           F   LG G FG V +   +          +AVKML+ S      E  ++E+  +  + +H
Sbjct: 45  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 104
Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSL--------DRHIFPKENKG------QTFGWEK 288
           +N+V LLG C+ G    ++ E+   G L        D  I  K +             E 
Sbjct: 105 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 164
Query: 289 LQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 348
           L   +   A+G+A+L      CI H D+   NILL H  I K+ DFGLA+    ++++V 
Sbjct: 165 LLSFSYQVAKGMAFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 221
Query: 349 ISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEM 387
               R  + ++APE I   F  V + +SDV+ +G+ L E+
Sbjct: 222 KGNARLPVKWMAPESI---FNCVYTFESDVWSYGIFLWEL 258

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 195 KLGQGGFGSVYKGQLH--TGRLI--AVKMLENSKFSAEE----FINEVSTIGRIHHVNVV 246
           KLG G FG V +G+    +G+ +  AVK L+    S  E    FI EV+ +  + H N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L G       + +V E  P GSL   +  ++++G  F    L   A+  A G+ YL + 
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRL--RKHQGH-FLLGTLSRYAVQVAEGMGYLESK 130
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPE-LI 364
                +H D+   N+LL    + K+ DFGL +  P+ +D   +   R     + APE L 
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 365 SRNFGTVSCKSDVYGFGMVLLEM 387
           +R F   S  SD + FG+ L EM
Sbjct: 188 TRTF---SHASDTWMFGVTLWEM 207

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V         K +      +AVKML++     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWE------------KLQEI 292
           ++ LLG C++     ++ E+   G+L  ++  +   G  + ++             L   
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
               ARG+ YL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 195 KLGQGGFGSVYKGQLH--TGRLI--AVKMLENSKFSAEE----FINEVSTIGRIHHVNVV 246
           KLG G FG V +G+    +G+ +  AVK L+    S  E    FI EV+ +  + H N++
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L G       + +V E  P GSL   +  ++++G  F    L   A+  A G+ YL + 
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSLLDRL--RKHQGH-FLLGTLSRYAVQVAEGMGYLESK 134
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPE-LI 364
                +H D+   N+LL    + K+ DFGL +  P+ +D   +   R     + APE L 
Sbjct: 135 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 365 SRNFGTVSCKSDVYGFGMVLLEM 387
           +R F   S  SD + FG+ L EM
Sbjct: 192 TRTF---SHASDTWMFGVTLWEM 211

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 195 KLGQGGFGSVYKGQLH--TGRLI--AVKMLENSKFSAEE----FINEVSTIGRIHHVNVV 246
           KLG G FG V +G+    +G+ +  AVK L+    S  E    FI EV+ +  + H N++
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L G       + +V E  P GSL   +  ++++G  F    L   A+  A G+ YL + 
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSLLDRL--RKHQGH-FLLGTLSRYAVQVAEGMGYLESK 134
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPE-LI 364
                +H D+   N+LL    + K+ DFGL +  P+ +D   +   R     + APE L 
Sbjct: 135 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 365 SRNFGTVSCKSDVYGFGMVLLEM 387
           +R F   S  SD + FG+ L EM
Sbjct: 192 TRTF---SHASDTWMFGVTLWEM 211

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 30/220 (13%)
Query: 192 FTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSKF--SAEEFINEVSTIGRI-HH 242
           F   LG G FG V +   +          +AVKML+ S      E  ++E+  +  + +H
Sbjct: 50  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 109
Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSL--------DRHIFPKENKG------QTFGWEK 288
           +N+V LLG C+ G    ++ E+   G L        D  I  K +             E 
Sbjct: 110 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 169
Query: 289 LQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 348
           L   +   A+G+A+L      CI H D+   NILL H  I K+ DFGLA+    ++++V 
Sbjct: 170 LLSFSYQVAKGMAFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 226
Query: 349 ISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEM 387
               R  + ++APE I   F  V + +SDV+ +G+ L E+
Sbjct: 227 KGNARLPVKWMAPESI---FNCVYTFESDVWSYGIFLWEL 263

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G+G +G V K +   TGR++A+K     ++ K   +  + E+  + ++ H N+V LL  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 252 CSEGSKRALVYEFMPNGSLDR-HIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           C +  +  LV+EF+ +  LD   +FP         ++ +Q+       G+ + H+     
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCHS---HN 144
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           I+H DIKP NIL+  + + K+ DFG A+      +         T  Y APEL+  +   
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV--ATRWYRAPELLVGDV-K 201
Query: 371 VSCKSDVYGFGMVLLEMAGG 390
                DV+  G ++ EM  G
Sbjct: 202 YGKAVDVWAIGCLVTEMFMG 221

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 179 RYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE--FINEVS 235
           R+   E I     F   LG G F  V   +   T +L+A+K +       +E    NE++
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 236 TIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALG 295
            + +I H N+V L      G    L+ + +  G L   I  K      +       +   
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQ 124
Query: 296 TARGVAYLHNGCDMCILHFDIKPHNIL---LDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
               V YLH   D+ I+H D+KP N+L   LD +    +SDFGL+K    E+    +S  
Sbjct: 125 VLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTA 178
Query: 353 RGTIGYIAPELISRNFGTVSCKSDVYGFGMV 383
            GT GY+APE++++     S   D +  G++
Sbjct: 179 CGTPGYVAPEVLAQK--PYSKAVDCWSIGVI 207

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 105/240 (43%), Gaps = 38/240 (15%)
Query: 193 THKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA--------------EEFINEVSTI 237
             KLG G +G V   +   G    A+K+++ S+F                EE  NE+S +
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
             + H N+++L     +     LV EF   G L   I  +    +      +++I     
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI----L 156
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHN---FIPKVSDFGLAKFHPKENDFVSISATRG 354
            G+ YLH      I+H DIKP NILL++       K+ DFGL+ F  K+     +    G
Sbjct: 157 SGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLG 210
Query: 355 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA------GGRRNSN-MNAIRSSKAYFP 407
           T  YIAPE++ + +     K DV+  G+++  +       GG+ + + +  +   K YF 
Sbjct: 211 TAYYIAPEVLKKKYNE---KCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 97/198 (48%), Gaps = 15/198 (7%)
Query: 195 KLGQGGFGSVYKGQLHTGRL---IAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +LG G FGSV +G     +    +A+K+L+    K   EE + E   + ++ +  +V+L+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G C +     LV E    G L + +     K +      + E+    + G+ YL    + 
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLE---EK 129
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRNF 368
             +H D+   N+LL +    K+SDFGL+K     ++ + + SA +  + + APE I  NF
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--NF 187
Query: 369 GTVSCKSDVYGFGMVLLE 386
              S +SDV+ +G+ + E
Sbjct: 188 RKFSSRSDVWSYGVTMWE 205

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 30/220 (13%)
Query: 192 FTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSKF--SAEEFINEVSTIGRI-HH 242
           F   LG G FG V +   +          +AVKML+ S      E  ++E+  +  + +H
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSL--------DRHIFPKENKG------QTFGWEK 288
           +N+V LLG C+ G    ++ E+   G L        D  I  K +             E 
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 289 LQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 348
           L   +   A+G+A+L      CI H D+   NILL H  I K+ DFGLA+    ++++V 
Sbjct: 147 LLSFSYQVAKGMAFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 349 ISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEM 387
               R  + ++APE I   F  V + +SDV+ +G+ L E+
Sbjct: 204 KGNARLPVKWMAPESI---FNCVYTFESDVWSYGIFLWEL 240

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 37/222 (16%)
Query: 196 LGQGGFGSVYKGQLH--TGR----LIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQ 247
           LG+G FG V K       GR     +AVKML+ +   +E  + ++E + + +++H +V++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 248 LLGFCSEGSKRALVYEFMPNGSL------DRHIFP----------------KENKGQTFG 285
           L G CS+     L+ E+   GSL       R + P                 + +  T G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 286 WEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 345
              L   A   ++G+ YL    +M ++H D+   NIL+      K+SDFGL++   +E+ 
Sbjct: 151 --DLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
            V  S  R  + ++A E +  +  T   +SDV+ FG++L E+
Sbjct: 206 XVKRSQGRIPVKWMAIESLFDHIYT--TQSDVWSFGVLLWEI 245

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 24/203 (11%)
Query: 195 KLGQGGFGSVYKGQLHT-GRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 252
           K+G+G  G V    + + G+L+AVK ++  K    E + NEV  +    H NVV++    
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
             G +  +V EF+  G+L   +            E++  + L   + ++ LH      ++
Sbjct: 218 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHA---QGVI 269
Query: 313 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISR-N 367
           H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELISR  
Sbjct: 270 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISRLP 323
Query: 368 FGTVSCKSDVYGFGMVLLEMAGG 390
           +G    + D++  G++++EM  G
Sbjct: 324 YGP---EVDIWSLGIMVIEMVDG 343

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 195 KLGQGGFGSVYKGQLH--TGRLI--AVKMLENSKFSAEE----FINEVSTIGRIHHVNVV 246
           KLG G FG V +G+    +G+ +  AVK L+    S  E    FI EV+ +  + H N++
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L G       + +V E  P GSL   +  ++++G  F    L   A+  A G+ YL + 
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSLLDRL--RKHQGH-FLLGTLSRYAVQVAEGMGYLES- 139
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPE-LI 364
                +H D+   N+LL    + K+ DFGL +  P+ +D   +   R     + APE L 
Sbjct: 140 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 197
Query: 365 SRNFGTVSCKSDVYGFGMVLLEM 387
           +R F   S  SD + FG+ L EM
Sbjct: 198 TRTF---SHASDTWMFGVTLWEM 217

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 194 HKLGQGGFGSVYK------GQLHTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNV 245
            +LG G F  V K      G  +  + I  +  ++S+   S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           + L       +   L+ E +  G L   +  KE+  +    E L++I      GV YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 306 GCDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 194 HKLGQGGFGSVYK------GQLHTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNV 245
            +LG G F  V K      G  +  + I  +  ++S+   S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           + L       +   L+ E +  G L   +  KE+  +    E L++I      GV YLH+
Sbjct: 77  ITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 306 GCDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 195 KLGQGGFGSVYKGQLH--TGRLI--AVKMLENSKFSAEE----FINEVSTIGRIHHVNVV 246
           KLG G FG V +G+    +G+ +  AVK L+    S  E    FI EV+ +  + H N++
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L G       + +V E  P GSL   +  ++++G  F    L   A+  A G+ YL + 
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSLLDRL--RKHQGH-FLLGTLSRYAVQVAEGMGYLES- 139
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPE-LI 364
                +H D+   N+LL    + K+ DFGL +  P+ +D   +   R     + APE L 
Sbjct: 140 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 365 SRNFGTVSCKSDVYGFGMVLLEM 387
           +R F   S  SD + FG+ L EM
Sbjct: 198 TRTF---SHASDTWMFGVTLWEM 217

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V         K + +    +AVKML++     +  + I+E+  +  I  H N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIF------------PKENKGQTFGWEKLQEI 292
           ++ LLG C++     ++ E+   G+L  ++             P  N  +    + L   
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
           A   ARG+ YL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 141 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 198 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 230

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLEN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           +LG G FG VYK Q   T  L A K+++  S+   E+++ E+  +    H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
              +   ++ EF   G++D  +   E   +     ++Q +   T   + YLH   D  I+
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH---DNKII 157
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELI---S 365
           H D+K  NIL   +   K++DFG++    +   + + F+      GT  ++APE++   +
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI------GTPYWMAPEVVMCET 211
Query: 366 RNFGTVSCKSDVYGFGMVLLEMA 388
                   K+DV+  G+ L+EMA
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMA 234

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLEN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           +LG G FG VYK Q   T  L A K+++  S+   E+++ E+  +    H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
              +   ++ EF   G++D  +   E   +     ++Q +   T   + YLH   D  I+
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH---DNKII 157
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHP----KENDFVSISATRGTIGYIAPELI---S 365
           H D+K  NIL   +   K++DFG++  +     + + F+      GT  ++APE++   +
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI------GTPYWMAPEVVMCET 211
Query: 366 RNFGTVSCKSDVYGFGMVLLEMA 388
                   K+DV+  G+ L+EMA
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMA 234

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 179 RYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE--FINEVS 235
           R+   E I     F   LG G F  V   +   T +L+A+K +       +E    NE++
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIA 68
Query: 236 TIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALG 295
            + +I H N+V L      G    L+ + +  G L   I  K      +       +   
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQ 124
Query: 296 TARGVAYLHNGCDMCILHFDIKPHNIL---LDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
               V YLH   D+ I+H D+KP N+L   LD +    +SDFGL+K    E+    +S  
Sbjct: 125 VLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTA 178
Query: 353 RGTIGYIAPELISRNFGTVSCKSDVYGFGMV 383
            GT GY+APE++++     S   D +  G++
Sbjct: 179 CGTPGYVAPEVLAQK--PYSKAVDCWSIGVI 207

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V         K +      +AVKML++     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWE------------KLQEI 292
           ++ LLG C++     ++ E+   G+L  ++  +   G  + ++             L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
               ARG+ YL      CI H D+   N+L+  N + K++DFGLA+     +     +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V         K + +    +AVKML++     +  + I+E+  +  I  H N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIF------------PKENKGQTFGWEKLQEI 292
           ++ LLG C++     ++ E+   G+L  ++             P  N  +    + L   
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
           A   ARG+ YL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 149 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 206 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 238

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V         K +      +AVKML++     +  + ++E+  +  I  H N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWE------------KLQEI 292
           ++ LLG C++     ++ E+   G+L  ++  +   G  + ++             L   
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
               ARG+ YL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 209 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 266 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 298

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V         K + +    +AVKML++     +  + I+E+  +  I  H N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIF------------PKENKGQTFGWEKLQEI 292
           ++ LLG C++     ++ E+   G+L  ++             P  N  +    + L   
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
           A   ARG+ YL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 145 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 202 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 234

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V         K + +    +AVKML++     +  + I+E+  +  I  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIF------------PKENKGQTFGWEKLQEI 292
           ++ LLG C++     ++ E+   G+L  ++             P  N  +    + L   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
           A   ARG+ YL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 156 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 213 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 103/202 (50%), Gaps = 18/202 (8%)
Query: 196 LGQGGFGSVYKGQL-----HTGRLIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG+G FG V   +      +TG  +AVK L  E+      +   E+  +  ++H N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 249 LGFCSE--GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
            G C+E  G+   L+ EF+P+GSL  ++   +NK      ++  + A+   +G+ YL + 
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLGS- 132
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPELIS 365
                +H D+   N+L++     K+ DFGL K    + +  ++   R + + + APE + 
Sbjct: 133 --RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 366 RNFGTVSCKSDVYGFGMVLLEM 387
           ++   ++  SDV+ FG+ L E+
Sbjct: 191 QSKFYIA--SDVWSFGVTLHEL 210

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V         K +      +AVKML++     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWE------------KLQEI 292
           ++ LLG C++     ++ E+   G+L  ++  +   G  + ++             L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
               ARG+ YL      CI H D+   N+L+  N + +++DFGLA+     + +   +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 26/210 (12%)
Query: 188 VTNHFT--HKLGQGGFGSVYK-GQLHTGRLIAVKMLENSKF-------SAEEFINEVSTI 237
           V +H+    +LG G F  V K  Q  TG+  A K ++  +        S EE   EV+ +
Sbjct: 24  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNIL 83
Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
             I H N++ L       +   L+ E +  G L   +  KE+  +    + L++I     
Sbjct: 84  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI----L 139
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATR 353
            GV YLH+     I HFD+KP NI+L    +P    K+ DFG+A      N+F +I    
Sbjct: 140 DGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--- 193
Query: 354 GTIGYIAPELISRNFGTVSCKSDVYGFGMV 383
           GT  ++APE++  N+  +  ++D++  G++
Sbjct: 194 GTPEFVAPEIV--NYEPLGLEADMWSIGVI 221

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 103/202 (50%), Gaps = 18/202 (8%)
Query: 196 LGQGGFGSVYKGQL-----HTGRLIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG+G FG V   +      +TG  +AVK L  E+      +   E+  +  ++H N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 249 LGFCSE--GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
            G C+E  G+   L+ EF+P+GSL  ++   +NK      ++  + A+   +G+ YL + 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLGS- 144
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPELIS 365
                +H D+   N+L++     K+ DFGL K    + +  ++   R + + + APE + 
Sbjct: 145 --RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 366 RNFGTVSCKSDVYGFGMVLLEM 387
           ++   ++  SDV+ FG+ L E+
Sbjct: 203 QSKFYIA--SDVWSFGVTLHEL 222

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 196 LGQGGFGSVY-----KGQLHTGRLIAVKMLENSKFSAEE--FINEVSTIGRIHHVNVVQL 248
           LG+G FG V           TG ++AVK L+          +  E+  +  ++H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 249 LGFCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
            G C +  +++L  V E++P GSL R   P+     + G  +L   A     G+AYLH+ 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSL-RDYLPR----HSIGLAQLLLFAQQICEGMAYLHS- 135
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPELIS 365
                +H ++   N+LLD++ + K+ DFGLAK  P+ +++  +     + + + APE + 
Sbjct: 136 --QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 193
Query: 366 RNFGTVSCKSDVYGFGMVLLEM 387
                    SDV+ FG+ L E+
Sbjct: 194 EY--KFYYASDVWSFGVTLYEL 213

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V         K +      +AVKML++     +  + ++E+  +  I  H N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWE------------KLQEI 292
           ++ LLG C++     ++ E+   G+L  ++  +   G  + ++             L   
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
               ARG+ YL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 150 TYQLARGMEYL--ASQKCI-HRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 207 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 239

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V         K + +    +AVKML++     +  + I+E+  +  I  H N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIF------------PKENKGQTFGWEKLQEI 292
           ++ LLG C++     ++ E+   G+L  ++             P  N  +    + L   
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
           A   ARG+ YL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 148 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 205 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 237

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V         K + +    +AVKML++     +  + I+E+  +  I  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIF------------PKENKGQTFGWEKLQEI 292
           ++ LLG C++     ++ E+   G+L  ++             P  N  +    + L   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
           A   ARG+ YL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 156 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 213 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLEN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           +LG G FG VYK Q   T  L A K+++  S+   E+++ E+  +    H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
              +   ++ EF   G++D  +   E   +     ++Q +   T   + YLH   D  I+
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH---DNKII 157
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELI---S 365
           H D+K  NIL   +   K++DFG++    +   + + F+      GT  ++APE++   +
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI------GTPYWMAPEVVMCET 211
Query: 366 RNFGTVSCKSDVYGFGMVLLEMA 388
                   K+DV+  G+ L+EMA
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMA 234

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 24/203 (11%)
Query: 195 KLGQGGFGSVYKGQLHT-GRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 252
           K+G+G  G V    + + G+L+AVK ++  K    E + NEV  +    H NVV++    
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
             G +  +V EF+  G+L   +            E++  + L   + ++ LH      ++
Sbjct: 141 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHA---QGVI 192
Query: 313 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISR-N 367
           H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELISR  
Sbjct: 193 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISRLP 246
Query: 368 FGTVSCKSDVYGFGMVLLEMAGG 390
           +G    + D++  G++++EM  G
Sbjct: 247 YGP---EVDIWSLGIMVIEMVDG 266

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 104/207 (50%), Gaps = 27/207 (13%)
Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE-----FINEVSTIGRIH---HVNV 245
           ++G G +G+VYK +  H+G  +A+K +     + EE      + EV+ + R+    H NV
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVP--NGEEGLPISTVREVALLRRLEAFEHPNV 68
Query: 246 VQLLGFCSEGS-----KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGV 300
           V+L+  C+        K  LV+E +     D   +  +        E ++++     RG+
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 125
Query: 301 AYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 360
            +LH  C   I+H D+KP NIL+      K++DFGLA+ +  +   ++++    T+ Y A
Sbjct: 126 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALAPVVVTLWYRA 179
Query: 361 PELISRNFGTVSCKSDVYGFGMVLLEM 387
           PE++ ++  T +   D++  G +  EM
Sbjct: 180 PEVLLQS--TYATPVDMWSVGCIFAEM 204

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 35/226 (15%)
Query: 191 HFTHKLGQGGFGSVYK------GQLHTGRLIAVKMLENSKFSAEE--FINEVSTIGRI-H 241
            F   LG G FG V +      G+      +AVKML+++  + E+   ++E+  +  +  
Sbjct: 34  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 93
Query: 242 HVNVVQLLGFCSEGSKRALVYEFMPNGSL--------------------DRHIFPKENKG 281
           H N+V LLG C+ G    ++ E+   G L                    D     KE+ G
Sbjct: 94  HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKED-G 152
Query: 282 QTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 341
           +      L   +   A+G+A+L      CI H D+   N+LL +  + K+ DFGLA+   
Sbjct: 153 RPLELRDLLHFSSQVAQGMAFL--ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIM 209
Query: 342 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
            +++++     R  + ++APE I     TV  +SDV+ +G++L E+
Sbjct: 210 NDSNYIVKGNARLPVKWMAPESIFDCVYTV--QSDVWSYGILLWEI 253

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V         K +      +AVKML++     +  + ++E+  +  I  H N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWE------------KLQEI 292
           ++ LLG C++     ++ E+   G+L  ++  +   G  + ++             L   
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
               ARG+ YL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 155 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 212 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 244

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 37/222 (16%)
Query: 196 LGQGGFGSVYKGQLH--TGR----LIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQ 247
           LG+G FG V K       GR     +AVKML+ +   +E  + ++E + + +++H +V++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 248 LLGFCSEGSKRALVYEFMPNGSL------DRHIFP----------------KENKGQTFG 285
           L G CS+     L+ E+   GSL       R + P                 + +  T G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 286 WEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 345
              L   A   ++G+ YL    +M ++H D+   NIL+      K+SDFGL++   +E+ 
Sbjct: 151 --DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
            V  S  R  + ++A E +  +  T   +SDV+ FG++L E+
Sbjct: 206 XVKRSQGRIPVKWMAIESLFDHIYT--TQSDVWSFGVLLWEI 245

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 113/222 (50%), Gaps = 31/222 (13%)
Query: 183 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MLENSKFSAEEFINEVSTIGRI 240
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 18  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 71
Query: 241 HHVNVVQL-LGFCSEGSKRALVY-----EFMPNG--SLDRHIFPKENKGQTFGWEKLQEI 292
            H N+V+L   F S G K+  VY     +++P     + RH + +  +     + KL   
Sbjct: 72  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 130
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 351
            L   R +AY+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 131 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 185
Query: 352 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 391
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 186 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V         K +      +AVKML++     +  + ++E+  +  I  H N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWE------------KLQEI 292
           ++ LLG C++     ++ E+   G+L  ++  +   G  + ++             L   
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
               ARG+ YL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 152 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 209 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 241

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 113/222 (50%), Gaps = 31/222 (13%)
Query: 183 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MLENSKFSAEEFINEVSTIGRI 240
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 70
Query: 241 HHVNVVQL-LGFCSEGSKRALVY-----EFMPNG--SLDRHIFPKENKGQTFGWEKLQEI 292
            H N+V+L   F S G K+  VY     +++P     + RH + +  +     + KL   
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 351
            L   R +AY+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 184
Query: 352 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 391
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 185 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 26/208 (12%)
Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRI---------HHVN 244
           ++G G +G+VYK +  H+G  +A+K +             +ST+  +          H N
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 245 VVQLLGFCSEGS-----KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARG 299
           VV+L+  C+        K  LV+E +     D   +  +        E ++++     RG
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 132
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
           + +LH  C   I+H D+KP NIL+      K++DFGLA+ +  +   ++++    T+ Y 
Sbjct: 133 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTPVVVTLWYR 186
Query: 360 APELISRNFGTVSCKSDVYGFGMVLLEM 387
           APE++ ++  T +   D++  G +  EM
Sbjct: 187 APEVLLQS--TYATPVDMWSVGCIFAEM 212

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 132/294 (44%), Gaps = 39/294 (13%)
Query: 196 LGQGGFGSVY-----KGQLHTGRLIAVKMLENSKFSA--EEFINEVSTIGRIHHVNVVQL 248
           LG+G FG V           TG ++AVK L+          +  E+  +  ++H ++V+ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 249 LGFCSEGSKRA--LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
            G C +  +++  LV E++P GSL R   P+       G  +L   A     G+AYLH  
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSL-RDYLPR----HCVGLAQLLLFAQQICEGMAYLHA- 130
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPELIS 365
                +H  +   N+LLD++ + K+ DFGLAK  P+ +++  +     + + + APE + 
Sbjct: 131 --QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 188
Query: 366 RNFGTVSCK----SDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE 421
                  CK    SDV+ FG+ L E+      +  ++ +S    F   +     +   L 
Sbjct: 189 ------ECKFYYASDVWSFGVTLYELL-----TYCDSNQSPHTKFTELIGHTQGQMTVLR 237
Query: 422 LRNVTEIESVIAR-KLCMIGLW-----CIQVKAADRPSMTKVLEMLEGSMDDLQ 469
           L  + E    + R   C   ++     C + +A+ RP+   ++ +L+ + +  Q
Sbjct: 238 LTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQEKYQ 291

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 113/222 (50%), Gaps = 31/222 (13%)
Query: 183 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MLENSKFSAEEFINEVSTIGRI 240
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 70
Query: 241 HHVNVVQL-LGFCSEGSKRALVY-----EFMPNG--SLDRHIFPKENKGQTFGWEKLQEI 292
            H N+V+L   F S G K+  VY     +++P     + RH + +  +     + KL   
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 351
            L   R +AY+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184
Query: 352 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 391
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 185 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 113/222 (50%), Gaps = 31/222 (13%)
Query: 183 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MLENSKFSAEEFINEVSTIGRI 240
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 70
Query: 241 HHVNVVQL-LGFCSEGSKRALVY-----EFMPNG--SLDRHIFPKENKGQTFGWEKLQEI 292
            H N+V+L   F S G K+  VY     +++P     + RH + +  +     + KL   
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 351
            L   R +AY+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 184
Query: 352 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 391
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 185 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 132/294 (44%), Gaps = 39/294 (13%)
Query: 196 LGQGGFGSVY-----KGQLHTGRLIAVKMLENSKFSA--EEFINEVSTIGRIHHVNVVQL 248
           LG+G FG V           TG ++AVK L+          +  E+  +  ++H ++V+ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 249 LGFCSEGSKRA--LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
            G C +  +++  LV E++P GSL R   P+       G  +L   A     G+AYLH  
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSL-RDYLPR----HCVGLAQLLLFAQQICEGMAYLHA- 129
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPELIS 365
                +H  +   N+LLD++ + K+ DFGLAK  P+ +++  +     + + + APE + 
Sbjct: 130 --QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 187
Query: 366 RNFGTVSCK----SDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE 421
                  CK    SDV+ FG+ L E+      +  ++ +S    F   +     +   L 
Sbjct: 188 ------ECKFYYASDVWSFGVTLYELL-----TYCDSNQSPHTKFTELIGHTQGQMTVLR 236
Query: 422 LRNVTEIESVIAR-KLCMIGLW-----CIQVKAADRPSMTKVLEMLEGSMDDLQ 469
           L  + E    + R   C   ++     C + +A+ RP+   ++ +L+ + +  Q
Sbjct: 237 LTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQEKYQ 290

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 113/222 (50%), Gaps = 31/222 (13%)
Query: 183 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MLENSKFSAEEFINEVSTIGRI 240
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 25  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 78
Query: 241 HHVNVVQL-LGFCSEGSKRALVY-----EFMPNG--SLDRHIFPKENKGQTFGWEKLQEI 292
            H N+V+L   F S G K+  VY     +++P     + RH + +  +     + KL   
Sbjct: 79  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 137
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 351
            L   R +AY+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 138 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 192
Query: 352 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 391
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 193 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 113/222 (50%), Gaps = 31/222 (13%)
Query: 183 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MLENSKFSAEEFINEVSTIGRI 240
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 29  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 82
Query: 241 HHVNVVQL-LGFCSEGSKRALVY-----EFMPNG--SLDRHIFPKENKGQTFGWEKLQEI 292
            H N+V+L   F S G K+  VY     +++P     + RH + +  +     + KL   
Sbjct: 83  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 141
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 351
            L   R +AY+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 142 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 196
Query: 352 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 391
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 197 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 33/225 (14%)
Query: 191 HFTHKLGQGGFGSVYKGQL------HTGRLIAVKML--ENSKFSAEEFINEVSTIGRIHH 242
            +   +G+G FG V++ +           ++AVKML  E S     +F  E + +    +
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSLD---RHIFP------------KENKGQTFGWE 287
            N+V+LLG C+ G    L++E+M  G L+   R + P               +  + G  
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 288 KLQ-----EIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 342
            L       IA   A G+AYL    +   +H D+   N L+  N + K++DFGL++    
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
            + + +       I ++ PE I  N  T   +SDV+ +G+VL E+
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTT--ESDVWAYGVVLWEI 269

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 113/222 (50%), Gaps = 31/222 (13%)
Query: 183 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MLENSKFSAEEFINEVSTIGRI 240
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 36  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 89
Query: 241 HHVNVVQL-LGFCSEGSKRALVY-----EFMPNG--SLDRHIFPKENKGQTFGWEKLQEI 292
            H N+V+L   F S G K+  VY     +++P     + RH + +  +     + KL   
Sbjct: 90  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 148
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 351
            L   R +AY+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 149 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 203
Query: 352 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 391
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 204 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 113/222 (50%), Gaps = 31/222 (13%)
Query: 183 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MLENSKFSAEEFINEVSTIGRI 240
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 30  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 83
Query: 241 HHVNVVQL-LGFCSEGSKRALVY-----EFMPNG--SLDRHIFPKENKGQTFGWEKLQEI 292
            H N+V+L   F S G K+  VY     +++P     + RH + +  +     + KL   
Sbjct: 84  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 142
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 351
            L   R +AY+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 143 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 197
Query: 352 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 391
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 198 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 196 LGQGGFGSVY-----KGQLHTGRLIAVKMLENSKFSAEE--FINEVSTIGRIHHVNVVQL 248
           LG+G FG V           TG ++AVK L+          +  E+  +  ++H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 249 LGFCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
            G C +  +++L  V E++P GSL R   P+     + G  +L   A     G+AYLH  
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSL-RDYLPR----HSIGLAQLLLFAQQICEGMAYLHA- 135
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPELIS 365
                +H ++   N+LLD++ + K+ DFGLAK  P+ +++  +     + + + APE + 
Sbjct: 136 --QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 193
Query: 366 RNFGTVSCKSDVYGFGMVLLEM 387
                    SDV+ FG+ L E+
Sbjct: 194 EY--KFYYASDVWSFGVTLYEL 213

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 103/207 (49%), Gaps = 27/207 (13%)
Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE-----FINEVSTIGRIH---HVNV 245
           ++G G +G+VYK +  H+G  +A+K +     + EE      + EV+ + R+    H NV
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVP--NGEEGLPISTVREVALLRRLEAFEHPNV 68
Query: 246 VQLLGFCSEGS-----KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGV 300
           V+L+  C+        K  LV+E +     D   +  +        E ++++     RG+
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 125
Query: 301 AYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 360
            +LH  C   I+H D+KP NIL+      K++DFGLA+ +  +   +++     T+ Y A
Sbjct: 126 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALDPVVVTLWYRA 179
Query: 361 PELISRNFGTVSCKSDVYGFGMVLLEM 387
           PE++ ++  T +   D++  G +  EM
Sbjct: 180 PEVLLQS--TYATPVDMWSVGCIFAEM 204

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 113/222 (50%), Gaps = 31/222 (13%)
Query: 183 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MLENSKFSAEEFINEVSTIGRI 240
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 29  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 82
Query: 241 HHVNVVQL-LGFCSEGSKRALVY-----EFMPNG--SLDRHIFPKENKGQTFGWEKLQEI 292
            H N+V+L   F S G K+  VY     +++P     + RH + +  +     + KL   
Sbjct: 83  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 141
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 351
            L   R +AY+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 142 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 196
Query: 352 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 391
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 197 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 113/222 (50%), Gaps = 31/222 (13%)
Query: 183 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MLENSKFSAEEFINEVSTIGRI 240
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 21  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 74
Query: 241 HHVNVVQL-LGFCSEGSKRALVY-----EFMPNG--SLDRHIFPKENKGQTFGWEKLQEI 292
            H N+V+L   F S G K+  VY     +++P     + RH + +  +     + KL   
Sbjct: 75  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 133
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 351
            L   R +AY+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 134 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 188
Query: 352 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 391
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 189 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 130/271 (47%), Gaps = 33/271 (12%)
Query: 196 LGQGGFGSVYKG----QLHTGRL-IAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG    +  T ++ +A+K+L  +       EF++E   +  + H ++V+L
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + LV + MP+G L  ++   ++     G + L    +  A+G+ YL    +
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKD---NIGSQLLLNWCVQIAKGMMYLE---E 135
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLA+    +    +    +  I ++A E I  ++
Sbjct: 136 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI--HY 193
Query: 369 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT 426
              + +SDV+ +G+ + E+   GG+     + I + +      + D L KG  L    + 
Sbjct: 194 RKFTHQSDVWSYGVTIWELMTFGGK---PYDGIPTRE------IPDLLEKGERLPQPPIC 244
Query: 427 EIESVIARKLCMIGLWCIQVKAADRPSMTKV 457
            I+      + M+ + C  + A  RP   ++
Sbjct: 245 TID------VYMVMVKCWMIDADSRPKFKEL 269

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V         K + +    +AVKML++     +  + I+E+  +  I  H N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIF------------PKENKGQTFGWEKLQEI 292
           ++ LLG C++     ++ E+   G+L  ++             P  N  +    + L   
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
           A   ARG+ YL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 197 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 254 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 286

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 113/222 (50%), Gaps = 31/222 (13%)
Query: 183 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MLENSKFSAEEFINEVSTIGRI 240
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 22  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 75
Query: 241 HHVNVVQL-LGFCSEGSKRALVY-----EFMPNG--SLDRHIFPKENKGQTFGWEKLQEI 292
            H N+V+L   F S G K+  VY     +++P     + RH + +  +     + KL   
Sbjct: 76  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 134
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 351
            L   R +AY+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 135 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 189
Query: 352 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 391
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 190 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 114/267 (42%), Gaps = 38/267 (14%)
Query: 178 KRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMLENSKFSA--EE 229
           K+    EI      F  +LG+  FG VYKG L         + +A+K L++       EE
Sbjct: 16  KQAKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE 75
Query: 230 FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIF---PKENKGQTFGW 286
           F +E     R+ H NVV LLG  ++    ++++ +  +G L   +    P  + G T   
Sbjct: 76  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 135
Query: 287 EKLQ---------EIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLA 337
             ++          +    A G+ YL +     ++H D+   N+L+      K+SD GL 
Sbjct: 136 RTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF 192
Query: 338 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM--------AG 389
           +     + +  +  +   I ++APE I   +G  S  SD++ +G+VL E+         G
Sbjct: 193 REVYAADYYKLLGNSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 250
Query: 390 GRRNSNMNAIRSSKAY-----FPSWVY 411
                 +  IR+ +        P+WVY
Sbjct: 251 YSNQDVVEMIRNRQVLPCPDDCPAWVY 277

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V         K + +    +AVKML++     +  + I+E+  +  I  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIF------------PKENKGQTFGWEKLQEI 292
           ++ LLG C++     ++ E+   G+L  ++             P  N  +    + L   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
           A   ARG+ YL      CI H D+   N+L+  + + K++DFGLA+     +     +  
Sbjct: 156 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 213 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 113/222 (50%), Gaps = 31/222 (13%)
Query: 183 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MLENSKFSAEEFINEVSTIGRI 240
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 45  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 98
Query: 241 HHVNVVQL-LGFCSEGSKRALVY-----EFMPNG--SLDRHIFPKENKGQTFGWEKLQEI 292
            H N+V+L   F S G K+  VY     +++P     + RH + +  +     + KL   
Sbjct: 99  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 157
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 351
            L   R +AY+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 158 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 212
Query: 352 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 391
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 213 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 27/207 (13%)
Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE-----FINEVSTIGRIH---HVNV 245
           ++G G +G+VYK +  H+G  +A+K +     + EE      + EV+ + R+    H NV
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVP--NGEEGLPISTVREVALLRRLEAFEHPNV 68
Query: 246 VQLLGFCSEGS-----KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGV 300
           V+L+  C+        K  LV+E +     D   +  +        E ++++     RG+
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 125
Query: 301 AYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 360
            +LH  C   I+H D+KP NIL+      K++DFGLA+ +  +     +     T+ Y A
Sbjct: 126 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV---TLWYRA 179
Query: 361 PELISRNFGTVSCKSDVYGFGMVLLEM 387
           PE++ ++  T +   D++  G +  EM
Sbjct: 180 PEVLLQS--TYATPVDMWSVGCIFAEM 204

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 113/222 (50%), Gaps = 31/222 (13%)
Query: 183 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MLENSKFSAEEFINEVSTIGRI 240
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 51  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 104
Query: 241 HHVNVVQL-LGFCSEGSKRALVY-----EFMPNG--SLDRHIFPKENKGQTFGWEKLQEI 292
            H N+V+L   F S G K+  VY     +++P     + RH + +  +     + KL   
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 163
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 351
            L   R +AY+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 164 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218
Query: 352 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 391
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 219 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 113/222 (50%), Gaps = 31/222 (13%)
Query: 183 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MLENSKFSAEEFINEVSTIGRI 240
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 51  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 104
Query: 241 HHVNVVQL-LGFCSEGSKRALVY-----EFMPNG--SLDRHIFPKENKGQTFGWEKLQEI 292
            H N+V+L   F S G K+  VY     +++P     + RH + +  +     + KL   
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 163
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 351
            L   R +AY+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 164 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 218
Query: 352 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 391
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 219 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKML----ENSKFSAEEFINEVSTIGRIHHVNVVQLL 249
           ++G G FG+VY  + +    ++A+K +    + S    ++ I EV  + ++ H N +Q  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G         LV E+    + D     K+   +     ++  +  G  +G+AYLH+    
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV----EIAAVTHGALQGLAYLHS---H 134
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 368
            ++H D+K  NILL    + K+ DFG A      N FV      GT  ++APE+I + + 
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAMDE 188
Query: 369 GTVSCKSDVYGFGMVLLEMAGGRRNS-NMNAIRS 401
           G    K DV+  G+  +E+A  +    NMNA+ +
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 196 LGQGGFGSVY-----KGQLHTGRLIAVKMLENSKFSAEE--FINEVSTIGRIHHVNVVQL 248
           LG+G FG V           TG ++AVK L+          +  E+  +  ++H ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 249 LGFCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
            G C +    +L  V E++P GSL R   P+     + G  +L   A     G+AYLH  
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSL-RDYLPR----HSIGLAQLLLFAQQICEGMAYLHA- 152
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPELIS 365
                +H D+   N+LLD++ + K+ DFGLAK  P+ ++   +     + + + APE + 
Sbjct: 153 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLK 210
Query: 366 RNFGTVSCKSDVYGFGMVLLEM 387
                    SDV+ FG+ L E+
Sbjct: 211 EY--KFYYASDVWSFGVTLYEL 230

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 106/205 (51%), Gaps = 18/205 (8%)
Query: 196 LGQGGFGSVYKG----QLHTGRL-IAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG    +  T ++ +A+K+L  +       EF++E   +  + H ++V+L
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + LV + MP+G L  ++   ++     G + L    +  A+G+ YL    +
Sbjct: 106 LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKD---NIGSQLLLNWCVQIAKGMMYLE---E 158
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLA+    +    +    +  I ++A E I  ++
Sbjct: 159 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI--HY 216
Query: 369 GTVSCKSDVYGFGMVLLEMA--GGR 391
              + +SDV+ +G+ + E+   GG+
Sbjct: 217 RKFTHQSDVWSYGVTIWELMTFGGK 241

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V         K +      +AVKML++     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWE------------KLQEI 292
           ++ LLG C++     ++  +   G+L  ++  +   G  + ++             L   
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
               ARG+ YL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V         K +      +AVKML++     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKG------------QTFGWEKLQEI 292
           ++ LLG C++     ++ E+   G+L  ++  +   G            +   ++ L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
               ARG+ YL      CI H D+   N+L+  N + K++DFGLA+     +     +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 101/219 (46%), Gaps = 17/219 (7%)
Query: 192 FTHKLGQGGFGSVYKGQ-LHTGRLIAVK-MLENSKFSAEEFINEVSTIGRIHHVNVVQLL 249
           F  KLG+GGF  V   + LH G   A+K +L + +   EE   E       +H N+++L+
Sbjct: 33  FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 250 GFC--SEGSKRA--LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
            +C    G+K    L+  F   G+L   I   ++KG     +++  + LG  RG+  +H 
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFG---LAKFHPKEN----DFVSISATRGTIGY 358
                  H D+KP NILL     P + D G    A  H + +         +A R TI Y
Sbjct: 153 KG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 359 IAPELIS-RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM 396
            APEL S ++   +  ++DV+  G VL  M  G    +M
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 19/200 (9%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENS---KFSAEEFIN-EVSTIGRIHHVNVVQLLG 250
           LG G FG V+     H GR  A+K+L+     +    E  N E   +  + H  ++++ G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
              +  +  ++ +++  G L    F    K Q F     +  A      + YLH+     
Sbjct: 74  TFQDAQQIFMIMDYIEGGEL----FSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--- 126
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           I++ D+KP NILLD N   K++DFG AK+ P     +      GT  YIAPE++S     
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC-----GTPDYIAPEVVSTKPYN 181
Query: 371 VSCKSDVYGFGMVLLEMAGG 390
            S   D + FG+++ EM  G
Sbjct: 182 KSI--DWWSFGILIYEMLAG 199

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 113/222 (50%), Gaps = 31/222 (13%)
Query: 183 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MLENSKFSAEEFINEVSTIGRI 240
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 53  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 106
Query: 241 HHVNVVQL-LGFCSEGSKRALVY-----EFMPNG--SLDRHIFPKENKGQTFGWEKLQEI 292
            H N+V+L   F S G K+  VY     +++P     + RH + +  +     + KL   
Sbjct: 107 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 165
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 351
            L   R +AY+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 166 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 220
Query: 352 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 391
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 221 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 112/261 (42%), Gaps = 38/261 (14%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMLENSKFSA--EEFINEVS 235
           EI      F  +LG+  FG VYKG L         + +A+K L++       EEF +E  
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64
Query: 236 TIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIF---PKENKGQTFGWEKLQ-- 290
              R+ H NVV LLG  ++    ++++ +  +G L   +    P  + G T     ++  
Sbjct: 65  LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 291 -------EIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 343
                   +    A G+ YL +     ++H D+   N+L+      K+SD GL +     
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM--------AGGRRNSN 395
           + +  +  +   I ++APE I   +G  S  SD++ +G+VL E+         G      
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 239
Query: 396 MNAIRSSKAY-----FPSWVY 411
           +  IR+ +        P+WVY
Sbjct: 240 VEMIRNRQVLPCPDDCPAWVY 260

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKML----ENSKFSAEEFINEVSTIGRIHHVNVVQLL 249
           ++G G FG+VY  + +    ++A+K +    + S    ++ I EV  + ++ H N +Q  
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G         LV E+    + D     K+   +     ++  +  G  +G+AYLH+    
Sbjct: 121 GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV----EIAAVTHGALQGLAYLHS---H 173
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 368
            ++H D+K  NILL    + K+ DFG A      N FV      GT  ++APE+I + + 
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAMDE 227
Query: 369 GTVSCKSDVYGFGMVLLEMAGGRRNS-NMNAIRS 401
           G    K DV+  G+  +E+A  +    NMNA+ +
Sbjct: 228 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 261

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 18/200 (9%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL----QKLSRFDEQRTATYITELANALSYCHS---KR 132
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL  N   K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 133 VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMH- 187
Query: 371 VSCKSDVYGFGMVLLEMAGG 390
              K D++  G++  E   G
Sbjct: 188 -DEKVDLWSLGVLCYEFLVG 206

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 246
           F   LG+G F +V    +L T R  A+K+LE      E  +     E   + R+ H   V
Sbjct: 34  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L     +  K      +  NG L ++I     K  +F     +         + YLH  
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHG- 148
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               I+H D+KP NILL+ +   +++DFG AK    E+     +A  GT  Y++PEL++ 
Sbjct: 149 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTE 206
Query: 367 NFGTVSCK-SDVYGFGMVLLEMAGG 390
                +CK SD++  G ++ ++  G
Sbjct: 207 K---SACKSSDLWALGCIIYQLVAG 228

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 113/222 (50%), Gaps = 31/222 (13%)
Query: 183 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MLENSKFSAEEFINEVSTIGRI 240
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 55  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 108
Query: 241 HHVNVVQL-LGFCSEGSKRALVY-----EFMPNG--SLDRHIFPKENKGQTFGWEKLQEI 292
            H N+V+L   F S G K+  VY     +++P     + RH + +  +     + KL   
Sbjct: 109 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 167
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 351
            L   R +AY+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 168 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 222
Query: 352 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 391
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 223 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 105/226 (46%), Gaps = 38/226 (16%)
Query: 196 LGQGGFGSVYKGQLHTGRLIAVKML----ENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G+G +G V++G  H G  +AVK+     E S F   E  N V     + H N+   LGF
Sbjct: 16  VGKGRYGEVWRGLWH-GESVAVKIFSSRDEQSWFRETEIYNTV----LLRHDNI---LGF 67
Query: 252 CSE-------GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
            +         ++  L+  +  +GSL   +     + QT        +A+  A G+A+LH
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSLYDFL-----QRQTLEPHLALRLAVSAACGLAHLH 122
Query: 305 -----NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI--SATRGTIG 357
                      I H D K  N+L+  N    ++D GLA  H + +D++ I  +   GT  
Sbjct: 123 VEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKR 182
Query: 358 YIAPELISRNFGTVSCKS----DVYGFGMVLLEMAGGRRNSNMNAI 399
           Y+APE++     T   +S    D++ FG+VL E+A   R + +N I
Sbjct: 183 YMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIA---RRTIVNGI 225

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 128
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL      K++DFG +   P        +A  GT+ Y+ PE+I      
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLDYLPPEMIEGRMH- 183
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
              K D++  G++  E   G+
Sbjct: 184 -DEKVDLWSLGVLCYEFLVGK 203

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 113/222 (50%), Gaps = 31/222 (13%)
Query: 183 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MLENSKFSAEEFINEVSTIGRI 240
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 96  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 149
Query: 241 HHVNVVQL-LGFCSEGSKRALVY-----EFMPNG--SLDRHIFPKENKGQTFGWEKLQEI 292
            H N+V+L   F S G K+  VY     +++P     + RH + +  +     + KL   
Sbjct: 150 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 208
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 351
            L   R +AY+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 209 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 263
Query: 352 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 391
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 264 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKK--- 128
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL      K++DFG +   P        +A  GT+ Y+ PE+I      
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLDYLPPEMIEGRMH- 183
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
              K D++  G++  E   G+
Sbjct: 184 -DEKVDLWSLGVLCYEFLVGK 203

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 15/198 (7%)
Query: 195 KLGQGGFGSVYKGQLHTGRL---IAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +LG G FGSV +G     +    +A+K+L+    K   EE + E   + ++ +  +V+L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G C +     LV E    G L + +     K +      + E+    + G+ YL    + 
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLE---EK 455
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRNF 368
             +H ++   N+LL +    K+SDFGL+K     ++ + + SA +  + + APE I  NF
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--NF 513
Query: 369 GTVSCKSDVYGFGMVLLE 386
              S +SDV+ +G+ + E
Sbjct: 514 RKFSSRSDVWSYGVTMWE 531

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 192 FTHKLGQGGFGSVYKGQLHTG---RLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 248
           F  KLG G FG V+  +  +    R+I     + S+   E+   E+  +  + H N++++
Sbjct: 26  FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
                +     +V E    G L   I   + +G+      + E+       +AY H+   
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS--- 142
Query: 309 MCILHFDIKPHNILLD----HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
             ++H D+KP NIL      H+ I K+ DFGLA+    ++D  S +A  GT  Y+APE+ 
Sbjct: 143 QHVVHKDLKPENILFQDTSPHSPI-KIIDFGLAELF--KSDEHSTNAA-GTALYMAPEVF 198
Query: 365 SRNFGTVSCKSDVYGFGMVL 384
            R+   V+ K D++  G+V+
Sbjct: 199 KRD---VTFKCDIWSAGVVM 215

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL----QKLSRFDEQRTATYITELANALSYCHS---KR 132
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL  N   K++DFG +   P            GT+ Y+ PE+I      
Sbjct: 133 VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----DTLCGTLDYLPPEMIEGRMH- 187
Query: 371 VSCKSDVYGFGMVLLEMAGG 390
              K D++  G++  E   G
Sbjct: 188 -DEKVDLWSLGVLCYEFLVG 206

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 117/291 (40%), Gaps = 42/291 (14%)
Query: 196 LGQGGFGSVYKGQLH------TGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 247
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I +++H N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 248 LLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
            +G   +   R ++ E M  G L    R   P+ ++  +     L  +A   A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 305 NGCDMCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE 421
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 216 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 255
Query: 422 LRNVTEIESVIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSMDD 467
           L  VT    +   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 256 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 306

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 246
           F   LG+G F +V    +L T R  A+K+LE      E  +     E   + R+ H   V
Sbjct: 33  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 92
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L     +  K      +  NG L ++I     K  +F     +         + YLH  
Sbjct: 93  KLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               I+H D+KP NILL+ +   +++DFG AK    E+     ++  GT  Y++PEL++ 
Sbjct: 149 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 205
Query: 367 NFGTVSCK-SDVYGFGMVLLEMAGG 390
                +CK SD++  G ++ ++  G
Sbjct: 206 K---SACKSSDLWALGCIIYQLVAG 227

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 196 LGQGGFGSVY--------KGQLHTGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 244
           LG+G FG V         K +      +AVKML++     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWE------------KLQEI 292
           ++ LLG C++     ++  +   G+L  ++  +   G  + ++             L   
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
               ARG+ YL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 353 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHS---KR 131
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL      K++DFG +   P        +A  GT+ Y+ PE+I      
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLDYLPPEMIEGRMHD 187
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
              K D++  G++  E   G+
Sbjct: 188 E--KVDLWSLGVLCYEFLVGK 206

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 246
           F   LG+G F +V    +L T R  A+K+LE      E  +     E   + R+ H   V
Sbjct: 11  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 70
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L     +  K      +  NG L ++I     K  +F     +         + YLH  
Sbjct: 71  KLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 127 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 183
Query: 367 NFGTVSCK-SDVYGFGMVLLEMAGG 390
                +CK SD++  G ++ ++  G
Sbjct: 184 K---SACKSSDLWALGCIIYQLVAG 205

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 117/291 (40%), Gaps = 42/291 (14%)
Query: 196 LGQGGFGSVYKGQLH------TGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 247
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I +++H N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 248 LLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
            +G   +   R ++ E M  G L    R   P+ ++  +     L  +A   A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 305 NGCDMCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE 421
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 230 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 269
Query: 422 LRNVTEIESVIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSMDD 467
           L  VT    +   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 270 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 320

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 246
           F   LG+G F +V    +L T R  A+K+LE      E  +     E   + R+ H   V
Sbjct: 13  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 72
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L     +  K      +  NG L ++I     K  +F     +         + YLH  
Sbjct: 73  KLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 129 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 185
Query: 367 NFGTVSCK-SDVYGFGMVLLEMAGG 390
                +CK SD++  G ++ ++  G
Sbjct: 186 K---SACKSSDLWALGCIIYQLVAG 207

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 246
           F   LG+G F +V    +L T R  A+K+LE      E  +     E   + R+ H   V
Sbjct: 12  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L     +  K      +  NG L ++I     K  +F     +         + YLH  
Sbjct: 72  KLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 128 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 184
Query: 367 NFGTVSCK-SDVYGFGMVLLEMAGG 390
                +CK SD++  G ++ ++  G
Sbjct: 185 K---SACKSSDLWALGCIIYQLVAG 206

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 246
           F   LG+G F +V    +L T R  A+K+LE      E  +     E   + R+ H   V
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L     +  K      +  NG L ++I     K  +F     +         + YLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGCLLKYI----RKIGSFDETCTRFYTAEIVSALEYLHG- 150
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               I+H D+KP NILL+ +   +++DFG AK    E+     ++  GT  Y++PEL++ 
Sbjct: 151 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 208
Query: 367 NFGTVSCKSDVYGFGMVLLEMAGG 390
              + S  SD++  G ++ ++  G
Sbjct: 209 K--SASKSSDLWALGCIIYQLVAG 230

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 246
           F   LG+G F +V    +L T R  A+K+LE      E  +     E   + R+ H   V
Sbjct: 14  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 73
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L     +  K      +  NG L ++I     K  +F     +         + YLH  
Sbjct: 74  KLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 130 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 186
Query: 367 NFGTVSCK-SDVYGFGMVLLEMAGG 390
                +CK SD++  G ++ ++  G
Sbjct: 187 K---SACKSSDLWALGCIIYQLVAG 208

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVVQLLG 250
           LG G FG V  G+   TG  +AVK+L   K  + + +     E+  +    H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
             S  S   +V E++  G L  +I       +       Q+I      GV Y H      
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL----SGVDYCHRHM--- 136
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H D+KP N+LLD +   K++DFGL+     + +F+  S   G+  Y APE+IS     
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRXSC--GSPNYAAPEVISGRL-Y 192
Query: 371 VSCKSDVYGFGMVLLEMAGG 390
              + D++  G++L  +  G
Sbjct: 193 AGPEVDIWSSGVILYALLCG 212

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 24/234 (10%)
Query: 192 FTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNV 245
           F   LG+G FG V   ++  TG L AVK+L+      ++ +    T  RI     +H  +
Sbjct: 27  FIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
            QL        +   V EF+  G L  HI     K + F   + +  A      + +LH 
Sbjct: 87  TQLFCCFQTPDRLFFVMEFVNGGDLMFHI----QKSRRFDEARARFYAAEIISALMFLH- 141
Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
             D  I++ D+K  N+LLDH    K++DFG+ K      + V+ +   GT  YIAPE++ 
Sbjct: 142 --DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEILQ 197
Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNAIRSSKAYFPSWVYD 412
                 +   D +  G++L EM  G         +    AI + +  +P+W+++
Sbjct: 198 EMLYGPAV--DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHE 249

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 246
           F   LG+G F +V    +L T R  A+K+LE      E  +     E   + R+ H   V
Sbjct: 18  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 77
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L     +  K      +  NG L ++I     K  +F     +         + YLH  
Sbjct: 78  KLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 134 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 190
Query: 367 NFGTVSCK-SDVYGFGMVLLEMAGG 390
                +CK SD++  G ++ ++  G
Sbjct: 191 K---SACKSSDLWALGCIIYQLVAG 212

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 246
           F   LG+G F +V    +L T R  A+K+LE      E  +     E   + R+ H   V
Sbjct: 37  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 96
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L     +  K      +  NG L ++I     K  +F     +         + YLH  
Sbjct: 97  KLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHG- 151
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               I+H D+KP NILL+ +   +++DFG AK    E+     ++  GT  Y++PEL++ 
Sbjct: 152 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 209
Query: 367 NFGTVSCK-SDVYGFGMVLLEMAGG 390
                +CK SD++  G ++ ++  G
Sbjct: 210 K---SACKSSDLWALGCIIYQLVAG 231

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 111/222 (50%), Gaps = 31/222 (13%)
Query: 183 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFIN-EVSTIGRI 240
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +   K     F N E+  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK----AFKNRELQIMRKL 70
Query: 241 HHVNVVQL-LGFCSEGSKRALVY-----EFMPNG--SLDRHIFPKENKGQTFGWEKLQEI 292
            H N+V+L   F S G K+  VY     +++P     + RH + +  +     + KL   
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 351
            L   R +AY+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184
Query: 352 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 391
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 185 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 102 YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHS---KR 154
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP--KENDFVSISATRGTIGYIAPELISRNF 368
           ++H DIKP N+LL      K++DFG +   P  + +D        GT+ Y+ PE+I    
Sbjct: 155 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC------GTLDYLPPEMIEGRM 208
Query: 369 GTVSCKSDVYGFGMVLLEMAGGR 391
                K D++  G++  E   G+
Sbjct: 209 HDE--KVDLWSLGVLCYEFLVGK 229

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 111/222 (50%), Gaps = 31/222 (13%)
Query: 183 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFIN-EVSTIGRI 240
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +   K     F N E+  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK----AFKNRELQIMRKL 70
Query: 241 HHVNVVQL-LGFCSEGSKRALVY-----EFMPNG--SLDRHIFPKENKGQTFGWEKLQEI 292
            H N+V+L   F S G K+  VY     +++P     + RH + +  +     + KL   
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 351
            L   R +AY+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184
Query: 352 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 391
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 185 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 116/291 (39%), Gaps = 42/291 (14%)
Query: 196 LGQGGFGSVYKGQLH------TGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 247
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 248 LLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
            +G   +   R ++ E M  G L    R   P+ ++  +     L  +A   A G  YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 305 NGCDMCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE 421
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 222 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 261
Query: 422 LRNVTEIESVIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSMDD 467
           L  VT    +   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 262 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 312

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHS---KR 129
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRR----TTLSGTLDYLPPEMIEGRMH- 184
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
              K D++  G++  E   G+
Sbjct: 185 -DEKVDLWSLGVLCYEFLVGK 204

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 246
           F   LG+G F +V    +L T R  A+K+LE      E  +     E   + R+ H   V
Sbjct: 33  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 92
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L     +  K      +  NG L ++I     K  +F     +         + YLH  
Sbjct: 93  KLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 149 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 205
Query: 367 NFGTVSCK-SDVYGFGMVLLEMAGG 390
                +CK SD++  G ++ ++  G
Sbjct: 206 K---SACKSSDLWALGCIIYQLVAG 227

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 115/291 (39%), Gaps = 42/291 (14%)
Query: 196 LGQGGFGSVYKGQLH------TGRLIAVKMLENSKFSAEE--FINEVSTIGRIHHVNVVQ 247
           LG G FG VY+GQ+       +   +AVK L       +E  F+ E   I + +H N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 248 LLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
            +G   +   R ++ E M  G L    R   P+ ++  +     L  +A   A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 305 NGCDMCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE 421
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 230 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 269
Query: 422 LRNVTEIESVIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSMDD 467
           L  VT    +   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 270 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 320

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 116/291 (39%), Gaps = 42/291 (14%)
Query: 196 LGQGGFGSVYKGQLH------TGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 247
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 248 LLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
            +G   +   R ++ E M  G L    R   P+ ++  +     L  +A   A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 305 NGCDMCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE 421
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 216 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 255
Query: 422 LRNVTEIESVIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSMDD 467
           L  VT    +   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 256 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 306

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 116/291 (39%), Gaps = 42/291 (14%)
Query: 196 LGQGGFGSVYKGQLH------TGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 247
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 248 LLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
            +G   +   R ++ E M  G L    R   P+ ++  +     L  +A   A G  YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 305 NGCDMCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE 421
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 242 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 281
Query: 422 LRNVTEIESVIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSMDD 467
           L  VT    +   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 282 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 332

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 128
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP--KENDFVSISATRGTIGYIAPELISRNF 368
           ++H DIKP N+LL      K++DFG +   P  +  D        GT+ Y+ PE+I    
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC------GTLDYLPPEMIEGRM 182
Query: 369 GTVSCKSDVYGFGMVLLEMAGGR 391
                K D++  G++  E   G+
Sbjct: 183 H--DEKVDLWSLGVLCYEFLVGK 203

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 116/291 (39%), Gaps = 42/291 (14%)
Query: 196 LGQGGFGSVYKGQLH------TGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 247
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 248 LLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
            +G   +   R ++ E M  G L    R   P+ ++  +     L  +A   A G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 305 NGCDMCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE 421
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 230 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 269
Query: 422 LRNVTEIESVIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSMDD 467
           L  VT    +   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 270 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 320

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 131
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHD 187
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
              K D++  G++  E   G+
Sbjct: 188 E--KVDLWSLGVLCYEFLVGK 206

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 111/222 (50%), Gaps = 31/222 (13%)
Query: 183 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFIN-EVSTIGRI 240
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +   K     F N E+  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK----AFKNRELQIMRKL 70
Query: 241 HHVNVVQL-LGFCSEGSKRALVY-----EFMPNG--SLDRHIFPKENKGQTFGWEKLQEI 292
            H N+V+L   F S G K+  VY     +++P     + RH + +  +     + KL   
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 351
            L   R +AY+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 184
Query: 352 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 391
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 185 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHS---KR 131
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP--KENDFVSISATRGTIGYIAPELISRNF 368
           ++H DIKP N+LL      K++DFG +   P  + +D        GT+ Y+ PE+I    
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC------GTLDYLPPEMIEGRM 185
Query: 369 GTVSCKSDVYGFGMVLLEMAGGR 391
                K D++  G++  E   G+
Sbjct: 186 H--DEKVDLWSLGVLCYEFLVGK 206

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 128
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP--KENDFVSISATRGTIGYIAPELISRNF 368
           ++H DIKP N+LL      K++DFG +   P  +  D        GT+ Y+ PE+I    
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC------GTLDYLPPEMIEGRM 182
Query: 369 GTVSCKSDVYGFGMVLLEMAGGR 391
                K D++  G++  E   G+
Sbjct: 183 HDE--KVDLWSLGVLCYEFLVGK 203

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 116/291 (39%), Gaps = 42/291 (14%)
Query: 196 LGQGGFGSVYKGQLH------TGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 247
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 248 LLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
            +G   +   R ++ E M  G L    R   P+ ++  +     L  +A   A G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 305 NGCDMCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE 421
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 215 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 254
Query: 422 LRNVTEIESVIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSMDD 467
           L  VT    +   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 255 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 131
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMH- 186
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
              K D++  G++  E   G+
Sbjct: 187 -DEKVDLWSLGVLCYEFLVGK 206

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 114/254 (44%), Gaps = 26/254 (10%)
Query: 148 LVFLIHKYRTTLQTVDNIEKFLHN---QQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSV 204
           L  L H+Y +     D ++    N   Q  W+ ++     +   T      LG+GGFG V
Sbjct: 145 LTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQ----PVTKNTFRQYRVLGKGGFGEV 200
Query: 205 YKGQLH-TGRLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVVQLLGFCSEGSKRA 259
              Q+  TG++ A K LE  +    +     +NE   + +++   VV L           
Sbjct: 201 CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260
Query: 260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEI--ALGTARGVAYLHNGCDMCILHFDIK 317
           LV   M  G L  HI+   + GQ  G+ + + +  A     G+  LH      I++ D+K
Sbjct: 261 LVLTLMNGGDLKFHIY---HMGQA-GFPEARAVFYAAEICCGLEDLHR---ERIVYRDLK 313
Query: 318 PHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 377
           P NILLD +   ++SD GLA   P+     +I    GT+GY+APE++     T S   D 
Sbjct: 314 PENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFS--PDW 368
Query: 378 YGFGMVLLEMAGGR 391
           +  G +L EM  G+
Sbjct: 369 WALGCLLYEMIAGQ 382

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 129
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP--KENDFVSISATRGTIGYIAPELISRNF 368
           ++H DIKP N+LL      K++DFG +   P  +  D        GT+ Y+ PE+I    
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC------GTLDYLPPEMIEGRM 183
Query: 369 GTVSCKSDVYGFGMVLLEMAGGR 391
                K D++  G++  E   G+
Sbjct: 184 HDE--KVDLWSLGVLCYEFLVGK 204

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIA------VKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 248
           +LG G FG+V KG     +++       +K   N     +E + E + + ++ +  +V++
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           +G C E     LV E    G L++++     + +    + + E+    + G+ YL    +
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLE---E 145
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 367
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 146 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 203
Query: 368 FGTVSCKSDVYGFGMVLLE 386
           +   S KSDV+ FG+++ E
Sbjct: 204 YYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIA------VKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 248
           +LG G FG+V KG     +++       +K   N     +E + E + + ++ +  +V++
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           +G C E     LV E    G L++++     + +    + + E+    + G+ YL    +
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLE---E 145
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 367
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 146 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 203
Query: 368 FGTVSCKSDVYGFGMVLLE 386
           +   S KSDV+ FG+++ E
Sbjct: 204 YYKFSSKSDVWSFGVLMWE 222

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIA------VKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 248
           +LG G FG+V KG     +++       +K   N     +E + E + + ++ +  +V++
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           +G C E     LV E    G L++++     + +    + + E+    + G+ YL    +
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLE---E 129
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 367
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 130 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECI--N 187
Query: 368 FGTVSCKSDVYGFGMVLLE 386
           +   S KSDV+ FG+++ E
Sbjct: 188 YYKFSSKSDVWSFGVLMWE 206

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 116/291 (39%), Gaps = 42/291 (14%)
Query: 196 LGQGGFGSVYKGQLH------TGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 247
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 248 LLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
            +G   +   R ++ E M  G L    R   P+ ++  +     L  +A   A G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 305 NGCDMCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE 421
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 215 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 254
Query: 422 LRNVTEIESVIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSMDD 467
           L  VT    +   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 255 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 75  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 127
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 128 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMH- 182
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
              K D++  G++  E   G+
Sbjct: 183 -DEKVDLWSLGVLCYEFLVGK 202

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 246
           F   LG+G F +V    +L T R  A+K+LE      E  +     E   + R+ H   V
Sbjct: 34  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L     +  K      +  NG L ++I     K  +F     +         + YLH  
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHG- 148
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 149 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 367 NFGTVSCK-SDVYGFGMVLLEMAGG 390
                +CK SD++  G ++ ++  G
Sbjct: 207 K---SACKSSDLWALGCIIYQLVAG 228

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 20/198 (10%)
Query: 192 FTHKLGQGGFGSVY-KGQLHTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNVVQLL 249
           F   LG G F  V+   Q  TG+L A+K ++ S  F      NE++ + +I H N+V L 
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH-NGCD 308
                 +   LV + +  G L   I  +    +      +Q++       V YLH NG  
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQV----LSAVKYLHENG-- 126
Query: 309 MCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
             I+H D+KP N+L    + N    ++DFGL+K   ++N  +S +   GT GY+APE+++
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTAC--GTPGYVAPEVLA 180
Query: 366 RNFGTVSCKSDVYGFGMV 383
           +     S   D +  G++
Sbjct: 181 QK--PYSKAVDCWSIGVI 196

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 116/291 (39%), Gaps = 42/291 (14%)
Query: 196 LGQGGFGSVYKGQLH------TGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 247
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 248 LLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
            +G   +   R ++ E M  G L    R   P+ ++  +     L  +A   A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 305 NGCDMCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE 421
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 216 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 255
Query: 422 LRNVTEIESVIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSMDD 467
           L  VT    +   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 256 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 306

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 116/291 (39%), Gaps = 42/291 (14%)
Query: 196 LGQGGFGSVYKGQLH------TGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 247
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 248 LLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
            +G   +   R ++ E M  G L    R   P+ ++  +     L  +A   A G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 305 NGCDMCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE 421
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 207 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 246
Query: 422 LRNVTEIESVIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSMDD 467
           L  VT    +   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 247 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 297

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 246
           F   LG+G F +V    +L T R  A+K+LE      E  +     E   + R+ H   V
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L     +  K      +  NG L ++I     K  +F     +         + YLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHG- 150
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 151 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 367 NFGTVSCK-SDVYGFGMVLLEMAGG 390
                +CK SD++  G ++ ++  G
Sbjct: 209 K---SACKSSDLWALGCIIYQLVAG 230

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHS---KR 128
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHD 184
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
              K D++  G++  E   G+
Sbjct: 185 E--KVDLWSLGVLCYEFLVGK 203

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 246
           F   LG+G F +V    +L T R  A+K+LE      E  +     E   + R+ H   V
Sbjct: 34  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L     +  K      +  NG L ++I     K  +F     +         + YLH  
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHG- 148
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 149 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 367 NFGTVSCK-SDVYGFGMVLLEMAGG 390
                +CK SD++  G ++ ++  G
Sbjct: 207 K---SACKSSDLWALGCIIYQLVAG 228

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 116/291 (39%), Gaps = 42/291 (14%)
Query: 196 LGQGGFGSVYKGQLH------TGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 247
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 248 LLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
            +G   +   R ++ E M  G L    R   P+ ++  +     L  +A   A G  YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 305 NGCDMCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 175 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE 421
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 232 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 271
Query: 422 LRNVTEIESVIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSMDD 467
           L  VT    +   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 272 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 322

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 81  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHS---KR 133
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP--KENDFVSISATRGTIGYIAPELISRNF 368
           ++H DIKP N+LL      K++DFG +   P  +  D        GT+ Y+ PE+I    
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC------GTLDYLPPEMIEGRM 187
Query: 369 GTVSCKSDVYGFGMVLLEMAGGR 391
                K D++  G++  E   G+
Sbjct: 188 HDE--KVDLWSLGVLCYEFLVGK 208

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 93  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 145
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 146 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHD 201
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
              K D++  G++  E   G+
Sbjct: 202 E--KVDLWSLGVLCYEFLVGK 220

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 27/230 (11%)
Query: 173 QSWMPKRYSYPEIIAVTNHFT-------HKLGQGGFGSVYKGQLHTGR-LIAVKMLENSK 224
           Q  M      P+I+  T HFT         LG+G FG+VY  +      ++A+K+L  S+
Sbjct: 3   QKVMENSSGTPDIL--TRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQ 60
Query: 225 FSAE----EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENK 280
              E    +   E+     +HH N+++L  +  +  +  L+ E+ P G L + +     K
Sbjct: 61  IEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL----QK 116
Query: 281 GQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 340
             TF  ++   I    A  + Y H      ++H DIKP N+LL      K++DFG +   
Sbjct: 117 SCTFDEQRTATIMEELADALMYCHGKK---VIHRDIKPENLLLGLKGELKIADFGWSVHA 173
Query: 341 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           P     +      GT+ Y+ PE+I         K D++  G++  E+  G
Sbjct: 174 PS----LRRKTMCGTLDYLPPEMIEGRMHNE--KVDLWCIGVLCYELLVG 217

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIA------VKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 248
           +LG G FG+V KG     +++       +K   N     +E + E + + ++ +  +V++
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           +G C E     LV E    G L++++     + +    + + E+    + G+ YL    +
Sbjct: 92  IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLE---E 143
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 367
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 144 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 201
Query: 368 FGTVSCKSDVYGFGMVLLE 386
           +   S KSDV+ FG+++ E
Sbjct: 202 YYKFSSKSDVWSFGVLMWE 220

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 246
           F   LG+G F +V    +L T R  A+K+LE      E  +     E   + R+ H   V
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L     +  K      +  NG L ++I     K  +F     +         + YLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHG- 150
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 151 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 367 NFGTVSCK-SDVYGFGMVLLEMAGG 390
                +CK SD++  G ++ ++  G
Sbjct: 209 K---SACKSSDLWALGCIIYQLVAG 230

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 192 FTHKLGQGGFGS-VYKGQLHTGRLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 246
           F   LG+G F + V   +L T R  A+K+LE      E  +     E   + R+ H   V
Sbjct: 34  FGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L     +  K      +  NG L ++I     K  +F     +         + YLH  
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHG- 148
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 149 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 367 NFGTVSCK-SDVYGFGMVLLEMAGG 390
                +CK SD++  G ++ ++  G
Sbjct: 207 K---SACKSSDLWALGCIIYQLVAG 228

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 115/291 (39%), Gaps = 42/291 (14%)
Query: 196 LGQGGFGSVYKGQLH------TGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 247
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 248 LLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
            +G   +   R ++ E M  G L    R   P+ ++  +     L  +A   A G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 305 NGCDMCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
                  +H DI   N LL       + K+ DFG+A+   +   +         + ++ P
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE 421
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 256 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 295
Query: 422 LRNVTEIESVIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSMDD 467
           L  VT    +   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 296 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 246
           F   LG+G F +V    +L T R  A+K+LE      E  +     E   + R+ H   V
Sbjct: 37  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 96
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L     +  K      +  NG L ++I     K  +F     +         + YLH  
Sbjct: 97  KLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHG- 151
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 152 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 209
Query: 367 NFGTVSCK-SDVYGFGMVLLEMAGG 390
                +CK SD++  G ++ ++  G
Sbjct: 210 K---SACKSSDLWALGCIIYQLVAG 231

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 114/254 (44%), Gaps = 26/254 (10%)
Query: 148 LVFLIHKYRTTLQTVDNIEKFLHN---QQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSV 204
           L  L H+Y +     D ++    N   Q  W+ ++     +   T      LG+GGFG V
Sbjct: 145 LTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQ----PVTKNTFRQYRVLGKGGFGEV 200
Query: 205 YKGQLH-TGRLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVVQLLGFCSEGSKRA 259
              Q+  TG++ A K LE  +    +     +NE   + +++   VV L           
Sbjct: 201 CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260
Query: 260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEI--ALGTARGVAYLHNGCDMCILHFDIK 317
           LV   M  G L  HI+   + GQ  G+ + + +  A     G+  LH      I++ D+K
Sbjct: 261 LVLTLMNGGDLKFHIY---HMGQA-GFPEARAVFYAAEICCGLEDLHR---ERIVYRDLK 313
Query: 318 PHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 377
           P NILLD +   ++SD GLA   P+     +I    GT+GY+APE++     T S   D 
Sbjct: 314 PENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFS--PDW 368
Query: 378 YGFGMVLLEMAGGR 391
           +  G +L EM  G+
Sbjct: 369 WALGCLLYEMIAGQ 382

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHS---KR 132
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 133 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMH- 187
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
              K D++  G++  E   G+
Sbjct: 188 -DEKVDLWSLGVLCYEFLVGK 207

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 246
           F   LG+G F +V    +L T R  A+K+LE      E  +     E   + R+ H   V
Sbjct: 41  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 100
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L     +  K      +  NG L ++I     K  +F     +         + YLH  
Sbjct: 101 KLYFCFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHG- 155
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 156 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 213
Query: 367 NFGTVSCK-SDVYGFGMVLLEMAGG 390
                +CK SD++  G ++ ++  G
Sbjct: 214 K---SACKSSDLWALGCIIYQLVAG 235

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 81  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHS---KR 133
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHD 189
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
              K D++  G++  E   G+
Sbjct: 190 E--KVDLWSLGVLCYEFLVGK 208

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 246
           F   LG+G F +V    +L T R  A+K+LE      E  +     E   + R+ H   V
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L     +  K      +  NG L ++I     K  +F     +         + YLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHG- 150
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 151 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 367 NFGTVSCK-SDVYGFGMVLLEMAGG 390
                +CK SD++  G ++ ++  G
Sbjct: 209 K---SACKSSDLWALGCIIYQLVAG 230

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 102 YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHS---KR 154
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 155 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHD 210
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
              K D++  G++  E   G+
Sbjct: 211 E--KVDLWSLGVLCYEFLVGK 229

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHS---KR 128
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TXLCGTLDYLPPEMIEGRMH- 183
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
              K D++  G++  E   G+
Sbjct: 184 -DEKVDLWSLGVLCYEFLVGK 203

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 115/291 (39%), Gaps = 42/291 (14%)
Query: 196 LGQGGFGSVYKGQLH------TGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 247
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 248 LLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
            +G   +   R ++ E M  G L    R   P+ ++  +     L  +A   A G  YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 305 NGCDMCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
                  +H DI   N LL       + K+ DFG+A+   +   +         + ++ P
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE 421
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 233 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 272
Query: 422 LRNVTEIESVIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSMDD 467
           L  VT    +   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 273 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 323

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 26/203 (12%)
Query: 191 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEE--FINEVSTIGRIHHVNVVQ 247
            F   LG G F  V   +   TG+L AVK +       +E    NE++ + +I H N+V 
Sbjct: 25  EFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVA 84
Query: 248 LLGFCSEGSKRALVYEFMPNGSL-DRHI---FPKENKGQTFGWEKLQEIALGTARGVAYL 303
           L       +   LV + +  G L DR +   F  E    T   + L          V YL
Sbjct: 85  LEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLD--------AVYYL 136
Query: 304 HNGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 360
           H    M I+H D+KP N+L    D      +SDFGL+K   K  D +S +   GT GY+A
Sbjct: 137 HR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGK-GDVMSTAC--GTPGYVA 190
Query: 361 PELISRNFGTVSCKSDVYGFGMV 383
           PE++++     S   D +  G++
Sbjct: 191 PEVLAQK--PYSKAVDCWSIGVI 211

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 246
           F   LG+G F +V    +L T R  A+K+LE      E  +     E   + R+ H   V
Sbjct: 39  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 98
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L     +  K      +  NG L ++I     K  +F     +         + YLH  
Sbjct: 99  KLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHG- 153
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 154 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 211
Query: 367 NFGTVSCK-SDVYGFGMVLLEMAGG 390
                +CK SD++  G ++ ++  G
Sbjct: 212 K---SACKSSDLWALGCIIYQLVAG 233

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHS---KR 128
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TELCGTLDYLPPEMIEGRMHD 184
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
              K D++  G++  E   G+
Sbjct: 185 E--KVDLWSLGVLCYEFLVGK 203

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIA------VKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 248
           +LG G FG+V KG     +++       +K   N     +E + E + + ++ +  +V++
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           +G C E     LV E    G L++++     + +    + + E+    + G+ YL    +
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLE---E 125
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 367
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 183
Query: 368 FGTVSCKSDVYGFGMVLLE 386
           +   S KSDV+ FG+++ E
Sbjct: 184 YYKFSSKSDVWSFGVLMWE 202

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 111/214 (51%), Gaps = 24/214 (11%)
Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           ++G+G FG VYKG   HT  ++A+K+  LE ++   E+   E++ + +     + +  G 
Sbjct: 26  RIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGS 85
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
             + +K  ++ E++  GS    + P   + +T+    L+EI     +G+ YLH+      
Sbjct: 86  YLKSTKLWIIMEYLGGGSALDLLKPGPLE-ETYIATILREIL----KGLDYLHSERK--- 137
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELISRN 367
           +H DIK  N+LL      K++DFG+A        K N FV      GT  ++APE+I ++
Sbjct: 138 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFV------GTPFWMAPEVIKQS 191
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNAIR 400
                 K+D++  G+  +E+A G   NS+++ +R
Sbjct: 192 --AYDFKADIWSLGITAIELAKGEPPNSDLHPMR 223

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIA------VKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 248
           +LG G FG+V KG     +++       +K   N     +E + E + + ++ +  +V++
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           +G C E     LV E    G L++++     + +    + + E+    + G+ YL    +
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLE---E 135
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 367
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 193
Query: 368 FGTVSCKSDVYGFGMVLLE 386
           +   S KSDV+ FG+++ E
Sbjct: 194 YYKFSSKSDVWSFGVLMWE 212

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIA------VKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 248
           +LG G FG+V KG     +++       +K   N     +E + E + + ++ +  +V++
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           +G C E     LV E    G L++++     + +    + + E+    + G+ YL    +
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLE---E 129
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 367
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 130 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 187
Query: 368 FGTVSCKSDVYGFGMVLLE 386
           +   S KSDV+ FG+++ E
Sbjct: 188 YYKFSSKSDVWSFGVLMWE 206

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 129
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL      K++DFG +   P            GT+ Y+ PE+I      
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DTLCGTLDYLPPEMIEGRMHD 185
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
              K D++  G++  E   G+
Sbjct: 186 E--KVDLWSLGVLCYEFLVGK 204

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 73  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 125
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 126 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMH- 180
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
              K D++  G++  E   G+
Sbjct: 181 -DEKVDLWSLGVLCYEFLVGK 200

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 246
           F   LG+G F +V    +L T R  A+K+LE      E  +     E   + R+ H   V
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L     +  K      +  NG L ++I     K  +F     +         + YLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHG- 150
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 151 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 367 NFGTVSCK-SDVYGFGMVLLEMAGG 390
                +CK SD++  G ++ ++  G
Sbjct: 209 K---SACKSSDLWALGCIIYQLVAG 230

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 78  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 130
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL      K++DFG +   P            GT+ Y+ PE+I      
Sbjct: 131 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGRMHD 186
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
              K D++  G++  E   G+
Sbjct: 187 E--KVDLWSLGVLCYEFLVGK 205

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 178 KRYSYPEIIAVTNHFTHKLGQGGFGSV-----YKGQLHTG-RLIAVKMLENSKFSAEEFI 231
           KR+  P II  T      LG+G FG V     YK Q     + I+ ++L+ S        
Sbjct: 5   KRHIGPYIIRET------LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VE 57
Query: 232 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQE 291
            E+S +  + H ++++L    +  +   +V E+   G L  +I  K+   +  G    Q+
Sbjct: 58  REISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQ 116
Query: 292 IALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 351
           I       + Y H      I+H D+KP N+LLD N   K++DFGL+      N F+  S 
Sbjct: 117 IICA----IEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTSC 168
Query: 352 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
             G+  Y APE+I+        + DV+  G+VL  M  GR
Sbjct: 169 --GSPNYAAPEVINGKL-YAGPEVDVWSCGIVLYVMLVGR 205

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIA------VKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 248
           +LG G FG+V KG     +++       +K   N     +E + E + + ++ +  +V++
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           +G C E     LV E    G L++++     + +    + + E+    + G+ YL    +
Sbjct: 72  IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLE---E 123
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 367
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 124 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 181
Query: 368 FGTVSCKSDVYGFGMVLLE 386
           +   S KSDV+ FG+++ E
Sbjct: 182 YYKFSSKSDVWSFGVLMWE 200

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 131
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL      K++DFG +   P            GT+ Y+ PE+I      
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGRMH- 186
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
              K D++  G++  E   G+
Sbjct: 187 -DEKVDLWSLGVLCYEFLVGK 206

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 194 HKLGQGGFG-SVYKGQLHTGRLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLL 249
            K+G+G FG ++       GR   +K +  S+ S+   EE   EV+ +  + H N+VQ  
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
               E     +V ++   G L + I     KG  F  +++ +  +     + ++H   D 
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHVH---DR 144
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS-ATRGTIGYIAPELISRNF 368
            ILH DIK  NI L  +   ++ DFG+A+     N  V ++ A  GT  Y++PE+     
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVL---NSTVELARACIGTPYYLSPEICENK- 200
Query: 369 GTVSCKSDVYGFGMVLLEM 387
              + KSD++  G VL E+
Sbjct: 201 -PYNNKSDIWALGCVLYEL 218

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 32/210 (15%)
Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG---- 250
           +G GGFG V+K +    G+   +K +   K++ E+   EV  + ++ HVN+V   G    
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAEREVKALAKLDHVNIVHYNGCWDG 75
Query: 251 ------FCSEGSKRA------LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR 298
                   S+ S R+      +  EF   G+L++ I  ++ +G+        E+     +
Sbjct: 76  FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLALELFEQITK 133
Query: 299 GVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 358
           GV Y+H+     +++ D+KP NI L      K+ DFGL      +ND      ++GT+ Y
Sbjct: 134 GVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVT--SLKNDGKR-XRSKGTLRY 187
Query: 359 IAPELI-SRNFGTVSCKSDVYGFGMVLLEM 387
           ++PE I S+++G    + D+Y  G++L E+
Sbjct: 188 MSPEQISSQDYGK---EVDLYALGLILAEL 214

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 33/202 (16%)
Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI--NEVSTIGRIHHVNVVQLLGF 251
           +LG G FG V++  +  TGR+   K + N+ +  +++   NE+S + ++HH  ++ L   
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFI-NTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC---- 307
             +  +  L+ EF+  G L   I  ++ K             +  A  + Y+   C    
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAEDYK-------------MSEAEVINYMRQACEGLK 163
Query: 308 ---DMCILHFDIKPHNILLDHNFIP--KVSDFGLA-KFHPKENDFVSISATRGTIGYIAP 361
              +  I+H DIKP NI+ +       K+ DFGLA K +P E     +  T  T  + AP
Sbjct: 164 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAP 219
Query: 362 ELISRNFGTVSCKSDVYGFGMV 383
           E++ R    V   +D++  G++
Sbjct: 220 EIVDRE--PVGFYTDMWAIGVL 239

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G     ++ +  K   F  ++        A  ++Y H+     
Sbjct: 81  YFHDATRVYLILEYAPRGE----VYKELQKLSKFDEQRTATYITELANALSYCHS---KR 133
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHD 189
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
              K D++  G++  E   G+
Sbjct: 190 E--KVDLWSLGVLCYEFLVGK 208

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G     ++ +  K   F  ++        A  ++Y H+     
Sbjct: 81  YFHDATRVYLILEYAPRGE----VYKELQKLSKFDEQRTATYITELANALSYCHS---KR 133
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL      K++DFG +   P            GT+ Y+ PE+I      
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLXGTLDYLPPEMIEGRMH- 188
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
              K D++  G++  E   G+
Sbjct: 189 -DEKVDLWSLGVLCYEFLVGK 208

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 23/199 (11%)
Query: 195 KLGQGGFGSVYKGQLH--TGRLIAVKMLENSKFSAEEFIN---EVSTIGRIHHVNVVQLL 249
           +LG+G F SV +  +H  TG   A K++   K SA +F     E     ++ H N+V+L 
Sbjct: 12  ELGKGAF-SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 70
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH-NGCD 308
               E S   LV++ +  G L   I  +E   +      +Q+I       +AY H NG  
Sbjct: 71  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI----LESIAYCHSNG-- 124
Query: 309 MCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
             I+H ++KP N+LL         K++DFGLA    + ND  +     GT GY++PE++ 
Sbjct: 125 --IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLK 179
Query: 366 RNFGTVSCKSDVYGFGMVL 384
           ++    S   D++  G++L
Sbjct: 180 KD--PYSKPVDIWACGVIL 196

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 194 HKLGQGGFGSVYK-GQLHTGRLIAVKMLENSKFSA-------EEFINEVSTIGRIHHVNV 245
            +LG G F  V K  +  TG   A K ++  +  A       EE   EVS + ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           + L       +   L+ E +  G L   +  KE+  +      +++I      GV YLH 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL----DGVNYLHT 133
Query: 306 GCDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
                I HFD+KP NI+L    IP    K+ DFGLA  H  E D V      GT  ++AP
Sbjct: 134 KK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE-DGVEFKNIFGTPEFVAP 187
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           E++  N+  +  ++D++  G++   +  G
Sbjct: 188 EIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 23/199 (11%)
Query: 195 KLGQGGFGSVYKGQLH--TGRLIAVKMLENSKFSAEEFIN---EVSTIGRIHHVNVVQLL 249
           +LG+G F SV +  +H  TG   A K++   K SA +F     E     ++ H N+V+L 
Sbjct: 13  ELGKGAF-SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH-NGCD 308
               E S   LV++ +  G L   I  +E   +      +Q+I       +AY H NG  
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI----LESIAYCHSNG-- 125
Query: 309 MCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
             I+H ++KP N+LL         K++DFGLA    + ND  +     GT GY++PE++ 
Sbjct: 126 --IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 366 RNFGTVSCKSDVYGFGMVL 384
           ++    S   D++  G++L
Sbjct: 181 KD--PYSKPVDIWACGVIL 197

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHS---KR 128
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL      K++DFG +   P            GT+ Y+ PE+I      
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGRMH- 183
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
              K D++  G++  E   G+
Sbjct: 184 -DEKVDLWSLGVLCYEFLVGK 203

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 195 KLGQGGFGSVYK-GQLHTGRLIAVKMLENSK-------FSAEEFINEVSTIGRIHHVNVV 246
           +LG G F  V K  +  TG   A K ++  +        S EE   EVS + ++ H NV+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
            L       +   L+ E +  G L   +  KE+  +      +++I      GV YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI----LDGVNYLHTK 134
Query: 307 CDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
               I HFD+KP NI+L    IP    K+ DFGLA  H  E D V      GT  ++APE
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE-DGVEFKNIFGTPEFVAPE 188
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           ++  N+  +  ++D++  G++   +  G
Sbjct: 189 IV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 194 HKLGQGGFGSVYK-GQLHTGRLIAVKMLENSK-------FSAEEFINEVSTIGRIHHVNV 245
            +LG G F  V K  +  TG   A K ++  +        S EE   EVS + ++ H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           + L       +   L+ E +  G L   +  KE+  +      +++I      GV YLH 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI----LDGVNYLHT 133
Query: 306 GCDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
                I HFD+KP NI+L    IP    K+ DFGLA  H  E D V      GT  ++AP
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE-DGVEFKNIFGTPEFVAP 187
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           E++  N+  +  ++D++  G++   +  G
Sbjct: 188 EIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 79/168 (47%), Gaps = 10/168 (5%)
Query: 224 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL---DRHIFPKENK 280
           K   ++F NE+  I  I +   +   G  +   +  ++YE+M N S+   D + F  +  
Sbjct: 84  KSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN 143
Query: 281 GQTF-GWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF 339
              F   + ++ I        +Y+HN  ++C  H D+KP NIL+D N   K+SDFG +++
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIHNEKNIC--HRDVKPSNILMDKNGRVKLSDFGESEY 201
Query: 340 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
              +     I  +RGT  ++ PE  S        K D++  G+ L  M
Sbjct: 202 MVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVM 245

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 117/248 (47%), Gaps = 32/248 (12%)
Query: 195 KLGQGGFGSVYKGQLH--TGRLIAVKMLENSKFSAEE--FINEVSTIGRIHHVN-VVQLL 249
           ++G+G +GSV K  +H  +G+++AVK + ++    E+   + ++  + R      +VQ  
Sbjct: 29  EIGRGAYGSVNK-MVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 250 GFCSEGSKRALVYEFMPNGSLDR-HIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           G         +  E M + S D+ + +           E L +I L T + + +L    +
Sbjct: 88  GALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--N 144
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI--SR 366
           + I+H DIKP NILLD +   K+ DFG++    +  D ++ +   G   Y+APE I  S 
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSA 201
Query: 367 NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW--VYDQLN---KGGDLE 421
           +      +SDV+  G+ L E+A GR              +P W  V+DQL    KG   +
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGRFP------------YPKWNSVFDQLTQVVKGDPPQ 249
Query: 422 LRNVTEIE 429
           L N  E E
Sbjct: 250 LSNSEERE 257

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 88/185 (47%), Gaps = 13/185 (7%)
Query: 215 IAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGS-LD 271
           +A+K   LE  + S +E + E+  + + HH N+V          +  LV + +  GS LD
Sbjct: 43  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 102
Query: 272 --RHIFPK-ENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFI 328
             +HI  K E+K        +  I      G+ YLH       +H D+K  NILL  +  
Sbjct: 103 IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGS 159
Query: 329 PKVSDFGLAKFHPKENDFVSISATR---GTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 385
            +++DFG++ F     D       +   GT  ++APE++ +  G    K+D++ FG+  +
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG-YDFKADIWSFGITAI 218
Query: 386 EMAGG 390
           E+A G
Sbjct: 219 ELATG 223

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 23/199 (11%)
Query: 195 KLGQGGFGSVYKGQLH--TGRLIAVKMLENSKFSAEEFIN---EVSTIGRIHHVNVVQLL 249
           +LG+G F SV +  +H  TG   A K++   K SA +F     E     ++ H N+V+L 
Sbjct: 13  ELGKGAF-SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH-NGCD 308
               E S   LV++ +  G L   I  +E   +      +Q+I       +AY H NG  
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI----LESIAYCHSNG-- 125
Query: 309 MCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
             I+H ++KP N+LL         K++DFGLA    + ND  +     GT GY++PE++ 
Sbjct: 126 --IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 366 RNFGTVSCKSDVYGFGMVL 384
           ++    S   D++  G++L
Sbjct: 181 KD--PYSKPVDIWACGVIL 197

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 11/178 (6%)
Query: 220 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGS-LD--RHIFP 276
           LE  + S +E + E+  + + HH N+V          +  LV + +  GS LD  +HI  
Sbjct: 45  LEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVA 104
Query: 277 K-ENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFG 335
           K E+K        +  I      G+ YLH       +H D+K  NILL  +   +++DFG
Sbjct: 105 KGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFG 161
Query: 336 LAKFHPKENDFVSISATR---GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           ++ F     D       +   GT  ++APE++ +  G    K+D++ FG+  +E+A G
Sbjct: 162 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG-YDFKADIWSFGITAIELATG 218

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 195 KLGQGGFGSVYK-GQLHTGRLIAVKMLENSK-------FSAEEFINEVSTIGRIHHVNVV 246
           +LG G F  V K  +  TG   A K ++  +        S EE   EVS + ++ H NV+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
            L       +   L+ E +  G L   +  KE+  +      +++I      GV YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI----LDGVNYLHTK 134
Query: 307 CDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
               I HFD+KP NI+L    IP    K+ DFGLA  H  E D V      GT  ++APE
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE-DGVEFKNIFGTPEFVAPE 188
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           ++  N+  +  ++D++  G++   +  G
Sbjct: 189 IV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 194 HKLGQGGFGSVYK-GQLHTGRLIAVKMLENSK-------FSAEEFINEVSTIGRIHHVNV 245
            +LG G F  V K  +  TG   A K ++  +        S EE   EVS + ++ H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           + L       +   L+ E +  G L   +  KE+  +      +++I      GV YLH 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI----LDGVNYLHT 133
Query: 306 GCDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
                I HFD+KP NI+L    IP    K+ DFGLA  H  E D V      GT  ++AP
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE-DGVEFKNIFGTPEFVAP 187
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           E++  N+  +  ++D++  G++   +  G
Sbjct: 188 EIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 19/206 (9%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLENSKF------SAEEFINEVSTIGRIHHVNVVQL 248
           +G+G F  V +     TG+  AVK+++ +KF      S E+   E S    + H ++V+L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           L   S      +V+EFM    L   I  + + G  +               + Y H   D
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---D 148
Query: 309 MCILHFDIKPHNILL--DHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
             I+H D+KP N+LL    N  P K+ DFG+A     E+  V+     GT  ++APE++ 
Sbjct: 149 NNIIHRDVKPENVLLASKENSAPVKLGDFGVA-IQLGESGLVA-GGRVGTPHFMAPEVVK 206
Query: 366 RN-FGTVSCKSDVYGFGMVLLEMAGG 390
           R  +G      DV+G G++L  +  G
Sbjct: 207 REPYGK---PVDVWGCGVILFILLSG 229

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 246
           F   LG+G F +V    +L T R  A+K+LE      E  +     E   + R+ H   V
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +L     +  K      +  NG L ++I     K  +F     +         + YLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHG- 150
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 151 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 367 NFGTVSCKSDVYGFGMVLLEMAGG 390
                S  SD++  G ++ ++  G
Sbjct: 209 KSAXKS--SDLWALGCIIYQLVAG 230

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 31/229 (13%)
Query: 171 NQQSW-MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKF 225
           N+ +W +PK Y  P         TH +G G +GSV       +G  +A+K L     S+ 
Sbjct: 16  NKTAWELPKTYVSP---------TH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI 65
Query: 226 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF---MPNGSLDRHIFPKENKGQ 282
            A+    E+  +  + H NV+ LL   +  S     Y+F   MP    D     ++  G 
Sbjct: 66  FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDL----QKIMGL 121
Query: 283 TFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 342
            F  EK+Q +     +G+ Y+H+     ++H D+KP N+ ++ +   K+ DFGLA+    
Sbjct: 122 KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADA 178
Query: 343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           E     ++    T  Y APE+I  ++   +   D++  G ++ EM  G+
Sbjct: 179 E-----MTGYVVTRWYRAPEVI-LSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 31/229 (13%)
Query: 171 NQQSW-MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKF 225
           N+ +W +PK Y  P         TH +G G +GSV       +G  +A+K L     S+ 
Sbjct: 34  NKTAWELPKTYVSP---------TH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI 83
Query: 226 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF---MPNGSLDRHIFPKENKGQ 282
            A+    E+  +  + H NV+ LL   +  S     Y+F   MP    D     ++  G 
Sbjct: 84  FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDL----QKIMGM 139
Query: 283 TFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 342
            F  EK+Q +     +G+ Y+H+     ++H D+KP N+ ++ +   K+ DFGLA+    
Sbjct: 140 EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADA 196
Query: 343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           E     ++    T  Y APE+I  ++   +   D++  G ++ EM  G+
Sbjct: 197 E-----MTGYVVTRWYRAPEVI-LSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 109/216 (50%), Gaps = 26/216 (12%)
Query: 194 HKLGQGGFGSVYKG-QLHTGRLIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
            ++G+G FG V+KG    T +++A+K+++   ++   E+   E++ + +     V +  G
Sbjct: 29  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYG 88
Query: 251 FCSEGSKRALVYEFMPNGS-LDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
              +GSK  ++ E++  GS LD        +   F   ++  +     +G+ YLH+    
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLL------RAGPFDEFQIATMLKEILKGLDYLHSEKK- 141
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELIS 365
             +H DIK  N+LL      K++DFG+A        K N FV      GT  ++APE+I 
Sbjct: 142 --IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEVIQ 193
Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNAIR 400
           ++      K+D++  G+  +E+A G   NS+M+ +R
Sbjct: 194 QS--AYDSKADIWSLGITAIELAKGEPPNSDMHPMR 227

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+   S+D   F   +         ++       +G+A+ H+     
Sbjct: 72  VIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HR 125
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 368
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 177
Query: 369 GTVSCK-----SDVYGFGMVLLEMAGGR 391
             + CK      D++  G +  EM   R
Sbjct: 178 --LGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 19/206 (9%)
Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQ 247
           H   K+G+G +G VYK Q + G   A+K +   K         I E+S +  + H N+V+
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
           L        +  LV+E + +  L + +   E   ++      +   L    G+AY H   
Sbjct: 65  LYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESV---TAKSFLLQLLNGIAYCH--- 117
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI-- 364
           D  +LH D+KP N+L++     K++DFGLA+ F      +        T+ Y AP+++  
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV---TLWYRAPDVLMG 174
Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGG 390
           S+ + T     D++  G +  EM  G
Sbjct: 175 SKKYSTT---IDIWSVGCIFAEMVNG 197

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 84  LGICLTSTVQ-LIMQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 136
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 137 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 196
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 197 YT--HQSDVWSYGVTVWEL 213

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+   S+D   F   +         ++       +G+A+ H+     
Sbjct: 73  VIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 126
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 368
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 178
Query: 369 GTVSCK-----SDVYGFGMVLLEMAGGR 391
             + CK      D++  G +  EM   R
Sbjct: 179 --LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 195 KLGQGGFGSVYK-GQLHTGRLIAVKMLENSK-------FSAEEFINEVSTIGRIHHVNVV 246
           +LG G F  V K  +  TG   A K ++  +        S EE   EVS + ++ H NV+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
            L       +   L+ E +  G L   +  KE+  +      +++I      GV YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI----LDGVNYLHTK 134
Query: 307 CDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
               I HFD+KP NI+L    IP    K+ DFGLA  H  E D V      GT  ++APE
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE-DGVEFKNIFGTPEFVAPE 188
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           ++  N+  +  ++D++  G++   +  G
Sbjct: 189 IV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 250
           +LG+G +G V K + + +G+++AVK +  +  S E+    ++   ++  +     V   G
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 117
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                    +  E M + SLD+      +KGQT   + L +IA+   + + +LH+   + 
Sbjct: 118 ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLS 174
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR--NF 368
           ++H D+KP N+L++     K+ DFG++ +     D V+ +   G   Y+APE I+   N 
Sbjct: 175 VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDSVAKTIDAGCKPYMAPERINPELNQ 231
Query: 369 GTVSCKSDVYGFGMVLLEMA 388
              S KSD++  G+ ++E+A
Sbjct: 232 KGYSVKSDIWSLGITMIELA 251

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 84  LGICLTSTVQ-LIMQLMPFGXLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 136
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 137 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 196
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 197 YT--HQSDVWSYGVTVWEL 213

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 19/206 (9%)
Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQ 247
           H   K+G+G +G VYK Q + G   A+K +   K         I E+S +  + H N+V+
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
           L        +  LV+E + +  L + +   E   ++      +   L    G+AY H   
Sbjct: 65  LYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESV---TAKSFLLQLLNGIAYCH--- 117
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI-- 364
           D  +LH D+KP N+L++     K++DFGLA+ F      +        T+ Y AP+++  
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV---TLWYRAPDVLMG 174
Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGG 390
           S+ + T     D++  G +  EM  G
Sbjct: 175 SKKYSTT---IDIWSVGCIFAEMVNG 197

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 77  LGICLTSTVQ-LITQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 129
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 190 YT--HQSDVWSYGVTVWEL 206

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 78  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 130
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL      K+++FG +   P        +   GT+ Y+ PE+I      
Sbjct: 131 VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHD 186
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
              K D++  G++  E   G+
Sbjct: 187 E--KVDLWSLGVLCYEFLVGK 205

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 131
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL      K+++FG +   P        +   GT+ Y+ PE+I      
Sbjct: 132 VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMH- 186
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
              K D++  G++  E   G+
Sbjct: 187 -DEKVDLWSLGVLCYEFLVGK 206

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 83  LGICLTSTVQ-LIMQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 135
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 196 YT--HQSDVWSYGVTVWEL 212

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 87  LGICLTSTVQ-LIMQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 139
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 140 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 199
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 200 YT--HQSDVWSYGVTVWEL 216

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 137
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 138 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 198 YT--HQSDVWSYGVTVWEL 214

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 93  LGICLTSTVQ-LITQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 145
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 146 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 205
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 206 YT--HQSDVWSYGVTVWEL 222

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 18/222 (8%)
Query: 190 NHFT--HKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKF----SAEEFINEVSTIGRIHH 242
           +HF     +G+G FG V   Q + T ++ A+K +   K            E+  +  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
             +V L     +     +V + +  G L  H+     +   F  E ++         + Y
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL----QQNVHFKEETVKLFICELVMALDY 130
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
           L N     I+H D+KP NILLD +    ++DF +A   P+E     I+   GT  Y+APE
Sbjct: 131 LQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---TQITTMAGTKPYMAPE 184
Query: 363 LISRNFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK 403
           + S   G   S   D +  G+   E+  GRR  ++ +  SSK
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK 226

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+   S+D   F   +         ++       +G+A+ H+     
Sbjct: 71  VIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HR 124
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 368
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 176
Query: 369 GTVSCK-----SDVYGFGMVLLEMAGGR 391
             + CK      D++  G +  EM   R
Sbjct: 177 --LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQ 247
           H   K+G+G +G VYK Q + G   A+K +   K         I E+S +  + H N+V+
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
           L        +  LV+E + +  L + +   E   ++      +   L    G+AY H   
Sbjct: 65  LYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESV---TAKSFLLQLLNGIAYCH--- 117
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELI- 364
           D  +LH D+KP N+L++     K++DFGLA+    P       I     T+ Y AP+++ 
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPDVLM 173
Query: 365 -SRNFGTVSCKSDVYGFGMVLLEMAGG 390
            S+ + T     D++  G +  EM  G
Sbjct: 174 GSKKYSTT---IDIWSVGCIFAEMVNG 197

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 83  LGICLTSTVQ-LITQLMPFGXLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 135
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 196 YT--HQSDVWSYGVTVWEL 212

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+   S+D   F   +         ++       +G+A+ H+     
Sbjct: 73  VIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HR 126
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 368
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 127 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 178
Query: 369 GTVSCK-----SDVYGFGMVLLEMAGGR 391
             + CK      D++  G +  EM   R
Sbjct: 179 --LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 135
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 196 YT--HQSDVWSYGVTVWEL 212

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 86  LGICLTSTVQ-LIMQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 138
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 139 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 199 YT--HQSDVWSYGVTVWEL 215

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 138
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 139 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 199 YT--HQSDVWSYGVTVWEL 215

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 85  LGICLTSTVQ-LITQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 137
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 138 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 198 YT--HQSDVWSYGVTVWEL 214

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 45/223 (20%)
Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG---- 250
           +G GGFG V+K +    G+   ++ +   K++ E+   EV  + ++ HVN+V   G    
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRV---KYNNEKAEREVKALAKLDHVNIVHYNGCWDG 76
Query: 251 ----------------FCSEGSKRA---------LVYEFMPNGSLDRHIFPKENKGQTFG 285
                           +  E SK +         +  EF   G+L++ I  ++ +G+   
Sbjct: 77  FDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLD 134
Query: 286 WEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 345
                E+     +GV Y+H+     ++H D+KP NI L      K+ DFGL      +ND
Sbjct: 135 KVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVT--SLKND 189
Query: 346 FVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEM 387
               + ++GT+ Y++PE I S+++G    + D+Y  G++L E+
Sbjct: 190 GKR-TRSKGTLRYMSPEQISSQDYGK---EVDLYALGLILAEL 228

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 108/244 (44%), Gaps = 40/244 (16%)
Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHV----------- 243
           LGQG FG V K +     R  A+K + +++      ++EV  +  ++H            
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 244 --NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE-NKGQTFGWEKLQEIALGTARGV 300
             N V+ +    + S   +  E+  NG+L   I  +  N+ +   W   ++I       +
Sbjct: 74  RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL----EAL 129
Query: 301 AYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV------------S 348
           +Y+H+     I+H D+KP NI +D +   K+ DFGLAK   +  D +            +
Sbjct: 130 SYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-----AGGRRNSNMNAIRSSK 403
           +++  GT  Y+A E++    G  + K D+Y  G++  EM      G  R + +  +RS  
Sbjct: 187 LTSAIGTAMYVATEVLD-GTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVS 245
Query: 404 AYFP 407
             FP
Sbjct: 246 IEFP 249

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 138
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 139 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 199 YT--HQSDVWSYGVTVWEL 215

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           +  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H+     
Sbjct: 81  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHS---KR 133
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE I      
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEXIEGRXHD 189
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
              K D++  G++  E   G+
Sbjct: 190 E--KVDLWSLGVLCYEFLVGK 208

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 89  LGICLTSTVQ-LITQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 141
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 142 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 201
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 202 YT--HQSDVWSYGVTVWEL 218

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 135
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 196 YT--HQSDVWSYGVTVWEL 212

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 138
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 139 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 199 YT--HQSDVWSYGVTVWEL 215

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 108 LGICLTSTVQ-LITQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 160
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 161 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 220
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 221 YT--HQSDVWSYGVTVWEL 237

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 194 HKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGF 251
            K+GQG  G+VY    + TG+ +A++ +   +   +E I NE+  +    + N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPK-ENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
              G +  +V E++  GSL   +     ++GQ      +  +     + + +LH+     
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ------IAAVCRECLQALEFLHSNQ--- 136
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
           ++H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R   
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRK-- 191
Query: 370 TVSCKSDVYGFGMVLLEMAGG 390
               K D++  G++ +EM  G
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEG 212

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +LG G  G V K Q   +G ++A K+  LE       + I E+  +   +   +V   G 
Sbjct: 23  ELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 82
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                + ++  E M  GSLD+ +     + +    E L ++++   RG+AYL       I
Sbjct: 83  FYSDGEISICMEHMDGGSLDQVL----KEAKRIPEEILGKVSIAVLRGLAYLREKHQ--I 136
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFG 369
           +H D+KP NIL++     K+ DFG++        N FV      GT  Y+APE   R  G
Sbjct: 137 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMAPE---RLQG 187
Query: 370 T-VSCKSDVYGFGMVLLEMAGGR 391
           T  S +SD++  G+ L+E+A GR
Sbjct: 188 THYSVQSDIWSMGLSLVELAVGR 210

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/263 (24%), Positives = 118/263 (44%), Gaps = 43/263 (16%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIA------VKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 248
           +LG G FG+V KG     +++       +K   N     +E + E + + ++ +  +V++
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 435
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           +G C E     LV E    G L++++     + +    + + E+    + G+ YL    +
Sbjct: 436 IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLE---E 487
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 367
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 488 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 545
Query: 368 FGTVSCKSDVYGFGMVLLEMAG-------GRRNSNMNAI--RSSKAYFPS---------- 408
           +   S KSDV+ FG+++ E          G + S + A+  +  +   P+          
Sbjct: 546 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLM 605
Query: 409 ---WVYDQLNKGG----DLELRN 424
              W YD  N+ G    +L LRN
Sbjct: 606 NLCWTYDVENRPGFAAVELRLRN 628

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 142
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 143 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 203 YT--HQSDVWSYGVTVWEL 219

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/263 (24%), Positives = 118/263 (44%), Gaps = 43/263 (16%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIA------VKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 248
           +LG G FG+V KG     +++       +K   N     +E + E + + ++ +  +V++
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 436
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           +G C E     LV E    G L++++     + +    + + E+    + G+ YL    +
Sbjct: 437 IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLE---E 488
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 367
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 489 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 546
Query: 368 FGTVSCKSDVYGFGMVLLEMAG-------GRRNSNMNAI--RSSKAYFPS---------- 408
           +   S KSDV+ FG+++ E          G + S + A+  +  +   P+          
Sbjct: 547 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLM 606
Query: 409 ---WVYDQLNKGG----DLELRN 424
              W YD  N+ G    +L LRN
Sbjct: 607 NLCWTYDVENRPGFAAVELRLRN 629

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRL--IAVKMLE----NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G    I V ++E     S  + +E ++E   +  + + +V +L
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 117 LGICLTSTVQ-LITQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 169
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 170 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 229
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 230 YT--HQSDVWSYGVTVWEL 246

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 23/199 (11%)
Query: 195 KLGQGGFGSVYKGQLH--TGRLIAVKMLENSKFSAEEFIN---EVSTIGRIHHVNVVQLL 249
           +LG+G F SV +  +H  TG   A K++   K SA +F     E     ++ H N+V+L 
Sbjct: 36  ELGKGAF-SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH-NGCD 308
               E S   LV++ +  G L   I  +E   +      +Q+I       +AY H NG  
Sbjct: 95  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI----LESIAYCHSNG-- 148
Query: 309 MCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
             I+H ++KP N+LL         K++DFGLA    + ND  +     GT GY++PE++ 
Sbjct: 149 --IVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSPEVLK 203
Query: 366 RNFGTVSCKSDVYGFGMVL 384
           ++    S   D++  G++L
Sbjct: 204 KD--PYSKPVDIWACGVIL 220

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLE-----NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           K+G+G F  VY+   L  G  +A+K ++     ++K  A+  I E+  + +++H NV++ 
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARAD-CIKEIDLLKQLNHPNVIKY 97
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
                E ++  +V E    G L R I   + + +      + +  +     + ++H+   
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS--- 154
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H DIKP N+ +    + K+ D GL +F   +    +  +  GT  Y++PE I  N 
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHEN- 211
Query: 369 GTVSCKSDVYGFGMVLLEMAG 389
              + KSD++  G +L EMA 
Sbjct: 212 -GYNFKSDIWSLGCLLYEMAA 231

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 250
           +LG+G +G V K + + +G+++AVK +  +  S E+    ++   ++  +     V   G
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                    +  E M + SLD+      +KGQT   + L +IA+   + + +LH+   + 
Sbjct: 74  ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLS 130
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR--NF 368
           ++H D+KP N+L++     K+ DFG++ +     D V+     G   Y+APE I+   N 
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 369 GTVSCKSDVYGFGMVLLEMA 388
              S KSD++  G+ ++E+A
Sbjct: 188 KGYSVKSDIWSLGITMIELA 207

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 194 HKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGF 251
            K+GQG  G+VY    + TG+ +A++ +   +   +E I NE+  +    + N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPK-ENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
              G +  +V E++  GSL   +     ++GQ      +  +     + + +LH+     
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ------IAAVCRECLQALEFLHSNQ--- 136
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
           ++H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R   
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---SXMVGTPYWMAPEVVTRK-- 191
Query: 370 TVSCKSDVYGFGMVLLEMAGG 390
               K D++  G++ +EM  G
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEG 212

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 194 HKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGF 251
            K+GQG  G+VY    + TG+ +A++ +   +   +E I NE+  +    + N+V  L  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPK-ENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
              G +  +V E++  GSL   +     ++GQ      +  +     + + +LH+     
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ------IAAVCRECLQALEFLHSNQ--- 137
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
           ++H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R   
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---SXMVGTPYWMAPEVVTRK-- 192
Query: 370 TVSCKSDVYGFGMVLLEMAGG 390
               K D++  G++ +EM  G
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEG 213

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 194 HKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGF 251
            K+GQG  G+VY    + TG+ +A++ +   +   +E I NE+  +    + N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPK-ENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
              G +  +V E++  GSL   +     ++GQ      +  +     + + +LH+     
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ------IAAVCRECLQALEFLHSNQ--- 136
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
           ++H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R   
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---SEMVGTPYWMAPEVVTRK-- 191
Query: 370 TVSCKSDVYGFGMVLLEMAGG 390
               K D++  G++ +EM  G
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEG 212

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 21/218 (9%)
Query: 186 IAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNV 245
           IA       ++G+G +G V+ G+   G  +AVK+   ++ ++     E+     + H N+
Sbjct: 35  IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENI 93
Query: 246 VQLLGFCSEGS----KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVA 301
           +  +    +G+    +  L+ ++  NGSL  ++     K  T   + + ++A  +  G+ 
Sbjct: 94  LGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLC 148
Query: 302 YLHNGC-----DMCILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISATR-G 354
           +LH           I H D+K  NIL+  N    ++D GLA KF    N+      TR G
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 355 TIGYIAPEL----ISRNFGTVSCKSDVYGFGMVLLEMA 388
           T  Y+ PE+    ++RN       +D+Y FG++L E+A
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A G+ YL    D
Sbjct: 80  LGICLTSTVQ-LITQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAEGMNYLE---D 132
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 133 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 192
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 193 YT--HQSDVWSYGVTVWEL 209

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 30/208 (14%)
Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G V+K +   TG+++A+K     E+     +  + E+  + ++ H N+V LL 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKG------QTFGWEKLQEIALGTARGVAYLH 304
                 +  LV+E+  +  L  H   +  +G      ++  W+ LQ      A    + H
Sbjct: 70  VFRRKRRLHLVFEYCDHTVL--HELDRYQRGVPEHLVKSITWQTLQ------AVNFCHKH 121
Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
           N    CI H D+KP NIL+  + + K+ DFG A+     +D+        T  Y +PEL+
Sbjct: 122 N----CI-HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV--ATRWYRSPELL 174
Query: 365 --SRNFGTVSCKSDVYGFGMVLLEMAGG 390
                +G      DV+  G V  E+  G
Sbjct: 175 VGDTQYGP---PVDVWAIGCVFAELLSG 199

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 121/287 (42%), Gaps = 49/287 (17%)
Query: 196 LGQGGFGSVYKGQLHTG---RLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           +G+G FG VY G+ H     RLI ++     +  A  F  EV    +  H NVV  +G C
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKA--FKREVMAYRQTRHENVVLFMGAC 98
Query: 253 SEGSKRALVYEFMPNGSL-----DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
                 A++       +L     D  I    NK         ++IA    +G+ YLH   
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNK--------TRQIAQEIVKGMGYLHA-- 148
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP-----KENDFVSISATRGTIGYIAPE 362
              ILH D+K  N+  D+  +  ++DFGL          +  D + I    G + ++APE
Sbjct: 149 -KGILHKDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQ--NGWLCHLAPE 204
Query: 363 LISR-------NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLN 415
           +I +       +    S  SDV+  G +  E+     ++     ++  A    W   Q+ 
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL-----HAREWPFKTQPAEAIIW---QMG 256
Query: 416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
            G    L  +      + +++  I L+C   +  +RP+ TK+++MLE
Sbjct: 257 TGMKPNLSQIG-----MGKEISDILLFCWAFEQEERPTFTKLMDMLE 298

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 26/204 (12%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSAE----EFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  S+   E    +   E+     + H N++++  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 251 FCSEGSKRALVYEFMPNGSL----DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +  +  +  L+ EF P G L     +H    E +  TF    ++E+A         LH  
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF----MEELADA-------LHYC 130
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
            +  ++H DIKP N+L+ +    K++DFG +   P     +      GT+ Y+ PE+I  
Sbjct: 131 HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRXMCGTLDYLPPEMIEG 186
Query: 367 NFGTVSCKSDVYGFGMVLLEMAGG 390
              T   K D++  G++  E   G
Sbjct: 187 K--THDEKVDLWCAGVLCYEFLVG 208

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 26/204 (12%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKFSAE----EFINEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +    + I A+K+L  S+   E    +   E+     + H N++++  
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 251 FCSEGSKRALVYEFMPNGSL----DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           +  +  +  L+ EF P G L     +H    E +  TF    ++E+A         LH  
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF----MEELADA-------LHYC 131
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
            +  ++H DIKP N+L+ +    K++DFG +   P     +      GT+ Y+ PE+I  
Sbjct: 132 HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRXMCGTLDYLPPEMIEG 187
Query: 367 NFGTVSCKSDVYGFGMVLLEMAGG 390
              T   K D++  G++  E   G
Sbjct: 188 K--THDEKVDLWCAGVLCYEFLVG 209

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLGF 251
           LG+G FG V K +   T +  AVK++  +    ++    + EV  + ++ H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
             + S   +V E    G L    F +  K + F       I      G+ Y+H      I
Sbjct: 90  LEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNI 142
Query: 312 LHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
           +H D+KP NILL   + +   K+ DFGL+    +      +    GT  YIAPE++    
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLR--- 196
Query: 369 GTVSCKSDVYGFGMVLLEMAGG 390
           GT   K DV+  G++L  +  G
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLGF 251
           LG+G FG V K +   T +  AVK++  +    ++    + EV  + ++ H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
             + S   +V E    G L    F +  K + F       I      G+ Y+H      I
Sbjct: 90  LEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNI 142
Query: 312 LHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
           +H D+KP NILL   + +   K+ DFGL+    +      +    GT  YIAPE++    
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLR--- 196
Query: 369 GTVSCKSDVYGFGMVLLEMAGG 390
           GT   K DV+  G++L  +  G
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG 218

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLGF 251
           LG+G FG V K +   T +  AVK++  +    ++    + EV  + ++ H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
             + S   +V E    G L    F +  K + F       I      G+ Y+H      I
Sbjct: 90  LEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 312 LHFDIKPHNILL---DHNFIPKVSDFGLA---KFHPKENDFVSISATRGTIGYIAPELIS 365
           +H D+KP NILL   + +   K+ DFGL+   + + K  D +      GT  YIAPE++ 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI------GTAYYIAPEVLR 196
Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGG 390
              GT   K DV+  G++L  +  G
Sbjct: 197 ---GTYDEKCDVWSAGVILYILLSG 218

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 196 LGQGGFGSVYKGQLHT----GRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +G+G FG V++G   +       +A+K  +N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G  +E     ++ E    G L   +   + +  +     L   A   +  +AYL +    
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLESKR-- 131
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
             +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 132 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 187
Query: 370 TVSCKSDVYGFGMVLLEM 387
             +  SDV+ FG+ + E+
Sbjct: 188 RFTSASDVWMFGVCMWEI 205

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 87  LGICLTSTVQ-LIMQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 139
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFG AK    E         +  I ++A E I    
Sbjct: 140 RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 199
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 200 YT--HQSDVWSYGVTVWEL 216

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 23/199 (11%)
Query: 195 KLGQGGFGSVY--KGQLHTGRLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVVQL 248
           KLG G +G V   K +L TG   A+K+++ S  +        ++EV+ + ++ H N+++L
Sbjct: 28  KLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 86
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
             F  +     LV E    G L   I  ++   +      ++++  GT     YLH    
Sbjct: 87  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTT----YLHK--- 139
Query: 309 MCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
             I+H D+KP N+LL+    + + K+ DFGL+           +    GT  YIAPE++ 
Sbjct: 140 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG---KMKERLGTAYYIAPEVLR 196
Query: 366 RNFGTVSCKSDVYGFGMVL 384
           + +     K DV+  G++L
Sbjct: 197 KKYDE---KCDVWSCGVIL 212

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL-LGXKY 180
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
            S   D++  G +  EM   R
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRR 201

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 196 LGQGGFGSVYKGQLHT----GRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +G+G FG V++G   +       +A+K  +N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G  +E     ++ E    G L   +   + +  +     L   A   +  +AYL +    
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLESKR-- 131
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
             +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 132 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 187
Query: 370 TVSCKSDVYGFGMVLLEM 387
             +  SDV+ FG+ + E+
Sbjct: 188 RFTSASDVWMFGVCMWEI 205

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           L  G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 135
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 196 YT--HQSDVWSYGVTVWEL 212

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 137
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFG AK    E         +  I ++A E I    
Sbjct: 138 RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 198 YT--HQSDVWSYGVTVWEL 214

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 135
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFG AK    E         +  I ++A E I    
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 196 YT--HQSDVWSYGVTVWEL 212

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 16/200 (8%)
Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFIN----EVSTIGRIHHVNVVQLLG 250
           LG G FG V  G+   TG  +AVK+L   K  + + +     E+  +    H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
             S  +   +V E++  G L  +I       +       Q+I       V Y H      
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL----SAVDYCHR---HM 131
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H D+KP N+LLD +   K++DFGL+     + +F+  S   G+  Y APE+IS     
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSC--GSPNYAAPEVISGRL-Y 187
Query: 371 VSCKSDVYGFGMVLLEMAGG 390
              + D++  G++L  +  G
Sbjct: 188 AGPEVDIWSCGVILYALLCG 207

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 137
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFG AK    E         +  I ++A E I    
Sbjct: 138 RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 198 YT--HQSDVWSYGVTVWEL 214

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 23/199 (11%)
Query: 195 KLGQGGFGSVY--KGQLHTGRLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVVQL 248
           KLG G +G V   K +L TG   A+K+++ S  +        ++EV+ + ++ H N+++L
Sbjct: 11  KLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
             F  +     LV E    G L   I  +    Q F       I      G  YLH    
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEIILR----QKFSEVDAAVIMKQVLSGTTYLHK--- 122
Query: 309 MCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
             I+H D+KP N+LL+    + + K+ DFGL+           +    GT  YIAPE++ 
Sbjct: 123 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG---KMKERLGTAYYIAPEVLR 179
Query: 366 RNFGTVSCKSDVYGFGMVL 384
           + +     K DV+  G++L
Sbjct: 180 KKYDE---KCDVWSCGVIL 195

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 196 LGQGGFGSVYKG----QLHTGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +G+G FG V++G      +    +A+K  +N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G  +E     ++ E    G L   +   + +  +     L   A   +  +AYL +    
Sbjct: 75  GVITENPV-WIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLESKR-- 128
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
             +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 129 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 184
Query: 370 TVSCKSDVYGFGMVLLEM 387
             +  SDV+ FG+ + E+
Sbjct: 185 RFTSASDVWMFGVCMWEI 202

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           L  G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 90  LGICLTSTVQ-LIMQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 142
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 143 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 203 YT--HQSDVWSYGVTVWEL 219

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 109/240 (45%), Gaps = 28/240 (11%)
Query: 158 TLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYK-GQLHTGRLIA 216
           TLQ    +E FL  +Q     +    E I+       +LG G  G V+K     +G ++A
Sbjct: 2   TLQQRKRLEAFLTQKQKVGELKDDDFEKIS-------ELGAGNGGVVFKVSHKPSGLVMA 54
Query: 217 VKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
            K+  LE       + I E+  +   +   +V   G      + ++  E M  GSLD+ +
Sbjct: 55  RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL 114
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                K      + L ++++   +G+ YL       I+H D+KP NIL++     K+ DF
Sbjct: 115 ----KKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDF 168
Query: 335 GLAK--FHPKENDFVSISATRGTIGYIAPELISRNFGT-VSCKSDVYGFGMVLLEMAGGR 391
           G++        N FV      GT  Y++PE   R  GT  S +SD++  G+ L+EMA GR
Sbjct: 169 GVSGQLIDSMANSFV------GTRSYMSPE---RLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 85  LGICLTSTVQ-LITQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 137
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFG AK    E         +  I ++A E I    
Sbjct: 138 RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 198 YT--HQSDVWSYGVTVWEL 214

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 194 HKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGF 251
            K+GQG  G+VY    + TG+ +A++ +   +   +E I NE+  +    + N+V  L  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPK-ENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
              G +  +V E++  GSL   +     ++GQ      +  +     + + +LH+     
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ------IAAVCRECLQALEFLHSNQ--- 137
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
           ++H +IK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R   
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRK-- 192
Query: 370 TVSCKSDVYGFGMVLLEMAGG 390
               K D++  G++ +EM  G
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEG 213

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 175
Query: 371 VSCK-----SDVYGFGMVLLEMAGGR 391
           + CK      D++  G +  EM   R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 69  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 174
Query: 371 VSCK-----SDVYGFGMVLLEMAGGR 391
           + CK      D++  G +  EM   R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 69  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 174
Query: 371 VSCK-----SDVYGFGMVLLEMAGGR 391
           + CK      D++  G +  EM   R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           L  G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 142
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 143 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 203 YT--HQSDVWSYGVTVWEL 219

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 25/207 (12%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 73  VIHTENKLYLVFEFLHQ---DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HR 126
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRNFG 369
           +LH D+KP N+L++     K++DFGLA+ F      +        T+ Y APE++     
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---TLWYRAPEIL----- 178
Query: 370 TVSCK-----SDVYGFGMVLLEMAGGR 391
            + CK      D++  G +  EM   R
Sbjct: 179 -LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 196 LGQGGFGSVYKG----QLHTGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +G+G FG V++G      +    +A+K  +N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G  +E     ++ E    G L   +   + +  +     L   A   +  +AYL +    
Sbjct: 106 GVITENPV-WIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLESKR-- 159
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
             +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 160 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 215
Query: 370 TVSCKSDVYGFGMVLLEM 387
             +  SDV+ FG+ + E+
Sbjct: 216 RFTSASDVWMFGVCMWEI 233

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 196 LGQGGFGSVYKG----QLHTGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +G+G FG V++G      +    +A+K  +N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G  +E     ++ E    G L   +   + +  +     L   A   +  +AYL +    
Sbjct: 80  GVITENPV-WIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLESKR-- 133
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
             +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 134 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 189
Query: 370 TVSCKSDVYGFGMVLLEM 387
             +  SDV+ FG+ + E+
Sbjct: 190 RFTSASDVWMFGVCMWEI 207

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 196 LGQGGFGSVYKG-QLHTGRLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 248
           LG G FG+VYKG  +  G  +    A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           LG C   + + L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL    D
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYV--REHK-DNIGSQYLLNWCVQIAKGMNYLE---D 142
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+   N+L+      K++DFG AK    E         +  I ++A E I    
Sbjct: 143 RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 369 GTVSCKSDVYGFGMVLLEM 387
            T   +SDV+ +G+ + E+
Sbjct: 203 YT--HQSDVWSYGVTVWEL 219

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 74  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HR 127
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 179
Query: 371 VSCK-----SDVYGFGMVLLEMAGGR 391
           + CK      D++  G +  EM   R
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 77  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HR 130
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 131 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL-LGXKY 187
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
            S   D++  G +  EM   R
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRR 208

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HR 123
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 175
Query: 371 VSCK-----SDVYGFGMVLLEMAGGR 391
           + CK      D++  G +  EM   R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 71  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HR 124
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 176
Query: 371 VSCK-----SDVYGFGMVLLEMAGGR 391
           + CK      D++  G +  EM   R
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 196 LGQGGFGSVYKGQLHT----GRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +G+G FG V++G   +       +A+K  +N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G  +E     ++ E    G L   +   + +  +     L   A   +  +AYL +    
Sbjct: 83  GVITENPV-WIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLESKR-- 136
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
             +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 137 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 192
Query: 370 TVSCKSDVYGFGMVLLEM 387
             +  SDV+ FG+ + E+
Sbjct: 193 RFTSASDVWMFGVCMWEI 210

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 196 LGQGGFGSVYKG----QLHTGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +G+G FG V++G      +    +A+K  +N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G  +E     ++ E    G L   +   + +  +     L   A   +  +AYL +    
Sbjct: 81  GVITENPV-WIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLESKR-- 134
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
             +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 135 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 190
Query: 370 TVSCKSDVYGFGMVLLEM 387
             +  SDV+ FG+ + E+
Sbjct: 191 RFTSASDVWMFGVCMWEI 208

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 77  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HR 130
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 131 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 182
Query: 371 VSCK-----SDVYGFGMVLLEMAGGR 391
           + CK      D++  G +  EM   R
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 69  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 368
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 174
Query: 369 GTVSCK-----SDVYGFGMVLLEMAGGR 391
             + CK      D++  G +  EM   R
Sbjct: 175 --LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 113/243 (46%), Gaps = 18/243 (7%)
Query: 152 IHKYRTTLQTVDNIEKFLHNQQSW-MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKG--- 207
           +  +  ++   D+  + +  + ++ MP    Y EI          +G+G FG V++G   
Sbjct: 354 VRSHTVSVSETDDYAEIIDEEDTYTMPSTRDY-EIQRERIELGRCIGEGQFGDVHQGIYM 412
Query: 208 -QLHTGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF 264
              +    +A+K  +N  S    E+F+ E  T+ +  H ++V+L+G  +E     ++ E 
Sbjct: 413 SPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMEL 471
Query: 265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD 324
              G L   +   + +  +     L   A   +  +AYL +      +H DI   N+L+ 
Sbjct: 472 CTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVS 525
Query: 325 HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 384
            N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF   +  SDV+ FG+ +
Sbjct: 526 SNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCM 582
Query: 385 LEM 387
            E+
Sbjct: 583 WEI 585

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 368
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 175
Query: 369 GTVSCK-----SDVYGFGMVLLEMAGGR 391
             + CK      D++  G +  EM   R
Sbjct: 176 --LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 368
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 175
Query: 369 GTVSCK-----SDVYGFGMVLLEMAGGR 391
             + CK      D++  G +  EM   R
Sbjct: 176 --LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HR 123
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 368
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 175
Query: 369 GTVSCK-----SDVYGFGMVLLEMAGGR 391
             + CK      D++  G +  EM   R
Sbjct: 176 --LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 69  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 368
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 174
Query: 369 GTVSCK-----SDVYGFGMVLLEMAGGR 391
             + CK      D++  G +  EM   R
Sbjct: 175 --LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 107/244 (43%), Gaps = 40/244 (16%)
Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHV----------- 243
           LGQG FG V K +     R  A+K + +++      ++EV  +  ++H            
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 244 --NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE-NKGQTFGWEKLQEIALGTARGV 300
             N V+ +    + S   +  E+  N +L   I  +  N+ +   W   ++I       +
Sbjct: 74  RRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL----EAL 129
Query: 301 AYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV------------S 348
           +Y+H+     I+H D+KP NI +D +   K+ DFGLAK   +  D +            +
Sbjct: 130 SYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-----AGGRRNSNMNAIRSSK 403
           +++  GT  Y+A E++    G  + K D+Y  G++  EM      G  R + +  +RS  
Sbjct: 187 LTSAIGTAMYVATEVLD-GTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVS 245
Query: 404 AYFP 407
             FP
Sbjct: 246 IEFP 249

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 368
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 175
Query: 369 GTVSCK-----SDVYGFGMVLLEMAGGR 391
             + CK      D++  G +  EM   R
Sbjct: 176 --LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 72  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HR 125
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 368
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 177
Query: 369 GTVSCK-----SDVYGFGMVLLEMAGGR 391
             + CK      D++  G +  EM   R
Sbjct: 178 --LGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 71  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HR 124
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 368
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 176
Query: 369 GTVSCK-----SDVYGFGMVLLEMAGGR 391
             + CK      D++  G +  EM   R
Sbjct: 177 --LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 20/200 (10%)
Query: 196 LGQGGFGSVYKG----QLHTGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +G+G FG V++G      +    +A+K  +N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G  +E     ++ E    G L   +   + +  +     L   A   +  +AYL +    
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYLESKR-- 131
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT--IGYIAPELISRN 367
             +H DI   N+L+  N   K+ DFGL+++     D     A++G   I ++APE I  N
Sbjct: 132 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTXXKASKGKLPIKWMAPESI--N 185
Query: 368 FGTVSCKSDVYGFGMVLLEM 387
           F   +  SDV+ FG+ + E+
Sbjct: 186 FRRFTSASDVWMFGVCMWEI 205

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 20/203 (9%)
Query: 195 KLGQGGFGSVY---KGQLHTGRLIAV-KMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           KLG G +G V        H  R I + +    S  S  + + EV+ +  + H N+++L  
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           F  +     LV E    G L   I  +      F       I      GV YLH      
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHK---HN 156
Query: 311 ILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
           I+H D+KP N+LL   + + + K+ DFGL+     +     +    GT  YIAPE++ + 
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLRKK 213
Query: 368 FGTVSCKSDVYGFGMVLLEMAGG 390
           +     K DV+  G++L  +  G
Sbjct: 214 YDE---KCDVWSIGVILFILLAG 233

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 37/216 (17%)
Query: 196 LGQGGFGSVYKGQLHTGRLIAVKML----ENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G+G +G V++G    G  +AVK+     E S F   E  N V     + H N+   LGF
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM----LRHENI---LGF 67
Query: 252 CSE-------GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
            +         ++  L+  +   GSL  ++     +  T        I L  A G+A+LH
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLH 122
Query: 305 -----NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI--SATRGTIG 357
                      I H D+K  NIL+  N    ++D GLA  H +  + + +  +   GT  
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 358 YIAPELISRNFGTVSC-----KSDVYGFGMVLLEMA 388
           Y+APE++      V C     + D++ FG+VL E+A
Sbjct: 183 YMAPEVLDETI-QVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 73  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HR 126
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 368
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 178
Query: 369 GTVSCK-----SDVYGFGMVLLEMAGGR 391
             + CK      D++  G +  EM   R
Sbjct: 179 --LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 72  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HR 125
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 368
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 177
Query: 369 GTVSCK-----SDVYGFGMVLLEMAGGR 391
             + CK      D++  G +  EM   R
Sbjct: 178 --LGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 16/200 (8%)
Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFIN----EVSTIGRIHHVNVVQLLG 250
           LG G FG V  G+   TG  +AVK+L   K  + + +     E+  +    H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
             S  +   +V E++  G L  +I       +       Q+I       V Y H      
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL----SAVDYCHR---HM 131
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H D+KP N+LLD +   K++DFGL+     + +F+  S   G+  Y APE+IS     
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRDSC--GSPNYAAPEVISGRL-Y 187
Query: 371 VSCKSDVYGFGMVLLEMAGG 390
              + D++  G++L  +  G
Sbjct: 188 AGPEVDIWSCGVILYALLCG 207

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 70  VIHTENKLYLVFEFLHQDLKD---FMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 368
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 124 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 175
Query: 369 GTVSCK-----SDVYGFGMVLLEMAGGR 391
             + CK      D++  G +  EM   R
Sbjct: 176 --LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 37/216 (17%)
Query: 196 LGQGGFGSVYKGQLHTGRLIAVKML----ENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G+G +G V++G    G  +AVK+     E S F   E  N V     + H N+   LGF
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM----LRHENI---LGF 67
Query: 252 CSE-------GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
            +         ++  L+  +   GSL  ++     +  T        I L  A G+A+LH
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLH 122
Query: 305 -----NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI--SATRGTIG 357
                      I H D+K  NIL+  N    ++D GLA  H +  + + +  +   GT  
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 358 YIAPELISRNFGTVSC-----KSDVYGFGMVLLEMA 388
           Y+APE++      V C     + D++ FG+VL E+A
Sbjct: 183 YMAPEVLDETI-QVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 25/207 (12%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 74  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HR 127
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRNFG 369
           +LH D+KP N+L++     K++DFGLA+ F      +        T+ Y APE++     
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---TLWYRAPEIL----- 179
Query: 370 TVSCK-----SDVYGFGMVLLEMAGGR 391
            + CK      D++  G +  EM   R
Sbjct: 180 -LGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 71  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HR 124
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 368
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 176
Query: 369 GTVSCK-----SDVYGFGMVLLEMAGGR 391
             + CK      D++  G +  EM   R
Sbjct: 177 --LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 73  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HR 126
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 368
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 178
Query: 369 GTVSCK-----SDVYGFGMVLLEMAGGR 391
             + CK      D++  G +  EM   R
Sbjct: 179 --LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 71  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HR 124
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 368
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 176
Query: 369 GTVSCK-----SDVYGFGMVLLEMAGGR 391
             + CK      D++  G +  EM   R
Sbjct: 177 --LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 72  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HR 125
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 368
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 126 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 177
Query: 369 GTVSCK-----SDVYGFGMVLLEMAGGR 391
             + CK      D++  G +  EM   R
Sbjct: 178 --LGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 188 VTNHFTHKLGQGGFGSVYKG----QLHTGRLIAVKMLE--NSKFSAEEFINEVSTIGRIH 241
           V  H    +G+G FG VY G    Q       A+K L         E F+ E   +  ++
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 242 HVNVVQLLGFC--SEGSKRALVYEFMPNGSLDRHIF-PKENKGQTFGWEKLQEIALGTAR 298
           H NV+ L+G     EG    L+  +M +G L + I  P+ N       + L    L  AR
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTV----KDLISFGLQVAR 135
Query: 299 GVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT--- 355
           G+ YL    +   +H D+   N +LD +F  KV+DFGLA+    + ++ S+   R     
Sbjct: 136 GMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR-DILDREYYSVQQHRHARLP 191
Query: 356 IGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 387
           + + A E L +  F T   KSDV+ FG++L E+
Sbjct: 192 VKWTALESLQTYRFTT---KSDVWSFGVLLWEL 221

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLENSKF------SAEEFINEVSTIGRIHHVNVVQL 248
           +G+G F  V +     TG+  AVK+++ +KF      S E+   E S    + H ++V+L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           L   S      +V+EFM    L   I  + + G  +               + Y H   D
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---D 148
Query: 309 MCILHFDIKPHNILL--DHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
             I+H D+KPH +LL    N  P K+  FG+A     E+  V+     GT  ++APE++ 
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA-IQLGESGLVA-GGRVGTPHFMAPEVVK 206
Query: 366 RN-FGTVSCKSDVYGFGMVLLEMAGG 390
           R  +G      DV+G G++L  +  G
Sbjct: 207 REPYGK---PVDVWGCGVILFILLSG 229

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 112/238 (47%), Gaps = 35/238 (14%)
Query: 196 LGQGGFGSVYKGQ----LHTGRLIAVKMLE------NSKFSAEEFINEVSTIGRIHHVNV 245
           LG+GG+G V++ +     +TG++ A+K+L+      N+K +A     E + +  + H  +
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-KAERNILEEVKHPFI 83
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKG---QTFGWEKLQEIALGTARGVAY 302
           V L+     G K  L+ E++  G L   +   E +G   +      L EI++     + +
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMA----LGH 136
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
           LH      I++ D+KP NI+L+H    K++DFGL K     +D        GTI Y+APE
Sbjct: 137 LHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPE 191
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEM-------AGGRRNSNMNAIRSSKAYFPSWVYDQ 413
           ++ R+    +   D +  G ++ +M        G  R   ++ I   K   P ++  +
Sbjct: 192 ILMRSGHNRAV--DWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQE 247

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 36/214 (16%)
Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVK--MLENSKFSAEEF----INEVSTIGRIHHVNVVQ 247
           K+GQG FG V+K +   TG+ +A+K  ++EN K   E F    + E+  +  + H NVV 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVN 81
Query: 248 LLGFCSEGSKRA--------LVYEFMPN--GSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
           L+  C   +           LV++F  +    L  ++  K      F   +++ +     
Sbjct: 82  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------FTLSEIKRVMQMLL 135
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATR-GT 355
            G+ Y+H      ILH D+K  N+L+  + + K++DFGLA+ F   +N   +    R  T
Sbjct: 136 NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 356 IGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEM 387
           + Y  PEL+   R++G      D++G G ++ EM
Sbjct: 193 LWYRPPELLLGERDYGP---PIDLWGAGCIMAEM 223

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 36/214 (16%)
Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVK--MLENSKFSAEEF----INEVSTIGRIHHVNVVQ 247
           K+GQG FG V+K +   TG+ +A+K  ++EN K   E F    + E+  +  + H NVV 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVN 80
Query: 248 LLGFCSEGSKRA--------LVYEFMPN--GSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
           L+  C   +           LV++F  +    L  ++  K      F   +++ +     
Sbjct: 81  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------FTLSEIKRVMQMLL 134
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATR-GT 355
            G+ Y+H      ILH D+K  N+L+  + + K++DFGLA+ F   +N   +    R  T
Sbjct: 135 NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 191
Query: 356 IGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEM 387
           + Y  PEL+   R++G      D++G G ++ EM
Sbjct: 192 LWYRPPELLLGERDYGP---PIDLWGAGCIMAEM 222

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 27/206 (13%)
Query: 196 LGQGGFGSVY--KGQLHTGRLIAVKMLEN----SKFSAEEFINEVSTIGRIHHVNVVQLL 249
           LG+G FG V   K ++ TG+  AVK++       K   E  + EV  + ++ H N+++L 
Sbjct: 34  LGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
            F  +     LV E    G L   I  ++     F       I      G+ Y+H     
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGITYMHKNK-- 146
Query: 310 CILHFDIKPHNILL-----DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
            I+H D+KP N+LL     D N   ++ DFGL+           +    GT  YIAPE++
Sbjct: 147 -IVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVL 200
Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGG 390
               GT   K DV+  G++L  +  G
Sbjct: 201 ---HGTYDEKCDVWSTGVILYILLSG 223

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 36/214 (16%)
Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVK--MLENSKFSAEEF----INEVSTIGRIHHVNVVQ 247
           K+GQG FG V+K +   TG+ +A+K  ++EN K   E F    + E+  +  + H NVV 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVN 81
Query: 248 LLGFCSEGSK-----RA---LVYEFMPN--GSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
           L+  C   +      +A   LV++F  +    L  ++  K      F   +++ +     
Sbjct: 82  LIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK------FTLSEIKRVMQMLL 135
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATR-GT 355
            G+ Y+H      ILH D+K  N+L+  + + K++DFGLA+ F   +N   +    R  T
Sbjct: 136 NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 356 IGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEM 387
           + Y  PEL+   R++G      D++G G ++ EM
Sbjct: 193 LWYRPPELLLGERDYGP---PIDLWGAGCIMAEM 223

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 186 IAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVK-MLENSKFSAEEFINEVSTIGRI-HHV 243
           IA TN     +G G FG V++ +L     +A+K +L++ +F   E       I RI  H 
Sbjct: 40  IAYTN--CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNREL-----QIMRIVKHP 92
Query: 244 NVVQLLGF-CSEGSKRA-----LVYEFMPNG--SLDRHIFPKENKGQTFGWEKLQEIALG 295
           NVV L  F  S G K+      LV E++P       RH        QT     ++     
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHY---AKLKQTMPMLLIKLYMYQ 149
Query: 296 TARGVAYLHNGCDMCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISATRG 354
             R +AY+H+   + I H DIKP N+LLD  + + K+ DFG AK        VS   +R 
Sbjct: 150 LLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSR- 205
Query: 355 TIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 391
              Y APELI   FG  +  +  D++  G V+ E+  G+
Sbjct: 206 --YYRAPELI---FGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 27/206 (13%)
Query: 196 LGQGGFGSVY--KGQLHTGRLIAVKMLEN----SKFSAEEFINEVSTIGRIHHVNVVQLL 249
           LG+G FG V   K ++ TG+  AVK++       K   E  + EV  + ++ H N+++L 
Sbjct: 40  LGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 98
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
            F  +     LV E    G L   I  ++     F       I      G+ Y+H     
Sbjct: 99  EFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGITYMHKNK-- 152
Query: 310 CILHFDIKPHNILL-----DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
            I+H D+KP N+LL     D N   ++ DFGL+           +    GT  YIAPE++
Sbjct: 153 -IVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVL 206
Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGG 390
               GT   K DV+  G++L  +  G
Sbjct: 207 H---GTYDEKCDVWSTGVILYILLSG 229

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+++ H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHR--- 123
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 175
Query: 371 VSCK-----SDVYGFGMVLLEMAGGR 391
           + CK      D++  G +  EM   R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 36/211 (17%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           +G+GGFG VY   +  TG++ A+K L+  +   ++        G    +N   +L   S 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--------GETLALNERIMLSLVST 248
Query: 255 GS---------------KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARG 299
           G                K + + + M  G L  H+    ++   F    ++  A     G
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILG 304
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
           + ++HN     +++ D+KP NILLD +   ++SD GLA    K+    S+    GT GY+
Sbjct: 305 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYM 357
Query: 360 APELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           APE++ +     S  +D +  G +L ++  G
Sbjct: 358 APEVLQKGVAYDSS-ADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 36/211 (17%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           +G+GGFG VY   +  TG++ A+K L+  +   ++        G    +N   +L   S 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--------GETLALNERIMLSLVST 248
Query: 255 GS---------------KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARG 299
           G                K + + + M  G L  H+    ++   F    ++  A     G
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILG 304
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
           + ++HN     +++ D+KP NILLD +   ++SD GLA    K+    S+    GT GY+
Sbjct: 305 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYM 357
Query: 360 APELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           APE++ +     S  +D +  G +L ++  G
Sbjct: 358 APEVLQKGVAYDSS-ADWFSLGCMLFKLLRG 387

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 36/214 (16%)
Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVK--MLENSKFSAEEF----INEVSTIGRIHHVNVVQ 247
           K+GQG FG V+K +   TG+ +A+K  ++EN K   E F    + E+  +  + H NVV 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVN 81
Query: 248 LLGFCSEGSKRA--------LVYEFMPN--GSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
           L+  C   +           LV++F  +    L  ++  K      F   +++ +     
Sbjct: 82  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------FTLSEIKRVMQMLL 135
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATR-GT 355
            G+ Y+H      ILH D+K  N+L+  + + K++DFGLA+ F   +N   +    R  T
Sbjct: 136 NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 356 IGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEM 387
           + Y  PEL+   R++G      D++G G ++ EM
Sbjct: 193 LWYRPPELLLGERDYGP---PIDLWGAGCIMAEM 223

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 195 KLGQGGFGSVYK-GQLHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +LG G  G V+K     +G ++A K+  LE       + I E+  +   +   +V   G 
Sbjct: 16  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 75
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                + ++  E M  GSLD+ +     K      + L ++++   +G+ YL       I
Sbjct: 76  FYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLRE--KHKI 129
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE--NDFVSISATRGTIGYIAPELISRNFG 369
           +H D+KP NIL++     K+ DFG++     E  N+FV      GT  Y++PE   R  G
Sbjct: 130 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV------GTRSYMSPE---RLQG 180
Query: 370 T-VSCKSDVYGFGMVLLEMAGGR 391
           T  S +SD++  G+ L+EMA GR
Sbjct: 181 THYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 112/238 (47%), Gaps = 35/238 (14%)
Query: 196 LGQGGFGSVYKGQ----LHTGRLIAVKMLE------NSKFSAEEFINEVSTIGRIHHVNV 245
           LG+GG+G V++ +     +TG++ A+K+L+      N+K +A     E + +  + H  +
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-KAERNILEEVKHPFI 83
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKG---QTFGWEKLQEIALGTARGVAY 302
           V L+     G K  L+ E++  G L   +   E +G   +      L EI++     + +
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMA----LGH 136
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
           LH      I++ D+KP NI+L+H    K++DFGL K     +D        GTI Y+APE
Sbjct: 137 LHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGTIEYMAPE 191
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEM-------AGGRRNSNMNAIRSSKAYFPSWVYDQ 413
           ++ R+    +   D +  G ++ +M        G  R   ++ I   K   P ++  +
Sbjct: 192 ILMRSGHNRAV--DWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQE 247

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 37/216 (17%)
Query: 196 LGQGGFGSVYKGQLHTGRLIAVKML----ENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G+G +G V++G    G  +AVK+     E S F   E  N V     + H N+   LGF
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTV----MLRHENI---LGF 96
Query: 252 CSE-------GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
            +         ++  L+  +   GSL  ++     +  T        I L  A G+A+LH
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLH 151
Query: 305 -----NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI--SATRGTIG 357
                      I H D+K  NIL+  N    ++D GLA  H +  + + +  +   GT  
Sbjct: 152 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 211
Query: 358 YIAPELISRNFGTVSC-----KSDVYGFGMVLLEMA 388
           Y+APE++      V C     + D++ FG+VL E+A
Sbjct: 212 YMAPEVLDETI-QVDCFDSYKRVDIWAFGLVLWEVA 246

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIA---VKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A   +++   ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 175
Query: 371 VSCK-----SDVYGFGMVLLEMAGGR 391
           + CK      D++  G +  EM   R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIA---VKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A   +++   ++      I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+     D   F   +         ++       +G+A+ H+     
Sbjct: 69  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 174
Query: 371 VSCK-----SDVYGFGMVLLEMAGGR 391
           + CK      D++  G +  EM   R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 196 LGQGGFGSVYKGQLH--TGRLIAVKMLENSKFSAEEFINEVSTIGRIH-HVNVVQLLGFC 252
           LG+G F S+ +  +H  + +  AVK++  SK        E++ +     H N+V+L    
Sbjct: 19  LGEGSF-SICRKCVHKKSNQAFAVKII--SKRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
            +     LV E +  G L    F +  K + F   +   I       V+++H   D+ ++
Sbjct: 76  HDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVV 128
Query: 313 HFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
           H D+KP N+L    + N   K+ DFG A+  P +N  +       T+ Y APEL+++N  
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF--TLHYAAPELLNQNGY 186
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
             SC  D++  G++L  M  G+
Sbjct: 187 DESC--DLWSLGVILYTMLSGQ 206

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 36/211 (17%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           +G+GGFG VY   +  TG++ A+K L+  +   ++        G    +N   +L   S 
Sbjct: 196 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--------GETLALNERIMLSLVST 247
Query: 255 GS---------------KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARG 299
           G                K + + + M  G L  H+    ++   F    ++  A     G
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILG 303
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
           + ++HN     +++ D+KP NILLD +   ++SD GLA    K+    S+    GT GY+
Sbjct: 304 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYM 356
Query: 360 APELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           APE++ +     S  +D +  G +L ++  G
Sbjct: 357 APEVLQKGVAYDSS-ADWFSLGCMLFKLLRG 386

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 36/211 (17%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           +G+GGFG VY   +  TG++ A+K L+  +   ++        G    +N   +L   S 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--------GETLALNERIMLSLVST 248
Query: 255 GS---------------KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARG 299
           G                K + + + M  G L  H+    ++   F    ++  A     G
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILG 304
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
           + ++HN     +++ D+KP NILLD +   ++SD GLA    K+    S+    GT GY+
Sbjct: 305 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYM 357
Query: 360 APELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           APE++ +     S  +D +  G +L ++  G
Sbjct: 358 APEVLQKGVAYDSS-ADWFSLGCMLFKLLRG 387

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLENSKF------SAEEFINEVSTIGRIHHVNVVQL 248
           +G+G F  V +     TG+  AVK+++ +KF      S E+   E S    + H ++V+L
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           L   S      +V+EFM    L   I  + + G  +               + Y H   D
Sbjct: 94  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---D 150
Query: 309 MCILHFDIKPHNILL--DHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
             I+H D+KPH +LL    N  P K+  FG+A     E+  V+     GT  ++APE++ 
Sbjct: 151 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA-IQLGESGLVA-GGRVGTPHFMAPEVVK 208
Query: 366 RN-FGTVSCKSDVYGFGMVLLEMAGG 390
           R  +G      DV+G G++L  +  G
Sbjct: 209 REPYGK---PVDVWGCGVILFILLSG 231

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 195 KLGQGGFGSVYK-GQLHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +LG G  G V+K     +G ++A K+  LE       + I E+  +   +   +V   G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                + ++  E M  GSLD+ +     K      + L ++++   +G+ YL       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKHK--I 126
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFG 369
           +H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  G
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQG 177
Query: 370 T-VSCKSDVYGFGMVLLEMAGGR 391
           T  S +SD++  G+ L+EMA GR
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 195 KLGQGGFGSVYK-GQLHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +LG G  G V+K     +G ++A K+  LE       + I E+  +   +   +V   G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                + ++  E M  GSLD+ +     K      + L ++++   +G+ YL       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKHK--I 126
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFG 369
           +H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  G
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQG 177
Query: 370 T-VSCKSDVYGFGMVLLEMAGGR 391
           T  S +SD++  G+ L+EMA GR
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 195 KLGQGGFGSVYK-GQLHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +LG G  G V+K     +G ++A K+  LE       + I E+  +   +   +V   G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                + ++  E M  GSLD+ +     K      + L ++++   +G+ YL       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKHK--I 126
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFG 369
           +H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  G
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQG 177
Query: 370 T-VSCKSDVYGFGMVLLEMAGGR 391
           T  S +SD++  G+ L+EMA GR
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 195 KLGQGGFGSVYK-GQLHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +LG G  G V+K     +G ++A K+  LE       + I E+  +   +   +V   G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                + ++  E M  GSLD+ +     K      + L ++++   +G+ YL       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKHK--I 126
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFG 369
           +H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  G
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQG 177
Query: 370 T-VSCKSDVYGFGMVLLEMAGGR 391
           T  S +SD++  G+ L+EMA GR
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 195 KLGQGGFGSVYK-GQLHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +LG G  G V+K     +G ++A K+  LE       + I E+  +   +   +V   G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                + ++  E M  GSLD+ +     K      + L ++++   +G+ YL       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKHK--I 126
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFG 369
           +H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  G
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQG 177
Query: 370 T-VSCKSDVYGFGMVLLEMAGGR 391
           T  S +SD++  G+ L+EMA GR
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 195 KLGQGGFGSVYK-GQLHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +LG G  G V+K     +G ++A K+  LE       + I E+  +   +   +V   G 
Sbjct: 75  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 134
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                + ++  E M  GSLD+ +     K      + L ++++   +G+ YL       I
Sbjct: 135 FYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLRE--KHKI 188
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFG 369
           +H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  G
Sbjct: 189 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQG 239
Query: 370 T-VSCKSDVYGFGMVLLEMAGGR 391
           T  S +SD++  G+ L+EMA GR
Sbjct: 240 THYSVQSDIWSMGLSLVEMAVGR 262

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 101/227 (44%), Gaps = 26/227 (11%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 250
           +G+G +G V     H  +  +A+K +  S F  + +    + E+  + R  H NV+ +  
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKI--SPFEHQTYCQRTLREIQILLRFRHENVIGIRD 108
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +  A+   ++    ++  ++ K  K Q    + +        RG+ Y+H+     
Sbjct: 109 ILRASTLEAMRDVYIVQDLMETDLY-KLLKSQQLSNDHICYFLYQILRGLKYIHSAN--- 164
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 369
           +LH D+KP N+L++     K+ DFGLA+    E+D    ++    T  Y APE++  + G
Sbjct: 165 VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKG 224
Query: 370 TVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVY-DQLN 415
                 D++  G +L EM             S++  FP   Y DQLN
Sbjct: 225 YTKS-IDIWSVGCILAEML------------SNRPIFPGKHYLDQLN 258

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 195 KLGQGGFGSVYKGQ--LHTGRLIAVKMLENSKFSAEE-----FINEVSTIGRIH---HVN 244
           ++G+G +G V+K +   + GR +A+K +     + EE      I EV+ +  +    H N
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQ--TGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 245 VVQLLGFCS-----EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARG 299
           VV+L   C+       +K  LV+E + +  L  ++      G     E ++++     RG
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPG--VPTETIKDMMFQLLRG 132
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
           + +LH+     ++H D+KP NIL+  +   K++DFGLA+ +  +    S+     T+ Y 
Sbjct: 133 LDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLWYR 186
Query: 360 APELISRNFGTVSCKSDVYGFGMVLLEM 387
           APE++ ++  + +   D++  G +  EM
Sbjct: 187 APEVLLQS--SYATPVDLWSVGCIFAEM 212

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 195 KLGQGGFGSVYKGQ--LHTGRLIAVKMLENSKFSAEE-----FINEVSTIGRIH---HVN 244
           ++G+G +G V+K +   + GR +A+K +     + EE      I EV+ +  +    H N
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQ--TGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 245 VVQLLGFCS-----EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARG 299
           VV+L   C+       +K  LV+E +     D   +  +        E ++++     RG
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
           + +LH+     ++H D+KP NIL+  +   K++DFGLA+ +  +    S+     T+ Y 
Sbjct: 133 LDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLWYR 186
Query: 360 APELISRNFGTVSCKSDVYGFGMVLLEM 387
           APE++ ++  + +   D++  G +  EM
Sbjct: 187 APEVLLQS--SYATPVDLWSVGCIFAEM 212

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 195 KLGQGGFGSVYKGQ--LHTGRLIAVKMLENSKFSAEE-----FINEVSTIGRIH---HVN 244
           ++G+G +G V+K +   + GR +A+K +     + EE      I EV+ +  +    H N
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQ--TGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 245 VVQLLGFCS-----EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARG 299
           VV+L   C+       +K  LV+E + +  L  ++      G     E ++++     RG
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPG--VPTETIKDMMFQLLRG 132
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
           + +LH+     ++H D+KP NIL+  +   K++DFGLA+ +  +    S+     T+ Y 
Sbjct: 133 LDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLWYR 186
Query: 360 APELISRNFGTVSCKSDVYGFGMVLLEM 387
           APE++ ++  + +   D++  G +  EM
Sbjct: 187 APEVLLQS--SYATPVDLWSVGCIFAEM 212

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 195 KLGQGGFGSVYK-GQLHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +LG G  G V+K     +G ++A K+  LE       + I E+  +   +   +V   G 
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                + ++  E M  GSLD+ +     K      + L ++++   +G+ YL       I
Sbjct: 100 FYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLRE--KHKI 153
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFG 369
           +H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  G
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQG 204
Query: 370 T-VSCKSDVYGFGMVLLEMAGGR 391
           T  S +SD++  G+ L+EMA GR
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGR 227

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 27/206 (13%)
Query: 196 LGQGGFGSVY--KGQLHTGRLIAVKMLEN----SKFSAEEFINEVSTIGRIHHVNVVQLL 249
           LG+G FG V   K ++ TG+  AVK++       K   E  + EV  + ++ H N+++L 
Sbjct: 57  LGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
            F  +     LV E    G L   I  ++     F       I      G+ Y+H     
Sbjct: 116 EFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGITYMHKNK-- 169
Query: 310 CILHFDIKPHNILL-----DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
            I+H D+KP N+LL     D N   ++ DFGL+           +    GT  YIAPE++
Sbjct: 170 -IVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVL 223
Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGG 390
               GT   K DV+  G++L  +  G
Sbjct: 224 ---HGTYDEKCDVWSTGVILYILLSG 246

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 27/206 (13%)
Query: 196 LGQGGFGSVY--KGQLHTGRLIAVKMLEN----SKFSAEEFINEVSTIGRIHHVNVVQLL 249
           LG+G FG V   K ++ TG+  AVK++       K   E  + EV  + ++ H N+++L 
Sbjct: 58  LGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
            F  +     LV E    G L   I  ++     F       I      G+ Y+H     
Sbjct: 117 EFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGITYMHKNK-- 170
Query: 310 CILHFDIKPHNILL-----DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
            I+H D+KP N+LL     D N   ++ DFGL+           +    GT  YIAPE++
Sbjct: 171 -IVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVL 224
Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGG 390
               GT   K DV+  G++L  +  G
Sbjct: 225 ---HGTYDEKCDVWSTGVILYILLSG 247

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 120/293 (40%), Gaps = 35/293 (11%)
Query: 176 MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHT-GRLIAVKMLENSKFSAEE---FI 231
           MP R    E++       + +G G +G   K +  + G+++  K L+    +  E    +
Sbjct: 1   MPSRAEDYEVL-------YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV 53
Query: 232 NEVSTIGRIHHVNVVQLLGFCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFGWEKL 289
           +EV+ +  + H N+V+      + +   L  V E+   G L   I     + Q    E +
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 290 QEIALGTARGVAYLHNGCD--MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 347
             +       +   H   D    +LH D+KP N+ LD     K+ DFGLA+    + DF 
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA 173
Query: 348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP 407
                 GT  Y++PE ++R   + + KSD++  G +L E+                A  P
Sbjct: 174 KEFV--GTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELC---------------ALMP 214
Query: 408 SWV-YDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
            +  + Q    G +       I    + +L  I    + +K   RPS+ ++LE
Sbjct: 215 PFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 194 HKLGQGGFGSVYKG-QLHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
            K+G+G FG V+KG    T +++A+K+  LE ++   E+   E++ + +     V +  G
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFP---KENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
              + +K  ++ E++  GS    + P    E +  T     L+EI     +G+ YLH+  
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATI----LREIL----KGLDYLHSEK 124
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPEL 363
               +H DIK  N+LL  +   K++DFG+A        K N FV      GT  ++APE+
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEV 175
Query: 364 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           I ++      K+D++  G+  +E+A G 
Sbjct: 176 IKQS--AYDSKADIWSLGITAIELARGE 201

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 16/198 (8%)
Query: 196 LGQGGFGSVYKGQLHT----GRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +G+G FG V++G   +       +A+K  +N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G  +E     ++ E    G L   +   + +  +     L   A   +  +AYL +    
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYLESKR-- 131
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
             +H DI   N+L+      K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 132 -FVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 187
Query: 370 TVSCKSDVYGFGMVLLEM 387
             +  SDV+ FG+ + E+
Sbjct: 188 RFTSASDVWMFGVCMWEI 205

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 196 LGQGGFGSVYKGQLHT--GRLIAVKMLENSKFSAEEFIN-----EVSTIGRIHHVNVVQL 248
           LG+G FG V K   HT  G+ +A+K++ N K  A+  +      E+S +  + H ++++L
Sbjct: 12  LGEGSFGKV-KLAYHTTTGQKVALKII-NKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 69
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
                   +  +V E+  N   D +I  ++   +       Q+I       V Y H    
Sbjct: 70  YDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQII----SAVEYCHRHK- 123
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             I+H D+KP N+LLD +   K++DFGL+     + +F+  S   G+  Y APE+IS   
Sbjct: 124 --IVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSC--GSPNYAAPEVISGKL 178
Query: 369 GTVSCKSDVYGFGMVLLEMAGGR 391
                + DV+  G++L  M   R
Sbjct: 179 -YAGPEVDVWSCGVILYVMLCRR 200

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 100/221 (45%), Gaps = 22/221 (9%)
Query: 184 EIIAVTNHFT--HKLGQGGFGSVYKGQL--HTGRLI--AVKMLENSKFSA---EEFINEV 234
           +++     FT    LG+G FGSV + QL    G  +  AVKML+    ++   EEF+ E 
Sbjct: 17  DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREA 76
Query: 235 STIGRIHHVNVVQLLGFCSEGSKRA------LVYEFMPNGSLDRHIFPKENKGQTFGW-- 286
           + +    H +V +L+G       +       ++  FM +G L   +         F    
Sbjct: 77  ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 287 EKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 346
           + L    +  A G+ YL +      +H D+   N +L  +    V+DFGL++     + +
Sbjct: 137 QTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY 193
Query: 347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
               A++  + ++A E ++ N  TV   SDV+ FG+ + E+
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTV--HSDVWAFGVTMWEI 232

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 23/198 (11%)
Query: 178 KRYSYPEIIA-----VTNHFT--HKLGQGGFGSVYK-GQLHTGRLIAVKMLENSKFSAEE 229
           K+Y YP+ +      V +H+    +LG G FG V++  +  TG   A K +     S +E
Sbjct: 35  KQY-YPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 93
Query: 230 FI-NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEK 288
            +  E+ T+  + H  +V L     + ++  ++YEFM  G L   +  + NK      ++
Sbjct: 94  TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDE 150
Query: 289 LQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL--DHNFIPKVSDFGL-AKFHPKEND 345
             E      +G+ ++H       +H D+KP NI+     +   K+ DFGL A   PK+  
Sbjct: 151 AVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-- 205
Query: 346 FVSISATRGTIGYIAPEL 363
             S+  T GT  + APE+
Sbjct: 206 --SVKVTTGTAEFAAPEV 221

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 194 HKLGQGGFGSVYKG-QLHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
            K+G+G FG V+KG    T +++A+K+  LE ++   E+   E++ + +     V +  G
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFP---KENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
              + +K  ++ E++  GS    + P    E +  T     L+EI     +G+ YLH+  
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATI----LREIL----KGLDYLHSEK 124
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPEL 363
               +H DIK  N+LL  +   K++DFG+A        K N FV      GT  ++APE+
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV------GTPFWMAPEV 175
Query: 364 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           I ++      K+D++  G+  +E+A G 
Sbjct: 176 IKQS--AYDSKADIWSLGITAIELARGE 201

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 23/198 (11%)
Query: 178 KRYSYPEIIA-----VTNHFT--HKLGQGGFGSVYK-GQLHTGRLIAVKMLENSKFSAEE 229
           K+Y YP+ +      V +H+    +LG G FG V++  +  TG   A K +     S +E
Sbjct: 141 KQY-YPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 199
Query: 230 FI-NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEK 288
            +  E+ T+  + H  +V L     + ++  ++YEFM  G L   +  + NK      ++
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDE 256
Query: 289 LQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL--DHNFIPKVSDFGL-AKFHPKEND 345
             E      +G+ ++H   +   +H D+KP NI+     +   K+ DFGL A   PK+  
Sbjct: 257 AVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-- 311
Query: 346 FVSISATRGTIGYIAPEL 363
             S+  T GT  + APE+
Sbjct: 312 --SVKVTTGTAEFAAPEV 327

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 124/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     +G G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E+MP G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     KV+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 192 FTHKLGQGGFG--SVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLL 249
           F   +G G FG   + + +L T  L+AVK +E      E    E+     + H N+V+  
Sbjct: 24  FVKDIGSGNFGVARLMRDKL-TKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFK 82
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
                 +  A++ E+   G L   I    N G+ F  ++ +        GV+Y H+   M
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERIC---NAGR-FSEDEARFFFQQLLSGVSYCHS---M 135
Query: 310 CILHFDIKPHNILLDHNFIP--KVSDFGLAK---FHPKENDFVSISATRGTIGYIAPELI 364
            I H D+K  N LLD +  P  K+ DFG +K    H +        +T GT  YIAPE++
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK------STVGTPAYIAPEVL 189
Query: 365 SRNF--GTVSCKSDVYGFGMVLLEMAGG 390
            R    G +   +DV+  G+ L  M  G
Sbjct: 190 LRQEYDGKI---ADVWSCGVTLYVMLVG 214

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+E +     D   F   +         ++       +G+A+ H+     
Sbjct: 69  VIHTENKLYLVFEHVHQ---DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 174
Query: 371 VSCK-----SDVYGFGMVLLEMAGGR 391
           + CK      D++  G +  EM   R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 92/209 (44%), Gaps = 33/209 (15%)
Query: 196 LGQGGFGSVY--KGQLHTGRLIAVKMLEN----SKFSAEEFINEVSTIGRIHHVNVVQLL 249
           LG+G FG V   K ++ TG+  AVK++       K   E  + EV  + ++ H N+ +L 
Sbjct: 34  LGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
            F  +     LV E    G L   I  ++     F       I      G+ Y H     
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGITYXHKNK-- 146
Query: 310 CILHFDIKPHNILL-----DHNFIPKVSDFGLA---KFHPKENDFVSISATRGTIGYIAP 361
            I+H D+KP N+LL     D N   ++ DFGL+   +   K  D +      GT  YIAP
Sbjct: 147 -IVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASKKXKDKI------GTAYYIAP 197
Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           E++    GT   K DV+  G++L  +  G
Sbjct: 198 EVL---HGTYDEKCDVWSTGVILYILLSG 223

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 100/235 (42%), Gaps = 40/235 (17%)
Query: 191 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQ 247
               +LG GGFG V +     TG  +A+K    E S  + E +  E+  + +++H NVV 
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 248 LLGFCSEGSKRA------LVYEFMPNGSLDRHIFPKENK-GQTFGWEKLQEIALGTARGV 300
                    K A      L  E+   G L +++   EN  G   G   ++ +    +  +
Sbjct: 77  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG--PIRTLLSDISSAL 134
Query: 301 AYLHNGCDMCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKE---NDFVSISATRG 354
            YLH      I+H D+KP NI+L       I K+ D G AK   +     +FV      G
Sbjct: 135 RYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV------G 185
Query: 355 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW 409
           T+ Y+APEL+ +   TV+   D + FG +  E   G R            + P+W
Sbjct: 186 TLQYLAPELLEQKKYTVTV--DYWSFGTLAFECITGFR-----------PFLPNW 227

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 100/235 (42%), Gaps = 40/235 (17%)
Query: 191 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQ 247
               +LG GGFG V +     TG  +A+K    E S  + E +  E+  + +++H NVV 
Sbjct: 18  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 77
Query: 248 LLGFCSEGSKRA------LVYEFMPNGSLDRHIFPKENK-GQTFGWEKLQEIALGTARGV 300
                    K A      L  E+   G L +++   EN  G   G   ++ +    +  +
Sbjct: 78  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG--PIRTLLSDISSAL 135
Query: 301 AYLHNGCDMCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKE---NDFVSISATRG 354
            YLH      I+H D+KP NI+L       I K+ D G AK   +     +FV      G
Sbjct: 136 RYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV------G 186
Query: 355 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW 409
           T+ Y+APEL+ +   TV+   D + FG +  E   G R            + P+W
Sbjct: 187 TLQYLAPELLEQKKYTVTV--DYWSFGTLAFECITGFR-----------PFLPNW 228

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 112/243 (46%), Gaps = 18/243 (7%)
Query: 152 IHKYRTTLQTVDNIEKFLHNQQSW-MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKG--- 207
           +  +  ++   D+  + +  + ++ MP    Y EI          +G+G FG V++G   
Sbjct: 354 VRSHTVSVSETDDYAEIIDEEDTYTMPSTRDY-EIQRERIELGRCIGEGQFGDVHQGIYM 412
Query: 208 -QLHTGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF 264
              +    +A+K  +N  S    E+F+ E  T+ +  H ++V+L+G  +E     ++ E 
Sbjct: 413 SPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMEL 471
Query: 265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD 324
              G L   +   + +  +     L   A   +  +AYL +      +H DI   N+L+ 
Sbjct: 472 CTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVS 525
Query: 325 HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 384
                K+ DFGL+++  +++ +   S  +  I ++APE I  NF   +  SDV+ FG+ +
Sbjct: 526 ATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCM 582
Query: 385 LEM 387
            E+
Sbjct: 583 WEI 585

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 196 LGQGGFGSVYKGQLHT--GRLIAVKMLENSKFSAEEFIN-----EVSTIGRIHHVNVVQL 248
           LG+G FG V K   HT  G+ +A+K++ N K  A+  +      E+S +  + H ++++L
Sbjct: 16  LGEGSFGKV-KLAYHTTTGQKVALKII-NKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 73
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
                   +  +V E+  N   D +I  ++   +       Q+I       V Y H    
Sbjct: 74  YDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQII----SAVEYCHR--- 125
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             I+H D+KP N+LLD +   K++DFGL+     + +F+  S   G+  Y APE+IS   
Sbjct: 126 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSC--GSPNYAAPEVISGKL 182
Query: 369 GTVSCKSDVYGFGMVLLEMAGGR 391
                + DV+  G++L  M   R
Sbjct: 183 -YAGPEVDVWSCGVILYVMLCRR 204

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 196 LGQGGFGSVYKGQLHT--GRLIAVKMLENSKFSAEEFIN-----EVSTIGRIHHVNVVQL 248
           LG+G FG V K   HT  G+ +A+K++ N K  A+  +      E+S +  + H ++++L
Sbjct: 22  LGEGSFGKV-KLAYHTTTGQKVALKII-NKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 79
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
                   +  +V E+  N   D +I  ++   +       Q+I       V Y H    
Sbjct: 80  YDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQII----SAVEYCHRHK- 133
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             I+H D+KP N+LLD +   K++DFGL+      N F+  S   G+  Y APE+IS   
Sbjct: 134 --IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-FLKTSC--GSPNYAAPEVISGKL 188
Query: 369 GTVSCKSDVYGFGMVLLEMAGGR 391
                + DV+  G++L  M   R
Sbjct: 189 -YAGPEVDVWSCGVILYVMLCRR 210

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 194 HKLGQGGFGSVYKG-QLHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
            K+G+G FG V+KG    T +++A+K+  LE ++   E+   E++ + +     V +  G
Sbjct: 33  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 92
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFP---KENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
              + +K  ++ E++  GS    + P    E +  T     L+EI     +G+ YLH+  
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATI----LREIL----KGLDYLHSEK 144
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPEL 363
               +H DIK  N+LL  +   K++DFG+A        K N FV      GT  ++APE+
Sbjct: 145 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEV 195
Query: 364 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           I ++      K+D++  G+  +E+A G 
Sbjct: 196 IKQS--AYDSKADIWSLGITAIELARGE 221

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 196 LGQGGFGSVYKGQLHT--GRLIAVKMLENSKFSAEEFIN-----EVSTIGRIHHVNVVQL 248
           LG+G FG V K   HT  G+ +A+K++ N K  A+  +      E+S +  + H ++++L
Sbjct: 21  LGEGSFGKV-KLAYHTTTGQKVALKII-NKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 78
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
                   +  +V E+  N   D +I  ++   +       Q+I       V Y H    
Sbjct: 79  YDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQII----SAVEYCHR--- 130
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             I+H D+KP N+LLD +   K++DFGL+      N F+  S   G+  Y APE+IS   
Sbjct: 131 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-FLKTSC--GSPNYAAPEVISGKL 187
Query: 369 GTVSCKSDVYGFGMVLLEMAGGR 391
                + DV+  G++L  M   R
Sbjct: 188 -YAGPEVDVWSCGVILYVMLCRR 209

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 194 HKLGQGGFGSVYKG-QLHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
            K+G+G FG V+KG    T +++A+K+  LE ++   E+   E++ + +     V +  G
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFP---KENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
              + +K  ++ E++  GS    + P    E +  T     L+EI     +G+ YLH+  
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATI----LREIL----KGLDYLHSEK 139
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPEL 363
               +H DIK  N+LL  +   K++DFG+A        K N FV      GT  ++APE+
Sbjct: 140 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV------GTPFWMAPEV 190
Query: 364 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           I ++      K+D++  G+  +E+A G 
Sbjct: 191 IKQS--AYDSKADIWSLGITAIELARGE 216

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 38/215 (17%)
Query: 194 HKLGQGGFGSVYKGQ-LHTGRLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLL 249
            K+G+G +G+V+K +   T  ++A+K +   ++ +      + E+  +  + H N+V+L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 250 GFCSEGSKRALVYEFMP----------NGSLDRHIFPKENKGQTFGWEKLQEIALGTARG 299
                  K  LV+EF            NG LD  I       ++F ++ L+ +    +R 
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIV------KSFLFQLLKGLGFCHSRN 121
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
           V           LH D+KP N+L++ N   K++DFGLA+           SA   T+ Y 
Sbjct: 122 V-----------LHRDLKPQNLLINRNGELKLADFGLARAFGIP--VRCYSAEVVTLWYR 168
Query: 360 APELISRNFGT--VSCKSDVYGFGMVLLEMAGGRR 392
            P+++   FG    S   D++  G +  E+A   R
Sbjct: 169 PPDVL---FGAKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 124/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     +G G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E+MP G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     KV+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 82/180 (45%), Gaps = 19/180 (10%)
Query: 216 AVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIF 275
           AVK+++ SK    E I  +   G+  H N++ L     +G    LV E M  G L   I 
Sbjct: 56  AVKVIDKSKRDPSEEIEILLRYGQ--HPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL 113
Query: 276 PKENKGQTFGWEKLQEIALGT-ARGVAYLHNGCDMCILHFDIKPHNIL-LDHNFIP---K 330
                 Q F  E+     L T  + V YLH+     ++H D+KP NIL +D +  P   +
Sbjct: 114 -----RQKFFSEREASFVLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGNPECLR 165
Query: 331 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           + DFG AK    EN  +       T  ++APE++ R      C  D++  G++L  M  G
Sbjct: 166 ICDFGFAKQLRAENGLLMTPCY--TANFVAPEVLKRQGYDEGC--DIWSLGILLYTMLAG 221

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 196 LGQGGFGSV-YKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 250
           LG+G FG V    +  TGR  A+K+L+     A++ +    T  R+     H  +  L  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                 +   V E+   G L  H+    ++ + F  ++ +         + YLH+  +  
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHS--EKN 269
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 369
           +++ D+K  N++LD +   K++DFGL K   K  D  ++    GT  Y+APE++  N +G
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDYG 327
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D +G G+V+ EM  GR
Sbjct: 328 RA---VDWWGLGVVMYEMMCGR 346

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 196 LGQGGFGSV-YKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 250
           LG+G FG V    +  TGR  A+K+L+     A++ +    T  R+     H  +  L  
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 218
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                 +   V E+   G L  H+    ++ + F  ++ +         + YLH+  +  
Sbjct: 219 SFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHS--EKN 272
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 369
           +++ D+K  N++LD +   K++DFGL K   K  D  ++    GT  Y+APE++  N +G
Sbjct: 273 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDYG 330
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D +G G+V+ EM  GR
Sbjct: 331 RA---VDWWGLGVVMYEMMCGR 349

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 183 PEIIAVTNHFTHKLGQGGFGSV-YKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI- 240
           P++      +   LG+G FG V    +  TGR  A+K+L      A++ +    T  R+ 
Sbjct: 5   PKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 64
Query: 241 ---HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
               H  +  L        +   V E+   G L  H+    ++ + F  E+ +       
Sbjct: 65  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIV 120
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
             + YLH+     +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  
Sbjct: 121 SALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPE 175
Query: 358 YIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGR 391
           Y+APE++  N +G      D +G G+V+ EM  GR
Sbjct: 176 YLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGR 207

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 120/293 (40%), Gaps = 35/293 (11%)
Query: 176 MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHT-GRLIAVKMLENSKFSAEE---FI 231
           MP R    E++       + +G G +G   K +  + G+++  K L+    +  E    +
Sbjct: 1   MPSRAEDYEVL-------YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV 53
Query: 232 NEVSTIGRIHHVNVVQLLGFCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFGWEKL 289
           +EV+ +  + H N+V+      + +   L  V E+   G L   I     + Q    E +
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 290 QEIALGTARGVAYLHNGCD--MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 347
             +       +   H   D    +LH D+KP N+ LD     K+ DFGLA+    +  F 
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173
Query: 348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP 407
              A  GT  Y++PE ++R   + + KSD++  G +L E+                A  P
Sbjct: 174 --KAFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELC---------------ALMP 214
Query: 408 SWV-YDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
            +  + Q    G +       I    + +L  I    + +K   RPS+ ++LE
Sbjct: 215 PFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 82/180 (45%), Gaps = 19/180 (10%)
Query: 216 AVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIF 275
           AVK+++ SK    E I  +   G+  H N++ L     +G    LV E M  G L   I 
Sbjct: 56  AVKVIDKSKRDPSEEIEILLRYGQ--HPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL 113
Query: 276 PKENKGQTFGWEKLQEIALGT-ARGVAYLHNGCDMCILHFDIKPHNIL-LDHNFIP---K 330
                 Q F  E+     L T  + V YLH+     ++H D+KP NIL +D +  P   +
Sbjct: 114 -----RQKFFSEREASFVLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGNPECLR 165
Query: 331 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           + DFG AK    EN  +       T  ++APE++ R      C  D++  G++L  M  G
Sbjct: 166 ICDFGFAKQLRAENGLLMTPCY--TANFVAPEVLKRQGYDEGC--DIWSLGILLYTMLAG 221

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 196 LGQGGFGSV-YKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 250
           LG+G FG V    +  TGR  A+K+L      A++ +    T  R+     H  +  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                 +   V E+   G L  H+    ++ + F  E+ +         + YLH+     
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHS---RD 125
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 369
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  Y+APE++  N +G
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D +G G+V+ EM  GR
Sbjct: 184 RA---VDWWGLGVVMYEMMCGR 202

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 196 LGQGGFGSV-YKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 250
           LG+G FG V    +  TGR  A+K+L      A++ +    T  R+     H  +  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                 +   V E+   G L  H+    ++ + F  E+ +         + YLH+     
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHS---RD 125
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 369
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  Y+APE++  N +G
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D +G G+V+ EM  GR
Sbjct: 184 RA---VDWWGLGVVMYEMMCGR 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 196 LGQGGFGSV-YKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 250
           LG+G FG V    +  TGR  A+K+L      A++ +    T  R+     H  +  L  
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 75
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                 +   V E+   G L  H+    ++ + F  E+ +         + YLH+     
Sbjct: 76  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHS---RD 128
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 369
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  Y+APE++  N +G
Sbjct: 129 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 186
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D +G G+V+ EM  GR
Sbjct: 187 RA---VDWWGLGVVMYEMMCGR 205

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 20/201 (9%)
Query: 196 LGQGGFGSVYKGQLH--TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS 253
           +G G + SV K  +H  T    AVK+++ SK    E I  +   G+  H N++ L     
Sbjct: 30  IGVGSY-SVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQ--HPNIITLKDVYD 86
Query: 254 EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILH 313
           +G    +V E M  G L   I     + + F   +   +     + V YLH      ++H
Sbjct: 87  DGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHA---QGVVH 139
Query: 314 FDIKPHNIL-LDHNFIP---KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
            D+KP NIL +D +  P   ++ DFG AK    EN  +       T  ++APE++ R   
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY--TANFVAPEVLERQGY 197
Query: 370 TVSCKSDVYGFGMVLLEMAGG 390
             +C  D++  G++L  M  G
Sbjct: 198 DAAC--DIWSLGVLLYTMLTG 216

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 196 LGQGGFGSV-YKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 250
           LG+G FG V    +  TGR  A+K+L      A++ +    T  R+     H  +  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                 +   V E+   G L  H+    ++ + F  E+ +         + YLH+     
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHS---RD 125
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 369
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  Y+APE++  N +G
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D +G G+V+ EM  GR
Sbjct: 184 RA---VDWWGLGVVMYEMMCGR 202

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 196 LGQGGFGSV-YKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 250
           LG+G FG V    +  TGR  A+K+L      A++ +    T  R+     H  +  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                 +   V E+   G L  H+    ++ + F  E+ +         + YLH+     
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHS---RD 125
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 369
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  Y+APE++  N +G
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D +G G+V+ EM  GR
Sbjct: 184 RA---VDWWGLGVVMYEMMCGR 202

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 183 PEIIAVTNHFTHKLGQGGFGSV-YKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI- 240
           P +      +   LG+G FG V    +  TGR  A+K+L+     A++ +    T  R+ 
Sbjct: 5   PRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 64
Query: 241 ---HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
               H  +  L        +   V E+   G L  H+    ++ + F  ++ +       
Sbjct: 65  QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIV 120
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
             + YLH+  +  +++ D+K  N++LD +   K++DFGL K   K  D  ++    GT  
Sbjct: 121 SALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKXFCGTPE 176
Query: 358 YIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGR 391
           Y+APE++  N +G      D +G G+V+ EM  GR
Sbjct: 177 YLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGR 208

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 124/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E+ P G +  H+
Sbjct: 73  ILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+++D     KV+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           GLAK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GLAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 107/246 (43%), Gaps = 39/246 (15%)
Query: 186 IAVTNHFTHK-LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRI--- 240
           + + +   HK LG+G FG V+  +   T +  A+K L+      ++ +       R+   
Sbjct: 14  LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 241 --HHVNVVQLLGFCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGT 296
              H  +  +  FC+  +K  L  V E++  G L  HI         F   +    A   
Sbjct: 74  AWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEI 127
Query: 297 ARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH----PKENDFVSISAT 352
             G+ +LH+     I++ D+K  NILLD +   K++DFG+ K +     K N F      
Sbjct: 128 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC----- 179
Query: 353 RGTIGYIAPELISRNFGTVSCKS-DVYGFGMVLLEMAGGR-------RNSNMNAIRSSKA 404
            GT  YIAPE++    G     S D + FG++L EM  G+            ++IR    
Sbjct: 180 -GTPDYIAPEIL---LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 235
Query: 405 YFPSWV 410
           ++P W+
Sbjct: 236 FYPRWL 241

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 196 LGQGGFGSV-YKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 250
           LG+G FG V    +  TGR  A+K+L      A++ +    T  R+     H  +  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                 +   V E+   G L  H+    ++ + F  E+ +         + YLH+     
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHS---RD 125
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 369
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  Y+APE++  N +G
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D +G G+V+ EM  GR
Sbjct: 184 RA---VDWWGLGVVMYEMMCGR 202

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 88/180 (48%), Gaps = 16/180 (8%)
Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFC 252
           LGQG   +V++G+   TG L A+K+  N  F    +  + E   + +++H N+V+L    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 253 SEGSKR--ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
            E + R   L+ EF P GSL   +   E     +G  +  E  +     V  +++  +  
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVL---EEPSNAYGLPE-SEFLIVLRDVVGGMNHLRENG 132
Query: 311 ILHFDIKPHNILL----DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
           I+H +IKP NI+     D   + K++DFG A+    +  FVS+    GT  Y+ P++  R
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTEEYLHPDMYER 189

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 108/246 (43%), Gaps = 39/246 (15%)
Query: 186 IAVTNHFTHK-LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRI--- 240
           + + +   HK LG+G FG V+  +   T +  A+K L+      ++ +       R+   
Sbjct: 15  LKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 74
Query: 241 --HHVNVVQLLGFCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGT 296
              H  +  +  FC+  +K  L  V E++  G L  HI         F   +    A   
Sbjct: 75  AWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEI 128
Query: 297 ARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH----PKENDFVSISAT 352
             G+ +LH+     I++ D+K  NILLD +   K++DFG+ K +     K N+F      
Sbjct: 129 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFC----- 180
Query: 353 RGTIGYIAPELISRNFGTVSCKS-DVYGFGMVLLEMAGGR-------RNSNMNAIRSSKA 404
            GT  YIAPE++    G     S D + FG++L EM  G+            ++IR    
Sbjct: 181 -GTPDYIAPEIL---LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 236
Query: 405 YFPSWV 410
           ++P W+
Sbjct: 237 FYPRWL 242

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G+G F  V   + + TG+ +AVK+++ ++    S ++   EV  +  ++H N+V+L   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                   LV E+   G +  ++          GW K +E      + V+ +       I
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLV-------AHGWMKEKEARAKFRQIVSAVQYCHQKFI 127
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELISRNF 368
           +H D+K  N+LLD +   K++DFG +      N+F     +    G+  Y APEL     
Sbjct: 128 VHRDLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDTFCGSPPYAAPELFQGK- 180
Query: 369 GTVSCKSDVYGFGMVLLEMAGG 390
                + DV+  G++L  +  G
Sbjct: 181 KYDGPEVDVWSLGVILYTLVSG 202

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 196 LGQGGFGSV-YKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 250
           LG+G FG V    +  TGR  A+K+L+     A++ +    T  R+     H  +  L  
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 75
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                 +   V E+   G L  H+    ++ + F  ++ +         + YLH+  +  
Sbjct: 76  SFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHS--EKN 129
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 369
           +++ D+K  N++LD +   K++DFGL K   K  D  ++    GT  Y+APE++  N +G
Sbjct: 130 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKXFCGTPEYLAPEVLEDNDYG 187
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D +G G+V+ EM  GR
Sbjct: 188 RA---VDWWGLGVVMYEMMCGR 206

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 119/293 (40%), Gaps = 35/293 (11%)
Query: 176 MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHT-GRLIAVKMLENSKFSAEE---FI 231
           MP R    E++       + +G G +G   K +  + G+++  K L+    +  E    +
Sbjct: 1   MPSRAEDYEVL-------YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV 53
Query: 232 NEVSTIGRIHHVNVVQLLGFCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFGWEKL 289
           +EV+ +  + H N+V+      + +   L  V E+   G L   I     + Q    E +
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 290 QEIALGTARGVAYLHNGCD--MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 347
             +       +   H   D    +LH D+KP N+ LD     K+ DFGLA+    +  F 
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173
Query: 348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP 407
                 GT  Y++PE ++R   + + KSD++  G +L E+                A  P
Sbjct: 174 KTFV--GTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELC---------------ALMP 214
Query: 408 SWV-YDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
            +  + Q    G +       I    + +L  I    + +K   RPS+ ++LE
Sbjct: 215 PFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 98/200 (49%), Gaps = 12/200 (6%)
Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE--FINEVSTIGR-IHHVNVVQLLG 250
           +LG+G +G V K + + +G++ AVK +  +  S E+   + ++    R +     V   G
Sbjct: 41  ELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYG 100
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                    +  E + + SLD+      +KGQT   + L +IA+   + + +LH+   + 
Sbjct: 101 ALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLS 157
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR--NF 368
           ++H D+KP N+L++     K  DFG++ +     D V+     G   Y APE I+   N 
Sbjct: 158 VIHRDVKPSNVLINALGQVKXCDFGISGYL---VDDVAKDIDAGCKPYXAPERINPELNQ 214
Query: 369 GTVSCKSDVYGFGMVLLEMA 388
              S KSD++  G+  +E+A
Sbjct: 215 KGYSVKSDIWSLGITXIELA 234

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 196 LGQGGFGSV-YKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 250
           LG+G FG V    +  TGR  A+K+L+     A++ +    T  R+     H  +  L  
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 76
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                 +   V E+   G L  H+    ++ + F  ++ +         + YLH+  +  
Sbjct: 77  SFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHS--EKN 130
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 369
           +++ D+K  N++LD +   K++DFGL K   K  D  ++    GT  Y+APE++  N +G
Sbjct: 131 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKXFCGTPEYLAPEVLEDNDYG 188
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D +G G+V+ EM  GR
Sbjct: 189 RA---VDWWGLGVVMYEMMCGR 207

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+E +     D   F   +         ++       +G+A+ H+     
Sbjct: 73  VIHTENKLYLVFEHVDQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HR 126
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 368
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 178
Query: 369 GTVSCK-----SDVYGFGMVLLEMAGGR 391
             + CK      D++  G +  EM   R
Sbjct: 179 --LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G+G F  V   + + TG+ +AVK+++ ++    S ++   EV  +  ++H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                   LV E+   G +  ++       +     K ++I       V Y H      I
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV----SAVQYCHQKF---I 134
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELISRNF 368
           +H D+K  N+LLD +   K++DFG +      N+F     + A  G   Y APEL  +  
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDAFCGAPPYAAPELF-QGK 187
Query: 369 GTVSCKSDVYGFGMVLLEMAGG 390
                + DV+  G++L  +  G
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSG 209

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G+G F  V   + + TGR +A+K+++ ++    S ++   EV  +  ++H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                   L+ E+   G +  ++       +     K ++I       V Y H      I
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----SAVQYCHQKR---I 135
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELISRNF 368
           +H D+K  N+LLD +   K++DFG +      N+F     + A  G   Y APEL  +  
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFS------NEFTVGGKLDAFCGAPPYAAPELF-QGK 188
Query: 369 GTVSCKSDVYGFGMVLLEMAGG 390
                + DV+  G++L  +  G
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSG 210

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 86/201 (42%), Gaps = 12/201 (5%)
Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+GGFG V+  Q+  TG+L A K L   +       +  + E   + ++H   +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   LV   M  G +  HI+  +     F   +          G+ +LH      
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RN 309
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           I++ D+KP N+LLD +   ++SD GLA    K           GT G++APEL+      
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQ-TKTKGYAGTPGFMAPELLLGEEYD 367
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
            S   D +  G+ L EM   R
Sbjct: 368 FSV--DYFALGVTLYEMIAAR 386

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 29/216 (13%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           LG+GGFG V++ +        A+K   L N + + E+ + EV  + ++ H  +V+     
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 253 SEGSKRALVYEFMPNGSL--DRHIFPKEN-KGQTFGWEKLQE--------IALGTARGVA 301
            E +    +    P   L     +  KEN K    G   ++E        I L  A  V 
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI----------SA 351
           +LH+     ++H D+KP NI    + + KV DFGL     ++ +  ++          + 
Sbjct: 133 FLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 352 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
             GT  Y++PE I  N  + S K D++  G++L E+
Sbjct: 190 QVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFEL 223

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 86/201 (42%), Gaps = 12/201 (5%)
Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+GGFG V+  Q+  TG+L A K L   +       +  + E   + ++H   +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   LV   M  G +  HI+  +     F   +          G+ +LH      
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RN 309
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           I++ D+KP N+LLD +   ++SD GLA    K           GT G++APEL+      
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQ-TKTKGYAGTPGFMAPELLLGEEYD 367
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
            S   D +  G+ L EM   R
Sbjct: 368 FSV--DYFALGVTLYEMIAAR 386

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 29/209 (13%)
Query: 200 GFGSVYKGQLH--TGRLIAVKMLE---NSKFSAEEF-------INEVSTIGRIH-HVNVV 246
           G  SV +  +H  T +  AVK+++      FSAEE        + EV  + ++  H N++
Sbjct: 28  GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 87
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           QL       +   LV++ M  G L  ++  K     T   ++ ++I       +  LH  
Sbjct: 88  QLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHK- 142
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISATRGTIGYIAPELI- 364
             + I+H D+KP NILLD +   K++DFG + +  P E     + +  GT  Y+APE+I 
Sbjct: 143 --LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK----LRSVCGTPSYLAPEIIE 196
Query: 365 ---SRNFGTVSCKSDVYGFGMVLLEMAGG 390
              + N      + D++  G+++  +  G
Sbjct: 197 CSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 86/201 (42%), Gaps = 12/201 (5%)
Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+GGFG V+  Q+  TG+L A K L   +       +  + E   + ++H   +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   LV   M  G +  HI+  +     F   +          G+ +LH      
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RN 309
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           I++ D+KP N+LLD +   ++SD GLA    K           GT G++APEL+      
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQ-TKTKGYAGTPGFMAPELLLGEEYD 367
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
            S   D +  G+ L EM   R
Sbjct: 368 FSV--DYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 86/201 (42%), Gaps = 12/201 (5%)
Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+GGFG V+  Q+  TG+L A K L   +       +  + E   + ++H   +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   LV   M  G +  HI+  +     F   +          G+ +LH      
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RN 309
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           I++ D+KP N+LLD +   ++SD GLA    K           GT G++APEL+      
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQ-TKTKGYAGTPGFMAPELLLGEEYD 367
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
            S   D +  G+ L EM   R
Sbjct: 368 FSV--DYFALGVTLYEMIAAR 386

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 109/247 (44%), Gaps = 32/247 (12%)
Query: 196 LGQGGFGSVY-KGQLHTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 250
           LG G FG V     + TG   A+K+L+  K       E  +NE   +  ++   +V+L  
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 94
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
              + S   +V E++P G +  H+     +   F     +  A        YLH+   + 
Sbjct: 95  SFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLHS---LD 147
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFG 369
           +++ D+KP N+L+D     +V+DFG AK   K   +       GT  Y+APE+I S+ + 
Sbjct: 148 LIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWTLC----GTPEYLAPEIILSKGYN 202
Query: 370 TVSCKSDVYGFGMVLLEMAGG-------RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL 422
                 D +  G+++ EMA G       +       I S K  FPS     L    DL L
Sbjct: 203 KA---VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-L 255
Query: 423 RNVTEIE 429
           RN+ +++
Sbjct: 256 RNLLQVD 262

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 107/244 (43%), Gaps = 40/244 (16%)
Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           LGQG FG V K +     R  A+K + +++      ++EV  +  ++H  VV+      E
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWLE 73
Query: 255 G----------SKRALVY---EFMPNGSLDRHIFPKE-NKGQTFGWEKLQEIALGTARGV 300
                       K++ ++   E+  N +L   I  +  N+ +   W   ++I       +
Sbjct: 74  RRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL----EAL 129
Query: 301 AYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV------------S 348
           +Y+H+     I+H ++KP NI +D +   K+ DFGLAK   +  D +            +
Sbjct: 130 SYIHS---QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-----AGGRRNSNMNAIRSSK 403
           +++  GT  Y+A E++    G  + K D Y  G++  E       G  R + +  +RS  
Sbjct: 187 LTSAIGTAXYVATEVLD-GTGHYNEKIDXYSLGIIFFEXIYPFSTGXERVNILKKLRSVS 245
Query: 404 AYFP 407
             FP
Sbjct: 246 IEFP 249

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G+G F  V   + + TGR +AVK+++ ++    S ++   EV  +  ++H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                   LV E+   G +  ++       +     K ++I       V Y H      I
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV----SAVQYCHQ---KYI 135
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELISRNF 368
           +H D+K  N+LLD +   K++DFG +      N+F     +    G+  Y APEL  +  
Sbjct: 136 VHRDLKAENLLLDGDMNIKIADFGFS------NEFTVGNKLDTFCGSPPYAAPELF-QGK 188
Query: 369 GTVSCKSDVYGFGMVLLEMAGG 390
                + DV+  G++L  +  G
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSG 210

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 20/197 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGF 251
           +G+G F  V +  +L TG   A K++   K SA   ++   E      + H N+V+L   
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
            SE     LV++ +  G L   I  +E   +      +Q+I       V + H    M +
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQI----LEAVLHCHQ---MGV 124
Query: 312 LHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN- 367
           +H D+KP N+LL         K++DFGLA     + D  +     GT GY++PE++ +  
Sbjct: 125 VHRDLKPENLLLASKCKGAAVKLADFGLAI--EVQGDQQAWFGFAGTPGYLSPEVLRKEA 182
Query: 368 FGTVSCKSDVYGFGMVL 384
           +G      D++  G++L
Sbjct: 183 YGK---PVDIWACGVIL 196

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     +G G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     KV+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 34/218 (15%)
Query: 192 FTHKLGQGGFGSVYKG---------QLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHH 242
           F   LGQG F  ++KG         QLH   ++   + +  +  +E F    S + ++ H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
            ++V   G C  G +  LV EF+  GSLD ++  K+NK       KL E+A   A  + +
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKL-EVAKQLAAAMHF 128
Query: 303 LHNGCDMCILHFDIKPHNILL---------DHNFIPKVSDFGLA-KFHPKENDFVSISAT 352
           L       ++H ++   NILL         +  FI K+SD G++    PK+         
Sbjct: 129 LEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI-KLSDPGISITVLPKD-------IL 177
Query: 353 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           +  I ++ PE I  N   ++  +D + FG  L E+  G
Sbjct: 178 QERIPWVPPECIE-NPKNLNLATDKWSFGTTLWEICSG 214

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E+ P G +  H+
Sbjct: 73  ILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+++D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           GLAK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GLAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 125/283 (44%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 73
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 133
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK   K   +       GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 187 GFAK-RVKGRTWTLC----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 238
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 239 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 277

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 29/209 (13%)
Query: 200 GFGSVYKGQLH--TGRLIAVKMLE---NSKFSAEEF-------INEVSTIGRIH-HVNVV 246
           G  SV +  +H  T +  AVK+++      FSAEE        + EV  + ++  H N++
Sbjct: 15  GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 74
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           QL       +   LV++ M  G L  ++  K     T   ++ ++I       +  LH  
Sbjct: 75  QLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHK- 129
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISATRGTIGYIAPELI- 364
             + I+H D+KP NILLD +   K++DFG + +  P E     +    GT  Y+APE+I 
Sbjct: 130 --LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK----LREVCGTPSYLAPEIIE 183
Query: 365 ---SRNFGTVSCKSDVYGFGMVLLEMAGG 390
              + N      + D++  G+++  +  G
Sbjct: 184 CSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E+ P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+++D     KV+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 86  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMAGFVATR---WYRAPE-IMLN 192
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 22/199 (11%)
Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLG 250
           +LG+G F  V +  ++ TG+  A K++   K SA   ++   E      + H N+V+L  
Sbjct: 11  ELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 70
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH-NGCDM 309
             SE     LV++ +  G L   I  +E   +      +Q+I       V + H NG   
Sbjct: 71  SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQI----LESVNHCHLNG--- 123
Query: 310 CILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
            I+H D+KP N+LL         K++DFGLA     + D  +     GT GY++PE++ +
Sbjct: 124 -IVHRDLKPENLLLASKSKGAAVKLADFGLAI--EVQGDQQAWFGFAGTPGYLSPEVLRK 180
Query: 367 N-FGTVSCKSDVYGFGMVL 384
           + +G      D++  G++L
Sbjct: 181 DPYGK---PVDMWACGVIL 196

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMAGFVATR---WYRAPE-IMLN 196
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 73
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 133
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 238
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 239 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 277

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMAGFVATR---WYRAPE-IMLN 196
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 29/209 (13%)
Query: 200 GFGSVYKGQLH--TGRLIAVKMLE---NSKFSAEEF-------INEVSTIGRIH-HVNVV 246
           G  SV +  +H  T +  AVK+++      FSAEE        + EV  + ++  H N++
Sbjct: 28  GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 87
Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           QL       +   LV++ M  G L  ++  K     T   ++ ++I       +  LH  
Sbjct: 88  QLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHK- 142
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISATRGTIGYIAPELI- 364
             + I+H D+KP NILLD +   K++DFG + +  P E     +    GT  Y+APE+I 
Sbjct: 143 --LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK----LREVCGTPSYLAPEIIE 196
Query: 365 ---SRNFGTVSCKSDVYGFGMVLLEMAGG 390
              + N      + D++  G+++  +  G
Sbjct: 197 CSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDXELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G+G F  V   + + TG+ +AVK+++ ++    S ++   EV  +  ++H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                   LV E+   G +  ++       +     K ++I       V Y H      I
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV----SAVQYCHQKF---I 134
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELISRNF 368
           +H D+K  N+LLD +   K++DFG +      N+F     +    G+  Y APEL  +  
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDTFCGSPPYAAPELF-QGK 187
Query: 369 GTVSCKSDVYGFGMVLLEMAGG 390
                + DV+  G++L  +  G
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSG 209

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G+G F  V   + + TG+ +AVK+++ ++    S ++   EV  +  ++H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                   LV E+   G +  ++       +     K ++I       V Y H      I
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV----SAVQYCHQKF---I 134
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELISRNF 368
           +H D+K  N+LLD +   K++DFG +      N+F     +    G+  Y APEL  +  
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDTFCGSPPYAAPELF-QGK 187
Query: 369 GTVSCKSDVYGFGMVLLEMAGG 390
                + DV+  G++L  +  G
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSG 209

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE-NSKFSAEEFINEVSTIGRIH-HVNVVQLLGFC 252
           LG+G +  V     L  G+  AVK++E  +  S      EV T+ +   + N+++L+ F 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
            + ++  LV+E +  GS+  HI     K + F   +   +    A  + +LH      I 
Sbjct: 81  EDDTRFYLVFEKLQGGSILAHI----QKQKHFNEREASRVVRDVAAALDFLHT---KGIA 133
Query: 313 HFDIKPHNILLD--HNFIP-KVSDFGLAKFHPKENDFVSISATR-----GTIGYIAPELI 364
           H D+KP NIL +      P K+ DF L       N    I+        G+  Y+APE++
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVV 193
Query: 365 -----SRNFGTVSCKSDVYGFGMVLLEMAGG 390
                   F    C  D++  G+VL  M  G
Sbjct: 194 EVFTDQATFYDKRC--DLWSLGVVLYIMLSG 222

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 100 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 155
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 156 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 206
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 207 WMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 95  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 151 ---IIHRDLKPSNLAVNEDXELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 201
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E+ P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+++D     KV+DF
Sbjct: 133 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 86  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 192
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 21/202 (10%)
Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G+G F  V   + + TG+ +AVK+++ ++    S ++   EV     ++H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                   LV E+   G +  ++       +     K ++I       V Y H      I
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIV----SAVQYCHQ---KFI 134
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELISRNF 368
           +H D+K  N+LLD +   K++DFG +      N+F     + A  G   Y APEL  +  
Sbjct: 135 VHRDLKAENLLLDADXNIKIADFGFS------NEFTFGNKLDAFCGAPPYAAPELF-QGK 187
Query: 369 GTVSCKSDVYGFGMVLLEMAGG 390
                + DV+  G++L  +  G
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSG 209

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 73
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 133
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 134 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 238
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 239 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 277

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 38/215 (17%)
Query: 194 HKLGQGGFGSVYKGQ-LHTGRLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLL 249
            K+G+G +G+V+K +   T  ++A+K +   ++ +      + E+  +  + H N+V+L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 250 GFCSEGSKRALVYEFMP----------NGSLDRHIFPKENKGQTFGWEKLQEIALGTARG 299
                  K  LV+EF            NG LD  I       ++F ++ L+ +    +R 
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIV------KSFLFQLLKGLGFCHSRN 121
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
           V           LH D+KP N+L++ N   K+++FGLA+           SA   T+ Y 
Sbjct: 122 V-----------LHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRCYSAEVVTLWYR 168
Query: 360 APELISRNFGT--VSCKSDVYGFGMVLLEMAGGRR 392
            P+++   FG    S   D++  G +  E+A   R
Sbjct: 169 PPDVL---FGAKLYSTSIDMWSAGCIFAELANAGR 200

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 34/218 (15%)
Query: 192 FTHKLGQGGFGSVYKG---------QLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHH 242
           F   LGQG F  ++KG         QLH   ++   + +  +  +E F    S + ++ H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
            ++V   G C  G +  LV EF+  GSLD ++  K+NK       KL E+A   A  + +
Sbjct: 72  KHLVLNYGVCFCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKL-EVAKQLAWAMHF 128
Query: 303 LHNGCDMCILHFDIKPHNILL---------DHNFIPKVSDFGLA-KFHPKENDFVSISAT 352
           L       ++H ++   NILL         +  FI K+SD G++    PK+         
Sbjct: 129 LEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI-KLSDPGISITVLPKD-------IL 177
Query: 353 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
           +  I ++ PE I  N   ++  +D + FG  L E+  G
Sbjct: 178 QERIPWVPPECIE-NPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 22/199 (11%)
Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLG 250
           +LG+G F  V +  ++ TG+  A K++   K SA   ++   E      + H N+V+L  
Sbjct: 11  ELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 70
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH-NGCDM 309
             SE     LV++ +  G L   I  +E   +      +Q+I       V + H NG   
Sbjct: 71  SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQI----LESVNHCHLNG--- 123
Query: 310 CILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
            I+H D+KP N+LL         K++DFGLA     + D  +     GT GY++PE++ +
Sbjct: 124 -IVHRDLKPENLLLASKSKGAAVKLADFGLAI--EVQGDQQAWFGFAGTPGYLSPEVLRK 180
Query: 367 N-FGTVSCKSDVYGFGMVL 384
           + +G      D++  G++L
Sbjct: 181 DPYGK---PVDMWACGVIL 196

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 95  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 151 ---IIHRDLKPSNLAVNEDXELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 201
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G+G F  V   + + TGR +A+K+++ ++    S ++   EV  +  ++H N+V+L   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                   L+ E+   G +  ++       +     K ++I       V Y H      I
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----SAVQYCHQ---KRI 132
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELISRNF 368
           +H D+K  N+LLD +   K++DFG +      N+F     +    G+  Y APEL  +  
Sbjct: 133 VHRDLKAENLLLDADMNIKIADFGFS------NEFTVGGKLDTFCGSPPYAAPELF-QGK 185
Query: 369 GTVSCKSDVYGFGMVLLEMAGG 390
                + DV+  G++L  +  G
Sbjct: 186 KYDGPEVDVWSLGVILYTLVSG 207

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 86/175 (49%), Gaps = 17/175 (9%)
Query: 195 KLGQGGFGSVYK-GQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS 253
           +LG+G    VY+  Q  T +  A+K+L+ +    +    E+  + R+ H N+++L     
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKT-VDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 254 EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH-NGCDMCIL 312
             ++ +LV E +  G L   I  K    +    + +++I       VAYLH NG    I+
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL----EAVAYLHENG----IV 170
Query: 313 HFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
           H D+KP N+L      +   K++DFGL+K    +   V +    GT GY APE++
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVCGTPGYCAPEIL 222

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 20/198 (10%)
Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLG 250
           +LG+G F  V +  ++  G+  A K++   K SA   ++   E      + H N+V+L  
Sbjct: 29  ELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 88
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
             SE     L+++ +  G L   I  +E   +      +Q+I       V + H    M 
Sbjct: 89  SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL----EAVLHCHQ---MG 141
Query: 311 ILHFDIKPHNILLDHNF---IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
           ++H D+KP N+LL         K++DFGLA     E +  +     GT GY++PE++ ++
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAI--EVEGEQQAWFGFAGTPGYLSPEVLRKD 199
Query: 368 -FGTVSCKSDVYGFGMVL 384
            +G      D++  G++L
Sbjct: 200 PYGK---PVDLWACGVIL 214

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 96  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 152 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 202
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGXVATR---WYRAPE-IMLN 196
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 92/202 (45%), Gaps = 21/202 (10%)
Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G+G F  V   + + TG+ +AV++++ ++    S ++   EV  +  ++H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                   LV E+   G +  ++       +     K ++I       V Y H      I
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV----SAVQYCHQKF---I 134
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAK---FHPKENDFVSISATRGTIGYIAPELISRNF 368
           +H D+K  N+LLD +   K++DFG +    F  K ++F       G+  Y APEL  +  
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFC------GSPPYAAPELF-QGK 187
Query: 369 GTVSCKSDVYGFGMVLLEMAGG 390
                + DV+  G++L  +  G
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSG 209

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 100/233 (42%), Gaps = 38/233 (16%)
Query: 176 MPKRYSYPEIIAVTNHFTHK--LGQGGFGSVYKG-QLHTGRLIAVKMLE--NSKFSAEEF 230
           MPKR  Y     +++ F  K  LG+G +G V       TG ++A+K +E  +    A   
Sbjct: 1   MPKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT 56
Query: 231 INEVSTIGRIHHVNVVQLLGFCSEGS-----KRALVYEFMPNGSLDRHIFPKENKGQTFG 285
           + E+  +    H N++ +       S     +  ++ E M    L R I       Q   
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI-----STQMLS 110
Query: 286 WEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF------ 339
            + +Q     T R V  LH      ++H D+KP N+L++ N   KV DFGLA+       
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 340 ---HP--KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
               P  +++  V   ATR    Y APE++  +    S   DV+  G +L E+
Sbjct: 168 DNSEPTGQQSGMVEFVATR---WYRAPEVMLTS-AKYSRAMDVWSCGCILAEL 216

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 200 GFGSVYKGQLH--TGRLIAVKMLE-NSKFSAEEFINEVSTIGRIH---------HVNVVQ 247
           G  SV +  +H  TG   AVK++E  ++  + E + EV    R           H +++ 
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164
Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
           L+      S   LV++ M  G L    F    +      ++ + I       V++LH   
Sbjct: 165 LIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETRSIMRSLLEAVSFLHANN 220
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISATRGTIGYIAPELISR 366
              I+H D+KP NILLD N   ++SDFG +    P E     +    GT GY+APE++  
Sbjct: 221 ---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK----LRELCGTPGYLAPEILKC 273
Query: 367 NFGTV----SCKSDVYGFGMVLLEMAGG 390
           +          + D++  G++L  +  G
Sbjct: 274 SMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 95  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 151 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 201
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 87  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 142
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 143 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 193
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 194 WMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 87  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 142
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 143 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 193
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 194 WMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 110 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 165
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 166 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 216
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV     + +G  IAVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 252 CSEGSKRA------LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
            +  +         LV   M    L+  +     K Q    + +Q +     RG+ Y+H+
Sbjct: 119 FTPATSLEEFNDVYLVTHLM-GADLNNIV-----KCQKLTDDHVQFLIYQILRGLKYIHS 172
Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
                I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++ 
Sbjct: 173 AD---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM- 223
Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGR 391
            N+   +   D++  G ++ E+  GR
Sbjct: 224 LNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 101 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 156
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 157 ---IIHRDLKPSNLAVNEDXELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 207
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 208 WMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 76/155 (49%), Gaps = 18/155 (11%)
Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKML----ENSKFSAEEFINEVSTIGRIH-HVNV 245
              KLG+G +G V+K     TG ++AVK +    +NS   A+    E+  +  +  H N+
Sbjct: 13  LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST-DAQRTFREIMILTELSGHENI 71
Query: 246 VQLLGFCSEGSKRA--LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V LL      + R   LV+++M     D H   + N  +       Q +     + + YL
Sbjct: 72  VNLLNVLRADNDRDVYLVFDYM---ETDLHAVIRANILEPV---HKQYVVYQLIKVIKYL 125
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK 338
           H+G    +LH D+KP NILL+     KV+DFGL++
Sbjct: 126 HSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 95  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 151 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 201
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 86  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 192
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 89  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 144
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 145 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 195
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 196 WMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 97  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 153 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 203
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 109 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 164
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 165 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 215
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 216 WMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 122/282 (43%), Gaps = 35/282 (12%)
Query: 164 NIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVKM 219
           ++++FL   +    K++  P +  A  + F     LG G FG V       TG   A+K+
Sbjct: 7   DVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKI 66
Query: 220 LENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIF 275
           L+  K       E  +NE   +  ++   +V+L     + S   +V E++P G +  H+ 
Sbjct: 67  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL- 125
Query: 276 PKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFG 335
               +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DFG
Sbjct: 126 ---RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG 179
Query: 336 LAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG---- 390
            AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G    
Sbjct: 180 FAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPPF 231
Query: 391 ---RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
              +       I S K  FPS     L    DL LRN+ +++
Sbjct: 232 FADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 269

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 96  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 152 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 202
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +G+V       TG  +A+K L     S+  A+    E+  +  + H NV+ LL  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 252 CSEGSKRALVYEF---MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
            +         +F   MP    D     K  K +  G +++Q +     +G+ Y+H    
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTD---LGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG- 148
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             I+H D+KP N+ ++ +   K+ DFGLA+    +++      TR    Y APE+I  N+
Sbjct: 149 --IIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMXGXVVTR---WYRAPEVIL-NW 200
Query: 369 GTVSCKSDVYGFGMVLLEMAGGR 391
              +   D++  G ++ EM  G+
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 92  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 148 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 198
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 96  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 152 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 202
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 92  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 148 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 198
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G+G F  V   + + TG+ +AV++++ ++    S ++   EV  +  ++H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                   LV E+   G +  ++       +     K ++I       V Y H      I
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV----SAVQYCHQKF---I 134
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELISRNF 368
           +H D+K  N+LLD +   K++DFG +      N+F     +    G+  Y APEL  +  
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDTFCGSPPYAAPELF-QGK 187
Query: 369 GTVSCKSDVYGFGMVLLEMAGG 390
                + DV+  G++L  +  G
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSG 209

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 96  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 152 ---IIHRDLKPSNLAVNEDSELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 202
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMK 73
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 133
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 238
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 239 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 277

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 92  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 148 ---IIHRDLKPSNLAVNEDSELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 198
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 110 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 165
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 166 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMXGXVATR---WYRAPE-IMLN 216
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 88  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 143
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 144 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 194
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 195 WMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 92  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 148 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 198
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 101 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 156
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 157 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 207
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 208 WMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E+ P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+++D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 102 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 158 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 208
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMK 73
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 133
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 238
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 239 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 277

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 102 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 158 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 208
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 102 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 158 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 208
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMK 73
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 133
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 238
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 239 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 277

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 113 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 168
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 169 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 219
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 220 WMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 122/282 (43%), Gaps = 35/282 (12%)
Query: 164 NIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVKM 219
           ++++FL   +    K++  P +  A  + F     LG G FG V       TG   A+K+
Sbjct: 7   DVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKI 66
Query: 220 LENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIF 275
           L+  K       E  +NE   +  ++   +V+L     + S   +V E++P G +  H+ 
Sbjct: 67  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL- 125
Query: 276 PKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFG 335
               +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DFG
Sbjct: 126 ---RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG 179
Query: 336 LAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG---- 390
            AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G    
Sbjct: 180 FAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPPF 231
Query: 391 ---RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
              +       I S K  FPS     L    DL LRN+ +++
Sbjct: 232 FADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 269

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMK 73
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E+ P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL 133
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+++D     KV+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDF 186
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 238
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 239 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 277

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 73
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   + +L     + S   +V E+ P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL 133
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+++D     KV+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDF 186
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 238
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 239 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 277

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 97  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  Y APE I  N
Sbjct: 153 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPE-IMLN 203
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 109 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 164
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 165 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 215
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 216 WMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 110 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 165
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 166 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 216
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 73
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   + +L     + S   +V E+ P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL 133
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+++D     KV+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDF 186
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 238
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 239 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 277

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       TG   A+K
Sbjct: 34  ESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMK 93
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++P G +  H+
Sbjct: 94  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 153
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 154 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 206
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 207 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 258
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 259 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 297

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 97  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  Y APE I  N
Sbjct: 153 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPE-IMLN 203
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 97  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  Y APE++  N
Sbjct: 153 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIM-LN 203
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 113 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 168
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 169 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMXGYVATR---WYRAPEIM-LN 219
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 220 WMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 39/215 (18%)
Query: 197 GQGGFGSVYKG-QLHTGRLIAVK-MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF--- 251
           GQG FG+V  G +  TG  +A+K ++++ +F   E +  +  +  +HH N+VQL  +   
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPNIVQLQSYFYT 90
Query: 252 CSEGSKRAL----VYEFMPN-------GSLDRHIFPKENKGQTFGWEKLQEIALGTARGV 300
             E  +R +    V E++P+           R + P     + F ++ +        R +
Sbjct: 91  LGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI--------RSI 142
Query: 301 AYLH-NGCDMCILHFDIKPHNILLDH-NFIPKVSDFGLA-KFHPKENDFVSISATRGTIG 357
             LH    ++C  H DIKPHN+L++  +   K+ DFG A K  P E +   I +      
Sbjct: 143 GCLHLPSVNVC--HRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY---- 196
Query: 358 YIAPELISRNFGT--VSCKSDVYGFGMVLLEMAGG 390
           Y APELI   FG    +   D++  G +  EM  G
Sbjct: 197 YRAPELI---FGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ D+GLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDYGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 30/228 (13%)
Query: 196 LGQGGFGSV---YKGQLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +G G +GSV   Y  +L     +AVK L     S   A     E+  +  + H NV+ LL
Sbjct: 36  VGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
              +  +      E     +L         K Q    E +Q +     RG+ Y+H+    
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAG-- 151
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
            I+H D+KP N+ ++ +   ++ DFGLA+    + +     ATR    Y APE++  N+ 
Sbjct: 152 -IIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEMTGYVATR---WYRAPEIM-LNWM 204
Query: 370 TVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVY-DQLNK 416
             +   D++  G ++ E+  G            KA FP   Y DQL +
Sbjct: 205 HYNQTVDIWSVGCIMAELLQG------------KALFPGSDYIDQLKR 240

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 102/245 (41%), Gaps = 27/245 (11%)
Query: 158 TLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQL----HTGR 213
            L+   NI+ FL N+   + K+    ++ A        +G+G FG V   QL     + +
Sbjct: 46  ALRKNKNIDNFL-NRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEV---QLVRHKASQK 101
Query: 214 LIAVKMLENSKF------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN 267
           + A+K+L  SKF       +  F  E   +   +   VVQL     +     +V E+MP 
Sbjct: 102 VYAMKLL--SKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPG 159
Query: 268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF 327
           G L   +    N      W K       TA  V  L     M ++H D+KP N+LLD + 
Sbjct: 160 GDL---VNLMSNYDVPEKWAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG 211
Query: 328 IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT--VSCKSDVYGFGMVLL 385
             K++DFG       E   V      GT  YI+PE++    G      + D +  G+ L 
Sbjct: 212 HLKLADFGTC-MKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLF 270
Query: 386 EMAGG 390
           EM  G
Sbjct: 271 EMLVG 275

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 73
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   + +L     + S   +V E+ P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL 133
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+++D     KV+DF
Sbjct: 134 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDF 186
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 238
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 239 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 277

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGL +    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDSELKILDFGLCRH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 191 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIH-------H 242
           H   K+G G FGSV+K  +   G + A+K    SK      ++E + +  ++       H
Sbjct: 10  HELEKIGSGEFGSVFKCVKRLDGCIYAIK---RSKKPLAGSVDEQNALREVYAHAVLGQH 66
Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
            +VV+     +E     +  E+   GSL   I         F   +L+++ L   RG+ Y
Sbjct: 67  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 126
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVS-------DFGLAKFHPKENDFVSIS----- 350
           +H+   M ++H DIKP NI +    IP  +       D+   K   K  D   ++     
Sbjct: 127 IHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 183
Query: 351 -ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
               G   ++A E++  N+ T   K+D++   + ++  AG 
Sbjct: 184 QVEEGDSRFLANEVLQENY-THLPKADIFALALTVVXAAGA 223

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 250
           +G+G +G V     +  ++ +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   +   ++    ++  ++ K  K Q    + +        RG+ Y+H+     
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 369
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D++  G +L EM   R
Sbjct: 205 YTKS-IDIWSVGCILAEMLSNR 225

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 30/225 (13%)
Query: 196 LGQGGFGSVY---KGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGR--IHHVNVVQLL 249
           LG G +G V+   K   H TG+L A+K+L+ +    +    E +   R  + H+     L
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 250 -----GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
                 F +E +K  L+ +++  G L  H+  +E     F   ++Q         + +LH
Sbjct: 122 VTLHYAFQTE-TKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLH 176
Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-----GTIGYI 359
               + I++ DIK  NILLD N    ++DFGL+K      +FV+    R     GTI Y+
Sbjct: 177 K---LGIIYRDIKLENILLDSNGHVVLTDFGLSK------EFVADETERAYDFCGTIEYM 227
Query: 360 APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA 404
           AP+++           D +  G+++ E+  G     ++  ++S+A
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA 272

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
               +   D++  G ++ E+  GR
Sbjct: 197 AMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 30/228 (13%)
Query: 196 LGQGGFGSV---YKGQLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +G G +GSV   Y  +L     +AVK L     S   A     E+  +  + H NV+ LL
Sbjct: 28  VGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
              +  +      E     +L         K Q    E +Q +     RG+ Y+H+    
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG-- 143
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
            I+H D+KP N+ ++ +   ++ DFGLA+    + +     ATR    Y APE++  N+ 
Sbjct: 144 -IIHRDLKPSNVAVNEDCELRILDFGLAR--QADEEMTGYVATR---WYRAPEIM-LNWM 196
Query: 370 TVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVY-DQLNK 416
             +   D++  G ++ E+  G            KA FP   Y DQL +
Sbjct: 197 HYNQTVDIWSVGCIMAELLQG------------KALFPGSDYIDQLKR 232

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 250
           +G+G +G V     +  ++ +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFP----KENKGQTFGWEKLQEIALGTARGVAYLHNG 306
                  RA   E M +  L  H+      K  K Q    + +        RG+ Y+H+ 
Sbjct: 109 II-----RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 163
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELIS 365
               +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++ 
Sbjct: 164 N---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGR 391
            + G      D++  G +L EM   R
Sbjct: 221 NSKGYTKS-IDIWSVGCILAEMLSNR 245

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 121/283 (42%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMK 73
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE      ++   +V+L     + S   +V E+ P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHL 133
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     KV+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADF 186
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 238
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 239 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 277

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 250
           +G+G +G V     +  ++ +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   +   ++    ++  ++ K  K Q    + +        RG+ Y+H+     
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 369
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D++  G +L EM   R
Sbjct: 205 YTK-SIDIWSVGCILAEMLSNR 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 250
           +G+G +G V     +  ++ +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   +   ++    ++  ++ K  K Q    + +        RG+ Y+H+     
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 369
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D++  G +L EM   R
Sbjct: 205 YTKS-IDIWSVGCILAEMLSNR 225

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 250
           +G+G +G V     +  ++ +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   +   ++    ++  ++ K  K Q    + +        RG+ Y+H+     
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 369
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D++  G +L EM   R
Sbjct: 205 YTKS-IDIWSVGCILAEMLSNR 225

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 99/233 (42%), Gaps = 38/233 (16%)
Query: 176 MPKRYSYPEIIAVTNHFTHK--LGQGGFGSVYKG-QLHTGRLIAVKMLE--NSKFSAEEF 230
           MPKR  Y     +++ F  K  LG+G +G V       TG ++A+K +E  +    A   
Sbjct: 1   MPKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT 56
Query: 231 INEVSTIGRIHHVNVVQLLGFCSEGS-----KRALVYEFMPNGSLDRHIFPKENKGQTFG 285
           + E+  +    H N++ +       S     +  ++ E M    L R I       Q   
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI-----STQMLS 110
Query: 286 WEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF------ 339
            + +Q     T R V  LH      ++H D+KP N+L++ N   KV DFGLA+       
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 340 ---HP--KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
               P  +++      ATR    Y APE++  +    S   DV+  G +L E+
Sbjct: 168 DNSEPTGQQSGMTEXVATR---WYRAPEVMLTS-AKYSRAMDVWSCGCILAEL 216

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 20/201 (9%)
Query: 196 LGQGGFGSVYKGQLH--TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS 253
           +G G + SV K  +H  T    AVK+++ SK    E I  +   G+  H N++ L     
Sbjct: 30  IGVGSY-SVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQ--HPNIITLKDVYD 86
Query: 254 EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILH 313
           +G    +V E    G L   I     + + F   +   +     + V YLH      ++H
Sbjct: 87  DGKYVYVVTELXKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHA---QGVVH 139
Query: 314 FDIKPHNIL-LDHNFIP---KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
            D+KP NIL +D +  P   ++ DFG AK    EN  +       T  ++APE++ R   
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY--TANFVAPEVLERQGY 197
Query: 370 TVSCKSDVYGFGMVLLEMAGG 390
             +C  D++  G++L     G
Sbjct: 198 DAAC--DIWSLGVLLYTXLTG 216

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 91/183 (49%), Gaps = 24/183 (13%)
Query: 196 LGQGGFGS-VYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCS 253
           LG G  G+ VY+G +   R +AVK +    FS  +   EV  +     H NV++   FC+
Sbjct: 32  LGHGAEGTIVYRG-MFDNRDVAVKRILPECFSFAD--REVQLLRESDEHPNVIRY--FCT 86
Query: 254 EGSKR-ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIAL--GTARGVAYLHNGCDMC 310
           E  ++   +   +   +L  ++  K+     F    L+ I L   T  G+A+LH+   + 
Sbjct: 87  EKDRQFQYIAIELCAATLQEYVEQKD-----FAHLGLEPITLLQQTTSGLAHLHS---LN 138
Query: 311 ILHFDIKPHNILLD----HNFIPK-VSDFGLA-KFHPKENDFVSISATRGTIGYIAPELI 364
           I+H D+KPHNIL+     H  I   +SDFGL  K     + F   S   GT G+IAPE++
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 365 SRN 367
           S +
Sbjct: 199 SED 201

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 99/233 (42%), Gaps = 38/233 (16%)
Query: 176 MPKRYSYPEIIAVTNHFTHK--LGQGGFGSVYKG-QLHTGRLIAVKMLE--NSKFSAEEF 230
           MPKR  Y     +++ F  K  LG+G +G V       TG ++A+K +E  +    A   
Sbjct: 1   MPKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT 56
Query: 231 INEVSTIGRIHHVNVVQLLGFCSEGS-----KRALVYEFMPNGSLDRHIFPKENKGQTFG 285
           + E+  +    H N++ +       S     +  ++ E M    L R I       Q   
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI-----STQMLS 110
Query: 286 WEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF------ 339
            + +Q     T R V  LH      ++H D+KP N+L++ N   KV DFGLA+       
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 340 ---HP--KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
               P  +++      ATR    Y APE++  +    S   DV+  G +L E+
Sbjct: 168 DNSEPTGQQSGMTEYVATR---WYRAPEVMLTS-AKYSRAMDVWSCGCILAEL 216

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 250
           +G+G +G V     +  ++ +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 90
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   +   ++    ++  ++ K  K Q    + +        RG+ Y+H+     
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 146
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 369
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D++  G +L EM   R
Sbjct: 207 YTK-SIDIWSVGCILAEMLSNR 227

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 250
           +G+G +G V     +  ++ +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 96
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   +   ++    ++  ++ K  K Q    + +        RG+ Y+H+     
Sbjct: 97  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 152
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 369
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 153 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 212
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D++  G +L EM   R
Sbjct: 213 YTK-SIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 250
           +G+G +G V     +  ++ +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   +   ++    ++  ++ K  K Q    + +        RG+ Y+H+     
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 369
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D++  G +L EM   R
Sbjct: 205 YTK-SIDIWSVGCILAEMLSNR 225

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K      + +Q +     RG+ Y+H+  
Sbjct: 86  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 192
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 97/229 (42%), Gaps = 30/229 (13%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHT--GRLIAVKMLENSKFSAEEFINEVSTIGRIH 241
           ++++        LG+G FG V +   H   GR +AVK+++N     E   +E+  +  ++
Sbjct: 10  DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLN 69
Query: 242 HVN------VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALG 295
             +       VQ+L +        +V+E +   + D   F KEN    F  + ++++A  
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYD---FIKENGFLPFRLDHIRKMAYQ 126
Query: 296 TARGVAYLHNGCDMCILHFDIKPHNILLDHN-----FIPKVS---------DFGLAKFHP 341
             + V +LH+     + H D+KP NIL   +     + PK+          D  +  F  
Sbjct: 127 ICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 342 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
              D    S    T  Y APE+I     +  C  DV+  G +L+E   G
Sbjct: 184 ATYDDEHHSTLVSTRHYRAPEVILALGWSQPC--DVWSIGCILIEYYLG 230

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 30/228 (13%)
Query: 196 LGQGGFGSV---YKGQLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +G G +GSV   Y  +L     +AVK L     S   A     E+  +  + H NV+ LL
Sbjct: 36  VGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
              +  +      E     +L         K Q    E +Q +     RG+ Y+H+    
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG-- 151
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
            I+H D+KP N+ ++ +   ++ DFGLA+    + +     ATR    Y APE++  N+ 
Sbjct: 152 -IIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEMTGYVATR---WYRAPEIM-LNWM 204
Query: 370 TVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVY-DQLNK 416
             +   D++  G ++ E+  G            KA FP   Y DQL +
Sbjct: 205 HYNQTVDIWSVGCIMAELLQG------------KALFPGSDYIDQLKR 240

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 250
           +G+G +G V     +  ++ +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   +   ++    ++  ++ K  K Q    + +        RG+ Y+H+     
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 369
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 149 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D++  G +L EM   R
Sbjct: 209 YTKS-IDIWSVGCILAEMLSNR 229

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 191 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIH-------H 242
           H   K+G G FGSV+K  +   G + A+K    SK      ++E + +  ++       H
Sbjct: 12  HELEKIGSGEFGSVFKCVKRLDGCIYAIK---RSKKPLAGSVDEQNALREVYAHAVLGQH 68
Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
            +VV+     +E     +  E+   GSL   I         F   +L+++ L   RG+ Y
Sbjct: 69  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 128
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVS-------DFGLAKFHPKENDFVSIS----- 350
           +H+   M ++H DIKP NI +    IP  +       D+   K   K  D   ++     
Sbjct: 129 IHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 185
Query: 351 -ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
               G   ++A E++  N+ T   K+D++   + ++  AG 
Sbjct: 186 QVEEGDSRFLANEVLQENY-THLPKADIFALALTVVCAAGA 225

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 250
           +G+G +G V     +  ++ +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYXQRTLREIKILLRFRHENIIGIND 92
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   +   ++    ++  ++ K  K Q    + +        RG+ Y+H+     
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 369
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 149 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D++  G +L EM   R
Sbjct: 209 YTKS-IDIWSVGCILAEMLSNR 229

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 250
           +G+G +G V     +  ++ +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   +   ++    ++  ++ K  K Q    + +        RG+ Y+H+     
Sbjct: 109 IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 164
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 369
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 165 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 224
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D++  G +L EM   R
Sbjct: 225 YTK-SIDIWSVGCILAEMLSNR 245

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 250
           +G+G +G V     +  ++ +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 86
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   +   ++    ++  ++ K  K Q    + +        RG+ Y+H+     
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 142
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 369
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 202
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D++  G +L EM   R
Sbjct: 203 YTK-SIDIWSVGCILAEMLSNR 223

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 250
           +G+G +G V     +  ++ +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 93
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   +   ++    ++  ++ K  K Q    + +        RG+ Y+H+     
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 149
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 369
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 209
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D++  G +L EM   R
Sbjct: 210 YTK-SIDIWSVGCILAEMLSNR 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 250
           +G+G +G V     +  ++ +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 86
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   +   ++    ++  ++ K  K Q    + +        RG+ Y+H+     
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 142
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 369
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 202
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D++  G +L EM   R
Sbjct: 203 YTK-SIDIWSVGCILAEMLSNR 223

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 250
           +G+G +G V     +  ++ +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 94
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   +   ++    ++  ++ K  K Q    + +        RG+ Y+H+     
Sbjct: 95  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 150
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 369
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 151 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 210
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D++  G +L EM   R
Sbjct: 211 YTK-SIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 250
           +G+G +G V     +  ++ +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 85
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   +   ++    ++  ++ K  K Q    + +        RG+ Y+H+     
Sbjct: 86  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 141
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 369
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 142 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 201
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D++  G +L EM   R
Sbjct: 202 YTK-SIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 250
           +G+G +G V     +  ++ +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   +   ++    ++  ++ K  K Q    + +        RG+ Y+H+     
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 369
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D++  G +L EM   R
Sbjct: 209 YTK-SIDIWSVGCILAEMLSNR 229

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 250
           +G+G +G V     +  ++ +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   +   ++    ++  ++ K  K Q    + +        RG+ Y+H+     
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKCQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 369
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D++  G +L EM   R
Sbjct: 209 YTK-SIDIWSVGCILAEMLSNR 229

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 191 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIH-------H 242
           H   K+G G FGSV+K  +   G + A+K    SK      ++E + +  ++       H
Sbjct: 12  HELEKIGSGEFGSVFKCVKRLDGCIYAIK---RSKKPLAGSVDEQNALREVYAHAVLGQH 68
Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
            +VV+     +E     +  E+   GSL   I         F   +L+++ L   RG+ Y
Sbjct: 69  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 128
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVS-------DFGLAKFHPKENDFVSIS----- 350
           +H+   M ++H DIKP NI +    IP  +       D+   K   K  D   ++     
Sbjct: 129 IHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 185
Query: 351 -ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
               G   ++A E++  N+ T   K+D++   + ++  AG 
Sbjct: 186 QVEEGDSRFLANEVLQENY-THLPKADIFALALTVVCAAGA 225

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ DF LA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFYLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 33/170 (19%)
Query: 228 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWE 287
           E+   E++ + ++ H NVV+L+    +           PN      +F   N+G      
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDD-----------PNEDHLYMVFELVNQGPVMEVP 129
Query: 288 KLQEIALGTAR--------GVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF 339
            L+ ++   AR        G+ YLH      I+H DIKP N+L+  +   K++DFG++  
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVS-- 184
Query: 340 HPKENDFVS----ISATRGTIGYIAPELISRNFGTVSCKS-DVYGFGMVL 384
               N+F      +S T GT  ++APE +S      S K+ DV+  G+ L
Sbjct: 185 ----NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 191 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIH-------H 242
           H   K+G G FGSV+K  +   G + A+K    SK      ++E + +  ++       H
Sbjct: 14  HELEKIGSGEFGSVFKCVKRLDGCIYAIK---RSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
            +VV+     +E     +  E+   GSL   I         F   +L+++ L   RG+ Y
Sbjct: 71  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVS-------DFGLAKFHPKENDFVSIS----- 350
           +H+   M ++H DIKP NI +    IP  +       D+   K   K  D   ++     
Sbjct: 131 IHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187
Query: 351 -ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
               G   ++A E++  N+ T   K+D++   + ++  AG 
Sbjct: 188 QVEEGDSRFLANEVLQENY-THLPKADIFALALTVVCAAGA 227

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 87/207 (42%), Gaps = 26/207 (12%)
Query: 196 LGQGGFGSVYKGQL----HTGRLIAVKMLENSKF------SAEEFINEVSTIGRIHHVNV 245
           +G+G FG V   QL     T ++ A+K+L  SKF       +  F  E   +   +   V
Sbjct: 77  IGRGAFGEV---QLVRHKSTRKVYAMKLL--SKFEMIKRSDSAFFWEERDIMAFANSPWV 131
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           VQL     +     +V E+MP G L   +    N      W +       TA  V  L  
Sbjct: 132 VQLFYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARFY-----TAEVVLALDA 183
Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
              M  +H D+KP N+LLD +   K++DFG      KE   V      GT  YI+PE++ 
Sbjct: 184 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLK 242
Query: 366 RNFGT--VSCKSDVYGFGMVLLEMAGG 390
              G      + D +  G+ L EM  G
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 250
           +G+G +G V     +  ++ +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   +   ++    ++  ++ K  K Q    + +        RG+ Y+H+     
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 369
           +LH D+KP N+LL+     K+ DFGLA+    ++D    +     T  Y APE++  + G
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG 208
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D++  G +L EM   R
Sbjct: 209 YTK-SIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 250
           +G+G +G V     +  ++ +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 93
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   +   ++    ++  ++ K  K Q    + +        RG+ Y+H+     
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 149
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 369
           +LH D+KP N+LL+     K+ DFGLA+    ++D    +     T  Y APE++  + G
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG 209
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D++  G +L EM   R
Sbjct: 210 YTK-SIDIWSVGCILAEMLSNR 230

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 87/207 (42%), Gaps = 26/207 (12%)
Query: 196 LGQGGFGSVYKGQL----HTGRLIAVKMLENSKF------SAEEFINEVSTIGRIHHVNV 245
           +G+G FG V   QL     T ++ A+K+L  SKF       +  F  E   +   +   V
Sbjct: 82  IGRGAFGEV---QLVRHKSTRKVYAMKLL--SKFEMIKRSDSAFFWEERDIMAFANSPWV 136
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           VQL     +     +V E+MP G L   +    N      W +       TA  V  L  
Sbjct: 137 VQLFYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARFY-----TAEVVLALDA 188
Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
              M  +H D+KP N+LLD +   K++DFG      KE   V      GT  YI+PE++ 
Sbjct: 189 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLK 247
Query: 366 RNFGT--VSCKSDVYGFGMVLLEMAGG 390
              G      + D +  G+ L EM  G
Sbjct: 248 SQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/201 (22%), Positives = 90/201 (44%), Gaps = 11/201 (5%)
Query: 196 LGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLGF 251
           +G+G +G V     +  + + V + + S F  + +    + E+  + R  H N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNK-VRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
               +   +   ++    ++  ++ K  K Q    + +        RG+ Y+H+     +
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 149
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFGT 370
           LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G 
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209
Query: 371 VSCKSDVYGFGMVLLEMAGGR 391
                D++  G +L EM   R
Sbjct: 210 TK-SIDIWSVGCILAEMLSNR 229

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 86/204 (42%), Gaps = 20/204 (9%)
Query: 196 LGQGGFGSVYKGQLHTGRLI-AVKMLENSKF------SAEEFINEVSTIGRIHHVNVVQL 248
           +G+G FG V   +  + R + A+K+L  SKF       +  F  E   +   +   VVQL
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLL--SKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 139
Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
                +     +V E+MP G L   +    N      W +       TA  V  L     
Sbjct: 140 FYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARFY-----TAEVVLALDAIHS 191
Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
           M  +H D+KP N+LLD +   K++DFG      KE   V      GT  YI+PE++    
Sbjct: 192 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQG 250
Query: 369 GT--VSCKSDVYGFGMVLLEMAGG 390
           G      + D +  G+ L EM  G
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 42/213 (19%)
Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEE------FINEVSTIGRIHHVNVVQ 247
           KLG+G +G VYK     T   +A+K +   +   EE       I EVS +  + H N+++
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRI---RLEHEEEGVPGTAIREVSLLKELQHRNIIE 97
Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY-LHNG 306
           L        +  L++E+  N  L +++            +K  ++++   +   Y L NG
Sbjct: 98  LKSVIHHNHRLHLIFEYAEN-DLKKYM------------DKNPDVSMRVIKSFLYQLING 144
Query: 307 CDMC----ILHFDIKPHNILL---DHNFIP--KVSDFGLAK-FHPKENDFVSISATRGTI 356
            + C     LH D+KP N+LL   D +  P  K+ DFGLA+ F      F        T+
Sbjct: 145 VNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII---TL 201
Query: 357 GYIAPELI--SRNFGTVSCKSDVYGFGMVLLEM 387
            Y  PE++  SR++ T     D++    +  EM
Sbjct: 202 WYRPPEILLGSRHYST---SVDIWSIACIWAEM 231

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 24/203 (11%)
Query: 196 LGQGGFG-SVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           +G G FG +       +  L+AVK +E  +   E    E+     + H N+V+       
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
            +  A+V E+   G L   I    N G+ F  ++ +        GV+Y H    M + H 
Sbjct: 86  PTHLAIVMEYASGGELFERIC---NAGR-FSEDEARFFFQQLISGVSYCHA---MQVCHR 138
Query: 315 DIKPHNILLDHNFIP--KVSDFGLAK---FHPKENDFVSISATRGTIGYIAPE-LISRNF 368
           D+K  N LLD +  P  K+ DFG +K    H +        +T GT  YIAPE L+ + +
Sbjct: 139 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK------STVGTPAYIAPEVLLKKEY 192
Query: 369 -GTVSCKSDVYGFGMVLLEMAGG 390
            G V   +DV+  G+ L  M  G
Sbjct: 193 DGKV---ADVWSCGVTLYVMLVG 212

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVK-MLENSKFSAEEFINEVSTIGRIH-HVNVVQLLGFC 252
           L +GGF  VY+ Q + +GR  A+K +L N +      I EV  + ++  H N+VQ     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 253 SEGSKRA-------LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           S G + +       L+   +  G L   +   E++G     + + +I   T R V ++H 
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG-PLSCDTVLKIFYQTCRAVQHMHR 154
Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLA---------KFHPKENDFVSISATRGTI 356
                I+H D+K  N+LL +    K+ DFG A          +  +    V    TR T 
Sbjct: 155 Q-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 357 G-YIAPELIS--RNFGTVSCKSDVYGFGMVL 384
             Y  PE+I    NF  +  K D++  G +L
Sbjct: 214 PMYRTPEIIDLYSNF-PIGEKQDIWALGCIL 243

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/272 (23%), Positives = 114/272 (41%), Gaps = 39/272 (14%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 250
           LG+GGF   Y+   + T  + A K++  S        E+   E++    + + +VV   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 251 FCSEGSKRALVYEFMPNGSL----DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           F  +     +V E     SL     R     E + + F  + +Q        GV YLHN 
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQ--------GVQYLHNN 161
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++ +
Sbjct: 162 R---VIHRDLKLGNLFLNDDMDVKIGDFGLAT--KIEFDGERKKTLCGTPNYIAPEVLCK 216
Query: 367 NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT 426
                S + D++  G +L  +  G+     + ++ +        Y ++ K      R++ 
Sbjct: 217 K--GHSFEVDIWSLGCILYTLLVGKPPFETSCLKET--------YIRIKKNEYSVPRHIN 266
Query: 427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVL 458
            + S + R++       +      RPS+ ++L
Sbjct: 267 PVASALIRRM-------LHADPTLRPSVAELL 291

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLI-AVKMLENS----KFSAEEFINEVSTIGR-IHHVN 244
           HF   +G+G FG V   +     +  AVK+L+      K   +  ++E + + + + H  
Sbjct: 41  HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
           +V L        K   V +++  G L  H+     + + F   + +  A   A  + YLH
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARFYAAEIASALGYLH 156
Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
           +   + I++ D+KP NILLD      ++DFGL K + + N   + S   GT  Y+APE++
Sbjct: 157 S---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVL 211
Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGG 390
            +         D +  G VL EM  G
Sbjct: 212 HKQ--PYDRTVDWWCLGAVLYEMLYG 235

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ D GLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDAGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+  FGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILGFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 24/203 (11%)
Query: 196 LGQGGFG-SVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           +G G FG +       +  L+AVK +E  +  A     E+     + H N+V+       
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILT 86
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
            +  A+V E+   G L   I    N G+ F  ++ +        GV+Y H    M + H 
Sbjct: 87  PTHLAIVMEYASGGELFERIC---NAGR-FSEDEARFFFQQLISGVSYCHA---MQVCHR 139
Query: 315 DIKPHNILLDHNFIP--KVSDFGLAK---FHPKENDFVSISATRGTIGYIAPE-LISRNF 368
           D+K  N LLD +  P  K+ DFG +K    H +        +T GT  YIAPE L+ + +
Sbjct: 140 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK------STVGTPAYIAPEVLLKKEY 193
Query: 369 -GTVSCKSDVYGFGMVLLEMAGG 390
            G V   +DV+  G+ L  M  G
Sbjct: 194 DGKV---ADVWSCGVTLYVMLVG 213

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 177 PKRYSYPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFINEVS 235
           PK+Y+  +   ++      LG G  G V +     TG+  A+K+L +S  + +E  +   
Sbjct: 2   PKKYAVTDDYQLSKQV---LGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQ 58
Query: 236 TIGRIHHVNVVQLLGFCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIA 293
             G  H V ++ +      G KR L  + E M  G L   I  +E   Q F   +  EI 
Sbjct: 59  ASGGPHIVCILDVYENMHHG-KRCLLIIMECMEGGELFSRI--QERGDQAFTEREAAEIM 115
Query: 294 LGTARGVAYLHNGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSIS 350
                 + +LH+     I H D+KP N+L    + + + K++DFG A    KE    ++ 
Sbjct: 116 RDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA----KETTQNALQ 168
Query: 351 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 384
               T  Y+APE++       SC  D++  G+++
Sbjct: 169 TPCYTPYYVAPEVLGPEKYDKSC--DMWSLGVIM 200

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ D GLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDRGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 182 YPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFS------AEEFIN-- 232
           YP+ +      +  LG G  G V    +  T + +A+K++   KF+      A+  +N  
Sbjct: 4   YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63
Query: 233 -EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQ 290
            E+  + +++H  ++++  F  +     +V E M  G L D+ +  K  K  T      Q
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122
Query: 291 EIALGTARGVAYLH-NGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDF 346
            +       V YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +  
Sbjct: 123 MLL-----AVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 173
Query: 347 VSISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVL 384
            ++    GT  Y+APE L+S      +   D +  G++L
Sbjct: 174 RTLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 182 YPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFS------AEEFIN-- 232
           YP+ +      +  LG G  G V    +  T + +A+K++   KF+      A+  +N  
Sbjct: 4   YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63
Query: 233 -EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQ 290
            E+  + +++H  ++++  F  +     +V E M  G L D+ +  K  K  T      Q
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122
Query: 291 EIALGTARGVAYLH-NGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDF 346
            +       V YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +  
Sbjct: 123 MLL-----AVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 173
Query: 347 VSISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVL 384
            ++    GT  Y+APE L+S      +   D +  G++L
Sbjct: 174 RTLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 182 YPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFS------AEEFIN-- 232
           YP+ +      +  LG G  G V    +  T + +A+K++   KF+      A+  +N  
Sbjct: 4   YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63
Query: 233 -EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQ 290
            E+  + +++H  ++++  F  +     +V E M  G L D+ +  K  K  T      Q
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122
Query: 291 EIALGTARGVAYLH-NGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDF 346
            +       V YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +  
Sbjct: 123 MLL-----AVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 173
Query: 347 VSISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVL 384
            ++    GT  Y+APE L+S      +   D +  G++L
Sbjct: 174 RTLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/272 (23%), Positives = 114/272 (41%), Gaps = 39/272 (14%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 250
           LG+GGF   Y+   + T  + A K++  S        E+   E++    + + +VV   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 251 FCSEGSKRALVYEFMPNGSL----DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           F  +     +V E     SL     R     E + + F  + +Q        GV YLHN 
Sbjct: 94  FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQ--------GVQYLHNN 145
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++ +
Sbjct: 146 R---VIHRDLKLGNLFLNDDMDVKIGDFGLAT--KIEFDGERKKDLCGTPNYIAPEVLCK 200
Query: 367 NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT 426
                S + D++  G +L  +  G+     + ++ +        Y ++ K      R++ 
Sbjct: 201 K--GHSFEVDIWSLGCILYTLLVGKPPFETSCLKET--------YIRIKKNEYSVPRHIN 250
Query: 427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVL 458
            + S + R++       +      RPS+ ++L
Sbjct: 251 PVASALIRRM-------LHADPTLRPSVAELL 275

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 177 PKRYSYPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFINEVS 235
           PK+Y+  +   ++      LG G  G V +     TG+  A+K+L +S  + +E  +   
Sbjct: 21  PKKYAVTDDYQLSKQV---LGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQ 77
Query: 236 TIGRIHHVNVVQLLGFCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIA 293
             G  H V ++ +      G KR L  + E M  G L   I  +E   Q F   +  EI 
Sbjct: 78  ASGGPHIVCILDVYENMHHG-KRCLLIIMECMEGGELFSRI--QERGDQAFTEREAAEIM 134
Query: 294 LGTARGVAYLHNGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSIS 350
                 + +LH+     I H D+KP N+L    + + + K++DFG A    KE    ++ 
Sbjct: 135 RDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA----KETTQNALQ 187
Query: 351 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 384
               T  Y+APE++       SC  D++  G+++
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDKSC--DMWSLGVIM 219

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/272 (23%), Positives = 114/272 (41%), Gaps = 39/272 (14%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 250
           LG+GGF   Y+   + T  + A K++  S        E+   E++    + + +VV   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 251 FCSEGSKRALVYEFMPNGSL----DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           F  +     +V E     SL     R     E + + F  + +Q        GV YLHN 
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQ--------GVQYLHNN 161
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++ +
Sbjct: 162 R---VIHRDLKLGNLFLNDDMDVKIGDFGLAT--KIEFDGERKKXLCGTPNYIAPEVLCK 216
Query: 367 NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT 426
                S + D++  G +L  +  G+     + ++ +        Y ++ K      R++ 
Sbjct: 217 K--GHSFEVDIWSLGCILYTLLVGKPPFETSCLKET--------YIRIKKNEYSVPRHIN 266
Query: 427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVL 458
            + S + R++       +      RPS+ ++L
Sbjct: 267 PVASALIRRM-------LHADPTLRPSVAELL 291

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 182 YPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFS------AEEFIN-- 232
           YP+ +      +  LG G  G V    +  T + +A+K++   KF+      A+  +N  
Sbjct: 3   YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 62
Query: 233 -EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQ 290
            E+  + +++H  ++++  F  +     +V E M  G L D+ +  K  K  T      Q
Sbjct: 63  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 121
Query: 291 EIALGTARGVAYLH-NGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDF 346
            +       V YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +  
Sbjct: 122 MLL-----AVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 172
Query: 347 VSISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVL 384
            ++    GT  Y+APE L+S      +   D +  G++L
Sbjct: 173 RTLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 208

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 18/199 (9%)
Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGR----IHHVNVVQLL 249
           +LG G +G V+K +    GRL AVK   +     ++   +++ +G       H   V+L 
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
               EG    L  E     SL +H    E  G +    ++      T   +A+LH+    
Sbjct: 124 QAWEEGGILYLQTELC-GPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAHLHS---Q 176
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
            ++H D+KP NI L      K+ DFGL     +     +     G   Y+APEL+  ++G
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELLQGSYG 233
Query: 370 TVSCKSDVYGFGMVLLEMA 388
           T    +DV+  G+ +LE+A
Sbjct: 234 TA---ADVFSLGLTILEVA 249

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQ 247
           +F  KL +   G ++KG+   G  I VK+L+   +S   + +F  E   +    H NV+ 
Sbjct: 13  NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 248 LLGFCSE--GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEI--ALGTARGVAYL 303
           +LG C         L+  +MP GSL   +    ++G  F  ++ Q +  AL  ARG+A+L
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVL----HEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
           H   +  I    +   ++++D +   ++S     KF      F S         ++APE 
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARIS-MADVKF-----SFQSPGRMYAP-AWVAPEA 179
Query: 364 ISRNFGTVSCKS-DVYGFGMVLLEM 387
           + +     + +S D++ F ++L E+
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWEL 204

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 123/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        ++     GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLA-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 24/203 (11%)
Query: 196 LGQGGFG-SVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           +G G FG +          L+AVK +E  +   E    E+     + H N+V+       
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
            +  A+V E+   G L   I    N G+ F  ++ +        GV+Y H    M + H 
Sbjct: 87  PTHLAIVMEYASGGELFERIC---NAGR-FSEDEARFFFQQLISGVSYAHA---MQVAHR 139
Query: 315 DIKPHNILLDHNFIP--KVSDFGLAK---FHPKENDFVSISATRGTIGYIAPE-LISRNF 368
           D+K  N LLD +  P  K++DFG +K    H +    V      GT  YIAPE L+ + +
Sbjct: 140 DLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAV------GTPAYIAPEVLLKKEY 193
Query: 369 -GTVSCKSDVYGFGMVLLEMAGG 390
            G V   +DV+  G+ L  M  G
Sbjct: 194 DGKV---ADVWSCGVTLYVMLVG 213

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKE----NKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +    R+L  E   +  L  H+   +     K Q    + +Q +     RG+ Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              I+H D+KP N+ ++ +   K+ D GLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDGGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 182 YPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFS------AEEFIN-- 232
           YP+ +      +  LG G  G V    +  T + +A+K++   KF+      A+  +N  
Sbjct: 10  YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 69
Query: 233 -EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQ 290
            E+  + +++H  ++++  F  +     +V E M  G L D+ +  K  K  T      Q
Sbjct: 70  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 128
Query: 291 EIALGTARGVAYLH-NGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDF 346
            +       V YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +  
Sbjct: 129 MLL-----AVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 179
Query: 347 VSISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVL 384
            ++    GT  Y+APE L+S      +   D +  G++L
Sbjct: 180 RTLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 215

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 64/272 (23%), Positives = 114/272 (41%), Gaps = 39/272 (14%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 250
           LG+GGF   Y+   + T  + A K++  S        E+   E++    + + +VV   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 251 FCSEGSKRALVYEFMPNGSL----DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           F  +     +V E     SL     R     E + + F  + +Q        GV YLHN 
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQ--------GVQYLHNN 161
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++ +
Sbjct: 162 R---VIHRDLKLGNLFLNDDMDVKIGDFGLAT--KIEFDGERKKDLCGTPNYIAPEVLCK 216
Query: 367 NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT 426
                S + D++  G +L  +  G+     + ++ +        Y ++ K      R++ 
Sbjct: 217 K--GHSFEVDIWSLGCILYTLLVGKPPFETSCLKET--------YIRIKKNEYSVPRHIN 266
Query: 427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVL 458
            + S + R++       +      RPS+ ++L
Sbjct: 267 PVASALIRRM-------LHADPTLRPSVAELL 291

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFAEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 92/198 (46%), Gaps = 20/198 (10%)
Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLG 250
           +LG+G F  V +  ++  G+  A  ++   K SA   ++   E      + H N+V+L  
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
             SE     L+++ +  G L   I  +E   +      +Q+I       V + H    M 
Sbjct: 78  SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL----EAVLHCHQ---MG 130
Query: 311 ILHFDIKPHNILLDHNF---IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
           ++H ++KP N+LL         K++DFGLA     E +  +     GT GY++PE++ ++
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAI--EVEGEQQAWFGFAGTPGYLSPEVLRKD 188
Query: 368 -FGTVSCKSDVYGFGMVL 384
            +G      D++  G++L
Sbjct: 189 PYGK---PVDLWACGVIL 203

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 191 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFIN----EVSTIGRIHHVNV 245
           +F   LG+G FG V       T  L A+K+L+      ++ +     E   +  +     
Sbjct: 22  NFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPF 81
Query: 246 VQLLGFCSEGSKRA-LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEI--ALGTARGVAY 302
           +  L  C +   R   V E++  G L  HI       Q   +++ Q +  A   + G+ +
Sbjct: 82  LTQLHSCFQTVDRLYFVMEYVNGGDLMYHI------QQVGKFKEPQAVFYAAEISIGLFF 135
Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
           LH      I++ D+K  N++LD     K++DFG+ K H    D V+     GT  YIAPE
Sbjct: 136 LHK---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEH--MMDGVTTREFCGTPDYIAPE 190
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           +I+  +       D + +G++L EM  G+
Sbjct: 191 IIA--YQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 24/203 (11%)
Query: 196 LGQGGFG-SVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           +G G FG +       +  L+AVK +E  +   E    E+     + H N+V+       
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
            +  A+V E+   G L   I    N G+ F  ++ +        GV+Y H    M + H 
Sbjct: 87  PTHLAIVMEYASGGELFERIC---NAGR-FSEDEARFFFQQLISGVSYCHA---MQVCHR 139
Query: 315 DIKPHNILLDHNFIP--KVSDFGLAK---FHPKENDFVSISATRGTIGYIAPE-LISRNF 368
           D+K  N LLD +  P  K+  FG +K    H +  D V      GT  YIAPE L+ + +
Sbjct: 140 DLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTV------GTPAYIAPEVLLKKEY 193
Query: 369 -GTVSCKSDVYGFGMVLLEMAGG 390
            G V   +DV+  G+ L  M  G
Sbjct: 194 DGKV---ADVWSCGVTLYVMLVG 213

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 73
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++  G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 133
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 238
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 239 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 277

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 121/283 (42%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK               GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRT-----WXLXGTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 29/225 (12%)
Query: 182 YPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFS------AEEFIN-- 232
           YP+ +      +  LG G  G V    +  T + +A++++   KF+      A+  +N  
Sbjct: 143 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVE 202
Query: 233 -EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQ 290
            E+  + +++H  ++++  F  +     +V E M  G L D+ +  K  K  T      Q
Sbjct: 203 TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 261
Query: 291 EIALGTARGVAYLH-NGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDF 346
            +       V YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +  
Sbjct: 262 MLL-----AVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 312
Query: 347 VSISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEMAGG 390
            ++    GT  Y+APE L+S      +   D +  G++L     G
Sbjct: 313 RTLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 8   ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 67
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++  G +  H+
Sbjct: 68  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 127
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 128 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 180
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 181 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 232
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 233 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 271

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 5/92 (5%)
Query: 296 TARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT 355
            A+G+ +L      CI H D+   NILL    + K+ DFGLA+   K+ D+V     R  
Sbjct: 200 VAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 356 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
           + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 257 LKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 286

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 5/92 (5%)
Query: 296 TARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT 355
            A+G+ +L      CI H D+   NILL    + K+ DFGLA+   K+ D+V     R  
Sbjct: 202 VAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 356 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
           + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 259 LKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 288

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/202 (22%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 250
           +G+G +G V     +  ++ +A+K +  S F  + +    + E+  +    H N++ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   +   ++    ++  ++ K  K Q    + +        RG+ Y+H+     
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 146
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 369
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D++  G +L EM   R
Sbjct: 207 YTK-SIDIWSVGCILAEMLSNR 227

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/81 (38%), Positives = 43/81 (53%), Gaps = 3/81 (3%)
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRNFG 369
           I+H D+KP NIL+      KV DFG+A+      N     +A  GT  Y++PE    +  
Sbjct: 137 IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGD-- 194
Query: 370 TVSCKSDVYGFGMVLLEMAGG 390
           +V  +SDVY  G VL E+  G
Sbjct: 195 SVDARSDVYSLGCVLYEVLTG 215

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 96/229 (41%), Gaps = 30/229 (13%)
Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQLHT--GRLIAVKMLENSKFSAEEFINEVSTIGRIH 241
           ++++        LG+G FG V +   H   GR +AVK+++N     E   +E+  +  ++
Sbjct: 10  DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLN 69
Query: 242 HVN------VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALG 295
             +       VQ+L +        +V+E +   + D   F KEN    F  + ++++A  
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYD---FIKENGFLPFRLDHIRKMAYQ 126
Query: 296 TARGVAYLHNGCDMCILHFDIKPHNILLDHN-----FIPKVS---------DFGLAKFHP 341
             + V +LH+     + H D+KP NIL   +     + PK+          D  +  F  
Sbjct: 127 ICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 342 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
              D    S       Y APE+I     +  C  DV+  G +L+E   G
Sbjct: 184 ATYDDEHHSTLVXXRHYRAPEVILALGWSQPC--DVWSIGCILIEYYLG 230

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 5/92 (5%)
Query: 296 TARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT 355
            A+G+ +L      CI H D+   NILL    + K+ DFGLA+   K+ D+V     R  
Sbjct: 207 VAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 356 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
           + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 264 LKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 293

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 121/282 (42%), Gaps = 35/282 (12%)
Query: 164 NIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGRLIAVKM 219
           ++++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K+
Sbjct: 1   SVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI 60
Query: 220 LENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIF 275
           L+  K       E  +NE   +  ++   +V+L     + S   +V E++  G +  H+ 
Sbjct: 61  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL- 119
Query: 276 PKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFG 335
               +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DFG
Sbjct: 120 ---RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFG 173
Query: 336 LAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG---- 390
            AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G    
Sbjct: 174 FAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPPF 225
Query: 391 ---RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
              +       I S K  FPS     L    DL LRN+ +++
Sbjct: 226 FADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 263

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 5/92 (5%)
Query: 296 TARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT 355
            A+G+ +L      CI H D+   NILL    + K+ DFGLA+   K+ D+V     R  
Sbjct: 209 VAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 356 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
           + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 266 LKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 295

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 29/220 (13%)
Query: 182 YPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFS------AEEFIN-- 232
           YP+ +      +  LG G  G V    +  T + +A++++   KF+      A+  +N  
Sbjct: 129 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVE 188
Query: 233 -EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQ 290
            E+  + +++H  ++++  F  +     +V E M  G L D+ +  K  K  T      Q
Sbjct: 189 TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 247
Query: 291 EIALGTARGVAYLH-NGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDF 346
            +       V YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +  
Sbjct: 248 MLL-----AVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 298
Query: 347 VSISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLL 385
            ++    GT  Y+APE L+S      +   D +  G++L 
Sbjct: 299 RTLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 335

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 34  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 93
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++  G +  H+
Sbjct: 94  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 153
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 154 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 206
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK         +     GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 207 GFAKRVKG-----ATWTLCGTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 258
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 259 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 297

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/81 (37%), Positives = 43/81 (53%), Gaps = 3/81 (3%)
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRNFG 369
           I+H D+KP NI++      KV DFG+A+      N     +A  GT  Y++PE    +  
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-- 194
Query: 370 TVSCKSDVYGFGMVLLEMAGG 390
           +V  +SDVY  G VL E+  G
Sbjct: 195 SVDARSDVYSLGCVLYEVLTG 215

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/81 (37%), Positives = 43/81 (53%), Gaps = 3/81 (3%)
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRNFG 369
           I+H D+KP NI++      KV DFG+A+      N     +A  GT  Y++PE    +  
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-- 194
Query: 370 TVSCKSDVYGFGMVLLEMAGG 390
           +V  +SDVY  G VL E+  G
Sbjct: 195 SVDARSDVYSLGCVLYEVLTG 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/81 (37%), Positives = 43/81 (53%), Gaps = 3/81 (3%)
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRNFG 369
           I+H D+KP NI++      KV DFG+A+      N     +A  GT  Y++PE    +  
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-- 194
Query: 370 TVSCKSDVYGFGMVLLEMAGG 390
           +V  +SDVY  G VL E+  G
Sbjct: 195 SVDARSDVYSLGCVLYEVLTG 215

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 249
           +G+G +  V   +L  T R+ A+K+++    + +E I+ V T   +     +H  +V L 
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
                 S+   V E++  G L  H+  +    +        EI+L     + YLH   + 
Sbjct: 73  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH---ER 125
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 368
            I++ D+K  N+LLD     K++D+G+ K   +  D  + S   GT  YIAPE++   ++
Sbjct: 126 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEILRGEDY 183
Query: 369 GTVSCKSDVYGFGMVLLEMAGGR 391
           G      D +  G+++ EM  GR
Sbjct: 184 G---FSVDWWALGVLMFEMMAGR 203

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/81 (37%), Positives = 43/81 (53%), Gaps = 3/81 (3%)
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRNFG 369
           I+H D+KP NI++      KV DFG+A+      N     +A  GT  Y++PE    +  
Sbjct: 154 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-- 211
Query: 370 TVSCKSDVYGFGMVLLEMAGG 390
           +V  +SDVY  G VL E+  G
Sbjct: 212 SVDARSDVYSLGCVLYEVLTG 232

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/81 (37%), Positives = 43/81 (53%), Gaps = 3/81 (3%)
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRNFG 369
           I+H D+KP NI++      KV DFG+A+      N     +A  GT  Y++PE    +  
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-- 194
Query: 370 TVSCKSDVYGFGMVLLEMAGG 390
           +V  +SDVY  G VL E+  G
Sbjct: 195 SVDARSDVYSLGCVLYEVLTG 215

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 34  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 93
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++  G +  H+
Sbjct: 94  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 153
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 154 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 206
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G   
Sbjct: 207 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 258
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 259 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 297

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 249
           +G+G +  V   +L  T R+ A+K+++    + +E I+ V T   +     +H  +V L 
Sbjct: 28  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 87
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
                 S+   V E++  G L  H+  +    +        EI+L     + YLH   + 
Sbjct: 88  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH---ER 140
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 368
            I++ D+K  N+LLD     K++D+G+ K   +  D  + S   GT  YIAPE++   ++
Sbjct: 141 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEILRGEDY 198
Query: 369 GTVSCKSDVYGFGMVLLEMAGGR 391
           G      D +  G+++ EM  GR
Sbjct: 199 G---FSVDWWALGVLMFEMMAGR 218

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/202 (22%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 250
           +G+G +G V     +  ++ +A+K +  S F  + +    + E+  +    H N++ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   +   ++    ++  ++ K  K Q    + +        RG+ Y+H+     
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 146
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 369
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 147 VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 370 TVSCKSDVYGFGMVLLEMAGGR 391
                 D++  G +L EM   R
Sbjct: 207 YTKS-IDIWSVGCILAEMLSNR 227

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 99/241 (41%), Gaps = 50/241 (20%)
Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLI-AVKMLENSKF------SAEEFINEVSTIGRIHHV 243
           H    +GQG +G V     +  R I A+K++  +K         E    EV  + ++HH 
Sbjct: 29  HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSL-DR-HIFPKENKG-------------------- 281
           N+ +L     +     LV E    G L D+ ++F  ++ G                    
Sbjct: 89  NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 282 ----------QTFGWEKLQEIALGTAR----GVAYLHNGCDMCILHFDIKPHNILLDHN- 326
                     ++  + + +++     R     + YLHN     I H DIKP N L   N 
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNK 205
Query: 327 -FIPKVSDFGLAKFHPKEN--DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 383
            F  K+ DFGL+K   K N  ++  ++   GT  ++APE+++    +   K D +  G++
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 384 L 384
           L
Sbjct: 266 L 266

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 94/220 (42%), Gaps = 21/220 (9%)
Query: 177 PKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVS 235
           P  Y Y E +    H   +LG+G FG V++ +   TG   AVK +    F AEE +    
Sbjct: 64  PVDYEYREEVHWATHQL-RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELM---- 118
Query: 236 TIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALG 295
               +    +V L G   EG    +  E +  GSL + +     K Q    E      LG
Sbjct: 119 ACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV-----KEQGCLPEDRALYYLG 173
Query: 296 TA-RGVAYLHNGCDMCILHFDIKPHNILLDHNFI-PKVSDFGLAK-FHPK--ENDFVSIS 350
            A  G+ YLH+     ILH D+K  N+LL  +     + DFG A    P     D ++  
Sbjct: 174 QALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGD 230
Query: 351 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
              GT  ++APE++     +   K DV+    ++L M  G
Sbjct: 231 YIPGTETHMAPEVVLGR--SCDAKVDVWSSCCMMLHMLNG 268

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 249
           +G+G +  V   +L  T R+ A+K+++    + +E I+ V T   +     +H  +V L 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
                 S+   V E++  G L  H+  +    +        EI+L     + YLH   + 
Sbjct: 77  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH---ER 129
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 368
            I++ D+K  N+LLD     K++D+G+ K   +  D  + S   GT  YIAPE++   ++
Sbjct: 130 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEILRGEDY 187
Query: 369 GTVSCKSDVYGFGMVLLEMAGGR 391
           G      D +  G+++ EM  GR
Sbjct: 188 G---FSVDWWALGVLMFEMMAGR 207

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+++D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE +IS+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIIISKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 16/204 (7%)
Query: 195 KLGQGGFGSVYKGQLH-TGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVN-VVQLLG 250
           ++G G  G V+K +   TG +IAVK +  S  K   +  + ++  + + H    +VQ  G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   +  E M  G+    +  K+          L ++ +   + + YL       
Sbjct: 92  TFITNTDVFIAMELM--GTCAEKL--KKRMQGPIPERILGKMTVAIVKALYYLKE--KHG 145
Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H D+KP NILLD     K+ DFG++    +  D  +   + G   Y+APE I     T
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 371 ---VSCKSDVYGFGMVLLEMAGGR 391
                 ++DV+  G+ L+E+A G+
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQ 226

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ +MA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYQMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 249
           +G+G +  V   +L  T R+ A+++++    + +E I+ V T   +     +H  +V L 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
                 S+   V E++  G L  H+  +    +        EI+L     + YLH   + 
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH---ER 172
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 368
            I++ D+K  N+LLD     K++D+G+ K   +  D  + S   GT  YIAPE++   ++
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDY 230
Query: 369 GTVSCKSDVYGFGMVLLEMAGGR 391
           G      D +  G+++ EM  GR
Sbjct: 231 G---FSVDWWALGVLMFEMMAGR 250

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 101/244 (41%), Gaps = 50/244 (20%)
Query: 174 SWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHT--GRLIAVKMLENSKFSAEEFI 231
            W+ +RY   EI++        LG+G FG V +   H   G  +A+K+++N +   E   
Sbjct: 29  DWLQERY---EIVST-------LGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAAR 78
Query: 232 NEVSTIGRIHHVN------VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFG 285
            E++ + +I+  +       VQ+  +        + +E +   + D   F K+N    + 
Sbjct: 79  LEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFD---FLKDNNYLPYP 135
Query: 286 WEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNIL-------LDHNFIPK-------- 330
             +++ +A    + V +LH   D  + H D+KP NIL       L +N   K        
Sbjct: 136 IHQVRHMAFQLCQAVKFLH---DNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKS 192
Query: 331 ----VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 386
               V DFG A F     D    S    T  Y APE+I     +  C  DV+  G ++ E
Sbjct: 193 TAVRVVDFGSATF-----DHEHHSTIVSTRHYRAPEVILELGWSQPC--DVWSIGCIIFE 245
Query: 387 MAGG 390
              G
Sbjct: 246 YYVG 249

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 24/203 (11%)
Query: 196 LGQGGFG-SVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           +G G FG +       +  L+AVK +E  +   E    E+     + H N+V+       
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
            +  A+V E+   G L   I    N G+ F  ++ +        GV+Y H    M + H 
Sbjct: 87  PTHLAIVMEYASGGELFERIC---NAGR-FSEDEARFFFQQLISGVSYCHA---MQVCHR 139
Query: 315 DIKPHNILLDHNFIP--KVSDFGLAK---FHPKENDFVSISATRGTIGYIAPE-LISRNF 368
           D+K  N LLD +  P  K+  FG +K    H +        +T GT  YIAPE L+ + +
Sbjct: 140 DLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPK------STVGTPAYIAPEVLLKKEY 193
Query: 369 -GTVSCKSDVYGFGMVLLEMAGG 390
            G V   +DV+  G+ L  M  G
Sbjct: 194 DGKV---ADVWSCGVTLYVMLVG 213

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 182 YPEIIAVTNHFT------HKLGQGGFGSVYKGQLHT-GRLIAVKMLENSKFSA---EEFI 231
           Y + +A    FT       +LG+G F  V +    T  +  A K++   K SA   ++  
Sbjct: 19  YFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLE 78
Query: 232 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQE 291
            E      + H N+V+L    SE     LV++ +  G L   I  +E   +      + +
Sbjct: 79  REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQ 138
Query: 292 IALGTARGVAYLHNGCDMCILHFDIKPHNILLD---HNFIPKVSDFGLA-KFHPKENDFV 347
           I       V ++H      I+H D+KP N+LL         K++DFGLA +   ++  + 
Sbjct: 139 I----LESVNHIHQ---HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWF 191
Query: 348 SISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVL 384
             +   GT GY++PE++ ++ +G      D++  G++L
Sbjct: 192 GFA---GTPGYLSPEVLRKDPYGK---PVDIWACGVIL 223

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT  Y+AP +I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPAIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 106/254 (41%), Gaps = 34/254 (13%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           LG G  G V +     T    A+KML++   +  E           H V +V +      
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 85
Query: 255 GSKRAL-VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILH 313
           G K  L V E +  G L   I  ++   Q F   +  EI       + YLH+   + I H
Sbjct: 86  GRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAH 140
Query: 314 FDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
            D+KP N+L      N I K++DFG AK     N   S++    T  Y+APE++      
Sbjct: 141 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYD 197
Query: 371 VSCKSDVYGFGMVL---------------LEMAGGRRNSNMNAIRSSKAYFPSWVYDQLN 415
            SC  D++  G+++               L ++ G +      IR  +  FP+  + +++
Sbjct: 198 KSC--DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQYEFPNPEWSEVS 251
Query: 416 KGGDLELRNVTEIE 429
           +   + +RN+ + E
Sbjct: 252 EEVKMLIRNLLKTE 265

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 106/254 (41%), Gaps = 34/254 (13%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           LG G  G V +     T    A+KML++   +  E           H V +V +      
Sbjct: 31  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 90
Query: 255 GSKRAL-VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILH 313
           G K  L V E +  G L   I  ++   Q F   +  EI       + YLH+   + I H
Sbjct: 91  GRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAH 145
Query: 314 FDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
            D+KP N+L      N I K++DFG AK     N   S++    T  Y+APE++      
Sbjct: 146 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYD 202
Query: 371 VSCKSDVYGFGMVL---------------LEMAGGRRNSNMNAIRSSKAYFPSWVYDQLN 415
            SC  D++  G+++               L ++ G +      IR  +  FP+  + +++
Sbjct: 203 KSC--DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQYEFPNPEWSEVS 256
Query: 416 KGGDLELRNVTEIE 429
           +   + +RN+ + E
Sbjct: 257 EEVKMLIRNLLKTE 270

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 106/254 (41%), Gaps = 34/254 (13%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           LG G  G V +     T    A+KML++   +  E           H V +V +      
Sbjct: 25  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 84
Query: 255 GSKRAL-VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILH 313
           G K  L V E +  G L   I  ++   Q F   +  EI       + YLH+   + I H
Sbjct: 85  GRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAH 139
Query: 314 FDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
            D+KP N+L      N I K++DFG AK     N   S++    T  Y+APE++      
Sbjct: 140 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYD 196
Query: 371 VSCKSDVYGFGMVL---------------LEMAGGRRNSNMNAIRSSKAYFPSWVYDQLN 415
            SC  D++  G+++               L ++ G +      IR  +  FP+  + +++
Sbjct: 197 KSC--DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQYEFPNPEWSEVS 250
Query: 416 KGGDLELRNVTEIE 429
           +   + +RN+ + E
Sbjct: 251 EEVKMLIRNLLKTE 264

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 106/254 (41%), Gaps = 34/254 (13%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           LG G  G V +     T    A+KML++   +  E           H V +V +      
Sbjct: 30  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 89
Query: 255 GSKRAL-VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILH 313
           G K  L V E +  G L   I  ++   Q F   +  EI       + YLH+   + I H
Sbjct: 90  GRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAH 144
Query: 314 FDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
            D+KP N+L      N I K++DFG AK     N   S++    T  Y+APE++      
Sbjct: 145 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYD 201
Query: 371 VSCKSDVYGFGMVL---------------LEMAGGRRNSNMNAIRSSKAYFPSWVYDQLN 415
            SC  D++  G+++               L ++ G +      IR  +  FP+  + +++
Sbjct: 202 KSC--DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQYEFPNPEWSEVS 255
Query: 416 KGGDLELRNVTEIE 429
           +   + +RN+ + E
Sbjct: 256 EEVKMLIRNLLKTE 269

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 106/254 (41%), Gaps = 34/254 (13%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           LG G  G V +     T    A+KML++   +  E           H V +V +      
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 83
Query: 255 GSKRAL-VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILH 313
           G K  L V E +  G L   I  ++   Q F   +  EI       + YLH+   + I H
Sbjct: 84  GRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAH 138
Query: 314 FDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
            D+KP N+L      N I K++DFG AK     N   S++    T  Y+APE++      
Sbjct: 139 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYD 195
Query: 371 VSCKSDVYGFGMVL---------------LEMAGGRRNSNMNAIRSSKAYFPSWVYDQLN 415
            SC  D++  G+++               L ++ G +      IR  +  FP+  + +++
Sbjct: 196 KSC--DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQYEFPNPEWSEVS 249
Query: 416 KGGDLELRNVTEIE 429
           +   + +RN+ + E
Sbjct: 250 EEVKMLIRNLLKTE 263

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 106/254 (41%), Gaps = 34/254 (13%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           LG G  G V +     T    A+KML++   +  E           H V +V +      
Sbjct: 32  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 91
Query: 255 GSKRAL-VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILH 313
           G K  L V E +  G L   I  ++   Q F   +  EI       + YLH+   + I H
Sbjct: 92  GRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAH 146
Query: 314 FDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
            D+KP N+L      N I K++DFG AK     N   S++    T  Y+APE++      
Sbjct: 147 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYD 203
Query: 371 VSCKSDVYGFGMVL---------------LEMAGGRRNSNMNAIRSSKAYFPSWVYDQLN 415
            SC  D++  G+++               L ++ G +      IR  +  FP+  + +++
Sbjct: 204 KSC--DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQYEFPNPEWSEVS 257
Query: 416 KGGDLELRNVTEIE 429
           +   + +RN+ + E
Sbjct: 258 EEVKMLIRNLLKTE 271

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 89/200 (44%), Gaps = 20/200 (10%)
Query: 193 THKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAE---EFINEVSTIGRIHHV-NVVQ 247
           + +LG+G F  V +     TG+  A K L+  +   +   E ++E++ +        V+ 
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
           L       S+  L+ E+   G +     P+    +      +  +      GV YLH   
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 308 DMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
              I+H D+KP NILL  +  P    K+ DFG+++   K      +    GT  Y+APE+
Sbjct: 152 ---IVHLDLKPQNILLS-SIYPLGDIKIVDFGMSR---KIGHACELREIMGTPEYLAPEI 204
Query: 364 ISRNFGTVSCKSDVYGFGMV 383
           +  N+  ++  +D++  G++
Sbjct: 205 L--NYDPITTATDMWNIGII 222

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 250
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 251 FCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEK--LQEIALGTARGVAYLHNGC 307
           F  +     +V E     SL + H   K  K  T    +  L++I LG      YLH   
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLG----CQYLHRNR 135
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++S+ 
Sbjct: 136 ---VIHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKVLCGTPNYIAPEVLSKK 190
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
               S + DV+  G ++  +  G+
Sbjct: 191 --GHSFEVDVWSIGCIMYTLLVGK 212

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 106/254 (41%), Gaps = 34/254 (13%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           LG G  G V +     T    A+KML++   +  E           H V +V +      
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 83
Query: 255 GSKRAL-VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILH 313
           G K  L V E +  G L   I  ++   Q F   +  EI       + YLH+   + I H
Sbjct: 84  GRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAH 138
Query: 314 FDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
            D+KP N+L      N I K++DFG AK     N   S++    T  Y+APE++      
Sbjct: 139 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTEPCYTPYYVAPEVLGPEKYD 195
Query: 371 VSCKSDVYGFGMVL---------------LEMAGGRRNSNMNAIRSSKAYFPSWVYDQLN 415
            SC  D++  G+++               L ++ G +      IR  +  FP+  + +++
Sbjct: 196 KSC--DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQYEFPNPEWSEVS 249
Query: 416 KGGDLELRNVTEIE 429
           +   + +RN+ + E
Sbjct: 250 EEVKMLIRNLLKTE 263

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 191 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVN----- 244
           +F   LG+G FG V   +   T  L AVK+L+      ++ +       R+  +      
Sbjct: 23  NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 82
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
           + QL        +   V E++  G L  HI       +        EIA+G    + +L 
Sbjct: 83  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFLQ 138
Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN--DFVSISATRGTIGYIAPE 362
           +     I++ D+K  N++LD     K++DFG+     KEN  D V+     GT  YIAPE
Sbjct: 139 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMC----KENIWDGVTTKXFCGTPDYIAPE 191
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           +I+  +       D + FG++L EM  G+
Sbjct: 192 IIA--YQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +G V   +   TG+ +A+K + N+     +A+  + E+  +    H N++ +   
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 252 C------SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
                   E     +V + M    L + I    +  Q    E ++       RG+ Y+H+
Sbjct: 122 LRPTVPYGEFKSVYVVLDLM-ESDLHQII----HSSQPLTLEHVRYFLYQLLRGLKYMHS 176
Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK---FHPKENDFVSISATRGTIGYIAPE 362
                ++H D+KP N+L++ N   K+ DFG+A+     P E+ +  ++    T  Y APE
Sbjct: 177 AQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYF-MTEYVATRWYRAPE 232
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEMAGGRR 392
           L+  +    +   D++  G +  EM   R+
Sbjct: 233 LML-SLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 250
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 251 FCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEK--LQEIALGTARGVAYLHNGC 307
           F  +     +V E     SL + H   K  K  T    +  L++I LG      YLH   
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLG----CQYLHRNR 137
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++S+ 
Sbjct: 138 ---VIHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKTLCGTPNYIAPEVLSKK 192
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
               S + DV+  G ++  +  G+
Sbjct: 193 --GHSFEVDVWSIGCIMYTLLVGK 214

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 106/254 (41%), Gaps = 34/254 (13%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           LG G  G V +     T    A+KML++   +  E           H V +V +      
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 85
Query: 255 GSKRAL-VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILH 313
           G K  L V E +  G L   I  ++   Q F   +  EI       + YLH+   + I H
Sbjct: 86  GRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAH 140
Query: 314 FDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
            D+KP N+L      N I K++DFG AK     N   S++    T  Y+APE++      
Sbjct: 141 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYD 197
Query: 371 VSCKSDVYGFGMVL---------------LEMAGGRRNSNMNAIRSSKAYFPSWVYDQLN 415
            SC  D++  G+++               L ++ G +      IR  +  FP+  + +++
Sbjct: 198 KSC--DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQYEFPNPEWSEVS 251
Query: 416 KGGDLELRNVTEIE 429
           +   + +RN+ + E
Sbjct: 252 EEVKMLIRNLLKTE 265

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI-NEVSTIGRIH-HVNVVQLLGFC 252
           LG+G    V     L T +  AVK++E         +  EV  + +   H NV++L+ F 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
            E  +  LV+E M  GS+  HI    +K + F   +   +    A  + +LHN     I 
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHI----HKRRHFNELEASVVVQDVASALDFLHN---KGIA 133
Query: 313 HFDIKPHNILLDH--NFIP-KVSDFGLAKFHPKENDFVSISATR-----GTIGYIAPELI 364
           H D+KP NIL +H     P K+ DFGL        D   IS        G+  Y+APE++
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 365 ---SRNFGTVSCKSDVYGFGMVLLEMAGG 390
              S        + D++  G++L  +  G
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 106/254 (41%), Gaps = 34/254 (13%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           LG G  G V +     T    A+KML++   +  E           H V +V +      
Sbjct: 76  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 135
Query: 255 GSKRAL-VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILH 313
           G K  L V E +  G L   I  ++   Q F   +  EI       + YLH+   + I H
Sbjct: 136 GRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAH 190
Query: 314 FDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
            D+KP N+L      N I K++DFG AK     N   S++    T  Y+APE++      
Sbjct: 191 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYD 247
Query: 371 VSCKSDVYGFGMVL---------------LEMAGGRRNSNMNAIRSSKAYFPSWVYDQLN 415
            SC  D++  G+++               L ++ G +      IR  +  FP+  + +++
Sbjct: 248 KSC--DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQYEFPNPEWSEVS 301
Query: 416 KGGDLELRNVTEIE 429
           +   + +RN+ + E
Sbjct: 302 EEVKMLIRNLLKTE 315

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 83/194 (42%), Gaps = 15/194 (7%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           LG G  G V +     T    A+KML++   +  E           H V +V +      
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 129
Query: 255 GSKRAL-VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILH 313
           G K  L V E +  G L   I  ++   Q F   +  EI       + YLH+   + I H
Sbjct: 130 GRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAH 184
Query: 314 FDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
            D+KP N+L      N I K++DFG AK     N   S++    T  Y+APE++      
Sbjct: 185 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYD 241
Query: 371 VSCKSDVYGFGMVL 384
            SC  D++  G+++
Sbjct: 242 KSC--DMWSLGVIM 253

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           +G G +G V   +   TG+ +A+K + N+     +A+  + E+  +    H N++ +   
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 252 C------SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
                   E     +V + M    L + I    +  Q    E ++       RG+ Y+H+
Sbjct: 123 LRPTVPYGEFKSVYVVLDLM-ESDLHQII----HSSQPLTLEHVRYFLYQLLRGLKYMHS 177
Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK---FHPKENDFVSISATRGTIGYIAPE 362
                ++H D+KP N+L++ N   K+ DFG+A+     P E+ +  ++    T  Y APE
Sbjct: 178 AQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYF-MTEYVATRWYRAPE 233
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEMAGGRR 392
           L+  +    +   D++  G +  EM   R+
Sbjct: 234 LML-SLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 250
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 251 FCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEK--LQEIALGTARGVAYLHNGC 307
           F  +     +V E     SL + H   K  K  T    +  L++I LG      YLH   
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLG----CQYLHRNR 159
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++S+ 
Sbjct: 160 ---VIHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKVLCGTPNYIAPEVLSKK 214
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
               S + DV+  G ++  +  G+
Sbjct: 215 --GHSFEVDVWSIGCIMYTLLVGK 236

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 250
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 251 FCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEK--LQEIALGTARGVAYLHNGC 307
           F  +     +V E     SL + H   K  K  T    +  L++I LG      YLH   
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLG----CQYLHRNR 137
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++S+ 
Sbjct: 138 ---VIHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKTLCGTPNYIAPEVLSKK 192
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
               S + DV+  G ++  +  G+
Sbjct: 193 --GHSFEVDVWSIGCIMYTLLVGK 214

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 33/238 (13%)
Query: 211 TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL-VYEFMPNGS 269
           T    A+KML++   +  E           H V +V +      G K  L V E +  G 
Sbjct: 56  TQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE 115
Query: 270 LDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH---N 326
           L   I  ++   Q F   +  EI       + YLH+   + I H D+KP N+L      N
Sbjct: 116 LFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPN 170
Query: 327 FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL-- 384
            I K++DFG AK     N   S++    T  Y+APE++       SC  D++  G+++  
Sbjct: 171 AILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC--DMWSLGVIMYI 225
Query: 385 -------------LEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
                        L ++ G +      IR  +  FP+  + ++++   + +RN+ + E
Sbjct: 226 LLCGYPPFYSNHGLAISPGMKTR----IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE 279

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 35/283 (12%)
Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSVY-KGQLHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 219 MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG--- 390
           G AK        +      GT   +APE+I S+ +       D +  G+++ EMA G   
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEALAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
Query: 391 ----RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               +       I S K  FPS     L    DL LRN+ +++
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLK---DL-LRNLLQVD 276

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 250
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 251 FCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEK--LQEIALGTARGVAYLHNGC 307
           F  +     +V E     SL + H   K  K  T    +  L++I LG      YLH   
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLG----CQYLHRNR 141
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++S+ 
Sbjct: 142 ---VIHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKTLCGTPNYIAPEVLSKK 196
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
               S + DV+  G ++  +  G+
Sbjct: 197 GH--SFEVDVWSIGCIMYTLLVGK 218

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 196 LGQGGFGSVYK-GQLHTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 250
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 251 FCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEK--LQEIALGTARGVAYLHNGC 307
           F  +     +V E     SL + H   K  K  T    +  L++I LG      YLH   
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLG----CQYLHRNR 161
Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++S+ 
Sbjct: 162 ---VIHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKVLCGTPNYIAPEVLSKK 216
Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
               S + DV+  G ++  +  G+
Sbjct: 217 --GHSFEVDVWSIGCIMYTLLVGK 238

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 37/213 (17%)
Query: 177 PKRYSYPEIIAVTNHFTHK------LGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEE 229
           PK      + A    ++ K      LG G FG V+        + + VK ++  K   + 
Sbjct: 7   PKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC 66
Query: 230 FIN---------EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGS-----LDRHIF 275
           +I          E++ + R+ H N++++L          LV E   +G      +DRH  
Sbjct: 67  WIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH-- 124
Query: 276 PKENKG-QTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
           P+ ++   ++ + +L      +A G   L +     I+H DIK  NI++  +F  K+ DF
Sbjct: 125 PRLDEPLASYIFRQLV-----SAVGYLRLKD-----IIHRDIKDENIVIAEDFTIKLIDF 174
Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
           G A +  +   F +     GTI Y APE++  N
Sbjct: 175 GSAAYLERGKLFYTFC---GTIEYCAPEVLMGN 204

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 191 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVN----- 244
           +F   LG+G FG V   +   T  L AVK+L+      ++ +       R+  +      
Sbjct: 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 403
Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
           + QL        +   V E++  G L  HI       +        EIA+G    + +L 
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFLQ 459
Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN--DFVSISATRGTIGYIAPE 362
           +     I++ D+K  N++LD     K++DFG+     KEN  D V+     GT  YIAPE
Sbjct: 460 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMC----KENIWDGVTTKXFCGTPDYIAPE 512
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           +I+  +       D + FG++L EM  G+
Sbjct: 513 IIA--YQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 93/220 (42%), Gaps = 21/220 (9%)
Query: 177 PKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVS 235
           P  Y Y E +    H   +LG+G FG V++ +   TG   AVK +    F AEE +    
Sbjct: 83  PVDYEYREEVHWATHQL-RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELM---- 137
Query: 236 TIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALG 295
               +    +V L G   EG    +  E +  GSL + +     K Q    E      LG
Sbjct: 138 ACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV-----KEQGCLPEDRALYYLG 192
Query: 296 TA-RGVAYLHNGCDMCILHFDIKPHNILLDHNFI-PKVSDFGLAK-FHPK--ENDFVSIS 350
            A  G+ YLH+     ILH D+K  N+LL  +     + DFG A    P       ++  
Sbjct: 193 QALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGD 249
Query: 351 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
              GT  ++APE++     +   K DV+    ++L M  G
Sbjct: 250 YIPGTETHMAPEVVLGR--SCDAKVDVWSSCCMMLHMLNG 287

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 23/206 (11%)
Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQ 247
           +F  KL +   G ++KG+   G  I VK+L+   +S   + +F  E   +    H NV+ 
Sbjct: 13  NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 248 LLGFCSE--GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEI--ALGTARGVAYL 303
           +LG C         L+  + P GSL   +    ++G  F  ++ Q +  AL  ARG A+L
Sbjct: 72  VLGACQSPPAPHPTLITHWXPYGSLYNVL----HEGTNFVVDQSQAVKFALDXARGXAFL 127
Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG-TIGYIAPE 362
           H   +  I    +   ++ +D +   ++S   +         F   S  R     ++APE
Sbjct: 128 HT-LEPLIPRHALNSRSVXIDEDXTARISXADVK--------FSFQSPGRXYAPAWVAPE 178
Query: 363 LISRNFGTVSCKS-DVYGFGMVLLEM 387
            + +     + +S D + F ++L E+
Sbjct: 179 ALQKKPEDTNRRSADXWSFAVLLWEL 204

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 21/206 (10%)
Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQ 247
           F  ++G+G F +VYKG    T   +A   L++ K +  E   F  E   +  + H N+V+
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVR 89
Query: 248 LLGFCSEGSKR----ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
                    K      LV E   +G+L  ++     + +    + L+       +G+ +L
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYL----KRFKVXKIKVLRSWCRQILKGLQFL 145
Query: 304 HNGCDMCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
           H      I+H D+K  NI +       K+ D GLA    K   F    A  GT  + APE
Sbjct: 146 HTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASFA--KAVIGTPEFXAPE 200
Query: 363 LISRNFGTVSCKSDVYGFGMVLLEMA 388
                +       DVY FG   LE A
Sbjct: 201 XYEEKYDE---SVDVYAFGXCXLEXA 223

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI-NEVSTIGRIH-HVNVVQLLGFC 252
           LG+G    V     L T +  AVK++E         +  EV  + +   H NV++L+ F 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
            E  +  LV+E M  GS+  HI    +K + F   +   +    A  + +LHN     I 
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHI----HKRRHFNELEASVVVQDVASALDFLHN---KGIA 133
Query: 313 HFDIKPHNILLDH--NFIP-KVSDFGLAKFHPKENDFVSISATR-----GTIGYIAPELI 364
           H D+KP NIL +H     P K+ DF L        D   IS        G+  Y+APE++
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 365 ---SRNFGTVSCKSDVYGFGMVLLEMAGG 390
              S        + D++  G++L  +  G
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 65/147 (44%), Gaps = 14/147 (9%)
Query: 241 HHVNVVQLLGFCSEGSKRAL-VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARG 299
           H V +V +      G K  L V E +  G L   I  ++   Q F   +  EI       
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRI--QDRGDQAFTEREASEIXKSIGEA 173
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTI 356
           + YLH+   + I H D+KP N+L      N I K++DFG AK     N   S++    T 
Sbjct: 174 IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTP 227
Query: 357 GYIAPELISRNFGTVSCKSDVYGFGMV 383
            Y+APE++       SC  D +  G++
Sbjct: 228 YYVAPEVLGPEKYDKSC--DXWSLGVI 252

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 91/198 (45%), Gaps = 21/198 (10%)
Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHH-VNVVQLLGFC 252
           KLG+G +  V++   +     + VK+L+  K    +   E+  +  +    N++ L    
Sbjct: 44  KLGRGKYSEVFEAINITNNEKVVVKILKPVK--KNKIKREIKILENLRGGPNIITLADIV 101
Query: 253 SEGSKR--ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
            +   R  ALV+E + N    + ++      QT     ++       + + Y H+   M 
Sbjct: 102 KDPVSRTPALVFEHVNNTDF-KQLY------QTLTDYDIRFYMYEILKALDYCHS---MG 151
Query: 311 ILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
           I+H D+KPHN+++DH     ++ D+GLA+F+    ++    A+R   G   PEL+  ++ 
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLV-DYQ 207
Query: 370 TVSCKSDVYGFGMVLLEM 387
                 D++  G +L  M
Sbjct: 208 MYDYSLDMWSLGCMLASM 225

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 117/284 (41%), Gaps = 61/284 (21%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFIN-------EVSTIGRI----HHV 243
           LG+GGFG+V+ G   T RL +A+K++  ++      ++       EV+ + ++     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 244 NVVQLLGFCSEGSKRALVYEF-MPNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTAR 298
            V++LL +        LV E  +P   L  +I  K    E   + F  + +  I    +R
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR 158
Query: 299 GVAYLHNGCDMCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKE--NDFVSISATRGT 355
           GV           +H DIK  NIL+D      K+ DFG       E   DF       GT
Sbjct: 159 GV-----------VHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF------DGT 201
Query: 356 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA-IRSSKAYFPSWVYDQL 414
             Y  PE ISR+    +  + V+  G++L +M  G      +  I  ++ +FP+ V    
Sbjct: 202 RVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHV---- 256
Query: 415 NKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVL 458
                             +   C +   C+  K + RPS+ ++L
Sbjct: 257 ------------------SPDCCALIRRCLAPKPSSRPSLEEIL 282

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 103/246 (41%), Gaps = 51/246 (20%)
Query: 194 HKLGQGGFGSVYKG-QLHTGRLIAVKMLEN---SKFSAEEFINEVSTIGRIHHVNVVQLL 249
           H +G G +G V +       R++A+K +          +  + E++ + R++H +VV++L
Sbjct: 59  HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 250 GFC--SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWE-KLQEIALGTARGVAYLHNG 306
                 +  K   +Y  +     D   F K  +   +  E  ++ +      GV Y+H+ 
Sbjct: 119 DIVIPKDVEKFDELYVVLEIADSD---FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA 175
Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-------------FHPKEND--FVSISA 351
               ILH D+KP N L++ +   KV DFGLA+               P+E+D   V+   
Sbjct: 176 G---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
Query: 352 TRG----------TIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAI 399
           T+           T  Y APELI    N+       DV+  G +  E+        +N I
Sbjct: 233 TKNLKRQLTGHVVTRWYRAPELILLQENYTEA---IDVWSIGCIFAEL--------LNMI 281
Query: 400 RSSKAY 405
           + + AY
Sbjct: 282 KENVAY 287

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKML---ENSKFSAEEFINEVSTIGRI--HHVNVVQLL 249
           ++G GG   V++      ++ A+K +   E    + + + NE++ + ++  H   +++L 
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
            +         +Y  M  G++D + + K+ K     WE+ +         V  +H     
Sbjct: 95  DY---EITDQYIYMVMECGNIDLNSWLKKKKS-IDPWER-KSYWKNMLEAVHTIHQHG-- 147
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI----- 364
            I+H D+KP N L+    + K+ DFG+A     +   V   +  GT+ Y+ PE I     
Sbjct: 148 -IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 365 SRNFG----TVSCKSDVYGFGMVLLEMAGGR 391
           SR  G     +S KSDV+  G +L  M  G+
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKML---ENSKFSAEEFINEVSTIGRI--HHVNVVQLL 249
           ++G GG   V++      ++ A+K +   E    + + + NE++ + ++  H   +++L 
Sbjct: 19  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 78
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
            +         +Y  M  G++D + + K+ K     WE+ +         V  +H     
Sbjct: 79  DY---EITDQYIYMVMECGNIDLNSWLKKKKS-IDPWER-KSYWKNMLEAVHTIHQHG-- 131
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI----- 364
            I+H D+KP N L+    + K+ DFG+A     +   V   +  GT+ Y+ PE I     
Sbjct: 132 -IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 189
Query: 365 SRNFG----TVSCKSDVYGFGMVLLEMAGGR 391
           SR  G     +S KSDV+  G +L  M  G+
Sbjct: 190 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKML---ENSKFSAEEFINEVSTIGRI--HHVNVVQLL 249
           ++G GG   V++      ++ A+K +   E    + + + NE++ + ++  H   +++L 
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
            +         +Y  M  G++D + + K+ K     WE+ +         V  +H     
Sbjct: 95  DY---EITDQYIYMVMECGNIDLNSWLKKKKS-IDPWER-KSYWKNMLEAVHTIHQHG-- 147
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI----- 364
            I+H D+KP N L+    + K+ DFG+A     +   V   +  GT+ Y+ PE I     
Sbjct: 148 -IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 365 SRNFG----TVSCKSDVYGFGMVLLEMAGGR 391
           SR  G     +S KSDV+  G +L  M  G+
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 114/281 (40%), Gaps = 59/281 (20%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA-EEFIN------EVSTIGRIHH--VNV 245
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 246 VQLLGFCSEGSKRALVYEFM-PNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGV 300
           ++LL +        L+ E M P   L   I  +    E   ++F W+ L+         V
Sbjct: 76  IRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLE--------AV 127
Query: 301 AYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYI 359
            + HN     +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y 
Sbjct: 128 RHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VYS 180
Query: 360 APELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNAIRSSKAYFPSWVYDQLNK 416
            PE I   R  G  +    V+  G++L +M  G     +   I   + +F          
Sbjct: 181 PPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---------- 227
Query: 417 GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKV 457
                 R  +E + +I         WC+ ++ +DRP+  ++
Sbjct: 228 ----RQRVSSECQHLIR--------WCLALRPSDRPTFEEI 256

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKML---ENSKFSAEEFINEVSTIGRI--HHVNVVQLL 249
           ++G GG   V++      ++ A+K +   E    + + + NE++ + ++  H   +++L 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
            +         +Y  M  G++D + + K+ K     WE+ +         V  +H     
Sbjct: 123 DY---EITDQYIYMVMECGNIDLNSWLKKKKS-IDPWER-KSYWKNMLEAVHTIHQ---H 174
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI----- 364
            I+H D+KP N L+    + K+ DFG+A     +   V   +  GT+ Y+ PE I     
Sbjct: 175 GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 233
Query: 365 SRNFG----TVSCKSDVYGFGMVLLEMAGGR 391
           SR  G     +S KSDV+  G +L  M  G+
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKML---ENSKFSAEEFINEVSTIGRI--HHVNVVQLL 249
           ++G GG   V++      ++ A+K +   E    + + + NE++ + ++  H   +++L 
Sbjct: 15  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 74
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
            +         +Y  M  G++D + + K+ K     WE+ +         V  +H     
Sbjct: 75  DY---EITDQYIYMVMECGNIDLNSWLKKKKS-IDPWER-KSYWKNMLEAVHTIHQHG-- 127
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI----- 364
            I+H D+KP N L+    + K+ DFG+A     +   V   +  GT+ Y+ PE I     
Sbjct: 128 -IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 185
Query: 365 SRNFG----TVSCKSDVYGFGMVLLEMAGGR 391
           SR  G     +S KSDV+  G +L  M  G+
Sbjct: 186 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 216

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 50/106 (47%), Gaps = 15/106 (14%)
Query: 292 IALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND------ 345
           I +  A  V +LH+     ++H D+KP NI    + + KV DFGL     ++ +      
Sbjct: 169 IFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 346 ----FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
               + +     GT  Y++PE I  N    S K D++  G++L E+
Sbjct: 226 PMPAYATHXGQVGTKLYMSPEQIHGN--NYSHKVDIFSLGLILFEL 269

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/257 (23%), Positives = 111/257 (43%), Gaps = 27/257 (10%)
Query: 144 PIVFLVFLIHKYRTTLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGS 203
           P ++ + L  K R  +    N   +  +Q S++   + +   +A        +G+G FG 
Sbjct: 56  PEIYFLGLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDH---VAYRYEVLKVIGKGSFGQ 112
Query: 204 VYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHH------VNVVQLLGFCSEGS 256
           V K   H   + +A+KM+ N K    +   E+  +  +        +NV+ +L   +  +
Sbjct: 113 VVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172
Query: 257 KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDI 316
              + +E +   S++ +   K+NK Q F    +++ A    + +  LH      I+H D+
Sbjct: 173 HICMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDL 226
Query: 317 KPHNILLDHNFIP--KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSC 373
           KP NILL        KV DFG +  +  +  +  I +      Y APE+I    +G    
Sbjct: 227 KPENILLKQQGRSGIKVIDFG-SSCYEHQRVYTXIQSRF----YRAPEVILGARYGM--- 278
Query: 374 KSDVYGFGMVLLEMAGG 390
             D++  G +L E+  G
Sbjct: 279 PIDMWSLGCILAELLTG 295

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKML---ENSKFSAEEFINEVSTIGRI--HHVNVVQLL 249
           ++G GG   V++      ++ A+K +   E    + + + NE++ + ++  H   +++L 
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
            +         +Y  M  G++D + + K+ K     WE+ +         V  +H     
Sbjct: 76  DY---EITDQYIYMVMECGNIDLNSWLKKKKS-IDPWER-KSYWKNMLEAVHTIHQ---H 127
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI----- 364
            I+H D+KP N L+    + K+ DFG+A     +   V   +  GT+ Y+ PE I     
Sbjct: 128 GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 365 SRNFG----TVSCKSDVYGFGMVLLEMAGGR 391
           SR  G     +S KSDV+  G +L  M  G+
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 96/241 (39%), Gaps = 23/241 (9%)
Query: 156 RTTLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRL 214
           R   +T DN    L   +   P  Y Y E +    H   +LG+G FG V++ +   TG  
Sbjct: 43  RLGPETEDNEGVLL--TEKLKPVDYEYREEVHWMTH-QPRLGRGSFGEVHRMKDKQTGFQ 99
Query: 215 IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
            AVK +    F  EE +        +    +V L G   EG    +  E +  GSL + I
Sbjct: 100 CAVKKVRLEVFRVEELV----ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI 155
Query: 275 FPKENKGQTFGWEKLQEIALGTA-RGVAYLHNGCDMCILHFDIKPHNILLDHNFI-PKVS 332
                K      E      LG A  G+ YLH      ILH D+K  N+LL  +     + 
Sbjct: 156 -----KQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALC 207
Query: 333 DFGLAK-FHPK--ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG 389
           DFG A    P       ++     GT  ++APE++         K D++    ++L M  
Sbjct: 208 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLN 265
Query: 390 G 390
           G
Sbjct: 266 G 266

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA-EEFIN------EVSTIGRIHH--VNV 245
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIF------PKENKGQTFGWEKLQEIALGTARG 299
           ++LL +        L+ E  P    D   F       +E   ++F W+ L+         
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 155
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 358
           V + HN C   +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 156 VRHCHN-CG--VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 208
Query: 359 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK 416
             PE I   R  G  +    V+  G++L +M  G                P + +D+   
Sbjct: 209 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IP-FEHDEEII 250
Query: 417 GGDLELRN--VTEIESVIARKLCMIGLWCIQVKAADRPSMTKV 457
           GG +  R    +E + +I         WC+ ++ +DRP+  ++
Sbjct: 251 GGQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 285

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA-EEFIN------EVSTIGRIHH--VNV 245
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIF------PKENKGQTFGWEKLQEIALGTARG 299
           ++LL +        L+ E  P    D   F       +E   ++F W+ L+         
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 154
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 358
           V + HN C   +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 155 VRHCHN-CG--VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 207
Query: 359 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK 416
             PE I   R  G  +    V+  G++L +M  G                P + +D+   
Sbjct: 208 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IP-FEHDEEII 249
Query: 417 GGDLELRN--VTEIESVIARKLCMIGLWCIQVKAADRPSMTKV 457
           GG +  R    +E + +I         WC+ ++ +DRP+  ++
Sbjct: 250 GGQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 284

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/257 (23%), Positives = 111/257 (43%), Gaps = 27/257 (10%)
Query: 144 PIVFLVFLIHKYRTTLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGS 203
           P ++ + L  K R  +    N   +  +Q S++   + +   +A        +G+G FG 
Sbjct: 56  PEIYFLGLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDH---VAYRYEVLKVIGKGSFGQ 112
Query: 204 VYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHH------VNVVQLLGFCSEGS 256
           V K   H   + +A+KM+ N K    +   E+  +  +        +NV+ +L   +  +
Sbjct: 113 VVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172
Query: 257 KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDI 316
              + +E +   S++ +   K+NK Q F    +++ A    + +  LH      I+H D+
Sbjct: 173 HICMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDL 226
Query: 317 KPHNILLDHNFIP--KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSC 373
           KP NILL        KV DFG +  +  +  +  I +      Y APE+I    +G    
Sbjct: 227 KPENILLKQQGRSGIKVIDFG-SSCYEHQRVYTXIQSR----FYRAPEVILGARYGM--- 278
Query: 374 KSDVYGFGMVLLEMAGG 390
             D++  G +L E+  G
Sbjct: 279 PIDMWSLGCILAELLTG 295

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 116/283 (40%), Gaps = 63/283 (22%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA-EEFIN------EVSTIGRIHH--VNV 245
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIF------PKENKGQTFGWEKLQEIALGTARG 299
           ++LL +        L+ E  P    D   F       +E   ++F W+ L+         
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 122
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 358
           V + HN     +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 123 VRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 175
Query: 359 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK 416
             PE I   R  G  +    V+  G++L +M  G                P + +D+   
Sbjct: 176 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IP-FEHDEEII 217
Query: 417 GGDLELRN--VTEIESVIARKLCMIGLWCIQVKAADRPSMTKV 457
           GG +  R    +E + +I         WC+ ++ +DRP+  ++
Sbjct: 218 GGQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 252

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA-EEFIN------EVSTIGRIHH--VNV 245
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIF------PKENKGQTFGWEKLQEIALGTARG 299
           ++LL +        L+ E  P    D   F       +E   ++F W+ L+         
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 155
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 358
           V + HN C   +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 156 VRHCHN-CG--VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 208
Query: 359 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK 416
             PE I   R  G  +    V+  G++L +M  G                P + +D+   
Sbjct: 209 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IP-FEHDEEII 250
Query: 417 GGDLELRN--VTEIESVIARKLCMIGLWCIQVKAADRPSMTKV 457
           GG +  R    +E + +I         WC+ ++ +DRP+  ++
Sbjct: 251 GGQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 285

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 115/282 (40%), Gaps = 61/282 (21%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA-EEFIN------EVSTIGRIHH--VNV 245
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIF------PKENKGQTFGWEKLQEIALGTARG 299
           ++LL +        L+ E  P    D   F       +E   ++F W+ L+         
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 155
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 358
           V + HN C   +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 156 VRHCHN-CG--VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 208
Query: 359 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK 416
             PE I   R  G  +    V+  G++L +M  G                P + +D+   
Sbjct: 209 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IP-FEHDEEII 250
Query: 417 GGDLELRNVTEIESVIARKLCM-IGLWCIQVKAADRPSMTKV 457
           GG +  R     E       C  +  WC+ ++ +DRP+  ++
Sbjct: 251 GGQVFFRQRVSXE-------CQHLIRWCLALRPSDRPTFEEI 285

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA-EEFIN------EVSTIGRIHH--VNV 245
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIF------PKENKGQTFGWEKLQEIALGTARG 299
           ++LL +        L+ E  P    D   F       +E   ++F W+ L+         
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 154
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 358
           V + HN C   +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 155 VRHCHN-CG--VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 207
Query: 359 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK 416
             PE I   R  G  +    V+  G++L +M  G                P + +D+   
Sbjct: 208 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IP-FEHDEEII 249
Query: 417 GGDLELRN--VTEIESVIARKLCMIGLWCIQVKAADRPSMTKV 457
           GG +  R    +E + +I         WC+ ++ +DRP+  ++
Sbjct: 250 GGQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 284

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 32/213 (15%)
Query: 196 LGQGGFGSVYKGQLHTGRLIAVK-MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           LG G  G+V       GR +AVK ML +  F     +          H NV++   +CSE
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRY--YCSE 78
Query: 255 GSKRALVYEF-MPNGSLDRHIFPKENKGQTFGWEK-LQEIAL--GTARGVAYLHNGCDMC 310
            + R L     + N +L   +  K    +    +K    I+L    A GVA+LH+   + 
Sbjct: 79  TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LK 135
Query: 311 ILHFDIKPHNILLD-------------HNFIPKVSDFGL-AKFHPKENDF-VSISATRGT 355
           I+H D+KP NIL+               N    +SDFGL  K    ++ F  +++   GT
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGT 195
Query: 356 IGYIAPELI--SRNFGT---VSCKSDVYGFGMV 383
            G+ APEL+  S N  T   ++   D++  G V
Sbjct: 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 115/282 (40%), Gaps = 61/282 (21%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA-EEFIN------EVSTIGRIHH--VNV 245
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIF------PKENKGQTFGWEKLQEIALGTARG 299
           ++LL +        L+ E  P    D   F       +E   ++F W+ L+         
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 155
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 358
           V + HN C   +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 156 VRHCHN-CG--VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 208
Query: 359 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK 416
             PE I   R  G  +    V+  G++L +M  G                P + +D+   
Sbjct: 209 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IP-FEHDEEII 250
Query: 417 GGDLELRNVTEIESVIARKLCM-IGLWCIQVKAADRPSMTKV 457
           GG +  R     E       C  +  WC+ ++ +DRP+  ++
Sbjct: 251 GGQVFFRQRVSXE-------CQHLIRWCLALRPSDRPTFEEI 285

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 115/282 (40%), Gaps = 61/282 (21%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA-EEFIN------EVSTIGRIHH--VNV 245
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIF------PKENKGQTFGWEKLQEIALGTARG 299
           ++LL +        L+ E  P    D   F       +E   ++F W+ L+         
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 154
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 358
           V + HN C   +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 155 VRHCHN-CG--VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 207
Query: 359 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK 416
             PE I   R  G  +    V+  G++L +M  G                P + +D+   
Sbjct: 208 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IP-FEHDEEII 249
Query: 417 GGDLELRNVTEIESVIARKLCM-IGLWCIQVKAADRPSMTKV 457
           GG +  R     E       C  +  WC+ ++ +DRP+  ++
Sbjct: 250 GGQVFFRQRVSXE-------CQHLIRWCLALRPSDRPTFEEI 284

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKML---ENSKFSAEEFINEVSTIGRI--HHVNVVQLL 249
           ++G GG   V++      ++ A+K +   E    + + + NE++ + ++  H   +++L 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
            +         +Y  M  G++D + + K+ K     WE+ +         V  +H     
Sbjct: 123 DY---EITDQYIYMVMECGNIDLNSWLKKKKS-IDPWER-KSYWKNMLEAVHTIHQ---H 174
Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI----- 364
            I+H D+KP N L+    + K+ DFG+A     +   V   +  GT+ Y+ PE I     
Sbjct: 175 GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 233
Query: 365 SRNFG----TVSCKSDVYGFGMVLLEMAGGR 391
           SR  G     +S KSDV+  G +L  M  G+
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 113/282 (40%), Gaps = 61/282 (21%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA-EEFIN------EVSTIGRIHH--VNV 245
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIF------PKENKGQTFGWEKLQEIALGTARG 299
           ++LL +        L+ E  P    D   F       +E   ++F W+ L+         
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 122
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 358
           V + HN     +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 123 VRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 175
Query: 359 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNAIRSSKAYFPSWVYDQLN 415
             PE I   R  G  +    V+  G++L +M  G     +   I   + +F         
Sbjct: 176 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ------- 225
Query: 416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKV 457
                  R  +E + +I         WC+ ++ +DRP+  ++
Sbjct: 226 -------RVSSECQHLIR--------WCLALRPSDRPTFEEI 252

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 113/282 (40%), Gaps = 61/282 (21%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA-EEFIN------EVSTIGRIHH--VNV 245
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIF------PKENKGQTFGWEKLQEIALGTARG 299
           ++LL +        L+ E  P    D   F       +E   ++F W+ L+         
Sbjct: 75  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 125
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 358
           V + HN     +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 126 VRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 178
Query: 359 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNAIRSSKAYFPSWVYDQLN 415
             PE I   R  G  +    V+  G++L +M  G     +   I   + +F         
Sbjct: 179 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ------- 228
Query: 416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKV 457
                  R  +E + +I         WC+ ++ +DRP+  ++
Sbjct: 229 -------RVSSECQHLIR--------WCLALRPSDRPTFEEI 255

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 113/282 (40%), Gaps = 61/282 (21%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA-EEFIN------EVSTIGRIHH--VNV 245
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIF------PKENKGQTFGWEKLQEIALGTARG 299
           ++LL +        L+ E  P    D   F       +E   ++F W+ L+         
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 127
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 358
           V + HN     +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 128 VRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 180
Query: 359 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNAIRSSKAYFPSWVYDQLN 415
             PE I   R  G  +    V+  G++L +M  G     +   I   + +F         
Sbjct: 181 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEEIIRGQVFF--------- 228
Query: 416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKV 457
                  R  +E + +I         WC+ ++ +DRP+  ++
Sbjct: 229 -----RQRVSSECQHLIR--------WCLALRPSDRPTFEEI 257

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 113/282 (40%), Gaps = 61/282 (21%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA-EEFIN------EVSTIGRIHH--VNV 245
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIF------PKENKGQTFGWEKLQEIALGTARG 299
           ++LL +        L+ E  P    D   F       +E   ++F W+ L+         
Sbjct: 76  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 126
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 358
           V + HN     +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 127 VRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 179
Query: 359 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNAIRSSKAYFPSWVYDQLN 415
             PE I   R  G  +    V+  G++L +M  G     +   I   + +F         
Sbjct: 180 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEEIIRGQVFF--------- 227
Query: 416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKV 457
                  R  +E + +I         WC+ ++ +DRP+  ++
Sbjct: 228 -----RQRVSSECQHLIR--------WCLALRPSDRPTFEEI 256

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/257 (23%), Positives = 111/257 (43%), Gaps = 27/257 (10%)
Query: 144 PIVFLVFLIHKYRTTLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGS 203
           P ++ + L  K R  +    N   +  +Q S++   + +   +A        +G+G FG 
Sbjct: 56  PEIYFLGLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDH---VAYRYEVLKVIGKGXFGQ 112
Query: 204 VYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHH------VNVVQLLGFCSEGS 256
           V K   H   + +A+KM+ N K    +   E+  +  +        +NV+ +L   +  +
Sbjct: 113 VVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172
Query: 257 KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDI 316
              + +E +   S++ +   K+NK Q F    +++ A    + +  LH      I+H D+
Sbjct: 173 HICMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDL 226
Query: 317 KPHNILLDHNFIP--KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSC 373
           KP NILL        KV DFG +  +  +  +  I +      Y APE+I    +G    
Sbjct: 227 KPENILLKQQGRSGIKVIDFG-SSCYEHQRVYXXIQSR----FYRAPEVILGARYGM--- 278
Query: 374 KSDVYGFGMVLLEMAGG 390
             D++  G +L E+  G
Sbjct: 279 PIDMWSLGCILAELLTG 295

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 74/300 (24%), Positives = 113/300 (37%), Gaps = 60/300 (20%)
Query: 196 LGQGGFGSVYKGQLHTGRLIAVKMLENS------------KFSAEEFINEVSTIGRIHHV 243
           +  G +G+V  G    G  +A+K + N+             F  +  + E+  +   HH 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 244 NVVQLLGFCSEGSKRA-----LVYEFMPNGSL----DRHIFPKENKGQTFGWEKLQEIAL 294
           N++ L        + A     LV E M         D+ I       Q F +     I L
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH----ILL 145
Query: 295 GTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG 354
           G       LH   +  ++H D+ P NILL  N    + DF LA+    + +       R 
Sbjct: 146 G-------LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR- 197
Query: 355 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP-SWVYDQ 413
              Y APEL+ + F   +   D++  G V+ EM             + KA F  S  Y+Q
Sbjct: 198 --WYRAPELVMQ-FKGFTKLVDMWSAGCVMAEMF------------NRKALFRGSTFYNQ 242
Query: 414 LNK----GGDLELRNVTEIESVIARKLCMIGL-------WCIQVKAADRPSMTKVLEMLE 462
           LNK     G  ++ +V    S  AR      L       W   V  AD  ++  + +MLE
Sbjct: 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLE 302

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 58/135 (42%), Gaps = 13/135 (9%)
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR---NF 368
           +H DIKP N+LLD N   +++DFG +     ++  V  S   GT  YI+PE++       
Sbjct: 197 VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 255
Query: 369 GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAI---------RSSKAYFPSWVYDQLNKGGD 419
           G    + D +  G+ + EM  G       ++            +  FPS V D   +  D
Sbjct: 256 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKD 315
Query: 420 LELRNVTEIESVIAR 434
           L  R +   E  + +
Sbjct: 316 LIQRLICSRERRLGQ 330

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 114/282 (40%), Gaps = 61/282 (21%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA-EEFIN------EVSTIGRIHH--VNV 245
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIF------PKENKGQTFGWEKLQEIALGTARG 299
           ++LL +        L+ E  P    D   F       +E   ++F W+ L+         
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 127
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 358
           V + HN C   +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 128 VRHCHN-CG--VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 180
Query: 359 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNAIRSSKAYFPSWVYDQLN 415
             PE I   R  G  +    V+  G++L +M  G     +   I   + +F         
Sbjct: 181 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEEIIRGQVFF--------- 228
Query: 416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKV 457
                  R  +E + +I         WC+ ++ +DRP+  ++
Sbjct: 229 -----RQRVSSECQHLIR--------WCLALRPSDRPTFEEI 257

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 74/300 (24%), Positives = 113/300 (37%), Gaps = 60/300 (20%)
Query: 196 LGQGGFGSVYKGQLHTGRLIAVKMLENS------------KFSAEEFINEVSTIGRIHHV 243
           +  G +G+V  G    G  +A+K + N+             F  +  + E+  +   HH 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 244 NVVQLLGFCSEGSKRA-----LVYEFMPNGSL----DRHIFPKENKGQTFGWEKLQEIAL 294
           N++ L        + A     LV E M         D+ I       Q F +     I L
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH----ILL 145
Query: 295 GTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG 354
           G       LH   +  ++H D+ P NILL  N    + DF LA+    + +       R 
Sbjct: 146 G-------LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR- 197
Query: 355 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP-SWVYDQ 413
              Y APEL+ + F   +   D++  G V+ EM             + KA F  S  Y+Q
Sbjct: 198 --WYRAPELVMQ-FKGFTKLVDMWSAGCVMAEMF------------NRKALFRGSTFYNQ 242
Query: 414 LNK----GGDLELRNVTEIESVIARKLCMIGL-------WCIQVKAADRPSMTKVLEMLE 462
           LNK     G  ++ +V    S  AR      L       W   V  AD  ++  + +MLE
Sbjct: 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLE 302

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 114/282 (40%), Gaps = 61/282 (21%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA-EEFIN------EVSTIGRIHH--VNV 245
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIF------PKENKGQTFGWEKLQEIALGTARG 299
           ++LL +        L+ E  P    D   F       +E   ++F W+ L+         
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 127
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 358
           V + HN C   +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 128 VRHCHN-CG--VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 180
Query: 359 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNAIRSSKAYFPSWVYDQLN 415
             PE I   R  G  +    V+  G++L +M  G     +   I   + +F         
Sbjct: 181 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEEIIRGQVFF--------- 228
Query: 416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKV 457
                  R  +E + +I         WC+ ++ +DRP+  ++
Sbjct: 229 -----RQRVSSECQHLIR--------WCLALRPSDRPTFEEI 257

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 38/78 (48%), Gaps = 3/78 (3%)
Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+KP NIL+  +    + DFG+A     E     +  T GT+ Y APE  S +  T  
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEK-LTQLGNTVGTLYYXAPERFSESHATY- 214
Query: 373 CKSDVYGFGMVLLEMAGG 390
            ++D+Y    VL E   G
Sbjct: 215 -RADIYALTCVLYECLTG 231

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 113/282 (40%), Gaps = 61/282 (21%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA-EEFIN------EVSTIGRIHH--VNV 245
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIF------PKENKGQTFGWEKLQEIALGTARG 299
           ++LL +        L+ E  P    D   F       +E   ++F W+ L+         
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 141
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 358
           V + HN     +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 142 VRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 194
Query: 359 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNAIRSSKAYFPSWVYDQLN 415
             PE I   R  G  +    V+  G++L +M  G     +   I   + +F         
Sbjct: 195 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEEIIRGQVFF--------- 242
Query: 416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKV 457
                  R  +E + +I         WC+ ++ +DRP+  ++
Sbjct: 243 -----RQRVSSECQHLIR--------WCLALRPSDRPTFEEI 271

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 58/135 (42%), Gaps = 13/135 (9%)
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR---NF 368
           +H DIKP N+LLD N   +++DFG +     ++  V  S   GT  YI+PE++       
Sbjct: 213 VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 271
Query: 369 GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAI---------RSSKAYFPSWVYDQLNKGGD 419
           G    + D +  G+ + EM  G       ++            +  FPS V D   +  D
Sbjct: 272 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKD 331
Query: 420 LELRNVTEIESVIAR 434
           L  R +   E  + +
Sbjct: 332 LIQRLICSRERRLGQ 346

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 71/149 (47%), Gaps = 18/149 (12%)
Query: 191 HFTHKLGQGGFGSVY-KGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVN----- 244
           H   KLG G F +V+    +   + +A+K++++++   E  ++E+  +  + + +     
Sbjct: 24  HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPN 83
Query: 245 ---VVQLLGFCS----EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
              VVQLL         G+   +V+E + +  L   I   ++  Q      +++I     
Sbjct: 84  REMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWII---KSNYQGLPLPCVKKIIQQVL 140
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHN 326
           +G+ YLH  C   I+H DIKP NILL  N
Sbjct: 141 QGLDYLHTKCR--IIHTDIKPENILLSVN 167

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 114/282 (40%), Gaps = 61/282 (21%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA-EEFIN------EVSTIGRIHH--VNV 245
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIF------PKENKGQTFGWEKLQEIALGTARG 299
           ++LL +        L+ E  P    D   F       +E   ++F W+ L+         
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 154
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 358
           V + HN C   +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 155 VRHCHN-CG--VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 207
Query: 359 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNAIRSSKAYFPSWVYDQLN 415
             PE I   R  G  +    V+  G++L +M  G     +   I   + +F         
Sbjct: 208 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEEIIRGQVFF--------- 255
Query: 416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKV 457
                  R  +E + +I         WC+ ++ +DRP+  ++
Sbjct: 256 -----RQRVSSECQHLIR--------WCLALRPSDRPTFEEI 284

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 113/282 (40%), Gaps = 61/282 (21%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA-EEFIN------EVSTIGRIHH--VNV 245
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIF------PKENKGQTFGWEKLQEIALGTARG 299
           ++LL +        L+ E  P    D   F       +E   ++F W+ L+         
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 142
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 358
           V + HN     +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 143 VRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 195
Query: 359 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNAIRSSKAYFPSWVYDQLN 415
             PE I   R  G  +    V+  G++L +M  G     +   I   + +F         
Sbjct: 196 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEEIIRGQVFF--------- 243
Query: 416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKV 457
                  R  +E + +I         WC+ ++ +DRP+  ++
Sbjct: 244 -----RQRVSSECQHLIR--------WCLALRPSDRPTFEEI 272

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 112/282 (39%), Gaps = 61/282 (21%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA-EEFIN------EVSTIGRIHH--VNV 245
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIF------PKENKGQTFGWEKLQEIALGTARG 299
           ++LL +        L+ E  P    D   F       +E   ++F W+ L+         
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 122
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 358
           V + HN     +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 123 VRHCHN---XGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 175
Query: 359 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNAIRSSKAYFPSWVYDQLN 415
             PE I   R  G  +    V+  G++L +M  G     +   I   + +F         
Sbjct: 176 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ------- 225
Query: 416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKV 457
                  R   E + +I         WC+ ++ +DRP+  ++
Sbjct: 226 -------RVSXECQHLIR--------WCLALRPSDRPTFEEI 252

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 99/246 (40%), Gaps = 33/246 (13%)
Query: 156 RTTLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRL 214
           R   +T DN    L   +   P  Y Y E +    H   ++G+G FG V++ +   TG  
Sbjct: 45  RLGPETEDNEGVLL--TEKLKPVDYEYREEVHWMTH-QPRVGRGSFGEVHRMKDKQTGFQ 101
Query: 215 IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
            AVK +    F  EE +        +    +V L G   EG    +  E +  GSL + I
Sbjct: 102 CAVKKVRLEVFRVEELV----ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI 157
Query: 275 -----FPKENKGQTFGWEKLQEIALGTA-RGVAYLHNGCDMCILHFDIKPHNILLDHNFI 328
                 P E++   +         LG A  G+ YLH      ILH D+K  N+LL  +  
Sbjct: 158 KQMGCLP-EDRALYY---------LGQALEGLEYLHT---RRILHGDVKADNVLLSSDGS 204
Query: 329 -PKVSDFGLAK-FHPK--ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 384
              + DFG A    P       ++     GT  ++APE++         K D++    ++
Sbjct: 205 RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMM 262
Query: 385 LEMAGG 390
           L M  G
Sbjct: 263 LHMLNG 268

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 114/282 (40%), Gaps = 61/282 (21%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA-EEFIN------EVSTIGRIHH--VNV 245
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIF------PKENKGQTFGWEKLQEIALGTARG 299
           ++LL +        L+ E  P    D   F       +E   ++F W+ L+         
Sbjct: 111 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 161
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 358
           V + HN C   +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 162 VRHCHN-CG--VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 214
Query: 359 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNAIRSSKAYFPSWVYDQLN 415
             PE I   R  G  +    V+  G++L +M  G     +   I   + +F         
Sbjct: 215 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEEIIRGQVFF--------- 262
Query: 416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKV 457
                  R  +E + +I         WC+ ++ +DRP+  ++
Sbjct: 263 -----RQRVSSECQHLIR--------WCLALRPSDRPTFEEI 291

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 71/149 (47%), Gaps = 18/149 (12%)
Query: 191 HFTHKLGQGGFGSVY-KGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVN----- 244
           H   KLG G F +V+    +   + +A+K++++++   E  ++E+  +  + + +     
Sbjct: 40  HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPN 99
Query: 245 ---VVQLLGFCS----EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
              VVQLL         G+   +V+E + +  L   I   ++  Q      +++I     
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWII---KSNYQGLPLPCVKKIIQQVL 156
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHN 326
           +G+ YLH  C   I+H DIKP NILL  N
Sbjct: 157 QGLDYLHTKCR--IIHTDIKPENILLSVN 183

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 99/246 (40%), Gaps = 33/246 (13%)
Query: 156 RTTLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRL 214
           R   +T DN    L   +   P  Y Y E +    H   ++G+G FG V++ +   TG  
Sbjct: 29  RLGPETEDNEGVLL--TEKLKPVDYEYREEVHWMTH-QPRVGRGSFGEVHRMKDKQTGFQ 85
Query: 215 IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
            AVK +    F  EE +        +    +V L G   EG    +  E +  GSL + I
Sbjct: 86  CAVKKVRLEVFRVEELV----ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI 141
Query: 275 -----FPKENKGQTFGWEKLQEIALGTA-RGVAYLHNGCDMCILHFDIKPHNILLDHNFI 328
                 P E++   +         LG A  G+ YLH      ILH D+K  N+LL  +  
Sbjct: 142 KQMGCLP-EDRALYY---------LGQALEGLEYLHT---RRILHGDVKADNVLLSSDGS 188
Query: 329 -PKVSDFGLAK-FHPK--ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 384
              + DFG A    P       ++     GT  ++APE++         K D++    ++
Sbjct: 189 RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMM 246
Query: 385 LEMAGG 390
           L M  G
Sbjct: 247 LHMLNG 252

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 114/282 (40%), Gaps = 61/282 (21%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA-EEFIN------EVSTIGRIHH--VNV 245
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIF------PKENKGQTFGWEKLQEIALGTARG 299
           ++LL +        L+ E  P    D   F       +E   ++F W+ L+         
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 169
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 358
           V + HN C   +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 170 VRHCHN-CG--VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 222
Query: 359 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNAIRSSKAYFPSWVYDQLN 415
             PE I   R  G  +    V+  G++L +M  G     +   I   + +F         
Sbjct: 223 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEEIIRGQVFF--------- 270
Query: 416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKV 457
                  R  +E + +I         WC+ ++ +DRP+  ++
Sbjct: 271 -----RQRVSSECQHLIR--------WCLALRPSDRPTFEEI 299

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/82 (34%), Positives = 42/82 (51%), Gaps = 4/82 (4%)
Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR---NF 368
           +H DIKP NIL+D N   +++DFG +     E+  V  S   GT  YI+PE++       
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255
Query: 369 GTVSCKSDVYGFGMVLLEMAGG 390
           G    + D +  G+ + EM  G
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYG 277

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 28/209 (13%)
Query: 196 LGQGGFGSVYKGQLHTGRLIAVK-MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           LG G  G+V       GR +AVK ML +  F     +          H NV++   +CSE
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRY--YCSE 96
Query: 255 GSKRALVYEF-MPNGSLDRHIFPKENKGQTFGWEK-LQEIAL--GTARGVAYLHNGCDMC 310
            + R L     + N +L   +  K    +    +K    I+L    A GVA+LH+   + 
Sbjct: 97  TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LK 153
Query: 311 ILHFDIKPHNILLD-------------HNFIPKVSDFGL-AKFHPKENDF-VSISATRGT 355
           I+H D+KP NIL+               N    +SDFGL  K    +  F  +++   GT
Sbjct: 154 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGT 213
Query: 356 IGYIAPELISRNFGTVSCKS-DVYGFGMV 383
            G+ APEL+  +      +S D++  G V
Sbjct: 214 SGWRAPELLEESTKRRLTRSIDIFSMGCV 242

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 36/218 (16%)
Query: 196 LGQGGFGSVYKGQLHT--GRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQL----- 248
           LG GG G V+    +    R+   K++     S +  + E+  I R+ H N+V++     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 249 ---------LGFCSEGSKRALVYEFMPN---GSLDRHIFPKENKGQTFGWEKLQEIALGT 296
                    +G  +E +   +V E+M       L++    +E+  + F ++ L       
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEH-ARLFMYQLL------- 130
Query: 297 ARGVAYLHNGCDMCILHFDIKPHNILLD-HNFIPKVSDFGLAK-FHPKENDFVSISATRG 354
            RG+ Y+H+     +LH D+KP N+ ++  + + K+ DFGLA+   P  +    +S    
Sbjct: 131 -RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 355 TIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           T  Y +P  L+S N  T +   D++  G +  EM  G+
Sbjct: 187 TKWYRSPRLLLSPNNYTKAI--DMWAAGCIFAEMLTGK 222

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 24/169 (14%)
Query: 232 NEVSTIGRIHHVNVVQLLG--FCSEGSKRALVYEFMPNG------SLDRHIFPKENKGQT 283
            E+  + R+ H NV+QL+   +  E  K  +V E+   G      S+    FP     Q 
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPV---CQA 111
Query: 284 FGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPK 342
            G+            G+ YLH+     I+H DIKP N+LL      K+S  G+A+  HP 
Sbjct: 112 HGY------FCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162
Query: 343 ENDFVSISATRGTIGYIAPELISRNFGTVSC-KSDVYGFGMVLLEMAGG 390
             D  +   ++G+  +  PE I+    T S  K D++  G+ L  +  G
Sbjct: 163 AAD-DTCRTSQGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 28/209 (13%)
Query: 196 LGQGGFGSVYKGQLHTGRLIAVK-MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           LG G  G+V       GR +AVK ML +  F     +          H NV++   +CSE
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRY--YCSE 96
Query: 255 GSKRALVYEF-MPNGSLDRHIFPKENKGQTFGWEK-LQEIAL--GTARGVAYLHNGCDMC 310
            + R L     + N +L   +  K    +    +K    I+L    A GVA+LH+   + 
Sbjct: 97  TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LK 153
Query: 311 ILHFDIKPHNILLD-------------HNFIPKVSDFGL-AKFHPKENDF-VSISATRGT 355
           I+H D+KP NIL+               N    +SDFGL  K    +  F  +++   GT
Sbjct: 154 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGT 213
Query: 356 IGYIAPELISRNFGTVSCKS-DVYGFGMV 383
            G+ APEL+  +      +S D++  G V
Sbjct: 214 SGWRAPELLEESTKRRLTRSIDIFSMGCV 242

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 97/244 (39%), Gaps = 46/244 (18%)
Query: 180 YSYPEIIAVTNHF--THKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVST 236
           +S+ + + + N F    K+G G FG V   Q +   +  AVK++ N K        E   
Sbjct: 25  FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADI 84
Query: 237 IGRIHHVNVVQLLGFCSEGSKRALVYEFM-----PNGSLDRHIFPKENKGQTFGWEKLQE 291
           + +I + ++         G  + + Y+ M     P G     I  + N    F  E ++ 
Sbjct: 85  LKKIQNDDINNNNIVKYHG--KFMYYDHMCLIFEPLGPSLYEIITRNNYN-GFHIEDIKL 141
Query: 292 IALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIP---------------------- 329
             +   + + YL     M + H D+KP NILLD  +                        
Sbjct: 142 YCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
Query: 330 ---KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 386
              K+ DFG A F  K +   SI  TR    Y APE+I  N G     SD++ FG VL E
Sbjct: 199 TGIKLIDFGCATF--KSDYHGSIINTR---QYRAPEVI-LNLGW-DVSSDMWSFGCVLAE 251
Query: 387 MAGG 390
           +  G
Sbjct: 252 LYTG 255

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 32/213 (15%)
Query: 196 LGQGGFGSVYKGQLHTGRLIAVK-MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           LG G  G+V       GR +AVK ML +  F     +          H NV++   +CSE
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRY--YCSE 78
Query: 255 GSKRALVYEF-MPNGSLDRHIFPKENKGQTFGWEK-LQEIAL--GTARGVAYLHNGCDMC 310
            + R L     + N +L   +  K    +    +K    I+L    A GVA+LH+   + 
Sbjct: 79  TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LK 135
Query: 311 ILHFDIKPHNILLD-------------HNFIPKVSDFGL-AKFHPKENDF-VSISATRGT 355
           I+H D+KP NIL+               N    +SDFGL  K    +  F  +++   GT
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGT 195
Query: 356 IGYIAPELI--SRNFGT---VSCKSDVYGFGMV 383
            G+ APEL+  S N  T   ++   D++  G V
Sbjct: 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 112/282 (39%), Gaps = 61/282 (21%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA-EEFIN------EVSTIGRIHH--VNV 245
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIF------PKENKGQTFGWEKLQEIALGTARG 299
           ++LL +        L+ E  P    D   F       +E   ++F W+ L+         
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 141
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 358
           V + HN     +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 142 VRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 194
Query: 359 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNAIRSSKAYFPSWVYDQLN 415
             PE I   R  G  +    V+  G++L +M  G     +   I   + +F         
Sbjct: 195 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEEIIRGQVFF--------- 242
Query: 416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKV 457
                  R   E + +I         WC+ ++ +DRP+  ++
Sbjct: 243 -----RQRVSXECQHLIR--------WCLALRPSDRPTFEEI 271

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 113/282 (40%), Gaps = 61/282 (21%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA-EEFIN------EVSTIGRIHH--VNV 245
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIF------PKENKGQTFGWEKLQEIALGTARG 299
           ++LL +        L+ E  P    D   F       +E   ++F W+ L+         
Sbjct: 99  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 149
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 358
           V + HN C   +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 150 VRHCHN-CG--VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 202
Query: 359 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNAIRSSKAYFPSWVYDQLN 415
             PE I   R  G  +    V+  G++L +M  G     +   I   + +F         
Sbjct: 203 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEEIIRGQVFF--------- 250
Query: 416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKV 457
                  R   E + +I         WC+ ++ +DRP+  ++
Sbjct: 251 -----RQRVSXECQHLIR--------WCLALRPSDRPTFEEI 279

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 112/282 (39%), Gaps = 61/282 (21%)
Query: 196 LGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSA-EEFIN------EVSTIGRIHH--VNV 245
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIF------PKENKGQTFGWEKLQEIALGTARG 299
           ++LL +        L+ E  P    D   F       +E   ++F W+ L+         
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 142
Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 358
           V + HN     +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 143 VRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 195
Query: 359 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNAIRSSKAYFPSWVYDQLN 415
             PE I   R  G  +    V+  G++L +M  G     +   I   + +F         
Sbjct: 196 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEEIIRGQVFF--------- 243
Query: 416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKV 457
                  R   E + +I         WC+ ++ +DRP+  ++
Sbjct: 244 -----RQRVSXECQHLIR--------WCLALRPSDRPTFEEI 272

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 49/91 (53%), Gaps = 8/91 (8%)
Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTI 356
           + + Y H+   M I+H D+KPHN+L+DH     ++ D+GLA+F+    ++    A+R   
Sbjct: 142 KALDYCHS---MGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 198
Query: 357 GYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
           G   PEL+  ++       D++  G +L  M
Sbjct: 199 G---PELLV-DYQMYDYSLDMWSLGCMLASM 225
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	511
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-115
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-101
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-100
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-71
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-65
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-60
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-58
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-58
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-57
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-57
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-56
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-55
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-55
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-52
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-52
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-51
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-50
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-49
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-41
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-40
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-40
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-40
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-40
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-40
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-40
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-40
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-39
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-39
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-38
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-38
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-38
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-37
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-37
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-36
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-36
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-36
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-36
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-36
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-36
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-36
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-36
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	9e-36
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-35
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-35
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-35
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-35
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-35
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-35
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	8e-35
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	8e-35
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-34
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-34
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-34
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-34
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-34
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-34
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	8e-34
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	9e-34
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-33
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-33
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-33
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-33
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-33
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-33
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-33
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-33
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-33
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	8e-33
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-32
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-32
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-32
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-31
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-31
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-31
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-31
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-30
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-30
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-30
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-30
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-30
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	9e-30
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-29
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-29
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-29
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-29
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-29
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-29
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-29
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-29
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-28
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-28
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-27
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-27
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-27
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-27
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-26
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-26
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-26
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-26
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-26
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-26
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-26
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-26
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-26
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-26
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-25
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-25
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-25
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-25
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-25
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-24
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-24
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-24
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-24
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-24
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-24
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-24
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-24
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	7e-24
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	7e-24
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-24
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-24
3niz_A	311	Rhodanese family protein; structural genomics, str	8e-24
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-24
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	9e-24
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-23
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-23
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-23
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-23
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-23
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-23
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-23
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-23
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-23
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	9e-23
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	9e-23
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-22
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-22
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-22
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-22
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-22
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	8e-22
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-21
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-21
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-21
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-21
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-21
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-05
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-21
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-20
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-20
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-20
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	7e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-20
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-19
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-18
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-18
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	9e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-15
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	9e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-13
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-13
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-12
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-12
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-12
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-10
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-09
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-08
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-08
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-06

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  341 bits (876), Expect = e-115
 Identities = 114/302 (37%), Positives = 162/302 (53%), Gaps = 25/302 (8%)

Query: 177 PKRYSYPEIIAVTNHF--THKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAE--EFIN 232
            KR+S  E+   +++F   + LG+GGFG VYKG+L  G L+AVK L+  +      +F  
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 233 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEI 292
           EV  I    H N+++L GFC   ++R LVY +M NGS+   +  +        W K Q I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
           ALG+ARG+AYLH+ CD  I+H D+K  NILLD  F   V DFGLAK    ++  V+   T
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT---T 193

Query: 353 R--GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMN-AIRSSKAYFPSW 409
              GTIG+IAPE +S   G  S K+DV+G+G++LLE+  G+R  ++             W
Sbjct: 194 AVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251

Query: 410 VYDQLNKGGDLEL--------RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEML 461
           V   L +     L            E+E +I      + L C Q    +RP M++V+ ML
Sbjct: 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQ-----VALLCTQSSPMERPKMSEVVRML 306

Query: 462 EG 463
           EG
Sbjct: 307 EG 308

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  304 bits (782), Expect = e-101
 Identities = 93/309 (30%), Positives = 145/309 (46%), Gaps = 39/309 (12%)

Query: 177 PKRYSYPEIIAVTNHF--------THKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSA- 227
              +S+ E+  VTN+F         +K+G+GGFG VYKG ++    +AVK L        
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITT 70

Query: 228 ----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQT 283
               ++F  E+  + +  H N+V+LLGF S+G    LVY +MPNGSL   +   +     
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PP 129

Query: 284 FGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 343
             W    +IA G A G+ +LH       +H DIK  NILLD  F  K+SDFGLA+   K 
Sbjct: 130 LSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186

Query: 344 ND-FVSISATR--GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIR 400
               ++   +R  GT  Y+APE +    G ++ KSD+Y FG+VLLE+  G    + +   
Sbjct: 187 AQTVMT---SRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEH--- 237

Query: 401 SSKAYFPSWVYDQLNKGGDLE------LRNVTEIESVIARKLCMIGLWCIQVKAADRPSM 454
                      +  ++   +E      + +           +  +   C+  K   RP +
Sbjct: 238 REPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS---VEAMYSVASQCLHEKKNKRPDI 294

Query: 455 TKVLEMLEG 463
            KV ++L+ 
Sbjct: 295 KKVQQLLQE 303

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  302 bits (776), Expect = e-100
 Identities = 103/298 (34%), Positives = 152/298 (51%), Gaps = 18/298 (6%)

Query: 178 KRYSYPEIIAVTNHF--THKLGQGGFGSVYKGQLHTGRLIAVKML-ENSKFSAEEFINEV 234
            R    ++   TN+F     +G G FG VYKG L  G  +A+K     S    EEF  E+
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86

Query: 235 STIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIAL 294
            T+    H ++V L+GFC E ++  L+Y++M NG+L RH++  +    +  WE+  EI +
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146

Query: 295 GTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-FVSISATR 353
           G ARG+ YLH      I+H D+K  NILLD NF+PK++DFG++K   + +   +S   T 
Sbjct: 147 GAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS---TV 200

Query: 354 --GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVY 411
             GT+GYI PE   +   T   KSDVY FG+VL E+   R     +  R        W  
Sbjct: 201 VKGTLGYIDPEYFIKGRLTE--KSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAV 257

Query: 412 DQLNKGGDLEL---RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD 466
           +  N G   ++       +I     RK     + C+ + + DRPSM  VL  LE ++ 
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  228 bits (582), Expect = 6e-71
 Identities = 74/316 (23%), Positives = 118/316 (37%), Gaps = 36/316 (11%)

Query: 181 SYPEIIAVTNHFT--HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIG 238
               +   +          +G FG V+K QL     +AVK+       + +   EV ++ 
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLP 73

Query: 239 RIHHVNVVQLLGFCSEGSKRA----LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIAL 294
            + H N++Q +G    G+       L+  F   GSL   +     K     W +L  IA 
Sbjct: 74  GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHIAE 128

Query: 295 GTARGVAYLH-------NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 347
             ARG+AYLH       +G    I H DIK  N+LL +N    ++DFGLA          
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188

Query: 348 SISATRGTIGYIAPELISRNFGT---VSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA 404
                 GT  Y+APE++            + D+Y  G+VL E+A     ++         
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV-DEYML 247

Query: 405 YFPSWVYDQ----------LNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSM 454
            F   +             ++K     LR+  +  + +   LC     C    A  R S 
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGM-AMLCETIEECWDHDAEARLSA 306

Query: 455 TKVLEMLEG--SMDDL 468
             V E +     + ++
Sbjct: 307 GCVGERITQMQRLTNI 322

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  213 bits (544), Expect = 2e-65
 Identities = 80/288 (27%), Positives = 143/288 (49%), Gaps = 30/288 (10%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQ 247
           +   K+G G FG+V++ + H G  +AVK+L    F A    EF+ EV+ + R+ H N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98

Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +G  ++    ++V E++  GSL R +     + +     +   +A   A+G+ YLHN  
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAR-EQLDERRRLSMAYDVAKGMNYLHN-R 156

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
           +  I+H ++K  N+L+D  +  KV DFGL++   K + F+S  +  GT  ++APE++   
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDE 214

Query: 368 FGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT 426
               + KSDVY FG++L E+A  ++   N+N  +         V     K   LE+    
Sbjct: 215 --PSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--------VVAAVGFKCKRLEIPRNL 264

Query: 427 --EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPP 472
             ++ ++I          C   +   RPS   ++++L   +    +PP
Sbjct: 265 NPQVAAIIEG--------CWTNEPWKRPSFATIMDLLR-PLIKSAVPP 303

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  200 bits (511), Expect = 2e-60
 Identities = 74/342 (21%), Positives = 129/342 (37%), Gaps = 51/342 (14%)

Query: 181 SYPEIIAVTNHFT--HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINE--VST 236
           +  E     ++      +G+G +G+VYKG L   R +AVK+   S  + + FINE  +  
Sbjct: 4   AASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVF--SFANRQNFINEKNIYR 60

Query: 237 IGRIHHVNVVQLLGFCSEGSKRA-----LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQE 291
           +  + H N+ + +      +        LV E+ PNGSL +++        T  W     
Sbjct: 61  VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCR 115

Query: 292 IALGTARGVAYLHN------GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH----P 341
           +A    RG+AYLH            I H D+   N+L+ ++    +SDFGL+        
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175

Query: 342 KENDFVSISATR--GTIGYIAPELIS-----RNFGTVSCKSDVYGFGMVLLEMAGGRRNS 394
                   +A    GTI Y+APE++      R+  +   + D+Y  G++  E+    R +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF--MRCT 233

Query: 395 NMNAIRSSKAY---FPSWVYDQ----------LNKGGDLELRNVTEIESVIARKLCMIGL 441
           ++    S   Y   F + V +             +    +     +  S+  R L     
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 442 WCIQVKAADRPSMTKVLEMLEG--SMDDLQMPPKPCFSSSRH 481
            C    A  R +     E +     + +      P      H
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHHHH 335

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  193 bits (493), Expect = 3e-58
 Identities = 85/275 (30%), Positives = 145/275 (52%), Gaps = 26/275 (9%)

Query: 194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAE---EFINEVSTIGRIHHVNVVQLLG 250
            ++G G FG+VYKG+ H G  +AVKML  +  + +    F NEV  + +  HVN++  +G
Sbjct: 30  QRIGSGSFGTVYKGKWH-GD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
           + +   + A+V ++    SL  H+   E K   F  +KL +IA  TARG+ YLH      
Sbjct: 88  YSTAP-QLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHA---KS 140

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFG 369
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200

Query: 370 TVSCKSDVYGFGMVLLEMAGGRR-NSNMNAIRSSKAYFPSWVYDQLNKGGDLELR-NVTE 427
             S +SDVY FG+VL E+  G+   SN+N            + + + +G    L  ++++
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--------IIEMVGRGS---LSPDLSK 249

Query: 428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
           + S   +++  +   C++ K  +RPS  ++L  +E
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  194 bits (494), Expect = 4e-58
 Identities = 72/295 (24%), Positives = 130/295 (44%), Gaps = 31/295 (10%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
                +G+G FG V K +    + +A+K +E+     + FI E+  + R++H N+V+L G
Sbjct: 11  EVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER-KAFIVELRQLSRVNHPNIVKLYG 68

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
            C       LV E+   GSL   +   E     +         L  ++GVAYLH+     
Sbjct: 69  ACLN--PVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHSMQPKA 125

Query: 311 ILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
           ++H D+KP N+LL     + K+ DFG A           ++  +G+  ++APE+   +  
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGS-- 178

Query: 370 TVSCKSDVYGFGMVLLEMAGGRR-NSNMNAIRSSKAYFPSWVYDQLNKGGDLEL-RNV-T 426
             S K DV+ +G++L E+   R+    +             +   ++ G    L +N+  
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIG-------GPAFRIMWAVHNGTRPPLIKNLPK 231

Query: 427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKPCFSSSRH 481
            IES++ R        C     + RPSM ++++++   M       +P     +H
Sbjct: 232 PIESLMTR--------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQH 278

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  190 bits (485), Expect = 5e-57
 Identities = 66/288 (22%), Positives = 116/288 (40%), Gaps = 42/288 (14%)

Query: 192 FTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSA--------EEFINEVSTIGRIHH 242
           +  ++G+GGFG V+KG+ +    ++A+K L               +EF  EV  +  ++H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82

Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
            N+V+L G         +V EF+P G L   +    +K     W     + L  A G+ Y
Sbjct: 83  PNIVKLYGLMHNPP--RMVMEFVPCGDLYHRL---LDKAHPIKWSVKLRLMLDIALGIEY 137

Query: 303 LHNGCDMCILHFDIKPHNILLD-----HNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
           + N  +  I+H D++  NI L           KV+DFGL++         S+S   G   
Sbjct: 138 MQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQ 191

Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNAIRSSKAYFPSWVYDQLNK 416
           ++APE I     + + K+D Y F M+L  +  G       +  +        ++     +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK------IKFINMIREE 245

Query: 417 GGDLELRNVT--EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
           G    +       + +VI          C       RP  + +++ L 
Sbjct: 246 GLRPTIPEDCPPRLRNVIEL--------CWSGDPKKRPHFSYIVKELS 285

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  187 bits (476), Expect = 7e-56
 Identities = 72/288 (25%), Positives = 116/288 (40%), Gaps = 44/288 (15%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKML-----ENSKFSAEEFINEVSTIGRIHHVNV 245
                +G GGFG VY+     G  +AVK       E+   + E    E      + H N+
Sbjct: 10  TLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68

Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           + L G C +     LV EF   G L+R +      G+    + L   A+  ARG+ YLH+
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHD 123

Query: 306 GCDMCILHFDIKPHNILLD--------HNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
              + I+H D+K  NIL+          N I K++DFGLA+   +     +  +  G   
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT----TKMSAAGAYA 179

Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNAIRSSKAYFPSWVYDQLNK 416
           ++APE+I  +    S  SDV+ +G++L E+  G      ++ +           Y     
Sbjct: 180 WMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA--------VAYGVAMN 229

Query: 417 GGDLELRNVT--EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
              L + +        ++          C       RPS T +L+ L 
Sbjct: 230 KLALPIPSTCPEPFAKLMED--------CWNPDPHSRPSFTNILDQLT 269

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  185 bits (472), Expect = 2e-55
 Identities = 57/279 (20%), Positives = 109/279 (39%), Gaps = 32/279 (11%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQ 247
           +F  KL +   G ++KG+   G  I VK+L+   +S     +F  E   +    H NV+ 
Sbjct: 13  NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71

Query: 248 LLGFCSE--GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           +LG C         L+  +MP GSL   +   E         +  + AL  ARG+A+LH 
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFLHT 129

Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI- 364
             +  I    +   ++++D +   ++S   +                     ++APE + 
Sbjct: 130 -LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPEALQ 181

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNAIRSSKAYFPSWVYDQLNKGGDLELR 423
            +   T    +D++ F ++L E+       ++++ +                +G    LR
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM--------EIGMKVALEG----LR 229

Query: 424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
               I   I+  +  +   C+    A RP    ++ +LE
Sbjct: 230 --PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  186 bits (475), Expect = 3e-55
 Identities = 62/286 (21%), Positives = 114/286 (39%), Gaps = 37/286 (12%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQ 247
                +G+G FG VY G+ H G  +A+++++  + +    + F  EV    +  H NVV 
Sbjct: 36  EIGELIGKGRFGQVYHGRWH-GE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93

Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +G C      A++       +L   +    +        K ++IA    +G+ YLH   
Sbjct: 94  FMGACMSPPHLAIITSLCKGRTLYSVV---RDAKIVLDVNKTRQIAQEIVKGMGYLHA-- 148

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELI 364
              ILH D+K  N+  D+  +  ++DFGL               +    G + ++APE+I
Sbjct: 149 -KGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206

Query: 365 SRNFGTVSC-------KSDVYGFGMVLLEMAGGRR-NSNMNAIRSSKAYFPSWVYDQLNK 416
            +               SDV+  G +  E+                       +  Q+  
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP---------AEAIIWQMGT 257

Query: 417 GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
           G    L      +  + +++  I L+C   +  +RP+ TK+++MLE
Sbjct: 258 GMKPNL-----SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  180 bits (458), Expect = 1e-52
 Identities = 64/315 (20%), Positives = 125/315 (39%), Gaps = 36/315 (11%)

Query: 183 PEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHH 242
              IA       ++G+G +G V+ G+   G  +AVK+   ++ ++     E+     + H
Sbjct: 32  QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRH 90

Query: 243 VNVVQLLGFCSEGSKR----ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR 298
            N++  +    +G+       L+ ++  NGSL  ++     K  T   + + ++A  +  
Sbjct: 91  ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVS 145

Query: 299 GVAYLH-----NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT- 352
           G+ +LH           I H D+K  NIL+  N    ++D GLA     + + V I    
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205

Query: 353 -RGTIGYIAPELISRNFGTVSC----KSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP 407
             GT  Y+ PE++  +           +D+Y FG++L E+A  RR  +   +   +  + 
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA--RRCVSGGIVEEYQLPYH 263

Query: 408 SWVYDQ----------LNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKV 457
             V               K       N    +  + R++  +   C     A R +  +V
Sbjct: 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECL-RQMGKLMTECWAHNPASRLTALRV 322

Query: 458 LEMLE--GSMDDLQM 470
            + L       D+++
Sbjct: 323 KKTLAKMSESQDIKL 337

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  177 bits (451), Expect = 9e-52
 Identities = 70/286 (24%), Positives = 113/286 (39%), Gaps = 34/286 (11%)

Query: 191 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSA-EEFINEVSTIGRIHHVNVVQL 248
                LG+G FG   K     TG ++ +K L          F+ EV  +  + H NV++ 
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF 72

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           +G   +  +   + E++  G+L   I   ++    + W +    A   A G+AYLH    
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMAYLH---S 126

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKF------------HPKENDFVSISATRGTI 356
           M I+H D+  HN L+  N    V+DFGLA+               K+ D        G  
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 357 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK 416
            ++APE+I  N  +   K DV+ FG+VL E+ G                 P ++   ++ 
Sbjct: 187 YWMAPEMI--NGRSYDEKVDVFSFGIVLCEIIGRVNA------------DPDYLPRTMDF 232

Query: 417 GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
           G ++                  I + C  +    RPS  K+   LE
Sbjct: 233 GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  172 bits (439), Expect = 4e-50
 Identities = 60/297 (20%), Positives = 111/297 (37%), Gaps = 34/297 (11%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
                +G+G +G V++G    G  +AVK+  +    +     E+     + H N++  + 
Sbjct: 11  TLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 251 FCSEGSKRA----LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH-- 304
                   +    L+  +   GSL  ++     +  T        I L  A G+A+LH  
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 305 ---NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT--RGTIGYI 359
                    I H D+K  NIL+  N    ++D GLA  H +  + + +      GT  Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 360 APELI----SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQ-- 413
           APE++      +      + D++ FG+VL E+A  RR  +   +   K  F   V +   
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA--RRMVSNGIVEDYKPPFYDVVPNDPS 242

Query: 414 --------LNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
                           + N    +  +   L  +   C     + R +  ++ + L 
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTL-TSLAKLMKECWYQNPSARLTALRIKKTLT 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  172 bits (438), Expect = 1e-49
 Identities = 70/315 (22%), Positives = 127/315 (40%), Gaps = 36/315 (11%)

Query: 183 PEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHH 242
              IA T      +G+G FG V++G+   G  +AVK+  + +  +     E+     + H
Sbjct: 37  QRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRH 95

Query: 243 VNVVQLLGFCSEGSKRA----LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR 298
            N++  +   ++ +       LV ++  +GSL  ++        T   E + ++AL TA 
Sbjct: 96  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTAS 150

Query: 299 GVAYLH-----NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT- 352
           G+A+LH           I H D+K  NIL+  N    ++D GLA  H    D + I+   
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210

Query: 353 -RGTIGYIAPELISRNFGTVSC----KSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP 407
             GT  Y+APE++  +          ++D+Y  G+V  E+A  RR S        +  + 
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGGIHEDYQLPYY 268

Query: 408 SWVYDQ----------LNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKV 457
             V               +     + N  +    + R +  I   C     A R +  ++
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEAL-RVMAKIMRECWYANGAARLTALRI 327

Query: 458 LEMLE--GSMDDLQM 470
            + L      + ++M
Sbjct: 328 KKTLSQLSQQEGIKM 342

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  154 bits (391), Expect = 1e-41
 Identities = 76/279 (27%), Positives = 122/279 (43%), Gaps = 36/279 (12%)

Query: 192 FTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
             HKLG G +G VY+G        +AVK L+      EEF+ E + +  I H N+VQLLG
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
            C+      ++ EFM  G+L    + +E   Q      L  +A   +  + YL       
Sbjct: 284 VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLE---KKN 338

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
            +H ++   N L+  N + KV+DFGL++     + + + +  +  I + APE +   +  
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESL--AYNK 395

Query: 371 VSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW------VYDQLNKGGDLEL-R 423
            S KSDV+ FG++L E+A             +    P        VY+ L K   +E   
Sbjct: 396 FSIKSDVWAFGVLLWEIA-------------TYGMSPYPGIDLSQVYELLEKDYRMERPE 442

Query: 424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
              E       K+  +   C Q   +DRPS  ++ +  E
Sbjct: 443 GCPE-------KVYELMRACWQWNPSDRPSFAEIHQAFE 474

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  151 bits (384), Expect = 2e-40
 Identities = 78/278 (28%), Positives = 126/278 (45%), Gaps = 36/278 (12%)

Query: 192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
              KLGQG FG V+ G  +    +A+K L+    S E F+ E   + ++ H  +VQL   
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
            SE     +V E+M  GSL    F K   G+     +L ++A   A G+AY+     M  
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 384

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           +H D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE     +G  
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAA--LYGRF 441

Query: 372 SCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW------VYDQLNKGGDLEL-RN 424
           + KSDV+ FG++L E+              +K   P        V DQ+ +G  +     
Sbjct: 442 TIKSDVWSFGILLTELT-------------TKGRVPYPGMVNREVLDQVERGYRMPCPPE 488

Query: 425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
             E        L  +   C + +  +RP+   +   LE
Sbjct: 489 CPE-------SLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  150 bits (380), Expect = 3e-40
 Identities = 78/278 (28%), Positives = 126/278 (45%), Gaps = 36/278 (12%)

Query: 192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
              KLGQG FG V+ G  +    +A+K L+    S E F+ E   + ++ H  +VQL   
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
            SE     +V E+M  GSL    F K   G+     +L ++A   A G+AY+     M  
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 301

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           +H D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE     +G  
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAA--LYGRF 358

Query: 372 SCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW------VYDQLNKGGDLEL-RN 424
           + KSDV+ FG++L E+              +K   P        V DQ+ +G  +     
Sbjct: 359 TIKSDVWSFGILLTELT-------------TKGRVPYPGMVNREVLDQVERGYRMPCPPE 405

Query: 425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
             E        L  +   C + +  +RP+   +   LE
Sbjct: 406 CPE-------SLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  145 bits (369), Expect = 3e-40
 Identities = 73/279 (26%), Positives = 127/279 (45%), Gaps = 36/279 (12%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
               +LG G FG V+ G  +    +AVK L+    S + F+ E + + ++ H  +V+L  
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
             ++     ++ E+M NGSL    F K   G      KL ++A   A G+A++    +  
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 129

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
            +H D++  NIL+      K++DFGLA+   ++N++ +    +  I + APE I  N+GT
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAI--NYGT 186

Query: 371 VSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW------VYDQLNKGGDLEL-R 423
            + KSDV+ FG++L E+              +    P        V   L +G  +    
Sbjct: 187 FTIKSDVWSFGILLTEIV-------------THGRIPYPGMTNPEVIQNLERGYRMVRPD 233

Query: 424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
           N  E       +L  +   C + +  DRP+   +  +LE
Sbjct: 234 NCPE-------ELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  145 bits (367), Expect = 3e-40
 Identities = 69/283 (24%), Positives = 123/283 (43%), Gaps = 44/283 (15%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
               +LG G FG V  G+      +AVKM++    S +EF  E  T+ ++ H  +V+  G
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
            CS+     +V E++ NG L  ++    + G+     +L E+      G+A+L       
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQ 124

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
            +H D+   N L+D +   KVSDFG+ ++   ++ +VS   T+  + + APE+   ++  
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVF--HYFK 181

Query: 371 VSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW------VYDQLNKGGDLEL-- 422
            S KSDV+ FG+++ E+              S    P        V  ++++G  L    
Sbjct: 182 YSSKSDVWAFGILMWEVF-------------SLGKMPYDLYTNSEVVLKVSQGHRLYRPH 228

Query: 423 ---RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
                + +I         M    C       RP+  ++L  +E
Sbjct: 229 LASDTIYQI---------M--YSCWHELPEKRPTFQQLLSSIE 260

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  149 bits (379), Expect = 4e-40
 Identities = 72/274 (26%), Positives = 129/274 (47%), Gaps = 28/274 (10%)

Query: 192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
              KLG G FG V+    +    +AVK ++    S E F+ E + +  + H  +V+L   
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
            ++     ++ EFM  GSL    F K ++G      KL + +   A G+A++        
Sbjct: 252 VTK-EPIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNY 305

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           +H D++  NIL+  + + K++DFGLA+   ++N++ +    +  I + APE I  NFG+ 
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAI--NFGSF 362

Query: 372 SCKSDVYGFGMVLLEMA--GGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL-RNVTEI 428
           + KSDV+ FG++L+E+   G      M+            V   L +G  +    N  E 
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---------VIRALERGYRMPRPENCPE- 412

Query: 429 ESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
                 +L  I + C + +  +RP+   +  +L+
Sbjct: 413 ------ELYNIMMRCWKNRPEERPTFEYIQSVLD 440

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  145 bits (368), Expect = 5e-40
 Identities = 77/279 (27%), Positives = 120/279 (43%), Gaps = 34/279 (12%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGRL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLL 249
              HKLG G +G VY+G      L +AVK L+      EEF+ E + +  I H N+VQLL
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G C+      ++ EFM  G+L    + +E   Q      L  +A   +  + YL      
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLE---KK 130

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
             +H D+   N L+  N + KV+DFGL++     + + + +  +  I + APE +   + 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESL--AYN 187

Query: 370 TVSCKSDVYGFGMVLLE-MAGGRR----NSNMNAIRSSKAYFPSWVYDQLNKGGDLEL-R 423
             S KSDV+ FG++L E    G                       VY+ L K   +E   
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------------VYELLEKDYRMERPE 235

Query: 424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
              E       K+  +   C Q   +DRPS  ++ +  E
Sbjct: 236 GCPE-------KVYELMRACWQWNPSDRPSFAEIHQAFE 267

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  146 bits (370), Expect = 5e-40
 Identities = 69/280 (24%), Positives = 118/280 (42%), Gaps = 33/280 (11%)

Query: 192 FTHKLGQGGFGSVYKGQLHTGRL-----IAVKML--ENSKFSAEEFINEVSTIGRIHHVN 244
               LG G FG+VYKG            +A+K L    S  + +E ++E   +  + + +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
           V +LLG C   S   L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL 
Sbjct: 79  VCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDN-IGSQYLLNWCVQIAKGMNYLE 134

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
              D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL 422
                  + +SDV+ +G+ + E+   G +    + A           +   L KG  L  
Sbjct: 192 --LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILEKGERLPQ 240

Query: 423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
             +  I+      + MI   C  + A  RP   +++    
Sbjct: 241 PPICTID------VYMIMRKCWMIDADSRPKFRELIIEFS 274

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  143 bits (364), Expect = 1e-39
 Identities = 75/282 (26%), Positives = 129/282 (45%), Gaps = 42/282 (14%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
            F  ++G G FG V+ G       +A+K +     S E+FI E   + ++ H  +VQL G
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
            C E +   LV EFM +G L    + +  +G  F  E L  + L    G+AYL    + C
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSD--YLRTQRGL-FAAETLLGMCLDVCEGMAYL---EEAC 124

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ++H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+   +F  
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVF--SFSR 181

Query: 371 VSCKSDVYGFGMVLLE-MAGGRRNSNMNAIRSSKAYFPSW----VYDQLNKGGDLELRNV 425
            S KSDV+ FG+++ E  + G+              + +     V + ++ G  L     
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIP------------YENRSNSEVVEDISTGFRLY---- 225

Query: 426 TEIESVIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 462
                    +L       I   C + +  DRP+ +++L  L 
Sbjct: 226 -------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  143 bits (363), Expect = 2e-39
 Identities = 67/283 (23%), Positives = 121/283 (42%), Gaps = 44/283 (15%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
            F  +LG G FG V  G+      +A+KM++    S +EFI E   +  + H  +VQL G
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
            C++     ++ E+M NG L    + +E + + F  ++L E+       + YL       
Sbjct: 87  VCTKQRPIFIITEYMANGCLLN--YLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQ 140

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
            LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +  
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVL--MYSK 197

Query: 371 VSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW------VYDQLNKGGDLELRN 424
            S KSD++ FG+++ E+              S    P          + + +G  L    
Sbjct: 198 FSSKSDIWAFGVLMWEIY-------------SLGKMPYERFTNSETAEHIAQGLRLY--- 241

Query: 425 VTEIESVIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 462
                      L       I   C   KA +RP+   +L  + 
Sbjct: 242 --------RPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 276

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  145 bits (368), Expect = 4e-39
 Identities = 62/282 (21%), Positives = 112/282 (39%), Gaps = 38/282 (13%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGRL-IAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQ 247
               ++G+G FG V+ G+L      +AVK            +F+ E   + +  H N+V+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176

Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
           L+G C++     +V E +  G     +     +G     + L ++    A G+ YL    
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLE--- 230

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
             C +H D+   N L+    + K+SDFG+++         S    +  + + APE +  N
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL--N 288

Query: 368 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW------VYDQLNKGGDLE 421
           +G  S +SDV+ FG++L E               S    P          + + KGG L 
Sbjct: 289 YGRYSSESDVWSFGILLWETF-------------SLGASPYPNLSNQQTREFVEKGGRLP 335

Query: 422 L-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
                 +        +  +   C   +   RPS + + + L+
Sbjct: 336 CPELCPD-------AVFRLMEQCWAYEPGQRPSFSTIYQELQ 370

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  140 bits (356), Expect = 3e-38
 Identities = 64/291 (21%), Positives = 118/291 (40%), Gaps = 35/291 (12%)

Query: 191 HFTHKLGQGGFGSVYKGQLH-----TGRLIAVKML--ENSKFSAEEFINEVSTIGRIHHV 243
                LG+G FG V   +       TG  +AVK L  E+      +   E+  +  ++H 
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83

Query: 244 NVVQLLGFCSEGSKRA--LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVA 301
           N+V+  G C+E       L+ EF+P+GSL    +  +NK +    ++  + A+   +G+ 
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKE--YLPKNKNK-INLKQQLKYAVQICKGMD 140

Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGY 358
           YL        +H D+   N+L++     K+ DFGL K    + ++   +        + +
Sbjct: 141 YLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY--YTVKDDRDSPVFW 195

Query: 359 IAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMNAIRSSKAYFPSW------VY 411
            APE +          SDV+ FG+ L E +     +S+  A+                + 
Sbjct: 196 YAPECL--MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253

Query: 412 DQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
           + L +G  L        E      +  +   C + + ++R S   ++E  E
Sbjct: 254 NTLKEGKRLPCPPNCPDE------VYQLMRKCWEFQPSNRTSFQNLIEGFE 298

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  141 bits (357), Expect = 4e-38
 Identities = 75/323 (23%), Positives = 129/323 (39%), Gaps = 44/323 (13%)

Query: 192 FTHKLGQGGFGSVYKGQLHTGR-----LIAVKML--ENSKFSAEEFINEVSTIGRIHHVN 244
               LG G FG+VYKG            +A+K L    S  + +E ++E   +  + + +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
           V +LLG C   S   L+ + MP G L  ++  +E+K    G + L    +  A+G+ YL 
Sbjct: 79  VCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDN-IGSQYLLNWCVQIAKGMNYLE 134

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
              D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL 422
                  + +SDV+ +G+ + E+   G +    + A           +   L KG  L  
Sbjct: 192 --LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILEKGERLPQ 240

Query: 423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG-----------SMDDLQMP 471
             +  I+      + MI + C  + A  RP   +++                  D+    
Sbjct: 241 PPICTID------VYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHL 294

Query: 472 PKPCFSSSRHISGREIESDSSTE 494
           P P  S+       E + D   +
Sbjct: 295 PSPTDSNFYRALMDEEDMDDVVD 317

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  139 bits (353), Expect = 7e-38
 Identities = 72/302 (23%), Positives = 120/302 (39%), Gaps = 45/302 (14%)

Query: 192 FTHKLGQGGFGSVYKGQLH-----TGRLIAVKML-ENSKFSAEEFINEVSTIGRIHHVNV 245
           F  +LG+G FGSV   +       TG ++AVK L  +++    +F  E+  +  + H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 246 VQLLGFCSEGSKRA--LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V+  G C    +R   L+ E++P GSL    + +++K +     KL +      +G+ YL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKER-IDHIKLLQYTSQICKGMEYL 130

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYIA 360
                   +H D+   NIL+++    K+ DFGL K  P++ +F            I + A
Sbjct: 131 G---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF--FKVKEPGESPIFWYA 185

Query: 361 PELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNAIRSSKAYFPSW------VYD 412
           PE +       S  SDV+ FG+VL E+     +  S                     + +
Sbjct: 186 PESL--TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243

Query: 413 QLNKGGDLELRNVTEIESVIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSMDD 467
            L   G L                C     MI   C       RPS   +   ++   D+
Sbjct: 244 LLKNNGRLP-----------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292

Query: 468 LQ 469
           + 
Sbjct: 293 MA 294

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  140 bits (354), Expect = 1e-37
 Identities = 75/323 (23%), Positives = 143/323 (44%), Gaps = 40/323 (12%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGRL-----IAVKML--ENSKFSAEEFINEVSTIGRIHHV 243
                LG G FG+V+KG            + +K++  ++ + S +   + +  IG + H 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75

Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           ++V+LLG C   S   LV +++P GSL  H+  ++++G   G + L    +  A+G+ YL
Sbjct: 76  HIVRLLGLCPG-SSLQLVTQYLPLGSLLDHV--RQHRGA-LGPQLLLNWGVQIAKGMYYL 131

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
               +  ++H ++   N+LL      +V+DFG+A   P ++  +  S  +  I ++A E 
Sbjct: 132 E---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188

Query: 364 ISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE 421
           I  +FG  + +SDV+ +G+ + E+   G    + +           + V D L KG  L 
Sbjct: 189 I--HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL---------AEVPDLLEKGERLA 237

Query: 422 L-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKPCFSSSR 480
             +  T         + M+ + C  +    RP+  ++           + PP+  +   +
Sbjct: 238 QPQICTI-------DVYMVMVKCWMIDENIRPTFKELANEFT---RMARDPPR--YLVIK 285

Query: 481 HISGREIESDSSTEFLVSEWTEE 503
             SG  I        L ++  EE
Sbjct: 286 RESGPGIAPGPEPHGLTNKKLEE 308

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  138 bits (350), Expect = 4e-37
 Identities = 79/288 (27%), Positives = 131/288 (45%), Gaps = 47/288 (16%)

Query: 192 FTHKLGQGGFGSVYKGQLHTGR-----LIAVKML--ENSKFSAEEFINEVSTIGRIHHVN 244
               +G G FG VYKG L T        +A+K L    ++    +F+ E   +G+  H N
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107

Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
           +++L G  S+     ++ E+M NG+LD+  F +E  G+ F   +L  +  G A G+ YL 
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGE-FSVLQLVGMLRGIAAGMKYLA 164

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYIAP 361
              +M  +H D+   NIL++ N + KVSDFGL++    E+D  +   T G    I + AP
Sbjct: 165 ---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWTAP 219

Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW------VYDQLN 415
           E I  ++   +  SDV+ FG+V+ E+              +    P W      V   +N
Sbjct: 220 EAI--SYRKFTSASDVWSFGIVMWEVM-------------TYGERPYWELSNHEVMKAIN 264

Query: 416 KGGDLEL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
            G  L    +           +  + + C Q + A RP    ++ +L+
Sbjct: 265 DGFRLPTPMDCPS-------AIYQLMMQCWQQERARRPKFADIVSILD 305

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  135 bits (342), Expect = 2e-36
 Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 42/280 (15%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKML-ENSKFSAEEFINEVSTIGRIHHVNVVQLL 249
                +G+G FG V  G    G  +AVK +  ++  +A+ F+ E S + ++ H N+VQLL
Sbjct: 24  KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLL 80

Query: 250 GFCSEGSKRA-LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           G   E      +V E+M  GSL    + +       G + L + +L     + YL     
Sbjct: 81  GVIVEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---G 135

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
              +H D+   N+L+  + + KVSDFGL K         +    +  + + APE +    
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL--RE 188

Query: 369 GTVSCKSDVYGFGMVLLE-MAGGRRNSNMNAIRSSKAYFPSW----VYDQLNKGGDLEL- 422
              S KSDV+ FG++L E  + GR              +P      V  ++ KG  ++  
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRVP------------YPRIPLKDVVPRVEKGYKMDAP 236

Query: 423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
                        +  +   C  + AA RPS  ++ E LE
Sbjct: 237 DGCPP-------AVYEVMKNCWHLDAAMRPSFLQLREQLE 269

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  137 bits (347), Expect = 2e-36
 Identities = 82/334 (24%), Positives = 138/334 (41%), Gaps = 58/334 (17%)

Query: 192 FTHKLGQGGFGSVYKGQLHTGR----LIAVKML--ENSKFSAEEFINEVSTIGRIHHVNV 245
               +G G FG V  G+L         +A+K L    ++    +F+ E S +G+  H N+
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108

Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           ++L G  ++     +V E+M NGSLD   F +++  Q F   +L  +  G A G+ YL  
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQ-FTVIQLVGMLRGIASGMKYLS- 164

Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYIAPE 362
             DM  +H D+   NIL++ N + KVSDFGL +    + +      TRG    I + +PE
Sbjct: 165 --DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA--YTTRGGKIPIRWTSPE 220

Query: 363 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW------VYDQLNK 416
            I   +   +  SDV+ +G+VL E+              S    P W      V   +++
Sbjct: 221 AI--AYRKFTSASDVWSYGIVLWEVM-------------SYGERPYWEMSNQDVIKAVDE 265

Query: 417 GGDLELRNVTEIESVIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLEG---SMDDL 468
           G  L                C   L+     C Q    +RP   +++ +L+    +   L
Sbjct: 266 GYRLP-----------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSL 314

Query: 469 QMPPKPCFSSSRHISGREIESDSSTEFLVSEWTE 502
           ++        S  +  +    D +T     +W  
Sbjct: 315 KIITSAAARPSNLLLDQS-NVDITTFRTTGDWLN 347

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  136 bits (344), Expect = 2e-36
 Identities = 70/302 (23%), Positives = 119/302 (39%), Gaps = 45/302 (14%)

Query: 192 FTHKLGQGGFGSVYKGQLH-----TGRLIAVKML-ENSKFSAEEFINEVSTIGRIHHVNV 245
           F  +LG+G FGSV   +       TG ++AVK L  +++    +F  E+  +  + H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104

Query: 246 VQLLGFCSEGSKRA--LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V+  G C    +R   L+ E++P GSL    + +++K +     KL +      +G+ YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKER-IDHIKLLQYTSQICKGMEYL 161

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYIA 360
                   +H D+   NIL+++    K+ DFGL K  P++ ++            I + A
Sbjct: 162 G---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY--YKVKEPGESPIFWYA 216

Query: 361 PELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNAIRSSKAYFPSW------VYD 412
           PE +       S  SDV+ FG+VL E+     +  S                     + +
Sbjct: 217 PESL--TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274

Query: 413 QLNKGGDLEL-----RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD 467
            L   G L         +  I         M   W        RPS   +   ++   D 
Sbjct: 275 LLKNNGRLPRPDGCPDEIYMI---------MTECW--NNNVNQRPSFRDLALRVDQIRDQ 323

Query: 468 LQ 469
           + 
Sbjct: 324 MA 325

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  135 bits (341), Expect = 3e-36
 Identities = 67/283 (23%), Positives = 113/283 (39%), Gaps = 46/283 (16%)

Query: 195 KLGQGGFGSVYKGQLHTGR---LIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +LG G FGSV +G     +    +A+K+L     K   EE + E   + ++ +  +V+L+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G C       LV E    G L +  F    + +      + E+    + G+ YL    + 
Sbjct: 77  GVCQA-EALMLVMEMAGGGPLHK--FLVGKREE-IPVSNVAELLHQVSMGMKYL---EEK 129

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYIAPELISR 366
             +H D+   N+LL +    K+SDFGL+K    ++ +   +A       + + APE I  
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY--YTARSAGKWPLKWYAPECI-- 185

Query: 367 NFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN 424
           NF   S +SDV+ +G+ + E    G +    M             V   + +G  +E   
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---------PEVMAFIEQGKRME--- 233

Query: 425 VTEIESVIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLE 462
                       C   L+     C   K  DRP    V + + 
Sbjct: 234 --------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  134 bits (340), Expect = 3e-36
 Identities = 64/289 (22%), Positives = 115/289 (39%), Gaps = 43/289 (14%)

Query: 192 FTHKLGQGGFGSVYKGQLHTGR----LIAVKML--ENSKFSAEEFINEVSTIGRIHHVNV 245
               +G+G FG V++G   +       +A+K      S    E+F+ E  T+ +  H ++
Sbjct: 19  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78

Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           V+L+G  +E +   ++ E    G L    F +  K        L   A   +  +AYL  
Sbjct: 79  VKLIGVITE-NPVWIIMELCTLGELRS--FLQVRKYS-LDLASLILYAYQLSTALAYLE- 133

Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
                 +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I 
Sbjct: 134 --SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESI- 189

Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW------VYDQLNKGGD 419
            NF   +  SDV+ FG+ + E+                   P        V  ++  G  
Sbjct: 190 -NFRRFTSASDVWMFGVCMWEIL-------------MHGVKPFQGVKNNDVIGRIENGER 235

Query: 420 LEL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD 467
           L +  N           L  +   C     + RP  T++   L   +++
Sbjct: 236 LPMPPNCPP-------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  135 bits (343), Expect = 4e-36
 Identities = 81/291 (27%), Positives = 130/291 (44%), Gaps = 52/291 (17%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGR----LIAVKML--ENSKFSAEEFINEVSTIGRIHHVN 244
           H    +G G  G V  G+L         +A+K L    ++    +F++E S +G+  H N
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111

Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
           +++L G  + G    +V E+M NGSLD   F + + GQ F   +L  +  G   G+ YL 
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQ-FTIMQLVGMLRGVGAGMRYLS 168

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYIAP 361
              D+  +H D+   N+L+D N + KVSDFGL++    + D      T G    I + AP
Sbjct: 169 ---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA--YTTTGGKIPIRWTAP 223

Query: 362 ELISRNFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMNAIRSSKAYFPSW----VYDQLNK 416
           E I   F T S  SDV+ FG+V+ E +A G R             + +     V   + +
Sbjct: 224 EAI--AFRTFSSASDVWSFGVVMWEVLAYGERP------------YWNMTNRDVISSVEE 269

Query: 417 GGDLEL-----RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
           G  L         + ++         M  L C     A RP  ++++ +L+
Sbjct: 270 GYRLPAPMGCPHALHQL---------M--LDCWHKDRAQRPRFSQIVSVLD 309

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  138 bits (349), Expect = 5e-36
 Identities = 69/276 (25%), Positives = 116/276 (42%), Gaps = 36/276 (13%)

Query: 192 FTHKLGQGGFGSVYKGQLHTGRLIAVKML-ENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
               +G+G FG V  G    G  +AVK +  ++  +A+ F+ E S + ++ H N+VQLLG
Sbjct: 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 253

Query: 251 FCSEGSKRA-LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
              E      +V E+M  GSL    + +       G + L + +L     + YL      
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GN 308

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
             +H D+   N+L+  + + KVSDFGL K         +    +  + + APE +     
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL--REK 361

Query: 370 TVSCKSDVYGFGMVLLEMA--GGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL-RNVT 426
             S KSDV+ FG++L E+   G      +             V  ++ KG  ++      
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------VVPRVEKGYKMDAPDGCP 412

Query: 427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
                    +  +   C  + AA RP+  ++ E LE
Sbjct: 413 P-------AVYDVMKNCWHLDAATRPTFLQLREQLE 441

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  134 bits (339), Expect = 5e-36
 Identities = 65/285 (22%), Positives = 116/285 (40%), Gaps = 51/285 (17%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF-- 251
            +G GGFG V+K +    G+   +K +   K++ E+   EV  + ++ HVN+V   G   
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAEREVKALAKLDHVNIVHYNGCWD 74

Query: 252 -----------CSEGSKRALVY---EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
                       S  SK   ++   EF   G+L++ I  ++ +G+        E+     
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLALELFEQIT 132

Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
           +GV Y+H      +++ D+KP NI L      K+ DFGL      +        ++GT+ 
Sbjct: 133 KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR---SKGTLR 186

Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMA-GGRRNSNMNAIRSSKAYFPSWVYDQLNK 416
           Y++PE IS        + D+Y  G++L E+          +             +  L  
Sbjct: 187 YMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFETSKF-----------FTDLRD 233

Query: 417 GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEML 461
           G          I  +  +K   +    +  K  DRP+ +++L  L
Sbjct: 234 G---------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  135 bits (341), Expect = 6e-36
 Identities = 66/300 (22%), Positives = 120/300 (40%), Gaps = 43/300 (14%)

Query: 192 FTHKLGQGGFGSVYKGQLH-----TGRLIAVKML--ENSKFSAEEFINEVSTIGRIHHVN 244
               LG+G FG V           TG ++AVK L  +        +  E+  +  ++H +
Sbjct: 35  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94

Query: 245 VVQLLGFCSEGSKRA--LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
           +++  G C +    +  LV E++P GSL  ++        + G  +L   A     G+AY
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAY 149

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF-VSISATRGTIGYIAP 361
           LH       +H D+   N+LLD++ + K+ DFGLAK  P+ +++          + + AP
Sbjct: 150 LH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206

Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMA-GGRRNSNMNAIRSSKAYFPSW------VYDQL 414
           E +          SDV+ FG+ L E+      + +                    + + L
Sbjct: 207 ECL--KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264

Query: 415 NKGGDLEL-----RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQ 469
            +G  L         V  +         M   W  + +A+ RP+   ++ +L+   +  Q
Sbjct: 265 ERGERLPRPDKCPAEVYHL---------MKNCW--ETEASFRPTFENLIPILKTVHEKYQ 313

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  135 bits (341), Expect = 7e-36
 Identities = 71/309 (22%), Positives = 124/309 (40%), Gaps = 40/309 (12%)

Query: 192 FTHKLGQGGFGSVYKGQLH-----TGRLIAVKML-ENSKFSAEEFINEVSTIGRIHHVNV 245
           +  +LG+G FGSV   +       TG L+AVK L  +      +F  E+  +  +H   +
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 246 VQLLGFCSEGSKRA--LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V+  G      +++  LV E++P+G L    F + ++ +     +L   +    +G+ YL
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRAR-LDASRLLLYSSQICKGMEYL 143

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-FVSISATRGTIGYIAPE 362
                   +H D+   NIL++     K++DFGLAK  P + D +V     +  I + APE
Sbjct: 144 G---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 200

Query: 363 LISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNAIRSSKAYFPSW-----VYDQLN 415
            +  +    S +SDV+ FG+VL E+     +  S                    + + L 
Sbjct: 201 SL--SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258

Query: 416 KGGDLELRNVTEIESVIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQM 470
           +G  L            A   C      +   C      DRPS + +   L+      + 
Sbjct: 259 EGQRLP-----------APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307

Query: 471 PPKPCFSSS 479
                F++ 
Sbjct: 308 CETHAFTAH 316

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  134 bits (339), Expect = 9e-36
 Identities = 66/300 (22%), Positives = 112/300 (37%), Gaps = 64/300 (21%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS 253
            LGQG FG V K +     R  A+K + +++      ++EV  +  ++H  VV+      
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72

Query: 254 EGSKRA-------------LVYEFMPNGSLDRHIFPKENKGQTFG----WEKLQEIALGT 296
           E                  +  E+  NG+L   I    ++         W   ++I    
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRLFRQILEA- 128

Query: 297 ARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR--- 353
              ++Y+H      I+H D+KP NI +D +   K+ DFGLAK   +  D + + +     
Sbjct: 129 ---LSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 354 ---------GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA-----GGRRNSNMNAI 399
                    GT  Y+A E++    G  + K D+Y  G++  EM      G  R + +  +
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKL 241

Query: 400 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
           RS    FP    D                +  + +K+       I      RP    +L 
Sbjct: 242 RSVSIEFPPDFDDN---------------KMKVEKKII---RLLIDHDPNKRPGARTLLN 283

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  137 bits (346), Expect = 1e-35
 Identities = 69/278 (24%), Positives = 111/278 (39%), Gaps = 38/278 (13%)

Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCS 253
            LG G  G++    +   R +AVK +    FS  +   EV  +     H NV++      
Sbjct: 31  VLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD--REVQLLRESDEHPNVIRYFCTEK 88

Query: 254 EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILH 313
           +   + +  E     +L  ++   E K       +   +   T  G+A+LH    + I+H
Sbjct: 89  DRQFQYIAIELCA-ATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVH 141

Query: 314 FDIKPHNILL-----DHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 367
            D+KPHNIL+            +SDFGL K      + F   S   GT G+IAPE++S +
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201

Query: 368 FGT-VSCKSDVYGFGMVLLEM-AGGR----RNSNMNAIRSSKAYFPSWVYDQLNKGGDLE 421
                +   D++  G V   + + G     ++    A               L     L+
Sbjct: 202 CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-------------ILLGACSLD 248

Query: 422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
             +  + E VIAR+L  I    I +    RPS   VL+
Sbjct: 249 CLHPEKHEDVIAREL--I-EKMIAMDPQKRPSAKHVLK 283

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  134 bits (340), Expect = 1e-35
 Identities = 63/277 (22%), Positives = 112/277 (40%), Gaps = 41/277 (14%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 250
           K+G+G FG     +    GR   +K +  S+ S++E      EV+ +  + H N+VQ   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
              E     +V ++   G L + I     KG  F  +++ +  +     + ++H   D  
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHVH---DRK 145

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           ILH DIK  NI L  +   ++ DFG+A+      +        GT  Y++PE+       
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI--GTPYYLSPEICENK--P 201

Query: 371 VSCKSDVYGFGMVLLEMAGGRR---NSNMNA----IRSSKAYFPSWVYDQLNKGGDLELR 423
            + KSD++  G VL E+   +      +M      I S         +  ++     +LR
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-------FPPVSLHYSYDLR 254

Query: 424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM 460
           ++  +                +    DRPS+  +LE 
Sbjct: 255 SL--VSQ------------LFKRNPRDRPSVNSILEK 277

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  133 bits (336), Expect = 1e-35
 Identities = 67/280 (23%), Positives = 108/280 (38%), Gaps = 45/280 (16%)

Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 250
           ++G+G F +VYKG    T   +A   L++ K +  E   F  E   +  + H N+V+   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 251 FCSEGSKRA----LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
                 K      LV E M +G+L  ++     + +    + L+       +G+ +LH  
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHT- 147

Query: 307 CDMCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
               I+H D+K  NI +       K+ D GLA             A  GT  ++APE+  
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE 203

Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGRR----NSNMNAI--RSSKAYFPSWVYDQLNKGGD 419
             +       DVY FGM +LEMA          N   I  R +    P       +K   
Sbjct: 204 EKYDE---SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP----ASFDKVAI 256

Query: 420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
            E++ + E               CI+    +R S+  +L 
Sbjct: 257 PEVKEIIE--------------GCIRQNKDERYSIKDLLN 282

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  132 bits (334), Expect = 2e-35
 Identities = 70/285 (24%), Positives = 118/285 (41%), Gaps = 43/285 (15%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGRL----IAVKML--ENSKFSAEEFINEVSTIGRIHHVN 244
                LG+G FG VY+G     +     +AVK    + +  + E+F++E   +  + H +
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 74

Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
           +V+L+G   E     ++ E  P G L  ++  + NK        L   +L   + +AYL 
Sbjct: 75  IVKLIGIIEEEPTW-IIMELYPYGELGHYL--ERNKNS-LKVLTLVLYSLQICKAMAYLE 130

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
               +  +H DI   NIL+      K+ DFGL+++  ++ D+   S TR  I +++PE I
Sbjct: 131 ---SINCVHRDIAVRNILVASPECVKLGDFGLSRY-IEDEDYYKASVTRLPIKWMSPESI 186

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW------VYDQLNKGG 418
             NF   +  SDV+ F + + E+              S    P +      V   L KG 
Sbjct: 187 --NFRRFTTASDVWMFAVCMWEIL-------------SFGKQPFFWLENKDVIGVLEKGD 231

Query: 419 DLEL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
            L                L  +   C     +DRP  T+++  L 
Sbjct: 232 RLPKPDLCPP-------VLYTLMTRCWDYDPSDRPRFTELVCSLS 269

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  133 bits (336), Expect = 4e-35
 Identities = 76/325 (23%), Positives = 122/325 (37%), Gaps = 58/325 (17%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGR------LIAVKML--ENSKFSAEEFINEVSTIGRIHH 242
                LG G FG VY+GQ+           +AVK L    S+    +F+ E   I + +H
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92

Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQEIALGTARG 299
            N+V+ +G   +   R ++ E M  G L    R   P+ ++  +     L  +A   A G
Sbjct: 93  QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152

Query: 300 VAYLHNGCDMCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATR-GT 355
             YL    +   +H DI   N LL       + K+ DFG+A+      D    S  R G 
Sbjct: 153 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKGG 203

Query: 356 IGYI-----APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW- 409
              +      PE  +   G  + K+D + FG++L E+              S  Y P   
Sbjct: 204 CAMLPVKWMPPE--AFMEGIFTSKTDTWSFGVLLWEIF-------------SLGYMPYPS 248

Query: 410 -----VYDQLNKGGDLEL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 463
                V + +  GG ++  +N           +  I   C Q +  DRP+   +LE +E 
Sbjct: 249 KSNQEVLEFVTSGGRMDPPKNCPG-------PVYRIMTQCWQHQPEDRPNFAIILERIEY 301

Query: 464 SMDDLQMPPKPCFSSSRHISGREIE 488
              D  +           +   E +
Sbjct: 302 CTQDPDVINTALPIEYGPLVEEEEK 326

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  132 bits (333), Expect = 5e-35
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 17/204 (8%)

Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLE-NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS 253
           LG+G +G VY G  L     IA+K +       ++    E++    + H N+VQ LG  S
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 254 EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA---RGVAYLHNGCDMC 310
           E     +  E +P GSL   +  +   G     E+   I   T     G+ YLH   D  
Sbjct: 90  ENGFIKIFMEQVPGGSLSALL--RSKWGPLKDNEQT--IGFYTKQILEGLKYLH---DNQ 142

Query: 311 ILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPELISRNF 368
           I+H DIK  N+L++ ++ + K+SDFG +K   +       + T  GT+ Y+APE+I +  
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSK---RLAGINPCTETFTGTLQYMAPEIIDKGP 199

Query: 369 GTVSCKSDVYGFGMVLLEMAGGRR 392
                 +D++  G  ++EMA G+ 
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKP 223

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  132 bits (333), Expect = 8e-35
 Identities = 68/291 (23%), Positives = 111/291 (38%), Gaps = 47/291 (16%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVK-MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           KLG+GGF  V   + LH G   A+K +L + +   EE   E       +H N+++L+ +C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 253 SEGSKRA----LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
                      L+  F   G+L   I   ++KG     +++  + LG  RG+  +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-------ISATRGTIGYIAP 361
               H D+KP NILL     P + D G         +           +A R TI Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

Query: 362 ELIS-RNFGTVSCKSDVYGFGMVLLEMAGGR--------RNSNMNAIRSSKAYFPSW-VY 411
           EL S ++   +  ++DV+  G VL  M  G         +  ++     ++   P    +
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRH 272

Query: 412 DQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
                     L        ++           + V    RP +  +L  LE
Sbjct: 273 SS-------ALWQ------LLN--------SMMTVDPHQRPHIPLLLSQLE 302

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  131 bits (331), Expect = 8e-35
 Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 22/208 (10%)

Query: 191 HFTHKLGQGGFGSVYKGQLHT--GRLI--AVKMLENSKFS----AEEFINEVSTIGRIHH 242
               KLG G FG V +G+     G+ +  AVK L+    S     ++FI EV+ +  + H
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
            N+++L G         +V E  P GSL   +  ++++G  F    L   A+  A G+ Y
Sbjct: 81  RNLIRLYGVVLT-PPMKMVTELAPLGSLLDRL--RKHQGH-FLLGTLSRYAVQVAEGMGY 136

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYI 359
           L        +H D+   N+LL    + K+ DFGL +  P+ +D               + 
Sbjct: 137 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY--VMQEHRKVPFAWC 191

Query: 360 APELISRNFGTVSCKSDVYGFGMVLLEM 387
           APE +     T S  SD + FG+ L EM
Sbjct: 192 APESL--KTRTFSHASDTWMFGVTLWEM 217

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  131 bits (331), Expect = 1e-34
 Identities = 73/289 (25%), Positives = 113/289 (39%), Gaps = 46/289 (15%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGR----LIAVKML--ENSKFSAEEFINEVSTIGRIHHVN 244
           HF   +G+G FG VY G L          AVK L          +F+ E   +    H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 245 VVQLLGFCSEGSKRAL-VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V+ LLG C       L V  +M +G L   I  +         + L    L  A+G+ YL
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHN-PTVKDLIGFGLQVAKGMKYL 144

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYIA 360
                   +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    + ++A
Sbjct: 145 A---SKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEYYSVHNKTGAKLPVKWMA 200

Query: 361 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW------VYDQL 414
            E  S      + KSDV+ FG++L E+              ++   P        +   L
Sbjct: 201 LE--SLQTQKFTTKSDVWSFGVLLWELM-------------TRGAPPYPDVNTFDITVYL 245

Query: 415 NKGGDLEL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
            +G  L       +        L  + L C   KA  RPS ++++  + 
Sbjct: 246 LQGRRLLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 287

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  130 bits (329), Expect = 2e-34
 Identities = 66/289 (22%), Positives = 113/289 (39%), Gaps = 46/289 (15%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGR----LIAVKML--ENSKFSAEEFINEVSTIGRIHHVN 244
           H    +G+G FG VY G+           A+K L         E F+ E   +  ++H N
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83

Query: 245 VVQLLGFCSEGSKRAL-VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V+ L+G           +  +M +G L + I    +  +    + L    L  ARG+ YL
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYL 140

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYIA 360
               +   +H D+   N +LD +F  KV+DFGLA+    + ++ S+   R     + + A
Sbjct: 141 A---EQKFVHRDLAARNCMLDESFTVKVADFGLARD-ILDREYYSVQQHRHARLPVKWTA 196

Query: 361 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW------VYDQL 414
            E  S      + KSDV+ FG++L E+              ++   P        +   L
Sbjct: 197 LE--SLQTYRFTTKSDVWSFGVLLWELL-------------TRGAPPYRHIDPFDLTHFL 241

Query: 415 NKGGDLEL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
            +G  L       +        L  +   C +   A RP+   ++  +E
Sbjct: 242 AQGRRLPQPEYCPD-------SLYQVMQQCWEADPAVRPTFRVLVGEVE 283

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  129 bits (327), Expect = 3e-34
 Identities = 66/284 (23%), Positives = 115/284 (40%), Gaps = 48/284 (16%)

Query: 195 KLGQGGFGSVYKGQLHTGRL---IAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQL 248
           +LG G FG+V KG     ++   +AVK+L    N     +E + E + + ++ +  +V++
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           +G C       LV E    G L++++     + +    + + E+    + G+ YL    +
Sbjct: 84  IGICE-AESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLE---E 135

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYIAPELIS 365
              +H D+   N+LL      K+SDFGL+K    + ++    A       + + APE I 
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--YKAQTHGKWPVKWYAPECI- 192

Query: 366 RNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR 423
            N+   S KSDV+ FG+++ E    G +    M           S V   L KG  +   
Sbjct: 193 -NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---------SEVTAMLEKGERMG-- 240

Query: 424 NVTEIESVIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLE 462
                        C   ++     C      +RP    V   L 
Sbjct: 241 ---------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  131 bits (332), Expect = 3e-34
 Identities = 72/289 (24%), Positives = 113/289 (39%), Gaps = 46/289 (15%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGR----LIAVKML--ENSKFSAEEFINEVSTIGRIHHVN 244
           HF   +G+G FG VY G L          AVK L          +F+ E   +    H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151

Query: 245 VVQLLGFCSEG-SKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V+ LLG C        +V  +M +G L   I  +         + L    L  A+G+ +L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHN-PTVKDLIGFGLQVAKGMKFL 208

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYIA 360
                   +H D+   N +LD  F  KV+DFGLA+    + +F S+    G    + ++A
Sbjct: 209 A---SKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEFDSVHNKTGAKLPVKWMA 264

Query: 361 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW------VYDQL 414
            E  S      + KSDV+ FG++L E+              ++   P        +   L
Sbjct: 265 LE--SLQTQKFTTKSDVWSFGVLLWELM-------------TRGAPPYPDVNTFDITVYL 309

Query: 415 NKGGDLEL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
            +G  L       +        L  + L C   KA  RPS ++++  + 
Sbjct: 310 LQGRRLLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 351

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  130 bits (328), Expect = 5e-34
 Identities = 51/216 (23%), Positives = 81/216 (37%), Gaps = 25/216 (11%)

Query: 194 HKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
            ++G+G FG V++ +   TG   AVK +    F  EE    +     +    +V L G  
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE----LVACAGLSSPRIVPLYGAV 119

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA---RGVAYLHNGCDM 309
            EG    +  E +  GSL + I       +  G                G+ YLH     
Sbjct: 120 REGPWVNIFMELLEGGSLGQLI-------KQMGCLPEDRALYYLGQALEGLEYLH---TR 169

Query: 310 CILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISAT---RGTIGYIAPELIS 365
            ILH D+K  N+LL  +     + DFG A     +    S+       GT  ++APE++ 
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229

Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNAIR 400
                   K D++    ++L M  G    +      
Sbjct: 230 GK--PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  129 bits (327), Expect = 6e-34
 Identities = 76/324 (23%), Positives = 135/324 (41%), Gaps = 54/324 (16%)

Query: 165 IEKFLHNQQSWM-PKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTG---RLIAVKML 220
           ++K  H+      P    YP +      F   +G+G FG V K ++         A+K +
Sbjct: 1   MKKHHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM 60

Query: 221 -ENSKFSA-EEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSL------- 270
            E +      +F  E+  + ++ HH N++ LLG C       L  E+ P+G+L       
Sbjct: 61  KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS 120

Query: 271 -----DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH 325
                D       +   T   ++L   A   ARG+ YL        +H D+   NIL+  
Sbjct: 121 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGE 177

Query: 326 NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 385
           N++ K++DFGL++    +  +V  +  R  + ++A E  S N+   +  SDV+ +G++L 
Sbjct: 178 NYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLW 232

Query: 386 EMAGGRRNSNMNAIRSSKAYFPSW------VYDQLNKGGDLEL-RNVTEIESVIARKLCM 438
           E+              S    P        +Y++L +G  LE   N  +       ++  
Sbjct: 233 EIV-------------SLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD-------EVYD 272

Query: 439 IGLWCIQVKAADRPSMTKVLEMLE 462
           +   C + K  +RPS  ++L  L 
Sbjct: 273 LMRQCWREKPYERPSFAQILVSLN 296

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  130 bits (329), Expect = 8e-34
 Identities = 75/304 (24%), Positives = 117/304 (38%), Gaps = 58/304 (19%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGR------LIAVKML-ENSKFSAE-EFINEVSTIGRIHH 242
                LG G FG VY+GQ+           +AVK L E      E +F+ E   I + +H
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133

Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQEIALGTARG 299
            N+V+ +G   +   R ++ E M  G L    R   P+ ++  +     L  +A   A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 300 VAYLHNGCDMCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATR-GT 355
             YL    +   +H DI   N LL       + K+ DFG+A+      D       R G 
Sbjct: 194 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRAGYYRKGG 244

Query: 356 IGYI-----APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW- 409
              +      PE  +   G  + K+D + FG++L E+              S  Y P   
Sbjct: 245 CAMLPVKWMPPE--AFMEGIFTSKTDTWSFGVLLWEIF-------------SLGYMPYPS 289

Query: 410 -----VYDQLNKGGDLEL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 463
                V + +  GG ++  +N           +  I   C Q +  DRP+   +LE +E 
Sbjct: 290 KSNQEVLEFVTSGGRMDPPKNCPG-------PVYRIMTQCWQHQPEDRPNFAIILERIEY 342

Query: 464 SMDD 467
              D
Sbjct: 343 CTQD 346

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  128 bits (324), Expect = 9e-34
 Identities = 63/315 (20%), Positives = 113/315 (35%), Gaps = 61/315 (19%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
            LG+GGFG V++ +        A+K   L N + + E+ + EV  + ++ H  +V+    
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 252 CSEG---------SKRALVY---EFMPNGSLDRHIFPKENKGQTFGWEKL-QEIALGTAR 298
             E          S +  +Y   +     +L   +              +   I L  A 
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM--NGRCTIEERERSVCLHIFLQIAE 129

Query: 299 GVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR----- 353
            V +LH      ++H D+KP NI    + + KV DFGL     ++ +  ++         
Sbjct: 130 AVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186

Query: 354 -----GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-----AGGRRNSNMNAIRSSK 403
                GT  Y++PE I  N  + S K D++  G++L E+         R   +  +R+ K
Sbjct: 187 HTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLK 244

Query: 404 AYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 463
             FP                 +   +      +       +     +RP    ++E    
Sbjct: 245 --FPP----------------LFTQKYPCEYVMVQ---DMLSPSPMERPEAINIIEN--A 281

Query: 464 SMDDLQMPPKPCFSS 478
             +DL  P K     
Sbjct: 282 VFEDLDFPGKTVLRQ 296

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  129 bits (326), Expect = 1e-33
 Identities = 75/341 (21%), Positives = 130/341 (38%), Gaps = 65/341 (19%)

Query: 156 RTTLQTVDNIEKFLHNQQSWMPKRYSY---PEIIAVTNHFTHKLGQGGFGSVYKGQLHTG 212
            ++L   +     L       P+ +S      I         +LG+G FG V+  + H  
Sbjct: 6   GSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNL 65

Query: 213 R------LIAVKML-ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM 265
                  L+AVK L E S+ + ++F  E   +  + H ++V+  G C+EG    +V+E+M
Sbjct: 66  LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYM 125

Query: 266 PNGSL-----------DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF 314
            +G L                 ++      G  +L  +A   A G+ YL     +  +H 
Sbjct: 126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHR 182

Query: 315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYI-----APELISRNF 368
           D+   N L+    + K+ DFG+++      D  S    R G    +      PE I   +
Sbjct: 183 DLATRNCLVGQGLVVKIGDFGMSR------DIYSTDYYRVGGRTMLPIRWMPPESI--LY 234

Query: 369 GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW------VYDQLNKGGDLEL 422
              + +SDV+ FG+VL E+              +    P +        D + +G +LE 
Sbjct: 235 RKFTTESDVWSFGVVLWEIF-------------TYGKQPWYQLSNTEAIDCITQGRELER 281

Query: 423 -RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
            R           ++  I   C Q +   R S+  V   L+
Sbjct: 282 PRACPP-------EVYAIMRGCWQREPQQRHSIKDVHARLQ 315

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  128 bits (324), Expect = 1e-33
 Identities = 75/304 (24%), Positives = 121/304 (39%), Gaps = 58/304 (19%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGR------LIAVKML-ENSKFSA-EEFINEVSTIGRIHH 242
             + +LGQG FG VY+G             +A+K + E +      EF+NE S +   + 
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 87

Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSLD------RHIFPKENKGQTFGWEKLQEIALGT 296
            +VV+LLG  S+G    ++ E M  G L       R               K+ ++A   
Sbjct: 88  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147

Query: 297 ARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GT 355
           A G+AYL+       +H D+   N ++  +F  K+ DFG+ +      D       R G 
Sbjct: 148 ADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR------DIYETDYYRKGG 198

Query: 356 IGYI-----APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW- 409
            G +     +PE  S   G  +  SDV+ FG+VL E+A             + A  P   
Sbjct: 199 KGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA-------------TLAEQPYQG 243

Query: 410 -----VYDQLNKGGDLEL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 463
                V   + +GG L+   N  +        L  +   C Q     RPS  +++  ++ 
Sbjct: 244 LSNEQVLRFVMEGGLLDKPDNCPD-------MLFELMRMCWQYNPKMRPSFLEIISSIKE 296

Query: 464 SMDD 467
            M+ 
Sbjct: 297 EMEP 300

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  128 bits (323), Expect = 1e-33
 Identities = 63/278 (22%), Positives = 103/278 (37%), Gaps = 48/278 (17%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE---FINEVSTIGRI-HHVNVVQLL 249
           +LG G +G V+K +    GRL AVK   +     ++    + EV +  ++  H   V+L 
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
               EG    L  E     SL +H    E  G +    ++      T   +A+LH     
Sbjct: 124 QAWEEGGILYLQTELC-GPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAHLH---SQ 176

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKF---HPKENDFVSISATRGTIGYIAPELISR 366
            ++H D+KP NI L      K+ DFGL                    G   Y+APEL+  
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE------GDPRYMAPELLQG 230

Query: 367 NFGTVSCKSDVYGFGMVLLEMAGGRR----NSNMNAIRSSKAYFPSWVYDQLNKGGDLEL 422
           ++G     +DV+  G+ +LE+A              +R         +  +   G   EL
Sbjct: 231 SYG---TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY------LPPEFTAGLSSEL 281

Query: 423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM 460
           R+V                  ++     R +   +L +
Sbjct: 282 RSVLV--------------MMLEPDPKLRATAEALLAL 305

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  128 bits (323), Expect = 2e-33
 Identities = 62/282 (21%), Positives = 113/282 (40%), Gaps = 43/282 (15%)

Query: 194 HKLGQGGFGSVYKGQ-LHTGRLIAVK--MLENSKFSAE--EFINEVSTIGRIHHVNVVQL 248
            K+G+G F  VY+   L  G  +A+K   + +   +    + I E+  + +++H NV++ 
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
                E ++  +V E    G L R I   + + +      + +  +     + ++H    
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---S 154

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H DIKP N+ +    + K+ D GL +F   +          GT  Y++PE I  N 
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHEN- 211

Query: 369 GTVSCKSDVYGFGMVLLEMAGGRR-----NSNMNA-----IRSSKAYFPSWVYDQLNKGG 418
              + KSD++  G +L EMA  +        N+ +      +      PS  Y +     
Sbjct: 212 -GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE----- 265

Query: 419 DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM 460
             ELR +                 CI      RP +T V ++
Sbjct: 266 --ELRQLVN--------------MCINPDPEKRPDVTYVYDV 291

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  133 bits (335), Expect = 2e-33
 Identities = 67/281 (23%), Positives = 115/281 (40%), Gaps = 42/281 (14%)

Query: 195 KLGQGGFGSVYKGQLHTGR---LIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +LG G FGSV +G     +    +A+K+L     K   EE + E   + ++ +  +V+L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G C       LV E    G L +  F    + +      + E+    + G+ YL    + 
Sbjct: 403 GVCQA-EALMLVMEMAGGGPLHK--FLVGKREE-IPVSNVAELLHQVSMGMKYL---EEK 455

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-FVSISATRGTIGYIAPELISRNF 368
             +H ++   N+LL +    K+SDFGL+K    ++  + + SA +  + + APE I  NF
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--NF 513

Query: 369 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT 426
              S +SDV+ +G+ + E    G +    M             V   + +G  +E     
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---------PEVMAFIEQGKRME----- 559

Query: 427 EIESVIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLE 462
                     C   L+     C   K  DRP    V + + 
Sbjct: 560 ------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  127 bits (320), Expect = 2e-33
 Identities = 59/293 (20%), Positives = 106/293 (36%), Gaps = 59/293 (20%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE---FINEVSTIGRI-HHVNVVQLL 249
           K+G G FGSV+K      G + A+K  +     + +    + EV     +  H +VV+  
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
              +E     +  E+   GSL   I         F   +L+++ L   RG+ Y+H    M
Sbjct: 78  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SM 134

Query: 310 CILHFDIKPHNILLDHN-------------------FIPKVSDFGLAKFHPKENDFVSIS 350
            ++H DIKP NI +                       + K+ D G               
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE--- 191

Query: 351 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSN-MNAIRSSKAYF 406
              G   ++A E++  N+     K+D++   + ++  AG     RN +  + IR  +   
Sbjct: 192 ---GDSRFLANEVLQENYT-HLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGR--L 245

Query: 407 PSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
           P                    I  V++++   +    I      RPS   +++
Sbjct: 246 P-------------------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  127 bits (322), Expect = 3e-33
 Identities = 74/301 (24%), Positives = 123/301 (40%), Gaps = 48/301 (15%)

Query: 191 HFTHKLGQGGFGSVYKGQLH----TGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHV 243
                LG+G FGSV +G L     T   +AVK ++    S  E   F++E + +    H 
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96

Query: 244 NVVQLLGFCSEGSKRA-----LVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQEIALG 295
           NV++LLG C E S +      ++  FM  G L     +    E   +    + L +  + 
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL-ETGPKHIPLQTLLKFMVD 155

Query: 296 TARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT 355
            A G+ YL    +   LH D+   N +L  +    V+DFGL+K     + +      +  
Sbjct: 156 IALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212

Query: 356 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW------ 409
           + +IA E  S      + KSDV+ FG+ + E+A             ++   P        
Sbjct: 213 VKWIAIE--SLADRVYTSKSDVWAFGVTMWEIA-------------TRGMTPYPGVQNHE 257

Query: 410 VYDQLNKGGDLEL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDL 468
           +YD L  G  L+   +  +       +L  I   C +    DRP+ + +   LE  ++ L
Sbjct: 258 MYDYLLHGHRLKQPEDCLD-------ELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310

Query: 469 Q 469
            
Sbjct: 311 P 311

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  132 bits (334), Expect = 3e-33
 Identities = 65/293 (22%), Positives = 114/293 (38%), Gaps = 46/293 (15%)

Query: 192 FTHKLGQGGFGSVYKGQLHTGR----LIAVKML--ENSKFSAEEFINEVSTIGRIHHVNV 245
               +G+G FG V++G   +       +A+K      S    E+F+ E  T+ +  H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453

Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           V+L+G  +E +   ++ E    G L    F +  K        L   A   +  +AYL  
Sbjct: 454 VKLIGVITE-NPVWIIMELCTLGELRS--FLQVRKFS-LDLASLILYAYQLSTALAYLE- 508

Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
                 +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I 
Sbjct: 509 --SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESI- 564

Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW------VYDQLNKGGD 419
            NF   +  SDV+ FG+ + E+                   P        V  ++  G  
Sbjct: 565 -NFRRFTSASDVWMFGVCMWEIL-------------MHGVKPFQGVKNNDVIGRIENGER 610

Query: 420 LEL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMP 471
           L +  N           L  +   C     + RP  T++   L      L+  
Sbjct: 611 LPMPPNCPP-------TLYSLMTKCWAYDPSRRPRFTELKAQLS---TILEEE 653

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  126 bits (318), Expect = 4e-33
 Identities = 61/281 (21%), Positives = 110/281 (39%), Gaps = 40/281 (14%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 250
            +G G +G   K +    G+++  K L+    +  E    ++EV+ +  + H N+V+   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 251 FCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH--NG 306
              + +   L  V E+   G L   I     + Q    E +  +       +   H  + 
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               +LH D+KP N+ LD     K+ DFGLA+    +  F       GT  Y++PE ++R
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV--GTPYYMSPEQMNR 190

Query: 367 NFGTVSCKSDVYGFGMVLLEMAGGRR---NSNMNA----IRSSKAYFPSWVYDQLNKGGD 419
              + + KSD++  G +L E+          +       IR  K       + ++     
Sbjct: 191 M--SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-------FRRIPYRYS 241

Query: 420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM 460
            EL  +  I               + +K   RPS+ ++LE 
Sbjct: 242 DELNEI--ITR------------MLNLKDYHRPSVEEILEN 268

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  125 bits (317), Expect = 8e-33
 Identities = 64/304 (21%), Positives = 120/304 (39%), Gaps = 63/304 (20%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGR------LIAVKML-ENSKFSAEEFINEVSTIGRIHHV 243
               +LG+G FG V+  + +         L+AVK L + +  + ++F  E   +  + H 
Sbjct: 18  VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77

Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSL------------DRHIFPKENKGQTFGWEKLQE 291
           ++V+  G C +G    +V+E+M +G L                          G  ++  
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 292 IALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 351
           IA   A G+ YL        +H D+   N L+  N + K+ DFG+++      D  S   
Sbjct: 138 IASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSR------DVYSTDY 188

Query: 352 TR-GTIGYI-----APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY 405
            R G    +      PE I   +   + +SDV+ FG++L E+              +   
Sbjct: 189 YRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSFGVILWEIF-------------TYGK 233

Query: 406 FPSW------VYDQLNKGGDLEL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVL 458
            P +      V + + +G  LE  R   +       ++  + L C Q +   R ++ ++ 
Sbjct: 234 QPWFQLSNTEVIECITQGRVLERPRVCPK-------EVYDVMLGCWQREPQQRLNIKEIY 286

Query: 459 EMLE 462
           ++L 
Sbjct: 287 KILH 290

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  124 bits (314), Expect = 2e-32
 Identities = 65/314 (20%), Positives = 113/314 (35%), Gaps = 58/314 (18%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGRL--------IAVKML-ENSKFSAEEFINEVSTIGRIH 241
            F   LGQG F  ++KG               + +K+L +  +  +E F    S + ++ 
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70

Query: 242 HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVA 301
           H ++V   G C  G +  LV EF+  GSLD   + K+NK          E+A   A  + 
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDT--YLKKNKNC-INILWKLEVAKQLAAAMH 127

Query: 302 YLHNGCDMCILHFDIKPHNILLD--------HNFIPKVSDFGLAKFHPKENDFVSISATR 353
           +L    +  ++H ++   NILL         +    K+SD G++         +     +
Sbjct: 128 FLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI------TVLPKDILQ 178

Query: 354 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW---- 409
             I ++ PE I  N   ++  +D + FG  L E+              S    P      
Sbjct: 179 ERIPWVPPECIE-NPKNLNLATDKWSFGTTLWEIC-------------SGGDKPLSALDS 224

Query: 410 --VYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD 467
                       L      E+ ++I          C+  +   RPS   ++  L  S+  
Sbjct: 225 QRKLQFYEDRHQLPAPKAAELANLI--------NNCMDYEPDHRPSFRAIIRDLN-SLFT 275

Query: 468 LQMPPKPCFSSSRH 481
             + P+       H
Sbjct: 276 PDLVPRGSHHHHHH 289

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  124 bits (314), Expect = 4e-32
 Identities = 66/302 (21%), Positives = 114/302 (37%), Gaps = 49/302 (16%)

Query: 191 HFTHKLGQGGFGSVYKGQLH----TGRLIAVKMLENSKFS---AEEFINEVSTIGRIHHV 243
                LG+G FGSV + QL     +   +AVKML+    +    EEF+ E + +    H 
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85

Query: 244 NVVQLLGFCSEGSKRA------LVYEFMPNGSLD---RHIFPKENKGQTFGWEKLQEIAL 294
           +V +L+G       +       ++  FM +G L          EN       + L    +
Sbjct: 86  HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN-PFNLPLQTLVRFMV 144

Query: 295 GTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG 354
             A G+ YL        +H D+   N +L  +    V+DFGL++     + +    A++ 
Sbjct: 145 DIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201

Query: 355 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW----- 409
            + ++A E  S      +  SDV+ FG+ + E+              ++   P       
Sbjct: 202 PVKWLALE--SLADNLYTVHSDVWAFGVTMWEIM-------------TRGQTPYAGIENA 246

Query: 410 -VYDQLNKGGDLEL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD 467
            +Y+ L  G  L+      E       ++  +   C       RPS T +   LE  +  
Sbjct: 247 EIYNYLIGGNRLKQPPECME-------EVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299

Query: 468 LQ 469
           L 
Sbjct: 300 LS 301

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  123 bits (311), Expect = 6e-32
 Identities = 62/299 (20%), Positives = 109/299 (36%), Gaps = 52/299 (17%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGR------LIAVKML-ENSKFSA-EEFINEVSTIGRIHH 242
            F  +LG+  FG VYKG L           +A+K L + ++    EEF +E     R+ H
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71

Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKEN---------KGQTFGWEKLQ 290
            NVV LLG  ++    ++++ +  +G L        P  +                    
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 291 EIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 350
            +    A G+ YL       ++H D+   N+L+      K+SD GL +     + +  + 
Sbjct: 132 HLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188

Query: 351 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW- 409
            +   I ++APE I   +G  S  SD++ +G+VL E+              S    P   
Sbjct: 189 NSLLPIRWMAPEAI--MYGKFSIDSDIWSYGVVLWEVF-------------SYGLQPYCG 233

Query: 410 -----VYDQLNKGGDLEL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
                V + +     L    +           +  + + C     + RP    +   L 
Sbjct: 234 YSNQDVVEMIRNRQVLPCPDDCPA-------WVYALMIECWNEFPSRRPRFKDIHSRLR 285

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  122 bits (308), Expect = 3e-31
 Identities = 63/305 (20%), Positives = 113/305 (37%), Gaps = 54/305 (17%)

Query: 191 HFTHKLGQGGFGSVYKGQLH------TGRLIAVKML-ENSKFSA-EEFINEVSTIGRI-H 241
            F   LG G FG V +              +AVKML   +     E  ++E+  +  +  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108

Query: 242 HVNVVQLLGFCSEGSKRALVYEFMPNGSL----------DRHIFPKENKGQTFGWEKLQE 291
           H N+V LLG C+ G    ++ E+   G L                      T     L  
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 292 IALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 351
            +   A+G+A+L        +H D+   N+LL +  + K+ DFGLA+    +++++    
Sbjct: 169 FSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225

Query: 352 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA--------GGRRNSNMNAIRSSK 403
            R  + ++APE  S      + +SDV+ +G++L E+         G   NS         
Sbjct: 226 ARLPVKWMAPE--SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-------- 275

Query: 404 AYFPSWVYDQLNKGGDLEL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
                  Y  +  G  +       +        +  I   C  ++   RP+  ++   L+
Sbjct: 276 ------FYKLVKDGYQMAQPAFAPK-------NIYSIMQACWALEPTHRPTFQQICSFLQ 322

Query: 463 GSMDD 467
               +
Sbjct: 323 EQAQE 327

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  122 bits (309), Expect = 3e-31
 Identities = 56/301 (18%), Positives = 111/301 (36%), Gaps = 54/301 (17%)

Query: 184 EIIAVTN---HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE---FINEVSTI 237
           E I+V         ++G GG   V++      ++ A+K +   +   +    + NE++ +
Sbjct: 2   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61

Query: 238 GRI--HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALG 295
            ++  H   +++L  +        +V E   N  L+  +     K ++    + +     
Sbjct: 62  NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKN 116

Query: 296 TARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT 355
               V  +H      I+H D+KP N L+    + K+ DFG+A     +   V   +  GT
Sbjct: 117 MLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 172

Query: 356 IGYIAPELISRNFGT---------VSCKSDVYGFGMVLLEMAGGR--------RNSNMNA 398
           + Y+ PE I     +         +S KSDV+  G +L  M  G+        + S ++A
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 232

Query: 399 IRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVL 458
           I                           +I     + +      C++     R S+ ++L
Sbjct: 233 IIDPNHEIEFP-----------------DIPEKDLQDVLK---CCLKRDPKQRISIPELL 272

Query: 459 E 459
            
Sbjct: 273 A 273

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  121 bits (305), Expect = 5e-31
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 22/216 (10%)

Query: 191 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQ 247
             +  LGQG   +V++G+   TG L A+K+  N  F    +  + E   + +++H N+V+
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 248 LLGFCSEGSKRA--LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           L     E + R   L+ EF P GSL   +    N        +   +      G+ +L  
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVGGMNHLR- 129

Query: 306 GCDMCILHFDIKPHNILL----DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
             +  I+H +IKP NI+     D   + K++DFG A+    +  FVS+    GT  Y+ P
Sbjct: 130 --ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEYLHP 184

Query: 362 ELISRNFGTV------SCKSDVYGFGMVLLEMAGGR 391
           ++  R               D++  G+     A G 
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  121 bits (305), Expect = 6e-31
 Identities = 56/321 (17%), Positives = 116/321 (36%), Gaps = 59/321 (18%)

Query: 169 LHNQQSW-----MPKRYSYPEIIAVTN---HFTHKLGQGGFGSVYKGQLHTGRLIAVKML 220
           +H+         +     Y + ++V         ++G GG   V++      ++ A+K +
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV 60

Query: 221 ENSKFSAEE---FINEVSTIGRI--HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIF 275
              +   +    + NE++ + ++  H   +++L  +        +V E   N  L+  + 
Sbjct: 61  NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL- 118

Query: 276 PKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFG 335
               K ++    + +         V  +H      I+H D+KP N L+    + K+ DFG
Sbjct: 119 ---KKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFG 171

Query: 336 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGT---------VSCKSDVYGFGMVLLE 386
           +A     +   V   +  GT+ Y+ PE I     +         +S KSDV+  G +L  
Sbjct: 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231

Query: 387 MAGGR--------RNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCM 438
           M  G+        + S ++AI                           +I     + +  
Sbjct: 232 MTYGKTPFQQIINQISKLHAIIDPNHEIEFP-----------------DIPEKDLQDVLK 274

Query: 439 IGLWCIQVKAADRPSMTKVLE 459
               C++     R S+ ++L 
Sbjct: 275 ---CCLKRDPKQRISIPELLA 292

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  119 bits (301), Expect = 1e-30
 Identities = 58/221 (26%), Positives = 88/221 (39%), Gaps = 29/221 (13%)

Query: 179 RYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE-----FIN 232
           RY   +I+        KLG GG  +VY  +       +A+K +       +E     F  
Sbjct: 12  RY---KIVD-------KLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFER 60

Query: 233 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEI 292
           EV    ++ H N+V ++    E     LV E++   +L  +I            +     
Sbjct: 61  EVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINF 116

Query: 293 ALGTARGVAYLH-NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 351
                 G+ + H       I+H DIKP NIL+D N   K+ DFG+AK    E      + 
Sbjct: 117 TNQILDGIKHAHDMR----IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNH 171

Query: 352 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR 392
             GT+ Y +PE            +D+Y  G+VL EM  G  
Sbjct: 172 VLGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEP 210

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  118 bits (298), Expect = 3e-30
 Identities = 58/238 (24%), Positives = 106/238 (44%), Gaps = 43/238 (18%)

Query: 194 HKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQL 248
             LG+G FG+VY  +   +  ++A+K+L  ++        +   EV     + H N+++L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHI-----FPKENKGQTFGWEKLQEIALGTARGVAYL 303
            G+  + ++  L+ E+ P G++ R +     F  E +  T+    + E+A      ++Y 
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFD-EQRTATY----ITELANA----LSYC 125

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR----GTIGYI 359
           H+     ++H DIKP N+LL      K++DFG +   P        S+ R    GT+ Y+
Sbjct: 126 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--------SSRRTDLCGTLDYL 174

Query: 360 APELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNAIRSSKAYFPSWV 410
            PE+I         K D++  G++  E   G+              I   +  FP +V
Sbjct: 175 PPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 230

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  118 bits (297), Expect = 7e-30
 Identities = 68/308 (22%), Positives = 123/308 (39%), Gaps = 56/308 (18%)

Query: 191 HFTHKLGQGGFGSVYKGQLH------TGRLIAVKML-ENSKFSA-EEFINEVSTIGRI-H 241
            F   LG G FG V +   +          +AVKML  ++  +  E  ++E+  +  + +
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85

Query: 242 HVNVVQLLGFCSEGSKRALVYEFMPNGSL--------------DRHIFPKENKGQTFGWE 287
           H+N+V LLG C+ G    ++ E+   G L                     E+       E
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 288 KLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 347
            L   +   A+G+A+L        +H D+   NILL H  I K+ DFGLA+    ++++V
Sbjct: 146 DLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP 407
                R  + ++APE  S      + +SDV+ +G+ L E+              S    P
Sbjct: 203 VKGNARLPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELF-------------SLGSSP 247

Query: 408 -------SWVYDQLNKGGDLEL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
                  S  Y  + +G  +    +          ++  I   C       RP+  ++++
Sbjct: 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPA-------EMYDIMKTCWDADPLKRPTFKQIVQ 300

Query: 460 MLEGSMDD 467
           ++E  + +
Sbjct: 301 LIEKQISE 308

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  118 bits (297), Expect = 8e-30
 Identities = 73/325 (22%), Positives = 120/325 (36%), Gaps = 47/325 (14%)

Query: 194 HKLGQGGFGSVYKGQ-LHTGRLIAVK-MLENSKFSAEEFINEVSTIGRI-HHVNVVQLLG 250
             L +GGF  VY+ Q + +GR  A+K +L N +      I EV  + ++  H N+VQ   
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 251 FCSEGSKRA-------LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
             S G + +       L+   +  G L   +   E++G     + + +I   T R V ++
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP-LSCDTVLKIFYQTCRAVQHM 152

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF---------HPKENDFVSISATR- 353
           H      I+H D+K  N+LL +    K+ DFG A             +    V    TR 
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211

Query: 354 GTIGYIAPELISRNFG-TVSCKSDVYGFGMVLLEMAGGR---RNSNMNAIRSSKAYFPSW 409
            T  Y  PE+I       +  K D++  G +L  +   +    +     I + K   P  
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPH 271

Query: 410 VYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQ 469
                           T   S+I           +QV   +R S+ +V+  L+       
Sbjct: 272 ------------DTQYTVFHSLIR--------AMLQVNPEERLSIAEVVHQLQEIAAARN 311

Query: 470 MPPK-PCFSSSRHISGREIESDSST 493
           + PK P         G    + S  
Sbjct: 312 VNPKSPITELLEQNGGYGSATLSRG 336

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  119 bits (300), Expect = 8e-30
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 22/216 (10%)

Query: 191 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQ 247
             +  LGQG   +V++G+   TG L A+K+  N  F    +  + E   + +++H N+V+
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 248 LLGFCSEGSKRA--LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           L     E + R   L+ EF P GSL   +    N        +   +      G+ +L  
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVGGMNHLR- 129

Query: 306 GCDMCILHFDIKPHNILL----DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
             +  I+H +IKP NI+     D   + K++DFG A+    +  FVS+    GT  Y+ P
Sbjct: 130 --ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTEEYLHP 184

Query: 362 ELISRNFGTV------SCKSDVYGFGMVLLEMAGGR 391
           ++  R               D++  G+     A G 
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  118 bits (297), Expect = 9e-30
 Identities = 61/302 (20%), Positives = 121/302 (40%), Gaps = 55/302 (18%)

Query: 191 HFTHKLGQGGFGSVYKGQLH--------TGRLIAVKML-ENSKFSA-EEFINEVSTIGRI 240
                LG+G FG V   +              +AVKML +++      + ++E+  +  I
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97

Query: 241 -HHVNVVQLLGFCSEGSKRALVYEFMPNGSL------------DRHIFPKENKGQTFGWE 287
             H N++ LLG C++     ++ E+   G+L            +          +   ++
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157

Query: 288 KLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 347
            L       ARG+ YL        +H D+   N+L+  N + K++DFGLA+     + + 
Sbjct: 158 DLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214

Query: 348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP 407
             +  R  + ++APE  +      + +SDV+ FG+++ E+              +    P
Sbjct: 215 KTTNGRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLMWEIF-------------TLGGSP 259

Query: 408 ------SWVYDQLNKGGDLEL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM 460
                   ++  L +G  ++   N T        +L M+   C     + RP+  +++E 
Sbjct: 260 YPGIPVEELFKLLKEGHRMDKPANCTN-------ELYMMMRDCWHAVPSQRPTFKQLVED 312

Query: 461 LE 462
           L+
Sbjct: 313 LD 314

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  118 bits (299), Expect = 9e-30
 Identities = 61/302 (20%), Positives = 121/302 (40%), Gaps = 55/302 (18%)

Query: 191 HFTHKLGQGGFGSVYKGQLH--------TGRLIAVKML-ENSKFSA-EEFINEVSTIGRI 240
                LG+G FG V   +              +AVKML +++      + ++E+  +  I
Sbjct: 84  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143

Query: 241 -HHVNVVQLLGFCSEGSKRALVYEFMPNGSL------------DRHIFPKENKGQTFGWE 287
             H N++ LLG C++     ++ E+   G+L            +          +   ++
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203

Query: 288 KLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 347
            L       ARG+ YL        +H D+   N+L+  N + K++DFGLA+     + + 
Sbjct: 204 DLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260

Query: 348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP 407
             +  R  + ++APE  +      + +SDV+ FG+++ E+              +    P
Sbjct: 261 KTTNGRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLMWEIF-------------TLGGSP 305

Query: 408 ------SWVYDQLNKGGDLEL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM 460
                   ++  L +G  ++   N T        +L M+   C     + RP+  +++E 
Sbjct: 306 YPGIPVEELFKLLKEGHRMDKPANCTN-------ELYMMMRDCWHAVPSQRPTFKQLVED 358

Query: 461 LE 462
           L+
Sbjct: 359 LD 360

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  118 bits (297), Expect = 1e-29
 Identities = 67/314 (21%), Positives = 118/314 (37%), Gaps = 60/314 (19%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGR------LIAVKML-ENSKFSA-EEFINEVSTIGRIHH 242
            +   +G+G FG V++ +           ++AVKML E +      +F  E + +    +
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109

Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSL--------------------DRHIFPKENKGQ 282
            N+V+LLG C+ G    L++E+M  G L                                
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169

Query: 283 TFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 342
                +   IA   A G+AYL    +   +H D+   N L+  N + K++DFGL++    
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226

Query: 343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSS 402
            + + +       I ++ PE  S  +   + +SDV+ +G+VL E+              S
Sbjct: 227 ADYYKADGNDAIPIRWMPPE--SIFYNRYTTESDVWAYGVVLWEIF-------------S 271

Query: 403 KAYFPSW------VYDQLNKGGDLEL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMT 455
               P +      V   +  G  L    N          +L  +   C     ADRPS  
Sbjct: 272 YGLQPYYGMAHEEVIYYVRDGNILACPENCPL-------ELYNLMRLCWSKLPADRPSFC 324

Query: 456 KVLEMLEGSMDDLQ 469
            +  +L+   +  +
Sbjct: 325 SIHRILQRMCERAE 338

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  117 bits (295), Expect = 1e-29
 Identities = 71/314 (22%), Positives = 126/314 (40%), Gaps = 60/314 (19%)

Query: 191 HFTHKLGQGGFGSVYKGQLH------TGRLIAVKML-ENSKFSA-EEFINEVSTIGRIHH 242
                LG+G FG V K              +AVKML EN+  S   + ++E + + +++H
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85

Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSL--------------------DRHIFPKENKGQ 282
            +V++L G CS+     L+ E+   GSL                               +
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145

Query: 283 TFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 342
                 L   A   ++G+ YL    +M ++H D+   NIL+      K+SDFGL++   +
Sbjct: 146 ALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202

Query: 343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSS 402
           E+ +V  S  R  + ++A E  S      + +SDV+ FG++L E+              +
Sbjct: 203 EDSYVKRSQGRIPVKWMAIE--SLFDHIYTTQSDVWSFGVLLWEIV-------------T 247

Query: 403 KAYFPSW------VYDQLNKGGDLEL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMT 455
               P        +++ L  G  +E   N +E       ++  + L C + +   RP   
Sbjct: 248 LGGNPYPGIPPERLFNLLKTGHRMERPDNCSE-------EMYRLMLQCWKQEPDKRPVFA 300

Query: 456 KVLEMLEGSMDDLQ 469
            + + LE  M   +
Sbjct: 301 DISKDLEKMMVKRR 314

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  119 bits (299), Expect = 1e-29
 Identities = 51/291 (17%), Positives = 105/291 (36%), Gaps = 51/291 (17%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHH--VNV 245
               ++G GG   V++      ++ A+K +   +   +    + NE++ + ++      +
Sbjct: 59  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 118

Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           ++L  +        +V E   N  L+  +     K ++    + +         V  +H 
Sbjct: 119 IRLYDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIH- 172

Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
                I+H D+KP N L+    + K+ DFG+A     +   V   +  G + Y+ PE I 
Sbjct: 173 --QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229

Query: 366 RNFGT---------VSCKSDVYGFGMVLLEMAGGR--------RNSNMNAIRSSKAYFPS 408
               +         +S KSDV+  G +L  M  G+        + S ++AI         
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289

Query: 409 WVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
                             +I     + +      C++     R S+ ++L 
Sbjct: 290 P-----------------DIPEKDLQDVLK---CCLKRDPKQRISIPELLA 320

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  118 bits (298), Expect = 2e-29
 Identities = 66/331 (19%), Positives = 128/331 (38%), Gaps = 55/331 (16%)

Query: 191 HFTHKLGQGGFGSVYKGQLH--------TGRLIAVKML-ENSKFSA-EEFINEVSTIGRI 240
                LG+G FG V   +              +AVKML  ++      + I+E+  +  I
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131

Query: 241 -HHVNVVQLLGFCSEGSKRALVYEFMPNGSL------------DRHIFPKENKGQTFGWE 287
             H N++ LLG C++     ++ E+   G+L            +    P  N  +    +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 288 KLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 347
            L   A   ARG+ YL        +H D+   N+L+  + + K++DFGLA+     + + 
Sbjct: 192 DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248

Query: 348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP 407
             +  R  + ++APE  +      + +SDV+ FG++L E+              +    P
Sbjct: 249 KTTNGRLPVKWMAPE--ALFDRIYTHQSDVWSFGVLLWEIF-------------TLGGSP 293

Query: 408 ------SWVYDQLNKGGDLEL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM 460
                   ++  L +G  ++   N T        +L M+   C     + RP+  +++E 
Sbjct: 294 YPGVPVEELFKLLKEGHRMDKPSNCTN-------ELYMMMRDCWHAVPSQRPTFKQLVED 346

Query: 461 LEGSMDDLQMPPKPCFSSSRHISGREIESDS 491
           L+  +          +    H       +++
Sbjct: 347 LDRIVALTSNQEMGYYHHHHHHDYDIPTTEN 377

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  117 bits (295), Expect = 2e-29
 Identities = 61/323 (18%), Positives = 116/323 (35%), Gaps = 47/323 (14%)

Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFI------------------NEVST 236
            L QG F  +   +    +  A+K  E S    +                     NE+  
Sbjct: 38  TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 237 IGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI----FPKENKGQTFGWEKLQEI 292
           I  I +   +   G  +   +  ++YE+M N S+ +         +N       + ++ I
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
                   +Y+HN  +  I H D+KP NIL+D N   K+SDFG +++   +     I  +
Sbjct: 157 IKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK----IKGS 210

Query: 353 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR----RNSNMNA----IRSSKA 404
           RGT  ++ PE  S        K D++  G+ L  M           ++      IR+   
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNI 270

Query: 405 YFPSWVYDQLNKGGDLELRNVTEIESVIARKL--CMIGLWCIQVKAADRPSMTKVLE--- 459
            +P      L    + +        S               ++   A+R +    L+   
Sbjct: 271 EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLF-----LRKNPAERITSEDALKHEW 325

Query: 460 MLEGSMDDLQMPPKPCFSSSRHI 482
           + + +++DL+   K  +   + +
Sbjct: 326 LADTNIEDLREFSKELYKKRKKL 348

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  120 bits (302), Expect = 5e-29
 Identities = 48/229 (20%), Positives = 86/229 (37%), Gaps = 50/229 (21%)

Query: 179 RYSYPEIIAVTNHFTHKLGQGGFGSVYKG---QLHTGRLIAVKMLENSK---FSAEEFIN 232
           +Y   E+          +  GG G +Y      ++ GR + +K L +S          + 
Sbjct: 81  QY---EVKGC-------IAHGGLGWIYLALDRNVN-GRPVVLKGLVHSGDAEA-QAMAMA 128

Query: 233 EVSTIGRIHHVNVVQLLGFCSEGSKRA-----LVYEFMPNGSLDRHIFPKENKGQTFGWE 287
           E   +  + H ++VQ+  F     +       +V E++   SL R        GQ     
Sbjct: 129 ERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK------GQKLPVA 182

Query: 288 KLQEIALGTARGVAYLH-NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 346
           +     L     ++YLH  G    +++ D+KP NI+L    + K+ D G           
Sbjct: 183 EAIAYLLEILPALSYLHSIG----LVYNDLKPENIMLTEEQL-KLIDLGAVS-------- 229

Query: 347 VSISATR---GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR 392
             I++     GT G+ APE++       +  +D+Y  G  L  +     
Sbjct: 230 -RINSFGYLYGTPGFQAPEIVR---TGPTVATDIYTVGRTLAALTLDLP 274

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  115 bits (291), Expect = 7e-29
 Identities = 66/304 (21%), Positives = 117/304 (38%), Gaps = 64/304 (21%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVVQLLG 250
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           F  +     +V E     SL      +    E + + +    L++I      G  YLH  
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY----LRQIV----LGCQYLHR- 159

Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIAPELIS 365
               ++H D+K  N+ L+ +   K+ DFGLA     + +         GT  YIAPE++S
Sbjct: 160 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK---VLCGTPNYIAPEVLS 214

Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNA----IRSSKAYFPSWVYDQLNKGG 418
           +     S + DV+  G ++  +  G+     S +      I+ ++   P  +        
Sbjct: 215 KK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI-------- 264

Query: 419 DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE---MLEGSMDD------LQ 469
                      + +A  L  I    +Q     RP++ ++L       G +        L 
Sbjct: 265 -----------NPVAASL--IQ-KMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLT 310

Query: 470 MPPK 473
           +PP+
Sbjct: 311 IPPR 314

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  115 bits (290), Expect = 7e-29
 Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 55/302 (18%)

Query: 191 HFTHKLGQGGFGSVYKGQLH------TGRLIAVKML-ENSKFSA-EEFINEVSTIGRI-H 241
                LG+G FG V +          T R +AVKML E +  S     ++E+  +  I H
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89

Query: 242 HVNVVQLLGFCS-EGSKRALVYEFMPNGSL------------DRHIFPKENKGQTFGWEK 288
           H+NVV LLG C+  G    ++ EF   G+L               + P++        E 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149

Query: 289 LQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 348
           L   +   A+G+ +L        +H D+   NILL    + K+ DFGLA+   K+ D+V 
Sbjct: 150 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206

Query: 349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPS 408
               R  + ++APE  +      + +SDV+ FG++L E+              S    P 
Sbjct: 207 KGDARLPLKWMAPE--TIFDRVYTIQSDVWSFGVLLWEIF-------------SLGASPY 251

Query: 409 W-------VYDQLNKGGDLEL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM 460
                      +L +G  +      T        ++    L C   + + RP+ ++++E 
Sbjct: 252 PGVKIDEEFCRRLKEGTRMRAPDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEH 304

Query: 461 LE 462
           L 
Sbjct: 305 LG 306

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  115 bits (290), Expect = 1e-28
 Identities = 72/313 (23%), Positives = 123/313 (39%), Gaps = 61/313 (19%)

Query: 191 HFTHKLGQGGFGSVYKGQLH------TGRLIAVKML-ENSKFSA-EEFINEVSTIGRI-H 241
            F   LG G FG V     +          +AVKML E +  S  E  ++E+  + ++  
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107

Query: 242 HVNVVQLLGFCSEGSKRALVYEFMPNGSL-------------------DRHIFPKENKGQ 282
           H N+V LLG C+      L++E+   G L                   ++    +E    
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 283 TFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 342
              +E L   A   A+G+ +L        +H D+   N+L+ H  + K+ DFGLA+    
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSS 402
           ++++V     R  + ++APE  S   G  + KSDV+ +G++L E+              S
Sbjct: 225 DSNYVVRGNARLPVKWMAPE--SLFEGIYTIKSDVWSYGILLWEIF-------------S 269

Query: 403 KAYFP-------SWVYDQLNKGGDLEL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSM 454
               P       +  Y  +  G  ++     TE       ++ +I   C    +  RPS 
Sbjct: 270 LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATE-------EIYIIMQSCWAFDSRKRPSF 322

Query: 455 TKVLEMLEGSMDD 467
             +   L   + D
Sbjct: 323 PNLTSFLGCQLAD 335

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  114 bits (287), Expect = 1e-28
 Identities = 67/310 (21%), Positives = 119/310 (38%), Gaps = 64/310 (20%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVVQLLG 250
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           F  +     +V E     SL      +    E + + +    L++I      G  YLH  
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY----LRQIV----LGCQYLHR- 133

Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIAPELIS 365
               ++H D+K  N+ L+ +   K+ DFGLA     + +         GT  YIAPE++S
Sbjct: 134 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK---VLCGTPNYIAPEVLS 188

Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNA----IRSSKAYFPSWVYDQLNKGG 418
           +     S + DV+  G ++  +  G+     S +      I+ ++   P  +        
Sbjct: 189 KK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI-------- 238

Query: 419 DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE---MLEGSMDD------LQ 469
                      + +A  L  I    +Q     RP++ ++L       G +        L 
Sbjct: 239 -----------NPVAASL--IQ-KMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLT 284

Query: 470 MPPKPCFSSS 479
           +PP+   + S
Sbjct: 285 IPPRFSIAPS 294

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  113 bits (285), Expect = 3e-28
 Identities = 58/229 (25%), Positives = 96/229 (41%), Gaps = 39/229 (17%)

Query: 179 RYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE-----FIN 232
           RY   E+          LG GG   V+  + L   R +AVK+L  +  + +      F  
Sbjct: 13  RY---ELGE-------ILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRR 61

Query: 233 EVSTIGRIHHVNVVQLL--GFCSEGSKRALVY---EFMPNGSLDRHIFPKENKGQTFGWE 287
           E      ++H  +V +   G  +E     L Y   E++   +L   +    +       +
Sbjct: 62  EAQNAAALNHPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPK 116

Query: 288 KLQEIALGTARGVAYLH-NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 346
           +  E+     + + + H NG    I+H D+KP NI++      KV DFG+A+     +  
Sbjct: 117 RAIEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIAR--AIADSG 170

Query: 347 VSISATR---GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR 392
            S++ T    GT  Y++PE       +V  +SDVY  G VL E+  G  
Sbjct: 171 NSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEP 217

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  111 bits (279), Expect = 1e-27
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 34/233 (14%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 250
           LG+G F  VY+ + +HTG  +A+KM++          +   NEV    ++ H ++++L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPK-----ENKGQTFGWEKLQEIALGTARGVAYLHN 305
           +  + +   LV E   NG ++R++  +     EN+ + F    + +I      G+ YLH+
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF----MHQII----TGMLYLHS 130

Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIAPELI 364
                ILH D+   N+LL  N   K++DFGLA      ++      T  GT  YI+PE+ 
Sbjct: 131 ---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY---TLCGTPNYISPEIA 184

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNA----IRSSKAYFPSWV 410
           +R+      +SDV+  G +   +  GR       +      +  +    PS++
Sbjct: 185 TRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFL 235

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  111 bits (279), Expect = 1e-27
 Identities = 58/236 (24%), Positives = 103/236 (43%), Gaps = 43/236 (18%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVVQLLG 250
           LG+G FG+VY  +      ++A+K+L  S+   E        E+     + H N++++  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 251 FCSEGSKRALVYEFMPNGSLDRHI-----FPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           +  +  +  L+ EF P G L + +     F  E +  TF    ++E+A      + Y H 
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFD-EQRSATF----MEELADA----LHYCHE 132

Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR----GTIGYIAP 361
                ++H DIKP N+L+ +    K++DFG +   P        S  R    GT+ Y+ P
Sbjct: 133 ---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP--------SLRRRTMCGTLDYLPP 181

Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNA----IRSSKAYFPSWV 410
           E+I     T   K D++  G++  E   G     + +       I +    FP ++
Sbjct: 182 EMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFL 235

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  112 bits (282), Expect = 2e-27
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 21/204 (10%)

Query: 194 HKLGQGGFGSVYKGQL-HTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
            +LG G  G V+K     +G ++A K+  LE       + I E+  +   +   +V   G
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98

Query: 251 -FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
            F S+G + ++  E M  GSLD+ +     K      + L ++++   +G+ YL      
Sbjct: 99  AFYSDG-EISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLRE--KH 151

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRN 367
            I+H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE +   
Sbjct: 152 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGT 205

Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR 391
               S +SD++  G+ L+EMA GR
Sbjct: 206 --HYSVQSDIWSMGLSLVEMAVGR 227

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  109 bits (275), Expect = 4e-27
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 28/211 (13%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKM--LENSKFSAEEFINEVSTIGR-IHHVNVVQLLG 250
           +LG+G +G V K + + +G+++AVK      +    +  + ++    R +     V   G
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                    +  E M + SLD+      +KGQT   + L +IA+   + + +LH+   + 
Sbjct: 74  ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLS 130

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFG--------LAKFHPKENDFVSISATRGTIGYIAPE 362
           ++H D+KP N+L++     K+ DFG        +AK     +         G   Y+APE
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK-----DIDA------GCKPYMAPE 179

Query: 363 LI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 391
            I    N    S KSD++  G+ ++E+A  R
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILR 210

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  110 bits (276), Expect = 4e-27
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 22/216 (10%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLE-NSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           +LG G FG VYK +   TG L A K++E  S+   E++I E+  +    H  +V+LLG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
               K  ++ EF P G++D  +       +     ++Q +       + +LH+     I+
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVVCRQMLEALNFLHS---KRII 139

Query: 313 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
           H D+K  N+L+      +++DFG      K   K + F+      GT  ++APE++    
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVMCET 193

Query: 369 GTVS---CKSDVYGFGMVLLEMAGGRR-NSNMNAIR 400
              +    K+D++  G+ L+EMA     +  +N +R
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 229

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  110 bits (278), Expect = 5e-27
 Identities = 46/187 (24%), Positives = 80/187 (42%), Gaps = 17/187 (9%)

Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI------NEVSTIGRIHHVN 244
               +G+G F  V +     TG+  AVK+++ +KF++   +       E S    + H +
Sbjct: 28  LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87

Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           +V+LL   S      +V+EFM    L    I  + + G  +               + Y 
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFE-IVKRADAGFVYSEAVASHYMRQILEALRYC 146

Query: 304 HNGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 360
           H   D  I+H D+KPH +LL   +++   K+  FG+A    +           GT  ++A
Sbjct: 147 H---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV--GTPHFMA 201

Query: 361 PELISRN 367
           PE++ R 
Sbjct: 202 PEVVKRE 208

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  110 bits (276), Expect = 5e-27
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 19/207 (9%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKM--LENSKFSAEEFINEVSTIGR-IHHVNVVQLLG 250
           ++G+G +GSV K     +G+++AVK       +   ++ + ++  + R      +VQ  G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 251 FCSEGSKRALVYEFMPNGSLDRHI-FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
                    +  E M + S D+   +           E L +I L T + + +L    ++
Sbjct: 89  ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NL 145

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG---YIAPELI-- 364
            I+H DIKP NILLD +   K+ DFG++         V   A     G   Y+APE I  
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISG------QLVDSIAKTRDAGCRPYMAPERIDP 199

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           S +      +SDV+  G+ L E+A GR
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGR 226

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  109 bits (275), Expect = 6e-27
 Identities = 46/205 (22%), Positives = 81/205 (39%), Gaps = 19/205 (9%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE-----FINEVSTIGRIHHVNVVQL 248
            +G+GG G VY+ +     R++A+K++ +   S++         E  T GR+   +VV +
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH-NGC 307
             F     +  +    +    L   +     +       +   I       +   H  G 
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAHAAG- 154

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
                H D+KP NIL+  +    + DFG+A     +     +  T GT+ Y+APE  S  
Sbjct: 155 ---ATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGNTVGTLYYMAPERFSE- 209

Query: 368 FGTVSCKSDVYGFGMVLLEMAGGRR 392
               + ++D+Y    VL E   G  
Sbjct: 210 -SHATYRADIYALTCVLYECLTGSP 233

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  108 bits (273), Expect = 1e-26
 Identities = 55/215 (25%), Positives = 104/215 (48%), Gaps = 24/215 (11%)

Query: 194 HKLGQGGFGSVYKGQ-LHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
            K+G+G FG V+KG    T +++A+K+  LE ++   E+   E++ + +     V +  G
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
              + +K  ++ E++  GS    +     +       ++  I     +G+ YLH+     
Sbjct: 88  SYLKDTKLWIIMEYLGGGSA-LDLL----EPGPLDETQIATILREILKGLDYLHS---EK 139

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISR 366
            +H DIK  N+LL  +   K++DFG    L     K N FV      GT  ++APE+I +
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEVIKQ 193

Query: 367 NFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNAIR 400
                  K+D++  G+  +E+A G   +S ++ ++
Sbjct: 194 --SAYDSKADIWSLGITAIELARGEPPHSELHPMK 226

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  111 bits (278), Expect = 1e-26
 Identities = 63/309 (20%), Positives = 101/309 (32%), Gaps = 51/309 (16%)

Query: 181 SYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI 240
           ++ + +         LG G  G+V       GR +AVK +       +  + E+  +   
Sbjct: 8   NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC--DIALMEIKLLTES 65

Query: 241 -HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIA---LGT 296
             H NV++     +      +  E   N +L   +  K    +    +K           
Sbjct: 66  DDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124

Query: 297 ARGVAYLHNGCDMCILHFDIKPHNILLDH-------------NFIPKVSDFGLAK-FHPK 342
           A GVA+LH    + I+H D+KP NIL+               N    +SDFGL K     
Sbjct: 125 ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181

Query: 343 ENDFVSISATR-GTIGYIAPELISRNFGTV-----SCKSDVYGFGMVLLEMAG------G 390
           ++ F +      GT G+ APEL+  +         +   D++  G V   +        G
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241

Query: 391 RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAAD 450
            + S  + I                                 A  L  I    I      
Sbjct: 242 DKYSRESNIIRGIFSLDEMKCLHDRS------------LIAEATDL--IS-QMIDHDPLK 286

Query: 451 RPSMTKVLE 459
           RP+  KVL 
Sbjct: 287 RPTAMKVLR 295

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  108 bits (273), Expect = 1e-26
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 22/202 (10%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 252
           K+G+G  G V   +  H+GR +AVKM++  K    E + NEV  +    H NVV++    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
             G +  ++ EF+  G+L   +            E++  +     + +AYLH      ++
Sbjct: 112 LVGEELWVLMEFLQGGALTDIV-----SQVRLNEEQIATVCEAVLQALAYLHA---QGVI 163

Query: 313 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
           H DIK  +ILL  +   K+SDFG    ++K  PK    V      GT  ++APE+ISR+ 
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVISRS- 216

Query: 369 GTVSCKSDVYGFGMVLLEMAGG 390
              + + D++  G++++EM  G
Sbjct: 217 -LYATEVDIWSLGIMVIEMVDG 237

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  108 bits (272), Expect = 1e-26
 Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 28/214 (13%)

Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
            +G G    V           +A+K   LE  + S +E + E+  + + HH N+V     
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQE--IAL---GTARGVAYLHNG 306
                +  LV + +  GS+   I              L E  IA        G+ YLH  
Sbjct: 82  FVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK- 139

Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF---------HPKENDFVSISATRGTIG 357
                +H D+K  NILL  +   +++DFG++ F         +     FV      GT  
Sbjct: 140 --NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV------GTPC 191

Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           ++APE++ +  G    K+D++ FG+  +E+A G 
Sbjct: 192 WMAPEVMEQVRG-YDFKADIWSFGITAIELATGA 224

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  112 bits (282), Expect = 1e-26
 Identities = 63/254 (24%), Positives = 95/254 (37%), Gaps = 46/254 (18%)

Query: 191 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQ 247
               +LG GGFG V +     TG  +A+K         + E +  E+  + +++H NVV 
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76

Query: 248 LLGFCSEGSKRA------LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR--- 298
                    K A      L  E+   G L +++   EN         L+E      R   
Sbjct: 77  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC------GLKEG---PIRTLL 127

Query: 299 -----GVAYLHNGCDMCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSIS 350
                 + YLH   +  I+H D+KP NI+L       I K+ D G AK   +        
Sbjct: 128 SDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV 184

Query: 351 ATRGTIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLEMAGGRR-------NSNMNAIRSS 402
              GT+ Y+APEL+  + +       D + FG +  E   G R           +     
Sbjct: 185 ---GTLQYLAPELLEQKKYT---VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238

Query: 403 KAYFPSWVYDQLNK 416
           K+     VYD L  
Sbjct: 239 KSNEHIVVYDDLTG 252

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  106 bits (268), Expect = 3e-26
 Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 17/222 (7%)

Query: 170 HNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSA- 227
           H+  S   +   +   I     F  KLG G FG V+   +  +G    +K +   +    
Sbjct: 4   HHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP 63

Query: 228 -EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFG 285
            E+   E+  +  + H N++++     +     +V E    G L +R I   + +G+   
Sbjct: 64  MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLER-IVSAQARGKALS 122

Query: 286 WEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPK 342
              + E+       +AY H      ++H D+KP NIL      +   K+ DFGLA+    
Sbjct: 123 EGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179

Query: 343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 384
           +    + +   GT  Y+APE+  R+      K D++  G+V+
Sbjct: 180 DEHSTNAA---GTALYMAPEVFKRDVTF---KCDIWSAGVVM 215

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  108 bits (272), Expect = 4e-26
 Identities = 27/229 (11%), Positives = 55/229 (24%), Gaps = 41/229 (17%)

Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKML----ENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           L  G    V+    +      A+K+     ENS+   E          R+   +  +   
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 251 FCSEGSKRA--------------------------LVYEFMP--NGSLDRHIFPKENKGQ 282
                                              L+          L   +        
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189

Query: 283 TFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 342
             G   L  +     R  A L       ++H    P N+ +  +    + D        K
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW---K 243

Query: 343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
                  S+    + Y   E ++ +  T +   + +  G+ +  +    
Sbjct: 244 VGTRGPASS--VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  107 bits (269), Expect = 4e-26
 Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 21/213 (9%)

Query: 194 HKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
            KLG+G +GSVYK     TG+++A+K +       +E I E+S + +    +VV+  G  
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSY 93

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
            + +   +V E+   GS+   I     + +T   +++  I   T +G+ YLH    M  +
Sbjct: 94  FKNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLHF---MRKI 147

Query: 313 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
           H DIK  NILL+     K++DFG    L     K N  +      GT  ++APE+I    
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI------GTPFWMAPEVIQE-- 199

Query: 369 GTVSCKSDVYGFGMVLLEMAGGRR-NSNMNAIR 400
              +C +D++  G+  +EMA G+   ++++ +R
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPPYADIHPMR 232

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  110 bits (276), Expect = 4e-26
 Identities = 53/203 (26%), Positives = 84/203 (41%), Gaps = 23/203 (11%)

Query: 191 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNV 245
                LG+G FG V       TG+  AVK++   +   +      + EV  + ++ H N+
Sbjct: 29  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 246 VQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
           ++L  F  +     LV E    G L D  I  ++     F       I      G+ Y+H
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGELFDE-IISRKR----FSEVDAARIIRQVLSGITYMH 143

Query: 305 NGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
                 I+H D+KP N+LL     +   ++ DFGL+                GT  YIAP
Sbjct: 144 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---GTAYYIAP 197

Query: 362 ELISRNFGTVSCKSDVYGFGMVL 384
           E++   +     K DV+  G++L
Sbjct: 198 EVLHGTYDE---KCDVWSTGVIL 217

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  107 bits (268), Expect = 5e-26
 Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 22/203 (10%)

Query: 194 HKLGQGGFGSVYKG-QLHTGRLIAVKMLE-NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
            K+GQG  G+VY    + TG+ +A++ +    +   E  INE+  +    + N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
              G +  +V E++  GSL   +             ++  +     + + +LH+     +
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHS---NQV 137

Query: 312 LHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISRN 367
           +H DIK  NILL  +   K++DFG    +     K +  V      GT  ++APE+++R 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV------GTPYWMAPEVVTRK 191

Query: 368 FGTVSCKSDVYGFGMVLLEMAGG 390
                 K D++  G++ +EM  G
Sbjct: 192 --AYGPKVDIWSLGIMAIEMIEG 212

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  110 bits (276), Expect = 5e-26
 Identities = 55/202 (27%), Positives = 85/202 (42%), Gaps = 22/202 (10%)

Query: 191 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVV 246
               KLG G +G V       T    A+K++  +  S       + EV+ +  + H N++
Sbjct: 40  QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99

Query: 247 QLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           +L  F  +     LV E    G L D  I  +      F       I      GV YLH 
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDE-IIHRMK----FNEVDAAVIIKQVLSGVTYLH- 153

Query: 306 GCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
                I+H D+KP N+LL   + + + K+ DFGL+     +          GT  YIAPE
Sbjct: 154 --KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL---GTAYYIAPE 208

Query: 363 LISRNFGTVSCKSDVYGFGMVL 384
           ++ + +     K DV+  G++L
Sbjct: 209 VLRKKYDE---KCDVWSIGVIL 227

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  109 bits (274), Expect = 9e-26
 Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 22/223 (9%)

Query: 170 HNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAE 228
           H+  S   +   +    A   +    LG+G FG V K     T +  AVK++  +    +
Sbjct: 4   HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63

Query: 229 E---FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTF 284
           +    + EV  + ++ H N+++L     + S   +V E    G L D  I  ++     F
Sbjct: 64  DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDE-IIKRKR----F 118

Query: 285 GWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHP 341
                  I      G+ Y+H      I+H D+KP NILL   + +   K+ DFGL+    
Sbjct: 119 SEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175

Query: 342 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 384
           +           GT  YIAPE++   +     K DV+  G++L
Sbjct: 176 QNTKMKDRI---GTAYYIAPEVLRGTYDE---KCDVWSAGVIL 212

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  106 bits (267), Expect = 1e-25
 Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 27/223 (12%)

Query: 194 HKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLG- 250
             +G G +G VYKG+ + TG+L A+K+++ +    EE   E++ + +  HH N+    G 
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89

Query: 251 -----FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
                      +  LV EF   GS+   I  K  KG T   E +  I     RG+++LH 
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGLSHLHQ 147

Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAP 361
                ++H DIK  N+LL  N   K+ DFG    L +   + N F+      GT  ++AP
Sbjct: 148 ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMAP 198

Query: 362 ELISRNFGTVS---CKSDVYGFGMVLLEMAGGR-RNSNMNAIR 400
           E+I+ +    +    KSD++  G+  +EMA G     +M+ +R
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 241

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  107 bits (268), Expect = 1e-25
 Identities = 45/251 (17%), Positives = 88/251 (35%), Gaps = 34/251 (13%)

Query: 170 HNQQSWMPKRYSYPEIIAVTNHFT--HKLGQG--GFGSVYKGQ-LHTGRLIAVKM--LEN 222
           H +  +     S+         +     +G+G     +V   +   TG  + V+   LE 
Sbjct: 8   HMENLYFQGMSSFL---PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA 64

Query: 223 SKFSAEEFI-NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKG 281
                  F+  E+      +H N+V         ++  +V  FM  GS  + +    +  
Sbjct: 65  CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLI-CTHFM 122

Query: 282 QTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLA---- 337
                  +  I  G  + + Y+H+   M  +H  +K  +IL+  +    +S         
Sbjct: 123 DGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179

Query: 338 -------KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 390
                    H      V        + +++PE++ +N      KSD+Y  G+   E+A G
Sbjct: 180 SHGQRQRVVHDFPKYSV------KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 233

Query: 391 RR-NSNMNAIR 400
                +M A +
Sbjct: 234 HVPFKDMPATQ 244

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  107 bits (269), Expect = 2e-25
 Identities = 67/208 (32%), Positives = 101/208 (48%), Gaps = 25/208 (12%)

Query: 195 KLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFIN-EVSTIGRIHHVNVVQLLG-F 251
            +G G FG VY+ +L  +G L+A+K +   K     F N E+  + ++ H N+V+L   F
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFF 116

Query: 252 CSEGSKRA-----LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
            S G K+      LV +++P  ++ R         QT     ++       R +AY+H+ 
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS- 174

Query: 307 CDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
               I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R    Y APELI 
Sbjct: 175 --FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELI- 228

Query: 366 RNFGTV--SCKSDVYGFGMVLLEMAGGR 391
             FG    +   DV+  G VL E+  G+
Sbjct: 229 --FGATDYTSSIDVWSAGCVLAELLLGQ 254

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  105 bits (263), Expect = 2e-25
 Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 24/226 (10%)

Query: 169 LHNQQSWMPKRYSYPEIIAVTNHFT--HKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKF 225
           +H+       R +          +     LG+G FG V K     T +  AVK++  +  
Sbjct: 1   MHHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA 60

Query: 226 SAEE---FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKG 281
             ++    + EV  + ++ H N+++L     + S   +V E    G L D  I  ++   
Sbjct: 61  KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDE-IIKRKR-- 117

Query: 282 QTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAK 338
             F       I      G+ Y+H      I+H D+KP NILL   + +   K+ DFGL+ 
Sbjct: 118 --FSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172

Query: 339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 384
              +           GT  YIAPE++   +     K DV+  G++L
Sbjct: 173 CFQQNTKMKDRI---GTAYYIAPEVLRGTYDE---KCDVWSAGVIL 212

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  106 bits (266), Expect = 2e-25
 Identities = 66/234 (28%), Positives = 109/234 (46%), Gaps = 38/234 (16%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKM--LENSKFSAEEF----INEVSTIGRIHHVNVVQ 247
            LG+G F +VYK +  +T +++A+K   L +   + +      + E+  +  + H N++ 
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76

Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
           LL      S  +LV++FM    L+  I   ++         ++   L T +G+ YLH   
Sbjct: 77  LLDAFGHKSNISLVFDFMET-DLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLH--- 129

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI-- 364
              ILH D+KP+N+LLD N + K++DFGLAK F      +     TR    Y APEL+  
Sbjct: 130 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR---WYRAPELLFG 186

Query: 365 SRNFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP-SWVYDQLNK 416
           +R +G  V    D++  G +L E+                 + P     DQL +
Sbjct: 187 ARMYGVGV----DMWAVGCILAELLLR------------VPFLPGDSDLDQLTR 224

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  104 bits (262), Expect = 2e-25
 Identities = 67/235 (28%), Positives = 97/235 (41%), Gaps = 35/235 (14%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFC 252
           LG+G +G V       T   +AVK+++  +     E    E+     ++H NVV+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR--------GVAYLH 304
            EG+ + L  E+   G L   I   E          + E     A+        GV YLH
Sbjct: 75  REGNIQYLFLEYCSGGELFDRI---EPDI------GMPE---PDAQRFFHQLMAGVVYLH 122

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
               + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGGR-----RNSNMN---AIRSSKAYFPSWVY 411
            R     +   DV+  G+VL  M  G       + +       +  K Y   W  
Sbjct: 180 KRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  106 bits (265), Expect = 3e-25
 Identities = 37/220 (16%), Positives = 73/220 (33%), Gaps = 32/220 (14%)

Query: 191 HFTHKLGQGGFGSVYKGQ------LHTGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHV 243
           +  H LG+G F  VY+            +   +K+ + +  +        +  +      
Sbjct: 68  YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQH 127

Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQE-----IALGTAR 298
             ++        +   LV E    G+L   I    N  +    + + +      A+    
Sbjct: 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAI----NLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 299 GVAYLHNGCDMCILHFDIKPHNILLDHNFIP-----------KVSDFGLAKFHPKENDFV 347
            +  +H   D  I+H DIKP N +L + F+             + D G +          
Sbjct: 184 MIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
             +A   T G+   E++S      + + D +G    +  M
Sbjct: 241 IFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCM 278

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  104 bits (262), Expect = 4e-25
 Identities = 48/206 (23%), Positives = 85/206 (41%), Gaps = 20/206 (9%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKM--LENSKFSAEEFINEVSTIGR-IHHVNVVQLLG 250
           ++G G  G V+K +   TG +IAVK      +K   +  + ++  + +      +VQ  G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +   +  E M   +       K+          L ++ +   + + YL       
Sbjct: 92  TFITNTDVFIAMELMGTCAEKL----KKRMQGPIPERILGKMTVAIVKALYYLKE--KHG 145

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR--GTIGYIAPELISRNF 368
           ++H D+KP NILLD     K+ DFG++            +  R  G   Y+APE I    
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISG-----RLVDDKAKDRSAGCAAYMAPERIDPPD 200

Query: 369 ---GTVSCKSDVYGFGMVLLEMAGGR 391
                   ++DV+  G+ L+E+A G+
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQ 226

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  105 bits (263), Expect = 5e-25
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 20/214 (9%)

Query: 194 HKLGQGGFGSVYKGQ-LHTGRLIAVKML----ENSKFSAEEFINEVSTIGRIHHVNVVQL 248
            ++G G FG+VY  + +    ++A+K +    + S    ++ I EV  + ++ H N +Q 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
            G         LV E+    + D      E   +     ++  +  G  +G+AYLH+   
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLL----EVHKKPLQEVEIAAVTHGALQGLAYLHS--- 172

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
             ++H D+K  NILL    + K+ DFG A      N FV      GT  ++APE+I    
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAMD 226

Query: 369 -GTVSCKSDVYGFGMVLLEMAGGRR-NSNMNAIR 400
            G    K DV+  G+  +E+A  +    NMNA+ 
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 260

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  103 bits (258), Expect = 1e-24
 Identities = 67/235 (28%), Positives = 97/235 (41%), Gaps = 35/235 (14%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFC 252
           LG+G +G V       T   +AVK+++  +     E    E+     ++H NVV+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR--------GVAYLH 304
            EG+ + L  E+   G L   I   E          + E     A+        GV YLH
Sbjct: 75  REGNIQYLFLEYCSGGELFDRI---EPDI------GMPE---PDAQRFFHQLMAGVVYLH 122

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
               + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGGR-----RNSNMN---AIRSSKAYFPSWVY 411
            R     +   DV+  G+VL  M  G       + +       +  K Y   W  
Sbjct: 180 KRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  105 bits (264), Expect = 2e-24
 Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 33/213 (15%)

Query: 191 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSA--------------EEFINEVS 235
               KLG G +G V    + +     A+K+++ S+F                EE  NE+S
Sbjct: 39  FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98

Query: 236 TIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEIAL 294
            +  + H N+++L     +     LV EF   G L ++ I  +      F       I  
Sbjct: 99  LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQ-IINRHK----FDECDAANIMK 153

Query: 295 GTARGVAYLHNGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISA 351
               G+ YLH      I+H DIKP NILL   +     K+ DFGL+ F  K+        
Sbjct: 154 QILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL- 209

Query: 352 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 384
             GT  YIAPE++ + +     K DV+  G+++
Sbjct: 210 --GTAYYIAPEVLKKKYNE---KCDVWSCGVIM 237

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  101 bits (255), Expect = 2e-24
 Identities = 47/182 (25%), Positives = 78/182 (42%), Gaps = 19/182 (10%)

Query: 194 HKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLL 249
            +LG+G F  V +     TG   A K++   K SA +      E     ++ H N+V+L 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71

Query: 250 GFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
               E S   LV++ +  G L +  I  +E     +               +AY H    
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFED-IVAREF----YSEADASHCIQQILESIAYCH---S 123

Query: 309 MCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
             I+H ++KP N+LL         K++DFGLA        +   +   GT GY++PE++ 
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYLSPEVLK 180

Query: 366 RN 367
           ++
Sbjct: 181 KD 182

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  102 bits (257), Expect = 2e-24
 Identities = 54/272 (19%), Positives = 97/272 (35%), Gaps = 57/272 (20%)

Query: 191 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSA------EEFINEVSTIGRIHHV 243
           H    +GQG +G V    +  T  + A+K++  +K         E    EV  + ++HH 
Sbjct: 29  HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88

Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR----- 298
           N+ +L     +     LV E    G L   +    +         + +  +         
Sbjct: 89  NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148

Query: 299 -------------------------------GVAYLHNGCDMCILHFDIKPHNILL--DH 325
                                           + YLHN     I H DIKP N L   + 
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNK 205

Query: 326 NFIPKVSDFGLAKFHP--KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 383
           +F  K+ DFGL+K        ++  ++   GT  ++APE+++    +   K D +  G++
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265

Query: 384 LLEMAGGR-----RNSN--MNAIRSSKAYFPS 408
           L  +  G       N    ++ + + K  F +
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFEN 297

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  103 bits (260), Expect = 2e-24
 Identities = 64/207 (30%), Positives = 96/207 (46%), Gaps = 24/207 (11%)

Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFIN-EVSTIGRIHHVNVVQLLG-FC 252
            +G G FG V++ +L     +A+K +   K     F N E+  +  + H NVV L   F 
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFY 102

Query: 253 SEGSKRA-----LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
           S G K+      LV E++P  ++ R         QT     ++       R +AY+H+  
Sbjct: 103 SNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-- 159

Query: 308 DMCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
            + I H DIKP N+LLD  + + K+ DFG AK        VS   +R    Y APELI  
Sbjct: 160 -IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR---YYRAPELI-- 213

Query: 367 NFGTV--SCKSDVYGFGMVLLEMAGGR 391
            FG    +   D++  G V+ E+  G+
Sbjct: 214 -FGATNYTTNIDIWSTGCVMAELMQGQ 239

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  103 bits (257), Expect = 4e-24
 Identities = 39/307 (12%), Positives = 88/307 (28%), Gaps = 71/307 (23%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFI----NEVSTIGRI---------- 240
           LGQ    +  +     TG    V +   ++      I     EV  +  +          
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 241 ---------------HHVNVVQLLGFCSEGSKRALVYEFM----PNGSLDRHIFPKENKG 281
                              ++++     +    +  + +        +    +    +  
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 282 QTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 341
           ++       ++ L   R +A LH      ++H  ++P +I+LD      ++ F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 254

Query: 342 KENDFVSISATRGTIGYIAPELISRNFGT---------VSCKSDVYGFGMVLLEMAGGRR 392
           ++   V    +  + G+  PEL +R             ++   D +  G+V+  +     
Sbjct: 255 RDGARVV---SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA-- 309

Query: 393 NSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRP 452
                         P    D    G +   R+   I     R L       ++    DR 
Sbjct: 310 ------------DLP-ITKDAALGGSEWIFRSCKNI-PQPVRALLE---GFLRYPKEDRL 352

Query: 453 SMTKVLE 459
              + +E
Sbjct: 353 LPLQAME 359

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  102 bits (256), Expect = 5e-24
 Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 19/181 (10%)

Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 250
           +LG+G F  V +     TG   A K++   K SA +      E     ++ H N+V+L  
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95

Query: 251 FCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
              E S   LV++ +  G L +  I  +E     +               +AY H     
Sbjct: 96  SIQEESFHYLVFDLVTGGELFED-IVAREF----YSEADASHCIQQILESIAYCH---SN 147

Query: 310 CILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
            I+H ++KP N+LL         K++DFGLA        +   +   GT GY++PE++ +
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYLSPEVLKK 204

Query: 367 N 367
           +
Sbjct: 205 D 205

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  101 bits (253), Expect = 6e-24
 Identities = 58/201 (28%), Positives = 86/201 (42%), Gaps = 36/201 (17%)

Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSA-------EEFINEVSTIGRIHHVNVV 246
           +LG G F  V K  +  TG   A K ++  +  A       EE   EVS + ++ H NV+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 247 QLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEI-ALGTAR----GV 300
            L       +   L+ E +  G L D  +  K         E L E  A    +    GV
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDF-LAQK---------ESLSEEEATSFIKQILDGV 128

Query: 301 AYLHNGCDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTI 356
            YLH      I HFD+KP NI+L    IP    K+ DFGLA    ++          GT 
Sbjct: 129 NYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIF--GTP 182

Query: 357 GYIAPELISRNFGTVSCKSDV 377
            ++APE+++     +  ++D+
Sbjct: 183 EFVAPEIVNYEP--LGLEADM 201

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  102 bits (255), Expect = 6e-24
 Identities = 59/201 (29%), Positives = 88/201 (43%), Gaps = 36/201 (17%)

Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSA-------EEFINEVSTIGRIHHVNVV 246
           +LG G F  V K  +  TG   A K ++  +  A       EE   EVS + ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 247 QLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEI-ALGTAR----GV 300
            L       +   L+ E +  G L D  +  K         E L E  A    +    GV
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDF-LAQK---------ESLSEEEATSFIKQILDGV 128

Query: 301 AYLHNGCDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTI 356
            YLH      I HFD+KP NI+L    IP    K+ DFGLA       +F +I    GT 
Sbjct: 129 NYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTP 182

Query: 357 GYIAPELISRNFGTVSCKSDV 377
            ++APE+++     +  ++D+
Sbjct: 183 EFVAPEIVNYEP--LGLEADM 201

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  100 bits (252), Expect = 7e-24
 Identities = 60/232 (25%), Positives = 97/232 (41%), Gaps = 38/232 (16%)

Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKM--LENSK----FSAEEFINEVSTIGRIHHVNVVQL 248
           K+G+G +G VYK Q + G   A+K   LE        +    I E+S +  + H N+V+L
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT---IREISILKELKHSNIVKL 65

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
                   +  LV+E +    L + +   +           +   L    G+AY H   D
Sbjct: 66  YDVIHTKKRLVLVFEHLDQ-DLKKLL---DVCEGGLESVTAKSFLLQLLNGIAYCH---D 118

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI--S 365
             +LH D+KP N+L++     K++DFGLA+ F      +     T     Y AP+++  S
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL---WYRAPDVLMGS 175

Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP-SWVYDQLNK 416
           + + T     D++  G +  EM  G               FP     DQL +
Sbjct: 176 KKYST---TIDIWSVGCIFAEMVNGT------------PLFPGVSEADQLMR 212

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  100 bits (251), Expect = 7e-24
 Identities = 45/200 (22%), Positives = 78/200 (39%), Gaps = 20/200 (10%)

Query: 191 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEE-FINEVSTIGRIHHVNVVQL 248
              + +G+G +G V    Q  T    A K +        + F  E+  +  + H N+++L
Sbjct: 12  TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71

Query: 249 LGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
                + +   LV E    G L +R +  K      F       I       VAY H   
Sbjct: 72  YETFEDNTDIYLVMELCTGGELFER-VVHKRV----FRESDAARIMKDVLSAVAYCH--- 123

Query: 308 DMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
            + + H D+KP N L      +   K+ DFGLA          +     GT  Y++P+++
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPYYVSPQVL 180

Query: 365 SRNFGTVSCKSDVYGFGMVL 384
              +G    + D +  G+++
Sbjct: 181 EGLYGP---ECDEWSAGVMM 197

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  101 bits (255), Expect = 7e-24
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 21/211 (9%)

Query: 193 THKLGQGGFGSVYKGQL-HTGRLIAVK-MLENSKFSAEEFINEVSTIGRIHHVNVVQLL- 249
               GQG FG+V  G+   TG  +A+K ++++ +F   E +  +  +  +HH N+VQL  
Sbjct: 28  ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPNIVQLQS 86

Query: 250 GFCSEGSKR------ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
            F + G +        +V E++P+ +L R       +        ++       R +  L
Sbjct: 87  YFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCL 145

Query: 304 HNGCDMCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
           H    + + H DIKPHN+L++  +   K+ DFG AK        V+   +R    Y APE
Sbjct: 146 HLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR---YYRAPE 201

Query: 363 LISRNFGTV--SCKSDVYGFGMVLLEMAGGR 391
           LI   FG    +   D++  G +  EM  G 
Sbjct: 202 LI---FGNQHYTTAVDIWSVGCIFAEMMLGE 229

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  101 bits (253), Expect = 7e-24
 Identities = 39/197 (19%), Positives = 75/197 (38%), Gaps = 20/197 (10%)

Query: 188 VTNHFT--HKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVN 244
           +   +     LG+G FG V++  +  + +    K ++           E+S +    H N
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRN 62

Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           ++ L        +  +++EF+    + +R               ++          + +L
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERIN----TSAFELNEREIVSYVHQVCEALQFL 118

Query: 304 HNGCDMCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 360
           H      I HFDI+P NI+      + I K+ +FG A+   K  D   +        Y A
Sbjct: 119 H---SHNIGHFDIRPENIIYQTRRSSTI-KIIEFGQARQL-KPGDNFRLLF--TAPEYYA 171

Query: 361 PELISRNFGTVSCKSDV 377
           PE+   +   VS  +D+
Sbjct: 172 PEVHQHDV--VSTATDM 186

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  100 bits (252), Expect = 8e-24
 Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 38/232 (16%)

Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKM--LENSK----FSAEEFINEVSTIGRIHHVNVVQL 248
           K+G+G +G VYK +   GR++A+K   L+        +A   I E+S +  +HH N+V L
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA---IREISLLKELHHPNIVSL 84

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           +          LV+EFM    L + +   +         +++       RGVA+ H    
Sbjct: 85  IDVIHSERCLTLVFEFMEK-DLKKVL---DENKTGLQDSQIKIYLYQLLRGVAHCH---Q 137

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI--S 365
             ILH D+KP N+L++ +   K++DFGLA+ F      +     T     Y AP+++  S
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL---WYRAPDVLMGS 194

Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP-SWVYDQLNK 416
           + + T     D++  G +  EM  G            K  FP     DQL K
Sbjct: 195 KKYST---SVDIWSIGCIFAEMITG------------KPLFPGVTDDDQLPK 231

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  102 bits (255), Expect = 8e-24
 Identities = 58/191 (30%), Positives = 90/191 (47%), Gaps = 19/191 (9%)

Query: 193 THKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLG 250
           T  LG G FG V+K  +  TG  +A K+++       EE  NE+S + ++ H N++QL  
Sbjct: 94  TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153

Query: 251 FCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
                +   LV E++  G L DR I    ++                  G+ ++H    M
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRII----DESYNLTELDTILFMKQICEGIRHMH---QM 206

Query: 310 CILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
            ILH D+KP NIL    D   I K+ DFGLA+ +             GT  ++APE+++ 
Sbjct: 207 YILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVNF---GTPEFLAPEVVNY 262

Query: 367 NFGTVSCKSDV 377
           +F  VS  +D+
Sbjct: 263 DF--VSFPTDM 271

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  100 bits (252), Expect = 9e-24
 Identities = 57/237 (24%), Positives = 101/237 (42%), Gaps = 47/237 (19%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEF--------INEVSTIGRIHHVNV 245
           K+G+G +G V+K +   TG+++A+K     KF   E         + E+  + ++ H N+
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLKQLKHPNL 64

Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH- 304
           V LL       +  LV+E+  + ++   +   +   +      ++ I   T + V + H 
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCDH-TVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCHK 120

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPEL 363
           +      +H D+KP NIL+  + + K+ DFG A+      + +    ATR    Y +PEL
Sbjct: 121 HN----CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR---WYRSPEL 173

Query: 364 I--SRNFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP-SWVYDQLNK 416
           +     +G  V    DV+  G V  E+  G               +P     DQL  
Sbjct: 174 LVGDTQYGPPV----DVWAIGCVFAELLSGV------------PLWPGKSDVDQLYL 214

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =   99 bits (250), Expect = 1e-23
 Identities = 56/233 (24%), Positives = 104/233 (44%), Gaps = 38/233 (16%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKM--LENSK----FSAEEFINEVSTIGRIHHVNVVQ 247
           K+G+G +G+V+K +   T  ++A+K   L++       SA   + E+  +  + H N+V+
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA---LREICLLKELKHKNIVR 65

Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
           L        K  LV+EF     L ++    ++       E ++       +G+ + H   
Sbjct: 66  LHDVLHSDKKLTLVFEFCDQ-DLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCH--- 118

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISR 366
              +LH D+KP N+L++ N   K+++FGLA+ F      + +   T     Y  P+++  
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTL---WYRPPDVL-- 173

Query: 367 NFGTV--SCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP-SWVYDQLNK 416
            FG    S   D++  G +  E+A              +  FP + V DQL +
Sbjct: 174 -FGAKLYSTSIDMWSAGCIFAELANAG-----------RPLFPGNDVDDQLKR 214

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  102 bits (254), Expect = 1e-23
 Identities = 24/233 (10%), Positives = 64/233 (27%), Gaps = 41/233 (17%)

Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFINE--------------------- 233
           LGQ    +  +     TG    V +   ++      I +                     
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 234 -----VSTIGRIHHVNVVQLLGFCSEGSKRALVYEF--MP-----NGSLDRHIFPKENKG 281
                +     +      +++    +     ++  F   P       +    +    +  
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 282 QTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 341
           ++       ++ L   R +A LH      ++H  ++P +I+LD      ++ F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-RD 261

Query: 342 KENDFVSISATRGTIGYIAPELISR---NFGTVSCKSDVYGFGMVLLEMAGGR 391
             +    I          A  ++     +   ++   D +  G+ +  +    
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 51/238 (21%), Positives = 87/238 (36%), Gaps = 37/238 (15%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFIN-----EVSTIGRIHHVNVVQLL 249
           LG+G +G V +     T    AVK+L+  K             E+  + R+ H NV+QL+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 250 GFCSEGSKRA--LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR--------G 299
                  K+   +V E+   G  +  +     +       +        A         G
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK------RFPV---CQAHGYFCQLIDG 121

Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
           + YLH+     I+H DIKP N+LL      K+S  G+A+         +   ++G+  + 
Sbjct: 122 LEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178

Query: 360 APELISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNA----IRSSKAYFPSWV 410
            PE+ +        K D++  G+ L  +  G       N+      I       P   
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDC 236

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 98.8 bits (247), Expect = 2e-23
 Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 38/210 (18%)

Query: 188 VTNHFT--HKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSA-------EEFINEVSTI 237
           V +H+    +LG G F  V K  Q  TG+  A K ++  + S+       EE   EV+ +
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62

Query: 238 GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEI-ALG 295
             I H N++ L       +   L+ E +  G L D  +  K         E L E  A  
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDF-LAEK---------ESLTEDEATQ 112

Query: 296 TAR----GVAYLHNGCDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFV 347
             +    GV YLH      I HFD+KP NI+L    +P    K+ DFG+A      N+F 
Sbjct: 113 FLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK 169

Query: 348 SISATRGTIGYIAPELISRNFGTVSCKSDV 377
           +I    GT  ++APE+++     +  ++D+
Sbjct: 170 NIF---GTPEFVAPEIVNYEP--LGLEADM 194

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 99.6 bits (249), Expect = 3e-23
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 38/232 (16%)

Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEE-----FINEVSTIGRIHHVNVVQL 248
           KLG+G + +VYKG    T  L+A+K +   +   EE      I EVS +  + H N+V L
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLKHANIVTL 65

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
                      LV+E++    L +++   ++ G       ++       RG+AY H    
Sbjct: 66  HDIIHTEKSLTLVFEYLDK-DLKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCH---R 118

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI--S 365
             +LH D+KP N+L++     K++DFGLA+        + +   T     Y  P+++  S
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTL---WYRPPDILLGS 175

Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP-SWVYDQLNK 416
            ++ T   + D++G G +  EMA GR              FP S V +QL+ 
Sbjct: 176 TDYST---QIDMWGVGCIFYEMATGR------------PLFPGSTVEEQLHF 212

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 99.2 bits (248), Expect = 3e-23
 Identities = 69/236 (29%), Positives = 106/236 (44%), Gaps = 41/236 (17%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFIN-----EVSTIGRIHHVNVVQL 248
           KLG G + +VYKG    TG  +A+K +   K  +EE        E+S +  + H N+V+L
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 249 LGFCSEGSKRALVYEFMPN---GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
                  +K  LV+EFM N     +D       N  +      ++       +G+A+ H 
Sbjct: 69  YDVIHTENKLTLVFEFMDNDLKKYMDSR--TVGNTPRGLELNLVKYFQWQLLQGLAFCH- 125

Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI 364
             +  ILH D+KP N+L++     K+ DFGLA+ F    N F S   T     Y AP+++
Sbjct: 126 --ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL---WYRAPDVL 180

Query: 365 --SRNFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP-SWVYDQLNK 416
             SR + T +    D++  G +L EM  G            K  FP +   +QL  
Sbjct: 181 MGSRTYSTSI----DIWSCGCILAEMITG------------KPLFPGTNDEEQLKL 220

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 98.4 bits (246), Expect = 4e-23
 Identities = 51/182 (28%), Positives = 85/182 (46%), Gaps = 18/182 (9%)

Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLL 249
           F   LG G F  V+   Q  TG+L A+K ++ S    +  + NE++ + +I H N+V L 
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 250 GFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
                 +   LV + +  G L DR I  +      +  +    +       V YLH   +
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDR-ILERGV----YTEKDASLVIQQVLSAVKYLH---E 124

Query: 309 MCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
             I+H D+KP N+L    + N    ++DFGL+K   +     +     GT GY+APE+++
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTAC---GTPGYVAPEVLA 180

Query: 366 RN 367
           + 
Sbjct: 181 QK 182

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 99.3 bits (248), Expect = 5e-23
 Identities = 46/183 (25%), Positives = 75/183 (40%), Gaps = 20/183 (10%)

Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFINEVSTIGR-IHHVNVVQLL 249
               +G G +    +     T    AVK+++ SK    E   E+  + R   H N++ L 
Sbjct: 26  VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEILLRYGQHPNIITLK 82

Query: 250 GFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
               +G    +V E M  G L D+ I  ++     F   +   +     + V YLH    
Sbjct: 83  DVYDDGKYVYVVTELMKGGELLDK-ILRQKF----FSEREASAVLFTITKTVEYLH---A 134

Query: 309 MCILHFDIKPHNILL----DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
             ++H D+KP NIL      +    ++ DFG AK    EN  +       T  ++APE++
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC--YTANFVAPEVL 192

Query: 365 SRN 367
            R 
Sbjct: 193 ERQ 195

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  100 bits (250), Expect = 7e-23
 Identities = 45/184 (24%), Positives = 79/184 (42%), Gaps = 18/184 (9%)

Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQ 247
              +LG+G F  V +  ++  G+  A  ++   K SA   ++   E      + H N+V+
Sbjct: 15  LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74

Query: 248 LLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
           L    SE     L+++ +  G L +  I  +E     +               V + H  
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGELFED-IVAREY----YSEADASHCIQQILEAVLHCH-- 127

Query: 307 CDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
             M ++H ++KP N+LL         K++DFGLA     E       A  GT GY++PE+
Sbjct: 128 -QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPEV 184

Query: 364 ISRN 367
           + ++
Sbjct: 185 LRKD 188

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 98.4 bits (246), Expect = 7e-23
 Identities = 60/235 (25%), Positives = 102/235 (43%), Gaps = 43/235 (18%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKM--LENSKFSAEEF----INEVSTIGRIHHVNVVQ 247
            +G+G +G V K +   TGR++A+K     +     +      + E+  + ++ H N+V 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD---KMVKKIAMREIKLLKQLRHENLVN 88

Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH-NG 306
           LL  C +  +  LV+EF+ + ++   +   E       ++ +Q+       G+ + H + 
Sbjct: 89  LLEVCKKKKRWYLVFEFVDH-TILDDL---ELFPNGLDYQVVQKYLFQIINGIGFCHSHN 144

Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI- 364
               I+H DIKP NIL+  + + K+ DFG A+        +    ATR    Y APEL+ 
Sbjct: 145 ----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR---WYRAPELLV 197

Query: 365 -SRNFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP-SWVYDQLNK 416
               +G  V    DV+  G ++ EM  G               FP     DQL  
Sbjct: 198 GDVKYGKAV----DVWAIGCLVTEMFMGE------------PLFPGDSDIDQLYH 236

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 99.0 bits (247), Expect = 9e-23
 Identities = 47/197 (23%), Positives = 84/197 (42%), Gaps = 19/197 (9%)

Query: 188 VTNHFT--HKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFS-AEEFINEVSTIGRIHHV 243
           V +++    +LG G FG V++  +  TGR+   K +            NE+S + ++HH 
Sbjct: 49  VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHP 108

Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
            ++ L     +  +  L+ EF+  G L DR       +       ++         G+ +
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIA----AEDYKMSEAEVINYMRQACEGLKH 164

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIP--KVSDFGLAKFHPKENDFVSISATRGTIGYIA 360
           +H   +  I+H DIKP NI+ +       K+ DFGLA     +      +    T  + A
Sbjct: 165 MH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAA 218

Query: 361 PELISRNFGTVSCKSDV 377
           PE++ R    V   +D+
Sbjct: 219 PEIVDREP--VGFYTDM 233

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 51/182 (28%), Positives = 76/182 (41%), Gaps = 18/182 (9%)

Query: 196 LGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEE-FINEVSTIGRI-HHVNVVQLLGFC 252
           LG+G    V     L T +  AVK++E            EV  + +   H NV++L+ F 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
            E  +  LV+E M  GS+  HI  + +    F   +   +    A  + +LHN     I 
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKRRH----FNELEASVVVQDVASALDFLHN---KGIA 133

Query: 313 HFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATR-----GTIGYIAPELI 364
           H D+KP NIL    +     K+ DF L        D   IS        G+  Y+APE++
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193

Query: 365 SR 366
             
Sbjct: 194 EA 195

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 97.3 bits (243), Expect = 1e-22
 Identities = 59/201 (29%), Positives = 90/201 (44%), Gaps = 36/201 (17%)

Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSA-------EEFINEVSTIGRIHHVNVV 246
           +LG G F  V K  +  TG   A K ++  +  +       E+   EVS +  I H NV+
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 247 QLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEI-ALGTAR----GV 300
            L       +   L+ E +  G L D  +  KE+         L E  A    +    GV
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDF-LAEKES---------LTEEEATEFLKQILNGV 127

Query: 301 AYLHNGCDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTI 356
            YLH    + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT 
Sbjct: 128 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTP 181

Query: 357 GYIAPELISRNFGTVSCKSDV 377
            ++APE+++     +  ++D+
Sbjct: 182 EFVAPEIVNYEP--LGLEADM 200

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 46/197 (23%), Positives = 85/197 (43%), Gaps = 30/197 (15%)

Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSA---EEFINEVSTIGRI-HHVNVVQLL 249
           +LG+G F  V +     TG+  A K L+  +       E ++E++ +        V+ L 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 250 GFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEK-----LQEIALGTARGVAYL 303
                 S+  L+ E+   G +      P+  +  +   E      +++I      GV YL
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSL-CLPELAEMVS---ENDVIRLIKQIL----EGVYYL 147

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIP---KVSDFGLAKFHPKENDFVSISATRGTIGYIA 360
           H      I+H D+KP NILL   +     K+ DFG+++        +      GT  Y+A
Sbjct: 148 H---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELREIM--GTPEYLA 201

Query: 361 PELISRNFGTVSCKSDV 377
           PE+++ +   ++  +D+
Sbjct: 202 PEILNYDP--ITTATDM 216

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 46/187 (24%), Positives = 80/187 (42%), Gaps = 24/187 (12%)

Query: 194 HKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSA----------EEFINEVSTIGRI-H 241
             LG+G    V +     T +  AVK+++ +   +          E  + EV  + ++  
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82

Query: 242 HVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEIALGTARGV 300
           H N++QL       +   LV++ M  G L D  +  K         ++ ++I       +
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDY-LTEKVT----LSEKETRKIMRALLEVI 137

Query: 301 AYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 360
             LH    + I+H D+KP NILLD +   K++DFG +           +    GT  Y+A
Sbjct: 138 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC---GTPSYLA 191

Query: 361 PELISRN 367
           PE+I  +
Sbjct: 192 PEIIECS 198

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 99.5 bits (248), Expect = 3e-22
 Identities = 47/197 (23%), Positives = 86/197 (43%), Gaps = 19/197 (9%)

Query: 188 VTNHFT--HKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFI-NEVSTIGRIHHV 243
           V +H+    +LG G FG V++  +  TG   A K +     S +E +  E+ T+  + H 
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 214

Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
            +V L     + ++  ++YEFM  G L ++      ++      ++  E      +G+ +
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA----DEHNKMSEDEAVEYMRQVCKGLCH 270

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIP--KVSDFGLAKFHPKENDFVSISATRGTIGYIA 360
           +H   +   +H D+KP NI+         K+ DFGL          V ++   GT  + A
Sbjct: 271 MH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTT--GTAEFAA 324

Query: 361 PELISRNFGTVSCKSDV 377
           PE+       V   +D+
Sbjct: 325 PEVA--EGKPVGYYTDM 339

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 96.2 bits (240), Expect = 3e-22
 Identities = 55/261 (21%), Positives = 96/261 (36%), Gaps = 66/261 (25%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFIN---------------------- 232
           +G+G +G V      +     A+K+L   K   +                          
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 233 -----EVSTIGRIHHVNVVQLLGFCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFG 285
                E++ + ++ H NVV+L+    + ++  L  V+E +  G +               
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLK---- 132

Query: 286 WEKLQEIALGTAR--------GVAYLH-NGCDMCILHFDIKPHNILLDHNFIPKVSDFGL 336
              L E     AR        G+ YLH       I+H DIKP N+L+  +   K++DFG+
Sbjct: 133 --PLSE---DQARFYFQDLIKGIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFGV 183

Query: 337 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS-CKSDVYGFGMVLLEMAGGR---R 392
           +      +  +S +   GT  ++APE +S      S    DV+  G+ L     G+    
Sbjct: 184 SNEFKGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241

Query: 393 NSNMNA----IRSSKAYFPSW 409
           +  +      I+S    FP  
Sbjct: 242 DERIMCLHSKIKSQALEFPDQ 262

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 96.7 bits (241), Expect = 4e-22
 Identities = 52/182 (28%), Positives = 75/182 (41%), Gaps = 29/182 (15%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
           +G G FG     +   T  L+AVK +E      E    E+     + H N+V+       
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87

Query: 255 GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR--------GVAYLHNG 306
            +  A++ E+   G L   I    N G      +  E     AR        GV+Y H+ 
Sbjct: 88  PTHLAIIMEYASGGELYERI---CNAG------RFSE---DEARFFFQQLLSGVSYCHS- 134

Query: 307 CDMCILHFDIKPHNILLDHNFIP--KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
             M I H D+K  N LLD +  P  K+ DFG +K     +     +   GT  YIAPE++
Sbjct: 135 --MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTV--GTPAYIAPEVL 189

Query: 365 SR 366
            R
Sbjct: 190 LR 191

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 95.8 bits (239), Expect = 5e-22
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 16/178 (8%)

Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFC 252
            LG+G F    K     + +  AVK++     +  +   E++ +     H N+V+L    
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--KEITALKLCEGHPNIVKLHEVF 75

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
            +     LV E +  G L   I  K++    F   +   I       V+++H   D+ ++
Sbjct: 76  HDQLHTFLVMELLNGGELFERIKKKKH----FSETEASYIMRKLVSAVSHMH---DVGVV 128

Query: 313 HFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
           H D+KP N+L    + N   K+ DFG A+  P +N  +       T+ Y APEL+++N
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC--FTLHYAAPELLNQN 184

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 95.6 bits (238), Expect = 7e-22
 Identities = 47/187 (25%), Positives = 76/187 (40%), Gaps = 29/187 (15%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFIN---------EVSTIGRIHHVNV 245
           LG G FG V+        + + VK ++  K   + +I          E++ + R+ H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 246 VQLLGFCSEGSKRALVYEFMPNGS-----LDRHIFPKENKGQTFGWEKLQEIALGTARGV 300
           +++L          LV E   +G      +DRH    E           +++       V
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYI----FRQLV----SAV 143

Query: 301 AYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 360
            YL       I+H DIK  NI++  +F  K+ DFG A +  +           GTI Y A
Sbjct: 144 GYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAY-LERGKLFYTFC--GTIEYCA 197

Query: 361 PELISRN 367
           PE++  N
Sbjct: 198 PEVLMGN 204

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 96.7 bits (241), Expect = 8e-22
 Identities = 44/196 (22%), Positives = 82/196 (41%), Gaps = 36/196 (18%)

Query: 191 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEE---------FINEVSTIGRI 240
             +  LG G  G V    +  T + +A++++   KF+               E+  + ++
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197

Query: 241 HHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQE-----IAL 294
           +H  ++++  F  +     +V E M  G L D+ +             +L+E        
Sbjct: 198 NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV----GNK------RLKEATCKLYFY 246

Query: 295 GTARGVAYLHNGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISA 351
                V YLH   +  I+H D+KP N+LL   + + + K++DFG +K    E   +    
Sbjct: 247 QMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC 302

Query: 352 TRGTIGYIAPELISRN 367
             GT  Y+APE++   
Sbjct: 303 --GTPTYLAPEVLVSV 316

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 32/216 (14%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKM--LENSK----FSAEEFINEVSTIGRIHHVNVVQ 247
           K+GQG FG V+K +   TG+ +A+K   +EN K     +A   + E+  +  + H NVV 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA---LREIKILQLLKHENVVN 80

Query: 248 LLGFCSEGSKRA--------LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARG 299
           L+  C   +           LV++F  +  L   +    N    F   +++ +      G
Sbjct: 81  LIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL---SNVLVKFTLSEIKRVMQMLLNG 136

Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--TIG 357
           + Y+H      ILH D+K  N+L+  + + K++DFGLA+      +      T    T+ 
Sbjct: 137 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 193

Query: 358 YIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           Y  PEL+   R++G      D++G G ++ EM    
Sbjct: 194 YRPPELLLGERDYGP---PIDLWGAGCIMAEMWTRS 226

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 42/207 (20%)

Query: 181 SYPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEE---------F 230
            YP+ +      +  LG G  G V    +  T + +A+K++   KF+             
Sbjct: 3   VYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNV 62

Query: 231 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKL 289
             E+  + +++H  ++++  F  +     +V E M  G L D+ +             +L
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV----GNK------RL 111

Query: 290 QEIALGTAR--------GVAYLHNGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAK 338
           +E    T +         V YLH   +  I+H D+KP N+LL   + + + K++DFG +K
Sbjct: 112 KE---ATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165

Query: 339 FHPKENDFVSISATRGTIGYIAPELIS 365
               E   +      GT  Y+APE++ 
Sbjct: 166 IL-GETSLMRTLC--GTPTYLAPEVLV 189

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 93.8 bits (234), Expect = 2e-21
 Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 29/231 (12%)

Query: 196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVVQLLG 250
           LG+G F +V   +   T R  A+K+LE      E  +     E   + R+ H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQ----EIALGTARGVAYLHNG 306
              +  K      +  NG L ++I     K  +F     +    EI       + YLH  
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSA----LEYLH-- 147

Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
               I+H D+KP NILL+ +   +++DFG AK    E+     ++  GT  Y++PEL++ 
Sbjct: 148 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206

Query: 367 NFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNA----IRSSKAYFPSWV 410
                S  SD++  G ++ ++  G    R  N       I   +  FP   
Sbjct: 207 KSACKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKF 255

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 51/234 (21%), Positives = 93/234 (39%), Gaps = 38/234 (16%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFIN---EVSTIGRIHHVNVVQLLGF 251
           +G+G F  V   + + TGR +A+K+++ ++ +         EV  +  ++H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR--------GVAYL 303
                   L+ E+   G +  ++      G      +++E     AR         V Y 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYL---VAHG------RMKE---KEARSKFRQIVSAVQYC 130

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
           H      I+H D+K  N+LLD +   K++DFG +         +      G   Y APEL
Sbjct: 131 HQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAFC--GAPPYAAPEL 184

Query: 364 ISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNA----IRSSKAYFPSWV 410
                     + DV+  G++L  +  G       N+      +   K   P ++
Sbjct: 185 FQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYM 237

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 17/180 (9%)

Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
              +LG+G    VY+  Q  T +  A+K+L+ +    +    E+  + R+ H N+++L  
Sbjct: 57  VESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKE 115

Query: 251 FCSEGSKRALVYEFMPNGSL-DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
                ++ +LV E +  G L DR I  K      +      +        VAYLH   + 
Sbjct: 116 IFETPTEISLVLELVTGGELFDR-IVEKGY----YSERDAADAVKQILEAVAYLH---EN 167

Query: 310 CILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
            I+H D+KP N+L      +   K++DFGL+K    +    ++    GT GY APE++  
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC---GTPGYCAPEILRG 224

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 91.5 bits (228), Expect = 6e-21
 Identities = 60/235 (25%), Positives = 104/235 (44%), Gaps = 39/235 (16%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFIN----EVSTIGRIHHVNVVQLLG 250
           LG G FG V  G+   TG  +AVK+L   K  + + +     E+  +    H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR--------GVAY 302
             S  +   +V E++  G L  +I      G      +++E     AR         V Y
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYIC---KHG------RVEE---MEARRLFQQILSAVDY 126

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
            H      ++H D+KP N+LLD +   K++DFGL+     + +F+  S   G+  Y APE
Sbjct: 127 CHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRTSC--GSPNYAAPE 180

Query: 363 LISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNA----IRSSKAYFPSWV 410
           +IS        + D++  G++L  +  G     + ++      IR    Y P ++
Sbjct: 181 VISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYL 234

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 93.2 bits (232), Expect = 7e-21
 Identities = 47/190 (24%), Positives = 81/190 (42%), Gaps = 31/190 (16%)

Query: 194 HKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSA---------EEFINEVSTIGRIH-H 242
             +G+G    V +     TG   AVK++E +             E    E   + ++  H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159

Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPK----ENKGQTFGWEKLQEIALGTA 297
            +++ L+      S   LV++ M  G L D  +  K    E + ++     ++ +     
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDY-LTEKVALSEKETRSI----MRSL----L 210

Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
             V++LH      I+H D+KP NILLD N   ++SDFG +           +    GT G
Sbjct: 211 EAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC---GTPG 264

Query: 358 YIAPELISRN 367
           Y+APE++  +
Sbjct: 265 YLAPEILKCS 274

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 92.3 bits (229), Expect = 9e-21
 Identities = 46/301 (15%), Positives = 94/301 (31%), Gaps = 51/301 (16%)

Query: 178 KRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTI 237
            +  +P I+   N +     +     + +  L            +   +    I  +   
Sbjct: 59  AKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPF 118

Query: 238 GRIHHVNVVQLLGFCSEGSKRALVY---EFMPNGSLDRHIFPKENKGQTFG-----WEKL 289
              + V            S +  +Y   +     +L   +                    
Sbjct: 119 STKNTVG------QLQPSSPKVYLYIQMQLCRKENLKDWM--NRRCSLEDREHGVCLHIF 170

Query: 290 QEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 349
            +IA      V +LH      ++H D+KP NI    + + KV DFGL     ++ +  ++
Sbjct: 171 IQIAEA----VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223

Query: 350 SATR----------GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAI 399
                         GT  Y++PE I  N    S K D++  G++L E+     ++ M  +
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQIHGN--NYSHKVDIFSLGLILFELLYS-FSTQMERV 280

Query: 400 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
           R         +   +             + +    +  M+    +     +RP  T ++E
Sbjct: 281 R---------IITDVRNL------KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325

Query: 460 M 460
            
Sbjct: 326 N 326

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 43.7 bits (103), Expect = 9e-05
 Identities = 15/57 (26%), Positives = 30/57 (52%), Gaps = 3/57 (5%)

Query: 194 HKLGQGGFGSVYKGQ-LHTGRLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQ 247
             +G+GGFG V++ +        A+K   L N + + E+ + EV  + ++ H  +V+
Sbjct: 12  QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR 68

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 94.5 bits (235), Expect = 9e-21
 Identities = 59/237 (24%), Positives = 94/237 (39%), Gaps = 35/237 (14%)

Query: 196 LGQGGFGSVYKGQLH-TGRLIAVKMLE----NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           LG+GGFG V+  Q+  TG+L A K L       +   +  + E   + ++H   +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251

Query: 251 FCSE-GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQ----EIALGTARGVAYLHN 305
           +  E  +   LV   M  G +  HI+  +     F   +      +I  G    + +LH 
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQ 307

Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIAPELI 364
                I++ D+KP N+LLD +   ++SD GLA                 GT G++APEL+
Sbjct: 308 ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK---GYAGTPGFMAPELL 361

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGGR-----RNSNMN------AIRSSKAYFPSWV 410
                  S   D +  G+ L EM   R     R   +        +      +P   
Sbjct: 362 LGEEYDFSV--DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKF 416

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 92.3 bits (230), Expect = 1e-20
 Identities = 61/245 (24%), Positives = 100/245 (40%), Gaps = 59/245 (24%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKM--LENSK----FSAEEFINEVSTIGRIHHVNVVQ 247
           KLG+G +G VYK     T   +A+K   LE+ +     +A   I EVS +  + H N+++
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA---IREVSLLKELQHRNIIE 97

Query: 248 LLGFCSEGSKRALVYEFMPN---GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
           L        +  L++E+  N     +D++        ++F ++ +         GV + H
Sbjct: 98  LKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLI--------NGVNFCH 149

Query: 305 NGCDMCILHFDIKPHNILLDHNFIP-----KVSDFGLAK-FHPKENDF----VSISATRG 354
                  LH D+KP N+LL  +        K+ DFGLA+ F      F    +       
Sbjct: 150 ---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII------- 199

Query: 355 TIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP-SWVY 411
           T+ Y  PE++  SR++ T     D++    +  EM                  FP     
Sbjct: 200 TLWYRPPEILLGSRHYST---SVDIWSIACIWAEMLMK------------TPLFPGDSEI 244

Query: 412 DQLNK 416
           DQL K
Sbjct: 245 DQLFK 249

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 91.6 bits (228), Expect = 1e-20
 Identities = 74/310 (23%), Positives = 114/310 (36%), Gaps = 78/310 (25%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGR-----------IHHV 243
           LG+GGFG+V+ G  L     +A+K++  ++      +++  T                H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 244 NVVQLLGFCSEGSKRALVYEF-MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR---- 298
            V++LL +        LV E  +P   L  +I     KG       L E   G +R    
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYI---TEKG------PLGE---GPSRCFFG 146

Query: 299 ----GVAYLHNGCDMCILHFDIKPHNILLD--HNFIPKVSDFGLAKFHPKEN--DFVSIS 350
                + + H      ++H DIK  NIL+D       K+ DFG       E   DF    
Sbjct: 147 QVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCA-KLIDFGSGALLHDEPYTDFD--- 199

Query: 351 ATRGTIGYIAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNAIRSSKAYFP 407
              GT  Y  PE ISR+         + V+  G++L +M  G         I  ++ +FP
Sbjct: 200 ---GTRVYSPPEWISRHQYHAL---PATVWSLGILLYDMVCGDIPFERDQEILEAELHFP 253

Query: 408 SWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE---MLEGS 464
           + V                   S     L  I   C+  K + RPS+ ++L    M   +
Sbjct: 254 AHV-------------------SPDCCAL--IR-RCLAPKPSSRPSLEEILLDPWMQTPA 291

Query: 465 MDDLQMPPKP 474
            D    P K 
Sbjct: 292 EDVPLNPSKG 301

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 58/244 (23%), Positives = 102/244 (41%), Gaps = 38/244 (15%)

Query: 190 NHFT-HK-LGQGGFGSVYKGQL-HTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHH 242
           +HF   + +G+G FG V   Q   T ++ A+K +   K            E+  +  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 243 VNVVQLLG-FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQ----EIALGTA 297
             +V L   F  E     +V + +  G L  H+     +   F  E ++    E+ +   
Sbjct: 75  PFLVNLWYSFQDE-EDMFMVVDLLLGGDLRYHL----QQNVHFKEETVKLFICELVMA-- 127

Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
             + YL    +  I+H D+KP NILLD +    ++DF +A   P+E    +++   GT  
Sbjct: 128 --LDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKP 179

Query: 358 YIAPELISRNFGTVSCKS-DVYGFGMVLLEMAGGRR----------NSNMNAIRSSKAYF 406
           Y+APE+ S   G     + D +  G+   E+  GRR             ++   ++   +
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY 239

Query: 407 PSWV 410
           PS  
Sbjct: 240 PSAW 243

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 90.9 bits (226), Expect = 3e-20
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 32/186 (17%)

Query: 195 KLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFC 252
            LG G  G V +     TG+  A+K+L +S     +   EV    +     ++V +L   
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVY 91

Query: 253 SEGSKRA----LVYEFMPNGSLDRHIFPKENKGQTFGWEK-----LQEIALGTARGVAYL 303
                      ++ E M  G L   I  + ++  T   E+     +++I       + +L
Sbjct: 92  ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFT---EREAAEIMRDIG----TAIQFL 144

Query: 304 HNGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 360
           H      I H D+KP N+L    + + + K++DFG AK    +N   +      T  Y+A
Sbjct: 145 H---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE-TTQNALQTPC---YTPYYVA 197

Query: 361 PELISR 366
           PE++  
Sbjct: 198 PEVLGP 203

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 91.7 bits (228), Expect = 3e-20
 Identities = 46/189 (24%), Positives = 75/189 (39%), Gaps = 31/189 (16%)

Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLL 249
            +  LG G  G V +     T    A+KML++      +   EV    R     ++V+++
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIV 121

Query: 250 GFCSEGSKRA----LVYEFMPNGSLDRHIFPKENKGQTFGWEK-----LQEIALGTARGV 300
                         +V E +  G L   I  + ++  T   E+     ++ I       +
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT---EREASEIMKSIG----EAI 174

Query: 301 AYLHNGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 357
            YLH    + I H D+KP N+L      N I K++DFG AK     N   +      T  
Sbjct: 175 QYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC---YTPY 228

Query: 358 YIAPELISR 366
           Y+APE++  
Sbjct: 229 YVAPEVLGP 237

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 90.6 bits (225), Expect = 7e-20
 Identities = 52/241 (21%), Positives = 93/241 (38%), Gaps = 31/241 (12%)

Query: 168 FLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ---LHTGRLIAVKMLENSK 224
           F     S   +     E          K+G+G +G VYK +       +  A+K +E + 
Sbjct: 7   FKVKLSSERERVEDLFEYEG------CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG 60

Query: 225 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA--LVYEFMPN---GSLDRHIFPKEN 279
            S      E++ +  + H NV+ L       + R   L++++  +     +  H   K N
Sbjct: 61  ISMSA-CREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN 119

Query: 280 KGQT-FGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL----DHNFIPKVSDF 334
           K         ++ +      G+ YLH      +LH D+KP NIL+          K++D 
Sbjct: 120 KKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM 176

Query: 335 GLA-KFHPKENDFVSISATRGTIGYIAPELI--SRNFGT-VSCKSDVYGFGMVLLEMAGG 390
           G A  F+        +     T  Y APEL+  +R++   +    D++  G +  E+   
Sbjct: 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTS 232

Query: 391 R 391
            
Sbjct: 233 E 233

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 89.2 bits (222), Expect = 7e-20
 Identities = 60/239 (25%), Positives = 102/239 (42%), Gaps = 41/239 (17%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKM--LENSKFSAEEF----INEVSTIGRIH---HVN 244
           ++G G +G+VYK +  H+G  +A+K   + N            + EV+ + R+    H N
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75

Query: 245 VVQLLGFCSEGSKRA-----LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARG 299
           VV+L+  C+           LV+E +     D   +  +        E ++++     RG
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 132

Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
           + +LH     CI+H D+KP NIL+      K++DFGLA+ +  +     +  T     Y 
Sbjct: 133 LDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTL---WYR 186

Query: 360 APELISRNFG-TVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP-SWVYDQLNK 416
           APE++      T +   D++  G +  EM               K  F  +   DQL K
Sbjct: 187 APEVL---LQSTYATPVDMWSVGCIFAEMFRR------------KPLFCGNSEADQLGK 230

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 92.3 bits (229), Expect = 7e-20
 Identities = 65/292 (22%), Positives = 116/292 (39%), Gaps = 51/292 (17%)

Query: 151 LIHKYRTTLQTVDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFT------HK-LGQGGFGS 203
           L   Y   +      + F    +S    R+   + + +  H T      H+ +G+GGFG 
Sbjct: 145 LFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGE 204

Query: 204 VYKGQL-HTGRLIAVKMLE----NSKFSAEEFINE---VSTIGRIHHVNVVQLLGFCSEG 255
           VY  +   TG++ A+K L+      K      +NE   +S +       +V +       
Sbjct: 205 VYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264

Query: 256 SKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQ----EIALGTARGVAYLHNGCDMCI 311
            K + + + M  G L  H+    ++   F    ++    EI LG    + ++HN     +
Sbjct: 265 DKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILG----LEHMHN---RFV 313

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE--NDFVSISATRGTIGYIAPELISRNFG 369
           ++ D+KP NILLD +   ++SD GLA    K+  +  V      GT GY+APE++ +   
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV------GTHGYMAPEVLQKGVA 367

Query: 370 -TVSCKSDVYGFGMVLLEMAGGR----------RNSNMNAIRSSKAYFPSWV 410
              S   D +  G +L ++  G           ++       +     P   
Sbjct: 368 YDSSA--DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 417

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 90.2 bits (224), Expect = 8e-20
 Identities = 53/258 (20%), Positives = 100/258 (38%), Gaps = 67/258 (25%)

Query: 177 PKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFIN-EV 234
            K+YS  + +          G G FG V +   + +G+  A+K +         + N E+
Sbjct: 6   SKKYSLGKTL----------GTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNREL 51

Query: 235 STIGRIHHVNVVQLL-GFCSEGSKRA---------------------------------- 259
             +  + HVN+++L+  F + G +                                    
Sbjct: 52  DIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNK 111

Query: 260 ---LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDI 316
              ++ E++P+ +L + +      G++     +        R V ++H+   + I H DI
Sbjct: 112 YLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDI 167

Query: 317 KPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV--SC 373
           KP N+L++  +   K+ DFG AK        V+   +R    Y APEL+    G    + 
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR---FYRAPELM---LGATEYTP 221

Query: 374 KSDVYGFGMVLLEMAGGR 391
             D++  G V  E+  G+
Sbjct: 222 SIDLWSIGCVFGELILGK 239

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 72/291 (24%), Positives = 107/291 (36%), Gaps = 75/291 (25%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFIN-------EVSTIGRIHHV--NV 245
           LG GGFGSVY G  +     +A+K +E  + S    +        EV  + ++      V
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 246 VQLLGFCSEGSKRALVYEF-MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR------ 298
           ++LL +        L+ E   P   L   I     +G       LQE     AR      
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERG------ALQE---ELARSFFWQV 158

Query: 299 --GVAYLHNGCDMCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKE--NDFVSISATR 353
              V + HN     +LH DIK  NIL+D N    K+ DFG           DF       
Sbjct: 159 LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------ 209

Query: 354 GTIGYIAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNAIRSSKAYFPS 408
           GT  Y  PE I  +   G     + V+  G++L +M  G     +     I   + +F  
Sbjct: 210 GTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGDIPFEHD--EEIIRGQVFFRQ 264

Query: 409 WVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
            V                   S   + L  I  WC+ ++ +DRP+  ++  
Sbjct: 265 RV-------------------SSECQHL--IR-WCLALRPSDRPTFEEIQN 293

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 89.1 bits (221), Expect = 4e-19
 Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 39/235 (16%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFIN----EVSTIGRIHHVNVVQLLG 250
           LG G FG V  G+   TG  +AVK+L   K  + + +     E+  +    H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR--------GVAY 302
             S  S   +V E++  G L  +I      G      +L E     +R        GV Y
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYIC---KNG------RLDE---KESRRLFQQILSGVDY 131

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
            H      ++H D+KP N+LLD +   K++DFGL+     + +F+  S   G+  Y APE
Sbjct: 132 CHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRTSC--GSPNYAAPE 185

Query: 363 LISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNA----IRSSKAYFPSWV 410
           +IS        + D++  G++L  +  G     + ++      I     Y P ++
Sbjct: 186 VISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYL 239

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 85.3 bits (212), Expect = 2e-18
 Identities = 51/214 (23%), Positives = 96/214 (44%), Gaps = 32/214 (14%)

Query: 195 KLGQGGFGSVYKGQ--LHTGRLIAVKM--LENSK----FSAEEFINEVST---IGRIHHV 243
           ++G+G +G V+K +   + GR +A+K   ++  +     S    I EV+    +    H 
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST---IREVAVLRHLETFEHP 74

Query: 244 NVVQLL-----GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR 298
           NVV+L            +K  LV+E +     D   +  +        E ++++     R
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHV---DQDLTTYLDKVPEPGVPTETIKDMMFQLLR 131

Query: 299 GVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 358
           G+ +LH      ++H D+KP NIL+  +   K++DFGLA+ +  +    S+  T     Y
Sbjct: 132 GLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL---WY 185

Query: 359 IAPELISRNFG-TVSCKSDVYGFGMVLLEMAGGR 391
            APE++      + +   D++  G +  EM   +
Sbjct: 186 RAPEVL---LQSSYATPVDLWSVGCIFAEMFRRK 216

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 54/231 (23%), Positives = 100/231 (43%), Gaps = 39/231 (16%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLG-F 251
           KLG+G +  V++   +     + VK+L+      ++   E+  +  +    N++ L    
Sbjct: 43  KLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIV 100

Query: 252 CSEGSKR-ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
               S+  ALV+E + N    +         QT     ++       + + Y H+   M 
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHS---MG 150

Query: 311 ILHFDIKPHNILLDH-NFIPKVSDFGLAKF-HPKE--NDFVSISATRGTIGYIAPELISR 366
           I+H D+KPHN+++DH +   ++ D+GLA+F HP +  N  V   A+R    +  PEL+  
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---ASR---YFKGPELLV- 203

Query: 367 NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP-SWVYDQLNK 416
           ++       D++  G +L  M   +             +F     YDQL +
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKE-----------PFFHGHDNYDQLVR 243

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 40/235 (17%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFIN----EVSTIGRIHHVNVVQLLG 250
           LG+G FG V       T + +A+K +        +       E+S +  + H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR--------GVAY 302
             +  +   +V E+   G L  +I     K       ++ E      R         + Y
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYIV---EKK------RMTE---DEGRRFFQQIICAIEY 123

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
            H      I+H D+KP N+LLD N   K++DFGL+     + +F+  S   G+  Y APE
Sbjct: 124 CHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNI-MTDGNFLKTSC--GSPNYAAPE 177

Query: 363 LISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNA----IRSSKAYFPSWV 410
           +I+        + DV+  G+VL  M  GR    +  +      + S     P ++
Sbjct: 178 VINGK-LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFL 231

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 83.6 bits (207), Expect = 4e-18
 Identities = 30/294 (10%), Positives = 73/294 (24%), Gaps = 73/294 (24%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLE----NSKFSAEEFINEVSTIGRIHHVNVVQLL 249
             G       ++       R +A+  ++          +E ++    + RI    V ++L
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 250 GFCSEGSKRALVYEFMPNGSL----DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH- 304
                 +   +V E++  GSL    D    P                    A      H 
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG----------AIRAMQSLAAAADAAHR 147

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
            G    +      P  + +  +    ++                          +     
Sbjct: 148 AG----VALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPD--- 178

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGGR----RNSNMNAIRSSKAYFPSWVYDQLNKGGDL 420
                  + + D+ G G  L  +   R         + +                +    
Sbjct: 179 ------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------PAERDTAG 220

Query: 421 ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKV--LEMLEGSMDDLQMPP 472
           +     +I+  I  ++  +    +Q     R + T +  ++      D  ++  
Sbjct: 221 QPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLG 274

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 86.0 bits (213), Expect = 6e-18
 Identities = 65/206 (31%), Positives = 92/206 (44%), Gaps = 25/206 (12%)

Query: 196 LGQGGFGSVYKGQL-HTGRLIAVKMLE----NSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           LG+GGFG V   Q+  TG++ A K LE      +      +NE   + +++   VV L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQ----EIALGTARGVAYLHNG 306
                    LV   M  G L  HI+     G  F   +      EI  G    +  LH  
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAG--FPEARAVFYAAEICCG----LEDLH-- 303

Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIAPELIS 365
               I++ D+KP NILLD +   ++SD GLA  H  E   +     R GT+GY+APE++ 
Sbjct: 304 -RERIVYRDLKPENILLDDHGHIRISDLGLAV-HVPEGQTIK---GRVGTVGYMAPEVVK 358

Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGR 391
               T S   D +  G +L EM  G+
Sbjct: 359 NERYTFSP--DWWALGCLLYEMIAGQ 382

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 83.6 bits (207), Expect = 2e-17
 Identities = 53/243 (21%), Positives = 92/243 (37%), Gaps = 40/243 (16%)

Query: 196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSKFS------AEEFINEVSTIGRIHHVNVVQL 248
           +G+G F  V   ++  TG++ A+K++  +K+          F  E   +       + QL
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIM--NKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126

Query: 249 LGFCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFGWEKLQ----EIALGTARGVAY 302
               +   +  L  V E+   G L   +      G+    E  +    EI +     +  
Sbjct: 127 --HFAFQDENYLYLVMEYYVGGDLLTLL---SKFGERIPAEMARFYLAEIVMA----IDS 177

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
           +H    +  +H DIKP NILLD     +++DFG       +    S+ A  GT  Y++PE
Sbjct: 178 VHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPE 233

Query: 363 LISRNFGTVSCKS-----DVYGFGMVLLEMAGGR-------RNSNMNAIRSSKAYFPSWV 410
           ++    G     S     D +  G+   EM  G+              I   K +    +
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL 293

Query: 411 YDQ 413
            D+
Sbjct: 294 VDE 296

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 82.5 bits (204), Expect = 4e-17
 Identities = 51/235 (21%), Positives = 88/235 (37%), Gaps = 38/235 (16%)

Query: 196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSKFS------AEEFINEVSTIGRIHHVNVVQL 248
           +G+G FG V   +L +  ++ A+K+L  +K+          F  E   +       +  L
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKIL--NKWEMLKRAETACFREERDVLVNGDSKWITTL 139

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQ----EIALGTARGVAYLH 304
                + +   LV ++   G L   +            E  +    E+ +     +  +H
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLL---SKFEDRLPEEMARFYLAEMVIA----IDSVH 192

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
               +  +H DIKP NIL+D N   +++DFG      ++    S  A  GT  YI+PE++
Sbjct: 193 Q---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEIL 248

Query: 365 SRNFG-----TVSCKSDVYGFGMVLLEMAGGR-------RNSNMNAIRSSKAYFP 407
               G        C  D +  G+ + EM  G               I + K  F 
Sbjct: 249 QAMEGGKGRYGPEC--DWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ 301

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 81.1 bits (201), Expect = 5e-17
 Identities = 66/245 (26%), Positives = 106/245 (43%), Gaps = 57/245 (23%)

Query: 196 LGQGGFGSVY----KGQLHTGRLIAVKMLENSKFSAEEFI---NEVSTIG------RIHH 242
           LGQG FG V+           +L A+K+L   K      +   + V T         ++H
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVL--KK----ATLKVRDRVRTKMERDILVEVNH 85

Query: 243 VNVVQLLGFCS--EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQ----EIALGT 296
             +V+L    +     K  L+ +F+  G L   +    +K   F  E ++    E+AL  
Sbjct: 86  PFIVKL--HYAFQTEGKLYLILDFLRGGDLFTRL----SKEVMFTEEDVKFYLAELALA- 138

Query: 297 ARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR-- 353
              + +LH    + I++ D+KP NILLD    I K++DFGL+K                 
Sbjct: 139 ---LDHLH---SLGIIYRDLKPENILLDEEGHI-KLTDFGLSKESIDHEKK-----AYSF 186

Query: 354 -GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNAIRSSKAY 405
            GT+ Y+APE+++R   T S   D + FG+++ EM  G        R   M  I  +K  
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSA--DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG 244

Query: 406 FPSWV 410
            P ++
Sbjct: 245 MPQFL 249

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 59/211 (27%), Positives = 91/211 (43%), Gaps = 32/211 (15%)

Query: 196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSKFS------AEEFINEVSTIGRIHHVNVVQL 248
           +G+G FG V   +   T ++ A+K+L  SKF       +  F  E   +   +   VVQL
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLL--SKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134

Query: 249 LGFCSEGSKRALVYEFMPNGSL----DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
                +     +V E+MP G L      +  P E   + +      E+ L     +  +H
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP-EKWARFY----TAEVVLA----LDAIH 185

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
           +   M  +H D+KP N+LLD +   K++DFG      KE      +A  GT  YI+PE++
Sbjct: 186 S---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVL 241

Query: 365 SRNFG----TVSCKSDVYGFGMVLLEMAGGR 391
               G       C  D +  G+ L EM  G 
Sbjct: 242 KSQGGDGYYGREC--DWWSVGVFLYEMLVGD 270

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 78.4 bits (194), Expect = 4e-16
 Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 51/243 (20%)

Query: 196 LGQGGFGSVY----KGQLHTGRLIAVKMLENSKFSAEEFINEV-STIG------RIHHVN 244
           LG+GG+G V+        +TG++ A+K+L   K        +   T         + H  
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVL--KKAMIVRNAKDTAHTKAERNILEEVKHPF 82

Query: 245 VVQLLGFCS--EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEK----LQEIALGTAR 298
           +V L    +   G K  L+ E++  G L   +     +   F  +     L EI++    
Sbjct: 83  IVDL--IYAFQTGGKLYLILEYLSGGELFMQL----EREGIFMEDTACFYLAEISMA--- 133

Query: 299 GVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR---G 354
            + +LH      I++ D+KP NI+L+H   + K++DFGL K    +        T    G
Sbjct: 134 -LGHLH---QKGIIYRDLKPENIMLNHQGHV-KLTDFGLCKESIHDGT-----VTHTFCG 183

Query: 355 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNAIRSSKAYFP 407
           TI Y+APE++ R+    +   D +  G ++ +M  G        R   ++ I   K   P
Sbjct: 184 TIEYMAPEILMRSGHNRAV--DWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP 241

Query: 408 SWV 410
            ++
Sbjct: 242 PYL 244

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 79.4 bits (196), Expect = 4e-16
 Identities = 60/239 (25%), Positives = 101/239 (42%), Gaps = 46/239 (19%)

Query: 196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEV-STIG------RIHHVNVVQ 247
           LG+G FG V   +   TGR  A+K+L+     A+   +EV  T+          H  +  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK---DEVAHTLTENRVLQNSRHPFLTA 212

Query: 248 LLGFCS--EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQ----EIALGTARGVA 301
           L    S     +   V E+   G L  H+    ++ + F  ++ +    EI       + 
Sbjct: 213 L--KYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSA----LD 262

Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR---GTIGY 358
           YLH+  +  +++ D+K  N++LD +   K++DFGL K   K+         +   GT  Y
Sbjct: 263 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-----TMKTFCGTPEY 315

Query: 359 IAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNAIRSSKAYFPSWV 410
           +APE++  N    +   D +G G+V+ EM  GR              I   +  FP  +
Sbjct: 316 LAPEVLEDNDYGRAV--DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL 372

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 62/268 (23%), Positives = 108/268 (40%), Gaps = 39/268 (14%)

Query: 163 DNIEKFLHNQQSWMPKRYSYPEIIAVT-NHFTHK--LGQGGFGSVYKGQL-HTGRLIAVK 218
           +++++FL   +    K++  P       + F     LG G FG V   +   +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72

Query: 219 MLENSKFSA----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132

Query: 275 FPKENKGQTFGWEKLQ----EIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPK 330
                +   F     +    +I L       YLH    + +++ D+KP N+L+D     +
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLT----FEYLH---SLDLIYRDLKPENLLIDQQGYIQ 181

Query: 331 VSDFGLAKFHP-KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG 389
           V+DFG AK    +           GT   +APE+I       +   D +  G+++ EMA 
Sbjct: 182 VTDFGFAKRVKGRTWTLC------GTPEALAPEIILSKGYNKAV--DWWALGVLIYEMAA 233

Query: 390 GR-------RNSNMNAIRSSKAYFPSWV 410
           G               I S K  FPS  
Sbjct: 234 GYPPFFADQPIQIYEKIVSGKVRFPSHF 261

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 77.2 bits (191), Expect = 9e-16
 Identities = 63/235 (26%), Positives = 101/235 (42%), Gaps = 42/235 (17%)

Query: 196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 250
           LG G FG V+  +  H GR  A+K+L+          E   +E   +  + H  ++++ G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQ----EIALGTARGVAYLHNG 306
              +  +  ++ +++  G L   +     K Q F     +    E+ L     + YLH  
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLL----RKSQRFPNPVAKFYAAEVCLA----LEYLH-- 123

Query: 307 CDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR---GTIGYIAPE 362
               I++ D+KP NILLD N  I K++DFG AK      D      T    GT  YIAPE
Sbjct: 124 -SKDIIYRDLKPENILLDKNGHI-KITDFGFAK---YVPD-----VTYTLCGTPDYIAPE 173

Query: 363 LISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNAIRSSKAYFPSWV 410
           ++S      S   D + FG+++ EM  G               I +++  FP + 
Sbjct: 174 VVSTKPYNKSI--DWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFF 226

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 61/240 (25%), Positives = 98/240 (40%), Gaps = 49/240 (20%)

Query: 196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEV-STIG------RIHHVNVVQ 247
           LG+G FG V   +   TGR  A+K+L      A+   +EV  T+          H  +  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAK---DEVAHTVTESRVLQNTRHPFLTA 69

Query: 248 LLGFCS--EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQ----EIALGTARGVA 301
           L    +     +   V E+   G L  H+    ++ + F  E+ +    EI       + 
Sbjct: 70  L--KYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSA----LE 119

Query: 302 YLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR---GTIG 357
           YLH      +++ DIK  N++LD +  I K++DFGL K    +         +   GT  
Sbjct: 120 YLH---SRDVVYRDIKLENLMLDKDGHI-KITDFGLCKEGISDGA-----TMKTFCGTPE 170

Query: 358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNAIRSSKAYFPSWV 410
           Y+APE++  N    +   D +G G+V+ EM  GR              I   +  FP  +
Sbjct: 171 YLAPEVLEDNDYGRAV--DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTL 228

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 46/220 (20%), Positives = 96/220 (43%), Gaps = 36/220 (16%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHV---------- 243
           KLG G F +V+  + +     +A+K++   K   E   +E+  + R++            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 244 -NVVQLLG-FCSEGSKRA---LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTAR 298
            ++++LL  F  +G       +V+E +     +     K+ + +      +++I+     
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVL---GENLLALIKKYEHRGIPLIYVKQISKQLLL 142

Query: 299 GVAYLHNGCDMCILHFDIKPHNILLDH------NFIPKVSDFGLAKFHPKENDFVSISAT 352
           G+ Y+H  C   I+H DIKP N+L++           K++D G A +   +  + +   T
Sbjct: 143 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--YDEHYTNSIQT 198

Query: 353 RGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEMAGGR 391
           R    Y +PE++    G    C +D++    ++ E+  G 
Sbjct: 199 R---EYRSPEVL---LGAPWGCGADIWSTACLIFELITGD 232

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 76.1 bits (188), Expect = 3e-15
 Identities = 57/241 (23%), Positives = 92/241 (38%), Gaps = 50/241 (20%)

Query: 196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEV-STIG-------RIHHVNVV 246
           +G+G FG V   +        AVK+L+      +    E    +         + H  +V
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK---KEEKHIMSERNVLLKNVKHPFLV 102

Query: 247 QLLGFCS--EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQ----EIALGTARGV 300
            L    S     K   V +++  G L  H+     + + F   + +    EIA      +
Sbjct: 103 GL--HFSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARFYAAEIASA----L 152

Query: 301 AYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR---GTI 356
            YLH    + I++ D+KP NILLD    I  ++DFGL K + + N       T    GT 
Sbjct: 153 GYLH---SLNIVYRDLKPENILLDSQGHI-VLTDFGLCKENIEHNST-----TSTFCGTP 203

Query: 357 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNAIRSSKAYFPSW 409
            Y+APE++ +     +   D +  G VL EM  G             + I +        
Sbjct: 204 EYLAPEVLHKQPYDRTV--DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN 261

Query: 410 V 410
           +
Sbjct: 262 I 262

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 75.7 bits (187), Expect = 4e-15
 Identities = 63/243 (25%), Positives = 103/243 (42%), Gaps = 54/243 (22%)

Query: 196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFI---NEV-STIG--RI-----HHV 243
           LG+G FG V+  +   T +  A+K L   K    + +   ++V  T+   R+      H 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKAL--KK----DVVLMDDDVECTMVEKRVLSLAWEHP 78

Query: 244 NVVQLLG-FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQ----EIALGTAR 298
            +  +   F ++      V E++  G L  HI         F   +      EI LG   
Sbjct: 79  FLTHMFCTFQTK-ENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILG--- 130

Query: 299 GVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR---G 354
            + +LH      I++ D+K  NILLD +  I K++DFG+ K +   +       T    G
Sbjct: 131 -LQFLH---SKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAK-----TNTFCG 180

Query: 355 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNAIRSSKAYFP 407
           T  YIAPE++       S   D + FG++L EM  G+            ++IR    ++P
Sbjct: 181 TPDYIAPEILLGQKYNHSV--DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP 238

Query: 408 SWV 410
            W+
Sbjct: 239 RWL 241

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 75.8 bits (186), Expect = 9e-15
 Identities = 60/237 (25%), Positives = 97/237 (40%), Gaps = 42/237 (17%)

Query: 196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 249
           LG+G FG V   +   T  L AVK+L+      ++ +       R+         + QL 
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408

Query: 250 GFCSEGSKRA-LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQ----EIALGTARGVAYLH 304
             C +   R   V E++  G L  HI     +   F          EIA+G    + +L 
Sbjct: 409 -SCFQTMDRLYFVMEYVNGGDLMYHI----QQVGRFKEPHAVFYAAEIAIG----LFFLQ 459

Query: 305 NGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR---GTIGYIA 360
                 I++ D+K  N++LD    I K++DFG+ K +  +        T+   GT  YIA
Sbjct: 460 ---SKGIIYRDLKLDNVMLDSEGHI-KIADFGMCKENIWDGV-----TTKTFCGTPDYIA 510

Query: 361 PELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNAIRSSKAYFPSWV 410
           PE+I+      S   D + FG++L EM  G+        +    +I      +P  +
Sbjct: 511 PEIIAYQPYGKSV--DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM 565

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 67/242 (27%), Positives = 103/242 (42%), Gaps = 52/242 (21%)

Query: 196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFI---NEV-STIG--RI-----HHV 243
           LG+G FG V   ++  TG L AVK+L   K    + I   ++V  T+   RI     +H 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVL--KK----DVILQDDDVECTMTEKRILSLARNHP 84

Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQ----EIALGTARG 299
            + QL        +   V EF+  G L  HI     K + F   + +    EI       
Sbjct: 85  FLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI----QKSRRFDEARARFYAAEIISA---- 136

Query: 300 VAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR---GT 355
           + +LH   D  I++ D+K  N+LLDH     K++DFG+ K             T    GT
Sbjct: 137 LMFLH---DKGIIYRDLKLDNVLLDHEGHC-KLADFGMCKEGICNGVT-----TATFCGT 187

Query: 356 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNAIRSSKAYFPS 408
             YIAPE++       +   D +  G++L EM  G         +    AI + +  +P+
Sbjct: 188 PDYIAPEILQEMLYGPAV--DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT 245

Query: 409 WV 410
           W+
Sbjct: 246 WL 247

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 41/162 (25%), Positives = 66/162 (40%), Gaps = 30/162 (18%)

Query: 192 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLL 249
            +  LG G  G V +     T    A+KML++      +   EV    R     ++V+++
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIV 77

Query: 250 GFCSEGSKRA----LVYEFMPNGSL-DRHIFPKENKGQTFGWEK-----LQEIALGTARG 299
                         +V E +  G L  R I  + ++  T   E+     ++ I       
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSR-IQDRGDQAFT---EREASEIMKSIG----EA 129

Query: 300 VAYLHNGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAK 338
           + YLH    + I H D+KP N+L      N I K++DFG AK
Sbjct: 130 IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 73.0 bits (180), Expect = 3e-14
 Identities = 61/244 (25%), Positives = 99/244 (40%), Gaps = 56/244 (22%)

Query: 196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFI---NEV-STIG--RI-----HHV 243
           LG+G FG V   +   T  L AVK+L   K    + +   ++V  T+   R+        
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKIL--KK----DVVIQDDDVECTMVEKRVLALPGKPP 81

Query: 244 NVVQLLGFCS--EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQ----EIALGTA 297
            + QL          +   V E++  G L  HI     +   F          EIA+G  
Sbjct: 82  FLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHI----QQVGRFKEPHAVFYAAEIAIG-- 133

Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR--- 353
             + +L       I++ D+K  N++LD    I K++DFG+ K +  +        T+   
Sbjct: 134 --LFFLQ---SKGIIYRDLKLDNVMLDSEGHI-KIADFGMCKENIWDGV-----TTKTFC 182

Query: 354 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNAIRSSKAYF 406
           GT  YIAPE+I+      S   D + FG++L EM  G+        +    +I      +
Sbjct: 183 GTPDYIAPEIIAYQPYGKSV--DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY 240

Query: 407 PSWV 410
           P  +
Sbjct: 241 PKSM 244

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 72.3 bits (177), Expect = 6e-14
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 23/218 (10%)

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
           S+ S  +   E      ++    P++        E L   +   A+G+ +L      CI 
Sbjct: 159 SQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCI- 215

Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H D+   NILL    + K+ DFGLA+   K+ D+V     R  + ++APE I     T+ 
Sbjct: 216 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI- 274

Query: 373 CKSDVYGFGMVLLEMA--GGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL-RNVTEIE 429
            +SDV+ FG++L E+   G      +                +L +G  +      T   
Sbjct: 275 -QSDVWSFGVLLWEIFSLGASPYPGVKIDEE--------FCRRLKEGTRMRAPDYTTP-- 323

Query: 430 SVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD 467
                ++    L C   + + RP+ ++++E L   +  
Sbjct: 324 -----EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 39/158 (24%), Positives = 61/158 (38%), Gaps = 21/158 (13%)

Query: 191 HFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSKFSAE--EFINEVSTIGRI-H 241
                LG+G FG V +          T R +AVKML+     +E    ++E+  +  I H
Sbjct: 25  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84

Query: 242 HVNVVQLLGFCSEGSKRALV-YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGV 300
           H+NVV LLG C++     +V  EF   G+L            T+   K  E      +G 
Sbjct: 85  HLNVVNLLGACTKPGGPLMVIVEFCKFGNL-----------STYLRSKRNEFVPYKTKGA 133

Query: 301 AYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK 338
            +      +  +  D+K     +  +     S F   K
Sbjct: 134 RFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 72.5 bits (178), Expect = 7e-14
 Identities = 59/232 (25%), Positives = 96/232 (41%), Gaps = 52/232 (22%)

Query: 179 RYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTI 237
           RY   E++ V       +G+G FG V K       + +A+KM+ N K    +   E+  +
Sbjct: 98  RY---EVLKV-------IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRIL 147

Query: 238 GRIHHV------NVVQLLGF-------CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTF 284
             +         NV+ +L         C       + +E +   S++ +   K+NK Q F
Sbjct: 148 EHLRKQDKDNTMNVIHMLENFTFRNHIC-------MTFELL---SMNLYELIKKNKFQGF 197

Query: 285 GWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIP--KVSDFGLAKFHPK 342
               +++ A    + +  LH      I+H D+KP NILL        KV DFG + +   
Sbjct: 198 SLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY--- 251

Query: 343 ENDFVS--ISATRGTIGYIAPELISRNFGT-VSCKSDVYGFGMVLLEMAGGR 391
           E+  V   I  +R    Y APE+I    G       D++  G +L E+  G 
Sbjct: 252 EHQRVYTYIQ-SR---FYRAPEVI---LGARYGMPIDMWSLGCILAELLTGY 296

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 71.9 bits (177), Expect = 7e-14
 Identities = 57/249 (22%), Positives = 101/249 (40%), Gaps = 55/249 (22%)

Query: 196 LGQGGFGSVY----KGQLHTGRLIAVKMLENSKFSAEEFINEV-STIG--RI-----HHV 243
           LG G +G V+         TG+L A+K+L   K +  +       T    ++        
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVL--KKATIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 244 NVVQLLGFCS--EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQ----EIALGTA 297
            +V L    +    +K  L+ +++  G L  H+    ++ + F   ++Q    EI L   
Sbjct: 120 FLVTL--HYAFQTETKLHLILDYINGGELFTHL----SQRERFTEHEVQIYVGEIVLA-- 171

Query: 298 RGVAYLH-NGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR-- 353
             + +LH  G    I++ DIK  NILLD N  +  ++DFGL+    KE            
Sbjct: 172 --LEHLHKLG----IIYRDIKLENILLDSNGHV-VLTDFGLS----KEFVADETERAYDF 220

Query: 354 -GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSN----MNAIRS 401
            GTI Y+AP+++           D +  G+++ E+  G          ++       I  
Sbjct: 221 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 280

Query: 402 SKAYFPSWV 410
           S+  +P  +
Sbjct: 281 SEPPYPQEM 289

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 29/217 (13%)

Query: 188 VTNHFT--HKLGQGGFGSVYKGQ-LHTGRLIAVKMLEN---SKFSAEEFINEVSTIGRIH 241
           V   +     +G G +G+V       TG  +A+K L     S+  A+    E+  +  + 
Sbjct: 23  VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 82

Query: 242 HVNVVQLLG-FCSEGSKRA-----LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALG 295
           H NV+ LL  F  + +        LV  FM    L + +     K +  G +++Q +   
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM-----KHEKLGEDRIQFLVYQ 136

Query: 296 TARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRG 354
             +G+ Y+H      I+H D+KP N+ ++ +   K+ DFGLA+    +   +V    TR 
Sbjct: 137 MLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV---VTR- 189

Query: 355 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
              Y APE+I  N+   +   D++  G ++ EM  G+
Sbjct: 190 --WYRAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGK 223

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 38/226 (16%)

Query: 177 PKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLEN---SKFSAEEFIN 232
           PK Y  P  +          G G +GSV       +G  +A+K L     S+  A+    
Sbjct: 23  PKTYVSPTHV----------GSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR 72

Query: 233 EVSTIGRIHHVNVVQLLG-FCSEGSKRA-----LVYEFMPNGSLDRHIFPKENKGQTFGW 286
           E+  +  + H NV+ LL  F    S R      LV  FM    L + +      G  F  
Sbjct: 73  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM------GLKFSE 125

Query: 287 EKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKEND 345
           EK+Q +     +G+ Y+H+     ++H D+KP N+ ++ +   K+ DFGLA+    +   
Sbjct: 126 EKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 182

Query: 346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           +V    TR    Y APE+I  ++   +   D++  G ++ EM  G+
Sbjct: 183 YV---VTR---WYRAPEVIL-SWMHYNQTVDIWSVGCIMAEMLTGK 221

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 70.3 bits (173), Expect = 2e-13
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 35/211 (16%)

Query: 196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 249
           +G+G +  V   +L  T R+ A+K+++    + +E I+ V T   +     +H  +V L 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76

Query: 250 GFCSE-GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQ----EIALGTARGVAYLH 304
             C +  S+   V E++  G L  H+     + +    E  +    EI+L     + YLH
Sbjct: 77  -SCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLA----LNYLH 127

Query: 305 NGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR---GTIGYIA 360
              +  I++ D+K  N+LLD    I K++D+G+ K   +  D      T    GT  YIA
Sbjct: 128 ---ERGIIYRDLKLDNVLLDSEGHI-KLTDYGMCKEGLRPGDT-----TSTFCGTPNYIA 178

Query: 361 PELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
           PE++       S   D +  G+++ EM  GR
Sbjct: 179 PEILRGEDYGFSV--DWWALGVLMFEMMAGR 207

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 69.6 bits (171), Expect = 5e-13
 Identities = 53/253 (20%), Positives = 84/253 (33%), Gaps = 67/253 (26%)

Query: 171 NQQSW-MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEE 229
             +   M   Y               +  G +G+V  G    G  +A+K + N+      
Sbjct: 14  IAELHAMQSPY----------TVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRT 63

Query: 230 ---FIN---------EVSTIGRIHHVNVVQLLGFCSEGSKRA-----LVYEFM------- 265
                +         E+  +   HH N++ L        + A     LV E M       
Sbjct: 64  VNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV 123

Query: 266 ---PNGSL-DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNI 321
                  +  +HI       Q F +  L         G+  LH      ++H D+ P NI
Sbjct: 124 IHDQRIVISPQHI-------QYFMYHIL--------LGLHVLHEAG---VVHRDLHPGNI 165

Query: 322 LLDHNFIPKVSDFGLAKFHPKEN---DFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 378
           LL  N    + DF LA+    +     +V     R    Y APEL+   F   +   D++
Sbjct: 166 LLADNNDITICDFNLAREDTADANKTHYV---THR---WYRAPELVM-QFKGFTKLVDMW 218

Query: 379 GFGMVLLEMAGGR 391
             G V+ EM   +
Sbjct: 219 SAGCVMAEMFNRK 231

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 69.3 bits (170), Expect = 7e-13
 Identities = 58/246 (23%), Positives = 102/246 (41%), Gaps = 51/246 (20%)

Query: 196 LGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 249
           +G+G +  V   +L  T R+ A+++++    + +E I+ V T   +     +H  +V L 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119

Query: 250 GFCSEGSKRA-LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQ----EIALGTARGVAYLH 304
             C +   R   V E++  G L  H+     + +    E  +    EI+L     + YLH
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLA----LNYLH 170

Query: 305 NGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR---GTIGYIA 360
              +  I++ D+K  N+LLD    I K++D+G+ K   +  D      T    GT  YIA
Sbjct: 171 ---ERGIIYRDLKLDNVLLDSEGHI-KLTDYGMCKEGLRPGD-----TTSTFCGTPNYIA 221

Query: 361 PELISRNFGTVSCKSDVYGFGMVLLEMAGGR----------------RNSNMNAIRSSKA 404
           PE++       S   D +  G+++ EM  GR                 +     I   + 
Sbjct: 222 PEILRGEDYGFSV--DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 279

Query: 405 YFPSWV 410
             P  +
Sbjct: 280 RIPRSL 285

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 46/228 (20%), Positives = 85/228 (37%), Gaps = 42/228 (18%)

Query: 184 EIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-- 240
           E           +G+G FG V K         +A+K+++N K    +   EV  +  +  
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNK 109

Query: 241 ------HHVNVVQLLGF-------CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWE 287
                 +++  V L          C       LV+E +   S + +   +    +     
Sbjct: 110 HDTEMKYYI--VHLKRHFMFRNHLC-------LVFEML---SYNLYDLLRNTNFRGVSLN 157

Query: 288 KLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIP--KVSDFGLAKFHPKEND 345
             ++ A      + +L    ++ I+H D+KP NILL +      K+ DFG +        
Sbjct: 158 LTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ---LGQ 213

Query: 346 FV-SISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEMAGGR 391
            +     +R    Y +PE++    G       D++  G +L+EM  G 
Sbjct: 214 RIYQYIQSR---FYRSPEVL---LGMPYDLAIDMWSLGCILVEMHTGE 255

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 50/218 (22%), Positives = 89/218 (40%), Gaps = 27/218 (12%)

Query: 188 VTNHFT--HKLGQGGFGSVYKGQ-LHTGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHH 242
           V   +T    +G+G +G V           +A+K +     +   +  + E+  + R  H
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 84

Query: 243 VNVVQLLGFCSEGSKRA-----LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTA 297
            N++ +       +        +V + M    L + +     K Q    + +        
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL-----KTQHLSNDHICYFLYQIL 138

Query: 298 RGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS----ATR 353
           RG+ Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D         ATR
Sbjct: 139 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195

Query: 354 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
               Y APE++  N    +   D++  G +L EM   R
Sbjct: 196 ---WYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 229

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 35/226 (15%)

Query: 176 MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLEN---SKFSAEEFI 231
           +P+RY               +G G +GSV       TG  +AVK L     S   A+   
Sbjct: 27  VPERY----------QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 76

Query: 232 NEVSTIGRIHHVNVVQLLG-FCSEGSKRA-----LVYEFMPNGSLDRHIFPKENKGQTFG 285
            E+  +  + H NV+ LL  F    S        LV   M    L+  +     K Q   
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIV-----KCQKLT 130

Query: 286 WEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 345
            + +Q +     RG+ Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+     ++
Sbjct: 131 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTADE 185

Query: 346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
                ATR    Y APE++  N+   +   D++  G ++ E+  GR
Sbjct: 186 MTGYVATR---WYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 227

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 66.3 bits (162), Expect = 6e-12
 Identities = 57/243 (23%), Positives = 95/243 (39%), Gaps = 42/243 (17%)

Query: 188 VTNHFTH--KLGQGGFGSVYKGQ-LHTGRLIAVKMLEN---SKFSAEEFINEVSTIGRIH 241
           V   + +   +G G  G V         R +A+K L     ++  A+    E+  +  ++
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82

Query: 242 HVNVVQLLG-FCSEGSKRA-----LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALG 295
           H N++ LL  F  + S        +V E M   +L + I            E++  +   
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI------QMELDHERMSYLLYQ 135

Query: 296 TARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT 355
              G+ +LH+     I+H D+KP NI++  +   K+ DFGLA+             TR  
Sbjct: 136 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR-- 190

Query: 356 IGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVY-DQ 413
             Y APE+I    +       D++  G ++ EM  G               FP   + DQ
Sbjct: 191 -YYRAPEVILGMGYKE---NVDIWSVGCIMGEMIKG------------GVLFPGTDHIDQ 234

Query: 414 LNK 416
            NK
Sbjct: 235 WNK 237

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 66.4 bits (162), Expect = 7e-12
 Identities = 52/233 (22%), Positives = 89/233 (38%), Gaps = 51/233 (21%)

Query: 177 PKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLEN---SKFSAEEFIN 232
            KRY   + I          G G  G V         R +A+K L     ++  A+    
Sbjct: 61  LKRYQNLKPI----------GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR 110

Query: 233 EVSTIGRIHHVNVVQLLG-FCSEGSKRA-----LVYEFMPNGSLDRHIFPK----ENKGQ 282
           E+  +  ++H N++ LL  F  + +        LV E M     +     +      +  
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQMELDHERMS 167

Query: 283 TFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 342
              ++ L         G+ +LH+     I+H D+KP NI++  +   K+ DFGLA+    
Sbjct: 168 YLLYQML--------CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216

Query: 343 EN---DFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGGR 391
                 +V    TR    Y APE+I    +       D++  G ++ EM   +
Sbjct: 217 SFMMTPYV---VTR---YYRAPEVILGMGYKE---NVDIWSVGCIMGEMVRHK 260

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 66.4 bits (162), Expect = 7e-12
 Identities = 41/196 (20%), Positives = 72/196 (36%), Gaps = 30/196 (15%)

Query: 153 HKYRTTLQTVDNIEKFLHNQQSW-MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LH 210
            + R    +             W +P RY             H +G G +G V +     
Sbjct: 27  GQQRKQHHSSKPTASMPRPHSDWQIPDRY----------EIRHLIGTGSYGHVCEAYDKL 76

Query: 211 TGRLIAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLGFCSEGSKRA-----LV 261
             R++A+K +    F         + E++ + R++H +VV++L               +V
Sbjct: 77  EKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVV 135

Query: 262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNI 321
            E   +    +                ++ +      GV Y+H+     ILH D+KP N 
Sbjct: 136 LEIADS-DFKKLF----RTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANC 187

Query: 322 LLDHNFIPKVSDFGLA 337
           L++ +   KV DFGLA
Sbjct: 188 LVNQDCSVKVCDFGLA 203

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 63.4 bits (154), Expect = 5e-11
 Identities = 51/263 (19%), Positives = 97/263 (36%), Gaps = 78/263 (29%)

Query: 194 HKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVN-------- 244
            KLG G F +V+    +   + +A+K++++++   E  ++E+  +  + + +        
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102

Query: 245 VVQLLG-FCSEGSK---RALVYEFMPNG-SLDRHIFPKENKGQTFGWEKLQEIALGTARG 299
           VVQLL  F   G       +V+E +  G  L +  +  ++  Q      +++I     +G
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVL--GHHLLK--WIIKSNYQGLPLPCVKKIIQQVLQG 158

Query: 300 VAYLHNGCDMCILHFDIKPHNILL------------------------------------ 323
           + YLH  C   I+H DIKP NILL                                    
Sbjct: 159 LDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216

Query: 324 -------------DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
                              K++D G A     ++    I     T  Y + E++    G+
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNA-CWVHKHFTEDIQ----TRQYRSLEVL---IGS 268

Query: 371 -VSCKSDVYGFGMVLLEMAGGRR 392
             +  +D++    +  E+A G  
Sbjct: 269 GYNTPADIWSTACMAFELATGDY 291

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 63.0 bits (154), Expect = 6e-11
 Identities = 58/234 (24%), Positives = 95/234 (40%), Gaps = 32/234 (13%)

Query: 176 MPKRYSYPEIIAVTNHFT--HKLGQGGFGSVYKGQ-LHTGRLIAVKMLE--NSKFSAEEF 230
           MPKR  Y     +++ F     LG+G +G V       TG ++A+K +E  +    A   
Sbjct: 1   MPKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT 56

Query: 231 INEVSTIGRIHHVNVVQLLGFCSEGSKRA-----LVYEFMPNGSLDRHIFPKENKGQTFG 285
           + E+  +    H N++ +       S        ++ E M    L R I       Q   
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI-----STQMLS 110

Query: 286 WEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 345
            + +Q     T R V  LH      ++H D+KP N+L++ N   KV DFGLA+   +   
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167

Query: 346 FVSISATRGTI--GYI------APELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
             S    + +    ++      APE++       S   DV+  G +L E+   R
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYRAPEVML-TSAKYSRAMDVWSCGCILAELFLRR 220

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 53/280 (18%), Positives = 96/280 (34%), Gaps = 70/280 (25%)

Query: 168 FLHNQQSW-MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLEN--- 222
           +    ++  +P  Y             H +G+G +G VY     +T + +A+K +     
Sbjct: 15  YFQGIKNVHVPDNY----------IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE 64

Query: 223 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA-----LVYEFMP---------NG 268
                +  + E++ + R+    +++L                +V E              
Sbjct: 65  DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPI 124

Query: 269 SL-DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF 327
            L + HI       +T  +  L         G  ++H      I+H D+KP N LL+ + 
Sbjct: 125 FLTEEHI-------KTILYNLL--------LGENFIHESG---IIHRDLKPANCLLNQDC 166

Query: 328 IPKVSDFGLAKFHPKENDFVSISATRGTIG--------------------YIAPELISRN 367
             KV DFGLA+    E D   ++                           Y APELI   
Sbjct: 167 SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL-L 225

Query: 368 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP 407
               +   D++  G +  E+    + S++N   +    FP
Sbjct: 226 QENYTKSIDIWSTGCIFAELLNMLQ-SHINDPTNRFPLFP 264

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 60.7 bits (148), Expect = 2e-10
 Identities = 46/244 (18%), Positives = 91/244 (37%), Gaps = 47/244 (19%)

Query: 171 NQQSW-MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKML--ENSKFS 226
           N   + +  RY   + +          G GG G V+        + +A+K +   + +  
Sbjct: 3   NIHGFDLGSRYMDLKPL----------GCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS- 51

Query: 227 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA--------------LVYEFMPNGSLDR 272
            +  + E+  I R+ H N+V++         +               +V E+M    L  
Sbjct: 52  VKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLAN 110

Query: 273 HIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD-HNFIPKV 331
            +     +      E  +       RG+ Y+H+     +LH D+KP N+ ++  + + K+
Sbjct: 111 VL-----EQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162

Query: 332 SDFGLAKFHPKENDFVSIS----ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 387
            DFGLA+                 T+    Y +P L+  +    +   D++  G +  EM
Sbjct: 163 GDFGLARIMDPHYSHKGHLSEGLVTK---WYRSPRLLL-SPNNYTKAIDMWAAGCIFAEM 218

Query: 388 AGGR 391
             G+
Sbjct: 219 LTGK 222

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 60.1 bits (146), Expect = 5e-10
 Identities = 45/169 (26%), Positives = 77/169 (45%), Gaps = 22/169 (13%)

Query: 181 SYPEIIAVTNHF--THKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTI 237
           S   ++ V  +F    K+G G FG +  G+ L+T   +A+K LE  K  A +   E    
Sbjct: 1   SMGVLM-VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFY 58

Query: 238 GRIHH-VNVVQLLGFCSEGSKRALVYEFMPNG-SLDRHIFPKENKGQTFGWEKLQEIALG 295
            ++     + Q+  F   G   A+V E +  G SL+  +F  +   +TF  + +  IA+ 
Sbjct: 59  KQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLE-DLF--DLCDRTFSLKTVLMIAIQ 113

Query: 296 TARGVAYLHNGCDMCILHFDIKPHNILL------DHNFIPKVSDFGLAK 338
               + Y+H+     +++ D+KP N L+          I  + DF LAK
Sbjct: 114 LISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVI-HIIDFALAK 158

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 37/160 (23%), Positives = 67/160 (41%), Gaps = 17/160 (10%)

Query: 188 VTNHF--THKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHH-V 243
           V  H+    ++G+G FG +++G  L   + +A+K  E  +  A +  +E  T   +    
Sbjct: 8   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCT 66

Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
            +  +  F  EG    LV + +   SL+  +   +  G+ F  + +   A      V  +
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLL--DLCGRKFSVKTVAMAAKQMLARVQSI 122

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPK-----VSDFGLAK 338
           H      +++ DIKP N L+            V DFG+ K
Sbjct: 123 HE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 41/163 (25%), Positives = 70/163 (42%), Gaps = 18/163 (11%)

Query: 184 EIIAVTNHF--THKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRI 240
           E+  V N +    K+G G FG +Y G  +  G  +A+K+ E  K    +   E      +
Sbjct: 4   ELR-VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMM 61

Query: 241 HH-VNVVQLLGFCSEGSKRALVYEFMPNG-SLDRHIFPKENKGQTFGWEKLQEIALGTAR 298
              V +  +    +EG    +V E +  G SL+  +F      + F  + +  +A     
Sbjct: 62  QGGVGIPTIRWCGAEGDYNVMVMELL--GPSLE-DLF--NFCSRKFSLKTVLLLADQMIS 116

Query: 299 GVAYLHNGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAK 338
            + Y+H+      +H D+KP N L+       +  + DFGLAK
Sbjct: 117 RIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 57.3 bits (139), Expect = 4e-09
 Identities = 58/237 (24%), Positives = 90/237 (37%), Gaps = 64/237 (27%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQL 248
           K+G G FG V   Q +   +  AVK++ N K        E   + +I     ++ N+V+ 
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101

Query: 249 LGF-------CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVA 301
            G        C       L++E +       +     N    F  E ++   +   + + 
Sbjct: 102 HGKFMYYDHMC-------LIFEPL---GPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151

Query: 302 YLHNGCDMCILHFDIKPHNILLDHNFIP-------------------------KVSDFGL 336
           YL     M + H D+KP NILLD  +                           K+ DFG 
Sbjct: 152 YLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208

Query: 337 AKFHPKENDFVS--ISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEMAGG 390
           A F   ++D+    I+ TR    Y APE+I           SD++ FG VL E+  G
Sbjct: 209 ATF---KSDYHGSIIN-TR---QYRAPEVI---LNLGWDVSSDMWSFGCVLAELYTG 255

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 45/164 (27%), Positives = 70/164 (42%), Gaps = 20/164 (12%)

Query: 184 EIIAVTNHF--THKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRI 240
           E   V N F    K+G G FG +Y G  + T   +A+K+ EN K    + + E      +
Sbjct: 2   EPR-VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRIL 59

Query: 241 H-HVNVVQLLGFCSEGSKRALVYEFMPNG-SLDRHIFPKENKGQTFGWEKLQEIALGTAR 298
                +  +  F  EG    LV + +  G SL+  +F      +    + +  +A     
Sbjct: 60  QGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLE-DLF--NFCSRKLSLKTVLMLADQMIN 114

Query: 299 GVAYLHNGCDMCILHFDIKPHNILL----DHNFIPKVSDFGLAK 338
            V ++H+      LH DIKP N L+      N +  + DFGLAK
Sbjct: 115 RVEFVHS---KSFLHRDIKPDNFLMGLGRRANQV-YIIDFGLAK 154

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 51/242 (21%), Positives = 85/242 (35%), Gaps = 78/242 (32%)

Query: 195 KLGQGGFGSVYKGQLH--TGRLIAVKMLENSKFSAE---------EFINEVSTIGRIHHV 243
            LG+G FG V +   H      +A+K++ N     E         + I E     +   V
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCV 85

Query: 244 N-------------VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQ 290
                           +LLG           +EF+           KEN  Q +    ++
Sbjct: 86  LMSDWFNFHGHMCIAFELLGKN--------TFEFL-----------KENNFQPYPLPHVR 126

Query: 291 EIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIP-------------------KV 331
            +A      + +LH   +  + H D+KP NIL  ++                      +V
Sbjct: 127 HMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183

Query: 332 SDFGLAKFHPKENDFVS--ISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEMA 388
           +DFG A F   +++  +  ++ TR    Y  PE+I        +   DV+  G +L E  
Sbjct: 184 ADFGSATF---DHEHHTTIVA-TR---HYRPPEVI---LELGWAQPCDVWSIGCILFEYY 233

Query: 389 GG 390
            G
Sbjct: 234 RG 235

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 60/242 (24%), Positives = 89/242 (36%), Gaps = 78/242 (32%)

Query: 195 KLGQGGFGSVYKGQLH--TGRLIAVKMLENSKFSAE---------EFINEVSTIGRIHHV 243
            LG+G FG V +   H   GR +AVK+++N     E         E +N          V
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80

Query: 244 N-------------VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQ 290
                         V +LLG           Y+F+           KEN    F  + ++
Sbjct: 81  QMLEWFEHHGHICIVFELLGLS--------TYDFI-----------KENGFLPFRLDHIR 121

Query: 291 EIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIP-------------------KV 331
           ++A    + V +LH      + H D+KP NIL   +                      KV
Sbjct: 122 KMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178

Query: 332 SDFGLAKFHPKENDFVS--ISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEMA 388
            DFG A +   +++  S  +S TR    Y APE+I        S   DV+  G +L+E  
Sbjct: 179 VDFGSATY---DDEHHSTLVS-TR---HYRAPEVI---LALGWSQPCDVWSIGCILIEYY 228

Query: 389 GG 390
            G
Sbjct: 229 LG 230

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 54.5 bits (130), Expect = 3e-08
 Identities = 27/192 (14%), Positives = 51/192 (26%), Gaps = 56/192 (29%)

Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKML---------ENSKFSAEEFINEV---------ST 236
           K+G+G FG V++        +A+K++          + + + EE + E+         S 
Sbjct: 27  KIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 237 IGRIHHVNVVQLLGFC------------------------------SEGSKRALVYEFMP 266
                    + L                                   +  +  +V EF  
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN 326
            G     +  K            + I       +A           H D+   N+LL   
Sbjct: 146 GGIDLEQMRTK-----LSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKT 198

Query: 327 FIPKVSDFGLAK 338
            + K+      K
Sbjct: 199 SLKKLHYTLNGK 210

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 55/239 (23%), Positives = 91/239 (38%), Gaps = 52/239 (21%)

Query: 188 VTNHFT--HKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRI---- 240
           V   +    KLG+G +G V+K     TG ++AVK + ++      F N      R     
Sbjct: 7   VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA------FQNSTDAQ-RTFREI 59

Query: 241 -------HHVNVVQLLG-FCSEGSKRA-LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQE 291
                   H N+V LL    ++  +   LV+++M    L   I     +         Q 
Sbjct: 60  MILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVI-----RANILEPVHKQY 113

Query: 292 IALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 351
           +     + + YLH+G    +LH D+KP NILL+     KV+DFGL++         +   
Sbjct: 114 VVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170

Query: 352 TRGTIG-------------------YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 391
                                    Y APE++       +   D++  G +L E+  G+
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILL-GSTKYTKGIDMWSLGCILGEILCGK 228

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 34/232 (14%), Positives = 72/232 (31%), Gaps = 50/232 (21%)

Query: 195 KLGQGGFGSVYKGQLHTGRLI---------AVKM-LENSKFSAE----------EFINEV 234
              +   G +Y+    +             ++K+  ++ +   E            +N+ 
Sbjct: 49  FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108

Query: 235 STIGRIHHVNVVQLLGF-CSEGSKRALVYEFMPNG-SLDRHIFPKENKGQTFGWEKLQEI 292
             +     + +   +GF   +   R LV   +  G SL        +         + ++
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQ-SAL-DVSPKHVLSERSVLQV 164

Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKV--SDFGLAKF--------HPK 342
           A      + +LH       +H ++   NI +D     +V  + +G A             
Sbjct: 165 ACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV 221

Query: 343 ENDFVSISATRGTIGYIAPELISRN--FG-TVSCKSDVYGFGMVLLEMAGGR 391
           E          G + +     IS +   G   S +SD+   G  +L+   G 
Sbjct: 222 EGSRSPH---EGDLEF-----ISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 50.5 bits (121), Expect = 6e-07
 Identities = 36/192 (18%), Positives = 73/192 (38%), Gaps = 37/192 (19%)

Query: 176 MPKRYSYPEIIA--VTNHFT--HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKF------ 225
           + ++++  EII       +     +GQGGFG +Y   +++   +        K       
Sbjct: 19  LAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG 78

Query: 226 ------------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK----RALVYEFMPNG- 268
                       +  E I +     ++ ++ V +  G           R ++ +    G 
Sbjct: 79  PLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GS 136

Query: 269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFI 328
            L   I+  E   + F  + + +++L     + Y+H       +H DIK  N+LL++   
Sbjct: 137 DLQ-KIY--EANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNP 190

Query: 329 PKV--SDFGLAK 338
            +V   D+GLA 
Sbjct: 191 DQVYLVDYGLAY 202

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.9 bits (118), Expect = 2e-06
 Identities = 58/450 (12%), Positives = 111/450 (24%), Gaps = 145/450 (32%)

Query: 9   CLSNNQSNVYVYVAPDFIETTHLPD------------------SCAFITKVPVVLNG--- 47
            L + Q  +       F+E     +                  +  +I +   + N    
Sbjct: 70  TLLSKQEEMV----QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV 125

Query: 48  ----SVDKPS-YEDLRKLLES-------------GFDLTW--SDWSWSLSMTHFFP---- 83
               +V +   Y  LR+ L               G   TW   D   S  +         
Sbjct: 126 FAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF 185

Query: 84  -----ECNDYYGGIIRKF--ICYQDDILFHEISRRSYR---NIESRLGVWISFLLGFP-- 131
                 CN     ++     + YQ D  +   S  S      I S +   +  LL     
Sbjct: 186 WLNLKNCNSP-ETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS-IQAELRRLLKSKPY 243

Query: 132 VDVLIIGRFILAPIVFLVFLIHKYRTTLQTVD-NIEKFLHNQQSWMPKRYSYPEIIAVTN 190
            + L++   +     +  F +   +  L T    +  FL           ++  +   + 
Sbjct: 244 ENCLLVLLNVQNAKAWNAFNL-SCKILLTTRFKQVTDFL------SAATTTHISLDHHSM 296

Query: 191 HFTHKLGQGGFGSVYKG-------QLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHV 243
             T    +                ++ T     + ++      AE   + ++T     HV
Sbjct: 297 TLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII------AESIRDGLATWDNWKHV 350

Query: 244 NVVQL-------LGFCSEGSKRALVYEFMPNGSLDRHIFPKENK--GQTFG--WEKLQE- 291
           N  +L       L        R +             +FP             W  + + 
Sbjct: 351 NCDKLTTIIESSLNVLEPAEYRKMFDRLS--------VFPPSAHIPTILLSLIWFDVIKS 402

Query: 292 --------------IALGTARGVAYLHNGCDMCILHFDIKP--------HNILLDHNFIP 329
                         +          + +      ++ ++K         H  ++DH  IP
Sbjct: 403 DVMVVVNKLHKYSLVEKQPKESTISIPS------IYLELKVKLENEYALHRSIVDHYNIP 456

Query: 330 KVSDFGLAKFHPKENDFVSISATRGTIGYI 359
           K  D       P   D            Y 
Sbjct: 457 KTFDSD--DLIPPYLD-----------QYF 473

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 33/167 (19%), Positives = 64/167 (38%), Gaps = 32/167 (19%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKM--LENSK-------------FSAEEFINEVSTIG 238
           K+G GGFG +Y     +     A  +  +E  +              + ++ I +     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 239 RIHHVNVVQLLGF----CSEGSKRALVYEFMPNG-SLDRHIFPKENKGQTFGWEKLQEIA 293
           ++ ++ +    G         S R +V E +  G  L   I     +  TF    + ++ 
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQ-KIS---GQNGTFKKSTVLQLG 157

Query: 294 LGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKV--SDFGLAK 338
           +     + Y+H       +H DIK  N+LL +    +V  +D+GL+ 
Sbjct: 158 IRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	511
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.8
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.68
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.24
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.2
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.1
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.96
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.61
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.43
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.39
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.33
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.29
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.24
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.1
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.9
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.87
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.51
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.47
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.47
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.45
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.44
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.36
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.24
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.15
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.13
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.02
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.73
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.62
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.94
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.33
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.69
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	89.09
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.37
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	83.69

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.1e-57  Score=455.64  Aligned_cols=265  Identities=23%  Similarity=0.350  Sum_probs=218.1

Q ss_pred             CChHHHHHHHhhhccccCcCCcEEEEEEEec------CCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeece
Q 010434          180 YSYPEIIAVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGF  251 (511)
Q Consensus       180 ~~~~ei~~~t~~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~  251 (511)
                      ..+.||...+.+|.++||+|+||+||+|++.      +++.||||+++..  ....++|.+|+.++++++|||||+++|+
T Consensus        18 ~~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~   97 (308)
T 4gt4_A           18 AKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGV   97 (308)
T ss_dssp             -CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence            3344555566788999999999999999863      4689999999763  3356789999999999999999999999


Q ss_pred             eccCCceeEEEeecCCCCcccccccCCC------------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcC
Q 010434          252 CSEGSKRALVYEFMPNGSLDRHIFPKEN------------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPH  319 (511)
Q Consensus       252 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~  319 (511)
                      |.+++..+||||||++|+|.++|.....            ....++|..+.+|+.|||+||+|||+   ++|+||||||+
T Consensus        98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~  174 (308)
T 4gt4_A           98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATR  174 (308)
T ss_dssp             ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCcccc
Confidence            9999999999999999999999854321            23569999999999999999999999   69999999999


Q ss_pred             ceEEcCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCccc
Q 010434          320 NILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNA  398 (511)
Q Consensus       320 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~  398 (511)
                      ||||++++.+||+|||+|+...........+...||++|||||++.+.  .++.++|||||||++|||+| |+.||....
T Consensus       175 NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~  252 (308)
T 4gt4_A          175 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYS  252 (308)
T ss_dssp             GEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred             ceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC--CCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999876544433344566799999999999864  89999999999999999998 899986543


Q ss_pred             ccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          399 IRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      .        ..+...+..+.....+      ..++..+.+++.+||+.||++||||++|++.|+.
T Consensus       253 ~--------~~~~~~i~~~~~~~~p------~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          253 N--------QDVVEMIRNRQVLPCP------DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             H--------HHHHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             H--------HHHHHHHHcCCCCCCc------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            2        2234444444433322      2345678899999999999999999999999986

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.8e-56  Score=449.73  Aligned_cols=257  Identities=26%  Similarity=0.441  Sum_probs=205.0

Q ss_pred             hhccccCcCCcEEEEEEEec------CCcEEEEEEeccC-cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          191 HFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .+.++||+|+||.||+|+++      +++.||||+++.. ....++|.+|++++++++|||||+++|+|.++...+||||
T Consensus        44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E  123 (329)
T 4aoj_A           44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE  123 (329)
T ss_dssp             EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            45689999999999999864      4789999999763 3345789999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCC-----------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeee
Q 010434          264 FMPNGSLDRHIFPKEN-----------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVS  332 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~  332 (511)
                      ||++|+|.+++.....           ...+++|..+++|+.|||+||+|||+   ++|+||||||+||||++++.+||+
T Consensus       124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki~  200 (329)
T 4aoj_A          124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIG  200 (329)
T ss_dssp             CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEEC
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEEc
Confidence            9999999999854322           23579999999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhH
Q 010434          333 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVY  411 (511)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~  411 (511)
                      |||+|+...............||+.|||||++.+.  .++.++|||||||++|||+| |+.||.....        ..+.
T Consensus       201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~~  270 (329)
T 4aoj_A          201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--------TEAI  270 (329)
T ss_dssp             CCC----------------CCCCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--------HHHH
T ss_pred             ccccceeccCCCcceecCcccccccccChhhhcCC--CCCccccccchHHHHHHHHcCCCCCCCCCCH--------HHHH
Confidence            99999976555444444556799999999999865  88999999999999999999 8999865332        2234


Q ss_pred             HhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          412 DQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       412 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      ..+.++...+.+      ..+++.+.+|+.+||+.||++||||+||+++|+....
T Consensus       271 ~~i~~g~~~~~p------~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          271 DCITQGRELERP------RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HHHHHTCCCCCC------TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCc------ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            444444433322      2345678899999999999999999999999998654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.2e-56  Score=445.12  Aligned_cols=258  Identities=24%  Similarity=0.404  Sum_probs=212.3

Q ss_pred             hhhccccCcCCcEEEEEEEec------CCcEEEEEEeccC-cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      +.+.++||+|+||.||+|++.      +++.||||+++.. ....++|.+|++++++++|||||+++|+|.+++..+|||
T Consensus        15 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~   94 (299)
T 4asz_A           15 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF   94 (299)
T ss_dssp             EEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             eEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            345789999999999999853      4789999999763 334578999999999999999999999999999999999


Q ss_pred             eecCCCCcccccccCC---------CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeec
Q 010434          263 EFMPNGSLDRHIFPKE---------NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSD  333 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~D  333 (511)
                      |||++|+|.++|....         .....++|..++.|+.|||+||+|||+   ++|+||||||+||||++++.+||+|
T Consensus        95 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~D  171 (299)
T 4asz_A           95 EYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGD  171 (299)
T ss_dssp             ECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECC
T ss_pred             EcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEECC
Confidence            9999999999985432         234579999999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHH
Q 010434          334 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYD  412 (511)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~  412 (511)
                      ||+|+...............||+.|||||++.+.  .++.|+|||||||++|||+| |+.||.....        ..+..
T Consensus       172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~~~  241 (299)
T 4asz_A          172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEVIE  241 (299)
T ss_dssp             CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHH
T ss_pred             cccceecCCCCceeecCceecChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHH
Confidence            9999876554443333445699999999999875  89999999999999999998 8999865432        22344


Q ss_pred             hhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          413 QLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       413 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      .+.++.....+      ..++..+.+++.+||+.||++||||++|++.|+....
T Consensus       242 ~i~~~~~~~~p------~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          242 CITQGRVLQRP------RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             HHHHTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCC------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            44444433322      2345678899999999999999999999999987543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-55  Score=441.84  Aligned_cols=260  Identities=27%  Similarity=0.468  Sum_probs=203.2

Q ss_pred             hhhccccCcCCcEEEEEEEecCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          190 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      ..+.++||+|+||+||+|++++  .||||+++...   ...+.|.+|+.++++++|||||+++|++.+ +..+||||||+
T Consensus        38 l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~  114 (307)
T 3omv_A           38 VMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCE  114 (307)
T ss_dssp             CCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCS
T ss_pred             eEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCC
Confidence            3467899999999999998753  59999997533   234679999999999999999999999875 56899999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +|+|.+++..   ....++|..+..|+.|||.||+|||+   ++|+||||||+||||++++.+||+|||+|+........
T Consensus       115 gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          115 GSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             SCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             CCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            9999999843   33579999999999999999999999   69999999999999999999999999999876554443


Q ss_pred             eeeccccCCccccchhccccc-CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          347 VSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~-~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                      .......||+.|||||++.+. .+.++.|+|||||||++|||+||+.||......       ..+...+..+....  ..
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-------~~~~~~~~~~~~~p--~~  259 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-------DQIIFMVGRGYASP--DL  259 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHTTCCCC--CS
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcCCCCC--Cc
Confidence            444566799999999998653 346899999999999999999999999643211       12222233222111  11


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                      ......++..+.+++.+||+.||++||||.+|++.|+.....
T Consensus       260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence            122334567788999999999999999999999999865433

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.4e-53  Score=424.82  Aligned_cols=269  Identities=23%  Similarity=0.263  Sum_probs=202.3

Q ss_pred             hhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCC----ceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~----~~~lV~e~~  265 (511)
                      +.+.++||+|+||+||+|++ +|+.||||+++........+..|+..+.+++|||||+++|+|.+++    ..+||||||
T Consensus         5 i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~   83 (303)
T 3hmm_A            5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH   83 (303)
T ss_dssp             EEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred             EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence            44578999999999999997 4899999999765433334456777778899999999999997654    579999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCC-----CCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC-----DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      ++|+|.+++.     ...++|+.+.+++.|+|+||+|||+.+     .++|+||||||+||||++++++||+|||+|+..
T Consensus        84 ~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           84 EHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             TTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             CCCcHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            9999999983     246999999999999999999999742     348999999999999999999999999999876


Q ss_pred             CCCCCce--eeccccCCccccchhcccccC----CCcCccchHHHHHHHHHHHHhCCCCCCcccccccc-------cccc
Q 010434          341 PKENDFV--SISATRGTIGYIAPELISRNF----GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK-------AYFP  407 (511)
Q Consensus       341 ~~~~~~~--~~~~~~gt~~y~APE~~~~~~----~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~-------~~~~  407 (511)
                      .......  ......||+.|||||++.+..    +.++.|+|||||||++|||+||+.|+.........       ....
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            5544322  123456999999999986531    24788999999999999999998876543211100       0000


Q ss_pred             hhhHHh-hhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          408 SWVYDQ-LNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       408 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                      ..+... .....+..++... ...+..+.+.+++.+||+.||++||||.||++.|+...
T Consensus       239 ~~~~~~~~~~~~rp~~p~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~  296 (303)
T 3hmm_A          239 EEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGG-GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhcccCCCCCCccc-cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            111111 1222222222211 22345677899999999999999999999999998644

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.6e-53  Score=430.35  Aligned_cols=261  Identities=27%  Similarity=0.428  Sum_probs=214.9

Q ss_pred             HHHhhhccccCcCCcEEEEEEEecC------CcEEEEEEeccCcc--cHHHHHHHHHHhcccc-ccceEEeeceecc-CC
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQLHT------GRLIAVKMLENSKF--SAEEFINEVSTIGRIH-HVNVVQLLGFCSE-GS  256 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~~~------g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~-~~  256 (511)
                      ...+.+.++||+|+||.||+|.+.+      ++.||||+++....  ..++|.+|+.++.+++ |||||+++|+|.+ +.
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~  142 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  142 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence            3455667899999999999998542      36899999976432  3467999999999995 4899999999966 46


Q ss_pred             ceeEEEeecCCCCcccccccCCC------------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEc
Q 010434          257 KRALVYEFMPNGSLDRHIFPKEN------------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD  324 (511)
Q Consensus       257 ~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~  324 (511)
                      ..+||||||++|+|.++|.....            ....++|..+..++.|||+||+|||+   ++|+||||||+||||+
T Consensus       143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl~  219 (353)
T 4ase_A          143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS  219 (353)
T ss_dssp             CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred             EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceeeC
Confidence            78999999999999999854321            13569999999999999999999999   6999999999999999


Q ss_pred             CCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccc
Q 010434          325 HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSK  403 (511)
Q Consensus       325 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~  403 (511)
                      +++.+||+|||+|+...............||+.|||||++.+.  .++.++|||||||++|||+| |+.||.....    
T Consensus       220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~----  293 (353)
T 4ase_A          220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----  293 (353)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC----
T ss_pred             CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC--CCCCcccEeehHHHHHHHHhCCCCCCCCCCH----
Confidence            9999999999999987666655555667899999999999875  89999999999999999998 8999865321    


Q ss_pred             cccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          404 AYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                         ...+...+.++.+...+.      .+++.+.+++.+||+.||++|||+++|++.|+..+
T Consensus       294 ---~~~~~~~i~~g~~~~~p~------~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll  346 (353)
T 4ase_A          294 ---DEEFCRRLKEGTRMRAPD------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  346 (353)
T ss_dssp             ---SHHHHHHHHHTCCCCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHHHHHHHcCCCCCCCc------cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence               223445555554443322      23567889999999999999999999999998754

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.1e-52  Score=422.35  Aligned_cols=261  Identities=21%  Similarity=0.233  Sum_probs=206.8

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      +.+.++||+|+||.||+|+. .+|+.||||+++.....    .+|+.++++++|||||++++++.++...+|||||+++|
T Consensus        60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg  135 (336)
T 4g3f_A           60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG  135 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred             eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence            34457899999999999985 57999999999764432    47999999999999999999999999999999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC-CeeeecccccccCCCCCCce
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~-~~kl~DFGla~~~~~~~~~~  347 (511)
                      +|.++|.    ..+.+++..+..++.||+.||+|||+   ++|+||||||+||||+.++ .+||+|||+|+.........
T Consensus       136 ~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          136 SLGQLIK----QMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             BHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            9999983    34579999999999999999999998   6999999999999999987 69999999998765433221


Q ss_pred             ---eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          348 ---SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       348 ---~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                         ......||+.|||||++.+.  .++.++|||||||++|||++|+.||.......        +...+......    
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--------~~~~i~~~~~~----  274 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--------LCLKIASEPPP----  274 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC--------CHHHHHHSCCG----
T ss_pred             ceecCCccccCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--------HHHHHHcCCCC----
Confidence               12335699999999999875  78999999999999999999999996543221        11222221111    


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCCCCCCCC
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKPC  475 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~~p~~p~  475 (511)
                      ..+.+..+++.+.+++.+||+.||++|||+.|+++.|...+.....-..|.
T Consensus       275 ~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw  325 (336)
T 4g3f_A          275 IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPW  325 (336)
T ss_dssp             GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCS
T ss_pred             chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCC
Confidence            112333456788899999999999999999999998877654443333443

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.3e-52  Score=412.23  Aligned_cols=245  Identities=26%  Similarity=0.369  Sum_probs=197.3

Q ss_pred             hhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceecc----CCceeEEE
Q 010434          191 HFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRALVY  262 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~----~~~~~lV~  262 (511)
                      .|.++||+|+||.||+|.. .+++.||||++....   ...+.|.+|+.++++++|||||++++++.+    +...+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            4567899999999999985 478999999996533   245679999999999999999999999854    35579999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC-CCCeeeecccccccCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHP  341 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~-~~~~kl~DFGla~~~~  341 (511)
                      |||++|+|.+++.    ....+++..+..++.||+.||+|||+. ..+|+||||||+||||++ ++.+||+|||+|+...
T Consensus       109 Ey~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            9999999999983    346799999999999999999999983 123999999999999985 7999999999998654


Q ss_pred             CCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccc
Q 010434          342 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (511)
                      ...    .....||+.|||||++.+   .++.++|||||||++|||+||+.||.....       ...+...+..+....
T Consensus       184 ~~~----~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~-------~~~~~~~i~~~~~~~  249 (290)
T 3fpq_A          184 ASF----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVTSGVKPA  249 (290)
T ss_dssp             TTS----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHHTTTCCCG
T ss_pred             CCc----cCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-------HHHHHHHHHcCCCCC
Confidence            322    244579999999999864   689999999999999999999999964221       122333333332211


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                           ..+...++.+.+++.+||+.||++|||++|+++
T Consensus       250 -----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          250 -----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 122233456889999999999999999999986

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.5e-52  Score=423.24  Aligned_cols=246  Identities=25%  Similarity=0.328  Sum_probs=205.4

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC-cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      |.+.++||+|+||.||+|+. .+|+.||||++... ....+.+.+|+.++++++|||||++++++.+++..||||||+++
T Consensus        76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g  155 (346)
T 4fih_A           76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  155 (346)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred             cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence            45568899999999999985 47999999999753 33456789999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|.+++.     ...+++..+..++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+|+.......  
T Consensus       156 g~L~~~l~-----~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--  225 (346)
T 4fih_A          156 GALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--  225 (346)
T ss_dssp             EEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--
T ss_pred             CcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--
Confidence            99999882     2469999999999999999999999   6999999999999999999999999999987654432  


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      ......||+.|||||++.+.  .++.++|||||||++|||++|+.||......        .+...+.......+.    
T Consensus       226 ~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------~~~~~i~~~~~~~~~----  291 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------KAMKMIRDNLPPRLK----  291 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSSCCCCS----
T ss_pred             cccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHcCCCCCCC----
Confidence            23456799999999999765  7899999999999999999999999653321        122333332222221    


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ....+++.+.+++.+||+.||++|||+.|+++
T Consensus       292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            22335677889999999999999999999986

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1e-52  Score=426.66  Aligned_cols=248  Identities=24%  Similarity=0.346  Sum_probs=199.6

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      .|.+.++||+|+||.||+|+. .+|+.||||++.....   ..+.|.+|+.++++++|||||++++++.+++..||||||
T Consensus        25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy  104 (350)
T 4b9d_A           25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY  104 (350)
T ss_dssp             CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            356678999999999999985 5799999999976433   346799999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.++|..  ..+..+++..+..++.||+.||+|||+   ++|+||||||+||||++++.+||+|||+|+......
T Consensus       105 ~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          105 CEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            999999999842  234568999999999999999999999   699999999999999999999999999998654321


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                        ...+...||+.|||||++.+.  .++.++|||||||++|||++|+.||.......        +...+..+....   
T Consensus       180 --~~~~~~~GT~~YmAPE~l~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--------~~~~i~~~~~~~---  244 (350)
T 4b9d_A          180 --ELARACIGTPYYLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAFEAGSMKN--------LVLKIISGSFPP---  244 (350)
T ss_dssp             --HHHHHHHSCCTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHTCCCC---
T ss_pred             --ccccccCCCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--------HHHHHHcCCCCC---
Confidence              112345699999999999875  78999999999999999999999997543221        222232222211   


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                         ....++..+.+|+.+||+.||++|||+.|+++
T Consensus       245 ---~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          245 ---VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               12234567889999999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.6e-52  Score=416.07  Aligned_cols=245  Identities=23%  Similarity=0.315  Sum_probs=207.1

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      |.+.++||+|+||+||+++. .+|+.||||++.+.    ....+.+.+|++++++++|||||++++++.+++..||||||
T Consensus        34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy  113 (311)
T 4aw0_A           34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY  113 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            67789999999999999985 57999999999752    34567899999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++.    ..+.+++..+..++.||+.||+|||+   ++|+||||||+||||++++.+||+|||+|+......
T Consensus       114 ~~gG~L~~~i~----~~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          114 AKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             CTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             CCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            99999999983    34679999999999999999999999   699999999999999999999999999999876544


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      ........+||+.|||||++.+.  .++.++||||+||++|||++|+.||......        .+...+.+.. ..   
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------~~~~~i~~~~-~~---  252 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNEG--------LIFAKIIKLE-YD---  252 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHS--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTC-CC---
T ss_pred             CcccccCcccCcccCCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCC-CC---
Confidence            43344566799999999999875  7899999999999999999999999754321        1233333221 11   


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVL  458 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl  458 (511)
                         .+..+++.+.+++.+||+.||++|||+.|++
T Consensus       253 ---~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          253 ---FPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ---CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ---CCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence               1223456788999999999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.8e-51  Score=423.69  Aligned_cols=246  Identities=25%  Similarity=0.328  Sum_probs=205.2

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC-cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      |.+.++||+|+||.||+|+. .+|+.||||++... ....+.+.+|+.++++++|||||++++++.+++..|||||||++
T Consensus       153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g  232 (423)
T 4fie_A          153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  232 (423)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence            45568999999999999985 47999999999763 33456789999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|.+++.     ...+++..+..++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+|+.......  
T Consensus       233 G~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--  302 (423)
T 4fie_A          233 GALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--  302 (423)
T ss_dssp             EEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--
T ss_pred             CcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--
Confidence            99999882     2469999999999999999999999   6999999999999999999999999999987654432  


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      .....+||+.|||||++.+.  .++.++|||||||++|||++|+.||......        .+...+.......+.    
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------~~~~~i~~~~~~~~~----  368 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------KAMKMIRDNLPPRLK----  368 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSCCCCCS----
T ss_pred             cccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHcCCCCCCc----
Confidence            23456799999999999875  7899999999999999999999999653321        122333332222222    


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ....++..+.+|+.+||+.||++|||+.|+++
T Consensus       369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            12234567889999999999999999999986

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.6e-50  Score=398.41  Aligned_cols=244  Identities=22%  Similarity=0.352  Sum_probs=190.7

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .|.+.++||+|+||.||+++. .+|+.||||++.+..    ...+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE   93 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE   93 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence            466778999999999999985 579999999997532    235679999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+ +|+|.+++.    ..+.+++..+..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+|+.....
T Consensus        94 y~-~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           94 YA-GNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             CC-CEEHHHHHH----HSCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             CC-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            99 689988883    34679999999999999999999999   69999999999999999999999999999865433


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      .   ......||+.|+|||++.+. ...+.++||||+||++|||++|+.||......        .+.+.+..+.. .  
T Consensus       166 ~---~~~~~~GT~~Y~APE~~~~~-~y~~~~~DiwSlGvily~lltg~~PF~~~~~~--------~~~~~i~~~~~-~--  230 (275)
T 3hyh_A          166 N---FLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYVMLCRRLPFDDESIP--------VLFKNISNGVY-T--  230 (275)
T ss_dssp             ------------CTTSCHHHHSSS-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCC-C--
T ss_pred             C---ccCCeeECcccCChhhhcCC-CCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcCCC-C--
Confidence            2   22445799999999999865 23468999999999999999999999754321        12333333221 1  


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                          .+..+++.+.+++.+||+.||++|||+.|+++
T Consensus       231 ----~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          231 ----LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                11234567889999999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.7e-50  Score=403.47  Aligned_cols=245  Identities=23%  Similarity=0.307  Sum_probs=194.5

Q ss_pred             HhhhccccCcCCcEEEEEEEe----cCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL----HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~----~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  261 (511)
                      .|.+.++||+|+||+||+++.    .+++.||||+++...   .....+.+|+.++++++|||||++++++.+++..+||
T Consensus        25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv  104 (304)
T 3ubd_A           25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI  104 (304)
T ss_dssp             GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred             ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            367789999999999999974    257899999997532   2344788999999999999999999999999999999


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      |||+++|+|.+++.    ..+.+++..+..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+|+...
T Consensus       105 mEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          105 LDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             ECCCTTCEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEcCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            99999999999983    34679999999999999999999999   699999999999999999999999999998654


Q ss_pred             CCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccc
Q 010434          342 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (511)
                      ....  ......||+.|||||++.+.  .++.++||||+||++|||++|+.||.......        +...+.+... .
T Consensus       178 ~~~~--~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--------~~~~i~~~~~-~  244 (304)
T 3ubd_A          178 DHEK--KAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE--------TMTMILKAKL-G  244 (304)
T ss_dssp             ---C--CCCSCCCCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC-C
T ss_pred             CCCc--cccccccCcccCCHHHhccC--CCCCCCcccchHHHHHHHHhCCCCCCCcCHHH--------HHHHHHcCCC-C
Confidence            3322  22456799999999999875  78999999999999999999999997543221        2222222211 1


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCC-----HHHHHH
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPS-----MTKVLE  459 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~evl~  459 (511)
                            .+..+++.+.+++.+||+.||++|||     ++|+++
T Consensus       245 ------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          245 ------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             ------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence                  12234567889999999999999998     467764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.1e-49  Score=393.33  Aligned_cols=248  Identities=21%  Similarity=0.288  Sum_probs=185.5

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCC----------
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS----------  256 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~----------  256 (511)
                      |.+.+.||+|+||.||+|+. .+|+.||||+++...  ...+.+.+|+.++++++|||||++++++.+.+          
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~   86 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP   86 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred             CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence            45678999999999999985 479999999987533  34467999999999999999999999986543          


Q ss_pred             --ceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecc
Q 010434          257 --KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF  334 (511)
Q Consensus       257 --~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DF  334 (511)
                        ..++||||+++|+|.+++.... ......+..++.++.||+.||+|||+   ++|+||||||+||||+.++.+||+||
T Consensus        87 ~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DF  162 (299)
T 4g31_A           87 KVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDF  162 (299)
T ss_dssp             CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             CcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccC
Confidence              3689999999999999984322 22345677889999999999999999   69999999999999999999999999


Q ss_pred             cccccCCCCCCce----------eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc
Q 010434          335 GLAKFHPKENDFV----------SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA  404 (511)
Q Consensus       335 Gla~~~~~~~~~~----------~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~  404 (511)
                      |+|+.........          ..+...||+.|||||++.+.  .++.++|||||||++|||++   ||......    
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyell~---Pf~~~~~~----  233 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLY---PFSTQMER----  233 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHS---CCSSHHHH----
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCC--CCCCHHHHHHHHHHHHHHcc---CCCCccHH----
Confidence            9998765433211          12334699999999999875  78999999999999999996   65432111    


Q ss_pred             ccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          405 YFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                         ......+.....      +.......+.+.+++.+||+.||++|||+.|+++
T Consensus       234 ---~~~~~~~~~~~~------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          234 ---VRTLTDVRNLKF------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             ---HHHHHHHHTTCC------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---HHHHHHHhcCCC------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               001111111111      1133344556778999999999999999999987

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.9e-47  Score=392.14  Aligned_cols=262  Identities=20%  Similarity=0.243  Sum_probs=197.7

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceec------cCCce
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCS------EGSKR  258 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~------~~~~~  258 (511)
                      .|.+.++||+|+||.||+|+. .+|+.||||+++....   ..+.+.+|+.+|++++|||||++++++.      +....
T Consensus        55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~  134 (398)
T 4b99_A           55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV  134 (398)
T ss_dssp             SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred             CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence            356678999999999999985 5799999999976432   3457889999999999999999999875      34678


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      |||||||+ |+|.+++.    ..+.+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+|+
T Consensus       135 ~ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          135 YVVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceee
Confidence            99999995 78988883    34689999999999999999999999   699999999999999999999999999998


Q ss_pred             cCCCCCC--ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc-------cchh
Q 010434          339 FHPKEND--FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY-------FPSW  409 (511)
Q Consensus       339 ~~~~~~~--~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~-------~~~~  409 (511)
                      .......  ........||+.|+|||++.+. ..++.++||||+||++|||++|+.||........-..       .+..
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            6643321  1223456799999999998764 3578999999999999999999999975432110000       0000


Q ss_pred             h---------HHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          410 V---------YDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       410 ~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .         ...+.................++..+.+|+.+||+.||++|||+.|+++
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0         0000000000000001111223567889999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1e-45  Score=373.07  Aligned_cols=285  Identities=39%  Similarity=0.666  Sum_probs=228.9

Q ss_pred             CCCCChHHHHHHHhhhc--cccCcCCcEEEEEEEecCCcEEEEEEeccCcc--cHHHHHHHHHHhccccccceEEeecee
Q 010434          177 PKRYSYPEIIAVTNHFT--HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFC  252 (511)
Q Consensus       177 ~~~~~~~ei~~~t~~~~--~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~  252 (511)
                      .+.|++.++...+.++.  ++||+|+||.||+|..++|+.||||++.....  ....|.+|+.++++++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            35688888888777764  68999999999999988899999999976322  234789999999999999999999999


Q ss_pred             ccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeee
Q 010434          253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVS  332 (511)
Q Consensus       253 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~  332 (511)
                      ......++||||+++|+|.+++.........+++..+..++.|++.||+|||+.+..+|+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999986655556679999999999999999999999444499999999999999999999999


Q ss_pred             cccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccc-cccccchhhH
Q 010434          333 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRS-SKAYFPSWVY  411 (511)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~-~~~~~~~~~~  411 (511)
                      |||+++........ ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||+...... .......|+.
T Consensus       177 Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          177 DFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             CCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHS--EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             cCccccccCccccc-ccccccCCcCccCHHHhccC--CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            99999876544332 23445699999999998764  78999999999999999999999997543221 1222233333


Q ss_pred             HhhhcCCcccc---cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          412 DQLNKGGDLEL---RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       412 ~~~~~~~~~~~---~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                      ...........   ..........+..+.+++.+||+.||++|||+.+|+++|++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            32222211111   111234556778899999999999999999999999999974

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6e-46  Score=380.80  Aligned_cols=196  Identities=21%  Similarity=0.339  Sum_probs=167.2

Q ss_pred             HhhhccccCcCCcEEEEEEEec----CCcEEEEEEeccCcccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~----~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .|.+.++||+|+||+||+|+.+    +++.||||.+.... ....+.+|++++.++ +|||||++++++.+.+..++|||
T Consensus        22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE  100 (361)
T 4f9c_A           22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP  100 (361)
T ss_dssp             TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred             cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence            4567789999999999999743    46899999986543 456788999999998 69999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC-CCeeeecccccccCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPK  342 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~-~~~kl~DFGla~~~~~  342 (511)
                      |+++|+|.+++       +.+++..+..++.||+.||+|||+   .+|+||||||+|||++.+ +.+||+|||+|+....
T Consensus       101 ~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A          101 YLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             CCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             CCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            99999999988       358999999999999999999999   699999999999999887 7999999999986543


Q ss_pred             CCCc--------------------------eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCc
Q 010434          343 ENDF--------------------------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM  396 (511)
Q Consensus       343 ~~~~--------------------------~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~  396 (511)
                      ....                          ...+...||+.|+|||++.+. ..++.++||||+||++|||++|+.||..
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             CSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence            2110                          112334699999999998764 3588999999999999999999999854

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7e-45  Score=366.53  Aligned_cols=269  Identities=35%  Similarity=0.620  Sum_probs=217.2

Q ss_pred             hccccCcCCcEEEEEEEecCCcEEEEEEeccC-cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCc
Q 010434          192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL  270 (511)
Q Consensus       192 ~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  270 (511)
                      +.+.||+|+||.||+|+.++|+.||||++... ....+.+.+|+.++++++||||+++++++.+++..++||||+++|+|
T Consensus        43 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  122 (321)
T 2qkw_B           43 HKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL  122 (321)
T ss_dssp             CCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBT
T ss_pred             ccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcH
Confidence            45789999999999999888999999998763 34567899999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeec
Q 010434          271 DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  350 (511)
Q Consensus       271 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  350 (511)
                      .+++.........+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++............
T Consensus       123 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  199 (321)
T 2qkw_B          123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST  199 (321)
T ss_dssp             GGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBC
T ss_pred             HHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeeccccccccccccccccc
Confidence            99986554445579999999999999999999999   699999999999999999999999999998654433222234


Q ss_pred             cccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccc---cccch
Q 010434          351 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL---RNVTE  427 (511)
Q Consensus       351 ~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  427 (511)
                      ...||+.|+|||.+.+.  .++.++||||||+++|||++|+.|+....... ......|.............   .....
T Consensus       200 ~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (321)
T 2qkw_B          200 VVKGTLGYIDPEYFIKG--RLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE-MVNLAEWAVESHNNGQLEQIVDPNLADK  276 (321)
T ss_dssp             CCEEETTTCCHHHHHHC--BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS-CCCHHHHTHHHHTTTCCCSSSSSSCTTC
T ss_pred             ccCCCccccCHHHhcCC--CCCcccchHhHHHHHHHHHhCCCcccccCcHH-HHHHHHHhhhccccccHHHhcChhhccc
Confidence            45689999999998764  78999999999999999999999987543322 11122232222222111111   11122


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      .....+..+.+++.+||+.||++|||+.++++.|+..+.
T Consensus       277 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            445678889999999999999999999999999987553

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.6e-45  Score=397.82  Aligned_cols=249  Identities=21%  Similarity=0.301  Sum_probs=205.9

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .|.+.++||+|+||.||++.. .+|+.||||++.... ...+.+.+|+.+|+.++|||||++++++.++...+||||||+
T Consensus       158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~  237 (573)
T 3uto_A          158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS  237 (573)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence            466778999999999999985 479999999997643 345678999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC--CCeeeecccccccCCCCC
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN--FIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~--~~~kl~DFGla~~~~~~~  344 (511)
                      +|+|.++|.   .....+++..+..++.||+.||+|||+   ++|+||||||+|||++.+  +.+||+|||+|+......
T Consensus       238 gg~L~~~i~---~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          238 GGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             CCBHHHHHT---CTTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             CCcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            999999883   234679999999999999999999999   699999999999999854  899999999999775443


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                         ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||.......        +...+..... ..  
T Consensus       312 ---~~~~~~GT~~y~APEv~~~~--~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~--------~~~~i~~~~~-~~--  375 (573)
T 3uto_A          312 ---SVKVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--------TLRNVKSCDW-NM--  375 (573)
T ss_dssp             ---EEEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHTTCC-CC--
T ss_pred             ---ceeeeEECccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--------HHHHHHhCCC-CC--
Confidence               23445799999999999875  78999999999999999999999997543221        2222222211 11  


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .......++..+.+|+.+||+.||++|||+.|+++
T Consensus       376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11122335677889999999999999999999987

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8.4e-45  Score=366.59  Aligned_cols=269  Identities=26%  Similarity=0.333  Sum_probs=207.7

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCC----ceeEEEee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KRALVYEF  264 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~----~~~lV~e~  264 (511)
                      .+.+.++||+|+||.||+|+.. ++.||||++.........+..|+.++++++||||+++++++....    ..++||||
T Consensus        25 ~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~  103 (322)
T 3soc_A           25 PLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF  103 (322)
T ss_dssp             EEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             hchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEec
Confidence            3456789999999999999876 899999999776656667788999999999999999999997744    36999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCC-------CCceecccCCcCceEEcCCCCeeeeccccc
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC-------DMCILHFDIKPHNILLDHNFIPKVSDFGLA  337 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-------~~~ivH~DIkp~NILl~~~~~~kl~DFGla  337 (511)
                      +++|+|.+++.     ...+++..+..++.|++.||+|||+.+       ..+|+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~g~L~~~l~-----~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a  178 (322)
T 3soc_A          104 HEKGSLSDFLK-----ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA  178 (322)
T ss_dssp             CTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence            99999999982     245999999999999999999999820       119999999999999999999999999999


Q ss_pred             ccCCCCCCceeeccccCCccccchhcccccC---CCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc--------c
Q 010434          338 KFHPKENDFVSISATRGTIGYIAPELISRNF---GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY--------F  406 (511)
Q Consensus       338 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~--------~  406 (511)
                      +...............||+.|+|||++.+..   ..++.++||||||+++|||++|+.||...........        .
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  258 (322)
T 3soc_A          179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS  258 (322)
T ss_dssp             EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred             cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence            8766554433344567999999999987521   2567789999999999999999999875432211100        0


Q ss_pred             chhhHHhh-hcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          407 PSWVYDQL-NKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       407 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                      ........ .......+... ......+..+.+++.+||+.||++|||+.+|++.|+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          259 LEDMQEVVVHKKKRPVLRDY-WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             HHHHHHHHTTSCCCCCCCGG-GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhhhhhhhhcccCCCCcccc-ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            01111111 11111111111 12223456799999999999999999999999999864

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3e-44  Score=389.25  Aligned_cols=246  Identities=24%  Similarity=0.321  Sum_probs=197.8

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC----cccHHHHHH---HHHHhccccccceEEeeceeccCCceeEE
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS----KFSAEEFIN---EVSTIGRIHHVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~----~~~~~~f~~---Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  261 (511)
                      +.+.++||+|+||.||+++. .+|+.||||++.+.    ......+.+   ++.+++.++|||||++++++.+.+..|||
T Consensus       191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV  270 (689)
T 3v5w_A          191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI  270 (689)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence            55678999999999999985 47999999999652    222333334   46777888999999999999999999999


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      |||++||+|.++|.    ..+.+++..+..++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+|+...
T Consensus       271 mEy~~GGdL~~~l~----~~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          271 LDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             ECCCCSCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999983    34679999999999999999999998   799999999999999999999999999998765


Q ss_pred             CCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccc
Q 010434          342 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (511)
                      ...    ....+||+.|||||++.+. ..++.++||||+||++|||++|+.||........     ..+........ . 
T Consensus       344 ~~~----~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-----~~i~~~i~~~~-~-  411 (689)
T 3v5w_A          344 KKK----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTLTMA-V-  411 (689)
T ss_dssp             SCC----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-----HHHHHHHHHCC-C-
T ss_pred             CCC----CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhhcCCC-C-
Confidence            443    2445799999999999642 2688999999999999999999999975432211     11222221111 1 


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCC-----HHHHHH
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPS-----MTKVLE  459 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~evl~  459 (511)
                           ..+..+++.+.+|+.+||+.||++|++     +.+|++
T Consensus       412 -----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          412 -----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             -----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                 122235677899999999999999998     688865

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.2e-44  Score=356.74  Aligned_cols=277  Identities=34%  Similarity=0.568  Sum_probs=222.1

Q ss_pred             CCCCChHHHHHHHhhhc--------cccCcCCcEEEEEEEecCCcEEEEEEeccC-----cccHHHHHHHHHHhcccccc
Q 010434          177 PKRYSYPEIIAVTNHFT--------HKLGQGGFGSVYKGQLHTGRLIAVKMLENS-----KFSAEEFINEVSTIGRIHHV  243 (511)
Q Consensus       177 ~~~~~~~ei~~~t~~~~--------~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~-----~~~~~~f~~Ev~~l~~l~H~  243 (511)
                      .+.|++.++..++.+|.        ++||+|+||.||+|.. +++.||||++...     ....+.|.+|+.++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            35689999999999987        4599999999999987 5889999998652     22356899999999999999


Q ss_pred             ceEEeeceeccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEE
Q 010434          244 NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL  323 (511)
Q Consensus       244 niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl  323 (511)
                      ||+++++++.++...++||||+++|+|.+++... .....+++..+..++.|++.||+|||+   .+|+|+||||+||++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili  166 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILL  166 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEE
Confidence            9999999999999999999999999999988432 234579999999999999999999999   699999999999999


Q ss_pred             cCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc
Q 010434          324 DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK  403 (511)
Q Consensus       324 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~  403 (511)
                      +.++.+||+|||+++...............||+.|+|||.+.+   .++.++||||||+++|||++|+.|+.......  
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--  241 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--  241 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchH--
Confidence            9999999999999987665443333345569999999998864   57899999999999999999999987643221  


Q ss_pred             cccchhhHHhhhcC-Cccc---ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          404 AYFPSWVYDQLNKG-GDLE---LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       404 ~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                       .+..+. ...... ....   ...........+..+.+++.+||+.||.+|||+.+|++.|+...
T Consensus       242 -~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          242 -LLLDIK-EEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             -BTTHHH-HHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             -HHHHHH-HHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence             111111 111111 0000   00111234556788999999999999999999999999998743

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.9e-44  Score=350.46  Aligned_cols=256  Identities=26%  Similarity=0.437  Sum_probs=213.3

Q ss_pred             HHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      ..+.+.++||+|+||.||+++.+++..||||+++......+++.+|+.++.+++||||+++++++.++...++||||+++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   87 (268)
T 3sxs_A            8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISN   87 (268)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred             hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCC
Confidence            35566789999999999999988888999999988777888999999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      ++|.+++.   ..+..+++..+..++.|++.||+|||+   .+|+|+||||+||+++.++.+||+|||+++....... .
T Consensus        88 ~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~  160 (268)
T 3sxs_A           88 GCLLNYLR---SHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-V  160 (268)
T ss_dssp             CBHHHHHH---HHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-E
T ss_pred             CcHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhh-h
Confidence            99999883   233569999999999999999999999   6999999999999999999999999999987655432 2


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                      ......+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.|+.......        ..............   
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~---  227 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE--------VVLKVSQGHRLYRP---  227 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHS--EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------HHHHHHTTCCCCCC---
T ss_pred             cccCCCcCcccCCHHHHhcc--CCchhhhhHHHHHHHHHHHcCCCCCccccChHH--------HHHHHHcCCCCCCC---
Confidence            23445578889999999764  78899999999999999999 999986543221        22222222221111   


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                         ...+..+.+++.+||+.||++|||+.++++.|+...+
T Consensus       228 ---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          228 ---HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             ---TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             ---CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence               1124568899999999999999999999999997554

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.3e-44  Score=357.96  Aligned_cols=262  Identities=29%  Similarity=0.490  Sum_probs=199.2

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      .+.+.++||+|+||.||+|+. +|+.||||++.....   ..++|.+|+.++++++||||+++++++.+....++||||+
T Consensus        38 ~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  116 (309)
T 3p86_A           38 DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYL  116 (309)
T ss_dssp             GEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECC
T ss_pred             HceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecC
Confidence            456678999999999999986 588999999976443   3457899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCc--eecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC--ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      ++|+|.+++.... ....+++..+..++.|++.||+|||+   .+  |+||||||+|||++.++.+||+|||+++.....
T Consensus       117 ~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  192 (309)
T 3p86_A          117 SRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST  192 (309)
T ss_dssp             TTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred             CCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence            9999999884321 12349999999999999999999998   57  999999999999999999999999999854332


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhh-cCCcccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLN-KGGDLEL  422 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  422 (511)
                      .  .......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.......        ...... ...... 
T Consensus       193 ~--~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--------~~~~~~~~~~~~~-  259 (309)
T 3p86_A          193 F--LSSKSAAGTPEWMAPEVLRDE--PSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--------VVAAVGFKCKRLE-  259 (309)
T ss_dssp             -----------CCTTSCHHHHTTC--CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--------HHHHHHHSCCCCC-
T ss_pred             c--cccccCCCCccccChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcCCCCC-
Confidence            2  122445699999999999865  67899999999999999999999986543211        111111 111111 


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCCCCCC
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPK  473 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~~p~~  473 (511)
                           .+..++..+.+++.+||+.||++|||+.++++.|+........||.
T Consensus       260 -----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~  305 (309)
T 3p86_A          260 -----IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN  305 (309)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred             -----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence                 1223456788999999999999999999999999988776554443

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.5e-44  Score=367.96  Aligned_cols=258  Identities=23%  Similarity=0.416  Sum_probs=209.9

Q ss_pred             HhhhccccCcCCcEEEEEEEec--------CCcEEEEEEeccCc--ccHHHHHHHHHHhccc-cccceEEeeceeccCCc
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH--------TGRLIAVKMLENSK--FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSK  257 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~--------~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~  257 (511)
                      .+.+.+.||+|+||.||+|+..        ++..||||+++...  ...+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus        82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  161 (370)
T 2psq_A           82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP  161 (370)
T ss_dssp             GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSS
T ss_pred             HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCC
Confidence            4556789999999999999752        45689999997643  2446799999999999 89999999999999999


Q ss_pred             eeEEEeecCCCCcccccccCCC------------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC
Q 010434          258 RALVYEFMPNGSLDRHIFPKEN------------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH  325 (511)
Q Consensus       258 ~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~  325 (511)
                      .++||||+++|+|.+++.....            ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.
T Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~  238 (370)
T 2psq_A          162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTE  238 (370)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECT
T ss_pred             EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEECC
Confidence            9999999999999998854321            12458999999999999999999999   69999999999999999


Q ss_pred             CCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCccccccccc
Q 010434          326 NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKA  404 (511)
Q Consensus       326 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~  404 (511)
                      ++.+||+|||+++...............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||......    
T Consensus       239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~p~~~~~~~----  312 (370)
T 2psq_A          239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----  312 (370)
T ss_dssp             TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----
T ss_pred             CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence            999999999999876554433333455688999999998764  78999999999999999999 99998654321    


Q ss_pred             ccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          405 YFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                          .+...+..+.....      +..++..+.+++.+||+.||++|||+.++++.|+..+
T Consensus       313 ----~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          313 ----ELFKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             ----GHHHHHHTTCCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----HHHHHHhcCCCCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                12233333322221      1224567889999999999999999999999998754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.3e-43  Score=356.14  Aligned_cols=260  Identities=23%  Similarity=0.322  Sum_probs=211.4

Q ss_pred             CCCCChHHHHHHHhh------------hccccCcCCcEEEEEEEec-CCcEEEEEEeccC-cccHHHHHHHHHHhccccc
Q 010434          177 PKRYSYPEIIAVTNH------------FTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS-KFSAEEFINEVSTIGRIHH  242 (511)
Q Consensus       177 ~~~~~~~ei~~~t~~------------~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~-~~~~~~f~~Ev~~l~~l~H  242 (511)
                      +..+++.++..++..            +.++||+|+||.||+|+.. +|+.||||++... ....+.+.+|+.++++++|
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence            456888888888764            3358999999999999965 7999999999763 4456789999999999999


Q ss_pred             cceEEeeceeccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceE
Q 010434          243 VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNIL  322 (511)
Q Consensus       243 ~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NIL  322 (511)
                      |||+++++++..+...++||||+++|+|.+++.     ...+++..+..++.|++.||+|||+   .+|+||||||+|||
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIl  173 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSIL  173 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEE
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEE
Confidence            999999999999999999999999999999872     2469999999999999999999999   69999999999999


Q ss_pred             EcCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccc
Q 010434          323 LDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSS  402 (511)
Q Consensus       323 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~  402 (511)
                      ++.++.+||+|||+++.......  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||......  
T Consensus       174 l~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~pf~~~~~~--  247 (321)
T 2c30_A          174 LTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRS--LYATEVDIWSLGIMVIEMVDGEPPYFSDSPV--  247 (321)
T ss_dssp             ECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--
T ss_pred             ECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--
Confidence            99999999999999987654322  12445699999999999764  7899999999999999999999998653221  


Q ss_pred             ccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          403 KAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                            .....+.........    ....++..+.+++.+||+.||++|||+.++++.
T Consensus       248 ------~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          248 ------QAMKRLRDSPPPKLK----NSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             ------HHHHHHHHSSCCCCT----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ------HHHHHHhcCCCCCcC----ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  122222222211111    122345678899999999999999999999873

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1e-43  Score=348.67  Aligned_cols=254  Identities=29%  Similarity=0.501  Sum_probs=211.1

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      .+.+.++||+|+||.||++...+++.||||++.......+++.+|+.++++++||||+++++++.++...++||||++++
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (269)
T 4hcu_A           11 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG   90 (269)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred             hceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCC
Confidence            45567899999999999999888999999999887778889999999999999999999999999999999999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      +|.+++..   ....+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus        91 ~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  163 (269)
T 4hcu_A           91 CLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS  163 (269)
T ss_dssp             BHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred             cHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccc-ccc
Confidence            99998832   33579999999999999999999999   699999999999999999999999999998654332 112


Q ss_pred             eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      .....+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.|+......        .....+.........    
T Consensus       164 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~----  229 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------EVVEDISTGFRLYKP----  229 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTCCCCCC----
T ss_pred             ccCcccccccCCHHHhcCC--CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHhcCccCCCC----
Confidence            2344578899999999765  78999999999999999999 89998654322        122223322221111    


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                        ...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus       230 --~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~  265 (269)
T 4hcu_A          230 --RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  265 (269)
T ss_dssp             --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence              123466889999999999999999999999998643

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=5.5e-44  Score=361.30  Aligned_cols=259  Identities=29%  Similarity=0.467  Sum_probs=207.5

Q ss_pred             HHHhhhccccCcCCcEEEEEEEec----CCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeE
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  260 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~~----~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  260 (511)
                      ...+.+.++||+|+||.||+|...    .+..||||+++..  ....+.|.+|+.++++++||||+++++++.++...++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            345566789999999999999863    3557999999763  3345679999999999999999999999999999999


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      ||||+++|+|.+++.   .....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       128 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          128 VTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             EEECCTTCBHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EeeCCCCCcHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            999999999999983   233579999999999999999999999   69999999999999999999999999999876


Q ss_pred             CCCCCc-eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCC
Q 010434          341 PKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGG  418 (511)
Q Consensus       341 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  418 (511)
                      ...... .......+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||......        .+...+..+.
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------~~~~~~~~~~  271 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--------DVISSVEEGY  271 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------HHHHHHHTTC
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHHcCC
Confidence            544322 222334578899999999764  78899999999999999999 99998653322        1222333332


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          419 DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       419 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                      ....      ...++..+.+++.+||+.||++|||+.+|++.|+.....
T Consensus       272 ~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          272 RLPA------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             CCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CCCC------CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence            2221      122456788999999999999999999999999986644

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6.5e-44  Score=377.26  Aligned_cols=260  Identities=25%  Similarity=0.418  Sum_probs=213.2

Q ss_pred             HHHHHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          185 IIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       185 i~~~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +....+.+.++||+|+||.||+|..+++..||||+++......++|.+|+.++++++|||||++++++. ....++||||
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            334455667899999999999999988999999999887778899999999999999999999999987 5678999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++...  .+..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       264 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          264 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             CTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             cCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            9999999998322  23468999999999999999999999   699999999999999999999999999998764321


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                       ........+|+.|+|||.+...  .++.++||||||+++|||++ |+.||......        .+...+..+..... 
T Consensus       339 -~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--------~~~~~i~~~~~~~~-  406 (454)
T 1qcf_A          339 -YTAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--------EVIRALERGYRMPR-  406 (454)
T ss_dssp             -HHTTCSSSSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHHHHHHHTCCCCC-
T ss_pred             -eeccCCCcccccccCHHHhccC--CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCC-
Confidence             1112334578899999999764  78999999999999999999 99998653221        12233333322221 


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                           +..++..+.+++.+||+.||++|||+.+|+++|+.....
T Consensus       407 -----~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          407 -----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             -----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence                 122456788999999999999999999999999986654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.6e-44  Score=369.32  Aligned_cols=254  Identities=24%  Similarity=0.413  Sum_probs=206.1

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      .+.+.++||+|+||.||+|+.. +++.||||+++...  ...++|.+|+.++++++||||+++++++..+...++||||+
T Consensus       115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  194 (377)
T 3cbl_A          115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV  194 (377)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcC
Confidence            4556789999999999999975 78999999987532  23357899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++|+|.+++.   ..+..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus       195 ~~g~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          195 QGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             TTCBHHHHHH---HHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             CCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            9999999883   234569999999999999999999999   6999999999999999999999999999986543221


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      ........+|+.|+|||.+...  .++.++||||||+++|||++ |+.|+......        .+...+..+...... 
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~-  337 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSNQ--------QTREFVEKGGRLPCP-  337 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--------HHHHHHHTTCCCCCC-
T ss_pred             eecCCCCCCCcCcCCHhHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCC-
Confidence            1111223467889999998764  78999999999999999998 89888653321        123333333322221 


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                           ..++..+.+++.+||+.||++|||+.++++.|+..
T Consensus       338 -----~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          338 -----ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             -----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence                 12346788999999999999999999999999864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.4e-43  Score=351.49  Aligned_cols=259  Identities=27%  Similarity=0.392  Sum_probs=205.8

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEecc-CcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLEN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .+.+.++||+|+||.||++.. .+++.||+|++.. +....+.|.+|+.++++++||||+++++++.++...++||||++
T Consensus        11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~   90 (310)
T 3s95_A           11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK   90 (310)
T ss_dssp             GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecC
Confidence            345678999999999999985 4689999998865 34456789999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +|+|.+++..   ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus        91 ~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           91 GGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             TCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             CCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            9999999832   24679999999999999999999999   69999999999999999999999999999876543321


Q ss_pred             e------------eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhh
Q 010434          347 V------------SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQL  414 (511)
Q Consensus       347 ~------------~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  414 (511)
                      .            ......||+.|+|||.+.+.  .++.++||||||+++|||++|..|+............  ......
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~--~~~~~~  240 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR--SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL--NVRGFL  240 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB--CHHHHH
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh--hhhccc
Confidence            1            01144699999999999764  7899999999999999999999887653322211110  011111


Q ss_pred             hcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          415 NKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       415 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                      ...          .+..++..+.+++.+||+.||++|||+.++++.|+.....
T Consensus       241 ~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          241 DRY----------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             HHT----------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccc----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            110          1122345688899999999999999999999999875443

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.5e-43  Score=378.49  Aligned_cols=260  Identities=29%  Similarity=0.449  Sum_probs=215.8

Q ss_pred             HHHHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          185 IIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       185 i~~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      +....+.+.++||+|+||.||+|..+ ++..||||+++......++|.+|+.++++++|||||++++++......++|||
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            34445667789999999999999976 48999999998877778899999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++|+|.+++..  .....+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       297 ~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          297 FMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             CCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             ccCCCCHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            9999999999842  233568999999999999999999999   69999999999999999999999999999876543


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                      . ........+|+.|+|||.+...  .++.++||||||+++|||++ |+.|+......        .+.+.+..+.....
T Consensus       372 ~-~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~  440 (495)
T 1opk_A          372 T-YTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEKDYRMER  440 (495)
T ss_dssp             C-EECCTTCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------GHHHHHHTTCCCCC
T ss_pred             c-eeecCCCcCCcceeCHhHHhcC--CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCC
Confidence            2 2223445578899999999764  78999999999999999999 88888654321        13333333322221


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                            +..++..+.+++.+||+.||++|||+.+|++.|+....
T Consensus       441 ------~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          441 ------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             ------CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence                  12345678899999999999999999999999998654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.1e-43  Score=375.20  Aligned_cols=260  Identities=28%  Similarity=0.448  Sum_probs=208.7

Q ss_pred             HHHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      ...+.+.++||+|+||.||+|..+++..||||+++......++|.+|+.++++++||||+++++++.+ ...++||||++
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~  261 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  261 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence            34456678999999999999999888899999998776778899999999999999999999999976 67899999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +|+|.+++..  ..+..+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++...... .
T Consensus       262 ~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~  335 (452)
T 1fmk_A          262 KGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  335 (452)
T ss_dssp             TCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-e
Confidence            9999999832  223568999999999999999999999   699999999999999999999999999998664332 1


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                      .......+|+.|+|||.+...  .++.++||||||+++|||++ |+.|+......        .+...+..+.....   
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--------~~~~~i~~~~~~~~---  402 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERGYRMPC---  402 (452)
T ss_dssp             -------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCCCCC---
T ss_pred             ecccCCcccccccCHhHHhcC--CCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCC---
Confidence            222344578899999998764  78999999999999999999 89998653221        12333333332221   


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCC
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQ  469 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~  469 (511)
                         +..++..+.+++.+||+.||++|||+.++++.|+.......
T Consensus       403 ---~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          403 ---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             ---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence               12345678899999999999999999999999998776544

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.3e-43  Score=352.16  Aligned_cols=247  Identities=24%  Similarity=0.351  Sum_probs=202.7

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEecc-CcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLEN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .|.+.++||+|+||.||++.. .+|+.||||++.. .....+.+.+|+.++++++||||+++++++..++..++||||++
T Consensus        21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  100 (297)
T 3fxz_A           21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (297)
T ss_dssp             TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence            345568999999999999984 5799999999865 34456789999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +|+|.+++.     ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....... 
T Consensus       101 ~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  171 (297)
T 3fxz_A          101 GGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (297)
T ss_dssp             TCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence            999999882     2468999999999999999999999   6999999999999999999999999999987654432 


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                       ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.......       .... ..........   
T Consensus       172 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~-~~~~~~~~~~---  237 (297)
T 3fxz_A          172 -KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-------ALYL-IATNGTPELQ---  237 (297)
T ss_dssp             -CBCCCCSCGGGCCHHHHHCS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHH-HHHHCSCCCS---
T ss_pred             -ccCCccCCcCccChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHH-HHhCCCCCCC---
Confidence             22445699999999999765  78999999999999999999999986533211       1111 1111111111   


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                       ....++..+.+++.+||+.||++|||+.++++
T Consensus       238 -~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          238 -NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             -CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence             12234567889999999999999999999986

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=6.4e-44  Score=360.93  Aligned_cols=256  Identities=25%  Similarity=0.415  Sum_probs=200.3

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCc----EEEEEEecc--CcccHHHHHHHHHHhccccccceEEeeceeccCCceeEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGR----LIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~----~vAvK~l~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  261 (511)
                      .+.+.++||+|+||.||+|+. .+++    +||+|.+..  .....++|.+|+.++++++||||+++++++.++. .++|
T Consensus        16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v   94 (327)
T 3poz_A           16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI   94 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEE
T ss_pred             HcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEE
Confidence            455678999999999999984 3444    468888754  3345678999999999999999999999998754 7899


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      +||+++|+|.+++..   ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        95 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           95 TQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            999999999998843   34679999999999999999999999   699999999999999999999999999998776


Q ss_pred             CCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcc
Q 010434          342 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDL  420 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (511)
                      ............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||.......        +...+..+...
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~~~~~~  238 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGERL  238 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCCC
T ss_pred             CCcccccccCCCccccccChHHhccC--CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--------HHHHHHcCCCC
Confidence            55444444455678899999999865  78999999999999999999 999987543221        22333333222


Q ss_pred             cccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          421 ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       421 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                      ...      ...+..+..++.+||+.||++|||+.++++.|+.....
T Consensus       239 ~~~------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          239 PQP------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CCC------TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCC------ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            211      12345688899999999999999999999999875543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.8e-43  Score=346.15  Aligned_cols=255  Identities=26%  Similarity=0.433  Sum_probs=208.8

Q ss_pred             HHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      ..+.+.++||+|+||.||++...++..||||++.......+++.+|+.++.+++||||+++++++.++...++||||+++
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  103 (283)
T 3gen_A           24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN  103 (283)
T ss_dssp             GGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTT
T ss_pred             HHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCC
Confidence            35566789999999999999998889999999988777788999999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      ++|.+++..   ....+++..+..++.|++.||+|||+   .+|+|+||||+|||++.++.+||+|||+++...... ..
T Consensus       104 ~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~  176 (283)
T 3gen_A          104 GCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YT  176 (283)
T ss_dssp             CBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HH
T ss_pred             CcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccc-cc
Confidence            999999832   23569999999999999999999999   699999999999999999999999999998664332 11


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                      ......+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||......        .....+.........   
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~---  243 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIAQGLRLYRP---  243 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTTCCCCCC---
T ss_pred             cccCCccCcccCCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccChh--------HHHHHHhcccCCCCC---
Confidence            22344578899999999765  78999999999999999998 99998654322        122223332222111   


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                         ...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus       244 ---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          244 ---HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             ---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence               112457889999999999999999999999998654

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4e-43  Score=349.41  Aligned_cols=263  Identities=21%  Similarity=0.294  Sum_probs=199.1

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhcc--ccccceEEeeceecc----CCceeEEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGR--IHHVNVVQLLGFCSE----GSKRALVY  262 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~--l~H~niv~l~g~~~~----~~~~~lV~  262 (511)
                      .+.+.++||+|+||.||+|+. +|+.||||++...  ..+.+..|.+++..  ++||||+++++++..    ....++||
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~   85 (301)
T 3q4u_A            9 DITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT   85 (301)
T ss_dssp             GCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             cEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence            456678999999999999987 5899999998654  34566667666665  799999999998644    35688999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCC-----CCceecccCCcCceEEcCCCCeeeeccccc
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC-----DMCILHFDIKPHNILLDHNFIPKVSDFGLA  337 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~ivH~DIkp~NILl~~~~~~kl~DFGla  337 (511)
                      ||+++|+|.+++     ....+++..+..++.|++.||+|||...     ..+|+||||||+|||++.++.+||+|||++
T Consensus        86 e~~~~g~L~~~l-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           86 HYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             CCCTTCBHHHHH-----TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             hhccCCCHHHHH-----hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            999999999998     2357999999999999999999999210     279999999999999999999999999999


Q ss_pred             ccCCCCCCcee--eccccCCccccchhcccccCC----CcCccchHHHHHHHHHHHHhC----------CCCCCcccccc
Q 010434          338 KFHPKENDFVS--ISATRGTIGYIAPELISRNFG----TVSCKSDVYGFGMVLLEMAGG----------RRNSNMNAIRS  401 (511)
Q Consensus       338 ~~~~~~~~~~~--~~~~~gt~~y~APE~~~~~~~----~~s~ksDVwS~Gvll~elltg----------~~p~~~~~~~~  401 (511)
                      +..........  .....||+.|+|||++.+...    .++.++||||||+++|||++|          +.||.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            86654433221  233469999999999875421    355799999999999999999          66664322111


Q ss_pred             cccccchhhHHhh-hcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          402 SKAYFPSWVYDQL-NKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       402 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                        .... ...... ......... ........+..+.+++.+||+.||++|||+.+|++.|+.
T Consensus       241 --~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          241 --PSFE-DMRKVVCVDQQRPNIP-NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             --CCHH-HHHHHHTTSCCCCCCC-GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             --cchh-hhhHHHhccCCCCCCC-hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence              1111 111111 111122211 122344567889999999999999999999999999985

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-43  Score=363.03  Aligned_cols=266  Identities=23%  Similarity=0.385  Sum_probs=215.1

Q ss_pred             HHHHHhhhccccCcCCcEEEEEEEec--------CCcEEEEEEeccCc--ccHHHHHHHHHHhccc-cccceEEeeceec
Q 010434          185 IIAVTNHFTHKLGQGGFGSVYKGQLH--------TGRLIAVKMLENSK--FSAEEFINEVSTIGRI-HHVNVVQLLGFCS  253 (511)
Q Consensus       185 i~~~t~~~~~~LG~G~fg~Vykg~~~--------~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~  253 (511)
                      +....+.+.++||+|+||.||+|+..        .+..||||+++...  ...+.+.+|+.+++++ +||||+++++++.
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            33446667789999999999999842        23689999997643  2346799999999999 9999999999999


Q ss_pred             cCCceeEEEeecCCCCcccccccCCC------------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCce
Q 010434          254 EGSKRALVYEFMPNGSLDRHIFPKEN------------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNI  321 (511)
Q Consensus       254 ~~~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NI  321 (511)
                      .++..++||||+++|+|.+++.....            ....+++..+..++.||+.||+|||+   .+|+||||||+||
T Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NI  222 (382)
T 3tt0_A          146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNV  222 (382)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGE
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceE
Confidence            99999999999999999998854321            12469999999999999999999999   6999999999999


Q ss_pred             EEcCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCccccc
Q 010434          322 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIR  400 (511)
Q Consensus       322 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~  400 (511)
                      |++.++.+||+|||+++...............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.|+......
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt~g~~p~~~~~~~  300 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  300 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999876654443444556688999999999764  78999999999999999999 99998654321


Q ss_pred             ccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCC
Q 010434          401 SSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQ  469 (511)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~  469 (511)
                              .+.+.+..+......      ..++..+.+++.+||+.||++|||+.+|++.|+.......
T Consensus       301 --------~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          301 --------ELFKLLKEGHRMDKP------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             --------HHHHHHHTTCCCCCC------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             --------HHHHHHHcCCCCCCC------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence                    233333333322221      1234678899999999999999999999999998765443

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.1e-43  Score=353.10  Aligned_cols=267  Identities=26%  Similarity=0.410  Sum_probs=204.4

Q ss_pred             HHHhhhccccCcCCcEEEEEEEe-----cCCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceecc--CCce
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQL-----HTGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKR  258 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~-----~~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~--~~~~  258 (511)
                      ...+.+.++||+|+||.||++++     .+++.||||++.... ...+.|.+|+.++++++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            34566788999999999999984     368899999997643 345689999999999999999999999854  3568


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      ++||||+++|+|.+++..   ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        89 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             EEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             EEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            999999999999999832   23469999999999999999999999   699999999999999999999999999998


Q ss_pred             cCCCCCCce-eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccc----ccccc----chh
Q 010434          339 FHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRS----SKAYF----PSW  409 (511)
Q Consensus       339 ~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~----~~~~~----~~~  409 (511)
                      ......... ......+|..|+|||.+.+.  .++.++||||||+++|||++|..|+.......    .....    ...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCC--CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            765443221 22334578889999999765  78999999999999999999999876543210    00000    111


Q ss_pred             hHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          410 VYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       410 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                      +...+.......      .+..++..+.+++.+||+.||++|||+.++++.|+...+.
T Consensus       241 ~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          241 LIELLKNNGRLP------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHHTTCCCC------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHhccCcCC------CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            222222222222      1223456788999999999999999999999999876554

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7e-44  Score=366.74  Aligned_cols=262  Identities=24%  Similarity=0.389  Sum_probs=208.5

Q ss_pred             HHhhhccccCcCCcEEEEEEEec------CCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCcee
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  259 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~  259 (511)
                      ..+.+.++||+|+||.||+|++.      +++.||||+++..  .....++.+|+.++++++||||+++++++.++...+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            45567789999999999999843      4678999999653  334557999999999999999999999999999999


Q ss_pred             EEEeecCCCCcccccccCC---CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC---Ceeeec
Q 010434          260 LVYEFMPNGSLDRHIFPKE---NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF---IPKVSD  333 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~---~~kl~D  333 (511)
                      +||||+++|+|.+++....   .....+++..++.++.||+.||+|||+   .+|+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999999999885432   123469999999999999999999999   6999999999999999554   599999


Q ss_pred             ccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHH
Q 010434          334 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYD  412 (511)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~  412 (511)
                      ||+++...............||+.|+|||.+.+.  .++.++|||||||++|||++ |+.||......        .+..
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--------~~~~  297 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------EVLE  297 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHHH
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHH
Confidence            9999754332222223445689999999998764  78999999999999999998 99998654321        1233


Q ss_pred             hhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCC
Q 010434          413 QLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDL  468 (511)
Q Consensus       413 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l  468 (511)
                      .+..+......      ..++..+.+++.+||+.||++|||+.+|++.|+......
T Consensus       298 ~i~~~~~~~~~------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          298 FVTSGGRMDPP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             HHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHHcCCCCCCC------ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            33333222211      123456889999999999999999999999998765443

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9.5e-44  Score=366.60  Aligned_cols=257  Identities=27%  Similarity=0.454  Sum_probs=195.4

Q ss_pred             HHhhhccccCcCCcEEEEEEEec----CCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEE
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~----~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  261 (511)
                      ..+.+.+.||+|+||.||+|+..    ++..||||+++..  ....++|.+|+.++++++||||+++++++.++...++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            34556789999999999999864    5778999999763  23456799999999999999999999999999999999


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      |||+++|+|.+++.   ..+..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       125 ~e~~~~~sL~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          125 TEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EECCTTCBHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EeCCCCCcHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            99999999999983   234579999999999999999999999   699999999999999999999999999998765


Q ss_pred             CCCCce-eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          342 KENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       342 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      ...... ......+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.|+......        .+...+..+..
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--------~~~~~i~~~~~  268 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--------DVIKAVDEGYR  268 (373)
T ss_dssp             ---------------CTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--------HHHHHHHTTEE
T ss_pred             cCCccceeccCCCcCCCccChhhhccC--CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCC
Confidence            433211 11223467889999999764  78999999999999999998 99998653321        12222222211


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      ...      ...++..+.+++.+||+.||++||++.+|+++|+....
T Consensus       269 ~~~------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          269 LPP------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             CCC------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCC------CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence            111      11234678899999999999999999999999987543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4e-43  Score=356.18  Aligned_cols=261  Identities=25%  Similarity=0.399  Sum_probs=208.3

Q ss_pred             HhhhccccCcCCcEEEEEEEec------CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  260 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  260 (511)
                      .+.+.+.||+|+||.||+|+..      +++.||||+++...  ...+.|.+|+.++++++||||+++++++.++...++
T Consensus        48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  127 (343)
T 1luf_A           48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL  127 (343)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEE
Confidence            3455689999999999999864      34899999997632  235679999999999999999999999999999999


Q ss_pred             EEeecCCCCcccccccCCCc--------------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCc
Q 010434          261 VYEFMPNGSLDRHIFPKENK--------------------GQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHN  320 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~N  320 (511)
                      ||||+++|+|.+++......                    ...+++..++.++.||+.||+|||+   .+|+||||||+|
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~N  204 (343)
T 1luf_A          128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRN  204 (343)
T ss_dssp             EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred             EEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcce
Confidence            99999999999988543211                    2579999999999999999999999   699999999999


Q ss_pred             eEEcCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccc
Q 010434          321 ILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAI  399 (511)
Q Consensus       321 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~  399 (511)
                      ||++.++.+||+|||+++...............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||.....
T Consensus       205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~  282 (343)
T 1luf_A          205 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  282 (343)
T ss_dssp             EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             EEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC--CcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence            99999999999999999865443332333455689999999998765  78999999999999999999 9989865332


Q ss_pred             cccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCC
Q 010434          400 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDL  468 (511)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l  468 (511)
                      .        .+...+..+.....      +..++..+.+++.+||+.||++|||+.++++.|+......
T Consensus       283 ~--------~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          283 E--------EVIYYVRDGNILAC------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             H--------HHHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             H--------HHHHHHhCCCcCCC------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            1        12223333322221      1224567889999999999999999999999999876543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4e-43  Score=351.46  Aligned_cols=259  Identities=25%  Similarity=0.402  Sum_probs=210.6

Q ss_pred             HhhhccccCcCCcEEEEEEEe------cCCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  260 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~------~~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  260 (511)
                      .+.+.+.||+|+||.||++..      .+++.||||++....  ...+.+.+|+.++++++||||+++++++.+++..++
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  103 (314)
T 2ivs_A           24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLL  103 (314)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEE
Confidence            455678999999999999975      245899999997632  244678999999999999999999999999999999


Q ss_pred             EEeecCCCCcccccccCCC--------------------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCc
Q 010434          261 VYEFMPNGSLDRHIFPKEN--------------------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHN  320 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~N  320 (511)
                      ||||+++|+|.+++.....                    ....+++..+..++.||+.||+|||+   .+|+||||||+|
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~N  180 (314)
T 2ivs_A          104 IVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARN  180 (314)
T ss_dssp             EEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGG
T ss_pred             EEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccchhe
Confidence            9999999999999854322                    12458999999999999999999999   699999999999


Q ss_pred             eEEcCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccc
Q 010434          321 ILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAI  399 (511)
Q Consensus       321 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~  399 (511)
                      ||+++++.+||+|||+++...............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.|+.....
T Consensus       181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC--CcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999877655544444555688999999998764  78999999999999999999 9999865432


Q ss_pred             cccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          400 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      .        .+...+........      ...++..+.+++.+||+.||++|||+.++++.|+....
T Consensus       259 ~--------~~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          259 E--------RLFNLLKTGHRMER------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             G--------GHHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H--------HHHHHhhcCCcCCC------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            1        12233333322221      12345678899999999999999999999999987543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.6e-42  Score=351.34  Aligned_cols=245  Identities=20%  Similarity=0.341  Sum_probs=201.9

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      |.+.+.||+|+||.||+|.. .+|+.||||++.....   ..+.+.+|+.++++++||||+++++++......++||||+
T Consensus        17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~   96 (328)
T 3fe3_A           17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA   96 (328)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECC
Confidence            45678999999999999985 6899999999976433   3457889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++|+|.+++.    ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        97 ~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  168 (328)
T 3fe3_A           97 SGGEVFDYLV----AHGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-  168 (328)
T ss_dssp             TTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred             CCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence            9999999883    23569999999999999999999999   699999999999999999999999999998665433 


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                        ......||+.|+|||.+.+. ...+.++||||||+++|||++|+.||.......        +...+..+.. .    
T Consensus       169 --~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~~-~----  232 (328)
T 3fe3_A          169 --KLDAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE--------LRERVLRGKY-R----  232 (328)
T ss_dssp             --GGGTTSSSGGGCCHHHHHTC-CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC-C----
T ss_pred             --ccccccCCcceeCcccccCC-CcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCC-C----
Confidence              23456799999999999765 234589999999999999999999997643221        2222222211 1    


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                        .+..++..+.+++.+||+.||.+|||+.++++.
T Consensus       233 --~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          233 --IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             --CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             --CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              111234668889999999999999999999874

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.5e-43  Score=358.26  Aligned_cols=260  Identities=28%  Similarity=0.436  Sum_probs=207.7

Q ss_pred             HHhhhccccCcCCcEEEEEEEe------cCCcEEEEEEeccCcc--cHHHHHHHHHHhccc-cccceEEeeceeccCC-c
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMLENSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGS-K  257 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~------~~g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~-~  257 (511)
                      ..+.+.++||+|+||.||+|++      .+++.||||+++....  ..+.+.+|+.++.++ +||||+++++++.+.+ .
T Consensus        22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~  101 (359)
T 3vhe_A           22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  101 (359)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence            3455678999999999999973      2468999999976432  345799999999999 8999999999987754 4


Q ss_pred             eeEEEeecCCCCcccccccCCCc---------------------------------------------------------
Q 010434          258 RALVYEFMPNGSLDRHIFPKENK---------------------------------------------------------  280 (511)
Q Consensus       258 ~~lV~e~~~~gsL~~~l~~~~~~---------------------------------------------------------  280 (511)
                      .++||||+++|+|.+++......                                                         
T Consensus       102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (359)
T 3vhe_A          102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  181 (359)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred             eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence            89999999999999998543321                                                         


Q ss_pred             -----CCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeeccccCC
Q 010434          281 -----GQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT  355 (511)
Q Consensus       281 -----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt  355 (511)
                           ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...............||
T Consensus       182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t  258 (359)
T 3vhe_A          182 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP  258 (359)
T ss_dssp             --CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred             ccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence                 1228999999999999999999999   69999999999999999999999999999876655544455566789


Q ss_pred             ccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHH
Q 010434          356 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIAR  434 (511)
Q Consensus       356 ~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  434 (511)
                      +.|+|||++.+.  .++.++||||||+++|||++ |+.||......       ..+...+.........      ..++.
T Consensus       259 ~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~------~~~~~  323 (359)
T 3vhe_A          259 LKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFCRRLKEGTRMRAP------DYTTP  323 (359)
T ss_dssp             GGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-------HHHHHHHHHTCCCCCC------TTCCH
T ss_pred             ceeEChhhhcCC--CCCchhhhhhHHHHHHHHHhcCCCCCCccchh-------HHHHHHHHcCCCCCCC------CCCCH
Confidence            999999999764  78999999999999999998 99998653221       1222333333222221      12346


Q ss_pred             HHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          435 KLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       435 ~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                      .+.+++..||+.||++|||+.+++++|+..+
T Consensus       324 ~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          324 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            7889999999999999999999999998754

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-43  Score=354.03  Aligned_cols=250  Identities=17%  Similarity=0.227  Sum_probs=206.1

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      .|.+.++||+|+||.||++... +++.+|+|.+.......+.+.+|+.++++++||||+++++++.+....++||||+++
T Consensus         6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g   85 (321)
T 1tki_A            6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG   85 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred             ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCC
Confidence            3556789999999999999854 689999999987666667899999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC--CCCeeeecccccccCCCCCC
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH--NFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~--~~~~kl~DFGla~~~~~~~~  345 (511)
                      |+|.+++.   .....+++..+..++.||+.||+|||+   .+|+||||||+|||++.  ++.+||+|||+++.......
T Consensus        86 ~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           86 LDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             CCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence            99999883   233579999999999999999999999   69999999999999987  78999999999987654432


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                         .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||.......        ....+......   ..
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~~~~---~~  223 (321)
T 1tki_A          160 ---FRLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--------IIENIMNAEYT---FD  223 (321)
T ss_dssp             ---EEEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHTCCC---CC
T ss_pred             ---cccccCChhhcCcHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH--------HHHHHHcCCCC---CC
Confidence               2445689999999999764  67899999999999999999999996543211        12222221111   11


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      ......++..+.+++.+||+.||++|||+.++++.
T Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11223456778999999999999999999999983

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.5e-42  Score=350.47  Aligned_cols=251  Identities=26%  Similarity=0.332  Sum_probs=200.6

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      |.+.++||+|+||.||++... +++.||||++....  ...+.+.+|+.++++++||||+++++++.++...++||||++
T Consensus         9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~   88 (323)
T 3tki_A            9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS   88 (323)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence            456789999999999999855 79999999986532  234678999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus        89 ~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           89 GGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             TEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             CCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            999999882    34569999999999999999999999   69999999999999999999999999999866444333


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                      .......||+.|+|||++.+. ...+.++||||||+++|||++|+.||.......  .     ........... ..   
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~-----~~~~~~~~~~~-~~---  229 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--Q-----EYSDWKEKKTY-LN---  229 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS--H-----HHHHHHTTCTT-ST---
T ss_pred             cccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH--H-----HHHHHhccccc-CC---
Confidence            333456799999999998764 234789999999999999999999997543211  0     11111111111 00   


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                       ....++..+.+++.+||+.||++|||+.|+++.
T Consensus       230 -~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          230 -PWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             -TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence             112345677889999999999999999999864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=5e-43  Score=353.89  Aligned_cols=254  Identities=26%  Similarity=0.433  Sum_probs=201.2

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCc----EEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGR----LIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~----~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      +.+.++||+|+||.||+|... +++    +||+|.+...  ....+.+.+|+.++++++||||+++++++. +...++||
T Consensus        15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~   93 (325)
T 3kex_A           15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVT   93 (325)
T ss_dssp             EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEE
T ss_pred             ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEE
Confidence            455689999999999999853 454    3888887542  233456889999999999999999999986 46789999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+++|+|.+++..   ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        94 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           94 QYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             ECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            99999999998842   23579999999999999999999999   6999999999999999999999999999998765


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCccc
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (511)
                      ...........+|..|+|||.+.+.  .++.++||||||+++|||++ |+.||......        .+...+.......
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~  237 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFG--KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--------EVPDLLEKGERLA  237 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--------HHHHHHHTTCBCC
T ss_pred             ccccccccCCCCcccccChHHhccC--CCChhhHhHHhHHHHHHHHhCCCCCccccCHH--------HHHHHHHcCCCCC
Confidence            5444444556688899999999764  78999999999999999999 99998754321        1223333332222


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      ...      .++..+.+++.+||+.||.+|||+.++++.|+....
T Consensus       238 ~~~------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          238 QPQ------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             CCT------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             CCC------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            111      123457789999999999999999999999987554

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=9.7e-43  Score=346.96  Aligned_cols=259  Identities=24%  Similarity=0.344  Sum_probs=203.8

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .|.+.++||+|+||.||++.. .+++.||+|++....    ...+.|.+|+.++++++||||+++++++.+++..++|||
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   91 (294)
T 4eqm_A           12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME   91 (294)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence            456678999999999999985 478999999985522    234678999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++++|.+++.    ...++++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        92 ~~~g~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           92 YIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             CCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             CCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            999999999883    33579999999999999999999999   69999999999999999999999999999865433


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      .. .......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.......       .....+.... ... 
T Consensus       165 ~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-------~~~~~~~~~~-~~~-  232 (294)
T 4eqm_A          165 SL-TQTNHVLGTVQYFSPEQAKGE--ATDECTDIYSIGIVLYEMLVGEPPFNGETAVS-------IAIKHIQDSV-PNV-  232 (294)
T ss_dssp             -----------CCSSCCHHHHHTC--CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH-------HHHHHHSSCC-CCH-
T ss_pred             cc-cccCccccCccccCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHhhccC-CCc-
Confidence            21 122345699999999999765  67899999999999999999999997543211       1111111111 100 


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCC-CHHHHHHHHhcCcCC
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRP-SMTKVLEMLEGSMDD  467 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-s~~evl~~Le~~~~~  467 (511)
                       .......++..+.+++.+||+.||.+|| +++++.+.|+..+..
T Consensus       233 -~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          233 -TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             -HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             -chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence             1112233457788999999999999998 899999999986654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.4e-42  Score=342.11  Aligned_cols=258  Identities=26%  Similarity=0.434  Sum_probs=210.6

Q ss_pred             HHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      ..+.+.+.||+|+||.||+|..++++.||||.+.......+.|.+|+.++++++||||+++++++.+ +..++||||+++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~   91 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN   91 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred             HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCC
Confidence            3566778999999999999998888899999998877778899999999999999999999999864 568999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      ++|.+++..  ..+..+++..+..++.|++.||+|||+   .+|+|+||||+||++++++.+||+|||+++...... ..
T Consensus        92 ~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  165 (279)
T 1qpc_A           92 GSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YT  165 (279)
T ss_dssp             CBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EE
T ss_pred             CCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-cc
Confidence            999999832  122369999999999999999999999   699999999999999999999999999998765432 22


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                      ......+|..|+|||.+.+.  .++.++||||||+++|||++ |+.|+......        .+...+..+.....    
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~----  231 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--------EVIQNLERGYRMVR----  231 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCCCCC----
T ss_pred             cccCCCCccCccChhhhccC--CCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--------HHHHHHhcccCCCC----
Confidence            22344578899999998754  78899999999999999999 88888653221        12222222221111    


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCC
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDL  468 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l  468 (511)
                        ...++..+.+++.+||+.||++|||+.++++.|+......
T Consensus       232 --~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          232 --PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             --cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence              1223467889999999999999999999999998765443

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.5e-42  Score=339.15  Aligned_cols=254  Identities=29%  Similarity=0.492  Sum_probs=209.9

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      .+.+.+.||+|+||.||++...+++.||+|++.......+++.+|+.++++++||||+++++++.++...++||||++++
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   88 (267)
T 3t9t_A            9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHG   88 (267)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTC
T ss_pred             heeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCC
Confidence            45567899999999999999888899999999887777889999999999999999999999999999999999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      +|.+++..   ....+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++...... ...
T Consensus        89 ~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~  161 (267)
T 3t9t_A           89 CLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS  161 (267)
T ss_dssp             BHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred             cHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccc-ccc
Confidence            99998832   23568999999999999999999999   699999999999999999999999999998654321 112


Q ss_pred             eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      .....+|..|+|||.+.+.  .++.++||||||+++|||++ |+.|+......        .....+..+.....     
T Consensus       162 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~i~~~~~~~~-----  226 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------EVVEDISTGFRLYK-----  226 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTCCCCC-----
T ss_pred             cccccccccccChhhhcCC--CccchhchhhhHHHHHHHhccCCCCCCCCCHH--------HHHHHHhcCCcCCC-----
Confidence            2344578899999999764  78899999999999999999 89888653321        12222222221111     


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                       +...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus       227 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          227 -PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             1123467889999999999999999999999998643

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.4e-42  Score=366.72  Aligned_cols=248  Identities=29%  Similarity=0.460  Sum_probs=202.6

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCC-ceeEEEeecCC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS-KRALVYEFMPN  267 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~~~~  267 (511)
                      .+.+.++||+|+||.||+|..+ |+.||||+++... ..+.|.+|+.++++++||||+++++++.+.. ..++||||+++
T Consensus       194 ~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~  271 (450)
T 1k9a_A          194 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK  271 (450)
T ss_dssp             GEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred             HeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence            3455689999999999999876 7899999997654 5678999999999999999999999986654 78999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|.+++...  ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++......   
T Consensus       272 g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---  343 (450)
T 1k9a_A          272 GSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  343 (450)
T ss_dssp             CBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             CcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc---
Confidence            9999998432  22347999999999999999999999   699999999999999999999999999998543221   


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                        ....+|+.|+|||.+...  .++.++||||||+++|||++ |+.|+......        .+...+..+.....    
T Consensus       344 --~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--------~~~~~i~~~~~~~~----  407 (450)
T 1k9a_A          344 --DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPRVEKGYKMDA----  407 (450)
T ss_dssp             -----CCCTTTSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--------THHHHHHTTCCCCC----
T ss_pred             --cCCCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCC----
Confidence              223578999999999764  78999999999999999998 99998654321        12333333333222    


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                        +..++..+.+++.+||+.||++|||+.++++.|+..
T Consensus       408 --p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          408 --PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence              123456788999999999999999999999999864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.3e-42  Score=348.42  Aligned_cols=250  Identities=24%  Similarity=0.302  Sum_probs=204.2

Q ss_pred             HHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc-------ccHHHHHHHHHHhccccccceEEeeceeccCCce
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK-------FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  258 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~-------~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~  258 (511)
                      ...|.+.+.||+|+||.||++... +|+.||||++....       ...+.+.+|+.++++++||||+++++++.+....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            345777899999999999999854 68999999986532       2467899999999999999999999999999999


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC----Ceeeecc
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF----IPKVSDF  334 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~----~~kl~DF  334 (511)
                      ++||||+++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++    .+||+||
T Consensus        90 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           90 ILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            99999999999999983    34579999999999999999999999   6999999999999998887    8999999


Q ss_pred             cccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhh
Q 010434          335 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQL  414 (511)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  414 (511)
                      |+++.......   .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||.......        ....+
T Consensus       163 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~~  229 (326)
T 2y0a_A          163 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQE--------TLANV  229 (326)
T ss_dssp             TTCEECCTTSC---CCCCCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHH
T ss_pred             CCCeECCCCCc---cccccCCcCcCCceeecCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--------HHHHH
Confidence            99987654332   2345699999999998764  78999999999999999999999986533211        11111


Q ss_pred             hcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          415 NKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       415 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .....   .........++..+.+++.+||+.||++|||+.++++
T Consensus       230 ~~~~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          230 SAVNY---EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHTCC---CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HhcCC---CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11110   0011122334567889999999999999999999987

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-42  Score=351.63  Aligned_cols=263  Identities=25%  Similarity=0.420  Sum_probs=208.9

Q ss_pred             HHHhhhccccCcCCcEEEEEEEe------cCCcEEEEEEeccC--cccHHHHHHHHHHhccc-cccceEEeeceeccCCc
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMLENS--KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSK  257 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~------~~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~  257 (511)
                      ...+.+.+.||+|+||.||+|..      .+++.||||++...  ....+.+.+|+.++.++ +||||+++++++...+.
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  123 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  123 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence            34556678999999999999985      24568999999753  23446899999999999 89999999999999999


Q ss_pred             eeEEEeecCCCCcccccccCCCc-------------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCc
Q 010434          258 RALVYEFMPNGSLDRHIFPKENK-------------------GQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKP  318 (511)
Q Consensus       258 ~~lV~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp  318 (511)
                      .++||||+++|+|.+++......                   ...+++..+..++.||+.||+|||+   .+|+||||||
T Consensus       124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp  200 (344)
T 1rjb_A          124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA  200 (344)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred             cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCh
Confidence            99999999999999988543211                   1348999999999999999999999   6999999999


Q ss_pred             CceEEcCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcc
Q 010434          319 HNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMN  397 (511)
Q Consensus       319 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~  397 (511)
                      +|||++.++.+||+|||+++...............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||...
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC--CCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            9999999999999999999876555444444556688999999998764  78999999999999999998 99998654


Q ss_pred             cccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          398 AIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                      ...       ......+.........      ..++..+.+++.+||+.||.+|||+.++++.|+.....
T Consensus       279 ~~~-------~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          279 PVD-------ANFYKLIQNGFKMDQP------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             CCS-------HHHHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CcH-------HHHHHHHhcCCCCCCC------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            321       1122233332222111      12346788999999999999999999999999986654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.4e-42  Score=354.53  Aligned_cols=248  Identities=22%  Similarity=0.294  Sum_probs=203.7

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcc-------cHHHHHHHHHHhccccccceEEeeceeccCCceeE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKF-------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  260 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~-------~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  260 (511)
                      .|.+.++||+|+||.||++... +|+.||||+++....       ..+.+.+|+.++++++||||+++++++.+....++
T Consensus        13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   92 (361)
T 2yab_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL   92 (361)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence            3566789999999999999854 799999999976322       35789999999999999999999999999999999


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC----Ceeeecccc
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF----IPKVSDFGL  336 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~----~~kl~DFGl  336 (511)
                      ||||+++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||+++++    .+||+|||+
T Consensus        93 v~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           93 ILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            999999999999983    34579999999999999999999999   6999999999999998877    799999999


Q ss_pred             cccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhc
Q 010434          337 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK  416 (511)
Q Consensus       337 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  416 (511)
                      ++......   ......||+.|+|||++.+.  .++.++||||||+++|+|++|+.||.......        ....+..
T Consensus       166 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~--------~~~~i~~  232 (361)
T 2yab_A          166 AHEIEDGV---EFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQE--------TLANITA  232 (361)
T ss_dssp             CEECCTTC---CCCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHT
T ss_pred             ceEcCCCC---ccccCCCCccEECchHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHh
Confidence            98765432   22445699999999999764  78899999999999999999999996543211        1222222


Q ss_pred             CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          417 GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ... .  ........++..+.+++.+||+.||++|||+.++++
T Consensus       233 ~~~-~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          233 VSY-D--FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             TCC-C--CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCC-C--CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111 0  111223345677889999999999999999999985

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.2e-42  Score=355.41  Aligned_cols=255  Identities=23%  Similarity=0.302  Sum_probs=206.4

Q ss_pred             HHHHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC------cccHHHHHHHHHHhccccccceEEeeceeccCCce
Q 010434          186 IAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS------KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  258 (511)
Q Consensus       186 ~~~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~------~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~  258 (511)
                      ....|.+.+.||+|+||.||++.. .+|+.||||++...      ....+.+.+|+.++++++||||+++++++.+++..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            345677889999999999999985 47899999998542      22567899999999999999999999999999999


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCC---eeeeccc
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFI---PKVSDFG  335 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~---~kl~DFG  335 (511)
                      ++||||+++|+|.+++......+..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            99999999999988875443445568999999999999999999999   69999999999999987655   9999999


Q ss_pred             ccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhh
Q 010434          336 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLN  415 (511)
Q Consensus       336 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  415 (511)
                      +++.......  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||.....         .+...+.
T Consensus       179 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~i~  245 (351)
T 3c0i_A          179 VAIQLGESGL--VAGGRVGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSGCLPFYGTKE---------RLFEGII  245 (351)
T ss_dssp             TCEECCTTSC--BCCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---------HHHHHHH
T ss_pred             ceeEecCCCe--eecCCcCCcCccCHHHHcCC--CCCchHhhHHHHHHHHHHHHCCCCCCCcHH---------HHHHHHH
Confidence            9987654332  22445699999999999765  789999999999999999999999975321         1122222


Q ss_pred             cCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .+...   ........++..+.+++.+||+.||++|||+.++++
T Consensus       246 ~~~~~---~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          246 KGKYK---MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HTCCC---CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCCC---CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            22111   011122334677899999999999999999999986

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.4e-43  Score=345.91  Aligned_cols=259  Identities=29%  Similarity=0.447  Sum_probs=214.0

Q ss_pred             HHHHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          185 IIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       185 i~~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      +....+.+.++||+|+||.||+|... +++.||||++..+....+.+.+|+.++++++||||+++++++.++...++|||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            34455667789999999999999865 58899999998877777899999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++++|.+++..  .....+++..+..++.|++.||+|||+   .+|+|+||||+||+++.++.+||+|||+++.....
T Consensus        90 ~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           90 FMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             CCTTEEHHHHHHH--CCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             cCCCCcHHHHHHh--cccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            9999999998842  234569999999999999999999999   69999999999999999999999999999876544


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                      .. .......+|+.|+|||.+.+.  .++.++||||||+++|+|++ |+.|+.......        +...+........
T Consensus       165 ~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--------~~~~~~~~~~~~~  233 (288)
T 3kfa_A          165 TY-TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYELLEKDYRMER  233 (288)
T ss_dssp             SS-EEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------HHHHHHTTCCCCC
T ss_pred             cc-ccccCCccccCcCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhccCCCCC
Confidence            32 233445578899999999765  78999999999999999999 888886543221        2222322222211


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                            ...++..+.+++.+||+.||++|||+.++++.|+...
T Consensus       234 ------~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~  270 (288)
T 3kfa_A          234 ------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  270 (288)
T ss_dssp             ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence                  1223467889999999999999999999999998654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.6e-43  Score=352.50  Aligned_cols=256  Identities=25%  Similarity=0.410  Sum_probs=198.1

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCc----EEEEEEecc--CcccHHHHHHHHHHhccccccceEEeeceeccCCceeEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGR----LIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~----~vAvK~l~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  261 (511)
                      .+.+.++||+|+||.||+|.. .+++    +||+|.+..  .....+.+.+|+.++++++||||+++++++..+. .++|
T Consensus        16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v   94 (327)
T 3lzb_A           16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI   94 (327)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEE
T ss_pred             HceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEE
Confidence            345678999999999999985 3454    457777754  3446788999999999999999999999998754 7899


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      +||+++|+|.+++..   ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        95 ~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           95 TQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             ECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             EEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            999999999998842   34579999999999999999999999   699999999999999999999999999998765


Q ss_pred             CCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcc
Q 010434          342 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDL  420 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (511)
                      ............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||.......        +...+......
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~~~~~~~~~~~  238 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGERL  238 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCCC
T ss_pred             CccccccccCCCccccccCHHHHcCC--CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCCC
Confidence            54433333445578899999999865  78999999999999999999 999987543221        22233333222


Q ss_pred             cccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          421 ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       421 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                      ...      ..++..+.+++.+||+.||.+|||+.++++.|+.....
T Consensus       239 ~~~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          239 PQP------PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CCC------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCC------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            211      12345688899999999999999999999999986643

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7.6e-43  Score=351.57  Aligned_cols=263  Identities=24%  Similarity=0.383  Sum_probs=194.3

Q ss_pred             HHhhhccccCcCCcEEEEEEEecC-C---cEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccCCce--
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLHT-G---RLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR--  258 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~~-g---~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~--  258 (511)
                      ..+.+.+.||+|+||.||+|.... +   ..||||+++..   ....+.|.+|+.++++++||||+++++++......  
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR  102 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence            356677899999999999998553 3   28999999763   33457899999999999999999999999776655  


Q ss_pred             ----eEEEeecCCCCcccccccCC--CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeee
Q 010434          259 ----ALVYEFMPNGSLDRHIFPKE--NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVS  332 (511)
Q Consensus       259 ----~lV~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~  332 (511)
                          ++||||+++|+|.+++....  .....+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+
T Consensus       103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl~  179 (323)
T 3qup_A          103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVA  179 (323)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEEC
T ss_pred             CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEEe
Confidence                99999999999999884322  122369999999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhH
Q 010434          333 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVY  411 (511)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~  411 (511)
                      |||+++...............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||.......        ..
T Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~~  249 (323)
T 3qup_A          180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--------IY  249 (323)
T ss_dssp             CCCC-----------------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HH
T ss_pred             eccccccccccccccccccccCcccccCchhhcCC--CCCCccchhhHHHHHHHHHhCCCCCccccChHH--------HH
Confidence            99999876554433333445578899999999765  78999999999999999999 898886543221        22


Q ss_pred             HhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCC
Q 010434          412 DQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQ  469 (511)
Q Consensus       412 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~  469 (511)
                      ..+........      ...++..+.+++.+||+.||++|||+.++++.|+..+..+.
T Consensus       250 ~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          250 NYLIGGNRLKQ------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             HHHHTTCCCCC------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHHhcCCCCCC------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence            22222222211      12234678899999999999999999999999998765543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-42  Score=346.45  Aligned_cols=275  Identities=20%  Similarity=0.288  Sum_probs=201.8

Q ss_pred             CChHHHHHHHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhcc--ccccceEEeeceeccC--
Q 010434          180 YSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGR--IHHVNVVQLLGFCSEG--  255 (511)
Q Consensus       180 ~~~~ei~~~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~--l~H~niv~l~g~~~~~--  255 (511)
                      ....+.....+.+.++||+|+||.||+|+.. |+.||||++....  ...+..|.+++..  ++||||+++++++...  
T Consensus        29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            3444556677888899999999999999876 8999999986543  3344555555544  4999999999998776  


Q ss_pred             --CceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCC-----CCceecccCCcCceEEcCCCC
Q 010434          256 --SKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC-----DMCILHFDIKPHNILLDHNFI  328 (511)
Q Consensus       256 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~ivH~DIkp~NILl~~~~~  328 (511)
                        ...++||||+++|+|.+++.     ...+++..+..++.|++.||+|||+.+     ..+|+||||||+|||++.++.
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~  180 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT  180 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred             CCCceEEEEeccCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence              67899999999999999982     246999999999999999999999821     129999999999999999999


Q ss_pred             eeeecccccccCCCCCCcee--eccccCCccccchhcccccCCCcCc------cchHHHHHHHHHHHHhCC---------
Q 010434          329 PKVSDFGLAKFHPKENDFVS--ISATRGTIGYIAPELISRNFGTVSC------KSDVYGFGMVLLEMAGGR---------  391 (511)
Q Consensus       329 ~kl~DFGla~~~~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~s~------ksDVwS~Gvll~elltg~---------  391 (511)
                      +||+|||+++..........  .....||+.|+|||++.+.  ..+.      ++||||||+++|||++|.         
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~  258 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES--LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY  258 (337)
T ss_dssp             EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTC--CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccc--cCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence            99999999986654432211  1244699999999998764  3333      499999999999999994         


Q ss_pred             -CCCCcccccccccccchhhHHhhhc-CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCC
Q 010434          392 -RNSNMNAIRSSKAYFPSWVYDQLNK-GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDL  468 (511)
Q Consensus       392 -~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l  468 (511)
                       .|+.......  ... ......... ....... .......++..+.+++.+||+.||++|||+.+|++.|+...+..
T Consensus       259 ~~p~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          259 QLPYHDLVPSD--PSY-EDMREIVCIKKLRPSFP-NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             CCTTTTTSCSS--CCH-HHHHHHHTTSCCCCCCC-GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             cccHhhhcCCC--Cch-hhhHHHHhhhccCcccc-ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence             4443221111  000 111111111 1111111 11123467788999999999999999999999999999866543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-42  Score=344.90  Aligned_cols=267  Identities=19%  Similarity=0.279  Sum_probs=209.5

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCC--ceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS--KRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~--~~~lV~e  263 (511)
                      .|.+.++||+|+||.||+|... +|+.||||++...  ....+.+.+|+.++++++||||+++++++....  ..++|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   89 (319)
T 4euu_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME   89 (319)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence            3556789999999999999865 6899999999763  335678899999999999999999999987654  7799999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEE----cCCCCeeeeccccccc
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL----DHNFIPKVSDFGLAKF  339 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl----~~~~~~kl~DFGla~~  339 (511)
                      |+++|+|.+++.... ....+++..+..++.||+.||+|||+   .+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        90 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           90 FCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             CCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             CCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            999999999984322 22349999999999999999999999   699999999999999    8888899999999987


Q ss_pred             CCCCCCceeeccccCCccccchhccccc------CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHh
Q 010434          340 HPKENDFVSISATRGTIGYIAPELISRN------FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQ  413 (511)
Q Consensus       340 ~~~~~~~~~~~~~~gt~~y~APE~~~~~------~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~  413 (511)
                      ......   .....||+.|+|||++...      ...++.++||||||+++|||++|+.||.........   ...+...
T Consensus       166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~  239 (319)
T 4euu_A          166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN---KEVMYKI  239 (319)
T ss_dssp             CCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC---HHHHHHH
T ss_pred             cCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh---HHHHHHH
Confidence            655432   2345699999999998631      247889999999999999999999998643221111   1111111


Q ss_pred             hhcCCc-----------------ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          414 LNKGGD-----------------LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       414 ~~~~~~-----------------~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                      +.....                 ............++..+.+++.+||+.||++|||+.|+++......
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            111100                 0111122355677888999999999999999999999999988644

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.2e-42  Score=344.76  Aligned_cols=261  Identities=26%  Similarity=0.447  Sum_probs=211.4

Q ss_pred             HHhhhccccCcCCcEEEEEEEe------cCCcEEEEEEeccCcc--cHHHHHHHHHHhccc-cccceEEeeceeccCCce
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMLENSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKR  258 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~------~~g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~  258 (511)
                      ..+.+.+.||+|+||.||+|+.      .+++.||||++.....  ..+.+.+|+.+++++ +||||+++++++..++..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  102 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence            3556678999999999999974      3568999999976432  456799999999999 999999999999999999


Q ss_pred             eEEEeecCCCCcccccccCCC--------------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEc
Q 010434          259 ALVYEFMPNGSLDRHIFPKEN--------------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD  324 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~  324 (511)
                      ++||||+++|+|.+++.....              ....+++..+..++.|++.||+|||+   .+|+||||||+|||++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~  179 (313)
T 1t46_A          103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT  179 (313)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEc
Confidence            999999999999998854321              12359999999999999999999999   6999999999999999


Q ss_pred             CCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccc
Q 010434          325 HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSK  403 (511)
Q Consensus       325 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~  403 (511)
                      .++.+||+|||+++...............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.|+......   
T Consensus       180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---  254 (313)
T 1t46_A          180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMPVD---  254 (313)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---
T ss_pred             CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCCcccch---
Confidence            9999999999999877665544444556688999999998764  78999999999999999998 99988653321   


Q ss_pred             cccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          404 AYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                          ......+........      ...++..+.+++.+||+.||.+|||+.+++++|+....
T Consensus       255 ----~~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          255 ----SKFYKMIKEGFRMLS------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             ----HHHHHHHHHTCCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----hHHHHHhccCCCCCC------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence                112222222221111      11234678899999999999999999999999987554

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7.3e-43  Score=350.68  Aligned_cols=249  Identities=24%  Similarity=0.300  Sum_probs=197.6

Q ss_pred             hHHHHHHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcc---cHHHHHHHHHHhccc-cccceEEeeceeccCC
Q 010434          182 YPEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKF---SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGS  256 (511)
Q Consensus       182 ~~ei~~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~  256 (511)
                      ..++....+.+.++||+|+||+||+|+.. +|+.||||++.....   ....+..|+..+.++ +||||+++++++.++.
T Consensus        51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~  130 (311)
T 3p1a_A           51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG  130 (311)
T ss_dssp             SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence            34566667778899999999999999865 799999999865333   334566666666665 8999999999999999


Q ss_pred             ceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccc
Q 010434          257 KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGL  336 (511)
Q Consensus       257 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGl  336 (511)
                      ..++||||+ +++|.+++..   .+..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~  203 (311)
T 3p1a_A          131 ILYLQTELC-GPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGL  203 (311)
T ss_dssp             EEEEEEECC-CCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTT
T ss_pred             EEEEEEecc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEcccee
Confidence            999999999 7788888732   34579999999999999999999999   6999999999999999999999999999


Q ss_pred             cccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhc
Q 010434          337 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK  416 (511)
Q Consensus       337 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  416 (511)
                      ++......   ......||++|+|||++.+   .++.++||||||+++|||++|..++.....           ...+..
T Consensus       204 a~~~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~-----------~~~~~~  266 (311)
T 3p1a_A          204 LVELGTAG---AGEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEG-----------WQQLRQ  266 (311)
T ss_dssp             CEECC---------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----------HHHHTT
T ss_pred             eeecccCC---CCcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HHHHhc
Confidence            98764432   2234569999999999864   688999999999999999999776543211           112222


Q ss_pred             CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          417 GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ...     .......++..+.+++.+||+.||++|||+.++++
T Consensus       267 ~~~-----~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          267 GYL-----PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             TCC-----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCC-----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            111     11233345678999999999999999999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7.8e-43  Score=376.37  Aligned_cols=259  Identities=29%  Similarity=0.447  Sum_probs=212.9

Q ss_pred             HHHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      ...+.+.++||+|+||.||+|.++++..||||+++......++|.+|+.++++++||||+++++++.+ ...++||||++
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~  344 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  344 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence            34556678999999999999999888899999998876778899999999999999999999999976 67899999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +|+|.+++..  ..+..+++..+..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+++...... .
T Consensus       345 ~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  418 (535)
T 2h8h_A          345 KGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  418 (535)
T ss_dssp             TEEHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-H
T ss_pred             CCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-e
Confidence            9999999832  223568999999999999999999999   699999999999999999999999999998654321 1


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                      .......+|..|+|||.+...  .++.++||||||+++|||++ |+.||......        .+...+..+......  
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--------~~~~~i~~~~~~~~~--  486 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERGYRMPCP--  486 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--------HHHHHHHTTCCCCCC--
T ss_pred             ecccCCcCcccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCC--
Confidence            112334578899999998764  78999999999999999999 89888653221        233333333322211  


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCC
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDL  468 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l  468 (511)
                          ..++..+.+++.+||+.||++|||+.+|+++|+......
T Consensus       487 ----~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          487 ----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             ----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence                234567889999999999999999999999999876554

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=6e-42  Score=341.28  Aligned_cols=248  Identities=22%  Similarity=0.320  Sum_probs=194.7

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc---------------------------cHHHHHHHHHHhccc
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF---------------------------SAEEFINEVSTIGRI  240 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~---------------------------~~~~f~~Ev~~l~~l  240 (511)
                      .|.+.++||+|+||.||+|+. .+|+.||||++.....                           ..+.+.+|+.+++++
T Consensus        14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   93 (298)
T 2zv2_A           14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL   93 (298)
T ss_dssp             TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred             ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence            355678999999999999985 4789999999865321                           125689999999999


Q ss_pred             cccceEEeeceecc--CCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCc
Q 010434          241 HHVNVVQLLGFCSE--GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKP  318 (511)
Q Consensus       241 ~H~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp  318 (511)
                      +||||+++++++.+  +...++||||+++++|.+++     ....+++..+..++.||+.||+|||+   .+|+||||||
T Consensus        94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp  165 (298)
T 2zv2_A           94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKP  165 (298)
T ss_dssp             CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCG
T ss_pred             CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCH
Confidence            99999999999976  56789999999999998875     23579999999999999999999999   6999999999


Q ss_pred             CceEEcCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCC-CcCccchHHHHHHHHHHHHhCCCCCCcc
Q 010434          319 HNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG-TVSCKSDVYGFGMVLLEMAGGRRNSNMN  397 (511)
Q Consensus       319 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~s~ksDVwS~Gvll~elltg~~p~~~~  397 (511)
                      +|||++.++.+||+|||+++.......  ......||+.|+|||.+.+... ..+.++||||||+++|||++|+.||...
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            999999999999999999987654332  2344579999999999875422 2478899999999999999999998653


Q ss_pred             cccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          398 AIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ...        .....+.... ......    ..++..+.+++.+||+.||++|||+.++++
T Consensus       244 ~~~--------~~~~~~~~~~-~~~~~~----~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          244 RIM--------CLHSKIKSQA-LEFPDQ----PDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SHH--------HHHHHHHHCC-CCCCSS----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cHH--------HHHHHHhccc-CCCCCc----cccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            221        1112222111 111111    123467889999999999999999999975

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=351.36  Aligned_cols=273  Identities=24%  Similarity=0.304  Sum_probs=197.5

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHH--HHhccccccceEEeecee-----ccCCceeEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEV--STIGRIHHVNVVQLLGFC-----SEGSKRALV  261 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev--~~l~~l~H~niv~l~g~~-----~~~~~~~lV  261 (511)
                      .+.+.++||+|+||.||+|+. +++.||||++....  .+.+..|.  ..+..++||||+++++.+     ......++|
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv   90 (336)
T 3g2f_A           14 NLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV   90 (336)
T ss_dssp             SEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred             HhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence            455678999999999999976 58999999997543  33444444  445568999999999744     334467899


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCC------CCceecccCCcCceEEcCCCCeeeeccc
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC------DMCILHFDIKPHNILLDHNFIPKVSDFG  335 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~------~~~ivH~DIkp~NILl~~~~~~kl~DFG  335 (511)
                      |||+++|+|.+++.     ....++..+..++.||+.||+|||+.+      ..+|+||||||+|||++.++.+||+|||
T Consensus        91 ~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG  165 (336)
T 3g2f_A           91 MEYYPNGSLXKYLS-----LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG  165 (336)
T ss_dssp             ECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred             EecCCCCcHHHHHh-----hcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence            99999999999982     234589999999999999999999821      1199999999999999999999999999


Q ss_pred             ccccCCCCCCc------eeeccccCCccccchhcccccC-----CCcCccchHHHHHHHHHHHHhCCCCCCccccc-ccc
Q 010434          336 LAKFHPKENDF------VSISATRGTIGYIAPELISRNF-----GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIR-SSK  403 (511)
Q Consensus       336 la~~~~~~~~~------~~~~~~~gt~~y~APE~~~~~~-----~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~-~~~  403 (511)
                      +++........      .......||+.|+|||++.+..     ..++.++||||||+++|||++|+.|+...... ...
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  245 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ  245 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence            99876543211      1123446999999999987521     25678999999999999999997765432211 111


Q ss_pred             ccc----------chhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCC
Q 010434          404 AYF----------PSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQ  469 (511)
Q Consensus       404 ~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~  469 (511)
                      ..+          ..+.......................++.+.+++.+||+.||++|||++++++.|+..+....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~  321 (336)
T 3g2f_A          246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE  321 (336)
T ss_dssp             CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred             HhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence            100          000000111111222222222233466789999999999999999999999999998775544

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=341.56  Aligned_cols=263  Identities=25%  Similarity=0.402  Sum_probs=201.5

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      .+.+.++||+|+||.||+++.. ++.||||++... ...+.|.+|+.++++++||||+++++++.+  ..++||||+++|
T Consensus         9 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~   84 (307)
T 2eva_A            9 EIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGG   84 (307)
T ss_dssp             GEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTC
T ss_pred             HeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCC
Confidence            3456789999999999999875 789999998643 356789999999999999999999999874  479999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCC-eeeecccccccCCCCCCce
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFI-PKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~-~kl~DFGla~~~~~~~~~~  347 (511)
                      +|.+++.... ....+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||+++.....    
T Consensus        85 ~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----  159 (307)
T 2eva_A           85 SLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----  159 (307)
T ss_dssp             BHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred             CHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence            9999984322 2235789999999999999999999854458999999999999998886 799999999754332    


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                       .....||+.|+|||.+.+.  .++.++||||||+++|||++|+.||........      .+......+.....     
T Consensus       160 -~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~-----  225 (307)
T 2eva_A          160 -MTNNKGSAAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF------RIMWAVHNGTRPPL-----  225 (307)
T ss_dssp             ------CCTTSSCHHHHTCC--CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH------HHHHHHHTTCCCCC-----
T ss_pred             -cccCCCCCceEChhhhCCC--CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH------HHHHHHhcCCCCCc-----
Confidence             1334599999999999764  789999999999999999999999864322110      01111122211111     


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCCCCCCCC
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKPC  475 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~~p~~p~  475 (511)
                       ...++..+.+++.+||+.||++|||+.+++++|+.....++.+..|.
T Consensus       226 -~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~  272 (307)
T 2eva_A          226 -IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL  272 (307)
T ss_dssp             -BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred             -ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence             12234678899999999999999999999999998776655444443

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.8e-42  Score=346.51  Aligned_cols=257  Identities=23%  Similarity=0.312  Sum_probs=198.3

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      .|.+.++||+|+||.||+++..+|+.||||++.....   ..+.+.+|+.++++++||||+++++++.++...++||||+
T Consensus        22 ~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  101 (311)
T 3niz_A           22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM  101 (311)
T ss_dssp             EEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECC
T ss_pred             hhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCC
Confidence            4556789999999999999988899999999975322   3467899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      + |+|.+.+.   .....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus       102 ~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A          102 E-KDLKKVLD---ENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             S-EEHHHHHH---TCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred             C-CCHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence            7 47777763   233569999999999999999999999   6999999999999999999999999999987643322


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCC-------
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG-------  418 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------  418 (511)
                        ......||+.|+|||++.+. ..++.++||||||+++|||++|+.||.........    ..+...+....       
T Consensus       175 --~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~  247 (311)
T 3niz_A          175 --SYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL----PKIFSILGTPNPREWPQV  247 (311)
T ss_dssp             -----CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH----HHHHHHHCCCCTTTSGGG
T ss_pred             --cccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH----HHHHHHHCCCChHHhhhh
Confidence              22445689999999998653 36789999999999999999999999754322110    00111000000       


Q ss_pred             ---------c---ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          419 ---------D---LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       419 ---------~---~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                               .   ............++..+.+++.+||+.||++|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                     0   0000011112234567889999999999999999999986

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.2e-42  Score=339.46  Aligned_cols=252  Identities=27%  Similarity=0.436  Sum_probs=200.6

Q ss_pred             HHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc--c------HHHHHHHHHHhccccccceEEeeceeccCCce
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF--S------AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  258 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~--~------~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~  258 (511)
                      ..+.+.++||+|+||.||+|+. .+++.||||++.....  .      .+.+.+|+.++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            3456678999999999999986 5789999999865221  1      167999999999999999999999997655  


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCc--eecccCCcCceEEcCCCC-----eee
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC--ILHFDIKPHNILLDHNFI-----PKV  331 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~DIkp~NILl~~~~~-----~kl  331 (511)
                      ++||||+++|+|.+++..   ....+++..+..++.|++.||+|||+   .+  |+||||||+|||++.++.     +||
T Consensus        97 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence            799999999999888742   34679999999999999999999998   57  999999999999988776     999


Q ss_pred             ecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhH
Q 010434          332 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVY  411 (511)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~  411 (511)
                      +|||+++....     ......||+.|+|||.+......++.++||||||+++|||++|+.||........     ....
T Consensus       171 ~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~  240 (287)
T 4f0f_A          171 ADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-----KFIN  240 (287)
T ss_dssp             CCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-----HHHH
T ss_pred             CCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-----HHHH
Confidence            99999974433     2244569999999999854445778999999999999999999999865432210     0111


Q ss_pred             HhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          412 DQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       412 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      ..........      ....++..+.+++.+||+.||++|||+.++++.|+.
T Consensus       241 ~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          241 MIREEGLRPT------IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHHHSCCCCC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHhccCCCCC------CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            1111111111      122345678899999999999999999999999975

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=9.8e-42  Score=346.77  Aligned_cols=245  Identities=23%  Similarity=0.318  Sum_probs=202.0

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+.+.||+|+||.||+++.+ +|+.||||+++..    ....+.+.+|+.++++++||||+++++++......++||||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~   86 (337)
T 1o6l_A            7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY   86 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeC
Confidence            456789999999999999854 7999999999652    34567899999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|..++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        87 ~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           87 ANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             CTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            99999998873    34579999999999999999999999   699999999999999999999999999998643322


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      .  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||......        .+...+.... ..   
T Consensus       160 ~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~~-~~---  223 (337)
T 1o6l_A          160 A--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELILMEE-IR---  223 (337)
T ss_dssp             C--CBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCC-CC---
T ss_pred             C--cccccccChhhCChhhhcCC--CCCchhhcccchhHHHHHhcCCCCCCCCCHH--------HHHHHHHcCC-CC---
Confidence            1  23455699999999999765  7899999999999999999999998653321        1222222211 11   


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCC-----CHHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRP-----SMTKVLEM  460 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~~  460 (511)
                         .+..++..+.+++.+||+.||++||     ++.++++.
T Consensus       224 ---~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          224 ---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ---CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence               1123456788999999999999999     89999763

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.6e-42  Score=345.42  Aligned_cols=268  Identities=22%  Similarity=0.348  Sum_probs=208.0

Q ss_pred             HHHHHHHhhhccccCcCCcEEEEEEEe-----cCCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccC
Q 010434          183 PEIIAVTNHFTHKLGQGGFGSVYKGQL-----HTGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG  255 (511)
Q Consensus       183 ~ei~~~t~~~~~~LG~G~fg~Vykg~~-----~~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~  255 (511)
                      ..+....+.+.++||+|+||.||++++     .+++.||||++...  ....+.+.+|+.++++++||||+++++++...
T Consensus        16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED   95 (302)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            334444566778999999999999983     46899999999753  34567899999999999999999999999776


Q ss_pred             --CceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeec
Q 010434          256 --SKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSD  333 (511)
Q Consensus       256 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~D  333 (511)
                        ...++||||+++|+|.+++.   .....+++..+..++.|++.||+|||+   .+|+|+||||+|||++.++.+||+|
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~D  169 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLP---KNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGD  169 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHH---HHTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECC
T ss_pred             CCceEEEEEEeCCCCcHHHHHH---hccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECc
Confidence              66899999999999999883   233569999999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCCCCce-eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccc-------ccc
Q 010434          334 FGLAKFHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSS-------KAY  405 (511)
Q Consensus       334 FGla~~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~-------~~~  405 (511)
                      ||+++......... ......+|..|+|||.+.+.  .++.++||||||+++|||++|+.|+........       ...
T Consensus       170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  247 (302)
T 4e5w_A          170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS--KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM  247 (302)
T ss_dssp             CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGG
T ss_pred             ccccccccCCCcceeccCCCCCCccccCCeeecCC--CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccccc
Confidence            99998776554322 22445688899999998765  788999999999999999999987543221100       000


Q ss_pred             cchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          406 FPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                      ....+...+.......      ....++..+.+++.+||+.||.+|||+.++++.|+..
T Consensus       248 ~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          248 TVTRLVNTLKEGKRLP------CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHHHHHHHHHTTCCCC------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CHHHHHHHHhccCCCC------CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            0111122222222221      1123456788999999999999999999999999864

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.3e-42  Score=346.54  Aligned_cols=262  Identities=23%  Similarity=0.407  Sum_probs=210.1

Q ss_pred             HHHhhhccccCcCCcEEEEEEEe--------cCCcEEEEEEeccCc--ccHHHHHHHHHHhccc-cccceEEeeceeccC
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQL--------HTGRLIAVKMLENSK--FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEG  255 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~--------~~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~  255 (511)
                      ...+.+.+.||+|+||.||+|..        .+++.||||++....  ...+.+.+|+.+++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            34566778999999999999985        356789999997633  3456799999999999 899999999999999


Q ss_pred             CceeEEEeecCCCCcccccccCCC------------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEE
Q 010434          256 SKRALVYEFMPNGSLDRHIFPKEN------------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL  323 (511)
Q Consensus       256 ~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl  323 (511)
                      +..++||||+++|+|.+++.....            ....+++..+..++.||+.||+|||+   .+|+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence            999999999999999999854322            12358999999999999999999999   699999999999999


Q ss_pred             cCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCccccccc
Q 010434          324 DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSS  402 (511)
Q Consensus       324 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~  402 (511)
                      +.++.+||+|||+++...............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.|+......  
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--  266 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--  266 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC--CcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--
Confidence            99999999999999877655444444555688999999998764  78899999999999999999 99998654321  


Q ss_pred             ccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          403 KAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                            .+...+..+.....      ...++..+..++.+||+.||.+|||+.++++.|+.....
T Consensus       267 ------~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~  319 (334)
T 2pvf_A          267 ------ELFKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  319 (334)
T ss_dssp             ------HHHHHHHHTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------HHHHHHhcCCCCCC------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                  12223333222221      122346788999999999999999999999999886543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7.8e-43  Score=346.31  Aligned_cols=266  Identities=30%  Similarity=0.491  Sum_probs=196.6

Q ss_pred             HHHHHHHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccCCcee
Q 010434          183 PEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  259 (511)
Q Consensus       183 ~ei~~~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~  259 (511)
                      .||....+.+.++||+|+||.||+|+.+  ..||||+++....   ..+.|.+|+.++++++||||+++++++ .....+
T Consensus        19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~   95 (289)
T 3og7_A           19 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA   95 (289)
T ss_dssp             CBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred             CccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence            3455556677899999999999999865  3599999976433   346799999999999999999999976 456689


Q ss_pred             EEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      +||||+++++|.+++.   .....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        96 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  169 (289)
T 3og7_A           96 IVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATE  169 (289)
T ss_dssp             EEEECCCEEEHHHHHT---TC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred             EEEEecCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccc
Confidence            9999999999999883   234679999999999999999999999   6999999999999999999999999999986


Q ss_pred             CCCCCCceeeccccCCccccchhccccc-CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCC
Q 010434          340 HPKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG  418 (511)
Q Consensus       340 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  418 (511)
                      ..............||+.|+|||.+... ...++.++||||||+++|||++|+.||......       ..+......+.
T Consensus       170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~  242 (289)
T 3og7_A          170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIEMVGRGS  242 (289)
T ss_dssp             --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-------HHHHHHHHHTS
T ss_pred             cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-------HHHHHHhcccc
Confidence            5543333333455699999999998622 236788999999999999999999998653221       11222222221


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          419 DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       419 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      ...  ........++..+.+++.+||+.||++|||+.++++.|+....
T Consensus       243 ~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          243 LSP--DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             CCC--CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cCc--chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            111  0111222345778999999999999999999999999997553

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.3e-42  Score=351.52  Aligned_cols=263  Identities=17%  Similarity=0.204  Sum_probs=206.1

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEeecCC
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      +.+.++||+|+||.||+|+. .+|+.||||++.... ..+.+.+|+.+++++ +||||+++++++..+...++||||+ +
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~   88 (330)
T 2izr_A           11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-G   88 (330)
T ss_dssp             EEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-C
T ss_pred             eEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-C
Confidence            45678999999999999984 579999999986543 234688999999999 9999999999999999999999999 9


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCC-----eeeecccccccCCC
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFI-----PKVSDFGLAKFHPK  342 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~-----~kl~DFGla~~~~~  342 (511)
                      ++|.+++..   ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.     +||+|||+++....
T Consensus        89 ~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~  162 (330)
T 2izr_A           89 PSLEDLFDL---CDRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID  162 (330)
T ss_dssp             CBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred             CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence            999998832   24679999999999999999999999   69999999999999998887     99999999987644


Q ss_pred             CCCce-----eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcC
Q 010434          343 ENDFV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG  417 (511)
Q Consensus       343 ~~~~~-----~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  417 (511)
                      .....     ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||........     ......+...
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~-----~~~~~~i~~~  235 (330)
T 2izr_A          163 PETKKHIPYREHKSLTGTARYMSINTHLGK--EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL-----KERYQKIGDT  235 (330)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH-----HHHHHHHHHH
T ss_pred             CCCCccccccccCCcCCCccccChHHHcCC--CCCchhHHHHHHHHHHHHhcCCCCccccccccH-----HHHHHHHHhh
Confidence            33211     12345699999999999875  789999999999999999999999976432211     1111111110


Q ss_pred             CcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCCC
Q 010434          418 GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQM  470 (511)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~~  470 (511)
                      ....  .........+ .+.+++.+||+.||.+||++.+|++.|+........
T Consensus       236 ~~~~--~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~  285 (330)
T 2izr_A          236 KRAT--PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY  285 (330)
T ss_dssp             HHHS--CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             hccC--CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            0000  0000111123 789999999999999999999999999876555443

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.5e-42  Score=335.23  Aligned_cols=250  Identities=29%  Similarity=0.437  Sum_probs=191.7

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCc-----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSK-----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~-----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .+.+.++||+|+||.||+|... |+.||||++....     ...+.+.+|+.++++++||||+++++++.++...++|||
T Consensus         8 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (271)
T 3dtc_A            8 ELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME   86 (271)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred             heeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence            3556789999999999999875 8999999986532     234689999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC--------CCCeeeeccc
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH--------NFIPKVSDFG  335 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~--------~~~~kl~DFG  335 (511)
                      |+++++|.+++     .+..+++..+..++.|++.||+|||+....+|+||||||+|||++.        ++.+||+|||
T Consensus        87 ~~~~~~L~~~~-----~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           87 FARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             CCTTEEHHHHH-----TSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             cCCCCCHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            99999999987     2357999999999999999999999941122999999999999986        7789999999


Q ss_pred             ccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhh
Q 010434          336 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLN  415 (511)
Q Consensus       336 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  415 (511)
                      +++.......    ....||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.......       .......
T Consensus       162 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~  228 (271)
T 3dtc_A          162 LAREWHRTTK----MSAAGAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-------VAYGVAM  228 (271)
T ss_dssp             C-----------------CCGGGSCHHHHHHC--CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH-------HHHHHHT
T ss_pred             cccccccccc----cCCCCccceeCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHhhhc
Confidence            9986543322    234689999999998765  78999999999999999999999986533211       1111111


Q ss_pred             cCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      ......      ....++..+.+++.+||+.||++|||+.++++.|+.
T Consensus       229 ~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          229 NKLALP------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             SCCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCCCCC------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            111111      112234678899999999999999999999999975

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1e-41  Score=343.44  Aligned_cols=250  Identities=20%  Similarity=0.306  Sum_probs=196.0

Q ss_pred             HHhhhccccCcCCcEEEEEEEec-CCcEEEEEEecc--CcccHHHHHHHHHHhccccccceEEeeceeccCC--------
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS--------  256 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~--------  256 (511)
                      ..+.+.++||+|+||.||+|+.. +|+.||||++..  .....+.+.+|+.++++++||||+++++++.+..        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            34566789999999999999965 799999999875  3335678999999999999999999999885543        


Q ss_pred             -------------------------------------------------ceeEEEeecCCCCcccccccCCCcCCccCHH
Q 010434          257 -------------------------------------------------KRALVYEFMPNGSLDRHIFPKENKGQTFGWE  287 (511)
Q Consensus       257 -------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~  287 (511)
                                                                       ..++||||+++|+|.+++.... .....++.
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~  164 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHG  164 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhH
Confidence                                                             2789999999999999985432 23456788


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc----------eeeccccCCcc
Q 010434          288 KLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF----------VSISATRGTIG  357 (511)
Q Consensus       288 ~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~  357 (511)
                      .+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            899999999999999999   69999999999999999999999999999876554321          11234569999


Q ss_pred             ccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHHHHH
Q 010434          358 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLC  437 (511)
Q Consensus       358 y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  437 (511)
                      |+|||.+.+.  .++.++||||||+++|||++|..|+....          .........      ............+.
T Consensus       242 y~aPE~~~~~--~~~~~~Di~slG~il~el~~~~~~~~~~~----------~~~~~~~~~------~~~~~~~~~~~~~~  303 (332)
T 3qd2_B          242 YMSPEQIHGN--NYSHKVDIFSLGLILFELLYSFSTQMERV----------RIITDVRNL------KFPLLFTQKYPQEH  303 (332)
T ss_dssp             GSCHHHHHCC--CCCTHHHHHHHHHHHHHHHSCCCCHHHHH----------HHHHHHHTT------CCCHHHHHHCHHHH
T ss_pred             ccChHHhcCC--CCcchhhHHHHHHHHHHHHHcCCChhHHH----------HHHHHhhcc------CCCcccccCChhHH
Confidence            9999999765  78999999999999999999876532111          011111111      11123344556778


Q ss_pred             HHHHHhcCcCCCCCCCHHHHHH
Q 010434          438 MIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       438 ~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      +++.+||+.||++|||+.++++
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCCCCcCCCHHHHhh
Confidence            9999999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.8e-42  Score=340.70  Aligned_cols=255  Identities=23%  Similarity=0.355  Sum_probs=193.9

Q ss_pred             HHHhhhccccCcCCcEEEEEEEec----CCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeE
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  260 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~~----~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  260 (511)
                      ...+.+.+.||+|+||.||+|...    .+..||+|++...  ....+.|.+|+.++++++||||+++++++. ++..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            345667789999999999999853    3567999998763  234567999999999999999999999985 467899


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      ||||+++|+|.+++..   ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        93 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           93 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccccc
Confidence            9999999999998832   23579999999999999999999999   69999999999999999999999999999876


Q ss_pred             CCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      ...... ......+|+.|+|||.+...  .++.++||||||+++|||++ |+.||.......        ....+.....
T Consensus       167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--------~~~~i~~~~~  235 (281)
T 1mp8_A          167 EDSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGER  235 (281)
T ss_dssp             -------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCC
T ss_pred             Cccccc-ccccCCCcccccChhhcccC--CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--------HHHHHHcCCC
Confidence            543221 22334578899999998764  78899999999999999996 898986543221        2222322222


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                      ...      ...++..+.+++.+||+.||++|||+.++++.|+...
T Consensus       236 ~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          236 LPM------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             CCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCC------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            211      1234567889999999999999999999999998654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-42  Score=340.80  Aligned_cols=260  Identities=25%  Similarity=0.398  Sum_probs=209.5

Q ss_pred             hhcc-ccCcCCcEEEEEEEec---CCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          191 HFTH-KLGQGGFGSVYKGQLH---TGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       191 ~~~~-~LG~G~fg~Vykg~~~---~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      .+.+ +||+|+||.||+|...   +++.||||+++..  ....+.+.+|+.++++++||||+++++++ .....++||||
T Consensus        12 ~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~   90 (287)
T 1u59_A           12 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEM   90 (287)
T ss_dssp             EEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEEC
T ss_pred             hhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEe
Confidence            3444 8999999999999743   6789999999763  23456799999999999999999999999 55678999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++++|.+++.   .....+++..+..++.|++.||+|||+   .+|+|+||||+||+++.++.+||+|||+++......
T Consensus        91 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           91 AGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  164 (287)
T ss_dssp             CTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             CCCCCHHHHHH---hCCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence            99999999883   234679999999999999999999999   699999999999999999999999999998775443


Q ss_pred             Cce-eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          345 DFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       345 ~~~-~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                      ... ......+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||......        .+...+..+.....
T Consensus       165 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~~~i~~~~~~~~  234 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQGKRMEC  234 (287)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------HHHHHHHTTCCCCC
T ss_pred             ceeeccccccccccccCHHHhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHhcCCcCCC
Confidence            322 12334578999999998764  78899999999999999998 99998653321        12223333322221


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCCCCCC
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPK  473 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~~p~~  473 (511)
                            +..++..+.+++.+||+.||++|||+.++++.|+........+..
T Consensus       235 ------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~  279 (287)
T 1u59_A          235 ------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE  279 (287)
T ss_dssp             ------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred             ------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence                  123456788999999999999999999999999987766555433

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.9e-42  Score=339.82  Aligned_cols=256  Identities=22%  Similarity=0.289  Sum_probs=196.4

Q ss_pred             hhhccccCcCCcEEEEEEEecCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          190 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      |.+.++||+|+||.||+++..+|+.||||++....   ...+.+.+|+.++++++||||+++++++..++..++||||++
T Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (288)
T 1ob3_A            4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD   83 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred             chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence            45678999999999999998889999999986532   234678999999999999999999999999999999999997


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      + +|.+++..   ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....... 
T Consensus        84 ~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  155 (288)
T 1ob3_A           84 Q-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-  155 (288)
T ss_dssp             E-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             C-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence            5 88887732   23579999999999999999999999   6999999999999999999999999999986543221 


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhc----------
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK----------  416 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------  416 (511)
                       ......||+.|+|||.+.+. ..++.++||||||+++|||++|+.||.........    ..+...+..          
T Consensus       156 -~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  229 (288)
T 1ob3_A          156 -KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL----MRIFRILGTPNSKNWPNVT  229 (288)
T ss_dssp             -------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHHHCCCCTTTSTTGG
T ss_pred             -ccccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHHHCCCChhhchhhh
Confidence             22344689999999998653 36889999999999999999999998753321100    000000000          


Q ss_pred             -CCc----c---cccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          417 -GGD----L---ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       417 -~~~----~---~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                       ...    .   ...........++..+.+++.+||+.||++|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             000    0   000001112234567889999999999999999999986

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=8.4e-42  Score=350.66  Aligned_cols=252  Identities=22%  Similarity=0.309  Sum_probs=204.2

Q ss_pred             HHHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccCCceeEE
Q 010434          186 IAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       186 ~~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  261 (511)
                      ....|.+.++||+|+||.||++... +|+.||+|++.....   ..+.+.+|+.++++++||||+++++++.++...++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3456777899999999999999854 789999999976433   345788999999999999999999999999999999


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC---CCeeeecccccc
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN---FIPKVSDFGLAK  338 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~---~~~kl~DFGla~  338 (511)
                      |||+++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.+   +.+||+|||+++
T Consensus       107 ~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          107 FDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             ECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            99999999998883    33579999999999999999999999   699999999999999765   459999999998


Q ss_pred             cCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCC
Q 010434          339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG  418 (511)
Q Consensus       339 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  418 (511)
                      .......   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||......        .+...+..+.
T Consensus       180 ~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--------~~~~~i~~~~  246 (362)
T 2bdw_A          180 EVNDSEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYAQIKAGA  246 (362)
T ss_dssp             CCTTCCS---CCCSCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTC
T ss_pred             EecCCcc---cccCCCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCC
Confidence            7654322   2345699999999999764  7899999999999999999999998654321        1222222221


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          419 DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       419 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      ...   .......++..+.+++.+||+.||++|||+.++++.
T Consensus       247 ~~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          247 YDY---PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             CCC---CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCC---CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            111   111222345678899999999999999999999763

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.8e-42  Score=348.43  Aligned_cols=266  Identities=26%  Similarity=0.375  Sum_probs=207.7

Q ss_pred             HhhhccccCcCCcEEEEEEEe-----cCCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceec--cCCceeE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-----HTGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCS--EGSKRAL  260 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-----~~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~--~~~~~~l  260 (511)
                      .+.+.++||+|+||.||++++     .+++.||||++.... ...+.+.+|+.++++++||||+++++++.  +....++
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l  103 (327)
T 3lxl_A           24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL  103 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred             hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence            456678999999999999983     468899999997643 34567999999999999999999999885  4566889


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      ||||+++++|.+++..   ....+++..+..++.|++.||+|||+   .+|+|+||||+|||++.++.+||+|||+++..
T Consensus       104 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          104 VMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEeecCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceec
Confidence            9999999999999832   23469999999999999999999999   69999999999999999999999999999877


Q ss_pred             CCCCCce-eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc-------cccchhhHH
Q 010434          341 PKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK-------AYFPSWVYD  412 (511)
Q Consensus       341 ~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~-------~~~~~~~~~  412 (511)
                      ....... ......+|..|+|||.+.+.  .++.++||||||+++|||++|+.|+.........       ......+..
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDN--IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE  255 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccC--CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence            6544332 22344588899999998765  7889999999999999999999987653321100       000111222


Q ss_pred             hhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCC
Q 010434          413 QLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDL  468 (511)
Q Consensus       413 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l  468 (511)
                      .+..+....      ....++..+.+++.+||+.||++|||+.++++.|+......
T Consensus       256 ~~~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          256 LLEEGQRLP------APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             HhhcccCCC------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            222222211      12234567889999999999999999999999999876554

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.4e-42  Score=343.30  Aligned_cols=266  Identities=17%  Similarity=0.249  Sum_probs=209.6

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEeecC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .+.+.+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+.++.++ +|+|++++++++.++...++||||+ 
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   88 (298)
T 1csn_A           11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   88 (298)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-
Confidence            455678999999999999984 679999999986533 334688999999999 7999999999999999999999999 


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCC-----eeeecccccccCC
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFI-----PKVSDFGLAKFHP  341 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~-----~kl~DFGla~~~~  341 (511)
                      +++|.+++..   .+..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.     +||+|||+++...
T Consensus        89 ~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           89 GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            9999999832   23569999999999999999999998   69999999999999987776     9999999998765


Q ss_pred             CCCCc-----eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhc
Q 010434          342 KENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK  416 (511)
Q Consensus       342 ~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  416 (511)
                      .....     .......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||........     ......+..
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-----~~~~~~~~~  235 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-----KQKYERIGE  235 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-----HHHHHHHHH
T ss_pred             cccccccccccCccCCCCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHcCCCCcchhhcccc-----HHHHHHHHh
Confidence            44321     122445699999999998765  689999999999999999999999976432211     111111111


Q ss_pred             CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCCCC
Q 010434          417 GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMP  471 (511)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~~p  471 (511)
                      ...  ..........++..+.+++.+||+.||++|||+.+|++.|+.....+..+
T Consensus       236 ~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~  288 (298)
T 1csn_A          236 KKQ--STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT  288 (298)
T ss_dssp             HHH--HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             hcc--CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence            100  00011122234578899999999999999999999999999877665433

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3e-42  Score=353.83  Aligned_cols=276  Identities=16%  Similarity=0.171  Sum_probs=204.5

Q ss_pred             HHhhhccccCcCCcEEEEEEEecC------CcEEEEEEeccCcc------------cHHHHHHHHHHhccccccceEEee
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLHT------GRLIAVKMLENSKF------------SAEEFINEVSTIGRIHHVNVVQLL  249 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~~------g~~vAvK~l~~~~~------------~~~~f~~Ev~~l~~l~H~niv~l~  249 (511)
                      ..+.+.++||+|+||.||+|..++      ++.||||++.....            ....+..|+..+..++||||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            356677899999999999998654      47899999865431            112345566777888999999999


Q ss_pred             ceeccC----CceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEc-
Q 010434          250 GFCSEG----SKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD-  324 (511)
Q Consensus       250 g~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~-  324 (511)
                      +++...    ...++||||+ +++|.+++..   ....+++..+..++.||+.||+|||+   .+|+||||||+|||++ 
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEES
T ss_pred             eeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEec
Confidence            998764    4589999999 9999998832   34679999999999999999999999   6999999999999999 


Q ss_pred             -CCCCeeeecccccccCCCCCCce-----eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccc
Q 010434          325 -HNFIPKVSDFGLAKFHPKENDFV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA  398 (511)
Q Consensus       325 -~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~  398 (511)
                       .++.+||+|||+++.........     ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||....
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV--APSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence             88999999999998664332211     11234499999999999765  68999999999999999999999997532


Q ss_pred             ccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCCCCCCCCC
Q 010434          399 IRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKPCF  476 (511)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~~p~~p~~  476 (511)
                      ....   +........... ...+....-....++..+.+++.+||+.+|++||++.+|+++|+..+.....+....+
T Consensus       266 ~~~~---~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~  339 (364)
T 3op5_A          266 KDPK---YVRDSKIRYREN-IASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKL  339 (364)
T ss_dssp             TCHH---HHHHHHHHHHHC-HHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             cCHH---HHHHHHHHhhhh-HHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCcc
Confidence            2110   000000000000 0000000000012356788999999999999999999999999988877665544433

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=359.14  Aligned_cols=251  Identities=20%  Similarity=0.286  Sum_probs=202.8

Q ss_pred             HHHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      ...|.+.++||+|+||.||++.. .+|+.+|+|++.....   ..+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            34667789999999999999984 5799999999976443   3457899999999999999999999999999999999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEc---CCCCeeeeccccccc
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD---HNFIPKVSDFGLAKF  339 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~---~~~~~kl~DFGla~~  339 (511)
                      ||+++|+|.+.+.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++   .++.+||+|||+++.
T Consensus        90 E~~~gg~L~~~i~----~~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           90 DLVTGGELFEDIV----AREYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             CCCBCCBHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            9999999998883    33579999999999999999999999   6999999999999998   467899999999986


Q ss_pred             CCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          340 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       340 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      ......  ......||+.|+|||++.+.  .++.++||||+|+++|+|++|+.||......        .+...+..+..
T Consensus       163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~~  230 (444)
T 3soa_A          163 VEGEQQ--AWFGFAGTPGYLSPEVLRKD--PYGKPVDLWACGVILYILLVGYPPFWDEDQH--------RLYQQIKAGAY  230 (444)
T ss_dssp             CCTTCC--BCCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHTCC
T ss_pred             ecCCCc--eeecccCCcccCCHHHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHhCCC
Confidence            654332  22445699999999999764  7899999999999999999999998654321        12223322221


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ...   ......+++.+.+++.+||+.||++|||+.++++
T Consensus       231 ~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          231 DFP---SPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CCC---TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCC---ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            110   1111234567889999999999999999999987

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.6e-42  Score=344.07  Aligned_cols=261  Identities=28%  Similarity=0.435  Sum_probs=208.6

Q ss_pred             HHhhhccccCcCCcEEEEEEEe------cCCcEEEEEEeccCcc--cHHHHHHHHHHhccc-cccceEEeeceeccCC-c
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMLENSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGS-K  257 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~------~~g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~-~  257 (511)
                      ..+.+.++||+|+||.||+|+.      .+++.||||++.....  ..+.+.+|+.++.++ +||||+++++++...+ .
T Consensus        27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  106 (316)
T 2xir_A           27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  106 (316)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence            3556678999999999999974      3568999999976432  345799999999999 7999999999987654 5


Q ss_pred             eeEEEeecCCCCcccccccCCCc------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC
Q 010434          258 RALVYEFMPNGSLDRHIFPKENK------------GQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH  325 (511)
Q Consensus       258 ~~lV~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~  325 (511)
                      .++||||+++|+|.+++......            ...+++..+..++.|++.||+|||+   .+|+||||||+||+++.
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~  183 (316)
T 2xir_A          107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSE  183 (316)
T ss_dssp             CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECG
T ss_pred             eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECC
Confidence            89999999999999998543321            2238999999999999999999999   69999999999999999


Q ss_pred             CCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCccccccccc
Q 010434          326 NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKA  404 (511)
Q Consensus       326 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~  404 (511)
                      ++.+||+|||+++...............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.|+......    
T Consensus       184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----  257 (316)
T 2xir_A          184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----  257 (316)
T ss_dssp             GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS----
T ss_pred             CCCEEECCCccccccccCccceeccCCCcceeecCchhhccc--cccchhHHHHHHHHHHHHHhCCCCCCcccchh----
Confidence            999999999999876655544444556689999999998764  78999999999999999998 99998653221    


Q ss_pred             ccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          405 YFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                         ......+..+......      ...+..+.+++.+||+.||.+|||+.++++.|+..+.
T Consensus       258 ---~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          258 ---EEFCRRLKEGTRMRAP------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             ---HHHHHHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHHHHhccCccCCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence               1222333333222211      1234678899999999999999999999999987543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-41  Score=337.56  Aligned_cols=252  Identities=22%  Similarity=0.332  Sum_probs=199.4

Q ss_pred             HHHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      ...+.+.++||+|+||.||++.. .+++.+|+|++...  ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            35677889999999999999985 47899999998763  3456889999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEE---cCCCCeeeecccccccC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl---~~~~~~kl~DFGla~~~  340 (511)
                      |+++|+|.+++......+..+++..+..++.|++.||+|||+   .+|+||||||+|||+   +.++.+||+|||+++..
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            999999999885544445789999999999999999999999   699999999999999   45688999999999865


Q ss_pred             CCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcc
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDL  420 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (511)
                      ....   ......||+.|+|||.+.+   .++.++||||||+++|||++|+.||.......        ...........
T Consensus       178 ~~~~---~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--------~~~~~~~~~~~  243 (285)
T 3is5_A          178 KSDE---HSTNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--------VQQKATYKEPN  243 (285)
T ss_dssp             ------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCC
T ss_pred             CCcc---cCcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--------HHhhhccCCcc
Confidence            4432   1244569999999999863   67899999999999999999999987543221        11111111110


Q ss_pred             cccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          421 ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       421 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ...    ....+++.+.+++.+||+.||++|||+.++++
T Consensus       244 ~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          244 YAV----ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CCC------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ccc----ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000    01113456788999999999999999999985

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=7.9e-42  Score=343.76  Aligned_cols=260  Identities=25%  Similarity=0.376  Sum_probs=208.1

Q ss_pred             HHhhhccccCcCCcEEEEEEEec------CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCcee
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  259 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~  259 (511)
                      ..+.+.++||+|+||.||+|+..      +++.||||++....  .....|.+|+.++++++||||+++++++.++...+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  104 (322)
T 1p4o_A           25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL  104 (322)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence            45566789999999999999754      47899999997633  23457999999999999999999999999999999


Q ss_pred             EEEeecCCCCcccccccCCC------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeec
Q 010434          260 LVYEFMPNGSLDRHIFPKEN------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSD  333 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~D  333 (511)
                      +||||+++|+|.+++.....      ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|
T Consensus       105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~D  181 (322)
T 1p4o_A          105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD  181 (322)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEECc
Confidence            99999999999998843211      12457999999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHH
Q 010434          334 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYD  412 (511)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~  412 (511)
                      ||+++...............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.|+......        ....
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~~  251 (322)
T 1p4o_A          182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--------QVLR  251 (322)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--------HHHH
T ss_pred             CccccccccccccccccCCCCCCCccChhhhccC--CCCchhhHHHHHHHHHHHHhcCCCccccCCHH--------HHHH
Confidence            9999865443332223344578999999998764  78899999999999999999 88888653221        1222


Q ss_pred             hhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          413 QLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       413 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      .+........      ...++..+.+++.+||+.||.+|||+.++++.|+....
T Consensus       252 ~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          252 FVMEGGLLDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHcCCcCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            2222222111      12234668899999999999999999999999998654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.5e-41  Score=330.77  Aligned_cols=251  Identities=21%  Similarity=0.327  Sum_probs=201.2

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccC--CceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~--~~~~lV~e  263 (511)
                      .+.+.++||+|+||.||+|+.+ ++.||||++....   ...+.|.+|+.++++++||||+++++++.+.  ...++|||
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   89 (271)
T 3kmu_A           11 QLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH   89 (271)
T ss_dssp             GCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred             HhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence            4566789999999999999975 8999999997643   2346799999999999999999999999876  78899999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCc--eecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC--ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      |+++|+|.+++..  .....+++..+..++.|++.||+|||+   .+  |+||||||+|||++.++.++|+|||++....
T Consensus        90 ~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           90 WMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             CCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            9999999999843  223469999999999999999999998   57  9999999999999999999999998875422


Q ss_pred             CCCCceeeccccCCccccchhccccc-CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcc
Q 010434          342 KENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDL  420 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (511)
                      .       ....||+.|+|||.+.+. ...++.++||||||+++|||++|+.||.......       ............
T Consensus       165 ~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~  230 (271)
T 3kmu_A          165 S-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME-------IGMKVALEGLRP  230 (271)
T ss_dssp             C-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH-------HHHHHHHSCCCC
T ss_pred             c-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH-------HHHHHHhcCCCC
Confidence            2       334589999999998753 1234458999999999999999999986533211       111222222222


Q ss_pred             cccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          421 ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       421 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                      ..      +..++..+.+++..||+.||++|||+.++++.|+...
T Consensus       231 ~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          231 TI------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             CC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            21      1224567889999999999999999999999998643

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.8e-41  Score=337.39  Aligned_cols=257  Identities=27%  Similarity=0.401  Sum_probs=199.6

Q ss_pred             hhhccccCcCCcEEEEEEEecC----CcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeecee-ccCCceeEEE
Q 010434          190 NHFTHKLGQGGFGSVYKGQLHT----GRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFC-SEGSKRALVY  262 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~~----g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~-~~~~~~~lV~  262 (511)
                      +.+.++||+|+||.||+|...+    +..+|+|.+....  ...+.+.+|+.++++++||||+++++++ ..+...++||
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  106 (298)
T 3f66_A           27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  106 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence            4567899999999999998532    2368999987632  2456799999999999999999999986 4566789999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+++|+|.+++.   .....+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++....
T Consensus       107 e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          107 PYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             ECCTTCBHHHHHH---CTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             eCCCCCCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            9999999999983   234678999999999999999999999   6999999999999999999999999999986544


Q ss_pred             CCCc--eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCC-CCCCcccccccccccchhhHHhhhcCCc
Q 010434          343 ENDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       343 ~~~~--~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      ....  .......+|+.|+|||.+.+.  .++.++||||||+++|||++|. +|+.......        ..........
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--------~~~~~~~~~~  250 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--------ITVYLLQGRR  250 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--------HHHHHHTTCC
T ss_pred             cchhccccccCCCCCccccChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--------HHHHHhcCCC
Confidence            3211  122344578899999999765  7889999999999999999955 4543322111        1112222221


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCC
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDL  468 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l  468 (511)
                      ...      +..++..+.+++.+||+.||++|||+.++++.|+.....+
T Consensus       251 ~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          251 LLQ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             CCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             CCC------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            111      1113456889999999999999999999999999876654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-42  Score=351.62  Aligned_cols=258  Identities=27%  Similarity=0.394  Sum_probs=193.7

Q ss_pred             hhhccccCcCCcEEEEEEEec--CC--cEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceec-cCCceeEEE
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH--TG--RLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCS-EGSKRALVY  262 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~--~g--~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~-~~~~~~lV~  262 (511)
                      +.+.++||+|+||.||+|...  ++  ..||||.++..  ....++|.+|+.++++++||||+++++++. .++..++||
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~  170 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  170 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence            345678999999999999853  22  46899998753  234578999999999999999999999875 456789999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+++|+|.+++.   .....+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++....
T Consensus       171 e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          171 PYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             ECCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             ECCCCCCHHHHHh---hcccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            9999999999983   334568999999999999999999999   6999999999999999999999999999986543


Q ss_pred             CCCc--eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          343 ENDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       343 ~~~~--~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      ....  .......+|+.|+|||.+.+.  .++.++||||||+++|||++ |..|+.......        +...+..+..
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--------~~~~~~~~~~  314 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--------ITVYLLQGRR  314 (373)
T ss_dssp             -------------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--------HHHHHHTTCC
T ss_pred             cccccccccCCCCCcccccChHHhcCC--CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--------HHHHHHcCCC
Confidence            3211  112344578899999998764  78999999999999999999 566665432111        1122222222


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCC
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQ  469 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~  469 (511)
                      ...      +..++..+.+++.+||+.||++|||+.++++.|+.....+.
T Consensus       315 ~~~------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          315 LLQ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             CCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             CCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            211      11234678899999999999999999999999998765543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.4e-41  Score=352.78  Aligned_cols=253  Identities=20%  Similarity=0.297  Sum_probs=200.2

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcc----cHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKF----SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      .+.+.++||+|+||.||+++.+ +++.||||++++...    ..+.+.+|..++.++ +|||||++++++.+....++||
T Consensus        53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~  132 (396)
T 4dc2_A           53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI  132 (396)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence            3556789999999999999854 688999999976432    224578899999887 8999999999999999999999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+++|+|..++.    ....+++..+..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+++....
T Consensus       133 E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          133 EYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             ECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EcCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            9999999998883    33579999999999999999999999   6999999999999999999999999999985333


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccc-ccccchhhHHhhhcCCccc
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSS-KAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  421 (511)
                      ...  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||........ .......+.+.+..... .
T Consensus       206 ~~~--~~~~~~gt~~Y~aPE~l~~~--~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~  280 (396)
T 4dc2_A          206 PGD--TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R  280 (396)
T ss_dssp             TTC--CBCCCCBCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-C
T ss_pred             CCC--ccccccCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-C
Confidence            222  23456799999999999875  789999999999999999999999965322111 11112223333322211 1


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCH------HHHHH
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSM------TKVLE  459 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~------~evl~  459 (511)
                            .+..++..+.+++.+||+.||++||++      .++++
T Consensus       281 ------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          281 ------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             ------CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence                  122345678899999999999999995      56654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=372.54  Aligned_cols=250  Identities=25%  Similarity=0.403  Sum_probs=201.0

Q ss_pred             ccCcCCcEEEEEEEec---CCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCC
Q 010434          195 KLGQGGFGSVYKGQLH---TGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGS  269 (511)
Q Consensus       195 ~LG~G~fg~Vykg~~~---~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  269 (511)
                      +||+|+||.||+|.+.   ++..||||+++..  ....++|.+|+.++++++|||||++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999764   5678999999763  3467889999999999999999999999976 56899999999999


Q ss_pred             cccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce-e
Q 010434          270 LDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-S  348 (511)
Q Consensus       270 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~  348 (511)
                      |.+++..   ....+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++......... .
T Consensus       422 L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  495 (613)
T 2ozo_A          422 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA  495 (613)
T ss_dssp             HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred             HHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence            9998842   34679999999999999999999999   699999999999999999999999999998765433221 1


Q ss_pred             eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      .....+|+.|+|||++...  .++.++|||||||++|||++ |+.||......        .+...+..+......    
T Consensus       496 ~~~~~~~~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~~~i~~~~~~~~p----  561 (613)
T 2ozo_A          496 RSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQGKRMECP----  561 (613)
T ss_dssp             ------CCTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--------HHHHHHHTTCCCCCC----
T ss_pred             ccCCCCccceeCHhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--------HHHHHHHcCCCCCCC----
Confidence            2233467899999999764  78999999999999999998 99998654321        133444444333222    


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                        ..++..+.+++.+||+.||++|||+.+|++.|+.....
T Consensus       562 --~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          562 --PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             --TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             --CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence              23456788999999999999999999999999875544

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.2e-42  Score=343.95  Aligned_cols=261  Identities=28%  Similarity=0.405  Sum_probs=196.0

Q ss_pred             HHhhhccccCcCCcEEEEEEEec----CCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccCC----
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGS----  256 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~----~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~----  256 (511)
                      ..+.+.+.||+|+||.||+|...    +++.||||++.....   ..+.+.+|+.++++++||||+++++++.+..    
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  113 (313)
T 3brb_A           34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI  113 (313)
T ss_dssp             GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred             HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence            34556789999999999999754    345899999876432   3467899999999999999999999997654    


Q ss_pred             -ceeEEEeecCCCCcccccccCC--CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeec
Q 010434          257 -KRALVYEFMPNGSLDRHIFPKE--NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSD  333 (511)
Q Consensus       257 -~~~lV~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~D  333 (511)
                       ..++||||+++|+|.+++....  .....+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus       114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~D  190 (313)
T 3brb_A          114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVAD  190 (313)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEECS
T ss_pred             cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEee
Confidence             3599999999999999874322  234679999999999999999999998   6999999999999999999999999


Q ss_pred             ccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHH
Q 010434          334 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYD  412 (511)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~  412 (511)
                      ||+++...............+++.|+|||.+.+.  .++.++||||||+++|||++ |+.|+.......        ...
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~  260 (313)
T 3brb_A          191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--------MYD  260 (313)
T ss_dssp             CSCC----------------CCGGGSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------HHH
T ss_pred             cCcceecccccccCcccccCCCccccCchhhcCC--CccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--------HHH
Confidence            9999876544333333445578899999999764  78999999999999999999 888886533221        222


Q ss_pred             hhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          413 QLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       413 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                      .+..+.....      ...++..+.+++.+||+.||++|||+.++++.|+.....
T Consensus       261 ~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          261 YLLHGHRLKQ------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             HHHTTCCCCC------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCCCCC------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            2222222211      122346788999999999999999999999999886554

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.9e-41  Score=341.38  Aligned_cols=279  Identities=23%  Similarity=0.291  Sum_probs=211.0

Q ss_pred             CCCChHHHHHHHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhcc--ccccceEEeeceeccC
Q 010434          178 KRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGR--IHHVNVVQLLGFCSEG  255 (511)
Q Consensus       178 ~~~~~~ei~~~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~--l~H~niv~l~g~~~~~  255 (511)
                      ..+...+.....+.+.+.||+|+||.||+|+.. |+.||||++...  ..+.+.+|++++..  ++||||+++++++...
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             CceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            344455677778888899999999999999874 899999998643  45678889888877  7899999999999876


Q ss_pred             C----ceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCC-----CCceecccCCcCceEEcCC
Q 010434          256 S----KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC-----DMCILHFDIKPHNILLDHN  326 (511)
Q Consensus       256 ~----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~ivH~DIkp~NILl~~~  326 (511)
                      .    ..++||||+++|+|.+++.     ...+++..+..++.|++.||+|||...     ..+|+||||||+|||++.+
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~  183 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN  183 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT
T ss_pred             CCccceeEEEEeecCCCcHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC
Confidence            5    7899999999999999983     246999999999999999999999210     1699999999999999999


Q ss_pred             CCeeeecccccccCCCCCCce--eeccccCCccccchhcccccCC----CcCccchHHHHHHHHHHHHhC----------
Q 010434          327 FIPKVSDFGLAKFHPKENDFV--SISATRGTIGYIAPELISRNFG----TVSCKSDVYGFGMVLLEMAGG----------  390 (511)
Q Consensus       327 ~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~----~~s~ksDVwS~Gvll~elltg----------  390 (511)
                      +.+||+|||+++.........  ......||+.|+|||.+.+...    .++.++||||||+++|||++|          
T Consensus       184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~  263 (342)
T 1b6c_B          184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY  263 (342)
T ss_dssp             SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence            999999999998665443321  1234469999999999875311    234789999999999999999          


Q ss_pred             CCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          391 RRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       391 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                      +.||.......  .....+............+.. ..........+.+++.+||+.||++|||+.+|++.|+.....
T Consensus       264 ~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          264 QLPYYDLVPSD--PSVEEMRKVVCEQKLRPNIPN-RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             CCTTTTTSCSS--CCHHHHHHHHTTSCCCCCCCG-GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ccCccccCcCc--ccHHHHHHHHHHHHhCCCCcc-cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence            55554322111  111111111111111222111 112335667899999999999999999999999999875543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5e-42  Score=339.69  Aligned_cols=252  Identities=23%  Similarity=0.327  Sum_probs=199.2

Q ss_pred             HHhhhccccCcCCcEEEEEEEec-CC-------cEEEEEEecc-CcccHHHHHHHHHHhccccccceEEeeceeccCCce
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH-TG-------RLIAVKMLEN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  258 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~-~g-------~~vAvK~l~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~  258 (511)
                      ..+.+.++||+|+||.||+|... ++       ..||+|++.. .....+.|.+|+.++++++||||+++++++.++...
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            35567789999999999999854 33       5799999966 344567899999999999999999999999999999


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCC--------ee
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFI--------PK  330 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~--------~k  330 (511)
                      ++||||+++|+|.+++..   ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.        +|
T Consensus        88 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             EEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             EEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceee
Confidence            999999999999999832   23459999999999999999999999   69999999999999998887        99


Q ss_pred             eecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhh
Q 010434          331 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWV  410 (511)
Q Consensus       331 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~  410 (511)
                      |+|||+++.....      ....+|+.|+|||.+.+. ..++.++||||||+++|||++|..|+.......       ..
T Consensus       162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-------~~  227 (289)
T 4fvq_A          162 LSDPGISITVLPK------DILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-------RK  227 (289)
T ss_dssp             ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HH
T ss_pred             eccCcccccccCc------cccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchH-------HH
Confidence            9999998654322      234488999999998763 368999999999999999999655443221110       01


Q ss_pred             HHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          411 YDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       411 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                      ............        ..+..+.+++.+||+.||++|||+.++++.|+....+
T Consensus       228 ~~~~~~~~~~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          228 LQFYEDRHQLPA--------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             HHHHHTTCCCCC--------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             HHHhhccCCCCC--------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            111111111111        1134578899999999999999999999999986654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=348.81  Aligned_cols=246  Identities=25%  Similarity=0.319  Sum_probs=198.1

Q ss_pred             HHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEE
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV  261 (511)
                      ..+.+.++||+|+||.||+++.+ +|+.||||+++..    ....+.+.+|..++..+ +||||+++++++.+....++|
T Consensus        23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv  102 (353)
T 3txo_A           23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV  102 (353)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence            34566789999999999999854 6899999999753    33456788999999988 799999999999999999999


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      |||+++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       103 ~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          103 MEFVNGGDLMFHIQ----KSRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            99999999999883    33579999999999999999999999   699999999999999999999999999998543


Q ss_pred             CCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccc
Q 010434          342 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (511)
                      ...  .......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......        +...+...... 
T Consensus       176 ~~~--~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--------~~~~i~~~~~~-  242 (353)
T 3txo_A          176 CNG--VTTATFCGTPDYIAPEILQEM--LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD--------LFEAILNDEVV-  242 (353)
T ss_dssp             C-----------CCGGGCCHHHHHHH--HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCC-
T ss_pred             cCC--ccccccCCCcCeEChhhcCCC--CcCCccCCCcchHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCCC-
Confidence            322  123455699999999999875  78899999999999999999999997543221        22222222111 


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCH------HHHHH
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSM------TKVLE  459 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~------~evl~  459 (511)
                            .+..++..+.+++.+||+.||++||++      .++++
T Consensus       243 ------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          243 ------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             ------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                  111244668889999999999999998      77765

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.7e-42  Score=350.78  Aligned_cols=245  Identities=22%  Similarity=0.303  Sum_probs=198.9

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .|.+.+.||+|+||.||+|.. .+|+.||||++...    ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus        10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (336)
T 3h4j_B           10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE   89 (336)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence            355678999999999999985 67999999998652    2234578999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+ +|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++.....
T Consensus        90 ~~-~g~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           90 YA-GGELFDYIV----EKKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             CC-CEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             CC-CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            99 788888873    23579999999999999999999999   69999999999999999999999999999865443


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      ..   .....||+.|+|||.+.+. ...+.++||||||+++|||++|+.||+.........        .+.... .   
T Consensus       162 ~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~--------~i~~~~-~---  225 (336)
T 3h4j_B          162 NF---LKTSCGSPNYAAPEVINGK-LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK--------KVNSCV-Y---  225 (336)
T ss_dssp             BT---TCCCTTSTTTSCGGGSCCS-GGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC--------CCCSSC-C---
T ss_pred             cc---cccccCCcCcCCHHHHcCC-CCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH--------HHHcCC-C---
Confidence            21   2445699999999999764 234789999999999999999999996543221111        111110 0   


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                         ..+..++..+.+++.+||+.||.+|||+.++++.
T Consensus       226 ---~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          226 ---VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             ---CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             ---CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence               1122245678899999999999999999999873

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=8.8e-42  Score=351.92  Aligned_cols=245  Identities=26%  Similarity=0.320  Sum_probs=194.8

Q ss_pred             ccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCc
Q 010434          193 THKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL  270 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  270 (511)
                      .+.||+|+||.||+|.. .+|+.||+|+++... ...+.|.+|+.++++++||||+++++++.+....++||||+++|+|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            35799999999999985 579999999997643 3567899999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEE--cCCCCeeeecccccccCCCCCCcee
Q 010434          271 DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL--DHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       271 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl--~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      .+++..   ....+++..+..++.||+.||+|||+   .+|+||||||+|||+  +.++.+||+|||+++.......   
T Consensus       174 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---  244 (373)
T 2x4f_A          174 FDRIID---ESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---  244 (373)
T ss_dssp             HHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred             HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence            988732   33579999999999999999999999   699999999999999  5678999999999987654332   


Q ss_pred             eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchh
Q 010434          349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEI  428 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  428 (511)
                      .....||+.|+|||++...  .++.++||||||+++|||++|+.||.......       .............    ...
T Consensus       245 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~~i~~~~~~~~----~~~  311 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYD--FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-------TLNNILACRWDLE----DEE  311 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTC--BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCCCSC----SGG
T ss_pred             cccccCCCcEeChhhccCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhccCCCC----hhh
Confidence            2344699999999998754  78899999999999999999999986543211       1111111111111    112


Q ss_pred             HHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          429 ESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       429 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ...++..+.+++.+||+.||.+|||+.++++
T Consensus       312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          312 FQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            2234567889999999999999999999987

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2e-41  Score=341.04  Aligned_cols=260  Identities=25%  Similarity=0.348  Sum_probs=189.2

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      .+.+.++||+|+||.||+|.. .+|+.||||+++..  ....+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   85 (317)
T 2pmi_A            6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM   85 (317)
T ss_dssp             -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred             ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence            455678999999999999985 47899999998753  234568999999999999999999999999999999999999


Q ss_pred             CCCCcccccccCC--CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          266 PNGSLDRHIFPKE--NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       266 ~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      + |+|.+++....  .....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  161 (317)
T 2pmi_A           86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP  161 (317)
T ss_dssp             C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred             C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence            7 68988874321  122468999999999999999999999   69999999999999999999999999999876433


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhh---------
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQL---------  414 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------  414 (511)
                      ..  ......||+.|+|||++.+. ..++.++||||||+++|||++|+.||.........    ..+.+..         
T Consensus       162 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          162 VN--TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL----KLIFDIMGTPNESLWP  234 (317)
T ss_dssp             CC--CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHHHCSCCTTTCG
T ss_pred             cc--cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH----HHHHHHhCCCChhHhh
Confidence            22  22345689999999998753 36789999999999999999999999754321100    0000000         


Q ss_pred             --hcCC----cccccccc--------hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          415 --NKGG----DLELRNVT--------EIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       415 --~~~~----~~~~~~~~--------~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                        ....    ........        .....++..+.+++.+||+.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence              0000    00000000        011124567899999999999999999999975

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-42  Score=347.20  Aligned_cols=257  Identities=30%  Similarity=0.463  Sum_probs=198.9

Q ss_pred             HhhhccccCcCCcEEEEEEEecC-----CcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHT-----GRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~-----g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  261 (511)
                      .+.+.+.||+|+||.||+|....     +..||||++....  .....|.+|+.++++++||||+++++++.+....++|
T Consensus        45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  124 (333)
T 1mqb_A           45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII  124 (333)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEE
Confidence            33456889999999999998542     2469999997632  2345799999999999999999999999999999999


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      |||+++|+|.+++..   ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       125 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          125 TEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            999999999999832   34579999999999999999999999   699999999999999999999999999998765


Q ss_pred             CCCCce-eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          342 KENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       342 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      ...... ......+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||......        .+...+..+..
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--------~~~~~~~~~~~  268 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSNH--------EVMKAINDGFR  268 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTCC
T ss_pred             cccccccccCCCCccccccCchhcccC--CCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHHCCCc
Confidence            432211 12233468899999998754  78899999999999999999 99998643221        12233333322


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                      ...      ...++..+.+++.+||+.||++||++.++++.|+.....
T Consensus       269 ~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          269 LPT------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             CCC------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCC------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            211      112346788999999999999999999999999875543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-41  Score=352.22  Aligned_cols=250  Identities=22%  Similarity=0.319  Sum_probs=202.5

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .|.+.++||+|+||.||+|... +|+.||+|++.... .....+.+|+.++++++||||+++++++.++...++||||++
T Consensus        52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~  131 (387)
T 1kob_A           52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS  131 (387)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence            4667789999999999999854 78999999987643 345678999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC--CCCeeeecccccccCCCCC
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH--NFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~--~~~~kl~DFGla~~~~~~~  344 (511)
                      +|+|.+++.   .....+++..+..++.||+.||+|||+   .+|+||||||+|||++.  ++.+||+|||+++......
T Consensus       132 gg~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          132 GGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             CCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCcHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            999999883   233579999999999999999999999   69999999999999974  4789999999998765443


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      .   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......        ....+..... ..  
T Consensus       206 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--------~~~~i~~~~~-~~--  269 (387)
T 1kob_A          206 I---VKVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--------TLQNVKRCDW-EF--  269 (387)
T ss_dssp             C---EEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHHCCC-CC--
T ss_pred             c---eeeeccCCCccCchhccCC--CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCC-CC--
Confidence            2   2334699999999999764  78899999999999999999999987543211        1111111110 00  


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      .......++..+.+++.+||+.||++|||+.++++.
T Consensus       270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            011122345678899999999999999999999874

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=8.2e-42  Score=345.48  Aligned_cols=260  Identities=25%  Similarity=0.433  Sum_probs=207.0

Q ss_pred             HHhhhccccCcCCcEEEEEEEec-CC-----cEEEEEEeccCc--ccHHHHHHHHHHhccc-cccceEEeeceeccCCce
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH-TG-----RLIAVKMLENSK--FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKR  258 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~-~g-----~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~  258 (511)
                      ..+.+.+.||+|+||.||+|... ++     ..||+|++....  ...+.+.+|+.+++++ +||||+++++++.+++..
T Consensus        46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  125 (333)
T 2i1m_A           46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV  125 (333)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence            34556789999999999999854 22     489999997643  2456799999999999 899999999999999999


Q ss_pred             eEEEeecCCCCcccccccCCC----------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCC
Q 010434          259 ALVYEFMPNGSLDRHIFPKEN----------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFI  328 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~  328 (511)
                      ++||||+++|+|.+++.....          ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.
T Consensus       126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~  202 (333)
T 2i1m_A          126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHV  202 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGGE
T ss_pred             EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCCe
Confidence            999999999999998843211          13468999999999999999999999   69999999999999999999


Q ss_pred             eeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccc
Q 010434          329 PKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFP  407 (511)
Q Consensus       329 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~  407 (511)
                      +||+|||+++...............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.|+......       
T Consensus       203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------  273 (333)
T 2i1m_A          203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-------  273 (333)
T ss_dssp             EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-------
T ss_pred             EEECccccccccccccceeecCCCCCCccccCHHHhccC--CCChHHHHHHHHHHHHHHHcCCCCCCcccchh-------
Confidence            999999999866544443334455688999999998764  78999999999999999998 88888653221       


Q ss_pred             hhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          408 SWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       408 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                      ................      ...+..+.+++.+||+.||.+|||+.+|++.|+...
T Consensus       274 ~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          274 SKFYKLVKDGYQMAQP------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             HHHHHHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCCCCC------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence            1122222222211111      112457889999999999999999999999998643

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-41  Score=346.22  Aligned_cols=259  Identities=23%  Similarity=0.257  Sum_probs=200.4

Q ss_pred             HHHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC------cccHHHHHHHHHHhccccccceEEeeceeccCCcee
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS------KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  259 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~------~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~  259 (511)
                      ...+.+.++||+|+||.||++.. .+++.||+|++...      ....+.+.+|+.++++++||||+++++++.+....+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            34667778999999999999985 47889999998642      234578999999999999999999999999999999


Q ss_pred             EEEeecCCCCcccccccCC------------------------------------CcCCccCHHHHHHHHHHHHHHHHHH
Q 010434          260 LVYEFMPNGSLDRHIFPKE------------------------------------NKGQTFGWEKLQEIALGTARGVAYL  303 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~------------------------------------~~~~~l~~~~~~~i~~~ia~~l~yL  303 (511)
                      +||||+++|+|.+++....                                    .....+++..+..++.||+.||+||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            9999999999998873110                                    0122356788899999999999999


Q ss_pred             HhCCCCceecccCCcCceEEcCCC--CeeeecccccccCCCCCC--ceeeccccCCccccchhcccccCCCcCccchHHH
Q 010434          304 HNGCDMCILHFDIKPHNILLDHNF--IPKVSDFGLAKFHPKEND--FVSISATRGTIGYIAPELISRNFGTVSCKSDVYG  379 (511)
Q Consensus       304 H~~~~~~ivH~DIkp~NILl~~~~--~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS  379 (511)
                      |+   .+|+||||||+|||++.++  .+||+|||+++.......  ........||+.|+|||.+.+..+.++.++||||
T Consensus       185 H~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws  261 (345)
T 3hko_A          185 HN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS  261 (345)
T ss_dssp             HH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred             HH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence            99   6999999999999998776  899999999986533221  1123455699999999998754457899999999


Q ss_pred             HHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          380 FGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       380 ~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ||+++|||++|+.||.......       ...............    ....++..+.+++.+||+.||.+|||+.++++
T Consensus       262 lG~il~el~~g~~pf~~~~~~~-------~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          262 AGVLLHLLLMGAVPFPGVNDAD-------TISQVLNKKLCFENP----NYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCTTSG----GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCChHH-------HHHHHHhcccccCCc----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            9999999999999986543221       112222222111111    12234567889999999999999999999987

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=8.8e-42  Score=345.23  Aligned_cols=249  Identities=22%  Similarity=0.314  Sum_probs=182.3

Q ss_pred             cccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhcccc-ccceEEeeceeccCCceeEEEeecCCCCcc
Q 010434          194 HKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLD  271 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  271 (511)
                      ++||+|+||.||++... +|+.||||++...  ....+.+|+.++.++. ||||+++++++.++...++||||+++|+|.
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~   94 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF   94 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence            67999999999999864 7899999998653  4567889999999997 999999999999999999999999999999


Q ss_pred             cccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC---CeeeecccccccCCCCCCcee
Q 010434          272 RHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF---IPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       272 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~---~~kl~DFGla~~~~~~~~~~~  348 (511)
                      +++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++   .+||+|||+++.......  .
T Consensus        95 ~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~  165 (325)
T 3kn6_A           95 ERIK----KKKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--P  165 (325)
T ss_dssp             HHHH----HCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             HHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--c
Confidence            9883    34679999999999999999999999   6999999999999997665   899999999986654332  2


Q ss_pred             eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchh
Q 010434          349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEI  428 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  428 (511)
                      .....||+.|+|||.+.+.  .++.++||||||+++|||++|+.||........... ...+...+..+..   ....+.
T Consensus       166 ~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~~~~~i~~~~~---~~~~~~  239 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS-AVEIMKKIKKGDF---SFEGEA  239 (325)
T ss_dssp             ------------------C--CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCC-HHHHHHHHTTTCC---CCCSHH
T ss_pred             ccccCCCcCccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCcccccccc-HHHHHHHHHcCCC---CCCccc
Confidence            2445689999999999765  789999999999999999999999976433211111 1222333333221   112223


Q ss_pred             HHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          429 ESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       429 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ...++..+.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            3456778999999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.3e-42  Score=346.86  Aligned_cols=263  Identities=25%  Similarity=0.397  Sum_probs=205.6

Q ss_pred             hhccccCcCCcEEEEEEEe-----cCCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceecc--CCceeEE
Q 010434          191 HFTHKLGQGGFGSVYKGQL-----HTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALV  261 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~-----~~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~--~~~~~lV  261 (511)
                      .+.++||+|+||.||++.+     .+++.||||++....  ...+.+.+|+.++++++||||+++++++.+  ....++|
T Consensus        34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  113 (318)
T 3lxp_A           34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV  113 (318)
T ss_dssp             EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred             hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence            5678999999999988864     268899999997643  345679999999999999999999999976  4678899


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      |||+++|+|.+++.     ...+++..+..++.|++.||+|||+   .+|+|+||||+|||++.++.+||+|||+++...
T Consensus       114 ~e~~~~~~L~~~l~-----~~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          114 MEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             ECCCTTCBHHHHGG-----GSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EecccCCcHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            99999999999982     2359999999999999999999999   699999999999999999999999999998776


Q ss_pred             CCCCce-eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccc---cccc----chhhHHh
Q 010434          342 KENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSS---KAYF----PSWVYDQ  413 (511)
Q Consensus       342 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~---~~~~----~~~~~~~  413 (511)
                      ...... ......+|..|+|||.+.+.  .++.++||||||+++|||++|+.|+........   ....    ...+.+.
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEY--KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL  263 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence            544322 22344588899999999765  788999999999999999999999865322100   0000    0011122


Q ss_pred             hhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCC
Q 010434          414 LNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQ  469 (511)
Q Consensus       414 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~  469 (511)
                      +.......      ....++..+.+++.+||+.||++|||+.++++.|+...+.++
T Consensus       264 ~~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          264 LERGERLP------RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             HHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HhcccCCC------CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            22222111      122345678999999999999999999999999988665543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.3e-41  Score=342.19  Aligned_cols=262  Identities=20%  Similarity=0.275  Sum_probs=207.1

Q ss_pred             CCCChHHHHHHHhhhc-cccCcCCcEEEEEEEec-CCcEEEEEEeccC---cccHHHHHHHHHHhccc-cccceEEeece
Q 010434          178 KRYSYPEIIAVTNHFT-HKLGQGGFGSVYKGQLH-TGRLIAVKMLENS---KFSAEEFINEVSTIGRI-HHVNVVQLLGF  251 (511)
Q Consensus       178 ~~~~~~ei~~~t~~~~-~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l-~H~niv~l~g~  251 (511)
                      ..|...+.....|.+. ++||+|+||.||++... +|+.||||++...   ......+.+|+.++.++ +||||++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~   97 (327)
T 3lm5_A           18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV   97 (327)
T ss_dssp             CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            4566677777777776 78999999999999854 7999999998762   33467899999999999 56999999999


Q ss_pred             eccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC---CCC
Q 010434          252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH---NFI  328 (511)
Q Consensus       252 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~---~~~  328 (511)
                      +.+....++||||+++|+|.+++..  .....+++..+..++.|++.||+|||+   .+|+||||||+|||++.   ++.
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~  172 (327)
T 3lm5_A           98 YENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGD  172 (327)
T ss_dssp             EECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCC
T ss_pred             EEeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCc
Confidence            9999999999999999999998832  234679999999999999999999999   69999999999999988   789


Q ss_pred             eeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccch
Q 010434          329 PKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPS  408 (511)
Q Consensus       329 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~  408 (511)
                      +||+|||+++.......   .....||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.......       
T Consensus       173 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------  240 (327)
T 3lm5_A          173 IKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYD--PITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-------  240 (327)
T ss_dssp             EEECCGGGCEEC------------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------
T ss_pred             EEEeeCccccccCCccc---cccccCCcCccCCeeecCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-------
Confidence            99999999987654322   2345699999999999764  78899999999999999999999986543221       


Q ss_pred             hhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          409 WVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       409 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                       ....+......   ........++..+.+++.+||+.||++|||+.++++.
T Consensus       241 -~~~~i~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          241 -TYLNISQVNVD---YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             -HHHHHHHTCCC---CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             -HHHHHHhcccc---cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence             11111111100   0111222345678899999999999999999999874

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.9e-42  Score=347.41  Aligned_cols=255  Identities=21%  Similarity=0.283  Sum_probs=192.9

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc----cHHHHHHHHHHhccccccceEEeeceeccCCce----e
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR----A  259 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~----~  259 (511)
                      .|.+.++||+|+||.||+++. .+++.||||++.....    ..+.|.+|+.++++++||||+++++++......    +
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   92 (311)
T 3ork_A           13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY   92 (311)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence            456778999999999999985 6789999999976322    235789999999999999999999998765544    9


Q ss_pred             EEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      +||||+++++|.+++.    ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        93 lv~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           93 IVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             EEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             EEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence            9999999999999883    33579999999999999999999999   6999999999999999999999999999986


Q ss_pred             CCCCCCc-eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCC
Q 010434          340 HPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG  418 (511)
Q Consensus       340 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  418 (511)
                      ....... .......||+.|+|||++.+.  .++.++||||||+++|||++|+.||.......       ..........
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-------~~~~~~~~~~  236 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-------VAYQHVREDP  236 (311)
T ss_dssp             ----------------CCTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHCCC
T ss_pred             ccccccccccccccCcCcccCCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHhcCCC
Confidence            6543222 122344689999999999765  78999999999999999999999986543211       1122222211


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHH-HHHhc
Q 010434          419 DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVL-EMLEG  463 (511)
Q Consensus       419 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl-~~Le~  463 (511)
                      ..    .......++..+.+++.+||+.||++||+..+++ ..|..
T Consensus       237 ~~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          237 IP----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             CC----HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CC----cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence            11    1111223456788999999999999999766655 44443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=9.2e-41  Score=341.36  Aligned_cols=242  Identities=23%  Similarity=0.288  Sum_probs=201.7

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .+.+.+.||+|+||.||+++.. +|+.||||++...    ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  121 (350)
T 1rdq_E           42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence            4556789999999999999864 7999999999653    2356789999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       122 ~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          122 YVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             CCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            999999999883    23569999999999999999999999   69999999999999999999999999999865432


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                           .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||......        .+...+..+.. .  
T Consensus       195 -----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~~~-~--  256 (350)
T 1rdq_E          195 -----TWTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQPI--------QIYEKIVSGKV-R--  256 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCC-C--
T ss_pred             -----cccccCCccccCHHHhcCC--CCCCcCCEecccHhHhHHhhCCCCCCCCCHH--------HHHHHHHcCCC-C--
Confidence                 1345699999999999765  7899999999999999999999998654321        12233322211 1  


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCC-----HHHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPS-----MTKVLE  459 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~evl~  459 (511)
                          .+..++..+.+++.+||+.||++||+     +.++++
T Consensus       257 ----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          257 ----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                11224567889999999999999998     888876

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.2e-41  Score=352.22  Aligned_cols=267  Identities=16%  Similarity=0.188  Sum_probs=200.5

Q ss_pred             HhhhccccCcC--CcEEEEEEEec-CCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          189 TNHFTHKLGQG--GFGSVYKGQLH-TGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       189 t~~~~~~LG~G--~fg~Vykg~~~-~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      .|.+.++||+|  +||.||+++.. +|+.||||++.....   ..+.+.+|+.++++++|||||++++++.+++..++||
T Consensus        26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  105 (389)
T 3gni_B           26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT  105 (389)
T ss_dssp             GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence            45677899999  99999999965 799999999976432   3456888999999999999999999999999999999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+++|+|.+++...  ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||.+.....
T Consensus       106 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          106 SFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             ECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            999999999988432  23569999999999999999999999   6999999999999999999999999998865422


Q ss_pred             CCCc-----eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc-----ccchhhHH
Q 010434          343 ENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA-----YFPSWVYD  412 (511)
Q Consensus       343 ~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~-----~~~~~~~~  412 (511)
                      ....     .......||+.|+|||++.+....++.++|||||||++|||++|+.||..........     ..+.....
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  260 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence            2111     1112346899999999998644578999999999999999999999996532211000     00000000


Q ss_pred             hh-------------------hcCC-----c--ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          413 QL-------------------NKGG-----D--LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       413 ~~-------------------~~~~-----~--~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      ..                   ....     .  ............++..+.+++.+||+.||++|||+.++++.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            00                   0000     0  00000011233456779999999999999999999999864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.1e-41  Score=336.33  Aligned_cols=257  Identities=20%  Similarity=0.289  Sum_probs=196.2

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      |.+.++||+|+||+||+|... +|+.||||++....   ...+.+.+|+.++++++||||+++++++.++...++||||+
T Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   83 (292)
T 3o0g_A            4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence            456789999999999999864 78999999997532   23467899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++ +|.+.+.   .....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        84 ~~-~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  156 (292)
T 3o0g_A           84 DQ-DLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             SE-EHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred             CC-CHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence            75 5554442   234679999999999999999999999   6999999999999999999999999999987643322


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCC-------
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG-------  418 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------  418 (511)
                        ......||+.|+|||.+.+. ..++.++||||||+++|||++|+.|+.........   ...+........       
T Consensus       157 --~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~---~~~i~~~~~~~~~~~~~~~  230 (292)
T 3o0g_A          157 --CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ---LKRIFRLLGTPTEEQWPSM  230 (292)
T ss_dssp             --CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH---HHHHHHHHCCCCTTTCTTG
T ss_pred             --cccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHHhCCCChhhhhhh
Confidence              22445689999999998754 34799999999999999999988885332111000   000000000000       


Q ss_pred             ----c-------ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          419 ----D-------LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       419 ----~-------~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                          .       ............++..+.+++.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                0       0000011122235567889999999999999999999986

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.5e-41  Score=338.85  Aligned_cols=250  Identities=23%  Similarity=0.290  Sum_probs=204.4

Q ss_pred             HHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcc-------cHHHHHHHHHHhccccccceEEeeceeccCCce
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKF-------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  258 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~-------~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~  258 (511)
                      ...|.+.+.||+|+||.||++... +|+.||||++.....       ..+.+.+|+.++++++||||+++++++.++...
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            446777899999999999999854 789999999865321       467899999999999999999999999999999


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC----Ceeeecc
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF----IPKVSDF  334 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~----~~kl~DF  334 (511)
                      ++||||+++++|.+++.    ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++    .+||+||
T Consensus        91 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           91 VLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            99999999999999883    34579999999999999999999999   6999999999999999887    7999999


Q ss_pred             cccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhh
Q 010434          335 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQL  414 (511)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  414 (511)
                      |+++.......   .....||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.......        ....+
T Consensus       164 g~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~i  230 (321)
T 2a2a_A          164 GLAHEIEDGVE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQE--------TLANI  230 (321)
T ss_dssp             TTCEECCTTCC---CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHH
T ss_pred             ccceecCcccc---ccccCCCCCccCcccccCC--CCCCccccHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHH
Confidence            99987654322   2345699999999998764  78899999999999999999999986533211        11112


Q ss_pred             hcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          415 NKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       415 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .....   ..........+..+.+++.+||+.||++|||+.++++
T Consensus       231 ~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          231 TSVSY---DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HTTCC---CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             Hhccc---ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11111   0111122334567889999999999999999999986

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.3e-41  Score=343.28  Aligned_cols=252  Identities=20%  Similarity=0.301  Sum_probs=193.5

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcc---cHHHHHHHHHHhccccc--cceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHH--VNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H--~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .|.+.++||+|+||.||++...+++.||||++.....   ..+.+.+|+.++.+++|  +||+++++++..+...++|||
T Consensus        10 ~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e   89 (343)
T 3dbq_A           10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME   89 (343)
T ss_dssp             EEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             EEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe
Confidence            3556789999999999999988899999999875433   34678999999999976  999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                       +.+++|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++ ++.+||+|||+++.....
T Consensus        90 -~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           90 -CGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             -CCSEEHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             -CCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence             56889999883    34679999999999999999999999   6999999999999997 578999999999876554


Q ss_pred             CCceeeccccCCccccchhccccc---------CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhh
Q 010434          344 NDFVSISATRGTIGYIAPELISRN---------FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQL  414 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~---------~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  414 (511)
                      ..........||+.|+|||++.+.         .+.++.++||||||+++|||++|+.||.......      ......+
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~  234 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAII  234 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH------HHHHHHH
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH------HHHHHHh
Confidence            433333455799999999998641         1468899999999999999999999986422110      1111111


Q ss_pred             hcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHH
Q 010434          415 NKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEML  461 (511)
Q Consensus       415 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L  461 (511)
                      ..........      ..+..+.+++.+||+.||.+|||+.++++..
T Consensus       235 ~~~~~~~~~~------~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          235 DPNHEIEFPD------IPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             CTTSCCCCCC------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             cCCcccCCcc------cCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence            1111111111      1235678899999999999999999998743

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-41  Score=338.71  Aligned_cols=242  Identities=25%  Similarity=0.351  Sum_probs=200.8

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .+.+.++||+|+||.||+++.. +|+.||+|+++..    ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus         7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e   86 (318)
T 1fot_A            7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD   86 (318)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence            3556789999999999999854 7999999999753    2356778899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        87 ~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           87 YIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             CCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             CCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            999999999883    34579999999999999999999998   69999999999999999999999999999865432


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                           .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||.......        ....+.... ..  
T Consensus       160 -----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~-~~--  221 (318)
T 1fot_A          160 -----TYTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--------TYEKILNAE-LR--  221 (318)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHCC-CC--
T ss_pred             -----cccccCCccccCHhHhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCC-CC--
Confidence                 2345699999999999765  78899999999999999999999986533211        222222211 11  


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCC-----CHHHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRP-----SMTKVLE  459 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~  459 (511)
                          .+..++..+.+++.+||+.||++||     ++.++++
T Consensus       222 ----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          222 ----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                1122346788999999999999999     8999885

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-40  Score=353.59  Aligned_cols=251  Identities=23%  Similarity=0.371  Sum_probs=205.3

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .|.+.+.||+|+||.||+|+.. +|+.||||++....    ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus        17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E   96 (476)
T 2y94_A           17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME   96 (476)
T ss_dssp             TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            3556789999999999999864 79999999996532    245678999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        97 ~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           97 YVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             CCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            999999999983    34579999999999999999999998   69999999999999999999999999999876543


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      .   ......||+.|+|||++.+. ...+.++||||||+++|||++|+.||+.....        .+...+..+...   
T Consensus       170 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~~~---  234 (476)
T 2y94_A          170 E---FLRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--------TLFKKICDGIFY---  234 (476)
T ss_dssp             C---CBCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--------HHHHHHHTTCCC---
T ss_pred             c---cccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHhcCCcC---
Confidence            2   22445699999999999764 23478999999999999999999999754321        122223222111   


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH--HHhcCc
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGSM  465 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~--~Le~~~  465 (511)
                          .+..++..+.+++.+||+.||++|||+.++++  .+....
T Consensus       235 ----~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          235 ----TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             ----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             ----CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence                11123456889999999999999999999997  455443

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.9e-41  Score=332.33  Aligned_cols=248  Identities=19%  Similarity=0.236  Sum_probs=203.3

Q ss_pred             HHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC-cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      ..+.+.++||+|+||.||+|... ++..+|+|++... ....+.+.+|+.++++++||||+++++++.++...++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC   88 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence            45677789999999999999854 5789999998763 446788999999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEE---cCCCCeeeecccccccCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl---~~~~~~kl~DFGla~~~~~  342 (511)
                      ++++|.+++.    ....+++..+..++.|++.||+|||+   .+|+|+||||+|||+   +.++.+||+|||++.....
T Consensus        89 ~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           89 TGGELFERVV----HKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             CCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            9999998873    33569999999999999999999999   699999999999999   8889999999999987654


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                      ..   ......||+.|+|||.+.+   .++.++||||||+++|||++|+.||......        .....+..+...  
T Consensus       162 ~~---~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~--  225 (277)
T 3f3z_A          162 GK---MMRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS--------EVMLKIREGTFT--  225 (277)
T ss_dssp             TS---CBCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCC--
T ss_pred             cc---chhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCCCC--
Confidence            33   2244569999999999864   5889999999999999999999998654321        122222222111  


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                       ........++..+.+++.+||+.||++|||+.++++
T Consensus       226 -~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          226 -FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             -CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             111112234677889999999999999999999985

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=6.2e-41  Score=346.57  Aligned_cols=249  Identities=23%  Similarity=0.346  Sum_probs=202.5

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .+.+.+.||+|+||.||++... +++.||+|++...    ....+.+.+|+.++++++|||||++++++.+....++|||
T Consensus        16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   95 (384)
T 4fr4_A           16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD   95 (384)
T ss_dssp             GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence            4566789999999999999854 6899999998652    3356789999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        96 ~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           96 LLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             CCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             cCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            999999999883    34579999999999999999999999   69999999999999999999999999999876543


Q ss_pred             CCceeeccccCCccccchhccccc-CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~-~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                      .   ......||+.|+|||++... ...++.++|||||||++|||++|+.||........     ..+...+..... . 
T Consensus       169 ~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-----~~~~~~~~~~~~-~-  238 (384)
T 4fr4_A          169 T---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-----KEIVHTFETTVV-T-  238 (384)
T ss_dssp             C---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH-----HHHHHHHHHCCC-C-
T ss_pred             C---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH-----HHHHHHHhhccc-C-
Confidence            3   23456799999999998643 13588999999999999999999999975432211     111222111111 1 


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCC-HHHHHH
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPS-MTKVLE  459 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-~~evl~  459 (511)
                           .+..++..+.+++.+||+.||.+||+ +.++++
T Consensus       239 -----~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          239 -----YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -----CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -----CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                 12224567889999999999999999 777764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=347.90  Aligned_cols=248  Identities=21%  Similarity=0.292  Sum_probs=186.3

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      .+.+.++||+|+||.||+|+.. +++.||||+++... ..+.+.+|+.++++++||||+++++++.+....++||||+++
T Consensus        54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  132 (349)
T 2w4o_A           54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG  132 (349)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence            3556789999999999999965 68899999997643 456788999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC---CCCeeeecccccccCCCCC
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~---~~~~kl~DFGla~~~~~~~  344 (511)
                      |+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.   ++.+||+|||+++......
T Consensus       133 ~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  205 (349)
T 2w4o_A          133 GELFDRIV----EKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV  205 (349)
T ss_dssp             CBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence            99999883    33569999999999999999999999   69999999999999975   8999999999998654332


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                         ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||......       ......+........  
T Consensus       206 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~i~~~~~~~~--  271 (349)
T 2w4o_A          206 ---LMKTVCGTPGYCAPEILRGC--AYGPEVDMWSVGIITYILLCGFEPFYDERGD-------QFMFRRILNCEYYFI--  271 (349)
T ss_dssp             ----------CGGGSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-------HHHHHHHHTTCCCCC--
T ss_pred             ---ccccccCCCCccCHHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCccc-------HHHHHHHHhCCCccC--
Confidence               12345699999999999764  7899999999999999999999998643221       112222222211111  


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                       ......++..+.+++.+||+.||++|||+.++++
T Consensus       272 -~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          272 -SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             -TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             1122234567889999999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.1e-41  Score=336.19  Aligned_cols=255  Identities=25%  Similarity=0.404  Sum_probs=203.1

Q ss_pred             Hhhhcc-ccCcCCcEEEEEEEe---cCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEE
Q 010434          189 TNHFTH-KLGQGGFGSVYKGQL---HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       189 t~~~~~-~LG~G~fg~Vykg~~---~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  261 (511)
                      .+.+.+ .||+|+||.||+|..   .+++.||||++....   ...+++.+|+.++++++||||+++++++ +....++|
T Consensus        17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv   95 (291)
T 1xbb_A           17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV   95 (291)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence            344555 899999999999964   357899999997632   2356899999999999999999999999 56778999


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      |||+++++|.+++.    ....+++..+..++.|++.||+|||+   .+|+|+||||+|||++.++.+||+|||+++...
T Consensus        96 ~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           96 MEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEeCCCCCHHHHHH----hCcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            99999999999983    23569999999999999999999999   699999999999999999999999999998765


Q ss_pred             CCCCcee-eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          342 KENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       342 ~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      ....... .....+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.|+......        .+...+..+..
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~  238 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKGER  238 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCC
T ss_pred             cCCCcccccccCCCCceeeChHHhccC--CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCC
Confidence            5443322 2334477899999999764  68899999999999999999 99998654321        12233333322


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                      ...      +..++..+.+++.+||+.||++|||+.++++.|+.....
T Consensus       239 ~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          239 MGC------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             CCC------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            221      123456788999999999999999999999999875543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.6e-41  Score=346.79  Aligned_cols=251  Identities=24%  Similarity=0.313  Sum_probs=192.0

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      .|.+.++||+|+||.||+++.. +++.||||++.......+.+.+|+.++++++||||+++++++.+....++||||+++
T Consensus        21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  100 (361)
T 3uc3_A           21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG  100 (361)
T ss_dssp             TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCC
Confidence            4667789999999999999865 799999999987666667899999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCC--eeeecccccccCCCCCC
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFI--PKVSDFGLAKFHPKEND  345 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~--~kl~DFGla~~~~~~~~  345 (511)
                      |+|.+++.    ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.  +||+|||+++...... 
T Consensus       101 ~~L~~~l~----~~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~-  172 (361)
T 3uc3_A          101 GELYERIC----NAGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  172 (361)
T ss_dssp             CBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence            99999873    33569999999999999999999999   69999999999999987765  9999999997433222 


Q ss_pred             ceeeccccCCccccchhcccccCCCcC-ccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVS-CKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s-~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                        ......||+.|+|||++.+.  .++ .++||||||+++|||++|+.||.......   .+...+ ..+.... .....
T Consensus       173 --~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~~~-~~~~~~~-~~~~~  243 (361)
T 3uc3_A          173 --QPKSTVGTPAYIAPEVLLRQ--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR---DYRKTI-QRILSVK-YSIPD  243 (361)
T ss_dssp             ----------CTTSCHHHHHCS--SCCHHHHHHHHHHHHHHHHHHSSCSCC----CC---CHHHHH-HHHHTTC-CCCCT
T ss_pred             --CCCCCcCCCCcCChhhhcCC--CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH---HHHHHH-HHHhcCC-CCCCC
Confidence              12344699999999998764  444 45999999999999999999997543211   111111 1111111 11111


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                          ...++..+.+++.+||+.||++|||+.++++.
T Consensus       244 ----~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          244 ----DIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ----TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ----cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence                11234678899999999999999999999874

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-41  Score=333.97  Aligned_cols=256  Identities=25%  Similarity=0.338  Sum_probs=201.3

Q ss_pred             hccccCcCCcEEEEEEEec-CC---cEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCce-eEEEee
Q 010434          192 FTHKLGQGGFGSVYKGQLH-TG---RLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR-ALVYEF  264 (511)
Q Consensus       192 ~~~~LG~G~fg~Vykg~~~-~g---~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~-~lV~e~  264 (511)
                      ..++||+|+||.||+|... ++   ..+|+|++....  ...+.|.+|+.++++++||||+++++++.+.+.. ++||||
T Consensus        25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~  104 (298)
T 3pls_A           25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY  104 (298)
T ss_dssp             EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred             cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence            4578999999999999843 23   379999987633  2456899999999999999999999999766655 999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +.+|+|.+++..   ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       105 ~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          105 MCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             CTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             ccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            999999999832   34678999999999999999999999   699999999999999999999999999998654332


Q ss_pred             Cc--eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          345 DF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       345 ~~--~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                      ..  .......+|+.|+|||.+.+.  .++.++||||||+++|||++|..|+......       ..+...+........
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-------~~~~~~~~~~~~~~~  249 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTY--RFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-------FDLTHFLAQGRRLPQ  249 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-------GGHHHHHHTTCCCCC
T ss_pred             ccccccCcCCCCCccccChhhhccC--CCChhhchhhHHHHHHHHhhCCCCCCccCCH-------HHHHHHhhcCCCCCC
Confidence            11  122345688999999999764  7889999999999999999966654322111       112222222222211


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCC
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDL  468 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l  468 (511)
                            ...++..+.+++.+||+.||.+|||+.++++.|+.....+
T Consensus       250 ------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          250 ------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ------CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence                  1123457889999999999999999999999999866554

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=9.4e-41  Score=328.06  Aligned_cols=252  Identities=26%  Similarity=0.326  Sum_probs=202.8

Q ss_pred             HHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      ..+.+.+.||+|+||.||++... +++.||||++...  ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            35667789999999999999864 7899999998653  23457899999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++++|.+++.    ....+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++......
T Consensus        87 ~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           87 CSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            99999999883    34579999999999999999999999   699999999999999999999999999998654333


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      .........||+.|+|||.+.+. ...+.++||||||+++|||++|+.||.......  .     ....+...... .. 
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~-----~~~~~~~~~~~-~~-  229 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--Q-----EYSDWKEKKTY-LN-  229 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS--H-----HHHHHHTTCTT-ST-
T ss_pred             chhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH--H-----HHHHhhhcccc-cC-
Confidence            22223455699999999998764 234789999999999999999999997543211  0     11111111110 11 


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                         ....++..+.+++.+||+.||++|||+.++++
T Consensus       230 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          230 ---PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence               11234567889999999999999999999975

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.1e-42  Score=361.21  Aligned_cols=253  Identities=18%  Similarity=0.228  Sum_probs=200.9

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+.++||+|+||.||+++.+ +++.||||++++..    ...+.+.+|+.++..++||||+++++++.++...++||||
T Consensus        76 y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey  155 (437)
T 4aw2_A           76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY  155 (437)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEec
Confidence            344578999999999999965 58899999996522    2233488999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++..   ....+++..+..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+++......
T Consensus       156 ~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          156 YVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             CTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             CCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence            999999999832   24679999999999999999999999   699999999999999999999999999998765443


Q ss_pred             CceeeccccCCccccchhccccc---CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhc-CCcc
Q 010434          345 DFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK-GGDL  420 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~---~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~  420 (511)
                      .. ......||+.|+|||++...   .+.++.++|||||||++|||++|+.||.......        .+..+.. ....
T Consensus       230 ~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~--------~~~~i~~~~~~~  300 (437)
T 4aw2_A          230 TV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TYGKIMNHKERF  300 (437)
T ss_dssp             CE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTHHHHC
T ss_pred             Cc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH--------HHHhhhhccccc
Confidence            32 23445799999999998621   2468999999999999999999999997543221        1111111 0011


Q ss_pred             cccccchhHHHHHHHHHHHHHHhcCcCCCC--CCCHHHHHHH
Q 010434          421 ELRNVTEIESVIARKLCMIGLWCIQVKAAD--RPSMTKVLEM  460 (511)
Q Consensus       421 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~evl~~  460 (511)
                      ..+.   ....++..+.+++.+||+.+|++  ||++.++++.
T Consensus       301 ~~p~---~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          301 QFPT---QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             CCCS---SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             cCCc---ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            1111   11123567888999999988888  9999999873

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.6e-41  Score=341.29  Aligned_cols=262  Identities=26%  Similarity=0.438  Sum_probs=205.4

Q ss_pred             HHHHHhhhccccCcCCcEEEEEEEec-CCcE--EEEEEecc--CcccHHHHHHHHHHhccc-cccceEEeeceeccCCce
Q 010434          185 IIAVTNHFTHKLGQGGFGSVYKGQLH-TGRL--IAVKMLEN--SKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKR  258 (511)
Q Consensus       185 i~~~t~~~~~~LG~G~fg~Vykg~~~-~g~~--vAvK~l~~--~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~  258 (511)
                      +....+.+.+.||+|+||.||+++.. +|..  +|||.+..  .....+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  101 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL  101 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence            33345667889999999999999854 5664  49999875  233456799999999999 899999999999999999


Q ss_pred             eEEEeecCCCCcccccccCC------------CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC
Q 010434          259 ALVYEFMPNGSLDRHIFPKE------------NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN  326 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~  326 (511)
                      ++||||+++|+|.+++....            .....+++..+..++.||+.||+|||+   .+|+||||||+|||++.+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGEN  178 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGG
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCC
Confidence            99999999999999985432            234579999999999999999999999   699999999999999999


Q ss_pred             CCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccc
Q 010434          327 FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAY  405 (511)
Q Consensus       327 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~  405 (511)
                      +.+||+|||+++.....   .......+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||......     
T Consensus       179 ~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----  248 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----  248 (327)
T ss_dssp             GCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----
T ss_pred             CeEEEcccCcCcccccc---ccccCCCCCccccChhhhccc--cCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-----
Confidence            99999999999743221   112334578899999998764  78899999999999999998 99998654321     


Q ss_pred             cchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCC
Q 010434          406 FPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDL  468 (511)
Q Consensus       406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l  468 (511)
                         .....+..+.....      ...++..+.+++.+||+.||++|||+.++++.|+......
T Consensus       249 ---~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          249 ---ELYEKLPQGYRLEK------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             ---HHHHHGGGTCCCCC------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             ---HHHHHhhcCCCCCC------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence               12233333222211      1123467889999999999999999999999998766543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.7e-41  Score=339.77  Aligned_cols=265  Identities=21%  Similarity=0.321  Sum_probs=198.9

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .+.+.++||+|+||.||+|.. .+|+.||||++...    ....+.+.+|+.++++++||||+++++++..+...++|||
T Consensus        33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  112 (310)
T 2wqm_A           33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE  112 (310)
T ss_dssp             GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence            466778999999999999985 57999999998752    2234678999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++++|.+++.........+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++.....
T Consensus       113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~  189 (310)
T 2wqm_A          113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  189 (310)
T ss_dssp             CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred             cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence            999999999885433345679999999999999999999999   69999999999999999999999999999865433


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      ..  ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.......      ......+.........
T Consensus       190 ~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~  259 (310)
T 2wqm_A          190 TT--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------YSLCKKIEQCDYPPLP  259 (310)
T ss_dssp             -----------CCSSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTC---CCH------HHHHHHHHTTCSCCCC
T ss_pred             Cc--cccccCCCeeEeChHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcccchhH------HHHHHHhhcccCCCCc
Confidence            22  12344689999999998764  78899999999999999999999986432110      1112222222211111


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCCCC
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMP  471 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~~p  471 (511)
                           ...++..+.+++.+||+.||++|||+.+|++.|+........|
T Consensus       260 -----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~  302 (310)
T 2wqm_A          260 -----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS  302 (310)
T ss_dssp             -----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred             -----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence                 1223567889999999999999999999999999866554443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.1e-41  Score=344.06  Aligned_cols=263  Identities=24%  Similarity=0.388  Sum_probs=204.1

Q ss_pred             HHHHhhhccccCcCCcEEEEEEEe------cCCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCc
Q 010434          186 IAVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  257 (511)
Q Consensus       186 ~~~t~~~~~~LG~G~fg~Vykg~~------~~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~  257 (511)
                      ....+.+.+.||+|+||.||+|+.      .+++.||||++...  .....++.+|+.++++++||||+++++++.+...
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            344566788999999999999983      35779999999653  3345679999999999999999999999999999


Q ss_pred             eeEEEeecCCCCcccccccCCC---cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC---CCCeee
Q 010434          258 RALVYEFMPNGSLDRHIFPKEN---KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH---NFIPKV  331 (511)
Q Consensus       258 ~~lV~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~---~~~~kl  331 (511)
                      .++||||+++|+|.+++.....   ....+++..+..++.|++.||.|||+   .+|+||||||+|||++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEE
Confidence            9999999999999999854321   12458999999999999999999999   69999999999999984   456999


Q ss_pred             ecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhh
Q 010434          332 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWV  410 (511)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~  410 (511)
                      +|||+++...............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.|+......        .+
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~  254 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------EV  254 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HH
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--------HH
Confidence            999999765443332333445689999999998764  78899999999999999998 88888653221        12


Q ss_pred             HHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          411 YDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       411 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                      ...+..+.....      ...++..+.+++.+||+.||.+|||+.++++.|+.....
T Consensus       255 ~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          255 LEFVTSGGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             HHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHhcCCCCCC------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            222333222221      112346788999999999999999999999999875544

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.6e-41  Score=344.80  Aligned_cols=252  Identities=20%  Similarity=0.307  Sum_probs=199.7

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcc----cHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEe
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKF----SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      +.+.+.||+|+||.||+++.+ +|+.||||++.....    ..+.+.+|..++.++ +||||+++++++.+....++|||
T Consensus        11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e   90 (345)
T 3a8x_A           11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE   90 (345)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEe
Confidence            456789999999999999864 689999999976322    345688999999988 89999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        91 ~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           91 YVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             CCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            999999998883    33579999999999999999999999   69999999999999999999999999999864332


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccc-ccccchhhHHhhhcCCcccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSS-KAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  422 (511)
                      ..  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||........ .......+.+.+.... .. 
T Consensus       164 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-~~-  237 (345)
T 3a8x_A          164 GD--TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-IR-  237 (345)
T ss_dssp             TC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-CC-
T ss_pred             CC--cccccCCCccccCccccCCC--CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-CC-
Confidence            22  23455799999999999865  789999999999999999999999965321110 0111122333332221 11 


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCH------HHHHH
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSM------TKVLE  459 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~------~evl~  459 (511)
                           .+..++..+.+++.+||+.||++||++      .++++
T Consensus       238 -----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          238 -----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             -----CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence                 112345678899999999999999995      66664

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.8e-41  Score=331.73  Aligned_cols=252  Identities=26%  Similarity=0.391  Sum_probs=199.2

Q ss_pred             HhhhccccCcCCcEEEEEEEecC----CcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHT----GRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~----g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      .+.+.+.||+|+||.||+|...+    +..||||.+...  ....+.|.+|+.++++++||||+++++++.+ ...++||
T Consensus        13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~   91 (281)
T 3cc6_A           13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIM   91 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEE
Confidence            45567899999999999998542    346999998764  2345789999999999999999999999865 4568999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+++++|.+++.   .....+++..+..++.|++.||+|||+   .+|+|+||||+|||++.++.+||+|||+++....
T Consensus        92 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           92 ELYPYGELGHYLE---RNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             ECCTTCBHHHHHH---HHTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             ecCCCCCHHHHHH---hccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            9999999999883   234569999999999999999999999   6999999999999999999999999999986654


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCccc
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (511)
                      ... .......+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||.......        ....+.......
T Consensus       166 ~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--------~~~~~~~~~~~~  234 (281)
T 3cc6_A          166 EDY-YKASVTRLPIKWMSPESINFR--RFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--------VIGVLEKGDRLP  234 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--------HHHHHHHTCCCC
T ss_pred             ccc-cccccCCCCcceeCchhhccC--CCCchhccHHHHHHHHHHHhCCCCCcccCChHH--------HHHHHhcCCCCC
Confidence            322 122345578899999998764  78899999999999999998 999986433221        222222222221


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                      ..      ..++..+.+++.+||+.||++|||+.++++.|+..
T Consensus       235 ~~------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          235 KP------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             CC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence            11      12346788999999999999999999999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.4e-41  Score=344.94  Aligned_cols=244  Identities=21%  Similarity=0.293  Sum_probs=200.2

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      .+.+.+.||+|+||.||+++.+ +|+.||||+++..    ....+.+..|..++.++ +||||+++++++.+....++||
T Consensus        18 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~   97 (345)
T 1xjd_A           18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM   97 (345)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEE
Confidence            4556789999999999999864 6899999999763    34566788999999877 8999999999999999999999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        98 E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  170 (345)
T 1xjd_A           98 EYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENML  170 (345)
T ss_dssp             ECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence            9999999999883    33579999999999999999999999   6999999999999999999999999999986433


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                      ...  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||......        .+...+..... . 
T Consensus       171 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~~~-~-  236 (345)
T 1xjd_A          171 GDA--KTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--------ELFHSIRMDNP-F-  236 (345)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCC-C-
T ss_pred             CCC--cccCCCCCcccCChhhhcCC--CCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHhCCC-C-
Confidence            221  23455799999999999765  7899999999999999999999999754321        12222222211 1 


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHH-HHH
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMT-KVL  458 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~-evl  458 (511)
                           .+..++..+.+++.+||+.||++||++. +++
T Consensus       237 -----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          237 -----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             -----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                 1122456788999999999999999997 665

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2e-41  Score=372.03  Aligned_cols=247  Identities=25%  Similarity=0.414  Sum_probs=198.8

Q ss_pred             cccCcCCcEEEEEEEec---CCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQLH---TGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~---~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      ++||+|+||.||+|.+.   +++.||||+++...   ...++|.+|+.++++++|||||++++++.. ...++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999643   56899999997632   345789999999999999999999999965 568899999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc-
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF-  346 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~-  346 (511)
                      |+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+++........ 
T Consensus       454 g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            99999983    34579999999999999999999999   69999999999999999999999999999876544322 


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                      .......+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||......        .+...+..+......  
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~~~i~~~~~~~~p--  594 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKGERMGCP--  594 (635)
T ss_dssp             --------CGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCCCCCC--
T ss_pred             ccccCCCCceeeeChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCC--
Confidence            222344578899999999764  78999999999999999998 99998654322        233444444333221  


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                          ..++..+.+++.+||+.||++|||+.+|++.|+..
T Consensus       595 ----~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          595 ----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             ----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ----CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                23456788999999999999999999999999864

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.3e-41  Score=336.81  Aligned_cols=257  Identities=24%  Similarity=0.294  Sum_probs=194.7

Q ss_pred             cccCcCCcEEEEEEEe-cCCcEEEEEEeccC-cccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEeecCCCCc
Q 010434          194 HKLGQGGFGSVYKGQL-HTGRLIAVKMLENS-KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSL  270 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~-~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  270 (511)
                      +.||+|+||.||++.. .+++.||||++... ....+.+.+|+.++.++ +||||+++++++.+++..++||||+++|+|
T Consensus        19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   98 (316)
T 2ac3_A           19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI   98 (316)
T ss_dssp             CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence            6799999999999984 57999999999764 34567899999999885 799999999999999999999999999999


Q ss_pred             ccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCC---eeeecccccccCCCCCCc-
Q 010434          271 DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFI---PKVSDFGLAKFHPKENDF-  346 (511)
Q Consensus       271 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~---~kl~DFGla~~~~~~~~~-  346 (511)
                      .+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.   +||+|||+++........ 
T Consensus        99 ~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  171 (316)
T 2ac3_A           99 LSHIH----KRRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS  171 (316)
T ss_dssp             HHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---------
T ss_pred             HHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccc
Confidence            99883    23578999999999999999999999   69999999999999988776   999999999765432211 


Q ss_pred             ----eeeccccCCccccchhccccc---CCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc----cc---chhhHH
Q 010434          347 ----VSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA----YF---PSWVYD  412 (511)
Q Consensus       347 ----~~~~~~~gt~~y~APE~~~~~---~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~----~~---~~~~~~  412 (511)
                          .......||+.|+|||++.+.   .+.++.++||||||+++|||++|+.||..........    ..   ...+..
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  251 (316)
T 2ac3_A          172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE  251 (316)
T ss_dssp             ----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHH
T ss_pred             cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHH
Confidence                112234599999999998641   1257889999999999999999999997643221000    00   011122


Q ss_pred             hhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          413 QLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       413 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      .+..+.. ..  +......++..+.+++.+||+.||++|||+.++++.
T Consensus       252 ~i~~~~~-~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          252 SIQEGKY-EF--PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHCCC-CC--CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhccCc-cc--CchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            2222211 11  111122345778999999999999999999999873

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.9e-41  Score=330.97  Aligned_cols=250  Identities=22%  Similarity=0.313  Sum_probs=201.1

Q ss_pred             HHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc-------ccHHHHHHHHHHhccccccceEEeeceeccCCce
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK-------FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  258 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~-------~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~  258 (511)
                      ...+.+.++||+|+||.||++... +|+.||+|+++...       ...+.+.+|+.++++++||||+++++++.+....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            456777899999999999999865 78999999986532       2467899999999999999999999999999999


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC----Ceeeecc
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF----IPKVSDF  334 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~----~~kl~DF  334 (511)
                      ++||||+++++|.+++.    ....+++..+..++.|++.||+|||+   .+++|+||||+||+++.++    .+||+||
T Consensus        84 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           84 VLILELVSGGELFDFLA----EKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEeecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEec
Confidence            99999999999999883    23579999999999999999999999   6999999999999998877    8999999


Q ss_pred             cccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhh
Q 010434          335 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQL  414 (511)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  414 (511)
                      |+++.......   .....||+.|+|||.+...  .++.++||||||+++|||++|+.||.......        ....+
T Consensus       157 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~  223 (283)
T 3bhy_A          157 GIAHKIEAGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGETKQE--------TLTNI  223 (283)
T ss_dssp             TTCEECC-----------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHH
T ss_pred             ccceeccCCCc---ccccCCCcCccCcceecCC--CCCcchhhhhHHHHHHHHHHCCCCCCCcchHH--------HHHHh
Confidence            99986644322   2344589999999998764  78899999999999999999999986543211        11111


Q ss_pred             hcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          415 NKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       415 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .....   ..........+..+.+++.+||+.||++|||+.++++
T Consensus       224 ~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          224 SAVNY---DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             HTTCC---CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             Hhccc---CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            11111   0111122334567889999999999999999999987

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.7e-41  Score=347.87  Aligned_cols=250  Identities=20%  Similarity=0.303  Sum_probs=193.9

Q ss_pred             hhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcc---cHHHHHHHHHHhcccc--ccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKF---SAEEFINEVSTIGRIH--HVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~--H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      |.+.++||+|+||.||++...+++.||||++.....   ..+.+.+|+.++.+++  ||||+++++++..+...++||| 
T Consensus        58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-  136 (390)
T 2zmd_A           58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-  136 (390)
T ss_dssp             EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred             eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence            566789999999999999988899999999975432   3467999999999996  5999999999999999999999 


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +.+++|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++ ++.+||+|||+++......
T Consensus       137 ~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          137 CGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             CCSEEHHHHHH----HCSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             cCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            56889999883    33578999999999999999999998   6999999999999995 5799999999998765443


Q ss_pred             CceeeccccCCccccchhccccc---------CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhh
Q 010434          345 DFVSISATRGTIGYIAPELISRN---------FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLN  415 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~---------~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  415 (511)
                      .........||+.|+|||++.+.         .+.++.++|||||||++|||++|+.||.......      ..+...+.
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~------~~~~~~~~  282 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAIID  282 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHC
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH------HHHHHHhC
Confidence            33333455799999999998641         1368899999999999999999999996432110      11111121


Q ss_pred             cCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      ..........      .+..+.+++.+||+.||++|||+.++++.
T Consensus       283 ~~~~~~~~~~------~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          283 PNHEIEFPDI------PEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             TTSCCCCCCC------SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccCCCCcc------chHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            1111111111      13568899999999999999999999874

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.9e-41  Score=345.37  Aligned_cols=264  Identities=25%  Similarity=0.303  Sum_probs=203.1

Q ss_pred             HHHHHHHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhcccc-----ccceEEeeceeccCC
Q 010434          183 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIH-----HVNVVQLLGFCSEGS  256 (511)
Q Consensus       183 ~ei~~~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~-----H~niv~l~g~~~~~~  256 (511)
                      .++....|.+.++||+|+||.||+|+. .+++.||||+++......+.+..|+.++++++     ||||+++++++...+
T Consensus        30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~  109 (360)
T 3llt_A           30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD  109 (360)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred             ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence            344455667779999999999999985 57899999999876666678889999999986     999999999999999


Q ss_pred             ceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC-----------
Q 010434          257 KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH-----------  325 (511)
Q Consensus       257 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~-----------  325 (511)
                      ..++||||+ +++|.+++...  ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.           
T Consensus       110 ~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~  183 (360)
T 3llt_A          110 HMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVR  183 (360)
T ss_dssp             EEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred             eeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchh
Confidence            999999999 99999988432  23469999999999999999999999   69999999999999975           


Q ss_pred             --------------CCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCC
Q 010434          326 --------------NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR  391 (511)
Q Consensus       326 --------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~  391 (511)
                                    ++.+||+|||+++......     ....||+.|+|||++.+.  .++.++|||||||++|||++|+
T Consensus       184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~  256 (360)
T 3llt_A          184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNL--GWDVSSDMWSFGCVLAELYTGS  256 (360)
T ss_dssp             CTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSS
T ss_pred             cccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCC--CCCCccchHHHHHHHHHHHHCC
Confidence                          7899999999998654332     345689999999999865  7899999999999999999999


Q ss_pred             CCCCccccccc-------ccccchhhHHhhhcCC--------c--cccccc--------------chhHHHHHHHHHHHH
Q 010434          392 RNSNMNAIRSS-------KAYFPSWVYDQLNKGG--------D--LELRNV--------------TEIESVIARKLCMIG  440 (511)
Q Consensus       392 ~p~~~~~~~~~-------~~~~~~~~~~~~~~~~--------~--~~~~~~--------------~~~~~~~~~~l~~l~  440 (511)
                      .||........       ....+...........        .  ......              ..........+.+++
T Consensus       257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  336 (360)
T 3llt_A          257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL  336 (360)
T ss_dssp             CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred             CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence            99975332110       0111111111100000        0  000000              001111125678999


Q ss_pred             HHhcCcCCCCCCCHHHHHH
Q 010434          441 LWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       441 ~~Cl~~~P~~RPs~~evl~  459 (511)
                      .+||+.||++|||++|+++
T Consensus       337 ~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          337 YSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHCCSSGGGSCCHHHHTT
T ss_pred             HHHhcCChhhCCCHHHHhc
Confidence            9999999999999999975

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.2e-41  Score=340.68  Aligned_cols=263  Identities=26%  Similarity=0.412  Sum_probs=205.1

Q ss_pred             HhhhccccCcCCcEEEEEEEe-----cCCcEEEEEEeccC-cccHHHHHHHHHHhccccccceEEeeceeccCC--ceeE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-----HTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS--KRAL  260 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-----~~g~~vAvK~l~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~--~~~l  260 (511)
                      .+.+.++||+|+||.||+++.     .+|+.||||++... ....+.|.+|+.++++++||||+++++++....  ..++
T Consensus        42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  121 (326)
T 2w1i_A           42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL  121 (326)
T ss_dssp             GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEE
T ss_pred             HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEE
Confidence            345678999999999999983     36899999999764 334568999999999999999999999986644  7899


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      ||||+++++|.+++..   ....+++..+..++.|++.||+|||+   .+|+|+||||+|||++.++.+||+|||+++..
T Consensus       122 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          122 IMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             EECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            9999999999999832   23569999999999999999999999   69999999999999999999999999999877


Q ss_pred             CCCCCcee-eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccc----ccccc----chhhH
Q 010434          341 PKENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRS----SKAYF----PSWVY  411 (511)
Q Consensus       341 ~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~----~~~~~----~~~~~  411 (511)
                      ........ .....++..|+|||.+.+.  .++.++||||||+++|||++|+.|+.......    .....    ...+.
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             cccccccccccCCCCceeEECchhhcCC--CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence            65543322 2334578889999998765  68899999999999999999998875431110    00000    01112


Q ss_pred             HhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          412 DQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       412 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                      +.+........      ...++..+.+++.+||+.||++|||+.++++.|+...
T Consensus       274 ~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          274 ELLKNNGRLPR------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHHHTTCCCCC------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhhcCCCCCC------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            22222222111      1224567889999999999999999999999998754

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7.3e-41  Score=338.68  Aligned_cols=246  Identities=23%  Similarity=0.331  Sum_probs=191.7

Q ss_pred             HHhhhccccCcCCcEEEEEEEe----cCCcEEEEEEeccCc-----ccHHHHHHHHHHhccccccceEEeeceeccCCce
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQL----HTGRLIAVKMLENSK-----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  258 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~----~~g~~vAvK~l~~~~-----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~  258 (511)
                      ..+.+.++||+|+||.||+++.    .+|+.||+|+++...     .....+.+|+.++++++||||+++++++..++..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            3566778999999999999986    478999999997632     2345688999999999999999999999999999


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      ++||||+++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        97 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           97 YLILEYLSGGELFMQLE----REGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEECCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEeCCCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            99999999999999883    33568999999999999999999999   699999999999999999999999999997


Q ss_pred             cCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCC
Q 010434          339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG  418 (511)
Q Consensus       339 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  418 (511)
                      .......  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||.......        ....+....
T Consensus       170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~i~~~~  237 (327)
T 3a62_A          170 ESIHDGT--VTHTFCGTIEYMAPEILMRS--GHNRAVDWWSLGALMYDMLTGAPPFTGENRKK--------TIDKILKCK  237 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHTC
T ss_pred             ccccCCc--cccccCCCcCccCHhhCcCC--CCCCcccchhHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhCC
Confidence            5433221  22345699999999999764  68899999999999999999999997543211        122222211


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhcCcCCCCCC-----CHHHHHH
Q 010434          419 DLELRNVTEIESVIARKLCMIGLWCIQVKAADRP-----SMTKVLE  459 (511)
Q Consensus       419 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~  459 (511)
                       ..      .+..++..+.+++.+||+.||++||     ++.++++
T Consensus       238 -~~------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 -LN------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             -CC------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             -CC------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence             11      1122456788999999999999999     7888876

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.5e-41  Score=342.29  Aligned_cols=241  Identities=21%  Similarity=0.275  Sum_probs=197.8

Q ss_pred             HHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc---------cHHHHHHHHHHhccccccceEEeeceeccCCc
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF---------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  257 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~---------~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~  257 (511)
                      ..|.+.++||+|+||.||+|.. .+++.||||++.....         ..+.+.+|+.++++++||||+++++++.+...
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            3556678999999999999984 5789999999976432         23467889999999999999999999999999


Q ss_pred             eeEEEeecCCC-CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccc
Q 010434          258 RALVYEFMPNG-SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGL  336 (511)
Q Consensus       258 ~~lV~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGl  336 (511)
                      .++||||+.+| +|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence            99999999777 9988872    34579999999999999999999999   6999999999999999999999999999


Q ss_pred             cccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhc
Q 010434          337 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK  416 (511)
Q Consensus       337 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  416 (511)
                      ++.......   .....||+.|+|||++.+. ...+.++||||||+++|||++|+.||.......             ..
T Consensus       177 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------------~~  239 (335)
T 3dls_A          177 AAYLERGKL---FYTFCGTIEYCAPEVLMGN-PYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------------EA  239 (335)
T ss_dssp             CEECCTTCC---BCEECSCGGGCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-------------TT
T ss_pred             ceECCCCCc---eeccCCCccccChhhhcCC-CCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-------------hh
Confidence            987654432   2334699999999998764 233789999999999999999999986422110             00


Q ss_pred             CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          417 GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      .  ..      .+..++..+.+++.+||+.||++|||+.++++.
T Consensus       240 ~--~~------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          240 A--IH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             C--CC------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             c--cC------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0  00      011134568899999999999999999999874

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.4e-41  Score=337.50  Aligned_cols=260  Identities=22%  Similarity=0.300  Sum_probs=195.5

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCccc---HHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~---~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      |.+.++||+|+||.||+|... +|+.||||++......   .+.+.+|+.++++++||||+++++++.++...++||||+
T Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (311)
T 4agu_A            5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC   84 (311)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence            456789999999999999864 6899999998664332   456889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++++|.+++.    ....+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++.......
T Consensus        85 ~~~~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           85 DHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             SEEHHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             CCchHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence            9999988762    34569999999999999999999999   6999999999999999999999999999987654332


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc--------ccchhhHH----h
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA--------YFPSWVYD----Q  413 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~--------~~~~~~~~----~  413 (511)
                        ......||+.|+|||.+.+. ..++.++||||||+++|||++|+.||..........        ..+.+...    .
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (311)
T 4agu_A          158 --YYDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ  234 (311)
T ss_dssp             ----------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred             --ccCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence              12345689999999998753 367899999999999999999999987543221100        00000000    0


Q ss_pred             hhcCCcc-cccc---cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          414 LNKGGDL-ELRN---VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       414 ~~~~~~~-~~~~---~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ....... ....   .......++..+.+++.+||+.||++|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0000000 0000   00011234567889999999999999999999986

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.1e-41  Score=342.40  Aligned_cols=247  Identities=25%  Similarity=0.341  Sum_probs=197.8

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc----cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .+...++||+|+||.||+|+. .+|+.||||++.....    ..+++.+|+.++++++||||+++++++..+...++|||
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  134 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME  134 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence            455668899999999999985 5799999999975322    23578999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |++ |+|.+++.   .....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       135 ~~~-g~l~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          135 YCL-GSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             CCS-EEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             cCC-CCHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            996 67777763   234679999999999999999999999   69999999999999999999999999999865432


Q ss_pred             CCceeeccccCCccccchhcccc-cCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          344 NDFVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                            ....||+.|+|||++.. ..+.++.++||||||+++|||++|+.|+......       ..+.... .......
T Consensus       208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-------~~~~~~~-~~~~~~~  273 (348)
T 1u5q_A          208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIA-QNESPAL  273 (348)
T ss_dssp             ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHH-HSCCCCC
T ss_pred             ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHH-hcCCCCC
Confidence                  33469999999999853 1247889999999999999999999998643221       1111111 1111111


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHH
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEML  461 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L  461 (511)
                      .     ....+..+.+++.+||+.||++|||+.++++..
T Consensus       274 ~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          274 Q-----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             C-----CCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            1     112345688899999999999999999998643

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.6e-41  Score=332.86  Aligned_cols=245  Identities=27%  Similarity=0.430  Sum_probs=180.4

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+.+.||+|+||.||+|+. .+|+.||||++....    ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus        13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   92 (278)
T 3cok_A           13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM   92 (278)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence            45568999999999999985 579999999996532    2357899999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++++|.+++.   .....+++..+..++.|++.||+|||+   .+|+|+||||+||+++.++.+||+|||++.......
T Consensus        93 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           93 CHNGEMNRYLK---NRVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             CTTEEHHHHHH---TCSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             CCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            99999999883   233679999999999999999999999   699999999999999999999999999998664332


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      .  ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.|+........        ....... ...   
T Consensus       167 ~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~~~-~~~---  230 (278)
T 3cok_A          167 E--KHYTLCGTPNYISPEIATRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--------LNKVVLA-DYE---  230 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCSS-CCC---
T ss_pred             C--cceeccCCCCcCCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--------HHHHhhc-ccC---
Confidence            2  12334689999999998765  678999999999999999999999875432211        0000000 001   


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                         .+..++..+.+++.+||+.||++|||+.++++
T Consensus       231 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          231 ---MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ---CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence               11224567889999999999999999999975

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.4e-41  Score=334.76  Aligned_cols=254  Identities=22%  Similarity=0.307  Sum_probs=202.0

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceec--cCCceeEEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCS--EGSKRALVY  262 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~--~~~~~~lV~  262 (511)
                      .+.+.+.||+|+||.||++... +|+.||+|.+....   ...+.+.+|+.++++++||||+++++++.  .+...++||
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   86 (279)
T 2w5a_A            7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM   86 (279)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred             heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence            3556789999999999999864 78999999997643   23467899999999999999999999874  467889999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCc-----eecccCCcCceEEcCCCCeeeeccccc
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC-----ILHFDIKPHNILLDHNFIPKVSDFGLA  337 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-----ivH~DIkp~NILl~~~~~~kl~DFGla  337 (511)
                      ||+++++|.+++.........+++..+..++.|++.||+|||+   .+     |+|+||||+||+++.++.+||+|||++
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            9999999999985444444569999999999999999999998   46     999999999999999999999999999


Q ss_pred             ccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcC
Q 010434          338 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG  417 (511)
Q Consensus       338 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  417 (511)
                      +........  .....||+.|+|||.+.+.  .++.++||||||+++|||++|+.|+......        .+...+..+
T Consensus       164 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~i~~~  231 (279)
T 2w5a_A          164 RILNHDTSF--AKTFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQK--------ELAGKIREG  231 (279)
T ss_dssp             HHC---CHH--HHHHHSCCTTCCHHHHHCC---CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHT
T ss_pred             eeecccccc--ccccCCCccccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCcccCHH--------HHHHHHhhc
Confidence            876443221  1234589999999998764  7889999999999999999999998754321        122223332


Q ss_pred             CcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          418 GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      ....+      ...++..+.+++.+||+.||++|||+.++++.+..
T Consensus       232 ~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          232 KFRRI------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             CCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ccccC------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            22111      12245678899999999999999999999986654

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.3e-41  Score=335.34  Aligned_cols=255  Identities=24%  Similarity=0.385  Sum_probs=205.2

Q ss_pred             HHHHHHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceecc-------
Q 010434          183 PEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-------  254 (511)
Q Consensus       183 ~ei~~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~-------  254 (511)
                      .......+.+.+.||+|+||.||++... +|+.||||++....   +.+.+|+.++++++||||+++++++..       
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B            6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            4455667777899999999999999865 79999999997643   467789999999999999999998754       


Q ss_pred             ---------CCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC
Q 010434          255 ---------GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH  325 (511)
Q Consensus       255 ---------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~  325 (511)
                               ....++||||+++|+|.+++..  .....+++..+..++.|++.||.|||+   .+|+|+||||+|||+++
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK--RRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVD  157 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHH--GGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEE
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcC
Confidence                     4557899999999999999843  234579999999999999999999999   69999999999999999


Q ss_pred             CCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc
Q 010434          326 NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY  405 (511)
Q Consensus       326 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~  405 (511)
                      ++.+||+|||+++.......   .....||+.|+|||.+.+.  .++.++||||||+++|||++|..|+....       
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~-------  225 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFETS-------  225 (284)
T ss_dssp             TTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCS--CCCTHHHHHHHHHHHHHHHSCCSSHHHHH-------
T ss_pred             CCCEEECcchhheecccccc---ccccCCcccccChhhhccC--CCcchhhhHHHHHHHHHHHhcCCcchhHH-------
Confidence            99999999999987654332   2344699999999998764  78999999999999999999988753211       


Q ss_pred             cchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCC
Q 010434          406 FPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQ  469 (511)
Q Consensus       406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~  469 (511)
                         .....+.....         ...++..+.+++.+||+.||++|||+.++++.|+.......
T Consensus       226 ---~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          226 ---KFFTDLRDGII---------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             ---HHHHHHHTTCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             ---HHHHHhhcccc---------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence               01112222111         11234567889999999999999999999999987655433

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.7e-41  Score=330.73  Aligned_cols=248  Identities=22%  Similarity=0.313  Sum_probs=200.2

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      .|.+.++||+|+||.||++... +|+.||+|++.....   ..+.+.+|+.++++++||||+++++++.++...++||||
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   86 (284)
T 3kk8_A            7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL   86 (284)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence            3456789999999999999854 689999999976433   345788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCC---eeeecccccccCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFI---PKVSDFGLAKFHP  341 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~---~kl~DFGla~~~~  341 (511)
                      +++++|.+.+.    ....+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.   +||+|||++....
T Consensus        87 ~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           87 VTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             CCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             CCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            99999988873    33569999999999999999999999   69999999999999987655   9999999998665


Q ss_pred             CCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccc
Q 010434          342 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (511)
                      ....   .....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.......        ....+..+....
T Consensus       160 ~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------~~~~~~~~~~~~  226 (284)
T 3kk8_A          160 DSEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQHR--------LYAQIKAGAYDY  226 (284)
T ss_dssp             SSCB---CCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCC
T ss_pred             cCcc---ccCCCCCcCCcCchhhcCC--CCCcccchHHHHHHHHHHHHCCCCCCCCchhH--------HHHHHHhccccC
Confidence            4332   2345699999999999765  78999999999999999999999986533211        122222221110


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                         .......++..+.+++.+||+.||++|||+.++++
T Consensus       227 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          227 ---PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             ---CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence               01111234567889999999999999999999987

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.5e-41  Score=340.36  Aligned_cols=260  Identities=23%  Similarity=0.351  Sum_probs=191.8

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCccc--HHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~--~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      |.+.++||+|+||.||+|+.. +++.||||++......  ...+.+|+.++++++||||+++++++..+...++||||++
T Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (324)
T 3mtl_A            4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD   83 (324)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred             eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence            456789999999999999865 7899999998653322  1246689999999999999999999999999999999996


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                       |+|.+++.   ..+..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....... 
T Consensus        84 -~~l~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-  155 (324)
T 3mtl_A           84 -KDLKQYLD---DCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-  155 (324)
T ss_dssp             -EEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             -cCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-
Confidence             58888773   234579999999999999999999999   6999999999999999999999999999986543321 


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc------------cccchhhHHh-
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK------------AYFPSWVYDQ-  413 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~------------~~~~~~~~~~-  413 (511)
                       ......||+.|+|||.+.+. ..++.++||||||+++|||++|+.||.........            ..++...... 
T Consensus       156 -~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          156 -TYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             --------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             -ccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence             22345689999999998753 36789999999999999999999999764322100            0000000000 


Q ss_pred             hhcCC--cccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          414 LNKGG--DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       414 ~~~~~--~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .....  .............++..+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00000  00000001111234567889999999999999999999987

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.8e-41  Score=331.15  Aligned_cols=248  Identities=29%  Similarity=0.466  Sum_probs=194.0

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceecc-CCceeEEEeecCC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRALVYEFMPN  267 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~~~  267 (511)
                      .+.+.+.||+|+||.||+++.+ |+.||||+++... ..+.|.+|+.++++++||||+++++++.+ ....++||||+++
T Consensus        22 ~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~   99 (278)
T 1byg_A           22 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK   99 (278)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred             hceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCC
Confidence            4566789999999999999875 8999999987543 56789999999999999999999998754 4578999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      ++|.+++...  ....+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++......   
T Consensus       100 ~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---  171 (278)
T 1byg_A          100 GSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  171 (278)
T ss_dssp             EEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc---
Confidence            9999988321  12348999999999999999999999   699999999999999999999999999987544322   


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                        ....+++.|+|||.+.+.  .++.++||||||+++|||++ |+.|+.......        +...+..+.....    
T Consensus       172 --~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~----  235 (278)
T 1byg_A          172 --DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKMDA----  235 (278)
T ss_dssp             ------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--------HHHHHTTTCCCCC----
T ss_pred             --cCCCccccccCHHHhCCC--CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhcCCCCCC----
Confidence              233578899999998764  78899999999999999998 999986543211        2222222222211    


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                        ...++..+.+++.+||+.||++|||+.++++.|+..
T Consensus       236 --~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          236 --PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence              122456788999999999999999999999999864

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1e-40  Score=328.98  Aligned_cols=243  Identities=23%  Similarity=0.405  Sum_probs=196.5

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+.+.||+|+||.||++... +++.||||++...    ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (279)
T 3fdn_A           11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY   90 (279)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence            456789999999999999854 6789999998652    22456789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++.    ....+++..+..++.|++.||+|||+   .+|+|+||||+|||++.++.+||+|||++.......
T Consensus        91 ~~~~~l~~~l~----~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~  163 (279)
T 3fdn_A           91 APLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  163 (279)
T ss_dssp             CTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence            99999998873    23569999999999999999999998   699999999999999999999999999986544332


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                          .....||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.......        ....+..... .   
T Consensus       164 ----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~-~---  225 (279)
T 3fdn_A          164 ----RTDLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--------TYKRISRVEF-T---  225 (279)
T ss_dssp             --------CCCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHTCC-C---
T ss_pred             ----ccccCCCCCccCHhHhccC--CCCccchhHhHHHHHHHHHHCCCCCCCCcHHH--------HHHHHHhCCC-C---
Confidence                2345689999999998764  77899999999999999999999987543211        1222222111 1   


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                         .+..++..+.+++.+||+.||++|||+.++++.
T Consensus       226 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          226 ---FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             ---CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             ---CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence               111234668889999999999999999999974

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.4e-41  Score=348.66  Aligned_cols=269  Identities=19%  Similarity=0.272  Sum_probs=209.8

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCC--ceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS--KRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~--~~~lV~e  263 (511)
                      .|.+.++||+|+||.||+|... +|+.||||++...  ....+.+.+|+.++++++||||+++++++....  ..++|||
T Consensus        10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e   89 (396)
T 4eut_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME   89 (396)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred             ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence            3556789999999999999865 6899999999763  335678899999999999999999999987654  6799999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEE----cCCCCeeeeccccccc
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL----DHNFIPKVSDFGLAKF  339 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl----~~~~~~kl~DFGla~~  339 (511)
                      |+++|+|.+++.... ....+++..+..++.||+.||+|||+   .+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        90 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           90 FCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             cCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            999999999984322 22349999999999999999999999   699999999999999    7888899999999987


Q ss_pred             CCCCCCceeeccccCCccccchhccccc------CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHh
Q 010434          340 HPKENDFVSISATRGTIGYIAPELISRN------FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQ  413 (511)
Q Consensus       340 ~~~~~~~~~~~~~~gt~~y~APE~~~~~------~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~  413 (511)
                      ......   .....||+.|+|||++.+.      ...++.++||||||+++|||++|+.||........   ....+...
T Consensus       166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~---~~~~~~~~  239 (396)
T 4eut_A          166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR---NKEVMYKI  239 (396)
T ss_dssp             CCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT---CHHHHHHH
T ss_pred             ccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc---hHHHHHHH
Confidence            654332   2345699999999998641      12678899999999999999999999864322111   11112221


Q ss_pred             hhcCCc-----------------ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          414 LNKGGD-----------------LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       414 ~~~~~~-----------------~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                      +.....                 ............++..+.+++.+||+.||++|||+.++++.++..+..
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            111100                 011112234467788899999999999999999999999998876654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.4e-41  Score=337.40  Aligned_cols=261  Identities=24%  Similarity=0.367  Sum_probs=196.2

Q ss_pred             HHHHHHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc------ccHHHHHHHHHHhcccc---ccceEEeeceec
Q 010434          184 EIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK------FSAEEFINEVSTIGRIH---HVNVVQLLGFCS  253 (511)
Q Consensus       184 ei~~~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~------~~~~~f~~Ev~~l~~l~---H~niv~l~g~~~  253 (511)
                      ++....|.+.++||+|+||.||+|+. .+|+.||||++....      .....+.+|+.++++++   ||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            34455677789999999999999985 578999999986422      22356778888877775   999999999987


Q ss_pred             cCC-----ceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCC
Q 010434          254 EGS-----KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFI  328 (511)
Q Consensus       254 ~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~  328 (511)
                      ...     ..++||||++ |+|.+++...  ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~  158 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGT  158 (308)
T ss_dssp             ECCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSC
T ss_pred             ccCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCC
Confidence            654     4789999996 6999887432  23459999999999999999999999   69999999999999999999


Q ss_pred             eeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccch
Q 010434          329 PKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPS  408 (511)
Q Consensus       329 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~  408 (511)
                      +||+|||+++......   ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||.........    .
T Consensus       159 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~----~  229 (308)
T 3g33_A          159 VKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL----G  229 (308)
T ss_dssp             EEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTS--CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH----H
T ss_pred             EEEeeCccccccCCCc---ccCCccccccccCchHHcCC--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH----H
Confidence            9999999998664432   22455689999999999764  7899999999999999999999999654322110    0


Q ss_pred             hhHHhhhcCCc----------------ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          409 WVYDQLNKGGD----------------LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       409 ~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .+.+.+.....                ............++..+.+++.+||+.||++|||+.++++
T Consensus       230 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          230 KIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            01111000000                0000001122234567889999999999999999999985

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.1e-40  Score=328.71  Aligned_cols=245  Identities=23%  Similarity=0.381  Sum_probs=198.8

Q ss_pred             HHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC---cccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEE
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS---KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      ..+.+.++||+|+||.||++... +++.||||++...   .....++.+|+..+.++ +||||+++++++.+++..++||
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            45667789999999999999865 7999999999753   33456789999999999 9999999999999999999999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC-----------------
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH-----------------  325 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~-----------------  325 (511)
                      ||+++++|.+++.........+++..+..++.||+.||+|||+   .+|+||||||+|||++.                 
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC------------------
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            9999999999985433334679999999999999999999999   69999999999999984                 


Q ss_pred             --CCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc
Q 010434          326 --NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK  403 (511)
Q Consensus       326 --~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~  403 (511)
                        +..+||+|||+++......      ...||+.|+|||.+.+. ..++.++||||||+++|||++|.+++....     
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----  235 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGD-----  235 (289)
T ss_dssp             --CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred             CCceEEEEcccccccccCCcc------ccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence              4479999999998765432      23489999999998754 356789999999999999999987653321     


Q ss_pred             cccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          404 AYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                            ....+..+.....      +..++..+.+++.+||+.||++|||+.++++
T Consensus       236 ------~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          236 ------QWHEIRQGRLPRI------PQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             ------HHHHHHTTCCCCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------HHHHHHcCCCCCC------CcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                  1122222222111      1223467889999999999999999999985

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.2e-41  Score=351.64  Aligned_cols=251  Identities=22%  Similarity=0.298  Sum_probs=201.4

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+.++||+|+||.||+++.. +++.||+|++.+.    ....+.+.+|+.+++.++|||||++++++.++...++||||
T Consensus        71 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~  150 (410)
T 3v8s_A           71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY  150 (410)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            445689999999999999865 6899999999652    22334688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++.     ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       151 ~~gg~L~~~l~-----~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~  222 (410)
T 3v8s_A          151 MPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  222 (410)
T ss_dssp             CTTEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             CCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence            99999999872     2468999999999999999999999   699999999999999999999999999998765443


Q ss_pred             CceeeccccCCccccchhcccccC--CCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcC-Cccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG-GDLE  421 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~--~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  421 (511)
                      . .......||+.|+|||++.+..  +.++.++|||||||++|||++|+.||.......        .+..+... ....
T Consensus       223 ~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--------~~~~i~~~~~~~~  293 (410)
T 3v8s_A          223 M-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--------TYSKIMNHKNSLT  293 (410)
T ss_dssp             E-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTHHHHCC
T ss_pred             c-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh--------HHHHHHhcccccc
Confidence            2 2234567999999999987642  127899999999999999999999997543221        12222111 0111


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCC--CCCHHHHHHHH
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAAD--RPSMTKVLEML  461 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~evl~~L  461 (511)
                      .+.    ...++..+.+++.+||+.+|.+  ||++.+|++.-
T Consensus       294 ~p~----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp  331 (410)
T 3v8s_A          294 FPD----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  331 (410)
T ss_dssp             CCT----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred             CCC----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence            111    1123567889999999999999  99999999743

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.1e-41  Score=343.16  Aligned_cols=253  Identities=18%  Similarity=0.171  Sum_probs=201.5

Q ss_pred             HHhhhccccCcCCcEEEEEEE------ecCCcEEEEEEeccCcccHHHHHHHHHHhcccc---ccceEEeeceeccCCce
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQ------LHTGRLIAVKMLENSKFSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKR  258 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~------~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~---H~niv~l~g~~~~~~~~  258 (511)
                      ..+.+.++||+|+||.||+|.      ..+++.||||++...  ...++..|+.++.+++   |+||+++++++..++..
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~  142 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS  142 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence            345567899999999999993      457899999998653  4567888888888886   99999999999999999


Q ss_pred             eEEEeecCCCCcccccccCCC-cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC-----------C
Q 010434          259 ALVYEFMPNGSLDRHIFPKEN-KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH-----------N  326 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~-----------~  326 (511)
                      ++||||+++|+|.+++..... ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.           +
T Consensus       143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~~  219 (365)
T 3e7e_A          143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLS  219 (365)
T ss_dssp             EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------C
T ss_pred             EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccccccc
Confidence            999999999999999853222 34679999999999999999999998   69999999999999998           8


Q ss_pred             CCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc
Q 010434          327 FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF  406 (511)
Q Consensus       327 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~  406 (511)
                      +.+||+|||+++...............||+.|+|||++.+.  .++.++|||||||++|||++|+.|+..........  
T Consensus       220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--  295 (365)
T 3e7e_A          220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKP--  295 (365)
T ss_dssp             TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEE--
T ss_pred             CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC--CCCccccHHHHHHHHHHHHhCCCccccCCCCceee--
Confidence            99999999999765433333445666799999999999875  68999999999999999999999985433211100  


Q ss_pred             chhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCC-CCHHHHHHHHhcCcC
Q 010434          407 PSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADR-PSMTKVLEMLEGSMD  466 (511)
Q Consensus       407 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R-Ps~~evl~~Le~~~~  466 (511)
                              ..  .  .....     ....+.+++..|++.+|.+| |+++++.+.|+....
T Consensus       296 --------~~--~--~~~~~-----~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          296 --------EG--L--FRRLP-----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             --------CS--C--CTTCS-----SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             --------ch--h--ccccC-----cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence                    00  0  00000     13456678899999999998 678888888876543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.1e-40  Score=341.09  Aligned_cols=245  Identities=23%  Similarity=0.274  Sum_probs=200.6

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      .+.+.+.||+|+||.||+++.+ +|+.||||+++..    ....+.+.+|..++..+ +||||+++++++.+....++||
T Consensus        21 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~  100 (353)
T 2i0e_A           21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM  100 (353)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEE
Confidence            4556789999999999999865 5889999999753    33567789999999988 8999999999999999999999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       101 E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A          101 EYVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            9999999999883    23569999999999999999999999   6999999999999999999999999999986433


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                      ...  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||......        .+.+.+..... . 
T Consensus       174 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~~~-~-  239 (353)
T 2i0e_A          174 DGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIMEHNV-A-  239 (353)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCC-C-
T ss_pred             CCc--ccccccCCccccChhhhcCC--CcCCcccccchHHHHHHHHcCCCCCCCCCHH--------HHHHHHHhCCC-C-
Confidence            221  23455799999999999765  7899999999999999999999999754321        12222222211 1 


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCC-----HHHHHH
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPS-----MTKVLE  459 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~evl~  459 (511)
                           .+..++..+.+++.+||+.||++||+     +.++++
T Consensus       240 -----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          240 -----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             -----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                 11234567889999999999999995     577765

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.3e-41  Score=332.69  Aligned_cols=266  Identities=17%  Similarity=0.264  Sum_probs=205.3

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeecee-ccCCceeEEEeecC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC-SEGSKRALVYEFMP  266 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~-~~~~~~~lV~e~~~  266 (511)
                      .+.+.+.||+|+||.||+|+. .+|+.||||++.... ..+++.+|+.++.+++|++++..++++ .++...++||||+ 
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   87 (296)
T 3uzp_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   87 (296)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence            345678999999999999985 679999999986543 234689999999999988866666655 5667789999999 


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEE---cCCCCeeeecccccccCCCC
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl---~~~~~~kl~DFGla~~~~~~  343 (511)
                      +++|.+++..   ....+++..+..++.|++.||+|||+   .+|+||||||+|||+   ++++.+||+|||+++.....
T Consensus        88 ~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           88 GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            9999998832   23579999999999999999999999   699999999999999   58899999999999876544


Q ss_pred             CCce-----eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCC
Q 010434          344 NDFV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG  418 (511)
Q Consensus       344 ~~~~-----~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  418 (511)
                      ....     ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||...........+..........  
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--  237 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST--  237 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS--
T ss_pred             ccccccccccccccccccccCChhhhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC--
Confidence            3211     12345699999999999865  68999999999999999999999997643222111111111111100  


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCCCC
Q 010434          419 DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMP  471 (511)
Q Consensus       419 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~~p  471 (511)
                           ........++..+.+++.+||+.||++|||+.+|++.|+........+
T Consensus       238 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~  285 (296)
T 3uzp_A          238 -----PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             -----CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             -----chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence                 001112234577899999999999999999999999999876655433

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.4e-41  Score=342.62  Aligned_cols=267  Identities=16%  Similarity=0.158  Sum_probs=196.7

Q ss_pred             HHHHHhhhccccCcCCcEEEEEEEec----CCcEEEEEEeccCcc------------cHHHHHHHHHHhccccccceEEe
Q 010434          185 IIAVTNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMLENSKF------------SAEEFINEVSTIGRIHHVNVVQL  248 (511)
Q Consensus       185 i~~~t~~~~~~LG~G~fg~Vykg~~~----~g~~vAvK~l~~~~~------------~~~~f~~Ev~~l~~l~H~niv~l  248 (511)
                      +....+.+.++||+|+||.||+|...    ++..+|||++.....            ....+.+|+..+..++||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            33445667889999999999999864    678999999876432            12346788899999999999999


Q ss_pred             eceecc----CCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEc
Q 010434          249 LGFCSE----GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD  324 (511)
Q Consensus       249 ~g~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~  324 (511)
                      ++++..    ....++||||+ +++|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~  185 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISG----QNGTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLG  185 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCB----GGGBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEE
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEc
Confidence            999877    77899999999 999999983    23389999999999999999999999   6999999999999999


Q ss_pred             CCC--CeeeecccccccCCCCCCc-----eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcc
Q 010434          325 HNF--IPKVSDFGLAKFHPKENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMN  397 (511)
Q Consensus       325 ~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~  397 (511)
                      .++  .+||+|||+++........     .......||+.|+|||++.+.  .++.++||||||+++|||++|+.||...
T Consensus       186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~  263 (345)
T 2v62_A          186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV--ALSRRSDVEILGYCMLRWLCGKLPWEQN  263 (345)
T ss_dssp             SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred             cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            887  9999999999876432211     111345699999999999865  7899999999999999999999999542


Q ss_pred             cccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          398 AIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                      ......  . .................. .....++..+.+++.+||+.||++|||+.+|++.|+...
T Consensus       264 ~~~~~~--~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          264 LKDPVA--V-QTAKTNLLDELPQSVLKW-APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             TTCHHH--H-HHHHHHHHHTTTHHHHHH-SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             ccccHH--H-HHHHHhhcccccHHHHhh-ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            211100  0 000001000000000000 000034567899999999999999999999999998744

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=8.5e-41  Score=353.56  Aligned_cols=194  Identities=24%  Similarity=0.347  Sum_probs=151.0

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceecc-----CCcee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSE-----GSKRA  259 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~-----~~~~~  259 (511)
                      .|.+.++||+|+||.||+|.. .+|+.||||++....   ...+.+.+|+.++++++|||||++++++..     ....+
T Consensus        54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  133 (458)
T 3rp9_A           54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY  133 (458)
T ss_dssp             TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence            456678999999999999985 478999999986532   245678999999999999999999999843     35789


Q ss_pred             EEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      +||||+ +|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+++.
T Consensus       134 lv~e~~-~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          134 VVLEIA-DSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEECCC-SEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEecc-ccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchh
Confidence            999998 578888872    34579999999999999999999999   6999999999999999999999999999987


Q ss_pred             CCCCCCc-------------------------eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCC
Q 010434          340 HPKENDF-------------------------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR  391 (511)
Q Consensus       340 ~~~~~~~-------------------------~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~  391 (511)
                      .......                         ...+...||+.|+|||++... ..++.++|||||||++|||++|.
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhc
Confidence            6432211                         122445689999999987433 36899999999999999999943

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.8e-41  Score=353.81  Aligned_cols=246  Identities=22%  Similarity=0.315  Sum_probs=191.5

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .+.+.++||+|+||.||+++. .+|+.||||++...    ......+.+|+.++++++||||+++++++...+..++|||
T Consensus       149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  228 (446)
T 4ejn_A          149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME  228 (446)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred             HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence            355678999999999999985 57899999999752    2344578899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++|+|.+++.    ....+++..+..++.||+.||+|||+.  .+|+||||||+||||+.++.+||+|||+++.....
T Consensus       229 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          229 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             CCSSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             eCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            999999998883    345799999999999999999999962  48999999999999999999999999999864333


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      ..  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||.......        +...+.... ..  
T Consensus       303 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------~~~~i~~~~-~~--  367 (446)
T 4ejn_A          303 GA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELILMEE-IR--  367 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCC-CC--
T ss_pred             Cc--ccccccCCccccCHhhcCCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--------HHHHHHhCC-CC--
Confidence            22  23456799999999999764  78999999999999999999999996543211        122221111 11  


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCC-----CHHHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRP-----SMTKVLE  459 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~  459 (511)
                          .+..++..+.+++.+||+.||.+||     |+.++++
T Consensus       368 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          368 ----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                1122456788999999999999999     9999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=7e-41  Score=336.12  Aligned_cols=262  Identities=26%  Similarity=0.330  Sum_probs=202.5

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEecc-CcccHHHHHHHHHHhccccccceEEeeceec----cCCceeEEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLEN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFCS----EGSKRALVY  262 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~----~~~~~~lV~  262 (511)
                      .|.+.++||+|+||.||+++. .+|+.||||++.. .....+.+.+|+.++++++||||+++++++.    .....++||
T Consensus        30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~  109 (317)
T 2buj_A           30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL  109 (317)
T ss_dssp             EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred             EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence            455678999999999999985 5799999999865 3345678999999999999999999999986    345788999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+++|+|.+++......+..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  186 (317)
T 2buj_A          110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI  186 (317)
T ss_dssp             ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred             EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence            9999999999885444456789999999999999999999999   6999999999999999999999999999875432


Q ss_pred             CCCc-------eeeccccCCccccchhcccccC-CCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhh
Q 010434          343 ENDF-------VSISATRGTIGYIAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQL  414 (511)
Q Consensus       343 ~~~~-------~~~~~~~gt~~y~APE~~~~~~-~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  414 (511)
                      ....       .......||+.|+|||.+.... ..++.++||||||+++|||++|+.||.........      .....
T Consensus       187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~  260 (317)
T 2buj_A          187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS------VALAV  260 (317)
T ss_dssp             EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC------HHHHH
T ss_pred             ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch------hhHHh
Confidence            1110       0012234799999999986431 24688999999999999999999998643211100      11111


Q ss_pred             hcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          415 NKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       415 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                      .....  ...    ...++..+.+++.+||+.||.+|||+.++++.|+...
T Consensus       261 ~~~~~--~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          261 QNQLS--IPQ----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             HCC----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             hccCC--CCc----cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            11111  111    1123467889999999999999999999999999754

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.6e-41  Score=350.21  Aligned_cols=255  Identities=21%  Similarity=0.315  Sum_probs=193.5

Q ss_pred             HHHHHHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc---------cHHHHHHHHHHhccccccceEEeeceec
Q 010434          184 EIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF---------SAEEFINEVSTIGRIHHVNVVQLLGFCS  253 (511)
Q Consensus       184 ei~~~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~---------~~~~f~~Ev~~l~~l~H~niv~l~g~~~  253 (511)
                      ......|.+.++||+|+||.||+|.. .+++.||||++.....         ....+.+|+.++++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            44455677789999999999999985 4689999999865321         1224889999999999999999999985


Q ss_pred             cCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC---CCee
Q 010434          254 EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN---FIPK  330 (511)
Q Consensus       254 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~---~~~k  330 (511)
                      . ...++||||+++|+|.+++.    ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.+   +.+|
T Consensus       211 ~-~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~k  282 (419)
T 3i6u_A          211 A-EDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIK  282 (419)
T ss_dssp             S-SEEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred             c-CceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEE
Confidence            4 45799999999999999883    34579999999999999999999999   699999999999999654   4599


Q ss_pred             eecccccccCCCCCCceeeccccCCccccchhcccc-cCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchh
Q 010434          331 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW  409 (511)
Q Consensus       331 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~  409 (511)
                      |+|||+++......   ......||+.|+|||++.. ....++.++||||||+++|||++|+.||.......       .
T Consensus       283 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-------~  352 (419)
T 3i6u_A          283 ITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-------S  352 (419)
T ss_dssp             ECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-------C
T ss_pred             EeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-------H
Confidence            99999998765432   2244569999999999853 22467889999999999999999999986432111       1


Q ss_pred             hHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          410 VYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       410 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ..+.+..+....   .......++..+.+++.+||+.||++|||+.++++
T Consensus       353 ~~~~i~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          353 LKDQITSGKYNF---IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHHHHHTTCCCC---CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHhcCCCCC---CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            122222221111   11223345677899999999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.1e-40  Score=350.30  Aligned_cols=198  Identities=23%  Similarity=0.353  Sum_probs=163.3

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccC-----Ccee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRA  259 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~-----~~~~  259 (511)
                      .|.+.++||+|+||.||+|.. .+|+.||||++....   ...+.+.+|+.++++++||||+++++++...     ...+
T Consensus        27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  106 (432)
T 3n9x_A           27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY  106 (432)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence            455678999999999999985 468999999997632   2456789999999999999999999999765     5789


Q ss_pred             EEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      +||||++ |+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       107 lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          107 IVLEIAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEECCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            9999985 69998882    34579999999999999999999999   6999999999999999999999999999987


Q ss_pred             CCCCCCc--------------------eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCC
Q 010434          340 HPKENDF--------------------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN  395 (511)
Q Consensus       340 ~~~~~~~--------------------~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~  395 (511)
                      .......                    ...+...||+.|+|||++... ..++.++|||||||++|||++|..|+.
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhcccccc
Confidence            6543221                    123456799999999987443 468999999999999999998766554

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.5e-41  Score=334.28  Aligned_cols=265  Identities=17%  Similarity=0.260  Sum_probs=203.4

Q ss_pred             HHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeecee-ccCCceeEEEeec
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC-SEGSKRALVYEFM  265 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~-~~~~~~~lV~e~~  265 (511)
                      ..+.+.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.++++++|+|++..++++ ..+...++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence            4566778999999999999985 678999999875532 223688999999999988877666655 6677889999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEE---cCCCCeeeecccccccCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl---~~~~~~kl~DFGla~~~~~  342 (511)
                       +++|.+++..   ....+++..+..++.||+.||+|||+   .+|+||||||+|||+   ++++.+||+|||+++....
T Consensus        88 -~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           88 -GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             -CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             -CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence             9999998832   24569999999999999999999999   699999999999999   8899999999999987654


Q ss_pred             CCCce-----eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcC
Q 010434          343 ENDFV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG  417 (511)
Q Consensus       343 ~~~~~-----~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  417 (511)
                      .....     ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||...........+.......... 
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-  237 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-  237 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCC--CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-
Confidence            43211     12345699999999999865  78999999999999999999999997643322111111111111100 


Q ss_pred             CcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCC
Q 010434          418 GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQ  469 (511)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~  469 (511)
                            ........++..+.+++.+||+.||++|||+.++++.|+.......
T Consensus       238 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          238 ------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             ------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             ------hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence                  0011112235678999999999999999999999999998766544

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.1e-41  Score=337.44  Aligned_cols=259  Identities=19%  Similarity=0.279  Sum_probs=198.6

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcc----cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .|.+.++||+|+||.||++... +++.||||++.....    ..+.+.+|+.++++++||||+++++++..++..++|||
T Consensus        35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 2h34_A           35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR  114 (309)
T ss_dssp             CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence            4566789999999999999854 789999999976322    23678999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++++|.+++.    ....+++..+..++.|++.||+|||+   .+|+|+||||+|||++.++.+||+|||+++.....
T Consensus       115 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          115 LINGVDLAAMLR----RQGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             CCCCEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             ecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            999999999883    23569999999999999999999999   69999999999999999999999999999765443


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      .. .......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||......        .+...+.....    
T Consensus       188 ~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~----  252 (309)
T 2h34_A          188 KL-TQLGNTVGTLYYMAPERFSES--HATYRADIYALTCVLYECLTGSPPYQGDQLS--------VMGAHINQAIP----  252 (309)
T ss_dssp             ----------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHH--------HHHHHHHSCCC----
T ss_pred             cc-ccccccCCCcCccCHHHHcCC--CCCchHhHHHHHHHHHHHHHCCCCCCCchHH--------HHHHHhccCCC----
Confidence            21 122345689999999998764  7889999999999999999999998754321        11222221111    


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCC-CHHHHHHHHhcCcCCCC
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRP-SMTKVLEMLEGSMDDLQ  469 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-s~~evl~~Le~~~~~l~  469 (511)
                      ........++..+.+++.+||+.||++|| |+.++++.|+..+....
T Consensus       253 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          253 RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            11112233456788999999999999999 99999999998766543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.4e-41  Score=342.03  Aligned_cols=251  Identities=22%  Similarity=0.312  Sum_probs=199.6

Q ss_pred             HHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEee
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      ...|.+.+.||+|+||.||++..+ +|+.||||++.....   .+.+|++++.++ +||||+++++++.++...++||||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~   97 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL   97 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence            345677789999999999999854 789999999976543   345788888888 799999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC----CCeeeecccccccC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN----FIPKVSDFGLAKFH  340 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~----~~~kl~DFGla~~~  340 (511)
                      +++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||+.++    +.+||+|||+++..
T Consensus        98 ~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           98 MKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             CCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            99999999883    33579999999999999999999999   699999999999998443    35999999999876


Q ss_pred             CCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcc
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDL  420 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (511)
                      .....  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||.......     ...+...+..+...
T Consensus       171 ~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~~~~i~~~~~~  241 (342)
T 2qr7_A          171 RAENG--LLMTPCYTANFVAPEVLERQ--GYDAACDIWSLGVLLYTMLTGYTPFANGPDDT-----PEEILARIGSGKFS  241 (342)
T ss_dssp             BCTTC--CBCCSSCCSSCCCHHHHHHH--HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC-----HHHHHHHHHHCCCC
T ss_pred             cCCCC--ceeccCCCccccCHHHhcCC--CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC-----HHHHHHHHccCCcc
Confidence            44332  22445689999999999765  68899999999999999999999997532111     12233333332211


Q ss_pred             cccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          421 ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       421 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .   .......++..+.+++.+||+.||++|||+.++++
T Consensus       242 ~---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          242 L---SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             C---CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             c---CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1   11122334567889999999999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.9e-40  Score=327.64  Aligned_cols=244  Identities=26%  Similarity=0.371  Sum_probs=195.5

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceecc----CCceeEE
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRALV  261 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~----~~~~~lV  261 (511)
                      +.+.++||+|+||.||+|.. .++..||+|++....   ...+.+.+|+.++++++||||+++++++..    +...++|
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            34567899999999999985 478899999987643   244678999999999999999999998754    4568999


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCc--eecccCCcCceEEc-CCCCeeeecccccc
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC--ILHFDIKPHNILLD-HNFIPKVSDFGLAK  338 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~DIkp~NILl~-~~~~~kl~DFGla~  338 (511)
                      |||+++|+|.+++.    ....+++..+..++.|++.||+|||+   .+  |+|+||||+|||++ +++.+||+|||++.
T Consensus       108 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          108 TELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEecCCCCHHHHHH----HccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            99999999999983    33578999999999999999999998   46  99999999999997 78999999999997


Q ss_pred             cCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCC
Q 010434          339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG  418 (511)
Q Consensus       339 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  418 (511)
                      ......    .....||+.|+|||.+.+   .++.++||||||+++|+|++|+.||......       .........+.
T Consensus       181 ~~~~~~----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~  246 (290)
T 1t4h_A          181 LKRASF----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSGV  246 (290)
T ss_dssp             GCCTTS----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTTC
T ss_pred             cccccc----cccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-------HHHHHHHhccC
Confidence            654432    234468999999998863   6889999999999999999999998643211       11222222221


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          419 DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       419 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ...     ......+..+.+++.+||+.||.+|||+.++++
T Consensus       247 ~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          247 KPA-----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CCG-----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Ccc-----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            111     122223456889999999999999999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-41  Score=347.68  Aligned_cols=255  Identities=22%  Similarity=0.267  Sum_probs=201.2

Q ss_pred             HhhhccccCcCCcEEEEEEEe----cCCcEEEEEEeccCc-----ccHHHHHHHHHHhccc-cccceEEeeceeccCCce
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL----HTGRLIAVKMLENSK-----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKR  258 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~----~~g~~vAvK~l~~~~-----~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~  258 (511)
                      .+.+.++||+|+||.||+++.    .+|+.||||+++...     ...+.+.+|+.++.++ +||||+++++++..+...
T Consensus        55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  134 (355)
T 1vzo_A           55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL  134 (355)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred             ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence            456678999999999999986    478999999986522     2445678899999999 699999999999999999


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      ++||||+++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       135 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          135 HLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEeecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            99999999999999883    23579999999999999999999999   699999999999999999999999999998


Q ss_pred             cCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCC
Q 010434          339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG  418 (511)
Q Consensus       339 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  418 (511)
                      ........ ......||+.|+|||++.+....++.++||||||+++|||++|+.||........    ...+........
T Consensus       208 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~----~~~~~~~~~~~~  282 (355)
T 1vzo_A          208 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----QAEISRRILKSE  282 (355)
T ss_dssp             ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----HHHHHHHHHHCC
T ss_pred             ecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch----HHHHHHHHhccC
Confidence            65433221 1234469999999999976434678999999999999999999999875432211    111111111111


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhcCcCCCCCC-----CHHHHHHHHh
Q 010434          419 DLELRNVTEIESVIARKLCMIGLWCIQVKAADRP-----SMTKVLEMLE  462 (511)
Q Consensus       419 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~~Le  462 (511)
                      .       .....++..+.+++.+||+.||++||     |+.++++...
T Consensus       283 ~-------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~  324 (355)
T 1vzo_A          283 P-------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF  324 (355)
T ss_dssp             C-------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             C-------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence            0       11223456788999999999999999     9999987553

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=9.1e-40  Score=325.98  Aligned_cols=251  Identities=22%  Similarity=0.271  Sum_probs=198.2

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC-----cccHHHHHHHHHHhccccccceEEeecee--ccCCceeE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS-----KFSAEEFINEVSTIGRIHHVNVVQLLGFC--SEGSKRAL  260 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~-----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~--~~~~~~~l  260 (511)
                      .|.+.+.||+|+||.||++.. .+++.||||++...     ....+.+.+|+.++++++||||+++++++  .+....++
T Consensus         6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (305)
T 2wtk_C            6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM   85 (305)
T ss_dssp             CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred             ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence            356678999999999999985 47899999999653     23457899999999999999999999998  45568899


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      ||||++++ |.+++..  .....+++..+..++.||+.||+|||+   .+|+|+||||+|||++.++.+||+|||+++..
T Consensus        86 v~e~~~~~-l~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           86 VMEYCVCG-MQEMLDS--VPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEECCSEE-HHHHHHH--STTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EehhccCC-HHHHHHh--CcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            99999876 6555532  234579999999999999999999999   69999999999999999999999999999876


Q ss_pred             CCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcc
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDL  420 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (511)
                      .............||+.|+|||++.+.....+.++||||||+++|||++|+.|+......        .....+..... 
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~i~~~~~-  230 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--------KLFENIGKGSY-  230 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHCCC-
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--------HHHHHHhcCCC-
Confidence            543333334556699999999998764334578999999999999999999998753321        12222222211 


Q ss_pred             cccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          421 ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       421 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      .      ....++..+.+++.+||+.||++|||+.++++.
T Consensus       231 ~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          231 A------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             C------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             C------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1      111234568889999999999999999999974

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2e-40  Score=341.68  Aligned_cols=242  Identities=25%  Similarity=0.326  Sum_probs=189.2

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcc----cHHHHHHHHHH-hccccccceEEeeceeccCCceeEEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKF----SAEEFINEVST-IGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~----~~~~f~~Ev~~-l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      .+.+.+.||+|+||.||+++.+ +++.||||++++...    ..+.+.+|..+ ++.++||||+++++++.+.+..++||
T Consensus        39 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~  118 (373)
T 2r5t_A           39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL  118 (373)
T ss_dssp             GEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEE
Confidence            4567789999999999999864 688999999976432    33456778777 57789999999999999999999999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       119 E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          119 DYINGGELFYHLQ----RERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            9999999999883    33578999999999999999999999   6999999999999999999999999999986433


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                      ...  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||......        .+++.+..... . 
T Consensus       192 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~~~-~-  257 (373)
T 2r5t_A          192 HNS--TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--------EMYDNILNKPL-Q-  257 (373)
T ss_dssp             CCC--CCCSBSCCCCCCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH--------HHHHHHHHSCC-C-
T ss_pred             CCC--ccccccCCccccCHHHhCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHhccc-C-
Confidence            221  23455799999999999765  7899999999999999999999999654321        12222222211 1 


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHH
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTK  456 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~e  456 (511)
                           ....++..+.+++.+||+.||++||++.+
T Consensus       258 -----~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          258 -----LKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             -----CCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             -----CCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence                 11123467889999999999999999853

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.5e-40  Score=354.52  Aligned_cols=252  Identities=25%  Similarity=0.332  Sum_probs=204.5

Q ss_pred             HHHHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEecc---CcccHHHHHHHHHHhccccccceEEeeceeccCCceeE
Q 010434          185 IIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLEN---SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  260 (511)
Q Consensus       185 i~~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~---~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  260 (511)
                      -....|.+.++||+|+||.||+++.. +|+.||||++..   .....+.+.+|+.++++++||||+++++++.+....++
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            34567888899999999999999864 789999999864   34457789999999999999999999999999999999


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEc---CCCCeeeeccccc
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD---HNFIPKVSDFGLA  337 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~---~~~~~kl~DFGla  337 (511)
                      ||||+++|+|.+.+.    ....+++..+..++.||+.||.|||+   .+|+||||||+|||++   .++.+||+|||++
T Consensus        99 v~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  171 (486)
T 3mwu_A           99 VGELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (486)
T ss_dssp             EECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred             EEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence            999999999988873    23579999999999999999999999   6999999999999995   4567999999999


Q ss_pred             ccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcC
Q 010434          338 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG  417 (511)
Q Consensus       338 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  417 (511)
                      +......   ......||+.|+|||++.+   .++.++||||+|+++|+|++|+.||......        .+...+..+
T Consensus       172 ~~~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~  237 (486)
T 3mwu_A          172 TCFQQNT---KMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--------DILKRVETG  237 (486)
T ss_dssp             TTBCCC-------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHT
T ss_pred             eECCCCC---ccCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC
Confidence            8664432   2344569999999999864   5889999999999999999999998654321        122222222


Q ss_pred             CcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          418 GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      ....   .......++..+.+++.+||+.||++|||+.++++.
T Consensus       238 ~~~~---~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          238 KYAF---DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             CCCS---CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CCCC---CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1111   011223345678899999999999999999999984

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=347.07  Aligned_cols=268  Identities=15%  Similarity=0.132  Sum_probs=203.5

Q ss_pred             HHhhhccccCcCCcEEEEEEEec---------CCcEEEEEEeccCcccHHHHHHHHHHhccccccceEE-----------
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH---------TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQ-----------  247 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~---------~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~-----------  247 (511)
                      ..|.+.++||+|+||.||+|+..         +++.||||++...    +.+.+|+.++++++||||++           
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL  117 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence            35667789999999999999865         3789999998754    46889999999999999988           


Q ss_pred             ----eeceecc-CCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceE
Q 010434          248 ----LLGFCSE-GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNIL  322 (511)
Q Consensus       248 ----l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NIL  322 (511)
                          +++++.. +...++||||+ +++|.+++...  ....+++..+..++.||+.||+|||+   .+|+||||||+|||
T Consensus       118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl  191 (352)
T 2jii_A          118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIF  191 (352)
T ss_dssp             SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEE
T ss_pred             CccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEE
Confidence                5566654 67889999999 99999998422  23679999999999999999999999   69999999999999


Q ss_pred             EcCCC--CeeeecccccccCCCCCCce-----eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCC
Q 010434          323 LDHNF--IPKVSDFGLAKFHPKENDFV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN  395 (511)
Q Consensus       323 l~~~~--~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~  395 (511)
                      ++.++  .+||+|||+++.........     ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC--GPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            99998  99999999998665332211     11334699999999999765  78999999999999999999999987


Q ss_pred             cccccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCCCC
Q 010434          396 MNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMP  471 (511)
Q Consensus       396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~~p  471 (511)
                      .......  .+..... ...... ..+.........++..+.+++.+||+.||++|||+.+++++|+........+
T Consensus       270 ~~~~~~~--~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~  341 (352)
T 2jii_A          270 NCLPNTE--DIMKQKQ-KFVDKP-GPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS  341 (352)
T ss_dssp             GGTTCHH--HHHHHHH-HHHHSC-CCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             cCCcCHH--HHHHHHH-hccCCh-hhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence            5431110  0011111 111110 1110000011123467889999999999999999999999999877666544

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.7e-40  Score=331.78  Aligned_cols=249  Identities=24%  Similarity=0.361  Sum_probs=200.5

Q ss_pred             HHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      ...+.+.+.||+|+||.||+++.. +|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            456777899999999999999864 79999999997643 3456789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEE---cCCCCeeeecccccccCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl---~~~~~~kl~DFGla~~~~  341 (511)
                      +++++|.+++.    ....+++..+..++.|++.||+|||+   .+|+|+||||+||++   ++++.+||+|||+++...
T Consensus        88 ~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           88 VSGGELFDRIL----ERGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             CCCccHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            99999998873    23568999999999999999999999   699999999999999   788999999999987543


Q ss_pred             CCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccc
Q 010434          342 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (511)
                      ...    .....||+.|+|||.+.+.  .++.++||||||+++|||++|+.||......        .....+.++....
T Consensus       161 ~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~~~~  226 (304)
T 2jam_A          161 NGI----MSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVITYILLCGYPPFYEETES--------KLFEKIKEGYYEF  226 (304)
T ss_dssp             CBT----THHHHSCCCBCCTTTBSSC--SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHCCCCC
T ss_pred             CCc----cccccCCCCccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence            321    2334589999999998764  7889999999999999999999998654321        1222222221110


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                         .......++..+.+++.+||+.||++|||+.++++
T Consensus       227 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          227 ---ESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             ---CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ---CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               01112234567889999999999999999999987

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5.1e-40  Score=324.84  Aligned_cols=243  Identities=22%  Similarity=0.339  Sum_probs=200.2

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .+.+.+.||+|+||.||+++.. +++.||||++...    ....+.+.+|+.++++++||||+++++++.++...++|||
T Consensus        15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   94 (284)
T 2vgo_A           15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE   94 (284)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence            4566789999999999999864 6889999998652    2345689999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++|+|.+++.    ....+++..+..++.|++.||+|||+   .+|+|+||||+||+++.++.+||+|||++......
T Consensus        95 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           95 FAPRGELYKELQ----KHGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             CCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             eCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            999999999883    23468999999999999999999998   69999999999999999999999999998765432


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      .    .....||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.......        ....+.... ..  
T Consensus       168 ~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~-~~--  230 (284)
T 2vgo_A          168 R----RRTMCGTLDYLPPEMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE--------THRRIVNVD-LK--  230 (284)
T ss_dssp             C----BCCCCSCGGGCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTC-CC--
T ss_pred             c----cccccCCCCcCCHHHhccC--CCCcccchhhHHHHHHHHHHCCCCCCCCCHhH--------HHHHHhccc-cC--
Confidence            2    2345689999999998764  78899999999999999999999986543211        111121111 11  


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                          .+..++..+.+++.+||+.||.+|||+.++++
T Consensus       231 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          231 ----FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             ----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                11223467889999999999999999999987

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.1e-41  Score=345.73  Aligned_cols=264  Identities=23%  Similarity=0.290  Sum_probs=187.7

Q ss_pred             HHHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC---cccHHHHHHHHHHhcccc-ccceEEeeceeccC--Ccee
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS---KFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEG--SKRA  259 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~--~~~~  259 (511)
                      ...|.+.++||+|+||.||+|.. .+|+.||||++...   ....+.+.+|+.++.++. ||||+++++++...  ...+
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            34566778999999999999985 57999999998653   234567889999999997 99999999998643  4689


Q ss_pred             EEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      +||||++ |+|.+++.     ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        88 lv~e~~~-~~L~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIR-----ANILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEECCS-EEHHHHHH-----HTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEecccC-cCHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            9999996 68888772     2479999999999999999999999   6999999999999999999999999999986


Q ss_pred             CCCCCC-------------------ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccc
Q 010434          340 HPKEND-------------------FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIR  400 (511)
Q Consensus       340 ~~~~~~-------------------~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~  400 (511)
                      ......                   ....+...||+.|+|||++.+. ..++.++|||||||++|||++|+.||......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            543111                   1122345699999999998753 47899999999999999999999999654321


Q ss_pred             cccc-------------------ccchhhHHhhhcCC---cccccccch----------hHHHHHHHHHHHHHHhcCcCC
Q 010434          401 SSKA-------------------YFPSWVYDQLNKGG---DLELRNVTE----------IESVIARKLCMIGLWCIQVKA  448 (511)
Q Consensus       401 ~~~~-------------------~~~~~~~~~~~~~~---~~~~~~~~~----------~~~~~~~~l~~l~~~Cl~~~P  448 (511)
                      ..-.                   .+.......+....   .........          ....++..+.+++.+||+.||
T Consensus       238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence            1000                   00000000000000   000000000          000234678899999999999


Q ss_pred             CCCCCHHHHHHH
Q 010434          449 ADRPSMTKVLEM  460 (511)
Q Consensus       449 ~~RPs~~evl~~  460 (511)
                      ++|||+.++++.
T Consensus       318 ~~R~t~~e~l~H  329 (388)
T 3oz6_A          318 NKRISANDALKH  329 (388)
T ss_dssp             GGSCCHHHHTTS
T ss_pred             ccCCCHHHHhCC
Confidence            999999999864

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.5e-40  Score=343.09  Aligned_cols=246  Identities=24%  Similarity=0.296  Sum_probs=187.5

Q ss_pred             cccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhcc-ccccceEEeeceecc----CCceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGR-IHHVNVVQLLGFCSE----GSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~-l~H~niv~l~g~~~~----~~~~~lV~e~~~~  267 (511)
                      +.||+|+||.||++... +|+.||||++...    ..+.+|+.++.+ .+||||+++++++..    ....++||||+++
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g  143 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG  143 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence            68999999999999854 7899999999643    467788888754 489999999998865    6678999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC---CCCeeeecccccccCCCCC
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~---~~~~kl~DFGla~~~~~~~  344 (511)
                      |+|.+++..  .....+++..+..++.||+.||+|||+   .+|+||||||+|||++.   ++.+||+|||+++......
T Consensus       144 g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~  218 (400)
T 1nxk_A          144 GELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN  218 (400)
T ss_dssp             EEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred             CcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence            999999843  223569999999999999999999999   69999999999999988   7899999999998654332


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                         ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.........    ......+..+.. ... 
T Consensus       219 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----~~~~~~i~~~~~-~~~-  287 (400)
T 1nxk_A          219 ---SLTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----PGMKTRIRMGQY-EFP-  287 (400)
T ss_dssp             -----------CTTCCGGGSCCC--CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC----CSHHHHHHHTCC-CCC-
T ss_pred             ---ccccCCCCCCccCHhhcCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc----HHHHHHHHcCcc-cCC-
Confidence               23455689999999999764  7899999999999999999999999754322111    111222222111 110 


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                       ......++..+.+++.+||+.||++|||+.++++.
T Consensus       288 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          288 -NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             -TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             01112345678899999999999999999999984

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.3e-40  Score=328.40  Aligned_cols=245  Identities=23%  Similarity=0.341  Sum_probs=201.5

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      +.+.++||+|+||.||+|.. .+++.||||++...  ....+.+.+|+.++++++||||+++++++.++...++||||++
T Consensus        24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  103 (303)
T 3a7i_A           24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG  103 (303)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence            45568999999999999985 47899999999753  3456789999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +++|.+++.     ...+++..+..++.|++.||.|||+   .+|+|+||||+||+++.++.+||+|||++........ 
T Consensus       104 ~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  174 (303)
T 3a7i_A          104 GGSALDLLE-----PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  174 (303)
T ss_dssp             TEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred             CCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence            999999882     3579999999999999999999999   6999999999999999999999999999986544321 


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                       ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.|+.......        ....+........    
T Consensus       175 -~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~----  239 (303)
T 3a7i_A          175 -KRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELARGEPPHSELHPMK--------VLFLIPKNNPPTL----  239 (303)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSCCCCC----
T ss_pred             -ccCccCCCcCccCHHHHhcC--CCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--------HHHHhhcCCCCCC----
Confidence             22445689999999999764  78899999999999999999999986532211        1112222211111    


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                        ...++..+.+++.+||+.||++|||+.++++.
T Consensus       240 --~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          240 --EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             --CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             --ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence              11234568899999999999999999999874

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1e-40  Score=359.88  Aligned_cols=249  Identities=27%  Similarity=0.341  Sum_probs=203.1

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+.+.||+|+||.||+++.. +|+.||||++...    ....+.+.+|+.++++++|||||++++++.+....++||||
T Consensus       186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy  265 (576)
T 2acx_A          186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL  265 (576)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence            445678999999999999864 7999999999652    33456789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++...  ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       266 ~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          266 MNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             CCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             CCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            9999999988432  23459999999999999999999999   699999999999999999999999999998765443


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      .   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......    ....+...+.....     
T Consensus       341 ~---~~~~~GT~~Y~APEvl~~~--~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~----~~~~i~~~i~~~~~-----  406 (576)
T 2acx_A          341 T---IKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI----KREEVERLVKEVPE-----  406 (576)
T ss_dssp             C---EECCCSCGGGCCHHHHTTC--EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC----CHHHHHHHHHHCCC-----
T ss_pred             c---ccccCCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCcccccch----hHHHHHHHhhcccc-----
Confidence            2   2345799999999999764  78999999999999999999999997543211    11122222222111     


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCC-----CHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRP-----SMTKVLE  459 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~  459 (511)
                        ..+..++..+.+++.+||+.||++||     ++.+|++
T Consensus       407 --~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          407 --EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             --cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence              11223456788999999999999999     7888875

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.4e-40  Score=354.44  Aligned_cols=250  Identities=26%  Similarity=0.348  Sum_probs=206.5

Q ss_pred             HHHHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCcee
Q 010434          185 IIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  259 (511)
Q Consensus       185 i~~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~  259 (511)
                      +....|.+.++||+|+||.||+++.. +|+.||||++...    ....+.+.+|+.++++++||||+++++++.+....+
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            44567888899999999999999864 7999999998653    345778999999999999999999999999999999


Q ss_pred             EEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEE---cCCCCeeeecccc
Q 010434          260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL---DHNFIPKVSDFGL  336 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl---~~~~~~kl~DFGl  336 (511)
                      +||||+++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||+   +.++.+||+|||+
T Consensus       103 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  175 (484)
T 3nyv_A          103 LVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGL  175 (484)
T ss_dssp             EEECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred             EEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence            9999999999998873    33579999999999999999999999   699999999999999   5678999999999


Q ss_pred             cccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhc
Q 010434          337 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK  416 (511)
Q Consensus       337 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  416 (511)
                      ++.......   .....||+.|+|||++.+   .++.++||||+|+++|+|++|+.||......        .+...+..
T Consensus       176 a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~  241 (484)
T 3nyv_A          176 STHFEASKK---MKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEY--------DILKKVEK  241 (484)
T ss_dssp             HHHBCCCCS---HHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHH
T ss_pred             eEEcccccc---cccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHc
Confidence            987654432   234569999999999864   6889999999999999999999999754321        12222222


Q ss_pred             CC-cccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          417 GG-DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       417 ~~-~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      +. .....    ....++..+.+++.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          242 GKYTFELP----QWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             CCCCCCSG----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCCCc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            21 11111    22335577889999999999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-41  Score=350.82  Aligned_cols=252  Identities=19%  Similarity=0.218  Sum_probs=199.6

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+.++||+|+||.||+++.+ +|+.||||++++..    ...+.+.+|..++.+++||||+++++++.+....++||||
T Consensus        63 f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~  142 (412)
T 2vd5_A           63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEY  142 (412)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcC
Confidence            344578999999999999864 79999999997532    2234588999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++..   .+..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       143 ~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          143 YVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             CCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             CCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence            999999999832   23579999999999999999999999   699999999999999999999999999998765443


Q ss_pred             CceeeccccCCccccchhccccc-----CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcC-C
Q 010434          345 DFVSISATRGTIGYIAPELISRN-----FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKG-G  418 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~-----~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~  418 (511)
                      . .......||+.|+|||++...     .+.++.++|||||||++|||++|+.||.......        .+..+... .
T Consensus       217 ~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~i~~~~~  287 (412)
T 2vd5_A          217 T-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE--------TYGKIVHYKE  287 (412)
T ss_dssp             C-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTHHH
T ss_pred             c-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH--------HHHHHHhccc
Confidence            2 222345799999999998732     2368899999999999999999999997543221        11111110 0


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhcCcCCCCC---CCHHHHHHH
Q 010434          419 DLELRNVTEIESVIARKLCMIGLWCIQVKAADR---PSMTKVLEM  460 (511)
Q Consensus       419 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R---Ps~~evl~~  460 (511)
                      ....   ......++..+.+++.+||+ +|++|   |++.++++.
T Consensus       288 ~~~~---p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          288 HLSL---PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HCCC---C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             CcCC---CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            0111   11123356778999999999 99998   699999863

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.6e-40  Score=338.01  Aligned_cols=251  Identities=22%  Similarity=0.276  Sum_probs=201.1

Q ss_pred             HHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcc---------cHHHHHHHHHHhccc-cccceEEeeceeccCC
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKF---------SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGS  256 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~---------~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~  256 (511)
                      ..|.+.+.||+|+||.||+++.. +|+.||||++.....         ..+.+.+|+.++.++ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            44556689999999999999975 799999999865321         135678999999999 7999999999999999


Q ss_pred             ceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccc
Q 010434          257 KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGL  336 (511)
Q Consensus       257 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGl  336 (511)
                      ..++||||+++++|.+++.    ....+++..+..++.||+.||+|||+   .+|+|+||||+|||++.++.+||+|||+
T Consensus       174 ~~~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~  246 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLT----EKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGF  246 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEEEeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCc
Confidence            9999999999999999883    33579999999999999999999999   6999999999999999999999999999


Q ss_pred             cccCCCCCCceeeccccCCccccchhccccc----CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHH
Q 010434          337 AKFHPKENDFVSISATRGTIGYIAPELISRN----FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYD  412 (511)
Q Consensus       337 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~  412 (511)
                      +........   .....||+.|+|||++.+.    ...++.++||||||+++|||++|+.||......        ....
T Consensus       247 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--------~~~~  315 (365)
T 2y7j_A          247 SCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--------LMLR  315 (365)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHH
T ss_pred             ccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--------HHHH
Confidence            987654332   2445699999999998642    135788999999999999999999998653211        1112


Q ss_pred             hhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          413 QLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       413 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .+..+....   ........+..+.+++.+||+.||++|||+.++++
T Consensus       316 ~i~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          316 MIMEGQYQF---SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHHTCCCC---CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhCCCCC---CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            222211100   01111223567889999999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.1e-40  Score=352.72  Aligned_cols=250  Identities=25%  Similarity=0.349  Sum_probs=199.7

Q ss_pred             HHHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccCCceeEE
Q 010434          186 IAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       186 ~~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  261 (511)
                      ....|.+.++||+|+||.||+++.. ++..||||++...   ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3456777899999999999999864 7899999999763   33457899999999999999999999999999999999


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC---CCeeeecccccc
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN---FIPKVSDFGLAK  338 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~---~~~kl~DFGla~  338 (511)
                      |||+++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.+   +.+||+|||+++
T Consensus       115 ~e~~~~g~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          115 MECYKGGELFDEII----HRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             EECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            99999999988873    33569999999999999999999999   699999999999999764   559999999998


Q ss_pred             cCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCC
Q 010434          339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG  418 (511)
Q Consensus       339 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  418 (511)
                      ......   ......||+.|+|||++.+   .++.++|||||||++|+|++|+.||......        .+...+..+.
T Consensus       188 ~~~~~~---~~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~  253 (494)
T 3lij_A          188 VFENQK---KMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--------EILRKVEKGK  253 (494)
T ss_dssp             ECBTTB---CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTC
T ss_pred             ECCCCc---cccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC
Confidence            765432   2344569999999999863   6889999999999999999999999754322        1222222221


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          419 DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       419 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ...   .......++..+.+++.+||+.||.+|||+.++++
T Consensus       254 ~~~---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          254 YTF---DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             CCC---CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCC---CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            111   01122234567889999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.4e-40  Score=357.56  Aligned_cols=250  Identities=22%  Similarity=0.296  Sum_probs=202.5

Q ss_pred             hccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          192 FTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       192 ~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      +.+.||+|+||.||+++.+ +|+.||||++...    ....+.+.+|+.++++++||||+++++++......++||||++
T Consensus       189 ~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~  268 (543)
T 3c4z_A          189 DFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMN  268 (543)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEecc
Confidence            3467999999999999864 7999999999653    2345689999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +|+|.+++.........+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....... 
T Consensus       269 gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~-  344 (543)
T 3c4z_A          269 GGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-  344 (543)
T ss_dssp             TCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred             CCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc-
Confidence            999999885544445679999999999999999999999   6999999999999999999999999999987654332 


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                       ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||........    ...+...+..... .     
T Consensus       345 -~~~~~~GT~~Y~APE~l~~~--~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~----~~~~~~~i~~~~~-~-----  411 (543)
T 3c4z_A          345 -KTKGYAGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----NKELKQRVLEQAV-T-----  411 (543)
T ss_dssp             -CBCCCCSCTTTSCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC----HHHHHHHHHHCCC-C-----
T ss_pred             -ccccccCCccccChhhhcCC--CCChHHhcCcchHHHHHHHhCCCCCCCCccchh----HHHHHHHHhhccc-C-----
Confidence             12345799999999999865  789999999999999999999999975432111    1112222222111 1     


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCH-----HHHHH
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSM-----TKVLE  459 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~-----~evl~  459 (511)
                       .+..++..+.+++.+||+.||++||++     .++++
T Consensus       412 -~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          412 -YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             -CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             -CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence             122345678899999999999999975     66664

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.1e-40  Score=351.25  Aligned_cols=257  Identities=21%  Similarity=0.231  Sum_probs=191.2

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccC------Cce
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKR  258 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~------~~~  258 (511)
                      .|.+.++||+|+||.||++.. .+|+.||||++...   ....+.+.+|+.++++++||||+++++++...      ...
T Consensus        63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~  142 (464)
T 3ttj_A           63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV  142 (464)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred             CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence            355678999999999999984 47899999999763   23456789999999999999999999998654      456


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      ++||||++++ |.+.+.      ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       143 ~lv~E~~~~~-l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          143 YLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             EEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             EEEEeCCCCC-HHHHHh------hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            9999999764 555441      348999999999999999999999   699999999999999999999999999998


Q ss_pred             cCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc--------cccch--
Q 010434          339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK--------AYFPS--  408 (511)
Q Consensus       339 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~--------~~~~~--  408 (511)
                      ......   ..+...||+.|+|||++.+.  .++.++|||||||++|||++|+.||........-        ...+.  
T Consensus       213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~  287 (464)
T 3ttj_A          213 TAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  287 (464)
T ss_dssp             ----CC---CC----CCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             ecCCCc---ccCCCcccccccCHHHHcCC--CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            654332   23445799999999999875  7899999999999999999999999754321100        00000  


Q ss_pred             -----hhHHhhhcCCcc------------cccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          409 -----WVYDQLNKGGDL------------ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       409 -----~~~~~~~~~~~~------------~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                           .....+......            ......+.....+..+.+++.+||+.||++|||+.|+++.
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                 000111110000            0011112334446789999999999999999999999873

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.1e-40  Score=354.88  Aligned_cols=247  Identities=26%  Similarity=0.345  Sum_probs=200.0

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc--------------ccHHHHHHHHHHhccccccceEEeeceec
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK--------------FSAEEFINEVSTIGRIHHVNVVQLLGFCS  253 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~--------------~~~~~f~~Ev~~l~~l~H~niv~l~g~~~  253 (511)
                      .|.+.++||+|+||+||+++.. +++.||||++....              ...+.+.+|+.++++++||||+++++++.
T Consensus        37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  116 (504)
T 3q5i_A           37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE  116 (504)
T ss_dssp             TEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            4566789999999999999854 68999999997532              23567999999999999999999999999


Q ss_pred             cCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC---Cee
Q 010434          254 EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF---IPK  330 (511)
Q Consensus       254 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~---~~k  330 (511)
                      ++...++||||+++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++   .+|
T Consensus       117 ~~~~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          117 DKKYFYLVTEFYEGGELFEQII----NRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             cCCEEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEE
Confidence            9999999999999999998873    23579999999999999999999999   6999999999999998775   699


Q ss_pred             eecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhh
Q 010434          331 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWV  410 (511)
Q Consensus       331 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~  410 (511)
                      |+|||+++......   ......||+.|+|||++.+   .++.++||||+|+++|+|++|+.||......        .+
T Consensus       190 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~  255 (504)
T 3q5i_A          190 IVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--------DI  255 (504)
T ss_dssp             ECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HH
T ss_pred             EEECCCCEEcCCCC---ccccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--------HH
Confidence            99999998765443   2244569999999999864   6889999999999999999999999754322        12


Q ss_pred             HHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          411 YDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       411 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ...+..+....   .......++..+.+++.+||+.||.+|||+.++++
T Consensus       256 ~~~i~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          256 IKKVEKGKYYF---DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHHHCCCCC---CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHcCCCCC---CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            22232221110   11122335677899999999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=9e-41  Score=345.18  Aligned_cols=268  Identities=22%  Similarity=0.283  Sum_probs=204.5

Q ss_pred             CCChHHHHHHHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhcccc--------ccceEEee
Q 010434          179 RYSYPEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIH--------HVNVVQLL  249 (511)
Q Consensus       179 ~~~~~ei~~~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~--------H~niv~l~  249 (511)
                      .+...++....|.+.++||+|+||.||+++. .+++.||||+++......+.+.+|+.++++++        |+||++++
T Consensus        28 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~  107 (397)
T 1wak_A           28 LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL  107 (397)
T ss_dssp             SSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred             EEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence            3444555556778889999999999999984 57899999999876666778999999999985        88899999


Q ss_pred             ceec----cCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCC-ceecccCCcCceEEc
Q 010434          250 GFCS----EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM-CILHFDIKPHNILLD  324 (511)
Q Consensus       250 g~~~----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~DIkp~NILl~  324 (511)
                      +++.    .+...++||||+ +++|.+.+..  .....+++..+..++.||+.||+|||+   . +|+||||||+|||++
T Consensus       108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~  181 (397)
T 1wak_A          108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLS  181 (397)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEEC
T ss_pred             cceeecCCCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEe
Confidence            9987    667899999999 5666665532  223569999999999999999999998   5 899999999999998


Q ss_pred             CCC-------------------------------------------------CeeeecccccccCCCCCCceeeccccCC
Q 010434          325 HNF-------------------------------------------------IPKVSDFGLAKFHPKENDFVSISATRGT  355 (511)
Q Consensus       325 ~~~-------------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt  355 (511)
                      .++                                                 .+||+|||+++.....     .....||
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt  256 (397)
T 1wak_A          182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQT  256 (397)
T ss_dssp             CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSC
T ss_pred             ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCC
Confidence            775                                                 8999999999876432     2345689


Q ss_pred             ccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc--chhhHHhhhc-----------------
Q 010434          356 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF--PSWVYDQLNK-----------------  416 (511)
Q Consensus       356 ~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~--~~~~~~~~~~-----------------  416 (511)
                      +.|+|||++.+.  .++.++|||||||++|||++|+.||............  ...+.+.+..                 
T Consensus       257 ~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  334 (397)
T 1wak_A          257 RQYRSLEVLIGS--GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFT  334 (397)
T ss_dssp             GGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBC
T ss_pred             CcccCChhhcCC--CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccC
Confidence            999999999865  6899999999999999999999999754322110000  0000000000                 


Q ss_pred             -CCc-ccc------------cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          417 -GGD-LEL------------RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       417 -~~~-~~~------------~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                       ... ...            ..........+..+.+++.+||+.||++|||+.++++
T Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          335 KKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             TTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence             000 000            0001134566788999999999999999999999985

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.4e-40  Score=326.96  Aligned_cols=246  Identities=23%  Similarity=0.325  Sum_probs=200.8

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .|.+.+.||+|+||.||++... +++.+|+|++....    ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   95 (294)
T 2rku_A           16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE   95 (294)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEe
Confidence            3455789999999999999865 68899999986532    235678999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++++|.+++.    ....+++..+..++.|++.||+|||+   .+|+|+||||+||+++.++.+||+|||+++.....
T Consensus        96 ~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           96 LCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             CCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             cCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            999999998872    33579999999999999999999999   69999999999999999999999999999876433


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      ..  ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.|+.......        ....+.... ..  
T Consensus       169 ~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~-~~--  233 (294)
T 2rku_A          169 GE--RKKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--------TYLRIKKNE-YS--  233 (294)
T ss_dssp             TC--CBCCCCSCCSSCCHHHHTTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTC-CC--
T ss_pred             cc--ccccccCCCCcCCcchhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhhcc-CC--
Confidence            22  12345689999999998764  68899999999999999999999986543221        111121111 11  


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                          .+..++..+.+++.+||+.||++|||+.++++.
T Consensus       234 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          234 ----IPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ----CccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                111234568889999999999999999999873

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.3e-40  Score=322.42  Aligned_cols=246  Identities=23%  Similarity=0.366  Sum_probs=193.3

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .+.+.++||+|+||.||+|+.. +|+.||||++...    ....+.+.+|+.++++++||||+++++++......++|||
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   91 (276)
T 2h6d_A           12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME   91 (276)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence            4556789999999999999865 7999999998652    2345689999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++++|.+++.    ....+++..+..++.|++.||+|||+   .+|+|+||||+||+++.++.+||+|||++......
T Consensus        92 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           92 YVSGGELFDYIC----KHGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             CCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             ccCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            999999999883    23568999999999999999999999   69999999999999999999999999999866443


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      ..   .....||+.|+|||.+.+. ...+.++||||||+++|||++|+.|+......        ...+.+..... .  
T Consensus       165 ~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~-~--  229 (276)
T 2h6d_A          165 EF---LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--------TLFKKIRGGVF-Y--  229 (276)
T ss_dssp             ---------------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCC-C--
T ss_pred             cc---eecccCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--------HHHHHhhcCcc-c--
Confidence            21   2344689999999998764 23468999999999999999999998653221        12222222211 1  


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                          .+..++..+.+++.+||+.||++|||+.++++.
T Consensus       230 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          230 ----IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ----CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                111234568889999999999999999999973

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-40  Score=334.71  Aligned_cols=261  Identities=25%  Similarity=0.338  Sum_probs=196.9

Q ss_pred             HHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCccc------HHHHHHHHHHhccccccceEEeeceeccCCceeE
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFS------AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  260 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~------~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  260 (511)
                      ..|.+.+.||+|+||.||+|... +|+.||||++......      .+.+.+|+.++++++||||+++++++.+....++
T Consensus        10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (346)
T 1ua2_A           10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL   89 (346)
T ss_dssp             ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred             cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence            35666789999999999999864 6899999998753221      2468899999999999999999999999999999


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      ||||+++ +|.+++.   .....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        90 v~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           90 VFDFMET-DLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             EEECCSE-EHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             EEEcCCC-CHHHHHH---hcCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            9999975 8887773   234578999999999999999999999   69999999999999999999999999999876


Q ss_pred             CCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCc-
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGD-  419 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  419 (511)
                      .....  ......||+.|+|||.+.+. ..++.++||||||+++|||++|..|+.........    ..+......... 
T Consensus       163 ~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~----~~i~~~~~~~~~~  235 (346)
T 1ua2_A          163 GSPNR--AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL----TRIFETLGTPTEE  235 (346)
T ss_dssp             TSCCC--CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHHHCCCCTT
T ss_pred             cCCcc--cCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH----HHHHHHcCCCChh
Confidence            44322  22445689999999998653 35789999999999999999999988654321100    000000000000 


Q ss_pred             -----------cccc-----ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          420 -----------LELR-----NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       420 -----------~~~~-----~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                                 ....     ........++..+.+++.+||+.||++|||+.|+++.-.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~  294 (346)
T 1ua2_A          236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY  294 (346)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred             hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence                       0000     000111234577899999999999999999999998543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=8.1e-40  Score=331.90  Aligned_cols=245  Identities=23%  Similarity=0.331  Sum_probs=200.5

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc----ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .|.+.+.||+|+||.||++... +++.+|+|++....    ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        42 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  121 (335)
T 2owb_A           42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE  121 (335)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEe
Confidence            3455789999999999999864 68899999986532    245678999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++++|.+++.    ....+++..+..++.||+.||+|||+   .+|+|+||||+|||++.++.+||+|||+++.....
T Consensus       122 ~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          122 LCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             CCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             cCCCCCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            999999999872    33579999999999999999999999   69999999999999999999999999999876533


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      ..  ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.......        ....+.... ..  
T Consensus       195 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~-~~--  259 (335)
T 2owb_A          195 GE--RKKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--------TYLRIKKNE-YS--  259 (335)
T ss_dssp             TC--CBCCCCSCCSSCCHHHHHTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHTC-CC--
T ss_pred             cc--cccccCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH--------HHHHHhcCC-CC--
Confidence            22  12345699999999998764  67899999999999999999999986543211        111121111 11  


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                          ....++..+.+++.+||+.||++|||+.++++
T Consensus       260 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          260 ----IPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ----CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                11123456788999999999999999999987

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=8.6e-40  Score=333.44  Aligned_cols=263  Identities=22%  Similarity=0.276  Sum_probs=196.1

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceecc--------CC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSE--------GS  256 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~--------~~  256 (511)
                      .|.+.++||+|+||.||+++. .+|+.||||++....   .....+.+|+.++++++||||+++++++..        ++
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   97 (351)
T 3mi9_A           18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG   97 (351)
T ss_dssp             GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred             ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence            566678999999999999986 579999999986532   234678899999999999999999999876        44


Q ss_pred             ceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccc
Q 010434          257 KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGL  336 (511)
Q Consensus       257 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGl  336 (511)
                      ..++||||+++ +|.+.+.   .....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus        98 ~~~lv~e~~~~-~l~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           98 SIYLVFDFCEH-DLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             EEEEEEECCSE-EHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             eEEEEEeccCC-CHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence            68999999975 6666652   233569999999999999999999999   6999999999999999999999999999


Q ss_pred             cccCCCCCCc--eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc-----------
Q 010434          337 AKFHPKENDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK-----------  403 (511)
Q Consensus       337 a~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~-----------  403 (511)
                      ++........  .......||+.|+|||++.+. ..++.++||||||+++|||++|+.||.........           
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            9876533221  222445689999999998653 36789999999999999999999998764322100           


Q ss_pred             -cccchhhHHhhhcCCcccccccchhHHH-----HHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          404 -AYFPSWVYDQLNKGGDLELRNVTEIESV-----IARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       404 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                       ..++.+......................     .++.+.+++.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence             0000000000000000000000111111     2456889999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.4e-40  Score=327.66  Aligned_cols=254  Identities=26%  Similarity=0.414  Sum_probs=194.5

Q ss_pred             HhhhccccCcCCcEEEEEEEec--CCc--EEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH--TGR--LIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  260 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~--~g~--~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  260 (511)
                      .+.+.++||+|+||.||+|++.  +++  .||||+++..    ....+.+.+|+.++++++||||+++++++..+. .++
T Consensus        19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~   97 (291)
T 1u46_A           19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM   97 (291)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred             HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence            4566789999999999999853  333  6999998753    234568999999999999999999999998754 889


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      |+||+++++|.+++..   ....+++..+..++.|++.||+|||+   .+|+|+||||+||+++.++.+||+|||+++..
T Consensus        98 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           98 VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             EEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            9999999999998842   23569999999999999999999999   69999999999999999999999999999877


Q ss_pred             CCCCCcee-eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcC-
Q 010434          341 PKENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKG-  417 (511)
Q Consensus       341 ~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-  417 (511)
                      ........ .....+|..|+|||.+.+.  .++.++||||||+++|||++ |+.||.......        ....+... 
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~  241 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--------ILHKIDKEG  241 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTSC
T ss_pred             cccccchhhhccCCCCceeeCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--------HHHHHHccC
Confidence            65443222 2344578899999998764  68899999999999999999 999986543211        12222211 


Q ss_pred             CcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          418 GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                      ....      ....++..+.+++.+||+.||++|||+.++++.|+...
T Consensus       242 ~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          242 ERLP------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             CCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CCCC------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence            1111      11224567889999999999999999999999998744

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4e-40  Score=331.93  Aligned_cols=255  Identities=21%  Similarity=0.303  Sum_probs=198.7

Q ss_pred             HHHHHHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc---------cHHHHHHHHHHhccccccceEEeeceec
Q 010434          184 EIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF---------SAEEFINEVSTIGRIHHVNVVQLLGFCS  253 (511)
Q Consensus       184 ei~~~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~---------~~~~f~~Ev~~l~~l~H~niv~l~g~~~  253 (511)
                      ......|.+.++||+|+||.||+|.. .+++.||||++.....         ....+.+|+.++++++||||+++++++.
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   85 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD   85 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence            34556778889999999999999985 4689999999865321         2235889999999999999999999987


Q ss_pred             cCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCC---ee
Q 010434          254 EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFI---PK  330 (511)
Q Consensus       254 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~---~k  330 (511)
                      .+. .++||||+++++|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.   +|
T Consensus        86 ~~~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~k  157 (322)
T 2ycf_A           86 AED-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIK  157 (322)
T ss_dssp             SSS-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEE
T ss_pred             CCc-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEE
Confidence            654 899999999999999873    34579999999999999999999999   69999999999999987654   99


Q ss_pred             eecccccccCCCCCCceeeccccCCccccchhcccc-cCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchh
Q 010434          331 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSW  409 (511)
Q Consensus       331 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~  409 (511)
                      |+|||+++......   ......||+.|+|||++.. ....++.++||||||+++|||++|+.||.......       .
T Consensus       158 l~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~  227 (322)
T 2ycf_A          158 ITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-------S  227 (322)
T ss_dssp             ECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-------C
T ss_pred             EccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-------H
Confidence            99999998764332   1233458999999999742 12468899999999999999999999986533211       1


Q ss_pred             hHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          410 VYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       410 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      +...+..+....   .......++..+.+++.+||+.||++|||+.++++
T Consensus       228 ~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          228 LKDQITSGKYNF---IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHHHHHTCCCC---CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhCcccc---CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            112222221111   11122345678899999999999999999999984

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-40  Score=339.98  Aligned_cols=257  Identities=22%  Similarity=0.290  Sum_probs=191.6

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCC------ce
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS------KR  258 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~------~~  258 (511)
                      .|.+.+.||+|+||.||+|.. .+|+.||||++....   ...+.+.+|+.++++++||||+++++++....      ..
T Consensus        26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~  105 (367)
T 1cm8_A           26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF  105 (367)
T ss_dssp             SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred             eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence            345678999999999999985 579999999986532   23467899999999999999999999987653      45


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      ++||||+ +++|.+++.     ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       106 ~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          106 YLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             EEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            9999999 889998872     2568999999999999999999999   699999999999999999999999999998


Q ss_pred             cCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc-------cccchhhH
Q 010434          339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK-------AYFPSWVY  411 (511)
Q Consensus       339 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~-------~~~~~~~~  411 (511)
                      .....     .....+|+.|+|||++.+. ..++.++||||+||+++||++|+.||........-       ...+....
T Consensus       177 ~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          177 QADSE-----MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             ECCSS-----CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccccc-----cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            75432     2445689999999998763 36899999999999999999999999754321100       00000000


Q ss_pred             H---------hhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          412 D---------QLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       412 ~---------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      .         .+..................+..+.+++.+||+.||++|||+.++++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            0         000000000011111222345678899999999999999999999983

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=334.67  Aligned_cols=261  Identities=24%  Similarity=0.380  Sum_probs=197.4

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      .+.+.+.||+|+||.||+|..++  .+|+|+++..   ....+.|.+|+.++++++||||+++++++.+....++||||+
T Consensus        34 ~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~  111 (319)
T 2y4i_B           34 QLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLC  111 (319)
T ss_dssp             CEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCC
T ss_pred             HeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecc
Confidence            34567899999999999998753  4999998653   223456889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++++|.+++.   ..+..+++..+..++.||+.||+|||+   .+|+|+||||+|||++ ++.+||+|||+++.......
T Consensus       112 ~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~  184 (319)
T 2y4i_B          112 KGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA  184 (319)
T ss_dssp             CSEEHHHHTT---SSCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred             cCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence            9999999983   233579999999999999999999999   6999999999999998 67999999999875432211


Q ss_pred             ---ceeeccccCCccccchhccccc-------CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhh
Q 010434          346 ---FVSISATRGTIGYIAPELISRN-------FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLN  415 (511)
Q Consensus       346 ---~~~~~~~~gt~~y~APE~~~~~-------~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  415 (511)
                         ........||+.|+|||.+...       ...++.++||||||+++|||++|+.||.......        ....+.
T Consensus       185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~~~  256 (319)
T 2y4i_B          185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA--------IIWQMG  256 (319)
T ss_dssp             ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH--------HHHHHH
T ss_pred             cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHhc
Confidence               1122344589999999998642       1357889999999999999999999986543221        222222


Q ss_pred             cCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCCCC
Q 010434          416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMP  471 (511)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~~p  471 (511)
                      .+........     .++..+.+++.+||+.||++|||+.+++++|+.........
T Consensus       257 ~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~  307 (319)
T 2y4i_B          257 TGMKPNLSQI-----GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL  307 (319)
T ss_dssp             TTCCCCCCCS-----SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred             cCCCCCCCcC-----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence            2222221111     13356788999999999999999999999999877654433

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.2e-40  Score=339.03  Aligned_cols=256  Identities=23%  Similarity=0.336  Sum_probs=199.1

Q ss_pred             HHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      ...+.+.++||+|+||.||++... +++.||+|++...  ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            345566789999999999999865 7899999999764  2345679999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++++|.+++.    ....+++..+..++.|++.||+|||+.  .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       112 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          112 HMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            999999999883    235699999999999999999999972  28999999999999999999999999998754221


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc-----------c-----
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF-----------P-----  407 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~-----------~-----  407 (511)
                          ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||...........+           +     
T Consensus       186 ----~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3eqc_A          186 ----MANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  259 (360)
T ss_dssp             ----C----CCCCTTCCHHHHTTC--CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred             ----cccCCCCCCCeECHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence                12344689999999999764  7899999999999999999999998754321100000           0     


Q ss_pred             ------------------hhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          408 ------------------SWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       408 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                                        ....+.+........     ....++..+.+++.+||+.||++|||+.++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKL-----PSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             --------------CCCHHHHHHHHHHSCCCCC-----CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCcccccccCCCCcccchhhhhHHhccCCCCC-----CcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                              000000000000000     11123567889999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=336.56  Aligned_cols=263  Identities=23%  Similarity=0.274  Sum_probs=186.4

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC-cccHHHHHHHHHHhcccc-ccceEEeecee--------ccCCc
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS-KFSAEEFINEVSTIGRIH-HVNVVQLLGFC--------SEGSK  257 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~-~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~--------~~~~~  257 (511)
                      .+.+.++||+|+||.||+++. .+|+.||||++... ....+.+.+|+.++.++. ||||+++++++        .....
T Consensus        29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~  108 (337)
T 3ll6_A           29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE  108 (337)
T ss_dssp             EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred             eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence            456678999999999999985 47899999998653 334567899999999996 99999999998        34455


Q ss_pred             eeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCc--eecccCCcCceEEcCCCCeeeeccc
Q 010434          258 RALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC--ILHFDIKPHNILLDHNFIPKVSDFG  335 (511)
Q Consensus       258 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~DIkp~NILl~~~~~~kl~DFG  335 (511)
                      .++||||+. |+|.+++.... ....+++..+..++.||+.||+|||+   .+  |+||||||+|||++.++.+||+|||
T Consensus       109 ~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          109 FLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             EEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             EEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecCc
Confidence            789999995 78888773321 23569999999999999999999998   57  9999999999999999999999999


Q ss_pred             ccccCCCCCCce----------eeccccCCccccchhcccc-cCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc
Q 010434          336 LAKFHPKENDFV----------SISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA  404 (511)
Q Consensus       336 la~~~~~~~~~~----------~~~~~~gt~~y~APE~~~~-~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~  404 (511)
                      +++.........          ......||+.|+|||++.. ....++.++||||||+++|||++|+.||.......   
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---  260 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---  260 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---
Confidence            998765433211          1113458999999999832 12367899999999999999999999986532211   


Q ss_pred             ccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCCCCCC
Q 010434          405 YFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPK  473 (511)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~~p~~  473 (511)
                              ...........      ...+..+.+++.+||+.||++|||+.++++.|+........++.
T Consensus       261 --------~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~  315 (337)
T 3ll6_A          261 --------IVNGKYSIPPH------DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK  315 (337)
T ss_dssp             -------------CCCCTT------CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTT
T ss_pred             --------hhcCcccCCcc------cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCC
Confidence                    00010000000      11123477899999999999999999999999987665444433

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=5.5e-40  Score=325.75  Aligned_cols=249  Identities=25%  Similarity=0.322  Sum_probs=195.4

Q ss_pred             ccccCcCCcEEEEEEEe-cCCcEEEEEEeccC-cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCc
Q 010434          193 THKLGQGGFGSVYKGQL-HTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL  270 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  270 (511)
                      ...||+|+||.||+|.. .+++.||||.+... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus        27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  106 (295)
T 2clq_A           27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL  106 (295)
T ss_dssp             BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred             cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence            34799999999999985 57899999998764 33467899999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC-CCCeeeecccccccCCCCCCceee
Q 010434          271 DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVSI  349 (511)
Q Consensus       271 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~  349 (511)
                      .+++... .....+++..+..++.|++.||+|||+   .+|+|+||||+||+++. ++.+||+|||+++.......  ..
T Consensus       107 ~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~  180 (295)
T 2clq_A          107 SALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CT  180 (295)
T ss_dssp             HHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------
T ss_pred             HHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--cc
Confidence            9988432 123457799999999999999999999   69999999999999987 89999999999987644321  12


Q ss_pred             ccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhH
Q 010434          350 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE  429 (511)
Q Consensus       350 ~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  429 (511)
                      ....||+.|+|||.+.+....++.++||||||+++|||++|+.||.......      ..............      .+
T Consensus       181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~~------~~  248 (295)
T 2clq_A          181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ------AAMFKVGMFKVHPE------IP  248 (295)
T ss_dssp             CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH------HHHHHHHHHCCCCC------CC
T ss_pred             cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh------HHHHhhcccccccc------cc
Confidence            3456899999999987643347899999999999999999999986432111      00111111111111      12


Q ss_pred             HHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          430 SVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       430 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ..++..+.+++.+||+.||++|||+.++++
T Consensus       249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          249 ESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            234567889999999999999999999985

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.7e-41  Score=338.61  Aligned_cols=261  Identities=23%  Similarity=0.349  Sum_probs=195.8

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCccc---HHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~---~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      .|.+.+.||+|+||.||+++.. +|+.||||++......   .+.+.+|+.++++++||||+++++++.+....++||||
T Consensus        26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  105 (331)
T 4aaa_A           26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF  105 (331)
T ss_dssp             GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence            4556689999999999999864 6899999998654332   45688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++++|.+++.    ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       106 ~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          106 VDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             CSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             CCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            99999988752    33569999999999999999999999   699999999999999999999999999998654432


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc-------ccchhhHHhhh--
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA-------YFPSWVYDQLN--  415 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~-------~~~~~~~~~~~--  415 (511)
                      .  ......||+.|+|||.+.+. ..++.++||||||+++|||++|+.||..........       ..+........  
T Consensus       179 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          179 E--VYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             c--ccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            2  22345689999999998753 367899999999999999999999987543221000       00000000000  


Q ss_pred             ---cCC-cccccc---cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          416 ---KGG-DLELRN---VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       416 ---~~~-~~~~~~---~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                         .+. ......   .......++..+.+++.+||+.||++|||+.++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence               000 000100   01111234678999999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.7e-40  Score=336.00  Aligned_cols=256  Identities=21%  Similarity=0.277  Sum_probs=189.3

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      .|.+.++||+|+||.||++.. .+|+.||||++.....   ..+.+.+|+.++++++||||+++++++.++...++||||
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  114 (329)
T 3gbz_A           35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY  114 (329)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence            456678999999999999984 5789999999975332   345688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEE-----cCCCCeeeeccccccc
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL-----DHNFIPKVSDFGLAKF  339 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl-----~~~~~~kl~DFGla~~  339 (511)
                      ++ |+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||+     +.++.+||+|||+++.
T Consensus       115 ~~-~~L~~~~~----~~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          115 AE-NDLKKYMD----KNPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             CS-EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             CC-CCHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            97 59988873    33569999999999999999999999   699999999999999     4555699999999987


Q ss_pred             CCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhc---
Q 010434          340 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK---  416 (511)
Q Consensus       340 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---  416 (511)
                      ......  ......||+.|+|||++.+. ..++.++||||||+++|||++|+.||.........    ..+...+..   
T Consensus       187 ~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----~~~~~~~~~~~~  259 (329)
T 3gbz_A          187 FGIPIR--QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL----FKIFEVLGLPDD  259 (329)
T ss_dssp             HC-------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHHHCCCCT
T ss_pred             cCCccc--ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH----HHHHHHhCCCch
Confidence            643322  22445689999999998753 35799999999999999999999998654321100    000000000   


Q ss_pred             -------------CCcccccc---cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          417 -------------GGDLELRN---VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       417 -------------~~~~~~~~---~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                                   ........   .......++..+.+++.+||+.||++|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                         00000000   00112224567889999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.6e-40  Score=330.71  Aligned_cols=260  Identities=22%  Similarity=0.320  Sum_probs=183.0

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      .+.+.+.||+|+||.||++.. .+++.||||++...  ....+++.+|+.++++++||||+++++++...+..++||||+
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   95 (303)
T 2vwi_A           16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLL   95 (303)
T ss_dssp             CCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECC
T ss_pred             hhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhc
Confidence            455678999999999999984 47899999998653  334567899999999999999999999999999999999999


Q ss_pred             CCCCcccccccC----CCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          266 PNGSLDRHIFPK----ENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       266 ~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      ++++|.+++...    ......+++..+..++.||+.||+|||+   .+|+|+||||+||+++.++.+||+|||+++...
T Consensus        96 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  172 (303)
T 2vwi_A           96 SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLA  172 (303)
T ss_dssp             TTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred             cCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence            999999987421    1134569999999999999999999999   699999999999999999999999999998665


Q ss_pred             CCCCc---eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCC
Q 010434          342 KENDF---VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG  418 (511)
Q Consensus       342 ~~~~~---~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  418 (511)
                      .....   .......||+.|+|||.+.+. ..++.++||||||+++|||++|+.||.......       ..........
T Consensus       173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~  244 (303)
T 2vwi_A          173 TGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMK-------VLMLTLQNDP  244 (303)
T ss_dssp             ---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-------HHHHHHTSSC
T ss_pred             cCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhh-------HHHHHhccCC
Confidence            43221   112334689999999998652 257899999999999999999999987543211       0111111110


Q ss_pred             c-ccc-cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          419 D-LEL-RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       419 ~-~~~-~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      . ... .........++..+.+++.+||+.||.+|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            0 000 0000111223467889999999999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=9.7e-40  Score=329.63  Aligned_cols=255  Identities=19%  Similarity=0.289  Sum_probs=197.3

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhcccc-ccceEEeeceecc--CCceeEEEee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSE--GSKRALVYEF  264 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~--~~~~~lV~e~  264 (511)
                      .+.+.++||+|+||.||+|.. .+++.||||+++..  ..+.+.+|+.++++++ ||||+++++++.+  ....++||||
T Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~  114 (330)
T 3nsz_A           37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH  114 (330)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred             ceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence            456678999999999999984 57899999998643  4578999999999997 9999999999987  6678999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC-CeeeecccccccCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKE  343 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~-~~kl~DFGla~~~~~~  343 (511)
                      +++++|.+++       ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++ .+||+|||+++.....
T Consensus       115 ~~~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          115 VNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             CCCCCHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             cCchhHHHHH-------HhCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            9999999887       358999999999999999999999   6999999999999999776 8999999999876543


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc------ccchhhHHhhhcC
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA------YFPSWVYDQLNKG  417 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~------~~~~~~~~~~~~~  417 (511)
                      ..   .....||..|+|||.+.+. ..++.++||||||+++|||++|+.|+..........      .-+....+.+...
T Consensus       185 ~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          185 QE---YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             CC---CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             Cc---cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence            32   2345689999999998653 468899999999999999999999984322110000      0000000101000


Q ss_pred             ---------------Ccccc--cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          418 ---------------GDLEL--RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       418 ---------------~~~~~--~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                                     .....  .........++..+.+++.+||+.||++|||++++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                           00000  0011122235678899999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.6e-40  Score=326.78  Aligned_cols=252  Identities=24%  Similarity=0.328  Sum_probs=192.0

Q ss_pred             HHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceecc------------
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE------------  254 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~------------  254 (511)
                      ..+.+.+.||+|+||.||+|+. .+|+.||||++.......+.+.+|+.++++++||||+++++++.+            
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK   85 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence            3556678999999999999985 479999999997765566789999999999999999999998754            


Q ss_pred             -CCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeec
Q 010434          255 -GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSD  333 (511)
Q Consensus       255 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~D  333 (511)
                       ....++||||+++|+|.+++..   ....+++..+..++.|++.||+|||+   .+|+|+||||+|||++.++.+||+|
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           86 KKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             cCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEee
Confidence             4678899999999999999842   34578899999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCCCC------------ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccc
Q 010434          334 FGLAKFHPKEND------------FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRS  401 (511)
Q Consensus       334 FGla~~~~~~~~------------~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~  401 (511)
                      ||+++.......            ........||+.|+|||.+.+. +.++.++||||||+++|||++   |+...... 
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~~-  234 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGMER-  234 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchhH-
Confidence            999986543211            1122344689999999998753 468899999999999999998   43321110 


Q ss_pred             cccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          402 SKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                            ......+..... ..  +.......+..+.+++.+||+.||.+|||+.++++
T Consensus       235 ------~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          235 ------VNILKKLRSVSI-EF--PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             ------HHHHHHHHSTTC-CC--CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------HHHHHhcccccc-cc--CccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence                  011122222111 11  11122334466889999999999999999999986

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.5e-40  Score=329.06  Aligned_cols=253  Identities=22%  Similarity=0.313  Sum_probs=185.3

Q ss_pred             HHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc--c-HHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF--S-AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~--~-~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      ..+.+.++||+|+||.||++.. .+|+.||||++.....  . .+.+.++...++.++||||+++++++.+++..++|||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e   86 (290)
T 3fme_A            7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME   86 (290)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred             HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence            3456678999999999999985 5799999999976322  2 2234455556888899999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCC-ceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM-CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      |++ |+|.+++......+..+++..+..++.|++.||+|||+   . +|+||||||+||+++.++.+||+|||+++....
T Consensus        87 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           87 LMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             CCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             hhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence            996 58877764333345789999999999999999999998   5 999999999999999999999999999986544


Q ss_pred             CCCceeeccccCCccccchhcccc--cCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcc
Q 010434          343 ENDFVSISATRGTIGYIAPELISR--NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDL  420 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~--~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (511)
                      ...   .....||+.|+|||.+..  ....++.++||||||+++|||++|+.|+.......      .......... ..
T Consensus       163 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~-~~  232 (290)
T 3fme_A          163 DVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF------QQLKQVVEEP-SP  232 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH------HHHHHHHHSC-CC
T ss_pred             ccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH------HHHHHHhccC-CC
Confidence            321   233469999999999732  12468899999999999999999999986422111      1111111111 11


Q ss_pred             cccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          421 ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       421 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ..     ....++..+.+++.+||+.||++|||+.++++
T Consensus       233 ~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          233 QL-----PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             CC-----CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             Cc-----ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            11     11223567889999999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.7e-40  Score=328.99  Aligned_cols=250  Identities=26%  Similarity=0.372  Sum_probs=198.1

Q ss_pred             HHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      ...+.+.++||+|+||.||+|... +|+.||||.+.... ..+.+.+|+.++++++||||+++++++......++||||+
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  106 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC  106 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence            344566789999999999999865 68999999997643 4568999999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++++|.+++.   .....+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++........
T Consensus       107 ~~~~L~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (314)
T 3com_A          107 GAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA  180 (314)
T ss_dssp             TTEEHHHHHH---HHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred             CCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence            9999999873   234679999999999999999999999   6999999999999999999999999999976543321


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                        ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.......        ..............  
T Consensus       181 --~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~--  246 (314)
T 3com_A          181 --KRNTVIGTPFWMAPEVIQEI--GYNCVADIWSLGITAIEMAEGKPPYADIHPMR--------AIFMIPTNPPPTFR--  246 (314)
T ss_dssp             --CBCCCCSCGGGCCHHHHSSS--CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSCCCCCS--
T ss_pred             --ccCccCCCCCccChhhcCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHhcCCCcccC--
Confidence              22345689999999998764  78899999999999999999999986532211        11111111111111  


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                        ....++..+.+++.+||+.||.+|||+.++++
T Consensus       247 --~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          247 --KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             --SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             --CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence              12223567889999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=9e-40  Score=332.35  Aligned_cols=256  Identities=21%  Similarity=0.294  Sum_probs=200.9

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCccc------------------HHHHHHHHHHhccccccceEEeec
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFS------------------AEEFINEVSTIGRIHHVNVVQLLG  250 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~------------------~~~f~~Ev~~l~~l~H~niv~l~g  250 (511)
                      .|.+.+.||+|+||.||++.. +|+.||||++......                  .+.|.+|+.++++++||||+++++
T Consensus        32 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~  110 (348)
T 2pml_X           32 DYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG  110 (348)
T ss_dssp             TEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred             ceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            456678999999999999998 8999999998653211                  178999999999999999999999


Q ss_pred             eeccCCceeEEEeecCCCCcccccc----cCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC
Q 010434          251 FCSEGSKRALVYEFMPNGSLDRHIF----PKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN  326 (511)
Q Consensus       251 ~~~~~~~~~lV~e~~~~gsL~~~l~----~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~  326 (511)
                      ++.+.+..++||||+++|+|.+++.    ........+++..+..++.|++.||+|||+.  .+|+|+||||+||+++.+
T Consensus       111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKN  188 (348)
T ss_dssp             EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT--SCEECCCCCGGGEEECTT
T ss_pred             EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhcc--CCEeecCCChHhEEEcCC
Confidence            9999999999999999999999831    1222257899999999999999999999972  599999999999999999


Q ss_pred             CCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCc-cchHHHHHHHHHHHHhCCCCCCcccccccccc
Q 010434          327 FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC-KSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY  405 (511)
Q Consensus       327 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~-ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~  405 (511)
                      +.+||+|||+++.....    ......||..|+|||.+.+. ..++. ++||||||+++|||++|+.||......     
T Consensus       189 ~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----  258 (348)
T 2pml_X          189 GRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-----  258 (348)
T ss_dssp             SCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-----
T ss_pred             CcEEEeccccccccccc----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-----
Confidence            99999999999865433    23456699999999998754 24455 999999999999999999998754321     


Q ss_pred             cchhhHHhhhcCCccccc------------ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          406 FPSWVYDQLNKGGDLELR------------NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       406 ~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                        ......+.........            ........++..+.+++.+||+.||.+|||+.++++
T Consensus       259 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 --VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             --HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             --HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              1111112111100000            000011335577899999999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6.1e-41  Score=345.79  Aligned_cols=241  Identities=16%  Similarity=0.158  Sum_probs=184.1

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEecc----CcccHHHHHHHH---HHhccccccceEEee-------ceecc
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLEN----SKFSAEEFINEV---STIGRIHHVNVVQLL-------GFCSE  254 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~----~~~~~~~f~~Ev---~~l~~l~H~niv~l~-------g~~~~  254 (511)
                      +.+.++||+|+||.||+|+. .+|+.||||++..    .....+.|.+|+   .++++++|||||+++       +++..
T Consensus        75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~  154 (377)
T 3byv_A           75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD  154 (377)
T ss_dssp             EEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEEC
T ss_pred             EEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhc
Confidence            44568899999999999995 5799999999964    233457899999   556666899999998       44443


Q ss_pred             CC-----------------ceeEEEeecCCCCcccccccCC---CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecc
Q 010434          255 GS-----------------KRALVYEFMPNGSLDRHIFPKE---NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHF  314 (511)
Q Consensus       255 ~~-----------------~~~lV~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~  314 (511)
                      .+                 ..++||||+ +|+|.+++....   .....+++..+..++.||+.||+|||+   .+|+||
T Consensus       155 ~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHr  230 (377)
T 3byv_A          155 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHT  230 (377)
T ss_dssp             TTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEECS
T ss_pred             cCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence            32                 378999999 689999884321   112345678999999999999999999   699999


Q ss_pred             cCCcCceEEcCCCCeeeecccccccCCCCCCceeeccccCCccccchhccccc---------CCCcCccchHHHHHHHHH
Q 010434          315 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN---------FGTVSCKSDVYGFGMVLL  385 (511)
Q Consensus       315 DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~---------~~~~s~ksDVwS~Gvll~  385 (511)
                      ||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.         ...++.++|||||||++|
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~  304 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY  304 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence            9999999999999999999999985332     2244557 999999998753         015789999999999999


Q ss_pred             HHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          386 EMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       386 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ||++|+.||.........    ..+    ...           ...++..+.+++.+||+.||++|||+.++++
T Consensus       305 elltg~~Pf~~~~~~~~~----~~~----~~~-----------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          305 WIWCADLPITKDAALGGS----EWI----FRS-----------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHSSCCC------CCS----GGG----GSS-----------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHCCCCCcccccccch----hhh----hhh-----------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            999999998654322110    001    000           0122466888999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.2e-40  Score=342.81  Aligned_cols=252  Identities=10%  Similarity=0.006  Sum_probs=177.6

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc----cHHHHHHHHHHhccc--cccceEEee-------ceeccC
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF----SAEEFINEVSTIGRI--HHVNVVQLL-------GFCSEG  255 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l--~H~niv~l~-------g~~~~~  255 (511)
                      +.+.++||+|+||.||+|.. .+|+.||||++.....    ..+.+.+|+.+++.+  +||||++++       +++...
T Consensus        64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~  143 (371)
T 3q60_A           64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ  143 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred             eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence            45678999999999999985 4789999999987432    345677885544444  699988855       333221


Q ss_pred             -----------------CceeEEEeecCCCCcccccccCCCcCCccCHHHH------HHHHHHHHHHHHHHHhCCCCcee
Q 010434          256 -----------------SKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKL------QEIALGTARGVAYLHNGCDMCIL  312 (511)
Q Consensus       256 -----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~~l~yLH~~~~~~iv  312 (511)
                                       ...++||||++ |+|.+++...   +..+.+..+      ..++.||+.||+|||+   .+|+
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~iv  216 (371)
T 3q60_A          144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLV  216 (371)
T ss_dssp             TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred             CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCc
Confidence                             34799999998 8999998432   234455566      7888999999999999   6999


Q ss_pred             cccCCcCceEEcCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCC
Q 010434          313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR  392 (511)
Q Consensus       313 H~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~  392 (511)
                      ||||||+|||++.++.+||+|||+++.....     .....+|+.|+|||++.+....++.++||||||+++|||++|+.
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999865422     12445779999999997632378999999999999999999999


Q ss_pred             CCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          393 NSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       393 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ||............ ...... .........    ....++..+.+++.+||+.||++|||+.++++
T Consensus       292 Pf~~~~~~~~~~~~-~~~~~~-~~~~~~~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          292 PFGLVTPGIKGSWK-RPSLRV-PGTDSLAFG----SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             STTBCCTTCTTCCC-BCCTTS-CCCCSCCCT----TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCcCcccccchh-hhhhhh-ccccccchh----hccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99765322111100 000000 000011111    11234567889999999999999999999975

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=9.1e-40  Score=343.08  Aligned_cols=198  Identities=25%  Similarity=0.327  Sum_probs=170.1

Q ss_pred             HHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccc------cccceEEeeceeccCCceeE
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRI------HHVNVVQLLGFCSEGSKRAL  260 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l------~H~niv~l~g~~~~~~~~~l  260 (511)
                      .+|.+.++||+|+||.||+|.. .+++.||||++.......+.+.+|+.+++.+      +|+||+++++++......++
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l  176 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM  176 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence            3466778999999999999985 4689999999987665667788899888887      57799999999999999999


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCC--eeeecccccc
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFI--PKVSDFGLAK  338 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~--~kl~DFGla~  338 (511)
                      ||||+. ++|.+++..  .....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.  +||+|||+++
T Consensus       177 v~e~~~-~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          177 TFELLS-MNLYELIKK--NKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EECCCC-CBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEeccC-CCHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            999995 688888743  223459999999999999999999999   69999999999999999987  9999999997


Q ss_pred             cCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccc
Q 010434          339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA  398 (511)
Q Consensus       339 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~  398 (511)
                      .....     .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||....
T Consensus       251 ~~~~~-----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          251 YEHQR-----VYTYIQSRFYRAPEVILGA--RYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             ETTCC-----CCSSCSCGGGCCHHHHHTB--CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ecCCc-----ccccCCCCCccChHHHhCC--CCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            65432     2345689999999999865  78999999999999999999999987543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=6.6e-40  Score=333.99  Aligned_cols=261  Identities=22%  Similarity=0.277  Sum_probs=195.2

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccC-----CceeE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRAL  260 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~-----~~~~l  260 (511)
                      .+.+.+.||+|+||.||+|... +|+.||||++....  .....+.+|+.++++++||||+++++++...     ...++
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   91 (353)
T 2b9h_A           12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI   91 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred             ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence            3456789999999999999864 78999999996532  2346788999999999999999999987654     67899


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      ||||++ |+|.+++.     ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        92 v~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           92 IQELMQ-TDLHRVIS-----TQMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             EECCCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEeccC-ccHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            999996 68888872     2469999999999999999999999   69999999999999999999999999999876


Q ss_pred             CCCCCce--------eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc-------
Q 010434          341 PKENDFV--------SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY-------  405 (511)
Q Consensus       341 ~~~~~~~--------~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~-------  405 (511)
                      .......        ......||+.|+|||++.+. +.++.++||||||+++|||++|+.||...........       
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            5332111        11234689999999987643 4788999999999999999999999975432110000       


Q ss_pred             ---------cc-hhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          406 ---------FP-SWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       406 ---------~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                               .. ....+...................++..+.+++.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                     00 0000000000000000011112235677889999999999999999999987

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.7e-40  Score=329.81  Aligned_cols=250  Identities=27%  Similarity=0.379  Sum_probs=193.6

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccc-cccceEEeeceecc------CCceeEE
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSE------GSKRALV  261 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~------~~~~~lV  261 (511)
                      +.+.+.||+|+||.||+|+. .+|+.||||++.......+.+.+|+.+++++ +||||+++++++..      ....++|
T Consensus        26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv  105 (326)
T 2x7f_A           26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV  105 (326)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEE
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEE
Confidence            45568999999999999985 5789999999987666778899999999999 89999999999866      4678999


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      |||+++|+|.+++...  ....+++..+..++.||+.||+|||+   .+|+|+||||+|||++.++.+||+|||++....
T Consensus       106 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  180 (326)
T 2x7f_A          106 MEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  180 (326)
T ss_dssp             EECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred             EEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence            9999999999988432  24579999999999999999999999   699999999999999999999999999987654


Q ss_pred             CCCCceeeccccCCccccchhccccc---CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCC
Q 010434          342 KENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG  418 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~---~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  418 (511)
                      ....  ......||+.|+|||.+...   ...++.++||||||+++|||++|+.|+.......        ....+....
T Consensus       181 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~  250 (326)
T 2x7f_A          181 RTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--------ALFLIPRNP  250 (326)
T ss_dssp             ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSC
T ss_pred             cCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--------HHHHhhcCc
Confidence            3221  12344689999999998621   2468899999999999999999999986432211        111111111


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          419 DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       419 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .....     ...++..+.+++.+||+.||.+|||+.++++
T Consensus       251 ~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          251 APRLK-----SKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             CCCCS-----CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cccCC-----ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            11111     1123467889999999999999999999987

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2e-40  Score=330.23  Aligned_cols=251  Identities=25%  Similarity=0.352  Sum_probs=195.4

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEecc-CcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLEN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .+.+.+.||+|+||.||+|... +|+.||+|++.. .....+.+.+|+.++++++||||+++++++..++..++||||++
T Consensus        20 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   99 (302)
T 2j7t_A           20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP   99 (302)
T ss_dssp             TEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCT
T ss_pred             ceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCC
Confidence            4566789999999999999965 689999999876 34467889999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +++|.+++..   ....+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.......  
T Consensus       100 ~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  171 (302)
T 2j7t_A          100 GGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--  171 (302)
T ss_dssp             TEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--
T ss_pred             CCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc--
Confidence            9999988732   24569999999999999999999999   699999999999999999999999999875321110  


Q ss_pred             eeeccccCCccccchhcccc---cCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          347 VSISATRGTIGYIAPELISR---NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~---~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      .......||+.|+|||.+..   ....++.++||||||+++|||++|+.|+.......        ..............
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~  243 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--------VLLKIAKSDPPTLL  243 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSCCCCCS
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH--------HHHHHhccCCcccC
Confidence            11133458999999999842   12467899999999999999999999986543211        11111111111111


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                          ....++..+.+++.+||+.||++|||+.++++
T Consensus       244 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          244 ----TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             ----SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ----CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                12233567889999999999999999999875

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.2e-39  Score=323.97  Aligned_cols=250  Identities=21%  Similarity=0.252  Sum_probs=200.3

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCc----------ccHHHHHHHHHHhcccc-ccceEEeeceeccCC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK----------FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGS  256 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~----------~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~  256 (511)
                      .+.+.++||+|+||.||++... +|+.||||++....          ...+.+.+|+.+++++. ||||+++++++..+.
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (298)
T 1phk_A           18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT   97 (298)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence            4456789999999999999864 78999999986532          12356889999999995 999999999999999


Q ss_pred             ceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccc
Q 010434          257 KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGL  336 (511)
Q Consensus       257 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGl  336 (511)
                      ..++||||+++++|.+++.    ....+++..+..++.||+.||+|||+   .+++|+||||+||+++.++.+||+|||+
T Consensus        98 ~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           98 FFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             EEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEeccCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccc
Confidence            9999999999999999883    23579999999999999999999999   6999999999999999999999999999


Q ss_pred             cccCCCCCCceeeccccCCccccchhccccc----CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHH
Q 010434          337 AKFHPKENDFVSISATRGTIGYIAPELISRN----FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYD  412 (511)
Q Consensus       337 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~  412 (511)
                      ++.......   .....||+.|+|||.+...    ...++.++||||||+++|||++|+.|+.......        ...
T Consensus       171 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~  239 (298)
T 1phk_A          171 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--------MLR  239 (298)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHH
T ss_pred             hhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH--------HHH
Confidence            987654332   2345689999999988531    2467889999999999999999999986532211        112


Q ss_pred             hhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          413 QLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       413 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .+..+....   .......++..+.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          240 MIMSGNYQF---GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHTCCCC---CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHhcCCccc---CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            222211110   01112234567889999999999999999999975

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=8.9e-40  Score=336.21  Aligned_cols=257  Identities=21%  Similarity=0.273  Sum_probs=180.1

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccC------Cce
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKR  258 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~------~~~  258 (511)
                      .|.+.+.||+|+||.||+|.. .+|+.||||++....   ...+.+.+|+.++++++||||+++++++...      ...
T Consensus        30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  109 (367)
T 2fst_X           30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV  109 (367)
T ss_dssp             TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred             ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence            345678999999999999984 578999999996532   2456788999999999999999999998653      567


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      ++|+|++ +++|.+++.     ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       110 ~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          110 YLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             EEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             EEEeccc-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            9999999 789998872     2579999999999999999999999   699999999999999999999999999998


Q ss_pred             cCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc------c-hh--
Q 010434          339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF------P-SW--  409 (511)
Q Consensus       339 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~------~-~~--  409 (511)
                      .....     .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||........-..+      + ..  
T Consensus       181 ~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          181 HTADE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             ccccc-----CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            65432     2345689999999998753 37889999999999999999999999754321100000      0 00  


Q ss_pred             -------hHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          410 -------VYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       410 -------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                             ....+..................+..+.+++.+||+.||++|||+.++++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence                   000000000000000011112235678899999999999999999999874

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.9e-39  Score=321.45  Aligned_cols=251  Identities=25%  Similarity=0.364  Sum_probs=203.5

Q ss_pred             HHHHHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccCCcee
Q 010434          184 EIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  259 (511)
Q Consensus       184 ei~~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~  259 (511)
                      ......|.+.++||+|+||.||+++.. +++.||||++...   ....+.+.+|+.++++++||||+++++++.+....+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            445567788899999999999999865 7899999998653   345678999999999999999999999999999999


Q ss_pred             EEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC---CCeeeecccc
Q 010434          260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN---FIPKVSDFGL  336 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~---~~~kl~DFGl  336 (511)
                      +|+||+++++|.+++.    ....+++..+..++.||+.||+|||+   .+++|+||||+||+++.+   +.+||+|||+
T Consensus        98 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           98 IVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            9999999999988873    23468999999999999999999999   699999999999999764   4799999999


Q ss_pred             cccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhc
Q 010434          337 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK  416 (511)
Q Consensus       337 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  416 (511)
                      ++.......   .....||+.|+|||.+.+   .++.++||||||+++|+|++|+.|+.......        +...+..
T Consensus       171 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~  236 (287)
T 2wei_A          171 STCFQQNTK---MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--------ILKRVET  236 (287)
T ss_dssp             GGTBCCCSS---CSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHH
T ss_pred             ceeecCCCc---cccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHc
Confidence            986654332   223358899999999864   57899999999999999999999986543211        1222222


Q ss_pred             CCc-ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          417 GGD-LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       417 ~~~-~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      +.. ....    ....++..+.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          237 GKYAFDLP----QWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CCCCCCSG----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCch----hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            211 1111    11234567889999999999999999999987

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=8.2e-40  Score=330.21  Aligned_cols=260  Identities=24%  Similarity=0.323  Sum_probs=201.7

Q ss_pred             HHHhhhccccCcCCcEEEEEEEe--cCCcEEEEEEeccCcccHHHHHHHHHHhccccccc------eEEeeceeccCCce
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQL--HTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVN------VVQLLGFCSEGSKR  258 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~--~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~n------iv~l~g~~~~~~~~  258 (511)
                      ...|.+.++||+|+||.||++..  .+++.||||+++......+.+.+|+.+++.++|+|      ++++++++...+..
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            34567788999999999999985  36899999999876656678999999999998775      99999999999999


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC-------------
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH-------------  325 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~-------------  325 (511)
                      ++||||+ +++|.+++..  .....+++..+..++.||+.||+|||+   .+|+||||||+|||++.             
T Consensus        93 ~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKE--NGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEcCC-CCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            9999999 8999988832  223468999999999999999999999   69999999999999987             


Q ss_pred             ------CCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccc
Q 010434          326 ------NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAI  399 (511)
Q Consensus       326 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~  399 (511)
                            ++.+||+|||+++......     ....||+.|+|||++.+.  .++.++||||||+++|||++|+.||.....
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILAL--GWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             ccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                  6789999999998654332     345689999999999764  789999999999999999999999975432


Q ss_pred             cccc-------cccchhhHHhhhcCC-----c-----------------ccccccchhHHHHHHHHHHHHHHhcCcCCCC
Q 010434          400 RSSK-------AYFPSWVYDQLNKGG-----D-----------------LELRNVTEIESVIARKLCMIGLWCIQVKAAD  450 (511)
Q Consensus       400 ~~~~-------~~~~~~~~~~~~~~~-----~-----------------~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~  450 (511)
                      ....       ..++...........     .                 .............+..+.+++.+||+.||++
T Consensus       240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence            2100       011111111000000     0                 0000001112345678999999999999999


Q ss_pred             CCCHHHHHH
Q 010434          451 RPSMTKVLE  459 (511)
Q Consensus       451 RPs~~evl~  459 (511)
                      |||+.|+++
T Consensus       320 Rpt~~ell~  328 (339)
T 1z57_A          320 RITLREALK  328 (339)
T ss_dssp             SCCHHHHTT
T ss_pred             ccCHHHHhc
Confidence            999999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=8.1e-40  Score=335.72  Aligned_cols=262  Identities=18%  Similarity=0.218  Sum_probs=197.1

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccC-----CceeE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRAL  260 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~-----~~~~l  260 (511)
                      .|.+.++||+|+||.||++.. .+++.||||++....  ...+.+.+|+.++.+++||||+++++++...     ...++
T Consensus        28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  107 (364)
T 3qyz_A           28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI  107 (364)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence            456678999999999999985 478899999997532  2346799999999999999999999998654     46899


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      ||||++ |+|.+++.     ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       108 v~e~~~-~~L~~~l~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          108 VQDLME-TDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEECCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEcccC-cCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            999996 58888772     2469999999999999999999999   69999999999999999999999999999876


Q ss_pred             CCCCCcee-eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc--------chhh-
Q 010434          341 PKENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF--------PSWV-  410 (511)
Q Consensus       341 ~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~--------~~~~-  410 (511)
                      ........ .....||+.|+|||++.+. ..++.++||||||+++|||++|+.||...........+        .... 
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred             CCCCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            54322211 2344699999999987643 35889999999999999999999999654322110000        0000 


Q ss_pred             -------HHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          411 -------YDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       411 -------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                             .....................++..+.+++.+||+.||++|||+.++++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                   00000000000000011112345678899999999999999999999873

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6.5e-40  Score=335.59  Aligned_cols=260  Identities=20%  Similarity=0.223  Sum_probs=189.0

Q ss_pred             hhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcc------------cHHHHHHHHHHhccccccceEEeeceec----
Q 010434          190 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKF------------SAEEFINEVSTIGRIHHVNVVQLLGFCS----  253 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~------------~~~~f~~Ev~~l~~l~H~niv~l~g~~~----  253 (511)
                      |.+.++||+|+||.||+|...+|+.||||++.....            ..+.+.+|+.++++++||||+++++++.    
T Consensus        24 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (362)
T 3pg1_A           24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEE  103 (362)
T ss_dssp             CEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCT
T ss_pred             eEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccC
Confidence            345689999999999999988899999999854221            1368999999999999999999999983    


Q ss_pred             -cCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeee
Q 010434          254 -EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVS  332 (511)
Q Consensus       254 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~  332 (511)
                       .....++||||++ |+|.+++.   .....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+
T Consensus       104 ~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~  176 (362)
T 3pg1_A          104 PAMHKLYLVTELMR-TDLAQVIH---DQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITIC  176 (362)
T ss_dssp             TTCCEEEEEEECCS-EEHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCcceEEEEEccCC-CCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCCEEEE
Confidence             3446799999997 68877773   234579999999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc------
Q 010434          333 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF------  406 (511)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~------  406 (511)
                      |||+++......   ......||+.|+|||.+.+. ..++.++||||||+++|||++|+.||...........+      
T Consensus       177 Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  252 (362)
T 3pg1_A          177 DFNLAREDTADA---NKTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT  252 (362)
T ss_dssp             CTTC------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             ecCccccccccc---ccceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence            999997543332   22345689999999998753 36889999999999999999999999754321100000      


Q ss_pred             ---ch-------hhHHhhhcCC-cccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          407 ---PS-------WVYDQLNKGG-DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       407 ---~~-------~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                         ..       ...+.+.... ..............+..+.+++.+||+.||++|||+.++++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence               00       0000000000 000011111222335678899999999999999999999863

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.4e-39  Score=357.81  Aligned_cols=244  Identities=23%  Similarity=0.277  Sum_probs=201.2

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC----cccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEe
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS----KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      +.+.++||+|+||.||+++.. +++.||||+++..    ....+.+..|..++..+ +||||+++++++.+....+||||
T Consensus       343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E  422 (674)
T 3pfq_A          343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME  422 (674)
T ss_dssp             EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEE
T ss_pred             eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEe
Confidence            455678999999999999854 6889999999752    33456788999999988 79999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++|+|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+++.....
T Consensus       423 ~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          423 YVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  495 (674)
T ss_dssp             CCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred             CcCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence            999999999883    33579999999999999999999999   69999999999999999999999999999864333


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      ..  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||......        .+...+..... .  
T Consensus       496 ~~--~~~~~~GT~~Y~APE~l~~~--~~~~~~DvwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~~~~-~--  560 (674)
T 3pfq_A          496 GV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIMEHNV-A--  560 (674)
T ss_dssp             TC--CBCCCCSCSSSCCHHHHTCC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHSSCC-C--
T ss_pred             Cc--ccccccCCCcccCHhhhcCC--CCCccceEechHHHHHHHHcCCCCCCCCCHH--------HHHHHHHhCCC-C--
Confidence            22  23456799999999999765  7899999999999999999999999754321        12333333211 1  


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCH-----HHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSM-----TKVLE  459 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~-----~evl~  459 (511)
                          .+..++..+.+++.+||+.||++||++     .+|++
T Consensus       561 ----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          561 ----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             ----CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             ----CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                122345778899999999999999997     77764

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2e-39  Score=332.75  Aligned_cols=260  Identities=19%  Similarity=0.303  Sum_probs=197.7

Q ss_pred             HHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhcccc-----------ccceEEeeceeccC
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIH-----------HVNVVQLLGFCSEG  255 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~-----------H~niv~l~g~~~~~  255 (511)
                      ..|.+.++||+|+||.||+|+. .+++.||||++.......+.+.+|+.++++++           |+||+++++++...
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~   98 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   98 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence            4566788999999999999985 57899999999876666778999999999886           89999999998754


Q ss_pred             C----ceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCC-ceecccCCcCceEEc------
Q 010434          256 S----KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM-CILHFDIKPHNILLD------  324 (511)
Q Consensus       256 ~----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~DIkp~NILl~------  324 (511)
                      .    ..++||||+ +++|.+++...  ....+++..+..++.||+.||+|||+   . +|+||||||+|||++      
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           99 GPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             ETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTT
T ss_pred             CCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCc
Confidence            4    789999999 89999988432  23569999999999999999999998   5 999999999999994      


Q ss_pred             CCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc
Q 010434          325 HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA  404 (511)
Q Consensus       325 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~  404 (511)
                      .++.+||+|||+++.....     .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||..........
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  245 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  245 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence            4458999999999866432     2344689999999999865  68999999999999999999999997543211100


Q ss_pred             -------------ccchhhHHh-------hhcC------Ccccc-------cccchhHHHHHHHHHHHHHHhcCcCCCCC
Q 010434          405 -------------YFPSWVYDQ-------LNKG------GDLEL-------RNVTEIESVIARKLCMIGLWCIQVKAADR  451 (511)
Q Consensus       405 -------------~~~~~~~~~-------~~~~------~~~~~-------~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R  451 (511)
                                   ..|......       ....      .....       ..........+..+.+++.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  325 (373)
T 1q8y_A          246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  325 (373)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence                         001110000       0000      00000       00011335677889999999999999999


Q ss_pred             CCHHHHHHH
Q 010434          452 PSMTKVLEM  460 (511)
Q Consensus       452 Ps~~evl~~  460 (511)
                      ||+.++++.
T Consensus       326 pt~~ell~h  334 (373)
T 1q8y_A          326 ADAGGLVNH  334 (373)
T ss_dssp             BCHHHHHTC
T ss_pred             CCHHHHhhC
Confidence            999999873

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.4e-39  Score=332.13  Aligned_cols=257  Identities=21%  Similarity=0.230  Sum_probs=188.8

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCC------ce
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS------KR  258 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~------~~  258 (511)
                      .|.+.++||+|+||.||++.. .+|+.||||++....   ...+.+.+|+.++++++||||+++++++....      ..
T Consensus        26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  105 (371)
T 2xrw_A           26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV  105 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred             heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence            345678999999999999985 478999999997633   23467889999999999999999999987654      67


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      ++||||++ |+|.+.+.      ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       106 ~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          106 YIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             EEEEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            99999996 57777662      358999999999999999999999   699999999999999999999999999998


Q ss_pred             cCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccc--------ccccc---
Q 010434          339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSS--------KAYFP---  407 (511)
Q Consensus       339 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~--------~~~~~---  407 (511)
                      ......   ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||........        ....+   
T Consensus       176 ~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          176 TAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  250 (371)
T ss_dssp             -----------------CTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred             cccccc---ccCCceecCCccCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            654322   22345689999999999864  788999999999999999999999975432110        00000   


Q ss_pred             ----hhhHHhhhcCCc------------ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          408 ----SWVYDQLNKGGD------------LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       408 ----~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                          ............            .......+.....+..+.+++.+||+.||++|||+.++++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                000000001000            00011112334457789999999999999999999999873

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.1e-39  Score=346.67  Aligned_cols=260  Identities=18%  Similarity=0.261  Sum_probs=202.3

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccccc-cceEEeeceeccCCceeEEEeecC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIHH-VNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .|.+.++||+|+||.||+|+. .+++.||||++.... ..+++.+|+.++..++| +++..+..++.++...+|||||+ 
T Consensus         8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-   85 (483)
T 3sv0_A            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-   85 (483)
T ss_dssp             TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence            355678999999999999985 579999999886533 23468899999999976 56666666777888899999999 


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEE---cCCCCeeeecccccccCCCC
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl---~~~~~~kl~DFGla~~~~~~  343 (511)
                      +++|.+++..   ....+++..++.|+.||+.||+|||+   .+|+||||||+||||   +.++.+||+|||+++.....
T Consensus        86 g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           86 GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            9999998832   24579999999999999999999999   699999999999999   68899999999999876544


Q ss_pred             CCce-----eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCC
Q 010434          344 NDFV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG  418 (511)
Q Consensus       344 ~~~~-----~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  418 (511)
                      ....     ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||...........+.........   
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~---  234 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA---  234 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH---
T ss_pred             ccccccccccccccCCCccccCHHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc---
Confidence            3221     12355699999999999875  7899999999999999999999999764322211111111111110   


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          419 DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       419 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                          .........++..+.+++..||+.+|++||++.+|+++|+...
T Consensus       235 ----~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~  277 (483)
T 3sv0_A          235 ----TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF  277 (483)
T ss_dssp             ----SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             ----ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence                0011122334578899999999999999999999999987653

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.2e-39  Score=333.48  Aligned_cols=256  Identities=22%  Similarity=0.297  Sum_probs=192.4

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccCCce------
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR------  258 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~------  258 (511)
                      +|.+.++||+|+||.||+|.. .+|+.||||++.....   ..+.+.+|+.++++++||||+++++++......      
T Consensus        43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  122 (371)
T 4exu_A           43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF  122 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred             cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence            345568899999999999985 4789999999976332   346789999999999999999999999877655      


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      ++||||++ ++|.+++      ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       123 ~lv~e~~~-~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          123 YLVMPFMQ-TDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             EEEEECCC-EEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             EEEEcccc-ccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence            99999996 6887766      2349999999999999999999999   699999999999999999999999999998


Q ss_pred             cCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc-------chhh-
Q 010434          339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF-------PSWV-  410 (511)
Q Consensus       339 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~-------~~~~-  410 (511)
                      .....     .....||+.|+|||.+.+. ..++.++||||||+++|||++|+.||............       +... 
T Consensus       193 ~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          193 HADAE-----MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  266 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccccC-----cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence            55332     2445689999999998753 37889999999999999999999999754321100000       0000 


Q ss_pred             --------HHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          411 --------YDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       411 --------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                              .....................++..+.+++.+||+.||++|||+.++++.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                    00000000000001111122346788999999999999999999999864

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3e-40  Score=341.41  Aligned_cols=260  Identities=18%  Similarity=0.211  Sum_probs=192.7

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceecc-------------
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-------------  254 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~-------------  254 (511)
                      .|.+.++||+|+||.||++.. .+|+.||||++..+..   ...+|+.++++++||||+++++++..             
T Consensus         8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~   84 (383)
T 3eb0_A            8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD   84 (383)
T ss_dssp             TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred             eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence            456678999999999999985 5799999999865432   23479999999999999999999843             


Q ss_pred             -------------------------CCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCC
Q 010434          255 -------------------------GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM  309 (511)
Q Consensus       255 -------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~  309 (511)
                                               ....++||||++ |+|.+.+......+..+++..+..++.||+.||+|||+   .
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~  160 (383)
T 3eb0_A           85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---L  160 (383)
T ss_dssp             -------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             ccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---C
Confidence                                     334789999997 58777764333445789999999999999999999998   6


Q ss_pred             ceecccCCcCceEEc-CCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHH
Q 010434          310 CILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA  388 (511)
Q Consensus       310 ~ivH~DIkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ell  388 (511)
                      +|+||||||+|||++ .++.+||+|||+++.......   .....+|+.|+|||.+.+. ..++.++||||+|+++|||+
T Consensus       161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell  236 (383)
T 3eb0_A          161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGELI  236 (383)
T ss_dssp             TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHHHHH
T ss_pred             cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHHHHH
Confidence            999999999999998 688999999999986644332   2345689999999998754 35899999999999999999


Q ss_pred             hCCCCCCccccccccccc--------chhhHHhhhcCCcccccc--c----chhHHHHHHHHHHHHHHhcCcCCCCCCCH
Q 010434          389 GGRRNSNMNAIRSSKAYF--------PSWVYDQLNKGGDLELRN--V----TEIESVIARKLCMIGLWCIQVKAADRPSM  454 (511)
Q Consensus       389 tg~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~--~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~  454 (511)
                      +|+.||........-..+        .......-..........  .    ...+...+..+.+++.+||+.||++|||+
T Consensus       237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  316 (383)
T 3eb0_A          237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP  316 (383)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence            999999754322100000        000000000000000000  0    00122245678999999999999999999


Q ss_pred             HHHHH
Q 010434          455 TKVLE  459 (511)
Q Consensus       455 ~evl~  459 (511)
                      .|+++
T Consensus       317 ~e~l~  321 (383)
T 3eb0_A          317 YEAMA  321 (383)
T ss_dssp             HHHHT
T ss_pred             HHHhc
Confidence            99985

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.6e-40  Score=328.04  Aligned_cols=261  Identities=21%  Similarity=0.252  Sum_probs=188.9

Q ss_pred             HhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccC-cccHHHHHHHHHHhccccccceEEeeceec-------------
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCS-------------  253 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~-------------  253 (511)
                      .|.+.++||+|+||.||+|... +|+.||||++... ....+.+.+|+.++++++||||+++++++.             
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   91 (320)
T 2i6l_A           12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL   91 (320)
T ss_dssp             TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred             ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence            3455689999999999999865 5899999998763 334578999999999999999999998873             


Q ss_pred             -cCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEc-CCCCeee
Q 010434          254 -EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD-HNFIPKV  331 (511)
Q Consensus       254 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~-~~~~~kl  331 (511)
                       +....++||||++ |+|.+++.     ...+++..+..++.|++.||+|||+   .+|+||||||+|||++ +++.+||
T Consensus        92 ~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           92 TELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             CSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEE
T ss_pred             cccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEE
Confidence             4467899999997 69998872     3568999999999999999999999   6999999999999997 5679999


Q ss_pred             ecccccccCCCCCCc-eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc-----
Q 010434          332 SDFGLAKFHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY-----  405 (511)
Q Consensus       332 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~-----  405 (511)
                      +|||+++........ .......+|..|+|||.+.+. ..++.++||||||+++|||++|+.||...........     
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI  241 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            999999865432211 122344579999999988653 3788999999999999999999999975432110000     


Q ss_pred             --cchhhHHhhhcC--------CcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          406 --FPSWVYDQLNKG--------GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       406 --~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                        ........+...        ..............++..+.+++.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence              000000000000        000000001112234678899999999999999999999987

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.2e-39  Score=359.15  Aligned_cols=255  Identities=23%  Similarity=0.359  Sum_probs=201.0

Q ss_pred             HHHhhhccccCcCCcEEEEEEEec----CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeE
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  260 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~~----~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  260 (511)
                      ...+.+.+.||+|+||.||+|...    .+..||||+++...  ...+.|.+|+.++++++||||+++++++.+ +..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence            345566788999999999999853    25689999987532  234689999999999999999999999854 56899


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      ||||+++|+|.+++.   ..+..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       468 v~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          468 IMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             EEECCTTCBHHHHHH---HTTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             EEEcCCCCcHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            999999999999883   233569999999999999999999999   69999999999999999999999999999876


Q ss_pred             CCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      ...... ......+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||.......        +...+..+..
T Consensus       542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--------~~~~i~~~~~  610 (656)
T 2j0j_A          542 EDSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGER  610 (656)
T ss_dssp             CC-----------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHHTCC
T ss_pred             CCCcce-eccCCCCCcceeCHHHhcCC--CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHcCCC
Confidence            543322 22344578899999999764  78999999999999999997 888986533211        2222333322


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                      ...      +..++..+.+++.+||+.||++|||+.++++.|+...
T Consensus       611 ~~~------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          611 LPM------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             CCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCC------CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            221      1224567889999999999999999999999998654

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.5e-39  Score=335.85  Aligned_cols=263  Identities=19%  Similarity=0.259  Sum_probs=179.8

Q ss_pred             ccccCcCCcEEEEEEEec---CCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeecee--ccCCceeEEEeecCC
Q 010434          193 THKLGQGGFGSVYKGQLH---TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC--SEGSKRALVYEFMPN  267 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~~---~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~--~~~~~~~lV~e~~~~  267 (511)
                      .++||+|+||.||+|+..   +++.||||++..... .+.+.+|+.++++++||||+++++++  ..+...++||||++ 
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-  103 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-  103 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-
Confidence            358999999999999854   578999999976443 35788999999999999999999999  45778999999996 


Q ss_pred             CCcccccccCC-----CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEE----cCCCCeeeecccccc
Q 010434          268 GSLDRHIFPKE-----NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL----DHNFIPKVSDFGLAK  338 (511)
Q Consensus       268 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl----~~~~~~kl~DFGla~  338 (511)
                      |+|.+++....     .....+++..+..++.||+.||+|||+   .+|+||||||+|||+    +.++.+||+|||+++
T Consensus       104 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  180 (405)
T 3rgf_A          104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  180 (405)
T ss_dssp             EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred             CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence            57776663211     122359999999999999999999999   699999999999999    778999999999998


Q ss_pred             cCCCCCCc-eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccc--cccccchhhHH---
Q 010434          339 FHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRS--SKAYFPSWVYD---  412 (511)
Q Consensus       339 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~--~~~~~~~~~~~---  412 (511)
                      ........ .......||+.|+|||++.+. ..++.++|||||||++|||++|+.||.......  ........+..   
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~  259 (405)
T 3rgf_A          181 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  259 (405)
T ss_dssp             ----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred             ecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence            76543211 223445689999999998763 358999999999999999999999996543211  00000000000   


Q ss_pred             hhhcCCcc---ccc-----------------ccchhHH-------HHHHHHHHHHHHhcCcCCCCCCCHHHHHHHH
Q 010434          413 QLNKGGDL---ELR-----------------NVTEIES-------VIARKLCMIGLWCIQVKAADRPSMTKVLEML  461 (511)
Q Consensus       413 ~~~~~~~~---~~~-----------------~~~~~~~-------~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L  461 (511)
                      .+......   ...                 .......       ..+..+.+|+.+||+.||++|||+.|+++.-
T Consensus       260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp  335 (405)
T 3rgf_A          260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP  335 (405)
T ss_dssp             HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence            00000000   000                 0000000       0145678999999999999999999999743

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.7e-39  Score=323.33  Aligned_cols=251  Identities=20%  Similarity=0.301  Sum_probs=191.8

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcc---cHHHHHHHHHHhcccc--ccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKF---SAEEFINEVSTIGRIH--HVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~--H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .|.+.++||+|+||.||++...+++.||||++.....   ..+.+.+|+.++.+++  |+||+++++++..+...++|||
T Consensus        29 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e  108 (313)
T 3cek_A           29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME  108 (313)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC
T ss_pred             eEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe
Confidence            3556789999999999999988899999999965432   4467899999999997  4999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                       +.+++|.+++.    ....+++..+..++.|++.||+|||+   .+|+||||||+|||+++ +.+||+|||+++.....
T Consensus       109 -~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          109 -CGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             -CCSEEHHHHHH----HCSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred             -cCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence             56889999883    33578999999999999999999999   69999999999999965 89999999999876544


Q ss_pred             CCceeeccccCCccccchhccccc---------CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhh
Q 010434          344 NDFVSISATRGTIGYIAPELISRN---------FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQL  414 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~---------~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  414 (511)
                      ..........||+.|+|||.+.+.         ...++.++||||||+++|||++|+.||.......      .......
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------~~~~~~~  253 (313)
T 3cek_A          180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAII  253 (313)
T ss_dssp             ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH------HHHHHHH
T ss_pred             cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH------HHHHHHH
Confidence            332223445699999999998641         1367889999999999999999999986432110      1111112


Q ss_pred             hcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          415 NKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       415 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      ..........      ..+..+.+++.+||+.||++|||+.++++.
T Consensus       254 ~~~~~~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          254 DPNHEIEFPD------IPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             CTTSCCCCCC------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hcccccCCcc------cchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            1111111111      123568889999999999999999999874

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2e-39  Score=331.27  Aligned_cols=264  Identities=23%  Similarity=0.251  Sum_probs=186.3

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCc-------eeE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK-------RAL  260 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~-------~~l  260 (511)
                      .+.+.++||+|+||.||+|+. .+|+.||||++..+......+.+++..+..++||||+++++++.....       .++
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~l  103 (360)
T 3e3p_A           24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNV  103 (360)
T ss_dssp             TEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEE
Confidence            455568999999999999986 478999999987765556678889999999999999999999865333       789


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHH--hCCCCceecccCCcCceEEcC-CCCeeeeccccc
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH--NGCDMCILHFDIKPHNILLDH-NFIPKVSDFGLA  337 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--~~~~~~ivH~DIkp~NILl~~-~~~~kl~DFGla  337 (511)
                      ||||+++ +|...+.........+++..+..++.|++.||.|||  +   .+|+||||||+|||++. ++.+||+|||++
T Consensus       104 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a  179 (360)
T 3e3p_A          104 VMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCDFGSA  179 (360)
T ss_dssp             EEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence            9999976 444433222234567899999999999999999999  6   69999999999999997 899999999999


Q ss_pred             ccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc-------chhh
Q 010434          338 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF-------PSWV  410 (511)
Q Consensus       338 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~-------~~~~  410 (511)
                      +.......   .....||+.|+|||++.+. ..++.++||||||+++|||++|+.||...........+       +...
T Consensus       180 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (360)
T 3e3p_A          180 KKLSPSEP---NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV  255 (360)
T ss_dssp             BCCCTTSC---CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             eecCCCCC---cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence            87654332   2345689999999998654 35899999999999999999999999764322100000       0000


Q ss_pred             HHhhhcC-Ccccccc--c-------chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          411 YDQLNKG-GDLELRN--V-------TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       411 ~~~~~~~-~~~~~~~--~-------~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      ...+... .......  .       .......+..+.+++.+||+.||.+|||+.++++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            0111000 0000000  0       00111145678999999999999999999999863

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6.7e-39  Score=327.26  Aligned_cols=255  Identities=22%  Similarity=0.285  Sum_probs=191.6

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccCCc------ee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK------RA  259 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~------~~  259 (511)
                      |.+.+.||+|+||.||+|.. .+|+.||||++.....   ..+.+.+|+.++++++||||+++++++.....      .+
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~  105 (353)
T 3coi_A           26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY  105 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred             EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence            45568899999999999985 4799999999976332   34678999999999999999999999977654      49


Q ss_pred             EEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      +||||++ ++|.+++.      ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       106 lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          106 LVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             EEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             EEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence            9999996 68888761      359999999999999999999999   6999999999999999999999999999986


Q ss_pred             CCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc--------cchhh-
Q 010434          340 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY--------FPSWV-  410 (511)
Q Consensus       340 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~--------~~~~~-  410 (511)
                      ....     .....+|+.|+|||.+.+. ..++.++||||||+++|||++|+.||...........        -..+. 
T Consensus       176 ~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  249 (353)
T 3coi_A          176 ADAE-----MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  249 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred             CCCC-----ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            4332     2345689999999998753 3688999999999999999999999875432110000        00000 


Q ss_pred             -------HHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          411 -------YDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       411 -------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                             ...+.................++..+.+++.+||+.||++|||+.++++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                   00000000000001111222346778999999999999999999999863

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.7e-39  Score=326.99  Aligned_cols=256  Identities=23%  Similarity=0.344  Sum_probs=194.9

Q ss_pred             HhhhccccCcCCcEEEEEEEe--cCCcEEEEEEeccCc---ccHHHHHHHHHHhccc---cccceEEeeceec-----cC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL--HTGRLIAVKMLENSK---FSAEEFINEVSTIGRI---HHVNVVQLLGFCS-----EG  255 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~--~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l---~H~niv~l~g~~~-----~~  255 (511)
                      .|.+.++||+|+||.||++..  .+|+.||||++....   .....+.+|+.+++++   +||||+++++++.     ..
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   91 (326)
T 1blx_A           12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   91 (326)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred             ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence            355678999999999999986  468899999986532   2234577788777766   8999999999987     56


Q ss_pred             CceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccc
Q 010434          256 SKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFG  335 (511)
Q Consensus       256 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFG  335 (511)
                      ...++||||++ |+|.+++...  ....+++..+..++.|++.||+|||+   .+|+|+||||+|||++.++.+||+|||
T Consensus        92 ~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           92 TKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             EEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             ceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCc
Confidence            77899999997 6999887432  23459999999999999999999999   699999999999999999999999999


Q ss_pred             ccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhh
Q 010434          336 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLN  415 (511)
Q Consensus       336 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  415 (511)
                      +++......   ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.........    ..+.+.+.
T Consensus       166 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~i~~~~~  236 (326)
T 1blx_A          166 LARIYSFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL----GKILDVIG  236 (326)
T ss_dssp             SCCCCCGGG---GGCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHHHC
T ss_pred             ccccccCCC---CccccccccceeCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH----HHHHHHcC
Confidence            998654322   22345689999999998764  7899999999999999999999998754321100    00000000


Q ss_pred             cC----------------CcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          416 KG----------------GDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       416 ~~----------------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ..                ..............++..+.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00                000000111122335567889999999999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.7e-40  Score=327.23  Aligned_cols=245  Identities=24%  Similarity=0.354  Sum_probs=190.2

Q ss_pred             HHHHHHHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc-------cHHHHHHHHHHhccc----cccceEEeec
Q 010434          183 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF-------SAEEFINEVSTIGRI----HHVNVVQLLG  250 (511)
Q Consensus       183 ~ei~~~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~-------~~~~f~~Ev~~l~~l----~H~niv~l~g  250 (511)
                      .+.....|.+.++||+|+||.||+|+. .+++.||||++.....       ....+.+|+.++.++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            345556777889999999999999985 5789999999966432       223466799999988    8999999999


Q ss_pred             eeccCCceeEEEee-cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEc-CCCC
Q 010434          251 FCSEGSKRALVYEF-MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD-HNFI  328 (511)
Q Consensus       251 ~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~-~~~~  328 (511)
                      ++...+..++|+|+ +++++|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+||+++ .++.
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~  178 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYIT----EKGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGC  178 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCe
Confidence            99999999999999 78999999883    23569999999999999999999999   6999999999999999 8899


Q ss_pred             eeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccch
Q 010434          329 PKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPS  408 (511)
Q Consensus       329 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~  408 (511)
                      +||+|||+++......    .....||..|+|||.+.+. ...+.++||||||+++|||++|+.||......        
T Consensus       179 ~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------  245 (312)
T 2iwi_A          179 AKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQEI--------  245 (312)
T ss_dssp             EEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------
T ss_pred             EEEEEcchhhhcccCc----ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChHHH--------
Confidence            9999999998765432    2345689999999998754 23356899999999999999999998643210        


Q ss_pred             hhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          409 WVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       409 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                           ....  ..      ....++..+.+++.+||+.||++|||+.++++.
T Consensus       246 -----~~~~--~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          246 -----LEAE--LH------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             -----HHTC--CC------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -----hhhc--cC------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0000  00      111234568899999999999999999999973

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=6.3e-39  Score=326.04  Aligned_cols=260  Identities=22%  Similarity=0.295  Sum_probs=198.7

Q ss_pred             HHHhhhccccCcCCcEEEEEEEec-CC-cEEEEEEeccCcccHHHHHHHHHHhccccccc------eEEeeceeccCCce
Q 010434          187 AVTNHFTHKLGQGGFGSVYKGQLH-TG-RLIAVKMLENSKFSAEEFINEVSTIGRIHHVN------VVQLLGFCSEGSKR  258 (511)
Q Consensus       187 ~~t~~~~~~LG~G~fg~Vykg~~~-~g-~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~n------iv~l~g~~~~~~~~  258 (511)
                      ...|.+.++||+|+||.||++... ++ +.||||+++......+.+.+|+.++++++|+|      ++.+.+++......
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~   97 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM   97 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence            445677889999999999999854 34 79999999876656678999999999998877      89999999999999


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEE---------------
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILL---------------  323 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl---------------  323 (511)
                      ++||||+ +++|.+++..  .....+++..+..++.||+.||+|||+   .+|+||||||+|||+               
T Consensus        98 ~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           98 CIAFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccc
Confidence            9999999 6666666532  223579999999999999999999998   699999999999999               


Q ss_pred             ----cCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccc
Q 010434          324 ----DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAI  399 (511)
Q Consensus       324 ----~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~  399 (511)
                          +.++.+||+|||+++......     ....||+.|+|||++.+.  .++.++||||||+++|||++|+.||.....
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILEL--GWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecC--CCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                678899999999998654332     345699999999999764  789999999999999999999999975432


Q ss_pred             cccc-------cccchhhHHhhhcCCcc----------------------cccccchhHHHHHHHHHHHHHHhcCcCCCC
Q 010434          400 RSSK-------AYFPSWVYDQLNKGGDL----------------------ELRNVTEIESVIARKLCMIGLWCIQVKAAD  450 (511)
Q Consensus       400 ~~~~-------~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~  450 (511)
                      ....       ...|.............                      ............+..+.+++.+||+.||++
T Consensus       245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence            2100       01111111111000000                      000000011233567899999999999999


Q ss_pred             CCCHHHHHH
Q 010434          451 RPSMTKVLE  459 (511)
Q Consensus       451 RPs~~evl~  459 (511)
                      |||+.++++
T Consensus       325 Rpt~~e~l~  333 (355)
T 2eu9_A          325 RITLAEALL  333 (355)
T ss_dssp             SCCHHHHTT
T ss_pred             CcCHHHHhc
Confidence            999999975

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.9e-39  Score=336.89  Aligned_cols=261  Identities=21%  Similarity=0.217  Sum_probs=191.2

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCC------ceeEEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS------KRALVY  262 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~------~~~lV~  262 (511)
                      +|.+.++||+|+||.||+++...+..+|+|++.....   ...+|+.+++.++||||+++++++....      ..++||
T Consensus        41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~  117 (394)
T 4e7w_A           41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL  117 (394)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence            4566789999999999999987777799998865322   1236999999999999999999985433      378999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEc-CCCCeeeecccccccCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~-~~~~~kl~DFGla~~~~  341 (511)
                      ||++++.+.... ........+++..+..++.||+.||+|||+   .+|+||||||+|||++ .++.+||+|||+++...
T Consensus       118 e~~~~~l~~~~~-~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~  193 (394)
T 4e7w_A          118 EYVPETVYRASR-HYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI  193 (394)
T ss_dssp             ECCSEEHHHHHH-HHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eccCccHHHHHH-HHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence            999765443322 112234679999999999999999999999   6999999999999999 79999999999998764


Q ss_pred             CCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc--------chhhHHh
Q 010434          342 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF--------PSWVYDQ  413 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~--------~~~~~~~  413 (511)
                      ....   .....||+.|+|||.+.+. ..++.++|||||||++|||++|+.||...........+        ...+...
T Consensus       194 ~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~  269 (394)
T 4e7w_A          194 AGEP---NVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM  269 (394)
T ss_dssp             TTCC---CCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             CCCC---CcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            4332   2345689999999998654 35899999999999999999999999764321100000        0000000


Q ss_pred             ---hhcCCccccccc---chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          414 ---LNKGGDLELRNV---TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       414 ---~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                         ............   .......+..+.+++.+||+.||++|||+.++++.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence               000000000000   00112245678999999999999999999999874

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.1e-39  Score=328.76  Aligned_cols=240  Identities=23%  Similarity=0.334  Sum_probs=195.2

Q ss_pred             HHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc-------cHHHHHHHHHHhcccc--ccceEEeeceeccCCc
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF-------SAEEFINEVSTIGRIH--HVNVVQLLGFCSEGSK  257 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~-------~~~~f~~Ev~~l~~l~--H~niv~l~g~~~~~~~  257 (511)
                      ..+.+.++||+|+||.||+|.. .+++.||||++.....       ..+.+.+|+.++++++  |+||+++++++..+..
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~  122 (320)
T 3a99_A           43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS  122 (320)
T ss_dssp             TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence            3456678999999999999984 5789999999976322       2346778999999996  5999999999999999


Q ss_pred             eeEEEeecCC-CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEc-CCCCeeeeccc
Q 010434          258 RALVYEFMPN-GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD-HNFIPKVSDFG  335 (511)
Q Consensus       258 ~~lV~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~-~~~~~kl~DFG  335 (511)
                      .++|+|++.+ ++|.+++.    ....+++..+..++.||+.||+|||+   .+|+||||||+|||++ +++.+||+|||
T Consensus       123 ~~lv~e~~~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          123 FVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             EEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEEcCCCCccHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            9999999976 89999883    23579999999999999999999999   6999999999999999 78999999999


Q ss_pred             ccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhh
Q 010434          336 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLN  415 (511)
Q Consensus       336 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  415 (511)
                      +++......    .....||+.|+|||++.+. ...+.++||||||+++|||++|+.||......             ..
T Consensus       196 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------------~~  257 (320)
T 3a99_A          196 SGALLKDTV----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-------------IR  257 (320)
T ss_dssp             TCEECCSSC----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------------HH
T ss_pred             ccccccccc----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhhh-------------hc
Confidence            998765432    2345699999999998754 23478899999999999999999998653211             00


Q ss_pred             cCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                       ... .      ....++..+.+++.+||+.||++|||+.++++.
T Consensus       258 -~~~-~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          258 -GQV-F------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             -CCC-C------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -ccc-c------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             000 0      011134568899999999999999999999873

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.6e-38  Score=328.19  Aligned_cols=199  Identities=22%  Similarity=0.280  Sum_probs=168.0

Q ss_pred             HHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhcccc-cc-----ceEEeeceeccCCceeE
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIH-HV-----NVVQLLGFCSEGSKRAL  260 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~-H~-----niv~l~g~~~~~~~~~l  260 (511)
                      ..|.+.++||+|+||.||+|... +++.||||+++......+++..|+.+++.++ |+     +|+++.+++......++
T Consensus        54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l  133 (382)
T 2vx3_A           54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL  133 (382)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred             eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence            35566789999999999999854 7889999999876555677888999988885 33     59999999999999999


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEc--CCCCeeeecccccc
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD--HNFIPKVSDFGLAK  338 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~--~~~~~kl~DFGla~  338 (511)
                      ||||++ |+|.+++...  ....+++..+..++.|++.||.|||.. ..+|+||||||+|||++  .++.+||+|||+++
T Consensus       134 v~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~  209 (382)
T 2vx3_A          134 VFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC  209 (382)
T ss_dssp             EEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence            999995 5998887432  224699999999999999999999952 26899999999999994  57889999999998


Q ss_pred             cCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcc
Q 010434          339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMN  397 (511)
Q Consensus       339 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~  397 (511)
                      .....     .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||...
T Consensus       210 ~~~~~-----~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          210 QLGQR-----IYQYIQSRFYRSPEVLLGM--PYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             ETTCC-----CCSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ecccc-----cccccCCccccChHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            76432     2345689999999999875  7899999999999999999999999754

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=8.8e-39  Score=334.65  Aligned_cols=260  Identities=23%  Similarity=0.264  Sum_probs=190.0

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceecc------CCceeEEE
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE------GSKRALVY  262 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~------~~~~~lV~  262 (511)
                      |.+.++||+|+||.||+|+.. +|+.||||++.....   .+.+|+.++++++|||||++++++..      ....++||
T Consensus        56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~  132 (420)
T 1j1b_A           56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL  132 (420)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred             EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence            455789999999999999964 699999999865332   23479999999999999999998843      22367999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC-CCeeeecccccccCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHP  341 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~-~~~kl~DFGla~~~~  341 (511)
                      ||+++ +|.+.+.........+++..+..++.||++||+|||+   .+|+||||||+|||++.+ +.+||+|||+++...
T Consensus       133 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          133 DYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  208 (420)
T ss_dssp             ECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             hcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence            99975 5555543222345679999999999999999999998   699999999999999965 578999999998764


Q ss_pred             CCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc--------chhhHHh
Q 010434          342 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF--------PSWVYDQ  413 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~--------~~~~~~~  413 (511)
                      ....   .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||........-..+        ...+...
T Consensus       209 ~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~  284 (420)
T 1j1b_A          209 RGEP---NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  284 (420)
T ss_dssp             TTCC---CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             cCCC---ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            4332   2345689999999998653 36889999999999999999999999754321100000        0000000


Q ss_pred             hhcCCccccccc--c----hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          414 LNKGGDLELRNV--T----EIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       414 ~~~~~~~~~~~~--~----~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      ............  .    ......+..+.+|+.+||+.||++|||+.|+++.
T Consensus       285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            000000001000  0    0112235678999999999999999999999863

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.1e-38  Score=335.42  Aligned_cols=251  Identities=22%  Similarity=0.249  Sum_probs=184.3

Q ss_pred             ccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEeecCCCCcc
Q 010434          193 THKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLD  271 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  271 (511)
                      .+.||+|+||+||.+...+|+.||||++...  ..+.+.+|+.++.++ +|||||++++++.++...++||||++ |+|.
T Consensus        20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~   96 (434)
T 2rio_A           20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ   96 (434)
T ss_dssp             EEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred             cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence            4679999999998776667999999998653  245688999999886 89999999999999999999999995 6999


Q ss_pred             cccccCCCcCCc---cCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC-------------CCeeeeccc
Q 010434          272 RHIFPKENKGQT---FGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-------------FIPKVSDFG  335 (511)
Q Consensus       272 ~~l~~~~~~~~~---l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~-------------~~~kl~DFG  335 (511)
                      +++.........   .++..+..++.||+.||+|||+   .+|+||||||+|||++.+             +.+||+|||
T Consensus        97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG  173 (434)
T 2rio_A           97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG  173 (434)
T ss_dssp             HHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred             HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence            988443221111   1334567899999999999999   699999999999999754             589999999


Q ss_pred             ccccCCCCCCce--eeccccCCccccchhccccc-----CCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccc
Q 010434          336 LAKFHPKENDFV--SISATRGTIGYIAPELISRN-----FGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFP  407 (511)
Q Consensus       336 la~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~-----~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~  407 (511)
                      +++.........  ......||+.|+|||++.+.     .+.++.++|||||||++|||++ |+.||.......      
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~------  247 (434)
T 2rio_A          174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE------  247 (434)
T ss_dssp             TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH------
T ss_pred             cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH------
Confidence            998765543221  12345699999999998651     2468899999999999999998 899986432211      


Q ss_pred             hhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          408 SWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       408 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                         ...+......... .......++..+.+++.+||+.||++|||+.+|++
T Consensus       248 ---~~i~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 ---SNIIRGIFSLDEM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             ---HHHHHTCCCCCCC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---HHHhcCCCCcccc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence               0111111111100 11123456778999999999999999999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.8e-38  Score=322.28  Aligned_cols=250  Identities=20%  Similarity=0.262  Sum_probs=169.0

Q ss_pred             Hhhhc-cccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceecc----CCceeEEE
Q 010434          189 TNHFT-HKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRALVY  262 (511)
Q Consensus       189 t~~~~-~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~----~~~~~lV~  262 (511)
                      .|.+. +.||+|+||.||++... +|+.||||++.......+   +....+..++||||+++++++..    +...++||
T Consensus        29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~  105 (336)
T 3fhr_A           29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM  105 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence            34553 46999999999999865 799999999976432222   22233556789999999999865    45589999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC---CCCeeeeccccccc
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH---NFIPKVSDFGLAKF  339 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~---~~~~kl~DFGla~~  339 (511)
                      ||+++|+|.+++..  .....+++..+..++.||+.||+|||+   .+|+||||||+|||++.   ++.+||+|||+++.
T Consensus       106 e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~  180 (336)
T 3fhr_A          106 ECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE  180 (336)
T ss_dssp             ECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             eccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence            99999999999843  223579999999999999999999999   69999999999999976   45599999999986


Q ss_pred             CCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          340 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       340 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      .....    .....||+.|+|||++...  .++.++||||||+++|||++|+.||...........    ....+.... 
T Consensus       181 ~~~~~----~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~-  249 (336)
T 3fhr_A          181 TTQNA----LQTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG----MKRRIRLGQ-  249 (336)
T ss_dssp             C--------------------------C--HHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             ccccc----cccCCCCcCccChhhhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh----HHHhhhccc-
Confidence            54322    2345689999999998654  788999999999999999999999865432221100    001111000 


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ...  .......++..+.+++.+||+.||++|||+.++++
T Consensus       250 ~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          250 YGF--PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -CC--CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccc--CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            000  11111234567889999999999999999999998

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=7.5e-39  Score=323.11  Aligned_cols=254  Identities=25%  Similarity=0.323  Sum_probs=174.9

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc--ccHHHHHHHHH-HhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK--FSAEEFINEVS-TIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~--~~~~~f~~Ev~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      +.+.+.||+|+||.||++.. .+|+.||||++....  ....++..|+. +++.++||||+++++++..++..++||||+
T Consensus        24 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~  103 (327)
T 3aln_A           24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM  103 (327)
T ss_dssp             EEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             hhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeec
Confidence            34567899999999999986 478999999997643  23345666666 677889999999999999999999999999


Q ss_pred             CCCCcccccccC-CCcCCccCHHHHHHHHHHHHHHHHHHHhCCCC-ceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          266 PNGSLDRHIFPK-ENKGQTFGWEKLQEIALGTARGVAYLHNGCDM-CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       266 ~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      ++ +|.+++... ......+++..+..++.|++.||.|||+   . +|+||||||+|||++.++.+||+|||+++.....
T Consensus       104 ~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  179 (327)
T 3aln_A          104 ST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS  179 (327)
T ss_dssp             SE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred             CC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence            75 777665211 1124679999999999999999999998   5 9999999999999999999999999999865433


Q ss_pred             CCceeeccccCCccccchhccccc--CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~--~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (511)
                      .   ......||+.|+|||.+...  ...++.++||||||+++|||++|+.||.........       ......+....
T Consensus       180 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~~~~~~~~~~  249 (327)
T 3aln_A          180 I---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-------LTQVVKGDPPQ  249 (327)
T ss_dssp             -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCCCC
T ss_pred             c---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-------HHHHhcCCCCC
Confidence            2   12334699999999998421  136889999999999999999999998653211000       00111111111


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      +..  .....++..+.+++.+||+.||++|||+.++++
T Consensus       250 ~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          250 LSN--SEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCC--CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCC--cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            111  011223567889999999999999999999975

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=8.7e-38  Score=313.25  Aligned_cols=250  Identities=22%  Similarity=0.290  Sum_probs=176.0

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCccc---HHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~---~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      +.+.++||+|+||.||++... +|+.||||++......   .+.+.++..+++.++||||+++++++.++...++||||+
T Consensus        27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~  106 (318)
T 2dyl_A           27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM  106 (318)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc
Confidence            455678999999999999864 7899999999764322   233445556778889999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                       ++.+..+.   ......+++..+..++.|++.||+|||+.  .+|+|+||||+||+++.++.+||+|||+++...... 
T Consensus       107 -~~~~~~l~---~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-  179 (318)
T 2dyl_A          107 -GTCAEKLK---KRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-  179 (318)
T ss_dssp             -SEEHHHHH---HHHTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             -CCcHHHHH---HHhccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence             44554443   12246799999999999999999999971  289999999999999999999999999997654332 


Q ss_pred             ceeeccccCCccccchhcccc---cCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          346 FVSISATRGTIGYIAPELISR---NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~---~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                        ......||+.|+|||.+..   ....++.++||||||+++|||++|+.||......       ...............
T Consensus       180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~  250 (318)
T 2dyl_A          180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-------FEVLTKVLQEEPPLL  250 (318)
T ss_dssp             ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHHHHHHHSCCCCC
T ss_pred             --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-------HHHHHHHhccCCCCC
Confidence              1234468999999999853   1236788999999999999999999998642211       111122222211111


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ...    ..++..+.+++.+||+.||.+|||+.++++
T Consensus       251 ~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          251 PGH----MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CSS----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             Ccc----CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            111    123466889999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.9e-38  Score=330.09  Aligned_cols=249  Identities=24%  Similarity=0.279  Sum_probs=182.7

Q ss_pred             hhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEeecCCC
Q 010434          190 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      +.+.++||+|+||+||.....+|+.||||++.....  +.+.+|+.+++++ +|||||++++++.+....++||||++ |
T Consensus        26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g  102 (432)
T 3p23_A           26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A  102 (432)
T ss_dssp             EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred             EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence            445678999999997655556799999999865322  2356899999999 79999999999999999999999995 6


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC-----CCCeeeecccccccCCCC
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH-----NFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~-----~~~~kl~DFGla~~~~~~  343 (511)
                      +|.+++...   ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.     +..+||+|||+++.....
T Consensus       103 ~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A          103 TLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             EHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             CHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            999888432   2344555667899999999999999   69999999999999943     346789999999876543


Q ss_pred             CC-ceeeccccCCccccchhccccc-CCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcc
Q 010434          344 ND-FVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDL  420 (511)
Q Consensus       344 ~~-~~~~~~~~gt~~y~APE~~~~~-~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (511)
                      .. ........||+.|+|||++.+. ...++.++|||||||++|||++ |+.|+.......        . .........
T Consensus       177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~--------~-~~~~~~~~~  247 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--------A-NILLGACSL  247 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH--------H-HHHTTCCCC
T ss_pred             CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH--------H-HHHhccCCc
Confidence            22 1223445699999999998742 2367889999999999999999 888875332111        1 111111111


Q ss_pred             cccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          421 ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       421 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ....   .....+..+.+++.+||+.||++|||+.+|++
T Consensus       248 ~~~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          248 DCLH---PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             TTSC---TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccC---ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            1111   11234556788999999999999999999984

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.9e-37  Score=341.26  Aligned_cols=236  Identities=21%  Similarity=0.280  Sum_probs=189.5

Q ss_pred             HHhhhccccCcCCcEEEEEEEec--CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCc-----e
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH--TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK-----R  258 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~--~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~-----~  258 (511)
                      ..|.+.++||+|+||.||++...  +|+.||||++....  ...+.|.+|+.++++++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            35667789999999999999864  68999999986532  234578999999999999999999999987665     6


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      +|||||+++++|.+++.      ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.+ .+||+|||+++
T Consensus       160 ~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             EEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccch
Confidence            99999999999998762      279999999999999999999999   699999999999999986 99999999998


Q ss_pred             cCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCC
Q 010434          339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG  418 (511)
Q Consensus       339 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  418 (511)
                      .....      ....||++|+|||++.+.   .+.++||||||+++|||++|..|+.......    .+           
T Consensus       230 ~~~~~------~~~~gt~~y~aPE~~~~~---~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----~~-----------  285 (681)
T 2pzi_A          230 RINSF------GYLYGTPGFQAPEIVRTG---PTVATDIYTVGRTLAALTLDLPTRNGRYVDG----LP-----------  285 (681)
T ss_dssp             ETTCC------SCCCCCTTTSCTTHHHHC---SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----CC-----------
T ss_pred             hcccC------CccCCCccccCHHHHcCC---CCCceehhhhHHHHHHHHhCCCCCccccccc----cc-----------
Confidence            76443      344699999999998753   4889999999999999999988765422111    00           


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhcCcCCCCCCC-HHHHHHHHhc
Q 010434          419 DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPS-MTKVLEMLEG  463 (511)
Q Consensus       419 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-~~evl~~Le~  463 (511)
                           . .......+..+.+++.+||+.||++||+ +.++...|.+
T Consensus       286 -----~-~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          286 -----E-DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             -----T-TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             -----c-cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                 0 0011223467889999999999999995 5666665554

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.3e-37  Score=306.13  Aligned_cols=233  Identities=13%  Similarity=0.085  Sum_probs=183.9

Q ss_pred             HHHHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcc----cHHHHHHHHHHhccccccceEEeeceeccCCcee
Q 010434          185 IIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  259 (511)
Q Consensus       185 i~~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~  259 (511)
                      +....|.+.++||+|+||.||+|... +|+.||||++.....    ..+.|.+|+.++.+++||||+++++++.+++..+
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            44456777899999999999999864 589999999976433    2367999999999999999999999999999999


Q ss_pred             EEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      +||||+++++|.+++.    . + .....+.+++.|++.||+|||+   .+|+||||||+|||+++++.+||+++|    
T Consensus       108 lv~e~~~g~~L~~~l~----~-~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~----  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVAD----T-S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA----  174 (286)
T ss_dssp             EEEECCCEEEHHHHHT----T-C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC----
T ss_pred             EEEEecCCCCHHHHHh----c-C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc----
Confidence            9999999999999982    1 2 3556788999999999999999   699999999999999999999998543    


Q ss_pred             CCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          340 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       340 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                                        |++         .++.++||||||+++|||++|+.||...........    .....    .
T Consensus       175 ------------------~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~----~~~~~----~  219 (286)
T 3uqc_A          175 ------------------TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP----AERDT----A  219 (286)
T ss_dssp             ------------------CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE----CCBCT----T
T ss_pred             ------------------ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH----HHHHh----c
Confidence                              332         357899999999999999999999976443211000    00000    0


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      ............++..+.+++.+||+.||++| |+.++++.|+....
T Consensus       220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            01111112223456778999999999999999 99999999987543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=9.9e-38  Score=340.33  Aligned_cols=260  Identities=23%  Similarity=0.299  Sum_probs=195.1

Q ss_pred             HHhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceecc------CCce
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSE------GSKR  258 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~------~~~~  258 (511)
                      ..|.+.++||+|+||.||+|.. .+|+.||||++...  ....+.|.+|+.++++++||||+++++++..      +...
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            4677889999999999999985 47899999998753  3345679999999999999999999998765      6778


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCC---eeeeccc
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFI---PKVSDFG  335 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~---~kl~DFG  335 (511)
                      ++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.   +||+|||
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            99999999999999884332 23468999999999999999999999   69999999999999997665   9999999


Q ss_pred             ccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccc-ccccch------
Q 010434          336 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSS-KAYFPS------  408 (511)
Q Consensus       336 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~-~~~~~~------  408 (511)
                      +++.......   .....||+.|+|||.+.+.  .++.++||||||+++|||++|+.||........ ......      
T Consensus       170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~--~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~  244 (676)
T 3qa8_A          170 YAKELDQGEL---CTEFVGTLQYLAPELLEQK--KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI  244 (676)
T ss_dssp             CCCBTTSCCC---CCCCCSCCTTCSSCSSCCS--CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred             cccccccccc---cccccCCcccCChHHhccC--CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence            9987654332   2345699999999998764  789999999999999999999999865321100 000000      


Q ss_pred             hhHHhhhcCC--cccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHH
Q 010434          409 WVYDQLNKGG--DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTK  456 (511)
Q Consensus       409 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~e  456 (511)
                      ...+......  ......+......++..+.+++.+||+.||++|||+.+
T Consensus       245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            0000000000  00111122244456788999999999999999999866

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-37  Score=323.29  Aligned_cols=238  Identities=15%  Similarity=0.125  Sum_probs=174.8

Q ss_pred             hccccCcCCcEEEEEEE-ecCCcEEEEEEeccCc----ccHHHHHHHHHHhccccc-cc---------------eEEee-
Q 010434          192 FTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSK----FSAEEFINEVSTIGRIHH-VN---------------VVQLL-  249 (511)
Q Consensus       192 ~~~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~~----~~~~~f~~Ev~~l~~l~H-~n---------------iv~l~-  249 (511)
                      ..+.||+|+||.||+|. ..+|+.||||++....    ...+.|.+|+.+++.++| +|               ++.+. 
T Consensus        82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (413)
T 3dzo_A           82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ  161 (413)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred             EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence            35689999999999998 5579999999987422    235689999999999976 21               11111 


Q ss_pred             -----ceecc-----CCceeEEEeecCCCCcccccccC---CCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccC
Q 010434          250 -----GFCSE-----GSKRALVYEFMPNGSLDRHIFPK---ENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDI  316 (511)
Q Consensus       250 -----g~~~~-----~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DI  316 (511)
                           .++..     ....+++|+++ +++|.+++...   ...+..+++..++.++.||+.||+|||+   .+|+||||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHrDi  237 (413)
T 3dzo_A          162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYL  237 (413)
T ss_dssp             ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCC
T ss_pred             CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCc
Confidence                 11111     12346667765 78998877211   2234678999999999999999999999   69999999


Q ss_pred             CcCceEEcCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccc--------cCCCcCccchHHHHHHHHHHHH
Q 010434          317 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR--------NFGTVSCKSDVYGFGMVLLEMA  388 (511)
Q Consensus       317 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~~~s~ksDVwS~Gvll~ell  388 (511)
                      ||+|||++.++.+||+|||+++.....     .....| +.|+|||++..        ....++.++|||||||++|||+
T Consensus       238 Kp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          238 RPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             CGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             ccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            999999999999999999998864332     344567 99999999832        1125788999999999999999


Q ss_pred             hCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHH
Q 010434          389 GGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVL  458 (511)
Q Consensus       389 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl  458 (511)
                      +|+.||.........        ......       ..    .++..+.+++.+||+.||++|||+.+++
T Consensus       312 tg~~Pf~~~~~~~~~--------~~~~~~-------~~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          312 CADLPNTDDAALGGS--------EWIFRS-------CK----NIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HSSCCCCTTGGGSCS--------GGGGSS-------CC----CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HCCCCCCCcchhhhH--------HHHHhh-------cc----cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            999999754322110        000000       00    1236688999999999999999976654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.8e-37  Score=310.74  Aligned_cols=243  Identities=15%  Similarity=0.130  Sum_probs=185.9

Q ss_pred             HHHHHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCc---------ccHHHHHHHHHHhcccc--------------
Q 010434          185 IIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSK---------FSAEEFINEVSTIGRIH--------------  241 (511)
Q Consensus       185 i~~~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~---------~~~~~f~~Ev~~l~~l~--------------  241 (511)
                      +....|.+.++||+|+||.||+|+. +|+.||||++....         ...+.+.+|+.++++++              
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            3345677889999999999999987 68999999997532         23478999999999886              


Q ss_pred             ------------ccceEEeeceecc-------------CCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHH
Q 010434          242 ------------HVNVVQLLGFCSE-------------GSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGT  296 (511)
Q Consensus       242 ------------H~niv~l~g~~~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i  296 (511)
                                  ||||+++++++.+             ....++||||+++|++.+.+.     ...+++..+..++.||
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi  170 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQL  170 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHH
Confidence                        5555555555554             688999999999998777662     2568999999999999


Q ss_pred             HHHHHHHH-hCCCCceecccCCcCceEEcCCC--------------------CeeeecccccccCCCCCCceeeccccCC
Q 010434          297 ARGVAYLH-NGCDMCILHFDIKPHNILLDHNF--------------------IPKVSDFGLAKFHPKENDFVSISATRGT  355 (511)
Q Consensus       297 a~~l~yLH-~~~~~~ivH~DIkp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt  355 (511)
                      +.||+||| +   .+|+||||||+|||++.++                    .+||+|||+|+.....       ...||
T Consensus       171 ~~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt  240 (336)
T 2vuw_A          171 TASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFC  240 (336)
T ss_dssp             HHHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECC
T ss_pred             HHHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEe
Confidence            99999999 7   6999999999999999887                    8999999999865432       33699


Q ss_pred             ccccchhcccccCCCcCccchHHHHHHH-HHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchhHHHHHH
Q 010434          356 IGYIAPELISRNFGTVSCKSDVYGFGMV-LLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIAR  434 (511)
Q Consensus       356 ~~y~APE~~~~~~~~~s~ksDVwS~Gvl-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  434 (511)
                      +.|+|||++.+.   .+.++||||+|++ .+++++|..|+.....       .....+.+.................+++
T Consensus       241 ~~y~aPE~~~g~---~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~s~  310 (336)
T 2vuw_A          241 DVSMDEDLFTGD---GDYQFDIYRLMKKENNNRWGEYHPYSNVLW-------LHYLTDKMLKQMTFKTKCNTPAMKQIKR  310 (336)
T ss_dssp             CCTTCSGGGCCC---SSHHHHHHHHHHHHHTTCTTSCCTHHHHHH-------HHHHHHHHHHTCCCSSCCCSHHHHHHHH
T ss_pred             ecccChhhhcCC---CccceehhhhhCCCCcccccccCCCcchhh-------hhHHHHhhhhhhccCcccchhhhhhcCH
Confidence            999999999864   3889999998777 7778889888743110       0011122221111222222335667889


Q ss_pred             HHHHHHHHhcCcCCCCCCCHHHHH
Q 010434          435 KLCMIGLWCIQVKAADRPSMTKVL  458 (511)
Q Consensus       435 ~l~~l~~~Cl~~~P~~RPs~~evl  458 (511)
                      .+.+++.+||+.|     |+.|++
T Consensus       311 ~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          311 KIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHHHhccC-----CHHHHH
Confidence            9999999999966     899887

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.3e-36  Score=300.23  Aligned_cols=224  Identities=21%  Similarity=0.253  Sum_probs=174.8

Q ss_pred             cccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHh-ccccccceEEeeceecc----CCceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTI-GRIHHVNVVQLLGFCSE----GSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l-~~l~H~niv~l~g~~~~----~~~~~lV~e~~~~  267 (511)
                      +.||+|+||.||++.. .+++.||||+++..    ..+.+|+.++ +.++||||+++++++..    +...++||||+++
T Consensus        24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~   99 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG   99 (299)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred             cccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence            6799999999999985 57899999999643    4677888888 55689999999999876    6778999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC---CCCeeeecccccccCCCCC
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~---~~~~kl~DFGla~~~~~~~  344 (511)
                      |+|.+++..  .....+++..+..++.|++.||+|||+   .+|+||||||+|||++.   ++.+||+|||+++....  
T Consensus       100 ~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~--  172 (299)
T 3m2w_A          100 GELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG--  172 (299)
T ss_dssp             CBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT--
T ss_pred             CcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccccccccc--
Confidence            999998843  223579999999999999999999999   69999999999999998   78999999999864321  


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                                              ..++.++||||||+++|||++|+.||.............    ....   ......
T Consensus       173 ------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~----~~~~---~~~~~~  221 (299)
T 3m2w_A          173 ------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK----TRIR---MGQYEF  221 (299)
T ss_dssp             ------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC----CSSC---TTCCSS
T ss_pred             ------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH----HHHh---hccccC
Confidence                                    256789999999999999999999986543221110000    0000   000111


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .......++..+.+++.+||+.||++|||+.++++
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            11122345678899999999999999999999997

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=3.9e-31  Score=286.48  Aligned_cols=184  Identities=16%  Similarity=0.152  Sum_probs=131.3

Q ss_pred             cccCcCCcEEEEEEE-ecCCcEEEEEEeccC-----------cccHHHHHHHHHHhccc-cccceEEeeceeccCCceeE
Q 010434          194 HKLGQGGFGSVYKGQ-LHTGRLIAVKMLENS-----------KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAL  260 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~-~~~g~~vAvK~l~~~-----------~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~l  260 (511)
                      ..++.|++|.+..++ ...|+.+|||.+...           +.+.++|.+|+++|+++ +|+||+++++++++++..||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            457788888777765 456899999998653           22446799999999999 79999999999999999999


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccC
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      ||||++|++|.++|.    .+++++..   +|+.||+.||+|||+   ++|+||||||+||||++++.+||+|||+|+..
T Consensus       320 VMEyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~  389 (569)
T 4azs_A          320 VMEKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTT  389 (569)
T ss_dssp             EEECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred             EEecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence            999999999999983    34567664   588999999999999   69999999999999999999999999999876


Q ss_pred             CCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCC
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR  392 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~  392 (511)
                      .....  ......||++|+|||++.+   .+..++|+||+|+++++|.++..
T Consensus       390 ~~~~~--~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          390 PQDCS--WPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             C---C--CSHHHHHHHHHHHHHHC--------------------CCCCTTHH
T ss_pred             CCCCc--cccCceechhhccHHHhCC---CCCCcccccccccchhhhccccc
Confidence            54432  2344569999999999975   46678999999999888766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=2.5e-27  Score=255.13  Aligned_cols=184  Identities=16%  Similarity=0.161  Sum_probs=145.0

Q ss_pred             ccccCcCCcEEEEEEEecCCcEEEEEEeccCcc---------cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          193 THKLGQGGFGSVYKGQLHTGRLIAVKMLENSKF---------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~---------~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .++||+|+||.||+|.. .++.+|+|+......         ..+.|.+|++++++++||||+++..++......+||||
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            46899999999999954 478899998643211         13458999999999999999976666667778899999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++++|.+++..            +..++.|+++||+|||+   .+|+||||||+|||+++  .+||+|||+++.....
T Consensus       420 ~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          420 YINGKLAKDVIED------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             CCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             CCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            9999999999832            56899999999999999   69999999999999998  9999999999977543


Q ss_pred             CCce-----eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCC
Q 010434          344 NDFV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS  394 (511)
Q Consensus       344 ~~~~-----~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~  394 (511)
                      ....     ......||+.|+|||++......++.++|+|+..+-.++.+.++.++
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            2211     11345699999999999864346788899999999999988777654

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=8.8e-24  Score=209.04  Aligned_cols=141  Identities=17%  Similarity=0.119  Sum_probs=115.5

Q ss_pred             hccccCcCCcEEEEEEEecCCcEEEEEEeccCcc-------------------cHHHHHHHHHHhccccccceEEeecee
Q 010434          192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKF-------------------SAEEFINEVSTIGRIHHVNVVQLLGFC  252 (511)
Q Consensus       192 ~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~-------------------~~~~f~~Ev~~l~~l~H~niv~l~g~~  252 (511)
                      +.++||+|+||.||+|...+|+.||||+++....                   ....+.+|+.++++++  | +++.+++
T Consensus        94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~  170 (282)
T 1zar_A           94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY  170 (282)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred             ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence            3478999999999999987899999999964221                   2456899999999998  5 6666655


Q ss_pred             ccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeee
Q 010434          253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVS  332 (511)
Q Consensus       253 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~  332 (511)
                      . .+..++||||+++|+|.+ +..          .....++.|++.||+|||+   .+|+||||||+|||++ ++.+||+
T Consensus       171 ~-~~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~  234 (282)
T 1zar_A          171 A-WEGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWII  234 (282)
T ss_dssp             E-EETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEEC
T ss_pred             e-ccceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEE
Confidence            3 366799999999999988 411          1244699999999999998   6999999999999999 9999999


Q ss_pred             cccccccCCCCCCceeeccccCCccccchhcccc
Q 010434          333 DFGLAKFHPKENDFVSISATRGTIGYIAPELISR  366 (511)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~  366 (511)
                      |||+++.               +..+.|||++.+
T Consensus       235 DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          235 DFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             CCTTCEE---------------TTSTTHHHHHHH
T ss_pred             ECCCCeE---------------CCCCCHHHHHHH
Confidence            9999862               345789998754

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.80  E-value=4.7e-20  Score=179.80  Aligned_cols=133  Identities=19%  Similarity=0.146  Sum_probs=103.4

Q ss_pred             hccccCcCCcEEEEEEEe-cCCcE--EEEEEeccCccc-------------------------HHHHHHHHHHhcccccc
Q 010434          192 FTHKLGQGGFGSVYKGQL-HTGRL--IAVKMLENSKFS-------------------------AEEFINEVSTIGRIHHV  243 (511)
Q Consensus       192 ~~~~LG~G~fg~Vykg~~-~~g~~--vAvK~l~~~~~~-------------------------~~~f~~Ev~~l~~l~H~  243 (511)
                      +.+.||+|+||.||+|.. .+|+.  ||||+++.....                         ...+.+|+..+.+++|+
T Consensus        51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~  130 (258)
T 1zth_A           51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA  130 (258)
T ss_dssp             EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence            457899999999999997 68989  999987543111                         13688999999999888


Q ss_pred             ce--EEeeceeccCCceeEEEeecCC-C----CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHH-hCCCCceeccc
Q 010434          244 NV--VQLLGFCSEGSKRALVYEFMPN-G----SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH-NGCDMCILHFD  315 (511)
Q Consensus       244 ni--v~l~g~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH-~~~~~~ivH~D  315 (511)
                      |+  +.++++    ...+|||||+.+ |    +|.+...       ..++..+..++.|++.||.||| +   .+|+|||
T Consensus       131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~---~givHrD  196 (258)
T 1zth_A          131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQE---AELVHAD  196 (258)
T ss_dssp             TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHT---SCEECSS
T ss_pred             CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHH---CCEEeCC
Confidence            64  333332    467899999942 4    4444331       1234567889999999999999 7   6999999


Q ss_pred             CCcCceEEcCCCCeeeecccccccC
Q 010434          316 IKPHNILLDHNFIPKVSDFGLAKFH  340 (511)
Q Consensus       316 Ikp~NILl~~~~~~kl~DFGla~~~  340 (511)
                      |||+|||+++  .++|+|||+|...
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCHHHEEEcC--cEEEEECcccccC
Confidence            9999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.68  E-value=2.2e-17  Score=168.61  Aligned_cols=137  Identities=12%  Similarity=0.069  Sum_probs=97.2

Q ss_pred             hhhccccCcCCcEEEEEEEecCCcEEEEEEeccCc---------------ccHHHHHHHHHHhccccccceEEeeceec-
Q 010434          190 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSK---------------FSAEEFINEVSTIGRIHHVNVVQLLGFCS-  253 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~---------------~~~~~f~~Ev~~l~~l~H~niv~l~g~~~-  253 (511)
                      |.+..+||+|+||.||+|...+|+.||||+++...               ........++++.....|+|+++++.... 
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            34567899999999999998899999999975321               11222333333333334455444433221 


Q ss_pred             -----cCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC-
Q 010434          254 -----EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF-  327 (511)
Q Consensus       254 -----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~-  327 (511)
                           .....+|||||+++++|.++...          +....++.|++.+|.+||+   .+||||||||.|||+++++ 
T Consensus       177 vp~p~~~~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          177 VPEPIAQSRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             CCCEEEEETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEEC
T ss_pred             CCeeeeccCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCCC
Confidence                 11234799999999998776411          1235678999999999999   6999999999999998876 


Q ss_pred             ---------Ceeeeccccccc
Q 010434          328 ---------IPKVSDFGLAKF  339 (511)
Q Consensus       328 ---------~~kl~DFGla~~  339 (511)
                               .+.|+||+.+-.
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEE
T ss_pred             cccccccccceEEEEeCCccc
Confidence                     389999997754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.24  E-value=9.2e-12  Score=120.66  Aligned_cols=138  Identities=14%  Similarity=0.073  Sum_probs=108.0

Q ss_pred             hhccccCcCCcEEEEEEEecCCcEEEEEEeccCc-ccHHHHHHHHHHhcccc-ccceEEeeceeccCCceeEEEeecCCC
Q 010434          191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSK-FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      .+...++.|+.+.||+.... ++.+++|+..... .....+.+|+.+++.+. +.++.++++++...+..++||||++|.
T Consensus        17 ~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~   95 (263)
T 3tm0_A           17 RCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGV   95 (263)
T ss_dssp             EEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSE
T ss_pred             eeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCe
Confidence            34567888888999999755 6899999986521 23346889999999884 677889999998888999999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG------------------------------------------  306 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~------------------------------------------  306 (511)
                      +|.+.+.         +......++.+++++++.||+-                                          
T Consensus        96 ~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T 3tm0_A           96 LCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             EHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred             ehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence            9877531         1112347888999999999981                                          


Q ss_pred             --------------CCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          307 --------------CDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       307 --------------~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                                    ....++|+|++|.||+++++..+.|+||+.+.
T Consensus       167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                          11459999999999999876666799998664

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.20  E-value=3.2e-11  Score=116.03  Aligned_cols=130  Identities=16%  Similarity=0.146  Sum_probs=98.7

Q ss_pred             ccC-cCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccc--eEEeeceeccCCceeEEEeecCCCCcc
Q 010434          195 KLG-QGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVN--VVQLLGFCSEGSKRALVYEFMPNGSLD  271 (511)
Q Consensus       195 ~LG-~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~n--iv~l~g~~~~~~~~~lV~e~~~~gsL~  271 (511)
                      .++ .|..+.||+....+|+.+++|+....  ....+.+|+.+++.+++.+  +.+++++...++..++||||++|.+|.
T Consensus        26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~  103 (264)
T 1nd4_A           26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL  103 (264)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             ecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence            344 55569999998777889999997553  2346788999999886544  566888888778899999999998884


Q ss_pred             cccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 010434          272 RHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC--------------------------------------------  307 (511)
Q Consensus       272 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--------------------------------------------  307 (511)
                        ..       ..+   ...++.++++.|..||+..                                            
T Consensus       104 --~~-------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (264)
T 1nd4_A          104 --SS-------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  171 (264)
T ss_dssp             --TS-------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             --cC-------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence              21       111   2357788888888888731                                            


Q ss_pred             -----------CCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          308 -----------DMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       308 -----------~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                                 ...++|+|++|.||+++++..++|.|||.+.
T Consensus       172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                       1239999999999999887667799999765

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.10  E-value=3.1e-10  Score=115.26  Aligned_cols=139  Identities=18%  Similarity=0.200  Sum_probs=107.0

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEEec--cCc--ccHHHHHHHHHHhcccc--ccceEEeeceeccC---CceeEEEee
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKMLE--NSK--FSAEEFINEVSTIGRIH--HVNVVQLLGFCSEG---SKRALVYEF  264 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~l~--~~~--~~~~~f~~Ev~~l~~l~--H~niv~l~g~~~~~---~~~~lV~e~  264 (511)
                      +.|+.|.++.||+.... +..+++|+..  ...  .....+.+|+.+++.++  +..++++++++.+.   +..++||||
T Consensus        44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~  122 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF  122 (359)
T ss_dssp             EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred             EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence            57899999999999876 4678888876  322  23457888999999886  45688888888776   458999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC-------------------------------------  307 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-------------------------------------  307 (511)
                      ++|..+.+..      -..++......++.++++.|+.||+..                                     
T Consensus       123 v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          123 VSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             CCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             cCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            9998885432      134778889999999999999999721                                     


Q ss_pred             ------------------CCceecccCCcCceEEcCCCC--eeeeccccccc
Q 010434          308 ------------------DMCILHFDIKPHNILLDHNFI--PKVSDFGLAKF  339 (511)
Q Consensus       308 ------------------~~~ivH~DIkp~NILl~~~~~--~kl~DFGla~~  339 (511)
                                        ...++|+|++|.|||++.++.  +.|.||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              257999999999999987753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.96  E-value=7.7e-10  Score=109.71  Aligned_cols=186  Identities=20%  Similarity=0.267  Sum_probs=123.2

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhcccc-cc--ceEEeeceeccCC---ceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIH-HV--NVVQLLGFCSEGS---KRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~-H~--niv~l~g~~~~~~---~~~lV~e~~~~  267 (511)
                      +.++.|....||+..    ..+++|+.... .....+.+|+++++.+. +.  .+.+.+.....+.   ..++||++++|
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            458899999999873    56889985432 34567899999998873 32  2445555543333   45799999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG-----------------------------------------  306 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-----------------------------------------  306 (511)
                      .+|.+...      ..++......++.++++.++.||+.                                         
T Consensus       101 ~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A          101 VPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             EECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             eECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            88875331      3567788888999999999999861                                         


Q ss_pred             --------------CCCceecccCCcCceEEcC--CCCeeeecccccccCCCCCCceeeccc---c---------CCccc
Q 010434          307 --------------CDMCILHFDIKPHNILLDH--NFIPKVSDFGLAKFHPKENDFVSISAT---R---------GTIGY  358 (511)
Q Consensus       307 --------------~~~~ivH~DIkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~~~~---~---------gt~~y  358 (511)
                                    ....++|+|++|.||++++  +..+.|.||+.+.......+.......   .         ...+.
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~  254 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH  254 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence                          1135899999999999998  556789999988754322111100000   0         00011


Q ss_pred             cc-hhcccccCCCcCccchHHHHHHHHHHHHhCCCCC
Q 010434          359 IA-PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS  394 (511)
Q Consensus       359 ~A-PE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~  394 (511)
                      .. |+...+    .....+.|++|.++|++.+|..++
T Consensus       255 ~~~~~~~~r----~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          255 KDIPTVLEK----YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             SCHHHHHHH----HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCcHHHHHH----HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            22 332221    122368999999999999998654

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.39  E-value=1.1e-06  Score=87.20  Aligned_cols=135  Identities=17%  Similarity=0.139  Sum_probs=95.1

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhcccccc---ceEEeeceec-cCCceeEEEeecCCCC
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHV---NVVQLLGFCS-EGSKRALVYEFMPNGS  269 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~---niv~l~g~~~-~~~~~~lV~e~~~~gs  269 (511)
                      +.++.|....||+.    |+.+++|+-. .......+.+|+.++..+.+.   .+.+.+.++. ..+..++|||+++|.+
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~   99 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI   99 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence            45788888899988    6778888843 223456789999999998642   3556666663 4556789999999988


Q ss_pred             cccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 010434          270 LDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG-------------------------------------------  306 (511)
Q Consensus       270 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-------------------------------------------  306 (511)
                      |.+...      ..++......++.++++.|+.||+-                                           
T Consensus       100 l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A          100 LGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             CHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             Cchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            865321      2344555566666666666666642                                           


Q ss_pred             --------------CCCceecccCCcCceEEcC---CCC-eeeeccccccc
Q 010434          307 --------------CDMCILHFDIKPHNILLDH---NFI-PKVSDFGLAKF  339 (511)
Q Consensus       307 --------------~~~~ivH~DIkp~NILl~~---~~~-~kl~DFGla~~  339 (511)
                                    ....++|+|++|.||+++.   ++. ..|.||+.+..
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                          1235699999999999987   455 48999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.33  E-value=1.7e-06  Score=87.35  Aligned_cols=79  Identities=6%  Similarity=0.054  Sum_probs=57.3

Q ss_pred             ccc-CcCCcEEEEEEEec-------CCcEEEEEEeccCc---c-cHHHHHHHHHHhccccc---cceEEeeceeccC---
Q 010434          194 HKL-GQGGFGSVYKGQLH-------TGRLIAVKMLENSK---F-SAEEFINEVSTIGRIHH---VNVVQLLGFCSEG---  255 (511)
Q Consensus       194 ~~L-G~G~fg~Vykg~~~-------~g~~vAvK~l~~~~---~-~~~~f~~Ev~~l~~l~H---~niv~l~g~~~~~---  255 (511)
                      +.| +.|....+|+....       +++.+++|+.....   . ....+.+|+.+++.+..   ..+.++++++.++   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            457 78888999998754       26788999865432   1 23567889999888853   3567788877655   


Q ss_pred             CceeEEEeecCCCCccc
Q 010434          256 SKRALVYEFMPNGSLDR  272 (511)
Q Consensus       256 ~~~~lV~e~~~~gsL~~  272 (511)
                      +..++||||++|..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999887765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.29  E-value=1.3e-06  Score=84.49  Aligned_cols=133  Identities=15%  Similarity=0.109  Sum_probs=92.2

Q ss_pred             cCcCCc-EEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhcccc-ccceEEeeceeccCCceeEEEeecCCCCccc
Q 010434          196 LGQGGF-GSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDR  272 (511)
Q Consensus       196 LG~G~f-g~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~  272 (511)
                      +..|.- +.||+.... ++..+.+|+-...  ...++.+|...++.+. +--+.++++++.+++..++|||++++.++.+
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~  109 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ  109 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence            333433 478988754 5678999985432  3557888999988874 4447788888888889999999999887765


Q ss_pred             ccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhC----------------------------------------------
Q 010434          273 HIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG----------------------------------------------  306 (511)
Q Consensus       273 ~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~----------------------------------------------  306 (511)
                      ....        .......+..+++..|.-||+.                                              
T Consensus       110 ~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          110 VLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            4310        1112234555555556666541                                              


Q ss_pred             ---------CCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          307 ---------CDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       307 ---------~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                               ....++|+|+.+.||+++++..+-|.||+.+.
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                     01237999999999999988777899998765

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.10  E-value=8.1e-06  Score=81.30  Aligned_cols=140  Identities=16%  Similarity=0.149  Sum_probs=81.1

Q ss_pred             ccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhcccccc--ceEEeece------eccCCceeEEEeecC
Q 010434          195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHV--NVVQLLGF------CSEGSKRALVYEFMP  266 (511)
Q Consensus       195 ~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~--niv~l~g~------~~~~~~~~lV~e~~~  266 (511)
                      .|+.|..+.||+....+| .+++|+....   .++...|+.++..+...  .+.+++..      ...++..+++|+|++
T Consensus        39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~  114 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE  114 (346)
T ss_dssp             ECC----CEEEEEEETTE-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred             eccccccCcEEEEEeCCC-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence            466677889999987655 5889988652   34445566666666422  23444431      123566789999999


Q ss_pred             CCCccc--------------ccccCCC----c------CCccCHHHH-------------------------------HH
Q 010434          267 NGSLDR--------------HIFPKEN----K------GQTFGWEKL-------------------------------QE  291 (511)
Q Consensus       267 ~gsL~~--------------~l~~~~~----~------~~~l~~~~~-------------------------------~~  291 (511)
                      |..+..              .++....    .      ...-.|...                               ..
T Consensus       115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  194 (346)
T 2q83_A          115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG  194 (346)
T ss_dssp             CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred             CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence            876531              0111000    0      001123211                               11


Q ss_pred             HHHHHHHHHHHHHh----------CCCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          292 IALGTARGVAYLHN----------GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       292 i~~~ia~~l~yLH~----------~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      +...+..++++|+.          .....++|+|++++|||++.++.+.|.||+.+.
T Consensus       195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            11223445666653          124689999999999999888899999999764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.90  E-value=3.3e-05  Score=79.11  Aligned_cols=73  Identities=15%  Similarity=0.113  Sum_probs=49.1

Q ss_pred             cccCcCCcEEEEEEEec-CCcEEEEEEeccCc--------ccHHHHHHHHHHhccccc---cceEEeeceeccCCceeEE
Q 010434          194 HKLGQGGFGSVYKGQLH-TGRLIAVKMLENSK--------FSAEEFINEVSTIGRIHH---VNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~--------~~~~~f~~Ev~~l~~l~H---~niv~l~g~~~~~~~~~lV  261 (511)
                      +.||.|..+.||++... +++.++||......        ...+.+..|.+++..+..   ..+.+++.+  +....++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence            57999999999999754 57899999764311        223456788888887742   344556544  33456899


Q ss_pred             EeecCCC
Q 010434          262 YEFMPNG  268 (511)
Q Consensus       262 ~e~~~~g  268 (511)
                      ||++++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999763

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.87  E-value=7.9e-05  Score=73.87  Aligned_cols=138  Identities=17%  Similarity=0.150  Sum_probs=92.3

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhcccc---ccceEEeeceeccCCceeEEEeecCCCCc
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRALVYEFMPNGSL  270 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~~gsL  270 (511)
                      +.|+.|....+|+... +++.+++|+....  ....|..|+..|+.|.   ...+++.++++...+..++||||+++..+
T Consensus        42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             EEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            4689999999999986 4678889986543  3567889999998884   35688888888777889999999998876


Q ss_pred             cc-----------ccccCCC---c---------------CCccCHHHHH---HHHH----------------HHHHH-HH
Q 010434          271 DR-----------HIFPKEN---K---------------GQTFGWEKLQ---EIAL----------------GTARG-VA  301 (511)
Q Consensus       271 ~~-----------~l~~~~~---~---------------~~~l~~~~~~---~i~~----------------~ia~~-l~  301 (511)
                      ..           .++....   -               ...-+|....   ++..                .+... ..
T Consensus       119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~  198 (312)
T 3jr1_A          119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD  198 (312)
T ss_dssp             CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred             CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence            32           1111111   0               0012455332   1111                11111 22


Q ss_pred             HHHh-CCCCceecccCCcCceEEcCCCCeeeeccc
Q 010434          302 YLHN-GCDMCILHFDIKPHNILLDHNFIPKVSDFG  335 (511)
Q Consensus       302 yLH~-~~~~~ivH~DIkp~NILl~~~~~~kl~DFG  335 (511)
                      .|.. .....++|+|+.+.|++++.++ +.|.|+.
T Consensus       199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            3421 2246899999999999999887 8899974

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.51  E-value=0.00039  Score=68.83  Aligned_cols=142  Identities=18%  Similarity=0.179  Sum_probs=84.3

Q ss_pred             ccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccc--eEEeece-----eccCCceeEEEeecCC
Q 010434          195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVN--VVQLLGF-----CSEGSKRALVYEFMPN  267 (511)
Q Consensus       195 ~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~n--iv~l~g~-----~~~~~~~~lV~e~~~~  267 (511)
                      .|+ |....||+....+|+.+++|.........+.+..|..++..+....  +++++..     ...++..+++|+|++|
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G  111 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  111 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence            356 7778999987777878999998654445677788888888875322  4444443     1123455789999988


Q ss_pred             CCcccc--------------cccC----C-CcCCccCHHHH----HHH---------------HHHHHHHHHHHHh----
Q 010434          268 GSLDRH--------------IFPK----E-NKGQTFGWEKL----QEI---------------ALGTARGVAYLHN----  305 (511)
Q Consensus       268 gsL~~~--------------l~~~----~-~~~~~l~~~~~----~~i---------------~~~ia~~l~yLH~----  305 (511)
                      ..+...              ++..    . .....+++...    ..+               ...+...++.+.+    
T Consensus       112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  191 (328)
T 1zyl_A          112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE  191 (328)
T ss_dssp             EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred             CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence            655310              1100    0 00112222211    000               1111122333322    


Q ss_pred             CCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       306 ~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      .....++|+|++++||+++ + .+.|.||+.+..
T Consensus       192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            1245789999999999999 4 899999987754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.47  E-value=0.00036  Score=72.33  Aligned_cols=73  Identities=14%  Similarity=0.248  Sum_probs=51.8

Q ss_pred             cccCcCCcEEEEEEEecC--------CcEEEEEEeccCcccHHHHHHHHHHhccccccce-EEeeceeccCCceeEEEee
Q 010434          194 HKLGQGGFGSVYKGQLHT--------GRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~--------g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~  264 (511)
                      +.|+.|....||+...++        ++.+.+|+.... ...+.+.+|..++..+...++ .++++.+.+    .+|+||
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~  153 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  153 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence            467888889999998653        578999987432 223567789999988854444 566766653    289999


Q ss_pred             cCCCCcc
Q 010434          265 MPNGSLD  271 (511)
Q Consensus       265 ~~~gsL~  271 (511)
                      +++.+|.
T Consensus       154 l~G~~l~  160 (429)
T 1nw1_A          154 IPSRPLS  160 (429)
T ss_dssp             CCEEECC
T ss_pred             eCCcccC
Confidence            9875554

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.47  E-value=0.00022  Score=69.52  Aligned_cols=74  Identities=20%  Similarity=0.242  Sum_probs=54.3

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEEeccCc-ccHHHHHHHHHHhccccc---cceEEeeceeccCCceeEEEeecCCCC
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSK-FSAEEFINEVSTIGRIHH---VNVVQLLGFCSEGSKRALVYEFMPNGS  269 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H---~niv~l~g~~~~~~~~~lV~e~~~~gs  269 (511)
                      +.+|.|..+.||+.++.+|+.+.+|+-.... .....|..|+..|+.|..   .-+++.+++.    ..++||||++++.
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~   96 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP   96 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence            5689999999999999999999999865432 233467889998888742   2344555542    3479999998765


Q ss_pred             cc
Q 010434          270 LD  271 (511)
Q Consensus       270 L~  271 (511)
                      ..
T Consensus        97 ~~   98 (288)
T 3f7w_A           97 PT   98 (288)
T ss_dssp             CC
T ss_pred             CC
Confidence            43

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.45  E-value=0.00038  Score=71.77  Aligned_cols=81  Identities=10%  Similarity=0.080  Sum_probs=48.2

Q ss_pred             CCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCC-CcCccchHHHHHHHHHH
Q 010434          308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG-TVSCKSDVYGFGMVLLE  386 (511)
Q Consensus       308 ~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~s~ksDVwS~Gvll~e  386 (511)
                      ...++|+|++|.|||++.++ ++|.||+.+...+..-+.... ...-...|.+|+......+ .-....++......+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAY-LGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHH-HHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHH-HHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            36899999999999998876 999999988754321111000 0001234566654431100 11223556677888888


Q ss_pred             HHhC
Q 010434          387 MAGG  390 (511)
Q Consensus       387 lltg  390 (511)
                      ...+
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7765

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.44  E-value=0.00042  Score=68.38  Aligned_cols=143  Identities=13%  Similarity=0.141  Sum_probs=81.2

Q ss_pred             cccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccc--eEEeecee------ccCCceeEEEeec
Q 010434          194 HKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVN--VVQLLGFC------SEGSKRALVYEFM  265 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~n--iv~l~g~~------~~~~~~~lV~e~~  265 (511)
                      +.|+.|....+|+....+| .+++|+.... ...+++..|+.++..+...+  +.+++...      ...+..+++++|+
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l  105 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL  105 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence            3577788889999987655 6788987652 12335667788777774322  23333221      1235578999999


Q ss_pred             CCCCcccc--------------cccCC----Cc----CCccCHHHHHH------------HHHHHHHHHHHHHhC----C
Q 010434          266 PNGSLDRH--------------IFPKE----NK----GQTFGWEKLQE------------IALGTARGVAYLHNG----C  307 (511)
Q Consensus       266 ~~gsL~~~--------------l~~~~----~~----~~~l~~~~~~~------------i~~~ia~~l~yLH~~----~  307 (511)
                      +|..+...              ++...    ..    .....|.....            +...+.+.++.+++.    .
T Consensus       106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~  185 (322)
T 2ppq_A          106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL  185 (322)
T ss_dssp             CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred             CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence            98765321              11100    00    00112332111            011244456666532    2


Q ss_pred             CCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       308 ~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      ...++|+|++++|||++++..+.|.||+.+.
T Consensus       186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            4579999999999999987666899998664

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.36  E-value=0.00046  Score=67.65  Aligned_cols=72  Identities=10%  Similarity=0.078  Sum_probs=44.2

Q ss_pred             ccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccce-EEeeceeccCCceeEEEeec-CCCCc
Q 010434          193 THKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEFM-PNGSL  270 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~-~~gsL  270 (511)
                      .+.|+.|....+|+.     +.+++|+.........+..+|+.+++.+...++ .+++++.  ...-++++||+ ++.++
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence            356888999999998     568888875422111123467777777643332 3555543  33457899999 66555


Q ss_pred             c
Q 010434          271 D  271 (511)
Q Consensus       271 ~  271 (511)
                      .
T Consensus        96 ~   96 (301)
T 3dxq_A           96 S   96 (301)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.24  E-value=0.0012  Score=67.02  Aligned_cols=141  Identities=16%  Similarity=0.171  Sum_probs=85.7

Q ss_pred             cccCcCCcEEEEEEEec--------CCcEEEEEEeccCcccHHHHHHHHHHhccccccc-eEEeeceeccCCceeEEEee
Q 010434          194 HKLGQGGFGSVYKGQLH--------TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVN-VVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~--------~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.|..|-...+|+....        +++.+.+|+............+|..+++.+...+ ..++++++.++    +||||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~  131 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQY  131 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEEC
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEE
Confidence            35666777788998764        2578999986443335667789999998885322 35667766543    99999


Q ss_pred             cCCCCccccc-----------------ccCC-CcCCcc--CHHHHHHHHHHHHH-------------------HHHHHHh
Q 010434          265 MPNGSLDRHI-----------------FPKE-NKGQTF--GWEKLQEIALGTAR-------------------GVAYLHN  305 (511)
Q Consensus       265 ~~~gsL~~~l-----------------~~~~-~~~~~l--~~~~~~~i~~~ia~-------------------~l~yLH~  305 (511)
                      ++|..|..--                 +... ..+...  -|.++.++..++..                   .++.|.+
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            9987664211                 1110 011122  24555555544322                   2333332


Q ss_pred             -----CCCCceecccCCcCceEEcCC----CCeeeecccccc
Q 010434          306 -----GCDMCILHFDIKPHNILLDHN----FIPKVSDFGLAK  338 (511)
Q Consensus       306 -----~~~~~ivH~DIkp~NILl~~~----~~~kl~DFGla~  338 (511)
                           .....++|+|+.+.||+++.+    +.+.|+||..+.
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence                 224579999999999999876    789999998765

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.15  E-value=0.0013  Score=68.71  Aligned_cols=74  Identities=12%  Similarity=0.059  Sum_probs=47.7

Q ss_pred             cccCcCCcEEEEEEEecC-CcEEEEEEeccCcccHHHHHHHHHHhccccccce-EEeeceeccCCceeEEEeecCCCCcc
Q 010434          194 HKLGQGGFGSVYKGQLHT-GRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEFMPNGSLD  271 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~-g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL~  271 (511)
                      +.|+.|-...+|+....+ +..+++|+........-+-.+|..++..|...++ .++++++..    .+||||+++.+|.
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l~  189 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYALS  189 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEECC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccCC
Confidence            468888889999998764 5788899874422111112478888888864444 567777643    2599999886654

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.13  E-value=0.0015  Score=64.86  Aligned_cols=34  Identities=32%  Similarity=0.334  Sum_probs=28.8

Q ss_pred             CCceecccCCcCceEEcCC----CCeeeecccccccCC
Q 010434          308 DMCILHFDIKPHNILLDHN----FIPKVSDFGLAKFHP  341 (511)
Q Consensus       308 ~~~ivH~DIkp~NILl~~~----~~~kl~DFGla~~~~  341 (511)
                      ...++|+|+.+.||+++.+    ..+.|.||+.+...+
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            4689999999999999874    678999999887543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.02  E-value=0.0012  Score=66.65  Aligned_cols=73  Identities=12%  Similarity=0.131  Sum_probs=44.0

Q ss_pred             cccCcCCcEEEEEEEecC---------CcEEEEEEeccCcccHHHHHHHHHHhccccccc-eEEeeceeccCCceeEEEe
Q 010434          194 HKLGQGGFGSVYKGQLHT---------GRLIAVKMLENSKFSAEEFINEVSTIGRIHHVN-VVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~---------g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e  263 (511)
                      +.|+.|..-.+|+....+         ++.+++|+.........+...|..+++.+...+ ..++++...    -.+|||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~e  114 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIEE  114 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEEE
Confidence            457778778999998654         268899987543221112357888887775434 345555442    368999


Q ss_pred             ecCCCCc
Q 010434          264 FMPNGSL  270 (511)
Q Consensus       264 ~~~~gsL  270 (511)
                      |++|..+
T Consensus       115 ~i~G~~l  121 (369)
T 3c5i_A          115 WLYGDPL  121 (369)
T ss_dssp             CCCSEEC
T ss_pred             EecCCcC
Confidence            9987655

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.73  E-value=0.006  Score=60.84  Aligned_cols=68  Identities=12%  Similarity=0.087  Sum_probs=43.7

Q ss_pred             CcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccc---cceEEeece------eccCCceeEEEeecCC
Q 010434          197 GQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHH---VNVVQLLGF------CSEGSKRALVYEFMPN  267 (511)
Q Consensus       197 G~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H---~niv~l~g~------~~~~~~~~lV~e~~~~  267 (511)
                      |.|....||+....+| .+++|+......     ..|+..+..|..   |++++.+..      ...++..+++|+|++|
T Consensus        32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G  105 (339)
T 3i1a_A           32 GADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA  105 (339)
T ss_dssp             TSCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred             cCccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence            4444679999987777 899998765432     345556655532   224444432      2334667899999998


Q ss_pred             CCc
Q 010434          268 GSL  270 (511)
Q Consensus       268 gsL  270 (511)
                      ..+
T Consensus       106 ~~~  108 (339)
T 3i1a_A          106 PNG  108 (339)
T ss_dssp             CBT
T ss_pred             CcC
Confidence            766

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.62  E-value=0.0065  Score=56.31  Aligned_cols=103  Identities=10%  Similarity=-0.029  Sum_probs=65.9

Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      -+|.+.|   +..+.++++++++.++.|.+.+|.-+-..  ..-..+=+.|..|+|..+|.+...+ +.+.         
T Consensus        33 vSL~eIL---~~~~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           33 LSLEEIL---RLYNQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEHHHHH---HHHTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             ccHHHHH---HHcCCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc---------
Confidence            3667776   34568999999999999999998776221  1112334557999999999987764 1110         


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCC
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRN  393 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p  393 (511)
                           .....+.|||...   ...+.+.=|||+|+++|.-+--..|
T Consensus        98 -----~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 -----AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             --------------CCSS---SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -----ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                 1123456888763   2557788999999999998854433

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.33  E-value=0.069  Score=54.90  Aligned_cols=141  Identities=9%  Similarity=0.136  Sum_probs=83.5

Q ss_pred             cccCcCCcEEEEEEEecC--------CcEEEEEEeccCcccHHHHHHHHHHhccccccc-eEEeeceeccCCceeEEEee
Q 010434          194 HKLGQGGFGSVYKGQLHT--------GRLIAVKMLENSKFSAEEFINEVSTIGRIHHVN-VVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~--------g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~  264 (511)
                      +.+..|-...+|+...++        ++.+++|+........-+-.+|..+++.+...+ ..++++.+.    -.+||||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef  151 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF  151 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence            456667778899988653        578999986543211112356888877775323 344555432    3789999


Q ss_pred             cCCCCcccc-c----------------ccCCC---------cCCccCHHHHHHHHHHH-------------------HHH
Q 010434          265 MPNGSLDRH-I----------------FPKEN---------KGQTFGWEKLQEIALGT-------------------ARG  299 (511)
Q Consensus       265 ~~~gsL~~~-l----------------~~~~~---------~~~~l~~~~~~~i~~~i-------------------a~~  299 (511)
                      ++|..|..- +                +....         ...+.-|.++.++..++                   ...
T Consensus       152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e  231 (424)
T 3mes_A          152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE  231 (424)
T ss_dssp             CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred             eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence            998765321 1                00000         11122244444443322                   223


Q ss_pred             HHHHHh---------------------CCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          300 VAYLHN---------------------GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       300 l~yLH~---------------------~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      ++.|.+                     .....++|+|+.+.||+ ++++.+.|+||..+..
T Consensus       232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            334331                     11356899999999999 8888999999987753

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.69  E-value=0.11  Score=52.87  Aligned_cols=29  Identities=28%  Similarity=0.309  Sum_probs=24.4

Q ss_pred             ceecccCCcCceEE------cCCCCeeeecccccc
Q 010434          310 CILHFDIKPHNILL------DHNFIPKVSDFGLAK  338 (511)
Q Consensus       310 ~ivH~DIkp~NILl------~~~~~~kl~DFGla~  338 (511)
                      .++|+|+.+.|||+      +++..++++||.+|.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            46799999999999      456779999998775

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=89.09  E-value=0.036  Score=57.79  Aligned_cols=60  Identities=3%  Similarity=0.007  Sum_probs=18.9

Q ss_pred             hhccccCcCCcEEEEEEEecC-CcEEEE------EEeccCc---ccHHHHHHHHHHhccccccceEEeeceec
Q 010434          191 HFTHKLGQGGFGSVYKGQLHT-GRLIAV------KMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCS  253 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~~-g~~vAv------K~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~  253 (511)
                      .+.++||   ||.||+|.+.. ..+|||      |..+...   .....|.+|..+++.++|||+++.++|..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            4456787   99999999764 468898      7665422   23356889999999999999999988753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.37  E-value=0.77  Score=42.24  Aligned_cols=84  Identities=11%  Similarity=0.118  Sum_probs=59.5

Q ss_pred             cccceEEeeceeccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCc
Q 010434          241 HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHN  320 (511)
Q Consensus       241 ~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~N  320 (511)
                      .||+++.. .+-.+++...+.|+.-+  +...+-     .-..++...+++++.+|+....+++.     -+|.-+.|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~-----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD-----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG-----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH-----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence            57877755 34445555555555433  232221     12567888999999999998876664     4899999999


Q ss_pred             eEEcCCCCeeeeccccc
Q 010434          321 ILLDHNFIPKVSDFGLA  337 (511)
Q Consensus       321 ILl~~~~~~kl~DFGla  337 (511)
                      ++++.++.|++.-.|+-
T Consensus       110 L~f~~~~~p~i~~RGik  126 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQ  126 (215)
T ss_dssp             EEECTTSCEEESCCEET
T ss_pred             EEEcCCCCEEEEEccCc
Confidence            99999999999887753

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=83.69  E-value=1.2  Score=41.05  Aligned_cols=83  Identities=12%  Similarity=0.025  Sum_probs=57.3

Q ss_pred             cccceEEeeceeccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHH-HHHhCCCCceecccCCcC
Q 010434          241 HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVA-YLHNGCDMCILHFDIKPH  319 (511)
Q Consensus       241 ~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~-yLH~~~~~~ivH~DIkp~  319 (511)
                      .||++  -..+-.+++...+.|+--+++.=...+       ..++...+++.+.+|+.... +++     .-+|.-+.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCc
Confidence            57777  223335555555666544332222222       45778889999999888776 555     4588999999


Q ss_pred             ceEEcCCCCeeeeccccc
Q 010434          320 NILLDHNFIPKVSDFGLA  337 (511)
Q Consensus       320 NILl~~~~~~kl~DFGla  337 (511)
                      |+++|.++.|++.-.|+-
T Consensus       114 NL~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             GEEECTTCCEEESCCEET
T ss_pred             eEEEeCCCcEEEEEcCCc
Confidence            999999999999887753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	511
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-68
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-62
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-62
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-62
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-62
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-60
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-58
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-57
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-57
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-56
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-55
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-55
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-55
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-54
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-54
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-53
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-53
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-53
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-52
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-52
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-51
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-51
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-51
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-51
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-51
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-50
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-49
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-49
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-49
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-49
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-47
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-46
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-46
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-44
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-42
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-42
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-40
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-39
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-39
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-39
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-38
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-38
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-38
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-37
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-37
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-37
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-37
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-37
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-36
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-34
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-34
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-33
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-31
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-29
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-26
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-18

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (557), Expect = 3e-68
 Identities = 81/277 (29%), Positives = 139/277 (50%), Gaps = 24/277 (8%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQ 247
               ++G G FG+VYKG+ H    +AVKML  +  +    + F NEV  + +  HVN++ 
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68

Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
            +G+ +   + A+V ++    SL  H+   E K   F   KL +IA  TA+G+ YLH   
Sbjct: 69  FMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHA-- 122

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SR 366
              I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  +
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 367 NFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV 425
           +    S +SDVY FG+VL E+  G+   SN+N            +   + +G      ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--------RDQIIFMVGRG--YLSPDL 231

Query: 426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
           +++ S   + +  +   C++ K  +RP   ++L  +E
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 1e-62
 Identities = 65/272 (23%), Positives = 125/272 (45%), Gaps = 22/272 (8%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
            F  +LG G FG V  G+      +A+KM++    S +EFI E   +  + H  +VQL G
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
            C++     ++ E+M NG L  ++    ++   F  ++L E+       + YL +     
Sbjct: 67  VCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLES---KQ 120

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
            LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++      
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMY--SK 177

Query: 371 VSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 430
            S KSD++ FG+++ E+    +          + +  S   + + +G  L          
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGK-------MPYERFTNSETAEHIAQGLRL------YRPH 224

Query: 431 VIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
           + + K+  I   C   KA +RP+   +L  + 
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (516), Expect = 3e-62
 Identities = 76/284 (26%), Positives = 123/284 (43%), Gaps = 22/284 (7%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
               KLGQG FG V+ G  +    +A+K L+    S E F+ E   + ++ H  +VQL  
Sbjct: 20  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 79

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
             SE     +V E+M  GSL      K   G+     +L ++A   A G+AY+     M 
Sbjct: 80  VVSEE-PIYIVTEYMSKGSLLDF--LKGETGKYLRLPQLVDMAAQIASGMAYVER---MN 133

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
            +H D++  NIL+  N + KV+DFGLA+    +N++ +    +  I + APE      G 
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALY--GR 190

Query: 371 VSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 430
            + KSDV+ FG++L E+    R                 V DQ+ +G  +          
Sbjct: 191 FTIKSDVWSFGILLTELTTKGR-------VPYPGMVNREVLDQVERGYRM------PCPP 237

Query: 431 VIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKP 474
                L  +   C + +  +RP+   +   LE      +   +P
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 3e-62
 Identities = 70/272 (25%), Positives = 123/272 (45%), Gaps = 22/272 (8%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
               +LG G FG V+ G  +    +AVK L+    S + F+ E + + ++ H  +V+L  
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
             ++     ++ E+M NGSL   +  K   G      KL ++A   A G+A++    +  
Sbjct: 76  VVTQE-PIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 129

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
            +H D++  NIL+      K++DFGLA+    +N++ +    +  I + APE I  N+GT
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAI--NYGT 186

Query: 371 VSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 430
            + KSDV+ FG++L E+    R                 V   L +G  +          
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGR-------IPYPGMTNPEVIQNLERGYRM------VRPD 233

Query: 431 VIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
               +L  +   C + +  DRP+   +  +LE
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 4e-62
 Identities = 71/271 (26%), Positives = 123/271 (45%), Gaps = 22/271 (8%)

Query: 192 FTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 251
           F  ++G G FG V+ G       +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 9   FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
           C E +   LV+EFM +G L  ++     +   F  E L  + L    G   +    + C+
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEG---MAYLEEACV 122

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           +H D+   N L+  N + KVSDFG+ +F   +    S   T+  + + +PE+   +F   
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVF--SFSRY 179

Query: 372 SCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESV 431
           S KSDV+ FG+++ E+    +    N          S V + ++ G  L          +
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYEN-------RSNSEVVEDISTGFRL------YKPRL 226

Query: 432 IARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
            +  +  I   C + +  DRP+ +++L  L 
Sbjct: 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 1e-60
 Identities = 64/301 (21%), Positives = 123/301 (40%), Gaps = 32/301 (10%)

Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 254
            +G+G FG V++G+   G  +AVK+  + +  +     E+     + H N++  +   ++
Sbjct: 10  SIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 68

Query: 255 G----SKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                ++  LV ++  +GSL  ++        T   E + ++AL TA G+A+LH      
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 311 -----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR--GTIGYIAPEL 363
                I H D+K  NIL+  N    ++D GLA  H    D + I+     GT  Y+APE+
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 364 ISRNF----GTVSCKSDVYGFGMVLLEMAGGRRNSNMNA--------IRSSKAYFPSWVY 411
           +  +          ++D+Y  G+V  E+A       ++         +  S         
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 412 DQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG--SMDDLQ 469
               +     + N  +    + R +  I   C     A R +  ++ + L      + ++
Sbjct: 244 VVCEQKLRPNIPNRWQSCEAL-RVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302

Query: 470 M 470
           M
Sbjct: 303 M 303

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  192 bits (489), Expect = 3e-58
 Identities = 77/289 (26%), Positives = 125/289 (43%), Gaps = 24/289 (8%)

Query: 177 PKRYSYPEIIAVTNHFT--HKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINE 233
           P   +Y +        T  HKLG G +G VY+G        +AVK L+      EEF+ E
Sbjct: 4   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 63

Query: 234 VSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIA 293
            + +  I H N+VQLLG C+      ++ EFM  G+L  ++   E   Q      L  +A
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMA 121

Query: 294 LGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 353
              +  + YL        +H D+   N L+  N + KV+DFGL++    +      +  +
Sbjct: 122 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAK 177

Query: 354 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQ 413
             I + APE ++      S KSDV+ FG++L E+A               + +P     Q
Sbjct: 178 FPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYG-----------MSPYPGIDLSQ 224

Query: 414 LNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
           + +  + + R   E       K+  +   C Q   +DRPS  ++ +  E
Sbjct: 225 VYELLEKDYRM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 1e-57
 Identities = 72/273 (26%), Positives = 117/273 (42%), Gaps = 28/273 (10%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
                +G+G FG V  G  + G  +AVK ++N   +A+ F+ E S + ++ H N+VQLLG
Sbjct: 10  KLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLG 67

Query: 251 FCSEGSKR-ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
              E      +V E+M  GSL  ++  +       G + L + +L     + YL      
Sbjct: 68  VIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GN 122

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
             +H D+   N+L+  + + KVSDFGL K      D       +  + + APE +     
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----KLPVKWTAPEALRE--K 175

Query: 370 TVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
             S KSDV+ FG++L E+    R                 V  ++ KG  +      +  
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGR-------VPYPRIPLKDVVPRVEKGYKM------DAP 222

Query: 430 SVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
                 +  +   C  + AA RPS  ++ E LE
Sbjct: 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  189 bits (481), Expect = 9e-57
 Identities = 64/271 (23%), Positives = 107/271 (39%), Gaps = 32/271 (11%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVVQLL 249
           ++G G FG+VY  + +    ++A+K +  S   + E     I EV  + ++ H N +Q  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G         LV E+    + D          +     ++  +  G  +G+AYLH     
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLH---SH 134

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 368
            ++H D+K  NILL    + K+ DFG A      N FV      GT  ++APE+I + + 
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAMDE 188

Query: 369 GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEI 428
           G    K DV+  G+  +E+A  +              F       L      E   +   
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKP-----------PLFNMNAMSALYHIAQNESPAL--Q 235

Query: 429 ESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
               +         C+Q    DRP+   +L+
Sbjct: 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  188 bits (479), Expect = 2e-56
 Identities = 71/303 (23%), Positives = 126/303 (41%), Gaps = 41/303 (13%)

Query: 180 YSYPEIIAVTNHFT-----------HKLGQGGFGSVYKGQLH----TGRLIAVKML--EN 222
           +++ +       F              +G G FG V  G L         +A+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 223 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQ 282
           ++    +F++E S +G+  H NV+ L G  ++ +   ++ EFM NGSLD  +   + +  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-- 124

Query: 283 TFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 342
            F   +L  +  G A G+ YL +   M  +H D+   NIL++ N + KVSDFGL++F   
Sbjct: 125 -FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 343 ENDFVSISAT---RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAI 399
           +    + ++    +  I + APE I   +   +  SDV+ +G+V+ E+            
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAI--QYRKFTSASDVWSYGIVMWEVMSYGE------- 231

Query: 400 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
           R         V + + +   L               L  + L C Q     RP   +++ 
Sbjct: 232 RPYWDMTNQDVINAIEQDYRL------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285

Query: 460 MLE 462
            L+
Sbjct: 286 TLD 288

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 1e-55
 Identities = 68/300 (22%), Positives = 123/300 (41%), Gaps = 40/300 (13%)

Query: 191 HFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSKFSA--EEFINEVSTIGRI-H 241
            F   LG G FG V +   +          +AVKML+ S      E  ++E+  +  + +
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85

Query: 242 HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK--------------ENKGQTFGWE 287
           H+N+V LLG C+ G    ++ E+   G L   +  K              E+       E
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 288 KLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 347
            L   +   A+G+A+L +      +H D+   NILL H  I K+ DFGLA+    ++++V
Sbjct: 146 DLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFP 407
                R  + ++APE I       + +SDV+ +G+ L E+     +              
Sbjct: 203 VKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPG------MPVD 254

Query: 408 SWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD 467
           S  Y  + +G  +              ++  I   C       RP+  ++++++E  + +
Sbjct: 255 SKFYKMIKEGFRM------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  185 bits (471), Expect = 2e-55
 Identities = 66/300 (22%), Positives = 114/300 (38%), Gaps = 46/300 (15%)

Query: 191 HFTHKLGQGGFGSVYKGQL------HTGRLIAVKML--ENSKFSAEEFINEVSTIGRIHH 242
            +   +G+G FG V++ +           ++AVKML  E S     +F  E + +    +
Sbjct: 16  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 75

Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIF--------------------PKENKGQ 282
            N+V+LLG C+ G    L++E+M  G L+  +                            
Sbjct: 76  PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 135

Query: 283 TFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 342
                +   IA   A G+AYL        +H D+   N L+  N + K++DFGL++    
Sbjct: 136 PLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192

Query: 343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSS 402
            + + +       I ++ PE I  N    + +SDV+ +G+VL E+               
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGLQPY------- 243

Query: 403 KAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
                  V   +  G      N+         +L  +   C     ADRPS   +  +L+
Sbjct: 244 YGMAHEEVIYYVRDG------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 7e-55
 Identities = 67/286 (23%), Positives = 116/286 (40%), Gaps = 28/286 (9%)

Query: 195 KLGQGGFGSVYKGQLH---TGRLIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQLL 249
           +LG G FGSV +G          +A+K+L     K   EE + E   + ++ +  +V+L+
Sbjct: 16  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G C +     LV E    G L + +     K +      + E+    + G+ YL      
Sbjct: 76  GVC-QAEALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEE---K 128

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI-SATRGTIGYIAPELISRNF 368
             +H D+   N+LL +    K+SDFGL+K    ++ + +  SA +  + + APE I  NF
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--NF 186

Query: 369 GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEI 428
              S +SDV+ +G+ + E     +       +  K      V   + +G  +      E 
Sbjct: 187 RKFSSRSDVWSYGVTMWEALSYGQ-------KPYKKMKGPEVMAFIEQGKRM------EC 233

Query: 429 ESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKP 474
                 +L  +   C   K  DRP    V + +      L    + 
Sbjct: 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 279

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 3e-54
 Identities = 61/277 (22%), Positives = 113/277 (40%), Gaps = 26/277 (9%)

Query: 191 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVV 246
              + +G G +G   K +    G+++  K L+    +  E    ++EV+ +  + H N+V
Sbjct: 7   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66

Query: 247 QLLGFCSEGSKRAL--VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
           +      + +   L  V E+   G L   I     + Q    E +  +       +   H
Sbjct: 67  RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126

Query: 305 --NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
             +     +LH D+KP N+ LD     K+ DFGLA+    +  F    A  GT  Y++PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTPYYMSPE 184

Query: 363 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL 422
            ++R   + + KSD++  G +L E+                A+    +  ++ +G     
Sbjct: 185 QMNR--MSYNEKSDIWSLGCLLYELCALMPPFT--------AFSQKELAGKIREG----- 229

Query: 423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
                I    + +L  I    + +K   RPS+ ++LE
Sbjct: 230 -KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (459), Expect = 6e-54
 Identities = 65/277 (23%), Positives = 110/277 (39%), Gaps = 33/277 (11%)

Query: 192 FTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQ 247
           F  ++G+G F +VYKG    T   +A   L++ K +    + F  E   +  + H N+V+
Sbjct: 13  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72

Query: 248 LLGFCSEGSKR----ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
                    K      LV E M +G+L  ++     + +    + L+       +G+ +L
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFL 128

Query: 304 HNGCDMCILHFDIKPHNILL-DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
           H      I+H D+K  NI +       K+ D GLA             A  GT  ++APE
Sbjct: 129 HTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPE 183

Query: 363 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL 422
           +    +       DVY FGM +LEMA             S+    + +Y ++  G     
Sbjct: 184 MYEEKYDE---SVDVYAFGMCMLEMATSEYP-------YSECQNAAQIYRRVTSGVKPA- 232

Query: 423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
                 + V   ++  I   CI+    +R S+  +L 
Sbjct: 233 ----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-53
 Identities = 63/275 (22%), Positives = 116/275 (42%), Gaps = 30/275 (10%)

Query: 195 KLGQGGFGSVYKGQLH---TGRLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQL 248
           +LG G FG+V KG        + +AVK+L+N        +E + E + + ++ +  +V++
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
           +G C E     LV E    G L++++     + +    + + E+    + G+ YL     
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE--- 125

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPELISRN 367
              +H D+   N+LL      K+SDFGL+K    + ++       +  + + APE I+  
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY- 184

Query: 368 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE 427
               S KSDV+ FG+++ E     +       +  +    S V   L KG  +       
Sbjct: 185 -YKFSSKSDVWSFGVLMWEAFSYGQ-------KPYRGMKGSEVTAMLEKGERM------G 230

Query: 428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
             +   R++  +   C      +RP    V   L 
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 3e-53
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 17/209 (8%)

Query: 189 TNHFT--HKLGQGGFGSVYKGQ-LHTGRLIAVKML--ENSKFSAEEFINEVSTIGRIHHV 243
            + F    +LG G  G V+K     +G ++A K++  E       + I E+  +   +  
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64

Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
            +V   G      + ++  E M  GSLD+ +     K      + L ++++   +G+ YL
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYL 120

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
                  I+H D+KP NIL++     K+ DFG++            ++  GT  Y++PE 
Sbjct: 121 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPER 174

Query: 364 ISRNFGTVSCKSDVYGFGMVLLEMAGGRR 392
           +       S +SD++  G+ L+EMA GR 
Sbjct: 175 LQG--THYSVQSDIWSMGLSLVEMAVGRY 201

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 7e-53
 Identities = 68/281 (24%), Positives = 113/281 (40%), Gaps = 30/281 (10%)

Query: 191 HFTHKLGQGGFGSVYKGQLH----TGRLIAVKMLENSKFS----AEEFINEVSTIGRIHH 242
               KLG G FG V +G+          +AVK L+    S     ++FI EV+ +  + H
Sbjct: 11  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 70

Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
            N+++L G       + +V E  P GSL   +   +     F    L   A+  A G+ Y
Sbjct: 71  RNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGY 126

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIAP 361
           L +      +H D+   N+LL    + K+ DFGL +  P+ +D   +   R     + AP
Sbjct: 127 LES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE 421
           E +     T S  SD + FG+ L EM    +               S +  +++K G+  
Sbjct: 184 ESLKT--RTFSHASDTWMFGVTLWEMFTYGQ-------EPWIGLNGSQILHKIDKEGE-- 232

Query: 422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
                       + +  + + C   K  DRP+   + + L 
Sbjct: 233 ---RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 1e-52
 Identities = 56/274 (20%), Positives = 110/274 (40%), Gaps = 33/274 (12%)

Query: 191 HFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNV 245
                LG+G FG+VY  +   +  ++A+K+L  ++        +   EV     + H N+
Sbjct: 9   EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 68

Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           ++L G+  + ++  L+ E+ P G++ R +     K   F  ++        A  ++Y H 
Sbjct: 69  LRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCH- 123

Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
                ++H DIKP N+LL      K++DFG +   P            GT+ Y+ PE+I 
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIE 177

Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV 425
                   K D++  G++  E   G+             +  +   +   +   +E    
Sbjct: 178 G--RMHDEKVDLWSLGVLCYEFLVGKP-----------PFEANTYQETYKRISRVEF--- 221

Query: 426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
                 +      +    ++   + RP + +VLE
Sbjct: 222 -TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 1e-52
 Identities = 63/270 (23%), Positives = 116/270 (42%), Gaps = 25/270 (9%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLE-NSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
           +LG G FG VYK Q   T  L A K+++  S+   E+++ E+  +    H N+V+LL   
Sbjct: 19  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
              +   ++ EF   G++D  +       +     ++Q +   T   + YLH   D  I+
Sbjct: 79  YYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLH---DNKII 132

Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI---SRNFG 369
           H D+K  NIL   +   K++DFG++  + +        +  GT  ++APE++   +    
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDR 190

Query: 370 TVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 429
               K+DV+  G+ L+EMA                  P  V  ++ K     L   +   
Sbjct: 191 PYDYKADVWSLGITLIEMAEIE--------PPHHELNPMRVLLKIAKSEPPTLAQPSRW- 241

Query: 430 SVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
           S   +        C++     R + +++L+
Sbjct: 242 SSNFKDFLK---KCLEKNVDARWTTSQLLQ 268

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (443), Expect = 1e-51
 Identities = 75/276 (27%), Positives = 123/276 (44%), Gaps = 29/276 (10%)

Query: 196 LGQGGFGSVYKGQLHTG-----RLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQL 248
           +G G FG VYKG L T        +A+K L+      +  +F+ E   +G+  H N+++L
Sbjct: 15  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
            G  S+     ++ E+M NG+LD+ +     K   F   +L  +  G A G+ YL N   
Sbjct: 75  EGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLAN--- 128

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-SISATRGTIGYIAPELISRN 367
           M  +H D+   NIL++ N + KVSDFGL++    + +   + S  +  I + APE IS  
Sbjct: 129 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY- 187

Query: 368 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE 427
               +  SDV+ FG+V+ E+            R         V   +N G  L       
Sbjct: 188 -RKFTSASDVWSFGIVMWEVMTYGE-------RPYWELSNHEVMKAINDGFRL------P 233

Query: 428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 463
                   +  + + C Q + A RP    ++ +L+ 
Sbjct: 234 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 2e-51
 Identities = 67/281 (23%), Positives = 107/281 (38%), Gaps = 30/281 (10%)

Query: 191 HFTHKLGQGGFGSVYKGQLH----TGRLIAVKML--ENSKFSAEEFINEVSTIGRIHHVN 244
           HF   +G+G FG VY G L          AVK L          +F+ E   +    H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89

Query: 245 VVQLLGFCSEGSKRA-LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
           V+ LLG C        +V  +M +G L   I    N+      + L    L  A+G   +
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKG---M 143

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF--HPKENDFVSISATRGTIGYIAP 361
                   +H D+   N +LD  F  KV+DFGLA+     + +   + +  +  + ++A 
Sbjct: 144 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE 421
           E +       + KSDV+ FG++L E+                      +   L +G  L 
Sbjct: 204 ESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPY-------PDVNTFDITVYLLQGRRL- 253

Query: 422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
                         L  + L C   KA  RPS ++++  + 
Sbjct: 254 -----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 2e-51
 Identities = 67/301 (22%), Positives = 119/301 (39%), Gaps = 49/301 (16%)

Query: 192 FTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSKFSAE--EFINEVSTIGRI-HH 242
           F   LG G FG V     +          +AVKML+    S+E    ++E+  + ++  H
Sbjct: 41  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100

Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENK-------------------GQT 283
            N+V LLG C+      L++E+   G L  ++  K  K                      
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160

Query: 284 FGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 343
             +E L   A   A+G+ +L        +H D+   N+L+ H  + K+ DFGLA+    +
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217

Query: 344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRN--SNMNAIRS 401
           +++V     R  + ++APE +    G  + KSDV+ +G++L E+     N    +     
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV--- 272

Query: 402 SKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEML 461
                 +  Y  +  G  +      +       ++ +I   C    +  RPS   +   L
Sbjct: 273 -----DANFYKLIQNGFKM------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

Query: 462 E 462
            
Sbjct: 322 G 322

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 3e-51
 Identities = 69/272 (25%), Positives = 102/272 (37%), Gaps = 23/272 (8%)

Query: 191 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQ 247
                LG+G +G V       T   +AVK++  + +    E    E+     ++H NVV+
Sbjct: 8   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67

Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
             G   EG+ + L  E+   G L   I P             Q        GV YLH   
Sbjct: 68  FYGHRREGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLH--- 120

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
            + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ R 
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 368 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE 427
               +   DV+  G+VL  M  G    +            S       K     L    +
Sbjct: 181 -EFHAEPVDVWSCGIVLTAMLAGELPWDQP--------SDSCQEYSDWKEKKTYLNPWKK 231

Query: 428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
           I       L       +    + R ++  + +
Sbjct: 232 I-DSAPLALLH---KILVENPSARITIPDIKK 259

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 3e-51
 Identities = 71/322 (22%), Positives = 131/322 (40%), Gaps = 43/322 (13%)

Query: 191 HFTHKLGQGGFGSVYKGQLHTG---RLIAVKML--ENSKFSAEEFINEVSTIGRI-HHVN 244
            F   +G+G FG V K ++         A+K +    SK    +F  E+  + ++ HH N
Sbjct: 13  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72

Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIF------------PKENKGQTFGWEKLQEI 292
           ++ LLG C       L  E+ P+G+L   +                +   T   ++L   
Sbjct: 73  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132

Query: 293 ALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 352
           A   ARG+ YL        +H D+   NIL+  N++ K++DFGL++       +V  +  
Sbjct: 133 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKKTMG 186

Query: 353 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYD 412
           R  + ++A E +  N+   +  SDV+ +G++L E+                    + +Y+
Sbjct: 187 RLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGG-------TPYCGMTCAELYE 237

Query: 413 QLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPP 472
           +L +G  L      E       ++  +   C + K  +RPS  ++L  L   +++ +   
Sbjct: 238 KLPQGYRL------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 291

Query: 473 KPCFSSSRHISGREIESDSSTE 494
                     +G     D S E
Sbjct: 292 NTTLYEKFTYAG----IDCSAE 309

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 4e-50
 Identities = 69/312 (22%), Positives = 123/312 (39%), Gaps = 30/312 (9%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRL----IAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQ 247
            LG G FG+VYKG  +  G      +A+K L    S  + +E ++E   +  + + +V +
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75

Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
           LLG C   + + L+ + MP G L  ++          G + L    +  A+G+ YL +  
Sbjct: 76  LLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLED-- 129

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 130 -RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH- 187

Query: 368 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE 427
               + +SDV+ +G+ + E+            +       S +   L KG  L       
Sbjct: 188 -RIYTHQSDVWSYGVTVWELMTFGS-------KPYDGIPASEISSILEKGERL------P 233

Query: 428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKPCFSSSRHISGREI 487
              +    + MI + C  + A  RP   +++        D Q           H+     
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLP-SPT 292

Query: 488 ESDSSTEFLVSE 499
           +S+     +  E
Sbjct: 293 DSNFYRALMDEE 304

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (430), Expect = 2e-49
 Identities = 66/290 (22%), Positives = 120/290 (41%), Gaps = 32/290 (11%)

Query: 191 HFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSKFSAE--EFINEVSTIGRIHH 242
             + +LGQG FG VY+G             +A+K +  +    E  EF+NE S +   + 
Sbjct: 23  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82

Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK------ENKGQTFGWEKLQEIALGT 296
            +VV+LLG  S+G    ++ E M  G L  ++                   K+ ++A   
Sbjct: 83  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 142

Query: 297 ARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 356
           A G+AYL+       +H D+   N ++  +F  K+ DFG+ +   + + +         +
Sbjct: 143 ADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199

Query: 357 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK 416
            +++PE +    G  +  SDV+ FG+VL E+A           +  +      V   + +
Sbjct: 200 RWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAE-------QPYQGLSNEQVLRFVME 250

Query: 417 GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD 466
           GG L      +        L  +   C Q     RPS  +++  ++  M+
Sbjct: 251 GGLL------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 6e-49
 Identities = 60/283 (21%), Positives = 112/283 (39%), Gaps = 29/283 (10%)

Query: 191 HFTHKLGQGGFGSVYKGQLH----TGRLIAVKMLENSKFSA--EEFINEVSTIGRIHHVN 244
                +G+G FG V++G           +A+K  +N    +  E+F+ E  T+ +  H +
Sbjct: 10  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 69

Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
           +V+L+G  +E     ++ E    G L   +     +  +     L   A   +  +AYL 
Sbjct: 70  IVKLIGVITEN-PVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLE 125

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
                  +H DI   N+L+  N   K+ DFGL+++      + + S  +  I ++APE I
Sbjct: 126 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESI 181

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN 424
             NF   +  SDV+ FG+ + E+                    + V  ++  G  L    
Sbjct: 182 --NFRRFTSASDVWMFGVCMWEILMHGVKPFQ-------GVKNNDVIGRIENGERL---- 228

Query: 425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD 467
              +       L  +   C     + RP  T++   L   +++
Sbjct: 229 --PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 7e-49
 Identities = 63/267 (23%), Positives = 112/267 (41%), Gaps = 26/267 (9%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE-FINEVSTIGRIHHVNVVQLLGFC 252
           K+GQG  G+VY    + TG+ +A++ +   +   +E  INE+  +    + N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 253 SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCIL 312
             G +  +V E++  GSL   +             ++  +     + + +LH      ++
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLH---SNQVI 138

Query: 313 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 372
           H DIK  NILL  +   K++DFG       E      S   GT  ++APE+++R      
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTR--KAYG 194

Query: 373 CKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVI 432
            K D++  G++ +EM  G                P      +   G  EL+N  ++ S I
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP--------YLNENPLRALYLIATNGTPELQNPEKL-SAI 245

Query: 433 ARKLCMIGLWCIQVKAADRPSMTKVLE 459
            R        C+ +    R S  ++L+
Sbjct: 246 FRDFLN---RCLDMDVEKRGSAKELLQ 269

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 8e-49
 Identities = 71/297 (23%), Positives = 125/297 (42%), Gaps = 39/297 (13%)

Query: 191 HFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSKFSAE--EFINEVSTIGRI-H 241
                LG+G FG V +          T R +AVKML+     +E    ++E+  +  I H
Sbjct: 16  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 75

Query: 242 HVNVVQLLGFCSE-GSKRALVYEFMPNGSLDRHIF------------PKENKGQTFGWEK 288
           H+NVV LLG C++ G    ++ EF   G+L  ++             P++        E 
Sbjct: 76  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135

Query: 289 LQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 348
           L   +   A+G+ +L +      +H D+   NILL    + K+ DFGLA+   K+ D+V 
Sbjct: 136 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192

Query: 349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPS 408
               R  + ++APE I       + +SDV+ FG++L E+     +               
Sbjct: 193 KGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDE 244

Query: 409 WVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM 465
               +L +G  +              ++    L C   + + RP+ ++++E L   +
Sbjct: 245 EFCRRLKEGTRM------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 9e-47
 Identities = 63/294 (21%), Positives = 122/294 (41%), Gaps = 41/294 (13%)

Query: 192 FTHKLGQGGFGSVYKGQL--------HTGRLIAVKML--ENSKFSAEEFINEVSTIGRI- 240
               LG+G FG V   +         +    +AVKML  + ++    + I+E+  +  I 
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76

Query: 241 HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIF------------PKENKGQTFGWEK 288
            H N++ LLG C++     ++ E+   G+L  ++             P  N  +    + 
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 289 LQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 348
           L   A   ARG+ YL        +H D+   N+L+  + + K++DFGLA+     + +  
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPS 408
            +  R  + ++APE +       + +SDV+ FG++L E+                     
Sbjct: 194 TTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGG-------SPYPGVPVE 244

Query: 409 WVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
            ++  L +G  +      +  S    +L M+   C     + RP+  +++E L+
Sbjct: 245 ELFKLLKEGHRM------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  162 bits (410), Expect = 5e-46
 Identities = 54/285 (18%), Positives = 108/285 (37%), Gaps = 42/285 (14%)

Query: 188 VTNHFT--HKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFS-AEEFINEVSTIGRIHHV 243
           V +H+    +LG G FG V++     TG   A K +     S  E    E+ T+  + H 
Sbjct: 24  VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 83

Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
            +V L     + ++  ++YEFM  G L   +    ++      ++  E      +G+ ++
Sbjct: 84  TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 304 HNGCDMCILHFDIKPHNILL--DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 361
           H   +   +H D+KP NI+     +   K+ DFGL      +        T GT  + AP
Sbjct: 141 H---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAP 194

Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNAIRSSKAYFPSWVYDQL 414
           E+       V   +D++  G++   +  G         +  +  ++S         +  +
Sbjct: 195 EVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252

Query: 415 NKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
           ++          + +  I +         +      R ++ + LE
Sbjct: 253 SE----------DGKDFIRK--------LLLADPNTRMTIHQALE 279

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 6e-46
 Identities = 59/284 (20%), Positives = 103/284 (36%), Gaps = 43/284 (15%)

Query: 191 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNV 245
            F   LG+G F +V   + L T R  A+K+LE      E        E   + R+ H   
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70

Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
           V+L     +  K      +  NG L ++I          G          TA  V+ L  
Sbjct: 71  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-------IGSFDETCTRFYTAEIVSALEY 123

Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
                I+H D+KP NILL+ +   +++DFG AK    E+     ++  GT  Y++PEL++
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGRR-------NSNMNAIRSSKAYFPSWVYDQLNKGG 418
               +    SD++  G ++ ++  G               I   +  FP   +       
Sbjct: 184 E--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP------ 235

Query: 419 DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 462
                   +   ++ +         + + A  R    ++     
Sbjct: 236 --------KARDLVEK--------LLVLDATKRLGCEEMEGYGP 263

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  158 bits (400), Expect = 1e-44
 Identities = 58/311 (18%), Positives = 116/311 (37%), Gaps = 42/311 (13%)

Query: 162 VDNIEKFLHNQQSWMPKRYSYPEIIAVTNHFT--HKLGQGGFGSVYKGQ-LHTGRLIAVK 218
           +++ +KF  +       +    +  +V +++    +LG G FG V++     TGR+   K
Sbjct: 1   INDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK 60

Query: 219 MLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK 277
            +            NE+S + ++HH  ++ L     +  +  L+ EF+  G L   I   
Sbjct: 61  FINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI--- 117

Query: 278 ENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIP--KVSDFG 335
             +       ++         G+ ++H   +  I+H DIKP NI+ +       K+ DFG
Sbjct: 118 AAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFG 174

Query: 336 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR--- 392
           LA     +        T  T  + APE++ R    V   +D++  G++   +  G     
Sbjct: 175 LATKLNPDEIVKV---TTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFA 229

Query: 393 ----NSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKA 448
                  +  ++     F    +  ++           E +  I           +Q + 
Sbjct: 230 GEDDLETLQNVKRCDWEFDEDAFSSVSP----------EAKDFIKN--------LLQKEP 271

Query: 449 ADRPSMTKVLE 459
             R ++   LE
Sbjct: 272 RKRLTVHDALE 282

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 9e-44
 Identities = 45/279 (16%), Positives = 96/279 (34%), Gaps = 39/279 (13%)

Query: 191 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLL 249
                LG+G FG V++     + +    K ++           E+S +    H N++ L 
Sbjct: 8   MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLH 67

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
                  +  +++EF+    +   I             ++          + +LH     
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLH---SH 121

Query: 310 CILHFDIKPHNILLDH--NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
            I HFDI+P NI+     +   K+ +FG A+     ++F           Y APE+    
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQH- 177

Query: 368 FGTVSCKSDVYGFGMVLLEMAGGRR-------NSNMNAIRSSKAYFPSWVYDQLNKGGDL 420
              VS  +D++  G ++  +  G            +  I +++  F    + +++     
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI---- 232

Query: 421 ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
                 E    + R         +  +   R + ++ L+
Sbjct: 233 ------EAMDFVDR--------LLVKERKSRMTASEALQ 257

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  149 bits (376), Expect = 6e-42
 Identities = 58/288 (20%), Positives = 113/288 (39%), Gaps = 51/288 (17%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSA----------EEFINEVSTIGRIH-H 242
            LG+G    V +     T +  AVK+++ +   +          E  + EV  + ++  H
Sbjct: 10  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69

Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
            N++QL       +   LV++ M  G L  ++     +  T   ++ ++I       +  
Sbjct: 70  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVICA 125

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
           LH    + I+H D+KP NILLD +   K++DFG +           +    GT  Y+APE
Sbjct: 126 LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPE 179

Query: 363 LIS----RNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNAIRSSKAYFPSWVY 411
           +I      N      + D++  G+++  +  G        +   +  I S    F S  +
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239

Query: 412 DQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
           D  +            ++ +++R         + V+   R +  + L 
Sbjct: 240 DDYSD----------TVKDLVSR--------FLVVQPQKRYTAEEALA 269

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  149 bits (378), Expect = 8e-42
 Identities = 53/278 (19%), Positives = 97/278 (34%), Gaps = 37/278 (13%)

Query: 192 FTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE--FINEVSTIGRIHHVNVVQL 248
           F   LG G F  V   +   T +L+A+K +       +E    NE++ + +I H N+V L
Sbjct: 13  FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72

Query: 249 LGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCD 308
                 G    L+ + +  G L   I     +   +       +       V YLH+   
Sbjct: 73  DDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQVLDAVKYLHDLGI 128

Query: 309 MCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 368
           +             LD +    +SDFGL+K     +   +     GT GY+APE++++  
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA---CGTPGYVAPEVLAQ-- 183

Query: 369 GTVSCKSDVYGFGMVLLEMAGGRR-------NSNMNAIRSSKAYFPSWVYDQLNKGGDLE 421
              S   D +  G++   +  G               I  ++  F S  +D ++      
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD----- 238

Query: 422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
                  +  I           ++     R +  + L+
Sbjct: 239 -----SAKDFIRH--------LMEKDPEKRFTCEQALQ 263

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  148 bits (374), Expect = 1e-40
 Identities = 54/270 (20%), Positives = 106/270 (39%), Gaps = 32/270 (11%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE-------FINEVSTIGRIHHVNVV 246
            +G+GGFG VY  +   TG++ A+K L+  +   ++           +S +       +V
Sbjct: 11  IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70

Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
            +        K + + + M  G L  H+    ++   F    ++  A     G+ ++H  
Sbjct: 71  CMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMH-- 124

Query: 307 CDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
            +  +++ D+KP NILLD +   ++SD GLA    K+        + GT GY+APE++ +
Sbjct: 125 -NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEVLQK 179

Query: 367 NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT 426
                   +D +  G +L ++  G               F        ++   + L    
Sbjct: 180 GVA-YDSSADWFSLGCMLFKLLRGHS------------PFRQHKTKDKHEIDRMTLTMAV 226

Query: 427 EIESVIARKLCMIGLWCIQVKAADRPSMTK 456
           E+    + +L  +    +Q     R     
Sbjct: 227 ELPDSFSPELRSLLEGLLQRDVNRRLGCLG 256

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  145 bits (366), Expect = 2e-40
 Identities = 57/289 (19%), Positives = 105/289 (36%), Gaps = 45/289 (15%)

Query: 192 FTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVV 246
               LG GG   V+  + L   R +AVK+L             F  E      ++H  +V
Sbjct: 11  LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70

Query: 247 QLLGFC----SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
            +          G    +V E++   +L   +    +       ++  E+     + + +
Sbjct: 71  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNF 126

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIAP 361
                   I+H D+KP NI++      KV DFG+A+      + V+ +A   GT  Y++P
Sbjct: 127 S---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRR-------NSNMNAIRSSKAYFPSWVYDQL 414
           E       +V  +SDVY  G VL E+  G          S            PS  ++ L
Sbjct: 184 EQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241

Query: 415 NKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRP-SMTKVLEMLE 462
           +           ++++V+ +         +     +R  +  ++   L 
Sbjct: 242 SA----------DLDAVVLK--------ALAKNPENRYQTAAEMRADLV 272

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 1e-39
 Identities = 64/289 (22%), Positives = 111/289 (38%), Gaps = 36/289 (12%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSA------EEFINEVSTIGRIHHVNVVQ 247
            LG+G F +VYK +  +T +++A+K ++    S          + E+  +  + H N++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 248 LLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC 307
           LL      S  +LV++FM             +         ++   L T +G+ YLH   
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLH--- 117

Query: 308 DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 367
              ILH D+KP+N+LLD N + K++DFGLAK     N   + +    T  Y APEL+   
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELL-FG 174

Query: 368 FGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNAIRSSKAYFPSWVYDQLNKGGD- 419
                   D++  G +L E+               +  I  +        +  +    D 
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 420 --------LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM 460
                   + L ++          L              R + T+ L+M
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALKM 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 2e-39
 Identities = 55/294 (18%), Positives = 108/294 (36%), Gaps = 27/294 (9%)

Query: 188 VTNHFT--HKLGQGGFGSVYKGQ-LHTGRLIAVKML--ENSKFSAEEFINEVSTIGRIHH 242
           V   +T    +G+G +G V           +A+K +     +   +  + E+  + R  H
Sbjct: 6   VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65

Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
            N++ +       +   +   ++    +   ++ K  K Q    + +        RG+ Y
Sbjct: 66  ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKY 124

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF-HPKENDFVSISATRGTIGYIAP 361
           +H      +LH D+KP N+LL+     K+ DFGLA+   P  +    ++    T  Y AP
Sbjct: 125 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181

Query: 362 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRR----NSNMNAIRSSKAYFPSWVYDQLNKG 417
           E++  + G  +   D++  G +L EM   R        ++ +        S   + LN  
Sbjct: 182 EIMLNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240

Query: 418 GDLELRNV------------TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
            +L+ RN               +      K   +    +      R  + + L 
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (356), Expect = 6e-39
 Identities = 50/301 (16%), Positives = 97/301 (32%), Gaps = 29/301 (9%)

Query: 188 VTNHFT--HKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHV 243
           V N +    K+G G FG +Y G  +  G  +A+K+    K    +   E      +   V
Sbjct: 5   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE-CVKTKHPQLHIESKIYKMMQGGV 63

Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
            +  +    +EG    +V E +     D          + F  + +  +A      + Y+
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFN----FCSRKFSLKTVLLLADQMISRIEYI 119

Query: 304 HNGCDMCILHFDIKPHNIL---LDHNFIPKVSDFGLAKFHPKENDFVSI-----SATRGT 355
           H       +H D+KP N L        +  + DFGLAK +        I         GT
Sbjct: 120 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 356 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLN 415
             Y +           S + D+   G VL+    G          + +  +      +++
Sbjct: 177 ARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234

Query: 416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMPPKPC 475
              ++  +           +      +C  ++  D+P  + + ++               
Sbjct: 235 TPIEVLCKGYPS-------EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYV 287

Query: 476 F 476
           F
Sbjct: 288 F 288

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 3e-38
 Identities = 54/236 (22%), Positives = 92/236 (38%), Gaps = 24/236 (10%)

Query: 192 FTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFS----AEEFINEVSTIGR-IHHVNV 245
               LG+G FG V+  +   T +  A+K L+          E  + E   +     H  +
Sbjct: 6   LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65

Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
             +            V E++  G L  HI         F   +    A     G+ +L  
Sbjct: 66  THMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQFL-- 119

Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
                I++ D+K  NILLD +   K++DFG+ K +   +     +   GT  YIAPE++ 
Sbjct: 120 -HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILL 176

Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGRR-------NSNMNAIRSSKAYFPSWVYDQL 414
                 +   D + FG++L EM  G+            ++IR    ++P W+  + 
Sbjct: 177 G--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA 230

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 5e-38
 Identities = 58/284 (20%), Positives = 107/284 (37%), Gaps = 52/284 (18%)

Query: 196 LGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFC- 252
           LG G  G V +     T    A+KML++      +   EV    R     ++V+++    
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRASQCPHIVRIVDVYE 75

Query: 253 ---SEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
              +      +V E +  G L   I  ++   Q F   +  EI       + YLH    +
Sbjct: 76  NLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130

Query: 310 CILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 366
            I H D+KP N+L      N I K++DFG AK     N   +   T     Y+APE++  
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP---YYVAPEVLGP 187

Query: 367 NFGTVSCKSDVYGFGMVLLEMAGGRR-----------NSNMNAIRSSKAYFPSWVYDQLN 415
                    D++  G+++  +  G                   IR  +  FP+  + +++
Sbjct: 188 --EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245

Query: 416 KGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
           +          E++ +I           ++ +   R ++T+ + 
Sbjct: 246 E----------EVKMLIRN--------LLKTEPTQRMTITEFMN 271

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 7e-38
 Identities = 56/287 (19%), Positives = 117/287 (40%), Gaps = 30/287 (10%)

Query: 195 KLGQGGFGSVYKGQ--LHTGRLIAVKML------ENSKFSAEEFINEVSTIGRIHHVNVV 246
           ++G+G +G V+K +   + GR +A+K +      E    S    +  +  +    H NVV
Sbjct: 14  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73

Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHI--FPKENKGQTFGWEKLQEIALGTARGVAYLH 304
           +L   C+           +    +D+ +  +  +        E ++++     RG+ +LH
Sbjct: 74  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
                 ++H D+KP NIL+  +   K++DFGLA+ +  +    S+     T+ Y APE++
Sbjct: 134 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV---VVTLWYRAPEVL 187

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGGRR----NSNMNAIR--------SSKAYFPSWVYD 412
            +   + +   D++  G +  EM   +     +S+++ +           +  +P  V  
Sbjct: 188 LQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245

Query: 413 QLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
                     + + +  + I      + L C+    A R S    L 
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  138 bits (349), Expect = 1e-37
 Identities = 55/232 (23%), Positives = 96/232 (41%), Gaps = 26/232 (11%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVVQLL 249
            LG G FG V+  +  H GR  A+K+L+          E   +E   +  + H  ++++ 
Sbjct: 11  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70

Query: 250 GFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDM 309
           G   +  +  ++ +++  G L   +   +            E+ L        L      
Sbjct: 71  GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL-------ALEYLHSK 123

Query: 310 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 369
            I++ D+KP NILLD N   K++DFG AK+ P            GT  YIAPE++S    
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVST--K 176

Query: 370 TVSCKSDVYGFGMVLLEMAGGRR-------NSNMNAIRSSKAYFPSWVYDQL 414
             +   D + FG+++ EM  G               I +++  FP +  + +
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDV 228

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 2e-37
 Identities = 58/277 (20%), Positives = 95/277 (34%), Gaps = 45/277 (16%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFS-------AEEFINEVSTIGRIH--HVN 244
            LG GGFGSVY G  +     +A+K +E  + S             EV  + ++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
           V++LL +        L+ E                +      E  +         V +  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHC- 126

Query: 305 NGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 363
              +  +LH DIK  NIL+D N    K+ DFG              +   GT  Y  PE 
Sbjct: 127 --HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEW 180

Query: 364 ISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNAIRSSKAYFPSWVYDQLNKGGDLEL 422
           I R        + V+  G++L +M  G     +   I   + +F   V  +         
Sbjct: 181 I-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE--------- 230

Query: 423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
                      + L     WC+ ++ +DRP+  ++  
Sbjct: 231 ----------CQHLIR---WCLALRPSDRPTFEEIQN 254

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  137 bits (345), Expect = 2e-37
 Identities = 48/305 (15%), Positives = 100/305 (32%), Gaps = 31/305 (10%)

Query: 185 IIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HH 242
           ++ V      ++G+G FG +++G  L   + +A+K     +  A +  +E  T   +   
Sbjct: 2   VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE-PRRSDAPQLRDEYRTYKLLAGC 60

Query: 243 VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
             +  +  F  EG    LV + +     D      +  G+ F  + +   A      V  
Sbjct: 61  TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLL----DLCGRKFSVKTVAMAAKQMLARVQS 116

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIP-----KVSDFGLAKFHPKEND-----FVSISAT 352
           +H   +  +++ DIKP N L+            V DFG+ KF+          +      
Sbjct: 117 IH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173

Query: 353 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYD 412
            GT  Y++           S + D+   G V +    G                 +    
Sbjct: 174 SGTARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQ--------GLKAATNKQ 223

Query: 413 QLNKGGDLELRN-VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQMP 471
           +  + G+ +    + E+ +    +      +   +     P    +  +    ++ L   
Sbjct: 224 KYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283

Query: 472 PKPCF 476
               F
Sbjct: 284 EDENF 288

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 2e-37
 Identities = 58/277 (20%), Positives = 102/277 (36%), Gaps = 35/277 (12%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKML-------ENSKFSAEEFINEVSTIGRIHHVNVV 246
           +LG G F  V K +   TG   A K +            S E+   EVS +  I H NV+
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 247 QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
            L       +   L+ E +  G L   +     + ++   E+  E       G   ++  
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNG---VYYL 129

Query: 307 CDMCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 362
             + I HFD+KP NI+L    +P    K+ DFGLA      N+F       GT  ++APE
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 186

Query: 363 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL 422
           ++  N+  +  ++D++  G++   +  G      +                ++       
Sbjct: 187 IV--NYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANVSAVNYEFE 236

Query: 423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
                  S +A+         +      R ++   L+
Sbjct: 237 DEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 2e-37
 Identities = 57/283 (20%), Positives = 109/283 (38%), Gaps = 27/283 (9%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G VYK +   TG ++A+K +     +       I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                +K  LV+EF+         F   +         ++       +G+A+        
Sbjct: 69  VIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFC---HSHR 122

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           +LH D+KP N+L++     K++DFGLA+         +      T+ Y APE++      
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV--VTLWYRAPEILLGC-KY 179

Query: 371 VSCKSDVYGFGMVLLEMAGGRR-------NSNMNAIRSSKAYFPSWVYDQLNKGGDLEL- 422
            S   D++  G +  EM   R           +  I  +       V+  +    D +  
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 423 ------RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
                 ++ +++   +      +    +      R S    L 
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 9e-37
 Identities = 74/346 (21%), Positives = 128/346 (36%), Gaps = 54/346 (15%)

Query: 177 PKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVS 235
           P+  SY +           +G G FG VY+ +L  +G L+A+K +   K        E+ 
Sbjct: 17  PQEVSYTDT--------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQ 65

Query: 236 TIGRIHHVNVVQLLGFCSEGSKR------ALVYEFMPNGSLDRHIFPKENKGQTFGWEKL 289
            + ++ H N+V+L  F     ++       LV +++P     R         QT     +
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYV 124

Query: 290 QEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVS 348
           +       R +AY+H      I H DIKP N+LLD +  + K+ DFG AK   +    VS
Sbjct: 125 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181

Query: 349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR---------------- 392
              +R    Y APELI       +   DV+  G VL E+  G+                 
Sbjct: 182 YICSR---YYRAPELIFGATD-YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

Query: 393 ---NSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAA 449
                    IR     +  + + Q+      ++          A  LC      ++    
Sbjct: 238 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR--PRTPPEAIALCS---RLLEYTPT 292

Query: 450 DRPSMTKVLE---MLEGSMDDLQMPPKPCFSSSRHISGREIESDSS 492
            R +  +        E    ++++P      +  + + +E+ S+  
Sbjct: 293 ARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPP 338

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  134 bits (337), Expect = 2e-36
 Identities = 57/282 (20%), Positives = 101/282 (35%), Gaps = 27/282 (9%)

Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGF 251
           K+G+G +G VYK Q + G   A+K +   K         I E+S +  + H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCI 311
                +  LV+E +           +            +   L    G+AY H   D  +
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCH---DRRV 121

Query: 312 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 371
           LH D+KP N+L++     K++DFGLA+           +    T+ Y AP+++       
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVL-MGSKKY 178

Query: 372 SCKSDVYGFGMVLLEMAGGRR-------NSNMNAIRSSKAYFPSWVYDQLNKGGDL---- 420
           S   D++  G +  EM  G            +  I        S  +  + +        
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 421 ---ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
              E          +      +    +++    R +  + LE
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 6e-35
 Identities = 56/296 (18%), Positives = 104/296 (35%), Gaps = 39/296 (13%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLG 250
           K+GQG FG V+K +   TG+ +A+K +             + E+  +  + H NVV L+ 
Sbjct: 17  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76

Query: 251 FCSEGSKRA--------LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAY 302
            C   +           LV++F  +           N    F   +++ +      G   
Sbjct: 77  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNG--- 129

Query: 303 LHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIA 360
           L+      ILH D+K  N+L+  + + K++DFGLA+     K +     +    T+ Y  
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189

Query: 361 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRR-------NSNMNAIRSSKAYFPSWVYDQ 413
           PEL+           D++G G ++ EM               +  I          V+  
Sbjct: 190 PELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248

Query: 414 LNKGGDLELRNVTEIESVIARKLCMIGLW----------CIQVKAADRPSMTKVLE 459
           ++     E   + + +    +      +            + +  A R      L 
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 2e-34
 Identities = 55/236 (23%), Positives = 93/236 (39%), Gaps = 23/236 (9%)

Query: 191 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNV 245
            +   LG+G FG V   +   TGR  A+K+L      A++     + E   +    H  +
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67

Query: 246 VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHN 305
             L        +   V E+   G L  H+    ++ + F  E+ +      A  V+ L  
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYG---AEIVSALEY 120

Query: 306 GCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
                +++ DIK  N++LD +   K++DFGL K    +   +      GT  Y+APE++ 
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--GTPEYLAPEVLE 178

Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGRR-------NSNMNAIRSSKAYFPSWVYDQL 414
                     D +G G+V+ EM  GR              I   +  FP  +  + 
Sbjct: 179 D--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 3e-34
 Identities = 50/284 (17%), Positives = 105/284 (36%), Gaps = 29/284 (10%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
           K+G+G +G+V+K +   T  ++A+K +   ++ +      + E+  +  + H N+V+L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
                 K  LV+EF                    G    + +     + +  L       
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCN-------GDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           +LH D+KP N+L++ N   K+++FGLA+         S      T+ Y  P+++      
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGA-KL 178

Query: 371 VSCKSDVYGFGMVLLEMAGGRR--------NSNMNAIRSSKAYFPSWVYDQLNKGGDLEL 422
            S   D++  G +  E+A   R        +  +  I           +  + K  D + 
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238

Query: 423 RNVTEIESVIARKLCMIG-------LWCIQVKAADRPSMTKVLE 459
             +    + +   +  +           ++     R S  + L+
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  129 bits (325), Expect = 5e-34
 Identities = 63/267 (23%), Positives = 109/267 (40%), Gaps = 29/267 (10%)

Query: 163 DNIEKFLHNQQSWMPKRYSYP-EIIAVTNHFT--HKLGQGGFGSVYKGQ-LHTGRLIAVK 218
           +++++FL   +    K++  P +  A  + F     LG G FG V   +   +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72

Query: 219 MLENSKFSA----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI 274
           +L+  K       E  +NE   +  ++   +V+L     + S   +V E++  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132

Query: 275 FPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDF 334
                +   F     +  A        YLH    + +++ D+KP N+L+D     +V+DF
Sbjct: 133 R----RIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDF 185

Query: 335 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR-- 392
           G AK        +      GT   +APE+I       +   D +  G+++ EMA G    
Sbjct: 186 GFAKRVKGRTWTL-----CGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPF 238

Query: 393 -----NSNMNAIRSSKAYFPSWVYDQL 414
                      I S K  FPS     L
Sbjct: 239 FADQPIQIYEKIVSGKVRFPSHFSSDL 265

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 6e-33
 Identities = 64/316 (20%), Positives = 119/316 (37%), Gaps = 31/316 (9%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLG 250
            +G G +G+V       TG  +A+K L     S+  A+    E+  +  + H NV+ LL 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
             +         +F            K  K +  G +++Q +     +G+ Y+H      
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAG 141

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  Y APE+I  N+  
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVI-LNWMR 195

Query: 371 VSCKSDVYGFGMVLLEMAGGRR-------NSNMNAIRSSKAYFPSWVYDQLNKGG----- 418
            +   D++  G ++ EM  G+           +  I       P+    +L         
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255

Query: 419 ----DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM--LEGSMDDLQMPP 472
               +LE ++   I +  +     +    + + A  R +  + L     E   D    P 
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ 315

Query: 473 KPCFSSSRHISGREIE 488
              +  S     R ++
Sbjct: 316 VQKYDDSFDDVDRTLD 331

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  120 bits (302), Expect = 5e-31
 Identities = 55/297 (18%), Positives = 116/297 (39%), Gaps = 44/297 (14%)

Query: 191 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQL 248
               KLG+G +  V++   +     + VK+L+  K   ++   E+  +  +    N++ L
Sbjct: 38  QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITL 95

Query: 249 LGFCSEGSKR--ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNG 306
                +   R  ALV+E + N    +         QT     ++       + + Y H  
Sbjct: 96  ADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCH-- 146

Query: 307 CDMCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 365
             M I+H D+KPHN+++DH +   ++ D+GLA+F+    ++   +    +  +  PEL+ 
Sbjct: 147 -SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELL- 201

Query: 366 RNFGTVSCKSDVYGFGMVLLEMAGGRR-----NSNMNAI-RSSKAYFPSWVYDQLNKGGD 419
            ++       D++  G +L  M   +      + N + + R +K      +YD ++K   
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261

Query: 420 LELRNVTEIESVIARKLCMIGL-----------------WCIQVKAADRPSMTKVLE 459
                  +I    +RK     +                   ++     R +  + +E
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 5e-29
 Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 18/208 (8%)

Query: 195 KLGQGGFGSVYKGQL----HTGRLIAVKMLENSKFS-----AEEFINEVSTIGRI-HHVN 244
            LG G +G V+  +      TG+L A+K+L+ +         E    E   +  I     
Sbjct: 31  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90

Query: 245 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
           +V L       +K  L+ +++  G L  H+  +E   +      + EI L        L 
Sbjct: 91  LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA-------LE 143

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
           +   + I++ DIK  NILLD N    ++DFGL+K    +    +     GTI Y+AP+++
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAPDIV 202

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGGRR 392
                      D +  G+++ E+  G  
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGAS 230

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 8e-27
 Identities = 58/288 (20%), Positives = 105/288 (36%), Gaps = 35/288 (12%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLG 250
            +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL 
Sbjct: 25  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84

Query: 251 FCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMC 310
             +         +      L         K Q    + +Q +     RG+ Y+H      
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 141

Query: 311 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 370
           I+H D+KP N+ ++ +   K+ DFGLA+    E      +    T  Y APE++  N+  
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIM-LNWMH 195

Query: 371 VSCKSDVYGFGMVLLEMAGGRR-------NSNMNAIRSSKAYFPSWVYDQLNKGGD---- 419
            +   D++  G ++ E+  GR           +  I        + +  +++        
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255

Query: 420 --------LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE 459
                   +   NV    + +A  L       + + +  R +  + L 
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDLLE---KMLVLDSDKRITAAQALA 300

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  108 bits (271), Expect = 1e-26
 Identities = 51/342 (14%), Positives = 118/342 (34%), Gaps = 55/342 (16%)

Query: 194 HKLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 252
            KLG G F +V+  + +     +A+K++   K   E   +E+  + R++  +  +     
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 253 SEGSKRALVY--EFMPNGSLDRHI----------FPKENKGQTFGWEKLQEIALGTARGV 300
           +    + L +     PNG     +            K+ + +      +++I+     G+
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 301 AYLHNGCDMCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 359
            Y+H      I+H DIKP N+L++       +    +A            + +  T  Y 
Sbjct: 139 DYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 360 APELISRNFGTVSCKSDVYGFGMVLLEMAGGRR-------------NSNMNAIRSSKAYF 406
           +PE++        C +D++    ++ E+  G               + ++  I       
Sbjct: 197 SPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254

Query: 407 PSWV----------YDQLNKGGDLELRNVTEIESVIARKLCMIGL----------WCIQV 446
           PS++          ++      ++       +E V+  K                  +Q+
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314

Query: 447 KAADRPSMTKVLEM----LEGSMDDLQMPPKPCFSSSRHISG 484
               R     ++          M+++++P +  + S   I G
Sbjct: 315 DPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPG 356

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 1e-25
 Identities = 46/207 (22%), Positives = 79/207 (38%), Gaps = 25/207 (12%)

Query: 195 KLGQGGFGSVYKGQ-LHTGRLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLG 250
            +G G  G V         R +A+K L     +   A+    E+  +  ++H N++ LL 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 251 FCS------EGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLH 304
             +      E     LV E M            +        E++  +      G+ +LH
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKHLH 136

Query: 305 NGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 364
           +     I+H D+KP NI++  +   K+ DFGLA+           +    T  Y APE+I
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVI 190

Query: 365 SRNFGTVSCKSDVYGFGMVLLEMAGGR 391
                      D++  G ++ EM   +
Sbjct: 191 LGM--GYKENVDIWSVGCIMGEMVRHK 215

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.8 bits (201), Expect = 1e-18
 Identities = 28/162 (17%), Positives = 47/162 (29%), Gaps = 22/162 (13%)

Query: 195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSA-----------EEFINEVSTIGRIHHV 243
            +G+G   +V+           VK  +    S              F        R    
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 244 NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYL 303
            + +L G          VY +  N  L   I  KE            E+       VA  
Sbjct: 67  ALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPD--EVLDMILEEVAKF 119

Query: 304 HNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 345
           ++     I+H D+  +N+L+       + DF  +    +E  
Sbjct: 120 YH---RGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGW 157

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	511
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.22
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.9
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.25
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.14
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.74
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.83

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-53  Score=413.81  Aligned_cols=252  Identities=29%  Similarity=0.486  Sum_probs=200.4

Q ss_pred             hhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCC
Q 010434          190 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGS  269 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  269 (511)
                      +.+.++||+|+||+||+|++.+++.||||+++......++|.+|+.++++++|||||+++|+|.+++..++||||+++|+
T Consensus         7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~   86 (263)
T d1sm2a_           7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC   86 (263)
T ss_dssp             EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence            34678999999999999999889999999998877788999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceee
Q 010434          270 LDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI  349 (511)
Q Consensus       270 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  349 (511)
                      |.+++.   .....+++..+..++.|||.||+|||+   .+|+||||||+|||+++++.+||+|||+++........ ..
T Consensus        87 L~~~l~---~~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~  159 (263)
T d1sm2a_          87 LSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SS  159 (263)
T ss_dssp             HHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             HHHHhh---ccccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCce-ee
Confidence            999874   234679999999999999999999999   69999999999999999999999999999876544322 22


Q ss_pred             ccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCC-CCcccccccccccchhhHHhhhcCCcccccccchh
Q 010434          350 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEI  428 (511)
Q Consensus       350 ~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  428 (511)
                      ....||+.|+|||.+.+.  .++.|+|||||||++|||+|+..| +.....        ..+...+..+.....+     
T Consensus       160 ~~~~gt~~y~aPE~l~~~--~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--------~~~~~~i~~~~~~~~p-----  224 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTGFRLYKP-----  224 (263)
T ss_dssp             -----CTTSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--------HHHHHHHHHTCCCCCC-----
T ss_pred             cceecCcccCChHHhcCC--CCCchhhhcchHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHhcCCCCCc-----
Confidence            345689999999999865  789999999999999999996544 432211        1123333333332221     


Q ss_pred             HHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcC
Q 010434          429 ESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  464 (511)
Q Consensus       429 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~  464 (511)
                       ...++.+.+++.+||+.||++||||++|++.|+..
T Consensus       225 -~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         225 -RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence             12346788999999999999999999999999864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-53  Score=416.54  Aligned_cols=253  Identities=26%  Similarity=0.436  Sum_probs=209.4

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG  268 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  268 (511)
                      .+.+.++||+|+||.||+|.+++++.||||+++......++|.+|+.++++++|||||+++|++.+ +..++||||+++|
T Consensus        14 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g   92 (272)
T d1qpca_          14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENG   92 (272)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTC
T ss_pred             HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCC
Confidence            456678999999999999999888999999998877788899999999999999999999998865 5679999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      +|.+++..  ..+..+++..+++|+.|||+||+|||+   .+|+||||||+||||++++.+||+|||+|+....... ..
T Consensus        93 ~L~~~~~~--~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~~  166 (272)
T d1qpca_          93 SLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TA  166 (272)
T ss_dssp             BHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-EC
T ss_pred             cHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCcc-cc
Confidence            99987732  233469999999999999999999999   6999999999999999999999999999997654332 23


Q ss_pred             eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccchh
Q 010434          349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEI  428 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  428 (511)
                      .....||+.|+|||++...  .++.++|||||||++|||+||..|+.....       ...+...+..+.....+     
T Consensus       167 ~~~~~gt~~y~APE~~~~~--~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-------~~~~~~~i~~~~~~~~p-----  232 (272)
T d1qpca_         167 REGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRP-----  232 (272)
T ss_dssp             CTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHTTCCCCCC-----
T ss_pred             ccccCCcccccChHHHhCC--CCCchhhhhhhHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhcCCCCCc-----
Confidence            3456799999999999764  789999999999999999997665432211       11233344444333222     


Q ss_pred             HHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          429 ESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       429 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                       ..+++.+.+++.+||+.||++||||++|+++|+.
T Consensus       233 -~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         233 -DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence             2245678899999999999999999999999985

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-53  Score=416.87  Aligned_cols=260  Identities=30%  Similarity=0.477  Sum_probs=202.6

Q ss_pred             hhhccccCcCCcEEEEEEEecCCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          190 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      +.+.++||+|+||+||+|+++  ..||||+++..   ....+.|.+|+.++++++|||||+++|++.+ ...++||||++
T Consensus        10 ~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~   86 (276)
T d1uwha_          10 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCE   86 (276)
T ss_dssp             CCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCC
T ss_pred             EEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCC
Confidence            345789999999999999865  36999999653   3345789999999999999999999999865 56899999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +|+|.+++..   ....+++..+..++.|||+||+|||+   ++|+||||||+||||+.++.+||+|||+|+........
T Consensus        87 ~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          87 GSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             EEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             CCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            9999998843   33579999999999999999999999   69999999999999999999999999999877654444


Q ss_pred             eeeccccCCccccchhccccc-CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          347 VSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~-~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                      .......||+.|+|||++... .+.++.++|||||||++|||+||+.||......       ..+...+..+....  ..
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-------~~~~~~~~~~~~~p--~~  231 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIFMVGRGYLSP--DL  231 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHHTSCCC--CG
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcCCCCC--cc
Confidence            444566799999999998653 246899999999999999999999998653211       11222222221111  11


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                      ......+++.+.+++.+||+.||++|||+++|++.|+.....
T Consensus       232 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            123334567889999999999999999999999999875543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-52  Score=417.24  Aligned_cols=265  Identities=28%  Similarity=0.469  Sum_probs=201.3

Q ss_pred             CChHHHHHHHhhh-----------ccccCcCCcEEEEEEEec-CC---cEEEEEEeccC--cccHHHHHHHHHHhccccc
Q 010434          180 YSYPEIIAVTNHF-----------THKLGQGGFGSVYKGQLH-TG---RLIAVKMLENS--KFSAEEFINEVSTIGRIHH  242 (511)
Q Consensus       180 ~~~~ei~~~t~~~-----------~~~LG~G~fg~Vykg~~~-~g---~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H  242 (511)
                      ++|+++..++.+|           .++||+|+||+||+|+++ +|   ..||||.+...  ....++|.+|+.++++++|
T Consensus         7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H   86 (299)
T d1jpaa_           7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH   86 (299)
T ss_dssp             GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred             CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence            4455555555555           367999999999999864 23   36999998653  3345689999999999999


Q ss_pred             cceEEeeceeccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceE
Q 010434          243 VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNIL  322 (511)
Q Consensus       243 ~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NIL  322 (511)
                      ||||+++|++.+++..++||||+++|+|.+++.   .....++|..+..++.|||+||+|||+   ++|+||||||+|||
T Consensus        87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~---~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NIL  160 (299)
T d1jpaa_          87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNIL  160 (299)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred             CCCccEEEEEeeCCEEEEEEEecCCCcceeeec---cccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEE
Confidence            999999999999999999999999999999873   234579999999999999999999999   69999999999999


Q ss_pred             EcCCCCeeeecccccccCCCCCCce---eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCccc
Q 010434          323 LDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNA  398 (511)
Q Consensus       323 l~~~~~~kl~DFGla~~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~  398 (511)
                      |++++.+||+|||+|+.........   ......||+.|+|||.+.+.  .++.++|||||||++|||+| |+.||....
T Consensus       161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~  238 (299)
T d1jpaa_         161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMT  238 (299)
T ss_dssp             ECTTCCEEECCC-----------------------CGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcC--CCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence            9999999999999998765443222   12234589999999998764  78999999999999999998 899986533


Q ss_pred             ccccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          399 IRSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      ..        .+...+..+......      ..++..+.+++.+||+.||++||||.+|++.|+..+.
T Consensus       239 ~~--------~~~~~i~~~~~~~~~------~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         239 NQ--------DVINAIEQDYRLPPP------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             HH--------HHHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HH--------HHHHHHHcCCCCCCC------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            21        133334443332221      2245678899999999999999999999999987543

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=402.29  Aligned_cols=250  Identities=26%  Similarity=0.434  Sum_probs=213.3

Q ss_pred             hhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCCCCc
Q 010434          191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL  270 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  270 (511)
                      .|.++||+|+||+||+|++++++.||||+++.+....++|.+|+.++++++|||||+++|+|.+++..++||||+++|+|
T Consensus         7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l   86 (258)
T d1k2pa_           7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL   86 (258)
T ss_dssp             CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred             EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence            46789999999999999998899999999998888889999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCceeec
Q 010434          271 DRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  350 (511)
Q Consensus       271 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  350 (511)
                      ..++.   .....+++..+.+++.|+|+||+|||+   .+|+||||||+|||+++++.+||+|||+++....... ....
T Consensus        87 ~~~~~---~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~  159 (258)
T d1k2pa_          87 LNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSV  159 (258)
T ss_dssp             HHHHH---SGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CCCC
T ss_pred             HHhhh---ccccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCc-eeec
Confidence            98873   234678999999999999999999999   6999999999999999999999999999986654432 2334


Q ss_pred             cccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccchhH
Q 010434          351 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTEIE  429 (511)
Q Consensus       351 ~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  429 (511)
                      ...||+.|+|||.+.+.  .++.|+|||||||++|||+| |+.||......        .+...+.++.....+      
T Consensus       160 ~~~~t~~y~aPE~~~~~--~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--------~~~~~i~~~~~~~~p------  223 (258)
T d1k2pa_         160 GSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIAQGLRLYRP------  223 (258)
T ss_dssp             CSCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------HHHHHHHTTCCCCCC------
T ss_pred             ccCCCCCcCCcHHhcCC--CCCcceeecccchhhHhHHhcCCCCCCCCCHH--------HHHHHHHhCCCCCCc------
Confidence            56699999999999875  78999999999999999998 78888654322        233444444333322      


Q ss_pred             HHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          430 SVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       430 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      ...++.+.+++.+||+.||++|||++++++.|..
T Consensus       224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            2234678899999999999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-52  Score=415.58  Aligned_cols=260  Identities=29%  Similarity=0.426  Sum_probs=215.7

Q ss_pred             HHHHhhhccccCcCCcEEEEEEEec-CCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          186 IAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       186 ~~~t~~~~~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      ....+.+.++||+|+||+||+|.++ +|+.||||+++.+....++|.+|+.++++++|||||+++|+|.+++..++||||
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            3345566789999999999999865 689999999988777888999999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++..  .....+++..+..++.|||.||+|||+   .+|+||||||+||||++++.+||+|||+|+......
T Consensus        95 ~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          95 MTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             CTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             ccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            999999998843  234679999999999999999999999   699999999999999999999999999998765543


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      . .......||+.|+|||++.+.  .++.|+|||||||++|||++|..|+.....       ...+.+.+..+.....  
T Consensus       170 ~-~~~~~~~g~~~y~aPE~~~~~--~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-------~~~~~~~i~~~~~~~~--  237 (287)
T d1opja_         170 Y-TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYELLEKDYRMER--  237 (287)
T ss_dssp             S-EEETTEEECGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHHHHHHHHTTCCCCC--
T ss_pred             c-eeeccccccccccChHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCcch-------HHHHHHHHhcCCCCCC--
Confidence            2 233455689999999998765  789999999999999999997776543211       1123333444333222  


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                          +..++..+.+++.+||+.||++|||+++|++.|+....
T Consensus       238 ----~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         238 ----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             ----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                12345678899999999999999999999999987543

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=404.01  Aligned_cols=250  Identities=26%  Similarity=0.322  Sum_probs=201.6

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      |.+.++||+|+||+||+|+. .+|+.||||++....  ...+.+.+|+.++++++|||||++++++.+++..++||||++
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~   86 (271)
T d1nvra_           7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS   86 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence            45678999999999999986 479999999986532  234679999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      +|+|.+++.    ....+++..+..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+|+........
T Consensus        87 gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          87 GGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             TEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             CCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            999999983    34679999999999999999999999   69999999999999999999999999999876554433


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccc
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVT  426 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (511)
                      .......||+.|+|||++.+. ...+.++|||||||++|||++|+.||.......       .............     
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~-~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-------~~~~~~~~~~~~~-----  226 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------QEYSDWKEKKTYL-----  226 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-------HHHHHHHTTCTTS-----
T ss_pred             ccccceeeCcCccCHhHhcCC-CCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-------HHHHHHhcCCCCC-----
Confidence            334556799999999999764 234678999999999999999999996543211       1111111111111     


Q ss_pred             hhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          427 EIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       427 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .....+++.+.+++.+||+.||++|||++|+++
T Consensus       227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            112234567788999999999999999999864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-51  Score=405.25  Aligned_cols=251  Identities=25%  Similarity=0.413  Sum_probs=205.8

Q ss_pred             hcc-ccCcCCcEEEEEEEec---CCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          192 FTH-KLGQGGFGSVYKGQLH---TGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       192 ~~~-~LG~G~fg~Vykg~~~---~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      +.+ +||+|+||+||+|.++   ++..||||+++..  ....++|.+|++++++++|||||+++|++.. +..++||||+
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~   90 (285)
T d1u59a_          12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA   90 (285)
T ss_dssp             EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             ECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeC
Confidence            345 5999999999999753   4568999999763  3345789999999999999999999999865 5689999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++|+|.+++.   ..+..+++..+..++.|||.||+|||+   ++|+||||||+||||+.++.+||+|||+++.......
T Consensus        91 ~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          91 GGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  164 (285)
T ss_dssp             TTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             CCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence            9999999873   234679999999999999999999999   6999999999999999999999999999997765443


Q ss_pred             ce-eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          346 FV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       346 ~~-~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      .. ......||+.|+|||++...  .++.++|||||||++|||+| |+.||......        .+...+.++...+.+
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--------~~~~~i~~~~~~~~p  234 (285)
T d1u59a_         165 YYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQGKRMECP  234 (285)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------HHHHHHHTTCCCCCC
T ss_pred             ccccccccccCccccChHHHhCC--CCCccchhhcchHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCC
Confidence            32 22345689999999999764  78999999999999999998 89998653221        233445555444332


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                            ..++..+.+++.+||+.||++|||+.+|++.|+...
T Consensus       235 ------~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         235 ------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             ------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                  234567889999999999999999999999987533

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=407.47  Aligned_cols=259  Identities=28%  Similarity=0.434  Sum_probs=207.1

Q ss_pred             HHhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      ..+++.++||+|+||.||+|++++++.||||+++......+.|.+|+.++++++|||||+++|++.+ +..++||||+++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~   95 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK   95 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence            3567789999999999999999888899999998887788899999999999999999999999965 568999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|..++...  ....++|..++.++.|||.||+|||+   .+|+||||||+|||||+++.+||+|||+++....... .
T Consensus        96 g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~  169 (285)
T d1fmka3          96 GSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  169 (285)
T ss_dssp             CBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             Cchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence            9999887432  33569999999999999999999999   6999999999999999999999999999987644332 2


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      ......||+.|+|||++...  .++.++||||||+++|||++|..|+.....       ...+...+..+...+.     
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~S~Giil~el~t~~~p~~~~~~-------~~~~~~~i~~~~~~~~-----  235 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQVERGYRMPC-----  235 (285)
T ss_dssp             ------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHTTCCCCC-----
T ss_pred             eeccccccccccChHHHhCC--CCCcHHhhhcchHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhcCCCCC-----
Confidence            33445699999999999764  889999999999999999997666543221       1112333333333222     


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCC
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDL  468 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l  468 (511)
                       ...+++.+.+++.+||+.||++||||++|+++|+......
T Consensus       236 -~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         236 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             -CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence             2234567889999999999999999999999999866554

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-51  Score=398.46  Aligned_cols=242  Identities=24%  Similarity=0.411  Sum_probs=204.0

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEecc----CcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLEN----SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~----~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      |.+.+.||+|+||.||+|+. .+|+.||||++..    .....+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus         8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy   87 (263)
T d2j4za1           8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY   87 (263)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence            66778999999999999986 4789999999864    233567899999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++.    ....+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+......
T Consensus        88 ~~~g~L~~~l~----~~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~  160 (263)
T d2j4za1          88 APLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  160 (263)
T ss_dssp             CTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred             cCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence            99999999883    34579999999999999999999999   699999999999999999999999999998665432


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                          .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||......        .+...+.+.. ..   
T Consensus       161 ----~~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~-~~---  222 (263)
T d2j4za1         161 ----RTTLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------ETYKRISRVE-FT---  222 (263)
T ss_dssp             ----CEETTEEGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTTC-CC---
T ss_pred             ----ccccCCCCcccCHHHHcCC--CCCchhhhhhHhHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCC-CC---
Confidence                2345699999999999875  6899999999999999999999999654321        1223332221 11   


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                         .+..+++.+.+++.+||+.||++|||++|+++
T Consensus       223 ---~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         223 ---FPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence               11234567889999999999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-51  Score=403.85  Aligned_cols=246  Identities=26%  Similarity=0.421  Sum_probs=200.3

Q ss_pred             cccCcCCcEEEEEEEec---CCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          194 HKLGQGGFGSVYKGQLH---TGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~---~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      ++||+|+||.||+|.++   .++.||||+++...   ...++|.+|+.++++++|||||+++|+|.. +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999854   35689999996532   235679999999999999999999999965 467899999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|.+++.    ....+++..+..++.|||.||+|||+   .+|+||||||+||||+.++.+||+|||+++.........
T Consensus        92 g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            99999883    34679999999999999999999999   699999999999999999999999999998766544333


Q ss_pred             e-eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          348 S-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       348 ~-~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                      . .....||+.|+|||.+.+.  .++.++|||||||++|||++ |+.||.....        ..+...+.++.....+  
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--------~~~~~~i~~~~~~~~p--  232 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKGERMGCP--  232 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCCCCC--
T ss_pred             ccccccCCCceecCchhhcCC--CCCchhhhccchhhhhHHhhCCCCCCCCCCH--------HHHHHHHHcCCCCCCC--
Confidence            2 2345699999999999765  78999999999999999998 8999865322        1233444444433322  


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                          ..+++.+.+++.+||+.||++|||+++|+++|+.
T Consensus       233 ----~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         233 ----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             ----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ----cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence                2345678899999999999999999999998875

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-52  Score=405.71  Aligned_cols=252  Identities=22%  Similarity=0.321  Sum_probs=193.5

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceecc--CCceeEEEe
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALVYE  263 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~--~~~~~lV~e  263 (511)
                      |.+.++||+|+||.||+|+. .+|+.||||++.....   ..+.|.+|++++++++|||||++++++.+  +...++|||
T Consensus         6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE   85 (269)
T d2java1           6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME   85 (269)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred             CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence            55678999999999999985 5799999999976433   34568999999999999999999998854  456899999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCC--CCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC--DMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      |+++|+|.+++......+..+++..++.++.||+.||+|||+..  ..+|+||||||+||||++++.+||+|||+|+...
T Consensus        86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~  165 (269)
T d2java1          86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN  165 (269)
T ss_dssp             CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred             cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence            99999999988544445678999999999999999999999831  1359999999999999999999999999999765


Q ss_pred             CCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccc
Q 010434          342 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (511)
                      ....  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......        .+...+..+....
T Consensus       166 ~~~~--~~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--------~~~~~i~~~~~~~  233 (269)
T d2java1         166 HDTS--FAKAFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQK--------ELAGKIREGKFRR  233 (269)
T ss_dssp             ------------CCCSCCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHTCCCC
T ss_pred             cCCC--ccccCCCCcccCCHHHHcCC--CCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence            4332  22446799999999999765  7899999999999999999999999653321        2333333332222


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      +      +..+++.+.+++.+||+.||++|||+.|+++
T Consensus       234 ~------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         234 I------PYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             C------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            2      2234567889999999999999999999975

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=401.42  Aligned_cols=246  Identities=24%  Similarity=0.344  Sum_probs=204.0

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC-cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~-~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      |.+.++||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+.++++++|||||++++++.+++..++||||+++
T Consensus        22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g  101 (293)
T d1yhwa1          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (293)
T ss_dssp             BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence            55678999999999999984 57999999999763 34667899999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|.+++.     ...+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+.......  
T Consensus       102 g~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--  171 (293)
T d1yhwa1         102 GSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (293)
T ss_dssp             CBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred             CcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--
Confidence            99998762     2469999999999999999999999   6999999999999999999999999999987654332  


Q ss_pred             eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          348 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                      ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......       .+....... .....    
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-------~~~~~~~~~-~~~~~----  237 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-------ALYLIATNG-TPELQ----  237 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHHC-SCCCS----
T ss_pred             cccccccCCCccChhhhcCC--CCCchhceehHhHHHHHHhhCCCCCCCCCHHH-------HHHHHHhCC-CCCCC----
Confidence            23455699999999999875  78999999999999999999999996532211       112222211 11111    


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .+..++..+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            22335677889999999999999999999974

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-51  Score=403.95  Aligned_cols=256  Identities=29%  Similarity=0.456  Sum_probs=199.0

Q ss_pred             hhhccccCcCCcEEEEEEEecCC-----cEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          190 NHFTHKLGQGGFGSVYKGQLHTG-----RLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~~g-----~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      +.+.+.||+|+||.||+|.+++.     ..||||++....  ....+|.+|+.++++++|||||+++|++.+....++||
T Consensus         9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~   88 (283)
T d1mqba_           9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT   88 (283)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence            34567899999999999986532     479999996532  33457999999999999999999999999999999999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+.+|++.+++.   .....++|..+..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+++....
T Consensus        89 e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          89 EYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             ECCTTEEHHHHHH---HTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EecccCcchhhhh---cccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            9999999988763   234679999999999999999999999   6999999999999999999999999999987654


Q ss_pred             CCCc-eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccc
Q 010434          343 ENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       343 ~~~~-~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (511)
                      .... .......||+.|+|||++.+.  .++.++|||||||++|||++|..|+.....       ...+...+.++....
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-------~~~~~~~i~~~~~~~  233 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELS-------NHEVMKAINDGFRLP  233 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTTCCCC
T ss_pred             CCccceEeccCCCCccccCHHHHccC--CCCCcccccccHHHHHHHHhCCCCccccCC-------HHHHHHHHhccCCCC
Confidence            3322 223345689999999999764  889999999999999999997666533211       112334444443333


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      ..      ..++..+.+|+.+||+.||++||||++|+++|+....
T Consensus       234 ~~------~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         234 TP------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             CC------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             Cc------hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence            22      2244678899999999999999999999999987543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=406.45  Aligned_cols=256  Identities=25%  Similarity=0.422  Sum_probs=207.0

Q ss_pred             HhhhccccCcCCcEEEEEEEecC-C-----cEEEEEEeccC--cccHHHHHHHHHHhccc-cccceEEeeceeccCCcee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHT-G-----RLIAVKMLENS--KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRA  259 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~-g-----~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~  259 (511)
                      .+.+.++||+|+||+||+|+... +     ..||||++...  ....+.|.+|+.++.++ +|||||+++|++.+.+..+
T Consensus        38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~  117 (325)
T d1rjba_          38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY  117 (325)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEE
Confidence            45667899999999999998542 2     37999998653  33456799999999998 8999999999999999999


Q ss_pred             EEEeecCCCCcccccccCCC-------------------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCc
Q 010434          260 LVYEFMPNGSLDRHIFPKEN-------------------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHN  320 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~N  320 (511)
                      +||||+++|+|.++|.....                   ....+++..++.++.||+.||+|||+   ++|+||||||+|
T Consensus       118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~N  194 (325)
T d1rjba_         118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARN  194 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGG
T ss_pred             EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchhc
Confidence            99999999999999854321                   12468999999999999999999999   699999999999


Q ss_pred             eEEcCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccc
Q 010434          321 ILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAI  399 (511)
Q Consensus       321 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~  399 (511)
                      ||++.++.+||+|||+|+...............||+.|+|||++.+.  .++.++|||||||++|||+| |+.||.....
T Consensus       195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC--CCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999877665554445566789999999999765  78999999999999999998 8999864322


Q ss_pred             cccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHh
Q 010434          400 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  462 (511)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le  462 (511)
                      .       ..+.+.+..+...+.+      ..+++.+.+|+.+||+.||++|||++||+++|.
T Consensus       273 ~-------~~~~~~~~~~~~~~~p------~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 D-------ANFYKLIQNGFKMDQP------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             S-------HHHHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             H-------HHHHHHHhcCCCCCCC------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            1       1233334443333222      223567889999999999999999999999996

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-50  Score=393.06  Aligned_cols=245  Identities=26%  Similarity=0.376  Sum_probs=196.5

Q ss_pred             hhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceecc----CCceeEEE
Q 010434          191 HFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRALVY  262 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~----~~~~~lV~  262 (511)
                      .|.++||+|+||+||+|.. .+++.||+|.+.....   ..+.|.+|++++++++|||||++++++..    +...++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            4667899999999999985 4788999999876332   34679999999999999999999999854    35578999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEc-CCCCeeeecccccccCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~-~~~~~kl~DFGla~~~~  341 (511)
                      ||+++|+|.+++.    ....+++..+..++.||+.||+|||+. ..+|+||||||+||||+ +++.+||+|||+|+...
T Consensus        92 E~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCcHHHHHh----ccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            9999999999883    345799999999999999999999983 12399999999999996 57899999999998654


Q ss_pred             CCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccc
Q 010434          342 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (511)
                      ...    .....||+.|+|||++.+   .++.++|||||||++|||++|+.||.....       ...+.+.+..+....
T Consensus       167 ~~~----~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-------~~~~~~~i~~~~~~~  232 (270)
T d1t4ha_         167 ASF----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVTSGVKPA  232 (270)
T ss_dssp             TTS----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHHTTTCCCG
T ss_pred             CCc----cCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCccc-------HHHHHHHHHcCCCCc
Confidence            332    234579999999999864   689999999999999999999999864321       112333333332211


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                           ......++.+.+++.+||+.||++|||+.|+++
T Consensus       233 -----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         233 -----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                 122233456889999999999999999999986

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=401.31  Aligned_cols=250  Identities=24%  Similarity=0.331  Sum_probs=203.3

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEecc-CcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLEN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~-~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      |.+.++||+|+||.||+|+. .+|+.||||+++. +....+.|.+|++++++++|||||++++++.+++..++||||+++
T Consensus        14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~   93 (288)
T d2jfla1          14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence            45678999999999999985 5789999999976 344557899999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCce
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  347 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  347 (511)
                      |+|.+++.   .....+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+......  .
T Consensus        94 g~L~~~~~---~~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~  165 (288)
T d2jfla1          94 GAVDAVML---ELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q  165 (288)
T ss_dssp             EEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--H
T ss_pred             CcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc--c
Confidence            99999873   234679999999999999999999999   699999999999999999999999999997543221  1


Q ss_pred             eeccccCCccccchhccccc---CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          348 SISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       348 ~~~~~~gt~~y~APE~~~~~---~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      ......||+.|+|||++...   ...++.++|||||||++|||++|+.||.......        +...+.......+. 
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--------~~~~i~~~~~~~~~-  236 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--------VLLKIAKSEPPTLA-  236 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--------HHHHHHHSCCCCCS-
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--------HHHHHHcCCCCCCC-
Confidence            22345699999999998532   2367899999999999999999999986543211        22222222222211 


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                         .+..++..+.+++.+||+.||++|||+.|+++
T Consensus       237 ---~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         237 ---QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ---SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               22234567889999999999999999999975

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.7e-50  Score=398.82  Aligned_cols=257  Identities=25%  Similarity=0.390  Sum_probs=207.1

Q ss_pred             hhhccccCcCCcEEEEEEEec------CCcEEEEEEeccCcc--cHHHHHHHHHHhccccccceEEeeceeccCCceeEE
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~~~--~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  261 (511)
                      +.+.++||+|+||+||+|+.+      +++.||||+++....  ..++|.+|+.++++++||||++++++|......+++
T Consensus        15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v   94 (301)
T d1lufa_          15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL   94 (301)
T ss_dssp             CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence            345789999999999999864      357899999976332  346799999999999999999999999999999999


Q ss_pred             EeecCCCCcccccccCC--------------------CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCce
Q 010434          262 YEFMPNGSLDRHIFPKE--------------------NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNI  321 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NI  321 (511)
                      |||+++|+|.+++....                    .....+++..++.|+.|+|.||+|||+   ++|+||||||+||
T Consensus        95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~NI  171 (301)
T d1lufa_          95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNC  171 (301)
T ss_dssp             EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred             EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccce
Confidence            99999999999884321                    112358999999999999999999999   6999999999999


Q ss_pred             EEcCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCC-CCCCccccc
Q 010434          322 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNAIR  400 (511)
Q Consensus       322 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~-~p~~~~~~~  400 (511)
                      |||.++.+||+|||+++...........+...||+.|+|||.+.+.  .++.|+|||||||++|||++|. +|+......
T Consensus       172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~  249 (301)
T d1lufa_         172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE  249 (301)
T ss_dssp             EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC--CCChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence            9999999999999999866554444444556689999999999875  7899999999999999999986 455543221


Q ss_pred             ccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          401 SSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                              .+...+.++.....      +..++..+.+|+.+||+.+|++||||.||+++|+...
T Consensus       250 --------e~~~~v~~~~~~~~------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         250 --------EVIYYVRDGNILAC------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             --------HHHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             --------HHHHHHHcCCCCCC------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence                    13334444433322      2234467889999999999999999999999999754

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-50  Score=395.87  Aligned_cols=246  Identities=23%  Similarity=0.313  Sum_probs=201.8

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEecc----CcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLEN----SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~----~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      |.+.+.||+|+||.||+|+. .+|+.||||++..    .....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus        10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy   89 (288)
T d1uu3a_          10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY   89 (288)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred             CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence            66788999999999999985 5799999999864    233557899999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++.    ..+.+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+|+......
T Consensus        90 ~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          90 AKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             CTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             cCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence            99999999872    34679999999999999999999999   699999999999999999999999999999876544


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      .........||+.|+|||++.+.  .++.++|||||||++|||++|+.||......        .+...+.+.. ..   
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~~~~-~~---  228 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNEY--------LIFQKIIKLE-YD---  228 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHTTC-CC---
T ss_pred             cccccccccCCccccCceeeccC--CCCcccceehhhHHHHHHhhCCCCCCCcCHH--------HHHHHHHcCC-CC---
Confidence            43334556799999999999875  7899999999999999999999999754321        2233333221 11   


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                         .+..+++.+.+++.+||+.||++|||++|+++
T Consensus       229 ---~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         229 ---FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             ---CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ---CCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence               11234567889999999999999999998743

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=405.93  Aligned_cols=259  Identities=22%  Similarity=0.319  Sum_probs=199.1

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      .|.+.++||+|+||+||+|+. .+|+.||||+++..  ....+.+.+|+.++++++|||||++++++.++...++||||+
T Consensus         7 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~   86 (322)
T d1s9ja_           7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM   86 (322)
T ss_dssp             GEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            455678999999999999985 57899999999753  334568999999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      ++|+|.+++.    +.+.+++..+..++.|++.||.|||+.  .+|+||||||+||||++++.+||+|||+|+...... 
T Consensus        87 ~gg~L~~~l~----~~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  159 (322)
T d1s9ja_          87 DGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  159 (322)
T ss_dssp             TTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred             CCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence            9999999983    335799999999999999999999961  389999999999999999999999999998653321 


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhH--------------
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVY--------------  411 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~--------------  411 (511)
                         .....||+.|+|||++.+.  .++.++||||+||++|||++|+.||.................              
T Consensus       160 ---~~~~~GT~~Y~APEvl~~~--~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         160 ---ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             ---C---CCSSCCCCHHHHHCS--CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             ---cccccCCccccCchHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence               2345799999999999875  789999999999999999999999965332110000000000              


Q ss_pred             Hhhhc---CCccccc------------ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          412 DQLNK---GGDLELR------------NVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       412 ~~~~~---~~~~~~~------------~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .....   .......            .+.......+..+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            00000   0000000            000000123467889999999999999999999987

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-49  Score=396.56  Aligned_cols=245  Identities=24%  Similarity=0.329  Sum_probs=200.3

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc----cHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .|...++||+|+||.||+|+. .+|+.||||++.....    ..+.|.+|+.++++++|||||++++++.+++..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            455678999999999999984 5789999999976432    23568999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++|+|..++    .....+++..+..++.||+.||+|||+   ++|+||||||+||||++++.+||+|||+|+.....
T Consensus        96 ~~~~g~l~~~~----~~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          96 YCLGSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             CCSEEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCCCchHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence            99999997665    234679999999999999999999999   69999999999999999999999999999865432


Q ss_pred             CCceeeccccCCccccchhccccc-CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~-~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                            ....||+.|+|||++.+. .+.++.++|||||||++|||++|+.||.......        ....+.......+
T Consensus       169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~--------~~~~i~~~~~~~~  234 (309)
T d1u5ra_         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNESPAL  234 (309)
T ss_dssp             ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSCCCCC
T ss_pred             ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhCCCCCC
Confidence                  345699999999998643 3468999999999999999999999986432111        1112222222221


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .     ...+++.+.+++.+||+.||++|||++++++
T Consensus       235 ~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         235 Q-----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             S-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C-----CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            1     1123567889999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=397.83  Aligned_cols=253  Identities=25%  Similarity=0.407  Sum_probs=201.7

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCc----EEEEEEecc--CcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGR----LIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~----~vAvK~l~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      +++.++||+|+||+||+|... +|+    +||||.++.  +....++|.+|+.++++++|||||+++|+|.++ ..++++
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~   89 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   89 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred             CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence            456789999999999999853 444    689998865  344577899999999999999999999999874 567889


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+.+|+|.+++.   .....+++..+++++.|||.||+|||+   ++|+||||||+||||+.++.+||+|||+|+....
T Consensus        90 e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          90 QLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             ECCTTCBHHHHHH---HTSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EeccCCccccccc---ccccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            9999999988773   334679999999999999999999999   6999999999999999999999999999998766


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCccc
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (511)
                      ...........||+.|+|||.+.+.  .++.++|||||||++|||+| |+.|++.....        .+...+..+....
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--------~~~~~i~~~~~~~  233 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EISSILEKGERLP  233 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--------GHHHHHHHTCCCC
T ss_pred             ccccccccccccCccccChHHHhcC--CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence            5544444555699999999999765  78999999999999999998 78887654322        1334444444333


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                      .+      ..++..+.+++.+||+.||++|||+.+|++.|+...
T Consensus       234 ~p------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         234 QP------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             CC------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC------cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence            22      223467889999999999999999999999887643

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-49  Score=396.17  Aligned_cols=248  Identities=23%  Similarity=0.330  Sum_probs=188.7

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      .|.+.+.||+|+||+||+|+. .+|+.||||++....  ...+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus        10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~   89 (307)
T d1a06a_          10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV   89 (307)
T ss_dssp             TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            467788999999999999985 478999999997633  23456889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEc---CCCCeeeecccccccCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~---~~~~~kl~DFGla~~~~~  342 (511)
                      ++|+|.+++.    ....+++..+..++.||+.||+|||+   ++|+||||||+|||+.   +++.+||+|||+|+....
T Consensus        90 ~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          90 SGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             CCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            9999999983    34679999999999999999999999   6999999999999994   578999999999986543


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccc
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLEL  422 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (511)
                      ..   ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......        +...+....... 
T Consensus       163 ~~---~~~~~~GT~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--------~~~~i~~~~~~~-  228 (307)
T d1a06a_         163 GS---VLSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--------LFEQILKAEYEF-  228 (307)
T ss_dssp             -------------CTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHTTCCCC-
T ss_pred             CC---eeeeeeeCccccCcHHHcCC--CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH--------HHHHHhccCCCC-
Confidence            32   22345699999999999875  78999999999999999999999996533211        222222221111 


Q ss_pred             cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          423 RNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       423 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                        .......+++.+.+++.+||+.||++|||++|+++
T Consensus       229 --~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         229 --DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             --CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence              11122335577899999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-49  Score=385.61  Aligned_cols=246  Identities=29%  Similarity=0.466  Sum_probs=195.8

Q ss_pred             hhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceecc-CCceeEEEeecCCC
Q 010434          190 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRALVYEFMPNG  268 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~~~g  268 (511)
                      +.|.++||+|+||.||+|+++ |+.||||+++.+. ..++|.+|++++++++|||||+++|+|.+ .+..++||||+++|
T Consensus         9 ~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g   86 (262)
T d1byga_           9 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG   86 (262)
T ss_dssp             EEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred             eEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence            456789999999999999985 7899999997643 55789999999999999999999999865 46689999999999


Q ss_pred             CcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCcee
Q 010434          269 SLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  348 (511)
Q Consensus       269 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  348 (511)
                      +|.+++...  ....++|..+++++.|||.||+|||+   .+|+||||||+|||++.++.+||+|||+++......    
T Consensus        87 ~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~----  157 (262)
T d1byga_          87 SLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----  157 (262)
T ss_dssp             EHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred             CHHHHHHhc--CCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC----
Confidence            999998432  23468999999999999999999999   699999999999999999999999999998654322    


Q ss_pred             eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCcccccccch
Q 010434          349 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNVTE  427 (511)
Q Consensus       349 ~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (511)
                       ....+|..|+|||++.+.  .++.++||||||+++|||+| |+.|+......        .+...+.++...+...   
T Consensus       158 -~~~~~~~~y~aPE~l~~~--~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--------~~~~~i~~~~~~~~~~---  223 (262)
T d1byga_         158 -DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPRVEKGYKMDAPD---  223 (262)
T ss_dssp             -----CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--------GHHHHHTTTCCCCCCT---
T ss_pred             -ccccccccCCChHHHhCC--CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--------HHHHHHHcCCCCCCCc---
Confidence             344689999999999764  78999999999999999998 67776543221        2334444444433322   


Q ss_pred             hHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          428 IESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       428 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                         .+++.+.+++.+||+.||++||||.+++++|+.
T Consensus       224 ---~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~  256 (262)
T d1byga_         224 ---GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  256 (262)
T ss_dssp             ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence               234678899999999999999999999999975

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-49  Score=390.85  Aligned_cols=270  Identities=23%  Similarity=0.261  Sum_probs=202.8

Q ss_pred             HhhhccccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCC----ceeEEEee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KRALVYEF  264 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~----~~~lV~e~  264 (511)
                      ++.+.++||+|+||.||+|++ +|+.||||++..+......+..|+..+.+++|||||+++|++.+.+    ..++||||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey   82 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence            345678999999999999986 4899999999765443333455666777889999999999997643    57899999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCC-----CCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGC-----DMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      +++|+|.+++.     ...++|..+++++.|+|.||+|||+..     .++|+||||||+||||+.++.+||+|||+++.
T Consensus        83 ~~~g~L~~~l~-----~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          83 HEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             CTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ccCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            99999999993     246999999999999999999999731     36999999999999999999999999999987


Q ss_pred             CCCCCCcee--eccccCCccccchhcccccC----CCcCccchHHHHHHHHHHHHhCCCCCCccccccccc-------cc
Q 010434          340 HPKENDFVS--ISATRGTIGYIAPELISRNF----GTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA-------YF  406 (511)
Q Consensus       340 ~~~~~~~~~--~~~~~gt~~y~APE~~~~~~----~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~-------~~  406 (511)
                      .........  .....||++|+|||++.+..    ..++.|+|||||||++|||+||..|+..........       ..
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            765443322  23456999999999986531    136789999999999999999988775432221100       01


Q ss_pred             chhhHHhhhc-CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          407 PSWVYDQLNK-GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       407 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                      .....+.... ..+..+... .........+.+++.+||+.||++|||+.||++.|+...
T Consensus       238 ~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         238 VEEMRKVVCEQKLRPNIPNR-WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGG-GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHhccccCCCCCcc-cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            1112222211 222222221 123345667899999999999999999999999998643

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-49  Score=389.27  Aligned_cols=253  Identities=23%  Similarity=0.359  Sum_probs=195.5

Q ss_pred             HhhhccccCcCCcEEEEEEEec----CCcEEEEEEeccC--cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  262 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~----~g~~vAvK~l~~~--~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~  262 (511)
                      .+.+.++||+|+||.||+|++.    .+..||||.++..  ....+.|.+|+.++++++|||||+++|++.+ +..++||
T Consensus         8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~   86 (273)
T d1mp8a_           8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIM   86 (273)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEE
Confidence            4567789999999999999853    2457999998653  2335679999999999999999999999964 6789999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      ||+++|+|.+++.   .....+++..++.++.||++||+|||+   .+|+||||||+||++++++.+||+|||+|+....
T Consensus        87 E~~~~g~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          87 ELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             ECCTTEEHHHHHH---HTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EeccCCcHHhhhh---ccCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            9999999998763   234679999999999999999999999   6999999999999999999999999999987654


Q ss_pred             CCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCccc
Q 010434          343 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       343 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (511)
                      .... ......||+.|+|||++.+.  .++.++|||||||++|||++ |+.|+......        .+...+.++....
T Consensus       161 ~~~~-~~~~~~gt~~y~apE~l~~~--~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--------~~~~~i~~~~~~~  229 (273)
T d1mp8a_         161 STYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGRIENGERLP  229 (273)
T ss_dssp             -----------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GHHHHHHTTCCCC
T ss_pred             Ccce-eccceecCcccchhhHhccC--CCCCccccccchHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence            3322 23445689999999999765  78999999999999999998 88888654322        2334444443333


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                      .      +..++..+.+++.+||+.||++|||+.+|++.|+..+
T Consensus       230 ~------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         230 M------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             C------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            2      2234567899999999999999999999999987643

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-49  Score=391.47  Aligned_cols=258  Identities=26%  Similarity=0.380  Sum_probs=205.0

Q ss_pred             HhhhccccCcCCcEEEEEEEecC----CcEEEEEEecc--CcccHHHHHHHHHHhccccccceEEeeceecc-CCceeEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHT----GRLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRALV  261 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~----g~~vAvK~l~~--~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~-~~~~~lV  261 (511)
                      +.+|.++||+|+||+||+|.+.+    ...||||+++.  +....++|.+|++++++++|||||+++|++.+ +...++|
T Consensus        28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred             eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence            33567899999999999998643    23699999975  33345789999999999999999999999865 5678999


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      |||+++|+|.+++.   .....+++..+++++.|+|.||.|||+   .+|+||||||+||||++++.+||+|||+++...
T Consensus       108 ~E~~~~g~l~~~~~---~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~  181 (311)
T d1r0pa_         108 LPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  181 (311)
T ss_dssp             EECCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred             EEEeecCchhhhhc---cccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence            99999999999874   334568899999999999999999999   699999999999999999999999999998765


Q ss_pred             CCCCce--eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          342 KENDFV--SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       342 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      ......  ......||+.|+|||.+...  .++.++||||||+++|||++|+.|+.......   .    +...+..+..
T Consensus       182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~---~----~~~~i~~g~~  252 (311)
T d1r0pa_         182 DKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---D----ITVYLLQGRR  252 (311)
T ss_dssp             TTTCCCTTCTTCSSCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCC
T ss_pred             ccccccceecccccccccccChHHHhcC--CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH---H----HHHHHHcCCC
Confidence            443221  22345689999999998764  78999999999999999999888775432111   1    2222333333


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                      ...+      ..++..+.+++.+||+.||++||||.||++.|+.....
T Consensus       253 ~~~p------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         253 LLQP------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCc------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            3221      12346788999999999999999999999999986644

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-49  Score=390.49  Aligned_cols=259  Identities=28%  Similarity=0.433  Sum_probs=199.2

Q ss_pred             HhhhccccCcCCcEEEEEEEec------CCcEEEEEEeccCc--ccHHHHHHHHHHhccc-cccceEEeeceecc-CCce
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSK--FSAEEFINEVSTIGRI-HHVNVVQLLGFCSE-GSKR  258 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~-~~~~  258 (511)
                      .+.+.++||+|+||.||+|...      +++.||||+++...  ...+.+.+|+..+.++ +|+|||.+++++.+ +...
T Consensus        14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~   93 (299)
T d1ywna1          14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL   93 (299)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred             HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeE
Confidence            4567789999999999999853      34689999997532  3456788899888887 68999999998765 4568


Q ss_pred             eEEEeecCCCCcccccccCCC------------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC
Q 010434          259 ALVYEFMPNGSLDRHIFPKEN------------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN  326 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~  326 (511)
                      ++||||+++|+|.+++.....            ....+++..+..++.||++||+|||+   ++|+||||||+||||+++
T Consensus        94 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~~  170 (299)
T d1ywna1          94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEK  170 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGG
T ss_pred             EEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECCC
Confidence            999999999999999854322            23468999999999999999999999   699999999999999999


Q ss_pred             CCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCC-CCCCcccccccccc
Q 010434          327 FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNAIRSSKAY  405 (511)
Q Consensus       327 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~-~p~~~~~~~~~~~~  405 (511)
                      +.+||+|||+|+...............||+.|+|||.+.+.  .++.++|||||||++|||++|. .|+.....      
T Consensus       171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~------  242 (299)
T d1ywna1         171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------  242 (299)
T ss_dssp             GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC------
T ss_pred             CcEEEccCcchhhccccccccccCceeeCccccchhHhhcC--CCCcccceeehHHHHHHHHhCCCCCCCCCCH------
Confidence            99999999999876655544444556799999999999875  7899999999999999999875 45543221      


Q ss_pred             cchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          406 FPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                       ...+...+.++......      ..+++.+.+++.+||+.||++|||+++|+++|+..+
T Consensus       243 -~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         243 -DEEFCRRLKEGTRMRAP------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             -SHHHHHHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHHHHHHhcCCCCCCC------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence             22334444444443322      223567889999999999999999999999998653

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.1e-48  Score=397.01  Aligned_cols=250  Identities=20%  Similarity=0.284  Sum_probs=205.1

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .|.+.++||+|+||.||+|+. .+|+.||||++.... ...+.+.+|+.++++++|||||++++++.+++..++||||++
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~  106 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS  106 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            467788999999999999985 579999999997643 345678999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC--CCCeeeecccccccCCCCC
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH--NFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~--~~~~kl~DFGla~~~~~~~  344 (511)
                      +|+|.+++.   .....+++..+..++.||+.||+|||+   .+|+||||||+|||++.  ++.+||+|||+|+......
T Consensus       107 gg~L~~~l~---~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         107 GGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             SCBHHHHHT---CTTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             CCCHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            999999883   234579999999999999999999999   69999999999999954  6789999999998765443


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      .   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......        +...+......   .
T Consensus       181 ~---~~~~~gT~~Y~aPEv~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--------~~~~i~~~~~~---~  244 (350)
T d1koaa2         181 S---VKVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--------TLRNVKSCDWN---M  244 (350)
T ss_dssp             C---EEEECSCTTTCCHHHHHTC--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCC---S
T ss_pred             c---cceecCcccccCHHHHcCC--CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCC---C
Confidence            2   2345699999999999875  78899999999999999999999996543211        22222222110   0


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      .......+++.+.+++.+||+.||++|||++|+++.
T Consensus       245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111223345678899999999999999999999884

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=386.53  Aligned_cols=248  Identities=24%  Similarity=0.308  Sum_probs=204.5

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc-------ccHHHHHHHHHHhccccccceEEeeceeccCCceeE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK-------FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  260 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~-------~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~l  260 (511)
                      .|.+.++||+|+||+||+|+. .+|+.||||++++..       ...+.|.+|+.++++++|||||++++++.++...+|
T Consensus        11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (293)
T d1jksa_          11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   90 (293)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            466778999999999999985 579999999986421       246789999999999999999999999999999999


Q ss_pred             EEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC----Ceeeecccc
Q 010434          261 VYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF----IPKVSDFGL  336 (511)
Q Consensus       261 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~----~~kl~DFGl  336 (511)
                      ||||+++|+|.+++.    ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++    .+||+|||+
T Consensus        91 v~E~~~gg~L~~~i~----~~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          91 ILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEcCCCccccchhc----cccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhh
Confidence            999999999999883    33579999999999999999999999   6999999999999998776    599999999


Q ss_pred             cccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhc
Q 010434          337 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK  416 (511)
Q Consensus       337 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  416 (511)
                      |+.......   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......        ....+..
T Consensus       164 a~~~~~~~~---~~~~~~t~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--------~~~~i~~  230 (293)
T d1jksa_         164 AHKIDFGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQE--------TLANVSA  230 (293)
T ss_dssp             CEECTTSCB---CSCCCCCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHT
T ss_pred             hhhcCCCcc---ccccCCCCcccCHHHHcCC--CCCCcccchhhhHHHHHHHcCCCCCCCCCHHH--------HHHHHHh
Confidence            987654432   2445699999999999864  78999999999999999999999997543221        2222222


Q ss_pred             CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          417 GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ...   .........++..+.+++.+||+.||++|||++|+++
T Consensus       231 ~~~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         231 VNY---EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             TCC---CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cCC---CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            211   1112233345677889999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-49  Score=391.18  Aligned_cols=260  Identities=25%  Similarity=0.368  Sum_probs=210.8

Q ss_pred             HHhhhccccCcCCcEEEEEEEec------CCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCCcee
Q 010434          188 VTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  259 (511)
Q Consensus       188 ~t~~~~~~LG~G~fg~Vykg~~~------~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~  259 (511)
                      ..+.+.++||+|+||+||+|.++      +++.||||+++...  .....|.+|+.++++++|||||+++|++..+...+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            34556789999999999999753      35789999997633  23356899999999999999999999999999999


Q ss_pred             EEEeecCCCCcccccccCC------CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeec
Q 010434          260 LVYEFMPNGSLDRHIFPKE------NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSD  333 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~D  333 (511)
                      +||||+++|+|.+++....      .....+++..+.+++.|+|+||.|||+   .+|+||||||+|||+++++++||+|
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEee
Confidence            9999999999999875322      122457999999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCC-CCCCcccccccccccchhhHH
Q 010434          334 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNAIRSSKAYFPSWVYD  412 (511)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~-~p~~~~~~~~~~~~~~~~~~~  412 (511)
                      ||+|+...............||+.|+|||.+.+.  .++.++||||||+++|||+||+ .|+.....        ..+..
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~--~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~--------~~~~~  246 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVLR  246 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------HHHHH
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccC--CCCcccccccHHHHHHHHHhCCCCCCCCCCH--------HHHHH
Confidence            9999876554444444555689999999999875  7889999999999999999985 55543321        12333


Q ss_pred             hhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcC
Q 010434          413 QLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMD  466 (511)
Q Consensus       413 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~  466 (511)
                      .+.++......      ..++..+.+++.+||+.+|++||||++|+++|+...+
T Consensus       247 ~i~~~~~~~~p------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         247 FVMEGGLLDKP------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHhCCCCCCc------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            44444433322      2234678999999999999999999999999998654

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.6e-48  Score=396.06  Aligned_cols=254  Identities=22%  Similarity=0.314  Sum_probs=207.4

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc-ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~-~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .|.+.++||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.++++++|||||++++++.+++..+|||||++
T Consensus        30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~  109 (352)
T d1koba_          30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS  109 (352)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            467789999999999999985 579999999997643 345678899999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEc--CCCCeeeecccccccCCCCC
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD--HNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~--~~~~~kl~DFGla~~~~~~~  344 (511)
                      +|+|.+++.   ..+.++++..+..++.||+.||+|||+   .+|+||||||+||||+  .++.+||+|||+|+......
T Consensus       110 gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         110 GGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            999988762   334579999999999999999999999   6999999999999997  67899999999998775543


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      .   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......        +...+......   .
T Consensus       184 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~i~~~~~~---~  247 (352)
T d1koba_         184 I---VKVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--------TLQNVKRCDWE---F  247 (352)
T ss_dssp             C---EEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHHCCCC---C
T ss_pred             c---eeeccCcccccCHHHHcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCC---C
Confidence            2   2445699999999999875  78999999999999999999999996543221        22222222111   0


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH--HhcC
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM--LEGS  464 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~--Le~~  464 (511)
                      .......+++.+.+|+.+||+.||++|||+.|+++.  +++.
T Consensus       248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            111223345678899999999999999999999874  5443

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=389.95  Aligned_cols=256  Identities=26%  Similarity=0.434  Sum_probs=204.2

Q ss_pred             hhhccccCcCCcEEEEEEEec-CCc--EEEEEEecc--CcccHHHHHHHHHHhccc-cccceEEeeceeccCCceeEEEe
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH-TGR--LIAVKMLEN--SKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~-~g~--~vAvK~l~~--~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      +.+.++||+|+||.||+|+++ +|.  .||||.+..  .....++|.+|+++++++ +|||||+++|++.+++..++|||
T Consensus        12 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e   91 (309)
T d1fvra_          12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   91 (309)
T ss_dssp             CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEE
Confidence            356789999999999999865 444  578888754  333556899999999999 79999999999999999999999


Q ss_pred             ecCCCCcccccccCC------------CcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeee
Q 010434          264 FMPNGSLDRHIFPKE------------NKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKV  331 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl  331 (511)
                      |+++|+|.+++....            .....+++..+..++.|||+||.|||+   .+|+||||||+|||++.++.+||
T Consensus        92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~kl  168 (309)
T d1fvra_          92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKI  168 (309)
T ss_dssp             CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEE
T ss_pred             ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceEE
Confidence            999999999985431            235679999999999999999999999   69999999999999999999999


Q ss_pred             ecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCC-CCCcccccccccccchhh
Q 010434          332 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNAIRSSKAYFPSWV  410 (511)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~-p~~~~~~~~~~~~~~~~~  410 (511)
                      +|||+++......   ......||..|+|||.+.+.  .++.++|||||||++|||++|.. |+....        ...+
T Consensus       169 ~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~--~~~~~sDvwSfGvil~ell~~~~~p~~~~~--------~~~~  235 (309)
T d1fvra_         169 ADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAEL  235 (309)
T ss_dssp             CCTTCEESSCEEC---CC----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHH
T ss_pred             ccccccccccccc---cccceecCCcccchHHhccC--CCCccceeehhHHHHHHHHhcCCCCCCCCC--------HHHH
Confidence            9999998654322   12344689999999999764  88999999999999999999765 554322        2223


Q ss_pred             HHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCC
Q 010434          411 YDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDD  467 (511)
Q Consensus       411 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~  467 (511)
                      ...+.++...+..      ..+++.+.+++.+||+.||++||||++|++.|+.....
T Consensus       236 ~~~i~~~~~~~~~------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         236 YEKLPQGYRLEKP------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             HHHGGGTCCCCCC------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHhcCCCCCC------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            4444444433322      22456788999999999999999999999999886643

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=389.27  Aligned_cols=263  Identities=25%  Similarity=0.425  Sum_probs=212.8

Q ss_pred             HHHHHhhhccccCcCCcEEEEEEEe------cCCcEEEEEEeccCc--ccHHHHHHHHHHhccc-cccceEEeeceeccC
Q 010434          185 IIAVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMLENSK--FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEG  255 (511)
Q Consensus       185 i~~~t~~~~~~LG~G~fg~Vykg~~------~~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~  255 (511)
                      +....+.+.++||+|+||.||+|++      .+++.||||+++...  ....+|.+|+.+++++ +|||||+++|+|.++
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            3334566788999999999999975      245789999997633  2445799999999999 699999999999999


Q ss_pred             CceeEEEeecCCCCcccccccCCC--------------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCce
Q 010434          256 SKRALVYEFMPNGSLDRHIFPKEN--------------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNI  321 (511)
Q Consensus       256 ~~~~lV~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NI  321 (511)
                      ...++||||+++|+|.+++.....              ....+++..+.+++.|||.||+|||+   ++++||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccc
Confidence            999999999999999998854321              23469999999999999999999999   6999999999999


Q ss_pred             EEcCCCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCC-CCccccc
Q 010434          322 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNAIR  400 (511)
Q Consensus       322 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p-~~~~~~~  400 (511)
                      |++.++.+|++|||+++...............||+.|+|||.+...  .++.++|||||||++|||+|++.| +......
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC--CCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999987766655556667899999999999764  789999999999999999995544 4332211


Q ss_pred             ccccccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          401 SSKAYFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                             ..+.+.+..+......      ...+..+.+|+.+||+.||++||||++|+++|+..+
T Consensus       255 -------~~~~~~i~~~~~~~~~------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i  306 (311)
T d1t46a_         255 -------SKFYKMIKEGFRMLSP------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (311)
T ss_dssp             -------HHHHHHHHHTCCCCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------HHHHHHHhcCCCCCCc------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence                   1123333343333222      223567899999999999999999999999998754

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=384.13  Aligned_cols=252  Identities=27%  Similarity=0.398  Sum_probs=194.2

Q ss_pred             hhhccccCcCCcEEEEEEEec--CC--cEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEE
Q 010434          190 NHFTHKLGQGGFGSVYKGQLH--TG--RLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~--~g--~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  261 (511)
                      +.+.++||+|+||.||+|+++  ++  ..||||+++..    ....++|.+|+.++++++|||||+++|++.+ ...++|
T Consensus        10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv   88 (273)
T d1u46a_          10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV   88 (273)
T ss_dssp             EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence            456789999999999999853  22  37999998753    2234689999999999999999999999976 467899


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      |||+++|+|.+++..   ....+++..++.++.|||.||.|||+   ++|+||||||+||||+.++.+||+|||+++...
T Consensus        89 ~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          89 TELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            999999999988742   34579999999999999999999999   699999999999999999999999999999876


Q ss_pred             CCCCcee-eccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          342 KENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       342 ~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      ....... .....||..|+|||.+.+.  .++.++|||||||++|||+| |+.||.......       .+......+..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~-------~~~~i~~~~~~  233 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-------ILHKIDKEGER  233 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTSCCC
T ss_pred             cCCCcceecCccccCcccCCHHHHhCC--CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH-------HHHHHHhCCCC
Confidence            5543322 2344588999999999875  78999999999999999998 899986433221       11222222222


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhc
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  463 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~  463 (511)
                      .+.      +..++..+.+++.+||+.||++|||+++|+++|+.
T Consensus       234 ~~~------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         234 LPR------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             CCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCC------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            221      12334678899999999999999999999999975

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-48  Score=384.27  Aligned_cols=258  Identities=24%  Similarity=0.405  Sum_probs=207.5

Q ss_pred             HhhhccccCcCCcEEEEEEEecC--------CcEEEEEEeccCc--ccHHHHHHHHHHhccc-cccceEEeeceeccCCc
Q 010434          189 TNHFTHKLGQGGFGSVYKGQLHT--------GRLIAVKMLENSK--FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSK  257 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~~~--------g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~~~~  257 (511)
                      .+.+.++||+|+||.||+|+..+        +..||||+++...  ....++.+|+..+.++ +|||||+++++|.++..
T Consensus        14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~   93 (299)
T d1fgka_          14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP   93 (299)
T ss_dssp             GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence            45667899999999999997432        3479999997643  3457899999999998 79999999999999999


Q ss_pred             eeEEEeecCCCCcccccccCCC------------cCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC
Q 010434          258 RALVYEFMPNGSLDRHIFPKEN------------KGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH  325 (511)
Q Consensus       258 ~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~  325 (511)
                      .++||||+++|+|.++|.....            ....+++..++.++.|||.||+|||+   .+|+||||||+|||++.
T Consensus        94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~~  170 (299)
T d1fgka_          94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTE  170 (299)
T ss_dssp             CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECT
T ss_pred             EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeecC
Confidence            9999999999999999854321            23569999999999999999999999   69999999999999999


Q ss_pred             CCCeeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHh-CCCCCCccccccccc
Q 010434          326 NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAIRSSKA  404 (511)
Q Consensus       326 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~ellt-g~~p~~~~~~~~~~~  404 (511)
                      ++.+||+|||+++...............+|+.|+|||.+.+.  .++.|+||||||+++|||++ |+.|+.....     
T Consensus       171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~--~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-----  243 (299)
T d1fgka_         171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  243 (299)
T ss_dssp             TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred             CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC--CCCchhhhHHhHHHHHHhccCCCCCCCCCCH-----
Confidence            999999999999877655544444556799999999999764  89999999999999999998 6777754332     


Q ss_pred             ccchhhHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          405 YFPSWVYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                         ..+.+.+.++.......      .++..+.+++.+||+.||++|||+.||+++|+..+
T Consensus       244 ---~~~~~~i~~~~~~~~p~------~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         244 ---EELFKLLKEGHRMDKPS------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             ---HHHHHHHHTTCCCCCCS------SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHHHHHHcCCCCCCCc------cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence               22445555554443322      23467889999999999999999999999998753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.8e-47  Score=380.61  Aligned_cols=241  Identities=25%  Similarity=0.350  Sum_probs=202.3

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      |.+.++||+|+||+||+|+. .+|+.||||+++..    ....+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~   85 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY   85 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence            55678999999999999985 57999999999652    34567899999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|..++    ..+..+++..+..++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+|+......
T Consensus        86 ~~gg~l~~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~  158 (316)
T d1fota_          86 IEGGELFSLL----RKSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT  158 (316)
T ss_dssp             CCSCBHHHHH----HHTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred             cCCccccccc----cccccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence            9999998887    345678999999999999999999998   699999999999999999999999999998765432


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                           ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||......        .+...+..+.. .   
T Consensus       159 -----~~~~Gt~~Y~APE~l~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~i~~~~~-~---  219 (316)
T d1fota_         159 -----YTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--------KTYEKILNAEL-R---  219 (316)
T ss_dssp             -----CCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHCCC-C---
T ss_pred             -----ccccCcccccCHHHHcCC--CCCchhhccccchhHHHHHhCCCCCCCcCHH--------HHHHHHHcCCC-C---
Confidence                 345799999999999765  7899999999999999999999999754321        12223322211 1   


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCC-----CHHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRP-----SMTKVLE  459 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~  459 (511)
                         .+..+++.+.+++.+||+.||.+||     |++++++
T Consensus       220 ---~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         220 ---FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence               1122456788999999999999996     8999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-47  Score=382.62  Aligned_cols=244  Identities=23%  Similarity=0.326  Sum_probs=204.2

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  264 (511)
                      |.+.+.||+|+||.||+++. .+|+.||||++++.    ....+.+.+|+.++++++|||||++++++.++...++||||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey   86 (337)
T d1o6la_           7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY   86 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence            55678999999999999985 57999999999752    33567899999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  344 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~  344 (511)
                      +++|+|.+++    .....+++..+..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+|+......
T Consensus        87 ~~gg~L~~~~----~~~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          87 ANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             CTTCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             cCCCchhhhh----hcccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            9999999988    344679999999999999999999999   799999999999999999999999999998654433


Q ss_pred             CceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCcccccc
Q 010434          345 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRN  424 (511)
Q Consensus       345 ~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (511)
                      .  ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||.......        +........ ..   
T Consensus       160 ~--~~~~~~GT~~Y~aPE~~~~~--~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--------~~~~i~~~~-~~---  223 (337)
T d1o6la_         160 A--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELILMEE-IR---  223 (337)
T ss_dssp             C--CBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCC-CC---
T ss_pred             c--ccccceeCHHHhhhhhccCC--CCChhhcccchhhHHHHHHHCCCCCCCcCHHH--------HHHHHhcCC-CC---
Confidence            2  23456799999999999875  78999999999999999999999997643221        222222221 11   


Q ss_pred             cchhHHHHHHHHHHHHHHhcCcCCCCCCC-----HHHHHH
Q 010434          425 VTEIESVIARKLCMIGLWCIQVKAADRPS-----MTKVLE  459 (511)
Q Consensus       425 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~evl~  459 (511)
                         .+..++..+.+++.+||+.||++||+     +.++++
T Consensus       224 ---~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         224 ---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence               12234567889999999999999995     788876

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-47  Score=382.52  Aligned_cols=249  Identities=17%  Similarity=0.227  Sum_probs=206.1

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecCC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN  267 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  267 (511)
                      .|.+.++||+|+||+||+|.. .+|+.||||+++....+...+.+|++++++++|||||++++++.+++..++||||+++
T Consensus         6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g   85 (321)
T d1tkia_           6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG   85 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence            356778999999999999985 4789999999987766667889999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCC--CCeeeecccccccCCCCCC
Q 010434          268 GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHN--FIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       268 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~--~~~kl~DFGla~~~~~~~~  345 (511)
                      |+|.+++.   ..+..+++..+..++.||+.||+|||+   ++|+||||||+|||++.+  ..+||+|||+++.......
T Consensus        86 g~L~~~i~---~~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~  159 (321)
T d1tkia_          86 LDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             CcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence            99999883   234579999999999999999999998   799999999999999854  5899999999987654332


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccccc
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELRNV  425 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (511)
                         .....+|+.|+|||.+.+.  .++.++||||+||++|||++|+.||......        .+...+.....   ...
T Consensus       160 ---~~~~~~t~~y~ape~~~~~--~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--------~~~~~i~~~~~---~~~  223 (321)
T d1tkia_         160 ---FRLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIENIMNAEY---TFD  223 (321)
T ss_dssp             ---EEEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCC---CCC
T ss_pred             ---ccccccccccccchhccCC--CCCchhhcccHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCC---CCC
Confidence               2345689999999998765  7899999999999999999999999764322        12222222211   111


Q ss_pred             chhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          426 TEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       426 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ......++..+.+++.+||+.||++|||+.|+++
T Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1222345677899999999999999999999987

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-47  Score=378.83  Aligned_cols=257  Identities=25%  Similarity=0.286  Sum_probs=194.7

Q ss_pred             ccccCcCCcEEEEEEEe-cCCcEEEEEEeccCccc------HHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          193 THKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFS------AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       193 ~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~------~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      .++||+|+||+||+|+. .+|+.||||+++.....      .+.+.+|+.++++++|||||++++++..++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            36899999999999995 47999999999653321      246889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      +++++..+.    ..+..+++..+..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+|+.......
T Consensus        83 ~~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          83 ETDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             SEEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             cchHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            988877665    344679999999999999999999999   6999999999999999999999999999986654432


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccc------------ccccchhhHHh
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSS------------KAYFPSWVYDQ  413 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~------------~~~~~~~~~~~  413 (511)
                        ......||+.|+|||++... ..++.++|||||||++|||++|+.||........            ...++.+....
T Consensus       156 --~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ua2a_         156 --AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP  232 (299)
T ss_dssp             --CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred             --cccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence              22345699999999998653 3678999999999999999999999865432110            00000000000


Q ss_pred             hhc-CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          414 LNK-GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       414 ~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ... ................++.+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            000 0000000001111234567899999999999999999999987

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.1e-47  Score=373.31  Aligned_cols=249  Identities=21%  Similarity=0.258  Sum_probs=203.0

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc----------cHHHHHHHHHHhcccc-ccceEEeeceeccCCc
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF----------SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSK  257 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~----------~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~  257 (511)
                      |.+.++||+|+||+||+++. .+|+.||||++.....          ..+.+.+|+.++++++ |||||++++++.+++.
T Consensus         5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~   84 (277)
T d1phka_           5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF   84 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence            45678999999999999985 5799999999865322          1245889999999997 9999999999999999


Q ss_pred             eeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccc
Q 010434          258 RALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLA  337 (511)
Q Consensus       258 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla  337 (511)
                      .+|||||+++|+|.+++.    ....+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus        85 ~~ivmE~~~~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          85 FFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             EEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEcCCCchHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhe
Confidence            999999999999999983    34579999999999999999999998   69999999999999999999999999999


Q ss_pred             ccCCCCCCceeeccccCCccccchhccccc----CCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHh
Q 010434          338 KFHPKENDFVSISATRGTIGYIAPELISRN----FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQ  413 (511)
Q Consensus       338 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~  413 (511)
                      +.......   .....||+.|+|||.+.+.    ...++.++||||+||++|||++|+.||.....        ......
T Consensus       158 ~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--------~~~~~~  226 (277)
T d1phka_         158 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLMLRM  226 (277)
T ss_dssp             EECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred             eEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--------HHHHHH
Confidence            87654332   2445699999999998642    23568899999999999999999999975432        112232


Q ss_pred             hhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          414 LNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       414 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      +..+... .  .......+++.+.+++.+||+.||++|||+.||++
T Consensus       227 i~~~~~~-~--~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         227 IMSGNYQ-F--GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHTCCC-C--CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHhCCCC-C--CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            3222211 1  11122335678899999999999999999999875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-46  Score=380.58  Aligned_cols=242  Identities=23%  Similarity=0.290  Sum_probs=202.9

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC----cccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEe
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      .|.+.++||+|+||.||+++. .+|+.||||++...    ....+.+.+|+.++++++|||||++++++.+....++|||
T Consensus        42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e  121 (350)
T d1rdqe_          42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence            466678999999999999985 57999999998642    3355789999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++|+|..++.    ..+.+++..+..++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+|+.....
T Consensus       122 ~~~~g~l~~~l~----~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         122 YVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             CCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cccccchhhhHh----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            999999999883    33579999999999999999999999   69999999999999999999999999999876432


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      .     ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ..+...+..+...   
T Consensus       195 ~-----~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~~~~---  256 (350)
T d1rdqe_         195 T-----WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSGKVR---  256 (350)
T ss_dssp             B-----CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCC---
T ss_pred             c-----ccccCccccCCHHHHcCC--CCCccccccchhHHHHHHHhCCCCCCCcCH--------HHHHHHHhcCCCC---
Confidence            2     345699999999999875  789999999999999999999999965321        1223333332211   


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCC-----CCHHHHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADR-----PSMTKVLE  459 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~R-----Ps~~evl~  459 (511)
                          .+..+++.+.+++.+||+.||.+|     ||++++++
T Consensus       257 ----~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         257 ----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                112345678899999999999999     48999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.3e-47  Score=377.12  Aligned_cols=255  Identities=21%  Similarity=0.283  Sum_probs=197.8

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc----cHHHHHHHHHHhccccccceEEeeceeccCC----cee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KRA  259 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~----~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~----~~~  259 (511)
                      .|.+.+.||+|+||.||+|+. .+|+.||||+++.+..    ..+.|.+|+.++++++|||||++++++....    ..+
T Consensus         8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~   87 (277)
T d1o6ya_           8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY   87 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence            466788999999999999984 5899999999975322    2457899999999999999999999986543    378


Q ss_pred             EEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      +||||+++|+|.+++.    ..+.+++..+..++.||+.||+|||+   .+|+||||||+|||++.++..+|+|||.++.
T Consensus        88 lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          88 IVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhh
Confidence            9999999999998872    34579999999999999999999999   6999999999999999999999999999876


Q ss_pred             CCCCCCc-eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCC
Q 010434          340 HPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG  418 (511)
Q Consensus       340 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  418 (511)
                      ....... .......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......       ......+....
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~~~~~~~  231 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVREDP  231 (277)
T ss_dssp             CC----------------TTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCC
T ss_pred             hccccccccccccccCcccccCHHHHcCC--CCCcceecccchHHHHHHHhCCCCCCCcCHH-------HHHHHHHhcCC
Confidence            5443322 223455699999999999764  7899999999999999999999999754321       11223333322


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhcCcCCCCCC-CHHHHHHHHhc
Q 010434          419 DLELRNVTEIESVIARKLCMIGLWCIQVKAADRP-SMTKVLEMLEG  463 (511)
Q Consensus       419 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-s~~evl~~Le~  463 (511)
                      ...    ......+++.+.+++.+||+.||++|| |++++++.|..
T Consensus       232 ~~~----~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         232 IPP----SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             CCG----GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCC----chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            211    112233457788999999999999999 89999888764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=379.96  Aligned_cols=249  Identities=22%  Similarity=0.274  Sum_probs=196.7

Q ss_pred             hhhc-cccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccc-cccceEEeeceecc----CCceeEEE
Q 010434          190 NHFT-HKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSE----GSKRALVY  262 (511)
Q Consensus       190 ~~~~-~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l-~H~niv~l~g~~~~----~~~~~lV~  262 (511)
                      |.+. +.||+|+||.||+|+. .+|+.||||+++..    ..+.+|+.++.++ +|||||++++++.+    +...++||
T Consensus        13 y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivm   88 (335)
T d2ozaa1          13 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM   88 (335)
T ss_dssp             EEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEE
Confidence            4444 4599999999999985 67999999999653    4677899987655 89999999998854    56789999


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC---CCCeeeeccccccc
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH---NFIPKVSDFGLAKF  339 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~---~~~~kl~DFGla~~  339 (511)
                      ||+++|+|.+++..  .....+++..+..++.||+.||+|||+   .+|+||||||+|||+++   ++.+||+|||+|+.
T Consensus        89 Ey~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          89 ECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             ECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             ECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeee
Confidence            99999999999842  223579999999999999999999999   69999999999999975   56799999999987


Q ss_pred             CCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          340 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       340 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      ......   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.........    ..+...+.   .
T Consensus       164 ~~~~~~---~~~~~gt~~y~aPE~~~~~--~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~----~~~~~~i~---~  231 (335)
T d2ozaa1         164 TTSHNS---LTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----PGMKTRIR---M  231 (335)
T ss_dssp             CCCCCC---CCCCSCCCSSCCCCCCCGG--GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCC---S
T ss_pred             ccCCCc---cccccCCcccCCcHHHcCC--CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH----HHHHHHHh---c
Confidence            655432   3455799999999999875  7899999999999999999999999654322111    11111111   1


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .....+......+++.+.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         232 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1111122234456788999999999999999999999988

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.1e-46  Score=381.01  Aligned_cols=246  Identities=23%  Similarity=0.319  Sum_probs=196.7

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc----ccHHHHHH---HHHHhccccccceEEeeceeccCCceeEE
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK----FSAEEFIN---EVSTIGRIHHVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~----~~~~~f~~---Ev~~l~~l~H~niv~l~g~~~~~~~~~lV  261 (511)
                      |.+.++||+|+||.||+|+. .+|+.||||++....    .....+.+   |+.+++.++|||||++++++.+++..++|
T Consensus         6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv   85 (364)
T d1omwa3           6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI   85 (364)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred             CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence            45678999999999999985 479999999986422    22334444   47778888999999999999999999999


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  341 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~  341 (511)
                      |||+++|+|.+++.    ....+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+...
T Consensus        86 mE~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          86 LDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             ECCCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEecCCCcHHHHHH----hcccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            99999999999883    34678999999999999999999999   699999999999999999999999999998765


Q ss_pred             CCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccc
Q 010434          342 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLE  421 (511)
Q Consensus       342 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (511)
                      ...    .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||.......     ...+....... ...
T Consensus       159 ~~~----~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~~~~~~~~-~~~  227 (364)
T d1omwa3         159 KKK----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTLTM-AVE  227 (364)
T ss_dssp             SSC----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-----HHHHHHHSSSC-CCC
T ss_pred             CCc----ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcccC-CCC
Confidence            443    2445699999999998643 267899999999999999999999997543221     11111111111 111


Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCcCCCCCCC-----HHHHHH
Q 010434          422 LRNVTEIESVIARKLCMIGLWCIQVKAADRPS-----MTKVLE  459 (511)
Q Consensus       422 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~evl~  459 (511)
                            .+..+++.+.+++.+||+.||++|||     ++++++
T Consensus       228 ------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         228 ------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ------CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ------CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                  12234567889999999999999999     688875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=376.45  Aligned_cols=244  Identities=21%  Similarity=0.296  Sum_probs=201.7

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC----cccHHHHHHHHHHhc-cccccceEEeeceeccCCceeEEEe
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS----KFSAEEFINEVSTIG-RIHHVNVVQLLGFCSEGSKRALVYE  263 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~----~~~~~~f~~Ev~~l~-~l~H~niv~l~g~~~~~~~~~lV~e  263 (511)
                      |.+.++||+|+||+||+|+. .+|+.||||+++++    ....+.+..|+.++. .++|||||++++++.+++..++|||
T Consensus         4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE   83 (320)
T d1xjda_           4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME   83 (320)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence            56778999999999999985 47999999999652    345567888888775 6899999999999999999999999


Q ss_pred             ecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCC
Q 010434          264 FMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       264 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~  343 (511)
                      |+++|+|.+++.    ....+++..+..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+++.....
T Consensus        84 y~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          84 YLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             CCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             ecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            999999999983    34578999999999999999999999   69999999999999999999999999999865543


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCccccc
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGDLELR  423 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  423 (511)
                      ..  ..+...||+.|+|||++.+.  .++.++|||||||++|||++|+.||......        .+...+..+.. .  
T Consensus       157 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~PF~~~~~~--------~~~~~i~~~~~-~--  221 (320)
T d1xjda_         157 DA--KTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--------ELFHSIRMDNP-F--  221 (320)
T ss_dssp             TC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCC-C--
T ss_pred             cc--cccccCCCCCcCCHHHHcCC--CCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCC-C--
Confidence            32  23455799999999999875  7899999999999999999999999754322        23333332211 1  


Q ss_pred             ccchhHHHHHHHHHHHHHHhcCcCCCCCCCHH-HHHH
Q 010434          424 NVTEIESVIARKLCMIGLWCIQVKAADRPSMT-KVLE  459 (511)
Q Consensus       424 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~-evl~  459 (511)
                          .+..+++.+.+|+.+||+.||++|||+. ++++
T Consensus       222 ----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         222 ----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                1223456788999999999999999995 6754

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=372.16  Aligned_cols=262  Identities=21%  Similarity=0.265  Sum_probs=197.8

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      |.+.++||+|+||+||+|+. .+|+.||||+++...   ...+.+.+|+.++++++|||||++++++.++...++||||+
T Consensus         4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~   83 (298)
T d1gz8a_           4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL   83 (298)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence            45568999999999999985 579999999996532   23568999999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      .++.+....   ......+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+|+.......
T Consensus        84 ~~~~~~~~~---~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          84 HQDLKKFMD---ASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             SEEHHHHHH---HTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             CCchhhhhh---hhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            665444332   2334679999999999999999999999   6999999999999999999999999999987654332


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc-------ccchhhHHhhhcC-
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA-------YFPSWVYDQLNKG-  417 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~-------~~~~~~~~~~~~~-  417 (511)
                        ......||+.|+|||.+... ...+.++|||||||++|||++|+.||........-.       ......+...... 
T Consensus       158 --~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         158 --TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             --CTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             --cceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence              23455799999999987664 456889999999999999999999997543111000       0000000000000 


Q ss_pred             ---Ccc---cccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          418 ---GDL---ELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       418 ---~~~---~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                         ...   ...........+++.+.+++.+||+.||++|||++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence               000   0000111122345678899999999999999999999874

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6.5e-46  Score=366.52  Aligned_cols=260  Identities=22%  Similarity=0.272  Sum_probs=198.7

Q ss_pred             hhhccccCcCCcEEEEEEEecCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeecC
Q 010434          190 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      |.+.++||+|+||+||+|+.++|+.||||++....   ...+.|.+|+.++++++|||||++++++..++..++++|++.
T Consensus         4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~   83 (286)
T d1ob3a_           4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD   83 (286)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred             ceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeeh
Confidence            45678999999999999999899999999996532   235789999999999999999999999999999999999998


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCCc
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  346 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  346 (511)
                      ++.+..+.    ...+.+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||.+........ 
T Consensus        84 ~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-  155 (286)
T d1ob3a_          84 QDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-  155 (286)
T ss_dssp             EEHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             hhhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence            87776665    344679999999999999999999998   6999999999999999999999999999987654322 


Q ss_pred             eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc---------cccchh--hHHhhh
Q 010434          347 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK---------AYFPSW--VYDQLN  415 (511)
Q Consensus       347 ~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~---------~~~~~~--~~~~~~  415 (511)
                       ......+++.|+|||.+.+. ..++.++|||||||++|||++|+.||.........         .....|  ......
T Consensus       156 -~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         156 -KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             -------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             -ccceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence             22344589999999998754 46789999999999999999999999754221100         000000  000000


Q ss_pred             cCCc---ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          416 KGGD---LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       416 ~~~~---~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ....   ............+++.+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000   0000111122334567889999999999999999999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=369.64  Aligned_cols=238  Identities=24%  Similarity=0.342  Sum_probs=192.9

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc-------cHHHHHHHHHHhcccc--ccceEEeeceeccCCce
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF-------SAEEFINEVSTIGRIH--HVNVVQLLGFCSEGSKR  258 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~-------~~~~f~~Ev~~l~~l~--H~niv~l~g~~~~~~~~  258 (511)
                      .|.+.++||+|+||+||+|+. .+|+.||||+++....       ....+.+|+.++++++  |||||++++++.+++..
T Consensus         5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~   84 (273)
T d1xwsa_           5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF   84 (273)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence            456678999999999999985 5799999999865321       2234778999999996  89999999999999999


Q ss_pred             eEEEeecCC-CCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC-CCCeeeecccc
Q 010434          259 ALVYEFMPN-GSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH-NFIPKVSDFGL  336 (511)
Q Consensus       259 ~lV~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~-~~~~kl~DFGl  336 (511)
                      ++||||+.+ +++.+++    .....+++..+..++.||+.||+|||+   .+|+||||||+|||++. ++.+||+|||+
T Consensus        85 ~lv~e~~~~~~~l~~~~----~~~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          85 VLILERPEPVQDLFDFI----TERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEECCSSEEEHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEeccCcchHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECcccc
Confidence            999999976 5666666    234679999999999999999999999   69999999999999985 47999999999


Q ss_pred             cccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhc
Q 010434          337 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK  416 (511)
Q Consensus       337 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  416 (511)
                      |+......    .+...||+.|+|||++.+. ..++.++|||||||++|||++|+.||.....              +..
T Consensus       158 a~~~~~~~----~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------------i~~  218 (273)
T d1xwsa_         158 GALLKDTV----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------IIR  218 (273)
T ss_dssp             CEECCSSC----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------HHH
T ss_pred             ceeccccc----ccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCchH--------------Hhh
Confidence            98654432    2445699999999998764 2346789999999999999999999865321              111


Q ss_pred             CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          417 GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      +.. .      ....++..+.+++.+||+.||++|||++|+++
T Consensus       219 ~~~-~------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         219 GQV-F------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             CCC-C------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccc-C------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            100 0      11123467889999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-45  Score=365.71  Aligned_cols=260  Identities=22%  Similarity=0.335  Sum_probs=192.6

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cC-CcEEEEEEeccC---cccHHHHHHHHHHhccc---cccceEEeeceec-----cC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HT-GRLIAVKMLENS---KFSAEEFINEVSTIGRI---HHVNVVQLLGFCS-----EG  255 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~-g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l---~H~niv~l~g~~~-----~~  255 (511)
                      .|.+.++||+|+||+||+|+. ++ ++.||||+++..   ......+.+|+.+++.+   +||||+++++++.     ..
T Consensus         8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~   87 (305)
T d1blxa_           8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   87 (305)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred             CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence            455678999999999999985 34 678999998652   22234567788777666   7999999999984     34


Q ss_pred             CceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccc
Q 010434          256 SKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFG  335 (511)
Q Consensus       256 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFG  335 (511)
                      ...+++|||++++++....   ......+++..+..++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||
T Consensus        88 ~~~~~~~e~~~~~~~~~~~---~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          88 TKLTLVFEHVDQDLTTYLD---KVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             EEEEEEEECCSCBHHHHHH---HSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             ceEEEEEEeccCCchhhhh---hccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchh
Confidence            5789999999888775443   2344678999999999999999999999   699999999999999999999999999


Q ss_pred             ccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc---------
Q 010434          336 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF---------  406 (511)
Q Consensus       336 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~---------  406 (511)
                      +++......   ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||........-..+         
T Consensus       162 ~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~--~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  236 (305)
T d1blxa_         162 LARIYSFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  236 (305)
T ss_dssp             SCCCCCGGG---GGCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred             hhhhhcccc---cCCCcccChhhcCcchhcCC--CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence            987543322   23456799999999999775  7899999999999999999999999754321100000         


Q ss_pred             chhhHHh---hhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          407 PSWVYDQ---LNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       407 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ..|....   ..................+++.+.+|+.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000000   0000000000111122334567888999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-44  Score=364.77  Aligned_cols=260  Identities=23%  Similarity=0.297  Sum_probs=192.1

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceeccCC------ce
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGS------KR  258 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~------~~  258 (511)
                      +|.+.++||+|+||+||+|.. .+|+.||||+++....   ..+.+.+|+.++++++|||||++++++...+      ..
T Consensus        19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~   98 (346)
T d1cm8a_          19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF   98 (346)
T ss_dssp             SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred             cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence            355678999999999999985 5799999999976332   3457899999999999999999999987654      46


Q ss_pred             eEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          259 ALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       259 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      ++||||+ +.+|..++     ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+|++|||+|+
T Consensus        99 ~lv~e~~-~~~l~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          99 YLVMPFM-GTDLGKLM-----KHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             EEEEECC-SEEHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecc-cccHHHHH-----HhccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhccccccccccccccee
Confidence            9999999 56676655     23579999999999999999999999   699999999999999999999999999998


Q ss_pred             cCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc-------cccchhhH
Q 010434          339 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK-------AYFPSWVY  411 (511)
Q Consensus       339 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~-------~~~~~~~~  411 (511)
                      .....     .+...||+.|+|||.+.+. ..++.++||||+||++|||++|+.||.........       ...+....
T Consensus       170 ~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         170 QADSE-----MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             ECCSS-----CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccCCc-----cccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            76443     2456699999999998754 36789999999999999999999998654321100       00000000


Q ss_pred             H---------hhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH--Hhc
Q 010434          412 D---------QLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM--LEG  463 (511)
Q Consensus       412 ~---------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~--Le~  463 (511)
                      .         ...................+++.+.+|+.+||+.||++|||++|+++.  +++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~  306 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES  306 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence            0         000000111111111222345677899999999999999999999984  544

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-44  Score=361.24  Aligned_cols=262  Identities=19%  Similarity=0.215  Sum_probs=193.0

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc--ccHHHHHHHHHHhccccccceEEeeceeccCC----ceeEEE
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KRALVY  262 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~--~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~----~~~lV~  262 (511)
                      |.+.++||+|+||+||+|+. .+|+.||||++....  ...+.+.+|+.++++++||||+++++++....    ..++++
T Consensus        10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~   89 (345)
T d1pmea_          10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV   89 (345)
T ss_dssp             EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence            55678999999999999984 589999999997533  23567899999999999999999999986543    234556


Q ss_pred             eecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCC
Q 010434          263 EFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  342 (511)
Q Consensus       263 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~  342 (511)
                      +++.+|+|.+++.     ...+++..+..++.||+.||+|||+   ++|+||||||+||||++++.+||+|||+++....
T Consensus        90 ~~~~~g~L~~~l~-----~~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          90 THLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EECCCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EeecCCchhhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            6677999999882     2469999999999999999999999   6999999999999999999999999999986544


Q ss_pred             CCCce-eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc------ccchhh-----
Q 010434          343 ENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA------YFPSWV-----  410 (511)
Q Consensus       343 ~~~~~-~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~------~~~~~~-----  410 (511)
                      ..... ......||+.|+|||.+... ..++.++||||+||++|||++|+.||..........      ..+...     
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence            32221 22445699999999998654 467889999999999999999999997543211000      000000     


Q ss_pred             -----HHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          411 -----YDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       411 -----~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                           .....................++.++.+++.+||+.||++|||++++++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 00000000000000011112234678899999999999999999999874

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-43  Score=352.57  Aligned_cols=260  Identities=17%  Similarity=0.238  Sum_probs=195.3

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccccccceE-EeeceeccCCceeEEEeecC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVV-QLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv-~l~g~~~~~~~~~lV~e~~~  266 (511)
                      +|.+.++||+|+||.||+|+. .+|+.||||++..... .+++..|++++++++|+|++ .+.++..++...++||||+ 
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-   85 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   85 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence            356778999999999999985 5789999999876432 34688999999999877655 4555567778889999999 


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEc---CCCCeeeecccccccCCCC
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKE  343 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~---~~~~~kl~DFGla~~~~~~  343 (511)
                      +++|.+.+.   .....+++..+..++.|++.||+|||+   ++|+||||||+|||++   .+..+||+|||+|+.....
T Consensus        86 ~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          86 GPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             CCchhhhhh---hccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            556665542   234679999999999999999999999   6999999999999985   4567999999999976543


Q ss_pred             CCc-----eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCC
Q 010434          344 NDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGG  418 (511)
Q Consensus       344 ~~~-----~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  418 (511)
                      ...     .......||+.|+|||.+.+.  .++.++|||||||++|||++|+.||..............+......   
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~---  234 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS---  234 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTB--CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH---
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCC--CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC---
Confidence            322     122345699999999999875  6899999999999999999999999654332211111111100000   


Q ss_pred             cccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCc
Q 010434          419 DLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSM  465 (511)
Q Consensus       419 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~  465 (511)
                          .........+++.+.+++..||+.+|++||+++++.+.|+...
T Consensus       235 ----~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         235 ----TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             ----SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             ----CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence                0011122234577889999999999999999999998887644

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-43  Score=355.14  Aligned_cols=264  Identities=22%  Similarity=0.282  Sum_probs=192.7

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccC---cccHHHHHHHHHHhccccccceEEeeceecc--------CC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSE--------GS  256 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~---~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~--------~~  256 (511)
                      .|.+.++||+|+||+||+|+. .+|+.||||++...   ....+.+.+|+.++++++||||+++++++..        ..
T Consensus        11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~   90 (318)
T d3blha1          11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG   90 (318)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred             CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence            456678999999999999985 58999999998653   2345678999999999999999999998754        34


Q ss_pred             ceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccc
Q 010434          257 KRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGL  336 (511)
Q Consensus       257 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGl  336 (511)
                      ..++||||+.++.+....    .....++...+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus        91 ~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          91 SIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             eEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecce
Confidence            678999999887776543    344678999999999999999999999   6999999999999999999999999999


Q ss_pred             cccCCCCCCce--eeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccccc-------c
Q 010434          337 AKFHPKENDFV--SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYF-------P  407 (511)
Q Consensus       337 a~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~-------~  407 (511)
                      ++.........  ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||...........+       +
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            98765433211  12334699999999998754 36789999999999999999999999753321110000       0


Q ss_pred             hhhHHhhhcCC---ccc-c-cccchhH-----HHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          408 SWVYDQLNKGG---DLE-L-RNVTEIE-----SVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       408 ~~~~~~~~~~~---~~~-~-~~~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                      ...........   ... . .......     ...++.+.+++.+||+.||++|||++|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            00000000000   000 0 0000011     1124567789999999999999999999864

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=8e-43  Score=350.96  Aligned_cols=255  Identities=19%  Similarity=0.302  Sum_probs=195.9

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhcccc-ccceEEeeceecc--CCceeEEEee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSE--GSKRALVYEF  264 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~--~~~~~lV~e~  264 (511)
                      .|.+.++||+|+||+||+|+. .+|+.||||+++..  ..+++.+|+.++++++ ||||+++++++..  ....++||||
T Consensus        36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~  113 (328)
T d3bqca1          36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH  113 (328)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence            566778999999999999985 57999999998653  4578999999999995 9999999999864  4568999999


Q ss_pred             cCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC-CeeeecccccccCCCC
Q 010434          265 MPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKE  343 (511)
Q Consensus       265 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~-~~kl~DFGla~~~~~~  343 (511)
                      +++++|..+.       +.+++..+..++.||+.||+|||+   ++|+||||||+|||++.++ .+||+|||+|+.....
T Consensus       114 ~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         114 VNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             CCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             cCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            9999998764       469999999999999999999999   6999999999999998655 6999999999876543


Q ss_pred             CCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc-c-----chhhHHhhh--
Q 010434          344 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY-F-----PSWVYDQLN--  415 (511)
Q Consensus       344 ~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~-~-----~~~~~~~~~--  415 (511)
                      ..   .....+|+.|+|||.+.+. ..++.++||||+||+++||++|+.|+........... +     .........  
T Consensus       184 ~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         184 QE---YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             CC---CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             Cc---ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence            32   2455689999999998764 3578999999999999999999999865321110000 0     000000000  


Q ss_pred             -------------cCCc--ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          416 -------------KGGD--LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       416 -------------~~~~--~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                                   ....  ............+++.+.+|+.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                         0000  0000011122345677889999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=360.20  Aligned_cols=260  Identities=22%  Similarity=0.254  Sum_probs=191.6

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccccccceEEeeceecc------CCceeEE
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE------GSKRALV  261 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~------~~~~~lV  261 (511)
                      +|+..++||+|+||+||+|+. .+|+.||||++.....   .+.+|++++++++|||||++++++..      ....+||
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence            345567899999999999995 4799999999976432   23479999999999999999999843      2347899


Q ss_pred             EeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCC-CeeeecccccccC
Q 010434          262 YEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNF-IPKVSDFGLAKFH  340 (511)
Q Consensus       262 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~-~~kl~DFGla~~~  340 (511)
                      |||++++.+..+. ........+++..+..++.||+.||+|||+   .+|+||||||+|||++.++ .+||+|||+++..
T Consensus        98 ~Ey~~~~~~~~l~-~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          98 LDYVPETVYRVAR-HYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EECCSEEHHHHHH-HHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EeccCCccHHHHH-hhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999866444332 222345679999999999999999999998   6999999999999999775 8999999999876


Q ss_pred             CCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc--------cccchhhHH
Q 010434          341 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK--------AYFPSWVYD  412 (511)
Q Consensus       341 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~--------~~~~~~~~~  412 (511)
                      .....   .....||..|+|||.+.+. ..++.++||||+||++|||++|+.||........-        .....+...
T Consensus       174 ~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         174 VRGEP---NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CTTSC---CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             cCCcc---cccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            54432   2345699999999987654 36899999999999999999999999654321100        000011111


Q ss_pred             hhhcCCcccccc------cchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          413 QLNKGGDLELRN------VTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       413 ~~~~~~~~~~~~------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      ............      ........++.+.+|+.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            100000000000      00112234567889999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-44  Score=357.45  Aligned_cols=251  Identities=21%  Similarity=0.263  Sum_probs=199.5

Q ss_pred             hhhccccCcCCcEEEEEEEe----cCCcEEEEEEeccC-----cccHHHHHHHHHHhccccc-cceEEeeceeccCCcee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL----HTGRLIAVKMLENS-----KFSAEEFINEVSTIGRIHH-VNVVQLLGFCSEGSKRA  259 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~----~~g~~vAvK~l~~~-----~~~~~~f~~Ev~~l~~l~H-~niv~l~g~~~~~~~~~  259 (511)
                      |.+.++||+|+||+||+|+.    .+|+.||||+++..     ....+.+.+|+.++++++| |||+++++++.+....+
T Consensus        26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~  105 (322)
T d1vzoa_          26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  105 (322)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence            67789999999999999974    25889999998652     2245678899999999966 89999999999999999


Q ss_pred             EEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      ++|||+.+|+|.+++.    ....++...+..++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+++.
T Consensus       106 ~v~e~~~~~~L~~~i~----~~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         106 LILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeeecccccHHHHHHH----hcccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            9999999999999883    34567889999999999999999999   6999999999999999999999999999986


Q ss_pred             CCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhcCCc
Q 010434          340 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNKGGD  419 (511)
Q Consensus       340 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  419 (511)
                      ....... ......|++.|+|||.+......++.++|||||||+||||++|+.||.......    ....+........ 
T Consensus       179 ~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~----~~~~i~~~~~~~~-  252 (322)
T d1vzoa_         179 FVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----SQAEISRRILKSE-  252 (322)
T ss_dssp             CCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC----CHHHHHHHHHHCC-
T ss_pred             hcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcccCC-
Confidence            6443322 223456999999999997654567889999999999999999999997543222    1111221111111 


Q ss_pred             ccccccchhHHHHHHHHHHHHHHhcCcCCCCCC-----CHHHHHH
Q 010434          420 LELRNVTEIESVIARKLCMIGLWCIQVKAADRP-----SMTKVLE  459 (511)
Q Consensus       420 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~  459 (511)
                      .      ..+..++..+.+++.+||+.||++||     |++|+++
T Consensus       253 ~------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         253 P------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             C------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             C------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            1      12223567889999999999999999     4888886

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-43  Score=347.72  Aligned_cols=258  Identities=20%  Similarity=0.274  Sum_probs=200.1

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCc---ccHHHHHHHHHHhccccccceEEeeceeccCCceeEEEeec
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM  265 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~---~~~~~f~~Ev~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  265 (511)
                      |++.++||+|+||+||+|+. .+|+.||||+++...   ...+.+.+|+.++++++||||+++++++.+....+++++++
T Consensus         4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~   83 (292)
T d1unla_           4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence            45678999999999999985 578999999996532   24578999999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeecccccccCCCCCC
Q 010434          266 PNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  345 (511)
Q Consensus       266 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~~~~~~~  345 (511)
                      .+++|..++    ...+.+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||.++.......
T Consensus        84 ~~~~l~~~~----~~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          84 DQDLKKYFD----SCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             SEEHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             ccccccccc----ccccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence            999988776    244678999999999999999999999   6999999999999999999999999999987655433


Q ss_pred             ceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc-------------cccchhhHH
Q 010434          346 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK-------------AYFPSWVYD  412 (511)
Q Consensus       346 ~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~-------------~~~~~~~~~  412 (511)
                        ......++..|+|||.+... ..++.++|||||||++|||++|+.|+.........             ..++...  
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  231 (292)
T d1unla_         157 --CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT--  231 (292)
T ss_dssp             --CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG--
T ss_pred             --cceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh--
Confidence              22344578899999988764 35789999999999999999999986432111000             0000000  


Q ss_pred             hhhcCCc----ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          413 QLNKGGD----LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       413 ~~~~~~~----~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                      .......    ............+++.+.+++.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000000    0001111222334567889999999999999999999976

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.1e-43  Score=349.85  Aligned_cols=264  Identities=18%  Similarity=0.261  Sum_probs=204.5

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhccccc-cceEEeeceeccCCceeEEEeecC
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIHH-VNVVQLLGFCSEGSKRALVYEFMP  266 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~  266 (511)
                      .|.+.++||+|+||.||+|+. .+|+.||||++.... ..+.+.+|++.++.++| +|++.+++++.++...++||||+ 
T Consensus         6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-   83 (293)
T d1csna_           6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   83 (293)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence            456778999999999999985 478999999986532 33457788899998865 89999999999999999999999 


Q ss_pred             CCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcC-----CCCeeeecccccccCC
Q 010434          267 NGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDH-----NFIPKVSDFGLAKFHP  341 (511)
Q Consensus       267 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~-----~~~~kl~DFGla~~~~  341 (511)
                      +++|.+++.   ..+..+++..+..++.|++.||+|||+   .+|+||||||+|||++.     ++.+||+|||+|+...
T Consensus        84 ~~~l~~~~~---~~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          84 GPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             CCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             CCCHHHHHH---hhccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            789988873   234579999999999999999999998   69999999999999964     5789999999998765


Q ss_pred             CCCCc-----eeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccccchhhHHhhhc
Q 010434          342 KENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAYFPSWVYDQLNK  416 (511)
Q Consensus       342 ~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  416 (511)
                      .....     .......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.........     .....+..
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~--~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~-----~~~~~i~~  230 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-----QKYERIGE  230 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-----HHHHHHHH
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCC--CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH-----HHHHHHHh
Confidence            43221     122345699999999999865  7899999999999999999999999754322211     11111111


Q ss_pred             CCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHHHhcCcCCCC
Q 010434          417 GGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSMDDLQ  469 (511)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~Le~~~~~l~  469 (511)
                      ...  .....+....+++.+.+++..|++.+|++||+++.+.+.|+.......
T Consensus       231 ~~~--~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~  281 (293)
T d1csna_         231 KKQ--STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  281 (293)
T ss_dssp             HHH--HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             ccC--CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence            100  001111222345678899999999999999999999998887655443

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-42  Score=350.30  Aligned_cols=256  Identities=20%  Similarity=0.194  Sum_probs=187.1

Q ss_pred             hhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceecc------CCcee
Q 010434          190 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSE------GSKRA  259 (511)
Q Consensus       190 ~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~------~~~~~  259 (511)
                      |++.++||+|+||+||+|.. .+|+.||||++.....   ..+.+.+|+.++++++|||||++++++..      ....|
T Consensus        19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~   98 (355)
T d2b1pa1          19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY   98 (355)
T ss_dssp             EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred             eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence            45568999999999999985 4799999999976433   33568899999999999999999999853      46789


Q ss_pred             EEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      +||||+.++.+....       ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+|++|||+++.
T Consensus        99 iv~Ey~~~~l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          99 LVMELMDANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEECCSEEHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEeccchHHHHhhh-------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhc
Confidence            999999766555432       468999999999999999999999   6999999999999999999999999999886


Q ss_pred             CCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccc--------ccc-----
Q 010434          340 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSK--------AYF-----  406 (511)
Q Consensus       340 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~--------~~~-----  406 (511)
                      .....   ..+...+|+.|+|||++.+.  .++.++||||+||+++||++|+.||.........        ...     
T Consensus       169 ~~~~~---~~~~~~~t~~y~aPE~l~~~--~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  243 (355)
T d2b1pa1         169 AGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_dssp             ---------------CCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccccc---ccccccccccccChhhhcCC--CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence            54432   23455699999999999875  7899999999999999999999998643211100        000     


Q ss_pred             --chhhHHhhhcCCc------------ccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHHH
Q 010434          407 --PSWVYDQLNKGGD------------LELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLEM  460 (511)
Q Consensus       407 --~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~  460 (511)
                        .............            .............+..+.+|+.+||+.||++|||++|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence              0000111111100            00111222445567889999999999999999999999853

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-42  Score=350.02  Aligned_cols=257  Identities=20%  Similarity=0.235  Sum_probs=191.4

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcc---cHHHHHHHHHHhccccccceEEeeceecc-----CCcee
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSE-----GSKRA  259 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~---~~~~f~~Ev~~l~~l~H~niv~l~g~~~~-----~~~~~  259 (511)
                      +|.+.++||+|+||+||+|+. .+|+.||||++.....   ..+.+.+|+.++++++|||||++++++..     ....+
T Consensus        19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~   98 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV   98 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred             CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence            355678999999999999984 5899999999976433   34578899999999999999999998853     33456


Q ss_pred             EEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeeeeccccccc
Q 010434          260 LVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       260 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      ++++|+.+|+|.+++.     .+.+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+|++|||++..
T Consensus        99 ~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          99 YLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             EEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             EEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcc
Confidence            7788888999999882     2469999999999999999999999   6999999999999999999999999999875


Q ss_pred             CCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCcccccccccc-------cchh---
Q 010434          340 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKAY-------FPSW---  409 (511)
Q Consensus       340 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~~-------~~~~---  409 (511)
                      ....     .....||+.|+|||.+.+. ..++.++|||||||++|||++|+.||...........       .+..   
T Consensus       171 ~~~~-----~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         171 TDDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             CTGG-----GSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             cCcc-----cccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            4322     2445689999999987654 3578899999999999999999999865432110000       0000   


Q ss_pred             ------hHHhhhcCCcccccccchhHHHHHHHHHHHHHHhcCcCCCCCCCHHHHHH
Q 010434          410 ------VYDQLNKGGDLELRNVTEIESVIARKLCMIGLWCIQVKAADRPSMTKVLE  459 (511)
Q Consensus       410 ------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~  459 (511)
                            ......................++..+.+++.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence                  00000000000000001111224567889999999999999999999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2e-38  Score=322.48  Aligned_cols=282  Identities=19%  Similarity=0.294  Sum_probs=200.3

Q ss_pred             HhhhccccCcCCcEEEEEEEe-cCCcEEEEEEeccCcccHHHHHHHHHHhcccc-----------ccceEEeeceeccC-
Q 010434          189 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMLENSKFSAEEFINEVSTIGRIH-----------HVNVVQLLGFCSEG-  255 (511)
Q Consensus       189 t~~~~~~LG~G~fg~Vykg~~-~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~-----------H~niv~l~g~~~~~-  255 (511)
                      +|.+.++||+|+||+||+|+. .+|+.||||+++......+.+.+|+.++++++           |+||+++++++... 
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence            367789999999999999985 57999999999876666678899999998885           57899999887543 


Q ss_pred             -CceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCC------
Q 010434          256 -SKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFI------  328 (511)
Q Consensus       256 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~------  328 (511)
                       ...+++++++..+...... ........+++..+..++.||+.||+|||+.  .+|+||||||+||||+.++.      
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          94 PNGVHVVMVFEVLGENLLAL-IKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             TTEEEEEEEECCCCEEHHHH-HHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             ccceeeeeeecccccccccc-cccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccce
Confidence             4556677776555433222 1223456789999999999999999999973  68999999999999987653      


Q ss_pred             eeeecccccccCCCCCCceeeccccCCccccchhcccccCCCcCccchHHHHHHHHHHHHhCCCCCCccccccccc----
Q 010434          329 PKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAIRSSKA----  404 (511)
Q Consensus       329 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~s~ksDVwS~Gvll~elltg~~p~~~~~~~~~~~----  404 (511)
                      +|++|||.+.......     ....||+.|+|||++...  .++.++||||+||+++||++|+.||..........    
T Consensus       171 ~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         171 IKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             eeEeeccccccccccc-----ccccccccccChhhcccc--CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence            8999999997654322     345699999999998764  78899999999999999999999986532211000    


Q ss_pred             ---------ccchhhHHh-------hh------cCCcccc-------cccchhHHHHHHHHHHHHHHhcCcCCCCCCCHH
Q 010434          405 ---------YFPSWVYDQ-------LN------KGGDLEL-------RNVTEIESVIARKLCMIGLWCIQVKAADRPSMT  455 (511)
Q Consensus       405 ---------~~~~~~~~~-------~~------~~~~~~~-------~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~  455 (511)
                               ..+......       ..      .......       ..........++.+.+++.+||+.||.+|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence                     000000000       00      0000000       001113356678899999999999999999999


Q ss_pred             HHHHH--Hhc--CcCCCCCCCCCCCCCCC
Q 010434          456 KVLEM--LEG--SMDDLQMPPKPCFSSSR  480 (511)
Q Consensus       456 evl~~--Le~--~~~~l~~p~~p~~~~~~  480 (511)
                      |+++.  ++.  ..+....|++|-..+.+
T Consensus       324 e~L~Hp~f~~~~~~~~~~~p~~~~~~~~~  352 (362)
T d1q8ya_         324 GLVNHPWLKDTLGMEEIRVPDRELYGSGS  352 (362)
T ss_dssp             HHHTCGGGTTCTTCTTCCCTTSCTTCBST
T ss_pred             HHhcCcccCCCCCcccCCCCCcccCCCCC
Confidence            99874  442  24455566666554443

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=2.9e-24  Score=197.80  Aligned_cols=163  Identities=18%  Similarity=0.138  Sum_probs=120.2

Q ss_pred             hhccccCcCCcEEEEEEEecCCcEEEEEEeccCcc-------------------cHHHHHHHHHHhccccccceEEeece
Q 010434          191 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMLENSKF-------------------SAEEFINEVSTIGRIHHVNVVQLLGF  251 (511)
Q Consensus       191 ~~~~~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~-------------------~~~~f~~Ev~~l~~l~H~niv~l~g~  251 (511)
                      .+.++||+|+||+||+|...+|+.||||+++.+..                   ....+..|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            35689999999999999988899999998753211                   01234568888999999999888765


Q ss_pred             eccCCceeEEEeecCCCCcccccccCCCcCCccCHHHHHHHHHHHHHHHHHHHhCCCCceecccCCcCceEEcCCCCeee
Q 010434          252 CSEGSKRALVYEFMPNGSLDRHIFPKENKGQTFGWEKLQEIALGTARGVAYLHNGCDMCILHFDIKPHNILLDHNFIPKV  331 (511)
Q Consensus       252 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~DIkp~NILl~~~~~~kl  331 (511)
                      .    ..+++|||+++..+.+           ++.....+++.|+++|++|||+   .+|+||||||+|||++++ .++|
T Consensus        83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEE
T ss_pred             c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEE
Confidence            3    3479999998765543           2333456799999999999999   699999999999999865 5899


Q ss_pred             ecccccccCCCCCCceeeccccCCccccc------hhcccccCCCcCccchHHHHHHHHH
Q 010434          332 SDFGLAKFHPKENDFVSISATRGTIGYIA------PELISRNFGTVSCKSDVYGFGMVLL  385 (511)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~gt~~y~A------PE~~~~~~~~~s~ksDVwS~Gvll~  385 (511)
                      +|||+|+....+...          .|..      .+.+.+   .++.++|+||..--++
T Consensus       144 iDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r---~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         144 IDFPQSVEVGEEGWR----------EILERDVRNIITYFSR---TYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHH---HHCCCCCHHHHHHHHH
T ss_pred             EECCCcccCCCCCcH----------HHHHHHHHHHHHHHcC---CCCCcccHHHHHHHHh
Confidence            999999765433211          1111      122322   5678999999765443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.22  E-value=1.7e-06  Score=80.81  Aligned_cols=130  Identities=15%  Similarity=0.104  Sum_probs=87.2

Q ss_pred             CCcEEEEEEEecCCcEEEEEEecc-CcccHHHHHHHHHHhcccc-ccceEEeeceeccCCceeEEEeecCCCCccccccc
Q 010434          199 GGFGSVYKGQLHTGRLIAVKMLEN-SKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFP  276 (511)
Q Consensus       199 G~fg~Vykg~~~~g~~vAvK~l~~-~~~~~~~f~~Ev~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~  276 (511)
                      ++.+.||+...+ ++.+.||+... .......+.+|+..+..++ +--+.+++.+...++..++||+++++.++.+....
T Consensus        25 ~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~  103 (263)
T d1j7la_          25 MSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED  103 (263)
T ss_dssp             CSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred             CCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence            344689998654 56677887654 3334446778888877764 44467778888888889999999999877543311


Q ss_pred             CCCcCCccCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------------
Q 010434          277 KENKGQTFGWEKLQEIALGTARGVAYLHNGC-------------------------------------------------  307 (511)
Q Consensus       277 ~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-------------------------------------------------  307 (511)
                      .         .....++.++++.++.||+..                                                 
T Consensus       104 ~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (263)
T d1j7la_         104 E---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL  174 (263)
T ss_dssp             C---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred             c---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence            0         012223444555555555311                                                 


Q ss_pred             -------CCceecccCCcCceEEcCCCCeeeecccccc
Q 010434          308 -------DMCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       308 -------~~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                             ...++|+|+.|.|||++++..+-|.||+.+.
T Consensus       175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                   1237999999999999987767799998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.90  E-value=1.6e-05  Score=73.50  Aligned_cols=75  Identities=16%  Similarity=0.181  Sum_probs=54.4

Q ss_pred             cCcCC-cEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccc--cceEEeeceeccCCceeEEEeecCCCCccc
Q 010434          196 LGQGG-FGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHH--VNVVQLLGFCSEGSKRALVYEFMPNGSLDR  272 (511)
Q Consensus       196 LG~G~-fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~  272 (511)
                      +..|. .+.||+...+++..+.+|.-....  ..++..|+..++.+..  ..+.+++++..+++..++||+++++.++.+
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~   95 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS   95 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence            34443 368999998888889999865432  2356778887777643  346677888888888999999998877654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.25  E-value=0.00044  Score=66.34  Aligned_cols=136  Identities=16%  Similarity=0.146  Sum_probs=81.5

Q ss_pred             EEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceE--Eeec-----eeccCCceeEEEeecCCCCccccc
Q 010434          202 GSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVV--QLLG-----FCSEGSKRALVYEFMPNGSLDRHI  274 (511)
Q Consensus       202 g~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv--~l~g-----~~~~~~~~~lV~e~~~~gsL~~~l  274 (511)
                      -.||+....+|+.+++|+......+.+++..|...+..|...++.  ..+.     ....+...+.++++++|..+...-
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~  115 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN  115 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence            379999999999999999876666778888999988888543321  1111     223455678899999875543110


Q ss_pred             --------------c----cC-CCcCCccCHH----------------------HHHHHHHHHHHHHHHH-HhCCCCcee
Q 010434          275 --------------F----PK-ENKGQTFGWE----------------------KLQEIALGTARGVAYL-HNGCDMCIL  312 (511)
Q Consensus       275 --------------~----~~-~~~~~~l~~~----------------------~~~~i~~~ia~~l~yL-H~~~~~~iv  312 (511)
                                    +    .. ......+++.                      .....+..+...+.-+ ......+++
T Consensus       116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li  195 (325)
T d1zyla1         116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL  195 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred             HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence                          0    00 0001111111                      1122223332222222 122346799


Q ss_pred             cccCCcCceEEcCCCCeeeeccccccc
Q 010434          313 HFDIKPHNILLDHNFIPKVSDFGLAKF  339 (511)
Q Consensus       313 H~DIkp~NILl~~~~~~kl~DFGla~~  339 (511)
                      |+|+.+.|||++++  ..+.||+-+..
T Consensus       196 HgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         196 HGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             cCCCCcccEEEeCC--ceEEechhccc
Confidence            99999999999754  45899997764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.14  E-value=0.00046  Score=68.11  Aligned_cols=75  Identities=15%  Similarity=0.083  Sum_probs=48.0

Q ss_pred             cccCcCCcEEEEEEEec-CCcEEEEEEecc--------CcccHHHHHHHHHHhcccc---ccceEEeeceeccCCceeEE
Q 010434          194 HKLGQGGFGSVYKGQLH-TGRLIAVKMLEN--------SKFSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRALV  261 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~-~g~~vAvK~l~~--------~~~~~~~f~~Ev~~l~~l~---H~niv~l~g~~~~~~~~~lV  261 (511)
                      +.||.|....||+.... +++.++||.-..        .....+....|++.++.+.   ...+++++.+.  ....++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence            46899999999999865 467899996421        1112334556777776652   24566666553  4456899


Q ss_pred             EeecCCCCc
Q 010434          262 YEFMPNGSL  270 (511)
Q Consensus       262 ~e~~~~gsL  270 (511)
                      ||++++..+
T Consensus       110 mE~L~~~~~  118 (392)
T d2pula1         110 MEDLSHLKI  118 (392)
T ss_dssp             ECCCTTSEE
T ss_pred             EeccCCccc
Confidence            999976543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.74  E-value=0.0026  Score=62.42  Aligned_cols=73  Identities=14%  Similarity=0.244  Sum_probs=51.2

Q ss_pred             cccCcCCcEEEEEEEecC--------CcEEEEEEeccCcccHHHHHHHHHHhccccccce-EEeeceeccCCceeEEEee
Q 010434          194 HKLGQGGFGSVYKGQLHT--------GRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEF  264 (511)
Q Consensus       194 ~~LG~G~fg~Vykg~~~~--------g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~  264 (511)
                      ++|+.|--=.+|+...++        .+.|.+++... .....+..+|..+++.+.-.++ .++++++.+    .+|+||
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef  122 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  122 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence            467778888999998654        35677777653 3344566789988888854444 477777754    689999


Q ss_pred             cCCCCcc
Q 010434          265 MPNGSLD  271 (511)
Q Consensus       265 ~~~gsL~  271 (511)
                      +++..|.
T Consensus       123 i~g~~l~  129 (395)
T d1nw1a_         123 IPSRPLS  129 (395)
T ss_dssp             CCEEECC
T ss_pred             eccccCC
Confidence            9876554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.83  E-value=0.015  Score=54.69  Aligned_cols=142  Identities=12%  Similarity=0.069  Sum_probs=73.6

Q ss_pred             ccCcCCcEEEEEEEecCCcEEEEEEeccCcccHHHHHHHHHHhccccccceE--Eeec------eeccCCceeEEEeecC
Q 010434          195 KLGQGGFGSVYKGQLHTGRLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVV--QLLG------FCSEGSKRALVYEFMP  266 (511)
Q Consensus       195 ~LG~G~fg~Vykg~~~~g~~vAvK~l~~~~~~~~~f~~Ev~~l~~l~H~niv--~l~g------~~~~~~~~~lV~e~~~  266 (511)
                      .|..|---+.|+.+.++|+ +++|+..... +.++...|+.++..|...++.  ..+-      +.....+...++.+..
T Consensus        25 ~i~~G~~N~ny~v~t~~g~-yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~  102 (316)
T d2ppqa1          25 GIAEGVENSNFLLHTTKDP-LILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE  102 (316)
T ss_dssp             EECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred             cCCCCcccCeEEEEECCCc-EEEEEcCCCC-CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecc
Confidence            3556666778999877654 8899876532 233455567777776543321  1111      1122345566777766


Q ss_pred             CCCccccc--------------------ccCCCcCCc-----------------cCHHHHHHHHHHHHHHHHHHHh-CCC
Q 010434          267 NGSLDRHI--------------------FPKENKGQT-----------------FGWEKLQEIALGTARGVAYLHN-GCD  308 (511)
Q Consensus       267 ~gsL~~~l--------------------~~~~~~~~~-----------------l~~~~~~~i~~~ia~~l~yLH~-~~~  308 (511)
                      +......-                    +........                 .....+...+..+...+.-.+. ...
T Consensus       103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~  182 (316)
T d2ppqa1         103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP  182 (316)
T ss_dssp             CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred             cccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccc
Confidence            54442211                    000000000                 0001111222222233333222 345


Q ss_pred             CceecccCCcCceEEcCCCCeeeecccccc
Q 010434          309 MCILHFDIKPHNILLDHNFIPKVSDFGLAK  338 (511)
Q Consensus       309 ~~ivH~DIkp~NILl~~~~~~kl~DFGla~  338 (511)
                      .+++|+|+.++||+++.+...-|.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            789999999999999998777899999764